PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Fujita, K; Imamura, Y; Shinoda, K; Matsumoto, CS; Mizutani, Y; Hashizume, K; Mizota, A; Yuzawa, M				Fujita, Kyoko; Imamura, Yutaka; Shinoda, Kei; Matsumoto, Celso Soiti; Mizutani, Yoshihiro; Hashizume, Kouhei; Mizota, Atsushi; Yuzawa, Mitsuko			One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy	OPHTHALMOLOGY			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; CHOROIDAL VASCULAR HYPERPERMEABILITY; PIGMENT EPITHELIAL DETACHMENT; OPTICAL COHERENCE TOMOGRAPHY; FLUENCE; THICKNESS; EFFICACY; VASCULOPATHY; ASSOCIATION; EXCAVATION	Purpose: To assess the 1-year outcome of half-dose verteporfin photodynamic therapy (PDT) for patients with chronic central serous chorioretinopathy (CSC). Design: Retrospective, interventional case series with no controls. Participants: A total of 204 eyes of 204 patients with chronic CSC were studied. Methods: Fluorescein angiography (FA) and indocyanine green angiography (ICGA) were performed before PDT. The best-corrected visual acuities (BCVAs) were measured and optical coherence tomography was performed before and 1, 3, 6, 9, and 12 months after PDT. Main Outcome Measures: The main outcome measures were the resolution of the serous retinal detachment (SRD), changes in BCVA, and ocular and systemic complications at 12 months. Results: A total of 182 of 204 eyes (89.2%) had complete resolution of the SRD at 12 months after the PDT. Eleven eyes (5.4%) had a persistent SRD throughout the follow-up period, and 12 eyes (5.9%) had a recurrence of the SRD after an earlier resolution. One of the 12 eyes had a spontaneous resolution of the SRD 6 months after PDT. The mean +/- standard deviation BCVA in logarithm of the minimum angle of resolution (logMAR) units significantly improved from 0.11 +/- 0.25 before to 0.07 +/- 0.23 at 1 month, 0.02 +/- 0.23 at 3 months, 0.01 +/- 0.23 at 6 months, 0.00 +/- 0.24 at 9 months, and -0.01 +/- 0.22 at 12 months (P < 0.0001). The eyes with an SRD at 12 months were more likely to have an intermediate hyperfluorescence on ICGA (chi-square test, P < 0.001) and poorer BCVA before the half-dose PDT (Student t test, P = 0.04) than those without SRD at 12 months. None of the patients developed any systemic complications or experienced any severe visual reduction after the half-dose PDT. However, polypoidal lesion appeared in 1 eye 8 months after the PDT. Conclusions: Half-dose PDT is an effective and safe method to treat eyes with chronic CSC with an SRD. The CSC resolved and the BCVA improved significantly after PDT. Half-dose PDT was less effective for cases without intense hyperpermeability on ICGA and those with lower BCVA before the PDT. (C) 2015 by the American Academy of Ophthalmology.	[Fujita, Kyoko; Shinoda, Kei; Mizutani, Yoshihiro; Yuzawa, Mitsuko] Surugadai Nihon Univ Hosp, Dept Ophthalmol, Tokyo, Japan; [Imamura, Yutaka] Teikyo Univ, Sch Med, Univ Hosp Mizonokuchi, Dept Ophthalmol, Tokyo, Kanagawa, Japan; [Shinoda, Kei; Matsumoto, Celso Soiti; Mizota, Atsushi] Teikyo Univ, Sch Med, Dept Ophthalmol, Univ Hosp Itabashi, Tokyo 1738606, Japan; [Hashizume, Kouhei] Iwate Med Univ, Sch Med, Dept Ophthalmol, Morioka, Iwate 020, Japan	Shinoda, K (reprint author), Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, Kaga 2-11-1, Tokyo 1738606, Japan.	shinodak@med.teikyo-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan	Support of this study was provided by a grant from the Ministry of Health, Labor, and Welfare, Japan.	Imamura Y, 2011, OPHTHALMOLOGY, V118, P700, DOI 10.1016/j.ophtha.2010.08.017; Ellabban AA, 2013, AM J OPHTHALMOL, V156, P673, DOI 10.1016/j.ajo.2013.05.010; Margolis R, 2011, ARCH OPHTHALMOL-CHIC, V129, P1320, DOI 10.1001/archophthalmol.2011.148; Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Iida T, 2003, RETINA-J RET VIT DIS, V23, P1, DOI 10.1097/00006982-200302000-00001; Rouvas A, 2012, EUR J OPHTHALMOL, V22, P417, DOI 10.5301/ejo.5000051; Yannuzzi LA, 2000, OPHTHALMOLOGY, V107, P767, DOI 10.1016/S0161-6420(99)00173-6; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; Karakus SH, 2013, EYE, V27, P612, DOI 10.1038/eye.2013.24; Inoue R, 2010, AM J OPHTHALMOL, V149, P441, DOI 10.1016/j.ajo.2009.10.011; Nicolo M, 2014, AM J OPHTHALMOL, V157, P1033, DOI 10.1016/j.ajo.2014.01.022; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Ruiz-Moreno JM, 2010, ACTA OPHTHALMOL, V88, P371, DOI 10.1111/j.1755-3768.2008.01408.x; Lee PY, 2009, JPN J OPHTHALMOL, V53, P52, DOI 10.1007/s10384-008-0613-z; Nicolo M, 2012, AM J OPHTHALMOL, V153, P474, DOI 10.1016/j.ajo.2011.08.015; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; Moon JW, 2009, GRAEF ARCH CLIN EXP, V247, P1315, DOI 10.1007/s00417-009-1104-8; Chan WM, 2008, RETINA-J RET VIT DIS, V28, P85, DOI 10.1097/IAE.0b013e318156777f; Senturk F, 2011, AM J OPHTHALMOL, V151, P303, DOI 10.1016/j.ajo.2010.08.019; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Lai TYY, 2006, BRIT J OPHTHALMOL, V90, P869, DOI 10.1136/bjo.2006.090282; Fujita K, 2014, RETINA-J RET VIT DIS, V34, P964, DOI 10.1097/IAE.0000000000000027; Copete S, 2012, GRAEF ARCH CLIN EXP, V250, P803, DOI 10.1007/s00417-011-1900-9; Gass JD, 1967, AM J OPHTHALMOL S, V63, P1; Goto S, 2012, AM J OPHTHALMOL, V154, P865, DOI 10.1016/j.ajo.2012.05.001; IE D, 1993, BRIT J OPHTHALMOL, V77, P349, DOI 10.1136/bjo.77.6.349; JALKH AE, 1984, OPHTHALMOLOGY, V91, P1544; Kang NH, 2013, EYE, V27, P387, DOI 10.1038/eye.2012.273; Lim JI, 2014, OPHTHALMOLOGY, V121, P1073, DOI 10.1016/j.ophtha.2013.11.040; Lim SH, 2013, EYE, V27, P353, DOI 10.1038/eye.2013.13; Ohkuma Y, 2013, GRAEF ARCH CLIN EXP, V251, P1909, DOI 10.1007/s00417-013-2289-4; Park Han Sang, 2012, Korean J Ophthalmol, V26, P15, DOI 10.3341/kjo.2012.26.1.15; Pryds A, 2013, RETINA-J RET VIT DIS, V33, P128, DOI 10.1097/IAE.0b013e3182618bc5; Reibaldi M, 2010, AM J OPHTHALMOL, V149, P307, DOI 10.1016/j.ajo.2009.08.026; Shin JY, 2011, RETINA-J RET VIT DIS, V31, P119, DOI 10.1097/IAE.0b013e3181e378f2; Silva RM, 2013, RETINA-J RET VIT DIS, V33, P309, DOI 10.1097/IAE.0b013e3182670fbe; Smretschnig E, 2013, RETINA-J RET VIT DIS, V33, P316, DOI 10.1097/IAE.0b013e318280769c; Spaide RF, 1996, RETINA-J RET VIT DIS, V16, P203, DOI 10.1097/00006982-199616030-00004	40	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	MAR	2015	122	3					555	561		10.1016/j.ophtha.2014.09.034		7	Ophthalmology	Ophthalmology	CC2DF	WOS:000350154600025		
J	Yuzawa, M; Fujita, K; Wittrup-Jensen, KU; Norenberg, C; Zeitz, O; Adachi, K; Wang, ECY; Heier, J; Kaiser, P; Chong, V; Korobelnik, JF				Yuzawa, Mitsuko; Fujita, Kyoko; Wittrup-Jensen, Kim U.; Norenberg, Christiane; Zeitz, Oliver; Adachi, Kenji; Wang, Edward C. Y.; Heier, Jeffrey; Kaiser, Peter; Chong, Victor; Korobelnik, Jean-Francois			Improvement in Vision-Related Function with Intravitreal Aflibercept Data from Phase 3 Studies in Wet Age-Related Macular Degeneration	OPHTHALMOLOGY			English	Article							QUALITY-OF-LIFE; VISUAL FUNCTION QUESTIONNAIRE; RANDOMIZED CLINICAL-TRIAL; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; RANIBIZUMAB TREATMENT; RESOURCE UTILIZATION; NEI VFQ-25; VEGF TRAP; RESPONSIVENESS	Purpose: To evaluate the effect of intravitreal aflibercept injection on visual function in wet age-related macular degeneration (AMD). Design: Prospective, multicenter, double-masked, active-controlled, parallel-group, randomized phase 3 clinical studies (VEGF Trap-Eye: Investigation of Efficacy and Safety in Wet AMD [VIEW] 1 and 2 [clinicaltrials.gov identifiers, NCT00509795 and NCT00637377, respectively]). Participants: Patients (n = 2419) with active, treatment-naive, exudative AMD. This analysis included patients who received intravitreal aflibercept 2.0 mg every 8 weeks (2q8; n = 607) or ranibizumab 0.5 mg every 4 weeks (0.5q4; n = 595). Intervention: Patients were randomized 1: 1: 1: 1 to receive intravitreal aflibercept 2q8 (after 3 initial monthly doses), intravitreal aflibercept 2q4, intravitreal aflibercept 0.5q4, or ranibizumab 0.5q4 in the study eye. Patients in the intravitreal aflibercept 2q8 group received a sham injection alternating with active treatment. Main Outcome Measures: The 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) was administered at baseline and at weeks 12, 24, 36, and 52. The NEI VFQ-25 subscale scores were compared between intravitreal aflibercept 2q8 and ranibizumab 0.5q4 treatment arms, the approved dosing for each agent worldwide. Change in composite NEI VFQ-25 score was evaluated based on categorical change in visual acuity (worsened, unchanged, improved). Results: Baseline NEI VFQ-25 scores were similar for both treatments in both studies. Mean change from baseline to 52 weeks was similar for ranibizumab 0.5q4 and intravitreal aflibercept 2q8 across all 12 subscales, with the greatest improvements noted for mental health and general vision (9.0-11.6 points, both treatments, both studies). Improvement of 4 points or more (both treatments, both studies) also was observed for subscales near vision, distance vision, role difficulties, and dependency. Mean change from baseline to 52 weeks in NEI VFQ-25 composite score (pooled data) stratified by clinical response showed meaningful improvement only in patients who gained 5 Early Treatment Diabetic Retinopathy letters or more (7.3 and 7.8 points for intravitreal aflibercept 2q8 and ranibizumab 0.5q4, respectively). Conclusions: Visual function outcomes were similar across all NEI VFQ-25 subscales over 52 weeks for intravitreal aflibercept 2q8 and ranibizumab 0.5q4, with clinically meaningful improvement recorded in 6 of 12 subscales. (C) 2015 by the American Academy of Ophthalmology.	[Yuzawa, Mitsuko; Fujita, Kyoko] Nihon Univ, Sch Med, Dept Ophthalmol, Chiyoda Ku, Tokyo 1018309, Japan; [Wittrup-Jensen, Kim U.; Norenberg, Christiane; Zeitz, Oliver] Bayer Pharma AG, Berlin, Germany; [Zeitz, Oliver] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Augenheilkunde, Hamburg, Germany; [Adachi, Kenji; Wang, Edward C. Y.] Bayer Yakuhin Ltd, Hlth Econ & Outcomes Res, Kita Ku, Osaka, Japan; [Heier, Jeffrey] Ophthalm Consultants Boston, Boston, MA USA; [Heier, Jeffrey] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Kaiser, Peter] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Chong, Victor] Univ Oxford, Oxford Eye Hosp, Oxford, England; [Korobelnik, Jean-Francois] CHU Bordeaux, Hop Pellegrind, Serv Ophtalmol, Bordeaux, France; [Korobelnik, Jean-Francois] Univ Bordeaux Segalen, Bordeaux, France; [Korobelnik, Jean-Francois] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France	Yuzawa, M (reprint author), Nihon Univ, Sch Med, Surugadai Nihon Univ Hosp, Dept Ophthalmol,Chiyoda Ku, 1-8-13 Kandasurugadai, Tokyo 1018309, Japan.	yuzawa.mitsuko@nihon-u.ac.jp		Chong, Victor/0000-0002-7693-522X	Acucela; Seattle; Washington; Aerpio; Blue Ash; OH; Alcon; Fort Worth; TX; Alimera; Alpharetta; GA; Allergan; Irvine; CA; Bayer HealthCare; Whippany; NJ; Fovea; Cambridge; MA ( acquired by Sanofi); Genentech; South San Francisco; Genzyme; MA; GlaxoSmithKline; Middlesex, United Kingdom; LPath; San Diego; Neovista; San Francisco; Notal Vision; Tel Aviv, Israel; Novartis; Basel, Switzerland; Ohr Pharmaceutical, New York, NY; Ophthotech, New York, NY; Paloma, Nagoya, Aichi, Japan; Regeneron Pharmaceuticals, Tarrytown, NY; Lecturer - Bayer HealthCare; Heidelberg; Ladenburg, Germany; Novartis International AG, Basel, Switzerland; Bayer Pharma AG, Berlin, Germany	J.H.: Consultant - Acucela, Seattle, WA, Aerpio, Blue Ash, OH, Alimera, Alpharetta, GA, Allergan, Irvine, CA, Bausch & Lomb, Bridgewater, NJ, Bayer HealthCare, Whippany, NJ, Dutch Ophthalmic, Exeter, NH, Endo Optiks, Little Silver, NJ, Forsight, Long Grove, IL, Genzyme, Cambridge, MA, Heidelberg Engineering, Carlsbad, CA, Kala Pharmaceuticals, Waltham, MA, Kanghong, Chengdu, China, LPath, San Diego, CA, Nicox, Fort Worth, TX, Notal Vision, Tel Aviv, Israel, Ohr Pharmaceutical, New York, NY, Ophthotech, New York, NY, Oraya, Newark, CA, QLT, Vancouver, BC, Regeneron Pharmaceuticals, Rensselaer, NY, Roche, Nutley, NJ, Sequenom, San Diego, CA, Thrombogenics, Leuven, Belgium, Vertex, Boston, MA, Xcovery, West Palm Beach, FL; financial support - Acucela, Seattle, Washington, Aerpio, Blue Ash, OH, Alcon, Fort Worth, TX, Alimera, Alpharetta, GA, Allergan, Irvine, CA, Bayer HealthCare, Whippany, NJ, Fovea, Cambridge, MA (acquired by Sanofi), Genentech, South San Francisco, CA, Genzyme, Cambridge, MA, GlaxoSmithKline, Middlesex, United Kingdom, LPath, San Diego, CA, Neovista, San Francisco, CA, Notal Vision, Tel Aviv, Israel, Novartis, Basel, Switzerland, Ohr Pharmaceutical, New York, NY, Ophthotech, New York, NY, Paloma, Nagoya, Aichi, Japan, Regeneron Pharmaceuticals, Tarrytown, NY; Travel support - Regeneron Pharmaceuticals, Tarrytown, NY.; V.C.: Consultant - Allergan, Irvine, CA, Bayer HealthCare, Whippany, NJ, Novartis, Basel, Switzerland, Quantel, New York, NY; Financial support - Allergan, Irvine, CA, Novartis International AG, Basel, Switzerland; Lecturer - Bayer HealthCare, Whippany, NJ, Heidelberg, Ladenburg, Germany, Novartis International AG, Basel, Switzerland; Travel support - Bayer HealthCare, Whippany, NJ.; Supported by Bayer Pharma AG, Berlin, Germany. The sponsor or funding organization participated in study design, data collection, data management, data analysis, and approval of the manuscript.	AMD Alliance International, GLOB EC COST VIS IMP; Chang TS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1460, DOI 10.1001/archopht.125.11.1460; Marella M, 2010, INVEST OPHTH VIS SCI, V51, P2878, DOI 10.1167/iovs.09-4494; [Anonymous], 2012, EYLEA PRESCR INF; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Berdeaux GH, 2005, AM J OPHTHALMOL, V139, P271, DOI 10.1016/j.ajo.2004.09.028; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; Bressler NM, 2009, ARCH OPHTHALMOL-CHIC, V127, P13, DOI 10.1001/archophthalmol.2008.562; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Soubrane G, 2007, ARCH OPHTHALMOL-CHIC, V125, P1249, DOI 10.1001/archopht.125.9.1249; Suner IJ, 2009, INVEST OPHTH VIS SCI, V50, P3629, DOI 10.1167/iovs.08-3225; Stein JD, 2003, BRIT J OPHTHALMOL, V87, P8, DOI 10.1136/bjo.87.1.8; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; Leys A, 2008, EYE, V22, P792, DOI 10.1038/sj.eye.6702900; Bressler NM, 2010, OPHTHALMOLOGY, V117, P747, DOI 10.1016/j.ophtha.2009.09.002; Brown Gary C, 2005, Trans Am Ophthalmol Soc, V103, P173; Cahill MT, 2005, OPHTHALMOLOGY, V112, P144, DOI 10.1016/j.ophtha.2004.06.035; Hubbard B, 2004, AM J OPHTHALMOL, V138, P91, DOI 10.1016/j.ajo.2004.02.011; European Medicines Agency, EMEA EYL AUTH DET; Heier JS, 2013, OPHTHALMOLOGY, V120, P209; Lindblad AS, 2005, ARCH OPHTHALMOL-CHIC, V123, P1207; Linder M, 1999, ARCH OPHTHALMOL-CHIC, V117, P1611; Miskala PH, 2003, ARCH OPHTHALMOL-CHIC, V121, P531; National Eye Institute, NAT EYE I 25 IT VIS; Orr P, 2011, INVEST OPHTH VIS SCI, V52, P3354, DOI 10.1167/iovs.10-5645; Suzukamo Yoshimi, 2005, Health Qual Life Outcomes, V3, P65, DOI 10.1186/1477-7525-3-65; Yanagisawa M, 2011, OPHTHALMIC RES, V45, P47, DOI 10.1159/000316135; Yuzawa Mitsuko, 2013, Clin Ophthalmol, V7, P1325, DOI 10.2147/OPTH.S45248	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	MAR	2015	122	3					571	578		10.1016/j.ophtha.2014.09.024		8	Ophthalmology	Ophthalmology	CC2DF	WOS:000350154600027		
J	Katsuragi, J; Sasho, T; Yamaguchi, S; Sato, Y; Watanabe, A; Akagi, R; Muramatsu, Y; Mukoyama, S; Akatsu, Y; Fukawa, T; Endo, J; Hoshi, H; Yamamoto, Y; Sasaki, T; Takahashi, K				Katsuragi, J.; Sasho, T.; Yamaguchi, S.; Sato, Y.; Watanabe, A.; Akagi, R.; Muramatsu, Y.; Mukoyama, S.; Akatsu, Y.; Fukawa, T.; Endo, J.; Hoshi, H.; Yamamoto, Y.; Sasaki, T.; Takahashi, K.			Hidden osteophyte formation on plain X-ray is the predictive factor for development of knee osteoarthritis after 48 months - data from the Osteoarthritis Initiative	OSTEOARTHRITIS AND CARTILAGE			English	Article						Intercondylar notch; Magnetic resonance imaging; Osteoarthritis; Osteoarthritis Initiative; Osteophyte formation; Pre-radiographic osteoarthritis	QUALITY-OF-LIFE; JOINT SPACE; SCORING SYSTEM; RHEUMATIC CONDITIONS; SUBCHONDRAL BONE; PROPENSITY SCORE; MRI ASSESSMENT; GROWTH-FACTOR; PREVALENCE; ASSOCIATION	Objective: To examine whether the detection of osteophytes anywhere in the knee could serve as a pre-radiographic biomarker for osteoarthritis (OA) development. Methods: Baseline magnetic resonance imaging (MRIs) of 132 participants in the Osteoarthritis Initiative (OAI) were studied. Based on radiographs, 66 knees were assessed as osteoarthritis-free (no-osteoarthritis [NOA], or Kellgren/Lawrence [K/L] severity grade 0/1 both at baseline and 48 months), and another 66 knees were assessed as having radiographic OA changes (pre-radiographic osteoarthritis [PROA], or with K/L grade 0/1 at baseline and grade >= 2 at 48 months). Using baseline MRI data, we examined eight sites of osteophyte formation: the medial and lateral femoral condyle (MFC and LFC, respectively); medial and lateral tibial plateau (MTP and LTP, respectively); medial and lateral facets of the patellofemoral joint (PM and PL, respectively); tibial spine (TS); and femoral intercondylar notch (IC). Knee joint osteophyte size was assessed via the 8-point marginal osteophytes item of the whole-organ magnetic resonance imaging score (WORMS). The frequencies and distributions of osteophytes were compared between groups. Results: Mild-size osteophytes (defined as score >= 2) were observed more frequently at the MFC (P = 0.00278), MTP (P = 0.0046), TS (P = 0.0146), PM (P < 0.0001), PL (P = 0.0012), and IC (P < 0.0001) in PROA knees than in NOA knees. Moderate-size osteophytes (defined as score >= 4) were more frequently observed in PROA knees than in NOA knees only at the IC (P < 0.0001). Conclusion: Knees with osteophyte formation at the IC, even those of K/L severity grade 0/1, are at risk for the development of radiographic OA by 48 months. (C) 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Katsuragi, J.; Sasho, T.; Yamaguchi, S.; Akagi, R.; Muramatsu, Y.; Mukoyama, S.; Akatsu, Y.; Fukawa, T.; Endo, J.; Hoshi, H.; Yamamoto, Y.; Sasaki, T.; Takahashi, K.] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba 2608670, Japan; [Sato, Y.] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Watanabe, A.] Chiba Univ, Grad Sch Med, Div Radiol, Dept Gen Med Serv, Chiba 2608670, Japan	Katsuragi, J (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	joe_katsuragi@hotmail.com; sasho@faculty.chiba-u.jp; y-satoshi@mvb.biglobe.ne.jp; yasu@faculty.chiba-u.jp; atsuyan1@chiba-u.jp; ryuichiro.akagi@gmail.com; yt.muramatsu@gmail.com; muko.524729@gmail.com; kkaazzuu54@yahoo.co.jp; fukawataisuke0625@yahoo.co.jp; orthopaedics@hotmail.co.jp; hiorokohoshi@yahoo.co.jp; yo_hey210@hotmail.com; t.sasaki020581@gmail.com; 19501114@faculty.chiba-u.jp			Comprehensive Research on Aging and Health, Health and Labor Sciences Research Grants of Japan; National Institutes of Health (NIH)	The OAI dataset is for public use; this manuscript does not necessarily reflect the opinions or views of the OAI investigators, the National Institutes of Health (NIH), or the private funding partners.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Guermazi A, 2012, SKELETAL RADIOL, V41, P179, DOI 10.1007/s00256-011-1142-2; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ning L, 2011, INT ORTHOP, V35, P831, DOI 10.1007/s00264-010-1045-1; Cotofana S, 2013, OSTEOARTHR CARTILAGE, V21, P1214, DOI 10.1016/j.joca.2013.04.001; Roemer FW, 2010, OSTEOARTHR CARTILAGE, V18, P1269, DOI 10.1016/j.joca.2010.07.008; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7; Peterfy CG, 2008, OSTEOARTHR CARTILAGE, V16, P1433, DOI 10.1016/j.joca.2008.06.016; Yelin E, 2007, ARTHRITIS RHEUM, V56, P1397, DOI 10.1002/art.22565; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Hayashi D, 2014, OSTEOARTHR CARTILAGE, V22, P76, DOI 10.1016/j.joca.2013.10.007; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Hunter DJ, 2008, ANN RHEUM DIS, V67, P206, DOI 10.1136/ard.2006.066183; Salaffi F, 2005, AGING CLIN EXP RES, V17, P255; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Muraki S, 2011, ARTHRITIS RHEUM-US, V63, P3859, DOI 10.1002/art.30641; Bedson J, 2005, FAM PRACT, V22, P103, DOI 10.1093/fampra/cmh700; MacLean CH, 1998, J RHEUMATOL, V25, P2213; Eckstein F, 2006, NMR BIOMED, V19, P822, DOI 10.1002/nbm.1063; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Sakao K, 2009, J ORTHOP SCI, V14, P738, DOI 10.1007/s00776-009-1401-4; Eckstein F, 2006, ANN RHEUM DIS, V65, P433, DOI 10.1136/ard.2005.039370; Kornaat PR, 2005, SKELETAL RADIOL, V34, P95, DOI 10.1007/s00256-004-0828-0; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Link TM, 2003, RADIOLOGY, V226, P373, DOI 10.1148/radiol.2262012190; Barker K, 2004, CLIN REHABIL, V18, P793, DOI 10.1191/0269215504cr754oa; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Boegard T, 1998, ANN RHEUM DIS, V57, P401, DOI 10.1136/ard.57.7.401; Conaghan PG, 2006, OSTEOARTHR CARTILAGE, V14, pA87, DOI 10.1016/j.joca.2006.02.028; Conaghan PG, 2006, OSTEOARTHR CARTILAGE, V14, pA116, DOI 10.1016/j.joca.2006.03.011; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Panzer S, 2012, SKELETAL RADIOL, V41, P1597, DOI 10.1007/s00256-012-1445-y; Parsons LS, P 26 ANN SAS US GROU, DOI www2. sas. com/ proceedings/ sugi26/ p214- 26. pdf.; Roemer FW, 2012, ARTHRITIS RHEUM-US, V64, P429, DOI 10.1002/art.33344; Sjolander A, 2009, STAT MED, V28, P1420; Sjolander A, 2009, STAT MED, V28, P1416, DOI 10.1002/sim.3532; Wolfe F, 2002, J RHEUMATOL, V29, P2597	40	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	MAR	2015	23	3					383	390		10.1016/j.joca.2014.11.026		8	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CB9PF	WOS:000349963300007		
J	Fujiwara, K; Furuta, Y; Fukuda, S				Fujiwara, Keishi; Furuta, Yasushi; Fukuda, Satoshi			Idiopathic Oculostapedial Synkinesis without History of Facial Nerve Palsy	OTOLOGY & NEUROTOLOGY			English	Article						Facial nerve; Muscular tinnitus; Oculostapedial synkinesis	MIDDLE-EAR MYOCLONUS; EYELID BLINKING; BELLS-PALSY; TINNITUS; CLOSURE	Objective: To report a case of idiopathic oculostapedial synkinesis without facial nerve disorder. Patient: A 30-year-old woman with tinnitus synchronous with eye closure is presented. The patient had no history of facial nerve disorder. Result: An impedance audiometer, in the absence of an auditory stimulus, was used to record tympanic membrane compliance without sound stimulation, revealing decreased compliance in the concomitant with eye blinking. Her symptoms disappeared spontaneously, so no intervention was undertaken. Conclusion: Although oculostapedial synkinesis is often observed as one of the sequelae of facial nerve palsy, idiopathic oculostapedial synkinesis is very rare. The use of an impedance audiometer in the absence of an auditory stimulus is very useful for demonstrating objective changes in the compliance of the tympanic membrane. It is assumed that the cause of the synkinesis in our case was abnormal transmission of signals for orbicularis oculi muscle to the stapedial and orbicularis oris muscles rather than misdirected regenerating fibers. Resection of the stapedial muscle tendon should be considered if her symptoms recur.	[Fujiwara, Keishi; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan; [Furuta, Yasushi] Teine Keijinkai Hosp, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan	Fujiwara, K (reprint author), N15W7,Kitaku, Sapporo, Hokkaido, Japan.	boron700@med.hokudai.ac.jp					Moran CJ, 1996, LARYNGOSCOPE, V106, P1491, DOI 10.1097/00005537-199612000-00009; Donne AJ, 2000, J LARYNGOL OTOL, V114, P135; Hidaka H, 2013, OTOL NEUROTOL, V34, P1552, DOI 10.1097/MAO.0000000000000126; Howsam GD, 2005, J LARYNGOL OTOL, V119, P489; Kim BG, 2013, AURIS NASUS LARYNX, V40, P518, DOI 10.1016/j.anl.2012.11.007; Lee GH, 2012, LARYNGOSCOPE, V122, P2071, DOI 10.1002/lary.23420; Liu HB, 2011, CLIN NEUROL NEUROSUR, V113, P57, DOI 10.1016/j.clineuro.2010.07.022; Murakami S, 1984, Ann Otol Rhinol Laryngol Suppl, V111, P3; Ohki M, 2012, OTOL NEUROTOL, V33, P267, DOI 10.1097/MAO.0b013e318241c25d; RAJAH V, 1992, J LARYNGOL OTOL, V106, P44, DOI 10.1017/S0022215100118560; THOMANDER L, 1981, ACTA OTO-LARYNGOL, V92, P221, DOI 10.3109/00016488109133259; WATANABE I, 1974, ORL J OTO-RHINO-LARY, V36, P217	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	MAR	2015	36	3					510	512				3	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CB6XI	WOS:000349769700029		
J	Saito, T; Ito, T; Ito, Y; Kato, Y; Manabe, Y; Narita, N				Saito, Takehisa; Ito, Tetsufumi; Ito, Yumi; Kato, Yuji; Manabe, Yasuhiro; Narita, Norihiko			Degeneration Process of Fungiform Taste Buds After Severing the Human Chorda Tympani Nerve-Observation by Confocal Laser Scanning Microscopy	OTOLOGY & NEUROTOLOGY			English	Article						Chorda tympani nerve; Confocal laser scanning microscopy; Degeneration; Fungiform taste buds; Middle ear surgery	LINGUAL NERVE; EAR SURGERY; IN-VIVO; PAPILLAE; DENERVATION; MODELS	Objective: To elucidate the degeneration process of fungiform taste buds after severing the chorda tympani nerve (CTN) by confocal laser scanning microscopy in vivo. Study Design: Prospective study. Setting: University hospital. Patients: Seven consecutive patients whose CTN was severed during tympanoplasty for middle ear cholesteatoma. Intervention: Diagnostic. Main Outcome Measures: Preoperative and postoperative gustatory functions were assessed by electrogustometry (EGM). An average of 10 fungiform papillae (FP) in the midlateral region of the tongue were periodically observed, and the number of taste buds was counted using a confocal laser microscope. Among them, 2 to 3 reference FPs were scelected based on the typical form of the FP or characteristic arrangements of taste pores. Observation was performed before surgery, 1 or 2 days after surgery, 2 or 3 times a week until 2 weeks after surgery, once a week between 2 and 4 weeks, and every 2 to 4 weeks thereafter until all taste buds had disappeared. Results: EGM thresholds showed no response within 1 month after surgery in all patients. The initial change in the degeneration process was the disappearance of taste pores. The surface of taste buds became covered with epithelium. Finally, taste buds themselves atrofied and disappeared. The time course of degeneration differed depending upon individuals, each FP, and each taste bud. By employing the generalized linear mixed model under the Poisson distribution, it was calculated that all taste buds would disappear at around 50 days after surgery. Conclusion: Confocal laser scanning microscopy was useful for clarifying the degeneration process of fungiform taste buds.	[Saito, Takehisa; Ito, Yumi; Kato, Yuji; Manabe, Yasuhiro; Narita, Norihiko] Univ Fukui, Fac Med, Dept Otolaryngol Head & Neck Surg, Eiheiji, Fukui 9101193, Japan; [Saito, Takehisa; Ito, Tetsufumi] Univ Fukui, Res & Educ Program Life Sci, Eiheiji, Fukui 9101193, Japan; [Ito, Tetsufumi] Univ Fukui, Fac Med, Dept Anat, Eiheiji, Fukui 9101193, Japan	Saito, T (reprint author), Univ Fukui, Fac Med, Dept Otolaryngol Head & Neck Surg, Matsuoka Shimoaizuki 23-3, Eiheiji, Fukui 9101193, Japan.	takehisa@u-fukui.ac.jp			Ministry of Education, Science and Culture, Japan [24592543]	This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 24592543) from the Ministry of Education, Science and Culture, Japan.	Akaike H., 1973, P 2 INT S INF THEOR, P267; Michael P, 2007, OTOLARYNG HEAD NECK, V136, P978, DOI 10.1016/j.otohns.2006.12.022; Saito T, 2011, ANN OTO RHINOL LARYN, V120, P300; Mahendran S, 2005, EUR ARCH OTO-RHINO-L, V262, P482, DOI 10.1007/s00405-004-0854-5; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.2307/2290687; CHEAL M, 1977, J COMP NEUROL, V172, P609, DOI 10.1002/cne.901720405; FARBMAN AI, 1969, J EMBRYOL EXP MORPH, V22, P55; Guagliardo NA, 2007, J COMP NEUROL, V504, P206, DOI 10.1002/cne.21436; Hard af Segerstad C, 1989, CHEM SENSES, V14, P335; Just T, 2009, J LARYNGOL OTOL, V123, P1125, DOI 10.1017/S0022215109005507; Just T, 2005, LARYNGOSCOPE, V115, P2178, DOI 10.1097/01.MLG.0000181502.07160.86; Just T, 2005, ORL J OTO-RHINO-LARY, V67, P207, DOI 10.1159/000087320; MILLER IJ, 1974, J COMP NEUROL, V158, P155, DOI 10.1002/cne.901580204; NAKASHIMA T, 1990, BRAIN RES, V533, P321, DOI 10.1016/0006-8993(90)91356-L; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OAKLEY B, 1993, MICROSC RES TECHNIQ, V26, P187, DOI 10.1002/jemt.1070260302; Ohishi Y, 2000, J LARYNGOL OTOL, V114, P576; Saito T, 2001, LARYNGOSCOPE, V111, P2064, DOI 10.1097/00005537-200111000-00037; Saito T, 2011, ANN OTO RHINOL LARYN, V120, P713; Saito T, 2014, OTOL NEUROTOL, V35, pE110, DOI 10.1097/MAO.0000000000000223; Srur E, 2011, AURIS NASUS LARYNX, V38, P512, DOI 10.1016/j.anl.2010.10.011; Srur E, 2010, AURIS NASUS LARYNX, V37, P449, DOI 10.1016/j.anl.2009.11.010; Tomita H, 1986, Auris Nasus Larynx, V13 Suppl 1, pS1	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	MAR	2015	36	3					539	544				6	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CB6XI	WOS:000349769700034		
J	Kuboki, Y; Shimizu, K; Hatori, T; Yamamoto, M; Shibata, N; Shiratori, K; Furukawa, T				Kuboki, Yuko; Shimizu, Kyoko; Hatori, Takashi; Yamamoto, Masakazu; Shibata, Noriyuki; Shiratori, Keiko; Furukawa, Toru			Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas	PANCREAS			English	Article						pancreatic cancer; GNAS; KRAS; beta-catenin; SMAD4; TP53	FREQUENT GNAS MUTATIONS; SOMATIC MUTATIONS; BETA-CATENIN; K-RAS; TUMORS; EXPRESSION; PIK3CA; CLASSIFICATION; ACTIVATION; CONSENSUS	Objectives: We aimed to identify molecular biomarkers for assessing the progression of intraductal papillary mucinous neoplasm of the pancreas (IPMN). Methods: We retrospectively investigated molecular aberrations and their associations with clinicopathological features in 172 IPMNs. Results: GNAS and KRAS mutations were detected in 48% and 56% of IPMNs, respectively. No mutations of EGFR, PIK3CA GNAO1, GNAQ, or GNAI2 were observed. Significant associations were observed between IPMN morphological types and GNAS mutations, KRAS mutations, the expression of phosphorylated MAPK (pMAPK), AKT, and phosphorylated AKT (pAKT), nuclear accumulation of beta-catenin, SMAD4 loss, and TP53 overexpression; histological grades and the expression of EGFR, pMAPK, AKT, and pAKT, the nuclear beta-catenin, SMAD4 loss, and TP53 overexpression; invasive phenotypes and KRAS mutations, the nuclear beta-catenin, and SMAD4 loss; and prognosis and SMAD4 loss and TP53 overexpression. Multivariate analysis to compare prognostic impacts of multiple molecular features revealed that TP53 overexpression was an independent prognostic factor (P = 0.030; hazard ratio, 5.533). Conclusions: These results indicate that mutations in GNAS and KRAS, the expression of EGFR and pMAPK, the nuclear beta-catenin, SMAD4 loss, and TP53 overexpression may be relevant for assessing the clinical course of IPMN, including its progression into different morphological types, invasion, and prognosis.	[Kuboki, Yuko; Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Kuboki, Yuko; Shimizu, Kyoko; Shiratori, Keiko] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo 1628666, Japan; [Hatori, Takashi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Dept Surg Gastroenterol, Inst Gastroenterol, Tokyo 1628666, Japan; [Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan; [Furukawa, Toru] Tokyo Womens Med Univ, Dept Surg Pathol, Tokyo 1628666, Japan	Furukawa, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	furukawa.toru@twmu.ac.jp			Pancreas Research Foundation of Japan; Yoshioka Hiroto Research Fund	This study was supported by Pancreas Research Foundation of Japan and Yoshioka Hiroto Research Fund.	Adsay NV, 2010, WHO CLASSIFICATION T, P304; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Garcia-Carracedo D, 2013, CLIN CANCER RES, V19, P6830, DOI 10.1158/1078-0432.CCR-13-0624; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Garcia-Marcos M, 2011, ONCOGENE, V30, P2691, DOI 10.1038/onc.2010.645; Xiao HD, 2011, J PATHOL, V224, P508, DOI 10.1002/path.2875; FURUKAWA T, 1992, CANCER, V70, P1505, DOI 10.1002/1097-0142(19920915)70:6<1505::AID-CNCR2820700611>3.0.CO;2-D; Chadwick B, 2009, APPL IMMUNOHISTO M M, V17, P31, DOI 10.1097/PAI.0b013e31817c02c6; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Matthaei H, 2012, ANN SURG, V255, P326, DOI 10.1097/SLA.0b013e3182378a18; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Nishikawa G, 2013, BRIT J CANCER, V108, P951, DOI 10.1038/bjc.2013.47; Yamaguchi H, 2011, AM J SURG PATHOL, V35, P1812, DOI 10.1097/PAS.0b013e31822769a0; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Chetty R, 2006, HUM PATHOL, V37, P212, DOI 10.1016/j.humpath.2005.11.002; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Biankin AV, 2002, GUT, V50, P861, DOI 10.1136/gut.50.6.861; Schonleben F, 2006, CLIN CANCER RES, V12, P3851, DOI 10.1158/1078-0432.CCR-06-0292; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Japanese Pancreas Society, 2009, GEN RUL STUD PANCR C; Komatsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087875; Kuboki Y, 2010, MODERN PATHOL, V23, P1127, DOI 10.1038/modpathol.2010.97; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Monzen M, 2013, PANCREATOLOGY, V13, P369, DOI 10.1016/j.pan.2013.06.003; Satoh K, 1996, PANCREAS, V12, P362, DOI 10.1097/00006676-199605000-00007; SESSA F, 1994, VIRCHOWS ARCH, V425, P357; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamada M, 2012, J PATHOL, V228, P113, DOI 10.1002/path.4012	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAR	2015	44	2					227	235				9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB6XF	WOS:000349769400009		
J	Ideno, N; Ohtsuka, T; Matsunaga, T; Kimura, H; Watanabe, Y; Tamura, K; Aso, T; Aishima, S; Miyasaka, Y; Ohuchida, K; Ueda, J; Takahata, S; Oda, Y; Mizumoto, K; Tanaka, M				Ideno, Noboru; Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Tamura, Koji; Aso, Teppei; Aishima, Shinichi; Miyasaka, Yoshihiro; Ohuchida, Kenoki; Ueda, Junji; Takahata, Shunichi; Oda, Yoshinao; Mizumoto, Kazuhiro; Tanaka, Masao			Clinical Significance of GNAS Mutation in Intraductal Papillary Mucinous Neoplasm of the Pancreas With Concomitant Pancreatic Ductal Adenocarcinoma	PANCREAS			English	Article						intraductal papillary mucinous neoplasm of the pancreas; pancreatic ductal adenocarcinoma; GNAS mutation	INTERNATIONAL CONSENSUS GUIDELINES; FOLLOW-UP; INTRAEPITHELIAL NEOPLASIA; REMNANT PANCREAS; FAMILY-HISTORY; CARCINOMA; CANCER; IPMN; JUICE; MANAGEMENT	Objective: The aims of this study were to investigate the GNAS mutational status in pancreatic intraductal papillary mucinous neoplasm (IPMN) with and without distinct pancreatic ductal adenocarcinoma (PDAC) and to evaluate the significance of GNAS analysis using duodenal fluid (DF) in patients with IPMN. Methods: The clinicopathologic features of 110 patients with IPMN including 16 with distinct PDAC were reviewed. The GNAS status in the IPMN tissue and 23 DF specimens was assessed by sensitive mutation scanning methods. Results: The GNAS mutation rate in IPMN with distinct PDAC was significantly lower than that in IPMN without PDAC (4/16, 25%, vs 61/94, 65%; P = 0.0047). By multivariate analysis, GNAS wild-type and gastric type IPMNs were significantly associated with distinct PDAC. Of 45 GNAS wild-type IPMNs, 10 (43%) of 23 gastric type IPMNs had distinct PDAC, whereas only 2 (9%) of 22 non-gastric type IPMNs had distinct PDAC (P = 0.017). The GNAS status in DF was consistent with that in tissue in 21 (91%) of 23 patients. Conclusions: Distinct PDACs frequently develop in the pancreas with gastric type IPMN without GNAS mutations. Duodenal fluid DNA test would predict the GNAS status of IPMN, whereas the detection of the gastric subtype using noninvasive test remains to be determined.	[Ideno, Noboru; Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Tamura, Koji; Aso, Teppei; Miyasaka, Yoshihiro; Ohuchida, Kenoki; Ueda, Junji; Takahata, Shunichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Aishima, Shinichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	masaotan@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293285]	This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 25293285).	Adsay NV, 2010, WHO CLASSIFICATION T, P304; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Mayo SC, 2012, J AM COLL SURGEONS, V214, P33, DOI 10.1016/j.jamcollsurg.2011.09.022; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c; Kanno A, 2010, J GASTROENTEROL, V45, P952, DOI 10.1007/s00535-010-0238-0; Kanda M, 2013, CLIN GASTROENTEROL H, V11, P719, DOI 10.1016/j.cgh.2012.11.016; Tamura K, 2014, ANN SURG, V259, P360, DOI 10.1097/SLA.0b013e3182a690ff; Tanno S, 2010, PANCREATOLOGY, V10, P173, DOI 10.1159/000231982; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Mori Y, 2013, PANCREAS, V42, P187, DOI 10.1097/MPA.0b013e3182649979; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Fritz S, 2012, ANN SURG, V256, P313, DOI 10.1097/SLA.0b013e31825d355f; Ohtsuka T, 2012, AM J SURG, V204, P44, DOI 10.1016/j.amjsurg.2011.04.007; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Hara T, 2013, ANN SURG, V257, P1103, DOI 10.1097/SLA.0b013e318281b824; Sawai Y, 2010, ENDOSCOPY, V42, P1077, DOI 10.1055/s-0030-1255971; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Dal Molin M, 2013, ANN SURG ONCOL, V20, P3802, DOI 10.1245/s10434-013-3096-1; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Wong J, 2013, J GASTROINTEST SURG, V17, P78, DOI 10.1007/s11605-012-2017-0; Ohtsuka T, 2013, J HEPATO-BIL-PAN SCI, V20, P356, DOI 10.1007/s00534-012-0541-7; Kubo H, 2009, ENDOSCOPY, V41, P684, DOI 10.1055/s-0029-1214952; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Hong SM, 2012, CLIN CANCER RES, V18, P4303, DOI 10.1158/1078-0432.CCR-12-1075; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Ikeuchi N, 2010, WORLD J GASTROENTERO, V16, P1890, DOI 10.3748/wjg.v16.i15.1890; Richter A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01659; Sai JK, 2013, GASTROINTEST ENDOSC, V77, P726, DOI 10.1016/j.gie.2012.11.008; Temesvári Manna, 2011, Mol Cell Probes, V25, P130, DOI 10.1016/j.mcp.2011.01.003; Watanabe H, 1999, CANCER, V86, P1441, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1441::AID-CNCR9>3.0.CO;2-I; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	39	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAR	2015	44	2					311	320				10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB6XF	WOS:000349769400020		
J	Taniuchi, K; Furihata, M; Hanazaki, K; Iwasaki, S; Tanaka, K; Shimizu, T; Saito, M; Saibara, T				Taniuchi, Keisuke; Furihata, Mutsuo; Hanazaki, Kazuhiro; Iwasaki, Shinji; Tanaka, Kenjiro; Shimizu, Takahiro; Saito, Motoaki; Saibara, Toshiji			Peroxiredoxin 1 Promotes Pancreatic Cancer Cell Invasion by Modulating p38 MAPK Activity	PANCREAS			English	Article						antioxidant defense enzyme; pancreatic cancer; cell invasion; p38 MAPK; actin-cytoskeleton	LASER CAPTURE MICRODISSECTION; HUMAN PROSTATE-CANCER; PHOSPHOLIPASE A(2); PROTEOME ANALYSIS; KINASE; MIGRATION; CARCINOMA; IDENTIFICATION; PROLIFERATION; ACTIVATION	Objective: The aim of this study was to investigate the role of peroxiredoxin 1 (Prdx1) in the invasiveness of pancreatic ductal adenocarcinoma (PDAC) cells. Methods: Immunohistochemistry was used to determine overexpression of Prdx1 in human PDAC tissues. Immunoprecipitation and immunocytochemistry were used to determine the interaction and intracellular distribution of Prdx1 and a member of the mitogen-activated protein kinase (MAPK) family protein, p38 MAPK, in PDAC cells. Finally, immunocytochemistry and Matrigel invasion assay were used to examine the effects of Prdx1 and p38 MAPK on the formation of cell protrusions and PDAC cell invasion. Results: Prdx1 is overexpressed in human PDAC tissues. Peroxiredoxin 1 interacts with active forms of p38 MAPK, and complexes of Prdx1 and phosphorylated p38 MAPK localize at the leading edges of migrating PDAC cells. Suppression of Prdx1 decreases active p38 MAPK localized in cell protrusions and inhibits the invasiveness of PDAC cells. Consequently, suppression of Prdx1 inhibits membrane ruffling and protrusions. The p38MAPK inhibitor SB203580 also decreases the formation of membrane protrusions and inhibits invasiveness. Conclusions: Prdx1 associates with the formation of membrane protrusions through modulation of the activity of p38MAPK, which in turn promotes PDAC cell invasion.	[Taniuchi, Keisuke; Tanaka, Kenjiro; Shimizu, Takahiro; Saito, Motoaki] Kochi Univ, Sch Med, Dept Pharmacol, Nankoku, Kochi 7838505, Japan; [Furihata, Mutsuo] Kochi Univ, Sch Med, Dept Pathol, Nankoku, Kochi 7838505, Japan; [Hanazaki, Kazuhiro] Kochi Univ, Sch Med, Dept Surg, Nankoku, Kochi 7838505, Japan; [Iwasaki, Shinji; Saibara, Toshiji] Kochi Univ, Sch Med, Dept Gastroenterol & Hepatol, Nankoku, Kochi 7838505, Japan	Taniuchi, K (reprint author), Kochi Univ, Sch Med, Dept Pharmacol, Nankoku, Kochi 7838505, Japan.	ktaniuchi@kochi-u.ac.jp			KAKENHI; Pancreas Research Foundation of Japan; Japanese Foundation for Multidisciplinary Treatment of Cancer	This study was supported by the Grants-in-Aid for Scientific Research (KAKENHI) (to K.T. and S.I.), by the Pancreas Research Foundation of Japan (to K.T.), and by the Japanese Foundation for Multidisciplinary Treatment of Cancer (to K.T.).	Ai JH, 2006, PROTEOMICS, V6, P538, DOI 10.1002/pmic.200500257; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Zhang M, 2004, ONCOGENE, V23, P3080, DOI 10.1038/sj.onc.1207435; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Qi YJ, 2005, PROTEOMICS, V5, P2960, DOI 10.1002/pmic.200401175; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Ho JN, 2010, MOL CANCER THER, V9, P825, DOI 10.1158/1535-7163.MCT-09-0904; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeadbiomed.2005.02.026; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Ridley AJ, 2001, J CELL SCI, V114, P2713; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05.4446; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Baumgart M, 2005, CELL ONCOL, V27, P3; Cheng Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-191; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Kim TS, 1997, J BIOL CHEM, V272, P2542; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Taniuchi K, 2012, NEOPLASIA, V14, P440, DOI 10.1593/neo.12352	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	MAR	2015	44	2					331	340				10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB6XF	WOS:000349769400023		
J	Yamazawa, H; Murakami, T; Takeda, A; Takei, K; Furukawa, T; Nakajima, H				Yamazawa, Hirokuni; Murakami, Tomoaki; Takeda, Atsuhito; Takei, Kouta; Furukawa, Takuo; Nakajima, Hiromichi			Serum Concentration of Procollagen Type III Amino-Terminal Peptide is Increased in Patients with Successfully Repaired Coarctation of the Aorta with Left Ventricular Hypertrophy	PEDIATRIC CARDIOLOGY			English	Article						Procollagen type III amino-terminal peptide; Coarctation of the aorta; Left ventricular hypertrophy; Myocardial fibrosis; Renin-angiotensin-aldosterone system	HEART-DISEASE; BODY-SIZE; MASS; CHILDREN; HYPERTENSION; ALDOSTERONE; STIFFNESS; FIBROSIS; ADULTS	Pathological left ventricular hypertrophy (LVH) with myocardial fibrosis is an independent risk factor for cardiovascular mortality. Previous studies indicated that patients with coarctation of the aorta (CoA) have increased left ventricular mass (LVM) including LVH, even after successful CoA repair. It is unclear whether the increased LVM is pathological one with cardiac fibrosis. Group A consisted of 17 patients with successfully repaired CoA. Group B consisted of 17 postoperative subjects who matched the age and postoperative periods of group A. Group C comprised 28 subjects for the geometric standard of the left ventricle. The LVM index (LVMI) and the relative wall thickness (RWT) of group A and B were compared with the values of 17 age-matched subjects from group C. The serum concentration of procollagen type III amino-terminal peptide (P-III-P), a biomarker for myocardial fibrosis, in group A was compared with the concentration in group B. The correlations between the serum P-III-P concentration and LVMI and RWT were studied in group A and non-A group. In group A, RWT and LVMI were significantly higher than those in group C (0.37 +/- A 0.05 vs. 0.31 +/- A 0.02, p < 0.01; 44.8 +/- A 11.2 vs. 36.5 +/- A 7.6, p = 0.04, respectively), and the serum P-III-P concentration was significantly higher than that in group B (1.59 +/- A 0.74 vs. 1.07 +/- A 0.33, p = 0.04). Serum P-III-P concentrations were well correlated with RWT and LVMI (r = 0.89, p < 0.01; r = 0.63, p < 0.01, respectively) in group A. LVH in patients with successfully repaired CoA may have an abnormal pathogenesis associated with myocardial fibrosis.	[Yamazawa, Hirokuni; Takeda, Atsuhito; Takei, Kouta; Furukawa, Takuo] Hokkaido Univ Sch Med, Dept Pediat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Murakami, Tomoaki; Nakajima, Hiromichi] Chiba Childrens Hosp, Dept Pediat Cardiol, Chiba, Japan	Yamazawa, H (reprint author), Hokkaido Univ Sch Med, Dept Pediat, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	h-yamazawa@umin.org					LEVY D, 1989, ANN INTERN MED, V110, P101; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Nakahara T, 2007, CIRC J, V71, P716, DOI 10.1253/circj.71.716; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; Foster BJ, 2008, CIRCULATION, V117, P2769, DOI 10.1161/CIRCULATIONAHA.107.741157; ROBERT V, 1995, HYPERTENSION, V26, P971; MARON BJ, 1973, CIRCULATION, V47, P119; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251; Diez J, 2001, CURR OPIN CARDIOL, V16, P328, DOI 10.1097/00001573-200111000-00003; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Brili S, 1998, AM J CARDIOL, V82, P1140, DOI 10.1016/S0002-9149(98)00575-X; Díez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Eerola A, 2007, SCAND CARDIOVASC J, V41, P370, DOI 10.1080/14017430701397839; Lammi Lauri, 1999, American Journal of Respiratory and Critical Care Medicine, V159, P818; LAWRIE GM, 1981, ARCH SURG-CHICAGO, V116, P1557; Murakami T, 2005, ANN THORAC SURG, V80, P995, DOI 10.1016/j.athoracsur.2005.03.055; Ou P, 2008, AM HEART J, V155, P187, DOI 10.1016/j.ahj.2007.09.008; Sasaguri M, 2000, HYPERTENS RES, V23, P317, DOI 10.1291/hypres.23.317; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Weber KT, 2001, HYPERTENSION, V38, P588; Xu JP, 1997, AM HEART J, V134, P93, DOI 10.1016/S0002-8703(97)70111-X	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	MAR	2015	36	3					555	560		10.1007/s00246-014-1049-5		6	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CC0OA	WOS:000350034000015		
J	Sugimoto, M; Oka, H; Kajihama, A; Nakau, K; Kuwata, S; Kurishima, C; Azuma, H				Sugimoto, Masaya; Oka, Hideharu; Kajihama, Aya; Nakau, Kouichi; Kuwata, Seiko; Kurishima, Clara; Azuma, Hiroshi			Ratio between fms-like Tyrosine Kinase 1 and Placental Growth Factor in Children with Congenital Heart Disease	PEDIATRIC CARDIOLOGY			English	Article						Congenital heart disease; Soluble fms-like tyrosine kinase 1; Placental growth factor; Volume overload; Hypoxia	ACUTE MYOCARDIAL-INFARCTION; ADVERSE OUTCOMES; ANGIOGENIC FACTORS; PRESSURE-OVERLOAD; PREECLAMPSIA; FAILURE; RISK; HYPERTENSION; RECEPTOR; FONTAN	Serum levels of soluble fms-like tyrosine kinase 1 (sFlt-1), an antiangiogenic factor, and its binding protein, placental growth factor (PlGF), are altered in women with preeclampsia. Recently, the sFlt-1/PlGF ratio has been shown to predict acute coronary syndrome in adults. However, few reports have described the use of the sFlt-1/PlGF ratio for evaluating an abnormal hemodynamic load in children with congenital heart disease (CHD). The sFlt-1/PlGF ratio was determined in 20 children with atrial septal defects (ASD), 26 children with ventricular septal defects (VSD), 57 children with tetralogy of Fallot (ToF), 35 children who were Fontan candidates (Fontan), and 14 controls. The preoperative sFlt-1/PlGF ratios in the ASD, VSD, and Fontan were significantly higher than those in the controls and were significantly decreased after surgical repair in the ASD and VSD. In the ToF, the sFlt-1/PlGF ratio was highest after first-stage repair and second-highest after final-stage palliation compared with the preoperative levels. The sFlt-1/PlGF ratio was highest after first-stage repair and much lower after final-stage palliation in the Fontan. Furthermore, these ratios correlated with the degree of the ventricular volume overload and hypoxia. Our study clearly demonstrated that the sFlt-1/PlGF ratio increases with volume overload and persistent hypoxia after surgery with CHD. These findings may prove useful in the management of CHD in children.	[Sugimoto, Masaya; Oka, Hideharu; Kajihama, Aya; Nakau, Kouichi; Azuma, Hiroshi] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido 0788510, Japan; [Kuwata, Seiko; Kurishima, Clara] Saitama Med Univ, Dept Pediat Cardiol, Saitama Med Ctr, Kawagoe, Saitama, Japan	Sugimoto, M (reprint author), Asahikawa Med Univ, Dept Pediat, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	masaya5p@asahikawa-med.ac.jp					Prakash A, 2012, AM J CARDIOL, V109, P1038, DOI 10.1016/j.amjcard.2011.11.040; Sugimoto M, 2011, CIRC J, V75, P2213, DOI 10.1253/circj.CJ-10-1211; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; Ky B, 2011, J AM COLL CARDIOL, V58, P386, DOI 10.1016/j.jacc.2011.03.032; Givvimani S, 2013, ARCH PHYSIOL BIOCHEM, V119, P65, DOI 10.3109/13813455.2012.755548; Llurba E, 2014, EUR HEART J, V35, P701, DOI 10.1093/eurheartj/eht389; Onoue K, 2009, AM J CARDIOL, V104, P1478, DOI 10.1016/j.amjcard.2009.07.016; Onoue K, 2009, CIRCULATION, V120, P2470, DOI 10.1161/CIRCULATIONAHA.109.867929; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Grosse-Wortmann L, 2009, CIRC-CARDIOVASC IMAG, V2, P219, DOI 10.1161/CIRCIMAGING.108.834192; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Sugimoto M, 2009, HEART, V95, P2023, DOI 10.1136/hrt.2009.170241; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Hochholzer W, 2011, EUR HEART J, V32, P326, DOI 10.1093/eurheartj/ehq429; NAKAZAWA M, 1976, CIRCULATION, V53, P884; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Schiettecatte J, 2010, CLIN BIOCHEM, V43, P768, DOI 10.1016/j.clinbiochem.2010.02.010; Roncal C, 2010, CARDIOVASC RES, V86, P29, DOI 10.1093/cvr/cvp380; TRIEDMAN JK, 1993, J AM COLL CARDIOL, V22, P207; Matsumoto T, 2013, INTERNAL MED, V52, P1019, DOI 10.2169/internalmedicine.52.9073; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Perni U, 2012, HYPERTENSION, V59, P740, DOI 10.1161/HYPERTENSIONAHA.111.181735; Hertig A, 2010, CLIN CHIM ACTA, V411, P1591, DOI 10.1016/j.cca.2010.07.020; Kapur NK, 2011, ARTERIOSCL THROM VAS, V31, P443, DOI 10.1161/ATVBAHA.110.215897; Powers RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013263; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d; Vikholm P, 2014, INTERACT CARDIOV TH, V18, P418, DOI 10.1093/icvts/ivt547	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	MAR	2015	36	3					591	599		10.1007/s00246-014-1054-8		9	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CC0OA	WOS:000350034000020		
J	Sakazaki, S; Masutani, S; Sugimoto, M; Tamura, M; Kuwata, S; Kurishima, C; Saiki, H; Iwamoto, Y; Ishido, H; Senzaki, H				Sakazaki, Sayaka; Masutani, Satoshi; Sugimoto, Masaya; Tamura, Masanori; Kuwata, Seiko; Kurishima, Clara; Saiki, Hirofumi; Iwamoto, Yoichi; Ishido, Hirotaka; Senzaki, Hideaki			Oxygen Supply to the Fetal Cerebral Circulation in Hypoplastic Left Heart Syndrome: A Simulation Study Based on the Theoretical Models of Fetal Circulation	PEDIATRIC CARDIOLOGY			English	Article						Cerebral circulation; Congenital heart disease; Fetus; Hypoplastic left heart syndrome	GREAT-ARTERIES; BLOOD-FLOW; NEUROLOGIC STATUS; DISEASE; TRANSPOSITION; DEFECTS; DOPPLER; FETUSES; INFANTS; SURGERY	Hypoxia due to congenital heart diseases (CHDs) adversely affects brain development during the fetal period. Head circumference at birth is closely associated with neuropsychiatric development, and it is considerably smaller in newborns with hypoplastic left heart syndrome (HLHS) than in normal newborns. We performed simulation studies on newborns with CHD to evaluate the cerebral circulation during the fetal period. The oxygen saturation of cerebral blood flow in newborns with CHD was simulated according to a model for normal fetal circulation in late pregnancy. We compared the oxygen saturation of cerebral blood flow between newborns with tricuspid atresia (TA; a disease showing univentricular circulation and hypoplasia of the right ventricle), those with transposition of the great arteries (TGA; a disease showing abnormal mixing of arterial and venous blood), and those with HLHS. The oxygen saturation of cerebral blood flow in newborns with normal circulation was 75.7 %, whereas it was low (49.5 %) in both newborns with HLHS and those with TA. Although the oxygen level is affected by the blood flow through the foramen ovale, the oxygen saturation in newborns with TGA was even lower (43.2 %). These data, together with previous reports, suggest that the cerebral blood flow rate is decreased in newborns with HLHS, and the main cause was strongly suspected to be retrograde cerebral perfusion through a patent ductus arteriosus. This study provides important information about the neurodevelopmental prognosis of newborns with HLHS and suggests the need to identify strategies to resolve this unfavorable cerebral circulatory state in utero.	[Sakazaki, Sayaka; Masutani, Satoshi; Kuwata, Seiko; Kurishima, Clara; Saiki, Hirofumi; Iwamoto, Yoichi; Ishido, Hirotaka; Senzaki, Hideaki] Saitama Med Univ, Saitama Med Ctr, Div Pediat Cardiol, Kawagoe, Saitama 3508550, Japan; [Sakazaki, Sayaka; Tamura, Masanori] Saitama Med Univ, Div Neonatol, Saitama Med Ctr, Kawagoe, Saitama, Japan; [Sugimoto, Masaya] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan	Senzaki, H (reprint author), Saitama Med Univ, Saitama Med Ctr, Div Pediat Cardiol, Kawagoe, Saitama 3508550, Japan.	hsenzaki@saitama-med.ac.jp					Donofrio MT, 2003, PEDIATR CARDIOL, V24, P436, DOI 10.1007/s00246-002-0404-0; Manzar S, 2005, SAUDI MED J, V26, P453; GRAMELLINI D, 1992, OBSTET GYNECOL, V79, P416; Licht DJ, 2009, J THORAC CARDIOV SUR, V137, P529, DOI 10.1016/j.jtcvs.2008.10.025; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Rosenthal GL, 1996, AM J EPIDEMIOL, V143, P505; Limperopoulos C, 1999, PEDIATRICS, V103, P402, DOI 10.1542/peds.103.2.402; RUDOLPH AM, 1985, CIRC RES, V57, P811; Shillingford AJ, 2007, CARDIOL YOUNG, V17, P189, DOI 10.1017/S1047951107000248; Jouannic JM, 2002, ULTRASOUND OBST GYN, V20, P122, DOI 10.1046/j.1469-0705.2002.00756.x; Limperopoulos C, 2002, J PEDIATR-US, V141, P51, DOI 10.1067/mpd.2002.125227; Maeno YV, 1999, CIRCULATION, V99, P1209; Barbu D, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.029; Berg C, 2009, ULTRASOUND OBST GYN, V34, P666, DOI 10.1002/uog.7474; Johnston MV, 2007, NEW ENGL J MED, V357, P1971, DOI 10.1056/NEJMe078138; Kaltman JR, 2005, ULTRASOUND OBST GYN, V25, P32, DOI 10.1002/uog.1785; Massaro AN, 2008, BRAIN DEV-JPN, V30, P437, DOI 10.1016/j.braindev.2007.12.013; Meise C, 2001, ULTRASOUND OBST GYN, V17, P398, DOI 10.1046/j.1469-0705.2001.00397.x; Rudolph AM, 2007, PEDIATR RES, V61, P375, DOI 10.1203/pdr.0b013e318030d5b9; Saiki H, 2013, ANN THORAC SURG, V96, P1382, DOI 10.1016/j.athoracsur.2013.05.108; vanHouten JP, 1996, AM J PERINAT, V13, P47, DOI 10.1055/s-2007-994202	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	MAR	2015	36	3					677	684		10.1007/s00246-014-1064-6		8	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CC0OA	WOS:000350034000030		
J	Hashimoto, M; Aoki, Y; Saito, S; Suzuki, S				Hashimoto, Maki; Aoki, Yoshinao; Saito, Seiya; Suzuki, Shunji			Characterisation of heteroplasmic status at codon 143 of the Botrytis cinerea cytochrome b gene in a semi-quantitative AS-PCR assay	PEST MANAGEMENT SCIENCE			English	Article						additional intron; AS-PCR; Botrytis cinerea; fungicide resistance; heteroplasmy; QoI fungicide	PLASMOPARA-VITICOLA POPULATIONS; QO INHIBITOR FUNGICIDES; RESISTANCE; STROBILURIN; PATHOGENS	BACKGROUNDAn in-depth understanding of quinone outside inhibitor (QoI)-fungicide-resistant Botrytis cinerea isolates in a vineyard is expected to contribute to the development of an optimum disease management programme for the control of grape grey mould. RESULTSThe resistance and structure of the cytochrome b gene in B. cinerea collected from a Japanese vineyard were characterised. The semi-quantitative allele-specific primer-polymerase chain reaction (AS-PCR) assay developed in the present study was able to distinguish heteroplasmic status from homoplasmic status at codon 143 of the cytochrome b gene in QoI-fungicide-resistant B. cinerea from vineyards in Japan. With this assay it was demonstrated that the repeated introduction of QoI fungicide selection pressure increased the ratio of G143A-mutated cytochrome b genes in B. cinerea isolates. CONCLUSIONIt is proposed that the semi-quantitative AS-PCR assay is a reliable tool for the detection of QoI fungicide resistance and the evaluation of homoplasmic/heteroplasmic status at codon 143 of the cytochrome b gene in B. cinerea isolates. (c) 2014 Society of Chemical Industry	[Hashimoto, Maki; Aoki, Yoshinao; Suzuki, Shunji] Univ Yamanashi, Inst Enol & Viticulture, Kofu, Yamanashi 4000005, Japan; [Saito, Seiya] USDA ARS, Commod Protect & Qual Res Unit, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA	Suzuki, S (reprint author), Univ Yamanashi, Inst Enol & Viticulture, Kofu, Yamanashi 4000005, Japan.	suzukis@yamanashi.ac.jp					Grasso V, 2006, PEST MANAG SCI, V62, P465, DOI 10.1002/ps.1236; Ishii H, 2009, PEST MANAG SCI, V65, P916, DOI 10.1002/ps.1773; Samuel S, 2011, PEST MANAG SCI, V67, P1029, DOI 10.1002/ps.2226; Furuya S, 2009, PEST MANAG SCI, V65, P840, DOI 10.1002/ps.1765; Fraaije BA, 2002, PLANT PATHOL, V51, P45, DOI 10.1046/j.0032-0862.2001.00650.x; Wood PM, 2003, PEST MANAG SCI, V59, P499, DOI 10.1002/ps.655; Fillinger S, 2008, ANTIMICROB AGENTS CH, V52, P3933, DOI 10.1128/AAC.00615-08; Jiang JH, 2009, PESTIC BIOCHEM PHYS, V93, P72, DOI 10.1016/j.pestbp.2008.11.004; Banno S, 2009, PLANT PATHOL, V58, P120, DOI 10.1111/j.1365-3059.2008.01909.x; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Ishii H, 2007, PHYTOPATHOLOGY, V97, P1458, DOI 10.1094/PHYTO-97-11-1458; Keller M, 2003, PHYTOPATHOLOGY, V93, P316, DOI 10.1094/PHYTO.2003.93.3.316; Saito S, 2009, PEST MANAG SCI, V65, P197, DOI 10.1002/ps.1668; Asadollahi M, 2013, J AGR SCI TECH-IRAN, V15, P397; De Miccolis A. R. M., 2012, PEST MANAG SCI, V68, P1231; Elad Y, 2004, BOTRYTIS BIOL PATHOL; Furuya S, 2010, PEST MANAG SCI, V66, P1268, DOI 10.1002/ps.2012	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-498X	1526-4998		PEST MANAG SCI	Pest Manag. Sci.	MAR	2015	71	3					467	477		10.1002/ps.3867		11	Agronomy; Entomology	Agriculture; Entomology	CC0AV	WOS:000349998100015		
J	Inoue, T; Yoshinaga, A; Takabe, K; Yoshioka, T; Ogawa, K; Sakamoto, M; Azuma, J; Honda, Y				Inoue, Tsuyoshi; Yoshinaga, Arata; Takabe, Keiji; Yoshioka, Terutaka; Ogawa, Kazunori; Sakamoto, Masahiro; Azuma, Jun-ichi; Honda, Yoichi			In Situ Detection and Identification of Hesperidin Crystals in Satsuma Mandarin (Citrus unshiu) Peel Cells	PHYTOCHEMICAL ANALYSIS			English	Article						In situ detection; Raman microscopy; scanning electron microscopy; albedo; flavedo; flavonoid; fruit peel; hesperidin; organic crystals; Citrus unshiu	RAMAN MICROSCOPY; FLAVONOIDS; FRUIT; XYLEM	IntroductionHesperidin, a flavonoid known to have important pharmacological effects, accumulates particularly in the peels of satsuma mandarin (Citrus unshiu). Although histochemical studies have suggested that hesperidin forms crystals in some tissues of the Rutaceae and Umbelliferae, there has been no rigorous in situ detection or identification of hesperidin crystals in C. unshiu. ObjectiveTo characterise the chemical component of the crystals found in C. unshiu peels using Raman microscopy. MethodsSections of C. unshiu peels were made. The distribution and morphology of crystals in the sections were analysed microscopically. Raman microscopy was used to detect hesperidin in the sections directly. ResultsThe crystals were more abundant in immature peel and were observed particularly in areas surrounding vascular bundles, around the border between the flavedo and albedo layers and just below the epidermal cells. In the morphological analysis by scanning electron microscopy, needle-shaped crystals aggregated and formed clusters of spherical crystals. Spectra obtained by Raman microscopy of the crystals in the peel sections were consistent with those of the hesperidin standard. ConclusionThis study showed the detailed distribution of crystals in C. unshiu peels and their main component was identified using Raman microscopy to be hesperidin for the first time. Copyright (c) 2014 John Wiley & Sons, Ltd. Flavonoids produced by plants have various derivatives and the accumulation pattern of them is different with each species. Hesperidin is one of the main flavonoids accumulated in Citrus species and has been focused on its pharmacological effects. In this study, we observed numerous needle-shaped crystals in the peel cells of satsuma mandarin (Citrus unshiu) and identified the main component of the crystals to be hesperidin by in situ detection using Raman microscopy for the first time.	[Inoue, Tsuyoshi; Sakamoto, Masahiro; Honda, Yoichi] Kyoto Univ, Grad Sch Agr, Div Environm Sci & Technol, Sakyo Ku, Kyoto 6068502, Japan; [Yoshinaga, Arata; Takabe, Keiji] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kyoto 6068502, Japan; [Yoshioka, Terutaka] Inst Fruit Tree Sci NIFTS, Natl Agr & Food Res Org, Citrus Res Div, Shimizu Ku, Shizuoka 4240292, Japan; [Ogawa, Kazunori] NIFTS, Grape & Persimmon Res Div, Higashihiroshima 7392494, Japan; [Azuma, Jun-ichi] Osaka Univ, Grad Sch Engn, Div Appl Chem, Suita, Osaka 5650871, Japan	Honda, Y (reprint author), Kyoto Univ, Grad Sch Agr, Div Environm Sci & Technol, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	honda@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science for Young Scientists	A Research Fellowship was provided to T. Inoue by the Japan Society for the Promotion of Science for Young Scientists.	Alves E, 2009, SCI AGR, V66, P218, DOI 10.1590/S0103-90162009000200011; Gierlinger N, 2007, SPECTROSC-INT J, V21, P69; Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074; Inoue T, 2010, FOOD CHEM, V123, P542, DOI 10.1016/j.foodchem.2010.04.051; CASTILLO J, 1992, PLANT PHYSIOL, V99, P67, DOI 10.1104/pp.99.1.67; Nogata Y, 2006, BIOSCI BIOTECH BIOCH, V70, P178, DOI 10.1271/bbb.70.178; Moriguchi T, 2001, PHYSIOL PLANTARUM, V111, P66, DOI 10.1034/j.1399-3054.2001.1110109.x; Matas AJ, 2010, J EXP BOT, V61, P3321, DOI 10.1093/jxb/erq153; Tozuka Y, 2011, EUR J PHARM BIOPHARM, V79, P559, DOI 10.1016/j.ejpb.2011.07.006; Hernandez I, 2010, PLANT SCI, V179, P297, DOI 10.1016/j.plantsci.2010.06.001; Williams CA, 2004, NAT PROD REP, V21, P539, DOI 10.1039/b311404j; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Baranska M, 2011, VIB SPECTROSC, V56, P166, DOI 10.1016/j.vibspec.2011.02.003; Baranska M, 2006, ANAL CHEM, V78, P7716, DOI 10.1021/ac061123q; Cornara L, 2009, PLANT BIOSYST, V143, P283, DOI 10.1080/11263500902722527; Gamsjaeger S, 2011, J RAMAN SPECTROSC, V42, P1240, DOI 10.1002/jrs.2860; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; HOMMA Y, 1992, PHYTOPATHOLOGY, V82, P310, DOI 10.1094/Phyto-82-310; IWASHINA T, 1988, BOT MAG TOKYO, V101, P175, DOI 10.1007/BF02488894; Lees SH, 2000, FOOD ANAL HPLC, P775; Macnish AJ, 2003, AUST J BOT, V51, P565, DOI 10.1071/BT03035; Majumdar S, 2009, PHARM RES-DORDR, V26, P1217, DOI 10.1007/s11095-008-9729-6; Metcalfes CR, 1983, ANATOMY DICOTYLEDONS, V2, P82; Morikawa Y, 2010, HOLZFORSCHUNG, V64, P61, DOI 10.1515/HF.2010.015; Socratess G, 2001, INFRARED RAMAN CHARA, P157	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0344	1099-1565		PHYTOCHEM ANALYSIS	Phytochem. Anal.	MAR-APR	2015	26	2					105	110		10.1002/pca.2541		6	Biochemical Research Methods; Plant Sciences; Chemistry, Analytical	Biochemistry & Molecular Biology; Plant Sciences; Chemistry	CB9PG	WOS:000349963400002		
J	Tazoe, Y; Santrucek, J				Tazoe, Youshi; Santrucek, Jiri			Superimposed behaviour of g(m) under ABA-induced stomata closing and low CO2	PLANT CELL AND ENVIRONMENT			English	Editorial Material							CARBON-ISOTOPE DISCRIMINATION; MESOPHYLL CONDUCTANCE; ABSCISIC-ACID; GAS-EXCHANGE; DIFFUSION; LEAVES; PHOTOSYNTHESIS; PLANTS		[Tazoe, Youshi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Santrucek, Jiri] Univ South Bohemia, Dept Expt Plant Biol, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Santrucek, Jiri] Biol Ctr ASCR, Inst Plant Mol Biol, Ceske Budejovice 37005, Czech Republic	Tazoe, Y (reprint author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.	utazoe@m.tohoku.ac.jp	Santrucek, Jiri/G-9776-2014; Tazoe, Youshi/K-5773-2015	Santrucek, Jiri/0000-0003-0430-5795; 			Uehlein N, 2012, PLANT CELL ENVIRON, V35, P1077, DOI 10.1111/j.1365-3040.2011.02473.x; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Tazoe Y, 2011, PLANT CELL ENVIRON, V34, P580, DOI 10.1111/j.1365-3040.2010.02264.x; Schaufele R, 2011, PLANT CELL ENVIRON, V34, P127, DOI 10.1111/j.1365-3040.2010.02230.x; Tazoe Y, 2009, J EXP BOT, V60, P2291, DOI 10.1093/jxb/erp035; Boyer JS, 1997, PLANT PHYSIOL, V114, P185; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281; Farquhar GD, 2012, PLANT CELL ENVIRON, V35, P1221, DOI 10.1111/j.1365-3040.2012.02484.x; Vrabl D, 2009, J EXP BOT, V60, P2315, DOI 10.1093/jxb/erp115; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; Buckley TN, 1997, PLANT CELL ENVIRON, V20, P867, DOI 10.1046/j.1365-3040.1997.d01-128.x; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Mizokami Y., 2014, PLANT CELL ENVIRON, V38, P388; SHARKEY TD, 1991, PLANTA, V185, P287, DOI 10.1007/BF00201046; TERASHIMA I, 1992, PHOTOSYNTH RES, V31, P195, DOI 10.1007/BF00035537; Tholen D, 2008, PLANT CELL ENVIRON, V31, P1688, DOI 10.1111/j.1365-3040.2008.01875.x; Tholen D, 2014, PLANT CELL ENVIRON, V37, P2456, DOI 10.1111/pce.12401	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	MAR	2015	38	3					385	387		10.1111/pce.12437		3	Plant Sciences	Plant Sciences	CB9ZS	WOS:000349994600001		
J	Mizokami, Y; Noguchi, K; Kojima, M; Sakakibara, H; Terashima, I				Mizokami, Yusuke; Noguchi, Ko; Kojima, Mikiko; Sakakibara, Hitoshi; Terashima, Ichiro			Mesophyll conductance decreases in the wild type but not in an ABA-deficient mutant (aba1) of Nicotiana plumbaginifolia under drought conditions	PLANT CELL AND ENVIRONMENT			English	Article						abscisic acid (ABA); stomatal conductance	CARBON-ISOTOPE DISCRIMINATION; PLASMA-MEMBRANE AQUAPORINS; ROOT WATER TRANSPORT; ABSCISIC-ACID; STOMATAL CONDUCTANCE; CO2 DIFFUSION; INTERNAL CONDUCTANCE; GUARD-CELL; PHOTOSYNTHESIS; STRESS	Under drought conditions, leaf photosynthesis is limited by the supply of CO2. Drought induces production of abscisic acid (ABA), and ABA decreases stomatal conductance (g(s)). Previous papers reported that the drought stress also causes the decrease in mesophyll conductance (g(m)). However, the relationships between ABA content and g(m) are unclear. We investigated the responses of g(m) to the leaf ABA content [(ABA)(L)] using an ABA-deficient mutant, aba1, and the wild type (WT) of Nicotiana plumbaginifolia. We also measured leaf water potential ((L)) because leaf hydraulics may be related to g(m). Under drought conditions, g(m) decreased with the increase in (ABA)(L) in WT, whereas both (ABA)(L) and g(m) were unchanged by the drought treatment in aba1. Exogenously applied ABA decreased g(m) in both WT and aba1 in a dose-dependent manner. (L) in WT was decreased by the drought treatment to -0.7MPa, whereas (L) in aba1 was around -0.8MPa even under the well-watered conditions and unchanged by the drought treatment. From these results, we conclude that the increase in (ABA)(L) is crucial for the decrease in g(m) under drought conditions. We discuss possible relationships between the decrease in g(m) and changes in the leaf hydraulics. This study aimed at investigating the possible involvement of ABA in decreasing mesophyll conductance under drought conditions. Here, we used the ABA deficient mutant of Nicotiana plumbaginifolia, aba1, and photosynthetic characteristics of this mutant and the wild type were compared. The experiments provided the clear evidence that the increase in leaf ABA decreased mesophyll conductance. Commentary:	[Mizokami, Yusuke; Noguchi, Ko; Terashima, Ichiro] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Kojima, Mikiko; Sakakibara, Hitoshi] RIKEN Ctr Sustainable Resource Sci, Plant Prod Syst Res Grp, Yokohama, Kanagawa 2300045, Japan	Mizokami, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	y-mzkm@bs.s.u-tokyo.ac.jp	Sakakibara, Hitoshi/A-6040-2010; TERASHIMA, ICHIRO/G-4943-2014	Sakakibara, Hitoshi/0000-0001-5449-6492; TERASHIMA, ICHIRO/0000-0001-7680-9867	Japan Science Society [21114007, 25.10531]; Japan Advanced Plant Science Network	We thank Dr Annie Marion-Poll and Dr Mitsunori Seo for providing the aba1 and wild-type Nicotiana plumbaginifolia seeds and Mr Shigemi Otsuka for manufacturing the leaf chamber. This study was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas (21114007), a Grant-in-Aid for JSPS Fellows (No. 25.10531), a Sasakawa scientific research grant from the Japan Science Society and Japan Advanced Plant Science Network.	Endo A, 2008, PLANT PHYSIOL, V147, P1984, DOI 10.1104/pp.108.116632; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Bunce JA, 2002, PHOTOSYNTH RES, V71, P273, DOI 10.1023/A:1015529909457; Van Wilder V, 2008, PLANT CELL PHYSIOL, V49, P1364, DOI 10.1093/pcp/pcn112; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; Flexas J, 2006, NEW PHYTOL, V172, P73, DOI 10.1111/j.1469-8137.2006.01794.x; Prak S, 2008, MOL CELL PROTEOMICS, V7, P1019, DOI 10.1074/mcp.M700566-MCP200; Assmann SM, 2000, PLANT CELL ENVIRON, V23, P387, DOI 10.1046/j.1365-3040.2000.00551.x; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Bunce JA, 1998, PLANT CELL ENVIRON, V21, P115, DOI 10.1046/j.1365-3040.1998.00253.x; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Shatil-Cohen A, 2011, PLANT J, V67, P72, DOI 10.1111/j.1365-313X.2011.04576.x; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Tazoe Y, 2011, PLANT CELL ENVIRON, V34, P580, DOI 10.1111/j.1365-3040.2010.02264.x; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; TERASHIMA I, 1988, PLANT CELL PHYSIOL, V29, P385; Galmes J, 2007, NEW PHYTOL, V175, P81, DOI 10.1111/j.1469-8137.2007.02087.x; Warren CR, 2008, J EXP BOT, V59, P327, DOI 10.1093/jxb/erm314; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Tazoe Y, 2009, J EXP BOT, V60, P2291, DOI 10.1093/jxb/erp035; Bauer H, 2013, CURR BIOL, V23, P53, DOI 10.1016/j.cub.2012.11.022; Boyer JS, 1997, PLANT PHYSIOL, V114, P185; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281; Lanigan GJ, 2008, PLANT PHYSIOL, V148, P2013, DOI 10.1104/pp.108.130153; Ferrio JP, 2012, PLANT CELL ENVIRON, V35, P611, DOI 10.1111/j.1365-3040.2011.02440.x; DOWNTON WJS, 1988, NEW PHYTOL, V110, P503, DOI 10.1111/j.1469-8137.1988.tb00289.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Flexas J, 2009, J EXP BOT, V60, P2361, DOI 10.1093/jxb/erp069; Christmann A, 2007, PLANT J, V52, P167, DOI 10.1111/j.1365-313X.2007.03234.x; Vrabl D, 2009, J EXP BOT, V60, P2315, DOI 10.1093/jxb/erp115; MAKINO A, 1986, AGR BIOL CHEM TOKYO, V50, P1911; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559; TARDIEU F, 1992, PLANT CELL ENVIRON, V15, P193, DOI 10.1111/j.1365-3040.1992.tb01473.x; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Caemmerer S, 1991, FUNCT PLANT BIOL, V18, P287; Canny M, 2012, FUNCT PLANT BIOL, V39, P91, DOI 10.1071/FP11172; Laisk A., 1977, KINETICS PHOTOSYNTHE; LEYDECKER MT, 1995, PLANT PHYSIOL, V107, P1427; Miyazawa S, 2008, FUNCT PLANT BIOL, V35, P553, DOI 10.1071/FP08117; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; OGUNKANM.AB, 1973, NEW PHYTOL, V72, P277, DOI 10.1111/j.1469-8137.1973.tb02033.x; TERASHIMA I, 1992, PHOTOSYNTH RES, V31, P195, DOI 10.1007/BF00035537; vonsCaemmerer S, 1981, PLANTA, V153, P376	50	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	MAR	2015	38	3					388	398		10.1111/pce.12394		11	Plant Sciences	Plant Sciences	CB9ZS	WOS:000349994600002		
J	Funayama-Noguchi, S; Noguchi, K; Terashima, I				Funayama-Noguchi, Sachiko; Noguchi, Ko; Terashima, Ichiro			Comparison of the response to phosphorus deficiency in two lupin species, Lupinus albus and L. angustifolius, with contrasting root morphology	PLANT CELL AND ENVIRONMENT			English	Article						cluster roots; construction cost; growth analysis; respiration	X-HYBRIDA PETALS; WHITE LUPIN; USE-EFFICIENCY; CLUSTER ROOTS; CARBOXYLATE SYNTHESIS; ALTERNATIVE OXIDASE; GROWTH TEMPERATURE; CITRATE EXUDATION; BEAN ROOTS; PHOSPHATE	White lupin (Lupinus albus) produces cluster roots, an adaptation to low soil phosphorus (P). Cluster roots exude large levels of P-solubilizing compounds such as citrate and malate. In contrast, narrow leaf lupin (L.angustifolius) is closely related to L.albus, but does not produce cluster roots. To examine the different strategies for P acquisition, we compared the growth, biomass allocation, respiratory properties and construction cost between L.albus and L.angustifolius under P-deficient conditions. Both Lupinus species were grown in hydroponic culture with 1 or 100M P. Under the P-deficient regime, L.albus produced cluster roots with little change in biomass allocation, while L.angustifolius significantly increased biomass allocation to roots. The rate of cyanide-resistant SHAM (salicylhydroxamic acid)-sensitive respiration was high in cluster roots and very low in roots of L.angustifolius. These results suggest a low alternative oxidase (AOX) activity in L.angustifolius roots, and thus, ATP would be produced efficiently in L.angustifolius roots. The construction cost was highest in cluster roots and lowest in L.angustifolius roots. This study shows that under P deficiency, L.albus produces high-cost cluster roots to increase the P availability, while L.angustifolius produces large quantities of low-cost roots to enhance P uptake. We investigated the difference of strategies for phosphorus (P) acquisition in white lupin (Lupinus albus) and narrow leaf lupin (L. angustifolius) in reference to carbon cost. In response to P deficiency, L. albus produced cluster roots, while L. angustifolius increased biomass allocation to roots. The construction cost was highest in cluster roots in L. albus, and lowest in L. angustifolius roots. Our results shows that under P-deficiency, L. albus produces high-cost cluster roots to increase the P-availability, while L. angustifolius produces large quantities of low-cost roots to enhance the P-uptake.	[Funayama-Noguchi, Sachiko; Noguchi, Ko; Terashima, Ichiro] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Funayama-Noguchi, S (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	funayama@biol.s.u-tokyo.ac.jp	TERASHIMA, ICHIRO/G-4943-2014	TERASHIMA, ICHIRO/0000-0001-7680-9867	Ministry of Education, Culture, Sports, Science and Technology of Japan [25119706]; Japan Society for the Promotion of Science for Young Scientists (RPD)	We are grateful to Dr J.C. Clements for providing the L. albus and L. angustifolius seeds. We also thank Dr T. Hachiya, Dr D. Sugiura and laboratory members for their kind advice, help and encouragement. This research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no 25119706) and the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (RPD).	Florez-Sarasa I, 2014, PLANT CELL ENVIRON, V37, P922, DOI 10.1111/pce.12208; DINKELAKER B, 1989, PLANT CELL ENVIRON, V12, P285, DOI 10.1111/j.1365-3040.1989.tb01942.x; Wang X, 2013, ANN BOT-LONDON, V112, P1449, DOI 10.1093/aob/mct210; Cen YP, 2001, PLANT PHYSIOL, V126, P1555, DOI 10.1104/pp.126.4.1555; Pearse SJ, 2006, PLANT SOIL, V288, P127, DOI 10.1007/s11104-006-9099-y; RYCHTER AM, 1992, PHYSIOL PLANTARUM, V84, P80, DOI 10.1034/j.1399-3054.1992.840113.x; Lambers H, 2013, AM J BOT, V100, P263, DOI 10.3732/ajb.1200474; Shane MW, 2005, PLANT SOIL, V274, P101, DOI 10.1007/s11104-004-2725-7; Vijayraghavan V, 2010, FUNCT PLANT BIOL, V37, P455, DOI 10.1071/FP09206; TRINICK MJ, 1977, NEW PHYTOL, V78, P297, DOI 10.1111/j.1469-8137.1977.tb04833.x; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Gilbert GA, 1999, PLANT CELL ENVIRON, V22, P801, DOI 10.1046/j.1365-3040.1999.00441.x; [Anonymous], 1974, J THEOR BIOL, DOI DOI 10.1016/0022-5193(74)90119-2; Bolland MDA, 1997, J PLANT NUTR, V20, P1239, DOI 10.1080/01904169709365332; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Shane MW, 2003, PLANT CELL ENVIRON, V26, P265, DOI 10.1046/j.1365-3040.2003.00957.x; Hocking PJ, 2004, PLANT SOIL, V258, P135, DOI 10.1023/B:PLSO.0000016544.18563.86; Neumann G, 1999, PLANT SOIL, V211, P121, DOI 10.1023/A:1004380832118; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Sulpice R, 2014, PLANT CELL ENVIRON, V37, P1276, DOI 10.1111/pce.12240; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; GARDNER WK, 1983, PLANT SOIL, V70, P107, DOI 10.1007/BF02374754; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Lambers H, 2012, NEW PHYTOL, V196, P1098, DOI 10.1111/j.1469-8137.2012.04285.x; Sieger SM, 2005, J EXP BOT, V56, P1499, DOI 10.1093/jxb/eri146; RYCHTER AM, 1990, PHYSIOL PLANTARUM, V79, P663, DOI 10.1111/j.1399-3054.1990.tb00041.x; MOTOMIZU S, 1983, ANALYST, V108, P361, DOI 10.1039/an9830800361; THEODOROU ME, 1993, PLANT PHYSIOL, V101, P339; Gonzalez-Meler MA, 2001, PLANT CELL ENVIRON, V24, P205, DOI 10.1046/j.1365-3040.2001.00674.x; Shane MW, 2004, PLANT PHYSIOL, V135, P549, DOI 10.1104/pp.103.035659; Pearse SJ, 2007, NEW PHYTOL, V173, P181, DOI 10.1111/j.1469-8137.2006.01897.x; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; Cheng LY, 2011, PLANT PHYSIOL, V156, P1025, DOI 10.1104/pp.111.175174; CLEMENTS JC, 1993, AUST J AGR RES, V44, P1367, DOI 10.1071/AR9931367; Hachiya T, 2008, PHYSIOL PLANTARUM, V134, P293, DOI 10.1111/j.1399-3054.2008.01132.x; Hachiya T, 2007, PLANT CELL ENVIRON, V30, P1269, DOI 10.1111/j.1365-3040.2007.01701.x; Hunt R., 1978, PLANT GROWTH ANAL; Kania A, 2003, PLANT SOIL, V248, P117, DOI 10.1023/A:1022371115788; Keerthisinghe G, 1998, PLANT CELL ENVIRON, V21, P467, DOI 10.1046/j.1365-3040.1998.00300.x; LAFITTE HR, 1988, ANN BOT-LONDON, V62, P353; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Oba H, 2001, SOIL SCI PLANT NUTR, V47, P685; Poorter Hendrik, 1994, P111; R Development Core Team, 2003, R LANG ENV STAT COMP; VERTREGT N, 1987, J THEOR BIOL, V128, P109, DOI 10.1016/S0022-5193(87)80034-6	46	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	MAR	2015	38	3					399	410		10.1111/pce.12390		12	Plant Sciences	Plant Sciences	CB9ZS	WOS:000349994600003		
J	Nagahara, S; Takeuchi, H; Higashiyama, T				Nagahara, Shiori; Takeuchi, Hidenori; Higashiyama, Tetsuya			Generation of a homozygous fertilization-defective gcs1 mutant by heat-inducible removal of a rescue gene	PLANT REPRODUCTION			English	Article						Double fertilization; GCS1/HAP2; Heat shock; Cre-loxP; Fertilization recovery	MULTIPLE POLLEN TUBES; SPERM CELLS; FEMALE GAMETOPHYTE; ARABIDOPSIS; PLANTS; ATTRACTION; ATTACHMENT; DYNAMICS; EXCISION; GUIDANCE	New gametic homozygous mutants. In angiosperms, a haploid male gamete (sperm cell) fuses with a haploid female gamete (egg cell) during fertilization to form a zygote carrying paternally and maternally derived chromosomes. Several fertilization-defective mutants in Arabidopsis thaliana, including a generative cell-specific 1 (gcs1)/hapless 2 mutant, the sperm cells of which are unable to fuse with female gametes, can only be maintained as heterozygous lines due to the infertile male or female gametes. Here, we report successful generation of a gcs1 homozygous mutant by heat-inducible removal of the GCS1 transgene. Using the gcs1 homozygous mutant as male, the defect in gamete fusion was observed with great frequency; in our direct observation by semi-in vivo fertilization assay using ovules, 100 % of discharged sperm cells in culture failed to show gamete fusion. More than 70 % of ovules in the pistil received a second pollen tube as attempted fertilization recovery. Moreover, gcs1 mutant sperm cells could fertilize female gametes at a low frequency in the pistil. This strategy to generate homozygous fertilization-defective mutants will facilitate novel approaches in plant reproduction research.	[Nagahara, Shiori; Takeuchi, Hidenori; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Takeuchi, Hidenori; Higashiyama, Tetsuya] Nagoya Univ, JST ERATO Higashiyama Live Holon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Higashiyama, T (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	higashi@bio.nagoya-u.ac.jp			Japan Society for the Promotion of Science Fellowship [9285]; Japan Advanced Plant Science Network; Japan Science and Technology Agency (ERATO project)	We thank Daisuke Kurihara for providing the vector (DKv137) used for construction and for critical comments on this work. We also thank Michitaka Notaguchi, Daisuke Maruyama, Minako Ueda, and Tomokazu Kawashima for discussion and technical advice. SN was supported by Grant number 9285 from the Japan Society for the Promotion of Science Fellowship. A part of this work was conducted at the Institute of Transformative Bio-Molecules (WPI-ITbM) at Nagoya University, supported by the Japan Advanced Plant Science Network. This work was supported by the Japan Science and Technology Agency (ERATO project to TH).	Abiko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069578; Borg M, 2011, PLANT CELL, V23, P534, DOI 10.1105/tpc.110.081059; Kessler SA, 2011, CURR OPIN PLANT BIOL, V14, P622, DOI 10.1016/j.pbi.2011.07.012; Zhao X, 2013, J PROTEOME RES, V12, P5058, DOI 10.1021/pr400291p; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Zuo JR, 2001, NAT BIOTECHNOL, V19, P157, DOI 10.1038/84428; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Okuda S, 2013, MOL PLANT, V6, P1074, DOI 10.1093/mp/sst050; Hamamura Y, 2011, CURR BIOL, V21, P497, DOI 10.1016/j.cub.2011.02.013; Maruyama D, 2013, DEV CELL, V25, P317, DOI 10.1016/j.devcel.2013.03.013; Volz R, 2013, DEV CELL, V25, P310, DOI 10.1016/j.devcel.2013.04.001; Takeuchi H, 2011, CURR OPIN PLANT BIOL, V14, P614, DOI 10.1016/j.pbi.2011.07.010; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; HULSKAMP M, 1995, PLANT CELL, V7, P57; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Kos CH, 2004, NUTR REV, V62, P243, DOI 10.1301/nr.2004.jun.243-246; Kurup S, 2005, PLANT J, V42, P444, DOI 10.1111/j.1365-313X.2005.02386.x; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Wuest SE, 2013, CURR OPIN PLANT BIOL, V16, P41, DOI 10.1016/j.pbi.2012.12.001; Mori T, 2014, CURR BIOL, V24, P170, DOI 10.1016/j.cub.2013.11.030; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Hirai M, 2008, CURR BIOL, V18, P607, DOI 10.1016/j.cub.2008.03.045; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Hamamura Y, 2012, CURR OPIN PLANT BIOL, V15, P70, DOI 10.1016/j.pbi.2011.11.001; Adachi S, 2011, P NATL ACAD SCI USA, V108, P10004, DOI 10.1073/pnas.1103584108; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Borges F, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-44; Brownfield L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000430; Denninger P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5645; Durbarry A, 2005, PLANT PHYSIOL, V137, P297, DOI 10.1104/pp.104.053165; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Kawashima T., 2014, ELIFE, V3; Mori T, 2010, PLOS ONE, V5; Ohnishi Y, 2014, PLANT PHYSIOL, V165, P1533, DOI 10.1104/pp.114.236059; Palanivelu R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-7; Qin Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000621; RUSSELL SH, 1992, MOL GEN GENET, V234, P49; SCHOFFL F, 1984, EMBO J, V3, P2491; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Wong JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000882	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2194-7953	2194-7961		PLANT REPROD	Plant Reprod.	MAR	2015	28	1	1				33	46		10.1007/s00497-015-0256-4		14	Plant Sciences; Reproductive Biology	Plant Sciences; Reproductive Biology	CB9SV	WOS:000349973700003		
J	Yoneyama, K; Kisugi, T; Xie, XN; Arakawa, R; Ezawa, T; Nomura, T; Yoneyama, K				Yoneyama, Kaori; Kisugi, Takaya; Xie, Xiaonan; Arakawa, Ryota; Ezawa, Tatsuhiro; Nomura, Takahito; Yoneyama, Koichi			Shoot-derived signals other than auxin are involved in systemic regulation of strigolactone production in roots	PLANTA			English	Article						Auxin transport inhibitor; Indole-3-acetic acid; Nitrogen deficiency; Phosphorus deficiency; Shoot-derived signal; Sorghum; Strigolactone	ARBUSCULAR MYCORRHIZAL FUNGI; GERMINATION STIMULANT; PHOSPHATE DEFICIENCY; SORGHUM-BICOLOR; PHOSPHORUS DEFICIENCY; PARASITIC PLANTS; LEAF SENESCENCE; BUD OUTGROWTH; ARABIDOPSIS; RICE	Nitrogen and phosphorus fertilization in one side of split-root sorghum plants systemically reduced root contents of strigolactones in both sides of the split roots. Shoot-derived signals other than auxin appeared to be involved in this process. Strigolactones (SLs) are a novel class of plant hormones regulating both shoot and root architectures and suggested to be functioning downstream of auxin. The levels of SLs in plant tissues and root exudates are regulated by nutrients, especially phosphorus (P) and nitrogen (N); however, the underlying mechanism remains elusive. We examined the effects of N and P fertilization on root contents of two SLs, sorgomol and 5-deoxystrigol, in sorghum plants pre-incubated under N and P free conditions using a split-root system. N and P fertilization to one side of the split-root plants systemically reduced root contents of SLs in both sides of the split roots. The shoot N and P levels increased when one side of the split-root plants was fertilized, while N and P levels in the non-fertilized split roots were unaffected. N fertilization decreased shoot and root IAA (indole-3-acetic acid) levels, while P fertilization did not affect them. IAA applied to the shoot apices increased root contents of 5-deoxystrigol but not that of sorgomol only when the plants were grown under P free conditions. Shoot (leaf) removal dramatically decreased the root contents of SLs but did not affect root IAA levels, and IAA applied to the stumps of leaves could not restore root contents of SLs. Consequently, shoot-derived signals other than auxin are suggested to be involved in the regulation of SL production in roots.	[Yoneyama, Kaori; Kisugi, Takaya; Xie, Xiaonan; Nomura, Takahito; Yoneyama, Koichi] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan; [Arakawa, Ryota; Ezawa, Tatsuhiro] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan	Yoneyama, K (reprint author), Utsunomiya Univ, Ctr Biosci Res & Educ, 350 Mine Machi, Utsunomiya, Tochigi 3218505, Japan.	yoneyama@cc.utsunomiya-u.ac.jp	Yoneyama, Koichi/A-9819-2012; Ezawa, Tatsuhiro/B-7735-2012; 	Ezawa, Tatsuhiro/0000-0001-6188-7635; YONEYAMA, KOICHI/0000-0002-4930-035X	SPS Research Fellowshipfor young scientists	We acknowledge Prof. Tadao Asami (University of Tokyo), and Dr. Hiroyuki Kasahara (RIKEN) for their generous gifts of 5-deoxystrigol-d<INF>6</INF> and [<SUP>13</SUP>C<INF>6</INF>] IAA, respectively. This work was supported by KAKENHI (22-9996) from the Japan Society for the Promotion of Science (JSPS) and by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry. Kaori Yoneyama was supported by a JSPS Research Fellowshipfor young scientists	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Foo E, 2013, MOL PLANT, V6, P76, DOI 10.1093/mp/sss115; Balzergue C, 2011, J EXP BOT, V62, P1049, DOI 10.1093/jxb/erq335; Marzec M, 2013, INT J MOL SCI, V14, P9286, DOI 10.3390/ijms14059286; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Foo E, 2011, PLANTA, V234, P1073, DOI 10.1007/s00425-011-1516-7; Alvarez JM, 2012, CURR OPIN PLANT BIOL, V15, P185, DOI 10.1016/j.pbi.2012.03.009; Yoneyama K, 2012, PLANTA, V235, P1197, DOI 10.1007/s00425-011-1568-8; Jain A, 2007, PLANT PHYSIOL, V144, P232, DOI 10.1104/pp.106.092130; SIAME BA, 1993, J AGR FOOD CHEM, V41, P1486, DOI 10.1021/jf00033a025; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Toh S, 2012, PLANT CELL PHYSIOL, V53, P107, DOI 10.1093/pcp/pcr176; Foo E, 2005, PLANT CELL, V17, P464, DOI 10.1105/tpc.104.026716; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Xie XN, 2008, TETRAHEDRON LETT, V49, P2066, DOI 10.1016/j.tetlet.2008.01.131; Foo E, 2013, J PLANT PHYSIOL, V170, P523, DOI 10.1016/j.jplph.2012.11.002; HAUCK C, 1992, J PLANT PHYSIOL, V139, P474; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Yamada Y, 2014, PLANTA, V240, P399, DOI 10.1007/s00425-014-2096-0; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc104.027714; Sun HW, 2014, J EXP BOT, V65, P6735, DOI 10.1093/jxb/eru029; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Karthikeyan AS, 2007, PLANTA, V225, P907, DOI 10.1007/s00425-006-0408-8; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; Mason MG, 2014, P NATL ACAD SCI USA, V111, P6092, DOI 10.1073/pnas.1322045111; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Nanamori M, 2004, PLANT CELL PHYSIOL, V45, P460, DOI 10.1093/pcp/pch056; Yoneyama K, 2013, PLANTA, V238, P885, DOI 10.1007/s00425-013-1943-8; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Koltai H, 2011, J PLANT PHYSIOL, V168, P1993, DOI 10.1016/j.jplph.2011.05.022; Yoneyama K, 2011, PLANT GROWTH REGUL, V65, P495, DOI 10.1007/s10725-011-9620-z; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Tsuchiya Y, 2010, NAT CHEM BIOL, V6, P741, DOI [10.1038/nchembio.435, 10.1038/NCHEMBIO.435]; Soto MJ, 2010, SOIL BIOL BIOCHEM, V42, P383, DOI 10.1016/j.soilbio.2009.11.007; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; Ejeta G, 2007, INTEGRATING NEW TECH; Jamil M, 2012, FIELD CROP RES, V134, P1, DOI 10.1016/j.fcr.2012.03.015; Koegel S., 2013, PLANT SIGNAL BEHAV, V8, P8, DOI DOI 10.4161/PSB.25229; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Tadano T., 1980, J SCI SOIL MANURE, V51, P399	53	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	MAR	2015	241	3					687	698		10.1007/s00425-014-2208-x		12	Plant Sciences	Plant Sciences	CB9NN	WOS:000349958600012		
J	Takemura, M; Maoka, T; Misawa, N				Takemura, Miho; Maoka, Takashi; Misawa, Norihiko			Biosynthetic routes of hydroxylated carotenoids (xanthophylls) in Marchantia polymorpha, and production of novel and rare xanthophylls through pathway engineering in Escherichia coli	PLANTA			English	Article						alpha-Xanthophyll; CYP97; Liverwort; Carotene hydroxylase; Marchantia polymorpha	BETA-CAROTENE; FUNCTIONAL-ANALYSIS; ARABIDOPSIS-THALIANA; GENE-CLUSTER; EXPRESSION; ASTAXANTHIN; CLONING; LUTEIN; P450; RING	MpBHY codes for a carotene beta-ring 3(,3')-hydroxylase responsible for both zeaxanthin and lutein biosynthesis in liverwort. MpCYP97C functions as an epsilon-ring hydroxylase (zeinoxanthin 3'-hydroxylase) to produce lutein in liverwort. Xanthophylls are oxygenated or hydroxylated carotenes that are most abundant in the light-harvesting complexes of plants. The plant-type xanthophylls consist of alpha-xanthophyll (lutein) and beta-xanthophylls (zeaxanthin, antheraxanthin, violaxanthin and neoxanthin). The alpha-xanthophyll and beta-xanthophylls are derived from alpha-carotene and beta-carotene by carotene hydroxylase activities, respectively. beta-Ring 3,3'-hydroxylase that mediates the route of zeaxanthin from beta-carotene via beta-cryptoxanthin is present in higher plants and is encoded by the BHY (BCH) gene. On the other hand, CYP97A (or BHY) and CYP97C genes are responsible for beta-ring 3-hydroxylation and epsilon-ring 3'-hydroxylation, respectively, in routes from alpha-carotene to lutein. To elucidate the evolution of the biosynthetic routes of such hydroxylated carotenoids from carotenes in land plants, we identified and functionally analyzed carotenoid hydroxylase genes of liverwort Marchantia polymorpha L. Three genes homologous to higher plants, BHY, CYP97A, and CYP97C, were isolated and named MpBHY, MpCYP97A, and MpCYP97C, respectively. MpBHY was found to code for beta-ring hydroxylase, which is responsible for both routes starting from beta-carotene and alpha-carotene. MpCYP97C functioned as an epsilon-ring hydroxylase not for alpha-carotene but for zeinoxanthin, while MpCYP97A showed no hydroxylation activity for beta-carotene or alpha-carotene. These findings suggest the original functions of the hydroxylation enzymes of carotenes in land plants, which are thought to diversify in higher plants. In addition, we generated recombinant Escherichia coli cells, which produced rare and novel carotenoids such as alpha-echinenone and 4-ketozeinoxanthin, through pathway engineering using bacterial carotenogenic genes that include crtW, in addition to the liverwort MpLCYb, MpLCYe and MpBHY genes.	[Takemura, Miho; Maoka, Takashi; Misawa, Norihiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Maoka, Takashi] Res Inst Prod Dev, Sakyo Ku, Kyoto 6060805, Japan	Takemura, M (reprint author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, 1-308 Suematsu, Nonoichi, Ishikawa 9218836, Japan.	mtake@ishikawa-pu.ac.jp					Albrecht M, 1997, J BIOTECHNOL, V58, P177, DOI 10.1016/S0168-1656(97)00151-X; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Takaichi S, 2011, MAR DRUGS, V9, P1101, DOI 10.3390/md9061101; Kim J, 2009, PLANT CELL PHYSIOL, V50, P463, DOI 10.1093/pcp/pcp005; Ye VM, 2012, BIOTECHNOL LETT, V34, P1405, DOI 10.1007/s10529-012-0921-8; MISAWA N, 1990, J BACTERIOL, V172, P6704; Sugiura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052643; Kim J, 2006, P NATL ACAD SCI USA, V103, P3474, DOI 10.1073/pnas.0511207103; Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Schuckel J, 2012, CHEMBIOCHEM, V13, P2758, DOI 10.1002/cbic.201200572; Misawa N, 2011, CURR OPIN BIOTECH, V22, P627, DOI 10.1016/j.copbio.2011.01.002; Kim JE, 2010, PHYTOCHEMISTRY, V71, P168, DOI 10.1016/j.phytochem.2009.10.011; Hasunuma T, 2008, PLANT J, V55, P857, DOI 10.1111/j.1365-313X.2008.03559.x; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; MISAWA N, 1995, J BACTERIOL, V177, P6575; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Tian L, 2003, PLANT CELL, V15, P1320, DOI 10.1105/tpc.011403; Lee PC, 2002, APPL MICROBIOL BIOT, V60, P1, DOI 10.1007/s00253-002-1101-x; Qin XQ, 2012, PLANT MOL BIOL, V80, P631, DOI 10.1007/s11103-012-9972-4; Sun ZR, 1996, J BIOL CHEM, V271, P24349; Li QR, 2010, TRANSGENIC RES, V19, P1053, DOI 10.1007/s11248-010-9381-x; Nishino H, 2000, BIOFACTORS, V13, P89; Tian L, 2004, P NATL ACAD SCI USA, V101, P402, DOI 10.1073/pnas.2237237100; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Das A, 2007, APPL MICROBIOL BIOT, V77, P505, DOI 10.1007/s00253-007-1206-3; Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Fraser PD, 1997, J BIOL CHEM, V272, P6128, DOI 10.1074/jbc.272.10.6128; Mayne ST, 1996, FASEB J, V10, P690; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Kajiwara S, 1997, BIOCHEM J, V324, P421; Fraser PD, 2000, PLANT J, V24, P551, DOI 10.1111/j.1365-313X.2000.00896.x; Nishida Y, 2005, APPL ENVIRON MICROB, V71, P4286, DOI 10.1128/AEM.71.8.4286-4296.2005; Quinlan RF, 2012, PLANT PHYSIOL, V160, P204, DOI 10.1104/pp.112.198556; Harada H, 2011, APPL MICROBIOL BIOT, V90, P467, DOI 10.1007/s00253-010-3062-9; CUNNINGHAM FX, 1993, FEBS LETT, V328, P130, DOI 10.1016/0014-5793(93)80980-9; Bak Søren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Breitenbach J, 2014, PHYTOCHEMISTRY, V98, P85, DOI 10.1016/j.phytochem.2013.12.008; Christopher MJ, 1998, BIOCHEMISTRY-US, V37, P6106; Cui HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-457; Harada H, 2014, TRANSGENIC RES, V23, P303, DOI 10.1007/s11248-013-9750-3; Hull AK, 2000, PROTEIN EXPRES PURIF, V18, P310, DOI 10.1006/prep.1999.1195; Iwamoto T, 2000, J Atheroscler Thromb, V7, P216; Kim IJ, 2001, PLANT SCI, V161, P1005, DOI 10.1016/S0168-9452(01)00511-8; Lv MZ, 2012, PLANT CELL PHYSIOL, V53, P987, DOI 10.1093/pcp/pcs041; Maoka T, 2014, TETRAHEDRON LETT, V55, P6708, DOI 10.1016/j.tetlet.2014.10.033; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Quinlan RF, 2007, ARCH BIOCHEM BIOPHYS, V458, P146, DOI 10.1016/j.abb.2006.11.019; Ruther A, 1997, APPL MICROBIOL BIOT, V48, P162, DOI 10.1007/s002530051032; Shindo K, 2008, TETRAHEDRON LETT, V49, P3294, DOI 10.1016/j.tetlet.2008.03.077; Stigliani AL, 2011, PLANT CELL PHYSIOL, V52, P851, DOI 10.1093/pcp/pcr037; Takemura M, 2014, PLANT CELL PHYSIOL, V55, P194, DOI 10.1093/pcp/pct170; Talegawkar SA, 2008, PUBLIC HEALTH NUTR, V11, P989, DOI 10.1017/S1368980007001310; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; Yang LE, 2014, J INTEGR PLANT BIOL, V56, P902, DOI 10.1111/jipb.12229; Yokoyama A, 1998, TETRAHEDRON LETT, V39, P3709, DOI 10.1016/S0040-4039(98)00542-5; YOKOYAMA A, 1995, FEMS MICROBIOL LETT, V128, P139, DOI 10.1016/0378-1097(95)00097-O	59	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	MAR	2015	241	3					699	710		10.1007/s00425-014-2213-0		12	Plant Sciences	Plant Sciences	CB9NN	WOS:000349958600013		
J	Helmy, HM; Yoshikawa, M; Shibata, T; Arai, S; Kagami, H				Helmy, Hassan M.; Yoshikawa, Masako; Shibata, Tomoyuki; Arai, Shoji; Kagami, Hiroo			Sm-Nd and Rb-Sr isotope geochemistry and petrology of Abu Hamamid intrusion, Eastern Desert, Egypt: An Alaskan-type complex in a backarc setting	PRECAMBRIAN RESEARCH			English	Article						Alaskan-type complex; Sm-Nd and Rb-Sr isotope geochemistry; Backarc setting; Eastern Desert	MAFIC-ULTRAMAFIC INTRUSIONS; TRACE-ELEMENT COMPOSITIONS; NI-PGE MINERALIZATION; ISLAND-ARC; CONTINENTAL-CRUST; SUBDUCTION ZONES; DEPLETED MANTLE; SULFIDE DEPOSIT; VOLCANIC-ROCKS; OCEANIC-CRUST	Alaskan-type complexes are uplifted fragments of the deep levels of island arcs. These complexes usually reveal chemical diversity that cannot be assigned to a unique setting within arcs. Here we report the petrology, Rb-Sr and Sm-Nd isotopic data of the Abu Hamamid intrusion from the Eastern Desert of Egypt as an example of Neoproterozoic backarc Alaskan-type complex. The intrusion comprises clinopyroxene dunite, olivine clinopyroxenite, amphibole clinopyroxenite and gabbro. All rock units represent cumulates crystallized from a high-MgO hydrous magma with geochemical characteristics intermediate between mid-ocean ridge basalt and island arc magmas. Slab signatures of the parental magma comprise elevated H2O, Sr-87/Sr-86 and large ion lithophile element contents and relative depletion in Nb. High positive initial epsilon(Nd) (+6.2 to +11.0) is consistent with the Abu Hamamid magma being extracted from a highly depleted mantle source. The parental magma was generated by 10% partial melting of a mantle source modified by 10% MORB (ecolgite) derived fluid. The Abu Hamamid Alaskan-type complex and the surrounding related volcanic rocks were formed in a Neoproterozoic backarc setting. The magmas forming the lower crust of the Arabian-Nubian shield were liberated from a depleted mantle before 900 Ma. (C) 2015 Elsevier B.V. All rights reserved.	[Helmy, Hassan M.; Yoshikawa, Masako; Shibata, Tomoyuki] Kyoto Univ, Inst Geothermal Sci, Beppu, Oita 8740903, Japan; [Helmy, Hassan M.] Menia Univ, Dept Geol, Al Minya 61519, Egypt; [Arai, Shoji] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; [Arai, Shoji] JAMSTEC, Res & Dev Ctr Ocean Drilling Sci, Yokosuka, Kanagawa 2370061, Japan; [Kagami, Hiroo] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan	Helmy, HM (reprint author), Menia Univ, Dept Geol, Misr Aswan Highway, Al Minya 61519, Egypt.	hmhelmy@yahoo.com					Ahmed AH, 2008, LITHOS, V104, P85, DOI 10.1016/j.lithos.2007.11.009; Polat A, 2009, PRECAMBRIAN RES, V175, P87, DOI 10.1016/j.precamres.2009.09.002; STERN RJ, 1991, GEOL RUNDSCH, V80, P155, DOI 10.1007/BF01828773; JAN MQ, 1990, J PETROL, V31, P667; Spandler CJ, 2003, CONTRIB MINERAL PETR, V144, P703, DOI 10.1007/s00410-002-0424-z; Helmy HM, 2008, J MINER PETROL SCI, V103, P333, DOI 10.2465/jmps.070906; Wallace PJ, 2005, J VOLCANOL GEOTH RES, V140, P217, DOI 10.1016/j.jvolgeores.2004.07.023; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; BURNS LE, 1985, CAN J EARTH SCI, V22, P1020, DOI 10.1139/e85-106; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Prouteau G, 2001, NATURE, V410, P197, DOI 10.1038/35065583; Plank T, 2013, EARTH PLANET SC LETT, V364, P168, DOI 10.1016/j.epsl.2012.11.044; Workman RK, 2005, EARTH PLANET SC LETT, V231, P53, DOI 10.1016/j.epsl.2004.12.005; Batanova VG, 2005, J PETROL, V46, P1345, DOI 10.1093/petrology/egi018; Pearce JA, 2006, GEOPH MONOG SERIES, V166, P63; HAWKESWORTH CJ, 1993, ANNU REV EARTH PL SC, V21, P175, DOI 10.1146/annurev.earth.21.1.175; Horodyskyj U, 2009, GEOSPHERE, V5, P426, DOI 10.1130/GES00502.1; Ali KA, 2009, PRECAMBRIAN RES, V171, P1, DOI 10.1016/j.precamres.2009.03.002; Spandler C, 2013, LITHOS, V170, P208, DOI 10.1016/j.lithos.2013.02.016; LUGMAIR GW, 1978, EARTH PLANET SC LETT, V39, P349, DOI 10.1016/0012-821X(78)90021-3; Polat A, 2012, PRECAMBRIAN RES, V214, P124, DOI 10.1016/j.precamres.2011.11.013; Krause J, 2007, LITHOS, V95, P19, DOI 10.1016/j.lithos.2006.07.018; ALT JC, 1993, EARTH PLANET SC LETT, V119, P477, DOI 10.1016/0012-821X(93)90057-G; Dhuime B, 2009, J PETROL, V50, P531, DOI 10.1093/petrology/egp010; Pettigrew NT, 2006, PRECAMBRIAN RES, V149, P21, DOI 10.1016/j.precamres.2006.06.004; Shibata T, 1997, J GEOPHYS RES-SOL EA, V102, P8051, DOI 10.1029/96JB03661; Otamendi JE, 2010, J S AM EARTH SCI, V29, P685, DOI 10.1016/j.jsames.2009.11.001; Jagoutz O, 2013, EARTH PLANET SC LETT, V371, P177, DOI 10.1016/j.epsl.2013.03.051; Maurice AE, 2013, PRECAMBRIAN RES, V224, P397, DOI 10.1016/j.precamres.2012.10.012; Pabst S, 2012, LITHOS, V132, P162, DOI 10.1016/j.lithos.2011.11.010; DEBARI SM, 1989, J GEOPHYS RES-SOLID, V94, P4373, DOI 10.1029/JB094iB04p04373; Tanaka T, 2000, CHEM GEOL, V168, P279, DOI 10.1016/S0009-2541(00)00198-4; Helmy HM, 2003, MINER PETROL, V77, P85, DOI 10.1007/s00710-001-0185-9; NOTSU K, 1987, GEOLOGY, V15, P345, DOI 10.1130/0091-7613(1987)15<345:SIROBV>2.0.CO;2; Arai S., 2000, J MINER PETROL SCI, V95, P9, DOI DOI 10.2465/JMPS.95.9; Brugmann G.E., 1997, PRECAMBRIAN RES, V81, P223; Chang Q., 2003, PRECISE DETERMINATIO, P357; DePaolo DJ, 1988, NEODYMIUM ISOTOPE GE, P1; El-Rahman Y.A., 2012, LITHOS, V155, P410; Farahat ES, 2006, J AFR EARTH SCI, V45, P187, DOI 10.1016/j.jafrearsci.2006.02.003; Fershtater GB, 1997, TECTONOPHYSICS, V276, P87, DOI 10.1016/S0040-1951(97)00049-8; FINDLAY DC, 1969, CAN J EARTH SCI, V6, P399, DOI 10.1139/e69-040; GARSON MS, 1976, GEOL SOC AM BULL, V87, P169, DOI 10.1130/0016-7606(1976)87<169:GAGEOT>2.0.CO;2; Hafez AMA, 1983, EGYPT J GEOL, V27, P73; Helmy H. M., 2013, NAT COMMUN, V4; Helmy HM, 2014, LITHOS, V198, P263, DOI 10.1016/j.lithos.2014.03.028; Helmy HM, 1999, CAN MINERAL, V37, P143; Helmy HM, 2005, ORE GEOL REV, V26, P305, DOI 10.1016/j.oregeorev.2005.04.001; Helmy HM, 2001, MINER DEPOSITA, V36, P58, DOI 10.1007/s001260050286; Helmy HM, 2004, CAN MINERAL, V42, P351, DOI 10.2113/gscanmin.42.2.351; Himmelberg G. R., 1995, 1564 US GEOL SURV; Himmelberg R. G., 1986, US GEOL SURV B, V1662, P1; HOCHSTAEDTER A, 2001, GEOCHEM GEOPHYS GEOS, V2; WHITE WM, 1982, NATURE, V296, P821, DOI 10.1038/296821a0; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Irvine TN, 1974, GEOL SOC AM MEM, V138, P240; Kelemen P.B., 2003, INSIDE SUBDUCTION FA, V138, P223, DOI DOI 10.1029/138GM11; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; Ludwig K. R., 2012, SPECIAL PUBLICATION, P75, DOI DOI 10.1016/S0016-7037(98)00059-3; Maurice AE, 2012, LITHOS, V132, P1, DOI 10.1016/j.lithos.2011.11.013; Morishita T, 2005, GEOSTAND GEOANAL RES, V29, P107, DOI 10.1111/j.1751-908X.2005.tb00659.x; Naldrett A.J., 2004, MAGMATIC SULFIDE DEP, P728; Nixon G. T., 1997, BR COLUMBIA GEOL SUR, V93, P142; Nixon G. T., 1990, GEOLOGIC FIELDWORK 1, V1, P307; Noble J. A., 1960, 21ST INT GEOL C C 13, P188; Ripley E. M., 2005, MINERAL DEPOSIT RES, V1, P49; Sappin AA, 2011, MINER DEPOSITA, V46, P211, DOI 10.1007/s00126-010-0321-8; Shalaby IM, 2004, MINER DEPOSITA, V39, P608, DOI 10.1007/s00126-004-0427-y; Shibata T., 2004, J MASS SPECTROM, V52, P317; SNOKE AW, 1981, J PETROL, V22, P501; Song XY, 2009, MINER DEPOSITA, V44, P303, DOI 10.1007/s00126-008-0219-x; Sugimoto T., 2007, J MINERALOGICAL PETR, V101, P270; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Taylor H. P., 1967, ULTRAMAFIC RELATED R, P96; TISTL M, 1994, EARTH PLANET SC LETT, V126, P41, DOI 10.1016/0012-821X(94)90241-0; Tollstrup D., 2010, GEOCHEM GEOPHY GEOSY, V11, P1, DOI DOI 10.HTTP://DX.D0L0RG/10.1029/2009GC002847; WOODHEAD J, 1993, EARTH PLANET SC LETT, V114, P491, DOI 10.1016/0012-821X(93)90078-N; Yoshikawa M., 2002, SR ND ISOTOPIC RATIO, P30	79	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-9268	1872-7433		PRECAMBRIAN RES	Precambrian Res.	MAR	2015	258						234	246		10.1016/j.precamres.2015.01.002		13	Geosciences, Multidisciplinary	Geology	CB8JH	WOS:000349875200013		
J	Nakayama, T; Mizohata, E; Yamashita, T; Nagatoishi, S; Nakakido, M; Iwanari, H; Mochizuki, Y; Kado, Y; Yokota, Y; Satoh, R; Tsumoto, K; Fujitani, H; Kodama, T; Hamakubo, T; Inoue, T				Nakayama, Taisuke; Mizohata, Eiichi; Yamashita, Takefumi; Nagatoishi, Satoru; Nakakido, Makoto; Iwanari, Hiroko; Mochizuki, Yasuhiro; Kado, Yuji; Yokota, Yuki; Satoh, Reiko; Tsumoto, Kouhei; Fujitani, Hideaki; Kodama, Tatsuhiko; Hamakubo, Takao; Inoue, Tsuyoshi			Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses	PROTEIN SCIENCE			English	Article						antigen-antibody interaction; antibody engineering; crystallography; molecular dynamics; thermodynamics	ANTIGEN; RECOGNITION; SLIT; AFFINITY; IDENTIFICATION; ROUNDABOUT; MUTATIONS; RECEPTORS; PROTEINS; GUIDANCE	ROBO1, fibronectin Type-III domain (Fn)-containing protein, is a novel immunotherapeutic target for hepatocellular carcinoma in humans. The crystal structure of the antigen-binding fragment (Fab) of B2212A, the monoclonal antibody against the third Fn domain (Fn3) of ROBO1, was determined in pursuit of antibody drug for hepatocellular carcinoma. This effort was conducted in the presence or absence of the antigen, with the chemical features being investigated by determining the affinity of the antibody using molecular dynamics (MD) and thermodynamics. The structural comparison of B2212A Fab between the complex and the free form revealed that the interfacial Tyr(L)50 (superscripts L, H, and F stand for the residues in the light chain, heavy chain, and Fn3, respectively) played important roles in Fn3 recognition. That is, the aromatic ring of Tyr(L)50 pivoted toward Phe(F)68, forming a CH/ interaction and a new hydrogen bond with the carbonyl O atom of Phe(F)68. MD simulations predicted that the Tyr(L)50-Phe(F)68 interaction almost entirely dominated Fab-Fn3 binding, and Ala-substitution of Tyr(L)50 led to a reduced binding of the resultant complex. On the contrary, isothermal titration calorimetry experiments underscored that Ala-substitution of Tyr(L)50 caused an increase of the binding enthalpy between B2212A and Fn3, but importantly, it induced an increase of the binding entropy, resulting in a suppression of loss in the Gibbs free energy in total. These results suggest that mutation analysis considering the binding entropy as well as the binding enthalpy will aid in the development of novel antibody drugs for hepatocellular carcinoma.	[Nakayama, Taisuke; Mizohata, Eiichi; Kado, Yuji; Yokota, Yuki; Satoh, Reiko; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Div Appl Chem, Struct Phys Chem, Suita, Osaka 5650871, Japan; [Yamashita, Takefumi; Fujitani, Hideaki; Kodama, Tatsuhiko] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Nagatoishi, Satoru; Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo 1538904, Japan; [Iwanari, Hiroko; Mochizuki, Yasuhiro; Hamakubo, Takao] Univ Tokyo, Dept Quantitat Biol & Med, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan	Inoue, T (reprint author), Osaka Univ, Grad Sch Engn, Div Appl Chem, Struct Phys Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hamakubo@qbm.rcast.u-tokyo.ac.jp; inouet@chem.eng.osaka-u.ac.jp			Molecular Dynamics for Antibody Drug Development (MDADD) project, JSPS; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program, JSPS; JST ERATO Lipid Active Structure Project; Japan Synchrotron Radiation Research Institute (JASRI) SACLA Project; MEXT SPIRE Supercomputational Life Science [hp120297, hp130006, hp140228]; JSPS KAKENHI [25282230, 24770096, 22550152]	Grant sponsors: Molecular Dynamics for Antibody Drug Development (MDADD) project, Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program, JSPS; JST ERATO Lipid Active Structure Project; Japan Synchrotron Radiation Research Institute (JASRI) SACLA Project; MEXT SPIRE Supercomputational Life Science Grant numbers: hp120297, hp130006, hp140228; JSPS KAKENHI Grant numbers: 25282230, 24770096, 22550152.	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Seki M, 2010, FEBS LETT, V584, P2909, DOI 10.1016/j.febslet.2010.05.009; Lafont V, 2007, CHEM BIOL DRUG DES, V69, P413, DOI 10.1111/j.1747-0285.2007.00519.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Fraser JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/j.jmb.2006.03.043; Chang CH, 2002, MOL CANCER THER, V1, P553; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401789101; Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Ito H, 2006, CLIN CANCER RES, V12, P3257, DOI 10.1158/1078-0432.CCR-05-2787; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Carter P, 2004, ENDOCR-RELAT CANCER, V11, P659, DOI 10.1677/erc.1.00766; Fujitani H, 2009, J CHEM THEORY COMPUT, V5, P1155, DOI 10.1021/ct8005437; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; Stoldt HS, 1997, EUR J CANCER, V33, P186, DOI 10.1016/S0959-8049(96)00477-7; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAR	2015	24	3					328	340		10.1002/pro.2619		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC1ZQ	WOS:000350144400007		
J	Yamanaka, M; Nagao, S; Komori, H; Higuchi, Y; Hirota, S				Yamanaka, Masaru; Nagao, Satoshi; Komori, Hirofumi; Higuchi, Yoshiki; Hirota, Shun			Change in structure and ligand binding properties of hyperstable cytochrome c(555) from Aquifex aeolicus by domain swapping	PROTEIN SCIENCE			English	Article						domain swapping; cytochrome c; thermostable; pH tolerance; ligand binding	AMYLOID-LIKE FIBRILS; HYDROGENOBACTER-THERMOPHILUS; PROTEIN NANOMATERIALS; AMPHITRITE-ORNATA; RIBONUCLEASE-A; DESIGN; HEME; THERMOSTABILITY; REPLACEMENT; ENHANCEMENT	Cytochrome c(555) from hyperthermophilic bacteria Aquifex aeolicus (AA cyt c(555)) is a hyperstable protein belonging to the cyt c protein family, which possesses a unique long 3(10)--3(10) helix containing the heme-ligating Met61. Herein, we show that AA cyt c(555) forms dimers by swapping the region containing the extra 3(10)--3(10) helix and C-terminal -helix. The asymmetric unit of the crystal of dimeric AA cyt c(555) contained two dimer structures, where the structure of the hinge region (Val53-Lys57) was different among all four protomers. Dimeric AA cyt c(555) dissociated to monomers at 921 degrees C according to DSC measurements, showing that the dimer was thermostable. According to CD measurements, the secondary structures of dimeric AA cyt c(555) were maintained at pH 2.2-11.0. CN- and CO bound to dimeric AA cyt c(555) in the ferric and ferrous states, respectively, owing to the flexibility of the hinge region close to Met61 in the dimer, whereas these ligands did not bind to the monomer under the same conditions. In addition, CN- and CO bound to the oxidized and reduced dimer at neutral pH and a wide range of pH (pH 2.2-11.0), respectively, in a wide range of temperature (25-85 degrees C), owing to the thermostability and pH tolerance of the dimer. These results show that the ligand binding character of hyperstable AA cyt c(555) changes upon dimerization by domain swapping.	[Yamanaka, Masaru; Nagao, Satoshi; Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Komori, Hirofumi] Kagawa Univ, Fac Educ, Takamatsu, Kagawa 7608522, Japan; [Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Higuchi, Yoshiki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Hirota, S (reprint author), 8916-5 Takayama, Nara 6300192, Japan.	hirota@ms.naist.jp			MEXT [26288080]	Grant sponsor: Grant-in-Aid for Scientific Research from MEXT (Category B); Grant number: 26288080 (to S.H.).	Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Petrik ID, 2014, CURR OPIN CHEM BIOL, V19, P67, DOI [10.1016/j.cbpa.2014.01.006, 10.1016/j.cpba.2014.01.006]; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Nagao S, 2012, DALTON T, V41, P11378, DOI 10.1039/c2dt30893b; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zastrow ML, 2012, NAT CHEM, V4, P118, DOI [10.1038/nchem.1201, 10.1038/NCHEM.1201]; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/nchem.473, 10.1038/NCHEM.473]; GOTO Y, 1993, BIOCHEMISTRY-US, V32, P11878, DOI 10.1021/bi00095a017; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Kohler V, 2010, CURR OPIN BIOTECH, V21, P744, DOI 10.1016/j.copbio.2010.09.004; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Huard DJE, 2013, NAT CHEM BIOL, V9, P169, DOI [10.1038/nchembio.1163, 10.1038/NCHEMBIO.1163]; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Oohora K, 2014, CURR OPIN CHEM BIOL, V19, P154, DOI 10.1016/j.cbpa.2014.02.014; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; Farid TA, 2013, NAT CHEM BIOL, V9, P826, DOI [10.1038/nchembio.1362, 10.1038/NCHEMBIO.1362]; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Han HJ, 2014, J BIOL CHEM, V289, P14121, DOI 10.1074/jbc.M114.554816; Hayashi Y, 2012, BIOCHEMISTRY-US, V51, P8608, DOI 10.1021/bi3011303; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Gotte G, 2004, J BIOL CHEM, V279, P36670, DOI 10.1074/jbc.M404780200; Oda K, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3519814; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Ptitsyn OB, 1998, J MOL BIOL, V278, P655, DOI 10.1006/jmbi.1997.1620; Newcomer ME, 2002, CURR OPIN STRUC BIOL, V12, P48, DOI 10.1016/S0959-440X(02)00288-9; Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673; Bartsch RG, 1971, METHOD ENZYMOL, V23, P344; Baymann F, 2001, BIOCHEMISTRY-US, V40, P13681, DOI 10.1021/bi011201y; BREN KL, 1993, J AM CHEM SOC, V115, P10382, DOI 10.1021/ja00075a073; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; DAVIS LA, 1974, J BIOL CHEM, V249, P2624; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hamada D, 1996, J MOL BIOL, V256, P172, DOI 10.1006/jmbi.1996.0075; Hunter CL, 2013, DALTON T, V42, P3151, DOI 10.1039/c2dt32558f; Kamagata K, 2012, J AM CHEM SOC, V134, P11525, DOI 10.1021/ja3020555; Marmorino JL, 1998, J MOL BIOL, V275, P379, DOI 10.1006/jmbi.1997.1450; Masanari M, 2014, EXTREMOPHILES, V18, P617, DOI 10.1007/s00792-014-0644-y; MYER YP, 1968, BIOCHEMISTRY-US, V7, P765, DOI 10.1021/bi00842a035; Nugraheni AD, 2013, J BIOL INORG CHEM, V18, P383, DOI 10.1007/s00775-013-0982-8; Obuchi M, 2009, ACTA CRYSTALLOGR D, V65, P804, DOI 10.1107/S0907444909017314; Oikawa K, 2005, J BIOL CHEM, V280, P5527; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sun SF, 2014, BIOCHEMISTRY-US, V53, P4956, DOI 10.1021/bi5002757; Sun SF, 2014, ARCH BIOCHEM BIOPHYS, V545, P108, DOI 10.1016/j.abb.2014.01.010; Tai HL, 2011, BIOCHEMISTRY-US, V50, P3161, DOI 10.1021/bi200256d; Takahashi YT, 2006, BIOCHEMISTRY-US, V45, P11005, DOI 10.1021/bi061164g; Tomlinson EJ, 2000, P NATL ACAD SCI USA, V97, P5156, DOI 10.1073/pnas.090089397; Travaglini-Allocatelli C, 2005, J BIOL CHEM, V280, P25729, DOI 10.1074/jbc.M502628200; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Wang ZH, 2011, ORG BIOMOL CHEM, V9, P4766, DOI 10.1039/c1ob05552f; Yamanaka M, 2009, BIOSCI BIOTECH BIOCH, V73, P2022, DOI 10.1271/bbb.90220; Yamanaka M, 2011, BIOCHEMISTRY-US, V50, P2313, DOI 10.1021/bi101646m	64	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAR	2015	24	3					366	375		10.1002/pro.2627		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC1ZQ	WOS:000350144400010		
J	Fujiwara, Y; Goda, N; Tamashiro, T; Narita, H; Satomura, K; Tenno, T; Nakagawa, A; Oda, M; Suzuki, M; Sakisaka, T; Takai, Y; Hiroaki, H				Fujiwara, Yoshie; Goda, Natsuko; Tamashiro, Tomonari; Narita, Hirotaka; Satomura, Kaori; Tenno, Takeshi; Nakagawa, Atsushi; Oda, Masayuki; Suzuki, Mamoru; Sakisaka, Toshiaki; Takai, Yoshimi; Hiroaki, Hidekazu			Crystal structure of afadin PDZ domain-nectin-3 complex shows the structural plasticity of the ligand-binding site	PROTEIN SCIENCE			English	Article						afadin-nectin complex; adherens junction; PDZ domain; sequence specific recognition; crystallography	CELL-CELL ADHESION; DOMAIN-SWAPPED DIMERIZATION; ADHERENS JUNCTIONS; E-CADHERIN; MACROMOLECULAR STRUCTURES; ALPHA-ACTININ; PROTEIN; NECTIN; AF-6; SPECIFICITY	Afadin, a scaffold protein localized in adherens junctions (AJs), links nectins to the actin cytoskeleton. Nectins are the major cell adhesion molecules of AJs. At the initial stage of cell-cell junction formation, the nectin-afadin interaction plays an indispensable role in AJ biogenesis via recruiting and tethering other components. The afadin PDZ domain (AFPDZ) is responsible for binding the cytoplasmic C-terminus of nectins. AFPDZ is a class II PDZ domain member, which prefers ligands containing a class II PDZ-binding motif, X--X-phi (phi, hydrophobic residues); both nectins and other physiological AFPDZ targets contain this class II motif. Here, we report the first crystal structure of the AFPDZ in complex with the nectin-3 C-terminal peptide containing the class II motif. We engineered the nectin-3 C-terminal peptide and AFPDZ to produce an AFPDZ-nectin-3 fusion protein and succeeded in obtaining crystals of this complex as a dimer. This novel dimer interface was created by forming an antiparallel sheet between 2 strands. A major structural change compared with the known AFPDZ structures was observed in the 2 helix. We found an approximately 2.5 angstrom-wider ligand-binding groove, which allows the PDZ to accept bulky class II ligands. Apparently, the last three amino acids of the nectin-3 C-terminus were sufficient to bind AFPDZ, in which the two hydrophobic residues are important.	[Fujiwara, Yoshie; Goda, Natsuko; Satomura, Kaori; Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fujiwara, Yoshie; Narita, Hirotaka; Nakagawa, Atsushi; Suzuki, Mamoru] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan; [Fujiwara, Yoshie; Goda, Natsuko; Takai, Yoshimi; Hiroaki, Hidekazu] Kobe Univ, Global COE Ctr Excellence, Program Integrat Membrane Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Goda, Natsuko; Tenno, Takeshi; Hiroaki, Hidekazu] Nagoya Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tamashiro, Tomonari; Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Dept Biomol Chem, Sakyo Ku, Kyoto 6068522, Japan; [Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Div Membrane Dynam, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Pathogen Signaling, Chuo Ku, Kobe, Hyogo 6500047, Japan	Hiroaki, H (reprint author), Lab Struct Mol Pharmacol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hiroaki.hidekazu@f.mbox.nagoya-u.ac.jp	Hiroaki, Hidekazu /G-9564-2012		Ministry of Education, Culture, Sports, Science, and Technology, Japan	Grant sponsor: Grants-in-aid for the Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" and the National Project on Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Radziwill G, 2003, MOL CELL BIOL, V23, P4663, DOI 10.1128/MCB.23.13.4663-4672.2003; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Ooshio T, 2004, J BIOL CHEM, V279, P31365, DOI 10.1074/jbc.M401957200; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Asada M, 2003, J BIOL CHEM, V278, P4103, DOI 10.1074/jbc.M209832200; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Joshi M, 2006, ANGEW CHEM INT EDIT, V45, P3790, DOI 10.1002/anie.200503965; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Radziwill G, 2007, EMBO J, V26, P2633, DOI 10.1038/sj.emboj.7601706; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Chen QA, 2007, PROTEIN SCI, V16, P1053, DOI 10.1110/ps.062440607; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Goda N, 2004, PROTEIN SCI, V13, P652, DOI 10.1110/ps.03439004; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Kurita S, 2011, J BIOL CHEM, V286, P36297, DOI 10.1074/jbc.M111.261768; Kusunoki H, 2007, BIOCHEM BIOPH RES CO, V359, P972, DOI 10.1016/j.bbrc.2007.05.215; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Momose Y, 2002, BIOCHEM BIOPH RES CO, V293, P45, DOI 10.1016/S0006-291X(02)00183-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narita H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197368; Ogita H, 2010, P JPN ACAD B-PHYS, V86, P621, DOI 10.2183/pjab.86.621; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shi YW, 2010, BIOCHEMISTRY-US, V49, P4432, DOI 10.1021/bi100269t; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Wu JW, 2007, J BIOL CHEM, V282, P35988, DOI 10.1074/jbc.M703826200; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3; Zhou HY, 2005, J BIOL CHEM, V280, P13841, DOI 10.1074/jbc.M411065200	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAR	2015	24	3					376	385		10.1002/pro.2628		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC1ZQ	WOS:000350144400011		
J	Hiromoto, T; Honjo, E; Noda, N; Tamada, T; Kazuma, K; Suzuki, M; Blaber, M; Kuroki, R				Hiromoto, Takeshi; Honjo, Eijiro; Noda, Naonobu; Tamada, Taro; Kazuma, Kohei; Suzuki, Masahiko; Blaber, Michael; Kuroki, Ryota			Structural basis for acceptor-substrate recognition of UDP-glucose: anthocyanidin 3-O-glucosyltransferase from Clitoria ternatea	PROTEIN SCIENCE			English	Article						glucosylation; glucosyltransferase; anthocyanidin; substrate specificity; crystal structure	FLOWER COLOR MODIFICATION; ACYLATED ANTHOCYANINS; MEDICAGO-TRUNCATULA; CRYSTAL-STRUCTURES; MOLECULAR-BASIS; GLYCOSYLTRANSFERASES; DELPHINIDIN; GLYCOSYLATION; STABILIZATION; BIOSYNTHESIS	UDP-glucose: anthocyanidin 3-O-glucosyltransferase (UGT78K6) from Clitoria ternatea catalyzes the transfer of glucose from UDP-glucose to anthocyanidins such as delphinidin. After the acylation of the 3-O-glucosyl residue, the 3- and 5-hydroxyl groups of the product are further glucosylated by a glucosyltransferase in the biosynthesis of ternatins, which are anthocyanin pigments. To understand the acceptor-recognition scheme of UGT78K6, the crystal structure of UGT78K6 and its complex forms with anthocyanidin delphinidin and petunidin, and flavonol kaempferol were determined to resolutions of 1.85 angstrom, 2.55 angstrom, 2.70 angstrom, and 1.75 angstrom, respectively. The enzyme recognition of unstable anthocyanidin aglycones was initially observed in this structural determination. The anthocyanidin- and flavonol-acceptor binding details are almost identical in each complex structure, although the glucosylation activities against each acceptor were significantly different. The 3-hydroxyl groups of the acceptor substrates were located at hydrogen-bonding distances to the N epsilon 2 atom of the His17 catalytic residue, supporting a role for glucosyl transfer to the 3-hydroxyl groups of anthocyanidins and flavonols. However, the molecular orientations of these three acceptors are different from those of the known flavonoid glycosyltransferases, VvGT1 and UGT78G1. The acceptor substrates in UGT78K6 are reversely bound to its binding site by a 180 degrees rotation about the O1-O3 axis of the flavonoid backbones observed in VvGT1 and UGT78G1; consequently, the 5- and 7-hydroxyl groups are protected from glucosylation. These substrate recognition schemes are useful to understand the unique reaction mechanism of UGT78K6 for the ternatin biosynthesis, and suggest the potential for controlled synthesis of natural pigments.	[Hiromoto, Takeshi; Honjo, Eijiro; Tamada, Taro; Blaber, Michael; Kuroki, Ryota] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan; [Noda, Naonobu] Natl Agr & Food Res Org, NARO Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan; [Kazuma, Kohei] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan; [Suzuki, Masahiko] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Blaber, Michael] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	Kuroki, R (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	kuroki.ryota@jaea.go.jp					Ananga A., 2013, MEDITERRANEAN GENETI, P247; Giusti MM, 2003, BIOCHEM ENG J, V14, P217, DOI 10.1016/S1369-703X(02)00221-8; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Dao LT, 1998, J AGR FOOD CHEM, V46, P3564, DOI 10.1021/jf980359v; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Tanaka Y, 2009, INT J MOL SCI, V10, P5350, DOI 10.3390/ijms10125350; Modolo LV, 2009, J MOL BIOL, V392, P1292, DOI 10.1016/j.jmb.2009.08.017; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; Zyoud A, 2011, SOLID STATE SCI, V13, P1268, DOI 10.1016/j.solidstatesciences.2011.03.020; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Hiromoto T, 2013, J SYNCHROTRON RADIAT, V20, P894, DOI 10.1107/S0909049513020712; MAZZA G, 1987, FOOD CHEM, V25, P207, DOI 10.1016/0308-8146(87)90147-6; [Anonymous], 2009, WORLD DYES ORGANIC P; He F, 2012, MOLECULES, V17, P1571, DOI 10.3390/molecules17021571; He XZ, 2006, J BIOL CHEM, V281, P34441, DOI 10.1074/jbc.M605767200; Leopoldini M, 2011, FOOD CHEM, V125, P288, DOI 10.1016/j.foodchem.2010.08.012; Bordoli L., 2008, NAT PROTOC, V4, P1, DOI DOI 10.1038/NPR0T.2008.197; Buraidah M. H., 2011, INT J PHOTOENERGY, V2011, P11; Del Pozo-Insfran D, 2004, J AGR FOOD CHEM, V52, P1539, DOI 10.1021/jf035189n; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Estevez L, 2007, J PHYS CHEM A, V111, P11100, DOI 10.1021/jp074941a; Estevez L, 2008, J PHYS CHEM A, V112, P10614, DOI 10.1021/jp8043237; Garzon GA, 2009, FOOD CHEM, V114, P44, DOI 10.1016/j.foodchem.2008.09.013; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kazuma K, 2004, CHEM BIODIVERS, V1, P1762, DOI 10.1002/cbdv.200490132; Kogawa K, 2007, PLANTA, V226, P1501, DOI 10.1007/s00425-007-0584-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozuomba JO, 2013, ADV APPL SCI RES, V4, P60; SAITO N, 1985, PHYTOCHEMISTRY, V24, P1583; Tanaka Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1760, DOI 10.1271/bbb.100358; TERAHARA N, 1990, PHYTOCHEMISTRY, V29, P949, DOI 10.1016/0031-9422(90)80053-J	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAR	2015	24	3					395	407		10.1002/pro.2630		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC1ZQ	WOS:000350144400013		
J	Okano, H; Kanaya, E; Ozaki, M; Angkawidjaja, C; Kanaya, S				Okano, Hiroyuki; Kanaya, Eiko; Ozaki, Masashi; Angkawidjaja, Clement; Kanaya, Shigenori			Structure, activity, and stability of metagenome-derived glycoside hydrolase family 9 endoglucanase with an N-terminal Ig-like domain	PROTEIN SCIENCE			English	Article						metagenome; GH family 9; endoglucanase; immunoglobulin-like (Ig-like) domain; crystal structure; thermal stability	THERMOCELLUM CELLULASE CELT; CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; ALICYCLOBACILLUS-ACIDOCALDARIUS; CELLOBIOHYDROLASE CBHA; IMMUNOGLOBULIN-LIKE; ETHANOL-PRODUCTION; CATALYTIC MODULES; EISENIA-FOETIDA; ENDO-1,4-BETA-GLUCANASE	A metagenome-derived glycoside hydrolase family 9 enzyme with an N-terminal immunoglobulin-like (Ig-like) domain, leaf-branch compost (LC)-CelG, was characterized and its crystal structure was determined. LC-CelG did not hydrolyze p-nitrophenyl cellobioside but hydrolyzed CM-cellulose, indicating that it is endoglucanase. LC-CelG exhibited the highest activity at 70 degrees C and >80% of the maximal activity at a broad pH range of 5-9. Its denaturation temperature was 81.4 degrees C, indicating that LC-CelG is a thermostable enzyme. The structure of LC-CelG resembles those of CelD from Clostridium thermocellum (CtCelD), Cel9A from Alicyclobacillus acidocaldarius (AaCel9A), and cellobiohydrolase CbhA from C. thermocellum (CtCbhA), which show relatively low (29-31%) amino acid sequence identities to LC-CelG. Three acidic active site residues are conserved as Asp194, Asp197, and Glu558 in LC-CelG. Ten of the thirteen residues that form the substrate binding pocket of AaCel9A are conserved in LC-CelG. Removal of the Ig-like domain reduced the activity and stability of LC-CelG by 100-fold and 6.3 degrees C, respectively. Removal of the Gln40- and Asp99-mediated interactions between the Ig-like and catalytic domains destabilized LC-CelG by 5.0 degrees C without significantly affecting its activity. These results suggest that the Ig-like domain contributes to the stabilization of LC-CelG mainly due to the Gln40- and Asp99-mediated interactions. Because the LC-CelG derivative lacking the Ig-like domain accumulated in Escherichia coli cells mostly in an insoluble form and this derivative accumulated in a soluble form exhibited very weak activity, the Ig-like domain may be required to make the conformation of the active site functional and prevent aggregation of the catalytic domain.	[Okano, Hiroyuki; Kanaya, Eiko; Ozaki, Masashi; Angkawidjaja, Clement; Kanaya, Shigenori] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Angkawidjaja, Clement] Osaka Univ, Int Coll, Toyonaka, Osaka 5600043, Japan	Kanaya, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kanaya@mls.eng.osaka-u.ac.jp	Okano, Hideyuki/J-5973-2013; 	Angkawidjaja, Clement/0000-0002-5019-2536	Ministry of Education, Culture, Sports, Science, and Technology, Japan [24380055]	Grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grant number: 24380055.	Ueda M, 2014, CARBOHYD POLYM, V101, P511, DOI 10.1016/j.carbpol.2013.09.057; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Mingardon F, 2011, APPL ENVIRON MICROB, V77, P1436, DOI 10.1128/AEM.01802-10; Khademi S, 2002, ACTA CRYSTALLOGR D, V58, P653, DOI 10.1107/S0907444902002366; Yanase S, 2010, BIOTECHNOL J, V5, P449, DOI 10.1002/biot.200900291; Arimori T, 2013, J SYNCHROTRON RADIAT, V20, P884, DOI 10.1107/S0909049513021110; Eckert K, 2002, APPL MICROBIOL BIOT, V60, P428, DOI 10.1007/s00253-002-1131-4; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Schubot FD, 2004, BIOCHEMISTRY-US, V43, P1163, DOI 10.1021/bi030202i; Kataeva IA, 2004, PROTEIN ENG DES SEL, V17, P759, DOI 10.1093/protein/gzh094; Mandelman D, 2003, J BACTERIOL, V185, P4127, DOI 10.1128/JB.185.14.4127-4135.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Brethauer S, 2010, BIORESOURCE TECHNOL, V101, P4862, DOI 10.1016/j.biortech.2009.11.009; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; CHAUVAUX S, 1995, J BIOL CHEM, V270, P9757, DOI 10.1074/jbc.270.17.9757; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Eckert K, 2009, J MOL BIOL, V394, P61, DOI 10.1016/j.jmb.2009.08.060; Kesavulu MM, 2012, ACTA CRYSTALLOGR D, V68, P310, DOI 10.1107/S0907444912001990; Kurokawa J, 2002, APPL MICROBIOL BIOT, V59, P455, DOI 10.1007/s00253-002-1048-y; lasGrange DC, 2010, APPL MICROBIOL BIOT, V87, P1195; Liu HB, 2010, FEBS LETT, V584, P3431, DOI 10.1016/j.febslet.2010.06.041; Miller G. L., 1960, ANAL BIOCHEM, V2, P127, DOI DOI 10.1016/0003-2697(60)90004-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okano H, 2014, FEBS OPEN BIO, V4, P936, DOI 10.1016/j.fob.2014.10.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsiegla G, 2002, BIOCHEMISTRY-US, V41, P11134, DOI 10.1021/bi025816m; Pereira JH, 2009, ACTA CRYSTALLOGR D, V65, P744, DOI 10.1107/S0907444909012773; Yamada R, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-34	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	MAR	2015	24	3					408	419		10.1002/pro.2632		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CC1ZQ	WOS:000350144400014		
J	Sugaya, N; Izawa, S; Yamamoto, R; Ogawa, N; Yajima, J; Okamura, H; Horiuchi, S; Tsuda, A; Nomura, S				Sugaya, Nagisa; Izawa, Shuhei; Yamamoto, Ryuichiro; Ogawa, Namiko; Yajima, Jumpei; Okamura, Hisayoshi; Horiuchi, Satoshi; Tsuda, Akira; Nomura, Shinobu			Salivary 3-methoxy-4-hydroxyphenylglycol increases after awakening in healthy young adults	PSYCHOPHYSIOLOGY			English	Article						MHPG; Saliva; Awakening; Central noradrenergic metabolism	DEPRESSIVE SYMPTOMS; VOLUNTEERS; RESPONSES; CORTISOL; MHPG	Levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) may reflect central noradrenergic activity. In this study, we investigated salivary MHPG changes after awakening, and explored their relationships with cortisol and peripheral autonomic activity. The participants were 25 college students. Saliva samples were collected on awakening and 30min after awakening to determine MHPG and cortisol. Ambulatory electrocardiograms were obtained to assess heart rate, cardiac sympathetic index (CSI), and cardiac vagal index (CVI) before and after awakening. MHPG levels increased significantly during the first 30min after awakening. Similarly, cortisol, heart rate, and CSI increased during the 30min after awakening, but changes in MHPG did not correlate with changes in cortisol, heart rate, CSI, and CVI during that period. This study demonstrated that salivary MHPG levels increase after awakening, in common with cortisol, heart rate, and cardiac sympathetic activity.	[Sugaya, Nagisa] Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Yokohama, Kanagawa 2360004, Japan; [Izawa, Shuhei] Natl Inst Occupat Safety & Hlth, Hlth Adm & Psychosocial Factor Res Grp, Kawasaki, Kanagawa, Japan; [Yamamoto, Ryuichiro] Joetsu Univ Educ, Grad Sch Educ, Div Clin Psychol Hlth Care & Special Support, Joetsu, Japan; [Ogawa, Namiko] Waseda Univ, Grad Sch Human Sci, Tokorozawa, Saitama, Japan; [Yajima, Jumpei] Beppu Univ, Dept Human Studies, Beppu, Oita, Japan; [Okamura, Hisayoshi] Kurume Univ, Cognit & Mol Res Inst Brain Dis, Kurume, Fukuoka 830, Japan; [Horiuchi, Satoshi] Japan Soc Promot Sci, Tokyo, Japan; [Horiuchi, Satoshi] Hlth Sci Univ Hokkaido, Sapporo, Hokkaido, Japan; [Tsuda, Akira] Kurume Univ, Fac Literature, Kurume, Fukuoka 830, Japan; [Nomura, Shinobu] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan	Sugaya, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	nagisa618@gmail.com					Hamer M, 2012, STRESS, V15, P562, DOI 10.3109/10253890.2011.648247; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Hamer M, 2007, BIOL PSYCHOL, V74, P20, DOI 10.1016/j.biopsycho.2006.06.003; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; Toichi M, 1997, J AUTONOM NERV SYST, V62, P79, DOI 10.1016/S0165-1838(96)00112-9; Schmidt-Reinwald A, 1999, LIFE SCI, V64, P1653, DOI 10.1016/S0024-3205(99)00103-4; Chamberlain SR, 2007, J PSYCHOPHARMACOL, V21, P545, DOI 10.1177/0269881106075274; Cubala WJ, 2014, J AFFECT DISORDERS, V161, P4, DOI 10.1016/j.jad.2014.02.041; DRICI MD, 1991, CLIN EXP PHARMACOL P, V18, P807, DOI 10.1111/j.1440-1681.1991.tb01399.x; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; Ministry of Health, 2011, NAT HLTH NUTR SURV; Okamura H, 2010, INT J PSYCHOPHYSIOL, V78, P209, DOI 10.1016/j.ijpsycho.2010.07.010; Steriade M, 2005, BRAIN CONTROL WAKEFU; Yajima J, 2001, BIOGENIC AMINES, V16, P173	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	MAR	2015	52	3					425	428		10.1111/psyp.12330		4	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CC0QD	WOS:000350039700014		
J	Matsuda, I; Ogawa, T; Tsuneoka, M; Verschuere, B				Matsuda, Izumi; Ogawa, Tokihiro; Tsuneoka, Michiko; Verschuere, Bruno			Using pretest data to screen low-reactivity individuals in the autonomic-based concealed information test	PSYCHOPHYSIOLOGY			English	Article						Concealed information test (CIT); Screening; Autonomic responses; Memory detection; Deception; Lie detection		The concealed information test (CIT) can be used to assess whether an individual possesses crime-related information. However, its discrimination performance has room for improvement. We examined whether screening out participants who do not respond distinctively on a pretest improves the diagnosticity of a mock-crime CIT. Before conducting the CIT, we gave a pretest to 152 participants, 80 of whom were assigned as guilty. Pretest screening significantly improved the diagnostic value of the mock-crime CIT; however, it also led to a substantial number of undiagnosed participants (33.6%). Pretest screening holds promise, but its application would benefit from dedicated measures for screening out participants.	[Matsuda, Izumi; Ogawa, Tokihiro; Tsuneoka, Michiko] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan; [Verschuere, Bruno] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Verschuere, Bruno] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Verschuere, Bruno] Maastricht Univ, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands	Matsuda, I (reprint author), Natl Res Inst Police Sci, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	izumi@nrips.go.jp					LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; Ben-Shakhar G, 2003, J APPL PSYCHOL, V88, P131, DOI 10.1037/0021-9010.88.1.131; Matsuda I, 2011, PSYCHOPHYSIOLOGY, V48, P1701, DOI 10.1111/j.1469-8986.2011.01266.x; Sawada Y, 2001, INT J PSYCHOPHYSIOL, V41, P1, DOI 10.1016/S0167-8760(00)00162-8; Noordraven E, 2013, APPL COGNITIVE PSYCH, V27, P328, DOI 10.1002/acp.2910; Gamer M, 2008, PHYSIOL BEHAV, V95, P333, DOI 10.1016/j.physbeh.2008.06.011; Matsuda I, 2006, BIOL PSYCHOL, V73, P157, DOI 10.1016/j.biopsycho.2006.01.013; Matsuda I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00532; Ogawa T., 2013, JAPANESE J FORENSIC, V18, P35; Rosenfeld J. P., 2011, MEMORY DETECTION THE, P63, DOI DOI 10.1017/CBO9780511975196.005; Verschuere B., 2011, MEMORY DETECTION THE	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	MAR	2015	52	3					436	439		10.1111/psyp.12328		4	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CC0QD	WOS:000350039700016		
J	Kawakubo, K; Kawakami, H; Kuwatani, M; Sakamoto, N				Kawakubo, Kazumichi; Kawakami, Hiroshi; Kuwatani, Masaki; Sakamoto, Naoya			Incidental Pancreatic Cyst is a Significant Predictor of Mortality? What Determines Life Expectancy?	RADIOLOGY			English	Letter							PAPILLARY MUCINOUS NEOPLASM; EXTRAPANCREATIC MALIGNANCIES; LESIONS; CANCER; RISK		[Kawakubo, Kazumichi; Kawakami, Hiroshi; Kuwatani, Masaki; Sakamoto, Naoya] Hokkaido Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0808638, Japan	Kawakubo, K (reprint author), Hokkaido Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kita Ku, Kita15 Nishi7, Sapporo, Hokkaido 0808638, Japan.	kkawakubo-gi@umin.ac.jp	Kawakubo, Kazumichi/F-2937-2011				Tada M, 2006, CLIN GASTROENTEROL H, V4, P1265, DOI 10.1016/j.cgh.2006.07.013; Chernyak V, 2015, RADIOLOGY, V274, P161, DOI 10.1148/radiol.14140796; Tateishi K, 1999, GUT, V45, P737; Kawakubo K, 2013, PANCREAS, V42, P687, DOI 10.1097/MPA.0b013e318270ea97; Kawakubo K, 2014, CLIN GASTROENTEROL H, V12, P486, DOI 10.1016/j.cgh.2013.06.032; Kawakubo K, 2011, GUT, V60, P1249, DOI 10.1136/gut.2010.227306; Larghi A, 2013, ANN ONCOL, V24, P1907, DOI 10.1093/annonc/mdt184	7	0	0	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	MAR	2015	274	3					939	939		10.1148/radiol.14141965		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB9YK	WOS:000349990500039		
J	Ono, N; Niiro, H; Ueda, A; Sawabe, T; Nishizaka, H; Furugo, I; Yoshizawa, S; Yoshizawa, S; Tsukamoto, H; Kiyohara, C; Tada, Y; Horiuchi, T				Ono, Nobuyuki; Niiro, Hiroaki; Ueda, Akira; Sawabe, Takuya; Nishizaka, Hiroaki; Furugo, Isao; Yoshizawa, Seiji; Yoshizawa, Shigeru; Tsukamoto, Hiroshi; Kiyohara, Chikako; Tada, Yoshifumi; Horiuchi, Takahiko			Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan	RHEUMATOLOGY INTERNATIONAL			English	Article						MPO-ANCA; Granulomatosis with polyangiitis; Microscopic polyangiitis; ANCA-associated vasculitis	MICROSCOPIC POLYANGIITIS; WEGENERS-GRANULOMATOSIS; SYSTEMIC VASCULITIS; CLINICAL-FEATURES; DISEASE; MYELOPEROXIDASE; CLASSIFICATION; COHORT; KOREA	We studied the clinico-pathological differences among PR3-ANCA-positive granulomatosis with polyangiitis (PR3-GPA), MPO-ANCA-positive GPA (MPO-GPA) and microscopic polyangiitis (MPA). ANCA-associated vasculitis (AAV) was classified using the European Medicines Agency classification. We retrospectively analyzed 38 patients with GPA and 41 with MPA treated in eight hospitals in Japan. Of the patients with GPA, 17 were positive for MPO-ANCA, and 15 for PR3-ANCA. All patients with MPA were MPO-ANCA positive. The mean ages of those with MPO-GPA were 69.6 years old, 10 years older than those with PR3-GPA. The majority (82 %) of patients with MPO-GPA were woman, a significantly greater proportion than for PR3-GPA. We also found that ear, nose and throat (ENT), nervous system involvement were significantly more common in MPO-GPA, but renal function was less impaired than those with MPA. Both PR3-GPA and MPO-GPA relapsed more frequently than MPA, but overall survival was significantly better (P < 0.01 and P < 0.05, respectively). Univariate analysis identified the following factors as predictors of a poor prognosis: MPA (P < 0.01), pulmonary UIP pattern (P < 0.005) Cr a parts per thousand yen 1.7 mg/dl (P < 0.01) and absence of ENT involvement (P < 0.05), which were characteristics of MPA. In our cohort, MPO-GPA was most likely to affect older women and was associated with otitis media, nervous system involvement, mild renal impairment and more favorable outcome. It is clinically useful to differentiate MPO-GPA from MPA and PR3-GPA in patients with AAV.	[Ono, Nobuyuki; Tada, Yoshifumi] Saga Univ, Dept Rheumatol, Fac Med, Saga 8498501, Japan; [Ono, Nobuyuki; Ueda, Akira] Miyazaki Prefectural Miyazaki Hosp, Dept Internal Med, Miyazaki, Japan; [Niiro, Hiroaki; Tsukamoto, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Sawabe, Takuya] Hiroshima Red Cross Hosp, Dept Rheumatol, Hiroshima, Japan; [Nishizaka, Hiroaki] Kitakyushu Med Ctr, Dept Rheumatol, Kitakyushu, Fukuoka, Japan; [Furugo, Isao] JR Kyushu Hosp, Dept Rheumatol, Kitakyushu, Fukuoka, Japan; [Yoshizawa, Seiji] Hamanomachi Hosp, Dept Rheumatol, Fukuoka, Japan; [Yoshizawa, Seiji] Fukuoka Natl Hosp, Dept Rheumatol, Fukuoka, Japan; [Kiyohara, Chikako] Kyushu Univ, Grad Sch Med Sci, Dept Publ Hlth, Fukuoka 812, Japan; [Horiuchi, Takahiko] Kyushu Univ, Beppu Hosp, Dept Rheumatol, Beppu, Oita, Japan	Ono, N (reprint author), Saga Univ, Dept Rheumatol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	nono@cc.saga-u.ac.jp					Furuta S, 2014, J RHEUMATOL, V41, P325, DOI 10.3899/jrheum.130602; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Liu LJ, 2008, RHEUMATOLOGY, V47, P708, DOI 10.1093/rheumatology/ken079; Arulkumaran N, 2011, RHEUMATOLOGY, V50, P2035, DOI 10.1093/rheumatology/ker236; Mahr A, 2001, RHEUMATOLOGY, V40, P492, DOI 10.1093/rheumatology/40.5.492; Guillevin L, 2011, MEDICINE, V90, P19, DOI 10.1097/MD.0b013e318205a4c6; Kim HW, 2013, MOD RHEUMATOL, V23, P864, DOI 10.1007/s10165-012-0754-2; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Watts Richard, 2007, Ann Rheum Dis, V66, P222, DOI 10.1136/ard.2006.054593; Mohammad AJ, 2007, RHEUMATOLOGY, V46, P1329, DOI 10.1093/rheumatology/kem107; Guillevin L, 1999, ARTHRITIS RHEUM, V42, P421, DOI 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Yamagata K, 2012, CLIN EXP NEPHROL, V16, P580, DOI 10.1007/s10157-012-0598-2; Lane SE, 2005, QJM-INT J MED, V98, P97, DOI 10.1093/qjmed/hci015; Oh JS, 2009, J KOREAN MED SCI, V24, P269, DOI 10.3346/jkms.2009.24.2.269; Ono N, 2013, MOD RHEUMATOL, V23, P554, DOI 10.1007/s10165-012-0682-1; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Yokoseki A, 2014, BRAIN, V137, P520, DOI 10.1093/brain/awt314	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	MAR	2015	35	3					555	559		10.1007/s00296-014-3106-z		5	Rheumatology	Rheumatology	CC0OP	WOS:000350035600022		
J	Ma, GC; Sawada, K; Yashima, A; Saito, H				Ma, Gui-Chen; Sawada, Kazuhide; Yashima, Atsushi; Saito, Hideki			Experimental Study of the Applicability of the Remotely Positioned Laser Doppler Vibrometer to Rock-Block Stability Assessment	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Rock slope; Risks and hazards; Rock failure; Rock mass; Stability analysis; Vibration measurement; Laser Doppler Vibrometer		This paper examines a new method for evaluating the stability of rock blocks on slopes using a remotely positioned Laser Doppler Vibrometer (LDV). A series of experiments using physical models were conducted to evaluate the validity of this new method. Based on the experimental studies, the applicability of LDV was examined by comparing results with a conventional seismometer measurement. To examine the quantitative correlations between vibration properties and the stability of a rock block, the effects on the vibration properties of the size of the rock block, the initial block position, the slope incline, and the type of ground surface were studied. The experimental results showed that LDV measurements agreed with conventional seismometer measurements. There was also a good correlation between vibration properties and rock-block stability. On the other hand, it was found that for a boulder on tightly compacted ground, the application of block stability assessment by tonometry was difficult when measuring microtremors or sloppy vibration due to nearby vehicle traffic. Furthermore, numerical analysis of the slope model was carried out to examine the validity of the model experiment and application of the suggested technique. The results of the analysis demonstrated that the suggested technique was effective for application to stability monitoring of a block and evaluation of the effect of stability measures.	[Ma, Gui-Chen; Saito, Hideki] OYO Corp, Engn Headquarters, Saitama, Japan; [Sawada, Kazuhide; Yashima, Atsushi] Gifu Univ, Dept Civil Engn, Gifu, Japan	Ma, GC (reprint author), OYO Corp, Engn Headquarters, Saitama, Japan.	ma-gc@oyonet.oyo.co.jp			Committee on Advanced Road Technology (CARD), Ministry of Land, Infrastructure, Transport and Tourism, Japan	This study has been supported by a program of the Committee on Advanced Road Technology (CARD), Ministry of Land, Infrastructure, Transport and Tourism, Japan.	Hayashi K, 2001, P 104 C SEGJ, P16; Kanda M, 2007, J JPN LANDSLIDE SOC, V44, P175, DOI 10.3313/jls.44.175; Ma G, 2011, 12 INT C ROCK MECH B, P1049; Ma G, 2009, 44 JAP NAT C GEOT EN, P157; Ma G, 1998, KAYAK GAKKAISHI, V59, P49; Ma G, 2007, P ICADD 8 BEIJ, P285; Ma G, 2011, P 40 S ROCK MECH COM, P339; Ma G, 2007, J JAPAN SOC CIVIL EN, V63, P913; Ma G, 2011, P 41 S ROCK MECH COM, P247; Ma GC, 2008, 3RD INTERNATIONAL SYMPOSIUM ON MODERN MINING & SAFETY TECHNOLOGY PROCEEDINGS, P67; Monma K, 2002, J JPN LANDSLIDE SOC, V39, P62; Monma K, 2004, J JPN SOC CIVIL ENG, V757, P45; Ogata K, 2003, J JPN SOC CIVIL ENG, V749, P123; Uehan F, 2006, J JPN COCRATE, V44, P77	14	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	MAR	2015	48	2					787	802		10.1007/s00603-014-0577-x		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CB8ON	WOS:000349889700023		
J	Hashiba, K; Fukui, K				Hashiba, K.; Fukui, K.			Index of Loading-Rate Dependency of Rock Strength	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Time-dependent behavior; Loading-rate dependency; Creep; Variability of strength; Size effect	STRAIN-RATE; UNIAXIAL COMPRESSION; JAPANESE ROCKS; GRANITE; DEFORMATION; FAILURE		[Hashiba, K.; Fukui, K.] Univ Tokyo, Dept Syst Innovat, Bunkyo Ku, Tokyo 1138656, Japan	Hashiba, K (reprint author), Univ Tokyo, Dept Syst Innovat, Bunkyo Ku, Tokyo 1138656, Japan.	hashiba@sys.t.u-tokyo.ac.jp					OLSSON WA, 1991, INT J ROCK MECH MIN, V28, P115, DOI 10.1016/0148-9062(91)93241-W; Cho SH, 2003, INT J ROCK MECH MIN, V40, P763, DOI 10.1016/S1365-1609(03)00072-8; Masuda K, 2001, J STRUCT GEOL, V23, P1653, DOI 10.1016/S0191-8141(01)00022-0; GOLDSMITH W, 1976, INT J ROCK MECH MIN, V13, P303, DOI 10.1016/0148-9062(76)91829-5; Bazant ZP, 1999, ARCH APPL MECH, V69, P703, DOI 10.1007/s004190050252; BRACE WF, 1971, J GEOPHYS RES, V76, P4913, DOI 10.1029/JB076i020p04913; Fujita Y, 2000, J MMIJ, V116, P565; Hashiba K, 2013, ROCK MECHANICS FOR RESOURCES, ENERGY AND ENVIRONMENT, P807; Hashiba K, 2006, INT J ROCK MECH MIN, V43, P894, DOI 10.1016/j.ijrmms.2005.12.005; Kajikawa S, 1990, JISHIN, V43, P179; Kobayashi R, 1964, J MIN METALL I JPN, V80, P429; Kobayashi R, 1969, J MIN METALL I JPN, V85, P911; LAJTAI EZ, 1991, ROCK MECH ROCK ENG, V24, P99, DOI 10.1007/BF01032501; MASUDA K, 1987, J PHYS EARTH, V35, P37; Mogi K, 1959, B EARTHQ RES I TOKYO, V37, P155; Mogi K, 1962, B EARTHQ RES I TOKYO, V40, P125; Okubo S, 2013, INT J ROCK MECH MIN, V58, P180, DOI 10.1016/j.ijrmms.2012.09.003; OKUBO S, 1985, INT J ROCK MECH MIN, V22, P323, DOI 10.1016/0148-9062(85)92064-9; SANGHA CM, 1975, INT J ROCK MECH MIN, V12, P277, DOI 10.1016/0148-9062(75)91085-2; SANO O, 1981, J GEOPHYS RES, V86, P9299, DOI 10.1029/JB086iB10p09299; Shin K, 2005, INT J ROCK MECH MIN, V42, P251, DOI 10.1016/j.ijrmms.2004.08.009; WILKINS BJS, 1980, INT J ROCK MECH MIN, V17, P365, DOI 10.1016/0148-9062(80)90520-3; Yamaguchi U, 1991, GANSEKI RIKIGAKU NYU, P114	23	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	MAR	2015	48	2					859	865		10.1007/s00603-014-0597-6		7	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CB8ON	WOS:000349889700028		
J	Koua, FHM; Kimbara, K; Tani, A				Koua, Faisal Hammad Mekky; Kimbara, Kazuhide; Tani, Akio			Bacterial-biota dynamics of eight bryophyte species from different ecosystems	SAUDI JOURNAL OF BIOLOGICAL SCIENCES			English	Article						16S rDNA fragments; Bryophytes; Bacterial community; DGGE analysis; Endophytes; Epiphytes; Moss; Microbial community dynamics	16S RIBOSOMAL-RNA; DIVERSITY; SPHAGNUM; MOSSES; PLANTS; GENUS	Despite the importance of bryophyte-associated microorganisms in various ecological aspects including their crucial roles in the soil-enrichment of organic mass and N-2 fixation, nonetheless, little is known about the microbial diversity of the bryophyte phyllospheres (epi-/endophytes). To get insights into bacterial community structures and their dynamics on the bryophyte habitats in different ecosystems and their potential biological roles, we utilized the 16S rRNA gene PCR-DGGE and subsequent phylogenetic analyses to investigate the bacterial community of eight bryophyte species collected from three distinct ecosystems from western Japan. Forty-two bacterial species belonging to gamma-proteobacteria and Firmicutes with 71.4% and 28.6%, respectively, were identified among 90 DGGE gel band population. These DGGE-bands were assigned to 13 different genera with obvious predomination the genus Clostridium with 21.4% from the total bacterial community. These analyses provide new insights into bryophyte-associated bacteria and their relations to the ecosystems. (C) 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.	[Koua, Faisal Hammad Mekky; Kimbara, Kazuhide; Tani, Akio] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Koua, FHM (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.	faisalkoua@nitech.ac.jp	Koua, Faisal Hammad Mekky/J-5553-2013	Koua, Faisal Hammad Mekky/0000-0001-8371-9587	Japanese Governmental Scholarship (MEXT); Kansai Bureau of economy, trade and industry; bio-oriented technology research advancement institution	We are thankful to Dr. Nishimura N, the Okayama University of Science for his assistance with bryophyte authentication. F. H. M. K. was supported by the Japanese Governmental Scholarship (MEXT). T. A. was supported by the regional new consortium projects of the Kansai Bureau of economy, trade and industry and by the bio-oriented technology research advancement institution.	Cornelissen JHC, 2007, ANN BOT-LONDON, V99, P987, DOI 10.1093/aob/mcm030; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.1890/1540-9295(2005)003[0421:UVAAFE]2.0.CO;2; Crowley KF, 2011, OECOLOGIA, V167, P253, DOI 10.1007/s00442-011-1970-8; Bragina A, 2012, ISME J, V6, P802, DOI 10.1038/ismej.2011.151; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Rochefort L, 2000, BRYOLOGIST, V103, P503, DOI 10.1639/0007-2745(2000)103[0503:SAKGIH]2.0.CO;2; Berg G, 2006, FEMS MICROBIOL ECOL, V56, P250, DOI 10.1111/j.1574-6941.2005.00025.x; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; Minamisawa K, 2004, APPL ENVIRON MICROB, V70, P3096, DOI 10.1128/AEM.70.5.3096-3102.2004; Bragina A, 2013, SCI REP, V3, P1995; Decker E.L., 2003, BIOFORUM EUR, V2, P2; Edwards A., 1995, NATURE, V374, P635; Hornschuh M, 2002, PLANT BIOLOGY, V4, P682, DOI 10.1055/s-2002-37403; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Oliver MJ, 2000, PLANT ECOL, V151, P73, DOI 10.1023/A:1026598724487; Opelt K, 2004, APPL ENVIRON MICROB, V70, P6569, DOI 10.1128/AEM.70.11.65-69.2004; Opelt K, 2007, FEMS MICROBIOL ECOL, V61, P38, DOI 10.1111/j.1574-6941.2007.00323.x; Pharo EJ, 2007, BIOL CONSERV, V135, P315, DOI 10.1016/j.biocon.2006.10.016; Tani A, 2011, J BIOSCI BIOENG, V112, P32, DOI 10.1016/j.jbiosc.2011.03.012; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033800	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1319-562X			SAUDI J BIOL SCI	Saudi J. Biol. Sci.	MAR	2015	22	2					204	210		10.1016/j.sjbs.2014.07.009		7	Biology	Life Sciences & Biomedicine - Other Topics	CB8YE	WOS:000349917500013		
J	Katagiri, N; Pantelis, C; Nemoto, T; Zalesky, A; Hori, M; Shimoji, K; Saito, J; Ito, S; Dwyer, DB; Fukunaga, I; Morita, K; Tsujino, N; Yamaguchi, T; Shiraga, N; Aoki, S; Mizuno, M				Katagiri, Naoyuki; Pantelis, Christos; Nemoto, Takahiro; Zalesky, Andrew; Hori, Masaaki; Shimoji, Keigo; Saito, Junichi; Ito, Shinya; Dwyer, Dominic B.; Fukunaga, Issei; Morita, Keiko; Tsujino, Naohisa; Yamaguchi, Taiju; Shiraga, Nobuyuki; Aoki, Shigeki; Mizuno, Masafumi			A longitudinal study investigating sub-threshold symptoms and white matter changes in individuals with an 'at risk mental state' (ARMS)	SCHIZOPHRENIA RESEARCH			English	Article						At risk mental state; Corpus callosum; Diffusion tensor imaging; Prodrome; Psychosis; White matter integrity	ULTRA-HIGH-RISK; CORPUS-CALLOSUM; ONSET SCHIZOPHRENIA; SPATIAL STATISTICS; PSYCHOSIS; ABNORMALITIES; MRI; CONNECTIVITY; METAANALYSIS; ADOLESCENT	Background: Evidence supports disruption in white matter (WM) connectivity in established schizophrenia, however, it is unclear when these abnormalities occur during the course of illness and if they are progressive. Here we investigated whether WM abnormalities predate illness onset by examining a group of individuals with an 'at risk mental state' (ARMS) and assess whether there is evidence of progressive change. We hypothesized that WM abnormalities are associated with symptom change. Methods: Sixteen healthy controls and 41 ARMS subjects at baseline underwent Diffusion Tensor Imaging (DTI). Sub-threshold positive symptoms were measured using the Scale of Prodromal Symptoms (SOPS). Imaging and symptoms were re-administered in the ARMS group after one year (52 weeks). Fractional anisotropy (FA) value differences between ARMS and control groups at baseline were localized using themethod of Tract-Based Spatial Statistics (TBSS). Results: At baseline, FA was significantly reduced in a sub-region of the corpus callosum (CC) in the ARMS group as a whole compared to controls. This reduction was also found in the 34 individuals who did not transition (ARMS-N) during the one-year follow-up. However, the ARMS-N group showed a significant improvement in sub-threshold positive symptoms at follow-up, which was correlated with an increase in FA in the same CC region (r=-0.664, p < 0.001). Discussion: There was a significant FA reduction in the CC in individuals at high risk for psychosis regardless of transition status at one year. This suggests that WM abnormalities in the CC may represent a biological vulnerability to psychosis. Improvement in sub-threshold positive symptoms was associated with improvement in measures of WM integrity in the CC. This may suggest that neurobiological 'resilience' is associated with improved outcomes, although this notion requires future study. (C) 2015 Elsevier B. V. All rights reserved.	[Katagiri, Naoyuki; Nemoto, Takahiro; Saito, Junichi; Morita, Keiko; Tsujino, Naohisa; Yamaguchi, Taiju; Mizuno, Masafumi] Toho Univ Sch Med, Dept Neuropsychiat, Tokyo 1438541, Japan; [Katagiri, Naoyuki; Pantelis, Christos; Zalesky, Andrew; Dwyer, Dominic B.] Univ Melbourne, Dept Psychiat, Melbourne Neuropsychiat Ctr, Parkville, Vic 3052, Australia; [Katagiri, Naoyuki; Pantelis, Christos; Zalesky, Andrew; Dwyer, Dominic B.] Melbourne Hlth, Parkville, Vic, Australia; [Zalesky, Andrew] Univ Melbourne, Melbourne Sch Engn, Melbourne, Vic, Australia; [Hori, Masaaki; Shimoji, Keigo; Fukunaga, Issei; Aoki, Shigeki] Juntendo Univ Grad Sch Med, Dept Radiol, Tokyo, Japan; [Shimoji, Keigo] Tokyo Metropolitan Geriatr Hosp, Dept Diagnost Radiol, Tokyo 173, Japan; [Ito, Shinya] Toho Univ Sch Med, Dept Social Med, Tokyo 1438541, Japan; [Shiraga, Nobuyuki] Toho Univ Sch Med, Dept Radiol, Tokyo 1438541, Japan	Nemoto, T (reprint author), Toho Univ Sch Med, Dept Neuropsychiat, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	takahiro.nemoto@med.toho-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [21591533]	Public Grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant Number 21591533 to Masafumi Mizuno.	Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Yucel M, 2002, BIOL PSYCHIAT, V52, P15, DOI 10.1016/S0006-3223(02)01312-4; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Bloemen OJN, 2010, PSYCHOL MED, V40, P1297, DOI 10.1017/S0033291709991711; Zalesky A, 2011, MAGN RESON IMAGING, V29, P111, DOI 10.1016/j.mri.2010.06.027; Andreasen NC, 1999, ARCH GEN PSYCHIAT, V56, P781, DOI 10.1001/archpsyc.56.9.781; Yung AR, 2007, SCHIZOPHRENIA BULL, V33, P673, DOI 10.1093/schbul/sbm015; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Highley JR, 1999, BRAIN, V122, P99, DOI 10.1093/brain/122.1.99; Crow TJ, 1998, SCHIZOPHR RES, V30, P111, DOI 10.1016/S0920-9964(97)00139-4; Peters BD, 2010, PSYCHIAT RES-NEUROIM, V181, P44, DOI 10.1016/j.pscychresns.2009.10.008; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Pantelis C, 2014, WORLD PSYCHIATRY, V13, P146, DOI 10.1002/wps.20123; Fornito A, 2006, SCHIZOPHR RES, V88, P192, DOI 10.1016/j.schres.2006.06.034; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Walterfang M, 2011, EXPERT REV NEUROTHER, V11, P971, DOI [10.1586/ern.11.76, 10.1586/ERN.11.76]; Walterfang M, 2006, NEUROSCI BIOBEHAV R, V30, P918, DOI 10.1016/j.neubiorev.2006.02.001; Penades R, 2013, BIOL PSYCHIAT, V73, P1015, DOI 10.1016/j.biopsych.2013.01.017; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Bora E, 2012, PSYCHOL MED, V42, P295, DOI 10.1017/S0033291711001450; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Bleich-Cohen M, 2012, SCHIZOPHR RES, V140, P155, DOI 10.1016/j.schres.2012.06.030; Carletti Francesco, 2012, Schizophr Bull, V38, P1170, DOI 10.1093/schbul/sbs053; Cook Norman D., 2002, VVolume 106, P169; Crow TJ, 2013, PSYCHIAT RES, V210, P1232, DOI 10.1016/j.psychres.2013.07.043; Crow TJ, 2007, INT REV PSYCHIATR, V19, P449, DOI 10.1080/09540260701486282; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045996; Knoche C, 2012, NEUROIMAGE, V59, P926, DOI 10.1016/j.neuroimage.2011.07.088; Lagopoulos J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059108; Mizuno M, 2009, EARLY INTERV PSYCHIA, V3, P5, DOI 10.1111/j.1751-7893.2008.00104.x; Nemoto T, 2012, East Asian Arch Psychiatry, V22, P110; Patel S, 2011, SCHIZOPHR RES, V129, P149, DOI 10.1016/j.schres.2011.03.014; Saito J., ABNORMAL WHITE MATTE; Savadjiev P, 2014, CEREB CORTEX, V24, P1389, DOI 10.1093/cercor/bhs422; Schneiderman JS, 2009, NEUROIMAGE, V45, P662, DOI 10.1016/j.neuroimage.2008.12.057; Serpa MH, 2012, SCHIZOPHR RES, V137, P258, DOI 10.1016/j.schres.2012.02.027; Walterfang M, 2008, BRIT J PSYCHIAT, V193, P210, DOI 10.1192/bjp.bp.107.043463; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	MAR	2015	162	1-3					7	13		10.1016/j.schres.2015.01.002		7	Psychiatry	Psychiatry	CB9QI	WOS:000349966400002		
J	Ohmuro, N; Matsumoto, K; Katsura, M; Obara, C; Kikuchi, T; Hamaie, Y; Sakuma, A; Iizuka, K; Ito, F; Matsuoka, H				Ohmuro, Noriyuki; Matsumoto, Kazunori; Katsura, Masahiro; Obara, Chika; Kikuchi, Tatsuo; Hamaie, Yumiko; Sakuma, Atsushi; Iizuka, Kunio; Ito, Fumiaki; Matsuoka, Hiroo			The association between cognitive deficits and depressive symptoms in at-risk mental state: A comparison with first-episode psychosis	SCHIZOPHRENIA RESEARCH			English	Article						Cognitive function; Psychopathology; Depressive symptoms; First-episode psychosis; At-risk mental state; Ultra-high risk	CLINICAL HIGH-RISK; ULTRA-HIGH-RISK; 1ST EPISODE SCHIZOPHRENIA; JAPANESE VERSION; NEUROCOGNITIVE DEFICITS; META-ANALYSIS; LOBE REGIONS; INDIVIDUALS; PRODROME; METAANALYSIS	Cognitive deficits and a high prevalence of depressive symptoms have been reported in at-risk mental state (ARMS) for psychosis, but the relationships between these variables remain unclear. The Brief Assessment of Cognition in Schizophrenia (BACS) was administered to 50 individuals with ARMS, 50 with first-episode psychosis (FEP), and 30 healthy controls (HC). Clinical symptomswere assessed by the Positive and Negative Syndrome Scale (PANSS) and the Beck Depression Inventory-2nd edition (BDI-II). Composite z-scores in BACS were compared between the three groups. Pearson correlations between composite z-scores on the BACS and indices of clinical symptoms were compared in the ARMS and FEP groups. Themean composite z-scores on the BACS for the ARMS (-2.82) and FEP (-2.85) groups were significantly lower than the HC group (P < 0.001); no differences between the ARMS and FEP groups emerged (P = 0.995). Cognitive deficits and depressive symptoms were significantly correlated in the ARMS group (PANSS depression: r = -0.36, P= 0.010; BDI-II: r = -0.34, P = 0.02), while the correlation between cognitive deficits and negative symptoms was significant in the FEP group (r = -0.46, P = 0.001) and approached significance in the ARMS group (r = -0.25, P = 0.08). The correlation between cognitive deficits and depressive symptoms significantly differed between the ARMS and FEP groups (PANSS depression: Z = 2.50, P = 0.012; BDI-II: Z = 1.96, P = 0.0499). Thus, a relationship between cognitive deficits and depression appears to be specific to ARMS compared to FEP. (C) 2015 Elsevier B.V. All rights reserved.	[Ohmuro, Noriyuki; Matsumoto, Kazunori; Katsura, Masahiro; Hamaie, Yumiko; Sakuma, Atsushi; Matsuoka, Hiroo] Tohoku Univ Hosp, Dept Psychiat, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Matsumoto, Kazunori] Tohoku Univ Grad Sch Med, Dept Prevent Psychiat, Aoba Ku, Sendai, Miyagi, Japan; [Obara, Chika; Kikuchi, Tatsuo; Hamaie, Yumiko; Iizuka, Kunio; Ito, Fumiaki; Matsuoka, Hiroo] Tohoku Univ Grad Sch Med, Dept Psychiat, Aoba Ku, Sendai, Miyagi, Japan; [Ito, Fumiaki] Tohoku Pharmaceut Univ Hosp, Dept Psychiat, Miyagino Ku, Sendai, Miyagi, Japan	Ohmuro, N (reprint author), Tohoku Univ Hosp, Dept Psychiat, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	ohmuro24@yahoo.co.jp; kaz-mat@umin.net; katsura-thk@umin.ac.jp; poaro-obara@carol.ocn.ne.jp; a1mb1032-thk@umin.ac.jp; hama-ie72@umin.ac.jp; asakuma-thk@umin.ac.jp; idee@diana.dti.ne.jp; itof-psy@umin.ac.jp; mtok-thk@umin.ac.jp			Japan Society for the Promotion of Science [22390219, 23791307, 25860984]	This research was supported in part by a Grant-in-Aid for Scientific Research (B) 22390219 and a Grant-in-Aid for Young Scientists (B) 23791307 and 25860984 from the Japan Society for the Promotion of Science.	Aas Monica, 2014, Front Psychiatry, V4, P182, DOI 10.3389/fpsyt.2013.00182; Addington J, 2003, SCHIZOPHR RES, V62, P59, DOI 10.1016/S0920-9964(02)00340-7; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Heydebrand G, 2004, SCHIZOPHR RES, V68, P1, DOI 10.1016/S0920-9964(03)00097-5; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Eastvold AD, 2007, SCHIZOPHR RES, V93, P266, DOI 10.1016/j.schres.2007.03.013; Dominguez MD, 2009, PSYCHOL BULL, V135, P157, DOI 10.1037/a0014415; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; Kim KR, 2011, COMPR PSYCHIAT, V52, P33, DOI 10.1016/j.comppsych.2010.04.010; Frommann I, 2011, SCHIZOPHRENIA BULL, V37, P861, DOI 10.1093/schbul/sbp155; Brewer WJ, 2006, SCHIZOPHRENIA BULL, V32, P538, DOI 10.1093/schbul/sbj077; Katsura M, 2014, SCHIZOPHR RES, V158, P32, DOI 10.1016/j.schres.2014.06.013; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Niendam TA, 2006, SCHIZOPHR RES, V84, P100, DOI 10.1016/j.schres.2006.02.005; Palmier-Claus JE, 2012, PSYCHOL MED, V42, P1003, DOI 10.1017/S0033291711001929; Ruhrmann S, 2010, ARCH GEN PSYCHIAT, V67, P241, DOI 10.1001/archgenpsychiatry.2009.206; Mohamed S, 1999, ARCH GEN PSYCHIAT, V56, P749, DOI 10.1001/archpsyc.56.8.749; Fusar-Poli P, 2013, EUR PSYCHIAT, V28, P315, DOI 10.1016/j.eurpsy.2012.08.002; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bora E, 2014, ACTA PSYCHIAT SCAND, V130, P1, DOI 10.1111/acps.12261; Rubin LH, 2008, NEUROPSYCHOPHARMACOL, V33, P290, DOI 10.1038/sj.npp.1301395; Cornblatt BA, 2007, J CLIN PSYCHIAT, V68, P546; Rund BR, 2004, AM J PSYCHIAT, V161, P466, DOI 10.1176/appi.ajp.161.3.466; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Simon AE, 2007, SCHIZOPHRENIA BULL, V33, P761, DOI 10.1093/schbul/sbm018; Jahshan C, 2010, NEUROPSYCHOLOGY, V24, P109, DOI 10.1037/a0016791; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; van der Gaag M, 2013, SCHIZOPHR RES, V149, P56, DOI 10.1016/j.schres.2013.07.004; Trivedi MH, 2014, J AFFECT DISORDERS, V152, P19, DOI 10.1016/j.jad.2013.09.012; Holtzman CW, 2013, NEUROSCIENCE, V249, P172, DOI 10.1016/j.neuroscience.2012.12.017; Keefe RSE, 2006, SCHIZOPHR RES, V88, P26, DOI 10.1016/j.schres.2006.06.041; Simon AE, 2012, SCHIZOPHR RES, V142, P108, DOI 10.1016/j.schres.2012.09.004; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Yung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0; Pruessner M, 2011, SCHIZOPHR RES, V129, P29, DOI 10.1016/j.schres.2011.03.022; Roth RM, 2004, AM J PSYCHIAT, V161, P157, DOI 10.1176/appi.ajp.161.1.157; Addington J, 2008, SCHIZOPHR RES, V99, P176, DOI 10.1016/j.schres.2007.07.004; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Ucok A, 2013, SCHIZOPHR RES, V151, P265, DOI 10.1016/j.schres.2013.10.030; Baare WFC, 1999, BIOL PSYCHIAT, V45, P1597, DOI 10.1016/S0006-3223(98)00266-2; Beck A. T., 1996, BECK DEPRESSION INVE; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; Brickman AM, 2004, J NERV MENT DIS, V192, P615, DOI 10.1097/01.nmd.0000138229.29157.3e; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; Fusar-Poli P., 2012, SCHIZOPHR B, V40, P120; Fusar-Poli P., 2013, PSYCHOL MED, P1; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Kaneda Y, 2013, SEISHIN IGAKU CLIN P, V55, P167; Lindsberg J, 2009, NORD J PSYCHIAT, V63, P493, DOI 10.3109/08039480903118182; Meyer E. C., 2014, SCHIZOPHR B; Miyakoshi T, 2009, EARLY INTERV PSYCHIA, V3, P123, DOI 10.1111/j.1751-7893.2009.00118.x; Mizuno M, 2009, EARLY INTERV PSYCHIA, V3, P5, DOI 10.1111/j.1751-7893.2008.00104.x; Nelson HE, 1982, NATL ADULT READING T; Nemoto T, 2008, JPN B SOC PSYCHIAT, V17, P188; Ozgurdal S, 2009, J CLIN EXP NEUROPSYC, V31, P392, DOI 10.1080/13803390802206406; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Ziermans T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093994	63	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	MAR	2015	162	1-3					67	73		10.1016/j.schres.2015.01.008		7	Psychiatry	Psychiatry	CB9QI	WOS:000349966400013		
J	Egashira, K; Matsuo, K; Nakashima, M; Watanuki, T; Harada, K; Nakano, M; Matsubara, T; Takahashi, K; Watanabe, Y				Egashira, Kazuteru; Matsuo, Koji; Nakashima, Mami; Watanuki, Toshio; Harada, Kenichiro; Nakano, Masayuki; Matsubara, Toshio; Takahashi, Kanji; Watanabe, Yoshifumi			Blunted brain activation in patients with schizophrenia in response to emotional cognitive inhibition: A functional near-infrared spectroscopy study	SCHIZOPHRENIA RESEARCH			English	Article						Emotion; Near-infrared spectroscopy; Face expression; Cognitive inhibition; Schizophrenia	VENTROLATERAL PREFRONTAL CORTEX; SUPERIOR TEMPORAL SULCUS; NEGATIVE SYNDROME SCALE; VERBAL FLUENCY TASK; JAPANESE VERSION; SOCIAL COGNITION; BIPOLAR DISORDER; NEUTRAL FACES; INDIVIDUALS; RECOGNITION	Introduction: Patients with schizophrenia (SZ) have deficits of facial emotion processing and cognitive inhibition, but the brain pathophysiology underlying these deficits and their interaction are not clearly understood. We tested brain activity during an emotional face go/no-go task that requires rapid executive control affected by emotional stimuli in patients with SZ using functional near-infrared spectroscopy (fNIRS). Methods: Twenty-five patients with SZ and 28 healthy control subjects were studied. We evaluated behavioral performance and used fNIRS to measure oxygenated hemoglobin concentration changes in fronto-temporal areas during the emotional go/no-go task with emotional and non-emotional blocks. Results: Patients with SZ made more errors and had longer reaction times in both test blocks compared with healthy subjects. Significantly greater activation in the inferior, superior, middle, and orbital frontal regions were observed in healthy subjects during the emotional go/no-go block compared to the non-emotional go/no-go block, but this difference was not observed in patients with SZ. Relative to healthy subjects, patients with SZ showed less activation in the superior and orbital frontal and middle temporal regions during the emotional go/no-go block. Discussion: Our results suggest that fronto-temporal dysfunction in patients with SZ is due to an interaction between abnormal processing of emotional facial expressions with negative valence and cognitive inhibition, especially during the rapid selection of rule-based associations that override automatic emotional response tendencies. They indicate that fronto-temporal dysfunction is involved in the pathophysiology of emotional-cognitive deficits in patients with SZ. (C) 2015 Elsevier B.V. All rights reserved.	[Egashira, Kazuteru; Matsuo, Koji; Nakashima, Mami; Watanuki, Toshio; Harada, Kenichiro; Matsubara, Toshio; Watanabe, Yoshifumi] Yamaguchi Univ Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Ube, Yamaguchi 7558505, Japan; [Egashira, Kazuteru] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 8078555, Japan; [Nakashima, Mami] Nagatoichinomiya Hosp, Shimonoseki, Yamaguchi 7510885, Japan; [Nakano, Masayuki; Takahashi, Kanji] Katakura Ube, Yamaguchi 7550151, Japan	Matsuo, K (reprint author), Yamaguchi Univ Grad Sch Med, Dept Neurosci, Div Neuropsychiat, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	kmatsuo@yamaguchi-u.ac.jp			JSPS KAKENHI [21591519, 24591716, 25861011, 25861012]	This was supported by JSPS KAKENHI (grant numbers 21591519 and 24591716 [KM], 25861011 [TM], and 25861012 [TW]).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Surguladze S, 2006, BIOL PSYCHIAT, V60, P423, DOI 10.1016/j.biopsych.2005.11.021; Habel U, 2010, SCHIZOPHR RES, V122, P113, DOI 10.1016/j.schres.2010.06.009; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Chan RCK, 2010, PSYCHIAT RES, V178, P381, DOI 10.1016/j.psychres.2009.03.035; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Wallwork RS, 2012, SCHIZOPHR RES, V137, P246, DOI 10.1016/j.schres.2012.01.031; Roelofs K, 2009, SOC COGN AFFECT NEUR, V4, P50, DOI 10.1093/scan/nsn036; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Roick C, 2004, SOC PSYCH PSYCH EPID, V39, P744, DOI 10.1007/s00127-004-0807-8; Li HJ, 2012, SCHIZOPHR RES, V134, P143, DOI 10.1016/j.schres.2011.10.019; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Schneider F, 2006, AM J PSYCHIAT, V163, P442, DOI 10.1176/appi.ajp.163.3.442; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Seiferth NY, 2008, NEUROIMAGE, V40, P289, DOI 10.1016/j.neuroimage.2007.11.020; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Kiehl KA, 2000, BIOL PSYCHIAT, V48, P210, DOI 10.1016/S0006-3223(00)00834-9; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Park IH, 2008, NEUROSCI LETT, V440, P119, DOI 10.1016/j.neulet.2008.05.094; Volman I, 2011, CURR BIOL, V21, P1766, DOI 10.1016/j.cub.2011.08.050; Adolphs R, 2000, J NEUROSCI, V20, P2683; Nishimura Y, 2011, BRAIN RES, V1370, P194, DOI 10.1016/j.brainres.2010.11.003; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Arce E, 2006, NEUROIMAGE, V32, P704, DOI 10.1016/j.neuroimage.2006.04.189; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Seiferth NY, 2009, NEUROPSYCHOPHARMACOL, V34, P477, DOI 10.1038/npp.2008.93; Li HJ, 2010, SCHIZOPHRENIA BULL, V36, P1029, DOI 10.1093/schbul/sbn190; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Vercammen A, 2012, J PSYCHIATR NEUROSCI, V37, P379, DOI 10.1503/jpn.110088; Okamoto M, 2004, NEUROIMAGE, V21, P1275, DOI 10.1016/j.neuroimage.2003.12.003; Brown MRG, 2012, NEUROIMAGE, V63, P434, DOI 10.1016/j.neuroimage.2012.06.056; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Hall J, 2008, BIOL PSYCHIAT, V64, P70, DOI 10.1016/j.biopsych.2007.12.014; Marwick K, 2008, BRIT MED BULL, V88, P43, DOI 10.1093/bmb/ldn035; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Wessa M, 2007, AM J PSYCHIAT, V164, P638, DOI 10.1176/appi.ajp.164.4.638; Leitman DI, 2011, SOC COGN AFFECT NEUR, V6, P66, DOI 10.1093/scan/nsq018; Beauregard M., 2004, CONSCIOUSNESS EMOTIO; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Damasio A., 2005, DESCARTES ERROR EMOT; Ekman P., 1988, JAPANESE CAUCASIAN F; HOLMESEBER P, 1990, SCHIZOPHRENIA BULL, V16, P157; Kaladjian A, 2007, SCHIZOPHR RES, V97, P184, DOI 10.1016/j.schres.2007.07.033; Kee KS, 2004, SCHIZOPHR RES, V67, P87, DOI 10.1016/S0920-9964(03)00217-2; Laurens KR, 2003, BRAIN, V126, P610, DOI 10.1093/brain/awg056; Matsubara T, 2014, NEUROIMAGE, V85, P489, DOI 10.1016/j.neuroimage.2013.04.098; Matsuo K, 2007, BIPOLAR DISORD, V9, P876; Suda M., 2011, PLOS ONE, V6; Takei Y, 2013, J PSYCHIATR RES, V47, P1581, DOI 10.1016/j.jpsychires.2013.07.029; Todd RM, 2012, DEV COGN NEUROS-NETH, V2, P340, DOI 10.1016/j.dcn.2012.01.004; Trémeau Fabien, 2006, Dialogues Clin Neurosci, V8, P59; Wible C.G., 2012, SCHIZOPHR RES TREAT, V2012, DOI DOI 10.1155/2012/920485; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x	61	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	MAR	2015	162	1-3					196	204		10.1016/j.schres.2014.12.038		9	Psychiatry	Psychiatry	CB9QI	WOS:000349966400032		
J	Takagi, S; Balu, DT; Coyle, JT				Takagi, Shunsuke; Balu, Darrick T.; Coyle, Joseph T.			Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice	SCHIZOPHRENIA RESEARCH			English	Article						Schizophrenia; D-Serine; Serine racemase; Tropomyosin receptor kinase B (TrkB); MK801	HIPPOCAMPAL SYNAPTIC PLASTICITY; SERINE RACEMASE; MOUSE MODEL; ANIMAL-MODEL; SCHIZOPHRENIA; BRAIN; BEHAVIOR; MK-801; RATS; PHENCYCLIDINE	NMDA receptor (NMDAR) hypofunction is a compelling hypothesis for the pathophysiology of schizophrenia, because in part, NMDAR antagonists cause symptoms in healthy adult subjects that resemble schizophrenia. Therefore, NMDAR antagonists have been used as a method to induce NMDAR hypofunction in animals as a pharmacological model of schizophrenia. Serine racemase-null mutant (SR-/-) mice display constitutive NMDAR hypofunction due to the lack of D-serine. SR-/- mice have deficits in tropomyosin-related kinase receptor (TrkB)/Akt signaling and activity regulated cytoskeletal protein (Arc) expression, which mirror what is observed in schizophrenia. Thus, we analyzed these signaling pathways in MK801 sub-chronically (0.15 mg/kg; 5 days) treated adult wild-type mice. We found that in contrast to SR-/- mice, the activated states of downstream signaling molecules, but not TrkB, increased in MK801 treated mice. Furthermore, there is an age-dependent change in the behavioral reaction of people to NMDAR antagonists. We therefore administered the same dosing regimen of MK801 to juvenile mice and compared them to juvenile SR-/- mice. Our findings demonstrate that pharmacological NMDAR antagonism has different effects on TrkB/Akt signaling than genetically-induced NMDAR hypofunction. Given the phenotypic disparity between the MK801 model and schizophrenia, our results suggest that SR-/- mice more accurately reflect NMDAR hypofunction in schizophrenia. (C) 2015 Elsevier B.V. All rights reserved.	[Takagi, Shunsuke] Tokyo Med & Dent Univ Grad Sch, Dept Psychiat & Behav Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Balu, Darrick T.; Coyle, Joseph T.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Takagi, Shunsuke; Balu, Darrick T.; Coyle, Joseph T.] McLean Hosp, Lab Psychiat & Mol Neurosci, Belmont, MA 02478 USA	Coyle, JT (reprint author), Harvard Univ, Sch Med, McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	stakagi@mclean.harvard.edu; joseph_coyle@hms.harvard.edu			Japan Society for the Promotion of Science [S2301]; Phyllis & Jerome Lyle Rappaport Mental Health Research Scholars Award;  [R01MH05190];  [P50MH0G0450];  [1K99MH099252-01A1]	Shunsuke Takagi was supported in part by Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science (S2301). A Phyllis & Jerome Lyle Rappaport Mental Health Research Scholars Award and 1K99MH099252-01A1 (DTB), as well as grants R01MH05190 and P50MH0G0450 (JTC) supported this work.	Seeman P, 2005, MOL PSYCHIATR, V10, P877, DOI 10.1038/sj.mp.4001682; Zou H, 2008, PHARMACOL BIOCHEM BE, V90, P753, DOI 10.1016/j.pbb.2008.06.002; Timms AE, 2013, JAMA PSYCHIAT, V70, P582, DOI 10.1001/jamapsychiatry.2013.1195; Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Adell A, 2012, SCHIZOPHRENIA BULL, V38, P9, DOI 10.1093/schbul/sbr133; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Manahan-Vaughan D, 2008, HIPPOCAMPUS, V18, P125, DOI 10.1002/hipo.20367; Balu DT, 2012, NEUROBIOL DIS, V45, P671, DOI 10.1016/j.nbd.2011.10.006; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; HOFFMAN DC, 1992, J NEURAL TRANSM-GEN, V89, P1, DOI 10.1007/BF01245347; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Balu DT, 2014, NEUROCHEM INT, V75, P76, DOI 10.1016/j.neuint.2014.05.015; Nishikawa T, 2011, J CHROMATOGR B, V879, P3169, DOI 10.1016/j.jchromb.2011.08.030; Javitt DC, 2009, SCHIZOPHRENIA BULL, V35, P1059, DOI 10.1093/schbul/sbp110; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; ITIL T, 1967, CAN PSYCHIAT ASSOC J, V12, P209; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Wiescholleck V, 2013, NEUROPHARMACOLOGY, V74, P48, DOI 10.1016/j.neuropharm.2013.01.001; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Lopez-Gil X, 2007, NEUROPSYCHOPHARMACOL, V32, P2087, DOI 10.1038/sj.npp.1301356; Khella R, 2014, PSYCHOPHARMACOLOGY, V231, P3071, DOI 10.1007/s00213-014-3481-x; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Okabe S, 1998, J NEUROSCI, V18, P4177; DeVito LM, 2011, GENES BRAIN BEHAV, V10, P210, DOI 10.1111/j.1601-183X.2010.00656.x; Morita Y, 2007, BIOL PSYCHIAT, V61, P1200, DOI 10.1016/j.biopsych.2006.07.025; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Balu, 2011, BRAIN RES, V1392, P1; Boulay D., 2013, BEHAV PHARM IN PRESS; Coyle Joseph T, 2010, Dialogues Clin Neurosci, V12, P359; Daya RP, 2014, NEUROPHARMACOLOGY, V77, P325, DOI 10.1016/j.neuropharm.2013.10.001; Eyjolfsson EM, 2006, NEUROCHEM INT, V48, P541, DOI 10.1016/j.neuint.2005.11.019; Hawken ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056105; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kornhuber J, 1997, BIOL PSYCHIAT, V41, P135, DOI 10.1016/S0006-3223(96)00047-9; Park Joon-Ki, 2014, J Exerc Rehabil, V10, P15, DOI 10.12965/jer.140088; Puhl M. D., 2014, NEUROBIOL DIS C, V73C, P269, DOI [10.1016/j.nbd.2014.10.009, DOI 10.1016/J.NBD.2014.10.009]; Puhl MD, 2015, NEUROBIOL DIS, V73, P269, DOI 10.1016/j.nbd.2014.10.009; Rabiner EA, 2007, J PSYCHOPHARMACOL, V21, P253, DOI 10.1177/0269881107077767; Sircar R, 2003, PHARMACOL BIOCHEM BE, V74, P943, DOI 10.1016/S0091-3057(03)00025-X	46	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	MAR	2015	162	1-3					216	221		10.1016/j.schres.2014.12.034		6	Psychiatry	Psychiatry	CB9QI	WOS:000349966400035		
J	Takeuchi, H; Suzuki, T; Bies, RR; Remington, G; Mamo, DC; Pollock, BG; MasaruMimura; Uchida, H				Takeuchi, Hiroyoshi; Suzuki, Takefumi; Bies, Robert R.; Remington, Gary; Mamo, David C.; Pollock, Bruce G.; MasaruMimura; Uchida, Hiroyuki			Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: An analysis of the CATIE data (vol 150, pg 373, 2013)	SCHIZOPHRENIA RESEARCH			English	Correction									[Takeuchi, Hiroyoshi; Suzuki, Takefumi; MasaruMimura; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Takeuchi, Hiroyoshi; Remington, Gary] Ctr Addict & Mental Hlth, Schizophrenia Div, Complex Mental Illness Program, Toronto, ON, Canada; [Takeuchi, Hiroyoshi; Remington, Gary; Mamo, David C.; Pollock, Bruce G.] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Bies, Robert R.; Mamo, David C.; Pollock, Bruce G.; Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada; [Bies, Robert R.] Indiana Univ Sch Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA; [Bies, Robert R.] Indiana Clin & Translat Sci Inst, Indianapolis, IN USA; [Remington, Gary; Pollock, Bruce G.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada	Takeuchi, H (reprint author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	hirotak@dk9.so-net.ne.jp	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036			Takeuchi H, 2013, SCHIZOPHR RES, V150, P373, DOI 10.1016/j.schres.2013.08.033	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	MAR	2015	162	1-3					296	296		10.1016/j.schres.2015.01.011		1	Psychiatry	Psychiatry	CB9QI	WOS:000349966400047		
J	Kawada, T				Kawada, Tomoyuki			Validation study on sleep parameters by actigraphy for normal subjects	SLEEP AND BREATHING			English	Letter							INSOMNIA		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Peterson BT, 2012, SLEEP MED, V13, P419, DOI 10.1016/j.sleep.2011.12.003; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lichstein KL, 2006, SLEEP, V29, P232; Natale V, 2014, SLEEP MED, V15, P111, DOI 10.1016/j.sleep.2013.08.792; O'Hare E, 2015, SLEEP BREATH, V19, P91, DOI 10.1007/s11325-014-0967-z	5	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	MAR	2015	19	1					11	11		10.1007/s11325-014-0977-x		1	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CB9WG	WOS:000349983900006		
J	Takeuchi, S; Kitamura, T; Ohbuchi, T; Koizumi, H; Takahashi, R; Hohchi, N; Suzuki, H				Takeuchi, Shoko; Kitamura, Takuro; Ohbuchi, Toyoaki; Koizumi, Hiroki; Takahashi, Risa; Hohchi, Nobusuke; Suzuki, Hideaki			Relationship between sleep apnea and thyroid function	SLEEP AND BREATHING			English	Article						Sleep apnea; Thyroid function; Thyroid-stimulating hormone; Triiodothyronine; Thyroxine; Mean apnea duration	SUBCLINICAL HYPOTHYROIDISM; PREVALENCE	Sleep apnea is sometimes associated with hypothyroidism, but the significance of thyroid function screening in sleep apnea patients has been controversial. In the present study, we investigated the relationship between thyroid function and sleep apnea in subjects who were suspected to have sleep apnea. We enrolled 156 consecutive subjects suspected of having sleep apnea. Subjects included 117 men and 39 women aged 21 to 84 years. They underwent nocturnal multichannel polysomnography during a one-night hospitalization. The examined indices of sleep apnea were apnea-hypopnea index (AHI), lowest oxygen saturation, oxygen desaturation index, longest apnea duration, mean apnea duration, and the percent of apnea time to sleep time. Serum thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) were concomitantly measured by electrochemiluminescence immunoassays. Three subjects (1.9 %) were diagnosed with primary hypothyroidism (high TSH and low FT4), and one subject (0.6 %) with subclinical hypothyroidism (high TSH and normal FT4). No significant difference in the level of TSH, FT3, or FT4 was seen among subjects with different severity of sleep apnea. The mean apnea duration significantly correlated with TSH in both simple and multiple regression analyses. Subjects with lower FT3 (a parts per thousand currency sign3.75 pg/ml) showed longer mean apnea time compared to those with higher FT3 (> 3.75 pg/ml) (24.9 +/- 0.8 vs. 20.2 +/- 1.2 s; P = 0.009). The other indices of sleep apnea did not show significant correlation with thyroid function. These results suggest that the mean apnea duration and TSH/FT3 may be helpful in understanding reciprocity between the two disease states, and for evaluating the validity of thyroid function tests in patients with sleep apnea.	[Takeuchi, Shoko; Kitamura, Takuro; Ohbuchi, Toyoaki; Koizumi, Hiroki; Takahashi, Risa; Hohchi, Nobusuke; Suzuki, Hideaki] Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Suzuki, H (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	suzuhyde@med.uoeh-u.ac.jp					Jha A, 2006, SLEEP MED, V7, P55, DOI 10.1016/j.sleep.2005.05.003; Resta O, 2004, NUTR METAB CARDIOVAS, V14, P248, DOI 10.1016/S0939-4753(04)80051-6; RAJAGOPAL KR, 1984, ANN INTERN MED, V101, P491; Bahammam SA, 2011, RESP MED, V105, P1755, DOI 10.1016/j.rmed.2011.07.007; GRUNSTEIN RR, 1988, AM J MED, V85, P775; Iber C, 2007, AASM MANUAL SCORING; Kapur VK, 1998, AM J RESP CRIT CARE, V158, P1379; KITTLE WM, 1988, SOUTHERN MED J, V81, P1421; LIN CC, 1992, CHEST, V102, P1663, DOI 10.1378/chest.102.6.1663; Mickelson S A, 1999, Ear Nose Throat J, V78, P768; Miller Chad M, 2003, Sleep Breath, V7, P185, DOI 10.1007/s11325-003-0185-6; PELTTARI L, 1994, J INTERN MED, V236, P177; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Resta O, 2005, J ENDOCRINOL INVEST, V28, P893; Sakellaropoulou AV, 2011, INT J IMMUNOPATH PH, V24, P377; Winkelman JW, 1996, SLEEP, V19, P790	16	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	MAR	2015	19	1					85	89		10.1007/s11325-014-0966-0		5	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CB9WG	WOS:000349983900022		
J	Yagi, K; Lowe, AA; Ayas, NT; Fleetham, JA; Almeida, FR				Yagi, Kazutomo; Lowe, Alan A.; Ayas, Najib T.; Fleetham, John A.; Almeida, Fernanda R.			Swallowing and breathing patterns during sleep in patients with obstructive sleep apnea	SLEEP AND BREATHING			English	Article						Swallowing; Arousal; Breathing route; Obstructive sleep apnea; Apnea-hypopnea index	POSITIVE AIRWAY PRESSURE; SURFACE-TENSION; LINING LIQUID; HUMAN INFANTS; NASAL; DEGLUTITION; ASPIRATION; FREQUENCY; LARYNGEAL; ADULTS	The aims of this study were to determine the frequencies of swallowing and swallowing associated with arousals during sleep in patients with obstructive sleep apnea (OSA) and to determine whether these were associated with the severity of OSA and differed according to the preceding breathing route. Standard audio-video polysomnography including an evaluation of swallowing-related elevation of the thyroid cartilage and breathing route (i.e., nasal or oronasal) was undertaken in an academic sleep laboratory. Fifty-six patients were analyzed (13 non-OSA patients, 17 mild, 10 moderate, and 16 severe OSA). The frequency of swallowing per hour of sleep was significantly higher in the severe OSA patients when compared to mild OSA patients (mild OSA, 3.1/h and severe OSA, 8.4/h). This was mainly due to the significantly higher frequency of swallowing associated with a respiratory event-related arousal in the severe OSA patients when compared to non- and mild OSA patients (non-OSA, 0.6/h; mild OSA, 1.0/h; severe OSA, 6.0/h), especially when swallowing was preceded by oronasal breathing (non-OSA, 0.2/h; mild OSA, 0.4/h; severe OSA, 4.2/h). Swallowing frequency during sleep can increase with increasing OSA severity in most OSA patients. These events are predominately associated with respiratory event-related arousals and are more frequent when preceded by oronasal breathing. The observed swallowing under high ventilatory needs may compromise the maintenance of the pharynx as a conduit for airflow in OSA patients.	[Yagi, Kazutomo; Lowe, Alan A.; Almeida, Fernanda R.] Univ British Columbia, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada; [Yagi, Kazutomo] Univ Tokushima, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Inst Hlth Biosci, Tokushima 7708504, Japan; [Ayas, Najib T.; Fleetham, John A.] Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada	Yagi, K (reprint author), Univ Tokushima, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Inst Hlth Biosci, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	yagi_k@tokushima-u.ac.jp			MITACS ACCELERATE BC	The authors would like to thank the sleep technologists for their assistance in data collection, Mrs. Mary Wong for her assistance in the software and statistical analysis, Miss Sandra Harrison for her assistance in the preparation of experimental equipments, and Miss Adrian Carney for her editorial assistance in the final preparation of this manuscript. The first author was supported as a postdoctoral fellow, in part, by MITACS ACCELERATE BC.	Flemons WW, 1999, SLEEP, V22, P667; WILSON SL, 1981, J APPL PHYSIOL, V50, P851; Don GW, 2003, J APPL PHYSIOL, V94, P2456, DOI 10.1152/japplphysiol.00361.2002; Dube C, 2004, J DENT RES, V83, P398; Sato K, 2006, ANN OTO RHINOL LARYN, V115, P334; Miyawaki S, 2003, SLEEP, V26, P461; Ruhle KH, 2008, RESPIRATION, V76, P40, DOI 10.1159/000111806; Kirkness JP, 2005, SLEEP, V28, P457; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; MILLER AJ, 1982, PHYSIOL REV, V62, P129; Bachour A, 2004, CHEST, V126, P1248, DOI 10.1378/chest.126.4.1248; Nguyen ATD, 2005, SLEEP, V28, P585; Tsuda H, 2011, J CLIN SLEEP MED, V7, P181; Beal M, 2004, LARYNGOSCOPE, V114, P965, DOI 10.1097/00005537-200406000-00002; Bowes G, 1984, SLEEP BREATH, P137; Fitzpatrick MF, 2003, J APPL PHYSIOL, V94, P883, DOI 10.1152/japplphysiol.00658.2002; FREIDIN N, 1991, GUT, V32, P1275, DOI 10.1136/gut.32.11.1275; GLEESON K, 1986, AM REV RESPIR DIS, V134, P115; Iber C, 2007, AASM MANUAL SCORING; Koutsourelakis I, 2006, EUR RESPIR J, V28, P1222, DOI 10.1183/09031936.00058406; LEAR C. S. C., 1965, ARCH ORAL BIOL, V10, P83, DOI 10.1016/0003-9969(65)90060-9; LICHTER I, 1975, ELECTROEN CLIN NEURO, V38, P427, DOI 10.1016/0013-4694(75)90267-9; Madronio MR, 2004, EUR RESPIR J, V24, P71, DOI 10.1183/09031936.04.00004303; Mathew OP, 1988, RESP FUNCTION UPPER, P535; MATHEW OP, 1982, J APPL PHYSIOL, V52, P445; MENON AP, 1984, AM REV RESPIR DIS, V130, P969; Nixon GM, 2008, RESP PHYSIOL NEUROBI, V160, P76, DOI 10.1016/j.resp.2007.08.010; Sato K, 2009, ANN OTO RHINOL LARYN, V118, P30; Verma M, 2006, J PHYSIOL-LONDON, V574, P859, DOI 10.1113/jphysiol.2005.102129	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	MAR	2015	19	1					377	384		10.1007/s11325-014-1031-8		8	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CB9WG	WOS:000349983900057		
J	Sasao, Y; Nohara, K; Okuno, K; Nakamura, Y; Sakai, T				Sasao, Yasuhiro; Nohara, Kanji; Okuno, Kentaro; Nakamura, Yuki; Sakai, Takayoshi			Videoendoscopic diagnosis for predicting the response to oral appliance therapy in severe obstructive sleep apnea (vol 18, pg 809, 2014)	SLEEP AND BREATHING			English	Correction									[Sasao, Yasuhiro] Ctr Oral Funct Disorders, Sasao Dent Clin, Iwakuni City, Yamaguchi 7400027, Japan; [Nohara, Kanji; Okuno, Kentaro; Nakamura, Yuki; Sakai, Takayoshi] Osaka Univ, Div Oral Facial Disorders, Dent Hosp, Suita, Osaka 5650871, Japan; [Sakai, Takayoshi] Osaka Univ, Grad Sch Dent, Div Oral Facial Disorders, Suita, Osaka 5650871, Japan	Sasao, Y (reprint author), Ctr Oral Funct Disorders, Sasao Dent Clin, 1-23-18 Nakatsumachi, Iwakuni City, Yamaguchi 7400027, Japan.	ysasao@ae.auone-net.jp; nohara@dent.osaka-u.ac.jp					Sasao Y, 2014, SLEEP BREATH, V18, P809, DOI 10.1007/s11325-014-0947-3	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	MAR	2015	19	1					419	420		10.1007/s11325-014-1012-y		2	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CB9WG	WOS:000349983900063		
J	Umehara, M; Takeda, Y; Oh-Ishi, K; Aoki, Y; Motohiro, T; Sakai, T; Maekawa, R				Umehara, Mitsutaro; Takeda, Yasuhiko; Oh-Ishi, Keiichiro; Aoki, Yuko; Motohiro, Tomoyoshi; Sakai, Takenobu; Maekawa, Ryosuke			Energy level diagram around Ge-rich grain boundaries in Cu2Sn1-xGexS3 (CTGS) thin-film solar cells	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						CTGA; CTS; 3DAP; Grain boundary; CZTS; Solar cell	CU2SNS3; TERNARY; FABRICATION	Using a 3-dimensional atom probe (or atom probe tomography) method, we measured the composition ratios around the grain boundaries of Cu2Sn1-xGexS3 (CTGS) films used for the bottom cells of thin-film double-junction solar cells. We found that the Ge composition ratio at the grain boundaries in the CTGS films was higher than that inside the grains when the films were fabricated by co-sputtering depositions of Cu and Sn followed by sulfurizations with S and GeS2 vapors. We also evaluated the bandgaps of Cu2Sn1-xGexS3 with changing the x value by measuring external quantum efficiency spectra of the solar cells. From these results, we have obtained the energy level diagram around the grain boundaries, and revealed that the conduction band minimum at the grain boundaries is 0.05 eV higher than that inside the grains, which suppresses recombination of photogenerated carriers. (C) 2014 Elsevier B.V. All rights reserved.	[Umehara, Mitsutaro; Takeda, Yasuhiko; Oh-Ishi, Keiichiro; Aoki, Yuko; Motohiro, Tomoyoshi] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Sakai, Takenobu; Maekawa, Ryosuke] Toyota Motor Co Ltd, Shizuoka 4101193, Japan	Umehara, M (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	umehara@mosk.tytlabs.co.jp					Zhai YT, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075213; Tiwari D, 2013, SOL ENERG MAT SOL C, V113, P165, DOI 10.1016/j.solmat.2013.02.017; Schwarz T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4788815; Shin B, 2013, PROG PHOTOVOLTAICS, V21, P72, DOI 10.1002/pip.1174; Zoppi G, 2009, PROG PHOTOVOLTAICS, V17, P315, DOI 10.1002/pip.886; Cojocaru-Miredin O, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560308; Wada T, 2012, PROG PHOTOVOLTAICS, V20, P520, DOI 10.1002/pip.2183; Berg DM, 2012, THIN SOLID FILMS, V520, P6291, DOI 10.1016/j.tsf.2012.05.085; Katagiri H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.041201; Su ZH, 2012, J MATER CHEM, V22, P16346, DOI 10.1039/c2jm31669b; KUKU TA, 1987, SOL ENERG MATER, V16, P199, DOI 10.1016/0165-1633(87)90019-0; Choi PP, 2011, J APPL PHYS, V110, DOI 10.1063/1.3665723; Bouaziz M, 2009, THIN SOLID FILMS, V517, P2527, DOI 10.1016/j.tsf.2008.11.039; Avellaneda D, 2010, J ELECTROCHEM SOC, V157, pD346, DOI 10.1149/1.3384660; Chino K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC35; Fernandes P.A., 2010, PHYS STATUS SOLIDI C, V901, P3; HALL RB, 1979, THIN SOLID FILMS, V63, P203, DOI 10.1016/0040-6090(79)90127-5; Kanai A., 2014, 19 INT C TERN MULT C; Koike J, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC34; ENNAOUI A, 1984, SOL CELLS, V13, P197, DOI 10.1016/0379-6787(84)90009-7; Umehara M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.045501; Umehara M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP10	22	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	MAR	2015	134						1	4		10.1016/j.solmat.2014.11.024		4	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CB6HM	WOS:000349728100001		
J	Elborg, M; Noda, T; Mano, T; Jo, M; Sakuma, Y; Sakoda, K; Han, LY				Elborg, Martin; Noda, Takeshi; Mano, Takaaki; Jo, Masafumi; Sakuma, Yoshiki; Sakoda, Kazuaki; Han, Liyuan			Voltage dependence of two-step photocurrent generation in quantum dot intermediate band solar cells	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Intermediate band solar cell; Quantum dot; Two-step photocurrent; Rate equation; High efficiency solar cell; Intersubband transition	ELECTRIC-FIELD; ESCAPE; TRANSITIONS; WELLS	We studied in detail the voltage dependence of two-step photocurrent generation through a two-step process of absorbing sub-band gap photons of different photon energies in a GaAs/AlGaAs quantum dot Intermediate Band Solar Cell. Our experiments revealed that two-step photocurrent generation is largely dependent on voltage, and exhibits a maximum at -0.3 V. A notable feature is a monotonic decrease in two-step photocurrent in the forward bias region, where the operating point of the solar cell lies. Using a model of rate equations, we extracted the voltage dependence of the individual escape and recombination rates, and found that the decrease in two-step photocurrent in the forward bias region is related to a monotonic increase in recombination rate in the quantum dots with increasing bias. (C) 2014 Elsevier B.V. All rights reserved.	[Elborg, Martin; Noda, Takeshi; Mano, Takaaki; Jo, Masafumi; Sakuma, Yoshiki; Sakoda, Kazuaki; Han, Liyuan] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Sakoda, Kazuaki] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan	Elborg, M (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	ELBORG.Martin@nims.go.jp	SAKODA, Kazuaki/H-3006-2011; ELBORG, Martin/J-4211-2015		Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [26790007]	This work was partially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant No. 26790007.	Lopez N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028701; MENDEZ EE, 1982, PHYS REV B, V26, P7101, DOI 10.1103/PhysRevB.26.7101; Kapteyn CMA, 1999, PHYS REV B, V60, P14265, DOI 10.1103/PhysRevB.60.14265; Luque A, 2012, NAT PHOTONICS, V6, P146, DOI [10.1038/nphoton.2012.1, 10.1038/NPHOTON.2012.1]; Nozawa T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583587; Green MA, 2002, PHYSICA E, V14, P65, DOI 10.1016/S1386-9477(02)00361-2; Sanguinetti S, 1999, PHYS REV B, V60, P8276, DOI 10.1103/PhysRevB.60.8276; Fry PW, 2000, APPL PHYS LETT, V77, P4344, DOI 10.1063/1.1334363; Antolin E, 2010, J APPL PHYS, V108, DOI 10.1063/1.3468520; Castan H, 2013, J APPL PHYS, V113, DOI 10.1063/1.4774241; Elborg M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10ND14; FOX AM, 1993, APPL PHYS LETT, V63, P2917, DOI 10.1063/1.110272; Gelinas G, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235426; Jo M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4721663; Jo M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/33/335201; Jolley G, 2013, PROG PHOTOVOLTAICS, V21, P736, DOI 10.1002/pip.2161; Lelong P, 2000, PHYSICA E, V7, P174, DOI 10.1016/S1386-9477(99)00315-X; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Luque A., 2012, PROG PHOTOVOLTAICS, V21, P658; Marti A, 2002, PHYSICA E, V14, P150, DOI 10.1016/S1386-9477(02)00368-5; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Shoji Y, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/2/024002; Tong CZ, 2007, J APPL PHYS, V101, DOI 10.1063/1.2722248	23	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	MAR	2015	134						108	113		10.1016/j.solmat.2014.11.038		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CB6HM	WOS:000349728100014		
J	Matsumoto, T; Hirose, R; Shibata, F; Ishibashi, D; Ogawara, S; Kobayashi, H				Matsumoto, Taketoshi; Hirose, Ryo; Shibata, Fumio; Ishibashi, Daisuke; Ogawara, Shoji; Kobayashi, Hikaru			Nitric acid oxidation of Si method for improvement of crystalline Si solar cell characteristics by surface passivation effect	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Nitric acid; NAOS; Silicon; Solar cell; Silicon nitride; Passivation	RAY PHOTOELECTRON-SPECTROSCOPY; MINORITY-CARRIER LIFETIME; PLASMA SILICON-NITRIDE; HCN AQUEOUS-SOLUTIONS; INTERFACE STATES; COPPER CONTAMINANTS; OXIDE LAYER; TEMPERATURE; REMOVAL; DENSITY	We have investigated effects of formation of an ultrathin silicon dioxide (SiO2) layer using the nitric acid oxidation of Si (NAOS) method and the subsequent ammonia (NH3) plasma treatment on single crystalline Si solar cell characteristics and the surface chemical structures, respectively. The NAOS SiO2 layer formed between Si and silicon nitride (SIN) improves the conversion efficiencies from 17.2 to 18.9% for n-Si-based solar cells, and from 16.6 to 17.5% for p-Si-based solar cells. The improvement is attributed to elimination of interface states, but not to fixed charges because the flat band-voltage of the < Al/SiN/Si > MIS diodes isn't largely changed by formation of a NAOS SiO2 layer at the SiN/Si interface. The minority carrier lifetime of the NAOS SiO2/p-Si structure is greatly improved from 12 to 45 mu s (or 35 mu s) by heat treatment in oxygen at 800 degrees C (or 600 degrees C). In the absence of a NAOS SiO2 layer, the NH3 plasma treatment forms an SiN layer of 0.3 nm thickness on the Si surface. In the presence of a NAOS SiO2 layer, on the other hand, only 0.1 monolayer of SiN is formed on the surface, and at the Si interface, silicon oxynitride species is produced. It is concluded that the NAOS SiO2 layer prevents direct nitridation of Si substrates, and thus avoids introduction of plasma damage in Si. (C) 2014 Elsevier B.V. All rights reserved.	[Matsumoto, Taketoshi; Hirose, Ryo; Kobayashi, Hikaru] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Matsumoto, Taketoshi; Hirose, Ryo; Kobayashi, Hikaru] Japan Sci & Technol Agcy, CREST, Osaka 5670047, Japan; [Shibata, Fumio; Ishibashi, Daisuke; Ogawara, Shoji] Canon Mkt Japan Inc, Minato Ku, Tokyo 1088011, Japan	Kobayashi, H (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Osaka 5670047, Japan.	h.kobayashi@sanken.osaka-u.ac.jp					BLAKERS AW, 1989, APPL PHYS LETT, V55, P1363, DOI 10.1063/1.101596; Aberle AG, 2001, SOL ENERG MAT SOL C, V65, P239, DOI 10.1016/S0927-0248(00)00099-4; Kobayashi H, 1997, APPL PHYS LETT, V71, P1978, DOI 10.1063/1.119760; Lauinger T, 1996, APPL PHYS LETT, V68, P1232, DOI 10.1063/1.115936; HIMPSEL FJ, 1988, PHYS REV B, V38, P6084, DOI 10.1103/PhysRevB.38.6084; Wilcoxon JP, 1999, PHYS REV B, V60, P2704, DOI 10.1103/PhysRevB.60.2704; Leguijt C, 1996, SOL ENERG MAT SOL C, V40, P297, DOI 10.1016/0927-0248(95)00155-7; Schmidt J, 2012, ENRGY PROCED, V15, P30, DOI 10.1016/j.egypro.2012.02.004; TERMAN LM, 1962, SOLID STATE ELECTRON, V5, P285, DOI 10.1016/0038-1101(62)90111-9; Kobayashi H, 2006, SOL ENERGY, V80, P645, DOI 10.1016/j.solener.2005.12.001; SZE SM, 1968, SOLID STATE ELECTRON, V11, P599, DOI 10.1016/0038-1101(68)90012-9; DEPAS M, 1994, SOLID STATE ELECTRON, V37, P433, DOI 10.1016/0038-1101(94)90009-4; Aberle AG, 2000, PROG PHOTOVOLTAICS, V8, P473, DOI 10.1002/1099-159X(200009/10)8:5<473::AID-PIP337>3.0.CO;2-D; HEZEL R, 1984, J ELECTROCHEM SOC, V131, P1679, DOI 10.1149/1.2115936; KOBAYASHI H, 1991, J APPL PHYS, V69, P1736, DOI 10.1063/1.347220; Kobayashi H, 2003, J APPL PHYS, V94, P7328, DOI 10.1063/1.1621720; BHAT M, 1994, APPL PHYS LETT, V64, P2116, DOI 10.1063/1.111701; Dao VA, 2010, J NON-CRYST SOLIDS, V356, P2880, DOI 10.1016/j.jnoncrysol.2010.09.025; DECLERCK G, 1973, SOLID STATE ELECTRON, V16, P1451, DOI 10.1016/0038-1101(73)90062-2; HEZEL R, 1981, SOLID STATE ELECTRON, V24, P863, DOI 10.1016/0038-1101(81)90103-9; HICKMOTT TW, 1977, J APPL PHYS, V48, P723, DOI 10.1063/1.323662; HOCHELLA MF, 1988, SURF SCI, V197, pL260, DOI 10.1016/0039-6028(88)90625-5; Hoex B., 2006, APPL PHYS LETT, V89; Izumi A, 2001, THIN SOLID FILMS, V395, P260, DOI 10.1016/S0040-6090(01)01268-8; KARCHER R, 1984, PHYS REV B, V30, P1896, DOI 10.1103/PhysRevB.30.1896; Kim W.-B., 2009, J APPL PHYS, V105; Kim W.-B., 2008, APPL PHYS LETT, V93; Kimura K., 2013, ECS J SOLID STATE SC, V3, pQ11; Kobayashi Asuha. T., 2002, APPL PHYS LETT, V81, P3410; Kobayashi H, 1998, J APPL PHYS, V83, P2098, DOI 10.1063/1.366943; Kobayashi H, 2006, APPL SURF SCI, V252, P7700, DOI 10.1016/j.apsusc.2006.03.055; Liu Asuha Y.-L., 2004, J ELECTROCHEM SOC, V151, pG824; Maida O, 2003, SURF SCI, V542, P244, DOI 10.1016/S0039-6028(03)00985-3; Matsumoto T., 2010, IEDM 2010; Matsumoto T, 2013, ECS J SOLID STATE SC, V2, pQ127, DOI 10.1149/2.026307jss; Matsumoto T, 2011, ECS TRANSACTIONS, V35, P217, DOI 10.1149/1.3572285; MYERS SM, 1987, J APPL PHYS, V61, P5428, DOI 10.1063/1.338284; Narita H, 2008, J ELECTROCHEM SOC, V155, pH103, DOI 10.1149/1.2816324; Nicollian E.H., 1982, MOS PHYS TECHNOLOGY; OKAMOTO Y, 1995, JPN J APPL PHYS 2, V34, pL955, DOI 10.1143/JJAP.34.L955; Shibata F, 2014, ECS J SOLID STATE SC, V3, pQ137, DOI 10.1149/2.024406jss; Sze S. M., 1981, PHYS SEMICONDUCTOR D, V2nd; Takahashi M, 2011, J ELECTROCHEM SOC, V158, pH825, DOI 10.1149/1.3599832; Takahashi M, 2006, SOLID STATE COMMUN, V137, P263, DOI 10.1016/j.ssc.2005.11.027; WHITE MH, 1972, IEEE T ELECTRON DEV, VED19, P1280, DOI 10.1109/T-ED.1972.17591; Zhao J., 1990, P 21 IEEE PHOT SPEC, P333	46	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	MAR	2015	134						298	304		10.1016/j.solmat.2014.11.040		7	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CB6HM	WOS:000349728100037		
J	Obukuro, Y; Matsushima, S; Yamada, H; Xu, CN; Watanabe, S; Ogasawara, K; Mizuno, M				Obukuro, Yuki; Matsushima, Shigenori; Yamada, Hiroshi; Xu, Chao-Nan; Watanabe, Shinta; Ogasawara, Kazuyoshi; Mizuno, Masataka			Molecular orbital calculations of Eu-doped SrAl2O4 clusters	SOLID STATE COMMUNICATIONS			English	Article						Eu2+-doped SrAl2O4; Molecular orbital calculation; Configuration interaction; Relativistic effect	ENERGY-BAND CALCULATION; ELECTRONIC-STRUCTURE; MONOCLINIC-STRUCTURE; STRESS-DISTRIBUTION; MECHANOLUMINESCENCE; PHOSPHOR	The electronic structures of uncloped and Eu2+-doped SrAl2O4 clusters are evaluated from the relativistic molecular orbital (RMO) calculation. The calculated forbidden gaps between the highest and lowest unoccupied molecular orbitals of [SrAl2O21](22-) and [SrAl12O38](34-) clusters are calculated to be 83 and 7.3 eV, respectively. When a Eu atom replaces a Sr atom, the Eu 4f states appear in the forbidden gap of the SrAl2O4 and the Eu 5d states are distributed widely in the conduction band. Combining the RMO calculation and the configuration interaction method for [EuO7](12-) and [EuO8](14-) clusters produces three or two theoretical peaks respectively for the transition 4f(7) -> 4f(6) 5d(1) in Eu2+-doped SrAl2O4, respectively. (C) 2015 Elsevier Ltd. All rights reserved.	[Obukuro, Yuki; Matsushima, Shigenori] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Biol Funct & Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan; [Matsushima, Shigenori] Kitakyushu Coll, Natl Inst Technol, Dept Mat Sci & Chem Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan; [Yamada, Hiroshi; Xu, Chao-Nan] Natl Inst Adv Ind Sci & Technol, Tosu, Saga 8410052, Japan; [Xu, Chao-Nan] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Watanabe, Shinta; Ogasawara, Kazuyoshi] Kwansei Gakuin Univ, Dept Chem, Sanda, Hyogo 6691337, Japan; [Mizuno, Masataka] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan	Matsushima, S (reprint author), Kitakyushu Coll, Natl Inst Technol, Dept Mat Sci & Chem Engn, Kokuraminami Ku, 5-20-1 Shii, Kitakyushu, Fukuoka 8020985, Japan.	smatsu@kct.ac.jp					Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Xu CN, 2004, APPL PHYS LETT, V84, P3040, DOI 10.1063/1.1705716; ADACHI H, 1978, J PHYS SOC JPN, V45, P875; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; MACDONALD AH, 1979, J PHYS C SOLID STATE, V12, P2977, DOI 10.1088/0022-3719/12/15/007; Matsushima S, 2007, J PHYS CHEM SOLIDS, V68, P206, DOI 10.1016/j.jpcs.2006.10.011; Xu CN, 2000, APPL PHYS LETT, V76, P179, DOI 10.1063/1.125695; Xu CN, 1999, APPL PHYS LETT, V74, P2414, DOI 10.1063/1.123865; Ogasawara K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.115413; Holsa J, 2009, J RARE EARTH, V27, P550, DOI 10.1016/S1002-0721(08)60286-0; Matsushima S, 2002, CHEM LETT, P700, DOI 10.1246/cl.2002.700; Obukuro Y, 2014, SOLID STATE COMMUN, V186, P46, DOI 10.1016/j.ssc.2014.01.026; Ogasawara K, 2004, JPN J APPL PHYS 2, V43, pL611, DOI 10.1143/JJAP.43.L611; ROSEN A, 1976, J CHEM PHYS, V65, P3629; Schulze V.A., 1981, Z ANORG ALLG CHEM, V475, P205; Xu C.N., 2002, ENCY SMART MAT, V1, P190; Yamada H, 2008, J ELECTROCHEM SOC, V155, pF139, DOI 10.1149/1.2907407	18	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	MAR	2015	206						42	45		10.1016/j.ssc.2015.01.013		4	Physics, Condensed Matter	Physics	CC1NZ	WOS:000350109300009		
J	Morise, M				Morise, Masanori			Cheap Trick, a spectral envelope estimator for high-quality speech synthesis	SPEECH COMMUNICATION			English	Article						Speech synthesis; Speech analysis; Spectral envelope; Time-varying component	TANDEM-STRAIGHT; VOICED SOUNDS; REPRESENTATION; SYSTEM; WAVE; F0	A spectral envelope estimation algorithm is presented to achieve high-quality speech synthesis. The concept of the algorithm is to obtain an accurate and temporally stable spectral envelope. The algorithm uses fundamental frequency (F0) and consists of F0-adaptive windowing, smoothing of the power spectrum, and spectral recovery in the quefrency domain. Objective and subjective evaluations were carried out to demonstrate the effectiveness of the proposed algorithm. Results of both evaluations indicated that the proposed algorithm can obtain a temporally stable spectral envelope and synthesize speech with higher sound quality than speech synthesized with other algorithms. (C) 2014 The Authors. Published by Elsevier B.V.	Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008511, Japan	Morise, M (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, 4-3-11 Takeda, Kofu, Yamanashi 4008511, Japan.	mmorise@yamanashi.ac.jp			JSPS KAKENHI [24300073, 26540087]; Research Institute of Electrical Communication, Tohoku University [H25/A08]	This work was supported by JSPS KAKENHI Grant Nos. 24300073 and 26540087 and the Research Institute of Electrical Communication, Tohoku University (H25/A08).	Dudley H, 1939, J ACOUST SOC AM, V11, P169, DOI 10.1121/1.1916020; Kenmochi H, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P5385; Zen H, 2009, SPEECH COMMUN, V51, P1039, DOI 10.1016/j.specom.2009.04.004; NOLL AM, 1964, J ACOUST SOC AM, V36, P296, DOI 10.1121/1.1918949; ATAL BS, 1971, J ACOUST SOC AM, V50, P637, DOI 10.1121/1.1912679; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Zen HG, 2013, INT CONF ACOUST SPEE, P7962; Unser M, 2000, P IEEE, V88, P569, DOI 10.1109/5.843002; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Badeau R, 2008, INT CONF ACOUST SPEE, P3761, DOI 10.1109/ICASSP.2008.4518471; Campedel-Oudot M, 2001, IEEE T SPEECH AUDI P, V9, P469, DOI 10.1109/89.928912; ELJAROUDI A, 1991, IEEE T SIGNAL PROCES, V39, P411, DOI 10.1109/78.80824; Kawahara H, 2011, SADHANA-ACAD P ENG S, V36, P713, DOI 10.1007/s12046-011-0043-3; Kawahara H, 2009, INT CONF ACOUST SPEE, P3905, DOI 10.1109/ICASSP.2009.4960481; Kawahara H, 2008, INT CONF ACOUST SPEE, P3933, DOI 10.1109/ICASSP.2008.4518514; Koriyama T, 2014, IEEE J-STSP, V8, P173, DOI 10.1109/JSTSP.2013.2283461; MATHEWS MV, 1961, J ACOUST SOC AM, V33, P179, DOI 10.1121/1.1908614; MCAULAY RJ, 1986, IEEE T ACOUST SPEECH, V34, P744, DOI 10.1109/TASSP.1986.1164910; Morise M., 2013, P SMAC 2013, P287; Morise M, 2009, LECT NOTES COMPUT SC, V5709, P185; Nakano T., 2012, P SAPA SCALE 2012, P11; Ohtani Y, 2010, IEICE T INF SYST, VE93D, P2491, DOI 10.1587/transinf.E93.D.2491; OPPENHEI.AV, 1969, J ACOUST SOC AM, V45, P458, DOI 10.1121/1.1911395; Toda T, 2008, INT CONF ACOUST SPEE, P3925	24	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6393	1872-7182		SPEECH COMMUN	Speech Commun.	MAR	2015	67						1	7		10.1016/j.specom.2014.09.003		7	Acoustics; Computer Science, Interdisciplinary Applications	Acoustics; Computer Science	CC1HD	WOS:000350090900001		
J	Hishida, T; Nakachi, Y; Mizuno, Y; Katano, M; Okazaki, Y; Ema, M; Takahashi, S; Hirasaki, M; Suzuki, A; Ueda, A; Nishimoto, M; Hishida-Nozaki, Y; Vazquez-Ferrer, E; Sancho-Martinez, I; Belmonte, JCI; Okuda, A				Hishida, Tomoaki; Nakachi, Yutaka; Mizuno, Yosuke; Katano, Miyuki; Okazaki, Yasushi; Ema, Masatsugu; Takahashi, Satoru; Hirasaki, Masataka; Suzuki, Ayumu; Ueda, Atsushi; Nishimoto, Masazumi; Hishida-Nozaki, Yuriko; Vazquez-Ferrer, Eric; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua; Okuda, Akihiko			Functional Compensation Between Myc and PI3K Signaling Supports Self- Renewal of Embryonic Stem Cells	STEM CELLS			English	Article						Embryonic stem cells; Pluripotency; Myc; PI3K; MAPK	TRANSCRIPTIONAL NETWORK; INDEPENDENT MECHANISMS; GROUND-STATE; PLURIPOTENCY; ACTIVATION; MOUSE; EXPRESSION; PATHWAYS; DIFFERENTIATION; NANOG	c-Myc and phosphatidylinositol 3-OH kinase (PI3K) both participate in diverse cellular processes, including cell cycle control and tumorigenic transformation. They also contribute to preserving embryonic stem cell (ESC) characteristics. However, in spite of the vast knowledge, the molecular relationship between c-Myc and PI3K in ESCs is not known. Herein, we demonstrate that c-Myc and PI3K function cooperatively but independently to support ESC self-renewal when murine ESCs are cultured under conventional culture condition. Interestingly, culture of ESCs in 2i-condition including a GSK3b and MEK inhibitor renders both PI3K and Myc signaling dispensable for the maintenance of pluripotent properties. These results suggest that the requirement for an oncogenic proliferation-dependent mechanism sustained by Myc and PI3K is context dependent and that the 2i-condition liberates ESCs from the dependence of this mechanism.	[Hishida, Tomoaki; Katano, Miyuki; Hirasaki, Masataka; Suzuki, Ayumu; Ueda, Atsushi; Okuda, Akihiko] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Hidaka, Saitama, Japan; [Hishida, Tomoaki; Okazaki, Yasushi; Takahashi, Satoru; Okuda, Akihiko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hishida, Tomoaki; Hishida-Nozaki, Yuriko; Vazquez-Ferrer, Eric; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Hidaka, Saitama, Japan; [Nakachi, Yutaka; Mizuno, Yosuke; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, Hidaka, Saitama, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Dep Anat & Embryol, Tsukuba, Ibaraki 305, Japan; [Nishimoto, Masazumi] Saitama Med Univ, Res Ctr Genom Med, Radioisotope Expt Lab, Hidaka, Saitama, Japan	Belmonte, JCI (reprint author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu; akiokuda@saitama-med.ac.jp	Ueda, Atsushi/O-2099-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS); Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; G. Harold and Leila Y. Mathers Charitable Foundation; Salk Institute Cancer Center Support Grant	We thank Dr. Hitoshi Niwa for helpful discussion. We also thank Keiko Amagai and Yukiko Yatsuka for technical assistance and May Schwarz and Peter Schwarz for administrative help. This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and primarily by a Grant-in-Aid for the Support Project of Strategic Research Center in Private Universities to the Saitama Medical University Research Center for Genomic Medicine. This study was performed as a part of the Core Research for Evolutional Science and Technology (CREST) Agency. T.H. was a recipient of a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS). Work in the laboratory of J.C.I.B. was supported by grants from The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), G. Harold and Leila Y. Mathers Charitable Foundation, and the Salk Institute Cancer Center Support Grant.	Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Haichar FEZ, 2007, ENVIRON MICROBIOL, V9, P625, DOI 10.1111/j.1462-2920.2006.01182.x; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Saunders A, 2013, STEM CELLS, V31, P1227, DOI 10.1002/stem.1384; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; DHAND R, 1994, EMBO J, V13, P511; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Bilderback TR, 2002, AM J PHYSIOL-CELL PH, V283, pC282, DOI 10.1152/ajpcell.00437.2001; Hishida T, 2012, STEM CELLS, V30, P1634, DOI 10.1002/stem.1147; Kingham E, 2009, J CELL SCI, V122, P2311, DOI 10.1242/jcs.046557; Liu N, 2009, J CELL BIOCHEM, V106, P1041, DOI 10.1002/jcb.22082; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAR	2015	33	3					713	725		10.1002/stem.1893		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CB7ZZ	WOS:000349849000008		
J	Kitamura, S; Sakurai, H; Makino, H				Kitamura, Shinji; Sakurai, Hiroyuki; Makino, Hirofumi			Single Adult Kidney Stem/Progenitor Cells Reconstitute Three-Dimensional Nephron Structures In Vitro	STEM CELLS			English	Article						Adult kidney tissue stem cells; Three-dimensional nephron structures in vitro; Organogenesis	PROGENITOR-LIKE CELLS; PLURIPOTENT STEM-CELLS; RAT-KIDNEY; GROWTH-FACTOR; MAMMALIAN KIDNEY; WATER CHANNEL; IDENTIFICATION; REGENERATION; MORPHOGENESIS; CULTURE	The kidneys are formed during development from two distinct primordial tissues, the metanephric mesenchyme and the ureteric bud. The metanephric mesenchyme develops into the kidney nephron, the minimal functional unit of the kidney. A nephron consists of several segments and regulates water, electrolyte, and acid-base homeostasis in addition to secreting certain hormones. It has been predicted that the kidney will be among the last organs successfully regenerated in vitro due to its complex structure and multiple functions. Here, we show that adult kidney stem/progenitor cells (KS cells), derived from the S3 segment of adult rat kidney nephrons, can reconstitute a three-dimensional kidney-like structure in vitro. Kidney-like structures were formed when a cluster of KS cells was suspended in an extracellular matrix gel and cultured in the presence of several growth factors. Morphological analyses revealed that these kidney-like structures contained every substructure of the kidney, including glomeruli, proximal tubules, the loop of Henle, distal tubules, and collecting ducts, but no vasculature. Our results demonstrate that a cluster of tissue stem/progenitor cells has the ability to reconstitute the minimum unit of its organ of origin by differentiating into specialized cells in the correct location. This process differs from embryonic kidney development, which requires the mutual induction of two different populations of progenitors, metanephric mesenchymal cells and ureteric bud cells.	[Kitamura, Shinji; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan; [Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo, Japan	Kitamura, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	s-kita@md.okayama-u.ac.jp			Health and Labor Sciences Research Grants for Research on Tissue Engineering from the Ministry of Health Labor and Welfare of Japan; programme for the promotion of fundamental studies in Health Sciences of the National Institute of Biomedical Innovation (VIBIO); Okayama Medical Foundation; Ministry of Economy, Trade and Industry (METI), Japan; Organ Technologies, Inc.	A portion of this study was supported by the Health and Labor Sciences Research Grants for Research on Tissue Engineering from the Ministry of Health Labor and Welfare of Japan, the programme for the promotion of fundamental studies in Health Sciences of the National Institute of Biomedical Innovation (VIBIO), a Grant-in-Aid for Young Scientists (B) and a grant from the Okayama Medical Foundation, the Ministry of Economy, Trade and Industry (METI), Japan, and joint research with Organ Technologies, Inc. We appreciate the technical contributions of Dr. Takeshi Sugaya (Cimic, Co., Ltd., Japan) and Dr. Naoshi Shinozaki (Cornea Center & Eye Bank, Tokyo Dental College, Ichikawa General Hospital) and the kind advice of Dr. Kazuhiro Sakurada (Sony Computer Science Laboratories, Inc., Japan) and Dr. Naoya Kobayashi (Okayama Saidaiji Hospital).	Abedin MJ, 2011, NEPHRON EXP NEPHROL, V119, pE75, DOI 10.1159/000328925; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Maeshima A, 2003, J AM SOC NEPHROL, V14, P3138, DOI 10.1097/01.ASN.0000098685.43700.28; Kitamura S, 2005, FASEB J, V19, P1789, DOI 10.1096/fj.05-3942.com; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Vega QC, 1996, P NATL ACAD SCI USA, V93, P10657, DOI 10.1073/pnas.93.20.10657; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Kinomura M, 2008, CELL TRANSPLANT, V17, P143, DOI 10.3727/000000008783907008; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; CYBULSKY AV, 1994, AM J PHYSIOL, V267, pF428; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; PERANTONI AO, 1995, P NATL ACAD SCI USA, V92, P4696, DOI 10.1073/pnas.92.10.4696; Rinkevich Y, 2014, CELL REP, V22, P1270; Rosines E, 2007, P NATL ACAD SCI USA, V104, P20938, DOI 10.1073/pnas.0710428105; SABOLIC I, 1992, AM J PHYSIOL, V263, pC1225; SANTOS OFP, 1994, DEV BIOL, V163, P525, DOI 10.1006/dbio.1994.1169; Saxen L, 1987, ORGANOGENESIS KIDNEY; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Taniguchi M, 2002, J PATHOL, V197, P638; YAMAMOTO T, 1986, NEPHRON, V43, P293, DOI 10.1159/000183857	28	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAR	2015	33	3					774	784		10.1002/stem.1891		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CB7ZZ	WOS:000349849000013		
J	Cho, JG; Lee, JH; Hong, SH; Lee, HN; Kim, CM; Kim, SY; Yoon, KJ; Oh, BJ; Kim, JH; Jung, SY; Asahara, T; Kwon, SM; Park, SG				Cho, Jin Gu; Lee, Jun Hee; Hong, Shin Hee; Lee, Han Na; Kim, Chul Min; Kim, Seo Yoon; Yoon, Kang Jun; Oh, Bae Jun; Kim, Jae Hyeon; Jung, Seok Yoon; Asahara, Takayuki; Kwon, Sang-Mo; Park, Sang Gyu			Tauroursodeoxycholic Acid, a Bile Acid, Promotes Blood Vessel Repair by Recruiting Vasculogenic Progenitor Cells	STEM CELLS			English	Article						Tauroursodeoxycholic acid; Hematopoietic stem cell; Endothelial colony forming cells	PRIMARY BILIARY-CIRRHOSIS; MYOCARDIAL-INFARCTION; URSODEOXYCHOLIC ACID; CARDIOVASCULAR RISK; FUNCTIONAL RECOVERY; INDUCED APOPTOSIS; NUCLEAR RECEPTOR; STEM-CELLS; MOBILIZATION; ACTIVATION	Although serum bile acid concentrations are approximately 10 mu M in healthy subjects, the crosstalk between the biliary system and vascular repair has never been investigated. In this study, tauroursodeoxycholic acid (TUDCA) induced dissociation of CD34(+) hematopoietic stem cells (HSCs) from stromal cells by reducing adhesion molecule expression. TUDCA increased CD34(+)/Sca1(+) progenitors in mice peripheral blood (PB), and CD34(+), CD31(+), and c-kit(+) progenitors in human PB. In addition, TUDCA increased differentiation of CD34(+) HSCs into EPC lineage cells via Akt activation. EPC invasion was increased by TUDCA, which was mediated by fibroblast activating protein via Akt activation. Interestingly, TUDCA induced integration of EPCs into human aortic endothelial cells (HAECs) by increasing adhesion molecule expression. In the mouse hind limb ischemia model, TUDCA promoted blood perfusion by enhancing angiogenesis through recruitment of Flk-1(+)/CD34(+) and Sca-1(+)/c-kit(+) progenitors into damaged tissue. In GFP(+) bone marrow-transplanted hind limb ischemia, TUDCA induced recruitment of GFP(+)/c-kit(+) progenitors to the ischemic area, resulting in an increased blood perfusion ratio. Histological analysis suggested that GFP(+) progenitors mobilized from bone marrow, integrated into blood vessels, and differentiated into VEGFR(+) cells. In addition, TUDCA decreased cellular senescence by reducing levels of p53, p21, and reactive oxygen species and increased nitric oxide. Transplantation of TUDCA-primed senescent EPCs in hind limb ischemia significantly improved blood vessel regeneration, as compared with senescent EPCs. Our results suggested that TUDCA promoted neovascularization by enhancing the mobilization of stem/progenitor cells from bone marrow, their differentiation into EPCs, and their integration with preexisting endothelial cells.	[Cho, Jin Gu; Lee, Han Na; Kim, Chul Min; Kim, Seo Yoon] CHA Univ, Dept Biomed Sci, Sungnamsi, Gyunggido, South Korea; [Lee, Jun Hee; Jung, Seok Yoon; Kwon, Sang-Mo] Pusan Natl Univ, Sch Med, Dept Physiol, Lab Vasc Med & Stem Cell Biol, Yangsan, South Korea; [Hong, Shin Hee; Park, Sang Gyu] Ajou Univ, Coll Pharm, Suwon 441749, Gyunggido, South Korea; [Yoon, Kang Jun] St Peters Kangnam Hosp, Dept Neurosurg, Seoul, South Korea; [Oh, Bae Jun; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Park, SG (reprint author), Ajou Univ, Coll Pharm, Dept Pharm, Suwon 441749, Gyunggido, South Korea.	smkwon323@pusan.ac.kr; sgpark@ajou.ac.kr			Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Korean Government [NRF-2012M3A9C6049719, NRF-2010-0020260, NRF-2012-R1A2A2A01045085, NRF-2012M3A9C6049720]	This work was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF), funded by Korean Government Grant NRF-2012M3A9C6049719 (to S.G.P.), and NRF-2010-0020260, NRF-2012-R1A2A2A01045085, and NRF-2012M3A9C6049720 (to S.M.K.).	Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Kim SY, 2011, CARDIOVASC RES, V92, P307, DOI 10.1093/cvr/cvr219; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Grover-Paez F, 2009, DIABETES RES CLIN PR, V84, P1, DOI 10.1016/j.diabres.2008.12.013; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Asahara T, 1999, CIRC RES, V85, P221; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Wang JY, 2009, J CELL PHYSIOL, V219, P617, DOI 10.1002/jcp.21711; Rosso A, 2006, J BIOL CHEM, V281, P4339, DOI 10.1074/jbc.M509293200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; POUPON RE, 1994, NEW ENGL J MED, V330, P1342, DOI 10.1056/NEJM199405123301903; Wagner W, 2007, EXP HEMATOL, V35, P314, DOI 10.1016/j.exphem.2006.10.003; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003; Sola S, 2003, MOL MED, V9, P226; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI13131; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Lemarie CA, 2011, AM J PHYSIOL-HEART C, V300, pH745, DOI 10.1152/ajpheart.00321.2010; Colak A, 2008, J CLIN NEUROSCI, V15, P665, DOI 10.1016/j.jocn.2007.06.002; Basiglio CL, 2010, CHEM-BIOL INTERACT, V188, P386, DOI 10.1016/j.cbi.2010.08.004; Castro RE, 2004, J PHARMACOL EXP THER, V311, P845, DOI 10.1124/jpet.104.070532; CRAVEN PA, 1987, J CLIN INVEST, V79, P532, DOI 10.1172/JCI112844; Degott C, 1999, HEPATOLOGY, V29, P1007, DOI 10.1002/hep.510290444; El-Mir MY, 2001, CLIN SCI, V100, P499, DOI 10.1042/CS20000199; Jujo K, 2013, CIRCULATION, V127, P63, DOI 10.1161/CIRCULATIONAHA.112.099242; Kwon SM, 2009, CIRC RES, V104, P969, DOI 10.1161/CIRCRESAHA.108.192856; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Maeda K, 2006, MOL PHARMACEUT, V3, P70, DOI 10.1021/mp050063u; MONSKY WL, 1994, CANCER RES, V54, P5702; Rodrigues CMP, 2000, J NEUROCHEM, V75, P2368, DOI 10.1046/j.1471-4159.2000.0752368.x; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; RUDOLPH G, 1993, HEPATOLOGY, V17, P1028; Sola S, 2006, MOL ENDOCRINOL, V20, P2292, DOI 10.1210/me.2006.0063; Xie Qing, 2002, Hepatology, V36, P592, DOI 10.1053/jhep.2002.35441; Yang JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013858; Yanguas-Casas N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-50	53	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAR	2015	33	3					792	805		10.1002/stem.1901		14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CB7ZZ	WOS:000349849000015		
J	Fujita, R; Tamai, K; Aikawa, E; Nimura, K; Ishino, S; Kikuchi, Y; Kaneda, Y				Fujita, Ryo; Tamai, Katsuto; Aikawa, Eriko; Nimura, Keisuke; Ishino, Saki; Kikuchi, Yasushi; Kaneda, Yasufumi			Endogenous Mesenchymal Stromal Cells in Bone Marrow Are Required to Preserve Muscle Function in mdx Mice	STEM CELLS			English	Article						Mesenchymal stromal cells; Duchenne muscular dystrophy; TNF-alpha-stimulated gene/protein-6; TSG-6; Muscle satellite cells; Bone marrow cells	HEMATOPOIETIC STEM-CELLS; ANTIINFLAMMATORY PROTEIN TSG-6; OSTEOBLAST PROGENITOR CELLS; LARGE GENE LISTS; SATELLITE CELLS; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; FIBRO/ADIPOGENIC PROGENITORS; MOUSE MODEL; NICHE	The physiological role of "endogenous" bone marrow (BM) mesenchymal stromal cells (MSCs) in tissue regeneration is poorly understood. Here, we show the significant contribution of unique endogenous BM-MSC populations to muscle regeneration in Duchenne muscular dystrophy (DMD) mice (mdx). Transplantation of BM cells (BMCs) from 10-week-old mdx into 3-4-week-old mdx mice increased inflammation and fibrosis and reduced muscle function compared with mdx mice that received BMCs from 10-week-old wild-type mice, suggesting that the alteration of BMC populations in mdx mice affects the progression of muscle pathology. Two distinct MSC populations in BM, that is, hematopoietic lineage (Lin)(-)/ckit(-)/CD106(+)/CD44(+) and Lin(-)/ckit(-)/CD106(+)/CD44(-) cells, were significantly reduced in 10-week-old mdx mice in disease progression. The results of a whole-transcriptome analysis indicated that these two MSC populations have distinct gene expression profiles, indicating that the Lin(-)/ckit(-)/CD106(+)/CD44(+) and Lin(-)/ckit(-)/CD106(+)/CD44(-) MSC populations are proliferative-and dormant-state populations in BM, respectively. BM-derived Lin(-) /CD106(+)/CD44(+) MSCs abundantly migrated to damaged muscles and highly expressed tumor necrosis factor-alpha-stimulated gene/protein-6 (TSG-6), an anti-inflammatory protein, in damaged muscles. We also demonstrated that TSG-6 stimulated myoblast proliferation. The injection of Lin(-)/ckit(-)/CD106(+)/CD44(+) MSCs into the muscle of mdx mice successfully ameliorated muscle dysfunction by decreasing inflammation and enhancing muscle regeneration through TSG-6-mediated activities. Thus, we propose a novel function of the unique endogenous BM-MSC population, which countered muscle pathology progression in a DMD model.	[Fujita, Ryo; Nimura, Keisuke; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan; [Tamai, Katsuto; Aikawa, Eriko; Kikuchi, Yasushi] Osaka Univ, Grad Sch Med, Dept Stem Cell Therapy Sci, Osaka, Japan; [Ishino, Saki] Osaka Univ, Grad Sch Med, Ctr Med Res & Educ, Osaka, Japan	Tamai, K (reprint author), Osaka Univ, Grad Sch Med, Dept Stem Cell Therapy Sci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	tamai@gts.med.osaka-u.ac.jp; kaneday@gts.med.osak-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [243873]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	R.F. was funded by a Research Fellowship (#243873) from the Japan Society for the Promotion of Science (JSPS), Japan. This study was also supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Health and Labour Sciences Research Grant (Research of Intractable Diseases) from the Ministry of Health, Labour, and Welfare of Japan.	Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Coutu DL, 2011, BLOOD, V117, P6801, DOI 10.1182/blood-2010-12-321539; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Koning JJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00049; Nakamura A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/184393; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Musaro A, 2010, METHODS MOL BIOL, V633, P101, DOI 10.1007/978-1-59745-019-5_8; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Milner CM, 2006, BIOCHEM SOC T, V34, P446; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; Skuk D, 2010, MOL THER, V18, P1689, DOI 10.1038/mt.2010.128; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Pisani DF, 2010, STEM CELLS, V28, P2182, DOI 10.1002/stem.537; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Percival JM, 2012, J PATHOL, V228, P77, DOI 10.1002/path.4054; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Gupta N, 2007, J IMMUNOL, V179, P1855; Fujita R, 2014, BBA-GEN SUBJECTS, V1840, P3170, DOI 10.1016/j.bbagen.2014.01.014; Hagiwara H, 2006, FEBS LETT, V580, P4463, DOI 10.1016/j.febslet.2006.07.015; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Miyagoe-Suzuki Y, 2010, EXP CELL RES, V316, P3087, DOI 10.1016/j.yexcr.2010.05.022; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Qian H, 2013, MOL CELL BIOL, V33, P661, DOI 10.1128/MCB.01287-12; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Yang ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059354	57	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAR	2015	33	3					962	975		10.1002/stem.1900		14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CB7ZZ	WOS:000349849000029		
J	Miyawaki, K; Arinobu, Y; Iwasaki, H; Kohno, K; Tsuzuki, H; Iino, T; Shima, T; Kikushige, Y; Takenaka, K; Miyamoto, T; Akashi, K				Miyawaki, Kohta; Arinobu, Yojiro; Iwasaki, Hiromi; Kohno, Kentaro; Tsuzuki, Hirofumi; Iino, Tadafumi; Shima, Takahiro; Kikushige, Yoshikane; Takenaka, Katsuto; Miyamoto, Toshihiro; Akashi, Koichi			CD41 Marks the Initial Myelo-Erythroid Lineage Specification in Adult Mouse Hematopoiesis: Redefinition of Murine Common Myeloid Progenitor	STEM CELLS			English	Article						Common myeloid progenitors; Hematopoietic stem cells; GATA-1 transcription factor; CD41; Sepsis; Myeloid leukemia	STEM-CELLS; BONE-MARROW; COMMITMENT; IDENTIFICATION; GATA-1; GENE; ERYTHROPOIESIS; TRANSCRIPTION; INDUCTION; RENEWAL	Previous studies have predicted that reciprocal activation of GATA-1 and PU.1 regulates myelo-erythroid versus myelo-lymphoid lineage commitment in early hematopoiesis. Such PU. 1-activating myelo-lymphoid progenitors exist within the lymphoid-primed multipotent progenitor (LMPP) population at the primitive Lineage(-)Sca-1(+) c-Kit(+) (LSK) stage. We here show that the counterpart of GATA-1-activating myelo-erythroid progenitor resides also at the LSK stage, expressing CD41 at a high level. Purified CD41(hi) LSK cells showed exceedingly strong and prolonged myelo-erythroid-restricted reconstitution, and primed myelo-erythroid gene expression with a more primitive molecular signature as compared to the original common myeloid progenitor (CMP). The CD41(hi) LSK cells more strongly contributed to emergent and malignant myelopoiesis than LMPPs, and produced the original CMP by downregulating Sca-1 and CD41, suggesting that they are the earliest CMPs. Thus, the hematopoietic developmental map should be revised by integrating the primary branchpoint comprised of the new, isolatable CD41(hi) CMP and the LMPP populations.	[Miyawaki, Kohta; Kohno, Kentaro; Tsuzuki, Hirofumi; Shima, Takahiro; Kikushige, Yoshikane; Takenaka, Katsuto; Miyamoto, Toshihiro; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Arinobu, Yojiro; Iwasaki, Hiromi; Iino, Tadafumi; Takenaka, Katsuto] Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 812, Japan	Akashi, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan.	akashi@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Uehara Memorial Foundation	We thank all our lab member for valuable discussion, and Mariko Nishihara for animal care. This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y.A. and K.A.), a grant-in-aid from the Ministry of Health, Labor and Welfare of Japan (to K.A.), and the Uehara Memorial Foundation (to K.A.).	Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sevinsky JR, 2004, MOL CELL BIOL, V24, P4534, DOI 10.1128/MCB.24.10.4534-4545.2004; Pear WS, 1998, BLOOD, V92, P3780; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Artinger EL, 2013, P NATL ACAD SCI USA, V110, P12000, DOI 10.1073/pnas.1301278110; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; LI CL, 1995, BLOOD, V85, P1472; MARTIN F, 1993, J BIOL CHEM, V268, P21606; Nerlov C, 2000, BLOOD, V95, P2543; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Socolovsky Merav, 2007, PLoS Biol, V5, pe252, DOI 10.1371/journal.pbio.0050252; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810	36	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAR	2015	33	3					976	987		10.1002/stem.1906		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CB7ZZ	WOS:000349849000030		
J	Kitamura, S; Senshu, M; Tokushige, H; Katsuyama, T; Ozaki, N; Tanaka, I; Sugimoto, Y				Kitamura, S.; Senshu, M.; Tokushige, H.; Katsuyama, T.; Ozaki, N.; Tanaka, I.; Sugimoto, Y.			Spectral and temporal photoluminescence behavior of colloidal PbS quantum dots	SUPERLATTICES AND MICROSTRUCTURES			English	Article						Quantum dot; Colloid; PbS; Photoluminescence; Radiative decay; Non-radiative decay; Energy transfer; Defect	ENERGY-TRANSFER; GAAS; NANOCRYSTALS; WHISKERS; GROWTH	We have studied a temporal and spectral behavior of the photoluminescence of the colloidal PbS quantum dots (QDs) with a controlled spacing between QDs. The high-speed streak camera system combined with a monochromator was used to obtain the time evolution of the luminescence spectrum itself. In the close-packed QD sample with a QD edge-to-edge spacing of 4.2 nm, the two-step photoluminescence decay with time constants of 30 and 200 ns was observed after initial fast change in the luminescence due to the fast energy transfer process. This two-step decay also occurred for the other QD samples with large QD edge-to-edge spacings, i.e., 5.8 and 12.5 nm. Here, the observed decay time for these samples showed the same spectral behavior even though the distance between QDs is considerably different. Such characteristic photon energy dependence strongly suggests a decay mechanism that the decay consists of (1) fast non-radiative decay from the excited state to the ground state through surface defect states and (2) slow intrinsic radiative decay. Thus, these results indicate a new aspect of the photoluminescence decay characteristics, which shows the importance of the non-radiative energy transfer path in the PbS QD luminescence. (C) 2014 Elsevier Ltd. All rights reserved.	[Kitamura, S.; Senshu, M.; Tokushige, H.; Katsuyama, T.] Univ Fukui, Grad Sch Engn, Fukui 9108507, Japan; [Ozaki, N.; Tanaka, I.] Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan; [Sugimoto, Y.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Katsuyama, T (reprint author), Univ Fukui, Grad Sch Engn, Bunkyo 3-9-1, Fukui 9108507, Japan.	t-katsu@u-fukui.ac.jp			JSPS KAKENHI [23560036]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by JSPS KAKENHI Grant Number 23560036 and NIMS Nanofabrication Platform in "Nanotechnology Platform Project" sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395; Clark SW, 2007, J PHYS CHEM C, V111, P7302, DOI 10.1021/jp0713561; Moreels I, 2009, ACS NANO, V3, P3023, DOI 10.1021/nn900863a; Wehrenberg BL, 2002, J PHYS CHEM B, V106, P10634, DOI 10.1021/jp021187e; Lingley Z, 2014, J APPL PHYS, V115, DOI 10.1063/1.4866368; McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299; Sahoo H, 2011, J PHOTOCH PHOTOBIO C, V12, P20, DOI 10.1016/j.jphotochemrev.2011.05.001; YABLONOVITCH E, 1987, APPL PHYS LETT, V51, P439, DOI 10.1063/1.98415; HIRUMA K, 1995, J APPL PHYS, V77, P447, DOI 10.1063/1.359026; Prabhakaran P, 2012, OPT MATER EXPRESS, V2, P578; Kagan CR, 1996, PHYS REV B, V54, P8633, DOI 10.1103/PhysRevB.54.8633; Klem EJD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2735674; Viswanath A. K., 1994, Applied Physics Communications, V13; Lu W, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3213349; Rinnerbauer V, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.085322; Rogach A L, 2008, SEMICONDUCTOR NANOCR; VISWANATH AK, 1994, MICROW OPT TECHN LET, V7, P94, DOI 10.1002/mop.4650070306; Warner JH, 2005, NANOTECHNOLOGY, V16, P175, DOI 10.1088/0957-4484/16/2/001; Zhang J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2907492	19	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0749-6036			SUPERLATTICE MICROST	Superlattices Microstruct.	MAR	2015	79						123	134		10.1016/j.spmi.2014.12.023		12	Physics, Condensed Matter	Physics	CC1GO	WOS:000350089400016		
J	Kim, JH; Kinugasa, Y; Hwang, SE; Murakami, G; Rodriguez-Vazquez, JF; Cho, BH				Kim, Ji Hyun; Kinugasa, Yusuke; Hwang, Si Eun; Murakami, Gen; Francisco Rodriguez-Vazquez, Jose; Cho, Baik Hwan			Denonvilliers' fascia revisited	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Denonvilliers' fascia; Peritoneum; Cul-de-sac; Rectum; Prostate; Vagina	STAGE HUMAN FETUSES; PARAPHARYNGEAL SPACE; RECTOVAGINAL SEPTUM; FETAL ANATOMY; TISSUE; TOPOHISTOLOGY; COMPARTMENT; PELVIS; MUSCLE; REPAIR	Although several studies have reported that the peritoneum does not contribute to the formation of a fascia between the urogenital organs and rectum, Denonvilliers' fascia (DF), a fascia between the mesorectum and prostate (or vagina) in adults, is believed to be a remnant of the peritoneum. Remnants of the peritoneum, however, were reportedly difficult to detect in other fusion fasciae of the abdominopelvic region in mid-term fetuses. To examine morphological changes of the pelvic cul-de-sac of the peritoneum, we examined 18 male and 6 female embryos and fetuses. A typical cul-de-sac was observed only at 7 weeks, whereas, at later stages, the peritoneal cavity did not extend inferiorly to the level of the prostatic colliculus or the corresponding structure in females. The cul-de-sac had completely disappeared in front of the rectum at 8 weeks and homogeneous and loose mesenchymal tissue was present in front of the rectum at the level of the colliculus at 12-16 weeks. We found no evidence that linearly arranged mesenchymal cells developed into a definite fascia. Therefore, the development of the DF in later stages of fetal development may result from the mechanical stress on the increased volumes of the mesorectum, seminal vesicle, prostate and vagina and/or enlarged rectum. Therefore, we considered the DF as a tension-induced structure rather than a fusion fascia. Fasciae around the viscera seemed to be classified into (1) a fusion fascia, (2) a migration fascia and (3) a tension-induced fascia although the second and third types are likely to be overlapped.	[Kim, Ji Hyun] Chonbuk Natl Univ, Sch Med, Dept Anat, Jeonju 561756, South Korea; [Kinugasa, Yusuke] Sizuoka Canc Inst, Div Colorectal Canc, Susono City, Sizuoka, Japan; [Hwang, Si Eun] Daejeon Sun Hosp, Dept Surg, Taejon, South Korea; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Japan; [Francisco Rodriguez-Vazquez, Jose] Univ Complutense, Inst Embryol, E-28040 Madrid, Spain; [Cho, Baik Hwan] Chonbuk Natl Univ, Dept Surg, Sch Med, Jeonju 561756, South Korea; [Cho, Baik Hwan] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju, South Korea	Cho, BH (reprint author), Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju, South Korea.	chobh@jbnu.ac.kr		Rodriguez-Vazquez, Jose Francisco/0000-0001-5423-4492	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0620220-1]	We are grateful to the families for agreeing to the fetuses and embryos donations for research and education on human anatomy without any economical benefit. This study was supported by a grant (0620220-1) from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea.	RICHARDSON AC, 1993, CLIN OBSTET GYNECOL, V36, P976, DOI 10.1097/00003081-199312000-00022; Kinugasa Y, 2008, CLIN ANAT, V21, P558, DOI 10.1002/ca.20654; HAYES MA, 1950, AM J ANAT, V87, P119, DOI 10.1002/aja.1000870105; Kinugasa Y, 2006, DIS COLON RECTUM, V49, P1024, DOI 10.1007/s10350-006-0557-7; Secin FP, 2007, J UROLOGY, V177, P521, DOI 10.1016/j.juro.2006.09.028; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Zhang C, 2010, DIS COLON RECTUM, V53, P1315, DOI 10.1007/DCR.0b013e3181e74525; Zhai LD, 2009, DIS COLON RECTUM, V52, P1564, DOI 10.1007/DCR.0b013e3181a8f75c; vanOphoven A, 1997, J UROLOGY, V157, P3, DOI 10.1016/S0022-5347(01)65266-2; Lin MB, 2010, WORLD J SURG, V34, P594, DOI 10.1007/s00268-009-0371-1; Miyake N, 2011, CLIN ANAT, V24, P607, DOI 10.1002/ca.21125; Mackey AL, 2008, CONNECT TISSUE RES, V49, P165, DOI 10.1080/03008200802151672; Arakawa Takashi, 2010, Okajimas Folia Anatomica Japonica, V87, P49; Charran O, 2013, CLIN ANAT, V26, P788, DOI 10.1002/ca.22092; Cho BH, 2009, J HEPATO-BILIARY-PAN, V16, P824, DOI 10.1007/s00534-009-0126-2; Cho KH, 2013, CLIN ANAT, V26, P347, DOI 10.1002/ca.22206; Cuneo B, 1989, J ANAT, V35, P235; Dietrich H, 1997, EUR UROL, V32, P124; FRITSCH H, 1992, EARLY HUM DEV, V28, P79, DOI 10.1016/0378-3782(92)90008-5; Hirata E, 2011, CLIN ANAT, V24, P469, DOI 10.1002/ca.21042; Jeong YJ, 2009, CLIN ANAT, V22, P716, DOI 10.1002/ca.20846; Katori Y, 2012, SURG RADIOL ANAT, V34, P909, DOI 10.1007/s00276-012-0975-2; Katori Y, 2013, CLIN ANAT, V26, P204, DOI 10.1002/ca.22088; Kinugasa Y, 2013, YONSEI MED J, V54, P778, DOI 10.3349/ymj.2013.54.3.778; Masumoto H, 2011, ANN ANAT, V193, P500, DOI 10.1016/j.aanat.2011.03.010; Matsubara A, 2009, CELLS TISSUES ORGANS, V190, P286, DOI 10.1159/000209231; Miyake N, 2010, ANAT REC, V293, P438, DOI 10.1002/ar.21089; Myers RP, 2010, CLIN ANAT, V23, P18, DOI 10.1002/ca.20895; Nagata I, 2007, INT UROGYNECOL J, V18, P863, DOI 10.1007/s00192-006-0249-9; Raychaudhuri B, 2008, ANN ROY COLL SURG, V90, P633, DOI 10.1308/003588408X321611; Silver OHS, 1956, J ANAT, V90, P538; TOBIN CE, 1945, SURG GYNECOL OBSTET, V80, P373; VANDERPUTTE SCJ, 2005, ADV ANAT EMBRYOL CEL, V177, P1; Walsh PC, 2002, CAMPBELLS UROLOGY, V4, P3107; Wesson MB, 1922, J UROLOGY, V8, P339; Yang JD, 2013, SURG RADIOL ANAT, V35, P403, DOI 10.1007/s00276-012-1051-7	36	3	5	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	MAR	2015	37	2					187	197		10.1007/s00276-014-1336-0		11	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CC0QK	WOS:000350040600010		
J	Hamano, M; Akimoto, M; Funada, K; Kagawa, N; Suzuki, N; Ishikawa, T				Hamano, Mizuna; Akimoto, Mayuko; Funada, Keiko; Kagawa, Natsuko; Suzuki, Noriyuki; Ishikawa, Tsutomu			Construction of a Bicyclo[3.2.1]octane System Carrying the (R)-Carvone Core under Oxidative Radical Conditions: Synthetic Access to (+)-Miroestrols	SYNLETT			English	Article						natural products; asymmetric synthesis; cyclization; radical reaction; bicyclic compounds	PUERARIA-MIRIFICA; CLAISEN REARRANGEMENT; KWAO KEUR; MIROESTROL; DEOXYMIROESTROL; CYCLIZATIONS; ETHERS	Bicyclo[3.2.1]octane systems carrying an (R)-carvone core were successfully constructed by 5-exo-cyclization between a beta-keto ester function and a 3,3-dimethylallyl group under oxidative radical conditions.	[Hamano, Mizuna; Akimoto, Mayuko; Funada, Keiko; Kagawa, Natsuko; Suzuki, Noriyuki; Ishikawa, Tsutomu] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Med Organ Chem, Chuo Ku, Chiba 2608675, Japan	Suzuki, N (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Med Organ Chem, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	n-suzuki@chiba-u.jp	Kagawa, Natsuko/M-8543-2015	Kagawa, Natsuko/0000-0002-2762-8995	JSPS [23590041]	The project was financially supported by a JSPS Grant-in-Aid for Scientific Research (C) (Grant No. 23590041).	Chansakaow S, 2000, J NAT PROD, V63, P173, DOI 10.1021/np990547v; CAIN JC, 1960, NATURE, V188, P774, DOI 10.1038/188774a0; COREY EJ, 1993, J AM CHEM SOC, V115, P9327, DOI 10.1021/ja00073a074; BATEY RA, 1992, TETRAHEDRON, V48, P8031, DOI 10.1016/S0040-4020(01)80475-0; Rodriguez JR, 2001, ORG LETT, V3, P1181; Snider BB, 1996, CHEM REV, V96, P339, DOI 10.1021/cr950026m; Ley SV, 2008, CHEM-EUR J, V14, P10683, DOI 10.1002/chem.200801103; Batey RA, 1996, TETRAHEDRON, V52, P11421, DOI 10.1016/0040-4020(96)00635-7; BOUNDS DG, 1960, J CHEM SOC, P3696, DOI 10.1039/jr9600003696; Ho T., 1979, J AM CHEM SOC, V101, P159; Ito F, 2009, TETRAHEDRON, V65, P771, DOI 10.1016/j.tet.2008.11.055; Ito F, 2007, SYNTHESIS-STUTTGART, P1785, DOI 10.1055/s-2007-983712; Ito F, 2005, TETRAHEDRON LETT, V46, P7765, DOI 10.1016/j.tetlet.2005.09.028; Ito F., UNPUBLISHED RESULTS; Shimokawa S, 2013, NAT PROD RES, V27, P371, DOI 10.1080/14786419.2012.695370; TAYLOR NE, 1960, J CHEM SOC, P3685, DOI 10.1039/jr9600003685; Yoshimitsu T, 1999, TETRAHEDRON LETT, V40, P5215, DOI 10.1016/S0040-4039(99)00941-7	17	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	MAR	2015	26	4					547	551		10.1055/s-0034-1379700		5	Chemistry, Organic	Chemistry	CC0WI	WOS:000350059200021		
J	Ota, Y				Ota, Yuzo			Pigmentation patterns are useful for species identification of third-stage larvae of gnathiids (Crustacea: Isopoda) parasitising coastal elasmobranchs in southern Japan	SYSTEMATIC PARASITOLOGY			English	Article							GREAT-BARRIER-REEF; SP-NOV CRUSTACEA; LIZARD ISLAND; SOUTHWESTERN JAPAN; HAEMOGREGARINA-BIGEMINA; HEMISCYLLIUM-OCELLATUM; TRIMACULATA CRUSTACEA; RYUKYU ARCHIPELAGO; FEEDING ECOLOGY; REQUIEM SHARKS	Previous studies from southern Japan reported larval stages of eight gnathiid isopod species parasitising coastal elasmobranchs. Since gnathiid larvae of these different species closely resembled each other, it was necessary to obtain specimens of free-living adult males for identification to the species level. This was achieved by allowing larvae of the final stage to moult into adult males. From these males, specimens of a species new to science were discovered and described here as Gnathia rufescens n. sp. The main differentiating characteristics of G. rufescens n. sp. are: (i) the apex of pleotelson is oval shaped; (ii) the dorsal sulcus is wide in the posterior part; and (iii) the article 3 of the pylopod is not reduced in the male. Additionally, this paper summarises the specific pigmentation patterns of third-stage larvae of the new species and eight previously described species. Furthermore, host records and host use by the gnathiids were summarised based on data from 158 hosts and over 4,500 gnathiid samples; these are discussed with a focus on host-specificity of the nine gnathiid species studied.	Lake Biwa Museum, Kusatsu, Shiga 5250001, Japan	Ota, Y (reprint author), Lake Biwa Museum, Oroshimo 1091, Kusatsu, Shiga 5250001, Japan.	yota1164@gmail.com			 [23-527]	Part of the material examined in this study was collected during the KUMEJIMA 2009 Expedition organized by the Transdisciplinary Research Organization for Subtropical and Island Studies of the University of the Ryukyus, the Center for Marine Bioscience & Biotechnology of the National Taiwan Ocean University, the Raffles Museum of Biodiversity Research of the National University of Singapore, and the Biodiversity Research Center of the Academia Sinica. The expedition operated under a permit granted to Dr. T. Naruse by the Okinawa Prefectural Governor and the Kumejima Fisheries Cooperative. This study was partly supported by a Grant-in-Aid JSPS Fellows (No. 23-527). I would like to thank two anonymous reviewers for their valuable comments.	McKiernan JP, 2005, INT J PARASITOL, V35, P19, DOI 10.1016/j.ijpara.2004.10.016; Jones CM, 2005, J FISH BIOL, V66, P860, DOI 10.1111/j.1095-8649.2005.00640.x; Ota Y, 2012, ZOOTAXA, P79; Davies AJ, 2001, FOLIA PARASIT, V48, P169; Ferreira ML, 2009, J PARASITOL, V95, P1066, DOI 10.1645/GE-1920.1; Smit NJ, 2004, ADV PARASIT, V58, P289, DOI 10.1016/S0065-308X(04)58005-3; Wilson GDF, 2011, J CRUSTACEAN BIOL, V31, P509, DOI 10.1651/10-3432.1; Ota Y, 2012, MAR BIOL, V159, P2333, DOI 10.1007/s00227-012-2018-2; Farquharson C, 2012, ZOOTAXA, P47; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; Carpenter K. E., 1999, FAO SPECIES IDENTIFI, V3, P1397; Carpenter KE, 1998, FAO SPECIES IDENTIFI, V2, P687; Coetzee ML, 2009, SYST PARASITOL, V72, P97, DOI 10.1007/s11230-008-9158-2; Coetzee ML, 2008, J PARASITOL, V94, P608, DOI 10.1645/GE-1391.1; Curtis LM, 2013, INT J PARASITOL, V43, P361, DOI 10.1016/j.ijpara.2012.11.012; Ferreira ML, 2010, ZOOTAXA, P39; Grutter AS, 2003, MAR ECOL PROG SER, V259, P295, DOI 10.3354/meps259295; Grutter AS, 2011, BIOL LETTERS, V7, P292, DOI 10.1098/rsbl.2010.0916; Hadfield KA, 2008, ZOOTAXA, P23; Hayes PM, 2007, J FISH DIS, V30, P55, DOI 10.1111/j.1365-2761.2007.00777.x; Heupel MR, 1999, INT J PARASITOL, V29, P321, DOI 10.1016/S0020-7519(98)00218-5; Honma Y., 1991, REP SADO MAR BIOL ST, V21, P37; HONMA Y, 1991, FISH PATHOL, V26, P9; Jones CM, 2007, INT J PARASITOL, V37, P927, DOI 10.1016/j.ijpara.2007.01.011; Marino F, 2004, DIS AQUAT ORGAN, V59, P43, DOI 10.3354/dao059043; MONOD THEODORE, 1926, MEM SOC SCI NAT MAROC, V13, P1; MUGRIDGE RER, 1983, J FISH DIS, V6, P81, DOI 10.1111/j.1365-2761.1983.tb00054.x; Munday PL, 2003, J FISH BIOL, V62, P976, DOI 10.1046/j.1095-8649.2003.00078.x; Nagel L, 2007, J FISH BIOL, V70, P497, DOI 10.1111/j.1095-8649.2007.01320.x; Nakabo T., 1993, FISHES JAPAN PICTORI, V1; Nunomura Noboru, 2004, Contributions from the Biological Laboratory Kyoto University, V29, P343; Nunomura N, 1998, CONTRIBUTIONS TOYAMA, V21, P55; Nunomura N, 1981, CONTRIBUTIONS TOYAMA, V3, P19; Nunomura N, 2012, CONTRIBUTIONS TOYAMA, V35, P57; Ota Y, 2009, ZOOTAXA, P50; Ota Y, 2009, ZOOTAXA, P43; Ota Yuzo, 2011, Bulletin of the National Museum of Nature and Science Series A-Zoology, P41; Ota Y, 2007, ZOOL SCI, V24, P1266, DOI 10.2108/zsj.24.1266; Ota Y, 2014, ZOOTAXA, V3857, P478, DOI 10.11646/zootaxa.3857.4.2; Ota Y, 2013, ZOOTAXA, V 3737, P33, DOI 10.11646/zootaxa.3737.1.3; Patarnello P. P., 1995, B SOC ITALIANA PATOL, V17, P32; Schotte M., 2008, WORLD MARINE FRESHWA; Smit NJ, 2002, FOLIA PARASIT, V49, P137; Smit NJ, 1999, FOLIA PARASIT, V46, P229; Svavarsson J, 2012, ZOOTAXA, P1; Tanaka Katsuhiko, 2004, Crustacean Research, V33, P51; Yoshida Y., 1988, REPORTS ECTOPARASITE, P131	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-5752	1573-5192		SYST PARASITOL	Syst. Parasitol.	MAR	2015	90	3					269	284		10.1007/s11230-015-9548-1		16	Parasitology	Parasitology	CB9TD	WOS:000349974700006		
J	Liu, R; Ishimatsu, R; Yahiro, M; Adachi, C; Nakano, K; Imato, T				Liu, Rong; Ishimatsu, Ryoichi; Yahiro, Masayuki; Adachi, Chihaya; Nakano, Koji; Imato, Toshihiko			Fluorometric flow-immunoassay for alkylphenol polyethoxylates on a microchip containing a fluorescence detector comprised of an organic light emitting diode and an organic photodiode	TALANTA			English	Article						Organic light emitting diode (OLED); Organic photodiode (OPD); Fluorescence immunoassay; Microfluidic; Resorufin; Alkylphenol polyethoxylates	LINKED-IMMUNOSORBENT-ASSAY; MAGNETIC MICROBEADS; MICROFLUIDIC DEVICE; MASS-SPECTROMETRY; ENERGY-TRANSFER; SURFACTANTS; ELECTROPHOSPHORESCENCE; EFFICIENCY; COMPLEXES; PRODUCTS	A compact fluorescence detector was constructed on a microchip from an organic light emitting diode (OLED) as the light source and an organic photodiode (OPD) as the photo-detector and was used in an immunoassay for allcylphenol polyethoxylates (APE). The OLED based on a terbium complex emitted a sharp light at the main wavelength of 546 nm with a full width at half maximum of 9 nm. The incident photo-to-current conversion efficiency (IPCE) of the OPD fabricated with Fullerene 70(C-70) and tris[4-(5phenylthiopen-2-yephenyll-amine (TPTPA) was approximately 44% for light at a wavelength of 586 nm. The performance of the fluorescence detector was evaluated for the determination of resorufin (lambda(em)= 586 nm) and the photocurrent of the OPD due to the fluorescence of resorufin was proportional to the concentration of resorufin in the range from 0 to 18 mu M with a detection limit (S/N=3) of 0.6 mu M. The fluorescence detector was successfully utilized in a competitive enzyme-linked immunosorbent assay for APE, where an anti-APE antibody was immobilized on the surface of the channel of the Polydimethylsiloxane (PDMS) microchip or on the surface of magnetic microbeads. After an immunoreaction with a sample solution of APE containing a horse radish peroxidase (HRP)-labeled APE, the fluorescence of resorufin generated just after introduction of a mixed solution of Amplex Red and H2O2 was measured using the fluorescence detector. The calibration curve for the photocurrent signals of the OPD due to the fluorescence of resorufin against the logarithmic concentration of APE was sigmoidal in shape. The detection limits defined as IC80 were ca. 1 ppb and ca. 2 ppb, respectively, for the methods using the anti-APE antibody immobilized on the surface of the microchannel and in the case where the antibody was immobilized on the surface of magnetic microbeads. (C) 2014 Elsevier B.V. All rights reserved.	[Liu, Rong; Ishimatsu, Ryoichi; Adachi, Chihaya; Nakano, Koji; Imato, Toshihiko] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Yahiro, Masayuki] Inst Syst Informat Technol & Nanotechnol, Swawara Ku, Fukuoka 8190395, Japan; [Yahiro, Masayuki; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan	Imato, T (reprint author), Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	imato@cstf.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; JSPS KAKENHI [25620117]	This research was supported in part by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" and by JSPS KAKENHI Grant no. 25620117.	Hofmann O, 2005, LAB CHIP, V5, P863, DOI 10.1039/b504551g; Zhang RQ, 2007, ANAL CHIM ACTA, V600, P105, DOI 10.1016/j.aca.2007.02.052; Baldo MA, 2000, PHYS REV B, V62, P10958, DOI 10.1103/PhysRevB.62.10958; Kim S, 2011, IEEE T ELECTRON DEV, V58, P3609, DOI 10.1109/TED.2011.2162844; Yao B, 2006, ANAL CHEM, V78, P5845, DOI 10.1021/ac060445r; Ramuz M, 2011, J POLYM SCI POL PHYS, V49, P80, DOI 10.1002/polb.22111; Miyake M, 2012, TALANTA, V96, P132, DOI 10.1016/j.talanta.2012.02.006; Yang F, 2011, TALANTA, V84, P1099, DOI 10.1016/j.talanta.2011.03.020; Chen G, 2012, ADV MATER, V24, P2768, DOI 10.1002/adma.201200234; WHITE R, 1994, ENDOCRINOLOGY, V135, P175, DOI 10.1210/en.135.1.175; Yao B, 2005, LAB CHIP, V5, P1041, DOI 10.1039/b504959h; Yokoyama D, 2012, SOL ENERG MAT SOL C, V98, P472, DOI 10.1016/j.solmat.2011.10.014; Nakajima H, 2011, J SEP SCI, V34, P2906, DOI 10.1002/jssc.201100429; Zheng YQ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801647; Ryu G, 2011, LAB CHIP, V11, P1664, DOI 10.1039/c0lc00586j; Zhang QS, 2012, J AM CHEM SOC, V134, P14706, DOI 10.1021/ja306538w; Zhang QS, 2012, ADV FUNCT MATER, V22, P2327, DOI 10.1002/adfm.201101907; Ishimatsu R, 2013, TALANTA, V117, P139, DOI 10.1016/j.talanta.2013.08.044; Xue SH, 2012, J ENVIRON SCI-CHINA, V24, P564, DOI 10.1016/S1001-0742(11)60802-4; Holmes RJ, 2003, APPL PHYS LETT, V82, P2422, DOI 10.1063/1.1568146; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1897/1551-5028(1996)015<0241:EAOSAS>2.3.CO;2; Quirino WG, 2008, THIN SOLID FILMS, V517, P1096, DOI 10.1016/j.tsf.2008.06.012; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Collins GE, 2007, TALANTA, V72, P301, DOI 10.1016/j.talanta.2006.10.015; Corcia A.D., 1994, ENVIRON SCI TECHNOL, V28, P850; CRESCENZI C, 1995, ANAL CHEM, V67, P1797, DOI 10.1021/ac00107a008; Goda Y, 2004, WATER RES, V38, P4323, DOI 10.1016/j.watres.2004.07.030; Hofmann O., 2006, SENSOR ACTUAT B-CHEM, V6, P981; Kim YH, 2006, J MICROELECTROMECH S, V15, P1152, DOI 10.1109/JMEMS.2006.880355; Merfort C, 2010, MICROELECTRON ENG, V87, P712, DOI 10.1016/j.mee.2009.12.052; Misawa N, 2011, IEEJ T ELECTR ELECTR, V6, P97, DOI 10.1002/tee.20630; Ohishi H, 2004, CHEM LETT, V33, P1266, DOI 10.1246/cl.2004.1266; Onoshima D, 2012, ANAL METHODS-UK, V4, P4368, DOI 10.1039/c2ay26099a; Pan JZ, 2010, ANAL CHEM, V82, P3394, DOI 10.1021/ac100257z; Tanaka B.H., 2006, ADV MATER, V18, P2230; VENTURA F, 1988, WATER RES, V22, P1211, DOI 10.1016/0043-1354(88)90107-8; Zheng YQ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801954	37	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	MAR 1	2015	134						37	47		10.1016/j.talanta.2014.10.055		11	Chemistry, Analytical	Chemistry	CB6FT	WOS:000349723600006		
J	Jha, SK; Hayashi, K				Jha, Sunil K.; Hayashi, Kenshi			A quick responding quartz crystal microbalance sensor array based on molecular imprinted polyacrylic acids coating for selective identification of aldehydes in body odor	TALANTA			English	Article						QCM sensor; MIP; Body odor; Aldehydes; Pattern recognition	VOLATILE ORGANIC-COMPOUNDS; MOSQUITO AEDES-AEGYPTI; HUMAN SKIN EMANATIONS; QCM SENSOR; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; ELECTRONIC NOSE; POLYMER; HUMIDITY; ATTRACTANTS	In present work, a novel quartz crystal microbalance (QCM) sensor array has been developed for prompt identification of primary aldehydes in human body odor. Molecularly imprinted polymers (MIP) are prepared using the polyacrylic acid (PAA) polymer matrix and three organic acids (propenoic acid, hexanoic acid and octanoic acid) as template molecules, and utilized as QCM surface coating layer. The performance of MIP films is characterized by 4-element QCM sensor array (three coated with MIP layers and one with pure PAA for reference) dynamic and static responses to target aldehydes: hexanal, heptanal, and nonanal in single, binary, and tertiary mixtures at distinct concentrations. The target aldehydes were selected subsequent to characterization of body odor samples with solid phase-micro extraction gas chromatography mass spectrometer (SPME-GC-MS). The hexanoic acid and octanoic acid imprinted PAA exhibit fast response, and better sensitivity, selectivity and reproducibility than the propenoic acid, and non-imprinted PAA in array. The response time and recovery time for hexanoic acid imprinted PAA are obtained as 5 s and 12 s respectively to typical concentrations of binary and tertiary mixtures of aldehydes using the static response. Dynamic sensor array response matrix has been processed with principal component analysis (PCA) for visual, and support vector machine (SVM) classifier for quantitative identification of target odors. Aldehyde odors were identified successfully in principal component (PC) space. SVM classifier results maximum recognition rate 79% for three classes of binary odors and 83% including single, binary, and tertiary odor classes in 3-fold cross validation. (C) 2014 Elsevier B.V. All rights reserved.	[Jha, Sunil K.; Hayashi, Kenshi] Kyushu Univ, Dept Elect, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan	Jha, SK (reprint author), Kyushu Univ, Dept Elect, Grad Sch Informat Sci & Elect Engn, 744 Motooka, Fukuoka 8190395, Japan.	drsuniljha@o.ed.kyushu-u.ac.jp			JSPS KAKENHI [25420409]	This research work was supported by Grant-in-Aid for JSPS fellows 24.02367 and partly by JSPS KAKENHI Grant no. 25420409. The author S.K.J. gratefully acknowledges Dr. C. Liu, lab colleagues, Mrs. Anju Sunil Jha for their contribution and support during the study, and distinguished reviewers for their valuable comments and suggestions.	Gultekin A, 2014, TALANTA, V119, P533, DOI 10.1016/j.talanta.2013.11.053; Thorn RMS, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/024001; Preti G, 2010, J INVEST DERMATOL, V130, P344, DOI 10.1038/jid.2009.396; Haupt K, 2000, CHEM REV, V100, P2495, DOI 10.1021/cr990099w; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; Jha SK, 2014, SENSOR ACTUAT B-CHEM, V204, P74, DOI 10.1016/j.snb.2014.07.098; Percival CJ, 2001, ANAL CHEM, V73, P4225, DOI 10.1021/ac0155198; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Matsuguchi M, 2006, SENSOR ACTUAT B-CHEM, V113, P94, DOI 10.1016/j.snb.2005.02.028; Pandey SK, 2011, TRAC-TREND ANAL CHEM, V30, P784, DOI 10.1016/j.trac.2010.12.005; Liu CJ, 2013, SENSOR ACTUAT B-CHEM, V183, P117, DOI 10.1016/j.snb.2013.03.111; Yola ML, 2014, TALANTA, V120, P318, DOI 10.1016/j.talanta.2013.10.064; Mumyakmaz B, 2010, SENSOR ACTUAT B-CHEM, V147, P277, DOI 10.1016/j.snb.2010.03.019; D'Amico A, 2008, SENSOR ACTUAT B-CHEM, V130, P458, DOI 10.1016/j.snb.2007.09.044; Xu XM, 2009, TALANTA, V78, P711, DOI 10.1016/j.talanta.2008.12.031; Avila M, 2007, TALANTA, V72, P1362, DOI 10.1016/j.talanta.2007.01.045; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bakas I, 2014, TALANTA, V125, P313, DOI 10.1016/j.talanta.2014.03.020; Martinez-Lozano P, 2008, ANAL CHEM, V80, P8210, DOI 10.1021/ac801185e; Arshak K., 2004, Sensor Review, V24, DOI 10.1108/02602280410525977; Barko G, 1997, TALANTA, V44, P2237, DOI 10.1016/S0039-9140(97)00168-9; Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v; Bishop C. M., 2006, PATTERN RECOGNITION; Burges A., 1998, DATA MIN KNOWL DISC, P121; Dimitriadou E., 2008, E1071 MISC FUNCTIONS, P5; Dormont L, 2013, J EXP BIOL, V216, P2783, DOI 10.1242/jeb.085936; Fang L, 1998, INDOOR AIR, V8, P80, DOI 10.1111/j.1600-0668.1998.t01-2-00003.x; Gardener J.W., 1999, ELECT NOSES PRINCIPL; GOETZ N, 1988, J SOC COSMET CHEM, V39, P1; Havlicek J, 2006, CHEM SENSES, V31, P747, DOI 10.1093/chemse/bjl017; Huang HH, 2004, SENSOR ACTUAT B-CHEM, V101, P316, DOI 10.1016/j.snb.2004.04.001; Jain A.K., 2004, TECHNOLOGY, V14, P4, DOI DOI 10.1109/TCSVT.2003.818349; Jha SK, 2009, IEEE SENS J, V9, P1202, DOI 10.1109/JSEN.2009.2029452; Jha SK, 2011, SENSOR LETT, V9, P1612, DOI 10.1166/sl.2011.1740; Jha S.K., 2014, P IEEE ISSNIP SINGAP, P1; Kubota M., 1994, J SOC COSMET CHEM, V28, P295; Lafleur P.A., 1998, US Patent, Patent No. [5780020 A, 5780020]; Lide D R, 2004, HDB CHEM PHYS; Marx K.A., 2003, MACROMOLECULES, V4, P1099; Mirmohseni A, 2001, J APPL POLYM SCI, V79, P1062, DOI 10.1002/1097-4628(20010207)79:6<1062::AID-APP90>3.0.CO;2-V; Munk S, 2000, J SURFACTANTS DETERG, V3, P505, DOI 10.1007/s11743-000-0150-z; Natale C.D., 2000, SENSOR ACTUAT B-CHEM, V65, P216; Osuna R.G., 1999, IEEE T SYST MAN CY B, V29, P626; R Development Core Team, 2008, R LANG ENV STAT COMP; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Smith LI., 2002, TUTORIAL PRINCIPAL C, P1; Staples E.J., 1999, P 92 AIR WAST MAN M, P4093; Sun YL, 2007, TALANTA, V73, P857, DOI 10.1016/j.talanta.2007.05.002; Vapnik VN, 1982, ESTIMATION DEPENDENC; Vashist S.K., 2011, J SENSORS, P1; Wongchoosuk C, 2009, SENSORS-BASEL, V9, P7234, DOI 10.3390/s90907234; Yamazaki S., 2010, ANTIAGING MED, V7, P60; Yuwono A. S., 2004, J SCI RES DEV, V3, P9	56	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	MAR 1	2015	134						105	119		10.1016/j.talanta.2014.09.049		15	Chemistry, Analytical	Chemistry	CB6FT	WOS:000349723600014		
J	Ivandini, TA; Wicaksono, WP; Saepudin, E; Rismetov, B; Einaga, Y				Ivandini, Tribidasari A.; Wicaksono, Wiyogo P.; Saepudin, Endang; Rismetov, Bakhadir; Einaga, Yasuaki			Anodic stripping voltammetry of gold nanoparticles at boron-doped diamond electrodes and its application in immunochromatographic strip tests	TALANTA			English	Article						Melamine; Anodic stripping voltammetry; Gold nanoparticles; Boron-doped diamond electrode; Immunochromatographic strip tests	DIRECT ELECTROCHEMICAL OXIDATION; MASS-SPECTROMETRY; CYANURIC ACID; RAW-MILK; MELAMINE; IMMUNOASSAY; FABRICATION; BIOSENSOR; PROTEINS; PROBES	Anodic stripping voltammetry (ASV) of colloidal gold-nanoparticles (AuNPs) was investigated at borondoped diamond (BDD) electrodes in 50 mM HClO4. A deposition time of 300 s at -0.2 V (vs. Ag/AgCl) was fixed as the condition for the ASV. The voltammograms showed oxidation peaks that could be attributed to the oxidation of gold. These oxidation peaks were then investigated for potential application in immunochromatographic strip tests for the selective and quantitative detection of melamine, in which AuNPs were used as the label for the antibody of melamine. Linear regression of the oxidation peak currents appeared in the concentration range from 0.05-0.6 mu g/mL melamine standard, with an estimated LOD of 0.069 mu g/mL and an average relative standard deviation of 8.0%. This indicated that the method could be considered as an alternative method for selective and quantitative immunochromatographic applications. The validity was examined by the measurements of melamine injected into milk samples, which showed good recovery percentages during the measurements. (C) 2014 Elsevier B.V. All rights reserved.	[Ivandini, Tribidasari A.; Wicaksono, Wiyogo P.; Saepudin, Endang; Rismetov, Bakhadir] Univ Indonesia, Dept Chem, Fac Math & Sci, Depok, Indonesia; [Ivandini, Tribidasari A.; Einaga, Yasuaki] Keio Univ, Dept Chem, Yokohama, Kanagawa 2238522, Japan; [Einaga, Yasuaki] JST CREST, Yokohama, Kanagawa 2238522, Japan	Ivandini, TA (reprint author), Univ Indonesia, Dept Chem, Fac Math & Sci, Kampus UI, Depok, Indonesia.	einaga@chem.keio.ac.jp	Einaga, Yasuaki/F-1833-2014		Hibah Riset Utama Universitas Indonesia (RUUI) (DAMAS) [0974/H2.R12/HKP.05.00/2013]	This work was partly granted by Hibah Riset Utama Universitas Indonesia (RUUI) 2013 (DAMAS) Grant No. 0974/H2.R12/HKP.05.00/2013.	Ivandini TA, 2012, ANAL CHEM, V84, P9825, DOI 10.1021/ac302090y; Wang J, 2007, ELECTROANAL, V19, P769, DOI 10.1002/elan.200603789; Mao X, 2008, ELECTROCHEM COMMUN, V10, P1636, DOI 10.1016/j.elecom.2008.08.032; Castaneda MT, 2007, ELECTROANAL, V19, P743, DOI 10.1002/elan.200603784; Dequaire M, 2000, ANAL CHEM, V72, P5521, DOI 10.1021/ac000781m; Hutton LA, 2011, ANAL CHEM, V83, P735, DOI 10.1021/ac101626s; Lin YY, 2008, BIOSENS BIOELECTRON, V23, P1659, DOI 10.1016/j.bios.2008.01.037; Li XM, 2011, J AGR FOOD CHEM, V59, P6064, DOI 10.1021/jf2008327; Andersen WC, 2008, J AGR FOOD CHEM, V56, P4340, DOI 10.1021/jf800295z; Xu H, 2009, ANAL CHEM, V81, P669, DOI 10.1021/ac8020592; Ushizawa K, 1998, DIAM RELAT MATER, V7, P1719, DOI 10.1016/S0925-9635(98)00296-9; Terashima C, 2003, ANAL CHEM, V75, P1564, DOI 10.1021/ac020583q; Prado C, 2002, ELECTROANAL, V14, P262, DOI 10.1002/1521-4109(200202)14:4<262::AID-ELAN262>3.0.CO;2-D; Le T, 2013, FOOD CHEM, V138, P1610, DOI 10.1016/j.foodchem.2012.11.077; Chiku M, 2008, J ELECTROANAL CHEM, V612, P201, DOI 10.1016/j.jelechem.2007.09.027; Wang J, 1998, ANAL CHEM, V70, P1682, DOI 10.1021/ac971298n; HAYES FJ, 1994, ANAL CHEM, V66, P1860, DOI 10.1021/ac00083a014; Jans H, 2012, CHEM SOC REV, V41, P2849, DOI 10.1039/c1cs15280g; Brown CA, 2007, J VET DIAGN INVEST, V19, P525; Puschner B, 2007, J VET DIAGN INVEST, V19, P616; Sun FX, 2010, TRAC-TREND ANAL CHEM, V29, P1239, DOI 10.1016/j.trac.2010.06.011; LINTERN M, 1988, ANAL CHIM ACTA, V209, P193, DOI 10.1016/S0003-2670(00)84562-6; Kondo T, 2007, J PHYS CHEM C, V111, P12650, DOI 10.1021/jp0727704; Liu GD, 2007, ANAL CHEM, V79, P7644, DOI 10.1021/ac070691i; Choico R., 2003, IMMUNOLOGY SHORT COU; El Tall O, 2007, ELECTROANAL, V19, P1152, DOI 10.1002/elan.200603834; Fujishima A., 2005, DIAMOND ELECTROCHEMI; Gillespie A, 2012, ANAL LETT, V45, P1310, DOI 10.1080/00032719.2012.673141; Gonzalez Garcia M. B., 1995, Bioelectrochemistry and Bioenergetics, V38, P389, DOI 10.1016/0302-4598(95)01813-T; Hernandez-Santoz D., 2000, J ELECTROANAL CHEM, V46, P607; Honda Y, 2013, DIAM RELAT MATER, V40, P7, DOI 10.1016/j.diamond.2013.09.001; Ivandini TA, 2005, CHEM LETT, V34, P1086, DOI 10.1246/cl.2005.1086; Nagaoka Y, 2010, CHEM LETT, V39, P1055, DOI 10.1246/cl.2010.1055; Ouattara L, 2003, NEW DIAM FRONT C TEC, V13, P97; Pourbaix M., 1974, ATLAS ELECTROCHEMICA; SUBRAYAN RP, 1995, TRENDS POLYM SCI, V3, P165; Sugitani A., 2012, PHYS CHEM CHEM PHYS, V15, P142; Sun FX, 2012, INT J FOOD SCI TECH, V47, P1505, DOI 10.1111/j.1365-2621.2012.02998.x; Tian RH, 2007, ELECTROCHEM COMMUN, V9, P1120, DOI 10.1016/j.elecom.2006.12.027; Uchikado R, 2001, CHEM LETT, P144, DOI 10.1246/cl.2001.144; Weller M.G., 2000, ANAL CHEM, V266, P635; Wong R.C., LATERAL FLOW IMMUNOA, P1; Yu L, 2010, TALANTA, V28, P869; Zhao P.X., 2010, COORDIN CHEM REV, V257, P638	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	MAR 1	2015	134						136	143		10.1016/j.talanta.2014.11.010		8	Chemistry, Analytical	Chemistry	CB6FT	WOS:000349723600018		
J	Rahayu, A; Lim, LW; Takeuchi, T				Rahayu, Aster; Lim, Lee Wah; Takeuchi, Toyohide			Polymer monolithic methacrylate base modified with tosylated-polyethylene glycol monomethyl ether as a stationary phase for capillary liquid chromatography	TALANTA			English	Article						Polymer monoliths; Polyethylene glycol; Methacrylate base; Ion exchange chromatography	POLY(ETHYLENE GLYCOL); ION CHROMATOGRAPHY; BIOPOLYMER SEPARATION; SILICA COLUMNS; SEAWATER; PROTEIN; IODIDE	A polyethylene glycol (PEG) monolithic column was successfully prepared in situ for the separation of inorganic anions in ion exchange capillary chromatography. By attaching PEG-groups into the methacrylate-based polymer, the number of theoretical plates was improved from 1433 to 3346 plates/m (when nitrate was used as the analyte). The retention behavior of iodate, bromate, nitrite, bromide and nitrate was observed under various salt aqueous solutions. The retention was based on cations trapped among PEG chain and the positively charged pyridine that work as the anion exchange sites in the PEG monolith. The relative standard deviations (RSDs, for n=7) of retention time, peak height and peak area were less than 2.27% for all the analyte anions. The PEG monoliths showed satisfactory mechanical stability and did not swell or shrink significantly with swelling propensity value of 034 and 0.64 for methanol and THF, respectively. This stationary phase was successfully applied to the determination of these anions in seawater as well as public drinking water samples. (C) 2014 Elsevier B.V. All rights reserved.	[Rahayu, Aster; Lim, Lee Wah; Takeuchi, Toyohide] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Takeuchi, T (reprint author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	take-t@gifu-u.ac.jp					Takeuchi T, 2010, ANAL SCI, V26, P937; Linda R, 2013, J CHROMATOGR A, V1294, P117, DOI 10.1016/j.chroma.2013.04.052; Wang RW, 2006, COLLOID SURFACE B, V51, P93, DOI 10.1016/j.colsurfb.2006.05.015; Lim LW, 2012, ANAL SCI, V28, P205; Courtois J, 2006, POLYMER, V47, P2603, DOI 10.1016/j.polymer.2006.01.096; Ishizuka N, 2002, J CHROMATOGR A, V960, P85, DOI 10.1016/S0021-9673(01)01580-1; Tanaka N, 2002, J CHROMATOGR A, V965, P35, DOI 10.1016/S0021-9673(01)01582-5; NEVEJANS F, 1985, J CHROMATOGR, V350, P145, DOI 10.1016/S0021-9673(01)93514-9; Kitagawa F, 2010, J PHARMACEUT BIOMED, V53, P1272, DOI 10.1016/j.jpba.2010.07.008; Li Y, 2012, TALANTA, V99, P91, DOI 10.1016/j.talanta.2012.04.066; Lim L.W., 2014, CHROMATOGRAPHY, V35, P95; Lubbad SH, 2009, J SEP SCI, V32, P2521, DOI 10.1002/jssc.200900188; Moravcova D, 2004, J SEP SCI, V27, P789, DOI 10.1002/jssc.200401778; Nunez O, 2007, J CHROMATOGR A, V1175, P7, DOI 10.1016/j.chroma.2007.09.071; Rong L, 2006, J CHROMATOGR A, V1128, P68, DOI 10.1016/j.chroma.2006.06.041; Rong L, 2004, J CHROMATOGR A, V1042, P131, DOI 10.1016/j.chroma.2004.05.032; Siswoyo, 2012, ANAL SCI, V28, P107; Takeuchi T, 2009, ANAL BIOANAL CHEM, V393, P1267, DOI 10.1007/s00216-008-2533-7; Trojer L, 2006, J CHROMATOGR A, V1117, P56, DOI 10.1016/j.chroma.2006.03.051; Wieder W, 2008, J CHROMATOGR A, V1191, P253, DOI 10.1016/j.chroma.2007.11.070	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	MAR 1	2015	134						232	238		10.1016/j.talanta.2014.10.060		7	Chemistry, Analytical	Chemistry	CB6FT	WOS:000349723600030		
J	Wang, CQ; Jia, XH; Zhu, S; Komatsu, K; Wang, X; Cai, SQ				Wang, Chao-Qun; Jia, Xiu-Hong; Zhu, Shu; Komatsu, Katsuko; Wang, Xuan; Cai, Shao-Qing			A systematic study on the influencing parameters and improvement of quantitative analysis of multi-component with single marker method using notoginseng as research subject	TALANTA			English	Article						Notoginseng; Saponin; Quantitative analysis of multi-components with single marker(QAMS) method; Applicable concentration range; Relative correction factor (RCF); Influencing parameters		A new quantitative analysis of multi-component with single marker (QAMS) method for 11 saponins (ginsenosides Rg(1), Rb-1, Rg(2), Rh-1, Rf, Re and Rd; notoginsenosides R-1, R-4, Fa and K) in notoginseng was established, when 6 of these saponins were individually used as internal referring substances to investigate the influences of chemical structure, concentrations of quantitative components, and purities of the standard substances on the accuracy of the QAMS method. The results showed that the concentration of the analyte in sample solution was the major influencing parameter, whereas the other parameters had minimal influence on the accuracy of the QAMS method. A new method for calculating the relative correction factors by linear regression was established (linear regression method), which demonstrated to decrease standard method differences of the QAMS method from 1.20%+/- 0.02% - 23.29%+/- 3.23% to 0.10%+/- 0.09% - 8.84%+/- 2.85% in comparison with the previous method. And the differences between external standard method and the QAMS method using relative correction factors calculated by linear regression method were below 5% in the quantitative determination of Rg(1), Re, R-1, Rd and Fa in 24 notoginseng samples and Rb-1 in 21 notoginseng samples. And the differences were mostly below 10% in the quantitative determination of Rf, Rg(2), R-4 and N-K (the differences of these 4 constituents bigger because their contents lower) in all the 24 notoginseng samples. The results indicated that the contents assayed by the new QAMS method could be considered as accurate as those assayed by external standard method. In addition, a method for determining applicable concentration ranges of the quantitative components assayed by QAMS method was established for the first time, which could ensure its high accuracy and could be applied to QAMS methods of other TCMs. The present study demonstrated the practicability of the application of the QAMS method for the quantitative analysis of multi-component and the quality control of TCMs and TCM prescriptions. (C) 2014 Elsevier B.V. All rights reserved.	[Wang, Chao-Qun; Jia, Xiu-Hong; Wang, Xuan] Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100191, Peoples R China; [Zhu, Shu; Komatsu, Katsuko] Toyama Univ, Inst Nat Med, Dept Med Resources, Div Pharrnacognosy, Toyama 9300194, Japan; [Cai, Shao-Qing] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China	Wang, X (reprint author), Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100191, Peoples R China.	xuanwang6818@bjmu.edu.cn			National Natural Science Foundation of China [39970898]; National 973 Program Foundation of China [G1999054406]; State Administration of Traditional Chinese Medicine [200707009, 200807019]; Chinese Pharmacopoeia Commission [Y2-305]; National New Drug Discovery and Modernization of Chinese Materia Medica Project [2001BA701A55-3]	This project was supported by the National Natural Science Foundation of China (no. 39970898), the National 973 Program Foundation of China (no. G1999054406), the State Administration of Traditional Chinese Medicine (no. 200707009, 200807019), the Chinese Pharmacopoeia Commission (no. Y2-305), and the National New Drug Discovery and Modernization of Chinese Materia Medica Project (no. 2001BA701A55-3).	Gao H., 2012, CHINA J CHIN MAT MED, V4, P405; Gao X.Y., 2009, J CHROMATOGR A, V11, P2118; Hou J.J., 2011, J CHROMATOGR A, V33, P5618; Huang S.J., 2011, CHINA J CHIN MAT MED, V6, P780; Jia X.H., 2012, J NAT MED, V2, P339; Li J., 2004, CHIN J NAT MED, V1, P34; Li W.L., 2012, J ZHEJIANG U MED SCI, V1, P13; Wang C.Q, 2012, CHINA J CHIN MAT MED, V22, P3438; Wang R., 2011, J SHENYANG PHARM U, V8, P594; Wang Y.Y., 2012, CHINA J CHIN MAT MED, V2, P212; Yang F., 2012, CHINA J CHIN MAT MED, V7, P956; Zhu J.J., 2008, ACTA PHARMACOL SIN, V12, P1211	12	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	MAR 1	2015	134						587	595		10.1016/j.talanta.2014.11.028		9	Chemistry, Analytical	Chemistry	CB6FT	WOS:000349723600079		
J	Hagiwara, K; Inui, T; Koike, Y; Aizawa, M; Nakamura, T				Hagiwara, Kenta; Inui, Tetsuo; Koike, Yuya; Aizawa, Mamoru; Nakamura, Toshihiro			Speciation of inorganic arsenic in drinking water by wavelength-dispersive X-ray fluorescence spectrometry after in situ preconcentration with miniature solid-phase extraction disks	TALANTA			English	Article						Arsenic; Speciation; Solid-phase extraction; X-ray fluorescence spectrometry; In situ preconcentration	ATOMIC-ABSORPTION-SPECTROMETRY; NATURAL-WATER; EXCHANGE DISK; SAMPLES; AS(V); ACID; AS(III); SEPARATION; METALS; RESIN	A rapid and simple method using wavelength-dispersive X-ray fluorescence (WDXRF) spectrometry after in situ solid-phase extraction (SPE) was developed for the speciation and evaluation of the concentration of inorganic arsenic (As) in drinking water. The method involves the simultaneous collection of As(III) and As(V) using 13 mm 0 SPE miniature disks. The removal of Pb2+ from the sample water was first conducted to avoid the overlapping PbL alpha and AsK alpha spectra on the XRF spectrum. To this end, a 50 mL aqueous sample (pH 5-9) was passed through an iminodiacetate chelating disk. The filtrate was adjusted to pH 2-3 with HCl, and then ammonium pyrrolidine dithiocarbamate solution was added. The solution was passed through a hydrophilic polytetrafluoroethylene filter placed on a Zr and Ca loaded cation-exchange disk at a flow rate of 12.5 mL min(-1) to separate As(III)-pyrrolidine dithiocarbamate complex and As(V). Each SPE disk was affixed to an acrylic plate using adhesive cellophane tape, and then examined by WDXRF spectrometry. The detection limits of As(III) and As(V) were 0.8 and 0.6 mu g L-1, respectively. The proposed method was successfully applied to screening for As speciation and concentration evaluation in spring water and well water. (C) 2014 Elsevier B.V. All rights reserved.	[Hagiwara, Kenta; Koike, Yuya; Aizawa, Mamoru; Nakamura, Toshihiro] Meiji Univ, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Inui, Tetsuo] Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Nakamura, T (reprint author), Meiji Univ, Dept Appl Chem, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.	toshina@isc.meiji.ac.jp					NYAMAH D, 1986, WATER RES, V20, P1341, DOI 10.1016/0043-1354(86)90131-4; An J, 2013, J HAZARD MATER, V260, P24, DOI 10.1016/j.jhazmat.2013.04.033; Abe W, 2006, X-RAY SPECTROM, V35, P184, DOI 10.1002/xrs.892; Zachariadis GA, 2002, TALANTA, V57, P919, DOI 10.1016/S0039-9140(02)00132-7; Zhang L, 2007, TALANTA, V72, P723, DOI 10.1016/j.talanta.2006.12.001; Dasgupta PK, 2002, TALANTA, V58, P153, DOI 10.1016/S0039-9140(02)00264-3; Anezaki K, 1999, ANAL SCI, V15, P829, DOI 10.2116/analsci.15.829; Margui E, 2012, SPECTROCHIM ACTA B, V67, P17, DOI 10.1016/j.sab.2011.12.004; Bednar AJ, 2004, WATER RES, V38, P355, DOI 10.1016/j.watres.2003.09.034; Gallagher PA, 2004, ENVIRON SCI TECHNOL, V38, P2919, DOI 10.1021/es035071n; Sigrist M, 2011, J HAZARD MATER, V188, P311, DOI 10.1016/j.jhazmat.2011.01.126; Rasul SB, 2002, TALANTA, V58, P33, DOI 10.1016/S0039-9140(02)00254-0; Hagiwara K, 2013, ANAL SCI, V29, P1153; Balaji T, 2005, CHEMOSPHERE, V59, P1169, DOI 10.1016/j.chemosphere.2004.12.007; Liang P, 2009, MICROCHIM ACTA, V166, P47, DOI 10.1007/s00604-009-0162-2; Leyva D, 2012, J RADIOANAL NUCL CH, V291, P699, DOI 10.1007/s10967-011-1375-5; Funayama T, 2013, BUNSEKI KAGAKU, V62, P685; Barros H, 2010, SPECTROCHIM ACTA B, V65, P489, DOI 10.1016/j.sab.2010.04.004; Erdogan H, 2011, DESALINATION, V280, P391, DOI 10.1016/j.desal.2011.07.029; Hall GEM, 1999, J ANAL ATOM SPECTROM, V14, P205, DOI 10.1039/a807498d; Inui T., 2010, XRAY SPECTROMETRY, V40, P301; Inui T, 2010, ANAL SCI, V26, P1093; Kamakura N, 2014, SPECTROCHIM ACTA B, V93, P28, DOI 10.1016/j.sab.2014.01.003; Miyashita S, 2009, CHEMOSPHERE, V75, P1065, DOI 10.1016/j.chemosphere.2009.01.029; Mondal P, 2007, CLEAN-SOIL AIR WATER, V35, P255, DOI 10.1002/clen.200700002; Okumura M, 2003, BUNSEKI KAGAKU, V52, P1147, DOI 10.2116/bunsekikagaku.52.1147; Otles S, 2010, ENVIRON GEOCHEM HLTH, V32, P367, DOI 10.1007/s10653-010-9296-8; PERANIEMI S, 1995, ANAL CHIM ACTA, V302, P89, DOI 10.1016/0003-2670(94)00439-S; Rabieh S, 2013, MICROCHIM ACTA, V180, P415, DOI 10.1007/s00604-013-0946-2; Sathrugnan K, 2004, TALANTA, V64, P237, DOI 10.1016/j.talanta.2004.02.016; Shibata Y, 2009, X-RAY SPECTROM, V38, P410, DOI 10.1002/xrs.1195; Toda K, 2005, ANAL CHEM, V77, P4765, DOI 10.1021/ac050193e	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	MAR 1	2015	134						739	744		10.1016/j.talanta.2014.12.027		6	Chemistry, Analytical	Chemistry	CB6FT	WOS:000349723600098		
J	Nakanishi, T				Nakanishi, Takayuki			A Meta-Analysis of Extensive Reading Research	TESOL QUARTERLY			English	Article							EFL LEARNERS; L2; VOCABULARY; INSTRUCTION	The purposes of this study were to investigate the overall effectiveness of extensive reading, whether learners' age impacts learning, and whether the length of time second language learners engage in extensive reading influences test scores. The author conducted a meta-analysis to answer research questions and to identify future research directions. He included two types of empirical studiesthose including group contrasts based on a comparison of a control group and experimental groups, and pre-post contrasts that only include experimental groupsin the analysis. After a thorough literature search with numerous search engines and manual and electronic examination of related journals, the meta-analysis included 34 studies (two PhD dissertations and 32 research articles) that provided 43 different effect sizes and a total sample size of 3,942 participants. Findings show a medium effect size (d=0.46) for group contrasts and a larger one (d=0.71) for pre-post contrasts for students who received extensive reading instruction compared to those who did not. In sum, the available research to date suggests that extensive reading improves students' reading proficiency and should be a part of language learning curricula.	Tokiwa Univ, Ibaraki, Japan	Nakanishi, T (reprint author), Tokiwa Univ, Ibaraki, Japan.						Al-Homoud F, 2009, LANG TEACH RES, V13, P383, DOI 10.1177/1362168809341508; American Psychological Association, 2010, PUBL MAN AM PSYCH AS; Anderson N. J., 2009, 2 LANGUAGE READING R; Anderson N. J., 2009, 2 LANGUAGE READING R, P117; Norris JM, 2000, LANG LEARN, V50, P417, DOI 10.1111/0023-8333.00136; Horst M, 2005, CAN MOD LANG REV, V61, P355, DOI 10.1353/cml.2005.0018; Oswald FL, 2010, ANNU REV APPL LINGUI, V30, P85, DOI 10.1017/S0267190510000115; Schmitt N, 2008, LANG TEACH RES, V12, P329, DOI 10.1177/1362168808089921; Li SF, 2010, LANG LEARN, V60, P309, DOI 10.1111/j.1467-9922.2010.00561.x; Beglar D, 2012, LANG LEARN, V62, P665, DOI 10.1111/j.1467-9922.2011.00651.x; Bamford J, 2004, EXTENSIVE READING AC; Bell T, 2001, READING MATRIX, V1, P1; Cha Ji-Eun, 2009, [English Teaching, 영어교육], V64, P3; Coady J., 1997, 2 LANGUAGE VOCABULAR, P225; Cohen J., 1988, STAT POWER ANAL BEHA; Cooper HM, 2010, RES SYNTHESIS META A; Davis C, 1995, ELT J, V49, P329, DOI 10.1093/elt/49.4.329; Day RR, 1998, EXTENSIVE READING 2; desMorgado N. F., 2009, READING MATRIX, V9, P31; Elley W. B., 1981, IMPACT BOOK FLOOD FI; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1, DOI 10.1017/CBO9780511761676; Field AP, 2003, PSYCHOLOGIST, V16, P642; Fujimori C., 2006, KATE B, V20, P13; Fujita K., 2009, ANN REV ENGLISH LANG, V20, P21; Glass G. V., 1976, EDUC RES, V10, P3, DOI DOI 10.3102/0013189X005010003; Grabe W, 2009, CAM APPL L, P1; Grabe W., 2011, TEACHING RES READING; Greenberg D., 2006, ADULT BASIC ED, V16, P81; Hafiz F. M., 1990, SYSTEM, V18, P31, DOI 10.1016/0346-251X(90)90026-2; Hafiz F. M., 1989, ENGLISH LANGUAGE TEA, V43, P4, DOI 10.1093/elt/43.1.4; Hayashi K, 1999, RELC J, V30, P114, DOI 10.1177/003368829903000207; Hunt M., 1997, SCI TAKES STOCK STOR; Iwahori Y., 2008, READING FOREIGN LANG, V20, P70; Keck CM, 2006, LANG LEARN LANG TEAC, V13, P91; Koda K, 2004, INSIGHTS 2 LANGUAGE; Kweon S. O., 2008, READING FOREIGN LANG, V20, P191; Lai F. -K, 1993, SYSTEM, V21, P87, DOI 10.1016/0346-251X(93)90009-6; Lao C. Y., 2000, SYSTEM, V28, P261, DOI DOI 10.1016/S0346-251X(00)00011-7; Lee S. Y., 2007, RELC J, V38, P150, DOI DOI 10.1177/0033688207079730; Lin L. -F., 2010, J LANGUAGE TEACHING, V1, P20, DOI 10.4304/jltr.1.1.20-28; Lipsey M. W., 2001, PRACTICAL METAANALYS; Lituanas P. M., 2001, INT J EDUC RES, V35, P217, DOI [10.1016/S0883-0355(01)00018-0, DOI 10.1016/S0883-0355(01)00018-0]; Mason B., 2003, THESIS TEMPLE U TOKY; Mason B., 2007, P 16 INT S ENGL TEAC, P630; Mason B., 1997, SYSTEM, V25, P91, DOI 10.1016/S0346-251X(96)00063-2; Matsui T., 2010, ANN REV ENGLISH LANG, V21, P71; Nakanishi T., 2011, READING FOREIGN LANG, V23, P1; Nakanishi T., 2005, LANGUAGE TEACHER, V29, P35; Nation ISP, 2009, ESL APPL LING PROF, P1; Nuttall C., 2005, TEACHING READING FOR; Ortega L., 2006, SYNTHESIZING RES LAN; Oswald F. L., 2012, RES METHODS 2 LANGUA, P275; Pigott T. D., 2012, ADV META ANAL; Rezaee A. A., 2011, THEORY PRACTICE LANG, V1, P1167, DOI [10.4304/tpls.1.9.1167-1175, DOI 10.4304/TPLS.1.9.1167-1175]; Robb T. N., 1989, READING FOREIGN LANG, V5, P239; Rodrigo V., 2004, SYSTEM, V32, P53, DOI [10.1016/j.system.2003.08.003, DOI 10.1016/J.SYSTEM.2003.08.003]; Rosenthal R., 1994, HDB RES SYNTHESIS, P231; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037//0033-2909.86.3.638; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1; Schmitt N., 2001, LANG TEST, V18, P55, DOI DOI 10.1191/026553201668475857; Shadish WR, 1994, HDB RES SYNTHESIS, P261; Smith K, 2006, INT J FOREIGN LANGUA, V2, P12; Taguchi E., 2004, READING FOREIGN LANG, V16.2, P70; Takase A., 2007, READING FOREIGN LANG, V19, P1; Takase A., 2009, EXTENSIVE READING EN, P547; Takase A., 2010, EIGO TADOKU TACYOU S; Tanaka H., 2007, READING MATRIX, V7.1, P115; Tsang WK, 1996, APPL LINGUIST, V17, P210; Yamamoto Y., 2011, READING MATRIX, V11, P226; Yamashita J, 2007, TESOL QUART, V41, P81; Yamashita J, 2008, SYSTEM, V36, P661, DOI 10.1016/j.system.2008.04.003; Zimmerman CB, 1997, TESOL QUART, V31, P121, DOI 10.2307/3587978	72	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0039-8322	1545-7249		TESOL QUART	Tesol Q.	MAR	2015	49	1					6	37		10.1002/tesq.157		32	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CB8RP	WOS:000349898900001		
J	Aoki, K				Aoki, Kenichi			Modeling abrupt cultural regime shifts during the Palaeolithic and Stone Age	THEORETICAL POPULATION BIOLOGY			English	Article						Catastrophic bifurcation; Innovation; Carrying capacity; Creative explosion; Toolkit diversity; Neural hypothesis	MODERN HUMAN-BEHAVIOR; POPULATION-SIZE; CUMULATIVE CULTURE; EVOLUTION; COMPLEXITY; DEMOGRAPHY; ACCUMULATION; EMERGENCE; AFRICA; TRAITS	The coupled dynamics of the size and the mean cultural/technological level of a population, with positive feedback between these two variables, is modeled in the Malthusian-Boserupian framework. Bifurcation diagrams, with innovativeness or the cultureless carrying capacity as the parameter, show that abrupt transitions in the mean cultural level are possible. For example, a gradual evolutionary change toward greater innate innovativeness would produce an associated gradual increase in mean cultural level, until a threshold is crossed that triggers an abrupt cultural regime shift. Hence, the model may help explain the apparently sudden and dramatic efflorescences of Palaeolithic/Stone Age culture during the Late Pleistocene, without having to invoke major contemporaneous genetic changes in cognition. The results of statistical studies on the association between population size and toolkit diversity among ethnographic societies are also discussed. (C) 2014 Elsevier Inc. All rights reserved.	Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Nakano Ku, Tokyo 1648525, Japan	Aoki, K (reprint author), Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Nakano Ku, Nakano 4-21-1, Tokyo 1648525, Japan.	kenaoki@meiji.ac.jp			Monbukagakusho grant [22101004]	This work was begun during a visit to the Centre for Advanced Study in Oslo, Norway. I wish to express my sincere thanks to Bjorg Egelandsdal, Gro Amdam, Marije Oostindjer, and other members of the Centre for their hospitality during my stay. I benefited greatly from discussions with Ron Lee, with whom I shared an office, and with Shripad Tuljapurkar, whose office was just down the hall. I am grateful to Mayuko Nakamaru and Jeremy Kendal for directing me to the relevant literature, and to Alex Mesoudi, Laurent Lehmann and Stefano Ghirlanda for helpful comments on the manuscript. This work was supported in part by Monbukagakusho grant 22101004.	Derex M, 2013, NATURE, V503, P389, DOI 10.1038/nature12774; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; CARNEIRO RL, 1967, SOUTHWEST J ANTHROP, V23, P234; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Muthukrishna M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2511; Lehmann L, 2011, PHILOS T R SOC B, V366, P424, DOI 10.1098/rstb.2010.0313; Strimling P, 2009, THEOR POPUL BIOL, V76, P77, DOI 10.1016/j.tpb.2009.04.006; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Aoki K, 2011, THEOR POPUL BIOL, V79, P192, DOI 10.1016/j.tpb.2011.02.001; Feldman MW, 1996, ANTHROPOL SCI, V104, P209; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107; Kempe M, 2014, EVOL HUM BEHAV, V35, P285, DOI 10.1016/j.evolhumbehav.2014.02.009; Klein RG, 2013, P NATL ACAD SCI USA, V110, P10910, DOI 10.1073/pnas.1304750110; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5; Richerson PJ, 2009, HUM BIOL, V81, P211, DOI 10.3378/027.081.0306; Clark JL, 2011, J ANTHROPOL ARCHAEOL, V30, P273, DOI 10.1016/j.jaa.2011.04.002; Perreault C, 2011, J ANTHROPOL ARCHAEOL, V30, P62, DOI 10.1016/j.jaa.2010.10.003; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389; Read D, 2006, AM ANTIQUITY, V71, P164; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; Kobayashi Y, 2012, THEOR POPUL BIOL, V82, P38, DOI 10.1016/j.tpb.2012.04.001; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Aoki K, 2014, THEOR POPUL BIOL, V91, P3, DOI 10.1016/j.tpb.2013.10.004; Aoki K., 2013, DYNAMICS LEARNING NE, V1, P199; Aoki K, 2008, THEOR POPUL BIOL, V74, P356, DOI 10.1016/j.tpb.2008.09.006; Boyd R., 1985, CULTURE EVOLUTIONARY; Caldwell CA, 2010, LEARN BEHAV, V38, P310, DOI 10.3758/LB.38.3.310; Collard M., 2005, CANADIAN J ARCHAEOLO, V29, P1; Collard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072628; Fogarty L., 2015, LEARNING STRATEGIES; Ghirlanda S, 2007, QUAL QUANT, V41, P591, DOI 10.1007/s11135-007-9070-x; KUHN SL, 2012, ORIGINS HUMAN INNOVA, V16, P69; Kuhn S.L., 2013, DYNAMICS LEARNING NE, V1, P105; Lee R. D., 1986, STATE POPULATION THE, P96; Mesoudi A, 2011, PLOS ONE, V6, P1; Murray J. D., 1989, MATH BIOL; Premo L.S., 2015, LEARNING STRATEGIES; Richerson PJ, 2013, PENN MUSEUM INT RES, V5, P263; Shennan S, 2002, GENES MEMES HUMAN HI; Wakano JY, 2011, THEOR POPUL BIOL, V80, P132, DOI 10.1016/j.tpb.2011.06.001	42	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0040-5809	1096-0325		THEOR POPUL BIOL	Theor. Popul. Biol.	MAR	2015	100						6	12		10.1016/j.tpb.2014.11.006		7	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CB8NA	WOS:000349885700002		
J	Rogounovitch, TI; Bychkov, A; Takahashi, M; Mitsutake, N; Nakashima, M; Nikitski, AV; Hayashi, T; Hirokawa, M; Ishigaki, K; Shigematsu, K; Bogdanova, T; Matsuse, M; Nishihara, E; Minami, S; Yamanouchi, K; Ito, M; Kawaguchi, T; Kondo, H; Takamura, N; Ito, Y; Miyauchi, A; Matsuda, F; Yamashita, S; Saenko, VA				Rogounovitch, Tatiana I.; Bychkov, Andrey; Takahashi, Meiko; Mitsutake, Norisato; Nakashima, Masahiro; Nikitski, Alyaksandr V.; Hayashi, Tomayoshi; Hirokawa, Mitsuyoshi; Ishigaki, Katsu; Shigematsu, Kazuto; Bogdanova, Tetiana; Matsuse, Michiko; Nishihara, Eijun; Minami, Shigeki; Yamanouchi, Kosho; Ito, Masahiro; Kawaguchi, Takahisa; Kondo, Hisayoshi; Takamura, Noboru; Ito, Yasuhiro; Miyauchi, Akira; Matsuda, Fumihiko; Yamashita, Shunichi; Saenko, Vladimir A.			The Common Genetic Variant rs944289 on Chromosome 14q13.3 Associates with Risk of Both Malignant and Benign Thyroid Tumors in the Japanese Population	THYROID			English	Article							RAS ONCOGENE MUTATIONS; TRANSCRIPTION FACTORS; CARCINOMA; CANCER; FOXE1; SUSCEPTIBILITY; LOCUS; POLYMORPHISMS; CONFIRMATION; NEOPLASMS	Background: Several single nucleotide polymorphisms (SNP) have been identified to be associated with the risk for differentiated thyroid cancer in populations of distinct ethnic background. The relationship of these genetic markers to a benign tumor of the thyroid, follicular adenoma (FA), is not well established. Methods: In a multicenter retrospective case-control study, five thyroid cancer-related SNPs-rs966513 (9q22.33, FOXE1), rs944289 (14q13.3, PTCSC3), rs2439302 (8p12, NRG1), rs1867277 (9q22.23, FOXE1), and rs6983267 (8q24, POU5F1B)-were genotyped in 959 cases of histologically verified FA, 535 papillary thyroid carcinomas (PTC), and 2766 population controls. Results: A significant association was found between FA and rs944289 (p=0.002; OR 1.176 [CI 1.064-1.316]), and suggestively with rs2439302 (p=0.033; OR 1.149 [CI 1.010-1.315]). In PTC, significant associations were confirmed for rs965513 (p=4.21E-04; OR 1.587 [CI 1.235-2.000]) and rs944289 (p=0.003; OR 1.234 [CI 1.075-1.408]), newly found for rs2439302 (p=0.003; OR 1.266 [CI 1.087-1.493]) and rs1867277 (p=1.17E-04; OR 1.492 [CI 1.235-1.818]), and was not replicated for rs6983267 (p=0.082; OR 1.136 [CI 0.980-1.316]) in this series. A significant correlation between rs2439302 genotype and relative expression of NRG1 was detected in normal and tumor counterparts of PTC (about 10% decrease per each risk allele). NRG1 expression also significantly correlated with that of PTCSC3. Conclusions: Association of rs944289, which was previously known to confer risk for thyroid cancer, with FA, and the correlation between PTCSC3 and NRG1 expression demonstrates that predisposing genetic factors are partly common for benign and malignant thyroid tumors, and imply broader roles of the pathways they underlie in thyroid tumorigenesis, not limited to carcinogenesis.	[Rogounovitch, Tatiana I.; Takamura, Noboru] Nagasaki Univ, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 8528523, Japan; [Bychkov, Andrey; Mitsutake, Norisato; Nikitski, Alyaksandr V.; Matsuse, Michiko; Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 8528523, Japan; [Nakashima, Masahiro] Nagasaki Univ, Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki 8528523, Japan; [Yamashita, Shunichi; Saenko, Vladimir A.] Nagasaki Univ, Atom Bomb Dis Inst, Dept Mol Epidemiol, Nagasaki 8528523, Japan; [Kondo, Hisayoshi] Nagasaki Univ, Atom Bomb Dis Inst, Biostat Sect, Nagasaki 8528523, Japan; [Takahashi, Meiko; Kawaguchi, Takahisa; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Mitsutake, Norisato] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, Nagasaki 8528523, Japan; [Hayashi, Tomayoshi] Nagasaki Univ Hosp, Dept Pathol, Nagasaki, Japan; [Hirokawa, Mitsuyoshi; Nishihara, Eijun; Ito, Yasuhiro; Miyauchi, Akira] Kuma Hosp, Kobe, Hyogo, Japan; [Ishigaki, Katsu] Ishigaki Clin, Hamamatsu, Shizuoka, Japan; [Shigematsu, Kazuto] Japanese Red Cross Nagasaki Atom Bomb Hosp, Dept Pathol, Nagasaki, Japan; [Bogdanova, Tetiana] Inst Endocrinol & Metab, Dept Morphol Endocrine Syst, Kiev, Ukraine; [Minami, Shigeki; Yamanouchi, Kosho] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528523, Japan; [Ito, Masahiro] Natl Nagasaki Med Ctr, Dept Pathol, Omura, Nagasaki, Japan	Saenko, VA (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Epidemiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	saenko@nagasaki-u.ac.jp		Mitsutake, Norisato/0000-0002-2744-8046	Japan Society for the Promotion of Science (JSPS) [24591369, 24406031, 25257508]	This work was supported in part by research grants 24591369, 24406031, and 25257508 from the Japan Society for the Promotion of Science (JSPS).	Akulevich NM, 2009, ENDOCR-RELAT CANCER, V16, P491, DOI 10.1677/ERC-08-0336; Takami H, 2011, WORLD J SURG, V35, P111, DOI 10.1007/s00268-010-0832-6; Nikiforova MN, 2002, AM J SURG PATHOL, V26, P1016, DOI 10.1097/01.PAS.0000021228.30983.6A; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Zhu ZW, 2003, AM J CLIN PATHOL, V120, P71; SHI YF, 1991, CANCER RES, V51, P2690; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Matsuse M, 2011, J MED GENET, V48, P645, DOI 10.1136/jmedgenet-2011-100063; Vasko V, 2003, J CLIN ENDOCR METAB, V88, P2745, DOI 10.1210/jc.2002-021186; Bullock M, 2012, J CLIN ENDOCR METAB, V97, pE1814, DOI 10.1210/jc.2012-1456; Bychkov A, 2013, THYROID, V23, P817, DOI 10.1089/thy.2012.0466; DeLellis RA., 2004, PATHOLOGY GENETICS T; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Hoshi S, 2009, CARCINOGENESIS, V30, P1614, DOI 10.1093/carcin/bgp167; KARGA H, 1991, J CLIN ENDOCR METAB, V73, P832; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Liyanarachchi S, 2013, THYROID, V23, P1532, DOI 10.1089/thy.2013.0102; Nonaka D, 2008, MODERN PATHOL, V21, P192, DOI 10.1038/modpathol.3801002; Rosai J CM, 1992, ATLAS TUMOR PATHOL, P21; Taga M, 2013, INT J CLIN EXP PATHO, V6, P76; Wang YL, 2013, J MED GENET, V50, P689, DOI 10.1136/jmedgenet-2013-101687; Zhang P, 2006, PATHOL INT, V56, P240, DOI 10.1111/j.1440-1827.2006.01959.x	29	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	MAR 1	2015	25	3					333	340		10.1089/thy.2014.0431		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7LY	WOS:000350550400009		
J	Lin, TH; Sato, T; Barcay, KR; Waters, H; Loi, F; Zhang, R; Pajarinen, J; Egashira, K; Yao, ZY; Goodman, SB				Lin, Tzu-Hua; Sato, Taishi; Barcay, Katherine R.; Waters, Heather; Loi, Florence; Zhang, Ruth; Pajarinen, Jukka; Egashira, Kensuke; Yao, Zhenyu; Goodman, Stuart B.			NF-kappa B Decoy Oligodeoxynucleotide Enhanced Osteogenesis in Mesenchymal Stem Cells Exposed to Polyethylene Particle	TISSUE ENGINEERING PART A			English	Article							IN-VITRO; TGF-BETA; SYSTEMIC TRAFFICKING; STROMAL CELLS; BONE INGROWTH; DIFFERENTIATION; EXPRESSION; ACTIVATION; INTERLEUKIN-10; INFLAMMATION	Excessive generation of wear particles after total joint replacement may lead to local inflammation and periprosthetic osteolysis. Modulation of the key transcription factor NF-kappa B in immune cells could potentially mitigate the osteolytic process. We previously showed that local delivery of ultrahigh-molecular-weight polyethylene (UHMWPE) particles recruited osteoprogenitor cells and reduced osteolysis. However, the biological effects of modulating the NF-kappa B signaling pathway on osteoprogenitor/mesenchymal stem cells (MSCs) remain unclear. Here we showed that decoy oligodeoxynucleotide (ODN) increased cell viability when primary murine MSCs were exposed to UHMWPE particles, but had no effects on cellular apoptosis. Decoy ODN increased transforming growth factor-beta 1 (TGF-beta 1) and osteoprotegerin (OPG) in MSCs exposed to UHMWPE particles. Mechanistic studies showed that decoy ODN upregulated OPG expression through a TGF-beta 1-dependent pathway. By measuring the alkaline phosphatase activity, osteocalcin levels, Runx2 and osteopontin expression, and performing a bone mineralization assay, we found that decoy ODN increased MSC osteogenic ability when the cells were exposed to UHMWPE particles. Furthermore, the cellular response to decoy ODN and UHMWPE particles with regard to cell phenotype, cell viability, and osteogenic ability was confirmed using primary human MSCs. Our results suggest that modulation of wear particle-induced inflammation by NF-kappa B decoy ODN had no adverse effects on MSCs and may potentially further mitigate periprosthetic osteolysis by protecting MSC viability and osteogenic ability.	[Lin, Tzu-Hua; Sato, Taishi; Barcay, Katherine R.; Waters, Heather; Loi, Florence; Zhang, Ruth; Pajarinen, Jukka; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Egashira, Kensuke] Kyushu Univ, Dept Cardiovasc Res Dev & Translat Med, Kyushu, Japan; [Goodman, Stuart B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Goodman, SB (reprint author), Stanford Univ, Sch Med, Dept Orthopaed Surg, 450 Broadway St, Redwood City, CA 94063 USA.	goodbone@stanford.edu			NIH [2R01AR055650, 1R01AR063717]; Ellenburg Chair in Surgery at Stanford University	This work was supported by NIH grants 2R01AR055650 and 1R01AR063717 and the Ellenburg Chair in Surgery at Stanford University.	Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Shimizu H, 2009, ANTIOXID REDOX SIGN, V11, P2065, DOI 10.1089/ARS.2008.2355; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Bitzer M, 2000, GENE DEV, V14, P187; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Lin TH, 2014, ACTA BIOMATER, V10, P3747, DOI 10.1016/j.actbio.2014.04.034; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238; Wang ZJ, 2009, CELL BIOL INT, V33, P665, DOI 10.1016/j.cellbi.2009.03.006; CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118; Nakamura H, 2013, J BONE MINER RES, V28, P1457, DOI 10.1002/jbmr.1866; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Gibon E, 2012, BIOMATERIALS, V33, P3632, DOI 10.1016/j.biomaterials.2012.02.003; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Goodman SB, 2010, BIOMATERIALS, V31, P5045, DOI 10.1016/j.biomaterials.2010.03.046; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Chen X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.14; Goodman S, 2000, J BIOMED MATER RES, V53, P475, DOI 10.1002/1097-4636(200009)53:5<475::AID-JBM5>3.0.CO;2-0; Goodman SB, 1999, J BONE JOINT SURG BR, V81B, P1069, DOI 10.1302/0301-620X.81B6.9638; Huang CK, 2013, HEPATOLOGY, V57, P1550, DOI 10.1002/hep.26135; James AW, 2013, SCIENTIFICA CAIRO, V2013, DOI DOI 10.1155/2013/684736; Mafi R, 2011, Open Orthop J, V5 Suppl 2, P242, DOI 10.2174/1874325001105010242; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Otero JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038694; Purdue P Edward, 2006, HSS J, V2, P102, DOI 10.1007/s11420-006-9003-6; Ren PG, 2008, BIOMATERIALS, V29, P4760, DOI 10.1016/j.biomaterials.2008.09.004; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Trindade MCD, 2001, BIOMATERIALS, V22, P2067, DOI 10.1016/S0142-9612(00)00376-8; Wong N, 2004, J BIOMED MATER RES A, V69A, P40, DOI 10.1002/jbm.a.20097	36	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	MAR 1	2015	21	5-6					875	883		10.1089/ten.tea.2014.0144		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CC7LQ	WOS:000350549500002		
J	Tajima, S; Tobita, M; Orbay, H; Hyakusoku, H; Mizuno, H				Tajima, Satoshi; Tobita, Morikuni; Orbay, Hakan; Hyakusoku, Hiko; Mizuno, Hiroshi			Direct and Indirect Effects of a Combination of Adipose-Derived Stem Cells and Platelet-Rich Plasma on Bone Regeneration	TISSUE ENGINEERING PART A			English	Article							MEDIATED GENE-THERAPY; PERIODONTAL TISSUE REGENERATION; GROWTH-FACTOR LEVELS; OF-THE-ART; STROMAL CELLS; CALVARIAL DEFECT; AUTOGENOUS BONE; FEMORAL DEFECTS; ENGINEERED BONE; BASIC SCIENCE	A key goal for successful bone regeneration is to bridge a bone defect using healing procedures that are stable and durable. Adipose-derived stem cells (ASCs) have the potential to differentiate into bone. Meanwhile, platelet-rich plasma (PRP) is an interesting biological means to repair tissue by inducing chemotactic, proliferative, and anabolic cellular responses. This study evaluated bone regeneration using a combination of ASCs and PRP in a rat calvarial defect model. ASCs were isolated from inguinal fat pads of F344 inbred rats, while PRP was prepared from these rats. ASCs were cultured in control medium supplemented with 10% fetal bovine serum or 5% PRP in vitro. After 1 week, levels of growth factors including insulin-like growth factor-1, transforming growth factor-beta 1, hepatocyte growth factor, and vascular endothelial growth factor in the culture supernatant were measured by enzyme-linked immunosorbent assays. Moreover, the ASC/PRP admixture was transplanted into the rat calvarial defect. Microcomputed tomography, histological, and immunohistochemical (osteopontin and osteocalcin) analyses were performed at 4 and 8 weeks after transplantation. The in vitro study showed that the levels of growth factors secreted by ASCs were significantly increased by the addition of PRP. Transplantation of the ASC/PRP admixture had dramatic effects on bone regeneration overtime in comparison with rats that received other transplants. Furthermore, some ASCs directly differentiated into osteogenic cells in vivo. These findings suggest that the combination of ASCs and PRP has augmentative effects on bone regeneration. The ASC/PRP admixture may be a promising source for the clinical treatment of cranial defects.	[Tajima, Satoshi; Tobita, Morikuni; Mizuno, Hiroshi] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 1138421, Japan; [Tajima, Satoshi] Japan Self Def Force Yokosuka Hosp, Dept Dent & Oral Surg, Yokosuka, Kanagawa, Japan; [Orbay, Hakan] Univ Calif Davis, Div Plast Surg, Sacramento, CA 95817 USA; [Hyakusoku, Hiko] Nippon Med Sch, Dept Plast & Reconstruct Surg, Tokyo 113, Japan	Mizuno, H (reprint author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hmizuno@juntendo.ac.jp					Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107; Tobita M, 2008, TISSUE ENG PT A, V14, P945, DOI 10.1089/ten.tea.2007.0048; Nauta A, 2013, MOL THER, V21, P445, DOI 10.1038/mt.2012.234; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jems.2002.0285; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Osugi M, 2012, TISSUE ENG PT A, V18, P1479, DOI [10.1089/ten.TEA.2011.0325, 10.1089/ten.tea.2011.0325]; Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Yamada Y, 2004, CLIN ORAL IMPLAN RES, V15, P589, DOI 10.1111/j.1600-0501.2004.01038.x; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Luo HL, 2012, BIOMATERIALS, V33, P4277, DOI 10.1016/j.biomaterials.2012.02.042; Yamada Y, 2006, INT J PERIODONT REST, V26, P363; Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102; Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003; Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291; BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Chou YF, 2011, CONNECT TISSUE RES, V52, P109, DOI 10.3109/03008207.2010.484514; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Pourebrahim N, 2013, INT J ORAL MAX SURG, V42, P562, DOI 10.1016/j.ijom.2012.10.012; Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Eppley BL, 2000, CLEFT PALATE-CRAN J, V37, P229, DOI 10.1597/1545-1569(2000)037<0229:MOACBG>2.3.CO;2; Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183; Marx R E, 2001, Implant Dent, V10, P225; Monteiro BS, 2012, ACTA CIR BRAS, V27, P201, DOI 10.1590/S0102-86502012000300001; Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017; OIKARINEN J, 1979, CLIN ORTHOP RELAT R, P208; Parrilla C, 2011, ARCH OTOLARYNGOL, V137, P463, DOI 10.1001/archoto.2011.61; Landesberg R, 2000, J ORAL MAXIL SURG, V58, P297, DOI 10.1016/S0278-2391(00)90058-2; Tözüm Tolga Fikret, 2003, J Can Dent Assoc, V69, P664; Turgeman G, 2002, CURR OPIN MOL THER, V4, P390; Turgeman G, 2001, J GENE MED, V3, P240; Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515	58	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	MAR 1	2015	21	5-6					895	905		10.1089/ten.tea.2014.0336		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CC7LQ	WOS:000350549500004		
J	Shimizu, R; Kamei, N; Adachi, N; Hamanishi, M; Kamei, G; Mahmoud, EE; Nakano, T; Iwata, T; Yamato, M; Okano, T; Ochi, M				Shimizu, Ryo; Kamei, Naosuke; Adachi, Nobuo; Hamanishi, Michio; Kamei, Goki; Mahmoud, Elhussein Elbadry; Nakano, Tomohiro; Iwata, Takanori; Yamato, Masayuki; Okano, Teruo; Ochi, Mitsuo			Repair Mechanism of Osteochondral Defect Promoted by Bioengineered Chondrocyte Sheet	TISSUE ENGINEERING PART A			English	Article							MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; MARROW-DERIVED CELLS; BONE-MARROW; GROWTH-FACTOR; IN-VITRO; TISSUE; TRANSPLANTATION; SYNOVIUM; MODEL	Cell sheet engineering has developed as a remarkable method for cell transplantation. In the field of cartilage regeneration, several studies previously reported that cartilage defects could be regenerated by transplantation of a chondrocyte sheet using cell sheet engineering. However, it remains unclear how such a thin cell sheet could repair a deep cartilage defect. We, therefore, focused on the mechanism of cartilage repair using cell sheet engineering in this study. Chondrocyte sheets and synovial cell sheets were fabricated using cell sheet engineering, and these allogenic cell sheets were transplanted to cover an osteochondral defect in a rat model. Macroscopic and histological evaluation was performed at 4 and 12 weeks after transplantation. Analysis of the gene expression of each cell sheet and of the regenerated tissue at 1 week after transplantation was performed. In addition, green fluorescent protein (GFP) transgenic rats were used as donors (transplanted chondrocyte sheets) or recipients (osteochondral defect models) to identify the cell origin of regenerated cartilage. Cartilage repair was significantly better in the group implanted with a chondrocyte sheet than in that with a synovial cell sheet. The results of gene expression analysis suggest that the possible factor contributing to cartilage repair might be TGF beta 1. Cell tracking experiments using GFP transgenic rats showed that the regenerated cartilage was largely composed of cells derived from the transplanted chondrocyte sheets.	[Shimizu, Ryo; Kamei, Naosuke; Adachi, Nobuo; Hamanishi, Michio; Kamei, Goki; Mahmoud, Elhussein Elbadry; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Orthopaed Surg, Hiroshima 7348551, Japan; [Kamei, Naosuke] Hiroshima Univ Hosp, Translat Res Med Ctr, Hiroshima, Japan; [Nakano, Tomohiro] Junshin Gakuen Univ, Fac Hearth Sci, Dept Med Lab Sci, Fukuoka, Japan; [Iwata, Takanori; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	Shimizu, R (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	d123437@hiroshima-u.ac.jp					De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; [Anonymous], 1999, CLIN ORTHOP S, DOI 10.1097/00003086-199910001-00020; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Ebihara G, 2012, BIOMATERIALS, V33, P3846, DOI 10.1016/j.biomaterials.2012.01.056; Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167; Kaneshiro N, 2006, BIOCHEM BIOPH RES CO, V349, P723, DOI 10.1016/j.bbrc.2006.08.096; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Hamanishi M, 2013, J ORTHOP SCI, V18, P627, DOI 10.1007/s00776-013-0379-0; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Takaku Y, 2014, BIOMATERIALS, V35, P2199, DOI 10.1016/j.biomaterials.2013.11.071; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947; PINEDA S, 1992, ACTA ANAT, V143, P335; Buckley CT, 2010, J BIOMECH, V43, P920, DOI 10.1016/j.jbiomech.2009.11.005; Schindler OS, 2011, ACTA ORTHOP BELG, V77, P709; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Hamahashi K, 2015, J TISSUE ENG REGEN M, V9, P24, DOI 10.1002/term.1610; Ito S, 2012, BIOMATERIALS, V33, P5278, DOI 10.1016/j.biomaterials.2012.03.073; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.TEB.2013.0271, 10.1089/ten.teb.2013.0271]; Minas T, 2012, J BONE JOINT SURG BR, V94B, P141, DOI 10.1302/0301-620X.94B11.30679; Mitani G, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-17; Miyakoshi N, 2005, ARCH ORTHOP TRAUM SU, V125, P683, DOI 10.1007/s00402-005-0052-y; Miyamoto A, 2007, KNEE SURG SPORT TR A, V15, P1083, DOI 10.1007/s00167-006-0277-5; Oshima Y, 2005, J HISTOCHEM CYTOCHEM, V53, P207, DOI 10.1369/jhc.4A6280.2005; Shinomiya R, 2005, ACTA ORTHOP, V76, P920, DOI 10.1080/17453670510046109; Stewart AA, 2007, AM J VET RES, V68, P941, DOI 10.2460/ajvr.68.9.941; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Yamato M. K. V, 2014, J STEM CELL RES THER, DOI [10.4172/2157-7633.1000181, DOI 10.4172/2157-7633.1000181]; Zantop T, 2009, ARTHROSCOPY, V25, P1354, DOI 10.1016/j.arthro.2009.04.077	34	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	MAR 1	2015	21	5-6					1131	1141		10.1089/ten.tea.2014.0310		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CC7LQ	WOS:000350549500026		
J	Yoshii, Y; Ishii, T; Tanaka, T; Tung, WL; Sakai, S				Yoshii, Yuichi; Ishii, Tomoo; Tanaka, Toshikazu; Tung, Wen-Lin; Sakai, Shinsuke			DETECTING MEDIAN NERVE STRAIN CHANGES WITH CYCLIC COMPRESSION APPARATUS: A COMPARISON OF CARPAL TUNNEL SYNDROME PATIENTS AND HEALTHY CONTROLS	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Median nerve; Strain; Carpal tunnel syndrome; Elastography; Ultrasound	IN-VIVO; ELASTOGRAPHY; ULTRASOUND; DIAGNOSIS; SONOELASTOGRAPHY; ELASTICITY; MUSCLE	The objective of this study was to detect differences in median nerve strain between patients with carpal tunnel syndrome and healthy controls using cyclic compression apparatus. Twenty-eight patients with idiopathic carpal tunnel syndrome and 30 normal patients were examined by ultrasound elastography. Median nerve strain, strain ratio of reference coupler and median nerve area and perimeter were measured. The areas under receiver operating characteristic curves were compared among the parameters. Median nerve strains of the patients were significantly smaller than those of the controls (p < 0.001). Strain ratios, areas and perimeters were significantly larger in the patients than in the controls (p < 0.001). The areas under curves were 0.963, 0.917, 0.759 and 0.706 for strain, strain ratio, area and perimeter, respectively. The median nerve strain had the highest area under the curve. The ultrasonic strain measurements of the median nerve provided by the cyclic compression apparatus were superior to morphologic assessment in diagnosing carpal tunnel syndrome. (C) 2015 World Federation for Ultrasound in Medicine & Biology.	[Yoshii, Yuichi; Ishii, Tomoo; Sakai, Shinsuke] Tokyo Med Univ, Ibaraki Med Ctr, Endowed Dept Human Resources Dev Community Med, Dept Orthopaed Surg, Ami, Ibaraki, Japan; [Tanaka, Toshikazu] Kikkoman Gen Hosp, Dept Orthopaed Surg, Noda, Chiba, Japan; [Tung, Wen-Lin] Ibaraki Prefectural Univ Hlth Sci, Dept Rehabil Med, Ibaraki 3000394, Japan	Yoshii, Y (reprint author), Tokyo Med Univ, Ibaraki Med Ctr, Dept Orthopaed Surg, 3-20-1 Chuo, Inashiki, Ibaraki 3000395, Japan.	yy12721@yahoo.co.jp			Tokyo Medical University Ibaraki Medical Center	The authors thank Kozo Kobayashi for developing the automatic vibratory equipment. This study was supported by internal funds of the Tokyo Medical University Ibaraki Medical Center.	Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653; CESPEDES I, 1993, ULTRASONIC IMAGING, V15, P73, DOI 10.1006/uimg.1993.1007; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Niitsu M, 2011, ACTA RADIOL, V52, P99, DOI 10.1258/ar.2010.100190; Kantarci F, 2014, EUR RADIOL, V24, P434, DOI 10.1007/s00330-013-3023-7; De Zordo T, 2009, AM J ROENTGENOL, V193, P180, DOI 10.2214/AJR.08.2020; McCullough MB, 2011, MUSCLE NERVE, V43, P585, DOI 10.1002/mus.21923; Wu CH, 2011, RADIOLOGY, V259, P502, DOI [10.1148/radiol.11101665, 10.1148/radiol.10101665]; Witt JC, 2004, MUSCLE NERVE, V29, P515, DOI 10.1002/mus.20019; Miyamoto H, 2014, RADIOLOGY, V270, P481, DOI 10.1148/radiol.13122901; Orman G, 2013, ULTRASOUND MED BIOL, V39, P1184, DOI 10.1016/j.ultrasmedbio.2013.02.016; Sconfienza LM, 2010, CLIN EXP RHEUMATOL, V28, P373; Drakonaki EE, 2010, SKELETAL RADIOL, V39, P391, DOI 10.1007/s00256-009-0861-0; Fujihara Y, 2011, MEDIX, V55, P40; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Gomes I, 2006, CLIN NEUROPHYSIOL, V117, P964, DOI 10.1016/j.clinph.2005.12.020; Ma ZJ, 2013, J BIOMED MATER RES A, V101, P2718, DOI 10.1002/jbm.a.34573; Mackinnon S E, 1985, J Reconstr Microsurg, V1, P185, DOI 10.1055/s-2007-1007073; Shiina T, 1996, P IEEE INT ULTR S SA, V4, P1331; Yamakawa M, 2001, JPN J APPL PHYS 1, V40, P3872, DOI 10.1143/JJAP.40.3872; Yoshii Y, 2014, ULTRASOUND MED BIOL, V40, P2352, DOI 10.1016/j.ultrasmedbio.2014.04.005	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	MAR	2015	41	3					669	674		10.1016/j.ultrasmedbio.2014.09.020		6	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CB6RF	WOS:000349753600005		
J	Gui, G; Peng, W; Adachi, F				Gui, Guan; Peng, Wei; Adachi, Fumiyuki			Sub-Nyquist rate ADC sampling-based compressive channel estimation	WIRELESS COMMUNICATIONS & MOBILE COMPUTING			English	Article						compressive channel estimation; analog-to-digital converter (ADC); sub-Nyquist rate sampling; compressive sensing	SIGNAL RECONSTRUCTION; MATCHING PURSUIT; WIRELESS	To realize high-speed communication, broadband transmission has become an indispensable technique in the next-generation wireless communication systems. Broadband channel is often characterized by the sparse multipath channel model, and significant taps are widely separated in time, and thereby, a large delay spread exists. Accurate channel state information is required for coherent detection. Traditionally, accurate channel estimation can be achieved by sampling the received signal with large delay spread by analog-to-digital converter (ADC) at Nyquist rate and then estimate all of channel taps. However, as the transmission bandwidth increases, the demands of the Nyquist sampling rate already exceed the capabilities of current ADC. In addition, the high-speed ADC is very expensive for ordinary wireless communication. In this paper, we present a novel receiver, which utilizes a sub-Nyquist ADC that samples at much lower rate than the Nyquist one. On the basis of the sampling scheme, we propose a compressive channel estimation method using Dantzig selector algorithm. By comparing with the traditional least square channel estimation, our proposed method not only achieves robust channel estimation but also reduces the cost because low-speed ADC is much cheaper than high-speed one. Computer simulations confirm the effectiveness of our proposed method. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Gui, Guan; Peng, Wei; Adachi, Fumiyuki] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Peoples R China; [Peng, Wei] Tohoku Univ, Dept Commun Engn, Sendai, Miyagi 980, Japan	Peng, W (reprint author), Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Luoyu Rd 1037, Wuhan 430074, Peoples R China.	penwei1999@gmail.com			Japan Society for the Promotion of Science	The authors would like to thank the anonymous reviewers for their kind and constructive comments, which helped much to improve the quality of the paper. This work was supported by the Japan Society for the Promotion of Science postdoctoral fellowship.	Meng J, 2012, IEEE J-STSP, V6, P15, DOI 10.1109/JSTSP.2011.2169649; Cotter SF, 2002, IEEE T COMMUN, V50, P374, DOI 10.1109/26.990897; Carbonelli C, 2007, IEEE T WIREL COMMUN, V6, P1743, DOI 10.1109/TWC.2007.05604; Adachi F, 2007, WIREL COMMUN MOB COM, V7, P969, DOI [10.1002/wcm.507, 10.1002/wem.507]; Berger CR, 2010, IEEE T SIGNAL PROCES, V58, P1708, DOI 10.1109/TSP.2009.2038424; Tropp JA, 2010, IEEE T INFORM THEORY, V56, P520, DOI 10.1109/TIT.2009.2034811; Chen JM, 2010, IEEE COMMUN LETT, V14, P833, DOI 10.1109/LCOMM.2010.080210.100770; Mishali M, 2010, IEEE J-STSP, V4, P375, DOI 10.1109/JSTSP.2010.2042414; Candes E, 2007, ANN STAT, V35, P2392, DOI 10.1214/009053607000000532; Wang YL, 2010, SIAM J IMAGING SCI, V3, P462, DOI 10.1137/090772447; Raychaudhuri D, 2012, P IEEE, V100, P824, DOI 10.1109/JPROC.2011.2182095; Chen X, 2011, IEEE T CIRCUITS-I, V58, P507, DOI 10.1109/TCSI.2010.2072430; Tropp JA, 2007, IEEE T INFORM THEORY, V53, P4655, DOI 10.1109/TIT.2007.909108; Chen HY, 2012, IEEE T WIREL COMMUN, V11, P108, DOI 10.1109/TWC.2011.110811.101739; Bajwas UW, 2008, 42 ANN CISS PRINC NJ, P5; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candess EJ, 2008, COMPTE RENDUS ACAD 1, P589; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Guis G, 2013, EURASIP J WIREL COMM, V2013, P1, DOI [10.1186/1687-1499-2013-204, DOI 10.1186/1687-1499-2013-204]; Guis G, 2009, 12 INT S WIR PERS MU, P1; Guis G, 2010, 7 IEEE VEH TECHN SOC, P1; Hes SB, 2010, IEEE T VEH TECHNOL, V59, P2472; Markss RJ, 1991, INTRO SHANNON SAMPLI; Needell D., 2008, APPL COMPUT HARMON A, V26, P301, DOI DOI 10.1016/J.ACHA.2008.07.002; Proakiss JG., 2001, DIGITAL COMMUNICATIO, V4th; Ribshiranis T, 1996, J R STAT SOC B, V58, P267; Shis Q, 2010, IEEE T SIGNAL PROCES, V58, P3328; Taubocks G, 2008, IEEE INT C AC SPEECH, P1	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-8669	1530-8677		WIREL COMMUN MOB COM	Wirel. Commun. Mob. Comput.	MAR	2015	15	4					639	648		10.1002/wcm.2372		10	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Computer Science; Engineering; Telecommunications	CB8OQ	WOS:000349890100004		
J	James, A; Madhukumar, AS; Adachi, F				James, Ashish; Madhukumar, A. S.; Adachi, Fumiyuki			Efficient multihop transmission scheme for error-free relay forwarding in cooperative networks	WIRELESS COMMUNICATIONS & MOBILE COMPUTING			English	Article						cooperative communication; incremental relaying; RCPC; multihop	CONVOLUTIONAL-CODES; HYBRID-ARQ; DIVERSITY; COMMUNICATION; PERFORMANCE; PROTOCOLS; CHANNEL; DECODE	Multihop cooperative communication is emerging as a key concept to extend the coverage area of the network and potentially increase the capacity. The spectral efficiency of such networks can be improved by adapting the transmission to time-varying channel conditions, referred to as incremental relaying. Although such incremental relaying concepts are progressively being studied, many challenges, such as erroneous transmissions by intermediate nodes and end-to-end delay of the network, limit its practical use due to lack of an efficient implementation. This paper proposes an efficient multihop incremental relaying technique. In this method, erroneous relay forwarding is mitigated, and the overhead for coordination among nodes is reduced by exploiting the implicit feedback channel available due to the broadcast nature of wireless transmissions. The proposed scheme fully leverages the benefit of overhearing and eliminates the additional feedback slots required for validation. Further, it ensures reliable forwarding of information, which optimizes the throughput of multihop networks. Thorough analysis of the proposed scheme is performed under different deployment environments, and the theoretical analyses presented in this paper are supported with results from extensive simulation studies. Copyright (c) 2013 John Wiley & Sons, Ltd.	[James, Ashish; Madhukumar, A. S.] Nanyang Technol Univ, Sch Comp Engn, CeMNeT, Singapore 639798, Singapore; [Adachi, Fumiyuki] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan	James, A (reprint author), Nanyang Technol Univ, Sch Comp Engn, CeMNeT, Singapore 639798, Singapore.	ajames@ntu.edu.sg			Agency for Science, Technology and Research (A*STAR), Singapore under A*STAR-NIH joint grant (SERC) [102 149 0154]	This work was supported by Agency for Science, Technology and Research (A*STAR), Singapore under A*STAR-NIH joint grant (SERC grant No: 102 149 0154).	Mohapatra P, 2003, IEEE WIREL COMMUN, V10, P44, DOI 10.1109/MWC.2003.1209595; James A, 2011, IEEE T VEH TECHNOL, V60, P317, DOI 10.1109/TVT.2010.2089997; Zhao B, 2005, IEEE J SEL AREA COMM, V23, P7, DOI 10.1109/JSAC.2004.837352; [Anonymous], 2008, P80216JD5 IEEE; Hunter TE, 2006, IEEE T WIREL COMMUN, V5, P283, DOI 10.1109/TWC.2006.02006; Sendonaris A, 2003, IEEE T COMMUN, V51, P1939, DOI 10.1109/TCOMM.2003.819238; Caire G, 2001, IEEE T INFORM THEORY, V47, P1971, DOI 10.1109/18.930931; Sendonaris A, 2003, IEEE T COMMUN, V51, P1927, DOI 10.1109/TCOMM.2003.818096; Covers T. M., 1991, ELEMENTS INFORM THEO; Feghhis MM, 2009, COMM NETW SERV RES C, P350; Frodighs M, 2001, WIRELESS PERS COMMUN, V8, P10; HAGENAUER J, 1988, IEEE T COMMUN, V36, P389, DOI 10.1109/26.2763; Has J, 2004, IEEE T INFORM THEORY, V50, P2824; Jakess WC, 1974, MICROWAVE MOBILE COM; James A, 2013, WIRELESS PERS COMMUN, V68, P1837, DOI 10.1007/s11277-012-0552-3; Khuong HV, 2006, IEICE T FUND ELECTR, VE89A, P1832, DOI 10.1093/ietfec/e89-a.6.1832; Laneman JN, 2004, IEEE T INFORM THEORY, V50, P3062, DOI 10.1109/TIT.2004.838089; Lius P, 2007, IEEE J SEL AREA COMM, V25, P340; Lius R, 2008, IEEE T INFORM THEORY, V54, P1207; Morris R., 2005, SIGCOMM 05 PHIL US, V35, P133; Palat RC, 2008, IEEE VTS VEH TECHNOL, P615; Proakiss JG., 2001, DIGITAL COMMUNICATIO, V4th; VITERBI AJ, 1971, IEEE T COMMUN TECHN, VCO19, P751, DOI 10.1109/TCOM.1971.1090700	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-8669	1530-8677		WIREL COMMUN MOB COM	Wirel. Commun. Mob. Comput.	MAR	2015	15	4					755	769		10.1002/wcm.2381		15	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Computer Science; Engineering; Telecommunications	CB8OQ	WOS:000349890100012		
J	Kok, GX; Chow, CO; Ishii, H				Kok, Gin-Xian; Chow, Chee-Onn; Ishii, Hiroshi			Reducing Broadcast Redundancy in Wireless Ad-Hoc Networks with Implicit Coordination Among Forwarding Nodes	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Broadcasting; Wireless ad-hoc networks; Reduce redundant transmissions; Neighbourhood information; Pruning		Broadcasting is the process of sending a packet from a node to all other nodes in a network. In wireless ad-hoc networks, broadcasting might involve forwardings from intermediate nodes known as forwarding nodes because some nodes could be located physically far away from the source and are not covered by transmissions from the source. Without proper control, broadcasting in wireless ad-hoc networks could result in many redundant transmissions. Partial Dominant Pruning (PDP) is one of the most efficient broadcast schemes available for wireless ad-hoc networks. It uses neighbourhood information to reduce broadcast redundancy while ensuring packet reachability to all nodes in a network. During a selection process in PDP, the considered forwarding node selects its forwarding nodes independently. If it is made aware of other forwarding nodes of the same previous hop, a better decision could be made. In this paper, a novel broadcast scheme for wireless ad-hoc networks based on PDP is proposed. We show that it outperforms PDP while not introducing any additional overhead.	[Kok, Gin-Xian; Chow, Chee-Onn] Univ Malaya, Kuala Lumpur, Malaysia; [Ishii, Hiroshi] Tokai Univ, Profess Grad Sch Embedded Technol, Tokyo 151, Japan	Kok, GX (reprint author), Univ Malaya, Kuala Lumpur, Malaysia.	xian_kgx@hotmail.com; cochow@um.edu.my; ishii@ishiilab.net					Sasson Y, 2003, IEEE WCNC, P1124; Peng W, 2001, J COMPUT SCI TECHNOL, V16, P114, DOI 10.1007/BF02950416; Santi P, 2005, ACM COMPUT SURV, V37, P164, DOI 10.1145/1089733.1089736; LOVASZ L, 1975, DISCRETE MATH, V13, P383, DOI 10.1016/0012-365X(75)90058-8; Sheng M, 2005, IEEE T BROADCAST, V51, P216, DOI 10.1109/TBC.2005.847624; Guha S, 1998, ALGORITHMICA, V20, P374, DOI 10.1007/PL00009201; Lim H, 2001, COMPUT COMMUN, V24, P353, DOI 10.1016/S0140-3664(00)00233-4; Kwon TJ, 2002, ACM SIGCOMM COMP COM, V32, P44, DOI 10.1145/510726.510730; Arango J., 2004, P WIOPT; Even S., 1979, GRAPH ALGORITHMS; Hur I, 2012, J INTERNET TECHNOL, V13, P257; Kadi N., 2008, WIR DAYS 1 IFIP, P1; Lim H., 2000, P 3 ACM INT WORKSH M, P61, DOI 10.1145/346855.346865; [刘宏治 LIU Hongzhi], 2006, [高分子通报, Polymer Bulletin], P1; Lou W., 2002, IEEE T MOBILE COMPUT, V1, P111, DOI DOI 10.1109/TMC.2002.1038347; Murugesan M., 2010, INT J COMPUTERS APPL, V4, P29; Ni S., 1999, P 5 ANN ACM IEEE INT, P151, DOI 10.1145/313451.313525; Paruchuri V., 2003, CS0311013 ARXIV, P1; Perkins C. E., 1999, 2 IEEE WORKSH MOB CO, V6, P90, DOI DOI 10.1109/MCSA.1999.749281; Qayyum A., 2002, Proceedings of the 35th Annual Hawaii International Conference on System Sciences, DOI 10.1109/HICSS.2002.994521; Rahman Ashikur, 2009, Journal of Networks, V4, DOI 10.4304/jnw.4.9.895-904; Utsu K., 2010, 5 INT C MOB COMP UB, P3; Williams B., 2002, P ACM INT S MOB AD H, P194, DOI DOI 10.1145/513800.513825; Yi Y., 2003, 2 ANN MED AD HOC NET, P1	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	MAR	2015	81	1					253	278		10.1007/s11277-014-2127-y		26	Telecommunications	Telecommunications	CB9NU	WOS:000349959300014		
J	Morrow, PR				Morrow, Phillip R.			Directives in Japanese: Evidence from signs	WORLD ENGLISHES			English	Article								This study deals with the description and analysis of directives in Japanese. Data is drawn from public signs and announcements. The study is organized around two issues: the linguistic forms associated with directives and the use of graphics. Regarding linguistic forms, there was found to be a strong tendency for directives to be framed as requests. Imperative forms were avoided and other strong forms used infrequently. Although the directives were impersonal, being directed at a general audience, there was a clear concern with mitigating the face-threat of directives. This was evident in the preference for framing directives as requests, in the avoidance of imperative forms, and in the prefacing of directives by explanations or statements of purpose. One distinctive characteristic was the use of the -mashoo (let's') form for directives. This use can be attributed to politeness concerns and a sense of empathy. Graphics, usually in the forms of caricatures and cartoon-like characters, were often used on signs with directives. The association of graphics with directives is related to the popularity of anime and manga in Japanese culture, where they are used not only for entertainment, but instruction.	Nagoya Gakuin Univ, Fac Foreign Studies, Atsuta Ku, Ngoya, Aichi 4568612, Japan	Morrow, PR (reprint author), Nagoya Gakuin Univ, Fac Foreign Studies, Atsuta Ku, 1-25 Atsuta Nishi Machi, Ngoya, Aichi 4568612, Japan.	phil@ngu.ac.jp					Beebe L. M., 1996, SPEECH ACTS CULTURES, P65; Blum-Kulka Shoshana, 1989, CROSS CULTURAL PRAGM, P123; Brown P., 1987, POLITENESS SOME UNIV; ERVINTRIPP S, 1976, LANG SOC, V5, P25; Okabe Keizo, 1987, COMMUN THEORY, P123; ROSE KR, 1992, J PRAGMATICS, V17, P49, DOI 10.1016/0378-2166(92)90028-A; ROSE KR, 1995, LANG LEARN, V45, P191, DOI 10.1111/j.1467-1770.1995.tb00438.x; Takano S, 2005, J PRAGMATICS, V37, P633, DOI 10.1016/j.pragma.2004.06.007; Wolfson Nessa, 1989, CROSS CULTURAL PRAGM, P174	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0883-2919	1467-971X		WORLD ENGLISH	World Englishes	MAR	2015	34	1			SI		78	87		10.1111/weng.12119		10	Linguistics; Language & Linguistics	Linguistics	CB9NJ	WOS:000349958100009		
J	Yoshida, S; Hattori, J; Matsuda, M; Okada, K; Kazuyama, Y; Hashimoto, O; Ibe, S; Fujisawa, S; Chiba, H; Tatsumi, M; Kato, S; Sugiura, W				Yoshida, Shigeru; Hattori, Junko; Matsuda, Masakazu; Okada, Kiyomi; Kazuyama, Yukumasa; Hashimoto, Osamu; Ibe, Shiro; Fujisawa, Shin-ichi; Chiba, Hitoshi; Tatsumi, Masashi; Kato, Shingo; Sugiura, Wataru			Japanese External Quality Assessment Program to Standardize HIV-1 Drug-Resistance Testing (JEQS2010 Program) Using In Vitro Transcribed RNA as Reference Material	AIDS RESEARCH AND HUMAN RETROVIRUSES			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENOTYPING PROFICIENCY PROGRAM; PRIMER-TEMPLATE MISMATCHES; REVERSE-TRANSCRIPTASE; DUAL INFECTIONS; MUTATIONS; PERFORMANCE; PREVALENCE; SELECTION; REGIMEN	To design appropriate antiretroviral therapy regimens and avoid the emergence of human immunodeficiency virus (HIV)-1 variants with reduced susceptibility to antiretroviral drugs, genotypic drug-resistance testing (HIV genotyping) is strongly recommended. To monitor the quality of HIV genotyping in Japan, we performed an external quality assessment (EQA), named the Japanese external quality assessment program, to standardize HIV genotyping (JEQS). To accurately evaluate the quality of HIV genotyping, we employed as reference material (RM) a well-characterized sample, in vitro transcribed RNA (trRNA) that includes the HIV gag-pol sequence, and created a JEQS2010 panel consisting of three single variant and three mixed trRNA samples. All 11 participating laboratories showed high concordance rates (>96%) for the single variant samples. Eight laboratories also showed good rates of detecting minor variants, but three laboratories failed to detect the variants comprising one-half of the sample. These three laboratories used a common primer that had four internal mismatches to the minor trRNA clone. This program showed the usefulness of trRNA as RM, the high quality of HIV genotyping, and extensive interlaboratory variation in the ability to detect minor variants. These results suggest that improving the quality of HIV genotyping in Japan requires regularly implementing the EQA program and improving the HIV genotyping protocol in each laboratory.	[Yoshida, Shigeru; Chiba, Hitoshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Hattori, Junko; Matsuda, Masakazu; Ibe, Shiro; Sugiura, Wataru] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Okada, Kiyomi; Kazuyama, Yukumasa] Kitasato Otsuka Biomed Assay Labs Co Ltd, Sagamihara, Kanagawa, Japan; [Hashimoto, Osamu] Mitsubishi Chem Medience Corp, Cent Lab, Tokyo, Japan; [Fujisawa, Shin-ichi] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido 060, Japan; [Tatsumi, Masashi] Natl Inst Infect Dis, Tokyo, Japan; [Kato, Shingo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Sugiura, W (reprint author), Nagoya Med Ctr, Clin Res Ctr, Dept Infect & Immunol, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan.	wsugiura@nnh.go.jp			Ministry of Health, Labor, and Welfare of Japan [H22-AIDS-004]	This study was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan (H22-AIDS-004).	Dunn DT, 2011, CURR OPIN HIV AIDS, V6, P251, DOI 10.1097/COH.0b013e32834732e8; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Gatanaga H, 2007, ANTIVIR RES, V75, P75, DOI 10.1016/j.antiviral.2006.11.012; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Vandamme AM, 2011, AIDS REV, V13, P77; Descamps D, 2006, J MED VIROL, V78, P153, DOI 10.1002/jmv.20522; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Vandamme AM, 2001, ANTIVIR THER, V6, P21; Plebani M, 2010, CLIN CHEM LAB MED, V48, P983, DOI 10.1515/CCLM.2010.188; Christopherson C, 1997, NUCLEIC ACIDS RES, V25, P654, DOI 10.1093/nar/25.3.654; Cornelissen M, 2007, AIDS, V21, P807, DOI 10.1097/QAD.0b013e3280f3c08a; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Fujisaki S, 2007, JPN J INFECT DIS, V60, P113; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Geretti AM, 2006, AIDS REV, V8, P210; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Huang DD, 2003, J CLIN MICROBIOL, V41, P3265, DOI 10.1128/JCM.41.7.3265-3272.2003; Huang HY, 2008, HIV MED, V9, P285, DOI 10.1111/j.1468-1293.2008.00561.x; Land S, 2009, J VIROL METHODS, V159, P185, DOI 10.1016/j.jviromet.2009.03.016; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Neuwald PD, 2002, J CLIN VIROL, V25, pS55; Pandit A, 2008, J CLIN VIROL, V43, P401, DOI 10.1016/j.jcv.2008.08.021; Pawlotsky JM, 2000, HEPATOLOGY, V32, P654, DOI 10.1053/jhep.2000.16603; Sayer DC, 2003, J CLIN MICROBIOL, V41, P227, DOI 10.1128/JCM.41.1.227-236.2003; Segondy M, 1998, J CLIN MICROBIOL, V36, P3392; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; van der Kuyl AC, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-67	30	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0889-2229	1931-8405		AIDS RES HUM RETROV	Aids Res. Hum. Retrovir.	MAR 1	2015	31	3					318	325		10.1089/aid.2014.0059		8	Immunology; Infectious Diseases; Virology	Immunology; Infectious Diseases; Virology	CC0QW	WOS:000350041800011		
J	Salaria, SN; Graham, RP; Aishima, S; Mounajjed, T; Yeh, MM; Torbenson, MS				Salaria, Safia N.; Graham, Rondell P.; Aishima, Shinichi; Mounajjed, Taofic; Yeh, Matthew M.; Torbenson, Michael S.			Primary Hepatic Tumors With Myxoid Change Morphologically Unique Hepatic Adenomas and Hepatocellular Carcinomas	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						myxoid; mucinous; hepatocellular neoplasms; LFABP; adenoma; hepatocellular carcinoma	ACID-BINDING PROTEIN; LIVER	Mucin production in primary liver neoplasms is typically interpreted as evidence for biliary differentiation. However, we have observed benign and malignant liver tumors that have abundant extracellular myxoid/mucinous material, yet have only evidence of hepatocellular differentiation. To further characterize these unusual findings, 9 cases were identified and further studied. Four cases were hepatic adenomas, whereas 5 were hepatocellular carcinomas. Extracellular myxoid/mucinous material was diffuse in 7 cases and patchy in 2 cases. The extracellular myxoid/mucinous material was typically weakly mucicarmine positive (N = 6) and Alcian blue positive (N = 8). All tumors were well differentiated, and none had evidence for biliary differentiation by morphology or immunohistochemistry. The hepatic adenomas arose in nondiabetic and nonobese patients. Both the hepatic adenomas and the hepatocellular carcinomas were strongly and diffusely HepPar1 positive, CK19 negative, and showed loss of LFABP protein expression. These findings indicate that extracellular myxoid/mucinous material in isolation should not be interpreted as cholangiocarcinoma. Furthermore, the unique morphology, the clinical characteristics, and the immunophenotype results suggest that myxoid hepatic adenomas and hepatocellular carcinoma may be unique tumor variants.	[Salaria, Safia N.] Vanderbilt, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Graham, Rondell P.; Mounajjed, Taofic; Torbenson, Michael S.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN 55905 USA; [Yeh, Matthew M.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Aishima, Shinichi] Saga Univ, Dept Pathol & Microbiol, Saga 840, Japan	Torbenson, MS (reprint author), Mayo Clin, Div Anat Pathol, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA.	torbenson.michael@mayo.edu					Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Weickert MO, 2007, AM J PHYSIOL-ENDOC M, V293, pE1078, DOI 10.1152/ajpendo.00337.2007; Bosman FT, 2010, WHO CLASSIFICATION T; FUKUDA T, 1992, ACTA PATHOL JAPON, V42, P897; GALASSI A, 1995, LIVER, V15, P233; Singhi AD, 2011, AM J SURG PATHOL, V35, P364, DOI 10.1097/PAS.0b013e31820b0603; SUZUKI T, 1990, J PATHOL, V161, P79, DOI 10.1002/path.1711610113; Torbenson M., 2012, SCIENTIFICA CAIRO, V2012	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	MAR	2015	39	3					318	324				7	Pathology; Surgery	Pathology; Surgery	CB7JS	WOS:000349803400005		
J	Kohyama, TS; Potts, MD; Kohyama, TI; Kassim, AR; Ashton, PS				Kohyama, Takashi S.; Potts, Matthew D.; Kohyama, Tetsuo I.; Kassim, Abd Rahman; Ashton, Peter S.			Demographic Properties Shape Tree Size Distribution in a Malaysian Rain Forest	AMERICAN NATURALIST			English	Article						Bayesian model; coexistence; community ecology; demography; equilibrium; skewness; trade-off	MIXED DIPTEROCARP FOREST; ONE-SIDED COMPETITION; TROPICAL TREES; FUNCTIONAL TRAITS; GROWTH-RATE; COEXISTENCE; MORTALITY; HEIGHT; DYNAMICS; RECRUITMENT	Different mechanisms have been proposed to explain how vertical and horizontal heterogeneity in light conditions enhances tree species coexistence in forest ecosystems. The foliage partitioning theory proposes that differentiation in vertical foliage distribution, caused by an interspecific variation in mortality-to-growth ratio, promotes stable coexistence. In contrast, successional niche theory posits that horizontal light heterogeneity, caused by gap dynamics, enhances species coexistence through an interspecific trade-off between growth rate and survival. To distinguish between these theories of species coexistence, we analyzed tree inventory data for 370 species from the 50-ha plot in Pasoh Forest Reserve, Malaysia. We used community-wide Bayesian models to quantify size-dependent growth rate and mortality of every species. We compared the observed size distributions and the projected distributions from size-dependent demographic rates. We found that the observed size distributions were not simply correlated with the rate of population increase but were related to demographic properties such as size growth rate and mortality. Species with low relative abundance of juveniles in size distribution showed high growth rate and low mortality at small tree sizes and low per-capita recruitment rate. Overall, our findings were in accordance with those predicted by foliage partitioning theory.	[Kohyama, Takashi S.] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Kohyama, Takashi S.; Potts, Matthew D.; Ashton, Peter S.] Harvard Univ Hebaria, Cambridge, MA USA; [Potts, Matthew D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kohyama, Tetsuo I.] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Kassim, Abd Rahman] Forest Res Inst Malaysia, Kepong 52109, Malaysia	Kohyama, TS (reprint author), Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.	kohyama@ees.hokudai.ac.jp	Kohyama, Takashi /A-4031-2012; 	Kohyama, Takashi /0000-0001-7186-8585; Kohyama, Tetsuo/0000-0002-4567-2893	Harvard University; Japan Society for the Promotion of Science [24247003]	We acknowledge that the Pasoh 50-ha Forest Dynamics Plot is a collaborative project of the Forest Research Institute Malaysia; the National Institute for Environmental Studies, Japan; and the Center for Tropical Forest Science, Smithsonian Tropical Research Institute. We thank T. Kubo and Y. Iida for fruitful suggestions and M. Eichhorn and another reviewer for essential comments. A Bullard Fellowship from Harvard University to T.S.K. in 1998-1999 helped us start this study, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24247003) helped us finalize it.	Kohyama T, 2003, J ECOL, V91, P797, DOI 10.1046/j.1365-2745.2003.00810.x; Kohyama TS, 2012, J ECOL, V100, P1501, DOI 10.1111/j.1365-2745.2012.02029.x; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.1365-2745.2005.00992.x; Iida Y, 2011, FUNCT ECOL, V25, P1260, DOI 10.1111/j.1365-2435.2011.01884.x; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; King DA, 2006, J TROP ECOL, V22, P11, DOI 10.1017/S0266467405002774; Kohyama T, 2009, J ECOL, V97, P463, DOI 10.1111/j.1365-2745.2009.01490.x; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; King DA, 2006, FOREST ECOL MANAG, V223, P152, DOI 10.1016/j.foreco.2005.10.066; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Bin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052596; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; Condit R, 1998, TROPICAL FOREST CENS; Feeley KJ, 2007, J TROP ECOL, V23, P191, DOI 10.1017/S0266467406003919; Gelman A., 2003, BAYESIAN DATA ANAL; HARA T, 1984, J THEOR BIOL, V109, P173, DOI 10.1016/S0022-5193(84)80002-8; Iida Y, 2014, ECOLOGY, V95, P353, DOI 10.1890/11-2173.1; Kochummen K. M., 1997, TREE FLORA PASOH FOR; Kohyama T, 2005, ECOL RES, V20, P11, DOI 10.1007/s11284-004-0007-8; Kohyama T, 1998, J ECOL, V86, P633, DOI 10.1046/j.1365-2745.1998.00286.x; KOHYAMA T, 1992, FUNCT ECOL, V6, P206, DOI 10.2307/2389756; KOHYAMA T, 1989, ANN BOT-LONDON, V64, P47; Kohyama T. S., 2015, AM NATURALIST; Kubo T, 2000, J TROP ECOL, V16, P753, DOI 10.1017/S026646740000170X; Plummer M., 2011, JUST ANOTHER GIBBS S; R Development Core Team, 2013, R LANG ENV STAT COMP; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Ruger N, 2011, OIKOS, V120, P1047, DOI 10.1111/j.1600-0706.2010.19021.x; SHEA KL, 1985, AM J BOT, V72, P1823, DOI 10.2307/2443739; Su Y-S, 2012, R2JAGS PACKAGE RUNNI; Suzuki T., 1966, J JAPANESE FORESTRY, V48, P436; Takahashi K, 1996, ANN BOT-LONDON, V77, P159, DOI 10.1006/anbo.1996.0018; Takahashi K, 1999, J VEG SCI, V10, P833, DOI 10.2307/3237308; VANSICKLE J, 1977, J THEOR BIOL, V64, P571, DOI 10.1016/0022-5193(77)90289-2	41	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0003-0147	1537-5323		AM NAT	Am. Nat.	MAR	2015	185	3					367	379		10.1086/679664		13	Ecology; Evolutionary Biology	Environmental Sciences & Ecology; Evolutionary Biology	CB5NO	WOS:000349674700008		
J	Abe, J; Kamimura, Y				Abe, Jun; Kamimura, Yoshitaka			Sperm Economy between Female Mating Frequency and Male Ejaculate Allocation	AMERICAN NATURALIST			English	Article						evolutionarily stable strategies; game theory model; individual-based model; operational sex ratio; polyandry; sperm competition	EXTRA-PAIR PATERNITY; COMPETITION GAMES; SEX-RATIOS; EVOLUTIONARY CONSEQUENCES; DROSOPHILA-MELANOGASTER; TESTES SIZE; POLYANDRY; FERTILITY; CHOICE; STRATEGIES	Why females of many species mate multiply is a major question in evolutionary biology. Furthermore, if females accept matings more than once, ejaculates from different males compete for fertilization (sperm competition), which confronts males with the decision of how to allocate their reproductive resources to each mating event. Although most existing models have examined either female mating frequency or male ejaculate allocation while assuming fixed levels of the opposite sex's strategies, these strategies are likely to coevolve. To investigate how the interaction of the two sexes' strategies is influenced by the level of sperm limitation in the population, we developed models in which females adjust their number of allowable matings and males allocate their ejaculate in each mating. Our model predicts that females mate only once or less than once at an even sex ratio or in an extremely female-biased condition, because of female resistance and sperm limitation in the population, respectively. However, in a moderately female-biased condition, males favor partitioning their reproductive budgets across many females, whereas females favor multiple matings to obtain sufficient sperm, which contradicts the predictions of most existing models. We discuss our model's predictions and relationships with the existing models and demonstrate applications for empirical findings.	[Abe, Jun] Kanagawa Univ, Dept Biol, Hiratsuka, Kanagawa 2591293, Japan; [Kamimura, Yoshitaka] Keio Univ, Dept Biol, Yokohama, Kanagawa 2238521, Japan	Abe, J (reprint author), Kanagawa Univ, Dept Biol, Hiratsuka, Kanagawa 2591293, Japan.	abejun-bio@kanagawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [24770029]	We are very grateful to H. Ito, S. Noriyuki, and H.-S. Tee for their discussions, to M. Ichinokawa for programming suggestions, and to M. Setoyama for supporting the software installation. We thank two anonymous reviewers for their valuable comments on the manuscript. J.A. is funded by a Japan Society for the Promotion of Science grant-in-aid for scientific research (JSPS KAKENHI grant 24770029).	Alonzo SH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0044; Alonzo SH, 2010, AM NAT, V175, P174, DOI 10.1086/649596; Bleu J, 2012, ANIM BEHAV, V83, P131, DOI 10.1016/j.anbehav.2011.10.017; Parker GA, 2005, BIOL LETTERS, V1, P235, DOI 10.1098/rsbl.2004.0273; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Hasson O, 2009, BIOL REV, V84, P225, DOI 10.1111/j.1469-185X.2008.00068.x; Vahed K, 2012, ETHOLOGY, V118, P107, DOI 10.1111/j.1439-0310.2011.01991.x; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Bro-Jorgensen J, 2007, CURR BIOL, V17, P2157, DOI 10.1016/j.cub.2007.11.026; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Steiner S, 2008, ENTOMOL EXP APPL, V126, P131, DOI 10.1111/j.1570-7458.2007.00641.x; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Ball MA, 1997, J THEOR BIOL, V186, P459, DOI 10.1006/jtbi.1997.0406; Vahed K, 2011, BIOL LETTERS, V7, P261, DOI 10.1098/rsbl.2010.0840; WEDELL N, 1993, EVOLUTION, V47, P1203, DOI 10.2307/2409986; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; PITNICK S, 1994, AM NAT, V143, P785, DOI 10.1086/285633; Fromhage L, 2008, AM NAT, V172, P25, DOI 10.1086/587806; Reuter M, 2008, EVOLUTION, V62, P401, DOI 10.1111/j.1558-5646.2007.00300.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; Charlat S, 2007, CURR BIOL, V17, P273, DOI 10.1016/j.cub.2006.11.068; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; RIDLEY M, 1993, AM NAT, V142, P893, DOI 10.1086/285579; Tazzyman SJ, 2009, AM NAT, V174, pE71, DOI 10.1086/603612; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; Williams PD, 2005, EVOLUTION, V59, P492; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; Charlat S, 2007, SCIENCE, V317, P214, DOI 10.1126/science.1143369; Engqvist L, 2006, J EVOLUTION BIOL, V19, P1448, DOI 10.1111/j.1420-9101.2006.01134.x; Godfray H.C.J., 1994, PARASITOIDS BEHAV EV; HARDY ICW, 1994, TRENDS ECOL EVOL, V9, P202, DOI 10.1016/0169-5347(94)90242-9; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Jacob S, 2005, BIOL CONTROL, V32, P311, DOI 10.1016/j.biocontrol.2004.10.009; Katvala M, 2008, J EVOLUTION BIOL, V21, P471, DOI 10.1111/j.1420-9101.2007.01494.x; Kokko H., 2012, ENTOMOL EXP APPL, V146, P26; Maynard Smith J., 1982, EVOLUTION THEORY GAM; Mesterton-Gibbons M, 1999, P ROY SOC B-BIOL SCI, V266, P269, DOI 10.1098/rspb.1999.0632; Parker G., 1984, PRODUCERS SCROUNGERS, P127; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI 10.1016/B978-012100543-6/50026-X; PITNICK S, 1993, BEHAV ECOL SOCIOBIOL, V33, P383; Preston BT, 2005, P ROY SOC B-BIOL SCI, V272, P365, DOI 10.1098/rspb.2004.2977; Qazi MCB, 2010, J INSECT PHYSIOL, V56, P1332, DOI 10.1016/j.jinsphys.2010.04.014; Sagarra LA, 2002, J APPL ENTOMOL, V126, P400, DOI 10.1046/j.1439-0418.2002.00679.x; Santolamazza-Carbone S, 2010, ETHOL ECOL EVOL, V22, P51, DOI 10.1080/03949370903515984; Schulke O, 2004, BEHAV ECOL SOCIOBIOL, V55, P293, DOI 10.1007/s00265-003-0709-x; SCHWARTZ D, 1981, REPROD NUTR DEV, V21, P979, DOI 10.1051/rnd:19810710; Tazzyman SJ, 2012, P ROY SOC B-BIOL SCI, V279, P334, DOI 10.1098/rspb.2011.0633; West SA, 2009, MONOGR POPUL BIOL, V44, P1; West SA, 2002, J PARASITOL, V88, P258, DOI 10.1645/0022-3395(2002)088[0258:FIATSR]2.0.CO;2	60	2	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0003-0147	1537-5323		AM NAT	Am. Nat.	MAR	2015	185	3					406	416		10.1086/679586		11	Ecology; Evolutionary Biology	Environmental Sciences & Ecology; Evolutionary Biology	CB5NO	WOS:000349674700011		
J	Yabe, T; Hosoda-Yabea, R; Sakai, H; Kanamaru, Y; Kiso, M				Yabe, Tomio; Hosoda-Yabea, Ritsuko; Sakai, Hiroki; Kanamaru, Yoshihiro; Kiso, Makoto			Development of a photoreactive probe-based system for detecting heparin	ANALYTICAL BIOCHEMISTRY			English	Article						Detection; Heparin; Mastocytoma; Photoreactive probe	PHAGE DISPLAY TECHNOLOGY; MONOCLONAL-ANTIBODY; MAST-CELLS; SPECIFICALLY RECOGNIZES; SULFATE PROTEOGLYCANS; KERATAN SULFATE; GLYCOSAMINOGLYCAN; HETEROGENEITY; IDENTIFICATION; EXPRESSION	We previously identified a peptide heparin-associated peptide Y (Happy) that binds specifically to heparin. In this article, we report a novel heparin detection system using chemically modified Happy as a probe. The photoreactive HappY probe was serially diluted and dispensed into a 96-well plate coated with biotinylated heparin. After ultraviolet irraaiation, the HappY probe crosslinked to the heparin on the plate was detected with fluorescein isothiocyanate-conjugated streptavidin. Furthermore, the photoreactive Happy probe was used to stain cutaneous tissue sections obtained from dermatitis-affected or mastocytoma-affected cats and dogs. The photoreactive Happy probe stained limited resident mast cells in the connective tissue of skin compared with the anti-heparan sulfate monoclonal antibody 10E4, suggesting that the probe can be used to distinguish the structure of heparin in tissues. The interactions between glycosaminoglycans and proteins in vivo tend to be weak. Therefore, our method for enhancing such weak interactions may be a promising tool for intermolecular interaction studies in glycobiology research. (C) 2014 Elsevier Inc. All rights reserved.	[Yabe, Tomio; Hosoda-Yabea, Ritsuko; Kanamaru, Yoshihiro; Kiso, Makoto] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu 5011193, Japan; [Hosoda-Yabea, Ritsuko; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Sakai, Hiroki] Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Gifu 5011193, Japan	Yabe, T (reprint author), Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu 5011193, Japan.	yabet@gifu-u.ac.jp	Yabe, Tomio/B-5900-2013	Yabe, Tomio/0000-0002-9295-8560	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (WPI program) [17101007, 22380067]; Japan Science and Technology Agency - Japan JST, Research Seeds Quest Program [08-098]; Kiyomi Yoshizaki	The authors sincerely thank Kiyomi Yoshizaki for providing financial support. We also thank the members of the Division of Genomics Research, Life Science Research Center, Gifu University, for their support with conducting the experiments. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (WPI program and Grant-in-Aid for Scientific Research 17101007 and 22380067 to M.K.) and the Japan Science and Technology Agency - Japan JST, Research Seeds Quest Program 08-098 to T.Y.).	Welle M, 1997, J LEUKOCYTE BIOL, V61, P233; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; WINGREN U, 1983, HISTOCHEM J, V15, P571, DOI 10.1007/BF01954148; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Hayashi Y, 2005, ANAL SCI, V21, P167, DOI 10.2116/analsci.21.167; van Kuppevelt T H, 2001, Methods Mol Biol, V171, P519; CATERSON B, 1983, J BIOL CHEM, V258, P8848; de Mora F, 2006, BRIT J DERMATOL, V155, P1109, DOI 10.1111/j.1365-2133.2006.07494.x; Hermanson G. T., 2008, BIOCONJUGATE TECHNIQ, P336, DOI 10.1016/B978-0-12-370501-3.00006-0; Kobayashi N, 2007, YAKUGAKU ZASSHI, V127, P55, DOI 10.1248/yakushi.127.55; Kube P, 1998, HISTOCHEM CELL BIOL, V110, P129, DOI 10.1007/s004180050274; KURE S, 1986, J IMMUNOL, V137, P3900; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; SORRELL JM, 1990, HISTOCHEMISTRY, V94, P269; SORRELL JM, 1990, J HISTOCHEM CYTOCHEM, V38, P393; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; STRAUS AH, 1992, ANAL BIOCHEM, V201, P1, DOI 10.1016/0003-2697(92)90167-6; Ueda H, 2007, YAKUGAKU ZASSHI, V127, P71, DOI 10.1248/yakushi.127.71; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; Yabe T, 2005, GLYCOBIOLOGY, V15, P982, DOI 10.1093/glycob/cwi090; Yabe T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.172155	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	MAR 1	2015	472						1	6		10.1016/j.ab.2014.11.007		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB3FS	WOS:000349514200001		
J	Amao, M; Kitahara, Y; Tokunaga, A; Shimbo, K; Eto, Y; Yamada, N				Amao, Michiko; Kitahara, Yoshiro; Tokunaga, Ayaka; Shimbo, Kazutaka; Eto, Yuzuru; Yamada, Naoyuki			Simultaneous quantification of intracellular and secreted active and inactive glucagon-like peptide-1 from cultured cells	ANALYTICAL BIOCHEMISTRY			English	Article						Glucagon-like peptide-1; Incretin; Selected reaction monitoring; Absolute quantification; Secretopeptidome; LC-MS/MS	INSULINOTROPIC POLYPEPTIDES GIP(1-42); MASS-SPECTROMETRY; HUMAN PLASMA; ABSOLUTE QUANTIFICATION; CEREBROSPINAL-FLUID; BIOACTIVE PEPTIDES; IV ACTIVITY; HUMAN SERUM; IN-VITRO; DEGRADATION	Glucagon-like peptide-1 (GLP-1) is an incretin peptide that regulates islet hormone secretion. During recent years, incretin-based therapies have been widely used for patients with type 2 diabetes. GLP-1 peptides undergo N- and C-terminal processing for gain or loss of functions. We developed a method to quantify picomolar quantities of intact GLP-1 peptides using liquid chromatography-tandem mass spectrometry (LC-MS/MS). By employing this label-free selected reaction monitoring (SRM) method, we were able to analyze secreted GLP-1(1-37), GLP-1(7-37), and GLP-1(7-36) (amide) from human enteroendocrine NCI-H716 cells after stimulation with nateglinide, glucose, and sucralose. The absolute total concentrations of secreted GLP-1 peptides at baseline and after stimulation with nateglinide, glucose, and sucralose were 167.3, 498.9, 238.3, and 143.1 pM, respectively. Meanwhile, the ratios of GLP-1(1-37), GLP-1(7-37), and GLP-1(7-36) (amide) to total GLP-1 peptides were similar (6 +/- 3, 26 +/- 3, and 78 +/- 5%, respectively). The SRM assay can analyze the concentrations of individual GLP-1 peptides and, therefore, is a tool to investigate the physiological roles of GLP-1 peptides. Furthermore, the molecular species secreted from NCI-H716 cells were unknown. Therefore, we performed a secretopeptidome analysis of supernatants collected from cultured NCI-H716 cells. Together with GLP-1 peptides, we detected neuroendocrine convertase 1, which regulates peptide hormones released from intestinal endocrine L-cells. (C) 2014 Elsevier Inc. All rights reserved.	[Amao, Michiko; Kitahara, Yoshiro; Tokunaga, Ayaka; Shimbo, Kazutaka; Eto, Yuzuru; Yamada, Naoyuki] Ajinomoto, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan	Shimbo, K (reprint author), Ajinomoto, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan.	kazutaka_shinbo@ajinomoto.com					Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Shipkova P, 2008, RAPID COMMUN MASS SP, V22, P1359, DOI 10.1002/rcm.3511; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Sasaki K, 2009, MOL CELL PROTEOMICS, V8, P1638, DOI 10.1074/mcp.M900044-MCP200; Pannee J, 2013, J ALZHEIMERS DIS, V33, P1021, DOI 10.3233/JAD-2012-121471; Sasaki K, 2013, MOL CELL PROTEOMICS, V12, P700, DOI 10.1074/mcp.M112.017400; Suzuki A, 2003, P NATL ACAD SCI USA, V100, P5034, DOI 10.1073/pnas.0936260100; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Knudsen LB, 2004, J MED CHEM, V47, P4128, DOI 10.1021/jm030630m; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; van den Broek I, 2008, J CHROMATOGR B, V872, P1, DOI 10.1016/j.jchromb.2008.07.021; Sasaki K, 2010, J PROTEOME RES, V9, P5047, DOI 10.1021/pr1003455; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Kay R, 2013, CLIN ENDOCRINOL, V78, P424, DOI 10.1111/cen.12085; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Reimer RA, 2001, ENDOCRINOLOGY, V142, P4522, DOI 10.1210/en.142.10.4522; Chambery A, 2010, AMINO ACIDS, V38, P1031, DOI 10.1007/s00726-009-0311-2; Duffy NA, 2007, EUR J PHARMACOL, V568, P278, DOI 10.1016/j.ejphar.2007.05.010; Goda R, 2012, J CHROMATOGR B, V895, P137, DOI 10.1016/j.jchromb.2012.03.032; Ip W, 2013, AM J PHYSIOL-ENDOC M, V305, pE1348, DOI 10.1152/ajpendo.00376.2013; Kitahara Y, 2011, BIOL PHARM BULL, V34, P671; Lopez MF, 2010, CLIN CHEM, V56, P281, DOI 10.1373/clinchem.2009.137323; McKillop AM, 2009, EUR J ENDOCRINOL, V161, P877, DOI 10.1530/EJE-09-0547; Miyachi A, 2013, J PROTEOME RES, V12, P2690, DOI 10.1021/pr400069f; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Nikoulina SE, 2010, MOL CELL PROTEOMICS, V9, P728, DOI 10.1074/mcp.M900529-MCP200; ORSKOV C, 1992, DIABETOLOGIA, V35, P701; Pauly RP, 1996, J BIOL CHEM, V271, P23222; Rowzee A.M., 2011, EXP DIABESITY RES, V2011, P5; Siskos AP, 2009, J PROTEOME RES, V8, P3487, DOI 10.1021/pr900155h; Vahl TP, 2003, J CLIN ENDOCR METAB, V88, P1772, DOI 10.1210/jc.2002-021479; Wolf R, 2004, J CHROMATOGR B, V803, P91, DOI 10.1016/j.jchromb.2003.11.044; Wolf R, 2001, J CHROMATOGR A, V926, P21, DOI 10.1016/S0021-9673(01)00942-6; Yuji R., 2003, SEIKAGAKU, P75; Zhao LF, 2012, REGUL PEPTIDES, V178, P1, DOI 10.1016/j.regpep.2012.06.010	38	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	MAR 1	2015	472						45	51		10.1016/j.ab.2014.11.009		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB3FS	WOS:000349514200006		
J	Hall, D; Li, SL; Yamashita, K; Azuma, R; Carver, JA; Standley, DM				Hall, Damien; Li, Songling; Yamashita, Kazuo; Azuma, Ryuzo; Carver, John A.; Standley, Daron M.			RNA-LIM: A novel procedure for analyzing protein/single-stranded RNA propensity data with concomitant estimation of interface structure	ANALYTICAL BIOCHEMISTRY			English	Article						Analysis of single-stranded RNA affinities; Protein-RNA interface; Flexible docking; Heuristic optimization	3-DIMENSIONAL STRUCTURE; DOCKING; BINDING; PREDICTION; RECOGNITION; POTENTIALS; RESTRAINTS; RESIDUES	RNA-LIM is a procedure that can analyze various pseudo-potentials describing the affinity between single-stranded RNA (ssRNA) ribonucleotides and surface amino acids to produce a coarse-grained estimate of the structure of the ssRNA at the protein interface. The search algorithm works by evolving an ssRNA chain, of known sequence, as a series of walks between fixed sites on a protein surface. Optimal routes are found by application of a set of minimal "limiting" restraints derived jointly from (i) selective sampling of the ribonucleotide amino acid affinity pseudo-potential data, (ii) limited surface path exploration by prior determination of surface arc lengths, and (Hi) RNA structural specification obtained from a statistical potential gathered from a library of experimentally determined ssRNA structures. We describe the general approach using a NAST (Nucleic Acid Simulation Tool)-like approximation of the ssRNA chain and a generalized pseudo-potential reflecting the location of nucleic acid binding residues. Minimum and maximum performance indicators of the methodology are established using both synthetic data, for which the pseudo-potential defining nucleic acid binding affinity is systematically degraded, and a representative real case, where the RNA binding sites are predicted by the amplified antisense RNA (aaRNA) method. Some potential uses and extensions of the routine are discussed. RNA-LIM analysis programs along with detailed instructions for their use are available on request from the authors. Crown Copyright (C) 2014 Published by Elsevier Inc. All rights reserved.	[Hall, Damien; Carver, John A.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Hall, Damien; Li, Songling; Yamashita, Kazuo; Azuma, Ryuzo; Standley, Daron M.] Osaka Univ, Sect Syst Immunol, Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan	Hall, D (reprint author), Australian Natl Univ, Res Sch Chem, GPO Box 4, Canberra, ACT 2601, Australia.	damien.hall@anu.edu.au	Carver, John/J-3825-2014; Hall, Damien/D-9927-2012		Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare in Japan; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); ANU; National Health and Medical Research Council of Australia	We acknowledge helpful discussions with H. Nakamura, Y. Goto, A. R. Kinjo, and T. Huber. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labor, and Welfare in Japan as well as the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). The research of D.H. is also supported by an ANU Senior Research Fellowship. The research of J.A.C. is supported by a Project Grant from the National Health and Medical Research Council of Australia.	Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Spriggs RV, 2009, BIOINFORMATICS, V25, P1492, DOI 10.1093/bioinformatics/btp257; Jonikas MA, 2009, RNA, V15, P189, DOI 10.1261/rna.1270809; Tuszynska I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-348; Roberts VA, 2013, PROTEINS, V81, P2106, DOI 10.1002/prot.24395; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Re A, 2014, METHODS MOL BIOL, V1097, P491, DOI 10.1007/978-1-62703-709-9_23; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Nagarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091140; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Fernandez M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S5; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Biswas Sumit, 2008, Bioinformation, V2, P422; Gilli M, 2011, J HEURISTICS, V17, P373, DOI 10.1007/s10732-010-9138-y; Hall D, 2006, FEBS LETT, V580, P2584, DOI 10.1016/j.febslet.2006.04.005; Hall D, 2014, BIOPHYS CHEM, V190, P50, DOI 10.1016/j.bpc.2014.01.005; Hentenryck P.V., 2009, CONSTRAINT BASED LOC; Huang YY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01887; Jahandideh S, 2012, J THEOR BIOL, V312, P65, DOI 10.1016/j.jtbi.2012.07.013; Knegtel R. M., 1994, PROTEIN ENG, V7, P7761; Magee J, 2005, NUCLEIC ACIDS RES, V33, P6694, DOI 10.1093/nar/gki981; Marchand V, 2014, HANDBOOK OF RNA BIOCHEMISTRY, VOLS 1 AND 2, 2ND EDITION, P975; Muppirala U. K., 2013, COMPUT SCI SYST BIOL, V6, P182; Perez-Cano L., 2010, PAC S BIOCOMPUT, V15, P269; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasahara K, 2010, BIOCHEMISTRY-US, V49, P3040, DOI 10.1021/bi9019252; Schneidman-Duhovny D., 2005, NUCLEIC ACIDS RES, V33, pW363; Setny P, 2011, NUCLEIC ACIDS RES, V39, P9118, DOI 10.1093/nar/gkr636; Tzou WS, 1999, BIOPHYS J, V77, P1191, DOI 10.1016/S0006-3495(99)76971-7; Walia R. R., 2013, BMC BIOINFORMATICS, V13, P89; ZANAKIS SH, 1981, INTERFACES, V11, P84, DOI 10.1287/inte.11.5.84	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	MAR 1	2015	472						52	61		10.1016/j.ab.2014.11.004		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB3FS	WOS:000349514200007		
J	Akiyama, H; Ueda, Y; Nobumasa, H; Ooshima, H; Ishizawa, Y; Kitahiro, K; Miyagawa, I; Watanabe, K; Nakamura, T; Tanaka, R; Yamamoto, N; Nakae, H; Kawase, M; Gemma, N; Sekiguchi, Y; Fujibuchi, W; Matoba, R				Akiyama, Hideo; Ueda, Yoji; Nobumasa, Hitoshi; Ooshima, Hiroyuki; Ishizawa, Yohei; Kitahiro, Koji; Miyagawa, Isao; Watanabe, Kazufumi; Nakamura, Takazumi; Tanaka, Ritsuka; Yamamoto, Nobuko; Nakae, Hiroki; Kawase, Mitsuo; Gemma, Nobuhiro; Sekiguchi, Yuji; Fujibuchi, Wataru; Matoba, Ryo			A set of external reference controls/probes that enable quality assurance between different microarray platforms	ANALYTICAL BIOCHEMISTRY			English	Article						External RNA standards; DNA microarray; Dynamic range; Cross-platform; Multiplatform calibration	CONTROL MAQC PROJECT; BREAST-CANCER; AMPLIFICATION; SENSITIVITY; PERFORMANCE; DESIGN; TISSUE; TOOL	RNA external standards, although important to ensure equivalence across many microarray platforms, have yet to be fully implemented in the research community. In this article, a set of unique RNA external standards (or RNA standards) and probe pairs that were added to total RNA in the samples before amplification and labeling are described. Concentration-response curves of RNA external standards were used across multiple commercial DNA microarray platforms and/or quantitative real-time polymerase chain reaction (RT-PCR) and next-generation sequencing to identify problematic assays and potential sources of variation in the analytical process. A variety of standards can be added in a range of concentrations spanning high and low abundances, thereby enabling the evaluation of assay performance across the expected range of concentrations found in a clinical sample. Using this approach, we show that we are able to confirm the dynamic range and the limit of detection for each DNA microarray platform, RTPCR protocol, and next-generation sequencer. In addition, the combination of a series of standards and their probes was investigated on each platform, demonstrating that multiplatform calibration and validation is possible. (C) 2014 Elsevier Inc. All rights reserved.	[Akiyama, Hideo; Ueda, Yoji; Nobumasa, Hitoshi] Toray Industries Ltd, New Projects Dev Div, Kamakura, Kanagawa 2488555, Japan; [Ooshima, Hiroyuki] Mitsubishi Rayon Co Ltd, Yokohama Res Labs, Yokohama, Kanagawa 2300053, Japan; [Ishizawa, Yohei; Matoba, Ryo] DNA Chip Res Inc, Yokohama, Kanagawa 2300045, Japan; [Kitahiro, Koji; Miyagawa, Isao] Kurabo Ind Ltd, Tech Res Lab, Neyagawa, Osaka 5720823, Japan; [Watanabe, Kazufumi] Hokkaido Syst Sci Co Ltd, Sapporo, Hokkaido 0010932, Japan; [Nakamura, Takazumi] Sumitomo Bakelite Co Ltd, S BIO Business Div, Amagasaki, Hyogo 6618588, Japan; [Tanaka, Ritsuka] Kamakura Technosci Inc, Dept Bio Res, Kamakura, Kanagawa 2480036, Japan; [Yamamoto, Nobuko; Nakae, Hiroki] Japan Multiplex Bioanal Consortium JAMC, Chiyoda Ku, Tokyo 1020083, Japan; [Kawase, Mitsuo] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808579, Japan; [Gemma, Nobuhiro] Ricoh Co Ltd, Ricoh Inst Technol, Yokohama, Kanagawa 2240035, Japan; [Sekiguchi, Yuji] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biomeasurement Res Grp, Ibaraki 3058566, Japan; [Fujibuchi, Wataru] Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan	Akiyama, H (reprint author), Toray Industries Ltd, New Projects Dev Div, Kamakura, Kanagawa 2488555, Japan.	hideo_akiyama@nts.toray.co.jp; matoba@dna-chip.co.jp			New Energy and Industrial Technology Development Organization (NEDO) - Ministry of Economy, Trade and Industry - Japan [NEDO 10001779-0]	We thank Ayumi Hasegawa (Sumika Chemical Analysis Service) for the design of data analysis and Tatsunobu Fukushima (Mitsubishi Chemical Holdings) for helpful discussion during this work. We also acknowledge support from a New Energy and Industrial Technology Development Organization (NEDO) grant (NEDO 10001779-0) funded by the Ministry of Economy, Trade and Industry - Japan. We also thank Dr. Keith Hart, Cardiff University and members of Japan MicroArray Consortium (JMAC) for helpful discussion in this work.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Ambroise J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-413; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Nagino K, 2006, J BIOCHEM, V139, P697, DOI 10.1093/jb.mvj086; Mao Shihong, 2009, Journal of Bioinformatics and Computational Biology, V7, P157, DOI 10.1142/S0219720009004011; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Komatsu Y, 2008, BIOORGAN MED CHEM, V16, P941, DOI 10.1016/j.bmc.2007.10.011; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; de Leon J, 2006, MOL DIAGN THER, V10, P135; Dumur CI, 2011, AM J CLIN PATHOL, V136, P924, DOI 10.1309/AJCPDQPFO73SSNFR; Okuzaki D., 2010, DNA RES, V8, P1; Satoh T, 2013, J VIROL METHODS, V188, P83, DOI 10.1016/j.jviromet.2012.10.014; Schwers S, 2009, CLIN CHEM, V55, P1995, DOI 10.1373/clinchem.2009.128215; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Yamada Tomoyuki, 2004, J Bioinform Comput Biol, V2, P21, DOI 10.1142/S0219720004000454; Yamada T, 2006, NUCLEIC ACIDS RES, V34, pW665, DOI 10.1093/nar/gkl297	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	MAR 1	2015	472						75	83		10.1016/j.ab.2014.11.012		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CB3FS	WOS:000349514200010		
J	Takaoka, A; Maeda, T; Hori, Y; Fujita, K				Takaoka, Akiko; Maeda, Tomomi; Hori, Yusuke; Fujita, Kazuo			Do dogs follow behavioral cues from an unreliable human?	ANIMAL COGNITION			English	Article						Dog; Dog-human interaction; Selective trust; Pointing; Object choice task	CANIS-FAMILIARIS; DOMESTIC DOGS; HIDDEN FOOD; SOCIAL CUES; TRUST; COMPREHENSION; CHOICE	Dogs are known to consistently follow human pointing gestures. In this study, we asked whether dogs "automatically" do this or whether they flexibly adjust their behavior depending upon the reliability of the pointer, demonstrated in an immediately preceding event. We tested pet dogs in a version of the object choice task in which a piece of food was hidden in one of the two containers. In Experiment 1, Phase 1, an experimenter pointed at the baited container; the second container was empty. In Phase 2, after showing the contents of both containers to the dogs, the experimenter pointed at the empty container. In Phase 3, the procedure was exactly as in Phase 1. We compared the dogs' responses to the experimenter's pointing gestures in Phases 1 and 3. Most dogs followed pointing in Phase 1, but many fewer did so in Phase 3. In Experiment 2, dogs followed a new experimenter's pointing in Phase 3 following replication of procedures of Phases 1 and 2 in Experiment 1. This ruled out the possibility that dogs simply lost motivation to participate in the task in later phases. These results suggest that not only dogs are highly skilled at understanding human pointing gestures, but also they make inferences about the reliability of a human who presents cues and consequently modify their behavior flexibly depending on the inference.	[Takaoka, Akiko; Maeda, Tomomi; Hori, Yusuke; Fujita, Kazuo] Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto 6068501, Japan	Takaoka, A (reprint author), Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto 6068501, Japan.	takaoka.akk@gmail.com			MEXT Global COE program [D-07];  [225877];  [2022004];  [25240020]	This study was supported by Grant-in-for JSPS Research Fellows No. 225877 to Akiko Takaoka, Grant-in-Aid for Scientific Research Nos. 2022004 and 25240020 to Kazuo Fujita, and MEXT Global COE program, D-07 to Kyoto University. All of the experiments were conducted after collecting informed consent from the dogs' owners. We thank all of the dogs and dog owners who volunteered for this study. We also wish to thank James R. Anderson for his valuable comments. We also thank Sho Otaki for his help in the statistical analyses. We also thank the anonymous reviewers for their helpful comments on an earlier version of this manuscript.	Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Behne T, 2012, BRIT J DEV PSYCHOL, V30, P359, DOI 10.1111/j.2044-835X.2011.02043.x; Couillard NL, 1999, BRIT J DEV PSYCHOL, V17, P515, DOI 10.1348/026151099165447; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Vanderbilt KE, 2011, CHILD DEV, V82, P1372, DOI 10.1111/j.1467-8624.2011.01629.x; Corriveau K, 2009, DEVELOPMENTAL SCI, V12, P426, DOI 10.1111/j.1467-7687.2008.00792.x; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Heyman GD, 2013, COGNITIVE SCI, V37, P646, DOI 10.1111/cogs.12020; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Koenig MA, 2004, PSYCHOL SCI, V15, P694, DOI 10.1111/j.0956-7976.2004.00742.x; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Fujita K, 2012, ANIM COGN, V15, P1055, DOI 10.1007/s10071-012-0529-3; Udell MAR, 2008, J EXP ANAL BEHAV, V89, P247, DOI 10.1901/jeab.2008.89-247; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; Kundey SMA, 2011, ANIM COGN, V14, P291, DOI 10.1007/s10071-010-0362-5; Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Harris PL, 2011, PHILOS T R SOC B, V366, P1179, DOI 10.1098/rstb.2010.0321; Marshall-Pescini S, 2011, ANIM BEHAV, V81, P1177, DOI 10.1016/j.anbehav.2011.02.029; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Chow V, 2008, DEVELOPMENTAL SCI, V11, P761, DOI 10.1111/j.1467-7687.2008.00726.x; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Kundey SM, 2010, INT J COMP PSYCHOL, V23, P201; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Miklösi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Nitzschner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046880; Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Takaoka Akiko, 2009, Japanese Journal of Animal Psychology, V59, P15, DOI 10.2502/janip.59.1.15; Takaoka A., 2013, Japanese Journal of Animal Psychology, V63, P123, DOI 10.2502/janip.63.2.2	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9448	1435-9456		ANIM COGN	Anim. Cogn.	MAR	2015	18	2					475	483		10.1007/s10071-014-0816-2		9	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CB4VR	WOS:000349626900007		
J	Takamatsu, K; Hu, R				Takamatsu, Kuniyoshi; Hu, Rui			New reactor cavity cooling system having passive safety features using novel shape for HTGRs and VHTRs	ANNALS OF NUCLEAR ENERGY			English	Article						RCCS; Passive safety; HTGR; Core meltdown; LOCA; Depressurization accident		A new, highly efficient reactor cavity cooling system (RCCS) with passive safety features without a requirement for electricity and mechanical drive is proposed for high temperature gas cooled reactors (HTGRs) and very high temperature reactors (VHTRs). The RCCS design consists of continuous closed regions; one is an ex-reactor pressure vessel (RPV) region and another is a cooling region having heat transfer area to ambient air assumed at 40 (degrees C). The RCCS uses a novel shape to efficiently remove the heat released from the RPV with radiation and natural convection. Employing the air as the working fluid and the ambient air as the ultimate heat sink, the new RCCS design strongly reduces the possibility of losing the heat sink for decay heat removal. Therefore, HTGRs and VHTRs adopting the new RCCS design can avoid core melting due to overheating the fuels. The simulation results from a commercial CFD code, STAR-CCM+, show that the temperature distribution of the RCCS is within the temperature limits of the structures, such as the maximum operating temperature of the RPV, 713.15 (K) = 440 (degrees C), and the heat released from the RPV could be removed safely, even during a loss of coolant accident (LOCA). When the RCCS can remove 600 (kW) of the rated nominal state even during LOCA, the safety review for building the HTTR could confirm that the temperature distribution of the HTTR is within the temperature limits of the structures to secure structures and fuels after the shutdown because the large heat capacity of the graphite core can absorb heat from the fuel in a short period. Therefore, the capacity of the new RCCS design would be sufficient for decay heat removal. (C) 2014 Elsevier Ltd. All rights reserved.	[Takamatsu, Kuniyoshi] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan; [Hu, Rui] Argonne Natl Lab, Argonne, IL 60439 USA	Takamatsu, K (reprint author), Japan Atom Energy Agcy, 4002 Narita Cho, Oarai, Ibaraki 3111393, Japan.	takamatsu.kuniyoshi@jaea.go.jp; rhu@anl.gov	Hu, Rui/A-7624-2012	Hu, Rui/0000-0002-3771-2920	U.S. Department of Energy, Office of Nuclear Energy [DE-AC02-06CH11357]; U.S. Department of Energy Office of Science laboratory [DE-ACO2-06CH11357]	Argonne National Laboratory's work is supported by the U.S. Department of Energy, Office of Nuclear Energy under Contract # DE-AC02-06CH11357. The authors would like to express their gratitude to Dr. Thomas Y.C. Wei at Argonne National Laboratory for his valuable comments and advise throughout this work This paper has been co-created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract # DE-ACO2-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	Argonne National Laboratory, 2014, PASS SAF DEC HEAT RE; CD-Adapco, 2012, US GUID STAR CCM VER; DUNN PD, 1982, HEAT PIPES; Katanishi S., 2004, J ATOM ENERG SOC JPN, V3, P257; Lomperski S., 2011, GENERATION 4 NUCL EN, P179; Saito S., 1994, DESIGN HIGH TEMPERAT, P1332; Williams P. M., 1994, Progress in Nuclear Energy, V28, DOI 10.1016/0149-1970(94)90002-7	7	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	MAR	2015	77						165	171		10.1016/j.anucene.2014.11.011		7	Nuclear Science & Technology	Nuclear Science & Technology	CB6FR	WOS:000349723400017		
J	Fukano, Y				Fukano, Yoshitaka			SAS4A analysis on hypothetical total instantaneous flow blockage in SFRs based on in-pile experiments	ANNALS OF NUCLEAR ENERGY			English	Article						SFR; Sodium cooled fast reactor; Monju; Safety; Severe accident; LF	LOCAL FAULT-PROPAGATION; FUEL PIN BEHAVIOR; TRANSIENT-OVERPOWER; CABRI-FAST; ACCIDENT; REACTOR; TESTS	Local fault (LF) has been historically considered as one of the possible causes of severe accidents in sodium-cooled fast reactors (SFRs). Safety assessments on the consequences of three major LF initiators, adventitious-fuel-pin-failures, local over-powers and large flow blockages, have already been performed for the Japanese prototype fast breeder reactor (Monju) and resulted in limited damage within a fuel subassembly. Although the frequency of hypothetical total instantaneous flow blockage at the coolant inlet of a fuel subassembly (HTIB) is negligible, in-pile experiments on this event have been performed because it gives the most severe consequences among the abovementioned LF initiators. Therefore the most rapid damage propagation assumption was newly proposed in this study based on past experiments, and a safety evaluation was performed on the consequences of HTIB in Monju using the SAS4A code, additionally validated by an in-pile experiment specifically on the HTIB-related phenomena. It was shown through the evaluation that the consequences of HTIB were much less severe than that of the unprotected loss of flow (ULOF) events which represent the most severe accidents in Monju. Therefore it was concluded that all the consequences of LFs in Monju can be found among the consequences of ULOF. This evaluation method would be also applicable to enveloping safety assessments of LFs in generic SFRs. (C) 2014 Elsevier Ltd. All rights reserved.	Japan Atom Energy Agcy, Tsuruga, Fukui 9191279, Japan	Fukano, Y (reprint author), Japan Atom Energy Agcy, 1 Shiraki, Tsuruga, Fukui 9191279, Japan.	fukano.yoshitaka@jaea.go.jp					Kayser G, 1998, NUCL SCI ENG, V128, P144; Cahalan J. E., 1990, Proceedings of the 1990 International Fast Reactor Safety Meeting; Erp J.B., 1974, NUCL ENG DES, V31, P128; Fukano Y, 2013, J NUCL SCI TECHNOL, V50, P950, DOI 10.1080/00223131.2013.817319; Fukano Y., 2004, P 12 INT C NUCL ENG; Fukano Y, 2009, J NUCL SCI TECHNOL, V46, P1049, DOI 10.3327/jnst.46.1049; Fukano Y, 2010, J NUCL SCI TECHNOL, V47, P396, DOI 10.3327/jnst.47.396; Fukano Y., 2014, P PSAM12 2014 JUN 22; Fukano Y, 2014, J NUCL SCI TECHNOL, V51; Japan Atomic Energy Agency, 1980, LIC DOC CONSTR PERM; Japan Atomic Energy Agency, 2008, SUMM AM REP MONJ; Japan Nuclear Energy Safety Organization, 2005, JNESSAE05108; Martin S.P., 2014, P ICAP 2014 2014 APR, P506; Miles K.J., 1985, P INT TOP M FAST REA, P51; NONAKA N, 1992, NUCL TECHNOL, V98, P54; Nonaka N., 1985, P INT TOP M FAST REA, P413; Onoda Y, 2011, J NUCL SCI TECHNOL, V48, P188, DOI 10.3327/jnst.48.188; Sato I., 2007, ANAL ULOF ACCIDENT M; Schleisiek K, 1998, NUCL SCI ENG, V128, P93; Schleisiek K., 1985, P INT TOP M FAST REA, P141; SCHLEISIEK K, 1994, J NUCL SCI TECHNOL, V31, P1011, DOI 10.3327/jnst.31.1011; SCHLEISIEK K, 1992, NUCL TECHNOL, V99, P289; SCHLEISIEK K, 1987, NUCL ENG DES, V100, P435, DOI 10.1016/0029-5493(87)90091-4; STRAIN RV, 1992, NUCL TECHNOL, V97, P227; Suzuki T., 2014, P ICONE22 2014 2014; Tentner A.M., 1985, P INT TOP M FAST REA, P85; Tentner A.M., 1984, P INT M FAST REACT S, P989; Thompson D.H., 1984, P INT M FAST REACT S, P129; Vaughan GJ, 1985, P INT TOP M FAST REA, P457; Walter A. E., 2012, FAST SPECTRUM REACTO; WEIMAR P, 1991, NUCL TECHNOL, V96, P29; WEIMAR P, 1982, NUCL TECHNOL, V57, P81	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	MAR	2015	77						376	392		10.1016/j.anucene.2014.11.034		17	Nuclear Science & Technology	Nuclear Science & Technology	CB6FR	WOS:000349723400042		
J	Mitsukawa, N; Karube, D; Saiga, A; Akita, S; Kubota, Y; Kuriyama, M; Satoh, K				Mitsukawa, Nobuyuki; Karube, Daisuke; Saiga, Atsuomi; Akita, Shinsuke; Kubota, Yoshitaka; Kuriyama, Motone; Satoh, Kaneshige			Surgical Treatment for Congenital Curved Nail of the Fourth Toe	ANNALS OF PLASTIC SURGERY			English	Article						congenital curved nail of the fourth toe (CNFT); surgical treatment; nail deformity		Since congenital curved nail of the fourth toe (CNFT) was reported by Iwasawa et al in 1991, there have been only 19 cases of CNFT in 6 reports, which were from Japan and Taiwan. We performed surgery on 4 patients with CNFT and report here good results. There has been no previous detailed report on surgical treatment for this condition. This report will describe the treatment, mainly the surgical procedure.	[Mitsukawa, Nobuyuki; Akita, Shinsuke; Kubota, Yoshitaka; Satoh, Kaneshige] Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chuo Ku, Chiba 2608670, Japan; [Karube, Daisuke; Saiga, Atsuomi] Showa Univ, Fac Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Kuriyama, Motone] Kochi Med Sch Hosp, Dept Plast Surg, Kochi, Japan	Mitsukawa, N (reprint author), Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nmitsu@air.linkclub.or.jp					Higashi N, 1999, J PEDIAT DERMATOL, V18, P153; Ito S, 2000, HIFURINSHO, V42, P668; IWASAWA M, 1991, PLAST RECONSTR SURG, V87, P553, DOI 10.1097/00006534-199103000-00026; Juhlin L, 2001, DIS NAILS THEIR MANA, P370; Kuramochi M, 2009, JPN J CLIN DERMATOL, V63, P45; Lin YC, 2007, PEDIATR DERMATOL, V24, P380, DOI 10.1111/j.1525-1470.2007.00454.x; Yotsumoto S, 1999, J AM ACAD DERMATOL, V40, P124, DOI 10.1016/S0190-9622(99)70545-1	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	MAR	2015	74	3					361	364		10.1097/SAP.0b013e318295dd36		4	Surgery	Surgery	CB5PC	WOS:000349678900020		
J	Utsunomiya, T; Shimada, M; Kudo, M; Ichida, T; Matsui, O; Izumi, N; Matsuyama, Y; Sakamoto, M; Nakashima, O; Ku, Y; Takayama, T; Kokudo, N				Utsunomiya, Tohru; Shimada, Mitsuo; Kudo, Masatoshi; Ichida, Takafumi; Matsui, Osamu; Izumi, Namiki; Matsuyama, Yutaka; Sakamoto, Michiie; Nakashima, Osamu; Ku, Yonson; Takayama, Tadatoshi; Kokudo, Norihiro		Liver Canc Study Grp Japan	A Comparison of the Surgical Outcomes Among Patients With HBV-positive, HCV-positive, and Non-B Non-C Hepatocellular Carcinoma A Nationwide Study of 11,950 Patients	ANNALS OF SURGERY			English	Article						hepatic resection; nationwide study; non-B non-C hepatocellular carcinoma; prognosis	VIRUS SURFACE-ANTIGEN; PRIMARY LIVER-CANCER; HEPATITIS-B; CLINICAL CHARACTERISTICS; VIRAL-HEPATITIS; CLINICOPATHOLOGICAL CHARACTERISTICS; FOLLOW-UP; RESECTION; JAPAN; HEPATECTOMY	Objective: To compare the prognostic factors and outcomes after hepatic resection among patients with hepatitis B virus (HBV)-positive, hepatitis C virus (HCV)-positive, and negative for hepatitis B surface antigen and hepatitis Cantibody, so-called "NBNC"-hepatocellular carcinoma (HCC) using the data from a nationwide survey. Background: The incidence of NBNC-HCC is rapidly increasing in Japan. Methods: A total of 11,950 patients with HBV-HCC (n = 2194), HCV-HCC (n = 7018), or NBNC-HCC (n = 2738) who underwent a curative hepatic resection were enrolled in this study. The clinicopathological features were compared among the groups. The significant prognostic variables determined by univariate analysis were subjected to a multivariate analysis using a Cox proportional hazard regression model. Results: Liver function in the HCV-HCC group was significantly worse than that in the HBV-HCC and NBNC-HCC groups. The NBNC-HCC group had significantly more advanced HCC than the HCV-HCC group. The 5-year overall survival rates after hepatectomy in the HBV-HCC, HCV-HCC, and NBNC-HCC groups were 65%, 59%, and 68%, respectively. The 5-year recurrence-free survival (RFS) rates in these 3 groups were 41%, 31%, and 47%, respectively. Stratifying the RFS rates according to the TNM stage showed that the NBNC-HCC group had a significantly better prognosis than the HBV-HCC group in stages II, III, and IVA, and a significantly better prognosis than the HCV-HCC group in stages I and II. Multivariate analysis revealed a significantly better RFS rate in the NBNC-HCC group. Conclusions: The findings of this nationwide survey indicated that patients with NBNC-HCC had a significantly lower risk of HCC recurrence than those with HBV-HCC and HCV-HCC.	[Utsunomiya, Tohru; Shimada, Mitsuo] Univ Tokushima, Dept Surg, Tokushima 7708503, Japan; [Kudo, Masatoshi] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Higashiosaka, Osaka 577, Japan; [Ichida, Takafumi] Juntendo Shizuoka Hosp, Dept Gastroenterol & Hepatol, Shizuoka, Japan; [Matsui, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa, Japan; [Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Matsuyama, Yutaka] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Sakamoto, Michiie] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Nakashima, Osamu] Kurume Univ Hosp, Dept Clin Lab Med, Kurume, Fukuoka, Japan; [Ku, Yonson] Kobe Univ, Grad Sch Med, Dept Surg, Kobe, Hyogo 657, Japan; [Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan; [Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan	Utsunomiya, T (reprint author), Univ Tokushima, Dept Surg, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	utsunomiya@clin.med.tokushima-u.ac.jp					El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Kaibori M, 2012, AM J SURG, V204, P300, DOI 10.1016/j.amjsurg.2011.11.014; TAKENAKA K, 1995, HEPATOLOGY, V22, P20, DOI 10.1016/0270-9139(95)90347-X; Tanaka H, 2008, ANN INTERN MED, V148, P820; Kao WY, 2011, WORLD J SURG, V35, P858, DOI 10.1007/s00268-010-0928-z; Utsunomiya T, 2014, ANN SURG, V259, P336, DOI 10.1097/SLA.0b013e31829291e9; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Namiki I, 2010, HEPATOL RES, V40, P347, DOI 10.1111/j.1872-034X.2010.00642.x; Kaneda K, 2012, HEPATO-GASTROENTEROL, V59, P1889, DOI 10.5754/hge10778; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Nishikawa H, 2013, INT J ONCOL, V43, P1333, DOI 10.3892/ijo.2013.2061; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Cescon M, 2009, ARCH SURG-CHICAGO, V144, P906, DOI 10.1001/archsurg.2009.99; Shrager B, 2012, ANN SURG, V255, P1135, DOI 10.1097/SLA.0b013e31823e70a3; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI [10.1002/hep.22734, 10.1002/hep.227.34]; Sasaki Y, 2006, ANN SURG, V244, P771, DOI 10.1097/01.sla.0000225126.56483.b3; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1016/0270-9139(95)90605-3; Utsunomiya T, 2010, J GASTROENTEROL, V45, P146, DOI 10.1007/s00535-009-0164-1; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Huang ZY, 2012, ANN SURG ONCOL, V19, P2515, DOI 10.1245/s10434-012-2269-7; Takuma Y, 2011, J GASTROEN HEPATOL, V26, P1417, DOI 10.1111/j.1440-1746.2011.06775.x; Kondo K, 2008, J GASTROINTEST SURG, V12, P468, DOI 10.1007/s11605-007-0402-x; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; Nanashima A, 2007, J SURG ONCOL, V96, P487, DOI 10.1002/jso.20855; Abe H, 2008, J GASTROENTEROL, V43, P967, DOI 10.1007/s00535-008-2264-8; Kudo A, 2014, J GASTROENTEROL, V49, P1352, DOI 10.1007/s00535-013-0899-6; Li Q, 2007, J GASTROEN HEPATOL, V22, P1936, DOI 10.1111/j.1440-1746.2006.04619.x; Li T, 2013, CANCER-AM CANCER SOC, V119, P126, DOI 10.1002/cncr.27697; Liver Cancer Study Group of Japan, 2003, GEN RUL CLIN PATH ST, P13; Nishikawa H, 2013, J CANCER, V4, P502, DOI 10.7150/jca.6503; Pawlik TM, 2004, J GASTROINTEST SURG, V8, P794, DOI 10.1016/j.gassur.2004.06.013; Schneider HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033084; Tanaka K, 2007, ANN SURG ONCOL, V14, P1170, DOI 10.1245/s10434-006-9299-y; Tokushige K, 2011, J GASTROENTEROL, V46, P1230, DOI 10.1007/s00535-011-0431-9; Utsunomiya T, 2011, HEPATOL RES, V41, P711, DOI 10.1111/j.1872-034X.2011.00818.x; Wang B, 2013, J AM COLL SURGEONS, V217, P1054, DOI 10.1016/j.jamcollsurg.2013.07.402; Zhou YM, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-108	39	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAR	2015	261	3					513	520		10.1097/SLA.0000000000000821		8	Surgery	Surgery	CB3WK	WOS:000349559900048		
J	Fujita, T				Fujita, Tetsuji			Analyzing the Influence of Blood Loss on Outcomes of Cancer Surgery	ANNALS OF SURGERY			English	Letter									Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Fujita, T (reprint author), Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan.	tetsu@jg8.so-net.ne.jp					FUJITA T, 1995, AM J SURG, V169, P304, DOI 10.1016/S0002-9610(99)80163-9; Morner MEM, 2012, ANN SURG, V255, P1126, DOI 10.1097/SLA.0b013e3182512df0; Biau DJ, 2012, JAMA-J AM MED ASSOC, V307, P2023, DOI 10.1001/jama.2012.3613; Fujita T, 2002, EUR J SURG, V168, P535	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAR	2015	261	3					E70	E70		10.1097/SLA.0000000000000518		1	Surgery	Surgery	CB3WK	WOS:000349559900009		
J	Hida, K; Hasegawa, S; Sakai, Y				Hida, Koya; Hasegawa, Suguru; Sakai, Yoshiharu			Open Versus Laparoscopic Resection of Primary Tumor for Incurable Stage IV Colorectal Cancer: A Large Multicenter Consecutive Patients Cohort Study Reply	ANNALS OF SURGERY			English	Letter									[Hida, Koya; Hasegawa, Suguru; Sakai, Yoshiharu] Kyoto Univ Hosp, Dept Surg, Kyoto, Japan	Hida, K (reprint author), Kyoto Univ Hosp, Dept Surg, Kyoto, Japan.						Hida K, 2012, ANN SURG, V255, P929, DOI 10.1097/SLA.0b013e31824a99e4; Akagi T, 2013, J GASTROINTEST SURG, V17, P776, DOI 10.1007/s11605-013-2173-x	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAR	2015	261	3					E71	E71		10.1097/SLA.0000000000000528		1	Surgery	Surgery	CB3WK	WOS:000349559900012		
J	Yamashita, H; Katai, H				Yamashita, Hiroharu; Katai, Hitoshi			Should Adenocarcinoma of the Esophagogastric Junction Be Classified as Esophageal Cancer? Limited to Siewert Type II, Yes	ANNALS OF SURGERY			English	Letter									[Yamashita, Hiroharu; Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan	Yamashita, H (reprint author), Natl Canc Ctr, Gastr Surg Div, 1-1 Tsukiji 5 chome, Tokyo, Japan.	hkatai@ncc.go.jp	Yamashita, Hiroharu/E-7058-2011				Yamashita H, 2011, ANN SURG, V254, P274, DOI 10.1097/SLA.0b013e3182263911; Suh YS, 2012, ANN SURG, V255, P908, DOI 10.1097/SLA.0b013e31824beb95; Siewert JR, 1996, DIS ESOPHAGUS, V9, P173; Sobin LH, 2009, TNM CLASSIFICATION M	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAR	2015	261	3					E67	E67		10.1097/SLA.0000000000000589		1	Surgery	Surgery	CB3WK	WOS:000349559900007		
J	Kitagaki, J; Shi, GB; Miyauchi, S; Murakami, S; Yang, YL				Kitagaki, Jirouta; Shi, Genbin; Miyauchi, Shizuka; Murakami, Shinya; Yang, Yili			Cyclic depsipeptides as potential cancer therapeutics	ANTI-CANCER DRUGS			English	Review						aplidine; cancer therapy; cryptophycin 1; cyclic depsipeptides; kahalalide F; LY355703; PM02734; romidepsin	HISTONE DEACETYLASE INHIBITOR; SOUTHWEST-ONCOLOGY-GROUP; ADVANCED SOLID TUMORS; CELL LUNG-CANCER; PHASE-II TRIAL; CRYPTOPHYCIN ANALOG LY355703; CHROMOBACTERIUM-VIOLACEUM NO-968; BISINTERCALATOR NATURAL-PRODUCTS; REFRACTORY MULTIPLE-MYELOMA; NON-HODGKINS-LYMPHOMA	Cyclic depsipeptides are polypeptides in which one or more amino acid is replaced by a hydroxy acid, resulting in the formation of at least one ester bond in the core ring structure. Many natural cyclic depsipeptides possessing intriguing structural and biological properties, including antitumor, antifungal, antiviral, antibacterial, anthelmintic, and anti-inflammatory activities, have been identified from fungi, plants, and marine organisms. In particular, the potent effects of cyclic depsipeptides on tumor cells have led to a number of clinical trials evaluating their potential as chemotherapeutic agents. Although many of the trials have not achieved the desired results, romidepsin (FK228), a bicyclic depsipeptide that inhibits histone deacetylase, has been shown to have clinical efficacy in patients with refractory cutaneous T-cell lymphoma and has received Food and Drug Administration approval for use in treatment. In this review, we discuss antitumor cyclic depsipeptides that have undergone clinical trials and focus on their structural features, mechanisms, potential applications in chemotherapy, and pharmacokinetic and toxicity data. The results of this study indicate that cyclic depsipeptides could be a rich source of new cancer therapeutics.	[Kitagaki, Jirouta; Miyauchi, Shizuka; Murakami, Shinya] Osaka Univ, Dept Periodontol, Div Oral Biol & Dis Control, Grad Sch Dent, Suita, Osaka 565, Japan; [Kitagaki, Jirouta] Osaka Univ, Challenge Intractable Oral Dis, Ctr Translat Dent Res, Dent Hosp, Suita, Osaka 565, Japan; [Shi, Genbin] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21701 USA; [Yang, Yili] Second Mil Med Univ, Shanghai Changzheng Hosp, Ctr Translat Med, Shanghai, Peoples R China	Yang, YL (reprint author), Shanghai Changzheng Hosp, Ctr Translat Med, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	nathanyang@hotmail.com			 [25862045];  [23249086]	The authors started this work while both J.K. and Y.Y. were working at the Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health. They thank Dr Alan O. Perantoni for the encouragement and support. This work was supported in part by a Grant-in Aid for Scientific Research (No. 25862045, 23249086) to J.K. and S.M.	Tran TD, 2012, J NAT PROD, V75, P2200, DOI 10.1021/np3006474; Matsumoto T, 2001, PHYTOCHEMISTRY, V57, P251, DOI 10.1016/S0031-9422(00)00442-8; Sandor V, 2002, CLIN CANCER RES, V8, P718; Andavan GSB, 2010, MAR DRUGS, V8, P810, DOI 10.3390/md8030810; Cuadrado A, 2003, J BIOL CHEM, V278, P241, DOI 10.1074/jbc.M201010200; Kamyar M, 2004, ARCH BIOCHEM BIOPHYS, V429, P215, DOI 10.1016/j.abb.2004.06.013; RINEHART KL, 1981, SCIENCE, V212, P933, DOI 10.1126/science.7233187; BARROW RA, 1995, J AM CHEM SOC, V117, P2479, DOI 10.1021/ja00114a011; TRIMURTULU G, 1994, J AM CHEM SOC, V116, P4729, DOI 10.1021/ja00090a020; Rademaker-Lakhai JM, 2005, CLIN CANCER RES, V11, P1854, DOI 10.1158/1078-0432.CCR-04-1534; Sy-Cordero AA, 2012, J ANTIBIOT, V65, P541, DOI 10.1038/ja.2012.71; Liang J, 2005, INVEST NEW DRUG, V23, P213, DOI 10.1007/s10637-005-6729-9; Shilabin AG, 2007, J MED CHEM, V50, P4340, DOI 10.1021/jm061288r; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; GarciaRocha M, 1996, CANCER LETT, V99, P43, DOI 10.1016/0304-3835(95)04036-6; Mercurio C, 2010, PHARMACOL RES, V62, P18, DOI 10.1016/j.phrs.2010.02.010; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Martin-Algarra S, 2009, EUR J CANCER, V45, P732, DOI 10.1016/j.ejca.2008.12.005; Faircloth G, 2006, PROG MOLEC, V43, P363, DOI 10.1007/978-3-540-30880-5_16; Lobo C, 1997, ANTICANCER RES, V17, P333; Stevenson JP, 2002, CLIN CANCER RES, V8, P2524; Maroun JA, 2006, ANN ONCOL, V17, P1371, DOI 10.1093/annonc/mdl165; HAMANN MT, 1993, J AM CHEM SOC, V115, P5825, DOI 10.1021/ja00066a061; Bertino EM, 2011, EXPERT OPIN INV DRUG, V20, P1151, DOI 10.1517/13543784.2011.594437; Lemmens-Gruber R, 2009, CURR MED CHEM, V16, P1122; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Janmaat ML, 2005, MOL PHARMACOL, V68, P502, DOI 10.1124/mol.105.011361; Garcia-Fernandez LF, 2002, ONCOGENE, V21, P7533, DOI 10.1038/sj.onc.1205972; Gao JT, 2011, CHEM REV, V111, P3208, DOI 10.1021/cr100187n; Yu XD, 2007, CANCER J, V13, P105, DOI 10.1097/PPO.0b013e318046eedc; Sandor V, 2000, BRIT J CANCER, V83, P817, DOI 10.1054/bjoc.2000.1327; Liu SX, 2005, J MED CHEM, V48, P3630, DOI 10.1021/jm048952t; Stadler WM, 2006, CLIN GENITOURIN CANC, V5, P57, DOI 10.3816/CGC.2006.n.018; Klein B, 2011, APOPTOSIS, V16, P1101, DOI 10.1007/s10495-011-0642-9; Varadi T, 2011, EUR J PHARMACOL, V667, P91, DOI 10.1016/j.ejphar.2011.05.064; Harrison SJ, 2011, BLOOD, V118, P6274, DOI 10.1182/blood-2011-03-339879; Iacobazzi RM, 2013, ACS MED CHEM LETT, V4, P1189, DOI 10.1021/ml400300q; Munoz-Alonso MJ, 2008, J PHARMACOL EXP THER, V324, P1093, DOI 10.1124/jpet.107.132662; Sessa C, 2002, EUR J CANCER, V38, P2388, DOI 10.1016/S0959-8049(02)00489-6; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; Isaka M, 2007, J NAT PROD, V70, P675, DOI 10.1021/np060602h; Tonshin AA, 2010, TOXICOLOGY, V276, P49, DOI 10.1016/j.tox.2010.07.001; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Zhang Y, 2004, INT J CANCER, V110, P301, DOI 10.1002/ijc.20117; SCHWARTZ RE, 1990, J IND MICROBIOL, V5, P113, DOI 10.1007/BF01573860; Subramanian B, 2002, ANTI-CANCER DRUG, V13, P1061, DOI 10.1097/00001813-200211000-00010; Whitehead RP, 2009, INVEST NEW DRUG, V27, P469, DOI 10.1007/s10637-008-9190-8; SMITH CD, 1994, CANCER RES, V54, P3779; Rajgolikar G, 1998, BREAST CANCER RES TR, V51, P29, DOI 10.1023/A:1006091014092; Paoluzzi L, 2010, CLIN CANCER RES, V16, P554, DOI 10.1158/1078-0432.CCR-09-1937; Caers J, 2008, BRIT J CANCER, V98, P1966, DOI 10.1038/sj.bjc.6604388; Zolova OE, 2010, BIOPOLYMERS, V93, P777, DOI 10.1002/bip.21489; Wagner MM, 1999, CANCER CHEMOTH PHARM, V43, P115, DOI 10.1007/s002800050871; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Schrump DS, 2008, CLIN CANCER RES, V14, P188, DOI 10.1158/1078-0432.CCR-07-0135; Smith CD, 1996, J BIOL CHEM, V271, P6192; Shih C, 2001, CURR PHARM DESIGN, V7, P1259, DOI 10.2174/1381612013397474; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Sakai R, 1996, J MED CHEM, V39, P2819, DOI 10.1021/jm960048g; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; D'Agostino G, 2006, INT J GYNECOL CANCER, V16, P71, DOI 10.1111/j.1525-1438.2006.00276.x; AZZI A, 1965, BIOCHEM J, V96, pC1; Bai RL, 1996, CANCER RES, V56, P4398; Ballard CE, 2002, CURR MED CHEM, V9, P471; Baudin E, 2010, AM J CLIN ONCOL-CANC, V33, P83, DOI 10.1097/COC.0b013e31819fdf5e; BENVENUTO JA, 1992, INVEST NEW DRUG, V10, P113, DOI 10.1007/BF00873128; Biscardi M, 2005, ANN ONCOL, V16, P1667, DOI 10.1093/annonc/mdi311; Bonnard I, 2003, J NAT PROD, V66, P1466, DOI 10.1021/np030334c; Broggini M, 2003, LEUKEMIA, V17, P52, DOI 10.1038/sj.leu.2402788; CAIN JM, 1992, INVEST NEW DRUG, V10, P23, DOI 10.1007/BF01275473; Chen BDM, 1998, INT J CANCER, V77, P869, DOI 10.1002/(SICI)1097-0215(19980911)77:6<869::AID-IJC12>3.0.CO;2-X; Corbett TH, 1997, INVEST NEW DRUG, V15, P207, DOI 10.1023/A:1005875015011; Cuadrado A, 2004, ONCOGENE, V23, P4673, DOI 10.1038/sj.onc.1207636; Dawson S, 2007, NAT PROD REP, V24, P109, DOI 10.1039/b516347c; Depenbrock H, 1998, BRIT J CANCER, V78, P739, DOI 10.1038/bjc.1998.570; Edelman MJ, 2003, LUNG CANCER-J IASLC, V39, P197, DOI 10.1016/S0169-5002(02)00511-1; Eisen T, 2009, LUNG CANCER, V64, P60, DOI 10.1016/j.lungcan.2008.06.017; Eisen T, 2009, MELANOMA RES, V19, P185, DOI 10.1097/CMR.0b013e32832bbde6; Erba E, 2003, BRIT J CANCER, V89, P763, DOI 10.1038/sj.bjc.6601130; Erba E, 2002, BRIT J CANCER, V86, P1510, DOI 10.1038/sj/bjc/6600265; Faivre S, 2005, J CLIN ONCOL, V23, P7871, DOI 10.1200/JCO.2005.09.357; GAUMANN E, 1947, EXPERIENTIA, V3, P202, DOI 10.1007/BF02163993; Geoerger B, 2012, EUR J CANCER, V48, P289, DOI 10.1016/j.ejca.2011.10.036; Gomez SG, 2001, TOXICOL IN VITRO, V15, P347, DOI 10.1016/S0887-2333(01)00034-0; Gonzalez-Santiago L, 2006, CELL DEATH DIFFER, V13, P1968, DOI 10.1038/sj.cdd.4401898; Goss G, 1995, INVEST NEW DRUG, V13, P257, DOI 10.1007/BF00873810; Herrero AB, 2008, CANCER RES, V68, P9779, DOI 10.1158/0008-5472.CAN-08-1981; Hoshino I, 2007, ONCOL REP, V18, P585; HUANG CH, 1985, CANCER RES, V45, P3768; Hwang Y, 1999, MOL PHARMACOL, V55, P1049; Izquierdo MA, 2008, CLIN CANCER RES, V14, P3105, DOI 10.1158/1078-0432.CCR-07-1652; Kessel D, 2000, CANCER LETT, V151, P25, DOI 10.1016/S0304-3835(99)00409-7; Khan SB, 2004, BRIT J HAEMATOL, V125, P156, DOI 10.1111/j.1365-2141.2004.04882.x; Kitagaki J, 2011, BIOCHEM BIOPH RES CO, V414, P186, DOI 10.1016/j.bbrc.2011.09.054; Kobayashi J, 2001, J ORG CHEM, V66, P6626, DOI 10.1021/jo0103423; KOBAYASHI M, 1995, CHEM PHARM BULL, V43, P1598; Kwan JC, 2014, CHEMBIOCHEM, V15, P799, DOI 10.1002/cbic.201300762; LAM KS, 1995, J IND MICROBIOL, V15, P60, DOI 10.1007/BF01570015; Ling YH, 2009, EUR J CANCER, V45, P1855, DOI 10.1016/j.ejca.2009.03.003; Ling YH, 2011, CLIN CANCER RES, V17, P5353, DOI 10.1158/1078-0432.CCR-10-1948; Lu K, 2001, CANCER CHEMOTH PHARM, V47, P170, DOI 10.1007/s002800000210; Ma B, 2010, J AM CHEM SOC, V132, P1159, DOI 10.1021/ja909870g; MACKEDON.VV, 1969, FEBS LETT, V5, P73, DOI 10.1016/0014-5793(69)80296-6; Marshall John L, 2002, J Exp Ther Oncol, V2, P325, DOI 10.1046/j.1359-4117.2002.01039.x; Mateos MV, 2010, CLIN CANCER RES, V16, P3260, DOI 10.1158/1078-0432.CCR-10-0469; Molina-Guijarro JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019042; Panda D, 1998, P NATL ACAD SCI USA, V95, P9313, DOI 10.1073/pnas.95.16.9313; Pardo B, 2008, CLIN CANCER RES, V14, P1116, DOI 10.1158/1078-0432.CCR-07-4366; Patel VF, 1999, J MED CHEM, V42, P2588, DOI 10.1021/jm980706s; Piekarz RL, 2001, BLOOD, V98, P2865, DOI 10.1182/blood.V98.9.2865; Provencio M, 2009, CLIN LUNG CANCER, V10, P295, DOI 10.3816/CLC.2009.n.041; Ribrag V, 2013, HAEMATOLOGICA, V98, P357, DOI 10.3324/haematol.2012.069757; Salazar R, 2012, CANCER CHEMOTH PHARM, V70, P673, DOI 10.1007/s00280-012-1951-6; Salazar R, 2013, CANCER CHEMOTH PHARM, V72, P75, DOI 10.1007/s00280-013-2170-5; Schoffski P, 2009, MAR DRUGS, V7, P57, DOI 10.3390/md7010057; SHIN DM, 1994, INVEST NEW DRUG, V12, P243, DOI 10.1007/BF00873966; SONDAK VK, 1994, ANTI-CANCER DRUG, V5, P147, DOI 10.1097/00001813-199404000-00004; Straight AM, 2006, CANCER CHEMOTH PHARM, V57, P7, DOI 10.1007/s00280-005-0014-7; TAYLOR SA, 1992, INVEST NEW DRUG, V10, P55, DOI 10.1007/BF01275484; UEDA H, 1994, J ANTIBIOT, V47, P301; Urdiales JL, 1996, CANCER LETT, V102, P31, DOI 10.1016/0304-3835(96)04151-1; Viehrig K, 2013, J AM CHEM SOC, V135, P16885, DOI 10.1021/ja4047153; WEISS RB, 1994, INVEST NEW DRUG, V12, P41, DOI 10.1007/BF00873234; WILLIAMSON SK, 1995, INVEST NEW DRUG, V13, P167, DOI 10.1007/BF00872867; Zhang G, 2014, ONCOL LETT, V8, P248, DOI 10.3892/ol.2014.2121; Zhang Y, 2006, CELL DEATH DIFFER, V13, P129, DOI 10.1038/sj.cdd.4401686	126	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4973	1473-5741		ANTI-CANCER DRUG	Anti-Cancer Drugs	MAR	2015	26	3					259	271		10.1097/CAD.0000000000000183		13	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CB1KC	WOS:000349385100002		
J	Hayashi, M				Hayashi, Mahito			Rescaled "Rebel Cities", Nationalization, and the Bourgeois Utopia: Dialectics Between Urban Social Movements and Regulation for Japan's Homeless	ANTIPODE			English	Article						commoning; othering; workfare states; day labourers; autogestion; rescaling; homelessness	PEOPLE; SPACES; MOBILIZATION	Urban social movements (USMs) and regulation have co-evolved in Japan to deal with homelessness, spatializaing their politics on the national and subnational scales. The author first theorizes these USM-regulation relationships as scale-oriented dialectics between two opposing forcescommoning and otheringboth of which in my view are always internalized in today's rebel cities (Harvey 2012, Rebel Cities, Verso). Then, he analyzes two trajectories of USMs that attempted commoningie radical opening up of public goods/spaces within zones of weakness (Lefebvre )against policing and workfare disciplines. The author detects rescaling dialectics in the case of Yokohama and nationalizing dialectics in the case of Tokyo. Lastly, through exploring and refreshing Engels's notion of the (petit-)bourgeois utopia, the author concludes that our commoning projects and imaginaries are constrained by capitalist urban form that spatially others the homeless; but truly revolutionary moments of commoning emerge whenever peopleeven temporarilyconquer the fetishism of the public/private binary embedded in this urban form.	Kinjo Gakuin Univ, Coll Global & Media Studies, Nagoya, Aichi, Japan	Hayashi, M (reprint author), Kinjo Gakuin Univ, Coll Global & Media Studies, Nagoya, Aichi, Japan.	hayashi.mahito@gmail.com					Amamiya K, 2009, SUBARU, V31, P195; Pruijt H, 2003, INT J URBAN REGIONAL, V27, P133, DOI 10.1111/1468-2427.00436; Brenner N, 2013, PUBLIC CULTURE, V25, P85, DOI 10.1215/08992363-1890477; Brenner N, 2009, LEVIATHAN UNDONE: TOWARDS A POLITICAL ECONOMY OF SCALE, P27; Cress DM, 2000, AM J SOCIOL, V105, P1063, DOI 10.1086/210399; Aoki H, 1999, BASHO WO AKERO; Arnold K, 2004, HOMELESSNESS CITIZEN; Blau J, 1992, THE VISIBLE POOR; Bratt E, 1986, CRITICAL PERSPECTIVE; Brenner N., 2004, NEW STATE SPACES; Brenner N, 2013, NEW GEOGRAPHIES, V5, P2; Brenner N., 2011, CITIES PEOPLE NOT PR; Burrow R, 1997, HOMELESSNESS SOCIAL; Cabinet Office, 2012, MIN OUTL RESP POL SO; Cabinet Office, 2011, WORK GROUP B POL SOR; Castells M, 1983, CITY GRASSROOTS; City of Yokohama, 2004, YOK IMPL PLAN ASS SE; Davis Mike, 1992, VARIATIONS THEME PAR, P154; Devine J, 1998, BESIDE GOLDEN DOOR P; Engels F, 1954, THE HOUSING QUESTION; Engels Friedrich, 1993, CONDITION WORKING CL; Fishman R., 1987, BOURGEOIS UTOPIAS; Gill Tom, 2001, MEN UNCERTAINTY SOCI; Haken Toshikoshi, 2009, HAK MUR 6 DAYS SHOCK; Hansel K, 2011, NE J LAW SOCIAL POLI, V6, P445; Harvey D., 2012, REBEL CITIES; Hayakawa T, 2011, WE PROTECT NATIONS L; Hayashi M, 2014, ENVIRON PLANN A, V46, P1203, DOI 10.1068/a4621; Hayashi M, 2007, ANNALS OF REGIONAL A, V19, P94; Hayashi M, 2013, INT J URBAN REGIONAL, V37, P1188, DOI 10.1111/j.1468-2427.2012.01200.x; Hayashi M, 2014, HOMELESS URBAN SPACE; Hayashi M, 2007, SOSHIOROJI, V159, P53; Hayashi M, 2009, THESIS TOKYO METROPO; Headquarters of the Government and Ruling Parties, 2012, FIN DRAFT COMPR TAX; Ikeda N, 2009, COURAGE ABANDON HOPE; Jessop B., 1990, STATE THEORY; Jinbo T, 2009, SEKAI, V788, P126; Johnsen S, 2005, SOC CULT GEOGR, V6, P787, DOI 10.1080/14649360500353004; Kasai K, 1999, HOMELESS STRUGGLING; Katayama S, 2012, DISCOURAGING HONEST; Koryukai Kotobuki Shiensha, 1998, NOTES 25 KOTOBUKI OV; Kun Kawase Seiji, 1985, LIV LIF KOT; Lefebvre H, 2009, STATE SPACE WORLD SE, P138; Lefebvre H., 2003, URBAN REVOLUTION; Marx K, 1964, CLASS STRUGGLES FRAN; Marx K, 1976, CAPITAL, V1 & 2; Marx Karl, 1994, 18 BRUMAIRE L BONAPA; MHLW, 2009, MATT CONS ADV ASS TH; MHLW, 2009, THOR ENF ASS THOS WH; MHLW, 2012, INT REP LIF SUPP STR; Mingione E, 1996, PRBAN POVERTY UNDERC; Miyamoto K, 1967, SOCIAL CAPITAL THEOR; Murakami Y, 1984, AGE NEW MIDDLE MASS; NHK News Crew, 2012, SHOCK FACTS 3 TRILL; Nomoto S, 1977, NOTES KOTOBUKI SEIKA; Nomoto S, 2003, PERSONAL HIST ORDINA; Oakley D, 2002, J URBAN AFF, V24, P97, DOI 10.1111/1467-9906.00116; Offe C., 1996, MODERNITY STATE; Peck Jamie, 2001, WORKFARE STATES; Pereleman M, 2000, INVENTION CAPITALISM; Shinkawa T, 2005, DEV TRANSITION JAPAN; Smith Neil, 1996, NEW URBAN FRONTIER; Snow D. A., 1992, FRONTIERS SOCIAL MOV, P133; Stoner M, 1995, CIVIL RIGHTS HOMELES; Takenaka H, 2011, JAPANESE EC WILL PER; TMG, 2007, WHIT PAP TOK HOM 2; Utsunomiya K, 2009, HAKEN MURA; WAGNER D, 1991, SOC PROBL, V38, P543, DOI 10.1525/sp.1991.38.4.03a00090; Williams JC, 2005, POLIT RES QUART, V58, P497, DOI 10.2307/3595618; Yuasa M, 2009, SEKAI, V788, P138; Yuasa M, 2008, ANTIPOVERTY	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0066-4812	1467-8330		ANTIPODE	Antipode	MAR	2015	47	2					418	441		10.1111/anti.12106		24	Geography	Geography	CB1QC	WOS:000349401700008		
J	Hata, A; Katayama, H; Furumai, H				Hata, Akihiko; Katayama, Hiroyuki; Furumai, Hiroaki			Organic Substances Interfere with Reverse Transcription-Quantitative PCR-Based Virus Detection in Water Samples	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							MOLECULAR-WEIGHT; ENTERIC VIRUSES; INHIBITION; AMPLIFICATION; MATTER; EXCITATION; NOROVIRUS; REMOVAL	Reverse transcription (RT)-PCR-based virus detection from water samples is occasionally hampered by organic substances that are coconcentrated during virus concentration procedures. To characterize these organic substances, samples containing commercially available humic acid, which is known to inhibit RT-PCR, and river water samples were subjected to adsorption-elution-based virus concentration using an electronegative membrane. In this study, the samples before, during, and after the concentration were analyzed in terms of organic properties and virus detection efficiencies. Two out of the three humic acid solutions resulted in RT-quantitative PCR (qPCR) inhibition that caused >3-log(10)-unit underestimation of spiked poliovirus. Over 60% of the organics contained in the two solutions were recovered in the concentrate, while over 60% of the organics in the uninhibited solution were lost during the concentration process. River water concentrates also caused inhibition of RT-qPCR. Organic concentrations in the river water samples increased by 2.3 to 3.9 times after the virus concentration procedure. The inhibitory samples contained organic fractions in the 10- to 100-kDa size range, which are suspected to be RT-PCR inhibitors. According to excitation-emission matrices, humic acid-like and protein-like fractions were also recovered from river water concentrates, but these fractions did not seem to affect virus detection. Our findings reveal that detailed organic analyses are effective in characterizing inhibitory substances.	[Hata, Akihiko] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga, Japan; [Katayama, Hiroyuki; Furumai, Hiroaki] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, Tokyo, Japan	Hata, A (reprint author), Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga, Japan.	hata.akihiko.33c@st.kyoto-u.ac.jp			Japan Society for the Promotion of Science [12J08885]	This work was supported by a grant-in-aid for JSPS Fellows (grant number 12J08885) from the Japan Society for the Promotion of Science.	Abbaszadegan M, 1999, APPL ENVIRON MICROB, V65, P444; Cashdollar JL, 2013, J APPL MICROBIOL, V115, P1, DOI 10.1111/jam.12143; Imai A, 2002, WATER RES, V36, P859, DOI 10.1016/S0043-1354(01)00283-4; Villena C, 2003, EPIDEMIOL INFECT, V131, P1105, DOI 10.1017/S0950268803001353; Hata A, 2014, SCI TOTAL ENVIRON, V468, P757, DOI 10.1016/j.scitotenv.2013.08.093; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741; Hamza IA, 2009, WATER RES, V43, P2657, DOI 10.1016/j.watres.2009.03.020; Sinclair RG, 2009, J APPL MICROBIOL, V107, P1769, DOI 10.1111/j.1365-2672.2009.04367.x; CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Schriewer A, 2011, J MICROBIOL METH, V85, P16, DOI 10.1016/j.mimet.2010.12.027; Gibson KE, 2012, WATER RES, V46, P4281, DOI 10.1016/j.watres.2012.04.030; Fernandez MDB, 2012, SCI TOTAL ENVIRON, V437, P262, DOI 10.1016/j.scitotenv.2012.08.033; Gregory JB, 2006, APPL ENVIRON MICROB, V72, P3960, DOI 10.1128/AEM.02291-05; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Hata A, 2011, APPL ENVIRON MICROB, V77, P4336, DOI 10.1128/AEM.00077-11; Hata A, 2014, FOOD ENV VIROL  1018; International Humic Substances Society, 2007, WHAT AR HUM SUBST; Kawasaki N, 2011, WATER RES, V45, P6240, DOI 10.1016/j.watres.2011.09.021; OHLBAUM A, 1970, J GEN VIROL, V6, P429, DOI 10.1099/0022-1317-6-3-429; Rock C, 2010, APPL ENVIRON MICROB, V76, P8102, DOI 10.1128/AEM.02339-09; Rodriguez RA, 2012, J VIROL METHODS, V181, P43, DOI 10.1016/j.jviromet.2012.01.009; Ye XY, 2012, CURR MICROBIOL, V65, P244, DOI 10.1007/s00284-012-0152-1	26	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	MAR	2015	81	5					1585	1593		10.1128/AEM.03082-14		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CB3RY	WOS:000349547200005		
J	Iino, T; Ito, K; Wakai, S; Tsurumaru, H; Ohkuma, M; Harayama, S				Iino, Takao; Ito, Kimio; Wakai, Satoshi; Tsurumaru, Hirohito; Ohkuma, Moriya; Harayama, Shigeaki			Iron Corrosion Induced by Nonhydrogenotrophic Nitrate-Reducing Prolixibacter sp Strain MIC1-1	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							MAXIMUM-LIKELIHOOD; BACTERIA; REDUCTION; DENITRIFICATION; INJECTION; COMMUNITY; STEEL; TREES; CELL	Microbiologically influenced corrosion (MIC) of metallic materials imposes a heavy economic burden. The mechanism of MIC of metallic iron (Fe-0) under anaerobic conditions is usually explained as the consumption of cathodic hydrogen by hydrogenotrophic microorganisms that accelerates anodic Fe-0 oxidation. In this study, we describe Fe-0 corrosion induced by a nonhydrogenotrophic nitrate-reducing bacterium called MIC1-1, which was isolated from a crude-oil sample collected at an oil well in Akita, Japan. This strain requires specific electron donor-acceptor combinations and an organic carbon source to grow. For example, the strain grew anaerobically on nitrate as a sole electron acceptor with pyruvate as a carbon source and Fe-0 as the sole electron donor. In addition, ferrous ion and L-cysteine served as electron donors, whereas molecular hydrogen did not. Phylogenetic analysis based on 16S rRNA gene sequences revealed that strain MIC1-1 was a member of the genus Prolixibacter in the order Bacteroidales. Thus, Prolixibacter sp. strain MIC1-1 is the first Fe-0-corroding representative belonging to the phylum Bacteroidetes. Under anaerobic conditions, Prolixibacter sp. MIC1-1 corroded Fe-0 concomitantly with nitrate reduction, and the amount of iron dissolved by the strain was six times higher than that in an aseptic control. Scanning electron microscopy analyses revealed that microscopic crystals of FePO4 developed on the surface of the Fe-0 foils, and a layer of FeCO3 covered the FePO4 crystals. Wepropose that cells of Prolixibacter sp. MIC1-1 accept electrons directly from Fe-0 to reduce nitrate.	[Iino, Takao; Wakai, Satoshi; Tsurumaru, Hirohito; Harayama, Shigeaki] NITE, Biol Resource Ctr NBRC, Natl Inst Technol & Evaluat, Kisarazu, Chiba, Japan; [Iino, Takao; Ohkuma, Moriya] RIKEN BioResource Ctr RIKEN BRC, Japan Collect Microorganisms, Tsukuba, Ibaraki, Japan; [Ito, Kimio] Nippon Steel & Sumitomo Met Corp, Adv Technol Res Labs, Futtsu, Chiba, Japan; [Harayama, Shigeaki] Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, Tokyo 112, Japan	Iino, T (reprint author), NITE, Biol Resource Ctr NBRC, Natl Inst Technol & Evaluat, Kisarazu, Chiba, Japan.	iino@jcm.riken.jp	Ohkuma, Moriya/A-8100-2011		New Energy and Industrial Technology Development Organization (NEDO) [P05032]	This study was partly supported by the New Energy and Industrial Technology Development Organization (NEDO) (grant no. P05032).	Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Kaster KM, 2009, ANTON LEEUW INT J G, V96, P423, DOI 10.1007/s10482-009-9356-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P1783, DOI 10.1128/AEM.00668-09; Gittel A, 2009, APPL ENVIRON MICROB, V75, P7086, DOI 10.1128/AEM.01123-09; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; Cheng IF, 1997, CHEMOSPHERE, V35, P2689, DOI 10.1016/S0045-6535(97)00275-0; Kielemoes J, 2000, ENVIRON SCI TECHNOL, V34, P663, DOI 10.1021/es9902930; Kato S, 2015, APPL ENVIRON MICROB, V81, P67, DOI 10.1128/AEM.02767-14; Schwermer CU, 2008, APPL ENVIRON MICROB, V74, P2841, DOI 10.1128/AEM.02027-07; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; WOLIN EA, 1963, J BIOL CHEM, V238, P2882; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; Ginner JL, 2004, ENVIRON ENG SCI, V21, P219, DOI 10.1089/109287504773087381; Xu DK, 2013, CORROS SCI, V77, P385, DOI 10.1016/j.corsci.2013.07.044; Holmes DE, 2007, INT J SYST EVOL MICR, V57, P701, DOI 10.1099/ijs.0.64296-0; De Windt W, 2003, ENVIRON MICROBIOL, V5, P1192, DOI 10.1046/j.1462-2920.2003.00527.x; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Telang AJ, 1997, APPL ENVIRON MICROB, V63, P1785; Till BA, 1998, ENVIRON SCI TECHNOL, V32, P634, DOI 10.1021/es9707769; Enning D, 2012, ENVIRON MICROBIOL, V14, P1772, DOI 10.1111/j.1462-2920.2012.02778.x; Choe C, 2004, APPL GEOCHEM, V19, P335; Enning D, 2014, APPL ENVIRON MICROB, V80, P1226, DOI 10.1128/AEM.02848-13; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; HASEGAWA M, 1993, MOL PHYLOGENET EVOL, V2, P1, DOI 10.1006/mpev.1993.1001; Javaherdashti R., 2008, MICROBIOLOGICALLY IN; Knight VK, 1999, FEMS MICROBIOL ECOL, V29, P137, DOI 10.1111/j.1574-6941.1999.tb00605.x; Lin K-S, 2008, SCI TECHNOL ADV MAT, V9; Rakshit S, 2005, J ENVIRON QUAL, V34, P1286, DOI 10.2134/jeq2004.0459; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sandell EB, 1959, CHEM ANAL MONOGRAPH, V3; TOUZEL JP, 1983, FEMS MICROBIOL LETT, V16, P241; Widdel F, 1992, PROKARYOTES, V6, P3352; Xiaomeng F, 2009, J ENVIRON SCI, V21, P1028	34	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	MAR	2015	81	5					1830	1837		10.1128/AEM.03741-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CB3RY	WOS:000349547200032		
J	Nakamura, T; Hamasaki, M; Yoshitomi, H; Ishibashi, T; Yoshiyama, C; Maeda, E; Sera, N; Yoshida, H				Nakamura, Tomofumi; Hamasaki, Mitsuhiro; Yoshitomi, Hideaki; Ishibashi, Tetsuya; Yoshiyama, Chiharu; Maeda, Eriko; Sera, Nobuyuki; Yoshida, Hiromu			Environmental Surveillance of Poliovirus in Sewage Water around the Introduction Period for Inactivated Polio Vaccine in Japan	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							SABIN-3 POLIOVIRUS; TOYAMA PREFECTURE; GENOMIC ANALYSIS; STRAINS; IDENTIFICATION; ENTEROVIRUSES; PROVINCE; POLIOMYELITIS; EPIDEMIOLOGY; TRANSMISSION	Environmental virus surveillance was conducted at two independent sewage plants from urban and rural areas in the northern prefecture of the Kyushu district, Japan, to trace polioviruses (PVs) within communities. Consequently, 83 PVs were isolated over a 34-month period from April 2010 to January 2013. The frequency of PV isolation at the urban plant was 1.5 times higher than that at the rural plant. Molecular sequence analysis of the viral VP1 gene identified all three serotypes among the PV isolates, with the most prevalent serotype being type 2 (46%). Nearly all poliovirus isolates exhibited more than one nucleotide mutation from the Sabin vaccine strains. During this study, inactivated poliovirus vaccine (IPV) was introduced for routine immunization on 1 September 2012, replacing the live oral poliovirus vaccine (OPV). Interestingly, the frequency of PV isolation from sewage waters declined before OPV cessation at both sites. Our study highlights the importance of environmental surveillance for the detection of the excretion of PVs from an OPV-immunized population in a highly sensitive manner, during the OPV-to-IPV transition period.	[Nakamura, Tomofumi; Yoshida, Hiromu] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [Nakamura, Tomofumi; Hamasaki, Mitsuhiro; Yoshitomi, Hideaki; Ishibashi, Tetsuya; Yoshiyama, Chiharu; Maeda, Eriko; Sera, Nobuyuki] Fukuoka Inst Hlth & Environm Sci, Dazaifu, Fukuoka, Japan	Sera, N (reprint author), Fukuoka Inst Hlth & Environm Sci, Dazaifu, Fukuoka, Japan.	sera@fihes.pref.fukuoka.jp			Ministry of Health, Labor and Welfare of Japan	This study was supported by a grant for Research on Emerging and Re-Emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan.	Alexander JP, 1997, J INFECT DIS, V175, pS176; Amdiouni H, 2012, LETT APPL MICROBIOL, V54, P359, DOI 10.1111/j.1472-765X.2012.03220.x; Anis E, 2013, EURO SURVEILL, V18; TATEM JM, 1992, J VIROL, V66, P3194; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.0.CO;2-H; BOUCHARD MJ, 1995, J VIROL, V69, P4972; Tao ZX, 2011, APPL ENVIRON MICROB, V77, P3786, DOI 10.1128/AEM.03044-10; Huang QS, 2005, LANCET, V366, P394, DOI 10.1016/S0140-6736(05)66386-6; REZAPKIN GV, 1995, VIROLOGY, V211, P377, DOI 10.1006/viro.1995.1420; Buenz EJ, 2006, TRENDS MICROBIOL, V14, P28, DOI 10.1016/j.tim.2005.11.003; Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Iwai M, 2010, CLIN VACCINE IMMUNOL, V17, P764, DOI 10.1128/CVI.00239-09; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; MACADAM AJ, 1993, VIROLOGY, V192, P18, DOI 10.1006/viro.1993.1003; Okada K, 2013, J INFECT DIS, V208, P275, DOI 10.1093/infdis/jit155; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Apostol LNG, 2012, VIRUS GENES, V45, P207, DOI 10.1007/s11262-012-0776-z; BENYESHM.M, 1967, AM J EPIDEMIOL, V86, P112; Kew Olen M., 2012, Morbidity and Mortality Weekly Report, V61, P741; MELNICK JL, 1962, VIROLOGY, V16, P501; El Bassioni L, 2003, AM J EPIDEMIOL, V158, P807, DOI 10.1098/aje/kwg202; Esteves-Jaramillo A, 2014, J INFECT DIS, V210, pS315, DOI 10.1093/infdis/jiu183; GELFAND HM, 1959, JAMA-J AM MED ASSOC, V170, P2039; Guillot S, 2000, J VIROL, V74, P8434, DOI 10.1128/JVI.74.18.8434-8443.2000; HARA M, 1987, MICROBIOL IMMUNOL, V31, P327; Hosoda M, 2012, LANCET, V379, P520, DOI 10.1016/S0140-6736(12)60232-3; Infectious Disease Surveillance Center National Institute of Infectious Diseases, 2010, IASR, V31, P69; Iwai M, 2006, APPL ENVIRON MICROB, V72, P6381, DOI 10.1128/AEM.02621-05; Kuramitsu M, 2005, EPIDEMIOL INFECT, V133, P1131, DOI 10.1017/S0950268805004139; Laassri M, 2005, J CLIN MICROBIOL, V43, P2886, DOI [10.1128/JCM.43.6.2886-2894.2005, 10.1128/JCM.43.6.2886-2894.2004]; MATSUURA K, 1984, MICROBIOL IMMUNOL, V28, P575; Matsuura K, 2000, APPL ENVIRON MICROB, V66, P5087, DOI 10.1128/AEM.66.11.5087-5091.2000; Mizuta Katsumi, 2003, International Journal of Infectious Diseases, V7, P138, DOI 10.1016/S1201-9712(03)90010-5; Mueller JE, 2009, APPL ENVIRON MICROB, V75, P1395, DOI 10.1128/AEM.02201-08; Pallansch M, 2007, FIELDS VIROLOGY, P840; Racaniello VR, 1996, CURR TOP MICROBIOL, V206, P305; Saitoh A, 2012, VACCINE, V30, P4752, DOI 10.1016/j.vaccine.2012.04.026; Shulman LM, 2014, EURO SURVEILL, V19; Sugieda M, 2006, JPN J INFECT DIS, V59, P277; VANDERAVOORT HGA, 1995, EPIDEMIOL INFECT, V114, P481; Wahjuhono G, 2014, J INFECT DIS, V210, pS347, DOI 10.1093/infdis/jiu060; WEEKSLEVY C, 1991, VIROLOGY, V185, P934, DOI 10.1016/0042-6822(91)90576-W; WHO, 2013, POL ER ENDG STRAT PL; Yoshida H, 2002, J GEN VIROL, V83, P1107	46	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	MAR	2015	81	5					1850	1855		10.1128/AEM.03575-14		6	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CB3RY	WOS:000349547200034		
J	Shimogaki, T; Kawahara, H; Nakao, S; Higashihata, M; Ikenoue, H; Nakata, Y; Nakamura, D; Okada, T				Shimogaki, Tetsuya; Kawahara, Hirotaka; Nakao, Shihomi; Higashihata, Mitsuhiro; Ikenoue, Hiroshi; Nakata, Yoshiki; Nakamura, Daisuke; Okada, Tatsuo			Controlling ZnO nanowire surface density during its growth by altering morphological properties of a ZnO buffer layer by UV laser irradiation	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							PROBE FORCE MICROSCOPY; NANORODS; NANOPARTICLES; DEPOSITION; EMISSION; SIZE	Zinc oxide (ZnO) nanocrystals, which are characterized by their configurations and fine structures, are unique oxide semiconductors. In this report, it is demonstrated that the number density of ZnO nanowires can be controlled by proper treatments of the buffer layer with ultraviolet laser irradiation. ZnO nanowires were synthesized on the locally laser-irradiated ZnO buffer layer using nanoparticle-assisted pulsed-laser deposition (NAPLD). The number density of ZnO nanowires decreased in the region laser-irradiated with < 300 mJ/cm(2), whereas it increased in the region laser-irradiated with more than 400 mJ/cm(2). Effects of laser irradiation on ZnO buffer layers were investigated by atomic force microscopy, Kelvin probe force microscopy (KPFM), Raman spectroscopy, and X-ray diffraction analyses. In particular, the effects of laser irradiation on the surface work functions of ZnO buffer layers were investigated by KPFM, which is reported for the first time. Additionally, periodically aligned ZnO sub-microcrystals were fabricated as an application of controlling the number density of ZnO nanowires on micropatterned ZnO buffer layers using the four-beam interfered third harmonic of a Nd:YAG laser followed by NAPLD. ZnO sub-microcrystals can be used to fabricate field emitter arrays and can be developed for the application of ZnO nano/microcrystals due to their high throughput.	[Shimogaki, Tetsuya; Kawahara, Hirotaka; Nakao, Shihomi; Higashihata, Mitsuhiro; Ikenoue, Hiroshi; Nakamura, Daisuke; Okada, Tatsuo] Kyushu Univ, Dept Informat Sci & Elect Engn, Nishi Ku, Fukuoka 812, Japan; [Nakata, Yoshiki] Osaka Univ, Inst Laser Engn, Suita, Osaka 565, Japan	Shimogaki, T (reprint author), Kyushu Univ, Dept Informat Sci & Elect Engn, Nishi Ku, West 2,530-1,744 Motooka, Fukuoka 812, Japan.	wcfdp818@gmail.com	Nakata, Yoshiki/L-4957-2015	Nakata, Yoshiki/0000-0002-0680-999X	Japan Society for the Promotion of Science (JSPS) [25286071]	The measurements of Raman and XRD analyses were performed at the Center of Advanced Instrumental Analysis, Kyushu University. This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS, No. 25286071).	Alim KA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1944222; Kawakami M, 2003, JPN J APPL PHYS 2, V42, pL33, DOI 10.1143/JJAP.42.L33; Bai S, 2011, ADV FUNCT MATER, V21, P4464, DOI 10.1002/adfm.201101319; Nakata Y, 2007, APPL SURF SCI, V253, P6555, DOI 10.1016/j.apsusc.2007.01.080; Voisiat B, 2011, PHYSCS PROC, V12, P116, DOI 10.1016/j.phpro.2011.03.113; Xu JQ, 2000, SENSOR ACTUAT B-CHEM, V66, P277, DOI 10.1016/S0925-4005(00)00381-6; Chiou WT, 2003, DIAM RELAT MATER, V12, P1841, DOI 10.1016/S0925-9635(03)00274-7; Nakahara K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3459139; Rajalakshmi M, 2000, J APPL PHYS, V87, P2445, DOI 10.1063/1.372199; Chu S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908968; Lim JH, 2006, ADV MATER, V18, P2720, DOI 10.1002/adma.200502633; Gargas DJ, 2011, NANO LETT, V11, P3792, DOI 10.1021/nl201850k; MATSUOKA M, 1971, JPN J APPL PHYS, V10, P736, DOI 10.1143/JJAP.10.736; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Wermelinger T, 2007, ACTA MATER, V55, P4657, DOI 10.1016/j.actamat.2007.04.036; Kumar B, 2012, NANO ENERGY, V1, P342, DOI 10.1016/j.nanoen.2012.02.001; Chu S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3012579; Pan H, 2009, APPL PHYS A-MATER, V94, P111, DOI 10.1007/s00339-008-4925-0; ASOKAN T, 1987, J MATER SCI, V22, P2229, DOI 10.1007/BF01132965; Ben CV, 2012, THIN SOLID FILMS, V520, P4622, DOI 10.1016/j.tsf.2011.10.129; Chen J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2910769; Kurbanov S, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.021101; Nakamura D, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/3/034014; Shimogaki T, 2013, J LASER MICRO NANOEN, V8, P75, DOI 10.2961/jlmn.2013.01.0015; Sun X.W., 2009, APPL PHYS LETT, V95; Zhao Y, 2008, J APPL PHYS, V103, DOI 10.1063/1.2931005	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	MAR	2015	118	4					1239	1246		10.1007/s00339-014-8822-4		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CB4LA	WOS:000349598000012		
J	Ozeki, K; Sekiba, D; Uedono, A; Hirakuri, KK; Masuzawa, T				Ozeki, K.; Sekiba, D.; Uedono, A.; Hirakuri, K. K.; Masuzawa, T.			Effect of incorporation of deuterium on vacancy-type defects of a-C:H films prepared by plasma CVD	APPLIED SURFACE SCIENCE			English	Article						Deuterated amorphous carbon; Positron annihilation; ERDA; RBS; Hardness; Density	DIAMOND-LIKE CARBON; POSITRON-ANNIHILATION SPECTROSCOPY; AMORPHOUS HYDROGENATED CARBON; ABSOLUTE CROSS-SECTION; ENHANCED CVD; DLC FILMS; COATINGS; BEHAVIOR; BEAM; C/H	Amorphous deuterated carbon (a-C: D) films were prepared using plasma-enhanced chemical vapor deposition (PECVD) from CH4/CD4 and CH4/D-2 source gases. For CH4/CD4, the gas flow ratio of CD4/(CD4 + CH4) was varied from 0 to 100%. For CH4/D-2, the additional partial gas pressure of D-2 was increased from Ito 7 Pa as the flow rate increased, and the partial gas pressure and the flow rate of CH4 were maintained at 10 Pa and 10 sccm, respectively. The concentrations of hydrogen (H) and deuterium (D) relative to carbon (C) in the films and the film densities were determined by elastic recoil detection analysis (ERDA) and Rutherford backscattering spectroscopy (RBS). Positron annihilation spectroscopy (PAS) was performed to measure the vacancy-type defect of the film. The S value obtained from PAS measurement correlates to the vacancy-type defect in the film. The film hardness was also measured using a nanoindenter. For CH4/CD4, the D concentration in the film increased when the CD4/(CH4 + CD4) gas ratio increased, whereas the concentration of H decreased. For CH4/D-2, the D concentration in the film increased with increasing D-2 partial pressure, whereas the concentration of H decreased. From the PAS results, the S value increased with increasing CD4/(CH4 + CD4) gas ratio for CH4/CD4, whereas the S value did not change with any D-2 partial pressure for CH4/D-2. The hardness and the mass density of the films decreased when the CD4/( CH4 + CD4) gas ratio increased for CH4/CD4, whereas the hardness and the density did not change with any D-2 partial pressure for CH4/D-2. A correlation among the S value, the film hardness and the film density was observed, and the S value, the film hardness and the film density did not correlate to the D concentration in the film. These findings suggest that information about the vacancy-type defect of the hydrogenated amorphous carbon films is crucial for evaluation of their mechanical properties and density. (C) 2015 Elsevier BY. All rights reserved.	[Ozeki, K.; Masuzawa, T.] Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki 3168511, Japan; [Sekiba, D.; Uedono, A.] Univ Tsukuba, Ibaraki 3058573, Japan; [Hirakuri, K. K.] Tokyo Denki Univ, Adachi Ku, Tokyo 1208551, Japan	Ozeki, K (reprint author), Ibaraki Univ, Dept Mech Engn, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 3168511, Japan.	ozeki@mx.ibaraki.ac.jp					SIEGEL RW, 1980, ANNU REV MATER SCI, V10, P393, DOI 10.1146/annurev.ms.10.080180.002141; Wang YX, 2011, APPL SURF SCI, V257, P1990, DOI 10.1016/j.apsusc.2010.09.040; SAVVIDES N, 1993, THIN SOLID FILMS, V228, P289, DOI 10.1016/0040-6090(93)90618-Y; Ishihara M, 2006, DIAM RELAT MATER, V15, P1011, DOI 10.1016/j.diamond.2005.12.037; PUSKA MJ, 1994, REV MOD PHYS, V66, P841, DOI 10.1103/RevModPhys.66.841; [Anonymous], 2003, 14577 ISO DIN EN; BAGLIN JEE, 1992, NUCL INSTRUM METH B, V64, P469, DOI 10.1016/0168-583X(92)95518-V; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; WIBERG KB, 1955, CHEM REV, V55, P713, DOI 10.1021/cr50004a004; FREIRE FL, 1995, DIAM RELAT MATER, V4, P499, DOI 10.1016/0925-9635(94)05211-5; LISZKAY L, 1994, APPL PHYS LETT, V64, P1380, DOI 10.1063/1.111994; Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077; BESENBACHER F, 1986, NUCL INSTRUM METH B, V15, P459, DOI 10.1016/0168-583X(86)90343-5; Cao QS, 2014, FUSION ENG DES, V89, P1101, DOI 10.1016/j.fusengdes.2013.11.008; Caschera D, 2011, THIN SOLID FILMS, V519, P4087, DOI 10.1016/j.tsf.2011.01.197; Chou CC, 2013, SURF COAT TECH, V231, P418, DOI 10.1016/j.surfcoat.2012.01.020; Clement M, 1996, J APPL PHYS, V79, P9029, DOI 10.1063/1.362635; Cremer E, 1932, Z PHYS CHEM B-CHEM E, V19, P443; da Costa MEHM, 2010, SURF COAT TECH, V204, P1993, DOI 10.1016/j.surfcoat.2009.10.011; ERDEMIR A, 1991, SURF COAT TECH, V50, P17, DOI 10.1016/0257-8972(91)90187-2; Galindo RE, 2004, SURF COAT TECH, V180, P207, DOI 10.1016/j.surfcoat.2003.10.042; Hautojarvi P., 1991, TOPICS CURRENT PHYS, V12; Huang GF, 2003, DIAM RELAT MATER, V12, P1406, DOI 10.1016/S0925-9635(03)00168-7; Kawabata Y, 2004, NUCL INSTRUM METH A, V529, P84, DOI 10.1016/j.nima.2004.04.182; Krause-Rehberg R., 1999, SOLID STATE SCI, V127; Mathis N, 2008, SURF COAT TECH, V202, P2349, DOI 10.1016/j.surfcoat.2007.09.034; Ozeki K, 2009, APPL SURF SCI, V255, P7286, DOI 10.1016/j.apsusc.2009.03.082; Ozeki K, 2013, APPL SURF SCI, V265, P750, DOI 10.1016/j.apsusc.2012.11.100; Ravi N, 2007, DIAM RELAT MATER, V16, P90, DOI 10.1016/j.diamond.2006.04.001; Seker Z, 2014, APPL SURF SCI, V314, P46, DOI 10.1016/j.apsusc.2014.06.137; Sekiba D, 2012, DIAM RELAT MATER, V27-28, P60, DOI 10.1016/j.diamond.2012.05.014; Sekiba D., 2009, J APPL PHYS, V106; Sometani M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.021101; Tamor A., 1994, J APPL PHYS, V76, P3823; Tillmann W, 2011, SURF COAT TECH, V206, P1705, DOI 10.1016/j.surfcoat.2011.07.089; Uedono A, 1996, JPN J APPL PHYS 1, V35, P5986, DOI 10.1143/JJAP.35.5986; VAKIL HB, 1989, MATER RES BULL, V24, P733, DOI 10.1016/0025-5408(89)90090-1; van der Grinten MGD, 1999, NUCL INSTRUM METH A, V423, P421, DOI 10.1016/S0168-9002(98)01338-2; Wade D, 1999, CHEM-BIOL INTERACT, V117, P191, DOI 10.1016/S0009-2797(98)00097-0	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	MAR 1	2015	330						142	147		10.1016/j.apsusc.2014.12.181		6	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CB4SE	WOS:000349617400017		
J	Miyoshi, T; Yuasa, K; Ishigami, T; Rajabzadeh, S; Kamio, E; Ohmukai, Y; Saeki, D; Ni, JR; Matsuyama, H				Miyoshi, Taro; Yuasa, Kotaku; Ishigami, Toru; Rajabzadeh, Saeid; Kamio, Eiji; Ohmukai, Yoshikage; Saeki, Daisuke; Ni, Jinren; Matsuyama, Hideto			Effect of membrane polymeric materials on relationship between surface pore size and membrane fouling in membrane bioreactors	APPLIED SURFACE SCIENCE			English	Article						Membrane fouling; Membrane polymeric materials; Pore size; Membrane bioreactor (MBR); Polyvinylidene fluoride (PVDF)	MUNICIPAL WASTE-WATER; INDUCED PHASE-SEPARATION; MBRS; FLUX; PERFORMANCE; DIFFERENCE	We investigated the effect of different membrane polymeric materials on the relationship between membrane pore size and development of membrane fouling in a membrane bioreactor (MBR). Membranes with different pore sizes were prepared using three different polymeric materials, cellulose acetate butyrate (CAB), polyvinyl butyral (PVB), and polyvinylidene fluoride (PVDF), and the development of membrane fouling in each membrane was evaluated by batch filtration tests using a mixed liquor suspension obtained from a laboratory-scale MBR. The results revealed that the optimal membrane pore size to mitigate membrane fouling differed depending on membrane polymeric material. For PVDF membranes, the degree of membrane fouling decreased as membrane pore size increased. In contrast, CAB membranes with smaller pores had less fouling propensity than those with larger ones. Such difference can be attributed to the difference in major membrane foulants in each membrane; in PVDF, they were small colloids or dissolved organics in which proteins are abundant, and in CAB, microbial flocs. The results obtained in this study strongly suggested that optimum operating conditions of MBRs differ depending on the characteristics of the used membrane. (C) 2015 Elsevier B.V. All rights reserved.	[Miyoshi, Taro; Yuasa, Kotaku; Ishigami, Toru; Rajabzadeh, Saeid; Kamio, Eiji; Ohmukai, Yoshikage; Saeki, Daisuke; Matsuyama, Hideto] Kobe Univ, Ctr Membrane & Film Technol, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ni, Jinren] Peking Univ, Dept Environm Engn, Key Lab Water & Sediment Sci, Minist Educ, Beijing 100871, Peoples R China	Matsuyama, H (reprint author), Kobe Univ, Ctr Membrane & Film Technol, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	t-miyoshi@pegasus.kobe-u.ac.jp; k.yuasa06@gmail.com; ishigami.toru@nihon-u.ac.jp; rajabzadehk@people.kobe-u.ac.jp; e-kamio@people.kobe-u.ac.jp; yoshikage.ohmukai@daikin.co.jp; dsk.saeki@garnet.kobe-u.ac.jp; jinrenni@pku.edu.cn; matuyama@kobe-u.ac.jp	Miyoshi, Taro/F-6919-2013; Saeki, Daisuke/G-8774-2014	Miyoshi, Taro/0000-0002-3958-9647; Saeki, Daisuke/0000-0002-2370-5041	Strategic International Research Cooperative Program (SICP) of Japan Science and Technology Agency (JST), Ministry of Education, Culture, Sport, Science and Technology, Japan (MEXT); National Natural Science Foundation of China [21261140336/B070302]	This project was financially supported by the Strategic International Research Cooperative Program (SICP) of Japan Science and Technology Agency (JST), Ministry of Education, Culture, Sport, Science and Technology, Japan (MEXT). In addition, the support from National Natural Science Foundation of China (Grant Number 21261140336/B070302) is also appreciated.	Tang SJ, 2010, J HAZARD MATER, V178, P377, DOI 10.1016/j.jhazmat.2010.01.090; Ng TCA, 2010, WATER RES, V44, P2336, DOI 10.1016/j.watres.2009.12.038; Miyoshi T, 2012, INT BIODETER BIODEGR, V75, P15, DOI 10.1016/j.ibiod.2012.08.003; Choi JH, 2008, CHEMOSPHERE, V71, P853, DOI 10.1016/j.chemosphere.2007.11.029; Wang ZW, 2006, J MEMBRANE SCI, V284, P87, DOI 10.1016/j.memsci.2006.07.006; Trussell RS, 2006, WATER RES, V40, P2675, DOI 10.1016/j.watres.2006.04.020; Johir MAH, 2012, BIORESOURCE TECHNOL, V122, P42, DOI 10.1016/j.biortech.2012.02.107; Kimura K, 2005, ENVIRON SCI TECHNOL, V39, P6293, DOI 10.1021/es0502425; Kraume M, 2010, CHEM ENG TECHNOL, V33, P1251, DOI 10.1002/ceat.201000104; Miyoshi T, 2009, WATER RES, V43, P5109, DOI 10.1016/j.watres.2009.08.035; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Drews A, 2010, J MEMBRANE SCI, V363, P1, DOI 10.1016/j.memsci.2010.06.046; Yamato N, 2006, J MEMBRANE SCI, V280, P911, DOI 10.1016/j.memsci.2006.03.009; Matsuyama H, 2003, J MEMBRANE SCI, V223, P119, DOI 10.1016/S0376-7388(03)00314-4; Van den Broeck R, 2012, J MEMBRANE SCI, V401, P48, DOI 10.1016/j.memsci.2012.01.028; Guglielmi G, 2008, WATER SCI TECHNOL, V57, P1873, DOI 10.2166/wst.2008.126; Meng FG, 2009, WATER RES, V43, P1489, DOI 10.1016/j.watres.2008.12.044; Nosyk O, 2008, J MICROBIOL METH, V75, P449, DOI 10.1016/j.mimet.2008.07.024; Choi JH, 2009, SEP PURIF TECHNOL, V65, P184, DOI 10.1016/j.seppur.2008.10.019; Guglielmi G, 2007, J MEMBRANE SCI, V289, P241, DOI 10.1016/j.memsci.2006.12.004; Hashino M, 2011, J MEMBRANE SCI, V366, P258, DOI 10.1016/j.memsci.2010.10.014; Huyskens C, 2011, SEP PURIF TECHNOL, V81, P208, DOI 10.1016/j.seppur.2011.07.031; Jin L., 2010, WATER RES, V44, P5907; Kimura K, 2008, DESALINATION, V231, P268, DOI 10.1016/j.desal.2007.10.030; Kitaura T, 2013, J APPL POLYM SCI, V127, P4072, DOI 10.1002/app.38001; Sabia G, 2013, CHEM ENG J, V221, P176, DOI 10.1016/j.cej.2013.01.094; Stephenson T., 2000, MEMBRANE BIOREACTORS; Tian Y, 2011, CHEM ENG J, V168, P1093, DOI 10.1016/j.cej.2011.01.090; Tsuyuhara T, 2010, WATER SCI TECHNOL, V61, P2235, DOI 10.2166/wst.2010.122; van der Marel P, 2010, J MEMBRANE SCI, V348, P66, DOI 10.1016/j.memsci.2009.10.054	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	MAR 1	2015	330						351	357		10.1016/j.apsusc.2015.01.018		7	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CB4SE	WOS:000349617400043		
J	Bulbul, M; Kader, MA; Ambak, MA; Hossain, MS; Ishikawa, M; Koshio, S				Bulbul, Mahbuba; Kader, Md Abdul; Ambak, Mohd Azmi; Hossain, Md Sakhawat; Ishikawa, Manabu; Koshio, Shunsuke			Effects of crystalline amino acids, phytase and fish soluble supplements in improving nutritive values of high plant protein based diets for kuruma shrimp, Marsupenaeus japonicus	AQUACULTURE			English	Article						Fishmeal; Soybean meal; Canola meal; Crystalline amino acid; Fish soluble; Kuruma shrimp	PACIFIC WHITE SHRIMP; SALMON SALMO-SALAR; RED-SEA BREAM; TROUT ONCORHYNCHUS-MYKISS; BLACK TIGER SHRIMP; GROWTH-PERFORMANCE; SOYBEAN-MEAL; LITOPENAEUS-VANNAMEI; PENAEUS-MONODON; NUTRIENT UTILIZATION	Plant proteins are the most important alternatives to fishmeal in shrimp diets. However, there is a general trend of reducing feed intake and shrimp performance with dietary inclusion of high levels of plant proteins. Supplementation of feed additives could overcome the negative effects of high plant protein based diet. Therefore, an experiment was conducted to assess the effectiveness of different feed additives such as crystalline amino acids (CAA), phytase (PT) and fish soluble (FS) in enhancing the utilization of high levels of plant proteins in the diets of kuruma shrimp, Marsupenaeus japonicus. Six isocaloric diets (19 kJ g(-1)) were formulated where diet 1 was 40% fishmeal based control diet (FM). Diets 2 to 6 were prepared as follows, by replacing 60% fishmeal protein with a plant protein blend (soybean meal and canola meal; 6: 4) alone (PP); protein blend and 1.5% CAA (PAA); protein blend and 0.04% phytase (2000 FTU kg(-1)) (PPT); protein blend and 10% FS (PFS); and protein blend and a mixture of CAA, phytase and FS (PMX) respectively. Triplicate groups of shrimp (1.75 +/- 0.40 g; mean initial body weight +/- SD) were stocked in 54-l rectangular tanks at a rate of 15 shrimp per tank. The tanks were maintained under natural light/dark regime in a flow-through sea water system. Shrimp were fed the respective test diets at a rate of 80% of the body weight daily for 56 days. At the end of the feeding trial, final body weight (g), weight gain (%) and specific growth rate (% day(-1)) were significantly (P < 0.05) lower in shrimp fed PP diet. However, these growth parameters recovered when fed diets supplemented with CAA and FS. Although, growth parameters were slightly improved by the supplementation of PT, the differences in growth parameters between FM and PPT were still significant. The fastest growth was found in shrimp fed PMX among the dietary treatments. The growth results were mostly reflected by feed intake (FI). Significantly lowest FI was found in PP group, while similar values were found among the rest. Similarly, protein gain (g kg weight gain(-1)) and protein retention (%) were significantly decreased in PP and PPT groups. Whole body crude protein was significantly lowest in PP group and highest in PMX group. Protease activity (unit mg(-1) protein) in the digestive tract of shrimp was lowest in PP and PAA groups; and the values were comparable among the rest. Overall, the best results for most of the parameters were found in shrimp fed PMX diet. Based on the overall performance of shrimp, it can be concluded that CAA, PT and FS are effective supplements in high plant protein diets for juvenile kuruma shrimp. A mixture of these supplements in appropriate ratio could further reduce the fishmeal levels in shrimp diets. (C) 2015 Elsevier B.V. All rights reserved.	[Bulbul, Mahbuba; Kader, Md Abdul; Ambak, Mohd Azmi] Univ Malaysia Terengganu, Inst Trop Aquaculture, Kuala Terengganu 21030, Malaysia; [Bulbul, Mahbuba; Kader, Md Abdul; Hossain, Md Sakhawat; Ishikawa, Manabu; Koshio, Shunsuke] Kagoshima Univ, Lab Aquat Anim Nutr, Fac Fisheries, Kagoshima 9800056, Japan; [Kader, Md Abdul; Ambak, Mohd Azmi] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu 21030, Malaysia	Kader, MA (reprint author), Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu 21030, Malaysia.	abdulkader_fc@yahoo.com			Management Expense Grants of the United Graduate School of Agricultural Sciences, Kagoshima University	This research was partially supported by the Management Expense Grants of the United Graduate School of Agricultural Sciences, Kagoshima University provided to Prof. S. Koshio. The authors would like to thank Makurazaki Fish Processors Cooperatives, Kagoshima, Japan for kindly providing FS. The members of the Laboratory of Aquatic Animal Nutrition, Faculty of Fisheries, Kagoshima University, Japan are greatly acknowledged for their assistance.	Matsunari H, 2008, AQUACULTURE, V274, P142, DOI 10.1016/j.aquaculture.2007.11.002; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Vielma J, 2000, AQUACULTURE, V183, P349, DOI 10.1016/S0044-8486(99)00299-9; Kader MA, 2012, AQUACULTURE, V368, P95, DOI 10.1016/j.aquaculture.2012.09.014; Suarez JA, 2009, AQUACULTURE, V289, P118, DOI 10.1016/j.aquaculture.2009.01.001; Smith DM, 2007, AQUACULTURE, V269, P436, DOI 10.1016/j.aquaculture.2007.05.022; Tibaldi E, 2006, AQUACULTURE, V261, P182, DOI 10.1016/j.aquaculture.2006.06.026; LIM C, 1990, AQUACULTURE, V87, P53, DOI 10.1016/0044-8486(90)90210-E; Kousoulaki K, 2009, AQUACULTURE, V289, P74, DOI 10.1016/j.aquaculture.2008.12.034; Farhangi M, 2001, AQUAC RES, V32, P329, DOI 10.1046/j.1355-557x.2001.00044.x; Richard L, 2011, AQUACULTURE, V322, P109, DOI 10.1016/j.aquaculture.2011.09.032; Rahman SHA, 2010, AQUAC RES, V41, pe299, DOI 10.1111/j.1365-2109.2010.02530.x; TESHIMA S, 1986, AQUACULTURE, V51, P225, DOI 10.1016/0044-8486(86)90314-5; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Park GS, 2002, FISHERIES SCI, V68, P824, DOI 10.1046/j.1444-2906.2002.00498.x; Bulbul M, 2013, AQUACULTURE, V372, P45, DOI 10.1016/j.aquaculture.2012.10.023; Debnath D, 2005, AQUAC RES, V36, P180, DOI 10.1111/j.1365-2109.2004.01203.x; Liu XH, 2012, AQUAC RES, V43, P745, DOI 10.1111/j.1365-2109.2011.02883.x; Mendoza R, 2001, AQUACULT NUTR, V7, P143, DOI 10.1046/j.1365-2095.2001.00164.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Alam MS, 2002, COMP BIOCHEM PHYS B, V133, P289, DOI 10.1016/S1096-4959(02)00165-3; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Bulbul M, 2014, AQUAC RES, V45, P848, DOI 10.1111/are.12026; Refstie S, 2004, AQUACULTURE, V239, P331, DOI 10.1016/j.aquaculture.2004.06.015; Nunes BS, 2006, ENVIRON POLLUT, V144, P453, DOI 10.1016/j.envpol.2005.12.037; Teshima S, 2002, AQUAC RES, V33, P395, DOI 10.1046/j.1365-2109.2002.00684.x; Jackson LS, 1996, J WORLD AQUACULT SOC, V27, P309, DOI 10.1111/j.1749-7345.1996.tb00613.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Xu WJ, 2012, AQUACULTURE, V356, P147, DOI 10.1016/j.aquaculture.2012.05.022; Paripatananont T, 2001, AQUAC RES, V32, P369, DOI 10.1046/j.1355-557x.2001.00045.x; Chatzifotis S, 2008, AQUACULTURE, V275, P201, DOI 10.1016/j.aquaculture.2007.12.013; CAIN KD, 1995, PROG FISH CULT, V57, P114, DOI 10.1577/1548-8640(1995)057<0114:POSMWP>2.3.CO;2; Kader MA, 2012, AQUACULTURE, V350, P109, DOI 10.1016/j.aquaculture.2012.04.009; Biswas P, 2007, AQUACULTURE, V265, P253, DOI 10.1016/j.aquaculture.2006.10.037; Kader MA, 2010, AQUACULTURE, V308, P136, DOI 10.1016/j.aquaculture.2010.07.037; AOAC, 1990, OFFICIAL METHODS ANA; Bulbul M, 2015, AQUAC RES, V46, P572, DOI 10.1111/are.12201; Cupp-Enyard C., 2008, JOVE-J VIS EXP, V19, P1; Grey M, 2009, J WORLD AQUACULT SOC, V40, P547, DOI 10.1111/j.1749-7345.2009.00264.x; Kader, 2008, THESIS KAGOSHIMA U J; Kofuji PYM, 2006, AQUAC RES, V37, P366, DOI 10.1111/j.1365-2109.2005.01435.x; Laining A, 2012, AQUACULT NUTR, V18, P502, DOI 10.1111/j.1365-2095.2011.00914.x; Luo Z, 2011, AQUAC RES, V42, P1615, DOI 10.1111/j.1365-2109.2010.02751.x; Nwanna L.C., 2007, J ENG APPL SCI, V2, P972	45	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0044-8486	1873-5622		AQUACULTURE	Aquaculture	MAR 1	2015	438						98	104		10.1016/j.aquaculture.2015.01.007		7	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CB4TA	WOS:000349619900014		
J	How, KH; Zenke, K; Yoshinaga, T				How, Kah Hui; Zenke, Kosuke; Yoshinaga, Tomoyoshi			Dynamics and distribution properties of theronts of the parasitic ciliate Cryptocaryon irritans	AQUACULTURE			English	Article						Cryptocaryon irritans; Theront; Swimming ability; Dynamics; Movement	PEST-MANAGEMENT PROGRAM; BREAM PAGRUS-MAJOR; CHELON LABROSUS; CILIOPHORA; INFECTION; BIOLOGY; MULLET; FISH	Cryptocaryon irritans is a parasitic ciliate that causes major economic losses in marine fish aquaculture globally. Despite the wide array of treatment methods, control of cryptocaryoniasis is still very challenging, especially in food fish culture. Thus, additional control methods against this parasite might be required to further reduce the occurrence of this disease. In this study, the swimming ability, excystment sequence, and distribution of theronts, the infective stage of C. irritans, were investigated in our effort to develop a physical control strategy. A video analysis for assessing the swimming ability of theronts showed diminishing mobility over time. The excystment of theronts primarily occurred during the dark period. Examination of the vertical distribution of theronts showed that they were mostly distributed at the 5 cm sampling point measured from the substrate, indicating that they have low upward swimming ability. From these results, we conclude that theronts possess limited mobility. Theronts also displayed an excystment pattern that might be influenced by photoperiod, since most theronts were released during the dark period of the day. Control strategies can be developed from these properties, such as increasing the water flow in a culture tank during the release period. Further, combined treatment methods against multiple stages of C. irritans can help minimize the occurrence of cryptocaryoniasis in culture facilities. (C) 2014 Elsevier B.V. All rights reserved.	[How, Kah Hui; Zenke, Kosuke; Yoshinaga, Tomoyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 1138657, Japan	Yoshinaga, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Lab Fish Dis,Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	atyoshi@mail.ecc.u-tokyo.ac.jp					Dumbauld BR, 2006, AQUACULTURE, V261, P976, DOI 10.1016/j.aquaculture.2006.08.030; Brooks KM, 2009, J FISH DIS, V32, P59, DOI 10.1111/j.1365-2761.2008.01013.x; Yoshinaga T, 2011, AQUACULTURE, V321, P167, DOI 10.1016/j.aquaculture.2011.08.028; BURGESS PJ, 1995, FISH SHELLFISH IMMUN, V5, P459, DOI 10.1006/fsim.1995.0043; Kawano F, 2012, AQUACULTURE, V344, P35, DOI 10.1016/j.aquaculture.2012.02.028; COLORNI A, 1985, DIS AQUAT ORGAN, V1, P19, DOI 10.3354/dao001019; BURGESS PJ, 1994, J PARASITOL, V80, P288, DOI 10.2307/3283760; BURGESS PJ, 1994, J MAR BIOL ASSOC UK, V74, P535; COLORNI A, 1987, AQUACULTURE, V67, P236, DOI 10.1016/0044-8486(87)90041-X; Colorni Angelo, 1992, Israeli Journal of Aquaculture Bamidgeh, V44, P140; Colorni Angelo, 1997, Aquarium Sciences and Conservation, V1, P217, DOI 10.1023/A:1018360323287; Dickerson H.W., 2006, ICHTHYOPHTHIRIUS MUL; Herwig N., 1978, DRUM CROAKER, V18; Hirazawa N, 2001, AQUACULTURE, V198, P219, DOI 10.1016/S0044-8486(01)00503-8; HUFF JA, 1981, AQUACULTURE, V22, P181, DOI 10.1016/0044-8486(81)90144-7; Priya TAJ, 2012, VACCINE, V30, P893, DOI 10.1016/j.vaccine.2011.11.102; Sandler HA, 2010, RENEW AGR FOOD SYST, V25, P257, DOI 10.1017/S1742170510000207; Shinn AP, 2009, AQUACULT ENG, V41, P152, DOI 10.1016/j.aquaeng.2009.07.002; Sikama Y., 1937, SUISAN GAKUKAI, V7, P149; Spotte S., 1979, SEAWATER AQUARIUMS C; Stern V.M., 1959, INTEGRATION CHEM BIO; Thamsborg SM, 1999, VET PARASITOL, V84, P169, DOI 10.1016/S0304-4017(99)00035-7; Tookwinas S., 1990, ADV TROP AQUACULTURE, V9, P737; Van Dujin C, 1973, DIS FISHERS; WILKIE DW, 1969, CALIF FISH GAME, V55, P227; Yoshinaga T, 2001, FISH PATHOL, V36, P231; Yoshinaga T., 1994, Journal of Aquatic Animal Health, V6, P197, DOI 10.1577/1548-8667(1994)006<0197:LPOCIO>2.3.CO;2	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0044-8486	1873-5622		AQUACULTURE	Aquaculture	MAR 1	2015	438						170	175		10.1016/j.aquaculture.2014.12.013		6	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CB4TA	WOS:000349619900023		
J	Ochi, A; Abe, T; Yamada, K; Ibuki, S; Tateuchi, H; Ichihashi, N				Ochi, Akira; Abe, Tomokazu; Yamada, Kazumasa; Ibuki, Satoko; Tateuchi, Hiroshige; Ichihashi, Noriaki			Effect of balance exercise in combination with whole-body vibration on muscle activity of the stepping limb during a forward fall in older women: A randomized controlled pilot study	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Balance recovery; Electromyography; Whole-body vibration; Training; Older women; Tether-release	POSTMENOPAUSAL WOMEN; GENDER-DIFFERENCES; ELDERLY-WOMEN; RECOVERY; POWER; SINGLE; ADULTS; HISTORY; AGE; PERFORMANCE	This study investigated the effects of balance exercise combined with whole- body vibration (WBV) on step performance and lower limb muscle activity during simulated forward falls using the tether- release method in older women. Twenty older women were assigned to either a WBV plus balance exercise group (WBV, n = 10) or a balance exercise without vibration group (standard balance exercise group [STE], n = 10). WBV performed weight- bearing exercises on a WBV platform combined with other balance exercises as a home program, whereas STE performed the same exercises without WBV. The exercise volume was equal in both intervention groups (3x/week for 12 weeks x 30 min/session). The EMG and kinematic data of the stepping leg from the balance recovery step were examined before and after the intervention. While both groups extended step length during forward falls after the intervention, only WBV increased step velocity. EMG analysis of the balance recovery step showed that both groups increased peak EMG of knee flexor and extensor muscles after intervention. After intervention, WBV increased peak EMG of the plantar flexors, which are used to exert the push- off forces just before the leg swing. Balance exercise in older women resulted in significant improvements in the balance recovery step after a simulated forward fall. WBV also had the additional benefit of improved step velocity, which was reflected in increased activity of the plantar flexors in the stepping leg. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ochi, Akira; Abe, Tomokazu; Yamada, Kazumasa] Seijoh Univ, Fac Care & Rehabil, Div Phys Therapy, Toukai, Aichi 4768588, Japan; [Ibuki, Satoko; Tateuchi, Hiroshige; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Dept Phys Therapy Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan	Ochi, A (reprint author), Seijoh Univ, Fac Care & Rehabil, Div Phys Therapy, 2-172 Fukinodai, Toukai, Aichi 4768588, Japan.	ochi@seijoh-u.ac.jp			Japan Society for the Promotion of Science [23700674]	This study received financial support from a Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) (23700674).	Russo CR, 2003, ARCH PHYS MED REHAB, V84, P1854, DOI 10.1016/S0003-9993(03)00357-5; Ritzmann R, 2010, EUR J APPL PHYSIOL, V110, P143, DOI 10.1007/s00421-010-1483-x; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829; Sitja-Rabert M, 2012, DISABIL REHABIL, V34, P883, DOI 10.3109/09638288.2011.626486; Grabiner MD, 2012, MED SCI SPORT EXER, V44, P2410, DOI 10.1249/MSS.0b013e318268c89f; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Wojcik LA, 1999, J GERONTOL A-BIOL, V54, pM44, DOI 10.1093/gerona/54.1.M44; Rees SS, 2008, PHYS THER, V88, P462, DOI 10.2522/ptj.20070027; Hsiao-Wecksler ET, 2007, CLIN BIOMECH, V22, P574, DOI 10.1016/j.clinbiomech.2007.01.013; Wojcik LA, 2001, J BIOMECH, V34, P67, DOI 10.1016/S0021-9290(00)00152-4; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; Hsiao-Wecksler ET, 2008, J ELECTROMYOGR KINES, V18, P179, DOI 10.1016/j.jelekin.2007.06.007; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; Aragao FA, 2011, J ELECTROMYOGR KINES, V21, P512, DOI 10.1016/j.jelekin.2011.01.003; Kossev A, 2001, CLIN NEUROPHYSIOL, V112, P453, DOI 10.1016/S1388-2457(01)00473-4; Roudsari BS, 2005, INJURY, V36, P1316, DOI 10.1016/j.injury.2005.05.024; Bosco C, 1999, EUR J APPL PHYSIOL O, V79, P306, DOI 10.1007/s004210050512; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Raimundo AM, 2009, EUR J APPL PHYSIOL, V106, P741, DOI 10.1007/s00421-009-1067-9; Bruyere O, 2005, ARCH PHYS MED REHAB, V86, P303, DOI 10.1016/j.apmr.2004.05.019; Suzuki T, 2001, J AM GERIATR SOC, V49, P1161, DOI 10.1046/j.1532-5415.2001.49232.x; Lam FMH, 2012, MATURITAS, V72, P206, DOI 10.1016/j.maturitas.2012.04.009; Arampatzis A, 2011, J BIOMECH, V44, P52, DOI 10.1016/j.jbiomech.2010.08.023; Carty C. P., 2014, AGE AGEING; Carty CP, 2012, CLIN BIOMECH, V27, P1031, DOI 10.1016/j.clinbiomech.2012.07.009; Cronin NJ, 2013, J ELECTROMYOGR KINES, V23, P1139, DOI 10.1016/j.jelekin.2013.05.012; Kirkwood RN, 2011, GAIT POSTURE, V34, P60, DOI 10.1016/j.gaitpost.2011.03.012; Ochi A, 2014, AGING CLIN EXP RES, V26, P213, DOI 10.1007/s40520-013-0152-4; Osawa Y., 2013, J MUSCULOSKEL NEURON, V13, P342; Rogan S, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-72; Rogan S, 2014, RES SPORTS MED, V22, P294, DOI 10.1080/15438627.2014.919504; Rogan S., 2014, AGING CLIN EXPT RES; Rogers MW, 2003, J GERONTOL A-BIOL, V58, P46; Thelen DG, 2000, J ELECTROMYOGR KINES, V10, P93, DOI 10.1016/S1050-6411(99)00028-0; Zhang L, 2014, CLIN REHABIL, V28, P59, DOI 10.1177/0269215513492162	35	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	MAR-APR	2015	60	2					244	251		10.1016/j.archger.2014.11.011		8	Geriatrics & Gerontology	Geriatrics & Gerontology	CB5VF	WOS:000349695000003		
J	Sun, W; Aodeng, S; Tanimoto, Y; Watanabe, M; Han, JS; Wang, BW; Yu, LZ; Kono, K				Sun, Wei; Aodeng, Surita; Tanimoto, Yoshimi; Watanabe, Misuzu; Han, Jinsong; Wang, Bowen; Yu, Lianzheng; Kono, Koichi			Quality of life (QOL) of the community-dwelling elderly and associated factors: A population-based study in urban areas of China	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Elderly; QOL; Health status; Taking a walk; Epidemiology	VISUAL IMPAIRMENT; HEALTH; DEPRESSION	Objective: China has the most elderly people. Maintaining and improving the QOL of the elderly has emerged as a particularly important issue. This population-based study aimed to examine the QOL of the urban elderly and to clarify the associated factors. Methods: A cross-sectional study was performed in Liaoning Province. The elderly people without senile dementia composed our study population and were interviewed from March to November, 2012 with questionnaires pertaining to QOL (SF-36), cognitive ability, demographic characteristics, health status, behavioral factors, and social-psychological factors. 4067 effective responses were received (effective response rate: 86.0%). After further cognitive screening, 3714 participants were included as the subjects. Results: The mean scores of physical component summary (PCS) and mental component summary (MCS) were 53.7 +/- 21.5 (mean +/- SD) and 58.9 +/- 18.9, respectively. With adjustment for age and sex, general linear model analysis showed that, in standardized estimate (beta) sequence, PCS was significantly associated with chronic disease, taking a walk, visual ability, sleeping quality, marital status, alcohol consumption, hearing ability, smoking, neighborhood relationships, filial piety, ethnicity, and regular diet, and MCS was associated with chronic disease, sleeping quality, taking a walk, visual ability, marital status, ethnicity, filial piety, regular diet, alcohol consumption, smoking, and hearing ability. Conclusions: The community-dwelling elderly in urban areas had a low level of QOL. To improve QOL, the maintenance of health conditions was crucial. Efforts to encourage the elderly to perform feasible exercise and develop good lifestyles should be focused on. Also, children's filial duty to their parents should be enhanced. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Sun, Wei; Aodeng, Surita; Han, Jinsong; Wang, Bowen] China Med Univ, Sch Publ Hlth, Dept Environm Hlth, Shenyang North New Area, Shenyang 110013, Peoples R China; [Tanimoto, Yoshimi; Watanabe, Misuzu; Kono, Koichi] Osaka Med Coll, Dept Hyg & Publ Hlth, Takatsuki, Osaka 5698686, Japan; [Yu, Lianzheng] Liaoning Prov Ctr Dis Control & Prevent, Dept Noncommunicable Chron Dis Prevent, Shenyang 110005, Peoples R China	Sun, W (reprint author), China Med Univ, Sch Publ Hlth, Dept Environm Hlth, Shenyang North New Area, 77 Puhe Rd, Shenyang 110013, Peoples R China.	sunwei80@yahoo.com			National Natural Science Foundation of China [81102193]	This research was supported by the National Natural Science Foundation of China, Grant 81102193. The funding source had no role in the study design; in the collection, analysis or interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Aghamolaei Teamur, 2010, Acta Med Iran, V48, P185; Ibrahim N, 2013, ASIA-PAC PSYCHIAT, V5, P59, DOI 10.1111/appy.12068; Kvamme JM, 2011, QUAL LIFE RES, V20, P575, DOI 10.1007/s11136-010-9788-0; Ciorba A, 2012, CLIN INTERV AGING, V7, P159, DOI 10.2147/CIA.S26059; Sun W, 2012, J OCCUP HEALTH, V54, P1; Arias-Merino ED, 2012, ARCH GERONTOL GERIAT, V54, pE271, DOI 10.1016/j.archger.2012.02.010; Bekibele CO, 2008, BRIT J OPHTHALMOL, V92, P612, DOI 10.1136/bjo.2007.124859; d'Alessandro ED, 2011, CLIN TER, V162, pE13; China National Committee on Ageing, 2006, PRED POP AG TREND CH; 耿秀双, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P2947; Hui R, 2003, J NURSING SCI, V18, P567; Li C., 2001, CHINESE MENTAL HLTH, V15, P324; Li D., 2004, CHINESE MENTAL HLTH, V18, P114; 李金平, 2007, [中国老年学杂志, Chinese Journal of Gerontology], V27, P1505; Li Y., 2009, CHINESE J CLIN HEALT, V12, P615; Liu H., 2001, CHINESE J BEHAV MED, V10, P244; [欧阳雁 OUYANG Yan], 2009, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V30, P370; Renaud J, 2013, CLIN INTERV AGING, V8, P931, DOI 10.2147/CIA.S27717; Sun W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-297; Tamari K, 2011, J PHYSIOL ANTHROPOL, V30, P77, DOI 10.2114/jpa2.30.77; [汤军克 TANG Jun-ke], 2010, [中华老年医学杂志, Chinese Journal of Geriatrics], V29, P72; Wang H., 2001, CHIN J PREV MED, V35, P365; Wang Run-ping, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P115; WHO, 2003, WHO GLOB STRAT DIET; 邢凤梅, 2010, [中国老年学杂志, Chinese Journal of Gerontology], V30, P268; 徐波, 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P2791; [徐红 Xu Hong], 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P1450; Yang L., 2007, W CHINA MED J, V22, P884; [张皑频 ZHANG Ai-Pin], 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P1943; 张磊, 2002, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V11, P82; Zhang Q, 2005, J YUNNAN NATL U SOCI, V22, P79	31	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	MAR-APR	2015	60	2					311	316		10.1016/j.archger.2014.12.002		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CB5VF	WOS:000349695000013		
J	Saitou, M; Iida, Y; Komazaki, H; Narui, C; Matsuno, K; Kawabata, A; Ueda, K; Tanabe, H; Takakura, S; Isonishi, S; Sasaki, H; Okamoto, A				Saitou, Motoaki; Iida, Yasushi; Komazaki, Hiromi; Narui, Chikage; Matsuno, Kanae; Kawabata, Ayako; Ueda, Kazu; Tanabe, Hiroshi; Takakura, Satoshi; Isonishi, Seiji; Sasaki, Hiroshi; Okamoto, Aikou			Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Article						Ovarian cancer; Diaphragmatic surgery; Debulking surgery; Peritoneal cancer	PRIMARY CYTOREDUCTIVE SURGERY; CARCINOMA; SURVIVAL; DISEASE	In advanced epithelial ovarian and peritoneal cancer, residual tumor diameter correlates with prognosis; therefore, maximum debulking and optimal surgery (OS) for residual tumors < 1 cm is warranted. Here, we clarified the efficacy of tumor debulking with diaphragmatic surgery (DS). In 45 patients with epithelial ovarian or peritoneal cancer who underwent DS (ten, full-thickness resection; 35, stripping) between January 2010 and December 2013 at two related institutions, we retrospectively evaluated OS safety and success by surgical duration, blood loss, complications, hospitalization stay, and residual tumor diameter and site. Blood loss was 4,090.8 and 2,847.9 mL; surgical duration was 485.2 and 479.5 min; hospitalization stay was 21.7 and 24.8 days; and complications included intraoperative thoracotomy in 17 and 7 patients, unexpected thoracotomy in 11 and 3, chest drain insertion in one and three, and pleural effusion in 14 and 7, in the primary debulking surgery (PDS) and interval debulking surgery (IDS) groups, respectively. OS was successful in all patients with complete surgery (CS: no residual tumor) achieved in 16 (50.0 %) and 9 (69.2 %), residual tumor diameter < 5 mm in 11 (34.4 %) and 2 (15.4 %), and residual tumor diameter < 1 cm in 5 (15.6 %) and 2 (15.4 %) in the PDS and IDS groups, respectively. Tumor debulking surgery with DS resulted in controllable blood loss, and OS was successful in all patients without severe complications or postoperative treatment delay. Currently, OS is considered to have very few benefits over CS; thus, the success rate of CS rate should be improved while maintaining safety.	[Saitou, Motoaki; Iida, Yasushi; Komazaki, Hiromi; Narui, Chikage; Matsuno, Kanae; Kawabata, Ayako; Ueda, Kazu; Tanabe, Hiroshi; Takakura, Satoshi; Isonishi, Seiji; Sasaki, Hiroshi; Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet Gynecol, Minato Ku, Tokyo 105, Japan	Saitou, M (reprint author), Jikei Univ, Sch Med, Dept Obstet Gynecol, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 105, Japan.	smotoaki@jikei.ac.jp					du Bois A, 2009, CANCER, V115, P1234, DOI 10.1002/cncr.24149; Chi DS, 2006, GYNECOL ONCOL, V103, P559, DOI 10.1016/j.ygyno.2006.03.051; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Qayyum A, 2005, GYNECOL ONCOL, V96, P301, DOI 10.1016/j.ygyno.2004.06.054; Terauchi F, 2010, ONCOL LETT, V1, P861, DOI 10.3892/ol_00000152; Tsolakidis D, 2011, EUR J CANCER, V47, P191, DOI 10.1016/j.ejca.2010.08.020; Zivanovic O, 2010, GYNECOL ONCOL, V116, P351, DOI 10.1016/j.ygyno.2009.11.022; Zivanovic O, 2008, GYNECOL ONCOL, V108, P287, DOI 10.1016/j.ygyno.2007.10.001	9	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	MAR	2015	291	3					641	646		10.1007/s00404-014-3446-7		6	Obstetrics & Gynecology	Obstetrics & Gynecology	CB3TP	WOS:000349552000026		
J	Komatsu, M; Kimura, T; Yazaki, M; Tanaka, N; Yang, Y; Nakajima, T; Horiuchi, A; Fang, ZZ; Joshita, S; Matsumoto, A; Umemura, T; Tanaka, E; Gonzalez, FJ; Ikeda, SI; Aoyama, T				Komatsu, Michiharu; Kimura, Takefumi; Yazaki, Masahide; Tanaka, Naoki; Yang, Yang; Nakajima, Takero; Horiuchi, Akira; Fang, Zhong-Ze; Joshita, Satoru; Matsumoto, Akihiro; Umemura, Takeji; Tanaka, Eiji; Gonzalez, Frank J.; Ikeda, Shu-Ichi; Aoyama, Toshifumi			Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPAR alpha	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Urea cycle disorder; SLC25A13; NAFLD; PPAR alpha; Mitochondrial beta-oxidation; JNK	FATTY LIVER-DISEASE; ASPARTATE-GLUTAMATE CARRIER; CITRIN DEFICIENCY; SLC25A13 GENE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; HEPATIC STEATOSIS; UREA CYCLE; MICE; EXPRESSION	SLC25A13 (citrin or aspartate glutamate carrier 2) is located in the mitochondrial membrane in the liver and its genetic deficiency causes adult-onset type II citrullinemia (CTLN2). CTLN2 is one of the urea cycle disorders characterized by sudden-onset hyperammonemia due to reduced argininosuccinate synthase activity. This disorder is frequently accompanied with hepatosteatosis in the absence of obesity and ethanol consumption. However, the precise mechanism of steatogenesis remains unclear. The expression of genes associated with fatty add (FA) and triglyceride (TG) metabolism was examined using liver samples obtained from 16 CTLN2 patients and compared with 7 healthy individuals. Although expression of hepatic genes associated with lipogenesis and TG hydrolysis was not changed, the mRNAs encoding enzymes/proteins involved in FA oxidation (camitine palmitoyl-CoA transferase 1 alpha, medium-and very-long-chain acyl-CoA dehydrogenases, and acyl-CoA oxidase 1), very-low-density lipoprotein secretion (microsomal TG transfer protein), and FA transport (CD36 and FA-binding protein 1), were markedly suppressed in CTLN2 patients. Serum concentrations of ketone bodies were also decreased in these patients, suggesting reduced mitochondrial beta-oxidation activity. Consistent with these findings, the expression of peroxisome proliferator-activated receptor a (PPAR alpha), a master regulator of hepatic lipid metabolism, was significantly down-regulated. Hepatic PPARa expression was inversely correlated with severity of steatosis and circulating ammonia and citrulline levels. Additionally, phosphorylation of c-Jun-N-terminal kinase was enhanced in CTLN2 livers, which was likely associated with lower hepatic PPAR alpha. Collectively, down-regulation of PPARa is associated with steatogenesis in CTLN2 patients. These findings provide a novel link between urea cycle disorder, lipid metabolism, and PPAR alpha. (C) 2014 Elsevier B.V. All rights reserved.	[Komatsu, Michiharu; Kimura, Takefumi; Tanaka, Naoki; Joshita, Satoru; Matsumoto, Akihiro; Umemura, Takeji; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med Gastroenterol, Matsumoto, Nagano 3908621, Japan; [Kimura, Takefumi; Tanaka, Naoki; Yang, Yang; Nakajima, Takero; Aoyama, Toshifumi] Shinshu Univ, Sch Med, Dept Metab Regulat, Matsumoto, Nagano 3908621, Japan; [Yazaki, Masahide; Ikeda, Shu-Ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 3908621, Japan; [Yazaki, Masahide] Shinshu Univ, Inst Biomed Sci, Dept Biol Sci Intractable Neurol Dis, Matsumoto, Nagano 3908621, Japan; [Horiuchi, Akira] Showa Man Gen Hosp, Ctr Digest Dis, Tokyo, Japan; [Fang, Zhong-Ze] Tianjin Med Univ, Sch Publ Hlth, Dept Toxicol, Tianjin, Peoples R China; [Gonzalez, Frank J.] Natl Canc Inst, Natl Inst Hlth, Ctr Canc Res, Lab Metab, Rockville, MD USA	Tanaka, N (reprint author), Shinshu Univ, Sch Med, Dept Metab Regulat, Matsumoto, Nagano 3908621, Japan.	naopi@shinshu-u.ac.jp					Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Ibrahim SH, 2012, J HEPATOL, V56, P17, DOI 10.1016/j.jhep.2011.04.017; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Fiermonte G, 2011, MOL GENET METAB, V104, P501, DOI 10.1016/j.ymgme.2011.08.022; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; Drosatos K, 2011, J BIOL CHEM, V286, P36331, DOI 10.1074/jbc.M111.272146; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Nagaya T, 2010, J HEPATOL, V53, P724, DOI 10.1016/j.jhep.2010.04.033; Tanaka N, 2010, BIOCHEM PHARMACOL, V80, P1601, DOI 10.1016/j.bcp.2010.07.031; Thering BJ, 2009, J DAIRY SCI, V92, P2027, DOI 10.3168/jds.2008-1749; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; Badizadegan K, 1997, HEPATOLOGY, V26, P365, DOI 10.1002/hep.510260217; Begum L, 2002, BBA-GENE STRUCT EXPR, V1574, P283, DOI 10.1016/S0167-4781(01)00376-1; Dimmock D, 2009, MOL GENET METAB, V96, P44, DOI 10.1016/j.ymgme.2008.10.007; Fukushima K, 2010, INTERNAL MED, V49, P243, DOI 10.2169/internalmedicine.49.2712; Guo Y, 2007, TOXICOL SCI, V96, P294, DOI 10.1093/toxsci/kfm009; Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014; Hagiwara N, 2003, INTERNAL MED, V42, P978, DOI 10.2169/internalmedicine.42.978; HAUTEKEETE ML, 1990, ACTA CLIN BELG, V45, P311; Iacobazzi V., 2013, BIOL BASEL, V2, P284; Ikeda Shu-ichi, 2004, Ann Intern Med, V141, pW109; Kawashima H, 2000, ARCH BIOCHEM BIOPHYS, V378, P333, DOI 10.1006/abbi.2000.1831; Kimura T, 2012, PPAR RES, DOI 10.1155/2012/174932; Kimura T, 2012, DIGEST DIS SCI, V57, P1652, DOI 10.1007/s10620-012-2088-5; Saheki T, 2005, HEPATOL RES, V33, P181, DOI 10.1016/j.hepres.2005.09.031; Komatsu M, 2008, J HEPATOL, V49, P810, DOI 10.1016/j.jhep.2008.05.016; Lu YB, 2005, J HUM GENET, V50, P338, DOI 10.1007/s10038-005-0262-8; Nakamura M, 2011, J NUTR SCI VITAMINOL, V57, P239, DOI 10.3177/jnsv.57.239; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Saheki T, 2002, METAB BRAIN DIS, V17, P335, DOI 10.1023/A:1021961919148; Soeda J, 2008, J CLIN GASTROENTEROL, V42, P855, DOI 10.1097/01.mcg.0000225683.29841.9c; Song YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074544; SU TS, 1982, J CLIN INVEST, V70, P1334, DOI 10.1172/JCI110736; Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka Naoki, 2007, Clin Gastroenterol Hepatol, V5, pA32, DOI 10.1016/j.cgh.2006.06.014; Terada R, 2006, J GASTROEN HEPATOL, V21, P1634, DOI 10.1111/j.1440-1746.2006.04339.x; TOMOMURA M, 1992, BIOCHIM BIOPHYS ACTA, V1138, P167, DOI 10.1016/0925-4439(92)90058-U; Yasuda T, 2000, HUM GENET, V107, P537, DOI 10.1007/s004390000430; Yazaki M, 2004, LIVER TRANSPLANT, V10, P550, DOI 10.1002/lt.20131; Yazaki M, 2005, INTERNAL MED, V44, P188, DOI 10.2169/internalmedicine.44.188	50	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAR	2015	1852	3					473	481		10.1016/j.bbadis.2014.12.011		9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CB6LR	WOS:000349739000010		
J	Distelmaier, F; Valsecchi, F; Liemburg-Apers, DC; Lebiedzinska, M; Rodenburg, RJ; Heil, S; Keijer, J; Fransen, J; Imamura, H; Danhauser, K; Seibt, A; Viollet, B; Gellerich, FN; Smeitink, JAM; Wieckowski, MR; Willems, PHGM; Koopman, WJH				Distelmaier, Felix; Valsecchi, Federica; Liemburg-Apers, Dania C.; Lebiedzinska, Magdalena; Rodenburg, Richard J.; Heil, Sandra; Keijer, Jaap; Fransen, Jack; Imamura, Hiromi; Danhauser, Katharina; Seibt, Annette; Viollet, Benoit; Gellerich, Frank N.; Smeitink, Jan A. M.; Wieckowski, Mariusz R.; Willems, Peter H. G. M.; Koopman, Werner J. H.			Mitochondrial dysfunction in primary human fibroblasts triggers an adaptive cell survival program that requires AMPK-alpha	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Respirometry; glycolysis; redox signaling; mitochondrial dynamics; metabolic regulation; calcium homeostasis	COMPLEX-I DEFICIENCY; UBIQUINONE OXIDOREDUCTASE DEFICIENCY; ACTIVATED PROTEIN-KINASE; RESPIRATORY-CHAIN DYSFUNCTION; HUMAN NADH; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; MAMMALIAN-CELLS; ATP PRODUCTION; CANCER-CELLS	Dysfunction of complex I (CI) of the mitochondrial electron transport chain (ETC) features prominently in human pathology. Cell models of ETC dysfunction display adaptive survival responses that still are poorly understood but of relevance for therapy development Here we comprehensively examined how primary human skin fibroblasts adapt to chronic CI inhibition. CI inhibition triggered transient and sustained changes in metabolism, redox homeostasis and mitochondrial (ultra)structure but no cell senescence/death. CI-inhibited cells consumed no oxygen and displayed minor mitochondrial depolarization, reverse-mode action of complex V, a slower proliferation rate and futile mitochondrial biogenesis. Adaptation was neither prevented by antioxidants nor associated with increased PGC1-alpha/SIRT1/mTOR levels. Survival of CI-inhibited cells was strictly glucose-dependent and accompanied by increased AMPK-alpha phosphorylation, which occurred without changes in ATP or cytosolic calcium levels. Conversely, cells devoid of AMPK-alpha died upon CI inhibition. Chronic CI inhibition did not increase mitochondrial superoxide levels or cellular lipid peroxidation and was paralleled by a specific increase in SOD2/GR, whereas SOD1/CAT/Gpx1/Gpx2/Gpx5 levels remained unchanged. Upon hormone stimulation, fully adapted cells displayed aberrant cytosolic and ER calcium handling due to hampered ATP fueling of ER calcium pumps. It is concluded that CI dysfunction triggers an adaptive program that depends on extracellular glucose and AMPK-alpha. This response avoids cell death by suppressing energy crisis, oxidative stress induction and substantial mitochondrial depolarization. (C) 2014 Elsevier B.V. All rights reserved.	[Distelmaier, Felix; Valsecchi, Federica; Liemburg-Apers, Dania C.; Willems, Peter H. G. M.; Koopman, Werner J. H.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Biochem, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Distelmaier, Felix; Valsecchi, Federica; Rodenburg, Richard J.; Smeitink, Jan A. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Distelmaier, Felix; Danhauser, Katharina; Seibt, Annette] Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Lebiedzinska, Magdalena; Wieckowski, Mariusz R.] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Heil, Sandra; Keijer, Jaap] Wageningen Univ, Dept Human & Anim Physiol, NL-6708 WD Wageningen, Netherlands; [Fransen, Jack] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Cell Biol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Imamura, Hiromi] Kyoto Univ, Hakubi Project, Kyoto 6068501, Japan; [Viollet, Benoit] Univ Paris 05, NSERM U1016, Inst Cochin, F-75014 Paris, France; [Gellerich, Frank N.] Otto Von Guericke Univ, Dept Stereotact Neurosurg, D-39120 Magdeburg, Germany	Distelmaier, F (reprint author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Biochem, Med Ctr, NL-6500 HB Nijmegen, Netherlands.	werner.koopman@radboudumc.nl	Koopman, Werner/N-3586-2014; Willems, P.H.G.M./L-4759-2015; Smeitink, Jan/C-1351-2013; Rodenburg, Richard/N-3579-2014; Koopman, Werner/D-3592-2009	Rodenburg, Richard/0000-0001-5227-3527; 	ZON (Netherlands Organization for Health Research and Development [903-46-176]; NWO (Netherlands Organization for Scientific Research [911-02-008]; 'Forschungskommission der Medizinischen Fakultat' (Heinrich-Heine-University, Dusseldorf); 'Prinses Beatrix Fonds' [OP-05-04]; Dutch Ministry of Economic Affairs (Innovative Onderzoeks Projecten (IOP)) [IGE05003]; Polish National Science Centre [UMO-2011/01/M/NZ3/02128]; CSBR (Centres for Systems Biology Research) initiative from the "Nederlandse organisatie voor Wetenschappelijk Onderzoek" (NWO, Netherlands Organisation for Scientific Research) [CSBRO9/013V]; Foundation for Polish Science (Program Start); L'Oreal fellowship (For Women in Science)	We are grateful to Ing. H. Croes, Ing. M. Wijers, Dr. C.E.J. Dieteren and Prof. Dr. B. Wieringa (Dept. of Cell Biology, RIMLS) for performing tubulin staining, electron microscopy, and FLIP analysis. We also thank Dr. A.S. De Jong, Dr. J.J. Esseling, A. Klymov, Ing. S.E. van Emst-de Vries, and Ing. H.G. Swarts (all from the Dept. of Biochemistry, RIMLS) for HEt/MitoSOX Red measurements, ATeam analysis, Western blotting and molecular cloning. We further thank Ing. M. Bekkenkamp (Human and Animal Physiology, Wageningen University, Wageningen, The Netherlands) for respirometry analysis and Dr. M. Hoffmann (Department of General Pediatrics, Heinrich-Heine-University, Dusseldorf, Germany) for lactate/pyruvate measurements. The D1ER sensor cDNA was a kind gift from Prof. Dr. R.Y. Tsien (UCSD, San Diego, USA). This work was supported by equipment grants of ZON (Netherlands Organization for Health Research and Development, No: 903-46-176), NWO (Netherlands Organization for Scientific Research, No: 911-02-008), a grant from the 'Forschungskommission der Medizinischen Fakultat' (Heinrich-Heine-University, Dusseldorf), the 'Prinses Beatrix Fonds' (No: OP-05-04), the Dutch Ministry of Economic Affairs (Innovative Onderzoeks Projecten (IOP), Grant: #IGE05003), the Polish National Science Centre (Grant: UMO-2011/01/M/NZ3/02128 to MRW and ML), and by the CSBR (Centres for Systems Biology Research) initiative from the "Nederlandse organisatie voor Wetenschappelijk Onderzoek" (NWO, Netherlands Organisation for Scientific Research, Grant: #CSBRO9/013V). ML was recipient of a fellowship from the Foundation for Polish Science (Program Start) and the L'Oreal fellowship (For Women in Science).	Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Koopman WJH, 2010, ANTIOXID REDOX SIGN, V12, P1431, DOI 10.1089/ars.2009.2743; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roestenberg P, 2012, MITOCHONDRION, V12, P57, DOI 10.1016/j.mito.2011.06.011; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Gertz M, 2010, ANTIOXID REDOX SIGN, V13, P1417, DOI 10.1089/ars.2010.3147; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Rimbaud S, 2009, PHARMACOL REP, V61, P131; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; Valsecchi F, 2012, BBA-BIOENERGETICS, V1817, P1925, DOI 10.1016/j.bbabio.2012.03.006; Kilbride SM, 2013, ONCOGENE, V32, P2703, DOI 10.1038/onc.2012.348; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Tronstad KJ, 2014, CURR PHARM DESIGN, V20, P5634; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Aure K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061; Benard G, 2013, ANTIOXID REDOX SIGN, V19, P350, DOI 10.1089/ars.2011.4244; Blanchet L, 2011, CURR PHARM DESIGN, V17, P4023; Brose RD, 2012, HUM MOL GENET, V21, P4237, DOI 10.1093/hmg/dds247; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Distelmaier F, 2012, ANTIOXID REDOX SIGN, V17, P1657, DOI 10.1089/ars.2011.4294; DONNELLY M, 1976, J CELL PHYSIOL, V89, P39, DOI 10.1002/jcp.1040890105; Forkink M, 2014, BBA-BIOENERGETICS, V1837, P1247, DOI 10.1016/j.bbabio.2014.04.008; Ganapathy V., 2008, PHARMACOL THERAPEUT, V121, P29; Germain M, 2013, HUM MOL GENET, V22, P952, DOI 10.1093/hmg/dds500; Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883; Han YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015420; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Koopman WJH, 2007, BBA-BIOENERGETICS, V1767, P940, DOI 10.1016/j.bbabio.2007.03.013; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Koopman WJH, 2008, AM J PHYSIOL-CELL PH, V294, pC1124, DOI 10.1152/ajpcell.00079.2008; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Lebiedzinska M, 2013, INT J BIOCHEM CELL B, V45, P141, DOI 10.1016/j.biocel.2012.07.020; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; MCKAY ND, 1983, BIOCHIM BIOPHYS ACTA, V762, P198, DOI 10.1016/0167-4889(83)90071-X; Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015; Valsecchi F, 2013, MITOCHONDRION, V13, P436, DOI 10.1016/j.mito.2012.12.001; Valsecchi F, 2010, DEV DISABIL RES REV, V16, P175, DOI 10.1002/ddrr.107; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P1041, DOI 10.1016/j.bbadis.2007.05.004; Visch HJ, 2004, J BIOL CHEM, V279, P40328, DOI 10.1074/jbc.M408068200; Visch HJ, 2006, AM J PHYSIOL-CELL PH, V291, pC308, DOI 10.1152/ajpcell.00561.2005; WIJBURG FA, 1990, J INHERIT METAB DIS, V13, P355, DOI 10.1007/BF01799394; Willems P, 2013, ANTIOXID REDOX SIGN, V18, P129, DOI 10.1089/ars.2011.4253; Willems PHGM, 2008, CELL CALCIUM, V44, P123, DOI 10.1016/j.ceca.2008.01.002	71	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAR	2015	1852	3					529	540		10.1016/j.bbadis.2014.12.012		12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CB6LR	WOS:000349739000015		
J	Nakasaki, K; Mimoto, H; Tran, QNM; Oinuma, A				Nakasaki, Kiyohiko; Mimoto, Hiroshi; Quyen Ngoc Minh Tran; Oinuma, Akiko			Composting of food waste subjected to hydrothermal pretreatment and inoculated with Paecilomyces sp FA13	BIORESOURCE TECHNOLOGY			English	Article						Food waste; Composting; Hydrothermal pretreatment; Furan compounds; Paecilomyces sp.	FUNGI; BATCH; ACIDS	Food waste collected from restaurants, convenience stores, and food-processing factories was mixed with sawdust and subjected to hydrothermal pretreatment at 180 degrees C for 30 min to prepare compost raw material. Furan compounds such as 5-HMF (5-hydroxymethyl furfural) and furfural were produced at concentration levels of approximately 8 and 0.5 mg/g-ds, respectively, through hydrothermal pretreatment. The furan compounds inhibited the activity of composting microorganisms, thus delaying the start of organic matter degradation during composting. A newly identified fungus, Paecilomyces sp. FA13, which possesses the ability to degrade furan compounds, was isolated and used as an inoculum for the composting of the raw material prepared by hydrothermal pretreatment. By inoculating the FA13 into the compost raw material at 10(5) CFU/g-ds, the degradation of furan compounds was accelerated. As a result, bacterial activity, which contributed to composting, was enhanced, significantly promoting the start of vigorous degradation of organic materials. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakasaki, Kiyohiko; Mimoto, Hiroshi; Quyen Ngoc Minh Tran; Oinuma, Akiko] Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, Tokyo 1528550, Japan	Nakasaki, K (reprint author), Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	nakasaki@ide.titech.ac.jp					Al-Jabi LF, 2008, ENVIRON TECHNOL, V29, P1067, DOI 10.1080/09593330802175872; Nakasaki K, 1998, WASTE MANAGE RES, V16, P484, DOI 10.1177/0734242X9801600511; Nakasaki K, 2013, BIORESOURCE TECHNOL, V144, P521, DOI 10.1016/j.biortech.2013.07.005; Nakasaki K, 2011, WASTE MANAGE, V31, P495, DOI 10.1016/j.wasman.2010.11.011; Choi MH, 1998, LETT APPL MICROBIOL, V26, P175; Ke GR, 2010, BIORESOURCE TECHNOL, V101, P7424, DOI 10.1016/j.biortech.2010.04.051; Cheung HNB, 2010, BIORESOURCE TECHNOL, V101, P5925, DOI 10.1016/j.biortech.2010.02.062; Iyengar SR, 2006, WASTE MANAGE, V26, P1070, DOI 10.1016/j.wasman.2005.06.011; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Morgenstern I, 2012, FUNGAL BIOL-UK, V116, P489, DOI 10.1016/j.funbio.2012.01.010; Bagchi A, 2004, DESIGN LANDFILLS INT, P91; BOYER LJ, 1992, BIOMASS BIOENERG, V3, P41, DOI 10.1016/0961-9534(92)90018-L; Chai WM, 2013, INT J BIOL MACROMOL, V57, P151, DOI 10.1016/j.ijbiomac.2013.02.019; Chang JI, 2010, BIORESOURCE TECHNOL, V101, P5917, DOI 10.1016/j.biortech.2010.02.042; Girovich M.J, 1996, BIOSOLIDS TREATMENT, P205; Hristozova T, 2006, ENZYME MICROB TECH, V39, P1108, DOI 10.1016/j.enzmictec.2006.02.015; Kluczek-Turpeinen B, 2005, WORLD J MICROB BIOT, V21, P1603, DOI 10.1007/s11274-005-8291-1; Nakasaki K, 1996, COMPOST SCI UTIL, V4, P47; Nakhshiniev B, 2014, BIORESOURCE TECHNOL, V151, P306, DOI 10.1016/j.biortech.2013.10.083; Nakhshiniev B., 2013, COMPOST SCI UTIL, V20, P245; Safika S., 2013, J PURE APPL MICROBIO, V7, P2233; Veignie E., 2003, 8 INT FZK TNO C CONT, P702; Yadav K. S., 1982, Agricultural Wastes, V4, P329, DOI 10.1016/0141-4607(82)90029-4	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	180						40	46		10.1016/j.biortech.2014.12.094		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CB6CY	WOS:000349715700006		
J	Noda, S; Kawai, Y; Tanaka, T; Kondo, A				Noda, Shuhei; Kawai, Yoshifumi; Tanaka, Tsutomu; Kondo, Akihiko			4-Vinylphenol biosynthesis from cellulose as the sole carbon source using phenolic acid decarboxylase- and tyrosine ammonia lyase-expressing Streptomyces lividans	BIORESOURCE TECHNOLOGY			English	Article						4-Vinylphenol; Phenolic acid decarboxylase; Cellulose; Streptomyces lividans	ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ANALYSIS; ETHANOL-PRODUCTION; GENE CLONING; FERMENTATION; PURIFICATION; GLUCOSE; YEAST	Streptomyces lividans was adopted as a host strain for 4-vinylphenol (4VPh) production directly from cellulose. In order to obtain novel phenolic acid decarboxylase (PAD) expressed in S. lividans, PADs distributed among Streptomyces species were screened. Three novel PADs, derived from Streptomyces sviceus, Streptomyces hygroscopicus, and Streptomyces cattleya, were successfully obtained and expressed in S. lividans. S. sviceus PAD (SsPAD) could convert p-hydroxycinnamic acid (pHCA) to 4VPh more efficiently than the others both in vitro and in vivo. For 4VPh production directly from cellulose, L-tyrosine ammonia lyase derived from Rhodobacter sphaeroides and SsPAD were introduced into endoglucanase-secreting S. lividans, and the 4VPh biosynthetic pathway was constructed therein. The created transformants successfully produced 4VPh directly from cellulose. (C) 2014 Elsevier Ltd. All rights reserved.	[Noda, Shuhei; Kondo, Akihiko] RIKEN, Biomass Engn Program, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kawai, Yoshifumi; Tanaka, Tsutomu; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp			Special Coordination Funds for Promoting Science and Technology; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovation Bioproduction Kobe), MEXT, Japan	This work was supported by Special Coordination Funds for Promoting Science and Technology, from the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovation Bioproduction Kobe), MEXT, Japan.	Nijkamp K, 2007, APPL MICROBIOL BIOT, V74, P617, DOI 10.1007/s00253-006-0703-0; Verhoef S, 2009, APPL ENVIRON MICROB, V75, P931, DOI 10.1128/AEM.02186-08; Huang Q, 2013, BIOTECHNOL BIOENG, V110, P3188, DOI 10.1002/bit.24988; Okano K, 2010, APPL MICROBIOL BIOT, V85, P413, DOI 10.1007/s00253-009-2280-5; Zhang HR, 2013, APPL MICROBIOL BIOT, V97, P3333, DOI 10.1007/s00253-012-4544-8; Rodriguez H, 2010, PROTEINS, V78, P1662, DOI 10.1002/prot.22684; van Rensburg E, 2012, APPL MICROBIOL BIOT, V96, P197, DOI 10.1007/s00253-012-4037-9; Talebnia F, 2010, BIORESOURCE TECHNOL, V101, P4744, DOI 10.1016/j.biortech.2009.11.080; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Cavin JF, 1998, APPL ENVIRON MICROB, V64, P1466; Qi WW, 2007, METAB ENG, V9, P268, DOI 10.1016/j.ymben.2007.01.002; Noda S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-49; Lan EI, 2013, BIORESOURCE TECHNOL, V135, P339, DOI 10.1016/j.biortech.2012.09.104; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Fan LH, 2012, P NATL ACAD SCI USA, V109, P13260, DOI 10.1073/pnas.1209856109; Nielsen J, 2013, CURR OPIN BIOTECH, V24, P398, DOI 10.1016/j.copbio.2013.03.023; Cavin JF, 1997, APPL ENVIRON MICROB, V63, P1939; Flanagin LW, 1999, J POLYM SCI POL PHYS, V37, P2103, DOI 10.1002/(SICI)1099-0488(19990815)37:16<2103::AID-POLB13>3.0.CO;2-5; Hopwood DA., 1995, GENETIC MANIPULATION; Jung DH, 2013, APPL MICROBIOL BIOT, V97, P1501, DOI 10.1007/s00253-012-4358-8; Kawai Y, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-45; Kim S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-14; Noda S, 2013, APPL MICROBIOL BIOT, V97, P5711, DOI 10.1007/s00253-013-4880-3; Noda S, 2010, PROTEIN EXPRES PURIF, V73, P198, DOI 10.1016/j.pep.2010.05.011; Salgado JM, 2014, ENZYME MICROB TECH, V58-59, P22, DOI 10.1016/j.enzmictec.2014.02.005	26	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	180						59	65		10.1016/j.biortech.2014.12.064		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CB6CY	WOS:000349715700009		
J	Lu, XQ; Zhen, GY; Estrada, AL; Chen, M; Ni, JL; Hojo, T; Kubota, K; Li, YY				Lu, Xueqin; Zhen, Guangyin; Estrada, Adriana Ledezma; Chen, Mo; Ni, Jialing; Hojo, Toshimasa; Kubota, Kengo; Li, Yu-You			Operation performance and granule characterization of upflow anaerobic sludge blanket (UASB) reactor treating wastewater with starch as the sole carbon source	BIORESOURCE TECHNOLOGY			English	Article						Upflow anaerobic sludge blanket (UASB); Starch; Granular sludge; Methane; Extracellular polymeric substances (EPS)	EXTRACELLULAR POLYMERIC SUBSTANCES; FE(II)-ACTIVATED PERSULFATE OXIDATION; SULFATE-REDUCING BACTERIA; ACTIVATED-SLUDGE; METHANE PRODUCTION; DIGESTION; DEWATERABILITY; BIOREACTOR; EPS	Long-term performance of a lab-scale UASB reactor treating starch wastewater was investigated under different hydraulic retention times (HRT). Successful start-up could be achieved after 15 days' operation. The optimal HRT was 6 h with organic loading rate (OLR) 4 g COD/L d at COD concentration 1000 mg/L, attaining 81.1-98.7% total COD removal with methane production rate of 0.33 L CH4/g CODremoved. Specific methane activity tests demonstrated that methane formation via H-2-CO2 and acetate were the principal degradation pathways. Vertical characterizations revealed that main reactions including starch hydrolysis, acidification and methanogenesis occurred at the lower part of reactor ("main reaction zone''); comparatively, at the up converting acetate into methane predominated ("substrate-shortage zone''). Further reducing HRT to 3 h caused volatile fatty acids accumulation, sludge floating and performance deterioration. Sludge floating was ascribed to the excess polysaccharides in extracellular polymeric substances (EPS). More efforts are required to overcome sludge floating-related issues. (C) 2015 Elsevier Ltd. All rights reserved.	[Lu, Xueqin; Estrada, Adriana Ledezma; Ni, Jialing; Hojo, Toshimasa; Kubota, Kengo; Li, Yu-You] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Sendai, Miyagi 9808579, Japan; [Zhen, Guangyin] Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; [Chen, Mo; Li, Yu-You] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan	Li, YY (reprint author), Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Sendai, Miyagi 9808579, Japan.	luxq@epl1.civil.tohoku.ac.jp; zhenguangyin@163.com; yyli@epl1.civil.tohoku.ac.jp	Kubota, Kengo/C-8870-2009		China Scholarship Council (CSC) [201306890003]; Japan Society for the Promotion of Science (JSPS) [PU 14016, P 13046]	The authors wish to thank the China Scholarship Council (CSC, File No. 201306890003) and Japan Society for the Promotion of Science (JSPS, ID No. PU 14016; ID No. P 13046) for partial support of this study.	Ahmad A, 2011, J HAZARD MATER, V198, P40, DOI 10.1016/j.jhazmat.2011.10.008; Ahn JH, 2004, BIOTECHNOL PROGR, V20, P636, DOI 10.1021/bp0342811; Annachhatre B.A.P., 2000, J ENV ENG, V126, P1149; Mobed JJ, 1996, ENVIRON SCI TECHNOL, V30, P3061, DOI 10.1021/es960132l; Kryvoruchko V, 2009, BIOMASS BIOENERG, V33, P620, DOI 10.1016/j.biombioe.2008.10.003; Wang ZP, 2006, CHEMOSPHERE, V63, P1728, DOI 10.1016/j.chemosphere.2005.09.018; Kobayashi T, 2011, BIORESOURCE TECHNOL, V102, P7713, DOI 10.1016/j.biortech.2011.05.084; Ying W, 2010, ENVIRON SCI TECHNOL, V44, P8636, DOI 10.1021/es102309y; Chong SH, 2012, WATER RES, V46, P3434, DOI 10.1016/j.watres.2012.03.066; Badshah M, 2012, BIORESOURCE TECHNOL, V125, P318, DOI 10.1016/j.biortech.2012.08.109; Jing ZQ, 2013, BIORESOURCE TECHNOL, V137, P349, DOI 10.1016/j.biortech.2013.03.137; Tan XB, 2014, BIORESOURCE TECHNOL, V170, P538, DOI 10.1016/j.biortech.2014.07.086; Wang ZC, 2013, CHEMOSPHERE, V93, P2789, DOI 10.1016/j.chemosphere.2013.09.038; Sekiguchi Y, 2001, APPL ENVIRON MICROB, V67, P5740, DOI 10.1128/AEM.67.12.5740-5749.2001; Guerrero-Barajas C, 2014, INT BIODETER BIODEGR, V94, P182, DOI 10.1016/j.ibiod.2014.07.015; Avancini SRP, 2007, FOOD CHEM TOXICOL, V45, P2273, DOI 10.1016/j.fct.2007.06.006; Lu XQ, 2014, BIORESOURCE TECHNOL, V169, P644, DOI 10.1016/j.biortech.2014.07.056; Hinken L, 2014, WATER RES, V64, P82, DOI 10.1016/j.watres.2014.06.044; Yang Y, 2013, WATER RES, V47, P6790, DOI 10.1016/j.watres.2013.09.012; Zhen GY, 2012, BIORESOURCE TECHNOL, V124, P29, DOI 10.1016/j.biortech.2012.08.039; Zhen GY, 2013, BIORESOURCE TECHNOL, V136, P654, DOI 10.1016/j.biortech.2013.03.007; Fang C, 2011, BIORESOURCE TECHNOL, V102, P5734, DOI 10.1016/j.biortech.2011.03.013; Zhu L, 2012, BIORESOURCE TECHNOL, V124, P455, DOI 10.1016/j.biortech.2012.08.059; Li J, 2012, J ENVIRON SCI-CHINA, V24, P343, DOI 10.1016/S1001-0742(11)60772-9; Nizami AS, 2011, ENVIRON SCI TECHNOL, V45, P7561, DOI 10.1021/es201357r; Colin X, 2007, BIORESOURCE TECHNOL, V98, P1602, DOI 10.1016/j.biortech.2006.06.020; HARADA H, 1994, WATER RES, V28, P355, DOI 10.1016/0043-1354(94)90273-9; APHA, 1998, STANDARD METHODS EXA; Carrillo-Reyes J, 2014, BIOMASS BIOENERG, V63, P101, DOI 10.1016/j.biombioe.2014.01.050; Parthiban Rangasamy, 2007, J Environ Sci (China), V19, P1416; Rajbhandari BK, 2004, BIORESOURCE TECHNOL, V95, P135, DOI 10.1016/j.biortech.2004.01.017; Rizvi H., 2013, ARAB J CHEM; Sen B, 2012, INT J HYDROGEN ENERG, V37, P15588, DOI 10.1016/j.ijhydene.2012.04.027; Sun L, 2012, BIORESOURCE TECHNOL, V104, P280, DOI 10.1016/j.biortech.2011.11.070; Wang RM, 2009, CHEM ENG J, V148, P35, DOI 10.1016/j.cej.2008.07.028	35	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	180						264	273		10.1016/j.biortech.2015.01.010		10	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CB6CY	WOS:000349715700036		
J	Takeshita, H; Kawakami, S; Numao, N; Sakura, M; Tatokoro, M; Yamamoto, S; Kijima, T; Komai, Y; Saito, K; Koga, F; Fujii, Y; Fukui, I; Kihara, K				Takeshita, Hideki; Kawakami, Satoru; Numao, Noboru; Sakura, Mizuaki; Tatokoro, Manabu; Yamamoto, Shinya; Kijima, Toshiki; Komai, Yoshinobu; Saito, Kazutaka; Koga, Fumitaka; Fujii, Yasuhisa; Fukui, Iwao; Kihara, Kazunori			Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method	BJU INTERNATIONAL			English	Article						prostate cancer; extended biopsy; detection; PSA	EXTENDED PROSTATE BIOPSY; SEXTANT BIOPSIES; CANCER; DETECT; FEATURES; RISK	Objective To investigate the diagnostic performance and safety of a three-dimensional 14-core biopsy (3D14PBx) method, which is a combination of the transrectal six-core and transperineal eight-core biopsy methods. Patients and Methods Between December 2005 and August 2010, 1103 men underwent 3D14PBx at our institutions and were analysed prospectively. Biopsy criteria included a PSA level of 2.5-20 ng/mL or abnormal digital rectal examination (DRE) findings, or both. The primary endpoint of the study was diagnostic performance and the secondary endpoint was safety. We applied recursive partitioning to the entire study cohort to delineate the unique contribution of each sampling site to overall and clinically significant cancer detection. Results Prostate cancer was detected in 503 of the 1103 patients (45.6%). Age, family history of prostate cancer, DRE, PSA, percentage of free PSA and prostate volume were associated with the positive biopsy results significantly and independently. Of the 503 cancers detected, 39 (7.8%) were clinically locally advanced (>= cT3a), 348 (69%) had a biopsy Gleason score (GS) of >= 7, and 463 (92%) met the definition of biopsy-based significant cancer. Recursive partitioning analysis showed that each sampling site contributed uniquely to both the overall and the biopsy-based significant cancer detection rate of the 3D14PBx method. The overall cancer-positive rate of each sampling site ranged from 14.5% in the transrectal far lateral base to 22.8% in the transrectal far lateral apex. As of August 2010, 210 patients (42%) had undergone radical prostatectomy, of whom 55 (26%) were found to have pathologically non-organ-confined disease, 174 (83%) had prostatectomy GS >= 7 and 185 (88%) met the definition of prostatectomy-based significant cancer. Conclusions This is the first prospective analysis of the diagnostic performance of an extended biopsy method, which is a simplified version of the somewhat redundant super-extended three-dimensional 26-core biopsy. As expected, each sampling site uniquely contributed not only to overall cancer detection, but also to significant cancer detection. 3D14PBx is a feasible systematic biopsy method in men with PSA <20 ng/mL.	[Takeshita, Hideki; Kawakami, Satoru; Numao, Noboru; Tatokoro, Manabu; Kijima, Toshiki; Komai, Yoshinobu; Saito, Kazutaka; Koga, Fumitaka; Fujii, Yasuhisa; Kihara, Kazunori] Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Tokyo 1138519, Japan; [Sakura, Mizuaki; Yamamoto, Shinya; Fukui, Iwao] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan	Kawakami, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	kawakami@saitama-med.ac.jp					Komai Y, 2013, J UROLOGY, V190, P867, DOI 10.1016/j.juro.2013.03.078; Bittner N, 2013, J UROLOGY, V190, P509, DOI 10.1016/j.juro.2013.02.021; Kubo Y, 2009, INT J UROL, V16, P420, DOI 10.1111/j.1442-2042.2009.02269.x; Scattoni V, 2010, EUR UROL, V57, P1, DOI 10.1016/j.eururo.2009.08.011; [Anonymous], 2012, PROST CANC EARL DET; Stewart CS, 2001, J UROLOGY, V166, P86, DOI 10.1016/S0022-5347(05)66083-1; Numao N, 2007, EUR UROL, V52, P1663, DOI 10.1016/j.eururo.2007.01.025; Emiliozzi P, 2001, J UROLOGY, V166, P845, DOI 10.1016/S0022-5347(05)65849-1; Koppie TM, 2006, BJU INT, V98, P1167, DOI 10.1111/j.1464-410X.2006.06578.x; Kasivisvanathan V, 2013, J UROLOGY, V189, P860, DOI 10.1016/j.juro.2012.10.009; Kuru TH, 2013, J UROLOGY, V190, P1380, DOI 10.1016/j.juro.2013.04.043; Ukimura O, 2013, EUR UROL, V63, P214, DOI 10.1016/j.eururo.2012.09.033; Haffner J, 2009, PROSTATE, V69, P276, DOI 10.1002/pros.20881; Bittner N., 2013, AM J CLIN ONCOL; Chan TY, 2001, J UROLOGY, V166, P2181, DOI 10.1016/S0022-5347(05)65530-9; Egawa S, 2000, JPN J CLIN ONCOL, V30, P126, DOI 10.1093/jjco/hyd029; Eskew LA, 1998, J UROLOGY, V160, P794, DOI 10.1016/S0022-5347(01)62789-7; Galfano A, 2007, EAU EBU UPDATE SERIE, V5, P241, DOI 10.1016/j.eeus.2007.08.001; Giannarini G, 2009, EUR UROL, V56, P619, DOI 10.1016/j.eururo.2009.03.044; Heidenreich A, 2013, EAU GUIDELINES PROST; Igel TC, 2001, J UROLOGY, V165, P1575, DOI 10.1016/S0022-5347(05)66351-3; Kawakami S, 2007, INT J UROL, V14, P719, DOI 10.1111/j.1442-2042.2007.01810.x; Kawakami Satoru, 2006, Int J Clin Oncol, V11, P127, DOI 10.1007/s10147-005-0547-0; Kawakami S, 2007, EUR UROL, V51, P675, DOI 10.1016/j.eururo.2006.06.015; Kawakami S, 2004, INT J UROL, V11, P613, DOI 10.1111/j.1442-2042.2004.00863.x; KUBO Y, 2010, EUR UROL SUPPL, V9, P83; Sobin LH, 2002, TNM CLASSIFICATION M, P184; STAMEY TA, 1995, UROLOGY, V45, P2, DOI 10.1016/S0090-4295(95)96168-2; Suzuki M, 2009, INT J UROL, V16, P930, DOI 10.1111/j.1442-2042.2009.02386.x; Takeshita H, 2013, INT UROL NEPHROL, V45, P645, DOI 10.1007/s11255-013-0416-0	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	MAR	2015	115	3					412	418		10.1111/bju.12772		7	Urology & Nephrology	Urology & Nephrology	CC1OQ	WOS:000350111100018		
J	Ito, H; Sakamaki, K; Kawahara, T; Terao, H; Yasuda, K; Kuroda, S; Yao, M; Kubota, Y; Matsuzaki, J				Ito, Hiroki; Sakamaki, Kentaro; Kawahara, Takashi; Terao, Hideyuki; Yasuda, Kengo; Kuroda, Shinnosuke; Yao, Masahiro; Kubota, Yoshinobu; Matsuzaki, Junichi			Development and internal validation of a nomogram for predicting stone-free status after flexible ureteroscopy for renal stones	BJU INTERNATIONAL			English	Article						ureteroscopy; kidney stone; lithotripsy	HOLMIUM LASER LITHOTRIPSY; SHOCK-WAVE LITHOTRIPSY; SINGLE-CENTER EXPERIENCE; PERCUTANEOUS NEPHROLITHOTOMY; URETERAL CALCULI; INTRARENAL STONES; 2 CM; MANAGEMENT; SUCCESS; GREATER	Objective To develop and internally validate a preoperative nomogram for predicting stone-free status (SF) after flexible ureteroscopy (fURS) for renal stones, as there is a need to predict the outcome of fURS for the treatment of renal stone disease. Patients and Methods We retrospectively analysed 310 fURS procedures for renal stone removal performed between December 2009 and April 2013. Final outcome of fURS was determined by computed tomography 3 months after the last fURS session. Assessed preoperative factors included stone volume and number, age, sex, presence of hydronephrosis and lower pole calculi, and ureteric stent placement. Multivariate logistic regression analysis with backward selection was used to model the relationship between preoperative factors and SF after fURS. Bootstrapping was used to internally validate the nomogram. Results Five independent predictors of SF after fURS were identified: stone volume (P < 0.001), presence of lower pole calculi (P = 0.001), operator with experience of > 50 fURS (P = 0.026), stone number (P = 0.075), and presence of hydronephrosis (P = 0.047). We developed a nomogram to predict SF after fURS using these five preoperative characteristics. Total nomogram score (maximum 25) was derived from summing individual scores of each predictive variable; a high total score was predictive of successful fURS outcome, whereas a low total score was predictive of unsuccessful outcome. The area under the receiver operating characteristics for nomogram predictions was 0.87. Conclusion The nomogram can be used to reliably predict SF based on patient characteristics after fURS treatment of renal stone disease.	[Ito, Hiroki; Kawahara, Takashi; Terao, Hideyuki; Yao, Masahiro; Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan; [Ito, Hiroki; Kawahara, Takashi; Yasuda, Kengo; Kuroda, Shinnosuke; Matsuzaki, Junichi] Ohguchi East Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Sakamaki, Kentaro] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 2360004, Japan	Ito, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Urol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	pug_daikichi@yahoo.co.jp					Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; Akman T, 2012, BJU INT, V109, P1384, DOI 10.1111/j.1464-410X.2011.10691.x; Cohen J, 2013, BJU INT, V111, pE127, DOI 10.1111/j.1464-410X.2012.11352.x; Thomas K, 2011, UROLOGY, V78, P277, DOI 10.1016/j.urology.2010.12.026; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; Kanao K, 2006, J UROLOGY, V176, P1453, DOI 10.1016/j.juro.2006.06.089; Tiselius HG, 2001, EUR UROL, V40, P362, DOI 10.1159/000049803; Takazawa R, 2012, INT J UROL, V19, P264, DOI 10.1111/j.1442-2042.2011.02931.x; Riley JM, 2009, J ENDOUROL, V23, P1395, DOI 10.1089/end.2009.0391; Geavlete P, 2008, J ENDOUROL, V22, P2235, DOI 10.1089/end.2008.9719; Smith A, 2013, J UROLOGY, V190, P149, DOI 10.1016/j.juro.2013.01.047; Breda A, 2008, J UROLOGY, V179, P981, DOI 10.1016/j.juro.2007.10.083; Wiesenthal JD, 2011, J UROLOGY, V186, P556, DOI 10.1016/j.juro.2011.03.109; El-Nahas AR, 2012, BJU INT, V110, P898, DOI 10.1111/j.1464-410X.2012.10961.x; Papatsoris A, 2012, UROL RES, V40, P639, DOI 10.1007/s00240-012-0508-9; Imamura Y, 2013, INT J UROL, V20, P616, DOI 10.1111/j.1442-2042.2012.03229.x; Ito H, 2012, UROLOGY, V80, P524, DOI 10.1016/j.urology.2012.04.001; Ito H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065060; Ito H, 2012, J ENDOUROL, V26, P1125, DOI 10.1089/end.2012.0154; Lim Soo Hyun, 2010, Korean J Urol, V51, P777, DOI 10.4111/kju.2010.51.11.777; Pearle MS, 2008, J UROLOGY, V179, pS69, DOI 10.1016/j.juro.2008.03.140; Wong MYC, 2008, J ENDOUROL, V22, P1845, DOI 10.1089/end.2008.9793	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	MAR	2015	115	3					446	451		10.1111/bju.12775		6	Urology & Nephrology	Urology & Nephrology	CC1OQ	WOS:000350111100022		
J	Singh, S; Venkatesh, SK; Wang, Z; Miller, FH; Motosugi, U; Low, RN; Hassanein, T; Asbach, P; Godfrey, EM; Yin, M; Chen, J; Keaveny, AP; Bridges, M; Bohte, A; Murad, MH; Lomas, DJ; Talwalkar, JA; Ehman, RL				Singh, Siddharth; Venkatesh, Sudhakar K.; Wang, Zhen; Miller, Frank H.; Motosugi, Utaroh; Low, Russell N.; Hassanein, Tarek; Asbach, Patrick; Godfrey, Edmund M.; Yin, Meng; Chen, Jun; Keaveny, Andrew P.; Bridges, Mellena; Bohte, Anneloes; Murad, Mohammad Hassan; Lomas, David J.; Talwalkar, Jayant A.; Ehman, Richard L.			Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Article						IPD; Noninvasive; Elastography; Diagnostic Performance; Pooled Analysis	MULTIFREQUENCY MR ELASTOGRAPHY; CHRONIC HEPATITIS-C; NONINVASIVE ASSESSMENT; TRANSIENT ELASTOGRAPHY; TRANSPLANT RECIPIENTS; STIFFNESS MEASUREMENT; UNITED-STATES; DISEASE; BIOPSY; DIFFERENCE	BACKGROUND & AIMS: Magnetic resonance elastography (MRE) is a noninvasive tool for staging liver fibrosis. We conducted a meta-analysis of individual participant data collected from published studies to assess the diagnostic accuracy of MRE for staging liver fibrosis in patients with chronic liver diseases (CLD). METHODS: Through a systematic literature search of multiple databases (2003-2013), we identified studies on diagnostic performance of MRE for staging liver fibrosis in patients with CLD with native anatomy, using liver biopsy as the standard. We contacted study authors to collect data on each participant's age, sex, body mass index (BMI), liver stiffness (measured by MRE), fibrosis stage, staging system used, degree of inflammation, etiology of CLD, and interval between MRE and biopsy. Through a pooled analysis, we calculated cluster-adjusted area under the receiveroperating curve, sensitivity, and specificity of MRE for any fibrosis (>= stage 1), significant fibrosis (>= stage 2), advanced fibrosis (>= stage 3), and cirrhosis (stage 4). RESULTS: We analyzed data from 12 retrospective studies, comprising 697 patients (mean age, 55 +/- 13 y; 59.4% male; meanBMI, 26.9 +/- 6.7kg/m(2); 92.1% with< 1year interval betweenMREandbiopsy; and 47.1% with hepatitis C). Overall, 19.5%, 19.4%, 15.5%, 15.9%, and 29.7% patients had stage 0, 1, 2, 3, and 4 fibrosis, respectively. Themean area under the receiver-operating curve values (and 95% confidence intervals) for the diagnosis of any (>= stage 1), significant (>= stage 2), advanced fibrosis (>= stage 3), and cirrhosis, were as follows: 0.84 (0.76-0.92), 0.88 (0.84-0.91), 0.93 (0.90-0.95), and 0.92 (0.90-0.94), respectively. A similar diagnostic performance was observed in stratified analysis based on sex, obesity, and etiology of CLD. The overall rate of failure of MRE was 4.3%. CONCLUSIONS: Based on a pooled analysis of data from individual participants, MRE has a high accuracy for the diagnosis of significant or advanced fibrosis and cirrhosis, independent of BMI and etiology of CLD. Prospective studies are warranted to better understand the diagnostic performance of MRE.	[Singh, Siddharth; Talwalkar, Jayant A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Venkatesh, Sudhakar K.; Yin, Meng; Chen, Jun; Ehman, Richard L.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Wang, Zhen; Murad, Mohammad Hassan] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Miller, Frank H.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Motosugi, Utaroh] Univ Yamanashi, Dept Radiol, Yamanashi, Japan; [Low, Russell N.] Sharp & Childrens Magnet Resonance Imaging Ctr, San Diego, CA USA; [Hassanein, Tarek] Liver Ctr Southern Calif, Coronado, CA USA; [Asbach, Patrick] Charite, Dept Radiol, D-13353 Berlin, Germany; [Godfrey, Edmund M.; Lomas, David J.] Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Keaveny, Andrew P.] Mayo Clin, Dept Transplant, Jacksonville, FL 32224 USA; [Bridges, Mellena] Mayo Clin, Dept Radiol, Dept Med, Jacksonville, FL 32224 USA; [Bohte, Anneloes] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands	Venkatesh, SK (reprint author), Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA.	venkatesh.sudhakar@mayo.edu			National Institutes of Health [EB001981]	This work was supported in part by National Institutes of Health grant EB001981 (M.Y., J.C., and R.L.E.).	Altman DG, 2003, BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bohte AE, 2014, EUR RADIOL, V24, P638, DOI 10.1007/s00330-013-3046-0; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Regev A, 2002, AM J GASTROENTEROL, V97, P2614; Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Huwart L, 2007, RADIOLOGY, V245, P458, DOI 10.1148/radiol.2452061673; Kim BH, 2011, J MAGN RESON IMAGING, V34, P1110, DOI 10.1002/jmri.22723; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Rustogi R, 2012, J MAGN RESON IMAGING, V35, P1356, DOI 10.1002/jmri.23585; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Huwart L, 2006, NMR BIOMED, V19, P173, DOI 10.1002/nbm.1030; Godfrey EM, 2012, EUR RADIOL, V22, P2790, DOI 10.1007/s00330-012-2527-x; Myers RP, 2012, J HEPATOL, V56, P564, DOI 10.1016/j.jhep.2011.10.007; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942; Crespo S, 2013, CLIN TRANSPLANT, V27, P652, DOI 10.1111/ctr.12180; Wang QB, 2012, HEPATOLOGY, V56, P239, DOI 10.1002/hep.25610; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Petta S, 2011, ALIMENT PHARM THER, V33, P1350, DOI 10.1111/j.1365-2036.2011.04668.x; Alonzo TA, 2002, BIOSTATISTICS, V3, P421, DOI 10.1093/biostatistics/3.3.421; Asbach P, 2010, RADIOLOGY, V257, P80, DOI 10.1148/radiol.10092489; Kim D, 2013, RADIOLOGY, V268, P411, DOI 10.1148/radiol.13121193; Moher D, 2009, ANN INTERN MED, V151, P264; Yoon JH, 2013, KOREAN J RADIOL, V14, P202, DOI 10.3348/kjr.2013.14.2.202; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636; Batheja MJ, 2011, GASTROENTEROLOGY, V140, pS927; Bota S, 2014, EUR J RADIOL, V83, P268, DOI 10.1016/j.ejrad.2013.11.019; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Choi YR, 2013, INVEST RADIOL, V48, P607, DOI 10.1097/RLI.0b013e318289ff8f; Guo Y, 2014, ABDOM IMAGING; Huwart L, 2008, EUR RADIOL, V18, P2535, DOI 10.1007/s00330-008-1051-5; Ichikawa S, 2014, J MAGN RESON IMAGING; Ichikawa S, 2012, MAGN RESON MED SCI, V11, P291; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Klatt D, 2006, INVEST RADIOL, V41, P841, DOI 10.1097/01.rli.0000244341.16372.08; Klatt DAP, 2011, P INT SOC MAG RESON, V19, P1485; Lee VS, 2011, TRANSPLANTATION, V92, P581, DOI 10.1097/TP.0b013e31822805fa; Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362; Low RN, 2012, J HEPATOL, V56, pS415; Nguyen D, 2011, GASTROENTEROLOGY, V140, pS919; Riley RD, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c221; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932; Venkatesh SK, 2014, EUR RADIOL, V24, P1; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	54	8	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	MAR	2015	13	3					440	451		10.1016/j.cgh.2014.09.046		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB6RJ	WOS:000349754000012		
J	Aoki, T; Nagata, N; Niikura, R; Shimbo, T; Tanaka, S; Sekine, K; Kishida, Y; Watanabe, K; Sakurai, T; Yokoi, C; Akiyama, J; Yanase, M; Mizokami, M; Uemurak, N				Aoki, Tomonori; Nagata, Naoyoshi; Niikura, Ryota; Shimbo, Takuro; Tanaka, Shohei; Sekine, Katsunori; Kishida, Yoshihiro; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio; Mizokami, Masashi; Uemurak, Naomi			Recurrence and Mortality Among Patients Hospitalized for Acute Lower Gastrointestinal Bleeding	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Article						Antithrombotic Agents; Anticoagulants; Poor Clinical Outcomes; Lower Gastrointestinal Hemorrhage; LGIB; Recurrence; Mortality	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RISK-FACTORS; VALIDATION; HEMORRHAGE; SURVIVAL; THERAPY; ASPIRIN; TRENDS; IMPACT; NSAIDS	BACKGROUND & AIMS: The long-term recurrence of lower gastrointestinal bleeding (LGIB) and associated mortality have not been studied extensively. We investigated rates of recurrence of LGIB, mortality, and associated risk factors. METHODS: In a retrospective study, we analyzed data from 342 patients hospitalized for overt LGIB at the National Center for Global Health and Medicine in Japan from December 2004 through June 2013. All patients underwent colonoscopy. We assessed Charlson comorbidity index scores and the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, other antiplatelet drugs, or warfarin. Rebleeding, the total number of rebleeding episodes, and mortality were measured. The Cox proportional hazards model was used to estimate hazard ratios (HRs). RESULTS: Rebleeding occurred in 84 patients, at a mean follow-up time of 19 months. The cumulative percentages of patients with rebleeding at 1 and 5 years were 19% and 46%, respectively. During the follow-up period, 29 patients (39%) had secondary rebleeding and 18 patients (62%) had subsequent rebleeding. Multivariate analysis showed age 65 years and older (HR, 1.7; P = .04) and the use of nonsteroidal anti-inflammatory drugs (HR, 2.0; P < .01) and nonaspirin antiplatelet drugs (HR, 1.8; P < .05) as independent risk factors for rebleeding. Dual therapy had a higher risk than single therapy (adjusted HR, 1.8; P < .05). During the mean follow-up period of 28 months, 21 patients died (2 from bleeding). Cumulative mortality rates at 1 and 5 years were 4.2% and 13%, respectively. Mortality was associated significantly with age >= 65 years (P < .05), Charlson comorbidity index score, and warfarin use. CONCLUSIONS: Based on a retrospective analysis of patients with LGIB, 46% of all patients have rebleeding, and the overall mortality rate is 13% within 5 years after hospitalization. Besides age >= 65 years, use of antithrombotic drugs increases the risk of bleeding recurrence and mortality among patients with LGIB.	[Aoki, Tomonori; Nagata, Naoyoshi; Niikura, Ryota; Tanaka, Shohei; Sekine, Katsunori; Kishida, Yoshihiro; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo 1628655, Japan; [Mizokami, Masashi] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Uemurak, Naomi] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			Ministry of Health Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [271000]; National Center for Global Health and Medicine [22 -302]	This study was supported in part by a grant-in-aid from the Ministry of Health Labor and Welfare of Japan, a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (271000), and The Grant of National Center for Global Health and Medicine (22 -302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsberg K, 2010, SCAND J GASTROENTERO, V45, P1404, DOI 10.3109/00365521.2010.510567; Niikura R, 2012, COLORECTAL DIS, V14, P302, DOI 10.1111/j.1463-1318.2011.02611.x; Longstreth GF, 2010, CLIN GASTROENTEROL H, V8, P49, DOI 10.1016/j.cgh.2009.09.006; Sung JJY, 2010, AM J GASTROENTEROL, V105, P84, DOI 10.1038/ajg.2009.507; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Hallas J, 2006, BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Bhatt DL, 2008, AM J GASTROENTEROL, V103, P2890, DOI 10.1111/j.1572-0241.2008.02216.x; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832; Okamoto T, 2012, INT J COLORECTAL DIS, V27, P1161, DOI 10.1007/s00384-012-1491-x; Nishikawa H, 2013, ACTA GASTRO-ENT BELG, V76, P20; TANAKA H, 1981, STROKE, V12, P460; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1053/cmaj.070186; Poncet G, 2010, ALIMENT PHARM THER, V32, P466, DOI 10.1111/j.1365-2036.2010.04362.x; Laine L, 2006, ALIMENT PHARM THERAP, V24, P751, DOI 10.1111/j.1365-2036.2006.03043.x; Hreinsson JP, 2013, EUR J GASTROEN HEPAT, V25, P37, DOI 10.1097/MEG.0b013e32835948e3; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Wilcox CM, 1997, DIGEST DIS SCI, V42, P990, DOI 10.1023/A:1018832902287; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Uotani T, 2012, CLIN GASTROENTEROL H, V10, P879, DOI 10.1016/j.cgh.2012.04.016; Anthony T, 2004, AM J SURG, V188, P485, DOI 10.1016/j.amjsurg.2004.07.020; ASGE Standards of Practice Committee, 2009, GASTROINTEST ENDOSC, V70, P1060; Chait Maxwell M, 2010, World J Gastrointest Endosc, V2, P147, DOI 10.4253/wjge.v2.i5.147; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Edelman DA, 2007, SURG ENDOSC, V21, P514, DOI 10.1007/s00464-006-9191-7; Kaplan RC, 2002, PREV MED, V34, P455, DOI 10.1006/pmed.2002.1008; Wilcox CM, 1999, SOUTHERN MED J, V92, P44	31	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	MAR	2015	13	3					488	494		10.1016/j.cgh.2014.06.023		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB6RJ	WOS:000349754000018		
J	Ueno, K; Takahashi, T; Takahashi, K; Mizukami, K; Tanaka, Y; Wada, Y				Ueno, Kanji; Takahashi, Tetsuya; Takahashi, Koichi; Mizukami, Kimiko; Tanaka, Yuji; Wada, Yuji			Neurophysiological basis of creativity in healthy elderly people: A multiscale entropy approach	CLINICAL NEUROPHYSIOLOGY			English	Article						Creativity; Healthy elderly people; Electroencephalography (EEG); Complexity; Multiscale entropy (MSE); Multiple temporal scales; Neural network	RESTING FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; DIVERGENT-THINKING; FRONTOTEMPORAL DEMENTIA; APPROXIMATE ENTROPY; PREFRONTAL CORTEX; MENTAL-ILLNESS; EEG COMPLEXITY; SAMPLE ENTROPY; BRAIN	Objectives: Creativity, which presumably involves various connections within and across different neural networks, reportedly underpins the mental well-being of older adults. Multiscale entropy (MSE) can characterize the complexity inherent in EEG dynamics with multiple temporal scales. It can therefore provide useful insight into neural networks. Given that background, we sought to clarify the neurophysiological bases of creativity in healthy elderly subjects by assessing EEG complexity with MSE, with emphasis on assessment of neural networks. Methods: We recorded resting state EEG of 20 healthy elderly subjects. MSE was calculated for each subject for continuous 20-s epochs. Their relevance to individual creativity was examined concurrently with intellectual function. Results: Higher individual creativity was linked closely to increased EEG complexity across higher temporal scales, but no significant relation was found with intellectual function ( IQ score). Conclusions: Considering the general "loss of complexity'' theory of aging, our finding of increased EEG complexity in elderly people with heightened creativity supports the idea that creativity is associated with activated neural networks. Significance: Results reported here underscore the potential usefulness of MSE analysis for characterizing the neurophysiological bases of elderly people with heightened creativity. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Ueno, Kanji; Takahashi, Tetsuya; Takahashi, Koichi; Tanaka, Yuji; Wada, Yuji] Univ Fukui, Dept Neuropsychiat, Fac Med Sci, Eiheiji, Fukui 9101193, Japan; [Mizukami, Kimiko] Jin Ai Univ, Dept Psychol, Fac Human Studies, Fukui, Japan	Takahashi, T (reprint author), Univ Fukui, Dept Neuropsychiat, Fac Med Sci, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	takahash@u-fukui.ac.jp			Japan Society for the Promotion of Science [25461754, 25461755]; Fukui Prefecture	This study was supported by Grants-in-Aid for Scientific Research (C) No. 25461754 from the Japan Society for the Promotion of Science (K.U.), Grants-in-Aid for Scientific Research (C) No. 25461755 from the Japan Society for the Promotion of Science (T.T.), The Japan Health Foundation (T.T.), and a Scientific Research Grant from Fukui Prefecture (T.T.).	Abarbanel HD, 2001, CURR OPIN NEUROBIOL, V11, P423, DOI 10.1016/S0959-4388(00)00229-4; Jausovec N, 2000, INTELLIGENCE, V28, P213, DOI 10.1016/S0160-2896(00)00037-4; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Kyaga S, 2013, J PSYCHIATR RES, V47, P83, DOI 10.1016/j.jpsychires.2012.09.010; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Okazaki R, 2013, J AFFECT DISORDERS, V150, P389, DOI 10.1016/j.jad.2013.04.029; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Takahashi T, 2013, PROG NEURO-PSYCHOPH, V45, P258, DOI 10.1016/j.pnpbp.2012.05.001; Jausovec N, 2000, BRAIN TOPOGR, V12, P229, DOI 10.1023/A:1023446024923; Molle M, 1996, NEUROSCI LETT, V208, P61, DOI 10.1016/0304-3940(96)12539-8; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217; Wada Y, 1996, CLIN ELECTROENCEPHAL, V27, P84; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; Burch GSJ, 2006, BRIT J PSYCHOL, V97, P177, DOI 10.1348/000712605X60030; Miller BL, 2000, BRIT J PSYCHIAT, V176, P458, DOI 10.1192/bjp.176.5.458; Howard-Jones Paul A, 2005, Brain Res Cogn Brain Res, V25, P240; Arden R, 2010, BEHAV BRAIN RES, V214, P143, DOI 10.1016/j.bbr.2010.05.015; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Cummings JL, 2008, CNS SPECTRUMS, V13, P1; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Miller GF, 2007, SCHIZOPHR RES, V93, P317, DOI 10.1016/j.schres.2007.02.007; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Miller BL, 2004, ARCH NEUROL-CHICAGO, V61, P842, DOI 10.1001/archneur.61.6.842; Razumnikova OM, 2007, BRAIN RES BULL, V73, P96, DOI 10.1016/j.brainresbull.2007.02.008; Takahashi T, 2009, CLIN NEUROPHYSIOL, V120, P476, DOI 10.1016/j.clinph.2008.12.043; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; McFadden SH, 2010, CLIN GERIATR MED, V26, P149, DOI 10.1016/j.cger.2009.11.004; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; Folley BS, 2005, SCHIZOPHR RES, V80, P271, DOI 10.1016/j.schres.2005.06.016; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; SMITH LA, 1988, PHYS LETT A, V133, P283, DOI 10.1016/0375-9601(88)90445-8; Cohen GD, 2006, GENERATIONS, V30, P7; Miller BL, 1998, NEUROLOGY, V51, P978; Kowatari Y, 2009, HUM BRAIN MAPP, V30, P1678, DOI 10.1002/hbm.20633; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Razumnikova OM, 2004, NEUROSCI LETT, V362, P193, DOI 10.1016/j.neulet.2004.02.066; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; Flaherty AW, 2005, J COMP NEUROL, V493, P147, DOI 10.1002/cne.20768; Carson SH, 2003, J PERS SOC PSYCHOL, V85, P499, DOI 10.1037/0022-3514.85.3.499; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Costa Madalena, 2005, Phys Rev E Stat Nonlin Soft Matter Phys, V71, P021906, DOI 10.1103/PhysRevE.71.021906; Fell J, 2000, ACTA NEUROBIOL EXP, V60, P87; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornazzari LR, 2005, EUR J NEUROL, V12, P419, DOI 10.1111/j.1468-1331.2005.01128.x; Friston KJ, 1995, HUM BRAIN MAPP, V3, P302, DOI 10.1002/hbm.460030405; Friston KJ, 1996, BRIT MED BULL, V52, P644; Guilford J.P., 1967, NATURE HUMAN INTELLI; Jausovec N, 2000, INT J PSYCHOPHYSIOL, V36, P73, DOI 10.1016/S0167-8760(99)00113-0; Jung RE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00330; Jung RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009818; Krug R, 2003, NEUROPSYCHOPHARMACOL, V28, P1538, DOI 10.1038/sj.npp.1300200; Molle M, 1999, PSYCHOPHYSIOLOGY, V36, P95, DOI 10.1017/S0048577299961619; Moore DW, 2009, BRAIN COGNITION, V70, P267, DOI 10.1016/j.bandc.2009.02.011; Petsche H, 1996, INT J PSYCHOPHYSIOL, V24, P145, DOI 10.1016/S0167-8760(96)00050-5; Razoumnikova OM, 2000, COGNITIVE BRAIN RES, V10, P11, DOI 10.1016/S0926-6410(00)00017-3; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Richman JS, 2004, METHOD ENZYMOL, V384, P172; Society for Creative Minds, 1969, MAN S CREAT TEST; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023175; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025532; Torrance E. P., 1966, TORRANCE TESTS CREAT; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wei DT, 2014, CORTEX, V51, P92, DOI 10.1016/j.cortex.2013.09.004	75	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2015	126	3					524	531		10.1016/j.clinph.2014.06.032		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB4RX	WOS:000349616700015		
J	Kawabe, J; Higashiyama, S; Kotani, K; Onoda, N; Shiomi, S				Kawabe, Joji; Higashiyama, Shigeaki; Kotani, Kohei; Onoda, Naoyoshi; Shiomi, Susumu			I-131 Abnormal Uptake by the Thyroid Bed From Zuckerkandl Tubercle Diagnosis by I-131 SPECT/CT	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						thyroid cancer; SPECT/CT; I-131 scintigraphy; Zuckerkandl tubercle	RECURRENT LARYNGEAL NERVE; ANATOMICAL LANDMARK; SURGERY		[Kawabe, Joji; Higashiyama, Shigeaki; Kotani, Kohei; Shiomi, Susumu] Osaka City Univ, Grad Sch Med, Dept Nucl Med, Osaka 5458585, Japan; [Onoda, Naoyoshi] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan	Kawabe, J (reprint author), Osaka City Univ, Grad Sch Med, Dept Nucl Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	kawabe@med.osaka-cu.ac.jp					Pelizzo MR, 1998, J AM COLL SURGEONS, V187, P333, DOI 10.1016/S1072-7515(98)00160-4; Delbridge L, 2003, ANZ J SURG, V73, P761, DOI 10.1046/j.1445-2197.2003.02756.x; Gauger PG, 2001, EUR J SURG, V167, P249; Gravante G, 2007, AM J SURG, V193, P484, DOI 10.1016/j.amjsurg.2006.06.040; Lee TC, 2012, AM J NEURORADIOL, V33, P1134, DOI 10.3174/ajnr.A2914; Sheahan P, 2011, LARYNGOSCOPE, V121, P2335, DOI 10.1002/lary.22188; Wisotzki C, 2014, CLIN NUCL MED, V39, pE73, DOI 10.1097/RLU.0b013e3182816303; Yun JS, 2008, ENDOCR J, V55, P925, DOI 10.1507/endocrj.K08E-132	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	MAR	2015	40	3					275	277				3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB2PW	WOS:000349471100034		
J	Nishie, A; Kakihara, D; Asayama, Y; Ushijima, Y; Takayama, Y; Fujita, N; Shimamoto, D; Shirabe, K; Hida, T; Honda, H				Nishie, A.; Kakihara, D.; Asayama, Y.; Ushijima, Y.; Takayama, Y.; Fujita, N.; Shimamoto, D.; Shirabe, K.; Hida, T.; Honda, H.			Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation	CLINICAL RADIOLOGY			English	Article							GD-EOB-DTPA; SUPERPARAMAGNETIC IRON-OXIDE; ROW COMPUTED-TOMOGRAPHY; IMAGE QUALITY; SINGLE-SOURCE; PHASE; DISEASE; NODULES; MDCT; HCC	AIM: To clarify the detectability of hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MRI at 3 T with dual-source parallel radiofrequency (RF) excitation. MATERIALS AND METHODS: Twelve patients with 26 HCCs who each underwent multi-detector row CT (MDCT), gadoxetic acid-enhanced MRI with dual-source parallel RF excitation, and angiography-assisted CT prior to living related-liver transplantation. Three blinded readers independently reviewed the images obtained by each imaging technique for the presence of HCC on a segment-by-segment basis using a five-point confidence scale. The area under the receiver operating characteristic curve (Az), sensitivity, and specificity were compared among the three techniques. RESULTS: The Az values of gadoxetic acid-enhanced MRI were highest for all readers, although no significant difference in Az value among the three methods was obtained. No significant differences in sensitivity or specificity were observed among the three techniques for each reader. CONCLUSION: Gadoxetic acid-enhanced MRI at 3 T with dual-source parallel RF excitation has relatively high-level diagnostic potential for the detection of HCC in patients with severe liver dysfunction, which was equivalent to that of MDCT and angiography-assisted CT. Dual-source parallel RF excitation would have a clinical impact on 3 T MRI of the liver. (C) 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.	[Nishie, A.; Kakihara, D.; Asayama, Y.; Ushijima, Y.; Fujita, N.; Shimamoto, D.; Honda, H.] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Takayama, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, Fukuoka 8128582, Japan; [Shirabe, K.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan; [Hida, T.] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan	Nishie, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	anishie@radiol.med.kyushu-u.ac.jp					Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Baek CK, 2012, CLIN RADIOL, V67, P148, DOI 10.1016/j.crad.2011.08.011; Nishie A, 2012, EUR J RADIOL, V81, P1100, DOI 10.1016/j.ejrad.2011.02.053; Kim YK, 2010, CLIN RADIOL, V65, P358, DOI 10.1016/j.crad.2009.11.012; Tajima T, 2010, J COMPUT ASSIST TOMO, V34, P362, DOI 10.1097/RCT.0b013e3181cd3304; Kukuk GM, 2011, RADIOLOGY, V259, P421, DOI 10.1148/radiol.11101429; COUINAUD C, 1954, PRESSE MED, V62, P62; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Kim AY, 2012, ACTA RADIOL, V53, P830, DOI 10.1258/ar.2012.120099; Motosugi U, 2011, J MAGN RESON IMAGING, V34, P88, DOI 10.1002/jmri.22630; Inoue T, 2012, J GASTROENTEROL, V47, P1036, DOI 10.1007/s00535-012-0571-6; Takayama Y, 2012, EUR J RADIOL, V81, P3035, DOI 10.1016/j.ejrad.2012.03.026; Nishie A, 2012, J MAGN RESON IMAGING, V36, P664, DOI 10.1002/jmri.23691; Nakamura Y, 2013, J MAGN RESON IMAGING, V37, P684, DOI 10.1002/jmri.23855; Barth MM, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275065204; Willinek WA, 2010, RADIOLOGY, V256, P966, DOI 10.1148/radiol.10092127; Kim YK, 2009, J COMPUT ASSIST TOMO, V33, P844, DOI 10.1097/RCT.0b013e3181a7e3c7; Akai H, 2011, EUR J RADIOL, V80, P310, DOI 10.1016/j.ejrad.2010.07.026; Hwang J, 2012, J COMPUT ASSIST TOMO, V36, P546, DOI 10.1097/RCT.0b013e318264e4a7; Kakihara D, 2014, J MAGN RESON IMAGING, V40, P1112, DOI 10.1002/jmri.24454; Nishie A, 2010, J MAGN RESON IMAGING, V31, P373, DOI 10.1002/jmri.22059; Ooka Y, 2012, MAGN RESON IMAGING, V30, P854; Pazahr S, 2012, RADIOLOGY, V265, P591, DOI 10.1148/radiol.12112715	24	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0009-9260	1365-229X		CLIN RADIOL	Clin. Radiol.	MAR	2015	70	3					254	261		10.1016/j.crad.2014.11.006		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB6HB	WOS:000349727000005		
J	Tsuruya, K; Eriguchi, M				Tsuruya, Kazuhiko; Eriguchi, Masahiro			Cardiorenal syndrome in chronic kidney disease	CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION			English	Review						fibroblast growth factor 23; nitric oxide; renal venous hypertension; renin-angiotensin system; sympathetic nerve activity	CONGESTIVE-HEART-FAILURE; RENAL SYMPATHETIC DENERVATION; LEFT-VENTRICULAR HYPERTROPHY; NITRIC-OXIDE SYNTHASE; RANDOMIZED CONTROLLED-TRIAL; D-RECEPTOR ACTIVATION; RESISTANT HYPERTENSION; CARDIOVASCULAR EVENTS; ANGIOTENSIN-II; VENOUS-PRESSURE	Purpose of reviewThe purpose of this study is to review current perspectives regarding the pathogenesis of cardiorenal syndrome (CRS) in chronic kidney disease (CKD), and current treatment guidelines for this condition.Recent findingsThe pathophysiological mechanisms underlying the development of CRS in CKD include neurohumoral, haemodynamic and CKD-related mechanisms. Recent evidence suggests that sympathetic nerve activity plays a role in CRS, but the SYMPLICITY HTN-3 trial failed to show a reduction of blood pressure after catheter-based renal denervation in patients with resistant hypertension. Kidney injury in patients with heart failure was previously considered to result from arterial underfilling due to low cardiac output, but the role of renal venous hypertension in this process has also recently been investigated. It would be useful to develop a reliable treatment option for CRS due to haemodynamic mechanism other than volume control using diuretics. Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that has recently been identified as a CKD-related factor affecting CRS. FGF23 treatment has both advantages and disadvantages in terms of CRS progression.SummaryMultiple disorders underlie the development of CRS. Current treatment options include renin-angiotensin system blockade and volume control, but remain limited. A multidisciplinary approach is required to prevent CRS, including renal sympathetic denervation, treatment of renal venous hypertension and FGF23 treatment.	[Tsuruya, Kazuhiko] Kyushu Univ, Dept Integrated Therapy Chron Kidney Dis, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Tsuruya, Kazuhiko; Eriguchi, Masahiro] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan	Tsuruya, K (reprint author), Kyushu Univ, Dept Integrated Therapy Chron Kidney Dis, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp					Bongartz LG, 2005, EUR HEART J, V26, P11, DOI 10.1093/eurheratj/ehi020; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P637, DOI 10.1038/ncpneph0673; Torre-Amione G, 2008, LANCET, V371, P228, DOI 10.1016/S0140-6736(08)60134-8; Zhou YB, 2014, HYPERTENSION, V63, P330, DOI 10.1161/HYPERTENSIONAHA.113.01681; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Zoccali C, 2002, CIRCULATION, V105, P1354, DOI 10.1161/hc1102.105261; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI 10.1159/000349966; Moretti JL, 2012, J HYPERTENS, V30, P551, DOI 10.1097/HJH.0b013e328350133a; SAKUMA I, 1992, CIRC RES, V70, P607; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bongartz LG, 2012, AM J PHYSIOL-RENAL, V303, pF1253, DOI 10.1152/ajprenal.00392.2012; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Sud M, 2014, CIRCULATION, V130, P458, DOI 10.1161/CIRCULATIONAHA.113.007106; Brandt MC, 2012, J AM COLL CARDIOL, V60, P1956, DOI 10.1016/j.jacc.2012.08.959; Ueda S, 2014, CURR PHARM DESIGN, V20, P2448; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Heywood JT, 2007, J CARD FAIL, V13, P422, DOI 10.1016/j.cardfail.2007.03.011; GUYTON AC, 1987, HYPERTENSION, V10, P1; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Kopkan L, 2009, PHYSIOL RES, V58, pS55; Yamada S, 2012, J BONE MINER RES, V27, P474, DOI 10.1002/jbmr.539; Silverberg DS, 2003, NEPHROL DIAL TRANSPL, V18, P141, DOI 10.1093/ndt/18.1.141; Yamada S, 2014, AM J PHYSIOL-RENAL, V306, pF1418, DOI 10.1152/ajprenal.00633.2013; Messerli FH, 2014, NEW ENGL J MED, V370, P1454, DOI 10.1056/NEJMe1402388; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Hering D, 2012, J AM SOC NEPHROL, V23, P1250, DOI 10.1681/ASN.2011111062; Ikeda H, 2009, KIDNEY INT, V75, P147, DOI 10.1038/ki.2008.507; Colombo PC, 2012, HEART FAIL REV, V17, P177, DOI 10.1007/s10741-011-9261-3; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ye SH, 1998, AM J HYPERTENS, V11, P723, DOI 10.1016/S0895-7061(98)00030-2; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Brandt MC, 2012, J AM COLL CARDIOL, V59, P901, DOI 10.1016/j.jacc.2011.11.034; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; Mahfoud F, 2012, HYPERTENSION, V60, P419, DOI 10.1161/HYPERTENSIONAHA.112.193870; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Koomans HA, 2004, J AM SOC NEPHROL, V15, P524, DOI 10.1097/01.ASN.0000113320.57127.B9; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Armstrong EJ, 2013, J LEUKOCYTE BIOL, V93, P821, DOI 10.1189/jlb.0113037; BIGAZZI R, 1994, J AM SOC NEPHROL, V4, P1901; Bongartz LG, 2010, AM J PHYSIOL-REG I, V298, pR815, DOI 10.1152/ajpregu.00727.2009; Bongartz LG, 2012, AM J PHYSIOL-HEART C, V302, pH845, DOI 10.1152/ajpheart.00261.2011; Braam B, 2012, HEART FAIL REV, V17, P161, DOI 10.1007/s10741-011-9246-2; Campese VM, 2002, HYPERTENSION, V39, P519, DOI 10.1161/hy0202.102815; Couto GK, 2014, EXP PHYSIOL, V99, P1427, DOI 10.1113/expphysiol.2014.079236; de Beus E, 2014, J HYPERTENS, V32, P1751, DOI 10.1097/HJH.0000000000000210; Disease Kidney, 2009, KIDNEY INT S, V113, pS1; Eriguchi M, 2015, KIDNEY INT, V87, P116, DOI 10.1038/ki.2014.220; FIKSENOLSEN MJ, 1992, HYPERTENSION, V19, P137; George J, 2005, ARCH INTERN MED, V165, P1304, DOI 10.1001/archinte.165.11.1304; Gonzalez-Villalobos RA, 2013, J CLIN INVEST, V123, P2011, DOI 10.1172/JCI65460; Inker LA, 2014, AM J KIDNEY DIS, V64, P74, DOI 10.1053/j.ajkd.2014.02.020; Katz SD, 1999, CIRCULATION, V99, P2113; Klein IHHT, 2001, J AM SOC NEPHROL, V12, P2427; Kuro-o M, 2013, KIDNEY INT SUPPL, V3, P420, DOI 10.1038/kisup.2013.88; Lopez B, 2003, HYPERTENSION, V42, P1150, DOI 10.1161/01.HYP.0000101968.09376.79; Majid DSA, 2005, AM J PHYSIOL-RENAL, V288, pF412, DOI 10.1152/ajprenal.00294.2004; Panizo S, 2013, NEPHROL DIAL TRANSPL, V28, P2735, DOI 10.1093/ndt/gft268; SEMPLE SJG, 1959, CIRC RES, V7, P643	71	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1062-4821	1473-6543		CURR OPIN NEPHROL HY	Curr. Opin. Nephrol. Hypertens.	MAR	2015	24	2					154	162		10.1097/MNH.0000000000000099		9	Urology & Nephrology; Peripheral Vascular Disease	Urology & Nephrology; Cardiovascular System & Cardiology	CB1JW	WOS:000349384500007		
J	Kawano, M; Saeki, T				Kawano, Mitsuhiro; Saeki, Takako			IgG4-related kidney disease - an update	CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION			English	Review						IgG4; IgG4-related disease; membranous glomerulonephritis; tubulointerstitial nephritis	SCHONLEIN PURPURA NEPHRITIS; CHURG-STRAUSS-SYNDROME; TUBULOINTERSTITIAL NEPHRITIS; AUTOIMMUNE PANCREATITIS; MEMBRANOUS NEPHROPATHY; INFLAMMATORY PSEUDOTUMOR; RETROPERITONEAL FIBROSIS; DIAGNOSTIC-CRITERIA; GLOMERULONEPHRITIS; MANIFESTATION	Purpose of reviewIgG4-related disease (IgG4-RD) is a recently recognized systemic inflammatory disorder that can affect most organs/tissues such as sarcoidosis. The kidney is a frequently affected organ with tubulointerstitial nephritis (TIN), the representative lesion of IgG4-RD. This review focuses on the latest knowledge of IgG4-related kidney disease (IgG4-RKD).Recent findingsA wide range of renal manifestations of IgG4-RD, that is TIN, membranous glomerulonephritis (MGN) and other glomerular lesions, and pyelitis, are collectively referred to as IgG4-RKD. Clinically, decreased renal function, or characteristic imaging findings such as multiple low-density lesions on contrast-enhanced computed tomography or diffuse thickening of the renal pelvic wall, are typical presenting features. Although a rapid response to corticosteroid therapy is a very important feature of IgG4-TIN, in cases in which renal function is moderately to severely decreased before therapy, only partial recovery of renal function is obtained.SummaryTIN with characteristic imaging findings is a typical manifestation of IgG4-RKD in the interstitium, while MGN is a representative manifestation of the glomerular lesions. Although IgG4 is a central feature of IgG4-RD, the recent discovery of IgG4-negative IgG4-RD raises questions about the causative role of the IgG4 molecule in this context.	[Kawano, Mitsuhiro] Kanazawa Univ Hosp, Div Rheumatol, Kanazawa, Ishikawa 9208641, Japan; [Saeki, Takako] Nagaoka Red Cross Hosp, Dept Internal Med, Nagaoka, Niigata, Japan	Kawano, M (reprint author), Kanazawa Univ Hosp, Div Rheumatol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	sk33166@gmail.com			Ministry of Health, Labour and Welfare, Japan	This work was supported by Health and Labour Sciences Research Grants for the Study of Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan.	Mattoo H, 2014, ALLERGY, V69, P399, DOI 10.1111/all.12342; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Mizushima I, 2012, MOD RHEUMATOL, V22, P859, DOI 10.1007/s10165-011-0589-2; Vaglio A, 2012, ANN RHEUM DIS, V71, P390, DOI 10.1136/ard.2011.155382; Alexander MP, 2013, KIDNEY INT, V83, P455, DOI 10.1038/ki.2012.382; Sharma SG, 2013, AM J KIDNEY DIS, V61, P638, DOI 10.1053/j.ajkd.2012.07.031; Chang SY, 2013, HUM PATHOL, V44, P2432, DOI 10.1016/j.humpath.2013.05.023; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586; Mattoo H, 2014, J ALLERGY CLIN IMMUN, V134, P679, DOI 10.1016/j.jaci.2014.03.034; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Ito K, 2013, CLIN NEPHROL, V79, P246, DOI 10.5414/CN107114; Katano K, 2007, CLIN NEPHROL, V68, P308; Saeki T, 2013, KIDNEY INT, V84, P826, DOI 10.1038/ki.2013.191; Yamamoto M, 2010, INTERNAL MED, V49, P1365, DOI 10.2169/internalmedicine.49.3532; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Watanabe T, 2011, JPN J RADIOL, V29, P194, DOI 10.1007/s11604-010-0539-5; Yamaguchi Y, 2012, HUM PATHOL, V43, P536, DOI 10.1016/j.humpath.2011.06.002; Cornell LD, 2012, CURR OPIN NEPHROL HY, V21, P279, DOI 10.1097/MNH.0b013e32835265ac; Kamisawa T, 2014, J GASTROENTEROL, V49, P961, DOI 10.1007/s00535-014-0945-z; Cravedi P, 2011, AM J KIDNEY DIS, V58, P272, DOI 10.1053/j.ajkd.2011.05.002; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Yoshita K, 2012, NEPHROL DIAL TRANSPL, V27, P2755, DOI 10.1093/ndt/gfr761; Takahashi N, 2007, RADIOLOGY, V242, P791, DOI 10.1148/radiol.2423060003; Moteki H, 2011, ACTA OTO-LARYNGOL, V131, P518, DOI 10.3109/00016489.2010.533699; Raissian Y, 2011, J AM SOC NEPHROL, V22, P1343, DOI 10.1681/ASN.2011010062; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Sogabe Y, 2014, GRAEF ARCH CLIN EXP, V252, P531, DOI 10.1007/s00417-013-2548-4; Crumley S, 2013, ANN DIAGN PATHOL, V17, P403, DOI 10.1016/j.anndiagpath.2013.03.004; Wenniger LMD, 2013, UROLOGY, V82, pE15, DOI 10.1016/j.urology.2013.04.046; Hara S, 2014, MOD RHEUMATOL, DOI [10.3109/14397595.2014.916836, DOI 10.3109/14397595.2014.916836]; Hart PA, 2015, MODERN PATHOL, V28, P238, DOI 10.1038/modpathol.2014.91; Hart PA, 2012, HUM PATHOL, V43, P2084, DOI 10.1016/j.humpath.2012.05.017; Houghton DC, 2011, MODERN PATHOL, V24, P1480, DOI 10.1038/modpathol.2011.101; Imai T, 2013, RHEUMATOL INT, V33, P2141, DOI 10.1007/s00296-011-2271-6; Inoue D, 2014, IGG4 RELATED DIS, P99; Kanda H., 2013, Clinical Kidney Journal, V6, P204, DOI 10.1093/ckj/sfs180; Kawano M, 2014, IGG4 RELATED DIS, P45; Kawano M, 2013, MOD RHEUMATOL, DOI [10.3109/14397595.2013.844303, DOI 10.3109/14397595.2013.844303]; Kawano M., 2012, INT J RHEUMATOL, V2012; Khosroshahi A., 2012, INT J RHEUMATOL, V2012; Kim B, 2014, EUR J RADIOL, V83, P1057, DOI 10.1016/j.ejrad.2014.03.033; Kim F, 2011, INTERNAL MED, V50, P1239, DOI 10.2169/internalmedicine.50.5102; Kim SA, 2011, HUM PATHOL, V42, P1178, DOI 10.1016/j.humpath.2010.03.011; Makiishi T, 2013, BMJ CASE REP, V2013; Marando A, 2013, VIRCHOWS ARCH, V462, P673, DOI 10.1007/s00428-013-1421-5; Maruyama M, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/456965; Migita K, 2014, MOD RHEUMATOL, V24, P188, DOI 10.3109/14397595.2013.852841; Miyata KN, 2014, CASE REP NEPHROL, V2014; Mizushima I, 2014, IGG4 RELATED DIS, P213; Montironi R, 2013, EUR UROL, V64, P865, DOI 10.1016/j.eururo.2012.11.056; Morimoto J, 2009, INTERNAL MED, V48, P157, DOI 10.2169/internalmedicine.48.1339; Muraki T, 2006, PANCREAS, V32, P16, DOI 10.1097/01.mpa.0000188308.75043.e4; Nakajima K, 2014, IGG4 RELATED DIS, P129; Oliveira DBG, 1998, LANCET, V351, P670, DOI 10.1016/S0140-6736(97)04122-6; Palmisano A, 2010, CLIN NEPHROL, V74, P485; Saeki T, 2009, CLIN NEPHROL, V71, P173; Saeki T, 2014, IGG4 RELATED DIS, P169; Shoji S, 2010, INT J UROL, V17, P389, DOI 10.1111/j.1442-2042.2010.02483.x; Stone JH, 2014, IGG4 RELATED DIS, P51; Tamai R, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-5; Wada Y., 2013, Clinical Kidney Journal, V6, P486; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	67	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1062-4821	1473-6543		CURR OPIN NEPHROL HY	Curr. Opin. Nephrol. Hypertens.	MAR	2015	24	2					193	201		10.1097/MNH.0000000000000102		9	Urology & Nephrology; Peripheral Vascular Disease	Urology & Nephrology; Cardiovascular System & Cardiology	CB1JW	WOS:000349384500012		
J	Arawatari, R				Arawatari, Ryo			POLITICAL ECONOMY OF TRADE OPENNESS AND GOVERNMENT SIZE	ECONOMICS & POLITICS			English	Article							COUNTRY SIZE; EXPENDITURE	This paper proposes a theoretical model that may provide useful insights into the relationship between trade openness and the size of government, as well as a possible explanation for the results of empirical tests of such a relationship. We develop a Hecksher-Ohlin model with publicly provided goods, where the level of publicly provided goods is determined in a probabilistic voting framework. In this context, we show that the start of trade may increase or decrease government size depending on the capital-labor ratio in each country.	[Arawatari, Ryo] Nagoya Univ, Nagoya, Aichi 4648601, Japan	Arawatari, R (reprint author), Nagoya Univ, Grad Sch Econ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	arawatari@soec.nagoya-u.ac.jp					Abizadeh S, 2005, APPL ECON, V37, P1881, DOI 10.1080/00036840500173049; CAMERON DR, 1978, AM POLIT SCI REV, V72, P1243, DOI 10.2307/1954537; Alesina A, 1998, J PUBLIC ECON, V69, P305, DOI 10.1016/S0047-2727(98)00010-3; Rodrik D, 1998, J POLIT ECON, V106, P997, DOI 10.1086/250038; LINDBECK A, 1987, PUBLIC CHOICE, V52, P273, DOI 10.1007/BF00116710; ROBERTS KWS, 1977, J PUBLIC ECON, V8, P329, DOI 10.1016/0047-2727(77)90005-6; FERNANDEZ R, 1991, AM ECON REV, V81, P1146; Benarroch M, 2008, ECON LETT, V101, P157, DOI 10.1016/j.econlet.2008.06.016; Benarroch M, 2012, J MACROECON, V34, P239, DOI 10.1016/j.jmacro.2011.11.002; Caliendo L., 2011, DYNAMICS HECKS UNPUB; Cavallo E., 2008, ECONOMIA, V9, P105; Islam MQ, 2004, APPL ECON, V36, P995, DOI 10.1080/0003684042000233221; Molana H., 2004, 2004164 U DUND; Persson T., 2000, POLITICAL EC EXPLAIN; Ram R, 2009, J PUBLIC ECON, V93, P213, DOI 10.1016/j.jpubeco.2008.04.009; MELTZER AH, 1981, J POLIT ECON, V89, P914, DOI 10.1086/261013; ROMER T., 1975, J PUBLIC ECON, V4, P163, DOI DOI 10.1016/0047-2727(75)90016-X	17	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	0954-1985	1468-0343		ECON POLIT-OXFORD	Econ. Polit.	MAR	2015	27	1					28	52		10.1111/ecpo.12049		25	Economics; Political Science	Business & Economics; Government & Law	CB5SR	WOS:000349688400002		
J	Yokoyama, R; Shinano, Y; Taniguchi, S; Ohkura, M; Wakui, T				Yokoyama, Ryohei; Shinano, Yuji; Taniguchi, Syusuke; Ohkura, Masashi; Wakui, Tetsuya			Optimization of energy supply systems by MILP branch and bound method in consideration of hierarchical relationship between design and operation	ENERGY CONVERSION AND MANAGEMENT			English	Article						Energy supply systems; Optimal design; Optimal operation; Mixed-integer linear programming; Branch and bound method; Hierarchical approach	TURBINE COGENERATION PLANTS; STRUCTURAL DESIGN; UTILITY SYSTEMS	To attain the highest performance of energy supply systems, it is necessary to rationally determine types, capacities, and numbers of equipment in consideration of their operational strategies corresponding to seasonal and hourly variations in energy demands. In the combinatorial optimization method based on the mixed-integer linear programming (MILP), integer variables are used to express the selection, numbers, and on/off status of operation of equipment, and the number of these variables increases with those of equipment and periods for variations in energy demands, and affects the computation efficiency significantly. In this paper, a MILP method utilizing the hierarchical relationship between design and operation variables is proposed to solve the optimal design problem of energy supply systems efficiently: At the upper level, the optimal values of design variables are searched by the branch and bound method; At the lower level, the values of operation variables are optimized independently at each period by the branch and bound method under the values of design variables given tentatively during the search at the upper level; Lower bounds for the optimal value of the objective function to be minimized are evaluated, and are utilized for the bounding operations at both the levels. This method is implemented into open and commercial MILP solvers. Illustrative and practical case studies on the optimal design of co-generation systems are conducted, and the validity and effectiveness of the proposed method are clarified. (C) 2014 Elsevier Ltd. All rights reserved.	[Yokoyama, Ryohei; Taniguchi, Syusuke; Ohkura, Masashi; Wakui, Tetsuya] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Shinano, Yuji] Zuse Inst Berlin, Dept Optimizat, D-14195 Berlin, Germany	Yokoyama, R (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	yokoyama@me.osakafu-u.ac.jp			IBM Academic Initiative	A part of this work has been supported by the IBM Academic Initiative.	Adjiman CS, 1998, HDB COMBINATORIAL OP, V1, P1; Voll P, 2013, ENERGY, V50, P374, DOI 10.1016/j.energy.2012.10.045; Lozano MA, 2009, ENERG BUILDINGS, V41, P1063, DOI 10.1016/j.enbuild.2009.05.008; Iyer RR, 1998, COMPUT CHEM ENG, V22, P979, DOI 10.1016/S0098-1354(97)00270-6; PAPOULIAS SA, 1983, COMPUT CHEM ENG, V7, P695, DOI 10.1016/0098-1354(83)85022-4; Piacentino A, 2013, APPL ENERG, V111, P1204, DOI 10.1016/j.apenergy.2012.11.078; Carvalho M, 2011, ENERGY, V36, P3779, DOI 10.1016/j.energy.2010.09.023; Yokoyama R, 2006, J ENG GAS TURB POWER, V128, P336, DOI 10.1115/1.2131889; Lozano MA, 2010, ENERGY, V35, P794, DOI 10.1016/j.energy.2009.08.022; Yokoyama R, 2002, ENERG CONVERS MANAGE, V43, P771, DOI 10.1016/S0196-8904(01)00075-9; Zhou Z, 2013, APPL THERM ENG, V53, P387, DOI 10.1016/j.applthermaleng.2012.01.067; BALAS E, 1972, SIAM J APPL MATH, V23, P61, DOI 10.1137/0123007; HORII S, 1987, INT J ENERG RES, V11, P507, DOI 10.1002/er.4440110407; GLOVER F, 1975, MANAGE SCI, V22, P455, DOI 10.1287/mnsc.22.4.455; Voll P, 2012, ENERGY, V45, P424, DOI 10.1016/j.energy.2012.01.041; Buoro D, 2012, ENERG CONVERS MANAGE, V60, P96, DOI 10.1016/j.enconman.2012.02.008; Buoro D, 2013, ENERGY, V58, P128, DOI 10.1016/j.energy.2012.12.003; Fujita K, 1998, T JSME C, V64, P354; IBM, IBM ILOG CPLEX OPT S; Kuester IL, 1972, OPTIMIZATION TECHNIQ; Owen JH, 2002, OPER RES, V50, P810, DOI 10.1287/opre.50.5.810.370; PAINTON LA, 1994, COMPUT CHEM ENG, V18, P369, DOI 10.1016/0098-1354(94)88018-2; Voll P, 2013, CHEM ENGINEER TRANS, V35, P277, DOI 10.3303/CET1335046; Wakui T, 2014, ENERGY, V64, P719, DOI 10.1016/j.energy.2013.10.002; Yokoyama R, 2000, T JSME C, V66, P4016; Yokoyama R, 2012, P 25 INT C EFF COST	26	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0196-8904	1879-2227		ENERG CONVERS MANAGE	Energy Conv. Manag.	MAR 1	2015	92						92	104		10.1016/j.enconman.2014.12.020		13	Thermodynamics; Energy & Fuels; Mechanics; Physics, Nuclear	Thermodynamics; Energy & Fuels; Mechanics; Physics	CB6GF	WOS:000349724800009		
J	Hirokawa, M; Morita, H; Tajima, T; Takahashi, A; Ashikawa, K; Miya, F; Shigemizu, D; Ozaki, K; Sakata, Y; Nakatani, D; Suna, S; Imai, Y; Tanaka, T; Tsunoda, T; Matsuda, K; Kadowaki, T; Nakamura, Y; Nagai, R; Komuro, I; Kubo, M				Hirokawa, Megumi; Morita, Hiroyuki; Tajima, Tomoyuki; Takahashi, Atsushi; Ashikawa, Kyota; Miya, Fuyuki; Shigemizu, Daichi; Ozaki, Kouichi; Sakata, Yasuhiko; Nakatani, Daisaku; Suna, Shinichiro; Imai, Yasushi; Tanaka, Toshihiro; Tsunoda, Tatsuhiko; Matsuda, Koichi; Kadowaki, Takashi; Nakamura, Yusuke; Nagai, Ryozo; Komuro, Issei; Kubo, Michiaki			A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY-DISEASE; C-LIKE PROTEIN; ASIAN POPULATIONS; GENETIC RISK; METAANALYSIS; MECHANISMS; IMPUTATION; GENOTYPES; IMMUNE	Despite considerable progress in preventive and therapeutic strategies, myocardial infarction (MI) is one of the leading causes of death throughout the world. A total of 55 susceptibility genes have been identified mostly in European genome-wide association studies (GWAS). Nevertheless, large-scale GWAS from other population could possibly find additional susceptibility loci. To identify as many MI susceptibility loci as possible, we performed a large-scale genomic analysis in Japanese population. To identify MI susceptibility loci in Japanese, we conducted a GWAS using 1666 cases and 3198 controls using the Illumina Human610-Quad BeadChip and HumanHap550v3 Genotyping BeadChip. We performed replication studies using a total of 11 412 cases and 28 397 controls in the Japanese population. Our study identified two novel susceptibility loci for MI: PLCL2 on chromosome 3p24.3 (rs4618210: A>G, P = 2.60 x 10(-9), odds ratio (OR) =0.91) and AP3D1-DOT1L-SF3A2 on chromosome 19p13.3 (rs3803915: A>C, P = 3.84 x 10(-9), OR = 0.89). Besides, a total of 14 previously reported MI susceptibility loci were replicated in our study. In particular, we validated a strong association on chromosome 12q24 (rs3782886: A>G: P = 1.14 x 10(-14), OR = 1.46). Following pathway analysis using 265 genes related to MI or coronary artery disease, we found that these loci might be involved in the pathogenesis of MI via the promotion of atherosclerosis. In the present large-scale genomic analysis, we identified PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for MI in the Japanese population. Our findings will add novel findings for MI susceptibility loci.	[Hirokawa, Megumi; Tajima, Tomoyuki; Ashikawa, Kyota; Kubo, Michiaki] RIKEN Yokohama Inst, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Hirokawa, Megumi; Tajima, Tomoyuki; Imai, Yasushi; Nagai, Ryozo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Morita, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Tokyo 1138655, Japan; [Takahashi, Atsushi] RIKEN Yokohama Inst, Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Miya, Fuyuki; Shigemizu, Daichi; Tsunoda, Tatsuhiko] RIKEN Yokohama Inst, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa 2300045, Japan; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN Yokohama Inst, Ctr Genom Med, Lab Cardiovasc Dis, Yokohama, Kanagawa 2300045, Japan; [Sakata, Yasuhiko; Nakatani, Daisaku; Suna, Shinichiro; Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Sakata, Yasuhiko] Osaka Univ, Grad Sch Med, Dept Adv Cardiovasc Therapeut, Suita, Osaka, Japan; [Sakata, Yasuhiko] Tohoku Univ, Dept Evidence Based Cardiovasc Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Sakata, Yasuhiko] Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Matsuda, Koichi; Nakamura, Yusuke] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci, Tokyo 1138655, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138655, Japan	Morita, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hmrt-tky@umin.net; mkubo@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Tanaka, Toshihiro/J-9310-2014	Tanaka, Toshihiro/0000-0001-6201-9784	Ministry of Education, Culture, Sports, Science and Technology, Japan; BioBank Japan; Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan	We thank T Aoi, H Amitani, Y Tsuchiya, and E Kanno for their contributions to the SNP genotyping and their technical assistance. We also thank other staff members of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN. We thank all the subjects for participating in the study and also thank the collaborating physicians for performing the sample collection. We are grateful to the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was conducted as a part of the BioBank Japan Project, supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Takeuchi F, 2011, CIRC J, V75, P911, DOI 10.1253/circj.CJ-10-0774; Perry HM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00373; Aoki A, 2011, J HUM GENET, V56, P47, DOI 10.1038/jhg.2010.141; Fukuyama H, 2002, EUR J IMMUNOL, V32, P223, DOI 10.1002/1521-4141(200201)32:1<223::AID-IMMU223>3.0.CO;2-4; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; [Anonymous], 2013, NAT GENET, V45, P25; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Kobayashi SD, 2003, J IMMUNOL, V170, P3357; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; FALK E, 1995, CIRCULATION, V92, P657; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; BENNETT M, 1993, SCIENCE, V262, P105, DOI 10.1126/science.8211113; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Morita H, 2013, CIRC J, V77, P876, DOI 10.1253/circj.CJ-13-0126; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Zhou QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360	37	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1018-4813	1476-5438		EUR J HUM GENET	Eur. J. Hum. Genet.	MAR	2015	23	3					374	380		10.1038/ejhg.2014.110		7	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CB5MG	WOS:000349670900016		
J	Pham, NM; Nanri, A; Yasuda, K; Kurotani, K; Kuwahara, K; Akter, S; Sato, M; Hayabuchi, H; Mizoue, T				Ngoc Minh Pham; Nanri, Akiko; Yasuda, Kazuki; Kurotani, Kayo; Kuwahara, Keisuke; Akter, Shamima; Sato, Masao; Hayabuchi, Hitomi; Mizoue, Tetsuya			Habitual consumption of coffee and green tea in relation to serum adipokines: a cross-sectional study	EUROPEAN JOURNAL OF NUTRITION			English	Article						Coffee; Green tea; Adipokines; Japanese	PLASMINOGEN-ACTIVATOR INHIBITOR-1; INSULIN-RESISTANCE; COLORECTAL-CANCER; ADIPOSE-TISSUE; DECAFFEINATED COFFEE; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; PROSPECTIVE COHORT; CAFFEINE INTAKE; RISK-FACTORS	Coffee and green tea consumption may be associated with circulating adipokines, but data are inconsistent, scarce or lacking. We examined the association of coffee and green tea consumption with serum adiponectin, leptin, visfatin, resistin and plasminogen activator inhibitor-1 (PAI-1) among a Japanese working population. The authors analyzed data (n = 509) from a cross-sectional survey among Japanese workers aged 20-68 years. Serum adipokines were measured using a Luminex suspension bead-based multiplexed array. Coffee and green tea consumption was assessed using a validated diet history questionnaire, and caffeine consumption from these beverages was estimated. Multiple regression analysis was performed with adjustment for potential confounding variables. Coffee consumption was significantly, inversely associated with leptin and PAI-1 (P for trend = 0.007 and 0.02, respectively); compared with subjects consuming < 1 cup per day, those consuming a parts per thousand yen4 cups per day had 13 and 10 % lower means of leptin and PAI-1, respectively. Similar associations were observed for caffeine consumption (P for trend = 0.02 for both leptin and PAI-1). Additionally, we noted a significant positive association between coffee consumption and adiponectin in men (P for trend = 0.046), but not in women (P for trend = 0.43, P for interaction = 0.11). Moreover, there was a positive association between coffee consumption and resistin in current male smokers (P for trend = 0.01), but not in male non-smokers (P for trend = 0.35, P for interaction = 0.11). Green tea consumption was not associated with any adipokine. Higher consumption of coffee and caffeine but not green tea was associated with lower serum levels of leptin and PAI-1 in Japanese adults.	[Ngoc Minh Pham; Nanri, Akiko; Kurotani, Kayo; Kuwahara, Keisuke; Akter, Shamima; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, Tokyo 1628655, Japan; [Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Tokyo 1628655, Japan; [Sato, Masao] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Appl Biol Chem, Fukuoka 812, Japan; [Hayabuchi, Hitomi] Fukuoka Womens Univ, Grad Sch Nutr & Hlth Sci, Fukuoka, Japan	Pham, NM (reprint author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan.	minh.pn@tnu.edu.vn			Japan Society for the Promotion of Science [21390213]; Ministry of Education, Culture, Sports, Science and Technology [21790598]; National Center for Global Health and Medicine	We are grateful to the study participants for their cooperation and participation. We also thank Seiko Miyazaki and Yasutaka Horiuchi (Kyushu University); Emi Tanaka, Youko Tsuruda, Misaki Hirose, Meishu Sai, Miho Isayama, Midori Sasaki, Mie Shimomura and Azumi Uehara (Fukuoka Women's University); Yaeko Nagano (retired nurse); and Akiko Hayashi, Yu Teruyama, Kae Saito, Kayoko Washizuka and Yuho Mizoue (National Center for Global Health and Medicine) for their help in data collection. We extend our thanks to Kazuko Nagase and Dai Suzuki (Department of Metabolic Disorder, Diabetes Research Center, National Center for Global Health and Medicine) for their contributions to measurements of serum adipokines. This study was supported by a Grant-in-Aid for Scientific Research (B) (21390213) from the Japan Society for the Promotion of Science (To Dr Mizoue), a Grant-in-Aid for Young Scientists (B) (21790598) from the Ministry of Education, Culture, Sports, Science and Technology and a Grant of National Center for Global Health and Medicine (To Dr Nanri).	Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888; Buscemi S, 2009, EUR J CLIN NUTR, V63, P1200, DOI 10.1038/ejcn.2009.51; Greenberg JA, 2006, AM J CLIN NUTR, V84, P682; Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Cines DB, 1998, BLOOD, V91, P3527; Huang WS, 2013, J CELL PHYSIOL, V228, P1017, DOI 10.1002/jcp.24248; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952; Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834; Cabrera C, 2006, J AM COLL NUTR, V25, P79; Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796; Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002; Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007; Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548; Gils A, 2004, CURR MED CHEM, V11, P2323; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Andreasson AN, 2012, AM J HUM BIOL, V24, P595, DOI 10.1002/ajhb.22279; Danese E, 2012, CLIN CHIM ACTA, V413, P760, DOI 10.1016/j.cca.2012.01.019; Klatsky AL, 2008, AM J CARDIOL, V101, P825, DOI 10.1016/j.amjcard.2007.11.022; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Chen GC, 2014, OBES REV, V15, P134, DOI 10.1111/obr.12088; D'Avanzo B, 1993, Ann Epidemiol, V3, P595; Ding QX, 2011, TRENDS CARDIOVAS MED, V21, P20, DOI 10.1016/j.tcm.2012.01.004; Lagiou P, 1999, ANN NUTR METAB, V43, P23, DOI 10.1159/000012763; Marques-Vidal P, 2010, CLIN ENDOCRINOL, V72, P38, DOI 10.1111/j.1365-2265.2009.03628.x; Mure K, 2013, NUTRITION, V29, P982, DOI 10.1016/j.nut.2013.01.011; Grundy SM, 2002, CIRCULATION, V106, P3143; Nkondjock A., 2012, Coffee: emerging health effects and disease prevention, P197; Pham NM, 2012, EUR J CLIN NUTR, V66, P1323, DOI 10.1038/ejcn.2012.169; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Rosner B, 2010, MULTISAMPLE INFERENC, P516; Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001; Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61; Saito M, 2011, J NUTR METAB, V2011; Science and Technology Agency, 2005, STAND TABL FOOD COMP; Sone T, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.8326; Tsioufis C, 2006, J HUM HYPERTENS, V20, P470, DOI 10.1038/sj.jhh.1002014; Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93; Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142; Wu HY, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000191; Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6; Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097; Yu XF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-96	55	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-6207	1436-6215		EUR J NUTR	Eur. J. Nutr.	MAR	2015	54	2					205	214		10.1007/s00394-014-0701-4		10	Nutrition & Dietetics	Nutrition & Dietetics	CB6WF	WOS:000349766800005		
J	Asai, T				Asai, Tomohisa			Illusory body-ownership entails automatic compensative movement: for the unified representation between body and action	EXPERIMENTAL BRAIN RESEARCH			English	Article						Body; Action; Proprioceptive drift; Movement; Self-consciousness; Embodiment	TOUCH; ILLUSION; AGENCY; HANDS; MODEL; LIMB	The sense of body-ownership involves the integration of vision and somatosensation. In the rubber hand illusion (RHI), watching a rubber hand being stroked for a short time synchronously as one's own unseen hand is also stroked causes the observers to attribute the rubber hand to their own body. The RHI may elicit proprioceptive drift: The observers' sense of their own hand's location drifts toward the external proxy hand. The current experiments examined the possibility of observing, not the proprioceptive drift, but the actual drift "movement" during RHI induction. The participants' hand, located on horizontally movable board, tended to move toward the rubber hand only while they observed synchronous visuo-tactile stimulation. Furthermore, even when the participants' hand was located on a fixed, unmovable board (that is, the conventional RHI paradigm), participants automatically administered the force toward the rubber hand. These findings suggest that since awareness of our own body and action are fundamental to self-consciousness, these components of "minimal self" are closely related and integrated into "one agent" with a unified awareness of the body and action.	NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa 2430198, Japan	Asai, T (reprint author), NTT Commun Sci Labs, Human Informat Sci Lab, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	asai.tomohisa@lab.ntt.co.jp			 [22-415]	This study was conducted at Chiba University and supported by a Grant-in-Aid for JSPS Fellowship (22-415). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Tajadura-Jimenez A, 2012, CURR BIOL, V22, pR516, DOI 10.1016/j.cub.2012.04.028; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; WANN JP, 1992, EXP BRAIN RES, V91, P162; Schwabe L, 2007, CONSCIOUS COGN, V16, P661, DOI 10.1016/j.concog.2007.07.007; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Asai T, 2011, CONSCIOUS COGN, V20, P1744, DOI 10.1016/j.concog.2011.02.005; White RC, 2011, CONSCIOUS COGN, V20, P956, DOI 10.1016/j.concog.2011.03.021; Asai T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00244; Gallagher I. I., 2000, TRENDS COGN SCI, V4, P14, DOI DOI 10.1016/S1364-6613(99)01417-5; Kirk RE, 1995, EXPT DESIGN PROCEDUR, P150; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Ladavas E, 2010, COGNITIVE NEUROSCIEN; Preston C, 2011, NEUROCASE, V17, P473, DOI 10.1080/13554794.2010.532504; Rao AK, 2001, EXP BRAIN RES, V138, P438, DOI 10.1007/s002210100717; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	MAR	2015	233	3					777	785		10.1007/s00221-014-4153-0		9	Neurosciences	Neurosciences & Neurology	CB3UN	WOS:000349554600009		
J	Kitayama, S; Fujikake, H; Kokubu, M; Higuchi, T				Kitayama, Seiya; Fujikake, Hiroya; Kokubu, Masahiro; Higuchi, Takahiro			The relationship between spatial cognition and walking trajectory for passing through a doorway: Evident in individuals with dominant right eye?	EXPERIMENTAL BRAIN RESEARCH			English	Article						Spatial cognition; Pseudoneglect; Attention; Obstacle avoidance; Walking; Eye dominance	LINE-BISECTION JUDGMENTS; AIMING MOVEMENTS; FAR SPACE; NEGLECT; PSEUDONEGLECT; COLLISIONS; ATTENTION; ASYMMETRIES; REPRESENTATION; IMITATION	When individuals attempt to walk through the center of a doorway (i.e., spatial bisection), the body's midpoint at crossing can deviate from its true center. Such deviation could result from asymmetry in spatial cognition. However, previous studies failed to find a significant correlation between bisection performance during walking and that during line/spatial bisection. We investigated whether such failure would result from different effectors being used for bisection (i.e., body midpoint or finger/laser pointer). We also investigated whether the difference in an individual's eye dominance would affect the relationship. Thirty-two young adults (16 of them with right-eye dominance) participated. For a walking task, participants walked through the perceived center of a wide doorway. For a spatial bisection task, they observed the same doorway under two distance conditions (about 0.5 and 2 m) and aligned their body midpoint with the perceived center in the sagittal dimension. Both tasks were performed under three visual occlusion conditions (dominant eye, non-dominant eye, and no occlusion). The results showed that, for the spatial bisection task, occluding the dominant eye caused deviation of the bisected point to the contralateral side. However, for the walking task, such an effect was observed only in participants with a dominant right eye. Consequently, directional biases in both tasks were significantly correlated only for right-eye-dominant participants. These results suggest that, for right-eye-dominant individuals only, use of the same effector for both tasks showed a clear relationship between the two tasks. Possible explanations for these findings were discussed.	[Kitayama, Seiya; Fujikake, Hiroya; Higuchi, Takahiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo 1920397, Japan; [Kokubu, Masahiro] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	Higuchi, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, 1-1 Minami Ohsawa, Hachioji, Tokyo 1920397, Japan.	higuchit@tmu.ac.jp					Chaminade T, 2005, NEUROPSYCHOLOGIA, V43, P115, DOI 10.1016/j.neuropsychologia.2004.04.026; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Gamberini L, 2008, NEUROPSYCHOLOGIA, V46, P1298, DOI 10.1016/j.neuropsychologia.2007.12.016; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; KARNATH HO, 1994, BRAIN, V117, P1001, DOI 10.1093/brain/117.5.1001; Roth HL, 2002, BRAIN, V125, P2023, DOI 10.1093/brain/awf210; Miles WR, 1930, J GEN PSYCHOL, V3, P412; ROY EA, 1994, BRAIN COGNITION, V24, P289, DOI 10.1006/brcg.1994.1017; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Goodale MA, 2011, VISION RES, V51, P1567, DOI 10.1016/j.visres.2010.07.027; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Newport R, 2009, NEUROPSYCHOLOGIA, V47, P2008, DOI 10.1016/j.neuropsychologia.2009.02.017; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Lourenco SF, 2009, COGNITION, V112, P451, DOI 10.1016/j.cognition.2009.05.011; MILNER AD, 1992, NEUROPSYCHOLOGIA, V30, P515, DOI 10.1016/0028-3932(92)90055-Q; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; NICHELLI P, 1989, BRAIN COGNITION, V9, P57, DOI 10.1016/0278-2626(89)90044-4; Nicholls MER, 2007, NEUROPSYCHOLOGIA, V45, P1122, DOI 10.1016/j.neuropsychologia.2006.07.015; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Bouffard J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00077; Ceyte H, 2006, EXP BRAIN RES, V170, P136, DOI 10.1007/s00221-006-0389-7; ELLIOTT D, 1993, CAN J EXP PSYCHOL, V47, P570, DOI 10.1037/h0078856; Foxe JJ, 2003, NEUROIMAGE, V19, P710, DOI 10.1016/S1053-8119(03)00057-0; Fujikake H, 2011, EXP BRAIN RES, V210, P195, DOI 10.1007/s00221-011-2621-3; Graff-Radford J, 2006, CORTEX, V42, P699, DOI 10.1016/S0010-9452(08)70407-6; Hatin B, 2012, CORTEX, V48, P997, DOI 10.1016/j.cortex.2011.05.015; Nicholls MER, 2008, BRAIN COGNITION, V68, P166, DOI 10.1016/j.bandc.2008.04.003; Nicholls MER, 2010, ATTEN PERCEPT PSYCHO, V72, P1576, DOI 10.3758/APP.72.6.1576; Saj A, 2006, NEUROLOGY, V67, P1500, DOI 10.1212/01.wnl.0000239823.28570.87; Saj A, 2010, J NEUROSURG PSYCHIAT, V79, P991; Shumway-Cook A, 2001, MOTOR CONTROL THEORY; Thomas NA, 2009, J INT NEUROPSYCH SOC, V15, P225, DOI 10.1017/S1355617709090328; Turnbull OH, 1998, BRAIN COGNITION, V37, P31; Vale A, 2008, OPHTHAL PHYSL OPT, V28, P135, DOI 10.1111/j.1475-1313.2008.00543.x	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	MAR	2015	233	3					797	807		10.1007/s00221-014-4155-y		11	Neurosciences	Neurosciences & Neurology	CB3UN	WOS:000349554600011		
J	Morikawa, N; Minegishi, Y; Inoue, A; Maemondo, M; Kobayashi, K; Sugawara, S; Harada, M; Hagiwara, K; Okinaga, S; Oizumi, S; Nukiwa, T; Gemma, A				Morikawa, Naoto; Minegishi, Yuji; Inoue, Akira; Maemondo, Makoto; Kobayashi, Kunihiko; Sugawara, Shunichi; Harada, Masao; Hagiwara, Koichi; Okinaga, Shoji; Oizumi, Satoshi; Nukiwa, Toshihiro; Gemma, Akihiko		North-East Japan Study Grp	First-line gefitinib for elderly patients with advanced NSCLC harboring EGFR mutations. A combined analysis of North-East Japan Study Group studies	EXPERT OPINION ON PHARMACOTHERAPY			English	Review						EGFR tyrosine kinase inhibitors; elderly patients; gefitinib; NSCLC	CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; OPEN-LABEL; CARBOPLATIN-PACLITAXEL; PHASE-III; CHEMOTHERAPY; ERLOTINIB; TRIAL; MULTICENTER; SURVIVAL	Objective: To assess outcomes of elderly patients with advanced NSCLC harboring an EGFR mutation treated with gefitinib, as well as safety and impact on quality of life (QoL). Methods: We performed a retrospective analysis of pooled data from one Phase III and two Phase II studies of 71 patients aged >= 70 years with a performance status of 0-2. The main outcome measures were progression-free survival (PFS), overall survival (OS) and response rate (RR), as well as incidence of adverse events and time to 9.1% deterioration in QoL. Results: Median PFS (14.3 vs 5.7 months, p < 0.001) and overall RR (73.2 vs 26.5%, p < 0.001) in the gefitinib group were superior to those in the standard chemotherapy group, whereas median OS was not significantly different (30.8 vs 26.4 months, p = 0.42). Elevation of aspartate transaminase and/or alanine transaminase (18.3%) was the most common adverse event, and one treatment-related death (pneumonitis) occurred. Time to 9.1% deterioration in the QoL domains of pain and dyspnea, anxiety, and daily functioning was similar between the two age groups. Conclusion: First-line gefitinib is efficacious with acceptable toxicity in relatively fit elderly patients with advanced NSCLC harboring an EGFR mutation.	[Morikawa, Naoto] Iwate Med Univ, Sch Med, Div Pulm Med Allergy & Rheumatol, Dept Internal Med, Morioka, Iwate 0208505, Japan; [Minegishi, Yuji; Gemma, Akihiko] Nippon Med Sch, Tokyo 113, Japan; [Inoue, Akira; Okinaga, Shoji] Tohoku Univ, Sendai, Miyagi 980, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Natori, Miyagi, Japan; [Kobayashi, Kunihiko; Hagiwara, Koichi] Saitama Med Univ, Moroyama, Saitama, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Sendai, Miyagi, Japan; [Harada, Masao] Natl Hosp Org, Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; [Oizumi, Satoshi] Hokkaido Univ, Sapporo, Hokkaido 060, Japan; [Nukiwa, Toshihiro] AntiTB Assoc, Tokyo, Japan	Morikawa, N (reprint author), Iwate Med Univ, Sch Med, Div Pulm Med Allergy & Rheumatol, Dept Internal Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	carcinoma@nifty.com			AstraZeneca; Japan Society for Promotion of Science; Japanese Foundation for Multidisciplinary Treatment of Cancer; Tokyo Cooperative Oncology Group; AstraZeneca K.K. (Osaka, Japan)	K Kobayashi and K Hagiwara have received research support from AstraZeneca. The NEJ002 study was supported by Grants-in-Aid from the Japan Society for Promotion of Science and the Japanese Foundation for Multidisciplinary Treatment of Cancer and a grant from the Tokyo Cooperative Oncology Group. We wish to thank William Ng for providing medical writing support, which was funded by AstraZeneca K.K. (Osaka, Japan) according to a publication support agreement. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Maemondo M, 2012, J THORAC ONCOL, V7, P1417, DOI 10.1097/JTO.0b013e318260de8b; Wheatley-Price P, 2008, J CLIN ONCOL, V26, P2350, DOI 10.1200/JCO.2007.15.2280; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Crino L, 2008, J CLIN ONCOL, V26, P4253, DOI 10.1200/JCO.2007.15.0672; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Oizumi S, 2012, ONCOLOGIST, V17, P863, DOI 10.1634/theoncologist.2011-0426; Jackman DM, 2007, J CLIN ONCOL, V25, P760, DOI 10.1200/JCO.2006.07.5754; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Oizumi S., 2014, J CLIN ONCOL S, V32; Seto T, 2014, LANCET ONCOL, V15, P1236, DOI 10.1016/S1470-2045(14)70381-X; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033	20	1	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-6566	1744-7666		EXPERT OPIN PHARMACO	Expert Opin. Pharmacother.	MAR	2015	16	4					465	472		10.1517/14656566.2015.1002396		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CB5MC	WOS:000349670500004		
J	Uto, Y				Uto, Yoshikazu			Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676)	EXPERT OPINION ON THERAPEUTIC PATENTS			English	Article						Alzheimer's disease; cholesterol 24-hydroxylase; CYP46A1; imidazopyridine	CYTOCHROME-P450 46A1; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; CHOLESTEROL-24S-HYDROXYLASE CYP46A1; IN-VITRO; BRAIN; VORICONAZOLE; 24S-HYDROXYCHOLESTEROL; TURNOVER; HOMEOSTASIS	A series of imidazo[1,2-a]pyridine analogs that effectively inhibit cholesterol 24-hydroxylase (CYP46A1) was reported in WO2014061676. The treatment or prophylaxis of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, by these novel CYP46A1 inhibitors is claimed in the patent. These compounds represent a novel pharmacophore that is different from other structural motifs described in the prior patent publications by Takeda Pharmaceutical Company Ltd.	Daiichi Sankyo Co Ltd, Venture Sci Labs, Shinagawa Ku, Tokyo 1408710, Japan	Uto, Y (reprint author), Daiichi Sankyo Co Ltd, Venture Sci Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	uto.yoshikazu.pw@daiichisankyo.co.jp					Theuretzbacher U, 2006, CLIN PHARMACOKINET, V45, P649, DOI 10.2165/00003088-200645070-00002; Leoni V, 2006, NEUROSCI LETT, V397, P83, DOI 10.1016/j.neulet.2005.11.046; Fourgeux C, 2011, CHEM PHYS LIPIDS, V164, P496, DOI 10.1016/j.chemphyslip.2011.04.006; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Puzzo D, 2014, BIOCHEM PHARMACOL, V88, P450, DOI 10.1016/j.bcp.2014.01.011; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Paul SM, 2013, J NEUROSCI, V33, P17290, DOI 10.1523/JNEUROSCI.2619-13.2013; Shafaati M, 2010, J LIPID RES, V51, P318, DOI [10.1194/jlr.M900174-JLR200, 10.1194/jlr.M900174]; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046; Fourgeux C, 2014, BIOCHEM BIOPH RES CO, V446, P775, DOI 10.1016/j.bbrc.2014.01.118; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Jeong S, 2009, ANTIMICROB AGENTS CH, V53, P541, DOI 10.1128/AAC.01123-08; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Leoni V, 2013, J ALZHEIMERS DIS, V36, P739, DOI 10.3233/JAD-130035; Bjoerkhem I, 2013, NEUROSCI LETT, V555, P102; Heike K, 2009, EUR PSYCHIAT, V24, P183; Koelsch H., 2002, Molecular Psychiatry, V7, P899; Li L, 2013, J NEUROL, V260, P1701, DOI 10.1007/s00415-012-6690-4; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; McLean KJ, 2012, BIOCHEM SOC T, V40, P587, DOI 10.1042/BST20120077; Muijsers RBR, 2002, DRUGS, V62, P2655, DOI 10.2165/00003495-200262180-00010; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; Schonknecht P, 2002, NEUROSCI LETT, V324, P83, DOI 10.1016/S0304-3940(02)00164-7; Takeda Pharmaceutical Co. Ltd, 2010, Patent No. [WO10110400, 13054822]; Takeda Pharmaceutical Co. Ltd, 2013, Patent No. [WO13054822, 14092100]; Takeda Pharmaceutical Co. Ltd, 2014, Patent No. [WO14092100, 14061676]; Takeda Pharmaceutical Co. Ltd, 2010, Web Site 2014, Patent No. 10110400; Zhao S, 2009, NEUROSCIENCE, V164, P398, DOI 10.1016/j.neuroscience.2009.08.027	30	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-3776	1744-7674		EXPERT OPIN THER PAT	Expert Opin. Ther. Patents	MAR	2015	25	3					373	377		10.1517/13543776.2014.989214		5	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CB4XD	WOS:000349630800009		
J	Hayashi, T; Higo, E; Orito, H; Ago, K; Ogata, M				Hayashi, Takahito; Higo, Eri; Orito, Hideki; Ago, Kazutoshi; Ogata, Mamoru			Postmortem wounds caused by cookie-cutter sharks (Isistius species): an autopsy case of a drowning victim	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Editorial Material							INJURIES; ATTACKS; TRAUMA; HEART		[Hayashi, Takahito; Higo, Eri; Ago, Kazutoshi; Ogata, Mamoru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, Kagoshima 8908544, Japan; [Orito, Hideki] Japan Coast Guard, Reg Coast Guard Headquarters 10, Yatsushiro Coast Guard Stn, Kumamoto 8660033, Japan	Hayashi, T (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	takahito@m2.kufm.kagoshima-u.ac.jp					Byard RW, 2000, AM J FOREN MED PATH, V21, P225, DOI 10.1097/00000433-200009000-00008; Weiss BF, 2001, MED J AUSTRALIA, V175, P33; [Anonymous], 2013, STAT INF; Bell MD, 2005, FORENSIC PATHOLOGY P, P227; Bury D, 2012, J FORENSIC SCI, V57, P370, DOI 10.1111/j.1556-4029.2011.01921.x; Byard RW, 2002, AM J FOREN MED PATH, V23, P238, DOI 10.1097/00000433-200209000-00006; Ebert D.A., 2003, SHARKS RAYS CHIMAERA; Haddad V, 2008, WILD ENVIRON MED, V19, P114, DOI 10.1580/07-WEME-CR-1182.1; Harding BE, 2006, J FORENSIC SCI, V51, P674, DOI 10.1111/j.1556-4029.2006.00135.x; Honebrink R, 2011, PAC SCI, V65, P365, DOI 10.2984/65.3.365; Ihama Yoko, 2009, Legal Medicine, V11, P219, DOI 10.1016/j.legalmed.2009.06.002; Makino Y, 2004, AM J FOREN MED PATH, V25, P169, DOI 10.1097/01.paf.0000127390.07879.62; Meyer PK, 1997, WILD ENVIRON MED, V8, P24, DOI 10.1580/1080-6032(1997)008[0024:SI]2.3.CO;2; Morgan M., 2004, B ROY COLL PATHOL, V128, P16; Nambiar P, 1991, J Forensic Odontostomatol, V9, P1; Yoshino N, 2013, RES PRACT FORENS MED, V56, P193	16	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.	MAR	2015	11	1					119	121		10.1007/s12024-014-9597-9		3	Medicine, Legal; Pathology	Legal Medicine; Pathology	CB1PV	WOS:000349401000022		
J	Piras, V; Selvarajoo, K				Piras, Vincent; Selvarajoo, Kumar			The reduction of gene expression variability from single cells to populations follows simple statistical laws	GENOMICS			English	Article						Single cells; Gene expression; Transcriptomics; Noise analysis; Central limit theorem; Law of large numbers	MESSENGER-RNA-SEQ; SACCHAROMYCES-CEREVISIAE; NOISE; REVEALS; TRANSCRIPTOME; DYNAMICS; BACTERIA; CYCLE; HETEROGENEITY; STOCHASTICITY	Recent studies on single cells and population transcriptomics have revealed striking differences in global gene expression distributions. Single cells display highly variable expressions between cells, while cell populations present deterministic global patterns. The mechanisms governing the reduction of transcriptome-wide variability over cell ensemble size, however, remain largely unknown. To investigate transcriptome-wide variability of single cells to different sizes of cell populations, we examined RNA-Seq datasets of 6 mammalian cell types. Our statistical analyses show, for each cell type, increasing cell ensemble size reduces scatter in transcriptome-wide expressions and noise (variance over square mean) values, with corresponding increases in Pearson and Spearman correlations. Next, accounting for technical variability by the removal of lowly expressed transcripts, we demonstrate that transcriptome-wide variability reduces, approximating the law of large numbers. Subsequent analyses reveal that the entire gene expressions of cell populations and only the highly expressed portion of single cells are Gaussian distributed, following the central limit theorem. (C) 2014 Elsevier Inc. All rights reserved.	[Selvarajoo, Kumar] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970035, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2520882, Japan	Selvarajoo, K (reprint author), Keio Univ, Inst Adv Biosci, 14-1 Baba Cho, Tsuruoka, Yamagata 9970035, Japan.	kumar@ttck.keio.ac.jp	Piras, Vincent/K-3203-2012	Piras, Vincent/0000-0002-3427-0995	Japan Society for the Promotion of Science (JSPS) [J13108]; Tsuruoka City, Yamagata Prefecture	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research J13108 (K.S.), and Tsuruoka City, Yamagata Prefecture.	Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Gencay R, 1998, J FORECASTING, V17, P401, DOI 10.1002/(SICI)1099-131X(1998090)17:5/6<401::AID-FOR704>3.0.CO;2-C; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/nmeth.1315, 10.1038/NMETH.1315]; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Wills QF, 2013, NAT BIOTECHNOL, V31, P748, DOI 10.1038/nbt.2642; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Theraulaz G, 2003, PHILOS T ROY SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; [Anonymous], 1983, J R STAT SOC C-APPL; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; BOLCH BW, 1968, AM STAT, V22, P27, DOI 10.2307/2681802; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Giuliani A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S2; Grinstead Charles M., 2006, INTRO PROBABILITY; Hide C, 2003, J NAVIGATION, V56, P143, DOI 10.1017/S0373463302002151; Holtzendorff J, 2001, J BACTERIOL, V183, P915, DOI 10.1128/JB.183.3.915-920.2001; Kalnay E., 2002, ATMOSPHERIC MODELING; Murakami H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097870; PEIZER DB, 1968, J AM STAT ASSOC, V63, P1416, DOI 10.2307/2285895; Piras V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00439; Piras V, 2014, SCI REP-UK, V4, DOI 10.1038/srep07137; Romagnoli G, 2011, EXP CELL RES, V317, P2958, DOI 10.1016/j.yexcr.2011.09.007; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Selvarajoo K, 2012, WIRES SYST BIOL MED, V4, P385, DOI 10.1002/wsbm.1175; Selvarajoo K, 2013, SCIENCE, V339, P646, DOI 10.1126/science.339.6120.646-a; Selvarajoo K, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-23; Selvarajoo K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00007; Selvarajoo K, 2013, BIOSCIENCE, V63, P721, DOI 10.1525/bio.2013.63.9.7; Selvarajoo K, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-9; Sumpter D. J., 2005, PHILOS T R SOC B, V361, P5; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x	53	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543	1089-8646		GENOMICS	Genomics	MAR	2015	105	3					137	144		10.1016/j.ygeno.2014.12.007		8	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	CB7CC	WOS:000349782700002		
J	Inoue, Y; Funk, DC; Wann, DL; Yoshida, M; Nakazawa, M				Inoue, Yuhei; Funk, Daniel C.; Wann, Daniel L.; Yoshida, Masayuki; Nakazawa, Makoto			Team Identification and Postdisaster Social Well-Being: The Mediating Role of Social Support	GROUP DYNAMICS-THEORY RESEARCH AND PRACTICE			English	Article						disasters; social identification; social support; social well-being; team identification	PSYCHOLOGICAL HEALTH MODEL; IDENTITY; ORGANIZATION; CONTEXT; STRESS; SPORT; SELF; INTERVENTION; DEFINITION; STRATEGIES	This research confirms the relationship between team identification and social wellbeing in times of adversity, and demonstrates how the perception of 2 types of social support-instrumental and emotional support-mediates this relationship. Analysis of data from spectators attending Japanese professional soccer games in the aftermath of the 2011 Great East Japan Earthquake identified a positive relationship between spectators' identification with a hometown team and postdisaster community cohesion, an indicator of social well-being. However, this relationship was partially mediated by the level of emotional support spectators perceived being provided by the team. In addition, perceptions of instrumental support from the team were unaffected by team identification, but positively predicted community cohesion. Our findings offer unique evidence for the ability of team identification to generate psychological benefits in the face of adversity, and advances the understanding of the mechanisms by which team identification leads to social well-being. This research further demonstrates that the mediating role of social support in the relationship between social identification and well-being may depend on the context of social identification under investigation as well as types of social support and well-being measured.	[Inoue, Yuhei] Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA; [Funk, Daniel C.] Temple Univ, Sch Tourism & Hospitality Management, Philadelphia, PA 19122 USA; [Wann, Daniel L.] Murray State Univ, Dept Psychol, Murray, KY USA; [Yoshida, Masayuki] Biwako Seikei Sport Coll, Dept Athlet Sports, Otsu, Shiga, Japan; [Nakazawa, Makoto] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 305, Japan	Inoue, Y (reprint author), Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA.	yinoue@umn.edu			Japanese Professional Soccer League (J. League); University of Tsukuba; J. League	The data used for this research were collected as part of the Spectator Survey Project conducted and funded by the Japanese Professional Soccer League (J. League) and the University of Tsukuba in 2012. We thank the J. League for their support in this research.	Ahn T., 2012, J SPORT MANAGE, V27, P11; Ai A. L., 2011, RACE SOCIAL PROBLEMS, V3, P13; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037//0022-3514.77.1.135; Cox RS, 2011, AM J COMMUN PSYCHOL, V48, P395, DOI 10.1007/s10464-011-9427-0; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Dimmock JA, 2005, GROUP DYN-THEOR RES, V9, P75, DOI 10.1037/1089-2699.9.2.75; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; McNamara N, 2013, EUR J SOC PSYCHOL, V43, P393, DOI 10.1002/ejsp.1953; Adams GA, 1996, J APPL PSYCHOL, V81, P411, DOI 10.1037//0021-9010.81.4.411; Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468; Yoshida M, 2014, J SPORT MANAGE, V28, P399, DOI 10.1123/jsm.2013-0199; Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037; Outten HR, 2009, APPL PSYCHOL-INT REV, V58, P146, DOI 10.1111/j.1464-0597.2008.00386.x; Rossiter JR, 2002, INT J RES MARK, V19, P305, DOI 10.1016/S0167-8116(02)00097-6; Wu SH, 2012, J SPORT MANAGE, V26, P177; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; MAEL F, 1992, J ORGAN BEHAV, V13, P103, DOI 10.1002/job.4030130202; Cruwys T, 2014, PERS SOC PSYCHOL REV, V18, P215, DOI 10.1177/1088868314523839; Keyes CLM, 1998, SOC PSYCHOL QUART, V61, P121, DOI 10.2307/2787065; ASHFORTH BE, 1989, ACAD MANAGE REV, V14, P20, DOI 10.2307/258189; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; BRESLOW L, 1972, INT J EPIDEMIOL, V1, P347, DOI 10.1093/ije/1.4.347; Norris FH, 2001, HISPANIC J BEHAV SCI, V23, P469, DOI 10.1177/0739986301234008; Norris FH, 1996, J PERS SOC PSYCHOL, V71, P498, DOI 10.1037/0022-3514.71.3.498; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037//0022-3514.50.3.571; Wann DL, 2006, GROUP DYN-THEOR RES, V10, P272, DOI 10.1037/1089-2699.10.4.272; Kellezi B, 2009, APPL PSYCHOL-INT REV, V58, P59, DOI 10.1111/j.1464-0597.2008.00382.x; Levine M, 2004, J SOC PSYCHOL, V144, P229, DOI 10.3200/SOCP.144.3.229-245; Gleibs IH, 2011, PSYCHOL HEALTH, V26, P1361, DOI 10.1080/08870446.2010.529140; Bergami M, 2000, BRIT J SOC PSYCHOL, V39, P555, DOI 10.1348/014466600164633; Branscombe N. R., 1991, Journal of Sport and Social Issues, V15, P115, DOI 10.1177/019372359101500202; BUCKNER JC, 1988, AM J COMMUN PSYCHOL, V16, P771, DOI 10.1007/BF00930892; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037//0022-3514.56.2.267; Cimperman John, 1997, SPORT MARKETING Q, V6, P15; Drury J., 2009, INT J MASS EMERGENCI, V27, P66; Guha-Sapir D, 2012, ANN DISASTER STAT RE; Hair J. F. Jr., 1998, MULTIVARIATE DATA AN; Halabi S., 2010, PROSOCIAL MOTIVES EM, P181, DOI 10.1037/12061-010; Havard C. T., 2014, SPORT DISAS IN PRESS; HOLT DB, 1995, J CONSUM RES, V22, P1, DOI 10.1086/209431; Hunt K. A, 1999, J SERV MARK, V13, P439, DOI DOI 10.1108/08876049910298720; J. League, 2012, J LEAGUE FAN SURVEY; Kaniasty K, 2000, AM J COMMUN PSYCHOL, V28, P545, DOI 10.1023/A:1005192616058; Kaniasty K, 2012, PSYCHOL TRAUMA-US, V4, P22, DOI 10.1037/a0021412; KAUFMANN GM, 1989, HUM RELAT, V42, P185, DOI 10.1177/001872678904200205; Keyes C. L. M., 2002, HDB POSITIVE PSYCHOL, P45; Kwon HH, 2007, J SPORT MANAGE, V21, P540; League J., 2012, HIGASHI NIHON DAISHI; Mael FA, 2001, J THEOR SOC BEHAV, V31, P197, DOI 10.1111/1468-5914.00154; Markus F., 2013, 2 YEARS NEW PSYCHOL; Muthen L., 1998, MPLUS USERS GUIDE; Bergkvist L, 2007, J MARKETING RES, V44, P175, DOI 10.1509/jmkr.44.2.175; Rubin M, 1998, Pers Soc Psychol Rev, V2, P40, DOI 10.1207/s15327957pspr0201_3; Tajfel H., 1985, PSYCHOL INTERGROUP R, V2, P7; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Trail G. T., 2001, Journal of Sport Behavior, V24, P108; TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002; Wakefield K. L., 1995, Journal of Sport and Social Issues, V19, P335, DOI 10.1177/019372395019004002; Wann DL, 2003, GROUP DYN-THEOR RES, V7, P289, DOI 10.1037/1089-2699.7.4.289; Wann DL, 2011, GROUP DYN-THEOR RES, V15, P75, DOI 10.1037/a0020780; WANN D.L., 2001, SPORT FANS PSYCHOL S	63	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1089-2699	1930-7802		GROUP DYN-THEOR RES	Group Dyn.-Theory Res. Pract.	MAR	2015	19	1					31	44		10.1037/gdn0000019		14	Psychology, Social	Psychology	CB6BP	WOS:000349712200003		
J	Guo, TT; Yu, YN; Yip, GWC; Baeg, GH; Thike, AA; Lim, TKH; Tan, PH; Matsumoto, K; Bay, BH				Guo, TianTian; Yu, YingNan; Yip, George Wai-Cheong; Baeg, Gyeong Hun; Thike, Aye Aye; Lim, Tony Kiat-Hon; Tan, Puay Hoon; Matsumoto, Ken; Bay, Boon Huat			Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer	HISTOPATHOLOGY			English	Article						cell invasion; cell migration; immunohistochemistry; lauren classification; lymph node spread; YB-1	PROGNOSTIC-SIGNIFICANCE; HELICOBACTER-PYLORI; GENE AMPLIFICATION; YB-1; EXPRESSION; CARCINOMAS; MET; SURVIVAL; DISEASE; OVEREXPRESSION	AimsY-box binding protein-1 (YB-1) is known to modulate gene transcription and protein translation, as well as cellular response to drug treatment. The aim of this study is to correlate YB-1 protein expression levels with clinicopathological parameters in intestinal-type gastric cancer tissue samples (as categorized by the Lauren classification) and substantiate the findings with in vitro experimentation. Methods and resultsParaffin-embedded samples from 167 patients with intestinal-type gastric cancer were used for the construction of tissue microarrays (TMAs). TMA slides were immunostained and YB-1 immunoreactivity score was based on the weighted average intensity score. Univariate analysis revealed that YB-1 immunohistochemical expression was correlated significantly with lymph node status (P=0.054, borderline significance) and perforation (P=0.043). YB-1 expression was also found to be an independent predictor of lymph node spread by multivariate analysis. Furthermore, siRNA-mediated YB-1 gene knockdown in MKN7 gastric cancer cells (which is known to originate from an intestinal-type gastric cancer tissue) inhibited cell migration (P=0.0002) and invasion in vitro (P=0.0129) significantly. ConclusionYB-1 expression is associated with lymph node spread in intestinal-type gastric cancer and is a potential prognostic biomarker in this subtype of gastric cancer.	[Guo, TianTian; Yu, YingNan; Yip, George Wai-Cheong; Baeg, Gyeong Hun; Bay, Boon Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Thike, Aye Aye; Lim, Tony Kiat-Hon; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Matsumoto, Ken] Inst Phys & Chem Res RIKEN, Mol Entomol Lab, Saitama, Japan	Bay, BH (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, 4 Med Dr,MD10, Singapore 117597, Singapore.	boon_huat_bay@nuhs.edu.sg	Matsumoto, Ken/F-9083-2013	Matsumoto, Ken/0000-0002-7864-3394	National Research Foundation, Singapore [NMRC/TCR/001/NUS/2007]	This work was supported by a grant (NMRC/TCR/001/NUS/2007) from the National Research Foundation, Singapore.	Lasham A, 2003, J BIOL CHEM, V278, P35516, DOI 10.1074/jbc.M303920200; Thiel A, 2012, HELICOBACTER, V17, P26, DOI 10.1111/j.1523-5378.2012.00979.x; Kim SW, 2012, BRIT J RADIOL, V85, P1307, DOI 10.1259/bjr/21382039; Nakajima M, 1999, CANCER, V85, P1894; Lwin ZM, 2010, MODERN PATHOL, V23, P1559, DOI 10.1038/modpathol.2010.173; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Toyokawa T, 2009, ONCOL REP, V21, P875, DOI 10.3892/or_00000297; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Yu YN, 2010, INT J ONCOL, V37, P483, DOI 10.3892/ijo_00000697; Lasham A, 2012, J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Yoong J, 2011, DRUGS, V71, P1367, DOI 10.2165/11592530-000000000-00000; Bilici A, 2014, WORLD J GASTROENTERO, V20, P3905, DOI 10.3748/wjg.v20.i14.3905; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Kitadai Y, 1998, AM J PATHOL, V152, P93; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; van Rees BP, 2003, INT J CANCER, V107, P551, DOI 10.1002/ijc.11422; Jung JH, 2012, J GASTROENTEROL, V47, P37, DOI 10.1007/s00535-011-0463-1; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Stenina OI, 2000, J CLIN INVEST, V106, P579, DOI 10.1172/JCI9075; CUELLO C, 1979, AM J SURG PATHOL, V3, P491, DOI 10.1097/00000478-197912000-00002; Guo TT, 2013, ANAT REC, V296, P891, DOI 10.1002/ar.22702; Jurchott K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001231; Kabashima A, 2002, HUM PATHOL, V33, P80, DOI 10.1053/hupa.2002.30182; Nagashima N, 2008, ANTICANCER RES, V28, P1277; Tay WL, 2009, MODERN PATHOL, V22, P282, DOI 10.1038/modpathol.2008.181; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; Wayman J, 2001, CANCER CAUSE CONTROL, V12, P943, DOI 10.1023/A:1013756531219; Yasui W, 2001, Gastric Cancer, V4, P113, DOI 10.1007/PL00011733; Yokozaki H, 2001, INT REV CYTOL, V204, P49, DOI 10.1016/S0074-7696(01)04003-7	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAR	2015	66	4					491	499		10.1111/his.12570		9	Cell Biology; Pathology	Cell Biology; Pathology	CB4TU	WOS:000349621900004		
J	Takeuchi, Y; Miyagawa-Hayashino, A; Chen, F; Kubo, T; Handa, T; Date, H; Haga, H				Takeuchi, Yasuhide; Miyagawa-Hayashino, Aya; Chen, Fengshi; Kubo, Takeshi; Handa, Tomohiro; Date, Hiroshi; Haga, Hironori			Pleuroparenchymal fibroelastosis and non-specific interstitial pneumonia: frequent pulmonary sequelae of haematopoietic stem cell transplantation	HISTOPATHOLOGY			English	Article						bone marrow transplantation; fibroelastosis; interstitial pneumonia	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; BRONCHIOLITIS OBLITERANS; CLINICOPATHOLOGICAL ENTITY; LUNG TRANSPLANTATION; COMPLICATIONS; RECIPIENTS; DIAGNOSIS; CHEMOTHERAPY; DISORDERS	AimsPulmonary sequelae, reported as chronic graft-versus-host disease (cGVHD), of haematopoietic stem cell transplantation (HSCT) include constrictive bronchiolitis obliterans (CBO), lymphocytic bronchiolitis (LB), and veno-occlusive disease (VOD); recently, pleuroparenchymal fibroelastosis (PPFE) has also been described in bone marrow transplant recipients. The histological features of pulmonary HSCT sequelae have not been described systematically. The aim of the study was to review and identify the histological features of PPFE after bone marrow transplant. Methods and resultsA retrospective review of 20 patients who underwent lung transplantation for pulmonary disease following HSCT between 2004 and 2013 was conducted. The patient age at transplantation ranged from 8years to 57years (median, 27.5years). Fifteen patients had cGVHD in other organs (skin, nine; liver, six; salivary gland, six). Lung transplantation was performed at a median of 4.6years (range, 1.2-14.8years) post-HSCT. Histologically, all cases had CBO, with concurrent LB in 10, and VOD in three. PPFE was identified in 15 cases (75%), with subpleural (15), paraseptal (11) and centrilobular (13) distributions; and non-specific interstitial pneumonia (NSIP) was identified in 15 cases (75%), with fibrotic (nine) and cellular (six) patterns. PPFE was distributed in all lobes, with a predominance in the upper lobe. NSIP was mostly focal, with two cases having diffuse involvement. ConclusionsPPFE and NSIP were frequently seen in HSCT patients. Possible causes may include reactions to drugs or radiation, or cGVHD.	[Takeuchi, Yasuhide; Miyagawa-Hayashino, Aya; Haga, Hironori] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 6068517, Japan; [Chen, Fengshi; Date, Hiroshi] Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 6068517, Japan; [Kubo, Takeshi] Kyoto Univ Hosp, Dept Radiol, Kyoto 6068517, Japan; [Handa, Tomohiro] Kyoto Univ Hosp, Dept Resp Med, Kyoto 6068517, Japan	Miyagawa-Hayashino, A (reprint author), Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068517, Japan.	ayam@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science to A. Miyagawa-Hayashino. We thank Ms Hiroko Morita and Ms Hikari Inoue for secretarial work.	Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301.053SO; Becker CD, 2008, MODERN PATHOL, V21, P784, DOI 10.1038/modpathol.2008.56; Beynat-Mouterde C, 2014, EUR RESPIR J, V44, P523, DOI 10.1183/09031936.00214713; Fujikura Y, 2014, INTERNAL MED, V53, P43, DOI 10.2169/internalmedicine.53.1124; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Frankel SK, 2004, CHEST, V126, P2007, DOI 10.1378/chest.126.6.2007; Camus P, 2014, EUR RESPIR J, V44, P289, DOI 10.1183/09031936.00088414; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; Sharma S, 2005, CHEST, V128, P1385, DOI 10.1378/chest.128.3.1385; KATZENSTEIN ALA, 1994, AM J SURG PATHOL, V18, P136, DOI 10.1097/00000478-199402000-00003; Ofek E, 2013, MODERN PATHOL, V26, P350, DOI 10.1038/modpathol.2012.171; Tansey D, 2004, HISTOPATHOLOGY, V44, P585, DOI 10.1111/j.1365-2559.2004.01896.x; Soubani AO, 1996, CHEST, V109, P1066, DOI 10.1378/chest.109.4.1066; von der Thusen JH, 2011, MODERN PATHOL, V24, P1633, DOI 10.1038/modpathol.2011.114; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Flieder DB, 2004, CLIN CHEST MED, V25, P37, DOI 10.1016/S0272-5231(03)00138-2; Camus P, 2004, RESPIRATION, V71, P301, DOI 10.1159/000079633; Hildebrandt GC, 2011, BONE MARROW TRANSPL, V46, P1283, DOI 10.1038/bmt.2011.35; Chen F, 2011, AM J TRANSPLANT, V11, P1509, DOI 10.1111/j.1600-6143.2011.03591.x; Travis WD, 2008, AM J RESP CRIT CARE, V177, P1338, DOI 10.1164/rccm.200611-1685OC; CHAN CK, 1987, MEDICINE, V66, P327; Duncan CN, 2008, BONE MARROW TRANSPL, V41, P971, DOI 10.1038/bmt.2008.19; Kusagaya H, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-72; Miyagawa-Hayashino A, 2010, PATHOL INT, V60, P137, DOI 10.1111/j.1440-1827.2009.02492.x; Panoskaltsis-Mortari A, 2007, AM J RESP CRIT CARE, V176, P713, DOI 10.1164/rccm.200702-335OC; Parish JM, 2003, MAYO CLIN PROC, V78, P630; Piciucchi Sara, 2011, Respir Res, V12, P111, DOI 10.1186/1465-9921-12-111; Sverzellati N, 2007, J THORAC IMAG, V22, P230, DOI 10.1097/RTI.0b013e31802bddca; Wah TM, 2003, BRIT J RADIOL, V76, P373, DOI 10.1259/bjr/66835905; Watanabe Kentaro, 2012, Respir Investig, V50, P88, DOI 10.1016/j.resinv.2012.06.003; Yokoi T, 1997, VIRCHOWS ARCH, V431, P275, DOI 10.1007/s004280050099; YOUSEM SA, 1995, HUM PATHOL, V26, P668, DOI 10.1016/0046-8177(95)90174-4	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAR	2015	66	4					536	544		10.1111/his.12553		9	Cell Biology; Pathology	Cell Biology; Pathology	CB4TU	WOS:000349621900009		
J	Hirota, T; Yoshida, Y; Kitasato, Y; Yoshimi, M; Koga, T; Tsuruta, N; Minami, M; Harada, T; Ishii, H; Fujita, M; Nabeshima, K; Nagata, N; Watanabe, K				Hirota, Takako; Yoshida, Yuji; Kitasato, Yasuhiko; Yoshimi, Michihiro; Koga, Takaomi; Tsuruta, Nobuko; Minami, Masato; Harada, Taishi; Ishii, Hiroshi; Fujita, Masaki; Nabeshima, Kazuki; Nagata, Nobuhiko; Watanabe, Kentaro			Histological evolution of pleuroparenchymal fibroelastosis	HISTOPATHOLOGY			English	Article						acute lung injury; cellular interstitial pneumonia; idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; organizing pneumonia; pleuroparenchymal fibroelastosis; pulmonary upper lobe fibrosis	IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL PNEUMONIAS	AimsTo investigate the histological evolution in the development of pleuroparenchymal fibroelastosis (PPFE). Methods and resultsWe examined four patients who had undergone surgical lung biopsy twice, or who had undergone surgical lung biopsy and had been autopsied, and in whom the histological diagnosis of the first biopsy was not PPFE, but the diagnosis of the second biopsy or of the autopsy was PPFE. The histological patterns of the first biopsy were cellular and fibrotic interstitial pneumonia, cellular interstitial pneumonia (CIP) with organizing pneumonia, CIP with granulomas and acute lung injury in cases 1, 2, 3, and 4, respectively. Septal elastosis was already present in the non-specific interstitial pneumonia-like histology of case 1, but a few additional years were necessary to reach consolidated subpleural fibroelastosis. In case 3, subpleural fibroelastosis was already present in the first biopsy, but only to a small extent. Twelve years later, it was replaced by a long band of fibroelastosis. The septal inflammation and fibrosis and airspace organization observed in the first biopsies were replaced by less cellular subpleural fibroelastosis within 3-12years. ConclusionsInterstitial inflammation or acute lung injury may be an initial step in the development of PPFE.	[Hirota, Takako; Yoshida, Yuji; Harada, Taishi; Ishii, Hiroshi; Fujita, Masaki; Watanabe, Kentaro] Fukuoka Univ, Sch Med, Dept Resp Med, Fukuoka 8140180, Japan; [Kitasato, Yasuhiko; Yoshimi, Michihiro] Natl Hosp Org, Fukuoka Higashi Med Ctr, Dept Resp Med, Koga, Japan; [Koga, Takaomi] Natl Hosp Org, Fukuoka Higashi Med Ctr, Dept Lab Med, Koga, Japan; [Tsuruta, Nobuko] Hamanomachi Hosp, Dept Resp Med, Fukuoka, Japan; [Minami, Masato] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; [Nabeshima, Kazuki] Fukuoka Univ, Sch Med, Dept Pathol, Fukuoka 81401, Japan; [Nagata, Nobuhiko] Fukuoka Univ, Chikushi Hosp, Dept Resp Med, Fukuoka, Japan	Watanabe, K (reprint author), Fukuoka Univ, Sch Med, Dept Resp Med, Fukuoka 8140180, Japan.	watanabe@fukuoka-u.ac.jp			Ministry of Health, Labour and Welfare, Japan	This work was partly supported by a grant to the Diffuse Lung Diseases Research Group from the Ministry of Health, Labour and Welfare, Japan.	Amitani R, 1992, KOKYU, V11, P693; Frankel SK, 2004, CHEST, V126, P2007, DOI 10.1378/chest.126.6.2007; Camus P, 2014, EUR RESPIR J, V44, P289, DOI 10.1183/09031936.00088414; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Ofek E, 2013, MODERN PATHOL, V26, P350, DOI 10.1038/modpathol.2012.171; Hirota T, 2013, EUR RESPIR J, V41, P243, DOI 10.1183/09031936.00103912; Rozin GF, 2005, HISTOPATHOLOGY, V46, P413, DOI 10.1111/j.1365-2559.2005.02103.x; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680; Ishii H, 2003, THORAX, V58, P52, DOI 10.1136/thorax.58.1.52; Corrin B, 2011, PATHOLOGY LUNGS, P149; Enomoto N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-91; Flacherty KR, 2001, AM J RESP CRIT CARE, V164, P1722; Katzenstein AA, 2006, KATZENSTEIN ASKINS S, P75; KOHNO N, 1987, Hiroshima Journal of Medical Sciences, V36, P319; Negri EM, 2000, HISTOPATHOLOGY, V37, P393, DOI 10.1046/j.1365-2559.2000.00992.x; Watanabe K, 2013, CURR RESP MED REV, V9, P229; Watanabe Kentaro, 2012, Respir Investig, V50, P88, DOI 10.1016/j.resinv.2012.06.003	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAR	2015	66	4					545	554		10.1111/his.12554		10	Cell Biology; Pathology	Cell Biology; Pathology	CB4TU	WOS:000349621900010		
J	Yamaguchi, R; Tanaka, M; Tse, GM; Yamaguchi, M; Terasaki, H; Hirai, Y; Nonaka, Y; Morita, M; Yokoyama, T; Kanomata, N; Naito, Y; Akiba, J; Yano, H				Yamaguchi, Rin; Tanaka, Maki; Tse, Gary M.; Yamaguchi, Miki; Terasaki, Hiroshi; Hirai, Yoshitake; Nonaka, Yasuhide; Morita, Michi; Yokoyama, Toshiro; Kanomata, Naoki; Naito, Yoshiki; Akiba, Jun; Yano, Hirohisa			Management of breast papillary lesions diagnosed in ultrasound-guided vacuum-assisted and core needle biopsies	HISTOPATHOLOGY			English	Article						breast; core needle biopsy; mammotome; management; papillary lesions	SURGICAL FOLLOW-UP; INTRADUCTAL PAPILLOMA; DIFFERENTIAL-DIAGNOSIS; EXCISION; CARCINOMA; UNDERESTIMATION; FEATURES	AimsTo assess the outcome of breast papillary lesions diagnosed by ultrasound-guided core needle biopsy (CB) or vacuum-assisted mammotome' biopsy (MT), the accuracy of these diagnoses, and whether it is justified not to undertake surgical excision of non-malignant papillary lesions so diagnosed. Methods and resultsAmong 3219 (MT, 2195; CB, 1024) breast biopsies spanning 5years, 185 (5.7%) papillary lesions [MT, 162 (88%); CB, 23 (12%)] were identified. Of these, 142 cases (77%; MT/CB, 125/17) were benign, 24 (13%, 23/1) were atypical, and 19 (10%; 14/5) were malignant. Of the 142 benign cases, 114 had imaging follow-up (FU) (FU period 2-81months); 17 of 114 cases were excised, and four were malignant (3.5%) (FU period 4-57months). Of the 24 atypical cases (23 had FU), 19 were excised: six were benign (32%) and 13 malignant (68%). The remaining four cases were considered to be non-malignant (FU period 7-54months). ConclusionsBenign papillary lesions diagnosed by MT or CB might not require immediate excision, but should receive imaging FU for at least 5years. Excision should be performed in cases showing changes in imaging features, as the possibilities of carcinoma coexisting with papilloma or carcinoma developing from papilloma cannot be excluded, as illustrated by the 4% upgrade rate at excision in this study.	[Yamaguchi, Rin; Morita, Michi; Yokoyama, Toshiro] Kurume Gen Hosp, Dept Pathol, Kurume, Fukuoka, Japan; [Yamaguchi, Rin; Morita, Michi; Yokoyama, Toshiro] Kurume Gen Hosp, Lab Med, Kurume, Fukuoka, Japan; [Yamaguchi, Rin; Naito, Yoshiki; Akiba, Jun; Yano, Hirohisa] Kurume Gen Hosp, Dept Pathol, Kurume, Fukuoka, Japan; [Tanaka, Maki; Yamaguchi, Miki] Kurume Gen Hosp, Dept Surg, Kurume, Fukuoka, Japan; [Tse, Gary M.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Terasaki, Hiroshi] Kurume Gen Hosp, Dept Radiol, Kurume, Fukuoka, Japan; [Hirai, Yoshitake; Nonaka, Yasuhide] Kurume Gen Hosp, Dept Lab Med, Kurume, Fukuoka, Japan; [Kanomata, Naoki] Kawasaki Med Univ, Dept Pathol, Kurashiki, Okayama, Japan	Yamaguchi, R (reprint author), Kurume Univ, Sch Med, Dept Pathol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	rin@med.kurume-u.ac.jp					Collins LC, 2008, HISTOPATHOLOGY, V52, P20, DOI 10.1111/j.1365-2559.2007.02898.x; Sydnor MK, 2007, RADIOLOGY, V242, P58, DOI 10.1148/radiol.2421031988; Kil WH, 2008, BREAST, V17, P258, DOI 10.1016/j.breast.2007.10.008; Ellis IO, 2004, J CLIN PATHOL, V57, P897, DOI 10.1136/jcp.2003.010983; Skandarajah AR, 2008, ANN SURG ONCOL, V15, P2272, DOI 10.1245/s10434-008-9962-6; Shamonki J, 2013, ANN SURG ONCOL, V20, P4137, DOI 10.1245/s10434-013-3191-3; Ahmadiyeh N, 2009, ANN SURG ONCOL, V16, P2264, DOI 10.1245/s10434-009-0534-1; Kim MJ, 2008, EUR RADIOL, V18, P1774, DOI 10.1007/s00330-008-0960-7; Rizzo M, 2008, ANN SURG ONCOL, V15, P1040, DOI 10.1245/s10434-007-9780-2; Rizzo M, 2012, J AM COLL SURGEONS, V214, P280, DOI 10.1016/j.jamcollsurg.2011.12.005; Wen X, 2013, ANN SURG ONCOL, V20, P94, DOI 10.1245/s10434-012-2590-1; Bennett LE, 2010, ACAD RADIOL, V17, P553, DOI 10.1016/j.acra.2010.01.001; Sohn V, 2007, ANN SURG ONCOL, V14, P2979, DOI 10.1245/s10434-007-9470-0; Arora N, 2007, AM J SURG, V194, P444, DOI 10.1016/j.amjsurg.2007.07.004; Ashkenazi I, 2007, AM J SURG, V194, P183, DOI 10.1016/j.amjsurg.2006.11.028; AZZOPARDI JG, 1984, J PATHOL, V144, P15, DOI 10.1002/path.1711440103; Bernik SF, 2009, AM J SURG, V197, P473, DOI 10.1016/j.amjsurg.2008.04.007; Chang JM, 2011, ANN SURG ONCOL, V18, P2506, DOI 10.1245/s10434-011-1617-3; Cheng TY, 2009, ANN SURG ONCOL, V16, P3375, DOI 10.1245/s10434-009-0637-8; Fu CY, 2012, EJSO-EUR J SURG ONC, V38, P1029, DOI 10.1016/j.ejso.2012.08.019; Gilani S, 2013, Pathologica, V105, P51; Holley SO, 2012, RADIOLOGY, V265, P379, DOI 10.1148/radiol.12111926; Jaffer S, 2009, CANCER, V115, P2837, DOI 10.1002/cncr.24321; Jakate K, 2012, AM J SURG PATHOL, V36, P544, DOI 10.1097/PAS.0b013e318243fa00; Jung SY, 2010, WORLD J SURG, V34, P261, DOI 10.1007/s00268-009-0313-y; Kim MJ, 2011, CLIN RADIOL, V66, P530, DOI 10.1016/j.crad.2011.01.008; Ko ES, 2007, KOREAN J RADIOL, V8, P206, DOI 10.3348/kjr.2007.8.3.206; KRAUS FT, 1962, CANCER, V15, P444, DOI 10.1002/1097-0142(196205/06)15:3<444::AID-CNCR2820150303>3.0.CO;2-0; Lacambra MD, 2012, BREAST CANCER RES TR, V132, P917, DOI 10.1007/s10549-011-1639-3; O'Malley F., 2012, WHO CLASSIFICATION T, P99; Park HL, 2011, J BREAST CANCER, V14, P1, DOI 10.4048/jbc.2011.14.1.1; Shin HJ, 2008, AM J ROENTGENOL, V190, P630, DOI 10.2214/AJR.07.2664; Swapp RE, 2013, ANN SURG ONCOL, V20, P1900, DOI 10.1245/s10434-012-2846-9; Tan PH, 2005, AM J SURG PATHOL, V29, P625, DOI 10.1097/01.pas.0000157941.88161.39; Troxell ML, 2010, MODERN PATHOL, V23, P27, DOI 10.1038/modpathol.2009.142; Tse GM, 2010, HISTOPATHOLOGY, V56, P481, DOI 10.1111/j.1365-2559.2010.03510.x; Tse GM, 2009, J CLIN PATHOL, V62, P407, DOI 10.1136/jcp.2008.063016; Tseng HS, 2009, EJSO-EUR J SURG ONC, V35, P21, DOI 10.1016/j.ejso.2008.06.004; Yamaguchi R, 2009, PATHOL INT, V59, P185, DOI 10.1111/j.1440-1827.2009.02348.x; Yamaguchi R, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201749	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAR	2015	66	4					565	576		10.1111/his.12477		12	Cell Biology; Pathology	Cell Biology; Pathology	CB4TU	WOS:000349621900012		
J	Ide, F; Kikuchi, K; Kusama, K; Muramatsu, T				Ide, Fumio; Kikuchi, Kentaro; Kusama, Kaoru; Muramatsu, Takashi			Primordial odontogenic tumour: is it truly novel?	HISTOPATHOLOGY			English	Letter									[Ide, Fumio; Kikuchi, Kentaro; Kusama, Kaoru] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral Pathol, Saitama, Japan; [Muramatsu, Takashi] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Tokyo, Japan	Ide, F (reprint author), Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral Pathol, Saitama, Japan.						GORLIN RJ, 1961, CANCER, V14, P73, DOI 10.1002/1097-0142(196101/02)14:1<73::AID-CNCR2820140111>3.0.CO;2-T; Bernier JL, 1947, DENT J, V13, P560; HUNTER HA, 1954, ORAL SURG ORAL MED O, V7, P906, DOI 10.1016/0030-4220(54)90191-7; Inoue Y, 1979, Aichi Gakuin Daigaku Shigakkai Shi, V17, P87; MACLENNAN W D, 1963, J Oral Surg Anesth Hosp Dent Serv, V21, P429; Main DMG, 1965, BR J ORAL SURG, V3, P172; MEYERS A D, 1991, Ear Nose and Throat Journal, V70, P729; Morita S, 1994, JPN J ORAL MAXILLOFA, V40, P935; Mosqueda-Taylor A, 2014, HISTOPATHOLOGY, V65, P606, DOI 10.1111/his.12451; Sakaki T, 1993, JPN J ORAL MAXILLOFA, V39, P481; Semba I., 1996, DENTAL RADIOL, V36, P137; Tiecke RW, 1959, PATHOLOGIC PHYSL ORA, P312; Tomita K, 1972, JPN J ORAL SURG, V18, P653	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAR	2015	66	4					603	604		10.1111/his.12595		2	Cell Biology; Pathology	Cell Biology; Pathology	CB4TU	WOS:000349621900016		
J	Fujita, H; Yoshida, A; Taniguchi, H; Katai, H; Sekine, S				Fujita, Hiromi; Yoshida, Akihiko; Taniguchi, Hirokazu; Katai, Hitoshi; Sekine, Shigeki			Adult-onset inflammatory myofibroblastic tumour of the stomach with a TFG-ROS1 fusion	HISTOPATHOLOGY			English	Letter							EXPRESSION; ROS1		[Fujita, Hiromi; Yoshida, Akihiko; Taniguchi, Hirokazu; Sekine, Shigeki] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan; [Katai, Hitoshi] Natl Canc Ctr, Div Gastr Surg, Tokyo, Japan	Fujita, H (reprint author), Natl Canc Ctr, Div Pathol & Clin Labs, 1-1 Tsukiji 5 chome, Tokyo, Japan.						Yoshida A, 2014, MODERN PATHOL, V27, P711, DOI 10.1038/modpathol.2013.192; Cook JR, 2001, AM J SURG PATHOL, V25, P1364, DOI 10.1097/00000478-200111000-00003; Bjelovic M, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-35; Coffin CM, 2013, WHO CLASSIFICATION T, P83; Hornick JL, 2014, MODERN PATHOL, V27, p18A; Lovly CM, 2014, CANCER DISCOV, V4, P889, DOI 10.1158/2159-8290.CD-14-0377	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	MAR	2015	66	4					610	612		10.1111/his.12575		3	Cell Biology; Pathology	Cell Biology; Pathology	CB4TU	WOS:000349621900020		
J	Nakanishi, M; Sato, T				Nakanishi, Miwa; Sato, Tomohiro			Application of Digital Manuals with a Retinal Imaging Display in Manufacturing: Behavioral, Physiological, and Psychological Effects on Workers	HUMAN FACTORS AND ERGONOMICS IN MANUFACTURING & SERVICE INDUSTRIES			English	Article						Retinal imaging display; Digital manuals; Assembly task; Brain blood flow; ECG	AUGMENTED REALITY APPLICATIONS; ISCHEMIA; BRAIN	This study analyses the behavioral, physiological, and psychological effects of digital manuals presented by a retinal imaging display (RID) on workers in the manufacturing industry. An RID consists of wearable glasses that enable users to view a digital image overlaying the real world. We conducted an experiment in which subjects assembled an object by referring to different types of manuals. The experimental results suggest that an RID enables users to conveniently examine real objects against information in the manual, reduces the information-processing load while performing tasks, and supports effortless performance of tasks. However, using a monochrome picture manual with an RID increases the information-processing load. On the other hand, a full-color RID movie manual generates additional responses in users, such as psychological satisfaction. (C) 2012 Wiley Periodicals, Inc.	[Nakanishi, Miwa] Keio Univ, Fac Sci & Technol, Dept Adm Engn, Yokohama, Kanagawa 2238522, Japan; [Sato, Tomohiro] Brother Ind Ltd, NID Res & Dev Dept, Nagoya, Aichi, Japan	Nakanishi, M (reprint author), Keio Univ, Fac Engn, Dept Adm Engn, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	miwa_nakanishi@ae.keio.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [20710130]	This study was supported partly by a Grant-in-Aid for Young Scientists (B), 20710130 from the Ministry of Education, Science, Sports and Culture, Japan. We thank Mr. Hirokuni Kato and Mr. Hideki Tani for their valuable comments and suggestions. We also thank Mr. Kenji Ota, Mr. Yusuke Ogura, Mr. Akihisa Senda, and Mr. Yusuke Higa for their useful contributions to this study.	Azuma R, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.963459; BLUMENTHAL JA, 1995, CIRCULATION, V92, P2102; Burns DH, 2009, J ALZHEIMERS DIS, V17, P391, DOI 10.3233/JAD-2009-1053; Garde AH, 2002, EUR J APPL PHYSIOL, V87, P456, DOI 10.1007/s00421-002-0656-7; Neumann U, 1998, P IEEE VIRT REAL ANN, P4, DOI 10.1109/VRAIS.1998.658416; Jiang W, 1996, JAMA-J AM MED ASSOC, V275, P1651, DOI 10.1001/jama.275.21.1651; Ong SK, 2008, INT J PROD RES, V46, P2707, DOI 10.1080/00207540601064773; Madsen PL, 1999, PROG NEUROBIOL, V58, P541, DOI 10.1016/S0301-0082(98)00093-8; Baudhuin ES, 1996, 15TH DASC - AIAA/IEEE DIGITAL AVIONICS SYSTEMS CONFERENCE, P407, DOI 10.1109/DASC.1996.559193; Bowman D. A., 2002, HUM FACT ERG SOC ANN, P2134; Burg Matthew M., 1993, Journal of the American College of Cardiology, V22, P440; DAWSON BH, 1958, BRAIN, V81, P207, DOI 10.1093/brain/81.2.207; GAZZANIGA MS, 1963, EXP NEUROL, V8, P14, DOI 10.1016/0014-4886(63)90004-9; HEDREEN JC, 1984, J NEUROPATH EXP NEUR, V43, P1, DOI 10.1097/00005072-198401000-00001; Greenough R., 2001, Integrated Manufacturing Systems, V12, DOI 10.1108/EUM0000000006103; Miura T., 2007, P 12 INT C HCI HUM C; Mizell D. W., 1992, P 25 HAW INT C SYST; Nagel T, 1971, SYNTHESE, V22, P396, DOI 10.1007/BF00413435; Najjar L. J., 1997, PERS UBIQUIT COMPUT, V1, P251, DOI 10.1007/BF01682028; Nakanishi Miwa, 2010, Augmented Reality; Nakanishi Miwa, 2008, Journal of Multimedia, V3; Nakanishi M., 2007, P 4 INT C CITSA CYB; Randell C, 2007, ADV MANAGEMENT INFOR, V10, P165; Roland DG Corporation, 2010, D SHOP; Tang A, 2003, P SIGCHI C HUM FACT, P73; Tim S. L., 2006, J MANUFACTURING TECH, V17, P786; Yan X. T., 2008, ADV DESIGN MANUFACTU	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-8471	1520-6564		HUM FACTOR ERGON MAN	Hum. Factors Ergonom. Manuf. Serv. Ind.	MAR-APR	2015	25	2					228	238		10.1002/hfm.20535		11	Engineering, Manufacturing; Ergonomics	Engineering	CB5AL	WOS:000349639800007		
J	Iio, E; Matsuura, K; Nishida, N; Maekawa, S; Enomoto, N; Nakagawa, M; Sakamoto, N; Yatsuhashi, H; Kurosaki, M; Izumi, N; Hiasa, Y; Masaki, N; Ide, T; Hino, K; Tamori, A; Honda, M; Kaneko, S; Mochida, S; Nomura, H; Nishiguchi, S; Okuse, C; Itoh, Y; Yoshiji, H; Sakaida, I; Yamamoto, K; Watanabe, H; Hige, S; Matsumoto, A; Tanaka, E; Tokunaga, K; Tanaka, Y				Iio, Etsuko; Matsuura, Kentaro; Nishida, Nao; Maekawa, Shinya; Enomoto, Nobuyuki; Nakagawa, Mina; Sakamoto, Naoya; Yatsuhashi, Hiroshi; Kurosaki, Masayuki; Izumi, Namiki; Hiasa, Yoichi; Masaki, Naohiko; Ide, Tatsuya; Hino, Keisuke; Tamori, Akihiro; Honda, Masao; Kaneko, Shuichi; Mochida, Satoshi; Nomura, Hideyuki; Nishiguchi, Shuhei; Okuse, Chiaki; Itoh, Yoshito; Yoshiji, Hitoshi; Sakaida, Isao; Yamamoto, Kazuhide; Watanabe, Hisayoshi; Hige, Shuhei; Matsumoto, Akihiro; Tanaka, Eiji; Tokunaga, Katsushi; Tanaka, Yasuhito			Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C	HUMAN GENETICS			English	Article							PEGYLATED INTERFERON; RIBAVIRIN THERAPY; VIRUS-INFECTION; ANEMIA; GENE; IL28B; TELAPREVIR; OUTCOMES; ALPHA	Cytopenia during interferon-based (IFN-based) therapy for chronic hepatitis C (CHC) often necessitates reduction of doses of drugs and premature withdrawal from therapy resulting in poor response to treatment. To identify genetic variants associated with IFN-induced neutropenia, we conducted a genome-wide association study (GWAS) in 416 Japanese CHC patients receiving IFN-based therapy. Based on the results, we selected 192 candidate single nucleotide polymorphisms (SNPs) to carry out a replication analysis in an independent set of 404 subjects. The SNP rs2305482, located in the intron region of the PSMD3 gene on chromosome 17, showed a strong association when the results of GWAS and the replication stage were combined (OR = 2.18, P = 3.05 x 10(-7) in the allele frequency model). Logistic regression analysis showed that rs2305482 CC and neutrophil count at baseline were independent predictive factors for IFN-induced neutropenia (OR = 2.497, P = 0.0072 and OR = 0.998, P < 0.0001, respectively). Furthermore, rs2305482 genotype was associated with the doses of pegylated interferon (PEG-IFN) that could be tolerated in hepatitis C virus genotype 1-infected patients treated with PEG-IFN plus ribavirin, but not with treatment efficacy. Our results suggest that genetic testing for this variant might be useful for establishing personalized drug dosing in order to minimize drug-induced adverse events.	[Iio, Etsuko; Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Iio, Etsuko; Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Iio, Etsuko; Matsuura, Kentaro] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Nishida, Nao; Masaki, Naohiko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa 2728516, Japan; [Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Maekawa, Shinya; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Chuo 4093898, Japan; [Nakagawa, Mina; Sakamoto, Naoya] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo 1130034, Japan; [Sakamoto, Naoya; Hige, Shuhei] Hokkaido Univ, Grad Sch Med, Dept Internal Med, Sapporo, Hokkaido 0600814, Japan; [Yatsuhashi, Hiroshi] Natl Nagasaki Med Ctr, Clin Res Ctr, Omura 8568562, Japan; [Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo 1800023, Japan; [Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon 7910295, Japan; [Ide, Tatsuya] Kurume Univ, Dept Med, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan; [Hino, Keisuke] Kawasaki Med Univ, Dept Hepatol & Pancreatol, Kurashiki, Okayama 7010114, Japan; [Tamori, Akihiro] Osaka City Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan; [Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9200934, Japan; [Mochida, Satoshi] Saitama Med Univ, Div Gastroenterol & Hepatol, Iruma, Saitama 3500495, Japan; [Nomura, Hideyuki] Shin Kokura Hosp, Ctr Liver Dis, Kitakyushu, Fukuoka 8038505, Japan; [Nishiguchi, Shuhei] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo 6638131, Japan; [Okuse, Chiaki] St Marianna Univ, Sch Med, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa 2168511, Japan; [Itoh, Yoshito] Kyoto Prefectural Univ Med, Kyoto 6020841, Japan; [Yoshiji, Hitoshi] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara 6348522, Japan; [Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 7558505, Japan; [Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7000914, Japan; [Watanabe, Hisayoshi] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 9909585, Japan; [Hige, Shuhei] Sapporo Kosei Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido 0600033, Japan; [Matsumoto, Akihiro; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 3908621, Japan	Tanaka, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Mizuho Ku, Nagoya, Aichi 4678601, Japan.	ytanaka@med.nagoya-cu.ac.jp			Ministry of Health, Labor, and Welfare of Japan [H25-kanen-ippan-005]; KAKENHI from Ministry of Education, Culture, Sports, Science of Japan [22133008, 24790728]	We thank Ms. Yasuka Uehara-Shibata, Yuko Ogasawara-Hirano, Yoshimi Ishibashi, Natsumi Baba, Megumi Yamaoka-Sageshima, Takayo Tsuchiura, Yoriko Mawatari (Tokyo University), and Dr. Shintaro Ogawa (Nagoya City University) for technical assistance. This work was supported by the Ministry of Health, Labor, and Welfare of Japan (H25-kanen-ippan-005) to Yasuhito Tanka and Katsushi Tokunaga, KAKENHI (22133008) Grant-in-Aid for Scientific Research on Innovative Areas to Katsushi Tokunaga, and KAKENHI (24790728) Grant-in-Aid from the Ministry of Education, Culture, Sports, Science of Japan for Young Scientists (B) to Nao Nishida.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Sakamoto N, 2010, HEPATOL RES, V40, P1063, DOI 10.1111/j.1872-034X.2010.00741.x; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0; Kurosaki M, 2011, ANTIVIR THER, V16, P685, DOI 10.3851/IMP1796; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Thompson AJ, 2012, J HEPATOL, V56, P313, DOI 10.1016/j.jhep.2011.04.021; Tanaka Y, 2011, HUM MOL GENET, V20, P3507, DOI 10.1093/hmg/ddr249; Ochi H, 2010, GASTROENTEROLOGY, V139, P1190, DOI 10.1053/j.gastro.2010.06.071; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Matsuura K, 2014, J VIRAL HEPATITIS, V21, P466, DOI 10.1111/jvh.12171; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Yoshida H, 2004, GUT, V53, P425, DOI 10.1136/gut.2003.030353; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Bailly E, 1999, MOL CELL BIOL, V19, P6872; Crosslin DR, 2012, GENETIC VARIANTS ASS; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	MAR	2015	134	3					279	289		10.1007/s00439-014-1520-7		11	Genetics & Heredity	Genetics & Heredity	CB3UR	WOS:000349555000002		
J	Hosgood, HD; Song, MS; Hsiung, CA; Yin, ZH; Shu, XO; Wang, ZM; Chatterjee, N; Zheng, W; Caporaso, N; Burdette, L; Yeager, M; Berndt, SI; Landi, MT; Chen, CJ; Chang, GC; Hsiao, CF; Tsai, YH; Chien, LH; Chen, KY; Huang, MS; Su, WC; Chen, YM; Chen, CH; Yang, TY; Wang, CL; Hung, JY; Lin, CC; Perng, RP; Chen, CY; Chen, KC; Li, YJ; Yu, CJ; Chen, YS; Chen, YH; Tsai, FY; Kim, C; Seow, WJ; Bassig, BA; Wu, W; Guan, P; He, QC; Gao, YT; Cai, QY; Chow, WH; Xiang, YB; Lin, DX; Wu, C; Wu, YL; Shin, MH; Hong, YC; Matsuo, K; Chen, KX; Wong, MP; Lu, DR; Jin, L; Wang, JC; Seow, A; Wu, TC; Shen, HB; Fraumeni, JF; Yang, PC; Chang, IS; Zhou, BS; Chanock, SJ; Rothman, N; Lan, Q				Hosgood, H. Dean, III; Song, Minsun; Hsiung, Chao Agnes; Yin, Zhihua; Shu, Xiao-Ou; Wang, Zhaoming; Chatterjee, Nilanjan; Zheng, Wei; Caporaso, Neil; Burdette, Laurie; Yeager, Meredith; Berndt, Sonja I.; Landi, Maria Teresa; Chen, Chien-Jen; Chang, Gee-Chen; Hsiao, Chin-Fu; Tsai, Ying-Huang; Chien, Li-Hsin; Chen, Kuan-Yu; Huang, Ming-Shyan; Su, Wu-Chou; Chen, Yuh-Min; Chen, Chung-Hsing; Yang, Tsung-Ying; Wang, Chih-Liang; Hung, Jen-Yu; Lin, Chien-Chung; Perng, Reury-Perng; Chen, Chih-Yi; Chen, Kun-Chieh; Li, Yao-Jen; Yu, Chong-Jen; Chen, Yi-Song; Chen, Ying-Hsiang; Tsai, Fang-Yu; Kim, Christopher; Seow, Wei Jie; Bassig, Bryan A.; Wu, Wei; Guan, Peng; He, Qincheng; Gao, Yu-Tang; Cai, Qiuyin; Chow, Wong-Ho; Xiang, Yong-Bing; Lin, Dongxin; Wu, Chen; Wu, Yi-Long; Shin, Min-Ho; Hong, Yun-Chul; Matsuo, Keitaro; Chen, Kexin; Wong, Maria Pik; Lu, Dara; Jin, Li; Wang, Jiu-Cun; Seow, Adeline; Wu, Tangchun; Shen, Hongbing; Fraumeni, Joseph F., Jr.; Yang, Pan-Chyr; Chang, I-Shou; Zhou, Baosen; Chanock, Stephen J.; Rothman, Nathaniel; Lan, Qing			Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)	HUMAN GENETICS			English	Article							GENE-ENVIRONMENT INDEPENDENCE; COAL COMBUSTION EMISSIONS; XUAN-WEI; POOLED ANALYSIS; NEVER SMOKERS; RISK; INDOOR; CHINA; ASSOCIATION; ADENOCARCINOMA	We previously carried out a multi-stage genome-wide association study (GWAS) on lung cancer among never smokers in the Female Lung Cancer Consortium in Asia (FLCCA) (6,609 cases, 7,457 controls) that identified novel susceptibility loci at 10q25.2, 6q22.2, and 6p21.32, and confirmed two previously identified loci at 5p15.33 and 3q28. Household air pollution (HAP) attributed to solid fuel burning for heating and cooking, is the leading cause of the overall disease burden in Southeast Asia, and is known to contain lung carcinogens. To evaluate the gene-HAP interactions associated with lung cancer in loci independent of smoking, we analyzed data from studies participating in FLCCA with fuel use information available (n = 3; 1,731 cases; 1,349 controls). Coal use was associated with a 30 % increased risk of lung cancer (OR 1.3, 95 % CI 1.0-1.6). Among the five a priori SNPs identified by our GWAS, two showed a significant interaction with coal use (HLA Class II rs2395185, p = 0.02; TP63 rs4488809 (rs4600802), p = 0.04). The risk of lung cancer associated with coal exposure varied with the respective alleles for these two SNPs. Our observations provide evidence that genetic variation in HLA Class II and TP63 may modify the association between HAP and lung cancer risk. The roles played in the cell cycle and inflammation pathways by the proteins encoded by these two genes provide biological plausibility for these interactions; however, additional replication studies are needed in other non-smoking populations.	[Hosgood, H. Dean, III] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Hosgood, H. Dean, III; Song, Minsun; Chatterjee, Nilanjan; Caporaso, Neil; Berndt, Sonja I.; Landi, Maria Teresa; Kim, Christopher; Seow, Wei Jie; Bassig, Bryan A.; Fraumeni, Joseph F., Jr.; Chanock, Stephen J.; Rothman, Nathaniel; Lan, Qing] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Hsiung, Chao Agnes; Hsiao, Chin-Fu; Chien, Li-Hsin; Chen, Yi-Song; Chen, Ying-Hsiang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Yin, Zhihua; Wu, Wei; Guan, Peng; He, Qincheng; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Peoples R China; [Shu, Xiao-Ou; Zheng, Wei; Cai, Qiuyin] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Shu, Xiao-Ou; Zheng, Wei; Cai, Qiuyin] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Wang, Zhaoming; Burdette, Laurie; Yeager, Meredith] Natl Canc Inst Frederick, Core Genotype Facil, SAIC Frederick, NIH, Frederick, MD USA; [Chen, Chien-Jen; Li, Yao-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Gee-Chen] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh] Taichung Vet Gen Hosp, Div Chest Med, Taichung, Taiwan; [Tsai, Ying-Huang] Chang Gung Mem Hosp, Dept Resp Therapy, Chiayi, Taiwan; [Chen, Kuan-Yu; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Ming-Shyan; Hung, Jen-Yu] Kaohsiung Med Univ, Sch Med, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Wu-Chou; Lin, Chien-Chung] Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Yuh-Min; Perng, Reury-Perng] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Chen, Chung-Hsing; Tsai, Fang-Yu; Chang, I-Shou] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Taiwan; [Wang, Chih-Liang] Chang Gung Mem Hosp, Dept Pulm & Crit Care, Taoyuan, Taiwan; [Chen, Chih-Yi] China Med Univ & Hosp, Ctr Canc, Taichung, Taiwan; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Chow, Wong-Ho] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lin, Dongxin; Wu, Chen] Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Lin, Dongxin; Wu, Chen] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Lin, Dongxin; Wu, Chen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Med Res Ctr, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Ctr Canc, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Matsuo, Keitaro] Kyushu Univ, Dept Prevent Med, Fac Med Sci, Fukuoka 812, Japan; [Chen, Kexin] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Wong, Maria Pik] Univ Hong Kong, LKS Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Dara; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Lu, Dara; Jin, Li; Wang, Jiu-Cun] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Seow, Adeline] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wu, Tangchun] Huazhong Univ Sci & Technol, Inst Occupat Med, Wuhan 430074, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Shen, Hongbing] Nanjing Med Univ, Minist Educ, Key Lab Modern Toxicol, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan	Hosgood, HD (reprint author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave Belfer 1309, Bronx, NY 10461 USA.	dean.hosgood@einstein.yu.edu	Hsiung, Chao Agnes/E-3994-2010; Chang, I-Shou/D-2084-2010; Hsiao, Chin-Fu/E-3993-2010; Chen, Chien-Jen/C-6976-2008; Jin, Li/C-1468-2009; 	Jin, Li/0000-0002-4546-2415; Yu, Chong-Jen/0000-0001-5664-9392	NCI; National Research Program for Biopharmaceuticals in Taiwan [MOHW103-TDU-PB-211-144003]; Taiwan Bioinformatics Institute [NSC 102-2319-B-400-001]	This work was supported by the NCI intramural system. GELAC was supported in part by grants from the National Research Program for Biopharmaceuticals in Taiwan (MOHW103-TDU-PB-211-144003) and by Taiwan Bioinformatics Institute Core Facility (NSC 102-2319-B-400-001).	Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Lan Q, 2002, J NATL CANCER I, V94, P826; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322; Hosgood HD, 2008, BRIT J CANCER, V99, P1934, DOI 10.1038/sj.bjc.6604744; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; Truong T, 2010, J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Lan Q, 2000, CANCER EPIDEM BIOMAR, V9, P605; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Lee YJ, 2011, LUNG CANCER, V72, P9, DOI 10.1016/j.lungcan.2010.12.013; Mukherjee B, 2008, BIOMETRICS, V64, P685, DOI 10.1111/j.1541-0420.2007.00953.x; Gustafson P, 2008, ENVIRON SCI TECHNOL, V42, P5074, DOI 10.1021/es800304y; Zhang JF, 2003, BRIT MED BULL, V68, P209, DOI 10.1093/bmb/ldg029; Jou YS, 2009, LUNG CANCER, V64, P251, DOI 10.1016/j.lungcan.2008.09.014; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Gustafson P, 2007, J ENVIRON MONITOR, V9, P23, DOI 10.1039/b614142k; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Chatterjee N, 2005, BIOMETRIKA, V92, P399, DOI 10.1093/biomet/92.2.399; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Lan Q, 2008, INT J CANCER, V123, P2164, DOI 10.1002/ijc.23748; Hosgood HD, 2011, INT J EPIDEMIOL, V40, P719, DOI 10.1093/ije/dyq259; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Chanock SJ, 2008, NATURE, V452, P537, DOI 10.1038/452537a; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; Hernandez-Garduno E, 2004, INT J TUBERC LUNG D, V8, P377; Hosgood HD, 2007, MUTAT RES-REV MUTAT, V636, P134, DOI 10.1016/j.mrrev.2007.02.002; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; Hosgood HD, 2008, CARCINOGENESIS, V29, P1938, DOI 10.1093/carcin/bgn178; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; IARC, 2010, HOUS US SOL FUELS HI; Lee KM, 2007, CARCINOGENESIS, V28, P1437, DOI 10.1093/carcin/bgm030; Lim SS, 2013, LANCET, V380, P2224, DOI DOI 10.1016/S0140-6736(12)61766-8; Massion PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005611; Moldoveanu B, 2009, J Inflamm Res, V2, P1; Yin ZH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-153; Zhang YW, 2007, CANCER EPIDEM BIOMAR, V16, P2432, DOI 10.1158/1055-9965.EPI-07-0398	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	MAR	2015	134	3					333	341		10.1007/s00439-014-1528-z		9	Genetics & Heredity	Genetics & Heredity	CB3UR	WOS:000349555000007		
J	Satoh, M; Ohkubo, T; Asayama, K; Murakami, Y; Sakurai, M; Nakagawa, H; Iso, H; Okayama, A; Miura, K; Imai, Y; Ueshima, H; Okamura, T				Satoh, Michihiro; Ohkubo, Takayoshi; Asayama, Kei; Murakami, Yoshitaka; Sakurai, Masaru; Nakagawa, Hideaki; Iso, Hiroyasu; Okayama, Akira; Miura, Katsuyuki; Imai, Yutaka; Ueshima, Hirotsugu; Okamura, Tomonori		Evidence Cardiovasc Prevention	Combined Effect of Blood Pressure and Total Cholesterol Levels on Long-Term Risks of Subtypes of Cardiovascular Death Evidence for Cardiovascular Prevention From Observational Cohorts in Japan	HYPERTENSION			English	Article						Asia; coronary disease; epidemiology; hypercholesterolemia; hypertension; meta-analysis; stroke	CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; FACTOR INTERVENTION TRIAL; SERUM-CHOLESTEROL; INTRAPARENCHYMAL HEMORRHAGE; GENERAL-POPULATION; CIGARETTE-SMOKING; FOLLOW-UP; MORTALITY; STROKE	No large-scale, longitudinal studies have examined the combined effects of blood pressure (BP) and total cholesterol levels on long-term risks for subtypes of cardiovascular death in an Asian population. To investigate these relationships, a meta-analysis of individual participant data, which included 73 916 Japanese subjects (age, 57.7 years; men, 41.1%) from 11 cohorts, was conducted. During a mean follow-up of 15.0 years, deaths from coronary heart disease, ischemic stroke, and intraparenchymal hemorrhage occurred in 770, 724, and 345 cases, respectively. Cohort-stratified Cox proportional hazard models were used. After stratifying the participants by 4 systolic BP x4 total cholesterol categories, the group with systolic BP >= 160 mm Hg with total cholesterol >= 5.7 mmol/L had the greatest risk for coronary heart disease death (adjusted hazard ratio, 4.39; P<0.0001 versus group with systolic BP <120 mm Hg and total cholesterol <4.7 mmol/L). The adjusted hazard ratios of systolic BP (per 20 mm Hg) increased with increases in total cholesterol categories (hazard ratio, 1.52; P<0.0001 in group with total cholesterol >= 5.7 mmol/L). Similarly, the adjusted hazard ratios of total cholesterol increased with increases in systolic BP categories (P for interaction <= 0.04). Systolic BP was positively associated with ischemic stroke and intraparenchymal hemorrhage death, and total cholesterol was inversely associated with intraparenchymal hemorrhage, but no significant interactions between BP and total cholesterol were observed for stroke. High BP and high total cholesterol can synergistically increase the risk for coronary heart disease death but not for stroke in the Asian population.	[Satoh, Michihiro] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi 9808574, Japan; [Ohkubo, Takayoshi; Asayama, Kei] Teikyo Univ Sch Med, Dept Hyg & Publ Hlth, Tokyo, Japan; [Asayama, Kei; Imai, Yutaka] Tohoku Univ Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan; [Murakami, Yoshitaka] Toho Univ, Div Med Stat, Dept Social Med, Fac Med, Tokyo, Japan; [Sakurai, Masaru; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Kanazawa, Ishikawa, Japan; [Iso, Hiroyasu] Osaka Univ Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Tokyo, Japan; [Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 52021, Japan; [Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Satoh, M (reprint author), Tohoku Univ Hosp, Dept Pharm, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	satoh.mchr@hosp.tohoku.ac.jp	Okamura, Tomonori/L-1693-2013		Ministry of Health, Labour and Welfare, Health and Labor Sciences, Japan [H17-Kenkou-007, H18-Junkankitou[Seishuu]-Ippan-012, H19-Junkankitou [Seishuu]-Ippan-012, H20-Junkankitou [Seishuu]-Ippan-013, H23-Junkankitou [Seishuu]-Ippan-005, 22-4-5, H26-Junkankitou [Seisaku]-Ippan-001]	This research was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare, Health and Labor Sciences research grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular Disease and Life-Related Disease: H18-Junkankitou[Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular Disease and Life-Related Disease: H19-Junkankitou [Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou [Seishuu]-Ippan-013; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou [Seishuu]-Ippan-005), and an Intramural Research Fund (22-4-5) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center; and Comprehensive Research on Cardiovascular and LifeStyle Related Diseases: H26-Junkankitou [Seisaku]-Ippan-001.	Asayama K, 2014, HYPERTENSION, V63, P1189, DOI 10.1161/HYPERTENSIONAHA.113.03206; Nagasawa S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001974; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; Okamura T, 2003, J INTERN MED, V253, P169, DOI 10.1046/j.1365-2796.2003.01080.x; Murakami Y, 2008, HYPERTENSION, V51, P1483, DOI 10.1161/HYPERTENSIONAHA.107.102459; Liu LJ, 2014, AM J CARDIOL, V113, P84, DOI 10.1016/j.amjcard.2013.08.042; Thomas F, 2002, EUR HEART J, V23, P528, DOI 10.1053/euhj.2001.2888; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Wang X, 2013, STROKE, V44, P1833, DOI 10.1161/STROKEAHA.113.001326; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; JACOBS D, 1992, CIRCULATION, V86, P1046; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Noda H, 2009, CIRCULATION, V119, P2136, DOI 10.1161/CIRCULATIONAHA.108.795666; YANO K, 1989, STROKE, V20, P1460; Imamura T, 2009, STROKE, V40, P382, DOI 10.1161/STROKEAHA.108.529537; TANAKA H, 1982, STROKE, V13, P62; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Rodgers A, 2005, CIRCULATION, V112, P3384, DOI 10.1161/CIRCULATIONHA.105.537472; Cui RZ, 2007, ATHEROSCLEROSIS, V194, P415, DOI 10.1016/j.atherosclerosis.2006.08.022; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Lewington S, 2007, LANCET, V370, P1829; Okamura T, 2010, J ATHEROSCLER THROMB, V17, P312; Ross R, 1999, NEW ENGL J MED, V340, P115; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Tsukinoki R, 2014, AM J HYPERTENS, V27, P1362, DOI 10.1093/ajh/hpu059; UESHIMA H, 1980, PREV MED, V9, P722, DOI 10.1016/0091-7435(80)90017-1; Ueshima H, 2004, STROKE, V35, P1836, DOI 10.1161/01.STR.0000131747.84423.74; Woodward M, 2005, TEXTS STAT SCI	30	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	MAR	2015	65	3					517	524		10.1161/HYPERTENSIONAHA.114.04639		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB6CX	WOS:000349715600009		
J	Ishikawa, J; Ishikawa, S; Kario, K				Ishikawa, Joji; Ishikawa, Shizukiyo; Kario, Kazuomi			Prolonged Corrected QT Interval Is Predictive of Future Stroke Events Even in Subjects Without ECG-Diagnosed Left Ventricular Hypertrophy	HYPERTENSION			English	Article						electrocardiography; epidemiology; hypertrophy, left ventricular; stroke	JAPANESE POPULATION; GENERAL-POPULATION; DIABETES-MELLITUS; RISK; ELECTROCARDIOGRAPHY; HYPERTENSION; ASSOCIATION; HISAYAMA; SOCIETY; MARKER	We attempted to evaluate whether subjects who exhibit prolonged corrected QT (QTc) interval (>= 440 ms in men and >= 460 ms in women) on ECG, with and without ECG-diagnosed left ventricular hypertrophy (ECG-LVH; Cornell product, >= 244 mVxms), are at increased risk of stroke. Among the 10 643 subjects, there were a total of 375 stroke events during the follow-up period (128.7 +/- 28.1 months; 114 142 person-years). The subjects with prolonged QTc interval (hazard ratio, 2.13; 95% confidence interval, 1.22-3.73) had an increased risk of stroke even after adjustment for ECG-LVH (hazard ratio, 1.71; 95% confidence interval, 1.22-2.40). When we stratified the subjects into those with neither a prolonged QTc interval nor ECG-LVH, those with a prolonged QTc interval but without ECG-LVH, and those with ECG-LVH, multivariate-adjusted Cox proportional hazards analysis demonstrated that the subjects with prolonged QTc intervals but not ECG-LVH (1.2% of all subjects; incidence, 10.7%; hazard ratio, 2.70, 95% confidence interval, 1.48-4.94) and those with ECG-LVH (incidence, 7.9%; hazard ratio, 1.83; 95% confidence interval, 1.31-2.57) had an increased risk of stroke events, compared with those with neither a prolonged QTc interval nor ECG-LVH. In conclusion, prolonged QTc interval was associated with stroke risk even among patients without ECG-LVH in the general population.	[Ishikawa, Joji; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi 3290498, Japan; [Ishikawa, Shizukiyo] Jichi Med Univ, Ctr Community Med, Div Community & Family Med, Shimotsuke, Tochigi 3290498, Japan	Ishikawa, J (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	george@jichi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Foundation for the Development of the Community, Tochigi, Japan	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grants from the Foundation for the Development of the Community, Tochigi, Japan.	Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Cardoso CRL, 2003, STROKE, V34, P2187, DOI 10.1161/01.STR.0000085084.15144.66; Funada A, 2008, CLIN CARDIOL, V31, P270, DOI 10.1002/clc.20208; Okin PM, 2006, CIRCULATION, V113, P1588, DOI 10.1161/CIRCULATIONAHA.105.574822; Soliman EZ, 2012, J AM COLL CARDIOL, V59, P1460, DOI 10.1016/j.jacc.2012.01.025; ALGRA A, 1991, CIRCULATION, V83, P1888; LEPESCHKIN E, 1952, CIRCULATION, V6, P378; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Festa A, 1999, STROKE, V30, P1566; Ishikawa J, J CARDIOL, DOI [10.1016/j.jjcc.2014.05.008, DOI 10.1016/J.JJCC.2014.05.008]; Ishikawa J, 2009, HYPERTENSION, V53, P28, DOI 10.1161/HYPERTENSIONAHA.108.118026; Ishikawa Shizukiyo, 2002, J Epidemiol, V12, P408; Ishikawa S, 2008, J EPIDEMIOL, V18, P144, DOI 10.2188/jea.JE2007438; Iwahana H, 2011, J EPIDEMIOL, V21, P95, DOI 10.2188/jea.JE20090149; Maebuchi D, 2010, HYPERTENS RES, V33, P916, DOI 10.1038/hr.2010.88; Maebuchi D, 2008, HYPERTENS RES, V31, P1339, DOI 10.1291/hypres.31.1339; Nielsen JB, 2013, J AM COLL CARDIOL, V61, P2557, DOI 10.1016/j.jacc.2013.03.032; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	MAR	2015	65	3					554	U137		10.1161/HYPERTENSIONAHA.114.04722		15	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB6CX	WOS:000349715600014		
J	Hancock, CP; Burn, P; Goodman, AM; Duff, CI; Sloan, R; White, M; Bishop, J; Booton, M; Chaudhry, MS; Morris, S; Dharmasiri, N; Gulliford, C; Sibbons, P; Saunders, BP; Tsiamoulos, ZP; Wall, P				Hancock, Christopher P.; Burn, Patrick; Goodman, Andrew M.; Duff, Christopher I.; Sloan, Robin; White, Malcolm; Bishop, John; Booton, Martin; Chaudhry, Mohamad S.; Morris, Steve; Dharmasiri, Nuwan; Gulliford, Craig; Sibbons, Paul; Saunders, Brian P.; Tsiamoulos, Zacharias P.; Wall, Pete			A New Wave in Electrosurgery	IEEE MICROWAVE MAGAZINE			English	Article							MICROWAVE ABLATION; ANTENNA; SYSTEM; LIVER; RF; HYPERHIDROSIS; MEDICINE; THERAPY; DESIGN; TISSUE		[Hancock, Christopher P.; Burn, Patrick; Goodman, Andrew M.] Bangor Univ, Bangor, Gwynedd, Wales; [Hancock, Christopher P.; White, Malcolm; Bishop, John; Booton, Martin; Chaudhry, Mohamad S.; Morris, Steve; Dharmasiri, Nuwan; Gulliford, Craig] Creo Med, Tokyo, Japan; [Duff, Christopher I.; Sloan, Robin] Univ Manchester, Manchester M13 9PL, Lancs, England; [Sibbons, Paul] Northwick Pk Inst Med Res, Dept Surg Sci, Harrow, Middx, England; [Saunders, Brian P.; Tsiamoulos, Zacharias P.] St Marks Hosp, Acad Inst, Wolfson Unit Endoscopy, Harrow, Middx, England; [Wall, Pete] Isca Healthcare Res Ltd, Newport, Gwent, Wales	Hancock, CP (reprint author), Bangor Univ, Bangor, Gwynedd, Wales.	patrick.burn@yahoo.co.uk; andy.goodman@bangor.ac.uk; C.Duff@manchester.ac.uk; rob.sloan@manchester.ac.uk; Malcolm.White@creomedical.com; john@john-bishop.net; booton2@tiscali.co.uk; sabih@credentmedical.com; Steve.Morris@creomedical.com; Nuwan.Dharmasiri@creomedical.com; Craig.Gulliford@creomedical.com; p.sibbons@ucl.ac.uk; b.saunders@imperial.ac.uk; ztsiamoulos@nhs.net; pw@iscahcr.co.uk			Medical Devices Innovations (MDI) Ltd.	We would like to thank P. Hales, L. Turner, S. Holmes, F. Amoah, M. Jarman, D. Webb, G. Ulrich, and Prof. I. Darwazeh for all of their support during the development of the systems discussed in this work and for their support in general. C.P. Hancock would also like to thank the Creo Angel Investor Network and Finance Wales for believing in the inventors and for providing the funding necessary to enable the work on the new RF and microwave electrosurgical platform technology to be developed. [All intellectual property (IP) associated with the platform generator and the range of electrosurgical instruments is owned by Creo Medical Ltd.] Finally, we would like to thank Medical Devices Innovations (MDI) Ltd. for funding the development of the MicroBlate, GastroBlate, and PortaBlate systems. (All IP associated with these systems is owned by MDI Ltd.)	[Anonymous], 2014, MicroThermx microwave ablation system from BSD Medical, Patent No. 1989002808; Stang J, 2012, IEEE T BIO-MED ENG, V59, P2431, DOI 10.1109/TBME.2012.2199492; [Anonymous], 2014, PlasmaKinetic SuperPulse Electrosurgical Generator from Gyrus ACMI, Patent No. 2006155270; [Anonymous], 2014, Barrx Flex RFA Energy Generator and 360 RFA Balloon Catheter. 90 RFA Focal Catheter, Ultra Long RFA Focal Catheter and 60 RFA Focal Catheter for tissue ablation in the GI tract from Covidien, Patent No. 2010286686; [Anonymous], 2014, CLIN REV CRITERIA ST; Johnson JE, 2012, LASER SURG MED, V44, P20, DOI 10.1002/lsm.21142; [Anonymous], 2014, MICROTHERMX MICROWAV; Hancock CP, 2013, IEEE T MICROW THEORY, V61, P2230, DOI 10.1109/TMTT.2013.2255620; [Anonymous], 2005, Acculis microwave tissue ablation system, Patent No. 1726268; Palanker DV, 2008, IEEE T BIO-MED ENG, V55, P838, DOI 10.1109/TBME.2007.914539; [Anonymous], 2014, Evident microwave ablation system from Covidien, Patent No. 1990000039; Brace CL, 2005, IEEE T MICROW THEORY, V53, P215, DOI 10.1109/TMTT.2004.839308; Strickland AD, 2002, BRIT J SURG, V89, P1003, DOI 10.1046/j.1365-2168.2002.02155.x; Wright AS, 2003, ANN SURG ONCOL, V10, P275, DOI 10.1245/ASO.2003.03.045; [Anonymous], 2014, Pelleve S5 for wrinkle reduction, Surgitron Dual RF S5 for soft tissue cutting and coagulation. Surgitron Dual RF 120, Surgitron Dual/ EMC 90, and AcuSect from Ellman, Patent No. 2011340307; [Anonymous], 2012, National Keratoconus Foundation (NKCF) Clinical Study Bulletin, Patent No. 2012101492; [Anonymous], 2014, REFRACTIVE EYEC 0904; Rosen A, 2002, IEEE T MICROW THEORY, V50, P963, DOI 10.1109/22.989979; [Anonymous], 2014, ERBE VIO 300D, 300S, 200D, 200S, 100C, 50C electrosurgical generators and electrosurgical instruments, Patent No. 2010228244; Despretz D, 1996, IEEE T MICROW THEORY, V44, P1762, DOI 10.1109/22.539933; Hong HCH, 2012, DERMATOL SURG, V38, P728, DOI 10.1111/j.1524-4725.2012.02375.x; [Anonymous], 2014, Olympus ESG-400, ESG-100 and UES-40 Electrosurgical Generators and electrosurgical instruments, Patent No. 2010030107; Jones RP, 2012, INT J HYPERTHER, V28, P43, DOI 10.3109/02656736.2011.610428; [Anonymous], 2014, Phased RF catheter ablation system for treating atrial fibrillation from Medtronic, Patent No. 2487199; [Anonymous], 2014, Clinical review criteria stretta procedure (Electro-Surgical Coagulation-Radio-Frequency [ RF] Application-Curon Medical Inc's CSM Stretta System) for the treatment of GERD, Patent No. 0191072; Carrubba V, 2011, IEEE T MICROW THEORY, V59, P1294, DOI 10.1109/TMTT.2011.2117435; [Anonymous], 2014, OsteoCool RF ablation system for treating metastatic vertebral tumours, Patent No. 2068741; Arunachalam K., 2006, P IEEE ANT PROP SOC, P2191; Bjorn L. S., 1982, P IEEE 12 EUR MICR C, P413; Carr K. L., 1990, IEEE MTT S INT MICR, V1, P525; Chen R. K., 2008, IEEE T BIOMED ENG, V60, P453; Chiu H. M., 2000, P IEEE MICR C AS PAC, P50; Chou C. K., 1988, IEEE 5 INSTR MEAS TE, P69; Colebeck E., 2013, P NAT COMM URSI NAT, P1; Colebeck E., 2013, IEEE MTT S MICR S JU, P1; Cosman B. J., 1974, GUIDE RADIO FREQUENC; Cosman E. R., 1974, MED THERAPY MOVEMENT; Cresson PY, 2006, IEEE T MICROW THEORY, V54, P302, DOI 10.1109/TMTT.2005.861662; Crump R. E., 1988, ERBE VIO 300D 300S 2, Patent No. 1989/002808; Crump R. E., 1990, BARRX FLEX RFA ENERG, Patent No. WO1990000039 A1; Dodde RE, 2012, IEEE T BIO-MED ENG, V59, P167, DOI 10.1109/TBME.2011.2168956; Feldberg I. B., 1998, IEEE MTT S INT MICR, V2, P7; Gamez E. S., 2013, P US NAT COMM URSI N, P1; Golio M., 2008, RF MICROWAVE APPL SY; Gu Z., 2006, IEEE T MICROW THEORY, V48, P1892; GUY AW, 1986, IEEE T MICROW THEORY, V34, P502, DOI 10.1109/TMTT.1986.1133383; Habash R. W. Y., 2008, BIOEFFECTS THERAPE 2; Hancock C, 2013, IEEE T MICROW THEORY, V61, P2242, DOI 10.1109/TMTT.2013.2256141; Hancock C. P., 2013, CROSSFIRE ARTHROSCOP, Patent No. 2 011 340 307 (A1); Hancock C. P., 2012, PEAK SURG SYSTEM PEA, Patent No. 2 487 199 (A); Hancock C. P., 2009, PLASMAKINETIC SUPERP, Patent No. 101 583 398 (A); Hancock C. P., 2005, OLYMPUS ESG 400 ESG, Patent No. 1 726 268 (A1); Hancock C. P., 2012, RF 3000 RADIO FREQUE, Patent No. 2 068 741 (B1); Hancock C. P., 2009, OSTEOCOOL RF ABLATIO, Patent No. 2 010 228 244 (A1); Hancock C. P., 2010, PELLEVE S5 WRINKLE R, Patent No. 2 010 030 107 (A1); Hancock C. P., 2011, PHASED RF CATHETER A, Patent No. 2 010 286 686 (A1); Hancock C. P., 2012, EVIDENT MICROWAVE AB, Patent No. 0 191 072 (A1); Hancock C. P., 2012, STARBURST RADIO FREQ, Patent No. 2 012 101 492 (A1); Hancock C. P., 2006, NKCF CLIN STUD B, Patent No. 2 006 155 270 (A1); Hancock CP, 2007, MED BIOL ENG COMPUT, V45, P531, DOI 10.1007/s11517-007-0184-z; Hersh P. S., 2011, OCULAR SURG NEWS US, V29, P4; Hersh P. S., 2014, Refractive Eyecare, Patent No. 101583398; Hiraoka M, 2000, IEEE T MICROW THEORY, V48, P1789, DOI 10.1109/22.883855; Hodgson D. A., 2000, OBSTET GYNECOL SURV, V55, P95, DOI 10.1097/00006254-200002000-00020; HONIG WM, 1975, IEEE T BIO-MED ENG, VBM22, P58, DOI 10.1109/TBME.1975.324541; Hurter W., 1991, IEEE T MICROW THEORY, V39, P1086; Jackson J., 2004, P IEEE 26 ANN INT C, V2; Jacob C, 2013, SEMIN CUTAN MED SURG, V32, P2; Labonte L., 1996, IEEE T MICROW THEORY, V44, P1832; LaCourse J. R., 1993, P IEEE 19 ANN NE BIO, P39; LACOURSE JR, 1993, PROCEEDINGS OF THE 1993 IEEE NINETEENTH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P35, DOI 10.1109/NEBC.1993.404426; Lin J. C., 1989, P IEEE ANN INT C ENG, V4, P1141; Maini S., 2011, Proceedings of the 4th International Conference on Emerging Trends in Engineering and Technology (ICETET 2011), DOI 10.1109/ICETET.2011.41; Marshall J., 2014, OCCULAR SURG NE 0901; Ming-Hung W., 2013, P IEEE COMP SEM INT, P1; Nevels R. D., 1995, ANT PROP SOC INT S J, V3, P18; Nikawa Y., 1985, IEEE MTT S MICR S JU, P196; Okhai T. A., 2008, P IEEE 3 INT C BROAD, P23; RAPPAPORT CM, 1992, P IEEE EMBS, V14, P260; Rosen A., 1991, P 21 EUR MICR C, V1, P139; Rosen A., 1998, IEEE MTT S INT MICR, V1, P5; Rosen A., 2004, P 15 INT C MICR RAD, V2, P461; Rosen A., 1995, NRE FRONTIERS MED DE; Rosen H, 2010, IEEE PULSE, V1, P8, DOI 10.1109/MPUL.2010.937904; ROSENBAUM RM, 1993, IEEE MTT-S, P1155, DOI 10.1109/MWSYM.1993.277076; Rothgery G. A., 2006, P IEEE 33 INT C PLAS, P218; Saitou K, 2010, PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, VOL 5, PTS A AND B, P1; Saunders B. S., 2013, ORAL PRESENTATION DI; Saunders B. S., 2013, P OR PRES BRIT SOC G, P75; Schneider B, 2008, IEEE T BIO-MED ENG, V55, P589, DOI 10.1109/TBME.2007.903525; Shengjie Y., 2012, P 5 INT C BIOM ENG I, P711; Shindo Y, 2013, PROC EUR CONF ANTENN, P1168; Smith R. P., 2008, P IEEE COMP SEM INT, P1; STERZER F, 1980, IEEE SPECTRUM, V17, P32; SUN ML, 1988, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, PTS 1-4, P886, DOI 10.1109/IEMBS.1988.95219; SWICORD ML, 1981, IEEE T MICROW THEORY, V29, P1202, DOI 10.1109/TMTT.1981.1130532; Thuery J., 1992, MICROWAVES IND SCI M; Vorst A. V., 2006, RF MICROWAVE INTERAC; Ward AK, 2007, P ANN INT IEEE EMBS, P1180, DOI 10.1109/IEMBS.2007.4352507; WATERMAN FM, 1988, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, PTS 1-4, P856, DOI 10.1109/IEMBS.1988.95144; Xiang X., 2008, P 2 INT C BIOINF BIO, P1725; Yadava RL, 2003, PROCEEDINGS OF THE 8TH INTERNATIONAL CONFERENCE ON ELECTROMAGNETIC INTERFERENCE AND COMPATIBILITY, P81; Zucker K. A., 2001, SURG LAPAROSCOPY, P53	103	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1527-3342	1557-9581		IEEE MICROW MAG	IEEE Microw. Mag.	MAR	2015	16	2					14	30		10.1109/MMM.2014.2377571		17	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CB5NF	WOS:000349673600004		
J	Doclo, S; Kellermann, W; Makino, S; Nordholm, S				Doclo, Simon; Kellermann, Walter; Makino, Shoji; Nordholm, Sven			Multichannel Signal Enhancement Algorithms for Assisted Listening Devices	IEEE SIGNAL PROCESSING MAGAZINE			English	Article							BLIND SOURCE SEPARATION; NOISE-REDUCTION; HEARING-AIDS; FREQUENCY-DOMAIN; CONVOLUTIVE MIXTURES; SOURCE LOCALIZATION; LIKELIHOOD RATIO; WIENER FILTER; SPEECH; ROBUST		[Doclo, Simon] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany; [Doclo, Simon] Fraunhofer Inst Digital Media Technol, Munich, Germany; [Kellermann, Walter] Univ Erlangen Nurnberg, Nurnberg, Germany; [Kellermann, Walter] IEEE Signal Proc Soc SPS, New York, NY USA; [Kellermann, Walter; Makino, Shoji] IEEE SPS Tech Comm Audio & Acoust Signal Proc, New York, NY USA; [Kellermann, Walter; Makino, Shoji] IEEE, New York, NY USA; [Makino, Shoji] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Makino, Shoji] IEEE Signal Proc Soc SPS Tech Direct Board, Piscataway, NJ USA; [Makino, Shoji] Awards Board, New York, NY USA; [Makino, Shoji] Conf Board, New York, NY USA; [Nordholm, Sven] Curtin Univ, Perth, WA 6845, Australia; [Nordholm, Sven] Hearmore, New York, NY USA; [Nordholm, Sven] Sensear, Perth, WA, Australia	Doclo, S (reprint author), Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany.	simon.doclo@uni-oldenburg.de; wk@LNT.de; maki@tara.tsukuba.ac.jp; s.nordholm@curtin.edu.au	Doclo, Simon/A-5472-2008; Magazine, Signal Processing/E-9947-2015		Research Unit FOR "Individualized Hearing Acoustics" [1732]; Cluster of Excellence "Hearing4All" - German Research Foundation (DFG) [1077]; European Union [FP6004171]	This research was supported in part by the Research Unit FOR 1732 "Individualized Hearing Acoustics" and the Cluster of Excellence 1077 "Hearing4All," funded by the German Research Foundation (DFG), and by the European Union under contract FP6004171 (HEARCOM).	Benesty J, 2000, J ACOUST SOC AM, V107, P384, DOI 10.1121/1.428310; Cornelis B, 2010, IEEE T AUDIO SPEECH, V18, P342, DOI 10.1109/TASL.2009.2028374; May T, 2011, IEEE T AUDIO SPEECH, V19, P1, DOI 10.1109/TASL.2010.2042128; Maj JB, 2006, SPEECH COMMUN, V48, P957, DOI 10.1016/j.specom.2005.12.005; Lombard A, 2011, IEEE T AUDIO SPEECH, V19, P1490, DOI 10.1109/TASL.2010.2092765; Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001; Luo FL, 2002, IEEE T SIGNAL PROCES, V50, P1583; Araki S, 2003, EURASIP J APPL SIG P, V2003, P1157, DOI 10.1155/S1110865703305074; Gannot S, 2001, IEEE T SIGNAL PROCES, V49, P1614, DOI 10.1109/78.934132; Parra L, 2000, IEEE T SPEECH AUDI P, V8, P320, DOI 10.1109/89.841214; Cornelis B, 2012, J ACOUST SOC AM, V131, P4743, DOI 10.1121/1.4707534; Spriet A, 2004, SIGNAL PROCESS, V84, P2367, DOI 10.1016/j.sigpro.2004.07.028; CAPON J, 1969, P IEEE, V57, P1408, DOI 10.1109/PROC.1969.7278; Van den Bogaert T, 2008, J ACOUST SOC AM, V124, P484, DOI 10.1121/1.2931962; COX H, 1987, IEEE T ACOUST SPEECH, V35, P1365, DOI 10.1109/TASSP.1987.1165054; GRIFFITHS LJ, 1982, IEEE T ANTENN PROPAG, V30, P27, DOI 10.1109/TAP.1982.1142739; Hoshuyama O, 1999, IEEE T SIGNAL PROCES, V47, P2677, DOI 10.1109/78.790650; Smaragdis P, 1998, NEUROCOMPUTING, V22, P21, DOI 10.1016/S0925-2312(98)00047-2; KNAPP CH, 1976, IEEE T ACOUST SPEECH, V24, P320, DOI 10.1109/TASSP.1976.1162830; Welker DP, 1997, IEEE T SPEECH AUDI P, V5, P543, DOI 10.1109/89.641299; Grimm G, 2009, IEEE T AUDIO SPEECH, V17, P1408, DOI 10.1109/TASL.2009.2020531; Elko GW, 1996, SPEECH COMMUN, V20, P229, DOI 10.1016/S0167-6393(96)00057-X; Araki S, 2003, IEEE T SPEECH AUDI P, V11, P109, DOI 10.1109/TSA.2003.809193; Blauert J., 1997, SPATIAL HEARING PSYC; Blauert J., 2013, TECHNOLOGY BINAURAL; Brandstein Michael, 2001, MICROPHONE ARRAYS SI; BROOKS LW, 1972, IEEE T AERO ELEC SYS, VAES8, P690, DOI 10.1109/TAES.1972.309588; Buchner H, 2005, IEEE T SPEECH AUDI P, V13, P120, DOI 10.1109/TSA.2004.838775; Doclo S, 2007, SPEECH COMMUN, V49, P636, DOI 10.1016/j.specom.2007.02.001; Doclo S, 2007, IEEE T AUDIO SPEECH, V15, P617, DOI 10.1109/TASL.2006.881676; Duda RO, 1998, J ACOUST SOC AM, V104, P3048, DOI 10.1121/1.423886; Gerkmann T, 2008, IEEE T AUDIO SPEECH, V16, P910, DOI 10.1109/TASL.2008.921764; Hadad E., 2012, P INT WORKSH AC SIGN, P117; Kates JM, 1996, J ACOUST SOC AM, V99, P3138, DOI 10.1121/1.414798; Krueger A, 2011, IEEE T AUDIO SPEECH, V19, P206, DOI 10.1109/TASL.2010.2047324; Lotter T., 2006, EURASIP J APPL SIG P, V2006, P175; Luts H., 2010, J ACOUST SOC AM, V127, P2054; Mabande E, 2009, INT CONF ACOUST SPEE, P77, DOI 10.1109/ICASSP.2009.4959524; Makino S, 2007, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4020-6479-1; Marquardt D., 2014, P IEEE INT C AC SPEE, P3688; Martin R, 2008, ADV DIGITAL SPEECH T; Matsuoka K., 2001, P INT C IND COMP AN, P722; Nordholm S, 1999, IEEE T SPEECH AUDI P, V7, P241, DOI 10.1109/89.759030; Reindl K., 2012, COMPUTER SPEECH LANG, V27, P726; Reindl K., 2013, P IEEE WORKSH APPL S; Sawada H, 2004, IEEE T SPEECH AUDI P, V12, P530, DOI 10.1109/TSA.2004.832994; Scheuing J, 2008, IEEE T AUDIO SPEECH, V16, P1479, DOI 10.1109/TASL.2008.2004533; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Veen B. V., 1988, IEEE ASSP MAG    APR, V5, P4; Wang D. L., 2007, COMPUTATIONAL AUDITO	50	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1053-5888	1558-0792		IEEE SIGNAL PROC MAG	IEEE Signal Process. Mag.	MAR	2015	32	2					18	30		10.1109/MSP.2014.2366780		13	Engineering, Electrical & Electronic	Engineering	CB6XX	WOS:000349771400006		
J	Gerkmann, T; Krawczyk-Becker, M; Le Roux, J				Gerkmann, Timo; Krawczyk-Becker, Martin; Le Roux, Jonathan			Phase Processing for Single-Channel Speech Enhancement	IEEE SIGNAL PROCESSING MAGAZINE			English	Article							SPECTRAL MAGNITUDE ESTIMATION; TIME FOURIER-TRANSFORM; SIGNAL ESTIMATION; VOCODER; AUDIO	With the advancement of technology, both assisted listening devices and speech communication devices are becoming more portable and also more frequently used. As a consequence, users of devices such as hearing aids, cochlear implants, and mobile telephones, expect their devices to work robustly anywhere and at any time. This holds in particular for challenging noisy environments like a cafeteria, a restaurant, a subway, a factory, or in traffic. One way to making assisted listening devices robust to noise is to apply speech enhancement algorithms. To improve the corrupted speech, spatial diversity can be exploited by a constructive combination of microphone signals (so-called beamforming), and by exploiting the different spectro-temporal properties of speech and noise. Here, we focus on single-channel speech enhancement algorithms which rely on spectrotemporal properties. On the one hand, these algorithms can be employed when the miniaturization of devices only allows for using a single microphone. On the other hand, when multiple microphones are available, single-channel algorithms can be employed as a postprocessor at the output of a beamformer. To exploit the short-term stationary properties of natural sounds, many of these approaches process the signal in a time-frequency representation, most frequently the short-time discrete Fourier transform (STFT) domain. In this domain, the coefficients of the signal are complex-valued, and can therefore be represented by their absolute value (referred to in the literature both as STFT magnitude and STFT amplitude) and their phase. While the modeling and processing of the STFT magnitude has been the center of interest in the past three decades, phase has been largely ignored. In this article, we review the role of phase processing for speech enhancement in the context of assisted listening and speech communication devices. We explain why most of the research conducted in this field used to focus on estimating spectral magnitudes in the STFT domain, and why recently phase processing is attracting increasing interest in the speech enhancement community. Furthermore, we review both early and recent methods for phase processing in speech enhancement. We aim to show that phase processing is an exciting field of research with the potential to make assisted listening and speech communication devices more robust in acoustically challenging environments.	[Gerkmann, Timo; Krawczyk-Becker, Martin] Siemens Corp Res, Princeton, NJ USA; [Gerkmann, Timo] Royal Inst Technol, Stockholm, Sweden; [Gerkmann, Timo] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany; [Le Roux, Jonathan] Mitsubishi Elect Res Labs, Cambridge, MA USA; [Le Roux, Jonathan] Nippon Telegraph & Tel Commun Sci Labs, Kyoto, Japan	Gerkmann, T (reprint author), Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany.	timo.gerkmann@uni-oldenburg.de; martin.krawczyk-becker@uni-oldenburg.de; leroux@merl.com	Magazine, Signal Processing/E-9947-2015		German Research Foundation [GE2538/2-1]	This work was supported by grant GE2538/2-1 of the German Research Foundation.	EPHRAIM Y, 1984, IEEE T ACOUST SPEECH, V32, P1109, DOI 10.1109/TASSP.1984.1164453; Breithaupt C, 2008, INT CONF ACOUST SPEE, P4037, DOI 10.1109/ICASSP.2008.4518540; Krawczyk M, 2014, IEEE-ACM T AUDIO SPE, V22, P1931, DOI 10.1109/TASLP.2014.2354236; Paliwal K, 2011, SPEECH COMMUN, V53, P465, DOI 10.1016/j.specom.2010.12.003; Kazama M, 2010, J ACOUST SOC AM, V127, P1432, DOI 10.1121/1.3294554; Le Roux J, 2013, IEEE SIGNAL PROC LET, V20, P217, DOI 10.1109/LSP.2012.2225617; Laroche J, 1999, IEEE T SPEECH AUDI P, V7, P323, DOI 10.1109/89.759041; Mowlaee P, 2013, IEEE SIGNAL PROC LET, V20, P1235, DOI 10.1109/LSP.2013.2286748; FLANAGAN JL, 1966, AT&T TECH J, V45, P1493; Jensen J, 2001, IEEE T SPEECH AUDI P, V9, P731, DOI 10.1109/89.952491; Bello JP, 2005, IEEE T SPEECH AUDI P, V13, P1035, DOI 10.1109/TSA.2005.851998; Gerkmann T, 2013, IEEE SIGNAL PROC LET, V20, P129, DOI 10.1109/LSP.2012.2233470; Gerkmann T, 2014, IEEE T SIGNAL PROCES, V62, P4199, DOI 10.1109/TSP.2014.2336615; Gnann V., 2010, P INT C DIG AUD EFF; Griffin D. W., 1983, THESIS MIT; GRIFFIN DW, 1984, IEEE T ACOUST SPEECH, V32, P236, DOI 10.1109/TASSP.1984.1164317; Gunawan D, 2010, IEEE SIGNAL PROC LET, V17, P421, DOI 10.1109/LSP.2010.2042530; Hendriks R., 2013, DFT DOMAIN BASED SIN; Hershey J. R., 2012, TECHNIQUES NOISE ROB; Le Roux J., 2010, P AC SOC JAP AUT M S; Ono N., 2008, P SAPA SEPT, P23; Quatieri T. F., 1979, THESIS MIT; Stark AP, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2602; Sturmel N, 2013, IEEE T AUDIO SPEECH, V21, P176, DOI 10.1109/TASL.2012.2215597; Sturmel N, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P101; Sugiyama A., 2013, P IEEE WASPAA OCT, P1; VARY P, 1985, SIGNAL PROCESS, V8, P387, DOI 10.1016/0165-1684(85)90002-7; WANG DL, 1982, IEEE T ACOUST SPEECH, V30, P679, DOI 10.1109/TASSP.1982.1163920; YEGNANARAYANA B, 1992, IEEE T SIGNAL PROCES, V40, P2281, DOI 10.1109/78.157227; Zhu XL, 2007, IEEE T AUDIO SPEECH, V15, P1645, DOI 10.1109/TASL.2007.899236	30	0	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1053-5888	1558-0792		IEEE SIGNAL PROC MAG	IEEE Signal Process. Mag.	MAR	2015	32	2					55	66		10.1109/MSP.2014.2369251		12	Engineering, Electrical & Electronic	Engineering	CB6XX	WOS:000349771400009		
J	Cichocki, A; Mandic, DP; Phan, AH; Caiafa, CF; Zhou, GX; Zhao, QB; De Lathauwer, L				Cichocki, Andrzej; Mandic, Danilo P.; Anh Huy Phan; Caiafa, Cesar F.; Zhou, Guoxu; Zhao, Qibin; De Lathauwer, Lieven			Tensor Decompositions for Signal Processing Applications	IEEE SIGNAL PROCESSING MAGAZINE			English	Article							CANONICAL POLYADIC DECOMPOSITION; BLIND SOURCE SEPARATION; ALTERNATING LEAST-SQUARES; PARALLEL FACTOR-ANALYSIS; HIGHER-ORDER TENSORS; RANK APPROXIMATION; FACTOR MATRIX; 1) TERMS; L-R; CANDECOMP/PARAFAC		[Cichocki, Andrzej] Polish Acad Sci, Syst Res Inst, PL-00901 Warsaw, Poland; [Mandic, Danilo P.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Mandic, Danilo P.] Katholieke Univ Leuven, Louvain, Belgium; [Mandic, Danilo P.] RIKEN Brain Sci Inst, Tokyo, Japan; [Anh Huy Phan] Vietnam Televis, Broadcast Res & Applicat Ctr, Dept Res & Dev, Washington, DC USA; [De Lathauwer, Lieven] CNRS, F-75700 Paris, France; [De Lathauwer, Lieven] Grp Sci Engn & Technol Kulak, Louvain, Belgium; [De Lathauwer, Lieven] Elect Engn Dept ESAT, Ctr Dynam Syst Signal Proc & Data Analyt, Louvain, Belgium; [De Lathauwer, Lieven] IMinds Future Hlth Dept, Louvain, Belgium	Cichocki, A (reprint author), RIKEN Brain Sci Inst, Lab Adv Brain Signal Proc, Tokyo, Japan.	cia@brain.riken.jp; d.mandic@imperial.ac.uk; phan@brain.riken.jp; ccaiafa@gmail.com; zhouguoxu@brain.riken.jp; qbzhao@brain.riken.jp; Lieven.DeLathauwer@kuleuven--kulak.be	Magazine, Signal Processing/E-9947-2015				Acar E., 2011, P MIN LEARN GRAPHS M; vanderVeen AJ, 1996, IEEE T SIGNAL PROCES, V44, P1136, DOI 10.1109/78.502327; KRUSKAL JB, 1977, LINEAR ALGEBRA APPL, V18, P95, DOI 10.1016/0024-3795(77)90069-6; Zhao QB, 2013, IEEE T PATTERN ANAL, V35, P1660, DOI 10.1109/TPAMI.2012.254; Zhou GX, 2012, IEEE SIGNAL PROC LET, V19, P523, DOI 10.1109/LSP.2012.2205237; Li YO, 2009, IEEE T SIGNAL PROCES, V57, P3918, DOI 10.1109/TSP.2009.2021636; Krijnen WP, 2008, PSYCHOMETRIKA, V73, P431, DOI 10.1007/s11336-008-9056-1; HASTAD J, 1990, J ALGORITHMS, V11, P644, DOI 10.1016/0196-6774(90)90014-6; Oseledets I, 2010, LINEAR ALGEBRA APPL, V432, P70, DOI 10.1016/j.laa.2009.07.024; Timmerman ME, 2000, BRIT J MATH STAT PSY, V53, P1, DOI 10.1348/000711000159132; Morup M, 2009, J CHEMOMETR, V23, P352, DOI 10.1002/cem.1223; De Lathauwer L, 2000, SIAM J MATRIX ANAL A, V21, P1324, DOI 10.1137/S0895479898346995; Jiang T, 2004, IEEE T SIGNAL PROCES, V52, P2625, DOI 10.1109/TSP.2004.832022; Sidiropoulos ND, 2000, IEEE T SIGNAL PROCES, V48, P810, DOI 10.1109/78.824675; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Sorber L, 2013, SIAM J OPTIMIZ, V23, P695, DOI 10.1137/120868323; Tichavsky P, 2013, IEEE T SIGNAL PROCES, V61, P1986, DOI 10.1109/TSP.2013.2245660; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Cattell RB, 1944, PSYCHOMETRIKA, V9, P267, DOI 10.1007/BF02288739; De Lathauwer L, 2011, SIAM J MATRIX ANAL A, V32, P1451, DOI 10.1137/100805510; Acar E, 2009, IEEE T KNOWL DATA EN, V21, P6, DOI 10.1109/TKDE.2008.112; Liu XQ, 2001, IEEE T SIGNAL PROCES, V49, P2074; Lu HP, 2011, PATTERN RECOGN, V44, P1540, DOI 10.1016/j.patcog.2011.01.004; Uschmajew A, 2012, SIAM J MATRIX ANAL A, V33, P639, DOI 10.1137/110843587; Beylkin G, 2005, SIAM J SCI COMPUT, V26, P2133, DOI 10.1137/040604959; Sidiropoulos ND, 2001, IEEE T INFORM THEORY, V47, P1687, DOI 10.1109/18.923759; Domanov I, 2014, SIAM J MATRIX ANAL A, V35, P636, DOI 10.1137/130916084; Acar E, 2011, CHEMOMETR INTELL LAB, V106, P41, DOI 10.1016/j.chemolab.2010.08.004; Lim LH, 2009, J CHEMOMETR, V23, P432, DOI 10.1002/cem.1244; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Comon P, 2009, J CHEMOMETR, V23, P393, DOI 10.1002/cem.1236; De Lathauwer L, 2008, SIAM J MATRIX ANAL A, V30, P1022, DOI 10.1137/060661685; Zhou G, 2012, B POL ACAD SCI-TECH, V60, P389, DOI 10.2478/v10175-012-0051-4; De Lathauwer L, 2000, SIAM J MATRIX ANAL A, V21, P1253, DOI 10.1137/S0895479896305696; Comon P, 2014, IEEE SIGNAL PROC MAG, V31, P44, DOI 10.1109/MSP.2014.2298533; Paatero P, 1999, J COMPUT GRAPH STAT, V8, P854, DOI 10.2307/1390831; Elad M, 2004, IEEE T SIGNAL PROCES, V52, P1814, DOI 10.1109/TSP.2004.828919; Savas B, 2010, SIAM J SCI COMPUT, V32, P3352, DOI 10.1137/090763172; Goreinov SA, 1997, MATH NOTES+, V62, P515, DOI 10.1007/BF02358985; Razaviyayn M, 2013, SIAM J OPTIMIZ, V23, P1126, DOI 10.1137/120891009; Caiafa CF, 2013, NEURAL COMPUT, V25, P186, DOI 10.1162/NECO_a_00385; Duarte MF, 2012, IEEE T IMAGE PROCESS, V21, P494, DOI 10.1109/TIP.2011.2165289; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Chen BL, 2012, SIAM J OPTIMIZ, V22, P87, DOI 10.1137/110834524; Sidiropoulos ND, 2012, IEEE SIGNAL PROC LET, V19, P757, DOI 10.1109/LSP.2012.2210872; Nion D, 2009, IEEE T SIGNAL PROCES, V57, P2299, DOI 10.1109/TSP.2009.2016885; Signoretto M, 2014, MACH LEARN, V94, P303, DOI 10.1007/s10994-013-5366-3; Ishteva M, 2011, SIAM J MATRIX ANAL A, V32, P115, DOI 10.1137/090764827; Sorensen M, 2013, IEEE T SIGNAL PROCES, V61, P5507, DOI 10.1109/TSP.2013.2276416; ROY R, 1989, IEEE T ACOUST SPEECH, V37, P984, DOI 10.1109/29.32276; Sorensen M, 2012, SIAM J MATRIX ANAL A, V33, P1190, DOI 10.1137/110830034; de Silva V, 2008, SIAM J MATRIX ANAL A, V30, P1084, DOI 10.1137/06066518X; Oseledets IV, 2008, SIAM J MATRIX ANAL A, V30, P939, DOI 10.1137/060655894; Suter SK, 2013, COMPUT GRAPH FORUM, V32, P151, DOI 10.1111/cgf.12102; Domanov I, 2013, SIAM J MATRIX ANAL A, V34, P855, DOI 10.1137/120877234; Morup M, 2011, WIRES DATA MIN KNOWL, V1, P24, DOI 10.1002/widm.1; Bruckstein AM, 2009, SIAM REV, V51, P34, DOI 10.1137/060657704; Vorobyov SA, 2005, IEEE T SIGNAL PROCES, V53, P2678, DOI 10.1109/TSP.2005.850343; Stegeman A, 2009, LINEAR ALGEBRA APPL, V431, P211, DOI 10.1016/j.laa.2009.02.025; Bro R, 1996, J CHEMOMETR, V10, P47, DOI 10.1002/(SICI)1099-128X(199601)10:1<47::AID-CEM400>3.3.CO;2-3; Ceulemans E, 2006, BRIT J MATH STAT PSY, V59, P133, DOI 10.1348/000711005X64817; Caiafa CF, 2010, LINEAR ALGEBRA APPL, V433, P557, DOI 10.1016/j.laa.2010.03.020; Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Phan AH, 2013, SIAM J MATRIX ANAL A, V34, P126, DOI 10.1137/100808034; Salmi J, 2009, IEEE T SIGNAL PROCES, V57, P4719, DOI 10.1109/TSP.2009.2027740; Sidiropoulos ND, 2000, J CHEMOMETR, V14, P229, DOI 10.1002/1099-128X(200005/06)14:3<229::AID-CEM587>3.3.CO;2-E; De Lathauwer L, 2006, SIAM J MATRIX ANAL A, V28, P642, DOI 10.1137/040608830; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Haardt M, 2008, IEEE T SIGNAL PROCES, V56, P3198, DOI 10.1109/TSP.2008.917929; Bader B. W., 2012, MATLAB TENSOR TOOLBO; Ballani J., 2011, LINEAR ALGEBRA APPL, V433, P639; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Caiafa CF, 2013, WIRES DATA MIN KNOWL, V3, P355, DOI 10.1002/widm.1108; Calhoun V., 2009, NEUROIMAGE, V45, P163; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; CARDOSO JF, 1993, IEE PROC-F, V140, P362; Cichocki A., 2003, ADAPTIVE BLIND SIGNA; Cichocki A., 2013, P 2013 INT WORKSH SM, V2013, P30; Cichocki A., 2007, STAT PROCESS MODELS, P201; Cichocki A., 2011, J CONTROL MEASURE SY, V47, P507; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; De Lathauwer L., 2012, P 10 INT C LVA ICA T, P1; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Eldar Y., 2012, COMPRESSED SENSING T, V20, P12; Foster D., 2006, J OPT SOC AM A, V23, P2359; Gandy S., 2011, INVERSE PROBL, V27, P1; Goreinov S. A., 2008, DOKL MATH, V420, P404, DOI DOI 10.1134/S106456240803023X; Grasedyck L., 2013, CGAMM MITTEILUNGEN, V36, P53; Hackbusch W, 2012, SPRINGER SERIES COMP, V42; Harshman R. A., 1970, UCLA WORKING PAPERS, V16, P1; Hirsch M., 2012, P INT C COMP GRAPH I, P24; Hitchcock F.L., 1927, J MATH PHYS, V7, P39; Hyvarinen A., 2001, INDEPENDENT COMPONEN; Khoromskij B., 2011, CHEMOMETR INTEL LAB, V110, P1; Kressner D., 2012, HTUCKER MATLAB TOOLB; Kroonenberg P., 3 MODE CO CO DEVOTED; KROONENBERG P. M., 2008, APPL MULTIWAY DATA A; Landsberg JM, 2012, TENSORS GEOMETRY APP; Mahoney MW, 2008, SIAM J MATRIX ANAL A, V30, P957, DOI 10.1137/060665336; Mohlenkamp MJ, 2013, LINEAR ALGEBRA APPL, V438, P834, DOI 10.1016/j.laa.2011.04.019; Orus R., 2013, J CHEM PHYS; Oseledets I., 2012, TT TOOLBOX 2 2; Oseledets IV, 2011, SIAM J SCI COMPUT, V33, P2295, DOI 10.1137/090752286; Petropulu A.P., 1993, HIGHER ORDER SPECTRA; Phan A. H., 2010, NONLINEAR THEORY ITS, V1, P37, DOI 10.1587/nolta.1.37; Phan A.-H., 2012, TENSORBOX MATLAB PAC; Phan AH, 2011, NEUROCOMPUTING, V74, P1970, DOI 10.1016/j.neucom.2010.06.030; SANCHEZ E., 1990, J CHEMOMETR, V4, P29, DOI 10.1002/cem.1180040105; Smilde A., 2004, MULTIWAY ANAL APPL C; Sorber L., 2014, TENSORLAB V2 0; Tucker L. R., 1964, CONTRIBUTIONS MATH P, P110; Vasilescu M.A.O., 2002, P EUR C COMP VIS ECC, V2350, P447; Xu Z., 2012, ICML 12, P1023; Yilmaz K., 2010, P INT C LAT VAR AN S, V6365, P346; Zhou G., 2013, TDALAB TENSOR DECOMP; Zhou G., 2013, IEEE T PATTERN ANAL	117	15	15	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1053-5888	1558-0792		IEEE SIGNAL PROC MAG	IEEE Signal Process. Mag.	MAR	2015	32	2					145	163		10.1109/MSP.2013.2297439		19	Engineering, Electrical & Electronic	Engineering	CB6XX	WOS:000349771400016		
J	Sariyildiz, E; Ohnishi, K				Sariyildiz, Emre; Ohnishi, Kouhei			On the Explicit Robust Force Control via Disturbance Observer	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Disturbance observer (DOb); explicit force control; reaction force observer (RFOb); robust control; stability	MOTION CONTROL; VALIDATION	This paper analyzes the robustness and stability of disturbance observer (DOb)-based explicit force control systems. Conventional analysis methods, which only consider ideal robustness, are impractical due to the design constraints of a DOb, e.g., bandwidth limitations. This paper shows that not only the stability but also the robustness of a DOb-based explicit force control system changes by environmental impedance variations. The robustness of a DOb-based explicit force control system is clarified by deriving new sensitivity functions. Implicit and explicit environmental impedance estimation methods are considered by analyzing the dynamics of a force sensor and a reaction force observer (RFOb), respectively. It is shown that the stability and performance of an explicit force control system can be improved by using an explicit environmental impedance estimation method, i.e., an RFOb, intrinsically. However, an RFOb is more sensitive than a force sensor to external disturbances, and the stability of the explicit force control system drastically changes by the design parameters of a DOb and an RFOb. Force-sensor- and RFOb-based explicit robust force control systems are compared in terms of stability, robustness, and performance in detail. The validity of the proposals is verified by simulation and experimental results.	[Sariyildiz, Emre; Ohnishi, Kouhei] Keio Univ, Fac Sci & Technol, Dept Syst Design Engn, Ohnishi Lab, Yokohama, Kanagawa 2238522, Japan	Sariyildiz, E (reprint author), Keio Univ, Fac Sci & Technol, Dept Syst Design Engn, Ohnishi Lab, Yokohama, Kanagawa 2238522, Japan.	emre@sum.sd.keio.ac.jp; ohnishi@sd.keio.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25220903]	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan under Grant-in-Aid for Scientific Research (S) 25220903, 2013.	Cheah CC, 2010, IEEE-ASME T MECH, V15, P389, DOI 10.1109/TMECH.2009.2027115; Motoi N, 2014, IEEE T IND ELECTRON, V61, P1009, DOI 10.1109/TIE.2013.2251738; Sariyildiz E, 2015, IEEE-ASME T MECH, V20, P750, DOI 10.1109/TMECH.2014.2321014; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Katsura S, 2007, IEEE T IND ELECTRON, V54, P530, DOI 10.1109/TIE.2006.885459; Katsura S, 2006, IEEE T IND ELECTRON, V53, P922, DOI 10.1109/TIE.2006.874262; Khayati K, 2004, IEEE SYS MAN CYBERN, P6113; Mortl A, 2012, INT J ROBOT RES, V31, P1656, DOI 10.1177/0278364912455366; Sabanovic A., 2011, ADV MOTION CONTROL; Sariyildiz E, 2013, INT J CONTROL, V86, P1733, DOI 10.1080/00207179.2013.795663; Sariyildiz E., 2014, ASME T J DYN SYS MEA, V136, P1; Sariyildiz E, 2015, IEEE T IND ELECTRON, V62, P414, DOI 10.1109/TIE.2014.2327009; Sehoon Oh, 2014, IEEE Transactions on Industrial Electronics, V61, DOI 10.1109/TIE.2013.2270214; Villani L., 2008, SPRINGER HDB ROBOTIC, P161, DOI 10.1007/978-3-540-30301-5_8; Xi Chen, 2014, IEEE Transactions on Haptics, V7, DOI 10.1109/TOH.2013.38; Yuen SG, 2010, IEEE T ROBOT, V26, P888, DOI 10.1109/TRO.2010.2053734; Zemiti N, 2010, IEEE T CONTR SYST T, V18, P307, DOI 10.1109/TCST.2009.2022170	17	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	MAR	2015	62	3					1581	1589		10.1109/TIE.2014.2361611		9	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	CB5OI	WOS:000349676900025		
J	Dryer, R; Uesaka, Y; Manalo, E; Tyson, G				Dryer, Rachel; Uesaka, Yuri; Manalo, Emmanuel; Tyson, Graham			Cross-Cultural Examination of Beliefs About the Causes of Bulimia Nervosa Among Australian and Japanese Females	INTERNATIONAL JOURNAL OF EATING DISORDERS			English	Article						eating disorders; bulimia nervosa; causal beliefs; cultural similarities and differences; Australian and Japanese women	HIGH-SCHOOL-STUDENTS; EATING-DISORDERS; BODY DISSATISFACTION; ANOREXIA-NERVOSA; RISK-FACTORS; WOMEN; SELF; PREVALENCE; MODEL; IMAGE	ObjectiveTo identify similarities and differences in beliefs about the causes of Bulimia Nervosa (BN) held by Asian (Japanese) women and Western (Australian) women, and hence, to examine the applicability of belief models of eating disorders (ED) across different cultures. MethodFour hundred three Japanese and 256 Australian female university students (aged 17-35 years) completed a questionnaire that gauged beliefs about the causes of BN. ResultsAmong the Australian women, the four-component structure of perceived causes (dieting and eating practices, family dynamics, socio-cultural pressure, and psychological vulnerability) found in Dryer et al. (2012) was replicated. Among the Japanese women, however, a three-component structure (without the psychological vulnerability component) was obtained. The groups also differed in the causal component they most strongly endorsed, that being socio-cultural pressure for the Australian women, and dieting and eating practices for the Japanese women. DiscussionThe Japanese participants were found to endorse three out of the four Western-based causal explanations for BN, but the relative importance they placed on those explanations differed from that of the Australian participants. Further research is needed, particularly to establish whether Japanese women simply fail to see psychological vulnerability as a viable cause of BN, or there are in fact cultural differences in the extent to which such vulnerability causes BN. (c) 2014 Wiley Periodicals, Inc. (Int J Eat Disord 2015; 48:176-186)	[Dryer, Rachel; Tyson, Graham] Charles Sturt Univ, Sch Psychol, Bathurst, NSW 2795, Australia; [Uesaka, Yuri] Univ Tokyo, Ctr Excellence Sch Educ, Grad Sch Educ, Tokyo 1138654, Japan; [Manalo, Emmanuel] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	Dryer, R (reprint author), Charles Sturt Univ, Sch Psychol, Bathurst, NSW 2795, Australia.	rdryer@csu.edu.au					Akiba D., 2012, JIKO CHOUSEI GAKUSYU, P115; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Lee S, 2000, INT J EAT DISORDER, V27, P317, DOI 10.1002/(SICI)1098-108X(200004)27:3<317::AID-EAT9>3.3.CO;2-U; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; MUKAI T, 1994, J CHILD PSYCHOL PSYC, V35, P677, DOI 10.1111/j.1469-7610.1994.tb01213.x; Chisuwa N, 2010, APPETITE, V54, P5, DOI 10.1016/j.appet.2009.11.008; Striegel-Moore RH, 2007, AM PSYCHOL, V62, P181, DOI 10.1037/0003-066X.62.3.181; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Mukai T, 1998, SEX ROLES, V39, P751, DOI 10.1023/A:1018812218467; Eaton MJ, 1997, J EDUC PSYCHOL, V89, P433, DOI 10.1037/0022-0663.89.3.433; Yamamiya Y, 2008, INT J EAT DISORDER, V41, P88, DOI 10.1002/eat.20444; Nakamura K, 2000, INT J EAT DISORDER, V28, P173, DOI 10.1002/1098-108X(200009)28:2<173::AID-EAT6>3.0.CO;2-I; Vohs KD, 1999, J ABNORM PSYCHOL, V108, P695, DOI 10.1037/0021-843X.108.4.695; Bulik C. M., 2008, CHILD ADOL PSYCH CL, P643; Dryer R, 2013, AUST PSYCHOL, V48, P338, DOI 10.1111/j.1742-9544.2012.00077.x; Gordon RA., 2000, ANATOMY SOCIAL EPIDE; Jacobi C, 2010, HDB EATING DISORDERS, P123; Jorm AF, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-12; Kowner R, 2002, INT J PSYCHOL, V37, P149, DOI 10.1080/00207590143000298; Kowner R, 2004, GENET SOC GEN PSYCH, V130, P333, DOI 10.3200/MONO.130.4.333-364; Makino M, 2006, ARCH WOMEN MENT HLTH, V9, P203, DOI 10.1007/s00737-006-0128-x; Manalo E, 2013, THINK SKILLS CREAT, V10, P121, DOI 10.1016/j.tsc.2013.08.003; MCDONALDSCOTT P, 1992, PSYCHOL MED, V22, P147; Ministry of Health Labour and Welfare, MEAS LIF REL DIS HLT; Miyaji S., 2010, JAPAN WOMENS U J, V16, P153; Mond JM, 2008, J MENT HEALTH, V17, P565, DOI 10.1080/09638230701677787; Mond JM, 2004, AUST NZ J PSYCHIAT, V38, P463, DOI 10.1111/j.1440-1614.2004.01384.x; Nagai M, 2007, JAPANESE J SCH HLTH, V47, P436; Nishizawa Y, 2003, PSYCHIAT CLIN NEUROS, V57, P189, DOI 10.1046/j.1440-1819.2003.01100.x; Nishizono-Maher A, 1998, PSYCHIAT CLIN NEUROS, V52, pS320; Pike KM, 2004, CULT MED PSYCHIAT, V28, P493, DOI 10.1007/s11013-004-1066-6; Pike KM, 2005, INT J EAT DISORDER, V37, P26, DOI 10.1002/eat.20065; Smith April R, 2008, Eat Behav, V9, P513, DOI 10.1016/j.eatbeh.2008.07.003; Stark-Wroblewski K, 2005, PSYCHOL WOMEN QUART, V29, P38, DOI 10.1111/j.1471-6402.2005.00166.x; Takahata K, 2005, CLIN ED, V12, P13; Takano A, 2007, CAHE J HIGH ED TOHOK, V2, P157; Thompson J. K., 1999, EXACTING BEAUTY, DOI 10.1037/10312-000; Yasuhara D, 2002, INT CONGR SER, V1241, P297, DOI 10.1016/S0531-5131(02)00689-1; Zwick WR, 1986, PSYCHOL BULL, V99, P423	39	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0276-3478	1098-108X		INT J EAT DISORDER	Int. J. Eating Disord.	MAR	2015	48	2					176	186		10.1002/eat.22269		11	Psychology, Clinical; Nutrition & Dietetics; Psychiatry; Psychology	Psychology; Nutrition & Dietetics; Psychiatry	CB4ME	WOS:000349601100003		
J	Abe, T				Abe, Takayuki			Quantitative Evaluation of B-1 Insensitivity in Nonadiabatic Frequency-Selective Fat-Suppression RF Pulse Techniques	INTERNATIONAL JOURNAL OF IMAGING SYSTEMS AND TECHNOLOGY			English	Article						nonadiabatic RF pulse; fat suppression; B-1 insensitivity; B-1 inhomogeneity; reduced SAR	INVERSION-RECOVERY; SPECTRAL PRESATURATION; INHOMOGENEITY; B1; OPTIMIZATION; SPECTROSCOPY; EXCITATION; BREAST; WATER; TRAIN	Nonadiabatic frequency-selective fat-suppression radiofrequency (RF) pulses are simpler than adiabatic RF pulses because nonadiabatic RF pulses are only amplitude modulated. The specific absorption rate (SAR) is lower. However, nonadiabatic RF pulses tend to be sensitive to B-1 inhomogeneity. The purpose of this research was to evaluate whether conventional adiabatic RF pulses can replace nonadiabatic RF pulse techniques. The B-1 insensitivities of nonadiabatic frequency-selective fat-suppression RF pulse techniques were calculated by using the Bloch equation, and their effectiveness was evaluated by simulation using the measured B-1 field map. The B-1 insensitivities were compared quantitatively. The B-1 insensitivities of the nonadiabatic RF pulse techniques were +/- 5% (CHESS), a maximum of +/- 20% (inversion recovery RF pulse with the best inversion time), +/- 25% (RF pulse train with two subpulses), and +/- 44% (RF pulse train with three subpulses). The RF pulse train was the most effective. The B-1 insensitivity of different nonadiabatic RF pulse techniques was specified quantitatively. These results can be used to judge which nonadiabatic RF pulses can replace adiabatic RF pulses. Nonadiabatic RF pulses can reduce the SAR without compromising the image quality and would be useful in higher field-strength MRI. (c) 2015 Wiley Periodicals, Inc.	Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan	Abe, T (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan.	takayuki.abe.mri@gmail.com					Abe T, 2013, APPL MAGN RESON, V44, P1213, DOI 10.1007/s00723-013-0474-6; Abe T, 2012, MAGN RESON MED, V67, P464, DOI 10.1002/mrm.23015; Udayasankar UK, 2008, J MAGN RESON IMAGING, V28, P1133, DOI 10.1002/jmri.21574; STAEWEN RS, 1990, INVEST RADIOL, V25, P559, DOI 10.1097/00004424-199005000-00015; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; UGURBIL K, 1987, J MAGN RESON, V72, P177; UGURBIL K, 1988, J MAGN RESON, V80, P448; Kuhl CK, 2007, RADIOLOGY, V244, P929, DOI 10.1148/radiol.2443070266; FRAHM J, 1985, RADIOLOGY, V156, P441; Azlan CA, 2010, J MAGN RESON IMAGING, V31, P234, DOI 10.1002/jmri.22018; BENDALL MR, 1986, J MAGN RESON, V67, P376, DOI 10.1016/0022-2364(86)90447-6; Bernstein M. A., 2004, HDB MRI PULSE SEQUEN, P117; DPanfil S. L. Rosenfeld, 1997, MAGN RESON MED, V37, P793; FOO TKF, 1994, RADIOLOGY, V191, P85; Gu M, 2009, MAGN RESON MED, V61, P462, DOI 10.1002/mrm.21843; Lauenstein TC, 2008, J MAGN RESON IMAGING, V27, P1448, DOI 10.1002/jmri.21350; OGG RJ, 1994, J MAGN RESON SER B, V104, P1, DOI 10.1006/jmrb.1994.1048; PAULY J, 1991, IEEE T MED IMAGING, V10, P53, DOI 10.1109/42.75611; TERK MR, 1993, MAGN RESON IMAGING, V11, P931, DOI 10.1016/0730-725X(93)90212-V	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-9457	1098-1098		INT J IMAG SYST TECH	Int. J. Imaging Syst. Technol.	MAR	2015	25	1					86	91		10.1002/ima.22124		6	Engineering, Electrical & Electronic; Optics; Imaging Science & Photographic Technology	Engineering; Optics; Imaging Science & Photographic Technology	CB4VL	WOS:000349626300011		
J	Kono, D; Nishio, S; Yamaji, I; Matsubara, A				Kono, Daisuke; Nishio, Syuya; Yamaji, Iwao; Matsubara, Atsushi			A method for stiffness tuning of machine tool supports considering contact stiffness	INTERNATIONAL JOURNAL OF MACHINE TOOLS & MANUFACTURE			English	Article						Machine tool support; Contact stiffness; Rocking vibration; Stiffness tuning	LAYOUT OPTIMIZATION; MILLING MACHINES; DESIGN	A methodology for tuning the stiffness of machine tool supports is described based on a stiffness model using the contact stiffness approach. Using this model, the mathematical relationship between the load of the support and its stiffness is established. The relationship is separated into three regions. When the total stiffness of all supports is maximized, the load must be tuned so that the stiffness-support load relationship is in the critical region, whereby the contact stiffness is slightly larger than the bulk stiffness. Correspondingly, a placement method of supports is proposed that increases their stiffness without anchor bolts. The effectiveness of the proposed method is verified in two experiments. In the first experiment, the natural frequency of a small machine tool prototype is compared for several placements of three supports. The lowest natural frequency of the machine tool under the proposed placement scheme is maximized. In the second experiment, the proposed method is applied to increase the lowest natural frequency of a horizontal milling machine. The lowest natural frequency with a distinct arrangement of three supports is increased by 15-55%, compared to other popular placements of these three supports. The experimental results show that the proposed placement method is effective for enhancing the stiffness of machine tool supports. (C) 2015 Elsevier Ltd. All rights reserved.	[Kono, Daisuke; Nishio, Syuya; Yamaji, Iwao; Matsubara, Atsushi] Kyoto Univ, Grad Sch Engn, Dept Micro Engn, Nisikyo Ku, Kyoto 6158540, Japan	Kono, D (reprint author), Kyoto Univ, Grad Sch Engn, Dept Micro Engn, Nisikyo Ku, C1S09,C3, Kyoto 6158540, Japan.	kono@prec.kyoto-u.ac.jp			KAKENHI [24760104]; Mazak Foundation	This work was supported by KAKENHI (24760104) and Mazak Foundation.	Altintas Y., 2005, ANN CIRP, V54, P115, DOI DOI 10.1016/S0007-8506(07)60022-5; Zulaika JJ, 2011, INT J MACH TOOL MANU, V51, P591, DOI 10.1016/j.ijmachtools.2011.04.003; Huo DH, 2010, INT J MACH TOOL MANU, V50, P335, DOI 10.1016/j.ijmachtools.2009.10.009; Wan XJ, 2013, INT J MACH TOOL MANU, V70, P32, DOI 10.1016/j.ijmachtools2013.03.007; Law M, 2013, INT J MACH TOOL MANU, V68, P81, DOI 10.1016/j.ijmachtools.2013.02.003; Okwudire CE, 2013, PRECIS ENG, V37, P425, DOI 10.1016/j.precisioneng.2012.11.005; Li BT, 2014, INT J MACH TOOL MANU, V84, P33, DOI 10.1016/j.ijmachtools.2014.03.005; Brecher C, 2010, INT J MACH TOOL MANU, V50, P328, DOI 10.1016/j.ijmachtools.2009.11.007; De Meter EC, 1998, INT J MACH TOOL MANU, V38, P1221, DOI 10.1016/S0890-6955(97)00127-2; GREENWOO.JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; Huang DTY, 2001, INT J MACH TOOL MANU, V41, P1149, DOI 10.1016/S0890-6955(01)00012-8; Kono D, 2013, PRECIS ENG, V37, P650, DOI 10.1016/j.precisioneng.2013.01.010; Lee CH, 2015, INT J MACH TOOL MANU, V90, P29, DOI 10.1016/j.ijmachtools.2014.12.003; Makhult M., 1977, MACHINE SUPPORT DESI; RIVIN EI, 1995, PRECIS ENG, V17, P41, DOI 10.1016/0141-6359(94)00006-L; Rivin EI, 1999, STIFFNESS DAMPING ME; Wang L, 2015, INT J MACH TOOL MANU, V88, P71, DOI 10.1016/j.ijmachtools.2014.09.003; Wu BC, 2000, INT J MACH TOOL MANU, V40, P783, DOI 10.1016/S0890-6955(99)00113-3; YOSHIDA K, 1988, J MECH WORK TECHNOL, V17, P377, DOI 10.1016/0378-3804(88)90039-3; Yu Z., 2010, INT J AUTOM TECHNOL, V4, P303	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0890-6955	1879-2170		INT J MACH TOOL MANU	Int. J. Mach. Tools Manuf.	MAR	2015	90						50	59		10.1016/j.ijmachtools.2015.01.001		10	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CB6GO	WOS:000349725700006		
J	Aoki, A; Moro, H; Watanabe, T; Asakawa, K; Miura, S; Moriyama, M; Tanabe, Y; Kagamu, H; Narita, I				Aoki, Ami; Moro, Hiroshi; Watanabe, Takayuki; Asakawa, Katsuaki; Miura, Satoru; Moriyama, Masato; Tanabe, Yoshinari; Kagamu, Hiroshi; Narita, Ichiei			A case of severe thrombocytopaenia associated with acute HIV-1 infection	INTERNATIONAL JOURNAL OF STD & AIDS			English	Article						HIV; AIDS; acute HIV infection; seroconversion; antiretroviral therapy; thrombocytopaenia		A 23-year-old man was admitted to our hospital with severe thrombocytopaenia. He had unprotected sexual contact 6 weeks earlier. He was diagnosed with acute HIV infection by means of HIV RNA viral load testing and HIV-associated thrombocytopaenia. Although his thrombocytopaenia improved immediately with short-term dexamethasone therapy, this effect was not sustained after cessation of therapy. Antiretroviral therapy including raltegravir was initiated, and the patient recovered from severe thrombocytopaenia within several days. The findings from this case suggest that acute HIV infection should be suspected with unexplained thrombocytopaenia, and that antiretroviral therapy is the treatment of choice for severe HIV-associated thrombocytopaenia, even when in the early period following acquisition of the virus.	[Aoki, Ami; Moro, Hiroshi; Watanabe, Takayuki; Asakawa, Katsuaki; Miura, Satoru; Kagamu, Hiroshi; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Resp Med, Niigata, Japan; [Moriyama, Masato] Niigata Univ, Grad Sch Med & Dent Sci, Dept Med Oncol, Niigata, Japan; [Tanabe, Yoshinari] Niigata Univ, Med & Dent Hosp, Div Infect Control & Prevent, Niigata, Japan	Moro, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Resp Med, 1-757 Asahimachi Dori, Niigata, Japan.	hmoro@med.niigata-u.ac.jp					Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Chu C, 2010, AM FAM PHYSICIAN, V81, P1239; [Anonymous], 2013, GUIDELINES USE ANTIR; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; BALLEM PJ, 1992, NEW ENGL J MED, V327, P1779, DOI 10.1056/NEJM199212173272503; Caso JAA, 1999, NEW ENGL J MED, V341, P1239; Galli M, 1996, J ACQ IMMUN DEF SYND, V12, P268; Gentile I, 2013, PLATELETS, V24, P574, DOI 10.3109/09537104.2012.735721	9	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	MAR	2015	26	3					209	211		10.1177/0956462414531937		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CB3WY	WOS:000349561300010		
J	Adfa, M; Livandri, F; Meita, NP; Manaf, S; Ninomiya, M; Gustian, I; Putranto, AMH; Supriati, R; Koketsu, M				Adfa, Morina; Livandri, Fio; Meita, Neva Putri; Manaf, Syalfinaf; Ninomiya, Masayuki; Gustian, Irfan; Putranto, Agus Martono Hadi; Supriati, Rochmah; Koketsu, Mamoru			Termiticidal activity of Acorus calamus Linn. rhizomes and its main constituents against Coptotermes curvignathus Holmgren	JOURNAL OF ASIA-PACIFIC ENTOMOLOGY			English	Article						Acorus calamus Linn; Termiticidal; GC-MS; beta-asarone; alpha-asarone; Coptotermes curvignathus Holmgren	STORED-PRODUCT INSECTS; FORMOSANUS SHIRAKI; OIL	The termiticiclal activity of n-hexane and methanol fractions of Acorus calamus Linn rhizomes against Coptotermes curvignathus Holmgren was investigated. Both fractions have demonstrated strong termiticidal activity. The activity of n-hexane fraction was stronger than that of the methanol fraction. Based on GC-MS data,beta-asarone was found to be a major constituent of n-hexane fraction (70.1%) and isolation of beta-asarone was carried out on column chromatography to afford as a yellow oil in 59.1% yield. Furthermore, the antitermite properties of beta-asarone and alpha-asarone of the isomer were investigated. Our data suggested that the two asarone isomers have insect control potential. These findings lead to the discovery of more environmentally friendly termiticides against C. curvignathus. (C) 2014 Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society. Published by Elsevier B.V. All rights reserved.	[Adfa, Morina; Livandri, Fio; Meita, Neva Putri; Gustian, Irfan; Putranto, Agus Martono Hadi] Univ Bengkulu, Fac Math & Nat Sci, Dept Chem, Kandang Limun 38371, Bengkulu, Indonesia; [Manaf, Syalfinaf; Supriati, Rochmah] Univ Bengkulu, Fac Math & Nat Sci, Dept Biol, Kandang Limun 38371, Bengkulu, Indonesia; [Ninomiya, Masayuki; Koketsu, Mamoru] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Adfa, M (reprint author), Univ Bengkulu, Fac Math & Nat Sci, Dept Chem, Jl WR Supratman, Kandang Limun 38371, Bengkulu, Indonesia.	morinaadfa@yahoo.com; koketsu@gifu-u.ac.jp		Adfa, Morina/0000-0002-7944-3992	Directorate General of Higher Education (DIKTI), Ministry of National Education, Indonesia [3615/UN30.10.06.01/HK/2013]	We thank the Directorate General of Higher Education (DIKTI), Ministry of National Education, Indonesia for financial support with research grant Fundamental-BOPTN 2013. Contract number 3615/UN30.10.06.01/HK/2013.	Adfa M, 2013, NAT PROD RES, V27, P270, DOI 10.1080/14786419.2012.665917; Adfa M, 2012, INT BIODETER BIODEGR, V74, P129, DOI 10.1016/j.ibiod.2012.07.016; Adfa M, 2010, J CHEM ECOL, V36, P720, DOI 10.1007/s10886-010-9807-1; Verma M, 2009, INT BIODETER BIODEGR, V63, P959, DOI 10.1016/j.ibiod.2009.05.009; LOGAN JWM, 1990, B ENTOMOL RES, V80, P309; KOUL O, 1990, J CHEM ECOL, V16, P1911, DOI 10.1007/BF01020504; Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U; Balakumbahan R, 2010, J MED PLANTS RES, V4, P2740; Bong J. C. F., 2012, Journal of Entomology, V9, P68, DOI 10.3923/je.2012.68.78; ELNAHAL AKM, 1989, J STORED PROD RES, V25, P211, DOI 10.1016/0022-474X(89)90026-X; Jiyavorranant T., 2001, INT C MED AR PLANT 2, P223; Kirton L. G., 1999, Journal of Tropical Forest Science, V11, P822; Mariau D., 1992, OLEAGINEUX PARIS, V47, P56; Meyer J.R., 2005, ISOPTERA; Park CH, 2011, ARCH PHARM RES, V34, P1289, DOI 10.1007/s12272-011-0808-6; Rani AS, 2003, J SCI IND RES INDIA, V62, P623; SCHMIDT GH, 1994, J STORED PROD RES, V30, P227, DOI 10.1016/0022-474X(94)90050-R; Senthilkumar A., 2012, Asian Pacific Journal of Tropical Disease, V2, P324; SU HCF, 1991, J ENTOMOL SCI, V26, P76; Tare V., 2000, J MED AROM PLANTS S1, V22, P35; Wang H.Z., 1998, ACTA BOT YUNNANICA S, V20, P96	21	0	0	KOREAN SOC APPLIED ENTOMOLOGY	SUWON	NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA, 249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA	1226-8615	1876-7990		J ASIA-PAC ENTOMOL	J. Asia-Pac. Entomol.	MAR	2015	18	1					47	50		10.1016/j.aspen.2014.10.012		4	Entomology	Entomology	CB6GY	WOS:000349726700008		
J	Robles, R; Fresan, A; Medina-Mora, ME; Sharan, P; Roberts, MC; Mari, JD; Matsumoto, C; Maruta, T; Gureje, O; Ayuso-Mateos, JL; Xiao, ZP; Reed, GM				Robles, Rebeca; Fresan, Ana; Elena Medina-Mora, Maria; Sharan, Pratap; Roberts, Michael C.; Mari, Jair de Jesus; Matsumoto, Chihiro; Maruta, Toshimasa; Gureje, Oye; Luis Ayuso-Mateos, Jose; Xiao, Zeping; Reed, Geoffrey M.			Categories That Should Be Removed From Mental Disorders Classifications: Perspectives and Rationales of Clinicians From Eight Countries	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						mental disorders; classification; International Classification of Diseases (ICD); Diagnostic and Statistical Manual of Mental Disorders (DSM); clinical utility; psychologists; psychiatrists; stigma	META-STRUCTURE; GLOBAL BURDEN; UTILITY; ICD-11; DIAGNOSES; DSM; ORGANIZATION; VALIDITY	ObjectiveTo explore the rationales of mental health professionals (mainly psychiatrists and psychologists) from 8 countries for removing specific diagnostic categories from mental disorders classification systems. MethodAs part of a larger study, 505 participants indicated which of 60 major disorders should be omitted from mental disorders classification systems and provided rationales. Rationale statements were analyzed using inductive content analysis. ResultsThe majority of clinicians (60.4%) indicated that 1 or more disorders should be removed. The most common rationales were (a) problematic boundaries between normal and psychopathological conditions (45.9% of total removal recommendations), (b) problematic boundaries among mental disorders (25.4%), and (c) problematic boundaries between mental and physical disorders (24.0%). The categories most frequently recommended for deletion were gender identity disorder, sexual dysfunction, and paraphilias, usually because clinicians viewed these categories as being based on stigmatization of a way of being and behaving. A range of neurocognitive disorders were described as better conceptualized as nonpsychiatric medical conditions. Results were analyzed by country and country income level. Although gender identity disorder was the category most frequently recommended for removal overall, clinicians from Spain, India, and Mexico were most likely to do so and clinicians from Nigeria and Japan least likely, probably because of social and systemic factors that vary by country. Systematic differences in removal rationales by country income level may be related to the development, structure, and functioning of health systems. ConclusionImplications for development and dissemination of the classification of mental and behavioral disorders in WHO's ICD-11 are discussed.	[Robles, Rebeca; Fresan, Ana; Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon de la Fuente Muniz, Munich, Germany; [Sharan, Pratap] All India Inst Med Sci, New Delhi 110029, India; [Roberts, Michael C.] Univ Kansas, Lawrence, KS 66045 USA; [Mari, Jair de Jesus] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Matsumoto, Chihiro; Maruta, Toshimasa] Tokyo Med Univ, Tokyo 1608402, Japan; [Gureje, Oye] Univ Ibadan, Ibadan, Nigeria; [Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Xiao, Zeping] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Reed, Geoffrey M.] WHO, CH-1211 Geneva, Switzerland	Reed, GM (reprint author), WHO, Dept Mental Hlth & Subst Abuse, 20 Ave Appia, CH-1211 Geneva, Switzerland.	reedg@who.int	Mari, Jair/A-7309-2008	Mari, Jair/0000-0002-5403-0112	International Union of Psychological Science; National Institute of Mental Health (USA); World Psychiatric Association; Spanish Foundation of Psychiatry and Mental Health (Spain); Santander Bank UAM/UNAM endowed Chair for Psychiatry (Spain/Mexico)	The World Health Organization Department of Mental Health and Substance Abuse has received direct support that contributed to the conduct of this study from several sources: The International Union of Psychological Science, the National Institute of Mental Health (USA), the World Psychiatric Association, the Spanish Foundation of Psychiatry and Mental Health (Spain), and the Santander Bank UAM/UNAM endowed Chair for Psychiatry (Spain/Mexico).	WAKEFIELD JC, 1992, AM PSYCHOL, V47, P373, DOI 10.1037//0003-066X.47.3.373; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; First MB, 2010, PROF PSYCHOL-RES PR, V41, P465, DOI 10.1037/a0021511; Andrews G, 2009, PSYCHOL MED, V39, P1993, DOI 10.1017/S0033291709990250; Reed GM, 2010, PROF PSYCHOL-RES PR, V41, P457, DOI 10.1037/a0021701; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23; Reed GM, 2011, WORLD PSYCHIATRY, V10, P118; Evans SC, 2013, INT J PSYCHOL, V48, P177, DOI 10.1080/00207594.2013.804189; Cochran S. D., 2014, PROPOSED DECLASSIFIC; Drescher J, 2010, ARCH SEX BEHAV, V39, P427, DOI 10.1007/s10508-009-9531-5; Flanagan EH, 2008, J ABNORM PSYCHOL, V117, P693, DOI 10.1037/a0012535; Government of Mexico, 2003, LEY FED PREV EL DISC; Horwitz A. V., 2002, CREATING MENTAL ILLN; Int Advisory Grp Revision ICD-10, 2011, WORLD PSYCHIATRY, V10, P86; George B, 2014, LANCET PSYCHIAT, V1, P110, DOI 10.1016/S2215-0366(14)70249-4; Reed GM, 2013, J CLIN PSYCHOL, V69, P1191, DOI 10.1002/jclp.22031; Roberts MC, 2012, INT REV PSYCHIATR, V24, P578, DOI 10.3109/09540261.2012.736368; Rutter M, 2012, INT REV PSYCHIATR, V24, P514, DOI 10.3109/09540261.2012.719862; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581; World Health Organization, 1992, ICD 10 CLASS MENT BE; World Health Organization, 1992, INT CLASS DIS REL HL; Wright S, 2010, ARCH SEX BEHAV, V39, P1229, DOI 10.1007/s10508-010-9651-y	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	MAR	2015	71	3					267	281		10.1002/jclp.22145		15	Psychology, Clinical	Psychology	CB7BD	WOS:000349780200008		
J	Arakawa, K; Matsunaga, K; Takihiro, S; Moritoki, A; Ryuto, S; Kawai, Y; Masuda, T; Miyamoto, T				Arakawa, K.; Matsunaga, K.; Takihiro, S.; Moritoki, A.; Ryuto, S.; Kawai, Y.; Masuda, T.; Miyamoto, T.			Lactobacillus gasseri requires peptides, not proteins or free amino acids, for growth in milk	JOURNAL OF DAIRY SCIENCE			English	Article						Lactobacillus gasseri; peptide requirement; proteolysis; pepsin	DELBRUECKII SUBSP BULGARICUS; ACIDOPHILUS GROUP; BACTERIOCIN PRODUCTION; PROBIOTIC STRAIN; GENOME SEQUENCE; HUMAN FECES; MEDIA; LA39; JOHNSONII; REVEALS	Lactobacillus gasseri is a widespread commensal lactic acid bacterium inhabiting human mucosal niches and has many beneficial effects as a probiotic. However, L. gasseri is difficult to grow in milk, which hurts usability for the food industry. It had been previously reported that supplementation with yeast extract or proteose peptone, including peptides, enables L. gasseri to grow well in milk. In this study, our objective was to confirm peptide requirement of L. gasseri and evaluate efficacy of peptide release by enzymatic proteolysis on growth of L. gassei in milk. Three strains of L. gasseri did not grow well in modified DeMan, Rogosa, Sharpe broth without any nitrogen sources (MRS-N), but addition of a casein-derived peptide mixture, tryptone, promoted growth. In contrast, little effect was observed after adding casein or a casein-derived amino acid mixture, casamino acids. These results indicate that L. gasseri requires peptides, not proteins or free amino acids, among milk-derived nitrogen sources for growth. Lactobacillus gasseri JCM 1131(T) hardly had growth capacity in 6 kinds of milk-based media: bovine milk, human milk, skim milk, cheese whey, modified MRS-N (MRSL-N) supplemented with acid whey, and MRSL-N supplemented with casein. Moreover, treatment with digestive proteases, particularly pepsin, to release peptides made it grow well in each milk-based medium. The pepsin treatment was the most effective for growth of strain JCM 1131(T) in skim milk among the tested food-grade proteases such as trypsin, alpha-chymotrypsin, calf rennet, ficin, bromelain, and papain. As well as strain JCM 1131(T), pepsinolysis of milk improved growth of other L. gasseri strains and some strains of enteric lactobacilli such as Lactobacillus crispatus, Lactobacillus gallinarum, Lactobacillus johnsonii, and Lactobacillus reuteri. These results suggest that some relatives of L. gasseri also use peptides as desirable nitrogen sources, and that milk may be a good supplier of nutritious peptides to enteric lactobacilli including L. gasseri after peptic digestion in the gastrointestinal tract. This is the first report showing peptide requirement of L. gasseri and efficacy of pepsinolysis on the growth of L. gasseri and its relatives in milk. This study would contribute to increasing usability of L. gasseri and its relatives as probiotics in dairy foods.	[Arakawa, K.; Matsunaga, K.; Takihiro, S.; Moritoki, A.; Ryuto, S.; Miyamoto, T.] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Kawai, Y.; Masuda, T.] Nihon Univ, Grad Sch Bioresource Sci, Kanagawa 2520880, Japan	Miyamoto, T (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan.	tmnono@cc.okayama-u.ac.jp			Institute for Fermentation, Osaka; Japan Society for the Promotion of Science [26870393]	We are grateful to a volunteer who provided breast milk and the kind researchers at Godo Shusei Co. for the provision of bromelain and papain. We also thank Y. Omori, H. Takeda, C. Hano, and H. Mineyuki (Faculty of Agriculture, Okayama University) for their assistance with several measurements. This work was funded by a research grant of the Institute for Fermentation, Osaka, to K. Arakawa and the Grant-in-Aid for Young Scientists (B; no. 26870393) from the Japan Society for the Promotion of Science to K. Arakawa.	Elli M, 1999, INT DAIRY J, V9, P507, DOI 10.1016/S0958-6946(99)00127-2; Avonts L, 2004, INT DAIRY J, V14, P947, DOI 10.1016/j.idairyj.2004.04.003; Selle K, 2013, FEMS MICROBIOL REV, V37, P915, DOI 10.1111/1574-6976.12021; Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; JOHNSON JL, 1980, INT J SYST BACTERIOL, V30, P53; Kawai Y, 1998, BIOSCI BIOTECH BIOCH, V62, P2438, DOI 10.1271/bbb.62.2438; Savijoki K, 2006, APPL MICROBIOL BIOT, V71, P394, DOI 10.1007/s00253-006-0427-1; Dal Bello F, 2006, SYST APPL MICROBIOL, V29, P69, DOI 10.1016/j.syapm.2005.07.002; Wall R, 2007, FEMS MICROBIOL ECOL, V59, P127, DOI 10.1111/j.1574-6941.2006.00202.x; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; FUJISAWA T, 1992, INT J SYST BACTERIOL, V42, P487; Arakawa K, 2009, J DAIRY SCI, V92, P2365, DOI 10.3168/jds.2008-1240; Arakawa K, 2010, LETT APPL MICROBIOL, V50, P406, DOI 10.1111/j.1472-765X.2010.02810.x; Arakawa K, 2008, ANIM SCI J, V79, P634, DOI 10.1111/j.1740-0929.2008.00574.x; Bogovic-Matijasic B, 2000, FOOD TECHNOL BIOTECH, V38, P113; Bogovic-Matijasic B, 1998, APPL MICROBIOL BIOT, V49, P606, DOI 10.1007/s002530051221; Ewe JA, 2010, INT J FOOD SCI NUTR, V61, P87, DOI 10.3109/09637480903334163; Germond JE, 2003, APPL ENVIRON MICROB, V69, P3377, DOI 10.1128/AEM.69.6.3377-3384.2003; ITOH T, 1995, LETT APPL MICROBIOL, V21, P137, DOI 10.1111/j.1472-765X.1995.tb01025.x; Kafley S, 2010, MILCHWISSENSCHAFT, V65, P245; Kawai Y, 2000, BIOSCI BIOTECH BIOCH, V64, P2201, DOI 10.1271/bbb.64.2201; Kawai Y, 1997, BIOSCI BIOTECH BIOCH, V61, P179; Majhenic AC, 2004, APPL MICROBIOL BIOT, V63, P705, DOI 10.1007/s00253-003-1424-2; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Masuda T, 2005, FOOD SCI TECHNOL RES, V11, P328, DOI 10.3136/fstr.11.328; Masuda T, 2003, MILCHWISSENSCHAFT, V58, P366; Masuda T, 2003, MILCHWISSENSCHAFT, V58, P124; Matsumiya Yoshiko, 2002, Journal of Infection and Chemotherapy, V8, P43; Nakamura K, 2013, ANIM SCI J, V84, P144, DOI 10.1111/j.1740-0929.2012.01048.x; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Peltoniemi K, 2002, ARCH MICROBIOL, V177, P457, DOI 10.1007/s00203-002-0411-9; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Robitaille G, 2014, J DAIRY RES, V81, P319, DOI 10.1017/S0022029914000247; SAXENA SN, 1994, INT J FOOD MICROBIOL, V21, P271, DOI 10.1016/0168-1605(94)90034-5; TOBA T, 1991, LETT APPL MICROBIOL, V12, P228, DOI 10.1111/j.1472-765X.1991.tb00546.x; Treven P, 2013, FOLIA MICROBIOL, V58, P623, DOI 10.1007/s12223-013-0252-8; Yadav S, 2011, BIOFACTORS, V37, P58, DOI 10.1002/biof.137; Yasuta N., 2014, Milk Science, V63, P9	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	MAR	2015	98	3					1593	1603		10.3168/jds.2014-8860		11	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CB4FW	WOS:000349584600018		
J	Lee, EY; Kaneko, S; Jutabha, P; Zhang, X; Seino, S; Jomori, T; Anzai, N; Miki, T				Lee, Eun Young; Kaneko, Shuji; Jutabha, Promsuk; Zhang, Xilin; Seino, Susumu; Jomori, Takahito; Anzai, Naohiko; Miki, Takashi			Distinct action of the alpha-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion	JOURNAL OF ENDOCRINOLOGY			English	Article						miglitol; SGLT3; GLP1 secretion; L cell	GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETIC-PATIENTS; RAT SMALL-INTESTINE; INCRETIN SECRETION; MICE; HOMEOSTASIS; ACARBOSE; ABSORPTION; MECHANISMS; RECEPTORS	Oral ingestion of carbohydrate triggers glucagon-like peptide 1 (GLP1) secretion, but the molecular mechanism remains elusive. By measuring GLP1 concentrations in murine portal vein, we found that the ATP-sensitive K+ (K-ATP) channel is not essential for glucose-induced GLP1 secretion from enteroendocrine L cells, while the sodium-glucose co-transporter 1 (SGLT1) is required, at least in the early phase (5 min) of secretion. By contrast, co-administration of the alpha-glucosidase inhibitor (alpha-GI) miglitol plus maltose evoked late-phase secretion in a glucose transporter 2-dependent manner. We found that GLP1 secretion induced by miglitol plus maltose was significantly higher than that by another alpha-GI, acarbose, plus maltose, despite the fact that acarbose inhibits maltase more potently than miglitol. As miglitol activates SGLT3, we compared the effects of miglitol on GLP1 secretion with those of acarbose, which failed to depolarize the Xenopus laevis oocytes expressing human SGLT3. Oral administration of miglitol activated duodenal enterochromaffin (EC) cells as assessed by immunostaining of phosphorylated calcium-calmodulin kinase 2 (phospho-CaMK2). In contrast, acarbose activated much fewer enteroendocrine cells, having only modest phospho-CaMK2 immunoreactivity. Single administration of miglitol triggered no GLP1 secretion, and GLP1 secretion by miglitol plus maltose was significantly attenuated by atropine pretreatment, suggesting regulation via vagal nerve. Thus, while alpha-GIs generally delay carbohydrate absorption and potentiate GLP1 secretion, miglitol also activates duodenal EC cells, possibly via SGLT3, and potentiates GLP1 secretion through the parasympathetic nervous system.	[Lee, Eun Young; Zhang, Xilin; Miki, Takashi] Chiba Univ, Dept Med Physiol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Kaneko, Shuji; Anzai, Naohiko] Kyoto Univ, Dept Mol Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Jutabha, Promsuk; Anzai, Naohiko] Dokkyo Med Univ, Sch Med, Dept Pharmacol & Toxicol, Mibu, Tochigi 3210293, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Jomori, Takahito] Sanwa Kagaku Kenkyusho Co Ltd, Drug Dev Ctr, Higashi Ku, Nagoya, Aichi 4618631, Japan	Miki, T (reprint author), Chiba Univ, Dept Med Physiol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tmiki@faculty.chiba-u.jp			Ministry of Education, Science, Sports, and Culture, Japan; Japan Diabetes Foundation	This work was supported by Research Grants from the Ministry of Education, Science, Sports, and Culture, Japan, and a grant (the 3rd Lilly Incretin Basic Research Grant) from Japan Diabetes Foundation.	Anini Y, 2002, ENDOCRINOLOGY, V143, P2420, DOI 10.1210/en.143.6.2420; Enc FY, 2001, AM J PHYSIOL-GASTR L, V281, pG752; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Powell DR, 2013, J PHARMACOL EXP THER, V345, P250, DOI 10.1124/jpet.113.203364; Sakurai K, 2012, J DIABETES INVEST, V3, P156, DOI 10.1111/j.2040-1124.2011.00163.x; Seifarth C, 1998, DIABETIC MED, V15, P485, DOI 10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Hiki M, 2010, CIRC J, V74, P1471, DOI 10.1253/circj.CJ-10-0013; Gloster TM, 2012, NAT CHEM BIOL, V8, P683, DOI [10.1038/nchembio.1029, 10.1038/NCHEMBIO.1029]; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Cani PD, 2007, MOL CELL ENDOCRINOL, V276, P18, DOI 10.1016/j.mce.2007.06.003; Breen DM, 2013, DIABETES, V62, P3005, DOI 10.2337/db13-0523; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Arakawa M, 2008, METABOLISM, V57, P1299, DOI 10.1016/j.metabol.2008.04.027; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Cho YM, 2014, ANNU REV PHYSIOL, V76, P535, DOI 10.1146/annurev-physiol-021113-170315; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Moriya R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1358, DOI 10.1152/ajpendo.00412.2009; Mace OJ, 2012, J PHYSIOL-LONDON, V590, P2917, DOI 10.1113/jphysiol.2011.223800; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; Ohlsson L, 2014, REGUL PEPTIDES, V189, P40, DOI 10.1016/j.regpep.2014.02.001; Barcelona S, 2012, AM J PHYSIOL-CELL PH, V302, pC1073, DOI 10.1152/ajpcell.00436.2011; Marina AL, 2012, DIABETES CARE, V35, P1119, DOI 10.2337/dc11-2050; Matschinsky FM, 2006, DIABETES, V55, P1; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; SAMULITIS BK, 1987, DRUG EXP CLIN RES, V13, P517; Thorens B, 2003, PFLUG ARCH EUR J PHY, V445, P482, DOI 10.1007/s00424-002-0954-2; Vincent KM, 2011, NEUROGASTROENT MOTIL, V23, pE282, DOI 10.1111/j.1365-2982.2011.01673.x	29	3	3	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0022-0795	1479-6805		J ENDOCRINOL	J. Endocrinol.	MAR	2015	224	3					205	214		10.1530/JOE-14-0555		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CB3XK	WOS:000349562500006		
J	Suzuki, K; Minami, K; Inamuro, T				Suzuki, Kosuke; Minami, Keisuke; Inamuro, Takaji			Lift and thrust generation by a butterfly-like flapping wing-body model: immersed boundary-lattice Boltzmann simulations	JOURNAL OF FLUID MECHANICS			English	Article						aerodynamics; flow structure interactions; swimming/flying	LEADING-EDGE VORTICES; LOW REYNOLDS-NUMBERS; INSECT FLIGHT; FLOW; MOTION; VORTEX; AERODYNAMICS; KINEMATICS; COMPLEX	The flapping flight of tiny insects such as flies or larger insects such as butterflies is of fundamental interest not only in biology itself but also in its practical use for the development of micro air vehicles (MAVs). It is known that a butterfly flaps downward for generating the lift force and backward for generating the thrust force. In this study, we consider a simple butterfly-like flapping wing body model in which the body is a thin rod and the rectangular rigid wings flap in a simple motion. We investigate lift and thrust generation of the model by using the immersed boundary lattice Boltzmann method. First, we compute the lift and thrust forces when the body of the model is fixed for Reynolds numbers in the range of 50-1000. In addition, we estimate the supportable mass for each Reynolds number from the computed lift force. Second, we simulate free flights when the body can only move translationally. It is found that the expected supportable mass can be supported even in the free flight except when the mass of the body relative to the mass of the fluid is too small, and the wing body model with the mass of actual insects can go upward against the gravity. Finally, we simulate free flights when the body can move translationally and rotationally. It is found that the body has a large pitch motion and consequently gets off-balance. Then, we discuss a way to control the pitching angle by flexing the body of the wing body model.	[Suzuki, Kosuke; Minami, Keisuke; Inamuro, Takaji] Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Kyoto 6158540, Japan; [Inamuro, Takaji] Kyoto Univ, Grad Sch Engn, Adv Res Inst Fluid Sci & Engn, Kyoto 6158540, Japan	Inamuro, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Kyoto 6158540, Japan.	inamuro@kuaero.kyoto-u.ac.jp		Suzuki, Kosuke/0000-0001-9034-4082	ACCMS (Kyoto University) through the HPCI System Research Project [hp120112]; JSPS [25.1557]	This research used computational resources of the HPCI system provided by ACCMS (Kyoto University) through the HPCI System Research Project (Project ID: hp120112). K. Suzuki acknowledges the financial support of the JSPS Institutional Program for Young Researcher Overseas Visits and Grant-in-Aid for JSPS Fellows (No. 25.1557). The authors would like to thank Dr A. Medina for help with the simulation in B.2 and for providing his data computed by using the IB-FVM.	Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Sun M, 2002, J EXP BIOL, V205, P55; DUDLEY R, 1990, J EXP BIOL, V150, P37; Liu H, 1998, J EXP BIOL, V201, P461; Wu J, 2010, J COMPUT PHYS, V229, P5022, DOI 10.1016/j.jcp.2010.03.024; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Liu H, 1998, J COMPUT PHYS, V146, P124, DOI 10.1006/jcph.1998.6019; Tanaka H, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026003; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; Lentink D, 2009, J EXP BIOL, V212, P2705, DOI 10.1242/jeb.022269; [Anonymous], J EXP BIOL, V211, P239; Wu JH, 2004, J EXP BIOL, V207, P1137, DOI 10.1242/jeb.00868; Gilmanov A, 2005, J COMPUT PHYS, V207, P457, DOI 10.1016/j.jcp.2005.01.020; Feng ZG, 2004, J COMPUT PHYS, V195, P602, DOI 10.1016/j.jcp.2003.10.013; Zheng L, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/3/036001; Ota K, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/4/045504; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Wang ZJ, 2000, J FLUID MECH, V410, P323, DOI 10.1017/S0022112099008071; Shyy W, 2010, PROG AEROSP SCI, V46, P284, DOI 10.1016/j.paerosci.2010.01.001; Liu H, 2009, J COMPUT PHYS, V228, P439, DOI 10.1016/j.jcp.2008.09.020; Kruger T, 2011, COMPUT MATH APPL, V61, P3485, DOI 10.1016/j.camwa.2010.03.057; Taira K, 2009, J FLUID MECH, V623, P187, DOI 10.1017/S0022112008005314; Bai P, 2007, ACTA MECH SINICA, V23, P485, DOI 10.1007/s10409-007-0102-5; Kim J, 2001, J COMPUT PHYS, V171, P132, DOI 10.1006/jcph.2001.6778; Feng ZG, 2005, J COMPUT PHYS, V202, P20, DOI 10.1016/j.jcp.2004.06.020; Nakata T, 2012, J COMPUT PHYS, V231, P1822, DOI 10.1016/j.jcp.2011.11.005; Zhao L, 2010, J R SOC INTERFACE, V7, P485, DOI 10.1098/rsif.2009.0200; Sui Y, 2008, J COMPUT PHYS, V227, P6351, DOI 10.1016/j.jcp.2008.03.017; Dudley R, 2002, BIOMECHANICS INSECT; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; Gao T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2958318; Goldstein H, 2002, CLASSICAL MECH; Huang H, 2012, ACTA MECH SINICA-PRC, V28, P1590, DOI 10.1007/s10409-012-0209-1; Hunt J.C.R., 1988, P 1988 SUMM PROGR ST, V2, P193; IIMA M., 2001, THEOR APPL MECH, V50, P237; Inamuro T, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/2/024001; Kimura Y, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183113400202; MEDINA A., 2013, THESIS U CALIFORNIA; Minami K, 2015, FLUID DYN RES, V47, DOI 10.1088/0169-5983/47/1/015505; SHUSTER MD, 1993, J ASTRONAUT SCI, V41, P439; Shyy W, 2008, CAMB AERO SER, P1; Succi S., 2001, LATTICE BOLTZMANN EQ; Sun M, 2005, FLUID DYN RES, V37, P21, DOI 10.1016/j.fluiddyn.2004.04.006; SUNADA S, 1993, J EXP BIOL, V183, P249; Suzuki K, 2011, COMPUT FLUIDS, V49, P173, DOI 10.1016/j.compfluid.2011.05.011; TRIANTAFYLLOU GS, 1993, J FLUID STRUCT, V7, P205, DOI 10.1006/jfls.1993.1012; Yokoyama N, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4790882	51	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	MAR	2015	767						659	695		10.1017/jfm.2015.57		37	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CB5SW	WOS:000349688900030		
J	Tanaka, Y; Sato, T; Ohta, Y; Miura, S; Freymueller, JT; Klemann, V				Tanaka, Yoshiyuki; Sato, Tadahiro; Ohta, Yusaku; Miura, Satoshi; Freymueller, Jeffrey T.; Klemann, Volker			The effects of compressibility on the GIA in southeast Alaska	JOURNAL OF GEODYNAMICS			English	Article						GIA; Postglacial rebound; GNSS; Rheology; Alaska	MAXWELL EARTH; VISCOELASTIC EARTH; GLACIAL ISOSTASY; UPLIFT; RELAXATION; MODELS; DEFORMATION; RESPONSES; SURFACE	Recent theoretical simulations on the glacial isostatic adjustment (GIA) have revealed that the model differences arising from considering mantle compressibility are not necessarily negligible if compared with the observation accuracy of present-day deformation rates. In this study, a compressible model is constructed for the GIA in southeast Alaska, and the uplift rate is compared with GPS data and the incompressible case for the first time. It is shown that, for Maxwell rheology, the incompressible model potentially underestimates the mean uplift rate by approximately 27% (4mm/yr) with respect to the compressible case and the difference is detectable given observational precision. This difference between the compressible and incompressible models is reduced to 10% by matching the flexural rigidity of both earth models. When carrying out an inversion using incompressible models, this adjustment is important to infer a physically more correct viscoelastic structure. (C) 2014 Elsevier Ltd. All rights reserved.	[Tanaka, Yoshiyuki] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Sato, Tadahiro; Ohta, Yusaku; Miura, Satoshi] Tohoku Univ, Res Ctr Predict Earthquakes & Volcan Erupt, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Freymueller, Jeffrey T.] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Klemann, Volker] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany	Tanaka, Y (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	y-tanaka@eri.u-tokyo.ac.jp	Ohta, Yusaku/G-4457-2010; Klemann, Volker/H-3660-2013	Ohta, Yusaku/0000-0003-4818-477X; Klemann, Volker/0000-0002-8342-8947	JSPS KAKENHI [17253003]	The manuscript was greatly improved by the comments from the two anonymous reviewers. This work was partly supported by JSPS KAKENHI Grant Number 17253003.	Spada G, 2011, GEOPHYS J INT, V185, P106, DOI 10.1111/j.1365-246X.2011.04952.x; Cambiotti G, 2013, GEOPHYS J INT, V193, P1071, DOI 10.1093/gji/ggt026; Klemann V, 2008, J GEODYN, V46, P95, DOI 10.1016/j.jog.2008.04.005; Larsen CF, 2005, EARTH PLANET SC LETT, V237, P548, DOI 10.1016/j.epsl.2005.06.032; PELTIER WR, 1974, REV GEOPHYS, V12, P649, DOI 10.1029/RG012i004p00649; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; Sella GF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027081; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Ekman M, 1996, GEOPHYS J INT, V126, P229, DOI 10.1111/j.1365-246X.1996.tb05281.x; Bullen K. E., 1975, THE EARTHS DENSITY, P420; Cambiotti G, 2010, GEOPHYS J INT, V180, P475, DOI 10.1111/j.1365-246X.2009.04434.x; Cambiotti G, 2009, GEOPHYS J INT, V176, P995, DOI 10.1111/j.1365-246X.2008.04034.x; Cambiotti G, 2010, GEOPHYS J INT, V183, P1248, DOI 10.1111/j.1365-246X.2010.04791.x; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Elliott JL, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007139; FANG M, 1994, GEOPHYS RES LETT, V21, P2131, DOI 10.1029/94GL01886; FARRELL WE, 1972, REV GEOPHYS SPACE GE, V10, P761, DOI 10.1029/RG010i003p00761; Freymueller J.T., 2008, AGU GEOPHYS MONOGRAP, V179, P1, DOI DOI 10.1029/179GM02; HANYK L, 1995, GEOPHYS RES LETT, V22, P1285, DOI 10.1029/95GL01087; LAMBECK K, 1980, J GEOPHYS RES, V85, P6403, DOI 10.1029/JB085iB11p06403; Larsen CF, 2004, GEOPHYS J INT, V158, P1118, DOI 10.1111/j.1365-246X.2004.02356.x; Larsen CF, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001685; Sato T, 2011, TECTONOPHYSICS, V511, P79, DOI 10.1016/j.tecto.2010.05.009; Sato T., 2012, J GEOPHYS RES, V117; Spada G., 2004, GEODESY MODELING EAR, V85, P62; Spada G., 2003, TABOO USER GUIDE; Spada G., 2003, THEORY TABOO; Tanaka Y, 2009, PURE APPL GEOPHYS, V166, P1199, DOI 10.1007/s00024-009-0508-y; Tanaka Y, 2011, GEOPHYS J INT, V184, P220, DOI 10.1111/j.1365-246X.2010.04854.x; Triissel B. L., 2013, J GLACIOL, V59; Vermeersen LLA, 2000, GEOPHYS J INT, V142, P351, DOI 10.1046/j.1365-246x.2000.00159.x; Vermeersen LLA, 1996, GEOPHYS J INT, V126, P735, DOI 10.1111/j.1365-246X.1996.tb04700.x; WAHR J, 1995, GEOPHYS RES LETT, V22, P977, DOI 10.1029/94GL02840; Geruo A, 2013, GEOPHYS J INT, V192, P557, DOI 10.1093/gji/ggs030; WU P, 1982, GEOPHYS J ROY ASTR S, V70, P435, DOI 10.1111/j.1365-246X.1982.tb04976.x	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0264-3707			J GEODYN	J. Geodyn.	MAR	2015	84						55	61		10.1016/j.jog.2014.10.001		7	Geochemistry & Geophysics	Geochemistry & Geophysics	CB4CL	WOS:000349575700004		
J	Misu, T; Sato, DK; Nakashima, I; Fujihara, K				Misu, Tatsuro; Sato, Douglas Kazutoshi; Nakashima, Ichiro; Fujihara, Kazuo			MOG-IgG serological status matters in paediatric ADEM	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material									[Misu, Tatsuro; Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 9808574, Japan; [Misu, Tatsuro; Sato, Douglas Kazutoshi; Nakashima, Ichiro; Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan	Misu, T (reprint author), Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	misu@med.tohoku.ac.jp	Sato, Douglas/F-2508-2013	Sato, Douglas/0000-0002-7695-6020			Tenembaum SN, 2013, HAND CLINIC, V112, P1253, DOI 10.1016/B978-0-444-52910-7.00048-9; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; O'Connor KC, 2007, NAT MED, V13, P211, DOI 10.1038/nm1488; Baumann M, 2015, J NEUROL NEUROSUR PS, V86, P265, DOI 10.1136/jnnp-2014-308346	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2015	86	3					242	242		10.1136/jnnp-2014-308723		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CB6EX	WOS:000349720800002		
J	Yonekawa, T; Nishino, I				Yonekawa, Takahiro; Nishino, Ichizo			Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s)	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Review							COLLAGEN-VI DEFICIENCY; BETHLEM MYOPATHY; MUSCLE APOPTOSIS; FIBER ATROPHY; COL6A1 GENE; DISEASE; MUTATION; RESCUES; MICE; FIBROBLASTS	Collagen VI is widely distributed throughout extracellular matrices (ECMs) in various tissues. In skeletal muscle, collagen VI is particularly concentrated in and adjacent to basement membranes of myofibers. Ullrich congenital muscular dystrophy (UCMD) is caused by mutations in either COL6A1, COL6A2 or COL6A3 gene, thereby leading to collagen VI deficiency in the ECM. It is known to occur through either recessive or dominant genetic mechanism, the latter most typically by de novo mutations. UCMD is well defined by the clinicopathological hallmarks including distal hyperlaxity, proximal joint contractures, protruding calcanei, scoliosis and respiratory insufficiency. Recent reports have depicted the robust natural history of UCMD; that is, loss of ambulation by early teenage years, rapid decline in respiratory function by 10 years of age and early-onset, rapidly progressive scoliosis. Muscle pathology is characterised by prominent interstitial fibrosis disproportionate to the relative paucity of necrotic and regenerating fibres. To date, treatment for patients is supportive for symptoms such as joint contractures, respiratory failure and scoliosis. There have been clinical trials based on the theory of mitochondrion-mediated myofiber apoptosis or impaired autophagy. Furthermore, the fact that collagen VI producing cells in skeletal muscle are interstitial mesenchymal cells can support proof of concept for stem cell-based therapy.	[Yonekawa, Takahiro; Nishino, Ichizo] NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan; [Yonekawa, Takahiro] NCNP, Natl Ctr Hosp, Dept Child Neurol, Kodaira, Tokyo 1878502, Japan; [Nishino, Ichizo] NCNP, Translat Med Ctr, Dept Clin Dev, Kodaira, Tokyo 1878502, Japan	Nishino, I (reprint author), NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, 4-1-1 Ogawa Higashicho, Kodaira, Tokyo 1878502, Japan.	nishino@ncnp.go.jp			NCNP, Research on Rare and Intractable Diseases and Research on Applying Health Technology from the Ministry of Health, Labour and Welfare of Japan [23-5]	The authors thank Drs Ikuya Nonaka, Hirofumi Komaki and Akihiko Ishiyama for their valuable assistance. This study was supported by Intramural Research Grant (23-5) for Neurological and Psychiatric Disorders of NCNP, Research on Rare and Intractable Diseases and Research on Applying Health Technology from the Ministry of Health, Labour and Welfare of Japan.	Alexeev V, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt411; Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P303, DOI 10.1016/j.nmd.2005.01.004; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Gerard C, 2012, CELL TRANSPLANT, V21, P127, DOI 10.3727/096368911X576018; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Kawahara G, 2007, NEUROLOGY, V69, P1043, DOI 10.1212/01.wnl.0000271386.89878.22; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Butterfield RJ, 2013, HUM MUTAT, V34, P1558, DOI 10.1002/humu.22429; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Gualandi F, 2009, NEUROLOGY, V73, P1883, DOI 10.1212/WNL.0b013e3181c3fd2a; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Nadeau A, 2009, NEUROLOGY, V73, P25, DOI 10.1212/WNL.0b013e3181aae851; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Foley AR, 2009, NEUROMUSCULAR DISORD, V19, P813, DOI 10.1016/j.nmd.2009.09.010; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7; Claeys KG, 2012, NEUROLOGY, V79, P2288, DOI 10.1212/WNL.0b013e31827689fb; Braghetta P, 2008, EXP CELL RES, V314, P3508, DOI 10.1016/j.yexcr.2008.08.006; Ishikawa H, 2002, NEUROLOGY, V59, P920; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Wang CH, 2010, J CHILD NEUROL, V25, P1559, DOI 10.1177/0883073810381924; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; AUMAILLEY M, 1991, BIOCHEM SOC T, V19, P843; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Bolduc V, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.74; Camacho VO, 2001, P NATL ACAD SCI USA, V98, P7516; Foley AR, 2013, BRAIN, V136, P3625, DOI 10.1093/brain/awt284; Gualandi F, 2012, HUM GENE THER, V23, P1313, DOI 10.1089/hum.2012.109; Gualandi F, 2011, MUSCLE NERVE, V44, P80, DOI 10.1002/mus.21999; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; Howell SJ, 1998, EXP CELL RES, V241, P230, DOI 10.1006/excr.1998.4051; Ishikawa H, 2004, NEUROLOGY, V62, P620; Kawahara G, 2008, MUSCLE NERVE, V38, P1192, DOI 10.1002/mus.21030; Mercuri E, 2002, NEUROLOGY, V58, P1354; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Noguchi S, MOR THER NU IN PRESS; NONAKA I, 1981, NEUROPEDIATRICS, V12, P197, DOI 10.1055/s-2008-1059651; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pepe Guglielmina, 2002, Neuromuscul Disord, V12, P984, DOI 10.1016/S0960-8966(02)00139-6; Quijano-Roy S, 2007, NEUROMUSCULAR DISORD, V17, P844, DOI 10.1016/j.nmd.2007.06.279; Schessl J, 2008, MUSCLE NERVE, V38, P1184, DOI 10.1002/mus.21088; Takaso M, 2010, J ORTHOP SCI, V15, P493, DOI 10.1007/s00776-010-1486-9; Ullrich O, 1930, Z GES NEUROL PSYCH, V126, P171; Ullrich O, 1930, MONATSSCHR KINDERH, V47, P502; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Usuki F, 2004, ANN NEUROL, V55, P740, DOI 10.1002/ana.20107; Usuki F, 2013, P NATL ACAD SCI USA, V110, P15037, DOI 10.1073/pnas.1300654110; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Voermans NC, 2009, ANN NEUROL, V65, P687, DOI 10.1002/ana.21643; Yonekawa T, 2013, J NEUROL NEUROSUR PS, V84, P982, DOI 10.1136/jnnp-2012-304710	64	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2015	86	3					280	287		10.1136/jnnp-2013-307052		8	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CB6EX	WOS:000349720800009		
J	Hamano, T; Li, XJ; Lonn, SL; Nabika, T; Shiwaku, K; Sundquist, J; Sundquist, K				Hamano, Tsuyoshi; Li, Xinjun; Lonn, Sara Larsson; Nabika, Toru; Shiwaku, Kuninori; Sundquist, Jan; Sundquist, Kristina			Depression, stroke and gender: evidence of a stronger association in men	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							GENERAL-PRACTICE; RISK-FACTOR; METAANALYSIS; RECORDS; DISEASE	Background/aims Depression is associated with an increased risk for stroke. The aim of this study was to examine whether demographic and socioeconomic factors modify this association. Methods This follow-up study comprised 137 305 men and 188 924 women aged >= 30 years from a nationwide sample of primary healthcare centres in Sweden. We identified 4718 first-ever stroke cases (2217 men and 2501 women) during the follow-up period (2005-2007). Multilevel logistic regression models were used to calculate ORs and examine interactions in order to determine whether the association between depression and stroke differs by demographic or socioeconomic factors. Results Depression was associated with significantly greater odds of stroke after adjustment for potential confounding factors (OR=1.22, 95% CI 1.08 to 1.38). Interaction tests showed that the effect of depression on stroke was higher in men compared with women (the difference in OR between men and women was 1.30, 95% CI 1.01 to 1.68), that is, the association between depression and stroke was modified by gender. Conclusions Our findings suggest that the depression-stroke association is modified by gender. Further studies are required to examine the underlying mechanisms in men and women.	[Hamano, Tsuyoshi; Nabika, Toru; Shiwaku, Kuninori] Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ COHRE, Izumo, Shimane 6938501, Japan; [Li, Xinjun; Lonn, Sara Larsson; Sundquist, Jan; Sundquist, Kristina] Lund Univ, Ctr Primary Hlth Care, Malmo, Sweden; [Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane 6938501, Japan; [Shiwaku, Kuninori] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane 6938501, Japan; [Sundquist, Jan; Sundquist, Kristina] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Hamano, T (reprint author), Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ COHRE, 223-8 Enya Cho, Izumo, Shimane 6938501, Japan.	thamano@med.shimane-u.ac.jp			Swedish Research Council [2012-2378]; Swedish Research Council for Health, Working Life and Welfare [2013-1836]; ALF funding from Region Skane; Swedish Council for Working Life and Social Research [2007-1754]; Swedish Freemasons Foundation	KS: the Swedish Research Council, Forte: The Swedish Research Council for Health, Working Life and Welfare (reg. no.: 2013-1836) and ALF funding from Region Skane. JS: the Swedish Research Council (2012-2378), The Swedish Council for Working Life and Social Research (2007-1754), the Swedish Freemasons Foundation and ALF funding from Region Skane.	ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; Patten SB, 2009, PSYCHOSOM MED, V71, P273, DOI 10.1097/PSY.0b013e3181988e5f; CAMACHO TC, 1991, AM J EPIDEMIOL, V134, P220; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Mezuk B, 2013, HEALTH PLACE, V23, P63, DOI 10.1016/j.healthplace.2013.05.004; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Grimaud O, 2011, STROKE, V42, P1201, DOI 10.1161/STROKEAHA.110.596429; Buys YM, 2013, CAN J OPHTHALMOL, V48, P83, DOI 10.1016/j.jcjo.2012.10.003; Jackson CA, 2013, STROKE, V44, P1555, DOI 10.1161/STROKEAHA.113.001147; Sundquist K, 2011, DIABETES-METAB RES, V27, P244, DOI 10.1002/dmrr.1161; Salaycik KJ, 2007, STROKE, V38, P16, DOI 10.1161/01.STR.0000251695.39877.ca; Sundquist J, 1999, INT J EPIDEMIOL, V28, P841, DOI 10.1093/ije/28.5.841; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Grimsmo A, 2001, SCAND J PRIM HEALTH, V19, P76; Nilsson G, 2003, SCAND J PRIM HEALTH, V21, P33, DOI 10.1080/02813430310000537; Shimbo D, 2005, AM J CARDIOL, V96, P1016, DOI 10.1016/j.amjcard.2005.05.064	19	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2015	86	3					319	323		10.1136/jnnp-2014-307616		5	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CB6EX	WOS:000349720800015		
J	Iizuka, T; Tominaga, N; Kaneko, J; Sato, M; Akutsu, T; Hamada, J; Sakai, F; Nishiyama, K				Iizuka, Takahiro; Tominaga, Naomi; Kaneko, Juntaro; Sato, Mayumi; Akutsu, Tsugio; Hamada, Junichi; Sakai, Fumihiko; Nishiyama, Kazutoshi			Biphasic neurovascular changes in prolonged migraine aura in familial hemiplegic migraine type 2	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CORTICAL SPREADING DEPRESSION; VASOGENIC LEAKAGE; UNILATERAL HYPERPERFUSION; PERSISTENT AURA; PERFUSION-MRI; BLOOD-FLOW; ATP1A2; MECHANISMS; HYPOPERFUSION; ASTROCYTES	Objective To report biphasic changes in cerebral blood flow (CBF) in the acute phase of hemiplegic migraine with prolonged aura (HMPA), in which aura symptoms lasted longer than 24 h, in three patients with familial hemiplegic migraine (FHM) carrying a p.H916L mutation in ATP1A2 gene. Methods We assessed neurovascular changes with time in the affected cerebral hemisphere corresponding to aura symptoms during the acute phase of HMPA. Arterial spin labelling MRI, SPECT for CBF measurement and EEG in three attacks, in one attack FDG-PET measurement for cerebral metabolism was performed. We evaluated CBF at different phases of aura symptoms in 11 attacks of HMPA. Results In two attacks, we found biphasic CBF changes beginning with hypoperfusion followed by persistent hyperperfusion. FDG-PET revealed increased cerebral glucose metabolism in the regions corresponding to hyperperfusion on day 4 when aura symptoms still persisted. In four attacks, Z-score-based CBF mapping revealed multifocal hypoperfusion in the early phase. Hypoperfusion in our study was seen within 19 h of the onset of the symptoms in five of seven attacks, while hyperperfusion was seen 18 h or later in eight of nine attacks. EEG showed attenuated alpha activity without paroxysmal discharge. Conclusions This is the first report showing biphasic CBF changes during the prolonged aura of FHM2. This study suggested that the results of cross-sectional CBF studies should be interpreted carefully. Initial multifocal hypoperfusion is likely due to functional depression of multifocal origin in the affected hemisphere, but the mechanism of persistent hyperperfusion requires further investigation.	[Iizuka, Takahiro; Tominaga, Naomi; Kaneko, Juntaro; Sato, Mayumi; Akutsu, Tsugio; Hamada, Junichi; Nishiyama, Kazutoshi] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa 2520374, Japan; [Sakai, Fumihiko] Saitama Int Headache Ctr, Saitama Neuropsychiat Inst, Saitama, Japan	Iizuka, T (reprint author), Kitasato Univ, Sch Med, Dept Neurol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	takahiro@med.kitasato-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	We are extremely grateful to all participants for their contribution to this study and acknowledge the efforts of research staffs, who worked on the clinical, genetic and neuroimaging data collection. We particularly thank Professor Shoji Tsuji, Yuji Takahashi and Yoshio Momose in Department of Neurology, Graduate School of Medicine, University of Tokyo, for their genetic analysis in this family. This work was in part supported by Grants-in-Aid of the Research on Intractable Diseases (Mitochondrial Disorder) from the Ministry of Health, Labour and Welfare of Japan.	AMINIAN A, 1993, ANN NEUROL, V33, P43, DOI 10.1002/ana.410330108; ANDERSEN AR, 1988, ARCH NEUROL-CHICAGO, V45, P154; Iizuka T, 2012, J NEUROL NEUROSUR PS, V83, P205, DOI 10.1136/jnnp-2011-300843; Russell MB, 2011, LANCET NEUROL, V10, P457, DOI 10.1016/S1474-4422(11)70048-5; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010; Lindahl AJ, 2002, J NEUROL NEUROSUR PS, V73, P202, DOI 10.1136/jnnp.73.2.202; Ben Achour S, 2012, NEUROCHEM RES, V37, P2464, DOI 10.1007/s11064-012-0807-0; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Dodgson SJ, 2000, EPILEPSIA, V41, pS35, DOI 10.1111/j.1528-1157.2000.tb06047.x; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Barros J, 2012, J HEADACHE PAIN, V13, P581, DOI 10.1007/s10194-012-0462-5; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Eikermann-Haerter K, 2011, J NEUROSCI, V31, P5755, DOI 10.1523/JNEUROSCI.5346-10.2011; Eikermann-Haerter K, 2013, REV NEUROSCIENCE, V24, P353, DOI 10.1515/revneuro-2013-0005; Fellin Tommaso, 2006, Novartis Found Symp, V276, P208; GASTAUT JL, 1981, ANN NEUROL, V10, P392, DOI 10.1002/ana.410100414; Goadsby Peter J, 2013, Handb Clin Neurol, V117, P193, DOI 10.1016/B978-0-444-53491-0.00016-X; Gritz SM, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-8; Hansen JM, 2011, HEADACHE, V51, P1289, DOI 10.1111/j.1526-4610.2011.01963.x; Hara H., 1995, CNS DRUG REV, V1, P204, DOI 10.1111/j.1527-3458.1995.tb00284.x; Headache Classification Committee of the International Headache Society (IHS), 2013, INT CLASS HEAD DIS, V33, P629; Iizuka T, 2006, CEPHALALGIA, V26, P332, DOI 10.1111/j.1468-2982.2005.01025.x; Jakovcevic D, 2007, CURR TOP DEV BIOL, V79, P75, DOI 10.1016/S0070-2153(06)79004-4; Kraus J, 2007, NERVENARZT, V78, P1420, DOI 10.1007/s00115-007-2324-y; Lanfranconi S, 2009, J NEUROL SCI, V285, P227, DOI 10.1016/j.jns.2009.06.009; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Masuzaki M, 2001, AM J NEURORADIOL, V22, P1795; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; Mourand I, 2012, NEURORADIOLOGY, V54, P255, DOI 10.1007/s00234-011-0946-z; Oberndorfer S, 2004, CEPHALALGIA, V24, P533, DOI 10.1111/j.1468-2982.2003.00706.x; Relja G, 2005, CEPHALALGIA, V25, P56, DOI 10.1111/j.1468-2982.2004.00808.x; Smith M, 2002, NEUROLOGY, V58, P1308; Viana M, 2013, CEPHALALGIA, V33, P483, DOI 10.1177/0333102413479834	38	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2015	86	3					344	353		10.1136/jnnp-2014-307731		10	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CB6EX	WOS:000349720800020		
J	Nagata, N; Iwata-Yoshikawa, N; Hayasaka, D; Sato, Y; Kojima, A; Kariwa, H; Takashima, I; Takasaki, T; Kurane, I; Sata, T; Hasegawa, H				Nagata, Noriyo; Iwata-Yoshikawa, Naoko; Hayasaka, Daisuke; Sato, Yuko; Kojima, Asato; Kariwa, Hiroaki; Takashima, Ikuo; Takasaki, Tomohiko; Kurane, Ichiro; Sata, Tetsutaro; Hasegawa, Hideki			The Pathogenesis of 3 Neurotropic Flaviviruses in a Mouse Model Depends on the Route of Neuroinvasion After Viremia	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Encephalitis; Flavivirus; Japanese encephalitis virus; Mouse model; Peripheral neuritis; Tick-borne encephalitis virus; Viremia; West Nile virus	WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; RETROGRADE AXONAL-TRANSPORT; HERPES-SIMPLEX-VIRUS; JAPANESE ENCEPHALITIS; HEPARAN-SULFATE; TRANSGENIC MICE; INFECTION; NEUROVIRULENCE	Neurotropic flavivirus infection of humans results in viremia subsequently; in some cases, it causes meningitis encephalomyelitis, although the pathways from viremia to central nervous system (CNS) invasion are uncertain. Here, we intravenously infected BALB/c mice with 3 neurotropic flaviviruses, then examined the clinical manifestations and histopathologic changes. The Sofjin strain of tick-borne encephalitis virus-infected mice exhibited dose-dependent survival. The animals showed distention of the small intestine caused by peripheral neuritis because of infection of the myenteric plexus. Histopathologically, the strongly neurotropic Sofjin strain invaded the CNS of viremic mice via the autonomic nerves running from the plexus. The JaTH-160 strain of Japanese encephalitis virus was isolated from the lymph nodes during the preclinical phase of viral encephalitis. Therefore, this strain might infect the CNS via a hematogenous pathway, including through lymphoid tissues. The NY99-6922 strain of the West Nile virus caused clinical signs suggestive of intestinal, lymphoid, and/or neurologic involvement; the infected mice had prolonged viremia, suggesting that NY99-6922 may mainly use the hematogenous pathway; however, there was also histopathologic evidence of involvement of the autonomic nervous system pathway. In conclusion, the three neurotropic flaviviruses showed different pathogenesis, which were dependent upon overlapping but distinct pathways to CNS invasion after viremia.	[Nagata, Noriyo; Iwata-Yoshikawa, Naoko; Sato, Yuko; Kojima, Asato; Sata, Tetsutaro; Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Takasaki, Tomohiko; Kurane, Ichiro] Natl Inst Infect Dis, Dept Virol, Tokyo, Japan; [Hayasaka, Daisuke] Nagasaki Univ, Leading Grad Sch Program, GCOE Program, Dept Virol,Inst Trop Med, Nagasaki 852, Japan; [Kariwa, Hiroaki; Takashima, Ikuo] Hokkaido Univ, Grad Sch Vet Med, Publ Hlth Lab, Sapporo, Hokkaido, Japan	Nagata, N (reprint author), Natl Inst Infect Dis, Tokyo, Japan.	nnagata@niid.go.jp			Ministry of Health, Labour and Welfare [H25-Shinko-ippan-007, H26-Shinkogyosei-Shitei-002]	This work was supported by Grants-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare including H25-Shinko-ippan-007 and H26-Shinkogyosei-Shitei-002.	ABE S, 1995, VIROLOGY, V210, P160, DOI 10.1006/viro.1995.1327; Agamanolis DP, 2003, ANN NEUROL, V54, P547, DOI 10.1002/ana.10731; Aleyas AG, 2009, J IMMUNOL, V183, P2462, DOI 10.4049/jimmunol.0801952; Schultze D, 2007, J CLIN VIROL, V38, P172, DOI 10.1016/j.jcv.2006.11.008; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; REN RB, 1992, J INFECT DIS, V166, P747; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506; Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; Kojima A, 2003, J VIROL, V77, P8745, DOI 10.1128/JVI.77.16.8745-8755.2003; Hayes EB, 2005, EMERG INFECT DIS, V11, P1174; HORIE H, 1994, J VIROL, V68, P681; Takashima I, 1997, J CLIN MICROBIOL, V35, P1943; Cushing MM, 2004, AM J CLIN PATHOL, V121, P26, DOI [10.1309/G23CP54DAR1BCY8L, 10.1309/G23C-P54D-AR1B-CY8L]; Yoshii K, 2004, J GEN VIROL, V85, P3049, DOI 10.1099/vir.0.80169-0; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005; Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643; Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055; Ohka S, 2004, J VIROL, V78, P7186, DOI 10.1128/JVI.78.13.7186-7198.2004; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Liu Y, 2009, J CLIN VIROL, V46, P49, DOI 10.1016/j.jcv.2009.06.010; BAK IJ, 1978, BRAIN RES, V143, P361, DOI 10.1016/0006-8993(78)90576-0; Chiba N, 1999, VACCINE, V17, P779, DOI 10.1016/S0264-410X(98)00262-X; Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017; Clark DC, 2012, ARCH VIROL, V157, P1423, DOI 10.1007/s00705-012-1337-4; DIX RD, 1983, INFECT IMMUN, V40, P103; FUJISAKI Y, 1983, NATL I ANIM HEALTH Q, V23, P21; Garcia-Tapia D, 2007, J NEUROVIROL, V13, P130, DOI 10.1080/1350280601187185; Gea-Banacloche J, 2004, ANN INTERN MED, V140, P545; GILLET JP, 1986, J NEUROPATH EXP NEUR, V45, P619, DOI 10.1097/00005072-198611000-00002; Hayasaka D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071643; Hayasaka D, 2001, J GEN VIROL, V82, P1319; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Kleiter I, 2006, EUR J MED RES, V11, P261; Kurane I, 2002, CURR TOP MICROBIOL, V267, P91; LITWACK ED, 1994, J NEUROSCI, V14, P3713; MIURA K, 1988, EXP ANIM TOKYO, V37, P365; Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010; NISHIMUR.C, 1968, JPN J MED SCI BIOL, V21, P1; Ohtaki N, 2011, J VIROL METHODS, V174, P131, DOI 10.1016/j.jviromet.2011.03.021; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; Pierson TC, 2013, FIELDS VIROLOGY, V2, P747; SHAMANIN VA, 1990, J GEN VIROL, V71, P1505, DOI 10.1099/0022-1317-71-7-1505; Shirato K, 2003, MICROBIOL IMMUNOL, V47, P439; Williams JH, 2014, VET PATHOL, V52, P140; Wong KT, 2012, NEUROPATH APPL NEURO, V38, P443, DOI 10.1111/j.1365-2990.2011.01247.x; Yoshii K, 2013, ARCH VIROL, V158, P1039, DOI 10.1007/s00705-012-1579-1	52	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAR	2015	74	3					250	260				11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CB7AG	WOS:000349777700007		
J	Suehiro, E; Koizumi, H; Fujisawa, H; Fujita, M; Kaneko, T; Oda, Y; Yamashita, S; Tsuruta, R; Maekawa, T; Suzuki, M				Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Fujita, Motoki; Kaneko, Tadashi; Oda, Yasutaka; Yamashita, Susumu; Tsuruta, Ryosuke; Maekawa, Tsuyoshi; Suzuki, Michiyasu			Diverse Effects of Hypothermia Therapy in Patients with Severe Traumatic Brain Injury Based on the Computed Tomography Classification of the Traumatic Coma Data Bank	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; hypothermia; Traumatic Coma Data Bank; multicenter randomized controlled trial; heterogeneous pathophysiology; CT classification	POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CARDIAC-ARREST; AXONAL INJURY; HEAD-INJURY; INDUCTION; GLUTAMATE; DAMAGE; RAT	A multicenter randomized controlled trial of patients with severe traumatic brain injury who received therapeutic hypothermia or fever control was performed from 2002 to 2008 in Japan (BHYPO). There was no difference in the therapeutic effect on traumatic brain injury between the two groups. The efficacy of hypothermia treatment and the objective of the treatment were reexamined based on a secondary analysis of the BHYPO trial in 135 patients (88 treated with therapeutic hypothermia and 47 with fever control). This analysis was performed to examine clinical outcomes according to the CT classification of the Traumatic Coma Data Bank on admission. Clinical outcomes were evaluated with the Glasgow Outcome Scale and mortality at 6 months after injury. Good recovery and moderate disability were defined as favorable outcomes. Favorable outcomes in young patients (<= 50 years old) with evacuated mass lesions significantly increased from 33.3% with fever control to 77.8% with therapeutic hypothermia. Patients with diffuse injury III who were treated with therapeutic hypothermia, however, had significantly higher mortality than patients treated with fever control. It was difficult to control intracranial pressure with hypothermia for patients with diffuse injury III, but hypothermia was effective for young patients with an evacuated mass lesion.	[Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Suehiro, Eiichi; Fujita, Motoki; Kaneko, Tadashi; Oda, Yasutaka; Yamashita, Susumu; Tsuruta, Ryosuke] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan; [Maekawa, Tsuyoshi] Yamaguchi Grand Med Ctr, Hofu, Yamaguchi, Japan	Suehiro, E (reprint author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp			Japanese Ministry of Health, Labor and Welfare [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare, H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001, and by the Japanese Human Science Association, 2002-2004.	Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Holzer M, 2002, NEW ENGL J MED, V346, P549; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Delbarre B, 1992, EXS, V62, P199; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KURODA Y, 1992, NEUROSURGERY, V30, P687; Maekawa T., 2014, J NEUROTRAU IN PRESS; MARSHALL LF, 1991, J NEUROSURG, V75, pS14; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; Suehiro E, 2014, J NEUROTRAUM, V31, P315, DOI 10.1089/neu.2013.3057; The Japan Society of Neurotraumatology, 2001, GEN RUL CLIN PATH RE, P1; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906	25	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					353	358		10.1089/neu.2014.3584		6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700007		
J	Mata-Mbemba, D; Mugikura, S; Nakagawa, A; Murata, T; Kato, Y; Tatewaki, Y; Li, L; Takase, K; Ishii, K; Kushimoto, S; Tominaga, T; Takahashi, S				Mata-Mbemba, Daddy; Mugikura, Shunji; Nakagawa, Atsuhiro; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Li, Li; Takase, Kei; Ishii, Kiyoshi; Kushimoto, Shigeki; Tominaga, Teiji; Takahashi, Shoki			Intraventricular Hemorrhage on Initial Computed Tomography as Marker of Diffuse Axonal Injury after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; intraventricular hemorrhage; diffuse axonal injury; computed tomography; corpus callosum	CLOSED-HEAD INJURY; MAGNETIC-RESONANCE; INTRACRANIAL-PRESSURE; CT; MR; PROGNOSIS; CLASSIFICATION; MODERATE; LESIONS	Intraventricular hemorrhage (IVH) on initial computed tomography (CT) was reported to predict lesions of diffuse axonal injury (DAI) in the corpus callosum (CC) on subsequent magnetic resonance imaging (MRI). We aimed to examine the relationship between initial CT findings and DAI lesions detected on MRI as well as the relationship between the severity of IVH (IVH score) and severity of DAI (DAI staging). A consecutive 140 patients with traumatic brain injury (TBI) who underwent MRI within 30 days after onset were revisited. We reviewed their initial CT for the following six findings: Status of basal cistern, status of mid-line shift, epidural hematoma, IVH, subarachnoid hemorrhage, and volume of hemorrhagic mass and IVH score were assigned in each patient. Based on MRI findings, patients were divided into DAI and non-DAI groups and were assigned a DAI staging. Then, to confirm that the IVH on initial CT predicts DAI lesions on MRI, we used multi-variate analysis of the six CT findings, including IVH, and examined the relationship between IVH score and DAI staging. The IVH detected on CT was the only predictor of DAI (p=0.0139). The IVH score and DAI staging showed significant positive correlation (p<0.0003). IVH score in DAI stage 3 (with DAI involving the brain stem; p=0.0025) or stage 2 (with DAI involving CC; p=0.0042) was significantly higher than that of DAI stage 0 (no DAI lesions). In conclusion, IVH on initial CT is the only marker of DAI on subsequent MRI, specifically severe DAI (stage 2 or 3).	[Mata-Mbemba, Daddy; Mugikura, Shunji; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Li, Li; Takase, Kei; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 9808574, Japan; [Nakagawa, Atsuhiro; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan; [Kushimoto, Shigeki] Tohoku Univ, Grad Sch Med, Div Emergency Med, Sendai, Miyagi 9808574, Japan; [Ishii, Kiyoshi] Sendai City Hosp, Dept Radiol, Sendai, Miyagi, Japan	Mugikura, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mugi@rad.med.tohoku.ac.jp					Adams J. H., 1992, GREENFIELDS NEUROPAT, P106; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; GENTRY LR, 1994, RADIOLOGY, V191, P1; Holbourn AHS, 1943, LANCET, V2, P438; JAYAKUMAR PN, 1990, ACTA NEUROCHIR, V106, P48, DOI 10.1007/BF01809332; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Lagares A, 2006, NEUROCIRUGIA, V17, P105; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85; MARSHALL LF, 1991, J NEUROSURG, V75, pS14; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; SATO M, 1987, ACTA NEUROCHIR, V88, P95, DOI 10.1007/BF01404144; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163	33	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					359	365		10.1089/neu.2014.3453		7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700008		
J	Takahashi, S; Neuville, DR; Takebe, H				Takahashi, Shoji; Neuville, Daniel R.; Takebe, Hiromichi			Thermal properties, density and structure of percalcic and peraluminus CaO-Al2O3-SiO2 glasses	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article						Aluminosilicate glass; Infrared spectroscopy; Thermal properties; Density; Structure	CALCIUM ALUMINOSILICATE GLASSES; NON-BRIDGING OXYGEN; MQ-MAS NMR; HIGH-TEMPERATURE; HIGH-PRESSURE; ALUMINUM COORDINATION; AL COORDINATION; AL-27 NMR; SILICATE-GLASSES; MELTS	Calcium silicate and aluminosilicate glasses with various SiO2 contents (10-76 mol%) were prepared in the wide range of [Al2O3MCaO] molar ratio from 0.10 to 4.00 by conventional melt-quenching method and an aerodynamic levitation device for a part of peraluminus glasses. Variations of glass transition temperature, the coefficient of linear expansion, and ionic packing factor derived from density measurements with [Al2O3]/[CaO] molar ratio were studied. The glass structures of SiO4 three dimensional network, mixed anions of (Si, Al)O-4 tetrahedra, isolated AlO4 and Al-O-Al linkages were evaluated by FT-IR measurements. Compositional dependences of the properties are qualitatively related to the glass structure examined by IR spectroscopy and the proportions of AlOx (x = 4, 5, 6) species evaluated in a previous study by using Al-27 MQ NMR spectroscopy. (C) 2014 Elsevier B.V. All rights reserved.	[Takahashi, Shoji; Takebe, Hiromichi] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Neuville, Daniel R.] IPGP CNRS, F-75005 Paris, France	Takebe, H (reprint author), Ehime Univ, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	takebe.hiromichi.mk@ehime-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Innovative Zero-emission Coal Gasification Power Generation Project	This research is partly supported by the New Energy and Industrial Technology Development Organization (NEDO), Innovative Zero-emission Coal Gasification Power Generation Project.	RIEBLING EF, 1966, J CHEM PHYS, V44, P2857, DOI 10.1063/1.1727145; Lee SK, 2004, J PHYS CHEM B, V108, P5889, DOI 10.1021/jp037575d; Neuville DR, 2004, GEOCHIM COSMOCHIM AC, V68, P5071, DOI 10.1016/j.gca.2004.05.048; SHELBY JE, 1983, J AM CERAM SOC, V66, P225, DOI 10.1111/j.1151-2916.1983.tb10023.x; Okuno M, 2005, J NON-CRYST SOLIDS, V351, P1032, DOI 10.1016/j.jnoncrysol.2005.01.014; Malfait WJ, 2012, GEOCHIM COSMOCHIM AC, V77, P11, DOI 10.1016/j.gca.2011.11.011; Le Losq C, 2014, GEOCHIM COSMOCHIM AC, V126, P495, DOI 10.1016/j.gca.2013.11.010; Allwardt JR, 2005, AM MINERAL, V90, P1453, DOI 10.2138/am.2005.1736; Lin SL, 1996, J NON-CRYST SOLIDS, V202, P61, DOI 10.1016/0022-3093(96)00138-X; Moesgaard M, 2010, CHEM MATER, V22, P4471, DOI 10.1021/cm1011795; MERZBACHER CI, 1991, J NON-CRYST SOLIDS, V130, P18, DOI 10.1016/0022-3093(91)90152-V; Clayden NJ, 1999, J NON-CRYST SOLIDS, V258, P11, DOI 10.1016/S0022-3093(99)00555-4; Lee SK, 2006, GEOCHIM COSMOCHIM AC, V70, P4275, DOI 10.1016/j.gca.2006.06.1550; Park JH, 2004, METALL MATER TRANS B, V35, P269, DOI 10.1007/s11663-004-0028-2; MYSEN BO, 1985, AM MINERAL, V70, P88; YARGER JL, 1995, SCIENCE, V270, P1964, DOI 10.1126/science.270.5244.1964; Neuville DR, 2008, AM MINERAL, V93, P228, DOI 10.2138/am.2008.2646; Neuville DR, 2006, CHEM GEOL, V229, P173, DOI 10.1016/j.chemgeo.2006.01.019; Lee SK, 2000, J PHYS CHEM B, V104, P4091, DOI 10.1021/jp994273w; Licheron M, 2011, J NON-CRYST SOLIDS, V357, P2796, DOI 10.1016/j.jnoncrysol.2011.03.001; WINTER JK, 1979, AM MINERAL, V64, P573; Stebbins JF, 2008, GEOCHIM COSMOCHIM AC, V72, P910, DOI 10.1016/j.gca.2007.11.018; Neuville DR, 2014, REV MINERAL GEOCHEM, V78, P779, DOI 10.2138/rmg.2013.78.19; Sontakke AD, 2012, SPECTROCHIM ACTA A, V94, P180, DOI 10.1016/j.saa.2012.03.052; Allwardt JR, 2005, AM MINERAL, V90, P1218, DOI 10.2138/am.2005.1836; Stebbins JF, 1997, NATURE, V390, P60, DOI 10.1038/36312; NAGENO Y, 1993, J AM CERAM SOC, V76, P3081, DOI 10.1111/j.1151-2916.1993.tb06612.x; Toplis MJ, 1997, GEOCHIM COSMOCHIM AC, V61, P2605, DOI 10.1016/S0016-7037(97)00126-9; Cormier L, 2005, J AM CERAM SOC, V88, P2292, DOI 10.1111/j.1551-2916.2005.00428.x; HORMADALY J, 1986, J NON-CRYST SOLIDS, V79, P311, DOI 10.1016/0022-3093(86)90230-9; Kanehashi K, 2007, J NON-CRYST SOLIDS, V353, P4001, DOI 10.1016/j.jnoncrysol.2007.06.030; Lacy E.D., 1963, Physics and Chemistry of Glasses, V4; Masuda H, 1998, J JPN I MET, V62, P444; Mazurin O.V., 1987, HDB GLASS DATA C, P738; OHTANI E, 1985, NATURE, V314, P78, DOI 10.1038/314078a0; Schmucker M, 2002, J NON-CRYST SOLIDS, V311, P211; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; SIMON I, 1953, J AM CERAM SOC, V36, P160, DOI 10.1111/j.1151-2916.1953.tb12858.x; Suginohara Y., 1969, T JPN I MET, V12, P400; Takahashi K., 1975, Yogyo-Kyokai-Shi, V83; Takahashi S., 2012, J MMIJ, V128, P150; Tarte P., 1964, PHYS NONCRYSTALLINE, P549; Toyuki H., 1977, Yogyo-Kyokai-Shi, V85; Varshneya A.K., 1994, FUNDAMENTALS INORGAN; Yanagase T., 1969, J JPN I MET, V33, P443	45	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093	1873-4812		J NON-CRYST SOLIDS	J. Non-Cryst. Solids	MAR 1	2015	411						5	12		10.1016/j.jnoncrysol.2014.12.019		8	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	CB6GS	WOS:000349726100002		
J	Vernerova, M; Cincibusova, P; Klouzek, J; Maehara, T; Nemec, L				Vernerova, Miroslava; Cincibusova, Petra; Klouzek, Jaroslav; Maehara, Terutaka; Nemec, Lubomir			Method of examination of bubble nucleation in glass melts	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article						Bubble nucleation; Nucleation monitoring; Nucleation temperature; Nucleation intensity; Glass fining	SILICATE MELTS; SULFUR	The method of high temperature monitoring and image analysis was applied to determine the temperature at which the bubbles were nucleated on a platinum wire immersed in the melt of a float type of glass. The bubbles that rose during a slow increase of temperature were identified, monitored and subsequently, their diameter was measured and the obtained dependence between the bubble diameter and time was extrapolated to the zero size of the relevant bubbles. The bubble nucleation temperature has been determined at the temperature of bubble zero size. The obtained average value of the bubble nucleation temperature in glass with 0.185 wt.% of chemically dissolved SO3 was 1502.6 degrees C whereas the same quantity showed the value in glass with 0.250 wt.% of chemically dissolved SO3 to be 1501.4 degrees C. The intensity of bubble nucleation in the form of the number of nucleated bubbles and the volume of released gas versus time were also measured in both glass samples and described by a theoretical equation. The relation between the diffusion and thermodynamic barriers of the nucleation was determined and discussed. The results were also discussed with respect to the literature data relating to the bubble nucleation and the fining process. (C) 2015 Elsevier B.V. All rights reserved.	[Vernerova, Miroslava; Cincibusova, Petra; Klouzek, Jaroslav; Nemec, Lubomir] Inst Chem Technol Prague, Lab Inorgan Mat, Prague 16628 6, Czech Republic; [Vernerova, Miroslava; Cincibusova, Petra; Klouzek, Jaroslav; Nemec, Lubomir] Inst Rock Struct & Mech ASCR, Vvi, Prague 18209 8, Czech Republic; [Maehara, Terutaka] Asahi Glass Co LTD, Republ Prod Technol Ctr, Tokyo, Japan	Klouzek, J (reprint author), Inst Chem Technol Prague, Lab Inorgan Mat, Prague 16628 6, Czech Republic.	klouzekj@vscht.cz			Technology Agency of the Czech Republic in the project 'New Glasses and Their Technologies' [TAO1010844]; Research project of the Production Technology Center, Asahi Glass Co, LTD., Japan [141611004]	This work has been supported by the Technology Agency of the Czech Republic in the project No. TAO1010844 'New Glasses and Their Technologies' and by the Research project of the Production Technology Center, Asahi Glass Co, LTD., Japan in the Project No. 141611004.	Arkosiova M., 2008, ADV MAT RES, V39-40, P413; Arkosiova M, 2008, CERAM-SILIKATY, V52, P155; Backnaes L, 2008, J AM CERAM SOC, V91, P721, DOI 10.1111/j.1551-2916.2007.02044.x; Bartuska M., 2008, GLASS DEFECTS; Beerkens R., 2003, INT C ADV FUS PROC, V141, P1; Hlavac J., 1981, FUNDAMENTALS SILICAT, P41; HOLMQUIST S, 1966, J AM CERAM SOC, V49, P467, DOI 10.1111/j.1151-2916.1966.tb13301.x; Izumitani T., 1962, ADV GLASS TECHNOLOGY, P205; Jebsen-Marwedel H., 1980, GLASTECHNISCHE FABRI, P205; Klouzek J, 2000, GLASS SCI TECHNOL, V73, P329; Klouzek J, 2006, CERAM-SILIKATY, V50, P134; Klouzek J, 2007, GLASS TECHNOL-PART A, V48, P176; Matej J., 1998, SKLAR KERAMIK, V48, P269; NEMEC L, 1977, J AM CERAM SOC, V60, P436, DOI 10.1111/j.1151-2916.1977.tb15528.x; Volmer H., 1939, KINETIK PHASENBILDUN	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093	1873-4812		J NON-CRYST SOLIDS	J. Non-Cryst. Solids	MAR 1	2015	411						59	67		10.1016/j.jnoncrysol.2014.12.025		9	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	CB6GS	WOS:000349726100010		
J	Amano, K; Morita, T; Tatara, R; Katayama, H; Uno, T; Takagi, I				Amano, Koji; Morita, Tatsuya; Tatara, Ryohei; Katayama, Hirofumi; Uno, Teruaki; Takagi, Ibuki			Association between Early Palliative Care Referrals, Inpatient Hospice Utilization, and Aggressiveness of Care at the End of Life	JOURNAL OF PALLIATIVE MEDICINE			English	Article							ADVANCED CANCER-PATIENTS; CELL LUNG-CANCER; MEDICARE BENEFICIARIES; PROSPECTIVE COHORT; CHEMOTHERAPY USE; JAPAN; QUALITY; TRENDS; SATISFACTION; DISCUSSIONS	Background: Palliative care has a positive effect on many clinical outcomes, yet most referrals to palliative care have occurred late. End-of-life (EOL) cancer care has become increasingly aggressive. There have been no studies investigating the association between early palliative care referrals and aggressive EOL care in Japan. Objective: This study was designed to explore the association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of EOL care by investigating cancer decedents. Design: A retrospective cohort study in a cancer-designated hospital in Japan. Setting/Subjects: This study examined 266 consecutive cancer decedents. Inclusion criteria were adults and patients who died from cancer or causes related to cancer. Patients who died from causes unrelated to cancer were excluded. A total of 265 patients met the criteria. Measurements: We explored the association between early referrals (>3 months before death) and inpatient hospice utilization and the relationship between the timing of referrals and aggressive EOL care measured by a composite score adapted from Earle and colleagues. Results: Patients were divided into an early referral group (n=54) and a control group (n=211). The rate of inpatient hospice utilization was significantly higher in the early referral group (74% versus 47%, adjusted p<0.001). While each of six indicators of aggressiveness of EOL care did not differ significantly, the composite score was significantly lower in the early referral group (1.91 +/- 0.59 versus 2.14 +/- 0.78, adjusted p<0.001). Conclusions: Early palliative referrals were associated with more inpatient hospice utilization and less aggressive EOL care.	[Amano, Koji; Tatara, Ryohei; Katayama, Hirofumi; Uno, Teruaki; Takagi, Ibuki] Osaka City Gen Hosp, Palliat Care Team, Dept Palliat Med, Osaka 5340021, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Palliat Care Team, Dept Palliat & Support Care, Shizuoka, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Seirei Hosp, Shizuoka, Japan	Amano, K (reprint author), Osaka City Gen Hosp, Palliat Care Team, Dept Palliat Med, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	kojiamano4813@gmail.com					Daugherty CK, 2004, CANCER INVEST, V22, P123, DOI 10.1081/CNV-120027587; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Morita T, 2009, J PAIN SYMPTOM MANAG, V38, P191, DOI 10.1016/j.jpainsymman.2008.09.011; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Emanuel EJ, 2003, ANN INTERN MED, V138, P639; Morita T, 2005, J CLIN ONCOL, V23, P2637; Zimmermann C, 2008, JAMA-J AM MED ASSOC, V299, P1698, DOI 10.1001/jama.299.14.1698; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.036; Teno JM, 2005, J AM GERIATR SOC, V53, P1905, DOI 10.1111/j.1532-5415.2005.53563.x; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Huskamp HA, 2009, ARCH INTERN MED, V169, P954, DOI 10.1001/archinternmed.2009.127; McNiff KK, 2008, J CLIN ONCOL, V26, P3832, DOI 10.1200/JCO.2008.16.8674; Temel JS, 2008, CANCER-AM CANCER SOC, V113, P826, DOI 10.1002/cncr.23620; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Braga S, 2011, ANN ONCOL, V22, P2345, DOI 10.1093/annonc/mdr416; Cheng Wen-Wu, 2005, J Palliat Med, V8, P1025, DOI 10.1089/jpm.2005.8.1025; Fisher ES, 2003, ANN INTERN MED, V138, P288; Gonsalves W, 2010, J CLIN ONCOL, V28; Helft PR, 2005, J CLIN ONCOL, V23, P3146, DOI 10.1200/JCO.2005.07.003; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1743, DOI 10.1002/cncr.28628; Ida E, 2002, PALLIATIVE MED, V16, P179, DOI 10.1191/0269216302pm511oa; Maeyama E, 2003, SUPPORT CARE CANCER, V11, P509, DOI 10.1007/s00520-003-0465-5; Morita T, 2002, PALLIATIVE MED, V16, P185, DOI 10.1191/0269216302pm524oa; National Consensus Project for Quality Palliative Care, 2009, CLIN PRACT GUID QUAL; Norris K, 2007, J PALLIAT MED, V10, P1101, DOI 10.1089/jpm.2006.2546; Osta Badi El, 2008, J Palliat Med, V11, P51, DOI 10.1089/jpm.2007.0103; Saito AM, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-14; Wright AA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1219	33	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	MAR 1	2015	18	3					270	273		10.1089/jpm.2014.0132		4	Health Care Sciences & Services	Health Care Sciences & Services	CC1MO	WOS:000350105200013		
J	Arai, D; Hegab, AE; Soejima, K; Kuroda, A; Ishioka, K; Yasuda, H; Naoki, K; Kagawa, S; Hamamoto, J; Yin, YJ; Ornitz, DM; Betsuyaku, T				Arai, Daisuke; Hegab, Ahmed E.; Soejima, Kenzo; Kuroda, Aoi; Ishioka, Kota; Yasuda, Hiroyuki; Naoki, Katsuhiko; Kagawa, Shizuko; Hamamoto, Junko; Yin, Yongjun; Ornitz, David M.; Betsuyaku, Tomoko			Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma	JOURNAL OF PATHOLOGY			English	Article						FGF9; FGFR; adenocarcinoma; tumour propagation; lung cancer; tumour-associated lung fibroblasts	CANCER STEM-CELLS; FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; ADULT LUNG; II CELLS; IDENTIFICATION; MUTATIONS; GEFITINIB; EXPRESSION; EPITHELIUM	Fibroblast growth factor 9 (FGF9) is essential for lung development and is highly expressed in a subset of human lung adenocarcinomas. We recently described a mouse model in which FGF9 expression in the lung epithelium caused proliferation of the airway epithelium at the terminal bronchioles and led to rapid development of adenocarcinoma. Here, we used this model to characterize the effects of prolonged FGF9 induction on the proximal and distal lung epithelia, and examined the propagation potential of FGF9-induced lung tumours. We showed that prolonged FGF9 over-expression in the lung resulted in the development of adenocarcinomas arising from both alveolar type II and airway secretory cells in the lung parenchyma and airways, respectively. We found that tumour cells harboured tumour-propagating cells that were able to form secondary tumours in recipient mice, regardless of FGF9 expression. However, the highest degree of tumour propagation was observed when unfractionated tumour cells were co-administered with autologous, tumour-associated mesenchymal cells. Although the initiation of lung adenocarcinomas was dependent on activation of the FGF9-FGF receptor 3 (FGFR3) signalling axis, maintenance and propagation of the tumour was independent of this signalling. Activation of an alternative FGF-FGFR axis and the interaction with tumour stromal cells is likely to be responsible for the development of this independence. This study demonstrates the complex role of FGF-FGFR signalling in the initiation, growth and propagation of lung cancer. Our findings suggest that analysing the expressions of FGF-FGFRs in human lung cancer will be a useful tool for guiding customized therapy. Copyright (c) 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.	[Arai, Daisuke; Hegab, Ahmed E.; Soejima, Kenzo; Kuroda, Aoi; Ishioka, Kota; Yasuda, Hiroyuki; Naoki, Katsuhiko; Kagawa, Shizuko; Hamamoto, Junko; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 1608582, Japan; [Yin, Yongjun; Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Betsuyaku, T (reprint author), Keio Univ, Sch Med, Div Pulm Med, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	ahegab@a2.keio.jp; tbetsuyaku@z5.keio.jp			JSPS [25461196, 23390218]; National Institutes of Health (NIH) [HL111190]	We thank Yuichiro Hayashi for performing the pathological assessments, Miyuki Yamamoto and Mikiko Shibuya for technical support, and Steven Brody for the help with the ALI. This study was supported by a JSPS Grant-in-Aid for Scientific Research C and B (Nos 25461196 and 23390218, to AEH and TB, respectively) and the National Institutes of Health (NIH; Grant No. HL111190, to DMO).	Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Jeffery PK, 1997, EUR RESPIR J, V10, P1655, DOI 10.1183/09031936.97.10071655; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; KALINA M, 1992, AM J RESP CELL MOL, V6, P594; Terai H, 2013, MOL CANCER RES, V11, P759, DOI 10.1158/1541-7786.MCR-12-0652; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Taron M, 2005, CLIN CANCER RES, V11, P5878, DOI 10.1158/1078-0432.CCR-04-2618; Wynes MW, 2014, CLIN CANCER RES, V20, P3299, DOI 10.1158/1078-0432.CCR-13-3060; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; McQualter JL, 2013, STEM CELL RES, V11, P1222, DOI 10.1016/j.scr.2013.08.007; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Boch C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002560; Butts Charles A, 2013, Transl Lung Cancer Res, V2, P415, DOI 10.3978/j.issn.2218-6751.2013.10.09; Cho HC, 2011, CANCER RES, V71, P7250, DOI 10.1158/0008-5472.CAN-11-0903; Fagarasan S, 2010, ADV IMMUNOL, V107, P1; Geldof AA, 1989, IN VIVO, V3, P87; Li J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-8; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053817; Ohgino K, 2014, LUNG CANCER, V83, P90, DOI 10.1016/j.lungcan.2013.10.016; Sutherland KM, 2010, J HISTOCHEM CYTOCHEM, V58, P1107, DOI 10.1369/jhc.2010.956052; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Ornitz DM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008318; Yin YJ, 2013, CANCER RES, V73, P5730, DOI 10.1158/0008-5472.CAN-13-0495; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	45	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3417	1096-9896		J PATHOL	J. Pathol.	MAR	2015	235	4					593	605		10.1002/path.4486		13	Oncology; Pathology	Oncology; Pathology	CB5OQ	WOS:000349677700007		
J	Nihei, M; Okazaki, T; Ebihara, S; Kobayashi, M; Niu, KJ; Gui, PJ; Tamai, T; Nukiwa, T; Yamaya, M; Kikuchi, T; Nagatomi, R; Ebihara, T; Ichinose, M				Nihei, Mayumi; Okazaki, Tatsuma; Ebihara, Satoru; Kobayashi, Makoto; Niu, Kaijun; Gui, Peijun; Tamai, Tokiwa; Nukiwa, Toshihiro; Yamaya, Mutsuo; Kikuchi, Toshiaki; Nagatomi, Ryoichi; Ebihara, Takae; Ichinose, Masakazu			Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia	JOURNAL OF PATHOLOGY			English	Article						aspiration pneumonia; lymphangiogenesis; lung; chronic inflammation; blood vessel remodelling	GROWTH-FACTOR PRODUCTION; NURSING-HOME PATIENTS; NF-KAPPA-B; SWALLOWING REFLEX; OLDER-ADULTS; AIRWAY INFLAMMATION; LUNG; ANGIOGENESIS; INTERVENTIONS; LYMPHATICS	Chronic inflammation induces lymphangiogenesis and blood vessel remodelling. Since aged pneumonia patients often have repeated episodes of aspiration pneumonia, the pathogenesis may involve chronic inflammation. For lymphangiogenesis, VEGFR-3 and its ligand VEGF-C are key factors. No previous studies have examined chronic inflammation or vascular changes in aspiration pneumonia or its mouse models. In lung inflammation, little is known about the effect of blocking VEGFR-3 on lung lymphangiogenesis and, moreover, its effect on the disease condition. This study aimed to establish a mouse model of aspiration pneumonia, examine the presence of chronic inflammation and vascular changes in the model and in patients, and evaluate the effect of inhibiting VEGFR-3 on the lymphangiogenesis and disease condition in this model. To induce aspiration pneumonia, we repeated inoculation of pepsin at low pH and LPS into mice for 21-28 days, durations in which bronchioalveolar lavage and plasma leakage in the lung suggested the presence of exaggerated inflammation. Conventional and immunohistochemical analysis of tracheal whole mounts suggested the presence of chronic inflammation, lymphangiogenesis, and blood vessel remodelling in the model. Quantitative RT-PCR of the trachea and lung suggested the involvement of lymphangiogenic factor VEGF-C, VEGFR-3, and pro-inflammatory cytokines. In the lung, the aspiration model showed the presence of chronic inflammation and exaggerated lymphangiogenesis. Treatment with the VEGFR inhibitor axitinib or the VEGFR-3 specific inhibitor SAR131675 impaired lymphangiogenesis in the lung and improved oxygen saturation in the aspiration model. Since the lung is the main site of aspiration pneumonia, the changes were intensive in the lung and mild in the trachea. Human lung samples also showed the presence of chronic inflammation and exaggerated lymphangiogenesis, suggesting the relevance of the model to the disease. These results suggest lymphatics in the lung as a new target of analysis and therapy in aspiration pneumonia. Copyright (c) 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.	[Nihei, Mayumi; Okazaki, Tatsuma; Kobayashi, Makoto; Tamai, Tokiwa; Kikuchi, Toshiaki; Ichinose, Masakazu] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan; [Ebihara, Satoru] Toho Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Niu, Kaijun; Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Hlth & Welf, Sendai, Miyagi 980, Japan; [Gui, Peijun] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 980, Japan; [Nukiwa, Toshihiro] South Miyagi Med Ctr, Sendai, Miyagi, Japan; [Yamaya, Mutsuo] Tohoku Univ, Sch Med, Dept Adv Prevent Med Infect Dis, Sendai, Miyagi 980, Japan; [Ebihara, Takae] Tohoku Univ, Dept Geriatr & Gerontol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Okazaki, T (reprint author), 1-1 Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808574, Japan.	tmokazaki0808@gmail.com			Ministry of Education, Science and Culture of the Japanese Government [23890018, 26461176, 23659375, 24300187, 24659397, 25860633, 23390219]; Novartis Foundation for Gerontological Research	We thank Peter Baluk for experimental advice and Brent Bell for technical advice. This study was supported by a Grant-In-Aid for Scientific Research from the Ministry of Education, Science and Culture of the Japanese Government to TO (Nos 23890018 and 26461176), SE (Nos 23659375, 24300187, and 24659397), MK (No 25860633), and TK (No 23390219), and by a grant from Novartis Foundation for Gerontological Research to TO.	Albert RK, 2008, CLIN RESPIRATORY MED; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Erzurum S, 2010, AM J RESP CRIT CARE, V182, P1554, DOI 10.1164/rccm.201006-0869WS; Downing TE, 2008, EXP BIOL MED, V233, P1202, DOI 10.3181/0801-RM-17; LAUWERYNS JM, 1977, AM REV RESPIR DIS, V115, P625; Cao RH, 2012, P NATL ACAD SCI USA, V109, P15894, DOI 10.1073/pnas.1208324109; EBIHARA T, 1993, LANCET, V341, P432, DOI 10.1016/0140-6736(93)93023-T; Okazaki T, 2001, J IMMUNOL, V167, P1977; Ebihara T, 2005, J AM GERIATR SOC, V53, P824, DOI 10.1111/j.1532-5415.2005.53261.x; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; Yao LC, 2010, AM J PATHOL, V176, P1525, DOI 10.2353/ajpath.2010.090909; Krebs R, 2012, AM J PATHOL, V181, P1607, DOI 10.1016/j.ajpath.2012.07.021; Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0; Yamaya M, 2001, J AM GERIATR SOC, V49, P85, DOI 10.1046/j.1532-5415.2001.49015.x; Baluk P, 2013, AM J PATHOL, V182, P1434, DOI 10.1016/j.ajpath.2012.12.003; Fuxe J, 2010, AM J PATHOL, V176, P2009, DOI 10.2353/ajpath.2010.090976; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Kim KE, 2009, AM J PATHOL, V175, P1733, DOI 10.2353/ajpath.2009.090133; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Appel JZ, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-87; Das S, 2010, CANCER RES, V70, P1814, DOI 10.1158/0008-5472.CAN-09-3675; Ebihara S, 2012, LUNG, V190, P29, DOI 10.1007/s00408-011-9334-z; Ebihara T, 2010, J AM GERIATR SOC, V58, P196, DOI 10.1111/j.1532-5415.2009.02648.x; Ebihara T, 2006, BRIT J CLIN PHARMACO, V62, P369, DOI 10.1111/j.1365-2125.2006.02666.x; Ebihara T, 2004, J AM GERIATR SOC, V52, P1787, DOI 10.1111/j.1532-5415.2004.52479_10.x; El Solh Ali A, 2007, Am J Geriatr Pharmacother, V5, P352, DOI 10.1016/j.amjopharm.2007.12.005; Hasleton PS, 2012, SPENCERS PATHOLOGY L, V1; Kajiya K, 2012, AM J PATHOL, V180, P1273, DOI 10.1016/j.ajpath.2011.11.008; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Loeb MB, 2003, J AM GERIATR SOC, V51, P1018, DOI 10.1046/j.1365-2389.2003.51318.x; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; Ohrui T, 1997, CHEST, V111, P454, DOI 10.1378/chest.111.2.454; Okazaki T, 2005, J IMMUNOL, V174, P7531; Okazaki T, 2009, AM J PATHOL, V174, P2378, DOI 10.2353/ajpath.2009.080942; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Okazaki T, 2007, AM J PATHOL, V171, P1093, DOI 10.2353/ajpath.2007.061191; Sekizawa K, 1998, LANCET, V352, P1069, DOI 10.1016/S0140-6736(05)60114-6; Sozio F, 2012, J ANAT, V220, P396, DOI 10.1111/j.1469-7580.2011.01473.x; Watando A, 2004, CHEST, V126, P1066, DOI 10.1378/chest.126.4.1066	48	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3417	1096-9896		J PATHOL	J. Pathol.	MAR	2015	235	4					632	645		10.1002/path.4473		14	Oncology; Pathology	Oncology; Pathology	CB5OQ	WOS:000349677700010		
J	Yamamoto, A; Takagishi, K; Kobayashi, T; Shitara, H; Ichinose, T; Takasawa, E; Shimoyama, D; Osawa, T				Yamamoto, Atsushi; Takagishi, Kenji; Kobayashi, Tsutomu; Shitara, Hitoshi; Ichinose, Tsuyoshi; Takasawa, Eiji; Shimoyama, Daisuke; Osawa, Toshihisa			The impact of faulty posture on rotator cuff tears with and without symptoms	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Rotator cuff tear; asymptomatic rotator cuff tear; faulty posture; etiology; epidemiology; population-based study	3-DIMENSIONAL SCAPULAR KINEMATICS; SHOULDER IMPINGEMENT; ULTRASONOGRAPHY; INDIVIDUALS; POPULATION; STRENGTH; PEOPLE; TENDON	Hypothesis: We hypothesized that the prevalence of rotator cuff tears would be higher among individuals with poor posture, regardless of the presence of symptoms. Methods: The study initially comprised 525 residents of a mountain village who participated in an annual health check. Participants completed a background questionnaire, and physical examinations were performed to evaluate shoulder function. Ultrasonographic examinations were also performed to identify rotator cuff tears, and participants were grouped according to the presence or absence of tears. Posture was classified by 2 observers into 4 types according to the classification of Kendall, as follows: ideal alignment, kyphotic-lordotic posture, flat-back posture, and sway-back posture. Univariate analyses were performed to compare differences in background characteristics between groups, then multivariate analysis was performed to identify those factors associated with rotator cuff tears. Results: Final analysis was performed for 379 participants (135 men, 244 women; mean age, 62.0 years; range, 31-94 years) showing the same posture classification from both observers. Of these, 93 (24.5%) showed rotator cuff tear in one shoulder and 45 (11.9%) showed tears in both. Prevalence of rotator cuff tears was 2.9% with ideal alignment, 65.8% with kyphotic-lordotic posture, 54.3% with flat-back posture, and 48.9% with sway-back posture. Logistic regression analysis identified increased age, abnormal posture, and past pain as factors associated with rotator cuff tears. Conclusions: Postural abnormality represented an independent predictor of both symptomatic and asymptomatic rotator cuff tears. These results may help define preventive measures for rotator cuff tears and in design ing rehabilitation therapies for shoulder disease. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Yamamoto, Atsushi; Takagishi, Kenji; Shitara, Hitoshi; Ichinose, Tsuyoshi; Takasawa, Eiji; Shimoyama, Daisuke] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma 3718511, Japan; [Kobayashi, Tsutomu] Takasaki Univ Hlth & Welf, Dept Phys Therapy, Takasaki, Gunma, Japan; [Osawa, Toshihisa] Takasaki Gen Med Ctr, Natl Hosp Org, Dept Orthopaed Surg, Takasaki, Gunma, Japan	Yamamoto, A (reprint author), Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	a.yamamoto@gunma-u.ac.jp		Ichinose, Tsuyoshi/0000-0003-2663-5314			Teefey SA, 2000, J BONE JOINT SURG AM, V82A, P498; Smith A, 2008, SPINE, V33, P2101, DOI 10.1097/BRS.0b013e31817ec3b0; Ludewig PM, 2000, PHYS THER, V80, P276; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Sano H, 1997, J ORTHOPAED RES, V15, P719, DOI 10.1002/jor.1100150514; Endo K, 2004, CLIN BIOMECH, V19, P1009, DOI 10.1016/j.clinbiomech.2004.07.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MIDDLETON WD, 1986, J BONE JOINT SURG AM, V68A, P440; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Lin JJ, 2005, J ELECTROMYOGR KINES, V15, P576, DOI 10.1016/j.jelekin.2005.01.006; Takagishi K, 1996, SKELETAL RADIOL, V25, P221; McClure PW, 2006, PHYS THER, V86, P1075; Fedorak C, 2003, SPINE, V28, P1857, DOI 10.1097/01.BRS.0000083281.48923.BD; Kebaetse M, 1999, ARCH PHYS MED REHAB, V80, P945, DOI 10.1016/S0003-9993(99)90088-6; Michener LA, 2003, CLIN BIOMECH, V18, P369, DOI 10.1016/S0268-0033(03)00047-0; Ludewig PM, 2009, J ORTHOP SPORT PHYS, V39, P90, DOI 10.2519/jospt.2009.2808; Yamamoto A, 2011, J SHOULDER ELB SURG, V20, P1133, DOI 10.1016/j.jse.2011.01.011; BRAUN BL, 1989, ARCH PHYS MED REHAB, V70, P322; Yamamoto Atsushi, 2010, J Shoulder Elbow Surg, V19, P116, DOI 10.1016/j.jse.2009.04.006; Soslowsky LJ, 2002, ANN BIOMED ENG, V30, P1057, DOI 10.1114/1.1509765; Laudner KG, 2006, J ORTHOP SPORT PHYS, V36, P485; BRYAN J M, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P24; Cohen J., 1988, STAT POWER ANAL BEHA; Crawford Helen J., 1993, Physiotherapy Theory and Practice, V9, P143, DOI 10.3109/09593989309047453; GREENFIELD B, 1995, J ORTHOP SPORT PHYS, V21, P287; Hislop H.J., 1995, DANIELS WORTHINGHAMS; Kendall F. P., 2005, MUSCLES TESTING FUNC; Kibler W Ben, 2013, Br J Sports Med, V47, P877, DOI 10.1136/bjsports-2013-092425; LIPPITT SB, 1993, SHOULDER : A BALANCE OF MOBILITY AND STABILITY, P501; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Reichert B, 2010, PALPATION TECHNIQUES; Zuckerman J D, 1992, J Shoulder Elbow Surg, V1, P4, DOI 10.1016/S1058-2746(09)80010-4	32	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAR	2015	24	3					446	452		10.1016/j.jse.2014.07.012		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CB6SR	WOS:000349757500020		
J	Funayama, M; Ohe, K; Amo, T; Furuya, N; Yamaguchi, J; Saiki, S; Li, Y; Ogaki, K; Ando, M; Yoshino, H; Tomiyama, H; Nishioka, K; Hasegawa, K; Saiki, H; Satake, W; Mogushi, K; Sasaki, R; Kokubo, Y; Kuzuhara, S; Toda, T; Mizuno, Y; Uchiyama, Y; Ohno, K; Hattori, N				Funayama, Manabu; Ohe, Kenji; Amo, Taku; Furuya, Norihiko; Yamaguchi, Junji; Saiki, Shinji; Li, Yuanzhe; Ogaki, Kotaro; Ando, Maya; Yoshino, Hiroyo; Tomiyama, Hiroyuki; Nishioka, Kenya; Hasegawa, Kazuko; Saiki, Hidemoto; Satake, Wataru; Mogushi, Kaoru; Sasaki, Ryogen; Kokubo, Yasumasa; Kuzuhara, Shigeki; Toda, Tatsushi; Mizuno, Yoshikuni; Uchiyama, Yasuo; Ohno, Kinji; Hattori, Nobutaka			CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study	LANCET NEUROLOGY			English	Article							ESSENTIAL TREMOR; GENE; NEURODEGENERATION; ALGORITHM; UBIQUITIN; VARIANTS; PREDICT; FAMILY	Background Identification of causative genes in mendelian forms of Parkinson's disease is valuable for understanding the cause of the disease. We did genetic studies in a Japanese family with autosomal dominant Parkinson's disease to identify novel causative genes. Methods We did a genome-wide linkage analysis on eight affected and five unaffected individuals from a family with autosomal dominant Parkinson's disease (family A). Subsequently, we did exome sequencing on three patients and whole-genome sequencing on one patient in family A. Variants were validated by Sanger sequencing in samples from patients with autosomal dominant Parkinson's disease, patients with sporadic Parkinson's disease, and controls. Participants were identified from the DNA bank of the Comprehensive Genetic Study on Parkinson's Disease and Related Disorders (Juntendo University School of Medicine, Tokyo, Japan) and were classified according to clinical information obtained by neurologists. Splicing abnormalities of CHCHD2 mutants were analysed in SH-SY5Y cells. We used the Fisher's exact test to calculate the significance of allele frequencies between patients with sporadic Parkinson's disease and unaffected controls, and we calculated odds ratios and 95% CIs of minor alleles. Findings We identified a missense mutation (CHCHD2, 182C>T, Thr61Ile) in family A by next-generation sequencing. We obtained samples from a further 340 index patients with autosomal dominant Parkinson's disease, 517 patients with sporadic Parkinson's disease, and 559 controls. Three CHCHD2 mutations in four of 341 index cases from independent families with autosomal dominant Parkinson's disease were detected by CHCHD2 mutation screening: 182C>T (Thr61Ile), 434G>A (Arg145Gln), and 300+5G>A. Two single nudeotide variants (-9T>G and 5C>T) in CHCHD2 were confirmed to have different frequencies between sporadic Parkinson's disease and controls, with odds ratios of 2.51 (95% CI 1.48-4.24; p=0.0004) and 4.69 (1.59-13.83, p=0.0025), respectively. One single nucleotide polymorphism (rs816411) was found in CHCHD2 from a previously reported genome-wide association study; however, there was no significant difference in its frequency between patients with Parkinson's disease and controls in a previously reported genome-wide association study (odds ratio 1-17,95% CI 0.96-1.19; p=0.22). In SH-SY5Y cells, the 300+5G>A mutation but not the other two mutations caused exon 2 skipping. Interpretation CHCHD2 mutations are associated with, and might be a cause of, autosomal dominant Parkinson's disease. Further genetic studies in other populations are needed to confirm the pathogenicity of CHCHD2 mutations in autosomal dominant Parkinson's disease and susceptibility for sporadic Parkinson's disease, and further functional studies are needed to understand how mutant CHCHD2 might play a part in the pathophysiology of Parkinson's disease.	[Funayama, Manabu; Yoshino, Hiroyo; Uchiyama, Yasuo; Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo 1138421, Japan; [Furuya, Norihiko] Juntendo Univ, Grad Sch Med, Dept Res & Therapeut Movement Disorders, Tokyo 1138421, Japan; [Ohe, Kenji; Ohno, Kinji] Nagoya Univ, Ctr Neurol Dis & Canc, Grad Sch Med, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Ohe, Kenji] Kyoto Univ, Training Program Leaders Integrated Med Syst Frui, Grad Sch Med, Kyoto, Japan; [Amo, Taku] Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa 239, Japan; [Yamaguchi, Junji; Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cellular & Mol Neuropathol, Tokyo 1138421, Japan; [Funayama, Manabu; Furuya, Norihiko; Saiki, Shinji; Li, Yuanzhe; Ogaki, Kotaro; Ando, Maya; Tomiyama, Hiroyuki; Nishioka, Kenya; Mizuno, Yoshikuni; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138421, Japan; [Mogushi, Kaoru] Juntendo Univ, Sch Med, Ctr Genom & Regenerat Med, Tokyo 1138421, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Natl Hosp Org, Dept Neurol, Sagamihara, Kanagawa, Japan; [Saiki, Hidemoto] Tazuke Kofukai Med Res Inst, Dept Neurol, Osaka, Japan; [Saiki, Hidemoto] Kitano Hosp, Osaka, Japan; [Satake, Wataru; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol & Mol Brain Sci, Kobe, Hyogo 657, Japan; [Sasaki, Ryogen] Mie Univ, Dept Neurol, Grad Sch Med, Tsu, Mie 514, Japan; [Kokubo, Yasumasa] Mie Univ, Grad Sch Reg Innovat Studies, Kii ALS PDC Res Ctr, Tsu, Mie 514, Japan; [Kuzuhara, Shigeki] Suzuka Univ Med Sci, Sch Nursing, Dept Neurol & Med, Suzuka, Japan	Hattori, N (reprint author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nhattori@juntendo.ac.jp	Furuya, Norihiko/K-7299-2015; Funayama, Manabu/E-6485-2013	Furuya, Norihiko/0000-0001-7695-4271; 	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science [25461291, 24591920, 24500868, 25305030, 24390221, 24390224]; Japanese Ministry of Health, Labour and Welfare [H24-Nanchitou-Nan-Ippan-058, H26-Nanchitou-Nan-Ippan-085, H23-Jitsuyouka-Nanbyou-Ippan-015, H26-Itaku-Nan-Ippan-037, H26-Itaku-Nan-Ippan-024]; Life Science Foundation; Takeda Scientific Foundation; Cell Science Research Foundation; Nakajima Foundation;  [25129707];  [25111007];  [25110720];  [22129006];  [23111004];  [25118508];  [23111003];  [24790903];  [25860725];  [23689046];  [25860726];  [25713015];  [26870175];  [24659435];  [25670420];  [25670099];  [25670164]	We thank Yoko Imamichi for her assistance. We received a Grant-in-Aid for Scientific Research on Innovative Areas (25129707 to MF, 25111007 to SS, 25110720 to WS, 22129006 to TT, 23111004 to YU, 25118508 to KOhn, and 23111003 to NH), and a Grant-in-Aid for the Program for the Strategic Research Foundation at Private Universities from the Japanese Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid for Young Scientists (24790903 to TA, 25860725 to YL, 23689046 to SS, 25860726 to KN, 25713015 to WS, and, 26870175 to KM); a Grant-in-Aid for Challenging Exploratory Research (24659435 to SS, 25670420 to WS, 25670099 to YU and 25670164 to KOhn); a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25461291 to MF, 24591920 to KOhe, 24500868 to NF, 25305030 to YK, 24390221 to KOhn, and 24390224 to NH); a Grant-in-Aid for Health Labour Sciences Research Grant (H24-Nanchitou-Nan-Ippan-058 to YK, H26-Nanchitou-Nan-Ippan-085 to YK, TT, and NH; H23-Jitsuyouka-Nanbyou-Ippan-015 to TT; H26-Itaku-Nan-Ippan-037 to IT and NH; and H26-Itaku-Nan-Ippan-024 to KOhn) from the Japanese Ministry of Health, Labour and Welfare; and grants from the Life Science Foundation, the Takeda Scientific Foundation, the Cell Science Research Foundation, and the Nakajima Foundation (SS).	Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Fekete R, 2011, MOVEMENT DISORD, V26, P391, DOI 10.1002/mds.23512; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Aras S, 2015, MITOCHONDRION, V20, P43, DOI 10.1016/j.mito.2014.10.003; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fukuda Y, SNP HITLINK HIGH THR; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Liu Y, 2014, CELL DEATH DIFFER, DOI [10.1038/cdd.2014.194, DOI 10.1038/CDD.2014.194]; Masuda A, 2008, HUM MOL GENET, V17, P4022, DOI 10.1093/hmg/ddn305; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Ohe K, 2010, MOL CELL BIOL, V30, P2220, DOI 10.1128/MCB.00114-10; Puschmann A, 2011, NEUROLOGY, V76, P1623, DOI 10.1212/WNL.0b013e318219fb42; Sahashi K, 2007, NUCLEIC ACIDS RES, V35, P5995, DOI 10.1093/nar/gkm647; Shino MY, 2010, MOVEMENT DISORD, V25, P2587, DOI 10.1002/mds.23361	32	14	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2015	14	3					274	282		10.1016/S1474-4422(14)70266-2		9	Clinical Neurology	Neurosciences & Neurology	CB4JM	WOS:000349594000010		
J	Sato, M; Kamada, Y; Takeda, Y; Kida, S; Ohara, Y; Fujii, H; Akita, M; Mizutani, K; Yoshida, Y; Yamada, M; Hougaku, H; Takehara, T; Miyoshi, E				Sato, Motoya; Kamada, Yoshihiro; Takeda, Yuri; Kida, Sachiho; Ohara, Yuka; Fujii, Hironobu; Akita, Maaya; Mizutani, Kayo; Yoshida, Yuichi; Yamada, Makoto; Hougaku, Hidetaka; Takehara, Tetsuo; Miyoshi, Eiji			Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects	LIVER INTERNATIONAL			English	Article						BAMBI; IMT; NASH; NAFLD; TGF-1	CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; TGF-BETA; CARDIOVASCULAR-DISEASE; HEPATIC-FIBROSIS; NATURAL-HISTORY; CYTOKINE ANTAGONIST; METABOLIC SYNDROME; DIABETES-MELLITUS; NAFLD	Background & AimsFetuin-A (2HS-glycoprotein), a liver secretory glycoprotein, is known as a transforming growth factor (TGF)-1 signalling inhibitor. Serum fetuin-A concentration is associated with nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. However, the usefulness of serum fetuin-A as a predictive fibrosis biomarker in NAFLD patients remains unclear. In this study, we investigated the relationship between circulating fetuin-A levels and fibrosis-related markers [platelet count, NAFLD fibrosis score and carotid intima media thickness (IMT)] in subjects with NAFLD. MethodsA total of 295 subjects (male, 164; female, 131) who received medical health check-ups were enrolled in this study. NAFLD was diagnosed using abdominal ultrasonography. Serum fetuin-A was measured by ELISA. IMT was assessed using a high-resolution ultrasound scanner. Using recombinant human fetuin-A, we investigated the effects of fetuin-A on hepatic stellate cells, which play a pivotal role in the process of hepatic fibrosis. ResultsSerum fetuin-A concentration was significantly correlated with platelet count (R=0.19, P<0.01), NAFLD fibrosis score (R=-0.25, P<0.01) and mean IMT (R=-0.22, P<0.01). Multivariate analyses revealed that the fetuin-A concentration is a significant and independent determinant of platelet count, NAFLD fibrosis score and mean IMT. Recombinant fetuin-A suppressed TGF-1 signalling and fibrosis-related gene expression and increased the expression of TGF-1 pseudoreceptor bone morphogenic protein and activin membrane-bound inhibitor (BAMBI). ConclusionsSerum fetuin-A level is associated with liver/vessel fibrosis-related markers in NAFLD patients. Circulating fetuin-A could be a useful serum biomarker for predicting liver and vascular fibrosis progression in NAFLD patients.	[Sato, Motoya; Kamada, Yoshihiro; Takeda, Yuri; Kida, Sachiho; Ohara, Yuka; Fujii, Hironobu; Akita, Maaya; Mizutani, Kayo; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan; [Kamada, Yoshihiro; Yoshida, Yuichi; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Yamada, Makoto] aMs New Otani Clin, Osaka, Japan; [Hougaku, Hidetaka] Nara Inst Sci & Technol, Nara 6300101, Japan	Miyoshi, E (reprint author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [21249038, 24590972]; Global COE Program of Osaka University - Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported by Grants-in-Aid for Scientific Research (A), No. 21249038, and (C), No. 24590972, from the Japan Society for the Promotion of Science and by the Global COE Program of Osaka University, funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Salvi P, 2010, J HYPERTENS, V28, P1699, DOI 10.1097/HJH.0b013e32833a7de6; Demetriou M, 1996, J BIOL CHEM, V271, P12755; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Aminbakhsh A, 1999, CLIN INVEST MED, V22, P149; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Kamada Y, 2008, J GASTROENTEROL, V43, P811, DOI 10.1007/s00535-008-2213-6; BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1016/0270-9139(95)90530-8; Kamada Y, 2012, GLYCOBIOLOGY, V22, P778, DOI 10.1093/glycob/cws012; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Oni ET, 2013, ATHEROSCLEROSIS, V230, P258, DOI 10.1016/j.atherosclerosis.2013.07.052; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Toma I, 2012, CELL TISSUE RES, V347, P155, DOI 10.1007/s00441-011-1189-3; Udell JA, 2012, JAMA-J AM MED ASSOC, V307, P832, DOI 10.1001/jama.2012.186; Sookoian S, 2008, J HEPATOL, V49, P600, DOI 10.1016/j.jhep.2008.06.012; Kamada Y, 2013, CLIN CHIM ACTA, V417, P48, DOI 10.1016/j.cca.2012.12.014; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1053/S1542-3565(04)00440-9; Lonardo A, 2013, CURR PHARM DESIGN, V19, P5177; Gressner AM, 2002, FRONT BIOSCI, V7, pD793, DOI 10.2741/gressner; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Ballestri S, 2013, METAB SYNDR RELAT D, V11, P289, DOI 10.1089/met.2012.0149; COZZOLINO G, 1983, AM J GASTROENTEROL, V78, P442; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Guillory B, 2010, AM J PATHOL, V177, P2635, DOI 10.2353/ajpath.2010.100177; Hamano M, 2013, HEPATOL RES, V43, P238, DOI 10.1111/j.1872-034X.2012.01066.x; Hirata A, 2011, ATHEROSCLEROSIS, V219, P623, DOI 10.1016/j.atherosclerosis.2011.08.043; Kahraman A, 2013, CLIN SCI, V125, P391, DOI 10.1042/CS20120542; Kamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066328; Kuwamoto K, 2010, MOL MED REP, V3, P651, DOI 10.3892/mmr_00000311; Merx MW, 2005, J AM SOC NEPHROL, V16, P3357, DOI 10.1681/ASN.2005040365; Milicevic Z, 2008, DIABETES CARE, V31, pS155, DOI 10.2337/dc08-s240; Nakahara T, 2014, J GASTROENTEROL, V49, P1477, DOI 10.1007/s00535-013-0911-1; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062561; Rittenberg B, 2005, J ORTHOP RES, V23, P653, DOI 10.1016/j.orthres.2004.11.010; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Verma-Gandhu M, 2007, EUR J PHARMACOL, V572, P220, DOI 10.1016/j.ejphar.2007.06.039	57	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	MAR	2015	35	3					925	935		10.1111/liv.12478		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB7BU	WOS:000349781900026		
J	Sasaki, M; Sato, H; Kakuda, Y; Sato, Y; Choi, JH; Nakanuma, Y				Sasaki, Motoko; Sato, Hirohide; Kakuda, Yuko; Sato, Yasunori; Choi, Joon Hyuk; Nakanuma, Yasuni			Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma	LIVER INTERNATIONAL			English	Article						cholangiolocellular carcinoma; classical type; combined hepatocellular and cholangiocarcinoma; subtypes with stem-cell features	INTRAHEPATIC CHOLANGIOCARCINOMA; CHOLANGIOLOCELLULAR CARCINOMA; CIRRHOSIS; LIVER; PHENOTYPE	Backgrounds & AimsCombined hepatocellular-cholangiocarcinoma (cHC-CC), a malignant liver tumour with poor prognosis, is composed of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC) and diverse components with intermediate features between HCC and CC, which correspond to hepatic progenitor cells. According to the WHO classification 2010, we surveyed the prevalence and clinicopathological significance of each subtype with stem-cell features [SC subtype; typical subtype (TS), intermediate cell subtype (INT) and cholangiolocellular type (CLC)] in cHC-CC and HCC. MethodsSixty-two patients with cHC-CC (19 women and 43 men) and 26 patients with HCC (all men) were examined. The prevalence of each component was histologically assessed with assistance of mucin and immunohistochemical stainings. ResultsSC subtypes were observed in all cHC-CCs in various amount and combination. The prevalence of each SC subtype in cHC-CC was as follows: TS, 10 (16.1%); INT, 53 (83.9%) and CLC, 44 (71.0%). The proportion of INT was significantly correlated with gender (female-dominant) (P<0.05), tumour size (P<0.05), histological grading of HCC (P<0.01) and inversely correlated with the degree of stromal fibrosis (P<0.05). The proportion of CLC was significantly correlated with the degree of fibrosis (P<0.01) and inflammation (P<0.01), and inversely correlated with tumour size (P<0.01) and histological grading of HCC (P<0.05). The proportion of TS was significantly inversely correlated with the degree of inflammation (P<0.01). Histological diversity score was significantly correlated with vascular invasion and the positivity for -foetoprotein. ConclusionThe proportion of each SC subtype was significantly associated with certain clinicopathological factors, suggesting different properties of each SC subtypes.	[Sasaki, Motoko; Sato, Hirohide; Kakuda, Yuko; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan; [Choi, Joon Hyuk] Yeungnam Univ, Dept Pathol, Coll Med, Daegu City, South Korea; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka, Japan	Nakanuma, Y (reprint author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.	nakanuma@staff.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports and Science and Technology of Japan [24590409]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports and Science and Technology of Japan (24590409).	Aishima S, 2007, AM J SURG PATHOL, V31, P783, DOI 10.1097/01.pas.0000213421.53750.0a; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Xu J, 2012, LIVER INT, V32, P1156, DOI 10.1111/j.1478-3231.2012.02783.x; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Kobayashi M, 2000, CANCER, V88, P2471, DOI 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T; Koh KC, 2005, AM J SURG, V189, P120, DOI 10.1016/j.amjsurg.2004.03.018; Akiba J, 2013, AM J SURG PATHOL, V37, P496, DOI 10.1097/PAS.0b013e31827332b0; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; STEINER PE, 1959, CANCER, V12, P753, DOI 10.1002/1097-0142(195907/08)12:4<753::AID-CNCR2820120420>3.0.CO;2-L; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; HEPPNER GH, 1983, CANCER METAST REV, V2, P5, DOI 10.1007/BF00046903; Kim H, 2004, J HEPATOL, V40, P298, DOI 10.1016/j.jhep.2003.10.023; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Kozaka K, 2007, HISTOPATHOLOGY, V51, P390, DOI 10.1111/j.1365-2559.2007.02735.x; Sasaki M, 2003, HUM PATHOL, V34, P1337, DOI 10.1016/j.humpath.2003.07.012; Sasaki M, 1998, AM J CLIN PATHOL, V109, P302; Tanaka K., 1990, HEPATOLOGY, V12, P1420; Theise ND, 2010, WHO CLASSIFICATION T, P225; Xu J, 2011, HISTOPATHOLOGY, V59, P1090, DOI 10.1111/j.1365-2559.2011.04058.x	21	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	MAR	2015	35	3					1024	1035		10.1111/liv.12563		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB7BU	WOS:000349781900035		
J	Kohjima, M; Enjoji, M; Yada, R; Yoshimoto, T; Nakamura, T; Fukuizumi, K; Fukushima, N; Murata, Y; Nakashima, M; Kato, M; Kotoh, K; Shirabe, K; Maehara, Y; Nakajima, A; Nozaki, Y; Honda, A; Matsuzaki, Y; Nakamuta, M				Kohjima, Motoyuki; Enjoji, Munechika; Yada, Ryoko; Yoshimoto, Tsuyoshi; Nakamura, Tsukasa; Fukuizumi, Kunitaka; Fukushima, Nobuyoshi; Murata, Yusuke; Nakashima, Manabu; Kato, Masaki; Kotoh, Kazuhiro; Shirabe, Ken; Maehara, Yoshihiko; Nakajima, Atsushi; Nozaki, Yuichi; Honda, Akira; Matsuzaki, Yasushi; Nakamuta, Makoto			Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism	LIVER INTERNATIONAL			English	Article						cholesterol; choline; MDR3; OCT1; phospholipids; primary biliary cirrhosis	SINGLE-NUCLEOTIDE POLYMORPHISM; HEPATOBILIARY TRANSPORTER EXPRESSION; ORGANIC CATION TRANSPORTERS; JAPANESE PATIENTS; CLINICAL PROGRESSION; BEZAFIBRATE; LIVER; OCT1; CHOLESTASIS; ALPHA	Background & AimsInjury to biliary epithelial cells caused by disorders in bile composition may be the initial step in the pathogenesis of primary biliary cirrhosis (PBC). We therefore examined choline/phospholipid metabolism in livers of patients with PBC. MethodsHepatic levels of mRNA encoded by choline metabolism-related genes in early stage PBC patients were quantified by real-time RT-PCR. Serum cholesterol and triglyceride concentrations in each lipoprotein compartment and serum/tissue choline levels were also measured. OCT1 expression was quantified by genotype (rs683369 and rs622342). ResultsSerum choline concentrations were significantly higher in PBC patients than in normal individuals, with the concentrations in the former lowered by treatment with fibrates. Hepatic choline levels were markedly lower in PBC patients than in controls. The levels of expression of genes associated with choline uptake (OCT1 and CTL1), phosphatidylcholine synthesis (PEMT and BHMT), and phosphatidylcholine transport (MDR3) were significantly upregulated in PBC compared with control livers. Serum cholesterol concentrations and the cholesterol/triglyceride ratio in serum very low density lipoprotein were markedly higher in PBC patients than in controls. In PBC liver, OCT1 protein levels were lower in patients with minor (CG/GG at rs683369 and/or CC at rs622342) than major (CC at rs683369 and AA at rs622342) genotypes of the OCT1 gene. ConclusionDuring early stage PBC, hepatocellular choline uptake and PC synthesis become dysregulated. OCT1 genotypes may influence the pathogenesis of PBC.	[Kohjima, Motoyuki; Yoshimoto, Tsuyoshi; Nakamura, Tsukasa; Fukuizumi, Kunitaka; Fukushima, Nobuyoshi; Nakamuta, Makoto] Natl Hosp Org, Kyushu Med Ctr, Dept Gastroenterol, Fukuoka, Japan; [Enjoji, Munechika; Yada, Ryoko; Nakamuta, Makoto] Natl Hosp Org, Clin Res Ctr, Kyushu Med Ctr, Fukuoka, Japan; [Enjoji, Munechika; Murata, Yusuke; Nakashima, Manabu] Fukuoka Univ, Hlth Care Ctr, Fukuoka 8140180, Japan; [Kato, Masaki; Kotoh, Kazuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Nakajima, Atsushi; Nozaki, Yuichi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan; [Honda, Akira; Matsuzaki, Yasushi] Tokyo Med Univ, Dept Gastroenterol, Ibaraki Med Ctr, Ibaraki, Japan	Enjoji, M (reprint author), Fukuoka Univ, Hlth Care Ctr, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	enjoji@adm.fukuoka-u.ac.jp			Research Program of Intractable Disease by the Ministry of Health, Labour, and Welfare of Japan; National Hospital Organization of Japan	Financial support: This research was supported in part by the Research Program of Intractable Disease provided by the Ministry of Health, Labour, and Welfare of Japan and a Grant-in-Aid for Clinical Research from the National Hospital Organization of Japan.	Nakamuta M, 2010, INT J CLIN PHARM TH, V48, P22; Nie WX, 2005, AM J PHYSIOL-GASTR L, V288, pG207, DOI 10.1152/ajpgi.00057.2004; Kanda T, 2003, J GASTROENTEROL, V38, P573, DOI 10.1007/s00535-002-1102-7; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; Shoda J, 2007, HEPATOL RES, V37, P548, DOI 10.1111/j.1872-034X.2007.00069.x; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646; Becker ML, 2010, PHARMACOGENET GENOM, V20, P38, DOI 10.1097/FPC.0b013e328333bb11; Matsumoto T, 2004, HEPATOL RES, V30, P125, DOI 10.1016/j.hepres.2004.08.015; MITCHISON HC, 1989, HEPATOLOGY, V10, P420, DOI 10.1002/hep.1840100405; Ritzel U, 2002, J HEPATOL, V36, P454, DOI 10.1016/S0168-8278(02)00006-5; Michel V, 2006, EXP BIOL MED, V231, P490; Shoda J, 2004, J LIPID RES, V45, P1813, DOI 10.1194/jlr.M400132-JLR200; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; Chinale J, 1996, BIOCHEM J, V314, P781; Enjoji M, 2009, HEPATOL INT, V3, P490, DOI 10.1007/s12072-009-9137-y; Jansen PLM, 2003, LIVER INT, V23, P315, DOI 10.1034/j.1478-3231.2003.00856.x; KAMISAKO T, 1995, AM J GASTROENTEROL, V90, P1187; Kohjima M, 2012, HEPATOLOGY, V56, p1128A; KURIHARA T, 1993, CLIN THER, V15, P890; Luci S, 2006, BIOCHEM BIOPH RES CO, V350, P704, DOI 10.1016/j.bbrc.2006.09.099; Nagasaka H, 2005, J PEDIATR-US, V146, P329, DOI 10.1016/j.jpeds.2004.10.047; Nakamuta M, 2004, CASE REP CLIN PRACT, V5, P537; Ohishi Y, 2008, HEPATOLOGY, V48, P853, DOI 10.1002/hep.22382; Ohishi Y, 2011, HEPATOLOGY, V54, p1199A; Ohishi Y, 2014, J GASTROENTEROL, V49, P332, DOI 10.1007/s00535-013-0795-0; Oude Elfrrink RPJ, 2007, EUR J PHYSL, V453, P601; Pauli-Magnus C, 2004, HEPATOLOGY, V39, P779, DOI 10.1002/hep.20159; Sinclair CJ, 2000, J LIPID RES, V41, P1841; Stanca CM, 2008, DIGEST DIS SCI, V53, P1988, DOI 10.1007/s10620-007-0003-2; VansErpecum KJ, 2005, BIOL CELL, V97, P815	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	MAR	2015	35	3					1095	1102		10.1111/liv.12526		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB7BU	WOS:000349781900042		
J	Sakai, K; Turkay, M; Beuck, L; Freiwald, A				Sakai, K.; Tuerkay, M.; Beuck, L.; Freiwald, A.			A collection of the Infraorder Callianassidea (Decapoda, Pleocyemata) with one new genus and five new species from the Eastern Atlantic off Mauritania (R/V Maria S. Merian cruise MSM 16/3 "PHAETON")	MARINE BIODIVERSITY			English	Article						Mauritanian shelf; Taxa, Callianassidea; Axioidea; Callianassoidea; gen. & spp nov.: Gilvossius arguinensis sp nov.: Neocallichirus timiris sp nov.; Neocallianopsis africana sp nov.; Phaetoncalliax gen. nov.: Phaetoncalliax mauritana sp nov.; Paracalliax stenophthalmus sp nov.	DE-SAINT-LAURENT; THALASSINIDEA CRUSTACEA; TIMIRIS CANYON; CTENOCHELIDAE; SYSTEMATICS; LATREILLE; OFFSHORE; GENERA; DANA	A collection of Callianassidea (Decapoda, Pleocyemata), sampled during the R/V Maria S. Merian MSM 16/3 "PHAETON"-cruise offshore Mauritania in 2010, has been examined with respect to the new taxa of Callianassidea established by Sakai & Turkay (Crustaceana 87(2): 129-211, 2014). The collection has been deposited in the Senckenberg Research Institute and Natural History Museum, Frankfurt am Main and comprises specimens belonging to the Infraorder Callianassidea: two superfamilies, Axioidea and Callianassoidea; four families, seven genera including one new genus; and seven species including five spp. nov. are described.	[Sakai, K.] Shikoku Univ, Tokushima 7711192, Japan; [Tuerkay, M.] Senckenberg Forschungsinst & Naturmuseum, D-60325 Frankfurt, Germany; [Beuck, L.; Freiwald, A.] Senckenberg Meer, D-26382 Wilhelmshaven, Germany	Sakai, K (reprint author), Shikoku Univ, Tokushima 7711192, Japan.	ksakai@mf.pikara.ne.jp; michael.tuerkay@senckenberg.de; lydia.beuck@senckenberg.de; andre.freiwald@senckenberg.de		Freiwald, Andre/0000-0002-2335-4042	EU-FP7 Project CoralFISH [213144]; EU-FP7 Project HERMIONE [226354]; Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany	We express our sincere thanks to the captain and his crew of MSM 16/3 on R/V Maria S. Merian. Our thanks include the chief scientist, Hildegard Westphal from the Leibniz Center of Marine Tropical Ecology, Bremen, for the cruise organization and fruitful discussions. Achim Wehrmann from Senckenberg am Meer, Wilhelmshaven is thanked for the loan of the Leica microscope and camera. AF and LB received funds from the EU-FP7 Projects CoralFISH (contract no. 213144), HERMIONE (contract no. 226354) and the Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany.	Alcock A, 1896, ILLUSTRATIONS ZOOL 4; Santos AMP, 2005, J MAR RES, V63, P359, DOI 10.1357/0022240053693671; Antobreh AA, 2006, MAR PETROL GEOL, V23, P37, DOI 10.1016/j.marpetgeo.2005.06.003; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Henrich R, 2010, MAR GEOL, V275, P178, DOI 10.1016/j.margeo.2010.05.011; LELOEUFF P, 1974, CAH ORSTOM OCEANOGR, V12, P17; Ngoc-Ho N, 2003, ZOOSYSTEMA, V25, P439; MANNING RB, 1991, P BIOL SOC WASH, V104, P764; Tudge CC, 2000, J CRUSTACEAN BIOL, V20, P129; Sakai K, 2012, CRUSTACEANA, V85, P723, DOI 10.1163/156854012X643735; WOOSTER WS, 1976, J MAR RES, V34, P131; Sakai K, 2014, CRUSTACEANA, V87, P129, DOI 10.1163/15685403-00003281; BARNARD K. H., 1950, ANN S AFRICAN MUS, V38, P1; Bell T, 1853, HIST BRIT STALK EUR, P289; Bell T, 1853, HIST BRIT STALK EYED, P49; Bell T, 1853, HIST BIRT STALK EUR, P241; Bell T, 1853, HIST BRIT STALK EUED, P337; Bell T, 1846, HIST BRIT STALK EYED, pi; Bell T, 1853, HIST BRIT STALK EYED, P97; Bell T, 1853, HIST BRIT STALK EYED, P193; Bell T, 1853, HIST BRIT STALK EYED, P145; Bell T, 1853, HIST BRIT STALK EYED, P1; d'AcozCd' Udekem, 1999, PATRIOMONIES NATUREL, V40, P1; de Saint Laurent M., 1979, Annales de l'Institut Oceanographique, V55, P29; Hanebuth TJJ, 2013, GEOMORPHOLOGY; Hopkins CS, 1997, J CRUSTACEAN BIOL, V17, P236, DOI 10.2307/1549274; HUXLEY T. H., 1879, P ZOOL SOC LOND, V1878, P752; KENSLEY B, 1974, Annals of the South African Museum, V62, P265; Kirk TW, 1879, T P NZ I, V11, P401; KISHINOUYE KAMAKICHI, 1926, ANNOTATIONES ZOOL JAPONENSES, V11, P63; Komai Tomoyuki, 2008, Natural History Research, V10, P19; LEACH W. E., 1814, EDINBURGH ENCY, V7, P385; Lin FJ, 2007, CRUSTACEANA, V80, P1193, DOI 10.1163/156854007782321191; Man J.G. de, 1928, SIBOGA EXPEDITIE MON, V39, P1; Manning R.B., 1992, B MAR SCI, V49, P558; Michel J, 2011, J SEDIMENT RES, V81, P641, DOI 10.2110/jsr.2011.53; Montagu G, 1808, T LINN SOC LOND, V9, P18; Ngoc-Ho N, 2002, CRUSTACEANA, V75, P539, DOI 10.1163/156854002760095589; Nobili G., 1904, B MUSEUM HIST NATURE, V10, P228; Ortmann AE, 1891, LORICATA THALASSINID, V6, P1; Poore Gary C. B., 1994, Memoirs of the Museum of Victoria, V54, P79; Rathbun M. J., 1902, P US NATIONAL MUSEUM, V24, P885, DOI DOI 10.5479/SI.00963801.1272.885; Rossignol M, 1962, OCEANOGR, V2, P139; de Saint-Laurent M., 1979, COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DES SCIENCES SERIE D SCIENCES NATURELLES, V288, P1395; DESAINTL.M, 1973, CR ACAD SCI D NAT, V277, P513; Sakai K, 1988, RECORDS NO TERRITORY, V5, P51; SAKAI K., 2005, CRUSTACEANA, V77, P1117; Sakai K, 2006, CRUSTACEANA, V79, P1275, DOI 10.1163/156854006778859515; Sakai K., 2011, CRUSTACEANA MONOGRAP, V13, P1; Sakai K., 2005, CRUSTACEANA MONOGRAP, V4, P1; Sakai K., 1999, Zoologische Verhandelingen (Leiden), V326, P1; SAKAI K., 2006, CRUSTACEANA, V78, P1353; Stebbing TRR, 1902, S AFRICAN CRUSTACE 2, V2, p[1, 5]; Westphal H, 2010, INT J EARTH SCI, V99, pS153, DOI 10.1007/s00531-010-0563-9; Westphal HL, 2012, 153 MAR S, VMSM16/3, P1	55	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1867-1616	1867-1624		MAR BIODIVERS	Mar. Biodivers.	MAR	2015	45	1					113	133		10.1007/s12526-014-0227-2		21	Biodiversity Conservation; Marine & Freshwater Biology	Biodiversity & Conservation; Marine & Freshwater Biology	CB3UY	WOS:000349555800008		
J	Harima, T; Watanabe, J				Harima, Tadahito; Watanabe, Junzo			Completely m-full ideals and componentwise linear ideals	MATHEMATICAL PROCEEDINGS OF THE CAMBRIDGE PHILOSOPHICAL SOCIETY			English	Article							INITIAL IDEALS	We show that the class of completely m-full ideals coincides with the class of componentwise linear ideals in a polynomial ring over an infinite field.	[Harima, Tadahito] Niigata Univ, Dept Math Educ, Niigata 9502181, Japan; [Watanabe, Junzo] Tokai Univ, Dept Math, Hiratsuka, Kanagawa 2591292, Japan	Harima, T (reprint author), Niigata Univ, Dept Math Educ, Niigata 9502181, Japan.	harima@ed.niigata-u.ac.jp; watanabe.junzo@tokai-u.jp			 [23540052];  [24540050]	The first author was supported by Grant-in-Aid for Scientific Research (C) (23540052). The second author was supported by Grant-in-Aid for Scientific Research (C) (24540050).	Herzog J, 1999, NAGOYA MATH J, V153, P141; Green ML, 1998, PROG MATH, V166, P119; Conca A, 2003, P AM MATH SOC, V131, P1015, DOI 10.1090/S0002-9939-02-06607-8; GOTO S, 1987, J ALGEBRA, V108, P151, DOI 10.1016/0021-8693(87)90128-1; Goto S, 2002, P AM MATH SOC, V130, P3159, DOI 10.1090/S0002-9939-02-06436-5; HARIMA T., 2012, ILLINOIS J MATH, V156, P957; NAGEL U., 2015, COMMUN ALGEBRA, V43, P1; WATANABE J, 1992, MATH PROC CAMBRIDGE, V111, P231, DOI 10.1017/S0305004100075320; WATANABE J, 1987, NAGOYA MATH J, V106, P101; WATANABE J, 1991, MATH PROC CAMBRIDGE, V109, P7, DOI 10.1017/S0305004100069528	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0305-0041	1469-8064		MATH PROC CAMBRIDGE	Math. Proc. Camb. Philos. Soc.	MAR	2015	158	2					239	248		10.1017/S0305004114000632		10	Mathematics	Mathematics	CB5KP	WOS:000349666200004		
J	Hasegawa, T; Matsuoka, Y				Hasegawa, Tomoko; Matsuoka, Yuzuru			Climate change mitigation strategies in agriculture and land use in Indonesia	MITIGATION AND ADAPTATION STRATEGIES FOR GLOBAL CHANGE			English	Article						Climate change; Land use change; Agriculture; Mitigation potentials; Indonesia	GREENHOUSE-GAS EMISSIONS; SOUTHEAST-ASIA; PEATLANDS	We quantitatively evaluated mitigation potentials of greenhouse gas emissions from agriculture and land use sectors in Indonesia. We also determined for the land use sector 1) how much time is needed to plan the mitigation strategy, and 2) how much time is needed to evaluate the effectiveness of mitigation measures? We used a bottom-up type model on emission mitigation named Agriculture Forestry and Other Land Use Bottom-up model (AFOLU-B model) to consider a characteristics time sequence of actions, effects and costs of mitigation countermeasures. To input to the model, we developed future scenarios on human activities in these sectors based on data from Indonesian government. We found that i) evaluation on effects and costs of mitigation measures from a long-term viewpoint and their continuing implementation are required to increase future mitigation potentials under a limited budget. ii) a long-term reduction target will also play an important role for cost-effective countermeasure selection. iii) reforestation of slow glowing species and enhanced natural regeneration will cause great increase in mitigation potential in the country.	[Hasegawa, Tomoko] Natl Inst Environm Studies, Ctr Social & Environm Syst Res, Tsukuba, Ibaraki 3058506, Japan; [Matsuoka, Yuzuru] Kyoto Univ, Grad Sch Engn, Dept Urban & Environm Engn, Nishigyo Ku, Kyoto 6158540, Japan	Hasegawa, T (reprint author), Natl Inst Environm Studies, Ctr Social & Environm Syst Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	hasegawa.tomoko@nies.go.jp; matsuoka@env.kyoto-u.ac.jp			Japan Society for the Promotion of Science for Young Scientists [23-7066]; Ministry of the Environment, Japan [A-1103, S-6-1]; National Institute for Environmental Studies	This research was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (23-7066), the Environment Research and Technology Development Fund (A-1103) and the Global Environment Research Fund (S-6-1) of the Ministry of the Environment, Japan and the climate change research program of National Institute for Environmental Studies. I would like to thank Prof. Rizaldi Boer, Dr. Toni Bakhtiar and Dr Lukytawati Anggraeni Putra for discussions and their appropriate suggestions.	Amann M, 2008, EMISSION SCENARIOS N; Murdiyarso D, 2010, P NATL ACAD SCI USA, V107, P19655, DOI 10.1073/pnas.0911966107; Miettinen J, 2012, GCB BIOENERGY, V4, P908, DOI 10.1111/j.1757-1707.2012.01172.x; Shibata M, 2010, ANIM SCI J, V81, P2, DOI 10.1111/j.1740-0929.2009.00687.x; Akiyama H, 2010, GLOBAL CHANGE BIOL, V16, P1837, DOI 10.1111/j.1365-2486.2009.02031.x; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; van der Werf GR, 2008, P NATL ACAD SCI USA, V105, P20350, DOI 10.1073/pnas.0803375105; Hasegawa T, 2012, J INTEGR ENVIRON SCI, V9, P159, DOI 10.1080/1943815X.2012.701647; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; BAPPENAS, 2009, RED CARB EM IND PEAT; Bates J, 1998, OPTIONS REDUCE METHA, V3773, P3; Boer R., 2001, MITIGATION ADAPTATIO, V6, P257, DOI 10.1023/A:1013387305062; Boer R., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P1169, DOI 10.1007/s11027-006-9058-1; Boer R, 1999, J AGROMETEOROL, V13, P26; Dewan Nasional Perubahan Iklim [DNPI] McKinsey, 2010, IND GREENH GAS AB CO; Eggleston H S, 2006, 2006 IPCC GUIDELINES; Golan A., 1996, SERIES FINANCIAL EC; Graus W, 2004, MARGINAL GHG ABATEME; Hendriks CA, 2000, GLOBAL METHANE NITRO, P433; IFA/IFDC/FAO, 2002, FERT US CROP; IFA/IFDC/FAO, 1999, FERT US CROP; IRRI, 2011, IRRI WORLD RIC STAT; Metz B, 2007, CLIMATE CHANGE MITIG; Ministry of Environment (MoE), 2009, IND TECHN NEEDS ASS; Ministry of Environment (MoE), 2010, IND 2 NAT COMM UNFCC; Ministry of Forestry (MoF), 2008, RED EM DEF FOR DEGR; Nabuurs G. J., 2007, CLIMATE CHANGE 2007; Sathaye JA, 2001, MITIGATION ADAPTATIO, V6, P185, DOI 10.1023/A:1013398002336; Smith P, 2007, PHIL T R SOC B, V363, P2007, DOI DOI 10.1098/RSTB.2007.2184; USEPA, 2006, 430R06005 USEPA; World Bank, 2006, WORLD DEV IND	32	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1381-2386	1573-1596		MITIG ADAPT STRAT GL	Mitig. Adapt. Strateg. Glob. Chang.	MAR	2015	20	3					409	424		10.1007/s11027-013-9498-3		16	Environmental Sciences	Environmental Sciences & Ecology	CB4ZM	WOS:000349637200005		
J	Tin, MMY; Rheindt, FE; Cros, E; Mikheyev, AS				Tin, M. M. Y.; Rheindt, F. E.; Cros, E.; Mikheyev, A. S.			Degenerate adaptor sequences for detecting PCR duplicates in reduced representation sequencing data improve genotype calling accuracy	MOLECULAR ECOLOGY RESOURCES			English	Article						genotyping; methodology; next-generation sequencing; RAD-seq; RAD-tag	ANT WASMANNIA-AUROPUNCTATA; RARE MUTATIONS; RAD MARKERS; FIRE ANT; DNA; SNP; IDENTIFICATION; GENES; LOCI	RAD-tag is a powerful tool for high-throughput genotyping. It relies on PCR amplification of the starting material, following enzymatic digestion and sequencing adaptor ligation. Amplification introduces duplicate reads into the data, which arise from the same template molecule and are statistically nonindependent, potentially introducing errors into genotype calling. In shotgun sequencing, data duplicates are removed by filtering reads starting at the same position in the alignment. However, restriction enzymes target specific locations within the genome, causing reads to start in the same place, and making it difficult to estimate the extent of PCR duplication. Here, we introduce a slight change to the Illumina sequencing adaptor chemistry, appending a unique four-base tag to the first index read, which allows duplicate discrimination in aligned data. This approach was validated on the Illumina MiSeq platform, using double-digest libraries of ants (Wasmannia auropunctata) and yeast (Saccharomyces cerevisiae) with known genotypes, producing modest though statistically significant gains in the odds of calling a genotype accurately. More importantly, removing duplicates also corrected for strong sample-to-sample variability of genotype calling accuracy seen in the ant samples. For libraries prepared from low-input degraded museum bird samples (Mixornis gularis), which had low complexity, having been generated from relatively few starting molecules, adaptor tags show that virtually all of the genotypes were called with inflated confidence as a result of PCR duplicates. Quantification of library complexity by adaptor tagging does not significantly increase the difficulty of the overall workflow or its cost, but corrects for differences in quality between samples and permits analysis of low-input material.	[Tin, M. M. Y.; Mikheyev, A. S.] Okinawa Inst Sci & Technol Grad Univ, Ecol & Evolut Unit, Onna Son, Okinawa 9040495, Japan; [Rheindt, F. E.; Cros, E.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Mikheyev, AS (reprint author), Okinawa Inst Sci & Technol Grad Univ, Ecol & Evolut Unit, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan.	sasha@homologo.us	Mikheyev, Alexander/O-7670-2014	Mikheyev, Alexander/0000-0003-4369-1019			Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Mikheyev AS, 2009, MOL ECOL, V18, P2937, DOI 10.1111/j.1365-294X.2009.04213.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Boessenkool S, 2009, P R SOC B, V276, P815, DOI 10.1098/rspb.2008.1246; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Auwera GA, 2013, CURRENT PROTOCOLS BI, V43; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Chong ZC, 2012, BIOINFORMATICS, V28, P2732, DOI 10.1093/bioinformatics/bts482; Fournier D, 2005, MOL ECOL NOTES, V5, P239, DOI 10.1111/j.1471-8286.2005.00889.x; Fulton TL, 2012, METHODS MOL BIOL, V840, P29, DOI 10.1007/978-1-61779-516-9_4; Gorroochurn P., 2012, CLASSIC PROBLEMS PRO; Lijtmaer D. A., 2012, DNA BARCODES METHODS, V858, P127, DOI DOI 10.1007/978-1-61779-591-6_; Palaiokostas C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-566; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Scaglione D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-3; Stolle E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063960; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793	31	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-098X	1755-0998		MOL ECOL RESOUR	Mol. Ecol. Resour.	MAR	2015	15	2					329	336		10.1111/1755-0998.12314		8	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	CB7PE	WOS:000349819000011		
J	Yang, L; Yamamoto, K; Nishiumi, S; Nakamura, M; Matsui, H; Takahashi, S; Dohi, T; Okada, T; Kakimoto, K; Hoshi, N; Yoshida, M; Azuma, T				Yang, L.; Yamamoto, K.; Nishiumi, S.; Nakamura, M.; Matsui, H.; Takahashi, S.; Dohi, T.; Okada, T.; Kakimoto, K.; Hoshi, N.; Yoshida, M.; Azuma, T.			Interferon-gamma-producing B cells induce the formation of gastric lymphoid follicles after Helicobacter suis infection	MUCOSAL IMMUNOLOGY			English	Article							ADAPTIVE IMMUNE-RESPONSES; DNA-SEQUENCE ANALYSIS; GRADE MALT LYMPHOMA; 16S RIBOSOMAL-RNA; HELPER T-CELLS; IFN-GAMMA; DENDRITIC CELLS; UREASE GENES; HEILMANNII; PYLORI	Helicobacter (H.) suis is capable of infecting various animals including humans, and H. suis infections can lead to gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Recently, we reported that interferon-gamma (IFN-gamma) was highly expressed in the stomachs of H. suis-infected mice, but the direct relationship between the upregulation of IFN-gamma expression and the formation of gastric lymphoid follicles after H. suis infection remains unclear. Here, we demonstrated that the IFN-gamma produced by B cells plays an important role in the formation of gastric lymphoid follicles after H. suis infection. In addition, IFN-gamma-producing B cells evoked gastric lymphoid follicle formation independent of T-cell help, suggesting that they are crucial for the development of gastric MALT induced by Helicobacter infection.	[Yang, L.; Yamamoto, K.; Nishiumi, S.; Hoshi, N.; Yoshida, M.; Azuma, T.] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Nakamura, M.] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo, Japan; [Matsui, H.] Kitasato Inst Life Sci, Minato Ku, Tokyo, Japan; [Matsui, H.] Grad Sch Infect Control Sci, Minato Ku, Tokyo, Japan; [Takahashi, S.] Kyorin Univ, Dept Internal Med 3, Tokyo, Japan; [Dohi, T.; Okada, T.; Kakimoto, K.] Natl Ctr Global Hlth & Med, Res Inst, Res Ctr Hepatitis & Immunol, Dept Gastroenterol, Ichikawa, Japan; [Yoshida, M.] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 657, Japan; [Yoshida, M.] Kobe Univ, Grad Sch Med, Div Metabol Res, Kobe, Hyogo 657, Japan	Yoshida, M (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan.	myoshida@med.kobe-u.ac.jp			Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Center for Global Health and Medicine [21-110, 22-205, 25-104]; Ministry of Health, Labor, and Welfare of Japan; JSPS (Japan Society for the Promotion of Science) Asian CORE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported, in part, by a grant for the Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to L.Y., K.Y., M.Y., and T. A.); a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. A.); a grant from the "Young Researchers Training Program for Promoting Innovation'' run by the Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K.Y. and T. A.); a Grant-in-Aid for Scientific Research (B) (Overseas Academic Research) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. A.); a grant from the National Center for Global Health and Medicine (21-110, 22-205, 25-104) from the Ministry of Health, Labor, and Welfare of Japan (to T. D.); and a grant from the JSPS (Japan Society for the Promotion of Science) Asian CORE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.A.).	Acosta-Rodriguez EV, 2007, CYTOKINE GROWTH F R, V18, P73, DOI 10.1016/j.cytogfr.2007.01.007; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Sawai N, 1999, INFECT IMMUN, V67, P279; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Yamamoto K, 2014, MUCOSAL IMMUNOL, V7, P1244, DOI 10.1038/mi.2014.14; Sayi A, 2009, J IMMUNOL, V182, P7085, DOI 10.4049/jimmunol.0803293; Okiyama Y, 2005, PATHOL INT, V55, P398, DOI 10.1111/j.1440-1827.2005.01844.x; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Harris DP, 2005, J IMMUNOL, V174, P6781; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Gu YA, 2010, CANCER CAUSE CONTROL, V21, P1323, DOI 10.1007/s10552-010-9560-3; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Morgner A, 2000, GASTROENTEROLOGY, V118, P821, DOI 10.1016/S0016-5085(00)70167-3; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Fields RC, 1998, J IMMUNOTHER, V21, P323, DOI 10.1097/00002371-199809000-00001; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; D'Elios MM, 1999, GASTROENTEROLOGY, V117, P1105, DOI 10.1016/S0016-5085(99)70395-1; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Pellicano A, 2007, INFECT IMMUN, V75, P1738, DOI 10.1128/IAI.01446-06; Eaton KA, 2006, INFECT IMMUN, V74, P4673, DOI 10.1128/IAI.01887-05; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Smythies LE, 2000, J IMMUNOL, V165, P1022; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Bende RJ, 2009, HAEMATOL-HEMATOL J, V94, P1109, DOI 10.3324/haematol.2009.005983; Debongnie JC, 1998, EUR J GASTROEN HEPAT, V10, P251, DOI 10.1097/00042737-199803000-00011; DEBONGNIE JC, 1995, AM J GASTROENTEROL, V90, P411; D'Elios MM, 2005, FEMS IMMUNOL MED MIC, V44, P113, DOI 10.1016/j.femsin.2004.10.013; Dohi T, 2004, AM J PATHOL, V165, P1257, DOI 10.1016/S0002-9440(10)63385-8; Duttala Suneetha V, 2008, Indian J Gastroenterol, V27, P131; Ganapamo F, 2001, EUR J IMMUNOL, V31, P3460, DOI 10.1002/1521-4141(200112)31:12<3460::AID-IMMU3460>3.0.CO;2-X; Hellemans A, 2007, VET REC, V161, P189; Joo M, 2007, J KOREAN MED SCI, V22, P63; Jung TY, 2012, FISH SHELLFISH IMMUN, V33, P197, DOI 10.1016/j.fsi.2012.04.015; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Matsumoto T, 2009, J MICROBIOL, V47, P201, DOI 10.1007/s12275-008-0313-x; McDonald KG, 2005, J IMMUNOL, V174, P5720; Meining A, 1998, SCAND J GASTROENTERO, V33, P795; Mimura T, 2011, FEMS IMMUNOL MED MIC, V63, P25, DOI 10.1111/j.1574-695X.2011.00823.x; MORGNER A, 1995, LANCET, V346, P511, DOI 10.1016/S0140-6736(95)91364-5; Moser B, 2003, IMMUNOL LETT, V85, P105, DOI 10.1016/S0165-2478(02)00233-X; Mueller A, 2005, AM J PATHOL, V167, P797, DOI 10.1016/S0002-9440(10)62052-4; Nakamura M, 2007, INFECT IMMUN, V75, P1214, DOI 10.1128/IAI.01459-06; Nobutani K, 2010, FEMS IMMUNOL MED MIC, V60, P156, DOI 10.1111/j.1574-695X.2010.00731.x; Priestnall SL, 2004, J CLIN MICROBIOL, V42, P2144, DOI 10.1128/JCM.42.5.2144-2151.2004; Wang JD, 2000, INFECT IMMUN, V68, P4303, DOI 10.1128/IAI.68.7.4303-4311.2000; Yamamoto K, 2011, MICROBES INFECT, V13, P697, DOI 10.1016/j.micinf.2011.02.007	57	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	MAR	2015	8	2					279	295		10.1038/mi.2014.66		17	Immunology	Immunology	CB5PY	WOS:000349681200006		
J	Kondo, H; Fujino, H; Murakami, S; Tanaka, M; Kanazashi, M; Nagatomo, F; Ishihara, A; Roy, RR				Kondo, Hiroyo; Fujino, Hidemi; Murakami, Shinichiro; Tanaka, Masayuki; Kanazashi, Miho; Nagatomo, Fumiko; Ishihara, Akihiko; Roy, Roland R.			LOW-INTENSITY RUNNING EXERCISE ENHANCES THE CAPILLARY VOLUME AND PRO-ANGIOGENIC FACTORS IN THE SOLEUS MUSCLE OF TYPE 2 DIABETIC RATS	MUSCLE & NERVE			English	Article						microvascular disease; diabetes complications; exercise; angiogenic signalings; muscle 3D capillary architecture	ENDOTHELIAL GROWTH-FACTOR; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE CAPACITY; TRAINED RATS; VEGF; ENDURANCE; MELLITUS; MICE; MICROVASCULATURE	Introduction: We determined the effects of low-intensity exercise on the three-dimensional capillary structure and associated angiogenic factors in the soleus muscle of Goto-Kakizaki (GK) diabetic rats. Methods: Four groups of male rats were studied: sedentary nondiabetic (Con), exercised nondiabetic control (Ex), sedentary GK, and exercised GK (GK+Ex). Rats in the Ex and GK+Ex groups were subjected to chronic low-intensity running on a treadmill (15 m/min, 60 min/session, 5 sessions/week for 3 weeks). Results: Although mean capillary volume and diameter were lower in the GK compared with all other groups, low-intensity exercise increased both of these measures in GK rats. Mitochondrial markers, i.e., SDH activity and PGC-1 expression, and the levels of angiogenic factors were higher in the GK+Ex than all other groups. Exercise increased vascular endothelial growth factor (VEGF) protein levels and the VEGF-to-TSP-1 ratio, an indicator of angiogenesis, in GK rats. Conclusions: Combined, the results indicate that low-intensity exercise reduces some of the microcirculatory complications in type 2 diabetic muscles. Muscle Nerve 51: 391-399, 2015	[Kondo, Hiroyo] Nagoya Womens Univ, Dept Food Sci & Nutr, Nagoya, Aichi, Japan; [Fujino, Hidemi; Tanaka, Masayuki; Kanazashi, Miho] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Suma Ku, Kobe, Hyogo 6540142, Japan; [Murakami, Shinichiro] Himeji Dokkyo Univ, Dept Phys Therapy, Himeji, Hyogo, Japan; [Nagatomo, Fumiko; Ishihara, Akihiko] Kyoto Univ, Lab Cell Biol & Life Sci, Grad Sch Human & Environm Studies, Kyoto, Japan; [Roy, Roland R.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Roy, Roland R.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	Fujino, H (reprint author), Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	fujino@phoenix.kobe-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [19300196, 22300189, 25282165]	This study was supported by Grants-in-Aid for Scientific Research (19300196, 22300189, 25282165) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. No potential conflicts of interest relevant to this article are reported. *Drs. Kondo and Fujino contributed equally to this work.	Adachi T, 2007, EXP PHYSIOL, V92, P449, DOI 10.1113/expphysiol.2006.035451; ADAIR TH, 1990, AM J PHYSIOL, V259, pR393; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Ferrara N, 1999, J MOL MED-JMM, V77, P527, DOI 10.1007/s001099900019; Gustafsson T, 2005, J APPL PHYSIOL, V98, P2137, DOI 10.1152/japplphysiol.01402.2004; Zhou AL, 1998, ANAT REC, V252, P49, DOI 10.1002/(SICI)1097-0185(199809)252:1<49::AID-AR6>3.0.CO;2-9; Fujino H, 2005, J APPL PHYSIOL, V98, P1407, DOI 10.1152/japplphysiol.00961.2004; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Regensteiner JG, 1998, J APPL PHYSIOL, V85, P310; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Hoffner L, 2003, J PHYSIOL-LONDON, V550, P217, DOI 10.1113/jphysiol.2002.037051; LAUGHLIN MH, 1987, J APPL PHYSIOL, V62, P438; Gute D, 1996, J APPL PHYSIOL, V81, P619; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; SEXTON WL, 1994, AM J PHYSIOL, V266, pH1502; ROY RR, 1991, J APPL PHYSIOL, V70, P2522; Wagatsuma A, 2005, EXP PHYSIOL, V90, P403, DOI 10.1113/expphysiol.2004.029769; Kivela R, 2006, FASEB J, V20, P1570, DOI 10.1096/fj.05-4780fje; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; HUDLICKA O, 1984, J PHYSIOL-LONDON, V353, P435; Padilla DJ, 2006, AM J PHYSIOL-HEART C, V291, pH2439, DOI 10.1152/ajpheart.00290.2006; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453; MAXWELL LC, 1980, J APPL PHYSIOL, V49, P627; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gavin TP, 2007, ACTA PHYSIOL, V191, P139, DOI 10.1111/j.1748-1716.2007.01723.x; GOTO Y, 1981, P JPN ACAD B-PHYS, V57, P381, DOI 10.2183/pjab.57.381; HANSENSMITH FM, 1992, J APPL PHYSIOL, V73, P776; Ishihara A, 2004, NEUROSCI RES, V48, P119, DOI 10.1016/j.neures.2003.10.013; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; Kondo H, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-77; LASH JM, 1989, DIABETES, V38, P854, DOI 10.2337/diabetes.38.7.854; Lloyd PG, 2003, AM J PHYSIOL-HEART C, V284, pH1668, DOI 10.1152/ajpheart.00743.2002; Mathieu-Costello O, 2003, METABOLISM, V52, P540, DOI 10.1053/meta.2002.50108; Morifuji T, 2012, SCI WORLD J, DOI 10.1100/2012/645891; Murakami S, 2012, SCI WORLD J, DOI 10.1100/2012/680189; Nagatomo F, 2011, ACTA HISTOCHEM CYTOC, V44, P73, DOI 10.1267/ahc.10041; Toyota E, 2002, CIRCULATION, V105, P621, DOI 10.1161/hc0502.102964; Tyml K, 2001, FRONT BIOSCI, V6, pD45, DOI 10.2741/Tyml; Wagatsuma A, 2006, ACTA PHYSIOL, V187, P503, DOI 10.1111/j.1748-1716.2006.01594.x	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	MAR	2015	51	3					391	399		10.1002/mus.24316		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB5OM	WOS:000349677300013		
J	Vasanthakumar, A; Moro, K; Xin, AN; Liao, Y; Gloury, R; Kawamoto, S; Fagarasan, S; Mielke, LA; Afshar-Sterle, S; Masters, SL; Nakae, S; Saito, H; Wentworth, JM; Li, P; Liao, W; Leonard, WJ; Smyth, GK; Shi, W; Nutt, SL; Koyasu, S; Kallies, A				Vasanthakumar, Ajithkumar; Moro, Kazuyo; Xin, Annie; Liao, Yang; Gloury, Renee; Kawamoto, Shimpei; Fagarasan, Sidonia; Mielke, Lisa A.; Afshar-Sterle, Shoukat; Masters, Seth L.; Nakae, Susumu; Saito, Hirohisa; Wentworth, John M.; Li, Peng; Liao, Wei; Leonard, Warren J.; Smyth, Gordon K.; Shi, Wei; Nutt, Stephen L.; Koyasu, Shigeo; Kallies, Axel			The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells	NATURE IMMUNOLOGY			English	Article							LYMPHOID-CELLS; REG CELLS; DIFFERENTIATION; INFLAMMATION; INTERLEUKIN-33; EXPRESSION; CYTOKINES; BLIMP-1; OBESITY; FAMILY	Foxp3(+) regulatory T (T-reg) cells in visceral adipose tissue (VAT-T-reg cells) are functionally specialized tissue-resident cells that prevent obesity-associated inflammation and preserve insulin sensitivity and glucose tolerance. Their development depends on the transcription factor PPAR-gamma; however, the environmental cues required for their differentiation are unknown. Here we show that interleukin 33 (IL-33) signaling through the IL-33 receptor ST2 and myeloid differentiation factor MyD88 is essential for development and maintenance of VAT-T-reg cells and sustains their transcriptional signature. Furthermore, the transcriptional regulators BATF and IRF4 were necessary for VAT-T-reg differentiation through direct regulation of ST2 and PPAR-gamma expression. IL-33 administration induced vigorous population expansion of VAT-T-reg cells, which tightly correlated with improvements in metabolic parameters in obese mice. Human omental adipose tissue Treg cells also showed high ST2 expression, suggesting an evolutionarily conserved requirement for IL-33 in VAT-T-reg cell homeostasis.	[Vasanthakumar, Ajithkumar; Xin, Annie; Liao, Yang; Gloury, Renee; Mielke, Lisa A.; Afshar-Sterle, Shoukat; Masters, Seth L.; Wentworth, John M.; Smyth, Gordon K.; Shi, Wei; Nutt, Stephen L.; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Vasanthakumar, Ajithkumar; Xin, Annie; Liao, Yang; Gloury, Renee; Mielke, Lisa A.; Afshar-Sterle, Shoukat; Masters, Seth L.; Wentworth, John M.; Nutt, Stephen L.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Moro, Kazuyo; Koyasu, Shigeo] RIKEN, Ctr Integrat Med Sci, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan; [Moro, Kazuyo; Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Moro, Kazuyo] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Div Immunobiol, Yokohama, Kanagawa 232, Japan; [Kawamoto, Shimpei; Fagarasan, Sidonia] RIKEN, Res Ctr Integrat Med Sci, Lab Mucosal Immun, Yokohama, Kanagawa, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Kallies, A (reprint author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au	Koyasu, Shigeo/J-5583-2015; Nutt, Stephen/C-9256-2013	Koyasu, Shigeo/0000-0001-9585-3038; Nutt, Stephen/0000-0002-0020-6637	National Health and Medical Research Council of Australia; Sylvia and Charles Viertel Foundation; Australian Research Council; Diabetes Australia Research Trust; PRESTO from the Japan Science and Technology Agency; Japan Society for the Promotion of Science [22229004]; Division of Intramural Research, National Heart, Blood, and Lung Institute, US National Institutes of Health;  [26293110]	We thank P. O'Brien for assistance with tissue collection, S. Wada for animal care, M. Febbraio and A. Lew for critical advice, E. Cretney for mice and E. Bandala-Sanchez, V. Bryant and J. Brady for reagents. We are grateful to K. Nakanishi (Hyogo College of Medicine), T. Mak (The Campbell Family Institute for Breast Cancer Research), and U. Klein (Columbia University) for mice. Supported by the National Health and Medical Research Council of Australia (A.K., S.L.N. and G.K.S.), the Sylvia and Charles Viertel Foundation (A.K.), the Australian Research Council (A.K. and S.L.N.), the Diabetes Australia Research Trust (J. M. W.), PRESTO from the Japan Science and Technology Agency (K.M.), and a Grant-in Aid for Scientific Research (B) (26293110 to K.M.) and a Grant-in-Aid for Scientific Research (S) (22229004 to S. Koyasu) from the Japan Society for the Promotion of Science. W.L., P.L. and W.J.L. are supported by the Division of Intramural Research, National Heart, Blood, and Lung Institute, US National Institutes of Health. This study was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Williams Luke M, 2007, Nat Immunol, V8, P277; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Martin MU, 2013, SEMIN IMMUNOL, V25, P449, DOI 10.1016/j.smim.2013.10.006; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Zeyda M, 2013, INT J OBESITY, V37, P658, DOI 10.1038/ijo.2012.118; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jcm.20040973; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Han JM, 2013, J IMMUNOL, V191, P527, DOI 10.4049/jimmunol.1301035; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Gentleman R. C., 2004, GENOME BIOL, V5; Gratz IK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00333; Jacob J, 1999, NATURE, V399, P593; Kluge Reinhart, 2012, Methods Mol Biol, V933, P59, DOI 10.1007/978-1-62703-068-7_5; Lee HY, 2014, EXP LUNG RES, V40, P66, DOI 10.3109/01902148.2013.870261; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142	65	24	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					276	U239		10.1038/ni.3085		12	Immunology	Immunology	CB7XN	WOS:000349842100011		
J	Cui, YL; Toyoda, H; Sako, T; Onoe, K; Hayashinaka, E; Wada, Y; Yokoyama, C; Onoe, H; Kataoka, Y; Watanabe, Y				Cui, Yilong; Toyoda, Hiroshi; Sako, Takeo; Onoe, Kayo; Hayashinaka, Emi; Wada, Yasuhiro; Yokoyama, Chihiro; Onoe, Hirotaka; Kataoka, Yosky; Watanabe, Yasuyoshi			A voxel-based analysis of brain activity in high-order trigeminal pathway in the rat induced by cortical spreading depression	NEUROIMAGE			English	Article						Brain activity; FDG-PET; Migraine; SPM; Trigeminal nociceptive pathway	POSITRON-EMISSION-TOMOGRAPHY; TRIGEMINOVASCULAR NEURONS; MIGRAINE HEADACHE; CLASSIC MIGRAINE; STEM ACTIVATION; CEREBRAL-CORTEX; BLOOD-FLOW; AURA; PAIN; PET	Cortical spreading depression (SD) is a self-propagating wave of depolarization that is thought to be an underling mechanism of migraine aura. Growing evidence demonstrates that cortical SD triggers neurogenic meningeal inflammation and contributes to migraine headaches via subsequent activation of trigeminal afferents. Although direct and indirect evidence shows that cortical SD activates the trigeminal ganglion (peripheral pathway) and the trigeminal nucleus caudalis (TNC, the first central site of the trigeminal nociceptive pathway), it is not yet known whether cortical SD activates the high-order trigeminal nociceptive pathway in the brain. To address this, we induced unilateral cortical SD in rats, and then examined brain activity using voxel-based statistical parametric mapping analysis of FDG-PET imaging. The results show that approximately 40 h after the induction of unilateral cortical SD, regional brain activity significantly increased in several regions, including ipsilateral TNC, contralateral ventral posteromedial (VPM) and posterior thalamic nuclei (Po), the trigeminal barrel-field region of the primary somatosensory cortex (S1BF), and secondary somatosensory cortex (S-2). These results suggest that cortical SD is a noxious stimulus that can activate the high-order trigeminal nociceptive pathway even after cortical SD has subsided, probably due to prolonged meningeal inflammation. (C) 2014 Elsevier Inc. All rights reserved.	[Cui, Yilong; Toyoda, Hiroshi; Sako, Takeo; Onoe, Kayo; Hayashinaka, Emi; Wada, Yasuhiro; Yokoyama, Chihiro; Onoe, Hirotaka; Kataoka, Yosky; Watanabe, Yasuyoshi] RIKEN, Ctr Life Sci Technol, Mol Dynam Imaging Unit, Div Biofunct Dynam Imaging,Chuo Ku, Kobe, Hyogo 6500047, Japan	Cui, YL (reprint author), RIKEN, Ctr Life Sci Technol, Mol Dynam Imaging Unit, Div Biofunct Dynam Imaging,Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	cuiyl@riken.jp			Molecular Imaging Program on "Research Base for Exploring New Drugs" [KAKENHI 24659574]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japanese Government	This work was supported in part by a consignment expense from the Molecular Imaging Program on "Research Base for Exploring New Drugs", and by KAKENHI 24659574 to Y.C. from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japanese Government.	GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Schiffer WK, 2007, J NUCL MED, V48, P277; Lehnert W, 2012, NEUROIMAGE, V60, P2144, DOI 10.1016/j.neuroimage.2012.02.032; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Jaggi AS, 2011, FUND CLIN PHARMACOL, V25, P1, DOI 10.1111/j.1472-8206.2009.00801.x; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Jang DP, 2009, BEHAV BRAIN RES, V203, P43, DOI 10.1016/j.bbr.2009.04.020; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; MARKOWITZ S, 1987, J NEUROSCI, V7, P4129; HOFFMAN EJ, 1979, J COMPUT ASSIST TOMO, V3, P299; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; KIM SH, 1992, PAIN, V50, P355; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329; Sokoloff L, 1999, NEUROCHEM RES, V24, P321, DOI 10.1023/A:1022534709672; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Witting N, 2006, PAIN, V120, P145, DOI 10.1016/j.pain.2005.10.034; Arnold G, 1998, CEPHALALGIA, V18, P644, DOI 10.1046/j.1468-2982.1998.1809644.x; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12; Cui Y, 2008, J NEUROSCI RES, V86, P929, DOI 10.1002/jnr.21531; Cui YL, 2013, J NEUROSCI RES, V91, P737, DOI 10.1002/jnr.23209; Cui Y, 2003, BIOCHEM BIOPH RES CO, V300, P631, DOI 10.1016/S0006-291X(02)02906-6; Cui YL, 2009, J NUCL MED, V50, P1904, DOI 10.2967/jnumed.109.066498; DAVIS KD, 1988, BRAIN RES, V454, P89, DOI 10.1016/0006-8993(88)90806-2; Endepols H, 2010, J NEUROSCI, V30, P9708, DOI 10.1523/JNEUROSCI.1202-10.2010; Hosoi R, 2005, BRAIN RES, V1039, P199, DOI 10.1016/j.brainres.2005.01.064; Hume SP, 1998, NUCL MED BIOL, V25, P729, DOI 10.1016/S0969-8051(98)00055-9; Iizuka T, 2006, CEPHALALGIA, V26, P332, DOI 10.1111/j.1468-2982.2005.01025.x; Kobayashi M, 2013, J NEUROSCI RES, V91, P1363, DOI 10.1002/jnr.23252; Lashley KS, 1941, ARCH NEURO PSYCHIATR, V46, P331; LAURITZEN M, 1983, ANN NEUROL, V13, P633, DOI 10.1002/ana.410130609; MILNER PM, 1958, ELECTROEN CLIN NEURO, V10, P705, DOI 10.1016/0013-4694(58)90073-7; MOSKOWITZ MA, 1993, CEREBROVAS BRAIN MET, V5, P159; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; ONOE H, 1994, BRAIN RES, V663, P191, DOI 10.1016/0006-8993(94)91263-7; Ozawa M, 2011, J NUCL MED, V52, P1964, DOI 10.2967/jnumed.110.087072; Sung KK, 2009, NEUROIMAGE, V44, P1074, DOI 10.1016/j.neuroimage.2008.09.032; Takashima T, 2010, J PHARMACOL EXP THER, V335, P314, DOI 10.1124/jpet.110.170092; Thompson SJ, 2012, NEUROSCI LETT, V520, P131, DOI 10.1016/j.neulet.2012.03.015; WALL PD, 1979, PAIN, V6, P175, DOI 10.1016/0304-3959(79)90124-6	51	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAR	2015	108						17	22		10.1016/j.neuroimage.2014.12.047		6	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB4SO	WOS:000349618600002		
J	Minamikawa, K; Wagai, R; Nishimura, S; Yagi, K				Minamikawa, Kazunori; Wagai, Rota; Nishimura, Seiichi; Yagi, Kazuyuki			Heterotrophic denitrification constrains the upper limit of dissolved N2O-nitrate concentration ratio in agricultural groundwater	NUTRIENT CYCLING IN AGROECOSYSTEMS			English	Article						Carbon dioxide; Groundwater; Heterotrophic denitrification; Indirect emission; Nitrate; Nitrous oxide	NITROUS-OXIDE EMISSIONS; ORGANIC-CARBON; SHALLOW GROUNDWATER; N2O EMISSION; PADDY FIELD; NITRATE; SOIL; AQUIFER; FOREST; WATER	Indirect emission of nitrous oxide (N2O) through groundwater and surface drainage is commonly estimated based on the apparent positive relationship between the concentrations of nitrate ([NO3 (-)]) and dissolved N2O ([N2O]) for regional and national assessments. Field observations of the ratio of [N2O]-[NO3 (-)], however, rarely follow such relationship due to the complexity in N2O dynamics. Here we hypothesized that the temporal variation in [N2O] involves a phase shift as a function of [NO3 (-)] during heterotrophic denitrification (HD) based on the fact that high [NO3 (-)] inhibits N2O reduction to dinitrogen. We tested this hypothesis using the long-term, high frequency dataset of subsurface drainage water from the lysimeters under a cultivated soil in Japan. We identified the cases where [N2O] increased under high [NO3 (-)] conditions (phase 1) and decreased under low [NO3 (-)] conditions (phase 2) during the non-rainy periods. When [NO3 (-)] exceeded 20.4 mg N L-1 across the entire dataset, we found the positive correlation between [N2O] and the concentration of dissolved carbon dioxide ([CO2]), an end-product of HD, in accordance with phase 1. When [NO3 (-)] was < 5 mg N L-1 and [CO2] was > 28.3 mg C L-1, we found the positive correlation between [N2O] and [NO3 (-)], which agrees with phase 2. With this phase shift, [N2O]-[NO3 (-)] ratio increased (phase 1) and reached a plateau (phase 2). Our results suggest that the progress of HD, especially phase 1, contributes to the increases in [N2O]-[NO3 (-)] ratio and thus site-specific emission factor of N2O, EF5g.	[Minamikawa, Kazunori; Wagai, Rota; Yagi, Kazuyuki] Natl Inst Agroenvironm Sci, Carbon & Nutr Cycles Div, Tsukuba, Ibaraki 3058604, Japan; [Nishimura, Seiichi] NARO Agr Res Ctr, Dept Planning & Gen Adm, Tsukuba, Ibaraki 3058666, Japan	Minamikawa, K (reprint author), Natl Inst Agroenvironm Sci, Carbon & Nutr Cycles Div, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	minakazu@affrc.go.jp			Japan Society for the Promotion of Science (JSPS) [20-361]	We would like to thank Drs. Shigeto Sudo and Hiroko Akiyama (NIAES, Japan) for their help using the gas analysis system. We also would like to thank Dr. Syuntaro Hiradate (NIAES, Japan) for his valuable comments on the bioavailability of DOC. A portion of this study was funded by the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for JSPS Fellows (20-361).	Deurer M, 2008, CATENA, V72, P362, DOI 10.1016/j.catena.2007.07.013; Weymann D, 2008, BIOGEOSCIENCES, V5, P1215; Hedin LO, 1998, ECOLOGY, V79, P684, DOI 10.2307/176963; QUALLS RG, 1992, SOIL SCI SOC AM J, V56, P578; Senbayram M, 2012, AGR ECOSYST ENVIRON, V147, P4, DOI 10.1016/j.agee.2011.06.022; Liu SW, 2010, SCI TOTAL ENVIRON, V408, P906, DOI 10.1016/j.scitotenv.2009.11.002; FIRESTONE MK, 1980, SCIENCE, V208, P749, DOI 10.1126/science.208.4445.749; OBENHUBER DC, 1991, J ENVIRON QUAL, V20, P255; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110; Zhou S, 2012, SCI TOTAL ENVIRON, V430, P93, DOI 10.1016/j.scitotenv.2012.04.056; BLACKMER AM, 1978, SOIL BIOL BIOCHEM, V10, P187, DOI 10.1016/0038-0717(78)90095-0; Eggleston HS, 2006, AGR FOR OTH LAND US, p11 1; Groffman PM, 1996, J ENVIRON QUAL, V25, P1309; GRON C, 1992, SCI TOTAL ENVIRON, V118, P241; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; MCCARTY GW, 1992, BIOL FERT SOILS, V14, P219, DOI 10.1007/BF00346064; Minamikawa K, 2010, GLOBAL CHANGE BIOL, V16, P796, DOI 10.1111/j.1365-2486.2009.01931.x; Minamikawa K, 2011, SOIL SCI PLANT NUTR, V57, P719, DOI 10.1080/00380768.2011.625556; Minamikawa K, 2011, SOIL SCI PLANT NUTR, V57, P843, DOI 10.1080/00380768.2011.635427; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Muhlherr IH, 1998, J HYDROL, V211, P126, DOI 10.1016/S0022-1694(98)00224-8; Munoz-Leoz B, 2011, SCI TOTAL ENVIRON, V409, P763, DOI 10.1016/j.scitotenv.2010.10.008; Myhre G, 2013, CLIMATE CHANGE 2013, P659; Nishimura S, 2011, SOIL SCI PLANT NUTR, V57, P167, DOI 10.1080/00380768.2010.551346; Reay DS, 2009, AGR ECOSYST ENVIRON, V133, P163, DOI 10.1016/j.agee.2009.04.019; Sawamoto T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021625; Smith P., 2007, CLIMATE CHANGE 2007, P498; SPALDING RF, 1978, J ENVIRON QUAL, V7, P428; United Nations Framework Convention on Climate Change, 2012, GREENH GAS INV DAT; Vilain G, 2012, BIOGEOCHEMISTRY, V111, P253, DOI 10.1007/s10533-011-9642-7; von der Heide C, 2008, J HYDROL, V360, P230, DOI 10.1016/j.jhydrol.2008.07.034; Wagai R, 2002, BIOL FERT SOILS, V35, P18, DOI 10.1007/s00374-001-0434-4; Weier K. L., 1993, SOIL SCI SOC AM J, V57, P67	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-1314	1573-0867		NUTR CYCL AGROECOSYS	Nutr. Cycl. Agroecosyst.	MAR	2015	101	2					181	191		10.1007/s10705-014-9668-z		11	Soil Science	Agriculture	CB4OB	WOS:000349606200003		
J	Takata, M; Chikumi, H; Matsunami, K; Kodani, M; Sakamoto, T; Hashimoto, K; Nakamoto, M; Okada, K; Kitaura, T; Matsumoto, S; Kurai, J; Yamasaki, A; Igishi, T; Burioka, N; Shimizu, E				Takata, Miyako; Chikumi, Hiroki; Matsunami, Keiji; Kodani, Masahiro; Sakamoto, Tomohiro; Hashimoto, Kazuhiro; Nakamoto, Masaki; Okada, Kensaku; Kitaura, Tsuyoshi; Matsumoto, Shingo; Kurai, Jun; Yamasaki, Akira; Igishi, Tadashi; Burioka, Naoto; Shimizu, Eiji			A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer	ONCOLOGY REPORTS			English	Article						ultrarapid PCR; EGFR mutations; non-small cell lung cancer; epidermal growth factor receptor	REAL-TIME PCR; EGFR MUTATION; SENSITIVE DETECTION; 1ST-LINE TREATMENT; GENE-MUTATIONS; NEVER-SMOKERS; OPEN-LABEL; GEFITINIB; AMPLIFICATION; CHEMOTHERAPY	Mutations in the epidermal growth factor receptor (EGFR) gene are associated with a favorable clinical response to the EGFR tyrosine kinase inhibitors gefitinib and erlotinib in non-small cell lung cancer (NSCLC). We present here, a new method for the rapid detection of the two most common EGFR mutations (delE746-A750 and L858R) from clinical samples. The methodology involves the combination of newly designed mutation-specific primers and a novel real-time PCR machine with an innovative thermo-control mechanism that enables ultrarapid PCR. We evaluated this method using a cell mixture composed of various ratios of lung cancer cells harboring mutated or wild-type EGFR, lung cancer tissues obtained by surgery, and a cytology sample obtained by bronchoscopy from a lung cancer patient. In the cell. mixture analysis, our method detected 0.1% of cells with delE746-A750 and 1% of cells with L858R among cells with wild-type EGFR. In 143 lung cancer tissues, the result of this assay was concordant with those of direct sequencing in 138 samples. The five samples with discordant results were tested using a PCR-Invader assay and the result matched those of our method at 100%. We also successfully detected EGFR mutations in the lavage obtained from a lung cancer patient. The turnaround time for this method was <10 min, and all steps could be accomplished in <50 min after sample collection. Thus, our novel PCR method offers a rapid, simple, and less expensive test for EGFR mutations and can be applied as a point-of-care diagnostic test.	[Takata, Miyako; Chikumi, Hiroki; Matsunami, Keiji; Kodani, Masahiro; Sakamoto, Tomohiro; Nakamoto, Masaki; Okada, Kensaku; Kitaura, Tsuyoshi; Kurai, Jun; Yamasaki, Akira; Igishi, Tadashi; Burioka, Naoto; Shimizu, Eiji] Tottori Univ, Div Med Oncol & Mol Respirol, Dept Multidisciplinary Internal Med, Yonago, Tottori 6838504, Japan; [Chikumi, Hiroki; Nakamoto, Masaki] Tottori Univ Hosp, Ctr Infect Dis, Yonago, Tottori, Japan; [Hashimoto, Kazuhiro] Trust Med Co Ltd, Kobe, Hyogo, Japan; [Matsumoto, Shingo] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; [Burioka, Naoto] Tottori Univ, Dept Pathobiol Sci & Technol, Sch Hlth Sci, Yonago, Tottori 6838504, Japan	Chikumi, H (reprint author), Tottori Univ, Div Med Oncol & Mol Respirol, Dept Multidisciplinary Internal Med, Fac Med, 36-1 Nishi Machi, Yonago, Tottori 6838504, Japan.	chikumi@grape.med.tottori-u.ac.jp					Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Ellison G, 2013, J CLIN PATHOL, V66, P79, DOI 10.1136/jclinpath-2012-201194; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Hall JG, 2000, P NATL ACAD SCI USA, V97, P8272, DOI 10.1073/pnas.140225597; Fujimoto T, 2010, JPN J INFECT DIS, V63, P31; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Kim YH, 2008, BIOTECHNIQUES, V44, P495, DOI 10.2144/000112705; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Barbau-Piednoir E, 2013, APPL MICROBIOL BIOT, V97, P4021, DOI 10.1007/s00253-012-4477-2; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Ferlay J, 2010, Eur J Cancer, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Kimura H, 2006, CLIN CANCER RES, V12, P3915, DOI 10.1158/1078-0432.CCR-05-2324; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Naoki K, 2011, INT J CLIN ONCOL, V16, P335, DOI 10.1007/s10147-011-0187-5; NEWTON CR, 1988, NUCLEIC ACIDS RES, V16, P8233, DOI 10.1093/nar/16.17.8233; Nitsche A, 2007, REAL TIME PCR MICROB, P41; Takata M, 2012, CANCER BIOL THER, V13, P369, DOI [10.4161/cbt.19238, 10.4161/cbt.13.6.19238]	31	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAR	2015	33	3					1040	1048		10.3892/or.2015.3716		9	Oncology	Oncology	CB6KL	WOS:000349735800003		
J	Okano, M; Kumamoto, K; Saito, M; Onozawa, H; Saito, K; Abe, N; Ohtake, T; Takenoshita, S				Okano, Maiko; Kumamoto, Kensuke; Saito, Motonobu; Onozawa, Hisashi; Saito, Katsuharu; Abe, Noriko; Ohtake, Tohru; Takenoshita, Seiichi			Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer	ONCOLOGY REPORTS			English	Article						breast cancer; ANXA1; cellular invasion; metastasis	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROTEIN EXPRESSION; RANDOMIZED-TRIALS; DRUG-RESISTANCE; METASTASIS; CELLS; OVEREXPRESSION; CARCINOMA; ADENOCARCINOMA; CHEMOTHERAPY	Annexin A1 (ANXA1) is a calcium-dependent phospholipid-linked protein, involved in anti-inflammatory effects, regulation of cellular differentiation, proliferation and apoptosis. While many studies have investigated the ANXA1 expression in various tumor types, the role of ANXA1 is not fully understood. Therefore, in the present study, we evaluated the ANXA1 expression in 211 breast cancer patients and compared the levels with clinicopathological factors. ANXA1 was positively expressed in 31(14.7%) of the 211 cases in our cohort, and these positive cases were associated with triple-negative breast cancer (TNBC) (P=0.007) and venous invasion (P=0.028). The in vitro cell experiment found that the MDA-MB-231 cell line, which is a TNBC cell line, highly expressed ANXA1. Using this cell line, the functional role of ANXA1 in breast cancer was revealed and the knockdown of ANXA1 by specific siRNA demonstrated a significant reduction in cellular invasion. Further experiments indicated that ANXA1 was induced by hypoxia with hypoxia-inducible factor-la induction. These results suggested that ANXA1, which enhanced breast cancer invasion and metastasis under hypoxia, were significantly associated with the worst patient outcome. This is particularly noted in TNBC, the group of breast cancer with the worst outcome for which new therapeutic implications are required.	[Okano, Maiko; Kumamoto, Kensuke; Saito, Motonobu; Onozawa, Hisashi; Saito, Katsuharu; Abe, Noriko; Ohtake, Tohru; Takenoshita, Seiichi] Fukushima Med Univ, Dept Organ Regulatory Surg, Sch Med, Fukushima 9601295, Japan; [Saito, Motonobu] Natl Canc Ctr, Div Genome Biol, Res Inst, Tokyo 1040045, Japan	Kumamoto, K (reprint author), Fukushima Med Univ, Dept Organ Regulatory Surg, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	kumamotk@fmu.ac.jp					Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Turner NC, 2013, CLIN CANCER RES, V19, P6380, DOI 10.1158/1078-0432.CCR-13-0915; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Mastro AM, 2009, CANCER RES, V69, P4097, DOI 10.1158/0008-5472.CAN-08-4437; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1002/hep.510240114; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Wang LP, 2010, NEOPLASMA, V57, P253, DOI 10.4149/neo_2010_03_253; Shen DJ, 2005, BIOCHEM BIOPH RES CO, V326, P218, DOI 10.1016/j.bbrc.2004.10.214; Welsh SJ, 2002, CANCER RES, V62, P5089; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Kang JS, 2002, CLIN CANCER RES, V8, P117; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; CHEN WT, 1994, BREAST CANCER RES TR, V31, P217, DOI 10.1007/BF00666155; Chuthapisith S, 2009, EUR J CANCER, V45, P1274, DOI 10.1016/j.ejca.2008.12.026; Garcia Pedrero Juana Maria, 2004, American Journal of Pathology, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Pencil SD, 1998, CLIN EXP METASTAS, V16, P113, DOI 10.1023/A:1021917017109; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Saito M, 2014, BREAST CANCER-TOKYO, V21, P140, DOI 10.1007/s12282-012-0389-3; Saito M, 2014, CLIN CANCER RES, V20, P4784, DOI 10.1158/1078-0432.CCR-14-1096; Sato Y, 2011, EXP THER MED, V2, P239, DOI 10.3892/etm.2011.210; Sinha P, 1998, J BIOCHEM BIOPH METH, V37, P105, DOI 10.1016/S0165-022X(98)00020-7; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Wang Y, 2004, BIOCHEM BIOPH RES CO, V314, P565, DOI 10.1016/j.bbrc.2003.12.117	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAR	2015	33	3					1064	1070		10.3892/or.2015.3720		7	Oncology	Oncology	CB6KL	WOS:000349735800006		
J	Nishikawa, H; Osaki, Y; Komekado, H; Sakamoto, A; Saito, S; Nishijima, N; Nasu, A; Arimoto, A; Kita, R; Kimura, T				Nishikawa, Hiroki; Osaki, Yukio; Komekado, Hideyuki; Sakamoto, Azusa; Saito, Sumio; Nishijima, Norihiro; Nasu, Akihiro; Arimoto, Akira; Kita, Ryuichi; Kimura, Toru			Clinical implication of the preoperative GSA index in Tc-99m-GSA scintigraphy in hepatitis C virus-related hepatocellular carcinoma	ONCOLOGY REPORTS			English	Article						hepatocellular carcinoma; HCV; surgical resection; Tc-99m-GSA scintigraphy; GSA index; diagnostic accuracy; prognostic factor	SIMPLE NONINVASIVE INDEX; FATTY LIVER-DISEASE; LONG-TERM OUTCOMES; SIGNIFICANT FIBROSIS; FUNCTIONAL RESERVE; VIRAL-HEPATITIS; RECURRENCE; PREDICT; MANAGEMENT; RESECTION	We aimed to examine the relationship between the preoperative GSA index [uptake ratio of the liver to the liver plus heart at 15 min (LHL15) to uptake ratio of the heart at 15 min to that at 3 min (HH15) ratio] calculated from 99mTc4abeled diethylene triamine pentaacetate-galactosyl human serum albumin (Tc-99m-GSA) scintigraphy and background liver fibrosis and to investigate whether the GSA index can be a useful predictor in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) patients treated with surgical resection (SR). A total of 213 HCV-related HCC patients were analyzed. Receiver operating characteristic (ROC) curve analysis was performed for calculating the area under the ROC (AUROC) for nine noninvasive parameters including GSA index, indocyanine green retention at 15 min, aspartate aminotransferase (AST) to platelet ratio index, FIB-4 index, AST to alanine aminotransferase ratio, serum albumin, total bilirubin, platelet count and prothrombin time for cirrhosis. We also examined predictive factors associated with overall survival (OS) and recurrence-free survival (RFS) after SR in univariate and multivariate analyses. There were 153 males and 60 females with the mean age of 69.9 years. The median observation periods were 2.8 years. The mean maximum tumor size was 4.1 cm. HH15 ranged from 0.452 to 0.897. LHL15 ranged from 0.669 to 0.982. The mean value of the GSA index was 1.41. Among the nine parameters, the GSA index yielded the highest AUROC for cirrhosis with a level of 0.786 at an optimal cut-off value of 1.37 (sensitivity, 65.9%; specificity, 79.0%). In multivariate analyses, the GSA index was an independent predictor (P<0.001) linked to RFS and it had a marginal significance in terms of OS (P=0.074). In conclusion, the preoperative GSA index can be a useful predictor in HCV-related HCC patients treated with SR.	[Nishikawa, Hiroki; Osaki, Yukio; Komekado, Hideyuki; Sakamoto, Azusa; Saito, Sumio; Nishijima, Norihiro; Nasu, Akihiro; Kita, Ryuichi; Kimura, Toru] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, Osaka 5430027, Japan; [Arimoto, Akira] Osaka Red Cross Hosp, Dept Surg, Tennoji Ku, Osaka 5430027, Japan	Nishikawa, H (reprint author), Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka 5430027, Japan.	h-nishikawa@osaka-med.jrc.or.jp					El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Kaibori M, 2011, ANN NUCL MED, V25, P593, DOI 10.1007/s12149-011-0520-0; Kubota K, 1997, HEPATOLOGY, V26, P1176; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Shindoh J, 2013, HPB, V15, P31, DOI 10.1111/j.1477-2574.2012.00552.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; [Anonymous], 1989, JPN J SURG, V19, P98; Nalbantoglu I, 2014, WORLD J GASTROENTERO, V20, P9026, DOI 10.3748/wjg.v20.i27.9026; Lim KC, 2011, ANN SURG, V254, P108, DOI 10.1097/SLA.0b013e31821ad884; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Yoshizumi T, 2008, LIVER TRANSPLANT, V14, P1007, DOI 10.1002/lt.21462; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; Smith JO, 2009, ALIMENT PHARM THER, V30, P557, DOI 10.1111/j.1365-2036.2009.04062.x; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; Zhou WP, 2009, ANN SURG, V249, P195, DOI 10.1097/SLA.0b013e3181961c16; Chen CH, 2009, EUR J CANCER, V45, P1630, DOI 10.1016/j.ejca.2008.12.025; Gupta Sachin, 2012, Trop Gastroenterol, V33, P129; Harada K, 2012, J HEPATO-BIL-PAN SCI, V19, P667, DOI 10.1007/s00534-011-0486-2; Joo SK, 2014, J CLIN GASTROENTEROL; Kinoshita K, 2003, J GASTROEN HEPATOL, V18, P99, DOI 10.1046/j.1440-1746.2003.02920.x; KUDO M, 1992, AM J GASTROENTEROL, V87, P865; Makuuchi Masatoshi, 2013, Int J Surg, V11 Suppl 1, pS47, DOI 10.1016/S1743-9191(13)60015-1; Matsuzaki S, 1997, HEPATOLOGY, V25, P828, DOI 10.1002/hep.510250407; Nishikawa H, 2012, INT J ONCOL, V41, P903, DOI 10.3892/ijo.2012.1512; Ogasawara G, 2013, ANN NUCL MED, V27, P487, DOI 10.1007/s12149-013-0689-5; Osaki Y, 2015, HEPATOL RES, V45, P59, DOI 10.1111/hepr.12378; Shen SL, 2014, ANN SURG ONCOL, V21, P3802, DOI 10.1245/s10434-014-3771-x; Utsunomiya T, 2014, ANN SURG	34	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAR	2015	33	3					1071	1078		10.3892/or.2014.3691		8	Oncology	Oncology	CB6KL	WOS:000349735800007		
J	Sugiyama, M; Hasegawa, H; Ito, S; Sugiyama, K; Maeda, M; Aoki, K; Wakabayashi, T; Hamaguchi, M; Natsume, A; Senga, T				Sugiyama, Mai; Hasegawa, Hitoki; Ito, Satoko; Sugiyama, Kazuya; Maeda, Masao; Aoki, Kosuke; Wakabayashi, Toshihiko; Hamaguchi, Michinari; Natsume, Atsushi; Senga, Takeshi			Paired related homeobox 1 is associated with the invasive properties of glioblastoma cells	ONCOLOGY REPORTS			English	Article						glioblastoma; homeobox; PRRX1; invasion; Notch	TUMOR-INITIATING CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER; ROLES; GENES; EXPRESSION; PRRX1; SOX2; LOCALIZATION; ACTIVATION	Glioblastoma is a highly proliferative and invasive tumor. Despite extensive efforts to develop treatments for glioblastoma, the currently available therapies have only limited effects. To develop novel strategies for glioblastoma treatment, it is crucial to elucidate the molecular mechanisms that promote the invasive properties of glioblastoma. In the present study, we showed that the paired related homeobox 1 (PRRX1) is associated with glioblastoma cell invasion. The depletion of PRRX1 suppressed the invasion and neurosphere formation of glioblastoma cells. Conversely, the exogenous expression of PRRX1 promoted invasion. The Notch signaling pathway, which is an evolutionarily conserved pathway that is essential for developmental processes, plays an important role in the tumorigenesis of glioblastoma. The expression of PRRX1 induced the activation of Notch signaling, and the inhibition of Notch signaling suppressed PRRX1-mediated cell invasion. Our results indicate that activation of Notch signaling by PRRX1 is associated with the promotion of glioblastoma cell invasion.	[Sugiyama, Mai; Hasegawa, Hitoki; Ito, Satoko; Maeda, Masao; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Aoki, Kosuke; Wakabayashi, Toshihiko; Natsume, Atsushi] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Sugiyama, Kazuya] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4668550, Japan	Senga, T (reprint author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23107010]; Takeda Science Foundation	We would like to thank Dr Honjo, Dr Sasaki and Dr Moon for the Notch, Hedgehog and Wnt signaling reporter constructs. This study was funded by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nanomedicine Molecular Science, 23107010), and from the Takeda Science Foundation.	Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Shimozaki K, 2013, J NEUROSCI, V33, P4066, DOI 10.1523/JNEUROSCI.4586-12.2013; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Costa BM, 2010, CANCER RES, V70, P453, DOI 10.1158/0008-5472.CAN-09-2189; Bello L, 2004, CANC TREAT, V117, P263; Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Tanigaki K, 2010, CURR TOP DEV BIOL, V92, P231, DOI 10.1016/S0070-2153(10)92007-3; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Brouwer A, 2003, MECH DEVELOP, V120, P241, DOI 10.1016/S0925-4773(02)00416-1; Yuan H, 2013, CANCER RES, V73, P1581, DOI 10.1158/0008-5472.CAN-12-2377; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; [Anonymous], 2013, GENES DEV, V27, P288; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Chen X, 2012, CANCER RES, V72, P2294, DOI 10.1158/0008-5472.CAN-11-2181; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Norris RA, 2001, J BIOL CHEM, V276, P26829, DOI 10.1074/jbc.M100239200; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; Fang XF, 2010, OMICS, V14, P369, DOI 10.1089/omi.2010.0053; KERN MJ, 1994, GENOMICS, V19, P334, DOI 10.1006/geno.1994.1066; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Mimeault M, 2011, BRAIN PATHOL, V21, P479, DOI 10.1111/j.1750-3639.2011.00505.x; Norris RA, 2000, MAMM GENOME, V11, P1000, DOI 10.1007/s003350010193; Ohta S, 1997, J NEURO-ONCOL, V35, P7, DOI 10.1023/A:1005843600950; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Takahashi Y, 2013, BRIT J CANCER, V109, P307, DOI 10.1038/bjc.2013.339	32	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAR	2015	33	3					1123	1130		10.3892/or.2014.3681		8	Oncology	Oncology	CB6KL	WOS:000349735800013		
J	Jikihara, H; Qi, GY; Nozoe, K; Hirokawa, M; Sato, H; Sugihara, Y; Shimamoto, F				Jikihara, Hiroshi; Qi, Guangying; Nozoe, Koichiro; Hirokawa, Mayumi; Sato, Hiromi; Sugihara, Yuka; Shimamoto, Fumio			Aged garlic extract inhibits 1,2-dimethylhydrazine-induced colon tumor development by suppressing cell proliferation	ONCOLOGY REPORTS			English	Article						aged garlic extract; colorectal cancer; DMH; rat; cell cycle; cyclin B1	NF-KAPPA-B; GLUTATHIONE-S-TRANSFERASE; ABERRANT CRYPT FOCI; CANCER-CELLS; ORGANOSULFUR COMPOUNDS; GENE-EXPRESSION; HELA-CELLS; PRENEOPLASTIC LESIONS; IONIZING-RADIATION; DIALLYL TRISULFIDE	Garlic and its constituents are reported to have a preventive effect against colorectal cancer in animal models. Aged garlic extract (AGE), which is produced by natural extraction from fresh garlic for more than 10 months in aqueous ethanol, also has reputed chemopreventive effects on colon carcinogenesis, but has never been studied for its effects on colon cancer development. We investigated the antitumor effects of AGE in rats with 1,2-dimethylhydrazine (DMH)-induced carcinogenesis, and the mechanism of AGE in human colon cancer cell proliferation. F344 rats randomly divided into three groups were administered DMH (20 mg/kg weight) subcutaneously once a week for 8 weeks in a basal diet. After the last injection, one group of rats was then moved onto a basal diet containing 3% wt/wt AGE, and rats were sacrificed at 8 or 31 weeks. The number of aberrant crypt foci (ACF), histological type of tumor and proliferative activity of the tumor lesions were analyzed by macroscopic, pathological and immunohistochemical methods. DLD-1 human colon cancer cells were utilized to investigate the effect of AGE on anti-cell proliferation. AGE decreased the number of ACF but had no effect on gross tumor pathology. AGE showed a lower number of adenoma and adenocarcinoma lesions by histological analysis. Immunohistochemical staining indicated that AGE suppressed the proliferative activity in adenoma and adenocarcinoma lesions, but showed no effect on normal colon mucosa. Moreover, we demonstrated that AGE delayed cell cycle progression by downregulating cyclin B1 and cdk1 expression via inactivation of NF-kappa B in the human colorectal cancer cells but did not induce apoptosis. These findings suggest that AGE has an antitumor effect through suppression of cell proliferation.	[Jikihara, Hiroshi; Sugihara, Yuka; Shimamoto, Fumio] Prefectural Univ Hiroshima, Program Biol Syst Sci, Hiroshima 7348558, Japan; [Qi, Guangying; Nozoe, Koichiro; Hirokawa, Mayumi; Sato, Hiromi; Shimamoto, Fumio] Prefectural Univ Hiroshima, Dept Hlth Sci, Fac Human Culture & Sci, Minami Ku, Hiroshima 7348558, Japan; [Jikihara, Hiroshi] Wakunaga Pharmaceut Co Ltd, Mol Diagnost Div, Hiroshima 7391195, Japan	Shimamoto, F (reprint author), Prefectural Univ Hiroshima, Dept Hlth Sci, Fac Human Culture & Sci, Minami Ku, 1-1-71 Ujina Higashi, Hiroshima 7348558, Japan.	simamoto@pu-hiroshima.ac.jp			Prefectural University of Hiroshima	This study was supported in part by the important Research Grant from the Prefectural University of Hiroshima. The authors thank Drs Kodera and Imamura of Wakunaga Pharmaceutical Co. for the preparation of AGE, and Hiroshima Tsuchiya General Hospital for technical support.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; AMAGASE H, 1993, CARCINOGENESIS, V14, P1627, DOI 10.1093/carcin/14.8.1627; Shirin H, 2001, CANCER RES, V61, P725; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Soni KB, 1997, CANCER LETT, V115, P129, DOI 10.1016/S0304-3835(97)04710-1; Fleischauer AT, 2000, AM J CLIN NUTR, V72, P1047; Chen JZ, 2009, CANCER BIOL THER, V8, P1313, DOI 10.4161/cbt.8.14.8983; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Powolny AA, 2008, CANCER LETT, V269, P305, DOI 10.1016/j.canlet.2008.05.027; SPARNINS VL, 1988, CARCINOGENESIS, V9, P131, DOI 10.1093/carcin/9.1.131; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Gao CM, 1999, JPN J CANCER RES, V90, P614; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Hatono S, 1996, CARCINOGENESIS, V17, P1041, DOI 10.1093/carcin/17.5.1041; Ban JO, 2007, J PHARMACOL SCI, V104, P374, DOI 10.1254/jphs.FP0070789; Ryu DS, 2009, J MICROBIOL BIOTECHN, V19, P1482, DOI 10.4014/jmb.0902.0063; Tammariello AE, 2010, J NUTR BIOCHEM, V21, P77, DOI 10.1016/j.jnutbio.2009.09.014; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Janakiram NB, 2012, NEOPLASIA, V14, P159, DOI 10.1593/neo.111440; Ozeki M, 2004, ANTICANCER RES, V24, P2657; SUMIYOSHI H, 1990, CANCER RES, V50, P5084; Dong M, 2014, BIOMED REP, V2, P250; Ferreira CG, 2002, CLIN CANCER RES, V8, P2024; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; Herman-Antosiewicz A, 2007, ACTA PHARMACOL SIN, V28, P1355, DOI 10.1111/j.1745-7254.2007.00682.x; Hur K, 2000, J VET SCI, V1, P121; Kao GD, 1997, CANCER RES, V57, P753; Katsuki T, 2006, J NUTR, V136, P847; KNASMULLER S, 1989, ENVIRON MOL MUTAGEN, V13, P357, DOI 10.1002/em.2850130413; Knowles LM, 1998, NUTR CANCER, V30, P169; Kyo E, 2001, J NUTR, V131, p1075S; Lee SH, 2005, BIOCHEM PHARMACOL, V70, P1147, DOI 10.1016/j.bcp.2005.07.028; Liang DS, 2011, CANCER LETT, V310, P69, DOI 10.1016/j.canlet.2011.06.019; LIJINSKY W, 1985, CANCER RES, V45, P76; Matsuura N, 2006, J NUTR, V136, p842S; MCLELLAN EA, 1991, CANCER RES, V51, P5270; METTING NF, 1995, RADIAT RES, V143, P286, DOI 10.2307/3579215; Morihara N, 2002, LIFE SCI, V71, P509, DOI 10.1016/S0024-3205(02)01706-X; Morihara N, 2006, BIOL PHARM BULL, V29, P962, DOI 10.1248/bpb.29.962; MUSCHEL RJ, 1991, CANCER RES, V51, P5113; Pai MH, 2012, BR J NUTR, V14, P28; Perse M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473964; Pindborg JJ, 1997, HISTOLOGICAL TYPING, P21; PRETLOW TP, 1994, INT J CANCER, V56, P599, DOI 10.1002/ijc.2910560422; Sriram N, 2008, MOL CELL BIOCHEM, V311, P157, DOI 10.1007/s11010-008-9706-8; TADI PP, 1991, NUTR CANCER, V15, P87; Tanaka Shinji, 2004, Hiroshima Journal of Medical Sciences, V53, P39; Wang X, 2012, MOL MED REP, V5, P66, DOI 10.3892/mmr.2011.588; Xiao DH, 2003, CANCER RES, V63, P6825	52	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAR	2015	33	3					1131	1140		10.3892/or.2014.3705		10	Oncology	Oncology	CB6KL	WOS:000349735800014		
J	Laothong, U; Hiraku, Y; Oikawa, S; Intuyod, K; Murata, M; Pinlaor, S				Laothong, Umawadee; Hiraku, Yusuke; Oikawa, Shinji; Intuyod, Kitti; Murata, Mariko; Pinlaor, Somchai			Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen species-mediated mitochondrial pathway	ONCOLOGY REPORTS			English	Article						melatonin; apoptosis; cholangiocarcinoma; reactive oxygen species; DNA damage; mitochondrial pathway	CANCER-CHEMOTHERAPY; LIVER-INJURY; PROOXIDANT; HEPG2; ANTIOXIDANT; MECHANISMS; HAMSTERS	We previously demonstrated that melatonin could be used as a chemopreventive agent for inhibiting cholangiocarcinoma (CCA) development in a hamster model. However, the cytotoxic activity of melatonin in cancer remains unclear. In the present study; we investigated the effect of melatonin on CCA cell lines. Human CCA cell lines (KKU-M055 and KKU-M214) were treated with melatonin at concentrations of 0.5, 1 and 2 mM for 48 h. Melatonin treatment exerted a cytotoxic effect on CCA cells by inhibiting CCA cell viability in a concentration-dependent manner. Treatment with melatonin, especially at 2 mM, increased intracellular reactive oxygen species (ROS) production and in turn led to increased oxidative DNA damage and 8-oxodG formation. Moreover, melatonin treatment enhanced the production of cytochrome c leading to apoptosis in a concentration-dependent manner, as indicated by increased expression of apoptosis-related proteins caspase-3 and caspase-7. In conclusion, melatonin acts as a pro-oxidant by activating ROS-dependent DNA damage and thus leading to the apoptosis of CCA cells.	[Laothong, Umawadee; Pinlaor, Somchai] Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen 40002, Thailand; [Laothong, Umawadee; Hiraku, Yusuke; Oikawa, Shinji; Murata, Mariko] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie 5148507, Japan; [Laothong, Umawadee; Intuyod, Kitti; Pinlaor, Somchai] Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Fac Med, Khon Kaen 40002, Thailand; [Intuyod, Kitti] Khon Kaen Univ, Grad Sch, Program Biomed Sci, Khon Kaen 40002, Thailand	Pinlaor, S (reprint author), Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen 40002, Thailand.	mmurata@doc.medic.mie-u.ac.jp; psomec@kku.ac.th			Thailand Research Fund through Royal Golden Jubilee Ph.D. Program; Thailand Research Fund [RMU5380016]; Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), Khon Kaen University; Ministry of Education, Culture, Sports, Science and Technology of Japan [25293149]	The present study was supported by The Thailand Research Fund through Royal Golden Jubilee Ph.D. Program (to U.L. and S.P.), the Thailand Research Fund (RMU5380016), and The Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), Khon Kaen University. This study was partly supported by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 25293149). We thank Dr Justin Reese, Research Affairs, Faculty of Medicine, Khon Kaen University, Thailand for critically reading and improving this manuscript.	Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Jung B, 2006, CANCER RES, V66, P9789, DOI 10.1158/0008-5472.CAN-06-1776; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Laothong U, 2010, J PINEAL RES, V49, P271, DOI 10.1111/j.1600-079X.2010.00792.x; Buyukavci M, 2006, FUND CLIN PHARMACOL, V20, P73, DOI 10.1111/j.1472-8206.2005.00389.x; Hill SM, 2009, INTEGR CANCER THER, V8, P337, DOI 10.1177/1534735409353332; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Proietti S, 2013, CELL MOL LIFE SCI, V70, P2139, DOI 10.1007/s00018-012-1161-8; Osseni RA, 2000, LIFE SCI, V68, P387, DOI 10.1016/S0024-3205(00)00955-3; Carbajo-Pescador S, 2011, J PINEAL RES, V51, P463, DOI 10.1111/j.1600-079X.2011.00910.x; Motilva V, 2011, J PINEAL RES, V51, P44, DOI 10.1111/j.1600-079X.2011.00915.x; Sanchez-Barcelo EJ, 2003, ENDOCR-RELAT CANCER, V10, P153, DOI 10.1677/erc.0.0100153; Gerl R, 2005, CARCINOGENESIS, V26, P263, DOI 10.1093/carcin/bgh283; Rodriguez C, 2013, INT J MOL SCI, V14, P6597, DOI 10.3390/ijms14046597; Hannun YA, 1997, BLOOD, V89, P1845; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Bejarano I, 2011, MOL CELL BIOCHEM, V353, P167, DOI 10.1007/s11010-011-0783-8; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Anderson CD, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-1-43; Bejarano I, 2011, BASIC CLIN PHARMACOL, V108, P14, DOI 10.1111/j.1742-7843.2010.00619.x; Barrenetxe J, 2004, J PHYSIOL BIOCHEM, V60, P61; Bartsch C, 2002, NEUROENDOCRINOL LETT, V23, P30; Hail Numsen Jr, 2009, Mol Nutr Food Res, V53, P49, DOI 10.1002/mnfr.200700527; Han YY, 2011, AM J PHYSIOL-GASTR L, V301, pG623, DOI 10.1152/ajpgi.00118.2011; IARC, 2012, IARC MON EV CARC R B, V100, P341; Kim W, 2014, TUMOR BIOL, V135, P10919; Laothong U, 2013, J PINEAL RES, V55, P257, DOI 10.1111/jpi.12068; Lissoni P, 1996, BRIT J CANCER, V74, P1466, DOI 10.1038/bjc.1996.566; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAR	2015	33	3					1443	1449		10.3892/or.2015.3738		7	Oncology	Oncology	CB6KL	WOS:000349735800055		
J	Hashida, S; Yamamoto, H; Shien, K; Ohtsuka, T; Suzawa, K; Maki, Y; Furukawa, M; Soh, J; Asano, H; Tsukuda, K; Miyoshi, S; Kanazawa, S; Toyooka, S				Hashida, Shinsuke; Yamamoto, Hiromasa; Shien, Kazuhiko; Ohtsuka, Tomoaki; Suzawa, Ken; Maki, Yuho; Furukawa, Masashi; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Kanazawa, Susumu; Toyooka, Shinichi			Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors	ONCOLOGY REPORTS			English	Article						NVP-AUY922; 90-kDa heat shock protein inhibitor; epidermal growth factor receptor-tyrosine kinase inhibitor; drug resistance; radiation	GROWTH-FACTOR RECEPTOR; DNA-DAMAGE; INITIATING CELLS; TUMOR-CELLS; GEFITINIB; MUTATIONS; ACTIVATION; REPAIR; CYCLE; ATM	Acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is a critical issue that needs to be overcome in the treatment of patients with non-small cell lung cancer (NSCLC) harboring EGFR activating mutations. EGFR and AKT are client proteins of the 90-kDa heat shock protein (Hsp90). Therefore, it was hypothesized that the use of Hsp90 inhibitors might allow the resistance to EGFR-TKIs to be overcome. Furthermore, Hsp90 inhibitors are known to function as radiosensitizers in various types of cancer. In the present study, we evaluated the radiosensitizing effect of the novel Hsp90 inhibitor, NVP-AUY922 (AUY), on NSCLC cell lines harboring EGFR activating mutations and showing acquired resistance to EGFR-TKIs via any of several mechanisms. We used HCC827 and PC-9, which are NSCLC cell lines harboring EGFR exon 19 deletions, and gefitinib-resistant sublines derived from the same cell lines with T790M mutation, MET amplification or stem-cell like properties. AUY was more effective against the gefitinib-resistant sublines with T790M mutation and MET amplification than against the parental cell lines, although the subline with stem cell-like properties showed more than a 10-fold higher resistance to AUY than the parental cell line. AUY exerted a significant radiosensitizing effect on the parental cell line and the MET-amplified subline through inducing G(2)/M arrest and inhibition of non-homologous end joining (NHEJ). In contrast, the radiosensitizing effect of AUY was limited on the subline with stem cell-like properties, in which it did not induce G(2)/M arrest or inhibition of NHEJ. In conclusion, combined inhibition of Hsp90 plus radiation was effective, and therefore a promising treatment alternative for overcoming major EGFR-TKI resistance, such as that induced by T790M mutation or MET amplification. However, other approaches are required to overcome minor resistance to EGFR-TKIs, such as that observed in cells with stem cell-like properties.	[Hashida, Shinsuke; Yamamoto, Hiromasa; Shien, Kazuhiko; Ohtsuka, Tomoaki; Suzawa, Ken; Maki, Yuho; Furukawa, Masashi; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama 7008558, Japan; [Hashida, Shinsuke; Shien, Kazuhiko; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama 7008558, Japan; [Kanazawa, Susumu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan	Toyooka, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toyooka@md.okayama-u.ac.jp	Shien, Kazuhiko/B-8560-2012	Shien, Kazuhiko/0000-0002-4959-4220	Ministry of Education, Culture, Sports, Science and Technology of Japan [24791462]	The authors thank Mr. Seiji Tabara and Mr. Hirofumi Uno (Department of Radiology, Okayama University Hospital) for irradiating the cell lines and Ms. Fumiko Isobe (Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan) for her technical support. This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no. 24791462 to HY).	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Koll TT, 2008, MOL CANCER THER, V7, P1985, DOI 10.1158/1535-7163.MCT-07-2104; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Solit DB, 2003, CANCER RES, V63, P2139; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Ueno T, 2012, LUNG CANCER, V76, P26, DOI 10.1016/j.lungcan.2011.09.011; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Girard L, 2000, CANCER RES, V60, P4894; Oxnard GR, 2011, CLIN CANCER RES, V17, P5530, DOI 10.1158/1078-0432.CCR-10-2571; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Phillips TM, 2006, J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Ha K, 2011, MOL CANCER THER, V10, P1194, DOI 10.1158/1535-7163.MCT-11-0094; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kubo T, 2011, CLIN CANCER RES, V17, P4965, DOI 10.1158/1078-0432.CCR-10-3040; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Koizumi H, 2012, J THORAC ONCOL, V7, P1078, DOI 10.1097/JTO.0b013e3182519a2c; Lee JH, 2011, INT J MOL MED, V27, P441, DOI 10.3892/ijmm.2011.601; Lundholm L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.211; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Tse AN, 2009, MOL PHARMACOL, V75, P124, DOI 10.1124/mol.108.050807	40	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	MAR	2015	33	3					1499	1504		10.3892/or.2015.3735		6	Oncology	Oncology	CB6KL	WOS:000349735800062		
J	Suzuki, M; Yoshino, N; Shimada, M; Tetsumura, A; Matsumura, T; Fukayama, H; Kurabayashi, T				Suzuki, Madoka; Yoshino, Norio; Shimada, Masahiko; Tetsumura, Akemi; Matsumura, Tomoka; Fukayama, Haruhisa; Kurabayashi, Tohru			Abstracts from the 2014 American Academy of Oral Medicine meeting (vol 117, pg e334, 2014)	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Correction									[Suzuki, Madoka; Yoshino, Norio; Tetsumura, Akemi; Kurabayashi, Tohru] Tokyo Med & Dent Univ, Grad Sch, Dept Oral & Maxillofacial Radiol, Tokyo, Japan; [Shimada, Masahiko] Tokyo Med & Dent Univ, Grad Sch, Dept Orofacial Pain Management, Tokyo, Japan; [Matsumura, Tomoka; Fukayama, Haruhisa] Tokyo Med & Dent Univ, Grad Sch, Dept Anesthesiol & Clin Physiol, Tokyo, Japan	Suzuki, M (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Oral & Maxillofacial Radiol, Tokyo, Japan.						2015, ARAL, V119, P113	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	MAR	2015	119	3					366	366				1	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB2ZG	WOS:000349496400017		
J	Kobayashi, K; Maehata, Y; Okada, Y; Kusubata, M; Hattori, S; Tanaka, K; Miyamoto, C; Yoshino, F; Yoshida, A; Tokutomi, F; Wada-Takahashi, S; Komatsu, T; Otsuka, T; Takahashi, SS; Lee, MCI				Kobayashi, Kyo; Maehata, Yojiro; Okada, Yasue; Kusubata, Masashi; Hattori, Shunji; Tanaka, Keisuke; Miyamoto, Chihiro; Yoshino, Fumihiko; Yoshida, Ayaka; Tokutomi, Fumiaki; Wada-Takahashi, Satoko; Komatsu, Tomoko; Otsuka, Takero; Takahashi, Shun-Suke; Lee, Masaichi-Chang-Il			Medical-grade collagen peptide in injectables provides antioxidant protection	PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY			English	Article						Antioxidant property; electron spin resonance; reactive oxygen species	SPIN-RESONANCE SPECTROSCOPY; OXIDATIVE-DEGRADATION; SINGLET OXYGEN; AMINO-ACIDS; SCAVENGING ACTIVITY; DIRECT ASSESSMENTS; PROTEIN OXIDATION; MESENTERIC VEIN; DRUG-DELIVERY; HYDROXYL	Medical-grade collagen peptide is used as an additive agent in pharmaceutical formulations; however, it is unknown as to whether the compound exerts antioxidant effects in vitro. In this study, we evaluated the antioxidant effects of medical-grade collagen peptide on reactive oxygen species such as hydroxyl radical, superoxide anion radical and singlet oxygen using electron spin resonance and spin trapping. We confirmed that medical-grade collagen peptide directly inhibited hydroxyl radical generated by the Fenton reaction or by ultraviolet irradiation of hydrogen peroxide, and singlet oxygen. In addition, an antioxidant effect of medical-grade collagen peptide on singlet oxygen was observed in peptide fractions 12-22. The total amount of antioxidant amino acids (Gly, Hyp, Glu, Ala, Cys, Met and His) constituted more than half of the total amino acids in these fractions. These results suggest that the observed antioxidant properties of medical-grade collagen peptide are due to the compound containing antioxidant amino acids. Medical-grade collagen peptide, which is used in pharmaceuticals, and especially in injectables, could provide useful antioxidant properties to protect the active ingredient from oxidation.	[Kobayashi, Kyo; Maehata, Yojiro; Okada, Yasue; Miyamoto, Chihiro; Yoshino, Fumihiko; Yoshida, Ayaka; Tokutomi, Fumiaki; Wada-Takahashi, Satoko; Takahashi, Shun-Suke; Lee, Masaichi-Chang-Il] Kanagawa Dent Coll, Dept Clin Care Med, Div Pharmacol, Yokosuka, Kanagawa 2388580, Japan; [Kobayashi, Kyo; Maehata, Yojiro; Okada, Yasue; Miyamoto, Chihiro; Yoshino, Fumihiko; Yoshida, Ayaka; Tokutomi, Fumiaki; Wada-Takahashi, Satoko; Takahashi, Shun-Suke; Lee, Masaichi-Chang-Il] Kanagawa Dent Coll, Dept Clin Care Med, ESR Labs, Yokosuka, Kanagawa 2388580, Japan; [Kusubata, Masashi; Hattori, Shunji; Tanaka, Keisuke] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan; [Komatsu, Tomoko] Kanagawa Dent Coll, Dept Clin Care Med, Div Dent Special Patients, Yokosuka, Kanagawa 2388580, Japan; [Otsuka, Takero] Kanagawa Dent Coll, Div Orthodont, Dept Craniofacial Growth & Dev Dent, Yokosuka, Kanagawa 2388580, Japan	Lee, MCI (reprint author), Kanagawa Dent Coll, Dept Clin Care Med, Div Pharmacol, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	lee@kdu.ac.jp	Yoshida, Ayaka/D-9382-2014	Yoshida, Ayaka/0000-0001-8855-9228	Ministry of Education, Culture, Sports, Science and Technology of Japan [19791469, 19592371, 20791622, 23593049, 23660047]	This research was supported by a Grant-in-Aid for Scientific Research (No. 19791469, 19592371, 20791622, 23593049, 23660047) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors report no declarations of interest.	Meena C, 1999, P INDIAN AS-CHEM SCI, V111, P319; Lee CI, 2000, J BIOL CHEM, V275, P9369, DOI 10.1074/jbc.275.13.9369; Sakurai K, 2004, FREE RADICAL RES, V38, P487, DOI 10.1080/1071576042000209808; Waterman KC, 2002, PHARM DEV TECHNOL, V7, P1, DOI 10.1081/PDT-120002237; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Mitsuhashi H, 2005, SHOCK, V24, P529, DOI 10.1097/01.shk.0000183393.83272.de; Hovorka SW, 2001, J PHARM SCI-US, V90, P253; Tanaka M, 2009, BIOSCI BIOTECH BIOCH, V73, P930, DOI 10.1271/bbb.80649; Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4; Kumar MS, 2010, J SURG RES, V158, P162, DOI 10.1016/j.jss.2008.07.006; Zhuang YL, 2009, J SCI FOOD AGR, V89, P1722, DOI 10.1002/jsfa.3645; LEE CI, 1995, JPN J PHARMACOL, V67, P21, DOI 10.1254/jjp.67.21; Li B, 2007, FOOD CHEM, V102, P1135, DOI 10.1016/j.foodchem.2006.07.002; Ogasawara Y, 2007, FEBS LETT, V581, P2473, DOI 10.1016/j.febslet.2007.04.062; Wright A, 2002, PHOTOCHEM PHOTOBIOL, V76, P35, DOI 10.1562/0031-8655(2002)076<0035:SOMPOE>2.0.CO;2; MATHESON IBC, 1975, PHOTOCHEM PHOTOBIOL, V21, P165, DOI 10.1111/j.1751-1097.1975.tb06647.x; Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615; CHAN WKM, 1994, J AGR FOOD CHEM, V42, P1407, DOI 10.1021/jf00043a003; BLOOMFIELD SE, 1978, ARCH OPHTHALMOL-CHIC, V96, P885; Kim SK, 2001, J AGR FOOD CHEM, V49, P1984, DOI 10.1021/jf000494j; Zhu KX, 2006, PROCESS BIOCHEM, V41, P1296, DOI 10.1016/j.procbio.2005.12.029; Chen HM, 1996, J AGR FOOD CHEM, V44, P2619, DOI 10.1021/jf950833m; Asahara K, 1995, JPN J HOSP PHARM, V21, P15; Asahara K., 2003, J JSPEN, V18, P82; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; CLARK NB, 1980, AM J PHYSIOL, V238, pR406; GUNNISON AF, 1981, FOOD COSMET TOXICOL, V19, P667, DOI 10.1016/0015-6264(81)90519-8; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210; Hagiwara T, 2000, NEUROPHARMACOLOGY, V39, P1662, DOI 10.1016/S0028-3908(99)00240-3; Hawkins CL, 1997, BBA-MOL BASIS DIS, V1360, P84, DOI 10.1016/S0925-4439(96)00069-5; He YH, 2002, J BIOCHEM, V132, P373; Hong JY, 2004, PHARM DEV TECHNOL, V9, P171, DOI 10.1081/PDT-120030247; KANOFSKY JR, 1989, ARCH BIOCHEM BIOPHYS, V274, P229, DOI 10.1016/0003-9861(89)90434-7; Kasraian K, 1999, PHARM DEV TECHNOL, V4, P475, DOI 10.1081/PDT-100101384; Kim SK, 2001, J BIOCHEM MOL BIOL, V34, P219; Kobayashi K, 2011, J PHARMACOL SCI, V116, P97, DOI 10.1254/jphs.10321FP; Kobayashi K, 2008, ANESTHESIOLOGY, V109, P426, DOI 10.1097/ALN.0b013e318182a903; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; LEICHTER J, 1969, BIOCHEM J, V113, P611; Meftahizade H., 2010, Journal of Medicinal Plants Research, V4, P1391; Ohsugi M, 1999, J ETHNOPHARMACOL, V67, P111, DOI 10.1016/S0378-8741(98)00245-1; Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49; PALMIERI A, 1978, J PHARM SCI, V67, P1338, DOI 10.1002/jps.2600670946; PAULLS DA, 1995, ANALYST, V120, P467, DOI 10.1039/an9952000467; Sanga S V, 1979, J Parenter Drug Assoc, V33, P61; Vehabovic M, 2003, INT J PHARM, V256, P109, DOI 10.1016/S0378-5173(03)00067-X; Williams RR, 1935, J AM CHEM SOC, V57, P229, DOI 10.1021/ja01304a510; Xiao HL, 2007, SPECTROSC-INT J, V21, P91; Yoshino F, 2002, REDOX REP, V7, P266, DOI 10.1179/135100002125000767; ZSNAGY I, 1984, BIOCHIM BIOPHYS ACTA, V790, P238, DOI 10.1016/0167-4838(84)90028-1	50	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1083-7450	1097-9867		PHARM DEV TECHNOL	Pharm. Dev. Technol.	MAR	2015	20	2					219	226		10.3109/10837450.2013.860547		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CB6WX	WOS:000349768600012		
J	Kohara, Y; Kawaguchi, S; Kuwahara, R; Uchida, Y; Oku, Y; Yamashita, K				Kohara, Yumi; Kawaguchi, Shinichiro; Kuwahara, Rika; Uchida, Yutaro; Oku, Yushi; Yamashita, Kimihiro			Genistein improves spatial learning and memory in male rats with elevated glucose level during memory consolidation	PHYSIOLOGY & BEHAVIOR			English	Article						Genistein; Phytoestrogen; Glucose load; Oral administration; Rat; Spatial learning	ESTROGEN-RECEPTOR-BETA; INHIBITORY AVOIDANCE MEMORY; OVARIECTOMIZED RATS; BASOLATERAL AMYGDALA; PERINATAL EXPOSURE; DIABETES-MELLITUS; BRAIN; PHYTOESTROGENS; ISOFLAVONES; COGNITION	Cognitive dysfunction due to higher blood glucose level has been reported previously. Genistein (GEN) is a phytoestrogen that we hypothesized might lead to improved memory, despite elevated blood glucose levels at the time of memory consolidation. To investigate this hypothesis, we compared the effects of orally administered GEN on the central nervous system in normal versus glucose-loaded adult male rats. A battery of behavioral assessments was carried out In the MAZE test, which measured spatial learning and memory, the time of normal rats was shortened by GEN treatment compared to the vehicle group, but only in the early stages of testing. In the glucose-loaded group, GEN treatment improved performance as mazes were advanced. In the open-field test, GEN treatment delayed habituation to the new environment in normal rats, and increased the exploratory behaviors of glucose-loaded rats. There were no significant differences observed for emotionality or fear-motivated learning and memory. Together, these results indicate that GEN treatment improved spatial learning and memory only in the early stages of testing in the normal state, but improved spatial learning and memory when glucose levels increased during memory consolidation. (C) 2014 Elsevier Inc. All rights reserved.	[Kohara, Yumi; Uchida, Yutaro; Oku, Yushi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Kawaguchi, Shinichiro] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 8528521, Japan; [Kuwahara, Rika; Yamashita, Kimihiro] Nagasaki Univ, Div Environm Chem & Ecotoxicol, Inst Environm Studies, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan	Yamashita, K (reprint author), Nagasaki Univ, Div Environm Chem & Ecotoxicol, Inst Environm Studies, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan.	kimihiro@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22510069]	This study was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22510069).	Alonso A, 2010, AGE, V32, P421, DOI 10.1007/s11357-010-9148-6; Alonso-Magdalena P, 2013, DIABETES, V62, P2015, DOI 10.2337/db12-1562; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; Kuwahara R, 2013, J PHARMACOL SCI, V123, P132, DOI 10.1254/jphs.13093FP; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Bruehl H, 2009, BRAIN RES, V1280, P186, DOI 10.1016/j.brainres.2009.05.032; Moran J, 2013, EXP GERONTOL, V48, P414, DOI 10.1016/j.exger.2013.02.010; Evsen MS, 2013, EUR REV MED PHARMACO, V17, P1869; COWARD L, 1993, J AGR FOOD CHEM, V41, P1961, DOI 10.1021/jf00035a027; Komatsu T, 2008, EXP GERONTOL, V43, P339, DOI 10.1016/j.exger.2008.01.008; Cherbuin N, 2012, NEUROLOGY, V79, P1019, DOI 10.1212/WNL.0b013e31826846de; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Fu Z, 2012, APPL PHYSIOL NUTR ME, V37, P480, DOI [10.1139/h2012-005, 10.1139/H2012-005]; Bagheri M, 2012, BRAIN RES, V1429, P145, DOI 10.1016/j.brainres.2011.10.020; Soares E, 2013, NEUROSCIENCE, V250, P565, DOI 10.1016/j.neuroscience.2013.07.055; Lee JS, 2006, LIFE SCI, V79, P1578, DOI 10.1016/j.lfs.2006.06.030; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Arai Y, 2000, J Epidemiol, V10, P127; Belcher SM, 2001, J PHARMACOL EXP THER, V299, P408; Cortina B, 2013, EUR J PHARMACOL, V708, P88, DOI 10.1016/j.ejphar.2013.02.016; Donzelli A, 2010, J PHARMACOL SCI, V114, P158, DOI 10.1254/jphs.10164FP; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; Ha BG, 2012, J NUTR BIOCHEM, V23, P501, DOI 10.1016/j.jnutbio.2011.02.007; Huang YH, 2010, BRIT J NUTR, V104, P1297, DOI 10.1017/S0007114510002291; Kerti L, 2013, NEUROLOGY, V81, P1746, DOI 10.1212/01.wnl.0000435561.00234.ee; Kohara Y, 2014, PHYSIOL BEHAV, V130, P40, DOI 10.1016/j.physbeh.2014.03.006; Lee MS, 2009, BIOL PHARM BULL, V32, P504, DOI 10.1248/bpb.32.504; Nazari-Serenjeh F, 2013, PROG NEURO-PSYCHOPH, V40, P54, DOI 10.1016/j.pnpbp.2012.10.003; Pfitscher A, 2008, J STEROID BIOCHEM, V112, P87, DOI 10.1016/j.jsbmb.2008.08.007; Roesler R, 2000, BRAZ J MED BIOL RES, V33, P829, DOI 10.1590/S0100-879X2000000700014; Setchell KD, 1998, AM J CLIN NUTR S, V68, P1333; Tsai TH, 2005, J CHROMATOGR A, V1073, P317, DOI 10.1016/j.chroma.2004.10.048; Usui R., 2014, HIPPOCAMPUS, V00, P1; Xu J, 2007, J MOL NEUROSCI, V31, P101, DOI 10.1385/JMN/31:02:101; Zinn CG, 2009, NEUROBIOL LEARN MEM, V91, P266, DOI 10.1016/j.nlm.2008.09.016	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	MAR 1	2015	140						15	22		10.1016/j.physbeh.2014.12.005		8	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CB4HI	WOS:000349588400003		
J	Mitsuzuka, K; Narita, S; Koie, T; Kaiho, Y; Tsuchiya, N; Yoneyama, T; Kakoi, N; Kawamura, S; Tochigi, T; Ohyama, C; Habuchi, T; Arai, Y				Mitsuzuka, K.; Narita, S.; Koie, T.; Kaiho, Y.; Tsuchiya, N.; Yoneyama, T.; Kakoi, N.; Kawamura, S.; Tochigi, T.; Ohyama, C.; Habuchi, T.; Arai, Y.			Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin	PROSTATE CANCER AND PROSTATIC DISEASES			English	Article							PROGNOSTIC-SIGNIFICANCE; ADJUVANT RADIOTHERAPY; CANCER; SPECIMENS; SURVIVAL; DISEASE; PROGRESSION; PREDICTOR; FAILURE; TRIAL	BACKGROUND: The significance of lymphovascular invasion (LVI) remains controversial, and the association of LVI with biochemical relapse was investigated in men treated with radical prostatectomy according to pathological results. METHODS: Data from 1268 patients undergoing radical prostatectomy between 2000 and 2009 were retrospectively reviewed. Clinicopathological variables were compared between LVI-negative and LVI-positive patients. Multivariate analyses by Cox proportional hazard model and Kaplan-Meier method were performed to identify risk factors for biochemical relapse in all patients, patients with pT2N0 and pT2N0 negative resection margin (RM). RESULTS: LVI information was available in 1160 cases, and LVI was seen in 121 cases (10.4%). Clinicopathological variables were significantly worse in LVI-positive patients than in LVI-negative patients. On multivariate analyses, PSA >= 10 ng ml(-1), pathological Gleason score >= 8, pathological T stage >= 3, lymph node metastasis, positive RM and LVI were independent predictors for biochemical relapse in all patients. In patients with pT2N0, PSA >= 10 ng ml(-1), pathological Gleason score >= 8, positive RM and LVI were independent predictors for biochemical relapse. In patients with pT2N0 negative RM, LVI and pathological Gleason score >= 8 were independent predictors for biochemical relapse (LVI; hazard ratio 3.809, 95% confidence interval 1.900-7.635, P-value < 0.001, Gleason score >= 8; hazard ratio 2.189, 95% confidence interval 1.199-3.999, P-value = 0.011). With a median follow-up of 50 months, 5-year biochemical relapse-free survival in patients with pT2N0 negative RM was 95.7% in those with negative LVI in comparison to 85.3% in those with positive LVI (P < 0.001, log rank). CONCLUSIONS: LVI was consistently a significant predictor for biochemical relapse after radical prostatectomy in not only all patients but also in patients with pT2N0 and pT2N0 negative RM. These results strongly support the significance of LVI as a predictor for biochemical relapse.	[Mitsuzuka, K.; Kaiho, Y.; Arai, Y.] Tohoku Univ, Sch Med, Dept Urol, Sendai, Miyagi 9808574, Japan; [Mitsuzuka, K.; Narita, S.; Koie, T.; Kaiho, Y.; Tsuchiya, N.; Yoneyama, T.; Kakoi, N.; Kawamura, S.; Tochigi, T.; Ohyama, C.; Habuchi, T.; Arai, Y.] Michinoku Japan Urol Canc Study Grp, Sendai, Miyagi, Japan; [Narita, S.; Tsuchiya, N.; Ohyama, C.] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan; [Koie, T.; Yoneyama, T.; Habuchi, T.] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan; [Kakoi, N.; Kawamura, S.; Tochigi, T.] Miyagi Canc Ctr, Dept Urol, Natori, Miyagi 9811293, Japan	Mitsuzuka, K (reprint author), Tohoku Univ, Sch Med, Dept Urol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mitsuzuka@uro.med.tohoku.ac.jp					Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Mohler JL, 2014, J NATL COMPR CANC NE, V12, P686; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2013, J UROLOGY, V190, P441, DOI 10.1016/j.juro.2013.05.032; Ku JH, 2013, EUR J CANCER, V49, P2665, DOI 10.1016/j.ejca.2013.04.016; Messing EM, 2006, LANCET ONCOL, V7, P472, DOI 10.1016/S1470-2045(06)70700-8; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Ng J, 2012, BJU INT, V110, P1507, DOI 10.1111/j.1464-410X.2012.11115.x; Stamey TA, 2000, J UROLOGY, V163, P1155, DOI 10.1016/S0022-5347(05)67713-0; Tilki D, 2013, BJU INT, V111, P1215, DOI 10.1111/j.1464-410X.2012.11455.x; Cheng L, 2005, J UROLOGY, V174, P2181, DOI 10.1097/01.ju.0000181215.41607.c3; Gujam FJA, 2014, CRIT REV ONCOL HEMAT, V89, P231, DOI 10.1016/j.critrevonc.2013.08.014; Hashimoto Y, 2012, INT J CLIN ONCOL, V17, P119, DOI 10.1007/s10147-011-0267-6; Herman CM, 2000, AM J SURG PATHOL, V24, P859, DOI 10.1097/00000478-200006000-00012; Higgins KA, 2012, J THORAC ONCOL, V7, P1141, DOI 10.1097/JTO.0b013e3182519a42; Ito K, 2003, UROL INT, V70, P297, DOI 10.1159/000070139; Loeb S, 2006, UROLOGY, V68, P99, DOI 10.1016/j.urology.2006.02.004; May M, 2007, BJU INT, V99, P539, DOI 10.1111/j.1464-410X.2006.06650.x; Shariat SF, 2004, J UROLOGY, V171, P1122, DOI 10.1097/01.ju.0000113249.82533.28; Yamamoto S, 2008, INT J UROL, V15, P895, DOI 10.1111/j.1442-2042.2008.02140.x; Yee DS, 2011, BJU INT, V108, P502, DOI 10.1111/j.1464-410X.2010.09848.x	21	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1365-7852	1476-5608		PROSTATE CANCER P D	Prostate Cancer Prostatic Dis.	MAR	2015	18	1					25	30		10.1038/pcan.2014.40		6	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CB4VN	WOS:000349626500004		
J	Tahara, H; Naito, H; Kise, K; Wakabayashi, T; Kamoi, K; Okihara, K; Yanagisawa, A; Nakai, Y; Nonomura, N; Morii, E; Miki, T; Takakura, N				Tahara, H.; Naito, H.; Kise, K.; Wakabayashi, T.; Kamoi, K.; Okihara, K.; Yanagisawa, A.; Nakai, Y.; Nonomura, N.; Morii, E.; Miki, T.; Takakura, N.			Evaluation of PSF1 as a prognostic biomarker for prostate cancer	PROSTATE CANCER AND PROSTATIC DISEASES			English	Article							EUKARYOTIC DNA-REPLICATION; BLOOD-VESSELS; MOLECULAR BIOMARKERS; CONSENSUS CONFERENCE; DRUG-RESISTANCE; ANTIGEN LEVELS; CELLS; GINS; PROGRESSION; EXPRESSION	BACKGROUND: Partner of SLD5 1 (PSF1) is an evolutionarily conserved DNA replication factor. Previous studies have suggested that transcriptional activity of the PSF1 gene correlated with malignancy of cancer cells. The objective of the current study was to evaluate the relationship between PSF1 expression and the clinical features of prostate cancer. METHODS: We determined the expression of PSF1 in 120 needle biopsy samples of prostate cancer by immunohistochemistry. We divided patients into PSF1-positive or -negative groups and analyzed the relationships between the expression of PSF1, the Gleason score, PSA level, TNM classification and prognosis. RESULTS: Our results showed that the PSF1 expression correlated significantly with PSA values at diagnosis (P = 0.0028), with tumor grade (P < 0.0001), and with clinical stage (P = 0.0005). Moreover, the PSF1 expression correlated significantly with overall survival (hazard ratio (HR) 5.5; 95% confidence interval (CI) 2.17-15.8; P = 0.003) and progression-free survival in 99 consecutive patients with prostate cancer. Noteworthy, the prognosis of PSF1-positive cases was also worse in patients with a Gleason score of 8-10 (HR 3.7; 95% CI 1.28-13.43; P = 0.0143). Limitations include that this study had a retrospective design, that patients in the study were heterogeneous and included those with early and advanced cancer, and that small tumor fragments may not be representative of the entire carcinoma. CONCLUSIONS: PSF1 is expressed in high-grade prostate cancer and may be a useful biomarker to identify patients with a poor prognosis at the time of diagnosis.	[Tahara, H.; Naito, H.; Kise, K.; Wakabayashi, T.; Takakura, N.] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 5650871, Japan; [Tahara, H.; Kamoi, K.; Okihara, K.; Miki, T.] Kyoto Prefectural Univ Med, Dept Urol, Kamigyou Ku, Kyoto, Japan; [Yanagisawa, A.] Kyoto Prefectural Univ Med, Dept Surg Pathol, Kamigyou Ku, Kyoto, Japan; [Nakai, Y.; Nonomura, N.] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka, Japan; [Morii, E.] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Takakura, N.] JST, CREST, Chiyoda Ku, Tokyo, Japan	Takakura, N (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ntakaku@biken.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS) [25830080]	We thank Ms K Fukuhara, Ms N Fujimoto, Ms C Takeshita and Ms Y Morioka for technical assistance. This work was partly supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (NT) and Grants-in-Aid for Scientific Research (KAKENHI 25830080) from Japan Society for the Promotion of Science (JSPS) (HN).	Akimoto S, 1998, UROL INT, V60, P216, DOI 10.1159/000030257; Hankey BF, 1999, J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Kristiansen G, 2012, HISTOPATHOLOGY, V60, P125, DOI 10.1111/j.1365-2559.2011.04083.x; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Kinugasa Y, 2014, STEM CELLS, V32, P145, DOI 10.1002/stem.1556; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Fisher G, 2013, BRIT J CANCER, V108, P271, DOI 10.1038/bjc.2012.598; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Vergis R, 2010, INT J RADIAT ONCOL, V78, P35, DOI 10.1016/j.ijrobp.2009.07.1728; Bickers B, 2009, ANTICANCER RES, V29, P3289; Fradet Y, 2009, CURR OPIN UROL, V19, P243, DOI 10.1097/MOU.0b013e32832a08b5; Williams S, 2013, LANCET ONCOL, V14, pE524, DOI 10.1016/S1470-2045(13)70451-0; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Fall K, 2007, J NATL CANCER I, V99, P526, DOI 10.1093/jnci/djk110; Miller DC, 2003, CANCER, V98, P1169, DOI 10.1002/cncr.11635; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Epstein JI, 2006, ADV ANAT PATHOL, V13, P57, DOI 10.1097/01.pap.0000202017.78917.18; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Baade Peter D, 2013, Prostate Int, V1, P47, DOI 10.12954/PI.12014; D'Amico AV, 2008, UROLOGY, V71, P933, DOI 10.1016/j.urology.2007.11.005; Gulley James, 2003, Clin Adv Hematol Oncol, V1, P49; Matsui T, 2013, AM J PATHOL, V182, P1790, DOI 10.1016/j.ajpath.2013.01.019; Matsuura H, 2000, EUR UROL, V37, P212, DOI 10.1159/000020120; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nagahama Y, 2010, CANCER RES, V70, P1215, DOI 10.1158/0008-5472.CAN-09-3662; Naito H, 2012, CANCER SCI, V103, P433, DOI 10.1111/j.1349-7006.2011.02157.x; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; Ueno M, 2009, BLOOD, V113, P555, DOI 10.1182/blood-2008-01-136879	32	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1365-7852	1476-5608		PROSTATE CANCER P D	Prostate Cancer Prostatic Dis.	MAR	2015	18	1					56	62		10.1038/pcan.2014.46		7	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CB4VN	WOS:000349626500009		
J	Matsushima, N; Miyaoka, A				Matsushima, Noriaki; Miyaoka, Akira			The effects of resale-below-cost laws in the presence of a strategic manufacturer	QME-QUANTITATIVE MARKETING AND ECONOMICS			English	Article						Below-cost pricing; Channel power; Resale-below-cost laws; Vertical relations	DISTRIBUTION CHANNELS; STORE PERFORMANCE; DOMINANT RETAILER; PRICE PROMOTIONS; LOSS LEADER; COMPETITION; IMPACT; GASOLINE; COORDINATION; STABILITY	In retail markets, below-cost (or loss-leader) pricing is an important marketing tool to attract customers. However, several countries have adopted resale-below-cost laws that ban retailers from adopting this promotion strategy. In this study, we theoretically investigate how banning below-cost pricing influences equilibrium prices, firms' profits, and consumer surplus. We explicitly consider not only horizontal competition between retailers but also vertical channel relationships between manufacturers and retailers. In addition, we focus on asymmetric competition between dominant and weak retailers, which have heterogeneous bargaining positions vis-A -vis an upstream manufacturer. We show that this ban induces the manufacturer to reduce its wholesale price and can lead to a decrease in equilibrium retail prices including that of a loss-leader product. We also show that owing to the effects of such price reductions, the ban always improves the total consumer surplus and can benefit the weak retailer in terms of bargaining position, although it always harms the manufacturer and the dominant retailer.	[Matsushima, Noriaki; Miyaoka, Akira] Osaka Univ, Inst Social & Econ Res, Osaka 5670047, Japan	Miyaoka, A (reprint author), Osaka Univ, Inst Social & Econ Res, 6-1 Mihogaoka, Osaka 5670047, Japan.	nmatsush@iser.osaka-u.ac.jp; jge013ma@mail2.econ.osaka-u.ac.jp	Matsushima, Noriaki/D-1819-2012	Matsushima, Noriaki/0000-0002-7865-3875			Allain ML, 2011, INT J IND ORGAN, V29, P373, DOI 10.1016/j.ijindorg.2010.07.006; Anderson RW, 1999, REV IND ORGAN, V14, P189, DOI 10.1023/A:1007728100373; Dobson PW, 1996, J ECON MANAGE STRAT, V5, P317, DOI 10.1111/j.1430-9134.1996.00317.x; Lee E, 1997, MARKET SCI, V16, P185, DOI 10.1287/mksc.16.3.185; Raghubir P, 2004, CALIF MANAGE REV, V46, P23; Geylani T, 2007, MARKET SCI, V26, P164, DOI 10.1287/mksc.1060.0239; Hastings JS, 2004, AM ECON REV, V94, P317, DOI 10.1257/000282804322970823; Trivedi M, 1998, MANAGE SCI, V44, P896, DOI 10.1287/mnsc.44.7.896; Ailawadi KL, 2009, J RETAILING, V85, P42, DOI 10.1016/j.jretai.2008.11.002; HESS JD, 1987, MARKET SCI, V6, P358, DOI 10.1287/mksc.6.4.358; Srinivasan S, 2004, MANAGE SCI, V50, P617, DOI 10.1287/mnsc.1040.0225; Chen ZJ, 2012, AM ECON REV, V102, P3462, DOI 10.1257/aer.102.7.3462; Raju J, 2005, MARKET SCI, V24, P254, DOI 10.1287/mksc.1040.0081; Dukes AJ, 2006, J MARKETING RES, V43, P84, DOI 10.1509/jmkr.43.1.84; GUPTA S, 1988, J MARKETING RES, V25, P342, DOI 10.2307/3172945; DASPREMONT C, 1979, ECONOMETRICA, V47, P1145, DOI 10.2307/1911955; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Iyer G, 2003, J MARKETING RES, V40, P80, DOI 10.1509/jmkr.40.1.80.19134; Azar OH, 2010, J ECON BEHAV ORGAN, V76, P184, DOI 10.1016/j.jebo.2010.07.002; BAGWELL K, 1994, REV ECON STUD, V61, P153, DOI 10.2307/2297881; BLISS C, 1988, J IND ECON, V36, P375, DOI 10.2307/2098445; Caprice S, 2013, J ECON MANAGE STRAT, V22, P468, DOI 10.1111/jems.12022; Carranza J. E., J IND EC IN PRESS; CHOI SC, 1991, MARKET SCI, V10, P271, DOI 10.1287/mksc.10.4.271; Competition Commission, 2000, SUP REP SUPPL GROC M; DeGraba P, 2006, INT J IND ORGAN, V24, P613, DOI 10.1016/j.ijindorg.2005.08.013; Eckert A, 2013, J ECON SURV, V27, P140, DOI 10.1111/j.1467-6419.2011.00698.x; Federal Trade Commission, 2004, PETR IND MERG STRUCT; Gauri DK, 2008, J MARKETING RES, V45, P226, DOI 10.1509/jmkr.45.2.226; Inderst R., 2008, ABA ANTITRUST SECTIO; INMAN JJ, 1993, MARKET SCI, V12, P339, DOI 10.1287/mksc.12.4.339; Innes R, 2009, RAND J ECON, V40, P120, DOI 10.1111/j.1756-2171.2008.00058.x; LAL R, 1994, J BUS, V67, P345, DOI 10.1086/296637; Marvel Howard P., 1994, ANTITRUST LJ, V63, P59; McAlister L, 2009, J RETAILING, V85, P425, DOI 10.1016/j.jretai.2009.09.002; MILLS DE, 1995, J ECON MANAGE STRAT, V4, P509, DOI 10.1111/j.1430-9134.1995.00509.x; Munson C., 1999, BUS HORIZONS, V42, P55, DOI 10.1016/S0007-6813(99)80049-4; National Association of Convenience Stores, 2013, WHO SELLS AM FUEL; OECD, 2007, OECD J COMPETITION L, V9, P169; Rey P, 2010, J IND ECON, V58, P928, DOI 10.1111/j.1467-6451.2010.00439.x; Sachon M., 2009, 832 IESE BUS SCH, P832; Skidmore M, 2005, J URBAN ECON, V57, P189, DOI 10.1016/j.jue.2004.10.004; Smith G., 2002, BUSINESSWEEK, P26; Talukdar D, 2010, J RETAILING, V86, P336, DOI 10.1016/j.jretai.2010.06.002; Useem J., 2003, FORTUNE, P65; Vita MG, 2000, J REGUL ECON, V18, P217, DOI 10.1023/A:1008150819999; von Schlippenbach V, 2015, EUR REV AGRIC ECON, V42, P269, DOI 10.1093/erae/jbu022; WALTERS RG, 1986, J RETAILING, V62, P237; WALTERS RG, 1988, J MARKETING RES, V25, P51, DOI 10.2307/3172924; Wilmer Cutler Pickering Hale and Dorr, 2002, INT COMP LAW UPD GER	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-7156	1573-711X		QME-QUANT MARK ECON	QME-Quant. Mark. Econ.	MAR	2015	13	1					59	91		10.1007/s11129-015-9154-1		33	Business; Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CB6WD	WOS:000349766600003		
J	Shimizu, Y; Miyakura, R; Otsuka, Y				Shimizu, Yuri; Miyakura, Reiko; Otsuka, Yuzuru			Nuclear receptor subfamily 4, group A, member 1 inhibits extrinsic apoptosis and reduces caspase-8 activity in H2O2-induced human HUC-F2 fibroblasts	REDOX REPORT			English	Article						NR4A1; Apoptosis; Caspase-8; Oxidative stress	PROGRAMMED CELL-DEATH; MITOCHONDRIAL TRANSLOCATION; CARDIOMYOCYTE APOPTOSIS; ORPHAN RECEPTOR; NUR77; EXPRESSION; INDUCTION; ROS	Objective: Apoptosis is characterized by distinct morphological and biochemical changes that occur upon activation of a family of serine proteases known as caspases. Reactive oxygen species (ROS) induce apoptosis in many cell systems. Nuclear receptor subfamily 4, group A, member 1 (NR4A1) has been shown to induce apoptosis in a number of cell lineages, but can also paradoxically act as a death inhibitory factor. In the current study, we focused on the potential role of NR4A1 in hydrogen peroxide (H2O2)-induced apoptosis of normal human umbilical cord fibroblast (HUC-F2) cells. Methods: Growth of HUC-F2 cells treated with H2O2 was measured by MTT assay. Analysis of gene expression was performed with a STEP ONE PLUS Real Time PCR system. Inactivation of NR4A1 was treated with siRNA. Apoptosis was measured by Beckman Coulter flow cytometer after inhibition of NR4A1 with siRNA and H2O2 treatment. Caspase -3, -8 and -9 was measured by caspase assay kit. Results: H2O2 treatment led to enhanced NR4A1 expression. Moreover inhibition of NR4A1 with specific siRNA in HUC-F2 cells triggered an increase in apoptosis and caspase-8 and -3 activities following the addition of H2O2. Discussion: Our results collectively suggest that NR4A1 is a regulator that inhibits extrinsic apoptosis in HUC-F2 cells during oxidative stress through reduction of caspase-8 and -3 activities.	[Shimizu, Yuri; Miyakura, Reiko; Otsuka, Yuzuru] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Shimizu, Y (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	g1270505@edu.cc.ocha.ac.jp			Japan Society for the Promotion of Science fund	This work was supported by Japan Society for the Promotion of Science fund.	ANILKUMAR TV, 1992, VET HUM TOXICOL, V34, P251; Alho H, 1999, METHOD ENZYMOL, V299, P3; Rudin CM, 1997, ANNU REV MED, V48, P267; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Li QX, 2006, HISTOL HISTOPATHOL, V21, P533; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Ivanov VN, 2003, ONCOGENE, V22, P3152, DOI 10.1038/sj.onc.1206456; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Chen HZ, 2008, CARCINOGENESIS, V29, P2078, DOI 10.1093/carcin/bgn197; Liu WK, 2002, BIOCHEM PHARMACOL, V63, P951, DOI 10.1016/S0006-2952(01)00938-8; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Bras A, 2000, CELL DEATH DIFFER, V7, P262, DOI 10.1038/sj.cdd.4400653; Fantone J C, 1982, Am J Pathol, V107, P395; Hsu Hui-Chen, 2004, Current Drug Targets - Inflammation and Allergy, V3, P413, DOI 10.2174/1568010042634523; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399; Suzuki S, 2003, P NATL ACAD SCI USA, V100, P8276, DOI 10.1073/pnas.0932598100; Ueta E, 2001, BIOSCI BIOTECH BIOCH, V65, P2548, DOI 10.1271/bbb.65.2548; Xu AB, 2014, BIOCHEM BIOPH RES CO, V446, P1184, DOI 10.1016/j.bbrc.2014.03.089; Yu H, 2007, CANCER BIOL THER, V6, P405; Zhan YY, 2004, AI ZHENG, V23, P1593	27	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1351-0002			REDOX REP	Redox Rep.	MAR	2015	20	2					81	88		10.1179/1351000214Y.0000000109		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CB7BP	WOS:000349781400005		
J	Guo, X; Ma, SG; Li, B; Wang, MH; Wang, YC				Guo Xian; Ma ShuGen; Li Bin; Wang MingHui; Wang YueChao			Modeling and optimal torque control of a snake-like robot based on the fiber bundle theory	SCIENCE CHINA-INFORMATION SCIENCES			English	Article						snake-like robot; redundant torque; fiber bundle theory; nonholonomic; optimal control	LOCOMOTION; MECHANICS	For the snake-like robot with passive wheels, the side constraint force provides the required thrust which is less than the maximum static friction. Minimizing the side constraint force can reduce possibility of skidding which is important to ensure stable and efficient motion of the robot. In this paper we model the snakelike robot based on the fiber bundle theory. This method can reduce the complexity of the dynamics and derive the exact analytical solution for the side constraint force which is linear to the redundant torque. Using the linear relation, we can derive directly the optimal torque by minimizing the side constraint force. Additionally the nonholonomic constraint can be used for constructing the connection of the fiber bundle Using the connection, we can select the gait of the snake-like robot. The position and orientation of the head can be described in terms of the special Euclidean group SE(2) which is also the structure group of the fiber bundle. Using the symmetry of the structure group, we can reduce the dynamics equations and derive the analytical solution for the side constraint force. Kinematics and dynamics simulations validate the proposed methods.	[Guo Xian; Ma ShuGen; Li Bin; Wang MingHui; Wang YueChao] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Ma ShuGen] Ritsumeikan Univ, Dept Robot, Kyoto 5258577, Japan; [Guo Xian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Wang, MH (reprint author), Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China.	mhwang@sia.cn			National Natural Science Foundation of China [61333016]	This work was supported by National Natural Science Foundation of China (Grant No. 61333016).	Ali S., 2011, THESIS ECOLE MINES N; Boyer F, 2012, IEEE T ROBOT, V28, P303, DOI 10.1109/TRO.2011.2171616; Ma SG, 2001, ADV ROBOTICS, V15, P205; Saito M, 2002, IEEE CONTR SYST MAG, V22, P64; Boyer F, 2011, IEEE T ROBOT, V27, P215, DOI 10.1109/TRO.2010.2103450; Bullo F, 2003, IEEE T ROBOTIC AUTOM, V19, P494, DOI 10.1109/TRA.2003.810236; Hirose S., 1993, BIOL INSPIRED ROBOTS, P1; Ishikawa Masato, 2009, International Journal of Advanced Mechatronic Systems, V1, DOI 10.1504/IJAMECHS.2009.023200; KELLY SD, 1995, J ROBOTIC SYST, V12, P417, DOI 10.1002/rob.4620120607; Ostrowski J, 1996, IEEE INT CONF ROBOT, P1294, DOI 10.1109/ROBOT.1996.506885; Ostrowski J, 1998, INT J ROBOT RES, V17, P683, DOI 10.1177/027836499801700701; OSTROWSKI J, 1994, IEEE INT CONF ROBOT, P2391; Ostrowski J. P., 1995, THESIS CALTECH PASAD; Pendar H, 2005, P ASME INT MECH ENG; Shammas E, 2005, P ROB SCI SYST; Shammas EA, 2007, INT J ROBOT RES, V26, P1043, DOI 10.1177/0278364907082106; Transeth A, 2007, P IEEE RSJ INT C INT, P3539; Vossoughi G, 2007, ROBOTICA, V26, P267; Wang ZF, 2011, SCI CHINA INFORM SCI, V54, P318, DOI 10.1007/s11432-010-4161-z	19	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-733X	1869-1919		SCI CHINA INFORM SCI	Sci. China-Inf. Sci.	MAR	2015	58	3							032205	10.1007/s11432-014-5253-y		13	Computer Science, Information Systems	Computer Science	CB7MM	WOS:000349811500014		
J	Hirasawa, H				Hirasawa, Hiroyuki			WHAT'S NEW IN SHOCK? MARCH 2015	SHOCK			English	Editorial Material									Chiba Univ, Grad Sch Med, Eastern Chiba Med Ctr, Dept Emergency & Crit Care Med, Chiba, Japan	Hirasawa, H (reprint author), Chiba Univ, Grad Sch Med, Eastern Chiba Med Ctr, Dept Emergency & Crit Care Med, Chiba, Japan.						Andersen LW, 2015, SHOCK, V43, P250, DOI 10.1097/SHK.0000000000000306; Arora S, 2015, SHOCK, V43, P212, DOI 10.1097/SHK.0000000000000305; Chalkias A, 2015, SHOCK, V43, P285, DOI 10.1097/SHK.0000000000000285; Han J, 2015, SHOCK, V43, P244, DOI 10.1097/SHK.0000000000000303; Hayakawa M, 2015, SHOCK, V43, P261, DOI 10.1097/SHK.0000000000000281; Kraft R, 2015, SHOCK, V43, P222, DOI 10.1097/SHK.0000000000000294; Kuncewitch M, 2015, SHOCK, V43, P268, DOI 10.1097/SHK.0000000000000293; Lasker MV, 2015, SHOCK, V43, P228, DOI 10.1097/SHK.0000000000000289; ONPOINT Study Group, 2015, SHOCK, V43, P238; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; TraumaRegister DGU, 2015, SHOCK, V43, P233; Wang XT, 2015, SHOCK, V43, P292, DOI 10.1097/SHK.0000000000000286; Zhang JY, 2015, SHOCK, V43, P276, DOI 10.1097/SHK.0000000000000290	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAR	2015	43	3					209	211		10.1097/SHK.0000000000000334		3	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CB1UE	WOS:000349412700001		
J	Hayakawa, M; Gando, S; Ono, Y; Wada, T; Yanagida, Y; Sawamura, A; Ieko, M				Hayakawa, Mineji; Gando, Satoshi; Ono, Yuichi; Wada, Takeshi; Yanagida, Yuichiro; Sawamura, Atsushi; Ieko, Masahiro			NOBLE-COLLIP DRUM TRAUMA INDUCES DISSEMINATED INTRAVASCULAR COAGULATION BUT NOT ACUTE COAGULOPATHY OF TRAUMA-SHOCK	SHOCK			English	Article						Fibrinolysis; fibrinogenolysis; procoagulant; thrombin; fibrinolytic phenotype; ACoTS acute coagulopathy of trauma-shock; DIC disseminated intravascular coagulation; F factor; FDP fibrinogen; fibrin degradation products; FgDP fibrinogen degradation products; ETP endogenous thrombin potential; tPA tissue-type plasminogen activator; TIC trauma-induced coagulopathy	MULTIPLE ORGAN DYSFUNCTION; PROCOAGULANT ACTIVITY; NEUTROPHIL ELASTASE; TISSUE FACTOR; MARKERS; INJURY; TRANSFUSION; INCREASES; SEVERITY; SEPSIS	Background: There are two opposing possibilities for the main pathogenesis of trauma-induced coagulopathy: an acute coagulopathy of trauma shock and disseminated intravascular coagulation with the fibrinolytic phenotype. Objective: The objective of this study was to clarify the main pathogenesis of trauma-induced coagulopathy using a rat model of Noble-Collip drum trauma. Methods: Eighteen rats were divided into the control, trauma 0, and trauma 30 groups. The trauma 0 and 30 groups were exposed to Noble-Collip drum trauma. Blood samples were drawn without, immediately after, and 30 min after Noble-Collip drum trauma in the control, trauma 0, and trauma 30 groups, respectively. Coagulation and fibrinolysis markers were measured. Thrombin generation was assessed according to a calibrated automated thrombogram. Results: Spontaneous thrombin bursts resulting from circulating procoagulants were observed in the nonstimulated thrombin generation assay immediately after trauma. Soluble fibrin levels (a marker of thrombin generation in the systemic circulation) were 50-fold greater in the trauma groups than in the control group. The resultant coagulation activation consumed platelets, coagulation factors, and antithrombin. Endogenous thrombin potential and factor II ratio were significantly negatively correlated with antithrombin levels, suggesting insufficient control of thrombin generation by antithrombin. High levels of active tissue-type plasminogen activator induced hyperfibrin(ogen)olysis. Soluble thrombomodulin increased significantly. However, activated protein C levels did not change. Conclusions: The systemic thrombin generation accelerated by insufficient antithrombin control leads to the consumption of platelets and coagulation factors associated with hyperfibrin(ogen)olysis. These changes are collectively termed disseminated intravascular coagulation with the fibrinolytic phenotype.	[Hayakawa, Mineji; Gando, Satoshi; Ono, Yuichi; Wada, Takeshi; Yanagida, Yuichiro; Sawamura, Atsushi] Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med, Sapporo, Hokkaido 0608638, Japan; [Ieko, Masahiro] Hlth Sci Univ Hokkaido, Dept Internal Med, Sch Dent, Sapporo, Hokkaido, Japan	Hayakawa, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med,Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	mineji@dream.com			Japan Society for the Promotion of Science [23792068]	Source of Funding: Grant-in-Aid for Young Scientists (B) (no. 23792068) from the Japan Society for the Promotion of Science.	Aibiki M, 2007, SHOCK, V27, P139, DOI 10.1097/01.shk.0000239762.90335.68; Hayakawa M, 2013, SHOCK, V39, P514, DOI 10.1097/SHK.0b013e318293980d; Pham HP, 2013, BRIT J ANAESTH, V111, P71, DOI 10.1093/bja/aet376; Hess JR, 2008, J TRAUMA, V65, P748, DOI [10.1097/TA.0b013e3181877a9c, 10.1097/TA.0b013e181877a9c]; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; van Dreden P, 2009, BLOOD COAGUL FIBRIN, V20, P494, DOI 10.1097/MBC.0b013e32832c5e51; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Yanagida Y, 2013, SURGERY, V154, P48, DOI 10.1016/j.surg.2013.02.004; Ohlin AK, 2005, J THROMB HAEMOST, V3, P976, DOI 10.1111/j.1538-7836.2005.01267.x; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Reinhart K, 2002, CRIT CARE MED, V30, pS302, DOI 10.1097/00003246-200205001-00021; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Gando S, 2000, INTENS CARE MED, V26, P38, DOI 10.1007/s001340050009; Frith D, 2012, CURR OPIN CRIT CARE, V18, P631, DOI 10.1097/MCC.0b013e3283599ab9; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Chandler WL, 2010, AM J CLIN PATHOL, V134, P90, DOI 10.1309/AJCP3WPOYSKK6BFE; Frith D, 2012, CURR OPIN ANESTHESIO, V25, P229, DOI 10.1097/ACO.0b013e3283509675; Frith D, 2012, THROMB RES, V129, P551, DOI 10.1016/j.thromres.2011.11.053; Gando S, 2006, SEMIN THROMB HEMOST, V32, P48, DOI 10.1055/s-2006-933340; GANDO S, 1995, J TRAUMA, V39, P660, DOI 10.1097/00005373-199510000-00007; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; Hayakawa M, 2008, SHOCK, V30, P649, DOI 10.1097/SHK.0b013e318173e396; Noble RL, 1942, Q J EXP PHYSIOL CMS, V31, P187; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Wada H, 2008, SEMIN THROMB HEMOST, V34, P33, DOI 10.1055/s-2008-1066021; WEITZ JI, 1991, J CLIN INVEST, V87, P1082, DOI 10.1172/JCI115069	32	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAR	2015	43	3					261	267		10.1097/SHK.0000000000000281		7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CB1UE	WOS:000349412700010		
J	Leibacher, J; Sakurai, T; van Driel-Gesztelyi, L				Leibacher, John; Sakurai, Takashi; van Driel-Gesztelyi, Lidia			Untitled	SOLAR PHYSICS			English	Editorial Material									[Leibacher, John] Natl Opt Astron Observ, Natl Solar Observ, Tucson, AZ 85726 USA; [Leibacher, John] Univ Paris 11, CNRS, UMR 8617, Inst Astrophys Spatiale, F-91405 Orsay, France; [Sakurai, Takashi] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Sakurai, Takashi] Grad Univ Adv Studies, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [van Driel-Gesztelyi, Lidia] UPMC Univ Paris Diderot, CNRS, LESIA, Observ Paris, Meudon, France; [van Driel-Gesztelyi, Lidia] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [van Driel-Gesztelyi, Lidia] Hungarian Acad Sci, Konkoly Observ, Budapest, Hungary	Leibacher, J (reprint author), Natl Opt Astron Observ, Natl Solar Observ, Tucson, AZ 85726 USA.	john.leibacher@gmail.com; sakurai.takashi@nao.ac.jp; lidia.vandriel@obspm.fr						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-0938	1573-093X		SOL PHYS	Sol. Phys.	MAR	2015	290	3					657	658		10.1007/s11207-015-0658-3		2	Astronomy & Astrophysics	Astronomy & Astrophysics	CB8TF	WOS:000349903300001		
J	Judge, PG; Kleint, L; Uitenbroek, H; Rempel, M; Suematsu, Y; Tsuneta, S				Judge, P. G.; Kleint, L.; Uitenbroek, H.; Rempel, M.; Suematsu, Y.; Tsuneta, S.			Photon Mean Free Paths, Scattering, and Ever-Increasing Telescope Resolution	SOLAR PHYSICS			English	Article						Chromosphere; Instrumental effects; Photosphere; Spectrum, theory	LTE RADIATIVE-TRANSFER; SOLAR CHROMOSPHERE; STELLAR ATMOSPHERES; MAGNETIC FLUXTUBES; QUIET SUN; LINES; SPECTRUM; SHEET	We revisit an old question: what are the effects of observing stratified atmospheres on scales below a photon mean free path lambda? The mean free path of photons emerging from the solar photosphere and chromosphere is approximate to 10(2) km. Using current 1 m-class telescopes, lambda is on the order of the angular resolution. But the Daniel K. Inoue Solar Telescope will have a diffraction limit of 0.020 '' near the atmospheric cutoff at 310 nm, corresponding to 14 km at the solar surface. Even a small amount of scattering in the source function leads to physical smearing due to this solar "fog", with effects similar to a degradation of the telescope point spread function. We discuss a unified picture that depends simply on the nature and amount of scattering in the source function. Scalings are derived from which the scattering in the solar atmosphere can be transcribed into an effective Strehl ratio, a quantity useful to observers. Observations in both permitted (e.g., Fe I 630.2 nm) and forbidden (Fe I 525.0 nm) lines will shed light on both instrumental performance as well as on small-scale structures in the solar atmosphere.	[Judge, P. G.; Rempel, M.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Kleint, L.] Univ Appl Sci & Arts Northwestern Switzerland, Inst Technol 4D, CH-5210 Windisch, Switzerland; [Uitenbroek, H.] Natl Solar Observ, Sunspot, NM 88349 USA; [Suematsu, Y.; Tsuneta, S.] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo, Japan	Judge, PG (reprint author), Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA.	judge@ucar.edu; lucia.kleint@fnhw.ch; huitenbroek@nso.edu; rempel@ucar.edu; suematsu@solar.mtk.nao.ac.jp; saku.tsuneta@nao.ac.jp			National Science Foundation	Philip Judge is very grateful to NAOJ for support of a Visiting Professorship there during July and August of 2012, where this work was begun. The National Center for Atmospheric Research is sponsored by the National Science Foundation.	Allen C.W., 1973, ASTROPHYSICAL QUANTI, V43, P102; RYBICKI GB, 1991, ASTRON ASTROPHYS, V245, P171; Cauzzi G, 2008, ASTRON ASTROPHYS, V480, P515, DOI 10.1051/0004-6361:20078642; STENHOLM LG, 1978, ASTRON ASTROPHYS, V67, P33; VANREGEMORTER H, 1962, ASTROPHYS J, V136, P906, DOI 10.1086/147445; LINSKY JL, 1978, ASTROPHYS J, V220, P619, DOI 10.1086/155945; Norton AA, 2006, SOL PHYS, V239, P69, DOI 10.1007/s11207-006-0279-y; VERNAZZA JE, 1981, ASTROPHYS J SUPPL S, V45, P635, DOI 10.1086/190731; Bruls JHMJ, 2001, ASTRON ASTROPHYS, V366, P281, DOI 10.1051/0004-6361:20000099; STENHOLM LG, 1977, ASTRON ASTROPHYS, V58, P273; SCHARMER GB, 1985, J COMPUT PHYS, V59, P56, DOI 10.1016/0021-9991(85)90107-X; Athay R.G., 1976, SOLAR CHROMOSPHERE C; AVRETT EH, 1971, J QUANT SPECTROSC RA, V11, P559, DOI 10.1016/0022-4073(71)90038-0; BRULS JHMJ, 1993, ASTRON ASTROPHYS, V269, P509; DERE KP, 1983, ASTROPHYS J, V267, pL65, DOI 10.1086/184004; Faurobert M, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321259; Holzreuter R, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322135; Holzreuter R, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219477; Judge PG, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/1/L11; Judge PG, 2010, ASTROPHYS J, V719, P469, DOI 10.1088/0004-637X/719/1/469; Kiselman D., 1995, ASTRON ASTROPHYS, V302, P586; KNEER F, 1981, ASTRON ASTROPHYS, V93, P387; Knoelker M., 1988, ASTRON ASTROPHYS, V194, P257; Kurucz R., 1995, ATOMIC LINE DATA KUR; Landi Degl'Innocenti E., 2013, MEM S A IT, V84, P391; Leenaarts J, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/136; Leenaarts J, 2010, ASTROPHYS J, V709, P1362, DOI 10.1088/0004-637X/709/2/1362; Lipartito I, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/109; LITES BW, 1973, SOL PHYS, V32, P283, DOI 10.1007/BF00154942; Mihalas D, 1978, STELLAR ATMOSPHERES; OWOCKI SP, 1980, ASTROPHYS J, V241, P448, DOI 10.1086/158358; Rempel M, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/132; Seaton M. J., 1962, ATOMIC MOL PROCESSES, P11; Sekse DH, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/108; Socas-Navarro H, 2005, ASTROPHYS J, V631, pL167, DOI 10.1086/497334; Uitenbroek H, 2000, ASTROPHYS J, V531, P571, DOI 10.1086/308454	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-0938	1573-093X		SOL PHYS	Sol. Phys.	MAR	2015	290	3					979	996		10.1007/s11207-014-0643-2		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CB8TF	WOS:000349903300020		
J	Sei, T; Kume, A				Sei, Tomonari; Kume, Alfred			Calculating the normalising constant of the Bingham distribution on the sphere using the holonomic gradient method	STATISTICS AND COMPUTING			English	Article						Bingham distributions; Directional statistics; Holonomic functions		In this paper we implement the holonomic gradient method to exactly compute the normalising constant of Bingham distributions. This idea is originally applied for general Fisher-Bingham distributions in Nakayama et al. (Adv. Appl. Math. 47:639-658, 2011). In this paper we explicitly apply this algorithm to show the exact calculation of the normalising constant; derive explicitly the Pfaffian system for this parametric case; implement the general approach for the maximum likelihood solution search and finally adjust the method for degenerate cases, namely when the parameter values have multiplicities.	[Sei, Tomonari] Keio Univ, Dept Math, Tokyo, Japan; [Kume, Alfred] Univ Kent, SMSAS, Canterbury, Kent, England	Sei, T (reprint author), Keio Univ, Dept Math, Tokyo, Japan.	sei@math.keio.ac.jp; a.kume@kent.ac.uk			JSPS Institutional Program for Young Researcher Overseas Visits	The first author is supported by JSPS Institutional Program for Young Researcher Overseas Visits.	Kume A, 2005, BIOMETRIKA, V92, P465, DOI 10.1093/biomet/92.2.465; Nakayama H, 2011, ADV APPL MATH, V47, P639, DOI 10.1016/j.aam.2011.03.001; Barndorff-Nielsen O., 1978, WILEY SERIES PROBABI; Feller W., 1971, INTRO PROBABILITY TH, V2; Hashiguchi H, 2013, J MULTIVARIATE ANAL, V117, P296, DOI 10.1016/j.jmva.2013.03.011; KENT JT, 1994, J ROY STAT SOC B MET, V56, P285; Koyama T., 2012, ARXIV12013239; Koyama T., 2012, ARXIV12056144; Koyama T., 2011, ARXIV11041411; Kume A, 2007, STAT PROBABIL LETT, V77, P832, DOI 10.1016/j.spl.2006.12.003; Mardia K.V., 2000, WILEY SERIES PROBABI; Sei T, 2013, J MULTIVARIATE ANAL, V116, P440, DOI 10.1016/j.jmva.2013.01.010; Sun W, 2006, SPRINGER SER OPTIM A, V1, P1, DOI 10.1007/b106451; Takayama N., 1992, FUNKCIAL EKVAC, V35, P343	14	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0960-3174	1573-1375		STAT COMPUT	Stat. Comput.	MAR	2015	25	2					321	332		10.1007/s11222-013-9434-0		12	Computer Science, Theory & Methods; Statistics & Probability	Computer Science; Mathematics	CB3TH	WOS:000349551100011		
J	Takabayashi, S; Takahagi, T				Takabayashi, Susumu; Takahagi, Takayuki			Surface oxidation process of a diamond-like carbon film analyzed by difference X-ray photoelectron spectroscopy	SURFACE AND INTERFACE ANALYSIS			English	Article						diamond-like carbon (DLC); surface oxidation; X-ray photoelectron spectroscopy (XPS); difference spectrum	DIFFERENT ELECTRICAL RESISTIVITIES; GAS-PHASE DERIVATIZATION; AMORPHOUS-CARBON; FUNCTIONAL-GROUPS; CORONA-DISCHARGE; PHOTOEMISSION; XPS; GRAPHITE; COATINGS; SPECTRA	Difference X-ray photoelectron spectroscopy (D-XPS) revealed the surface oxidation process of a diamond-like carbon (DLC) film. Evaluation of surface functional groups on DLC solely by the C 1s spectrum is difficult because the spectrum is broad and has a secondary asymmetric lineshape. D-XPS clarified the subtle but critical changes at the DLC surface caused by wet oxidation. The hydroxyl (C?OH) group was dominant at the oxidized surface. Further oxidized carbonyl (CO) and carboxyl (including carboxylate) (COO) groups were also obtained; however, the oxidation of CO to COO was suppressed to some extent because the reaction required C?C bond cleavage. Wet oxidation cleaved the aliphatic hydrogenated and non-hydrogenated sp(2) carbon bonds (C?H sp(2) and C?C sp(2)) to create a pair of C?OH and hydrogenated sp(3) carbon (C?H sp(3)) bonds. The reaction yield for C?H sp(2) was superior at the surface, suggesting that the DLC film was hydrogen rich at the surface. Oxidation of aromatic sp(2) rings or polycyclic aromatic hydrocarbons such as nanographite to phenols did not occur because of their resonance stabilization with electron delocalization. Non-hydrogenated sp(3) carbon (C?C sp(3)) bonds were not affected by oxidation, suggesting that these bonds are chemically inert. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Takabayashi, Susumu] Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Takabayashi, Susumu; Takahagi, Takayuki] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Quantum Matter, Hiroshima 7398530, Japan	Takabayashi, S (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	stak@riec.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [26709017]	The authors acknowledge Dr. Keishi Okamoto and Dr. Tatsuyuki Nakatani, Toyo Advanced Technologies Co., Ltd., Hiroshima, for supplying DLC films. Part of this work was financially supported by the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid (KAKENHI) for Young Scientists (A), 26709017 (S. T.).	AISENBER.S, 1971, J APPL PHYS, V42, P2953, DOI 10.1063/1.1660654; Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768; Yang DQ, 2006, LANGMUIR, V22, P860, DOI 10.1021/la052922r; Takabayashi S, 2008, J APPL PHYS, V104, DOI 10.1063/1.2969792; GARDNER SD, 1995, CARBON, V33, P587, DOI 10.1016/0008-6223(94)00144-O; Takabayashi S, 2008, JPN J APPL PHYS, V47, P3376, DOI 10.1143/JJAP.47.3376; Takabayashi S, 2010, SURF INTERFACE ANAL, V42, P77, DOI 10.1002/sia.3156; NAKAYAMA Y, 1988, J POLYM SCI POL CHEM, V26, P559, DOI 10.1002/pola.1988.080260219; Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9; Zhou JH, 2007, CARBON, V45, P785, DOI 10.1016/j.carbon.2006.11.019; Hauert R, 2004, TRIBOL INT, V37, P991, DOI 10.1016/j.triboint.2004.07.017; Okamura M, 2006, CHEM MATER, V18, P3039, DOI 10.1021/cm0605623; Yue ZR, 1999, CARBON, V37, P1785, DOI 10.1016/S0008-6223(99)00047-0; GERENSER LJ, 1985, POLYMER, V26, P1162, DOI 10.1016/0032-3861(85)90245-9; Smith RD, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.245409; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3; Prince KC, 2000, PHYS REV B, V62, P6866, DOI 10.1103/PhysRevB.62.6866; Erdemir A, 2006, J PHYS D APPL PHYS, V39, pR311, DOI 10.1088/0022-3727/39/18/R01; Asakawa T., 2003, TOSOH RES TECHNOL RE, V47, P29; Balasubramanian T, 2001, PHYS REV B, V64, DOI [10.1103/PhysRevB.64.205420, 10.1103/PhysRevLett.87.205420]; Briggs D., 2003, SURFACE ANAL AUGER X; Diaz J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.094201; Diaz J, 1996, PHYS REV B, V54, P8064, DOI 10.1103/PhysRevB.54.8064; DICKIE RA, 1982, ANAL CHEM, V54, P2045, DOI 10.1021/ac00249a031; DONIACH S, 1970, J PHYS PART C SOLID, V3, P285, DOI 10.1088/0022-3719/3/2/010; Estrade-Szwarckopf H, 2004, CARBON, V42, P1713, DOI 10.1016/j.carbon.2004.03.005; Haerle R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.045101; Hammond J. S., 1980, POLYM PREPR AM CHEM, V21, P149; Hufner S., 2003, PHOTOELECTRON SPECTR; Hunt MRC, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.153408; ISHITANI A, 1981, CARBON, V19, P269, DOI 10.1016/0008-6223(81)90072-5; Morrison RT, 1992, ORGANIC CHEM; POCHAN JM, 1986, POLYMER, V27, P1058, DOI 10.1016/0032-3861(86)90072-8; Schmidt RJ, 2005, APPL CATAL A-GEN, V280, P89, DOI 10.1016/j.apcata.2004.08.030; Takabayashi S., 2013, J SURF ANAL, V20, P25; Takabayashi S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.092304; Takabayashi S, 2008, APPL SURF SCI, V254, P2666, DOI 10.1016/j.apsusc.2007.10.002; Takabayashi S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2735416; Takabayashi S., 2008, TANSO, V235, P280; Takabayashi S, 2014, J APPL PHYS, V116, DOI 10.1063/1.4894626; TAKAHAGI T, 1984, CARBON, V22, P43, DOI 10.1016/0008-6223(84)90131-3; Takami T., 2009, E J SURF SCI NANOTEC, V7, P882; vansAttekum P. M. T. M., 1979, PHYS REV LETT, V43, P1896	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	MAR	2015	47	3					345	349		10.1002/sia.5714		5	Chemistry, Physical	Chemistry	CB5RW	WOS:000349686200007		
J	Cussens, J; de Raedt, L; Kimmig, A; Sato, T				Cussens, James; de Raedt, Luc; Kimmig, Angelika; Sato, Taisuke			Introduction to the special issue on probability, logic and learning	THEORY AND PRACTICE OF LOGIC PROGRAMMING			English	Editorial Material							PROGRAMS		[Cussens, James] Univ York, Dept Comp Sci, York YO10 5GE, N Yorkshire, England; [Cussens, James] Univ York, York Ctr Complex Syst Anal, York YO10 5GE, N Yorkshire, England; [de Raedt, Luc; Kimmig, Angelika] Katholieke Univ Leuven, Dept Comp Sci, B-3001 Heverlee, Belgium; [Sato, Taisuke] Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 152, Japan	Cussens, J (reprint author), Univ York, Dept Comp Sci, York YO10 5GE, N Yorkshire, England.	james.cussens@york.ac.uk; luc.deraedt@cs.kuleuven.be; angelika.kimmig@cs.kuleuven.be; sato@mi.cs.titech.ac.jp					Richardson M, 2006, MACH LEARN, V62, P107, DOI 10.1007/s10994-006-5833-1; Vennekens J, 2004, LECT NOTES COMPUT SC, V3132, P431, DOI 10.1007/978-3-540-27775-0_30; Sato T, 2001, J ARTIF INTELL RES, V15, P391; De Raedt L., 2008, LECT NOTES COMPUTER, V4911; De Raedt L., 2007, P 20 INT JOINT C ART, P2462; Getoor L., 2007, STAT RELATIONAL LEAR; Kersting K, 2012, FRONT ARTIF INTEL AP, V242, P33, DOI 10.3233/978-1-61499-098-7-33; Poole D., 2008, LNCS LNAI, V4911, P222; Sato T., 1995, P 12 INT C LOG PROGR, P715	9	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1471-0684	1475-3081		THEOR PRACT LOG PROG	Theory Pract. Log. Program.	MAR	2015	15		2		SI		145	146		10.1017/S1471068413000665		2	Computer Science, Software Engineering; Computer Science, Theory & Methods; Logic	Computer Science; Science & Technology - Other Topics	CB5LO	WOS:000349668800001		
J	Sato, T; Kubota, K				Sato, Taisuke; Kubota, Keiichi			Viterbi training in PRISM	THEORY AND PRACTICE OF LOGIC PROGRAMMING			English	Article						Viterbi training; PRISM; exclusiveness condition	BAYESIAN NETWORK CLASSIFIERS; HIDDEN MARKOV-MODELS; ALGORITHM; PROGRAMS	VT (Viterbi training), or hard expectation maximization (EM), is an efficient way of parameter learning for probabilistic models with hidden variables. Given an observation y, it searches for a state of hidden variables x that maximizes p(x, y vertical bar theta) by coordinate ascent on parameters theta and x. In this paper we introduce VT to PRogramming In Statistical Modeling (PRISM), a logic-based probabilistic modeling system for generative models. VT improves PRISM in three ways. First, VT in PRISM converges faster than EM in PRISM due to VT's termination condition. Second, parameters learned by VT often show good prediction performance compared with those learned by EM. We conducted two parsing experiments with probabilistic grammars while learning parameters by a variety of inference methods, i.e. VT, EM, MAP and VB. The result is that VT achieved the best parsing accuracy among them in both experiments. Also, we conducted a similar experiment for classification tasks where a hidden variable is not a prediction target unlike probabilistic grammars. We found that in such a case VT does not necessarily yield superior performance. Third, since VT always deals with a single probability of a single explanation, Viterbi explanation, the exclusiveness condition imposed on PRISM programs is no more required if we learn parameters by VT. Last but not least, we can say that as VT in PRISM is general and applicable to any PRISM program, it largely reduces the need for the user to develop a specific VT algorithm for a specific model. Furthermore, since VT in PRISM can be used just by setting a PRISM flag appropriately, it makes VT easily accessible to (probabilistic) logic programmers.	[Sato, Taisuke; Kubota, Keiichi] Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan	Sato, T (reprint author), Tokyo Inst Technol, Meguro Ku, 2-12-1 Ookayama, Tokyo 152, Japan.	sato@mi.cs.titech.ac.jp; kubota@mi.cs.titech.ac.jp					Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Gutmann B, 2011, LECT NOTES ARTIF INT, V6911, P581, DOI 10.1007/978-3-642-23780-5_47; Jiang LX, 2009, IEEE T KNOWL DATA EN, V21, P1361, DOI 10.1109/TKDE.2008.234; De Raedt L, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2468; Sato T, 2001, J ARTIF INTELL RES, V15, P391; JUANG BH, 1990, IEEE T ACOUST SPEECH, V38, P1639, DOI 10.1109/29.60082; Riguzzi F, 2011, THEOR PRACT LOG PROG, V11, P433, DOI 10.1017/S147106841100010X; Kimmig A, 2008, LECT NOTES COMPUT SC, V5366, P175, DOI 10.1007/978-3-540-89982-2_22; Webb GI, 2005, MACH LEARN, V58, P5, DOI 10.1007/s10994-005-4258-6; Sato T, 2008, ANN MATH ARTIF INTEL, V54, P135, DOI 10.1007/s10472-009-9135-8; Bache K., 2013, UCI MACHINE LEARNING; Bellodi E., 2012, INTELL DATA ANAL, V16, P6; Brown P. F., 1993, Computational Linguistics, V19; Castillo G, 2005, LECT NOTES COMPUT SC, V3735, P70; Cohen S., 2010, P ASS COMP LING, P1502; De Raedt L., 2008, LNCS LNAI, V4911, P1; Getoor L, 2007, INTRO STAT RELATIONA; Goodman J., 1996, P 34 ANN M ASS COMP, P177, DOI 10.3115/981863.981887; Gutmann B, 2008, LECT NOTES ARTIF INT, V5211, P473, DOI 10.1007/978-3-540-87479-9_49; Huynh T., 2010, P AAAI 10 WORKSH STA, P32; Japkowicz N., 2011, EVALUATING LEARNING; Joshi D, 2006, IEEE T IMAGE PROCESS, V15, P1871, DOI 10.1109/TIP.2006.877039; Lember J, 2007, PROBAB ENG INFORM SC, V21, P451, DOI 10.1017/S0269964807000083; MacQueen J., 1967, P 5 BERK S MATH STAT, P281, DOI DOI 10.1234/12345678; Manning C., 1997, P INT WORKSH PARS TE, P147; Roark B., 1999, P 37 ANN M ASS COMP, P421, DOI 10.3115/1034678.1034743; Sato T., 2011, P 22 INT JOINT C ART, P1472; Sato T, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2605; Sato T., 1995, P 12 INT C LOG PROGR, P715; Sato T., 2008, LNCS, V4911, P118; Singla P., 2005, P 20 NAT C ART INT A, V5, P868; Spitkovsky V., 2010, P 14 C COMP NAT LANG, P9; Strom N., 1999, P IEEE AUT SPEECH RE, P139; Su J., 2006, P 23 INT C MACH LEAR, P897, DOI 10.1145/1143844.1143957; Uratani N., 1994, TRIT0056 ATR INT TEL; Van Uytsel D., 2001, P IEEE AUT SPEECH RE, P210; Zhou NF, 2008, THEOR PRACT LOG PROG, V8, P81, DOI 10.1017/S147106840700316X; Zhou NF, 2010, PROC INT C TOOLS ART, P213, DOI 10.1109/ICTAI.2010.103	39	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1471-0684	1475-3081		THEOR PRACT LOG PROG	Theory Pract. Log. Program.	MAR	2015	15		2		SI		147	168		10.1017/S1471068413000677		22	Computer Science, Software Engineering; Computer Science, Theory & Methods; Logic	Computer Science; Science & Technology - Other Topics	CB5LO	WOS:000349668800002		
J	Hiraizumi, S; Nishinomiya, H; Oikawa, T; Sakagami, N; Sano, F; Nishino, O; Kurahara, T; Nishimoto, N; Ishiyama, O; Hasegawa, Y; Hashiyada, Y				Hiraizumi, S.; Nishinomiya, H.; Oikawa, T.; Sakagami, N.; Sano, F.; Nishino, O.; Kurahara, T.; Nishimoto, N.; Ishiyama, O.; Hasegawa, Y.; Hashiyada, Y.			Superovulatory response in Japanese Black cows receiving a single subcutaneous porcine follicle-stimulating hormone treatment or six intramuscular treatments over three days	THERIOGENOLOGY			English	Article						Superovulatory response; Single subcutaneous administration; Japanese Black cow	BEEF-CATTLE; LUTEINIZING-HORMONE; FOLLTROPIN-V; PERIPHERAL CONCENTRATIONS; EMBRYO QUALITY; ESTROUS-CYCLE; FSH; INJECTION; PMSG; PROGESTERONE	To reduce labor for superovulation treatment by twice-daily intramuscular (im) administration of FSH for more than 3 to 4 days, we investigated the superovulatory responses of Japanese Black cows to porcine FSH (pFSH) used as a single subcutaneous (Sc) administration at two different doses in two different volumes of saline. In experiment 1,20 Armour units (AU) of pFSH dissolved in either 10 mL (treatment A; n = 14) or 50 mL (treatment B; n = 14) of saline was administered subcutaneously in the neck region. In experiment 2, 30 AU of pFSH dissolved in either 10 mL (treatment C; n = 15) or 50 mL (treatment D; n = 15) of saline was administered subcutaneously in the neck region. The control animals in experiment 1 (n = 14) and experiment 2 (n = 15) received 20 AU of pFSH administered intramuscularly twice daily in decreasing doses for more than 3 days. In experiment 1, mean (+/- SEM) numbers of CL (15.4 +/- 2.5, 18.1 +/- 3.4, and 17.2 +/- 2.6), total number of ova and embryos (12.9 +/- 1.4, 15.9 +/- 3.5, and 16.2 +/- 2.8), and transferable embryos (7.5 +/- 2.0, 10.4 +/- 2.8, and 8.0 +/- 2.1) did not differ among treatments A, B, and control. In experiment 2, mean (+/- SEM) numbers of CL (20.5 +/- 4.3, 20.4 +/- 2.7, and 20.1 +/- 3.4), total number of ova and embryos (21.7 +/- 4.2, 17.3 +/- 3.4, and 16.5 +/- 3.2), and transferable embryos (8.1 +/- 1.6, 9.3 +/- 2.2, and 9.5 +/- 1.9) did not differ among treatments C, D, and control. Although there were no differences in serum pFSH concentrations among the three treatments at each of the time points in experiment 1, in experiment 2, the serum pFSH concentration at 6 and 8 hours after pFSH administration in treatment C (3.1 +/- 0.8, 2.7 +/- 0.5 ng/mL, mean SEM) was significantly greater (P < 0.05) than in the control (0.7 +/- 0.1, 1.1 +/- 0.2 ng/mL). At 10 hours after administration, the pFSH concentration had decreased and there were no differences among the three treatments at subsequent time points. These results suggest that increasing the volume of saline or the dose of pFSH does not affect the absorption pattern of pFSH administered as a single sc administration. In conclusions, single sc administration of pFSH at a dose of 20 or 30 AU dissolved in 10 or 50 mL of saline is able to induce a superovulatory response comparable with that obtained by twice-daily im administration in Japanese Black cows. (C) 2015 Elsevier Inc. All rights reserved.	[Hiraizumi, S.; Nishimoto, N.; Ishiyama, O.] Livestock Res Inst, Aomori Prefectural Ind Technol Res Ctr, Noheji, Aomori, Japan; [Nishinomiya, H.] Akita Prefectural Agr Forestry & Fisheries Res Ct, Livestock Expt Stn, Akita, Japan; [Oikawa, T.] Miyagi Prefectural Livestock Expt Stn, Iwadeyama, Miyagi, Japan; [Sakagami, N.] Kanagawa Prefectural Livestock Technol Ctr, Kanagawa, Japan; [Sano, F.] Shizuoka Prefectural Res Inst Anim Ind, Shizuoka, Japan; [Nishino, O.] Nara Prefectural Livestock Technol Ctr, Nara, Japan; [Kurahara, T.] Oita Prefectural Agr Forestry & Fisheries Res Ctr, Liver Res Ctr, Oita, Japan; [Hasegawa, Y.] Kitasato Univ, Lab Expt Anim Sci, Towada, Aomori, Japan; [Hashiyada, Y.] Natl Livestock Breeding Ctr, Fukushima, Japan	Hiraizumi, S (reprint author), Livestock Res Inst, Aomori Prefectural Ind Technol Res Ctr, Noheji, Aomori, Japan.	Shingo_hiraizumi@aomori-itc.or.jp					KANEKO H, 1992, BIOL REPROD, V47, P76, DOI 10.1095/biolreprod47.1.76; JENSEN AM, 1982, THERIOGENOLOGY, V18, P33, DOI 10.1016/0093-691X(82)90046-2; Albrecht E, 2011, MEAT SCI, V89, P13, DOI 10.1016/j.meatsci.2011.03.012; HERRLER A, 1991, THERIOGENOLOGY, V35, P633, DOI 10.1016/0093-691X(91)90459-Q; Noguchi M, 2010, REPRODUCTION, V139, P153, DOI 10.1530/REP-09-0018; DIELEMAN SJ, 1993, THERIOGENOLOGY, V39, P25, DOI 10.1016/0093-691X(93)90022-W; Kaneko H, 2002, BIOL REPROD, V67, P38, DOI 10.1095/biolreprod67.1.38; Gotoh T, 2009, MEAT SCI, V82, P300, DOI 10.1016/j.meatsci.2009.01.026; MOOR RM, 1984, THERIOGENOLOGY, V21, P103, DOI 10.1016/0093-691X(84)90310-8; Sugano M, 1997, J VET MED SCI, V59, P223, DOI 10.1292/jvms.59.223; DEMOUSTIER MM, 1988, THERIOGENOLOGY, V30, P379, DOI 10.1016/0093-691X(88)90185-9; BEVERS MM, 1989, J REPROD FERTIL, V87, P745; BO GA, 1994, THERIOGENOLOGY, V42, P963, DOI 10.1016/0093-691X(94)90119-4; BOLAND MP, 1978, THERIOGENOLOGY, V10, P175, DOI 10.1016/0093-691X(78)90018-3; BOOTH WD, 1975, VET REC, V97, P366; da Costa LL, 2001, THERIOGENOLOGY, V56, P65, DOI 10.1016/S0093-691X(01)00543-X; DONALDSON L E, 1991, Theriogenology, V35, P195, DOI 10.1016/0093-691X(91)90171-9; DONALDSON LE, 1986, THERIOGENOLOGY, V25, P747, DOI 10.1016/0093-691X(86)90090-7; DONALDSON LE, 1986, VET REC, V119, P625; GOULDING D, 1991, THERIOGENOLOGY, V36, P949, DOI 10.1016/0093-691X(91)90320-D; HASLER JF, 1983, THERIOGENOLOGY, V19, P83, DOI 10.1016/0093-691X(83)90125-5; KANEKO H, 1990, Japanese Journal of Animal Reproduction, V36, P77; Kaneko H, 2002, BIOL REPROD, V67, P1840, DOI 10.1095/biolrepod.102.007591; Kimura K, 2007, THERIOGENOLOGY, V68, P633, DOI 10.1016/j.theriogenology.2007.02.016; National Agriculture and Food Research Organization NARO, 2008, JAP FEED STAND BEEF; Satoh H., 1996, Theriogenology, V45, P332, DOI 10.1016/0093-691X(96)84805-9; SMITH LE, 1973, J ANIM SCI, V37, P523; Stringfellow DA, 1998, MANUAL INT EMBRYO TR; SUZUKI T, 1994, VET REC, V135, P41; TAKEDOMI T, 1995, THERIOGENOLOGY, V43, P1259, DOI 10.1016/0093-691X(95)00097-R; Tribulo A, 2011, ANIM REPROD SCI, V129, P7, DOI 10.1016/j.anireprosci.2011.10.013; Tribulo A, 2012, THERIOGENOLOGY, V77, P1679, DOI 10.1016/j.theriogenology.2011.12.013; TRIBULO H, 1991, Theriogenology, V35, P286, DOI 10.1016/0093-691X(91)90262-C; Wagyu Registry Association, 2009, WAGY REG ASS HDB WAG; Yamamoto M, 1994, THERIOGENOLOGY, V41, P745; Yamamoto Masao, 1993, Journal of Reproduction and Development, V39, P353; Yamamoto Masao, 1995, Journal of Reproduction and Development, V41, P93, DOI 10.1262/jrd.41.93; ZEMBAYASHI M, 1994, MEAT SCI, V38, P367, DOI 10.1016/0309-1740(94)90063-9	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0093-691X	1879-3231		THERIOGENOLOGY	Theriogenology	MAR 1	2015	83	4					466	473		10.1016/j.theriogenology.2014.09.012		8	Reproductive Biology; Veterinary Sciences	Reproductive Biology; Veterinary Sciences	CB3FE	WOS:000349512800002		
J	Appeltant, R; Somfai, T; Nakai, M; Bodo, S; Maes, D; Kikuchi, K; Van Soom, A				Appeltant, R.; Somfai, T.; Nakai, M.; Bodo, S.; Maes, D.; Kikuchi, K.; Van Soom, A.			Interactions between oocytes and cumulus cells during in vitro maturation of porcine cumulus-oocyte complexes in a chemically defined medium: Effect of denuded oocytes on cumulus expansion and oocyte maturation	THERIOGENOLOGY			English	Article						Porcine; IVM; Cumulus expansion; Nuclear maturation; Defined medium; Denuded oocyte	GROWTH-DIFFERENTIATION FACTOR-9; DEVELOPMENTAL COMPETENCE; SECRETED FACTORS; FOLLICULAR-FLUID; BOVINE OOCYTES; PIG OOCYTES; FERTILIZATION; EMBRYO; VIVO; BLASTOCYSTS	The aim of the present study was to clarify interactions between oocytes and cumulus cells (CCs) on the level of cumulus expansion and oocyte maturation during IVM of cumulus-oocyte complexes (COCs) in a chemically defined medium using a system that allows individual tracking of oocytes. Especially, the influence of oocyte-secreted factors was investigated by the aid of addition of denuded oocytes (DOs) as a possible approach to improve the IVM system. The basic maturation medium was porcine oocyte medium with addition of gonadotropins only during the first 20 hours of IVM. During IVM, COCs were kept fixed to the bottom of culture dish by adhesive Cell-Tak coating, which enabled individual tracking of COCs during IVM. Size changes in COCs during IVM were measured by digital image analysis. Cumulus expansion in a porcine oocyte medium of intact COCs increased in a typical manner until 20 hours and decreased in size subsequently until 48 hours of IVM (P < 0.05). Removal of oocytes from COCs by oocytectomy allowed the expansion of CCs to some extent, although their expansion ability was lower than that of COCs (P < 0.05). Addition of DOs (COCs to DOs ratio of 9:16) did not improve cumulus expansion and oocyte maturation rates of intact COCs (P > 0.05) but did enhance cumulus expansion of oocytectomized complexes (P < 0.05). Furthermore, removal of CCs before IVM increased oocyte maturation rates compared with COCs (523% and 32.9%, respectively) (P < 0.05) and a similar effect was observed in COCs when the gap junction inhibitor carbenoxolone was added to the IVM medium: carbenoxolone repressed the expansion of COCs at 20 hours of IVM. In conclusion, the porcine oocyte enhances cumulus expansion both by gap junctional communications and presumably by oocyte-secreted factor production. Nevertheless, the presence of oocytes is not a prerequisite for this process. In return, CCs maintain meiotic arrest in cumulus-enclosed oocytes during the initial culture through gap junctions. On the basis of these findings, future research could investigate if coculture with DOs during IVM is beneficial for fertilization and embryo development. (C) 2015 Elsevier Inc. All rights reserved.	[Appeltant, R.; Maes, D.; Van Soom, A.] Univ Ghent, Dept Reprod Obstet & Herd Hlth, Fac Vet Med, Merelbeke, Belgium; [Somfai, T.] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Nakai, M.] Natl Inst Agrobiol Sci, Transgen Pig Res Unit, Ibaraki, Japan; [Bodo, S.] Szent Istvan Univ, NARIC Agr Biotechnol Inst, Godollo, Hungary; [Kikuchi, K.] Natl Inst Agrobiol Sci, Genet Div Dept, Tsukuba, Ibaraki, Japan	Appeltant, R (reprint author), Univ Ghent, Dept Reprod Obstet & Herd Hlth, Fac Vet Med, Merelbeke, Belgium.	ruth.appeltant@ugent.be			Facultaire commissie voor wetenschappelijk onderzoek (FCWO) of the UGent, Faculty of Veterinary Medicine; Fonds Wetenschappelijk Onderzoek-Flanders [FWO11/ASP/276]	The authors would like to thank the Facultaire commissie voor wetenschappelijk onderzoek (FCWO) of the UGent, Faculty of Veterinary Medicine for the financial support of this cooperation and to Fonds Wetenschappelijk Onderzoek-Flanders for the financial support (grant number FWO11/ASP/276). They would also like to thank the host institution UGent, Faculty of Veterinary Medicine, Department of Reproduction, Obstetrics, and Herd Health. This research has benefited from a statistical consulting services from Ghent University FIRE (Fostering Innovative Research based on Evidence).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Akaki Y, 2009, J REPROD DEVELOP, V55, P446; Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; Li HK, 2008, ANIM REPROD SCI, V103, P312, DOI 10.1016/j.anireprosci.2006.12.017; Bagg MA, 2006, MOL REPROD DEV, V73, P1326, DOI 10.1002/mrd.20555; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Maedomari N, 2007, THERIOGENOLOGY, V67, P983, DOI 10.1016/j.theriogenology.2006.11.012; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Hussein TS, 2005, J CELL SCI, V118, P5257, DOI 10.1242/jcs.02644; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Gomez MNL, 2012, ZYGOTE, V20, P135, DOI 10.1017/S0967199411000256; Stokes PJ, 2005, DEV BIOL, V284, P62, DOI 10.1016/j.ydbio.2005.05.001; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Gil MA, 2010, REPROD DOMEST ANIM, V45, P40, DOI 10.1111/j.1439-0531.2010.01623.x; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; ODoherty EM, 1997, THERIOGENOLOGY, V48, P161, DOI 10.1016/S0093-691X(97)00200-8; Xia GL, 2000, THERIOGENOLOGY, V53, P1807, DOI 10.1016/S0093-691X(00)00316-2; REED ML, 1993, J EXP ZOOL, V266, P74, DOI 10.1002/jez.1402660111; Funahashi H, 1996, BIOL REPROD, V54, P1412, DOI 10.1095/biolreprod54.6.1412; Bijttebier J, 2009, PROTEOMICS, V9, P4554, DOI 10.1002/pmic.200900270; Brankin Victoria, 2003, Reprod Biol Endocrinol, V1, P55, DOI 10.1186/1477-7827-1-55; Buccione R, 1990, BIOL REPROD, V41, P176; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; Chian R. C., 1994, Theriogenology, V41, P176, DOI 10.1016/S0093-691X(05)80086-X; COSKUN S, 1995, BIOL REPROD, V53, P670, DOI 10.1095/biolreprod53.3.670; Dragovic RA, 2005, ENDOCRINOLOGY, V146, P2798, DOI 10.1210/en.2005-0098; Matoba S, 2010, REPROD FERT DEVELOP, V22, P839; MATTIOLI M, 1994, J REPROD FERTIL, V100, P403; Mito T, 2013, MOL REPROD DEV, V80, P549, DOI 10.1002/mrd.22190; Nakai M, 2005, J MAMM OVA RES, V22, P159, DOI DOI 10.1274/JMOR.22.159; Ozawa M, 2010, J CELL PHYSIOL, V222, P294, DOI 10.1002/jcp.21949; PINYOPUMMINTR T, 1991, BIOL REPROD, V45, P736, DOI 10.1095/biolreprod45.5.736; PROCHAZKA R, 1991, J REPROD FERTIL, V93, P569; SINGH B, 1993, ENDOCRINOLOGY, V132, P1860, DOI 10.1210/en.132.4.1860; Somfai T, 2003, ZYGOTE, V11, P199, DOI 10.1017/S0967199403002247; VANDERHYDEN BC, 1993, J REPROD FERTIL, V98, P219	39	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0093-691X	1879-3231		THERIOGENOLOGY	Theriogenology	MAR 1	2015	83	4					567	576		10.1016/j.theriogenology.2014.10.026		10	Reproductive Biology; Veterinary Sciences	Reproductive Biology; Veterinary Sciences	CB3FE	WOS:000349512800016		
J	Sakurai, M; Suzuki, C; Yoshioka, K				Sakurai, Masahiro; Suzuki, Chie; Yoshioka, Koji			Effect of knockout serum replacement supplementation to culture medium on porcine blastocyst development and piglet production	THERIOGENOLOGY			English	Article						Blastocyst hatching; In vitro embryo production; Knockout serum replacement; Nonsurgical embryo transfer; Pig	IN-VITRO PRODUCTION; CHEMICALLY-DEFINED MEDIUM; PLASMINOGEN-ACTIVATOR PRODUCTION; INNER CELL MASS; EMBRYO DEVELOPMENT; BOVINE EMBRYOS; ENERGY-METABOLISM; OOCYTE MATURATION; GROWTH-FACTORS; COMPETENCE	We have previously developed chemically defined media suitable for in vitro production (IVP) of porcine embryos and subsequently generated piglets by nonsurgical embryo transfer. In this study, to further improve the culture conditions for IVP of porcine embryos, we evaluated the effect of knockout serum replacement (KSR), a substitute for serum or albumin, on the viability and development of porcine blastocysts. The addition of 5% (v:v) KSR to porcine blastocyst medium (PBM) on Day 5 (Day 0 = IVF) significantly increased the survival and hatching rates of blastocysts and the total cell number of Day-7 blastocysts compared with those in cultures without KSR or addition of 10% fetal bovine serum. Furthermore, the number of cells in the trophectoderm of Day-6 blastocysts and the ATP content of Day-7 blastocysts cultured with 5% KSR were significantly higher than those of blastocysts cultured without KSR. The mRNA expression of a rate-limiting enzyme in beta-oxidation, carnitine palmitoyltransferase 1, in Day-6 blastocysts, and a serine proteinase, urokinase-type plasminogen activator, in Day-7 blastocysts cultured in 5% KSR-PBM was significantly higher than that of blastocysts cultured in PBM alone. Four of eight recipients (50%), in which Day-5 blastocysts treated with 5% KSR were transferred nonsurgically, became pregnant. However, the efficiency of piglet production (percentage of piglets born based on the number of embryos transferred) was similar to recipients with transferred blastocysts treated without KSR. The present study demonstrated that the addition of KSR to PBM enhanced the in vitro viability of porcine blastocysts. In addition, our data suggest that KSR improved development to the hatching stage and blastocyst quality by increasing ATP content and hatching-related mRNA expression of blastocysts. (C) 2015 Elsevier Inc. All rights reserved.	[Sakurai, Masahiro; Suzuki, Chie; Yoshioka, Koji] Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki 305, Japan	Yoshioka, K (reprint author), Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki 305, Japan.	kojiyos@affrc.go.jp		Sakurai, Masahiro/0000-0002-6376-0299	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Society for the Promotion of Science (JSPS) [25292184]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [25052C]	This research was supported in part by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Technology Research Advancement Institution (BRAIN), a Grant-in-Aid for Scientific Research B (No. 25292184) from the Japan Society for the Promotion of Science (JSPS), and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (25052C) from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Bonen A, 2007, PHYSIOLOGY, V22, P15; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Noguchi M, 2010, REPRODUCTION, V139, P153, DOI 10.1530/REP-09-0018; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Mito T, 2012, REPROD FERT DEVELOP, V24, P443, DOI 10.1071/RD11197; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Biswas D, 2011, THERIOGENOLOGY, V76, P153, DOI 10.1016/j.theriogenology.2011.01.005; Funahashi H, 2001, MOL REPROD DEV, V58, P424, DOI 10.1002/1098-2795(20010401)58:4<424::AID-MRD10>3.0.CO;2-1; Marchal R, 2001, THERIOGENOLOGY, V56, P17, DOI 10.1016/S0093-691X(01)00539-8; Nagai T, 2006, FRONT BIOSCI, V11, P2565, DOI 10.2741/1991; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197; Beebe LFS, 2009, J REPROD DEVELOP, V55, P373; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Choi YH, 2002, THERIOGENOLOGY, V58, P1187, DOI 10.1016/S0093-691X(02)00946-9; COATES AA, 1994, J ANIM SCI, V72, P2936; Denker H W, 1977, Adv Anat Embryol Cell Biol, V53, P3; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Goldsborough MD, 1998, FOCUS, V20, P8; Im GS, 2004, THERIOGENOLOGY, V61, P1125, DOI 10.1016/j.theriogenology.2003.06.006; JOSHI MS, 1974, J REPROD FERTIL, V37, P361; KAAEKUAHIWI MA, 1990, J ANIM SCI, V68, P2009; Kikuchi K, 2008, REPROD DOMEST ANIM, V43, P401, DOI 10.1111/j.1439-0531.2008.01191.x; Krisher RL, 1999, BIOL REPROD, V60, P1345, DOI 10.1095/biolreprod60.6.1345; MENINO AR, 1987, BIOL REPROD, V36, P1289, DOI 10.1095/biolreprod36.5.1289; MENINO AR, 1989, BIOL REPROD, V41, P899, DOI 10.1095/biolreprod41.5.899; Mingoti GZ, 2011, IN VITRO CELL DEV-AN, V47, P361, DOI 10.1007/s11626-011-9400-0; PAPAIOANNOU VE, 1988, DEVELOPMENT, V102, P793; Price PJ, 1998, Embryonic stem cell serum replacement: U. S. Patent, Patent No. [WO/1998/30679, 199830679]; Sargent IL, 1998, HUM REPROD, V13, P239; Seshagiri PB, 2002, J REPROD IMMUNOL, V53, P203, DOI 10.1016/S0165-0378(01)00086-9; Suzuki M, 2006, THERIOGENOLOGY, V65, P374, DOI 10.1016/j.theriogenology.2005.05.039; Tilkins ML, 1998, Embryonic stem cell serum replacement: U. S. Patent, Patent No. [PCT/US1998/000467, 1998000467]; Tsujii H, 2001, J MAMM OVA RES, V18, P73, DOI DOI 10.1274/JMOR.18.73; Wang WH, 2002, ZYGOTE, V10, P109, DOI 10.1017/S0967199402002150; Yoshioka K, 2012, ANIM REPROD SCI, V131, P23, DOI 10.1016/j.anireprosci.2012.01.018; Yoshioka K, 2011, J REPROD DEVELOP, V57, P9, DOI 10.1262/jrd.10-196E; Zhang W, 2012, ANIM REPROD SCI, V132, P115, DOI 10.1016/j.anireprosci.2012.05.008; Zhang X, 1996, BIOL REPROD, V54, P1052, DOI 10.1095/biolreprod54.5.1052	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0093-691X	1879-3231		THERIOGENOLOGY	Theriogenology	MAR 1	2015	83	4					679	686		10.1016/j.theriogenology.2014.11.003		8	Reproductive Biology; Veterinary Sciences	Reproductive Biology; Veterinary Sciences	CB3FE	WOS:000349512800029		
J	Matsuura, K; Kodama, F; Sugiyama, K; Shimizu, T; Hagiwara, N; Okano, T				Matsuura, Katsuhisa; Kodama, Fumiko; Sugiyama, Kasumi; Shimizu, Tatsuya; Hagiwara, Nobuhisa; Okano, Teruo			Elimination of Remaining Undifferentiated Induced Pluripotent Stem Cells in the Process of Human Cardiac Cell Sheet Fabrication Using a Methionine-Free Culture Condition	TISSUE ENGINEERING PART C-METHODS			English	Article							FUNCTIONAL 3-DIMENSIONAL TISSUES; IN-VITRO; METHYLTHIOADENOSINE PHOSPHORYLASE; HUMAN FIBROBLASTS; MOUSE; METABOLISM; HEART; TRANSPLANTATION; CARDIOMYOCYTES; TECHNOLOGY	Cardiac tissue engineering is a promising method for regenerative medicine. Although we have developed human cardiac cell sheets by integration of cell sheet-based tissue engineering and scalable bioreactor culture, the risk of contamination by induced pluripotent stem (iPS) cells in cardiac cell sheets remains unresolved. In the present study, we established a novel culture method to fabricate human cardiac cell sheets with a decreased risk of iPS cell contamination while maintaining viabilities of iPS cell-derived cells, including cardiomyocytes and fibroblasts, using a methionine-free culture condition. When cultured in the methionine-free condition, human iPS cells did not survive without feeder cells and could not proliferate or form colonies on feeder cells or in coculture with cells for cardiac cell sheet fabrication. When iPS cell-derived cells after the cardiac differentiation were transiently cultured in the methionine-free condition, gene expression of OCT3/4 and NANOG was downregulated significantly compared with that in the standard culture condition. Furthermore, in fabricated cardiac cell sheets, spontaneous and synchronous beating was observed in the whole area while maintaining or upregulating the expression of various cardiac and extracellular matrix genes. These findings suggest that human iPS cells are methionine dependent and a methionine-free culture condition for cardiac cell sheet fabrication might reduce the risk of iPS cell contamination.	[Matsuura, Katsuhisa; Kodama, Fumiko; Sugiyama, Kasumi; Shimizu, Tatsuya; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; [Matsuura, Katsuhisa; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo 1628666, Japan	Matsuura, K (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	matsuura.katsuhisa@twmu.ac.jp			Japan Society for the Promotion of Science through Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy; Projects for Technological Development in Research Center Network for Realization of Regenerative Medicine of the Japan Science and Technology Agency	The authors would like to thank Dr. Akiyama and Dr. Iimuro for the fruitful discussion. This work was funded by a grant from the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy and a grant from Projects for Technological Development in Research Center Network for Realization of Regenerative Medicine of the Japan Science and Technology Agency.	Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Cavuoto P, 2012, CANCER TREAT REV, V38, P726, DOI 10.1016/j.ctrv.2012.01.004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Haberkorn U, 2011, ONCOGENE, V30, P4141, DOI 10.1038/onc.2011.169; Sato M, 2014, ANAT REC, V297, P36, DOI 10.1002/ar.22829; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Behrmann I, 2003, AM J PATHOL, V163, P683, DOI 10.1016/S0002-9440(10)63695-4; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Matsuura K, 2011, BIOMATERIALS, V32, P7355, DOI 10.1016/j.biomaterials.2011.05.042; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Christopher SA, 2002, CANCER RES, V62, P6639; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/nmeth.1403, 10.1038/NMETH.1403]; Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050; HALPERN BC, 1974, P NATL ACAD SCI USA, V71, P1133, DOI 10.1073/pnas.71.4.1133; Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Matsuura K, 2013, J CONTROL RELEASE, V169, P336, DOI 10.1016/j.jconrel.2013.03.003; Matsuura K, 2014, ANAT REC, V297, P65, DOI 10.1002/ar.22834; Matsuura K, 2014, INT HEART J, V55, P1; Matsuura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052176; Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316; Sakai H, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P229; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; Yu J, 1997, CLIN CANCER RES, V3, P433	35	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	MAR 1	2015	21	3					330	338		10.1089/ten.tec.2014.0198		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CC0RL	WOS:000350043400011		
J	Punpongsanon, P; Iwai, D; Sato, K				Punpongsanon, Parinya; Iwai, Daisuke; Sato, Kosuke			Projection-based visualization of tangential deformation of nonrigid surface by deformation estimation using infrared texture	VIRTUAL REALITY			English	Article						Projection-based mixed reality; User interaction; Deformable surface	FIELDS	In this paper, we propose a projection-based mixed reality system that visualizes the tangential deformation of a nonrigid surface by superimposing graphics directly onto the surface by projected imagery. The superimposed graphics are deformed according to the surface deformation. To achieve this goal, we develop a computer vision technique that estimates the tangential deformation by measuring the frame-by-frame movement of an infrared (IR) texture on the surface. IR ink, which can be captured by an IR camera under IR light, but is invisible to the human eye, is used to provide the surface texture. Consequently, the texture does not degrade the image quality of the augmented graphics. The proposed technique measures individually the surface motion between two successive frames. Therefore, it does not suffer from occlusions caused by interactions and allows touching, pushing, pulling, and pinching, etc. The moving least squares technique interpolates the measured result to estimate denser surface deformation. The proposed method relies only on the apparent motion measurement; thus, it is not limited to a specific deformation characteristic, but is flexible for multiple deformable materials, such as viscoelastic and elastic materials. Experiments confirm that, with the proposed method, we can visualize the surface deformation of various materials by projected illumination, even when the user's hand occludes the surface from the camera.	[Punpongsanon, Parinya; Iwai, Daisuke; Sato, Kosuke] Osaka Univ, Toyonaka, Osaka 5608531, Japan	Punpongsanon, P (reprint author), Osaka Univ, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	parinya@sens.sys.es.osaka-u.ac.jp; daisuke.iwai@sys.es.osaka-u.ac.jp; sato@sys.es.osakau.ac.jp					Sato T, 2009, UIST 2009: PROCEEDINGS OF THE 22ND ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P43; Schaefer S, 2006, ACM T GRAPHIC, V25, P533, DOI 10.1145/1141911.1141920; Raskar R, 2001, SPRING EUROGRAP, P89; Pilet J, 2008, INT J COMPUT VISION, V76, P109, DOI 10.1007/s11263-006-0017-9; Alvarez L, 2000, INT J COMPUT VISION, V39, P41, DOI 10.1023/A:1008170101536; Mine M, 2012, COMPUTER, V45, P32, DOI 10.1109/MC.2012.154; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593; Bandyopadhyay D, 2001, IEEE AND ACM INTERNATIONAL SYMPOSIUM ON AUGMENTED REALITY, PROCEEDINGS, P207; Bimber O, 2008, ACM T GRAPHIC, V27; Bimber O., 2005, SPATIAL AUGMENTED RE; Bluteau J, 2005, P 2005 INT C AUGM TE, P98, DOI 10.1145/1152399.1152418; Chang RC, 2010, 3 IEEE INT C UB MED, P44; Follmer S, 2011, P 24 ANN ACM S US IN, P527, DOI DOI 10.1145/2047196.2047265; Fujimoto Y, 2014, IEEE T VIS COMPUT GR, V20, P540, DOI 10.1109/TVCG.2014.25; Haouchine N, 2012, WORKSH VIRT REAL INT; Heo S., 2013, P SIGCHI C HUM FACT, P281; Hisada M, 2006, SICE ICASE INT JOINT, P4832; Ito Y, 2014, ADV ROBOT AUTOM, V3; Iwai D, 2010, VIRTUAL REAL, V15, P147; Johnson MH, 2011, SEMIN ULTRASOUND CT, V32, P1, DOI 10.1053/j.sult.2010.11.003; Jones B., 2013, P SIGCHI C HUM FACT, P869, DOI DOI 10.1145/2470654.2466112; Kamiyama K, 2005, IEEE COMPUT GRAPH, V25, P68, DOI 10.1109/MCG.2005.27; Kocev B, 2013, INT J COMPUT ASSIST, V8, P1015; Matoba Y, 2012, ACM SIGGRAPH EMERGIN; Ni T., 2011, P 2011 C HUM FACT CO, P3333; Piper B., 2002, P SIGCHI C HUM FACT, P355, DOI DOI 10.1145/503376.503439; Raskar R., 2006, P INT S NONPH AN REN, P7; Rivers A., 2012, ACM T GRAPHIC, V31, P157; Saakes D, 2010, ACM SIGGRAPH EMERGIN, P22; Shimazu S, 2011, P 2011 10 IEEE INT S, P235; Shimizu N, 2013, INT C COMP VIS THEOR, P1; Steimle J, 2013, P SIGCHI C HUM FACT, P237; Uchiyama H, 2011, P ISMAR, P237; Uchiyama H, 2011, P IEEE VIRT REAL ANN, P35, DOI 10.1109/VR.2011.5759433; Vlack K., 2005, CHI 05, P1154, DOI 10.1145/1056808.1056859; Wu HY, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185561	36	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1359-4338	1434-9957		VIRTUAL REAL-LONDON	Virtual Real.	MAR	2015	19	1					45	56		10.1007/s10055-014-0256-y		12	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	CB5CS	WOS:000349645700004		
J	Tsuboyama, T; Yamamoto, K; Nakai, G; Yamada, T; Fujiwara, S; Terai, Y; Ohmichi, M; Narumi, Y				Tsuboyama, Takahiro; Yamamoto, Kazuhiro; Nakai, Go; Yamada, Takashi; Fujiwara, Satoe; Terai, Yoshito; Ohmichi, Masahide; Narumi, Yoshifumi			A case of gastric-type adenocarcinoma of the uterine cervix associated with lobular endocervical glandular hyperplasia: radiologic-pathologic correlation	ABDOMINAL IMAGING			English	Article						Uterine cervix; Gastric-type adenocarcinoma; MDA; LEGH; MRI	ADENOMA MALIGNUM; IMMUNOPHENOTYPE; LESIONS	Gastric-type adenocarcinoma (GAS) of the uterine cervix is a recently defined subtype of mucinous adenocarcinoma. GAS is proposed to include minimal deviation adenocarcinoma (MDA) as a very well-differentiated form and has been suggested to arise from lobular endocervical glandular hyperplasia (LEGH). We report the magnetic resonance imaging (MRI) findings of a GAS associated with LEGH. On MRI, the LEGH component was detected as multiple cystic lesions arranged in a "cosmos pattern", while the GAS was depicted as a predominantly solid lesion containing obvious adenocarcinoma and MDA components, which appeared as mass-like and infiltrative components, respectively. The GAS exhibited tiny cysts on three-dimensional T2-weighted images, high intensity on diffusion-weighted images mostly due to T2 shine-through effect according to apparent diffusion coefficient (ADC) map, and reticular enhancement on dynamic contrast-enhanced MRI, which reflected numerous dilated glandular structures of the tumor. Low ADC was only observed at the deepest invasion front of the obvious adenocarcinoma component. Our case suggests that the MRI features of GAS vary depending on the tumor's histological components, and it is important to be aware of these imaging features when evaluating LEGH on MRI.	[Tsuboyama, Takahiro; Yamamoto, Kazuhiro; Nakai, Go; Narumi, Yoshifumi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan; [Yamada, Takashi] Osaka Med Coll, Dept Pathol, Takatsuki, Osaka 5698686, Japan; [Fujiwara, Satoe; Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan	Tsuboyama, T (reprint author), Osaka Med Coll, Dept Radiol, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ttsuboyama@gmail.com					Takatsu A, 2013, VIRCHOWS ARCH, V462, P645, DOI 10.1007/s00428-013-1417-1; Ishii K, 1998, VIRCHOWS ARCH, V432, P315, DOI 10.1007/s004280050172; Park SB, 2013, ACTA RADIOL, V54, P113, DOI 10.1258/ar.2012.120059; Tsuji T, 2011, HISTOPATHOLOGY, V59, P55, DOI 10.1111/j.1365-2559.2011.03886.x; Doi T, 1997, RADIOLOGY, V204, P39; Nucci MR, 1999, AM J SURG PATHOL, V23, P886, DOI 10.1097/00000478-199908000-00005; Mikami Y, 2004, MODERN PATHOL, V17, P962, DOI 10.1038/modpathol.3800148; Chen YB, 2011, ABDOM IMAGING, V36, P619, DOI 10.1007/s00261-010-9642-4; Mikami Y, 2013, ADV ANAT PATHOL, V20, P227, DOI 10.1097/PAP.0b013e31829c2d66; McCluggage WG, 2010, J CLIN PATHOL, V63, P935, DOI 10.1136/jcp.2010.080150; Kuang F, 2013, EUR RADIOL, V23, P1050, DOI 10.1007/s00330-012-2681-1; Kojima A, 2007, AM J SURG PATHOL, V31, P664, DOI 10.1097/01.pas.0000213434.91868.b0; Takatsu A, 2011, INT J GYNECOL CANCER, V21, P1287, DOI 10.1097/IGC.0b013e31821f746c; Kurman RJ, 2014, WHO CLASSIFICATION T	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	MAR	2015	40	3					459	465		10.1007/s00261-014-0323-6		7	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CB1CJ	WOS:000349363900001		
J	Kawai, Y; Nakamichi, R; Kamata, N; Miyake, H; Fujino, M; Itoh, S				Kawai, Yuichi; Nakamichi, Rei; Kamata, Noriko; Miyake, Hideo; Fujino, Masahiko; Itoh, Shigeki			A case of undifferentiated carcinoma of the pancreas mimicking main-duct intraductal papillary mucinous neoplasm (IPMN)	ABDOMINAL IMAGING			English	Article						Undifferentiated carcinoma of the pancreas; Main-duct intraductal papillary mucinous neoplasm; Intraductal tumor growth; Main pancreatic duct dilatation	ANAPLASTIC CARCINOMA; GIANT-CELLS; GROWTH; TUMOR; FEATURES	We report here a rare case of undifferentiated carcinoma of the pancreas mimicking main-duct intraductal papillary mucinous neoplasm. In an 80-year-old woman, an approximately 8-mm papillary mass was incidentally detected at the downstream edge of a dilatated main pancreatic duct lumen on CT and MRI. Main pancreatic duct dilatation in the pancreatic body and tail and parenchymal atrophy were observed in the upstream of the mass. Histopathologically, the tumor protruded into the downstream edge of the dilatated main pancreatic duct lumen in the pancreatic body. The tumor cells had highly atypical nuclei and abundant polymorphic structures, and showed positive staining for granulocyte colony-stimulating factor, which led to the diagnosis of undifferentiated carcinoma. A total of 13 cases of undifferentiated carcinoma with intraductal tumor growth have been reported to date. The case report by Bergmann et al. has been the smallest in histopathological specimen, and the present case is the smallest in size detected by radiological images. Since early undifferentiated carcinoma of the pancreas can resemble those of main-duct intraductal papillary mucinous neoplasm in cross-sectional images, we have to consider undifferentiated carcinoma in the differential diagnosis of the solitary and papillary mass with low contrast enhancement in early phase in the main pancreatic duct.	[Kawai, Yuichi; Nakamichi, Rei; Kamata, Noriko; Itoh, Shigeki] Japanese Red Cross Nagoya Daiichi Hosp, Dept Diagnost Radiol, Nakamura Ku, Nagoya, Aichi 4538511, Japan; [Miyake, Hideo] Japanese Red Cross Nagoya Daiichi Hosp, Nagoya, Aichi 4538511, Japan; [Fujino, Masahiko] Japanese Red Cross Nagoya Daiichi Hosp, Dept Pathol, Nagoya, Aichi 4538511, Japan	Kawai, Y (reprint author), Japanese Red Cross Nagoya Daiichi Hosp, Dept Diagnost Radiol, Nakamura Ku, 3-35 Michishita Cho, Nagoya, Aichi 4538511, Japan.	i4pt18sw@yk.commufa.jp					Adsay NV, 2010, WHO CLASSIFICATION T, P304; Strobel O, 2011, SURGERY, V149, P200, DOI 10.1016/j.surg.2010.04.026; Ichikawa T, 2000, ABDOM IMAGING, V25, P409; Bergmann F, 2007, AM J SURG PATHOL, V31, P1919, DOI 10.1097/PAS.0b013e318067bca8; Castellano-Megías Víctor M, 2014, World J Gastrointest Oncol, V6, P311, DOI 10.4251/wjgo.v6.i9.311; Higuchi R, 2004, SUIZO, V19, P516; Imamura M, 2009, SURG TODAY, V39, P1006, DOI 10.1007/s00595-009-3968-y; Isaka T, 2005, JPN J GASTROENTEROL, V102, P736; Ishigami K, 2008, AM J ROENTGENOL, V191, P1836, DOI 10.2214/AJR.07.4005; Ishii S, 2012, INTERNAL MED, V51, P3373, DOI 10.2169/internalmedicine.51.8779; Kuroda N, 2007, MED MOL MORPHOL, V40, P168, DOI 10.1007/s00795-006-0349-0; Maksymov Vlad, 2011, JOP, V12, P170; Matsumura Y, 2007, JPN J GASTROENTEROL, V40, P456, DOI [10.5833/jjgs.40.456, DOI 10.5833/JJGS.40.456]; Mizukami Yusuke, 1997, Japanese Journal of Gastroenterology, V94, P706; Nara S, 2010, JPN J CLIN ONCOL, V40, P96, DOI 10.1093/jjco/hyp189; Okazaki M, 2014, WORLD J GASTROENTERO, V20, P852, DOI 10.3748/wjg.v20.i3.852; Onoe S, 2007, JPN J GASTROENTEROL, V40, P313, DOI [10.5833/jjgs.40.313, DOI 10.5833/JJGS.40.313]; Paal E, 2001, Ann Diagn Pathol, V5, P129, DOI 10.1053/adpa.2001.25404; Shirobe T, 1995, SUIZO, V10, P387; Suzuki S, 2007, SUIZO, V22, P137, DOI 10.2958/suizo.22.137; Tezuka K, 2006, PANCREAS, V33, P304, DOI 10.1097/01.mpa.0000235303.11734.2a; Yamano T, 2013, J JAPAN SURG ASS, V74, P1053; Yazawa N, 2011, SURG TODAY, V41, P737, DOI 10.1007/s00595-009-4321-1	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	MAR	2015	40	3					466	470		10.1007/s00261-014-0326-3		5	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CB1CJ	WOS:000349363900002		
J	Kaneda, S; Fujii, S; Nosaka, K; Inoue, C; Tanabe, Y; Matsuki, T; Ogawa, T				Kaneda, Sachi; Fujii, Shinya; Nosaka, Kanae; Inoue, Chie; Tanabe, Yoshio; Matsuki, Tsutomu; Ogawa, Toshihide			MR imaging findings of mass-forming endosalpingiosis in both ovaries: a case report	ABDOMINAL IMAGING			English	Article						Endosalpingiosis; Ovary; Tumor-like; Magnetic resonance imaging	FLORID CYSTIC ENDOSALPINGIOSIS; TUMOR; INVOLVEMENT; EMPHASIS; UTERUS	A 50-year-old postmenopausal woman, who underwent ultrasonography at a periodic medical checkup, was found to have bilateral ovarian masses. Pelvic magnetic resonance imaging (MRI) showed bilateral multilocular cystic ovarian masses. The cyst walls and septal structure demonstrated contrast enhancement. She underwent bilateral salpingo-oophorectomy. Microscopic examination revealed that the cysts were lined with cuboidal or columnar epithelial cells, and some of the cells were ciliated. The final histopathological diagnosis was endosalpingiosis. Endosalpingiosis is defined as the presence of ectopic ciliated epithelium, resembling the normal endosalpinx, without endometrial stroma. It rarely presents as a tumor-like mass on MRI.	[Kaneda, Sachi; Tanabe, Yoshio; Matsuki, Tsutomu] Tottori Municipal Hosp, Dept Radiol, Tottori 6808501, Japan; [Fujii, Shinya; Inoue, Chie; Ogawa, Toshihide] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 683, Japan; [Nosaka, Kanae] Tottori Univ, Fac Med, Dept Pathol, Yonago, Tottori 683, Japan	Kaneda, S (reprint author), Tottori Municipal Hosp, Dept Radiol, 1-1 Matoba, Tottori 6808501, Japan.	sachi785@hotmail.com					Heinig J, 2002, EUR J OBSTET GYN R B, V103, P75, DOI 10.1016/S0301-2115(02)00020-9; Carrick KS, 2003, INT J GYNECOL PATHOL, V22, P412, DOI 10.1097/01.pgp.0000092155.33490.52; Djordjevic B, 2010, AM J SURG PATHOL, V34, P1442, DOI 10.1097/PAS.0b013e3181f17d33; Jung SE, 2002, RADIOGRAPHICS, V22, P1305, DOI 10.1148/rg.226025033; Arai Y, 1999, Nihon Hinyokika Gakkai Zasshi, V90, P802; Bazot M, 1999, CLIN RADIOL, V54, P482, DOI 10.1016/S0009-9260(99)90840-1; Brown DL, 2001, RADIOLOGY, V219, P213; Cil AP, 2008, ULTRASOUND OBST GYN, V32, P106, DOI 10.1002/uog.5346; Clement PB, 1999, AM J SURG PATHOL, V23, P166, DOI 10.1097/00000478-199902000-00005; Clement PB, 1994, BLAUSTEINS PATHOLOGY, P660; Esselen KM, 2014, GYNECOL ONCOL, V132, P316, DOI 10.1016/j.ygyno.2013.12.007; Katre R, 2010, AM J ROENTGENOL, V195, P1452, DOI 10.2214/AJR.10.4302; Kim JC, 2000, CLIN IMAG, V24, P28, DOI 10.1016/S0899-7071(00)00158-3; Koren J, 2006, VIRCHOWS ARCH, V449, P268, DOI 10.1007/s00428-006-0153-1; Lee SN, 2005, ACTA OBSTET GYN SCAN, V84, P98, DOI 10.1111/j.0001-6349.2005.0254d.x; Sampson JA, 1930, AM J OBSTET GYNECOL, V20, P443; Taneja S, 2010, KOREAN J RADIOL, V11, P476, DOI 10.3348/kjr.2010.11.4.476; Wagner B J, 1994, Radiographics, V14, P1351; ZINSSER KR, 1982, AM J SURG PATHOL, V6, P109, DOI 10.1097/00000478-198203000-00003	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	MAR	2015	40	3					471	474		10.1007/s00261-014-0327-2		4	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CB1CJ	WOS:000349363900003		
J	Yamada, K; Takahata, A; Ichijo, Y; Akazawa, K; Goto, M; Terayama, K; Yamada, K				Yamada, Kaori; Takahata, Akiko; Ichijo, Yusuke; Akazawa, Kentaro; Goto, Mariko; Terayama, Koshi; Yamada, Kei			A case of testicular seminoma in persistent Mullerian duct syndrome with transverse testicular ectopia	ABDOMINAL IMAGING			English	Article						Transverse testicular ectopia; Persistent Mullerian duct syndrome; Testicular tumor; Seminoma; MRI		We present a rare case of testicular seminoma in persistent Mullerian duct syndrome (PMDS) with transverse testicular ectopia (TTE). A 42-year-old man noticed scrotal swelling a few weeks earlier and underwent magnetic resonance imaging (MRI) on suspicion of testicular tumor. MRI revealed a normal left testis on the left side of the left scrotum and a heterogeneous mass on the right side within the left scrotum. No right testis was found in the right scrotum. A blind-ending tubular structure with thickened wall showed a three-layer appearance on T2-weighted imaging and extended from the prostate through the left inguinal canal to the left scrotum. Findings during surgery suggested right testicular tumor associated with right TTE. The histopathological and immunohistochemical diagnoses of the testicular tumor and blind-ending tubular structure were seminoma and persistent Mullerian duct, respectively. Testicular tumor in PMDS with TTE is rare but may possess a characteristic appearance on imaging. Proper knowledge of these diseases will allow correct preoperative diagnosis.	[Yamada, Kaori; Takahata, Akiko; Ichijo, Yusuke; Akazawa, Kentaro; Goto, Mariko; Terayama, Koshi; Yamada, Kei] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kamigyo Ku, Kyoto 6028566, Japan	Yamada, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kamigyo Ku, 465 Kajii, Kyoto 6028566, Japan.	b97b36@koto.kpu-m.ac.jp					Wuerstle M, 2007, J PEDIATR SURG, V42, P2116, DOI 10.1016/j.jpedsurg.2007.09.003; Alp BF, 2014, INT UROL NEPHROL, V46, P1557, DOI 10.1007/s11255-014-0667-4; Deepika Kumar A, 2014, J CLIN DIAGN RES, V8, P162; Gupta A, 2013, UROL J, V10, P909; Gutte AA, 2014, BRIT J RADIOL, V81, pe176; JOHNSON JO, 1990, AM J ROENTGENOL, V154, P539; Karnak I, 1997, J PEDIATR SURG, V32, P1362, DOI 10.1016/S0022-3468(97)90323-7; Lam WWM, 2002, PEDIATR RADIOL, V32, P126, DOI 10.1007/s00247-001-0616-0; MELMAN A, 1981, J UROLOGY, V125, P856; Morikawa M, 1985, Hinyokika Kiyo, V31, P1819; Moslemi MK, 2011, GER MED SCI, V9, P15; Nilson O, 1939, ACTA CHIR SCAND, V83, P231; Otsuka Takateru, 2003, Radiat Med, V21, P277; Von Lenhossek M, 1886, ANAT ANZEIGER, V1, P376	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	MAR	2015	40	3					475	479		10.1007/s00261-014-0329-0		5	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CB1CJ	WOS:000349363900004		
J	Takeuchi, M; Matsuzaki, K; Harada, M				Takeuchi, Mayumi; Matsuzaki, Kenji; Harada, Masafumi			MR manifestations of uterine polypoid adenomyoma	ABDOMINAL IMAGING			English	Article						Uterus; Polypoid adenomyoma; Magnetic resonance imaging (MRI); Diffusion-weighted imaging (DWI)	ENDOMETRIAL CANCER; UTERUS; MASSES; DIFFERENTIATION	Polypoid adenomyoma (PA) is an uncommon benign tumor of the uterus appearing as a submucosal polypoid mass, or rarely as a subserosal polypoid mass. PA should be differentiated from atypical polypoid adenomyoma or malignant uterine tumors. The purpose of our case series is to evaluate magnetic resonance (MR) manifestations of PA for the differential diagnosis. Seven cases with surgically proven PA, five submucosal, and two subserosal, were evaluated. MR imaging findings including contrast enhancement in six cases (four cases with dynamic contrast-enhanced MR study), diffusion-weighted imaging (DWI) in five cases, and susceptibility weighted imaging (SWI) in two cases were retrospectively reviewed. All seven lesions exhibited isointensity compared with the myometrium and 4 of 7 lesions (57%) contained high signal intensity hemorrhagic areas on T1-weighted images. On T2-weighted images, signal intensity was variable and all seven lesions contained cysts. None of five lesions with DWI exhibited high signal intensity compared with the normal myometrium. All six lesions showed intense contrast enhancement similar to that of the myometrium on post-contrast T1-weighted images. Punctate low intensity areas reflecting blood contents were revealed in all two lesions with SWI. Submucosal or subserosal polypoid masses containing hemorrhagic areas, and cysts reflecting functional endometrium and dilatation of endometrial glands are suggestive for PA. Intense contrast enhancement similar to that of the myometrium may be another characteristic finding for PA.	[Takeuchi, Mayumi; Matsuzaki, Kenji; Harada, Masafumi] Univ Tokushima, Dept Radiol, Tokushima 7708503, Japan	Takeuchi, M (reprint author), Univ Tokushima, Dept Radiol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	mayumi@tokushima-u.ac.jp					Gilks CB, 2000, INT J GYNECOL PATHOL, V19, P195, DOI 10.1097/00004347-200007000-00001; MAZUR MT, 1981, AM J SURG PATHOL, V5, P473, DOI 10.1097/00000478-198107000-00006; Takeuchi M, 2009, ACTA RADIOL, V50, P947, DOI 10.1080/02841850903099981; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Tahlan A, 2006, INT J GYNECOL PATHOL, V25, P361, DOI 10.1097/01.pgp.0000209570.08716.b3; HRICAK H, 1992, AM J ROENTGENOL, V158, P1043; Tamai K, 2007, J MAGN RESON IMAGING, V26, P682, DOI 10.1002/jmri.20997; Tamai K, 2008, EUR RADIOL, V18, P723, DOI 10.1007/s00330-007-0787-7; Takeuchi M, 2009, J COMPUT ASSIST TOMO, V33, P834, DOI 10.1097/RCT.0b013e318197ec6f; CLEMENT PB, 1988, SEMIN DIAGN PATHOL, V5, P199; Horikawa M, 2012, JPN J RADIOL, V30, P606, DOI 10.1007/s11604-012-0095-2; Kitajima K, 2007, J COMPUT ASSIST TOMO, V31, P463, DOI 10.1097/01.rct.0000243447.03116.0c; Lee EJ, 2004, J ULTRAS MED, V23, P1421; Longacre TA, 1996, AM J SURG PATHOL, V20, P1, DOI 10.1097/00000478-199601000-00001; Nakai G, 2014, J COMPUT ASSIST TOMO; NASU K, 1995, INT J GYNECOL OBSTET, V48, P319, DOI 10.1016/0020-7292(94)02312-M; Takeuchi Mayumi, 2005, Radiat Med, V23, P432; Takeuchi M, 2011, RADIOGRAPHICS, V31, P99, DOI 10.1148/rg.311105110	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	MAR	2015	40	3					480	487		10.1007/s00261-014-0330-7		8	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CB1CJ	WOS:000349363900005		
J	Hori, M; Okada, T; Higashiura, K; Sato, Y; Chen, YW; Kim, T; Onishi, H; Eguchi, H; Nagano, H; Umeshita, K; Wakasa, K; Tomiyama, N				Hori, Masatoshi; Okada, Toshiyuki; Higashiura, Keisuke; Sato, Yoshinobu; Chen, Yen-Wei; Kim, Tonsok; Onishi, Hiromitsu; Eguchi, Hidetoshi; Nagano, Hiroaki; Umeshita, Koji; Wakasa, Kenichi; Tomiyama, Noriyuki			Quantitative Imaging: Quantification of Liver Shape on CT Using the Statistical Shape Model to Evaluate Hepatic Fibrosis	ACADEMIC RADIOLOGY			English	Article						Quantitative evaluation; diagnosis, computer-assisted; fibrosis, liver; cirrhosis; computed tomography, x-ray	SUPPORT VECTOR REGRESSION; CHRONIC HEPATITIS-C; MAGNETIC-RESONANCE ELASTOGRAPHY; COMPUTER-AIDED DETECTION; HEPATOCELLULAR-CARCINOMA; FIBROSIS; SEGMENTATION; CIRRHOSIS; VOLUMETRY; THERAPY	Rationale and Objectives: To investigate the usefulness of the statistical shape model (SSM) for the quantification of liver shape to evaluate hepatic fibrosis. Materials and Methods: Ninety-one subjects (45 men and 46 women; age range, 20-75 years) were included in this retrospective study: 54 potential liver donors and 37 patients with chronic liver disease. The subjects were classified histopathologically according to the fibrosis stage as follows: F0 (n = 55); F1 (n = 6); F2 (3); F3 (n = 1); and F4 (n = 26). Each subject underwent contrast-enhanced computed tomography (CT) using a 64-channel scanner (0.625-mm slice thickness). An abdominal radiologist manually traced the liver boundaries on every CT section using an image workstation; the boundaries were used for subsequent analyses. An SSM was constructed by the principal component analysis of the subject data set, which defined a parametric model of the liver shapes. The shape parameters were calculated by fitting SSM to the segmented liver shape of each subject and were used for the training of a linear support vector regression (SVR), which classifies the liver fibrosis stage to maximize the area under the receiver operating characteristic curve (AUC). SSM/SVR models were constructed and were validated in a leave-one-out manner. The performance of our technique was compared to those of two previously reported types of caudate-right lobe ratios (C/RL-m and C/RL-r). Results: In our SSM/SVR models, the AUC values for the classification of liver fibrosis were 0.96 (F0 vs. F1-4), 0.95 (F0-1 vs. F2-4), 0.96 (F0-2 vs. F3-4), and 0.95 (F0-3 vs. F4). These values were significantly superior to AUC values using the C/RL-m or C/RL-r ratios (P < .005). Conclusions: SSM was useful for estimating the stage of hepatic fibrosis by quantifying liver shape.	[Hori, Masatoshi; Okada, Toshiyuki; Sato, Yoshinobu; Kim, Tonsok; Onishi, Hiromitsu; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan; [Okada, Toshiyuki] Univ Tsukuba, Fac Med, Dept Surg, Tsukuba, Ibaraki, Japan; [Higashiura, Keisuke] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu, Shiga, Japan; [Sato, Yoshinobu] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Eguchi, Hidetoshi; Nagano, Hiroaki; Umeshita, Koji] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan; [Umeshita, Koji] Osaka Univ, Div Hlth Sci, Suita, Osaka, Japan; [Wakasa, Kenichi] Ishikiriseiki Hosp, Dept Pathol, Higashiosaka, Osaka, Japan	Hori, M (reprint author), Osaka Univ, Grad Sch Med, Dept Radiol, D1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mhori@radiol.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22591330/26461789]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [21103003]	This research was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Number 22591330/26461789 and Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Grants-in-Aid for Scientific Research on Innovative Areas (KAKENHI) Number 21103003.	Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Wang YM, 2003, LECT NOTES COMPUT SC, V2732, P647; Everson GT, 2006, HEPATOLOGY, V44, P1675, DOI 10.1002/hep.21440; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; Gokturk SB, 2001, IEEE T MED IMAGING, V20, P1251, DOI 10.1109/42.974920; Gressner OA, 2007, CLIN CHIM ACTA, V381, P107, DOI 10.1016/j.cca.2007.02.038; HARBIN WP, 1980, RADIOLOGY, V135, P273; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Suzuki K, 2011, AM J ROENTGENOL, V197, pW706, DOI 10.2214/AJR.10.5958; Styner M, 2005, P NATL ACAD SCI USA, V102, P4872, DOI 10.1073/pnas.0501117102; Colli A, 2003, RADIOLOGY, V227, P89, DOI 10.1148/radiol.2272020193; Shen DG, 2001, IEEE T MED IMAGING, V20, P257, DOI 10.1109/42.921475; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Nakayama Y, 2006, RADIOLOGY, V240, P743, DOI 10.1148/radiol.2403050850; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Shen KK, 2012, NEUROIMAGE, V59, P2155, DOI 10.1016/j.neuroimage.2011.10.014; Tomoshige S, 2014, MED IMAGE ANAL, V18, P130, DOI 10.1016/j.media.2013.10.003; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Okada T, 2008, ACAD RADIOL, V15, P1390, DOI 10.1016/j.acra.2008.07.008; Yoshida H, 1999, ANN INTERN MED, V131, P174; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Venkatesh SK, 2014, EUR RADIOL, V24, P70, DOI 10.1007/s00330-013-2978-8; Awaya H, 2002, RADIOLOGY, V224, P769, DOI 10.1148/radiol.2243011495; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen Yen-Wei, 2013, COMPUT MATH METHOD M, V2013, P887; Cohen EB, 2010, J CLIN GASTROENTEROL, V44, P637, DOI 10.1097/MCG.0b013e3181e12c39; Drucker H, 1997, ADV NEUR IN, V9, P155; Goshima S, 2012, HEPATOLOGY, V55, P328, DOI 10.1002/hep.24677; Gutierrez-Becker B, 2013, MED BIOL ENG COMPUT, V51, P1021, DOI 10.1007/s11517-013-1082-1; Huynh HT, 2014, AM J ROENTGENOL, V202, P152, DOI 10.2214/AJR.13.10812; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Ogura S, 2013, HEPATOL RES, V43, P836, DOI 10.1111/hepr.12025; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Song X, 2013, MED PHYS, V40, DOI 10.1118/1.4819824; Xu JW, 2011, MED PHYS, V38, P1888, DOI 10.1118/1.3562898	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	MAR	2015	22	3					303	309		10.1016/j.acra.2014.10.001		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB5HY	WOS:000349659300006		
J	Ebara, K; Takashima, S; Jiang, B; Numasaki, H; Fujino, M; Tomita, Y; Nakanishi, K; Higashiyama, M				Ebara, Kiyonori; Takashima, Shodayu; Jiang, Binghu; Numasaki, Hodaka; Fujino, Mai; Tomita, Yasuhiko; Nakanishi, Katsuyuki; Higashiyama, Masahiko			Pleural Invasion by Peripheral Lung Cancer: Prediction with Three-Dimensional CT	ACADEMIC RADIOLOGY			English	Article						3D CT; pleural invasion; lung cancer; computer-aided diagnosis	CHEST-WALL INVASION; BRONCHOGENIC-CARCINOMA; CT EVALUATION	Rationale and Objectives: To evaluate the clinical utility of three-dimensional (3D) computed tomography (CT) for predicting pleural invasion by peripheral lung cancer. Materials and Methods: CT findings (tumor size, vertical diameter, length and area of the interface between tumor and the pleura, ratios of length and area [R-area] of interface between tumor and the pleura to tumor size, angle between the tumor and adjacent pleura, presence or absence of pleural thickening, and originally developed 3D pleural patterns) in 201 consecutive patients with lung cancer of <= 3 cm in contact with pleural surface were correlated with pathologic findings. Logistic modeling was used for determining the significant factors for prediction of pleural invasion, and receiver operating characteristic (ROC) curves were used for investigating diagnostic capability of significant factors, resulting in a recommendation to the optimal criteria for predicting pleural invasion and to the optimal threshold for differentiating parietal from visceral invasion. Results: Sixty-one (30%) of the 201 patients had pathologically verified pleural invasion. Logistic modeling revealed that the 3D pleural pattern was the only significant factor (P < .001; relative risk of 7.34). Among every combination of the 3D patterns, skirt-like pattern showed the highest accuracy of 77% for predicting pleural invasion. In differentiating parietal from visceral pleural invasion, ROC analysis revealed that R-area was optimal for differentiating parietal from visceral pleural invasion, and the highest accuracy of 77% was obtained with a cut-off value of 13.4 for this criterion. Conclusions: Computer-aided 3D CT analysis of the pleura was useful for predicting pleural invasion.	[Ebara, Kiyonori; Takashima, Shodayu; Jiang, Binghu; Numasaki, Hodaka; Fujino, Mai] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan; [Tomita, Yasuhiko; Nakanishi, Katsuyuki; Higashiyama, Masahiko] Osaka Med Ctr Canc & Cardiovasc Dis, Higashinari Ku, Osaka, Japan	Ebara, K (reprint author), Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	kiyoharu0825@yahoo.co.jp					PENNES DR, 1985, AM J ROENTGENOL, V144, P507; Imai K, 2013, RADIOLOGY, V267, P619, DOI 10.1148/radiol.12120864; UyBico SJ, 2010, RADIOGRAPHICS, V30, P1163, DOI 10.1148/rg.305095166; GLAZER HS, 1985, RADIOLOGY, V157, P191; Facciolo F, 2001, J THORAC CARDIOV SUR, V121, P649, DOI 10.1067/mtc.2001.112826; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; SHIMOSATO Y, 1980, AM J SURG PATHOL, V4, P365, DOI 10.1097/00000478-198008000-00005; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLUM A, 1995, J RADIOL, V76, P441; Di Perna CA, 2005, CLIN CANCER RES, V11, p5038S, DOI 10.1158/1078-0432.CCR-05-9007; GALLAGHER B, 1990, HUM PATHOL, V21, P512, DOI 10.1016/0046-8177(90)90007-R; HANLEY JA, 1983, RADIOLOGY, V148, P839; KURIYAMA K, 1994, RADIOLOGY, V191, P365; Oyama M, 2013, JPN J CLIN ONCOL, V43, P540, DOI 10.1093/jjco/hyt039; Tsuboi Masahiro, 2007, Ann Thorac Cardiovasc Surg, V13, P73	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	MAR	2015	22	3					310	319		10.1016/j.acra.2014.10.002		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB5HY	WOS:000349659300007		
J	Nishio, M; Matsumoto, S; Tsubakimoto, M; Nishii, T; Koyama, H; Ohno, Y; Sugimura, K				Nishio, Mizuho; Matsumoto, Sumiaki; Tsubakimoto, Maho; Nishii, Tatsuya; Koyama, Hisanobu; Ohno, Yoshiharu; Sugimura, Kazuro			Paired Inspiratory/Expiratory Volumetric CT and Deformable Image Registration for Quantitative and Qualitative Evaluation of Airflow Limitation in Smokers with or without COPD	ACADEMIC RADIOLOGY			English	Article						COPD; emphysema; airflow limitation; image registration	OBSTRUCTIVE PULMONARY-DISEASE; COMPUTED-TOMOGRAPHY; EMPHYSEMA; DIMENSIONS; QUANTIFICATION; PROGRESSION; PHENOTYPES; DIAGNOSIS	Rationale and Objectives: To evaluate paired inspiratory/expiratory computed tomography (CT; iCT/eCT) and deformable image registration for quantitative and qualitative assessment of airflow limitation in smokers. Materials and Methods: Paired iCT/eCT images acquired from 35 smokers (30 men and 5 women) were coregistered and subtraction images (air trapping CT images [aCT]) generated. To evaluate emphysema quantitatively, the percentage of low-attenuation volume (LAV%) on iCT was calculated at -950 HU, as were mean and kurtosis on aCT for quantitative assessment of air trapping. Parametric response maps of emphysema (PRMe) and of functional small airways disease (PRMs) were also obtained. For qualitative evaluation of emphysema, low-attenuation areas on iCT were scored by consensus of two radiologists using Goddard classification. To assess air trapping qualitatively, the degree of air trapping on aCT was scored. For each quantitative and qualitative index, the Spearman rank correlation coefficient for forced expiratory flow in 1 second was calculated, and differences in correlation coefficients were statistically tested. Results: The correlation coefficients for the indices were as follows: mean on aCT, 0.800; kurtosis on aCT, -0.726; LAV%, -0.472; PRMe, -0.570; PRMs, -0.565; addition of PRMe and PRMs, -0.653; emphysema score, -0.502; air trapping score, -0.793. The indices showing significant differences were as follows: mean on aCT and addition of PRMe and PRMs (P = 1.43 x 10(-8)); air trapping score and emphysema score (P = .0169). Conclusions: Air trapping images yielded more accurate quantitative and qualitative evaluation of airflow limitation than did LAV%, PRMe, PRMs, and Goddard classification.	[Nishio, Mizuho; Matsumoto, Sumiaki; Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nishio, Mizuho; Matsumoto, Sumiaki; Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res, Kobe, Hyogo 657, Japan; [Tsubakimoto, Maho; Nishii, Tatsuya; Koyama, Hisanobu; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Div Radiol, Kobe, Hyogo 657, Japan; [Tsubakimoto, Maho] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Okinawa, Japan	Nishio, M (reprint author), Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nmizuho@med.kobe-u.ac.jp					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akira M, 2009, AM J ROENTGENOL, V192, P267, DOI 10.2214/AJR.07.3953; Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; GODDARD PR, 1982, CLIN RADIOL, V33, P379, DOI 10.1016/S0009-9260(82)80301-2; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450; Vogelmeier CF, 2013, LANCET RESP MED, V1, P51, DOI 10.1016/S2213-2600(12)70052-8; Yuan R, 2009, THORAX, V64, P944, DOI 10.1136/thx.2008.112433; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Yamashiro T, 2011, COPD, V8, P13, DOI 10.3109/15412555.2010.541537; Madani A, 2006, RADIOLOGY, V238, P1036, DOI 10.1148/radiol.2382042196; Dirksen A, 2009, EUR RESPIR J, V33, P1345, DOI 10.1183/09031936.00159408; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; van Noord JA, 2010, THORAX, V65, P1086, DOI 10.1136/thx.2010.139113; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; [Anonymous], 2004, NIHON KOKYUKI GAKK S, P1; Barbosa EM, 2011, ACAD RADIOL, V18, P1258, DOI 10.1016/j.acra.2011.06.004; Heron MP, 2009, NATL VITAL STAT REP, P58; Koyama H, 2010, ACAD RADIOL, V17, P163, DOI 10.1016/j.acra.2009.08.009; Lee JJ, 2008, P 11 INT C MED IM CO, P195; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mets OM, 2012, EUR RADIOL, V22, P120, DOI 10.1007/s00330-011-2237-9; Mets OM, 2012, EUR RADIOL, V22, P2103, DOI 10.1007/s00330-012-2489-z; Nakaya T, 2000, ENVIRON PLANN A, V32, P91, DOI 10.1068/a31145; Sakamoto Y, 1983, JOUHOURYOU TOUKEI GA; Song G., 2010, MED IMAGE ANAL CLIN, P23; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Yamamoto T, 2011, PHYS MED BIOL, V56, P2279, DOI 10.1088/0031-9155/56/7/023	34	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	MAR	2015	22	3					330	336		10.1016/j.acra.2014.09.011		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB5HY	WOS:000349659300009		
J	Takahashi, H; Matsubara, S; Kobayashi, M; Ohkuchi, A				Takahashi, Hironori; Matsubara, Shigeki; Kobayashi, Mami; Ohkuchi, Akihide			Drainage failure of Bakri balloon: no drainage does not indicate no bleeding	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							POSTPARTUM HEMORRHAGE; CESAREAN-SECTION; PLACENTA PREVIA; TAMPONADE		[Takahashi, Hironori; Matsubara, Shigeki; Kobayashi, Mami; Ohkuchi, Akihide] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P120, DOI 10.1111/aogs.12241; Aibar L, 2013, ACTA OBSTET GYN SCAN, V92, P465, DOI 10.1111/j.1600-0412.2012.01497.x; Nesbitt A, 2013, ACTA OBSTET GYN SCAN, V92, P1118, DOI 10.1111/aogs.12172; Gronvall M, 2013, ACTA OBSTET GYN SCAN, V92, P433, DOI 10.1111/j.1600-0412.2012.01531.x; Matsubara S, 2014, AUST NZ J OBSTET GYN, V54, P283, DOI 10.1111/ajo.12184	5	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	MAR	2015	94	3					336	336		10.1111/aogs.12563		1	Obstetrics & Gynecology	Obstetrics & Gynecology	CB4ND	WOS:000349603600018		
J	Seemork, J; Siriprumpoonthum, M; Lee, Y; Nobukawa, S; Yamaguchi, M				Seemork, Jiraporn; Siriprumpoonthum, Monchai; Lee, Youngjun; Nobukawa, Shogo; Yamaguchi, Masayuki			Effect of Die Geometry on Drawdown Force of Polypropylene at Capillary Extrusion	ADVANCES IN POLYMER TECHNOLOGY			English	Article						Crystallization; Extrusion; Orientation; Poly(propylene); Rheology	MOLECULAR-WEIGHT POLYETHYLENE; LOW-DENSITY POLYETHYLENE; SORBITOL-BASED CLARIFIER; ELONGATIONAL VISCOSITY; POLYMER MELTS; ISOTACTIC POLYPROPYLENE; RHEOLOGICAL PROPERTIES; BEHAVIOR; FLOW; TEMPERATURE	Drawdown force, defined as the force needed to stretch a polymer melt uniaxially at capillary extrusion, is investigated using isotactic polypropylene. In this study, we focus on the effect of die geometry on the drawdown force. As similar to the swell ratio, which decreases with increasing die length, the drawdown force is found to increase with the die length. A prolonged residence time in a long die leads to the marked orientation. Consequently, crystallization occurs rapidly after passing through a long die, which is confirmed by wide-angle X-ray measurements. Moreover, the rapid crystallization by the addition of a nucleating agent also enhances the drawdown force.	[Seemork, Jiraporn; Siriprumpoonthum, Monchai; Lee, Youngjun; Nobukawa, Shogo; Yamaguchi, Masayuki] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Seemork, Jiraporn] Chulalongkorn Univ, Fac Sci, Program Petrochem, Bangkok 10330, Thailand	Yamaguchi, M (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.	m_yama@jaist.ac.jp			Chulalongkorn University, Thailand	The authors gratefully acknowledge the Dutsadiphiphat scholarship from Chulalongkorn University, Thailand for financial support.	Bao RY, 2012, COLLOID POLYM SCI, V290, P261, DOI 10.1007/s00396-011-2550-5; Wagner MH, 2002, RHEOL ACTA, V41, P316, DOI 10.1007/s00397-002-0228-0; Yamaguchi M, 2006, POLYMER, V47, P3629, DOI 10.1016/j.polymer.2006.03.052; Sentmanat ML, 2004, RHEOL ACTA, V43, P657, DOI 10.1007/s00397-004-0405-4; Zatloukal M, 2003, J NON-NEWTON FLUID, V113, P209, DOI 10.1016/S0377-0257(03)00112-5; Sano A, 2001, POLYMER, V42, P5859, DOI 10.1016/S0032-3861(00)00899-5; Lau HC, 1998, POLYM ENG SCI, V38, P1915, DOI 10.1002/pen.10362; Muke S, 2001, J NON-NEWTON FLUID, V101, P77, DOI 10.1016/S0377-0257(01)00142-2; Yokohara T, 2011, J RHEOL, V55, P1205, DOI 10.1122/1.3626414; KANAMOTO T, 1987, POLYMER, V28, P1517, DOI 10.1016/0032-3861(87)90352-1; Liang JZ, 2008, POLYM TEST, V27, P936, DOI 10.1016/j.polymertesting.2008.08.001; Yamaguchi M, 2002, J APPL POLYM SCI, V86, P79, DOI 10.1002/app.10915; WILCHINSKY ZW, 1960, J APPL PHYS, V31, P1969, DOI 10.1063/1.1735481; MEISSNER J, 1994, RHEOL ACTA, V33, P1, DOI 10.1007/BF00453459; COGSWELL FN, 1972, POLYM ENG SCI, V12, P64, DOI 10.1002/pen.760120111; Tenma M, 2007, POLYM ENG SCI, V47, P1441, DOI 10.1002/pen.20839; AXTELL FH, 1990, POLYM TEST, V9, P53, DOI 10.1016/0142-9418(90)90049-J; Bernnat A., 2001, POLYM MELT RHEOLOGY; BINDING DM, 1988, J NON-NEWTON FLUID, V27, P173, DOI 10.1016/0377-0257(88)85012-2; Doi M., 1980, THEORY POLYM DYNAMIC; Feigl K, 2003, J NON-NEWTON FLUID, V115, P191, DOI 10.1016/j.jnnfm.2003.08.002; ISHIZUKA O, 1980, POLYMER, V21, P164, DOI 10.1016/0032-3861(80)90055-5; Liang JZ, 2001, POLYM TEST, V20, P29; Liang JZ, 2002, POLYM TEST, V21, P927, DOI 10.1016/S0142-9418(02)00036-3; Liang JZ, 2010, POLYM TEST, V29, P624, DOI 10.1016/j.polymertesting.2010.03.014; Md Ali M. A. B., 2009, J POLYM SCI POL PHYS, V47, P2008; Meissner J., 1971, RHEOL ACTA, V10, P230; Mieda N, 2011, J NON-NEWTON FLUID, V166, P231, DOI 10.1016/j.jnnfm.2010.11.011; MULLER R, 1985, POLYMER, V26, P1477, DOI 10.1016/0032-3861(85)90080-1; MUNSTEDT H, 1981, RHEOL ACTA, V20, P211, DOI 10.1007/BF01678022; Okamoto M, 1998, POLYMER, V39, P2149, DOI 10.1016/S0032-3861(97)00514-4; Phulkerd P, 2014, J MACROMOL SCI B, V53, P1222, DOI 10.1080/00222348.2014.895624; Rolon-Garrido M. H., 2013, IBERO AM J RHEOLOGY, V1, P19; Sawai D, 2000, J POLYM SCI POL PHYS, V38, P2571, DOI 10.1002/1099-0488(20001001)38:19<2571::AID-POLB90>3.3.CO;2-W; Sawai D, 2006, J POLYM SCI POL PHYS, V44, P3369, DOI 10.1002/polb.20988; Schulze JS, 2001, RHEOL ACTA, V40, P457, DOI 10.1007/s003970100170; Sitticharoen W, 2012, J APPL POLYM SCI, V124, P3751, DOI 10.1002/app.35378; Sun JS, 1996, RHEOL ACTA, V35, P1, DOI 10.1007/BF00366548; TAKAHASHI T, 1994, POLYMER, V35, P4472, DOI 10.1016/0032-3861(94)90111-2; Tanner R.I., 1970, J POLYM SCI       A2, V8, P2067, DOI 10.1002/pol.1970.160081203; Tenma M, 2008, J POLYM SCI POL PHYS, V46, P41, DOI 10.1002/polb.21340; Thevenon A, 2013, POLYM TEST, V32, P691, DOI 10.1016/j.polymertesting.2013.03.003; Uematsu H, 2008, RHEOL ACTA, V47, P237, DOI 10.1007/s00397-007-0242-3; Vlachopoulos J., 1974, RHEOL ACTA, V13, P223, DOI [10.1007/BF01520879, DOI 10.1007/BF01520879]; Wagner MH, 2004, RHEOL ACTA, V44, P198, DOI 10.1007/s00397-004-0400-9; Yamaguchi M., 2014, FOAM EXTRUSION PRINC; Yamaguchi M, 1999, MACROMOLECULES, V32, P5911, DOI 10.1021/ma990004s	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-6679	1098-2329		ADV POLYM TECH	Adv. Polym. Technol.	SPR	2015	34	1							21477	10.1002/adv.21477		7	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CB0IV	WOS:000349310100009		
J	Araki, M; Morita, K; Takahashi, Y; Kojima, T; Taguchi, H; Shiga, S				Araki, Mikiya; Morita, Kohei; Takahashi, Yasuhiro; Kojima, Takayuki; Taguchi, Hideyuki; Shiga, Seiichi			Experimental Investigation of Jet Noise Sources in a Hypersonic Nozzle at Takeoff	AIAA JOURNAL			English	Article							HIGH-SPEED JETS; FLOW		[Araki, Mikiya; Morita, Kohei; Takahashi, Yasuhiro] Gunma Univ, Gunma 3768515, Japan; [Kojima, Takayuki; Taguchi, Hideyuki] Japan Aerosp Explorat Agcy, Tokyo 1828522, Japan; [Shiga, Seiichi] Gunma Univ, Gunma 3768515, Japan	Araki, M (reprint author), Div Mech Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gumma, Japan.				 [22686078]	This research is partly supported by the Grand-in-Aid for Scientific Research (project no. 22686078). This research is carried out as cooperative research between the Japan Aerospace Exploration Agency and Gunma University. The authors thank Masahiro Tsukamoto, Yasuhiro Ijuin, and Mizuho Muraki of Gunma University for their help in experimentation and meaningful discussions.	Panda J, 2005, J FLUID MECH, V537, P349, DOI 10.1017/S0022112005005148; Tam CKW, 2008, J FLUID MECH, V615, P253, DOI 10.1017/S0022112008003704; Doty MJ, 2005, EXP FLUIDS, V38, P415, DOI 10.1007/s00348-004-0920-1; Araki M, 2012, AIAA J, V50, P751, DOI 10.2514/1.J051474; Araki M, 2012, J PROPUL POWER, V28, P1258, DOI 10.2514/1.B34546; Araki M, 2014, J PROPUL POWER, V30, P221, DOI 10.2514/1.B34972; Dahl MD, 2000, AIAA J, V38, P584, DOI 10.2514/2.1026; Panda J, 2002, J FLUID MECH, V450, P97, DOI 10.1017/S002211200100622X; Panda J, 1999, J FLUID MECH, V378, P71, DOI 10.1017/S0022112098003383; Papamoschou D, 2010, AIAA J, V48, P2445, DOI 10.2514/1.J050325; Tam CKW, 2000, AIAA J, V38, P592, DOI 10.2514/2.1029	11	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	MAR	2015	53	3					789	794		10.2514/1.J053336		6	Engineering, Aerospace	Engineering	CB1PI	WOS:000349399700023		
J	Ando, N; Nakamura, Y; Ishimaru, K; Ogawa, H; Okumura, K; Shimada, S; Nakao, A				Ando, N.; Nakamura, Y.; Ishimaru, K.; Ogawa, H.; Okumura, K.; Shimada, S.; Nakao, A.			Allergen-specific basophil reactivity exhibits daily variations in seasonal allergic rhinitis	ALLERGY			English	Article						allergic rhinitis; basophils; IgE; the circadian clock	CIRCADIAN VARIATION; CLOCK; CELLS; EOSINOPHILS; EXPRESSION; CD203C	It remains poorly understood how symptoms in allergic rhinitis are most severe during overnight or early in the morning. The circadian clock consisting of a network of several clock genes' including Clock drives daily rhythms in physiology. This study showed that allergen-induced surface CD203c expression on basophils in seasonal allergic rhinitis caused by Japanese cedar pollen exhibited a time-of-day-dependent variation associated with temporal variations in canonical circadian clock gene expression. We also found that bone-marrow-derived basophils (BM basophils) generated from wild-type mice exhibited a time-of-day-dependent variation in IgE-mediated IL-4 and histamine production, which was not observed in BM basophils generated from Clock-mutated mice. Therefore, allergen-specific basophil reactivity shows daily variations depending on the circadian clock activity in basophils, which could partly explain temporal symptomatic variations in allergic rhinitis. Additionally, circadian variations in CD203c expression should be considered for interpretation of this biomarker in clinical research.	[Ando, N.; Shimada, S.] Univ Yamanashi, Fac Med, Dept Dermatol, Yamanashi 4093898, Japan; [Nakamura, Y.; Ishimaru, K.; Nakao, A.] Univ Yamanashi, Fac Med, Dept Immunol, Yamanashi 4093898, Japan; [Ogawa, H.; Okumura, K.; Nakao, A.] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 113, Japan	Nakao, A (reprint author), Univ Yamanashi, Fac Med, Dept Immunol, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	anakao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; REINBERG A, 1988, J ALLERGY CLIN IMMUN, V81, P51, DOI 10.1016/0091-6749(88)90220-5; Aoyagi M, 1999, INT ARCH ALLERGY IMM, V120, P95, DOI 10.1159/000053604; Nakamura Y, 2014, J ALLERGY CLIN IMMUN, V133, P568, DOI 10.1016/j.jaci.2013.07.040; Nakamura Y, 2011, J ALLERGY CLIN IMMUN, V127, P1038, DOI 10.1016/j.jaci.2011.02.006; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Nagao M, 2008, INT ARCH ALLERGY IMM, V146, P47, DOI 10.1159/000126061; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Gelfand EW, 2004, J ALLERGY CLIN IMMUN, V114, pS135, DOI 10.1016/j.jaci.2004.08.043; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Baumann A, 2013, IMMUNOLOGY, V140, P465, DOI 10.1111/imm.12157; Dugas-Breit S, 2005, ALLERGY, V60, P689, DOI 10.1111/j.1398-9995.2005.00771.x; Jankowski R, 2000, RHINOLOGY, V38, P23	14	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	MAR	2015	70	3					319	322		10.1111/all.12552		4	Allergy; Immunology	Allergy; Immunology	CB0EL	WOS:000349298100009		
J	Horimukai, K; Hayashi, K; Tsumura, Y; Nomura, I; Narita, M; Ohya, Y; Saito, H; Matsumoto, K				Horimukai, K.; Hayashi, K.; Tsumura, Y.; Nomura, I.; Narita, M.; Ohya, Y.; Saito, H.; Matsumoto, K.			Total serum IgE level influences oral food challenge tests for IgE-mediated food allergies	ALLERGY			English	Article						food allergy; oral food challenge test; specific IgE; total IgE	CHILDHOOD; UTILITY; EGG	Probability curves predicting oral food challenge test (OFC) results based on specific IgE levels are widely used to prevent serious allergic reactions. Although several confounding factors are known to affect probability curves, the main factors that affect OFC outcomes are currently unclear. We hypothesized that an increased total IgE level would reduce allergic reactivity. Medical records of 337 and 266 patients who underwent OFCs for 3.5g boiled hen's egg white and 3.1ml raw cow's milk, respectively, were examined retrospectively. We subdivided the patients into three groups based on total IgE levels and age by percentile (<25th, 25-75th, and >75th percentiles), and logistic regression analyses were performed on each group. Patients with higher total IgE levels were significantly less responsive. In addition, age did not significantly affect the OFC results. Therefore, total IgE levels should be taken into account when predicting OFC results based on food-specific IgE levels.	[Horimukai, K.; Tsumura, Y.; Nomura, I.; Narita, M.; Ohya, Y.] Natl Res Inst Child Hlth & Dev, Dept Med Specialties, Div Allergy, Tokyo 1578535, Japan; [Horimukai, K.] Jikei Univ, Dept Pediat, Katsushika Med Ctr, Tokyo, Japan; [Hayashi, K.] Pkwy Hlth, Mandarin City Med Ctr, Shanghai, Peoples R China; [Saito, H.; Matsumoto, K.] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 1578535, Japan	Horimukai, K (reprint author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	horimukai-k@ncchd.go.jp; matsumoto-k@ncchd.go.jp		Narita, Masami/0000-0002-5862-679X	Health and Labor Sciences Research Grants, Research on Allergic Diseases from Ministry of Health, Labor and Welfare, Japan; Grant for Child Health and Development from Ministry of Health, Labor and Welfare [23-05]	This work was supported in part by the Health and Labor Sciences Research Grants, Research on Allergic Diseases from the Ministry of Health, Labor and Welfare, Japan (to H.S.), and a Grant for Child Health and Development from the Ministry of Health, Labor and Welfare (No. 23-05 to K.M.).	Mehl A, 2005, ALLERGY, V60, P1034, DOI 10.1111/j.1398-9995.2005.00806.x; Komata T, 2007, J ALLERGY CLIN IMMUN, V119, P1272, DOI 10.1016/j.jaci.2007.01.038; Hamilton RG, 2010, IMMUNOL RES, V47, P273, DOI 10.1007/s12026-009-8160-3; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Lieberman JA, 2013, J ALLER CL IMM-PRACT, V1, P75, DOI 10.1016/j.jaip.2012.11.002; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Beigelman A, 2012, ALLERGY ASTHMA PROC, V33, P467, DOI 10.2500/aap.2012.33.3607; Haneda Y, 2012, J ALLERGY CLIN IMMUN, V129, P1681, DOI 10.1016/j.jaci.2012.03.041; Kamemura N, 2014, J ALLERGY CLIN IMMUN, V133, P904, DOI 10.1016/j.jaci.2013.09.034; Matricardi PM, 2009, ALLERGY, V64, P1093, DOI 10.1111/j.1398-9995.2009.02055.x; Sturm GJ, 2007, ALLERGY, V62, P884, DOI 10.1111/j.1398-9995.2007.01413.x; Thompson MM, 2005, J AM ACAD DERMATOL, V53, pS214, DOI 10.1016/j.jaad.2005.04.065; Vultaggio A, 2009, CLIN EXP ALLERGY, V39, P838, DOI 10.1111/j.1365-2222.2009.03219.x; WALKER WA, 1985, PEDIATRICS, V75, P167	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	MAR	2015	70	3					334	337		10.1111/all.12562		4	Allergy; Immunology	Allergy; Immunology	CB0EL	WOS:000349298100012		
J	Nara, A; Nagai, H; Yamaguchi, R; Yoshida, K; Iwase, H; Mizuguchi, M				Nara, Akina; Nagai, Hisashi; Yamaguchi, Rutsuko; Yoshida, Ken-ichi; Iwase, Hirotaro; Mizuguchi, Masashi			An Unusual Autopsy Case of Cytokine Storm-Derived Influenza-Associated Encephalopathy Without Typical Histopathological Findings Autopsy Case Report	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						acute encephalopathy; influenza; cytokine storm; infants; clasmatodendrosis	VIRUS-ASSOCIATED ENCEPHALOPATHY; SERUM-LEVELS; INTERLEUKIN-6	Cytokine storm-derived influenza-associated encephalopathy is a severe complication, affecting not only the brain but also multiple systemic organs including the heart and lungs. Hundreds of Japanese children are afflicted by influenza-associated encephalopathy every year. Influenza-associated encephalopathy can be diagnosed by pathological changes, such as advanced brain edema and disruption of astrocytic projections, which is known as clasmatodendrosis. In the present case, despite the absence of significant histopathological findings in the brain, the diagnosis of influenza-associated encephalopathy was made on the basis of autopsy findings such as brain swelling, pathological findings including diffuse alveolar damage, and increase in the concentrations of interleukin-6 in both the serum and cerebrospinal fluid. In this case, the interval from high fever to death was approximately 7 hours and may have been too short for histopathological features to develop. This is an unusual autopsy case of cytokine storm-derived influenza-associated encephalopathy without typical histopathological findings.	[Nara, Akina; Yamaguchi, Rutsuko; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Tokyo 1130033, Japan; [Nagai, Hisashi] Tokyo Med & Dent Univ, Sect Forens Med, Tokyo, Japan; [Yoshida, Ken-ichi] Tokyo Med Univ, Dept Forens Med, Tokyo 1608402, Japan; [Mizuguchi, Masashi] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Tokyo 1130033, Japan	Nara, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	narachin@m.u-toyko.ac.jp					Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Aiba H, 2001, NEUROLOGY, V57, P295; Hasegawa S, 2011, CYTOKINE, V54, P167, DOI 10.1016/j.cyto.2011.01.006; Ito Y, 1999, J MED VIROL, V58, P420, DOI 10.1002/(SICI)1096-9071(199908)58:4<420::AID-JMV16>3.0.CO;2-T; Ichiyama T, 2003, SCAND J INFECT DIS, V35, P59, DOI 10.1080/0036554021000026986; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Jaffer U, 2010, HSR Proc Intensive Care Cardiovasc Anesth, V2, P161; Laycock H., 2010, British Journal of Medical Practitioners, V3, P324; Morishima Tsuneo, 2009, Uirusu, V59, P59; Nagao T, 2008, PEDIATR INFECT DIS J, V27, P384, DOI 10.1097/INF.0b013e318162a13b; Nakajima N, 2012, MODERN PATHOL, V25, P1, DOI 10.1038/modpathol.2011.125; Ogiu N, 1997, HEALTH PHYS, V72, P368, DOI 10.1097/00004032-199703000-00004; Section of the Influenza-Associated Encephalopathy Research Division of Japanese Ministry of Health Labour and Welfare, 2009, GUID INFL ASS ENC RE, P1; Tsokos M, 2001, FORENSIC SCI INT, V119, P47, DOI 10.1016/S0379-0738(00)00391-1; Watanabe C, 2008, NEUROCHEM RES, V33, P1017, DOI 10.1007/s11064-007-9543-2; Yamada Shinichiro, 2012, Rinsho Shinkeigaku, V52, P480; Yamazaki K, 2013, RES PRACT FORENS MED, V56, P71; Yoshimura Hajime, 2008, Rinsho Shinkeigaku, V48, P713	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2015	36	1					3	5		10.1097/PAF.0000000000000129		3	Medicine, Legal; Pathology	Legal Medicine; Pathology	CB2TT	WOS:000349481900002		
J	Morita, S; Furukawa, S; Nishi, K				Morita, Satomu; Furukawa, Satoshi; Nishi, Katsuji			Classification of Contraction Bands Using Immunohistochemistry	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						contraction bands; contraction band necrosis; immunohistochemistry; forensic pathology; cardiopulmonary resuscitation	MYOCARDIAL-INFARCTION; CATECHOLAMINES; REPERFUSION; NECROSIS; HEART; C9	Pathological contraction bands (CBs) are a type of necrosis pattern found in the myocardium. The composition of CB is not well studied. This is because CBs have diverse forms and can be observed in various causes of death. In pathology fields, CBs are classified artifactual CB and CB necrosis. We have identified different forms of CB by examining the expression and distribution of complement component C9 (CCC9) and Sirtuin1 by immunohistochemistry in the myocardium of patients who died because of different causes of death. We used cardiac tissues with CB from 30 forensic autopsy cases in our department from the last 2 years. We excluded the cases that had very little CB. We found that our CB classification based on expression levels of both CCC9 and Sirtuin1 correlated well with the agonal situation, including high temperature, myocardial infarction, cardiopulmonary resuscitation, and hypothermia. On the basis of these results, we here advocate a classification scheme based on immunohistochemistry. Furthermore, we found that CB necrosis could be detected using immunostaining with CCC9. Using our classification scheme, it will be possible to more accurately research each type of CB and the causative mechanisms.	[Morita, Satomu; Furukawa, Satoshi; Nishi, Katsuji] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan	Morita, S (reprint author), Shiga Univ Med Sci, Dept Legal Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	m.satomu@gmail.com					MIYAZAKI S, 1987, CIRCULATION, V75, P1074; Mallory GK, 1939, AM HEART J, V18, P647; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Billingham ME, 1991, CARDIOVASC PATHOL, P1465; Ferreira MAS, 1998, J CLIN PATHOL, V51, P548; Furukawa S, 2012, ROM J LEG MED, V20, P241, DOI 10.4323/rjlm.2012.241; Inamasu J, 2012, ACTA NEUROCHIR, V154, P2179, DOI 10.1007/s00701-012-1515-x; Jasra SK, 2012, J FORENSIC SCI, V57, P1595, DOI 10.1111/j.1556-4029.2012.02172.x; KARCH SB, 1986, HUM PATHOL, V17, P9, DOI 10.1016/S0046-8177(86)80150-2; KARCH SB, 1987, AM J FOREN MED PATH, V8, P3, DOI 10.1097/00000433-198703000-00002; LUNT DWR, 1987, ARCH PATHOL LAB MED, V111, P939; Morita S, 2015, AUST J FORENSIC SCI, V47, P138, DOI 10.1080/00450618.2014.906653; Morita S, 2013, A AGGRAWAL INTERNET, V14, P12; Rodriguez-Sinovas A, 2007, HEART FAIL REV, V12, P207, DOI 10.1007/s10741-007-9039-9; SCVP, 2013, ART SCVP WEB SIT	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2015	36	1					23	26		10.1097/PAF.0000000000000124		4	Medicine, Legal; Pathology	Legal Medicine; Pathology	CB2TT	WOS:000349481900007		
J	Ando, M; Ninosaka, Y; Okamura, K; Ishi, Y				Ando, Michiyo; Ninosaka, Yasuyoshi; Okamura, Kazuhisa; Ishi, Yoko			Difficulties in Caring for a Patient With Cancer at the End of Life at Home and Complicated Grief	AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE			English	Article						family caregivers; difficulties in caring; complicated grief	OF-LIFE; FAMILYS DIFFICULTIES; GOOD-DEATH; BEREAVEMENT; PREDICTORS; CAREGIVERS; INDIVIDUALS; POPULATION; DEPRESSION; DEMENTIA	The present study aimed to investigate difficulties in caring for a patient with cancer at the end of life at home and to examine relationships between difficulties with care and complicated grief. The 45 bereaved family members completed the Family Difficulty Scale (FDS) and the Inventory of Complicated Grief (ICG). The FDS score for Patient's pain and condition was the highest, followed by Caregivers did not want home care and No support from others. There was a significant relationship between FDS and ICG scores. These results suggest that the condition of the patient, the view of the caregiver on home care, and the absence of other support are important factors contributing to difficulties of family caregivers, and that these difficulties may lead to complicated grief.	[Ando, Michiyo] St Marys Coll, Fac Nursing, Kurume, Fukuoka, Japan; [Ninosaka, Yasuyoshi; Okamura, Kazuhisa] Ninosaka Clin, Sawara Ku, Fukuoka, Japan; [Ishi, Yoko] Nasu Red Cross Hosp, Otawara, Tochigi, Japan	Ando, M (reprint author), St Marys Coll, Tsubukuhonmachi 422, Kurume, Fukuoka, Japan.	andou@st-mary.ac.jp					Allen JY, 2013, J PALLIAT MED, V16, P751; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Grov EK, 2005, ANN ONCOL, V16, P1185, DOI 10.1093/annonc/mdi210; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Kim H, 2012, J ADV NURS, V68, P846, DOI 10.1111/j.1365-2648.2011.05787.x; Sanjo M, 2007, ANN ONCOL, V18, P1539, DOI 10.1093/annonc/mdm199; Fujisawa D, 2010, J AFFECT DISORDERS, V127, P352, DOI 10.1016/j.jad.2010.06.008; Lombardo L, 2012, PSYCHOTHER PSYCHOSOM, V81, P256, DOI 10.1159/000336428; Ott CH, 2003, DEATH STUD, V27, P249, DOI 10.1080/07481180390137044; Boelen PA, 2012, DEATH STUD, V36, P771, DOI 10.1080/07481187.2012.706982; Doorenbos AZ, 2006, J PAIN SYMPTOM MANAG, V32, P403, DOI 10.1016/j.jpainsymman.2006.05.025; Schulz R, 2006, AM J GERIAT PSYCHIAT, V14, P650, DOI 10.1097/01.JGP.0000203178.44894.db; Burnell G. M., 1989, CLIN MANAGEMENT BERE; Choi J, 2010, SUPPORT CARE CANCER, V18, P1445, DOI 10.1007/s00520-009-0767-3; Conde-Sala JL, 2010, INT J NURS STUD, V47, P1262, DOI 10.1016/j.ijnurstu.2010.03.001; Glajchen Myra, 2004, J Support Oncol, V2, P145; Ishii Y, 2012, J PAIN SYMPTOM MANAG, V44, P552, DOI 10.1016/j.jpainsymman.2011.10.011; Ishii Y, 2012, J PALLIAT MED, V15, P210, DOI 10.1089/jpm.2011.0248; Kitayama O, 2010, PROHIBITION DONT LOO; Lai C, 2013, AM J HOSP PALLIA CAR; Emanuel EJ, 1998, LANCET, V351, P21; Mangan Patricia A, 2003, Palliat Support Care, V1, P247; Nakajima S, 2009, RES AID PAPER MEIJI, V45, P119; Rossi FS, 2004, PALLIATIVE MED, V18, P129; Shear MK, 2009, AM J PSYCHIAT, V166, P746, DOI 10.1176/appi.ajp.2009.09050698; Stroeve M, 2007, LANCET, V370, P1963	26	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-9091	1938-2715		AM J HOSP PALLIAT ME	Am. J. Hosp. Palliat. Med.	MAR	2015	32	2					173	177		10.1177/1049909113514626		5	Health Care Sciences & Services	Health Care Sciences & Services	CB4LO	WOS:000349599400006		
J	Takebayashi, A; Kimura, F; Kishi, Y; Ishida, M; Takahashi, A; Yamanaka, A; Wu, D; Zheng, LY; Takahashi, K; Suginami, H; Murakami, T				Takebayashi, Akie; Kimura, Fuminori; Kishi, Yohei; Ishida, Mitsuaki; Takahashi, Akimasa; Yamanaka, Akiyoshi; Wu, Di; Zheng, Luyi; Takahashi, Kentaro; Suginami, Hiroshi; Murakami, Takashi			Subpopulations of Macrophages within Eutopic Endometrium of Endometriosis Patients	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						CD163; CD68; endometriosis; M1 macrophage; M2 macrophage	PERITONEAL-FLUID; WOMEN; POLARIZATION; ACTIVATION; GROWTH; EXPRESSION; DISEASE; LESIONS; CANCER; INFLAMMATION	ProblemEndometriosis is recognized as a chronic inflammatory disease and is related to immune response. There have been reports that revealed the different distribution of macrophage within the eutopic endometrium of women with endometriosis. Macrophages are functionally polarized into M1 and M2 cell lineages. We studied a difference in the subpopulations of M1 and M2 macrophages within the eutopic endometrium in patients with or without endometriosis to investigate how the eutopic endometrium is stimulated immunologically. Method of studyThirty-six patients with endometriosis (endometriosis group) and 37 without endometriosis (non-endometriosis group) were analyzed. Paraffin-embedded endometrial specimens were used for the study. Consecutive sections were used for immunostaining of CD68 (pan-macrophage marker) and CD163 (M2 macrophage marker). Cells positive for each marker were quantified, and the ratio of M2 macrophages in pan-macrophages was calculated. ResultThe endometriosis group had a significantly higher number of pan-macrophages than the control group in all phases (P<0.05). The ratios of M2 macrophages in pan-macrophages were significantly lower in all phases in the endometriosis group (P<0.05). ConclusionThe macrophage population slants toward M1 in the endometrium of endometriosis patients. The endometrium appeared to be stimulated by some organelles and/or substances that induce M1 in endometriosis patients.	[Takebayashi, Akie; Kimura, Fuminori; Takahashi, Akimasa; Yamanaka, Akiyoshi; Wu, Di; Zheng, Luyi; Murakami, Takashi] Shiga Univ Med Sci, Dept Obstet & Gynecol, Otsu, Shiga 5202192, Japan; [Kishi, Yohei; Suginami, Hiroshi] Takanohara Cent Hosp, Dept Obstet & Gynecol, Nara, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 5202192, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Div Diagnost Pathol, Otsu, Shiga 5202192, Japan; [Takahashi, Kentaro] Shiga Univ Med Sci, Dept Community Perinatal Med, Otsu, Shiga 5202192, Japan	Takebayashi, A (reprint author), Shiga Univ Med Sci, Dept Obstet & Gynecol, Otsu, Shiga 5202192, Japan.	akiie21@belle.shiga-med.ac.jp			Japan Society for the Promotion of Science [24659729, 23592400]	This study was supported by Grants-in-Aid for Scientific Research of the Japan Society for the Promotion of Science, Grant Numbers 24659729 and 23592400.	Canis M, 1997, FERTIL STERIL, V67, P817; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Harada T, 1997, AM J OBSTET GYNECOL, V176, P593, DOI 10.1016/S0002-9378(97)70553-2; Matarese G, 2003, TRENDS MOL MED, V9, P223, DOI 10.1016/S1471-4914(03)00051-0; Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; Russell P, 2011, J REPROD IMMUNOL, V91, P90, DOI 10.1016/j.jri.2011.03.013; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Braun DP, 1998, CURR OPIN OBSTET GYN, V10, P365, DOI 10.1097/00001703-199810000-00003; Hsu CC, 1997, FERTIL STERIL, V67, P1059, DOI 10.1016/S0015-0282(97)81439-2; Ho HN, 1996, AM J OBSTET GYNECOL, V175, P1236, DOI 10.1016/S0002-9378(96)70034-0; Martinez FO, 2006, J IMMUNOL, V177, P7303; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Benoit M, 2008, J IMMUNOL, V181, P3733; Berbic M, 2009, HUM REPROD, V24, P325, DOI 10.1093/humrep/den393; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Porta C, 2011, CANCER LETT, V305, P250, DOI 10.1016/j.canlet.2010.10.012; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Thiruchelvam U, 2013, J LEUKOCYTE BIOL, V93, P217, DOI 10.1189/jlb.0712327; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Braun DP, 2002, FERTIL STERIL, V78, P830, DOI 10.1016/S0015-0282(02)03334-4; Cicinelli E, 2008, FERTIL STERIL, V89, P677, DOI 10.1016/j.fertnstert.2007.03.074; Cominelli A, 2014, MOL HUM REPROD, V20, P767, DOI 10.1093/molehr/gau034; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Gazvani R, 2002, FERTIL STERIL, V77, P62, DOI 10.1016/S0015-0282(01)02954-5; Jensen AL, 2012, AM J REPROD IMMUNOL, V68, P374, DOI 10.1111/j.1600-0897.2012.01181.x; Jones RK, 1998, HUM REPROD UPDATE, V4, P702, DOI 10.1093/humupd/4.5.702; Khan KN, 2012, HUM REPROD, V27, P3417, DOI 10.1093/humrep/des331; Khan KN, 2010, FERTIL STERIL, V94, P2860, DOI 10.1016/j.fertnstert.2010.04.053; Lebovic DI, 2004, J CLIN ENDOCR METAB, V89, P1397, DOI 10.1210/jc.2003-031010; Matalliotakis IM, 2003, INT IMMUNOPHARMACOL, V3, P81, DOI 10.1016/S1567-5769(02)00216-3; Matteo M, 2009, AM J REPROD IMMUNOL, V61, P322, DOI 10.1111/j.1600-0897.2009.00698.x; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; OOSTERLYNCK DJ, 1993, ARCH GYNECOL OBSTET, V253, P197, DOI 10.1007/BF02766646; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sharpe-Timms KL, 2001, ANN NY ACAD SCI, V943, P131; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	MAR	2015	73	3					221	231		10.1111/aji.12331		11	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CB4SJ	WOS:000349618000004		
J	Nagasaki, T; Hongo, Y; Koito, T; Nakamura-Kusakabe, I; Shimamura, S; Takaki, Y; Yoshida, T; Maruyama, T; Inoue, K				Nagasaki, Toshihiro; Hongo, Yuki; Koito, Tomoko; Nakamura-Kusakabe, Ikumi; Shimamura, Shigeru; Takaki, Yoshihiro; Yoshida, Takao; Maruyama, Tadashi; Inoue, Koji			Cysteine dioxygenase and cysteine sulfinate decarboxylase genes of the deep-sea mussel Bathymodiolus septemdierum: possible involvement in hypotaurine synthesis and adaptation to hydrogen sulfide	AMINO ACIDS			English	Article						Amino acids; Hydrothermal vents; Marine invertebrates; Metabolism; Taurine synthesis	TAURINE TRANSPORTER; HYDROTHERMAL VENTS; THIOTROPHIC ENDOSYMBIONTS; AMINO-ACIDS; THIOTAURINE; EXPOSURE; LIVER; INVERTEBRATES; BIVALVES; BACTERIA	It has been suggested that invertebrates inhabiting deep-sea hydrothermal vent areas use the sulfinic acid hypotaurine, a precursor of taurine, to protect against the toxicity of hydrogen sulfide contained in the seawater from the vent. In this protective system, hypotaurine is accumulated in the gill, the primary site of sulfide exposure. However, the pathway for hypotaurine synthesis in mollusks has not been identified. In this study, we screened for the mRNAs of enzymes involved in hypotaurine synthesis in the deep-sea mussel Bathymodiolus septemdierum and cloned cDNAs encoding cysteine dioxygenase and cysteine sulfinate decarboxylase. As mRNAs encoding cysteamine dioxygenase and cysteine lyase were not detected, the cysteine sulfinate pathway is suggested to be the major pathway of hypotaurine and taurine synthesis. The two genes were found to be expressed in all the tissues examined, but the gill exhibited the highest expression. The mRNA level in the gill was not significantly changed by exposure to sulfides or thiosulfate. These results suggests that the gill of B. septemdierum maintains high levels of expression of the two genes regardless of ambient sulfide level and accumulates hypotaurine continuously to protect against sudden exposure to high level of sulfide.	[Nagasaki, Toshihiro; Nakamura-Kusakabe, Ikumi; Inoue, Koji] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Hongo, Yuki; Shimamura, Shigeru; Takaki, Yoshihiro; Yoshida, Takao; Maruyama, Tadashi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Koito, Tomoko] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Inoue, K (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	inouek@aori.u-tokyo.ac.jp			Japan Society for the Promotion of Science KAKENHI [22380107]	The authors thank Dr. Christopher A. Loretz for critical reading the manuscript and Prof. Toshitaka Gamo for information on chemical components of hydrothermal fluids. The authors also thank the operating team of ROV Hyper-Dolphin and the crew of the R/V Natsushima of JAMSTEC. This work was supported by Japan Society for the Promotion of Science KAKENHI No. 22380107.	ALLEN K, 1960, BIOL BULL, V118, P173, DOI 10.2307/1538995; Koito T, 2010, FISHERIES SCI, V76, P381, DOI 10.1007/s12562-010-0219-5; Rosenberg NK, 2006, J EXP ZOOL PART A, V305A, P655, DOI 10.1002/jez.a.316; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Vitvitsky V, 2011, J BIOL CHEM, V286, P32002, DOI 10.1074/jbc.M111.253344; Duperron S, 2013, BIOGEOSCIENCES, V10, P3241, DOI 10.5194/bg-10-3241-2013; Sen A, 2013, DEEP-SEA RES PT I, V72, P48, DOI 10.1016/j.dsr.2012.11.003; Pruski AM, 2003, J EXP BIOL, V206, P2923, DOI 10.1242/jeb.00513; Koito T, 2010, CAH BIOL MAR, V51, P429; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Ueki I, 2009, J NUTR, V139, P207, DOI 10.3945/jn.108.099085; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Stipanuk MH, 2011, AMINO ACIDS, V41, P91, DOI 10.1007/s00726-010-0518-2; Brand GL, 2007, MAR ECOL-EVOL PERSP, V28, P208, DOI 10.1111/j.1439-0485.2006.00113.x; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Van Dover CL, 2004, J EXP MAR BIOL ECOL, V300, P273, DOI 10.1016/j.jembe.2003.12.024; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Inoue K, 2008, FEBS LETT, V582, P1542, DOI 10.1016/j.febslet.2008.03.052; Thubaut J, 2013, ECOL EVOL, V3, P4748, DOI 10.1002/ece3.749; Stipanuk MH, 2004, NEUROCHEM RES, V29, P105, DOI 10.1023/B:NERE.0000010438.40376.c9; Ueki I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1292, DOI 10.1152/ajpendo.00589.2011; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Fujinoki M, 2012, FISHERIES SCI, V78, P139, DOI 10.1007/s12562-011-0419-7; Gamo T, 2006, GEOPH MONOG SERIES, V166, P147; JACKSON FR, 1990, J MOL EVOL, V31, P325, DOI 10.1007/BF02101126; Kinjo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082410; Martins E, 2013, BIOGEOSCI DISCUSS, V10, P2675; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058563; Ortega JA, 2008, J EXP BIOL, V211, P3816, DOI 10.1242/jeb.021303; OUCHI S, 1959, J BIOCHEM-TOKYO, V46, P765; Pruski AM, 2000, MAR BIOL, V136, P411, DOI 10.1007/s002270050700; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Ubuka T, 2008, AMINO ACIDS, V35, P53, DOI 10.1007/s00726-007-0633-x; Waite TJ, 2008, J SHELLFISH RES, V27, P163, DOI 10.2983/0730-8000(2008)27[163:VISSWS]2.0.CO;2; Yancey PH, 2009, J EXP ZOOL PART A, V311A, P439, DOI 10.1002/jez.541; YONEDA T, 1968, Bulletin of the Faculty of Fisheries Hokkaido University, V19, P140	40	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	MAR	2015	47	3					571	578		10.1007/s00726-014-1891-z		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CB1MB	WOS:000349390700012		
J	Kawasaki, D; Fujii, K; Fukunaga, M; Fukuda, N; Masuyama, T; Ohkubo, N; Kato, M				Kawasaki, Daizo; Fujii, Kenichi; Fukunaga, Masashi; Fukuda, Nobuhisa; Masuyama, Tohru; Ohkubo, Nobukazu; Kato, Masaaki			Safety and Efficacy of Carbon Dioxide and Intravascular Ultrasound-Guided Stenting for Renal Artery Stenosis in Patients With Chronic Renal Insufficiency	ANGIOLOGY			English	Article						renal artery stenosis; carbon dioxide angiography; intravascular ultrasound	SOLITARY FUNCTIONING KIDNEY; RENOVASCULAR DISEASE; MANAGEMENT; ARTERIOGRAPHY; ANGIOGRAPHY	We evaluated the feasibility, safety, and mid-term outcomes of renal artery stenting using carbon dioxide (CO2) digital subtraction angiography and intravascular ultrasound (IVUS) for patients with renal insufficiency and significant atherosclerotic renal artery stenosis (RAS). Eighteen consecutive patients with chronic renal insufficiency underwent renal artery stenting under the guidance of CO2 angiography and IVUS without contrast media. Renal function and blood pressure were assessed pre- and postintervention. A total of 27 de novo RAS in 18 patients (15 males; mean age: 72 +/- 9 years) with renal insufficiency were treated by renal artery stenting with the combined use of the CO2 angiography and IVUS without any procedural complications. Although the mean serum creatinine concentration preprocedure and 6 months after treatment did not change (2.7 +/- 1.0-2.4 +/- 1.1 mg/dL), blood pressure significantly decreased 6 months after stenting (158 +/- 10-147 +/- 11 mm Hg, P < .01).	[Kawasaki, Daizo; Fukuda, Nobuhisa] Morinomiya Hosp, Div Cardiovasc, Dept Internal Med, Osaka 5360025, Japan; [Fujii, Kenichi; Fukunaga, Masashi; Masuyama, Tohru] Hyogo Coll Med, Div Cardiovasc, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Ohkubo, Nobukazu; Kato, Masaaki] Morinomiya Hosp, Dept Cardiovasc Surg, Osaka 5360025, Japan	Kawasaki, D (reprint author), Morinomiya Hosp, Div Cardiovasc, Joutou Ku, 2-1-88 Morinomiya, Osaka 5360025, Japan.	daizou0524909@hotmail.com					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Schweiger MJ, 2007, CATHETER CARDIO INTE, V69, P135, DOI 10.1002/ccd.20964; HARDING MB, 1992, J AM SOC NEPHROL, V2, P1608; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; HAWKINS IF, 1982, AM J ROENTGENOL, V139, P19; Kawasaki D, 2012, CIRC J, V76, P1722, DOI 10.1253/circj.CJ-11-1382; Cambria RP, 1999, J VASC SURG, V29, P1012, DOI 10.1016/S0741-5214(99)70242-9; Chatziioannou A, 2002, EUR J VASC ENDOVASC, V23, P49, DOI 10.1053/ejvs.2001.1535; DEAN RH, 1981, ARCH SURG-CHICAGO, V116, P1408; Dorros G, 1998, CIRCULATION, V98, P642; Eschelman DJ, 1998, AM J ROENTGENOL, V171, P1265; Isles CG, 1999, QJM-MON J ASSOC PHYS, V92, P159, DOI 10.1093/qjmed/92.3.159; Kawarada O, 2007, CATHETER CARDIO INTE, V70, P784, DOI 10.1002/ccd.21330; Kawarada O, 2007, CIRC J, V71, P1942, DOI 10.1253/circj.71.1942; Klonaris C, 2008, J VASC SURG, V48, P1414, DOI 10.1016/j.jvs.2008.07.056; MAXWELL MH, 1972, J AMER MED ASSOC, V220, P1195, DOI 10.1001/jama.220.9.1195; Meier P, 2011, CURR OPIN CARDIOL, V26, P463, DOI 10.1097/HCO.0b013e32834a6fe8; Spinosa DJ, 1999, RADIOLOGY, V210, P663; Tan J, 2007, NEPHROL DIAL TRANSPL, V22, P1916, DOI 10.1093/ndt/gfm; TOLLEFSON DFJ, 1991, J VASC SURG, V14, P327; WOLLENWE.J, 1968, AM J CARDIOL, V21, P60, DOI 10.1016/0002-9149(68)90014-3; Zhang HL, 2009, PROG CARDIOVASC DIS, V52, P209, DOI 10.1016/j.pcad.2009.10.003	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	MAR	2015	66	3					231	236		10.1177/0003319714524297		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB0MU	WOS:000349321200006		
J	Abe, N; Kashima, Y; Izawa, A; Motoki, H; Ebisawa, S; Miyashita, Y; Imamura, H; Ikeda, U				Abe, Naoyuki; Kashima, Yuichiro; Izawa, Atsushi; Motoki, Hirohiko; Ebisawa, Souichiro; Miyashita, Yusuke; Imamura, Hiroshi; Ikeda, Uichi			A 2-Year Follow-Up of Oxidative Stress Levels in Patients With ST-Segment Elevation Myocardial Infarction: A Subanalysis of the ALPS-AMI Study	ANGIOLOGY			English	Article						ST-segment elevation myocardial infarction; oxidative stress; biological antioxidant potential; diacron-reactive oxygen metabolite	CORONARY-ARTERY-DISEASE; CARDIOVASCULAR EVENTS; STENT IMPLANTATION; VASCULAR-DISEASE; MECHANISMS; GUIDELINES; MANAGEMENT; PREDICTOR; INJURY	We sought to determine whether serial measurements of oxidative stress levels could serve as a predictive marker for cardiovascular (CV) events in patients with ST-segment elevation myocardial infarction (STEMI). Biological antioxidant potential (BAP) levels were measured at admission and at 6, 12, and 24 months in 69 patients with STEMI. The CV events abruptly increased 6 to 10 months after successful percutaneous coronary intervention in patients with STEMI, and the 6-month BAP levels were significantly lower in patients with CV events (2456 mol/L [interquartile range: 2237-2615 mol/L]) than in those without (2849 mol/L [2575-2987 mol/L], P < .001). A decreased 6-month BAP level was an independent and significant predictor of long-term CV events (hazard ratio = 2.45; 95% confidence intervals 1.10-5.78; P = .04). Our findings suggest that serial changes in antioxidant capacity, assessed by BAP levels, may serve as a predictive marker for CV events after STEMI.	[Abe, Naoyuki; Kashima, Yuichiro; Izawa, Atsushi; Motoki, Hirohiko; Ebisawa, Souichiro; Miyashita, Yusuke; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 3900802, Japan; [Imamura, Hiroshi] Shinshu Univ, Sch Med, Dept Emergency & Intens Care Med, Matsumoto, Nagano 3900802, Japan	Kashima, Y (reprint author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, 3-1-1 Asahi, Matsumoto, Nagano 3900802, Japan.	ykashima@shinshu-u.ac.jp					Amoroso G, 2001, INT J CARDIOL, V79, P265, DOI 10.1016/S0167-5273(01)00448-X; Strobel NA, 2011, INT J CARDIOL, V147, P191, DOI 10.1016/j.ijcard.2010.08.008; Farb A, 2003, CIRCULATION, V108, P1701, DOI 10.1161/01.CIR.0000091115.05480.B0; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Cavalleri A, 2004, INT J BIOL MARKER, V19, P250; Vassalle C, 2012, CLIN CHEM LAB MED, V50, P1463, DOI 10.1515/cclm-2011-0919; Kashima Y, 2009, J CARDIOL, V54, P76, DOI 10.1016/j.jjcc.2009.04.008; Juni RP, 2013, J AM COLL CARDIOL, V61, P1471, DOI 10.1016/j.jacc.2012.11.068; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P29, DOI 10.1161/01.ATV.0000150649.39934.13; Kakita H, 2006, PEDIATR RES, V60, P675, DOI 10.1203/01.pdr.0000245911.79943.8a; Vassalle C, 2012, J ATHEROSCLER THROMB, V19, P712; Kochiadakis GE, 2010, INT J CARDIOL, V142, P33, DOI 10.1016/j.ijcard.2008.12.105; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Ohtani K, 2006, HYPERTENSION, V48, P664, DOI 10.1161/01.HYP.0000237974.74488.30; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; van Beusekom HMM, 1998, J AM COLL CARDIOL, V32, P1109, DOI 10.1016/S0735-1097(98)00348-9	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	MAR	2015	66	3					271	277		10.1177/0003319714525656		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB0MU	WOS:000349321200013		
J	Chen, LC; Sakai, A				Chen, Lung-Chi; Sakai, Akira			CRITICAL TWO-POINT FUNCTIONS FOR LONG-RANGE STATISTICAL-MECHANICAL MODELS IN HIGH DIMENSIONS	ANNALS OF PROBABILITY			English	Article						Critical behavior; long-range random walk; self-avoiding walk; percolation; the Ising model; two-point function; lace expansion	SELF-AVOIDING WALK; MEAN-FIELD BEHAVIOR; LACE EXPANSION; ORIENTED PERCOLATION; LIMIT DISTRIBUTION; ISING-MODELS; INEQUALITIES; EXPONENTS	We consider long-range self-avoiding walk, percolation and the Ising model on Z(d) that are defined by power-law decaying pair potentials of the form D(x) asymptotic to vertical bar x vertical bar(-d-alpha) with alpha > 0. The upper-critical dimension d(c) is 2(alpha boolean AND 2) for self-avoiding walk and the Ising model, and 3(alpha boolean AND 2) for percolation. Let alpha not equal 2 and assume certain heat-kernel bounds on the n-step distribution of the underlying random walk. We prove that, for d > d(c) (and the spread-out parameter sufficiently large), the critical two-point function G p(c) (X) for each model is asymptotically C vertical bar x vertical bar(alpha boolean AND 2-d), where the constant C is an element of (0, infinity) is expressed in terms of the model-dependent lace-expansion coefficients and exhibits crossover between alpha < 2 and alpha > 2. We also provide a class of random walks that satisfy those heat-kernel bounds.	[Chen, Lung-Chi] Fu Jen Catholic Univ, Dept Math, Hsinchuang 24205, Taipei County, Taiwan; [Sakai, Akira] Hokkaido Univ, Dept Math, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Chen, LC (reprint author), Fu Jen Catholic Univ, Dept Math, 510 Chung Cheng Rd, Hsinchuang 24205, Taipei County, Taiwan.	lcchen@math.fju.edu.tw; sakai@math.sci.hokudai.ac.jp			NSC [99-2115-M-030-004-MY3, 102-2115-M-030-001-MY2]; JSPS [21740059, 24540106]	Supported in part by NSC Grant 99-2115-M-030-004-MY3 and in part by NSC Grant 102-2115-M-030-001-MY2.; Supported in part by JSPS Grant-in-Aid for Young Scientists (B) 21740059 and in part by JSPS Grant-in-Aid for Scientific Research (C) 24540106.	AIZENMAN M, 1984, J STAT PHYS, V36, P107, DOI 10.1007/BF01015729; AIZENMAN M, 1986, J STAT PHYS, V44, P393, DOI 10.1007/BF01011304; AIZENMAN M, 1986, COMMUN MATH PHYS, V107, P611, DOI 10.1007/BF01205489; Bogdan K, 2007, COMMUN MATH PHYS, V271, P179, DOI 10.1007/s00220-006-0178-y; HARA T, 1990, COMMUN MATH PHYS, V128, P333, DOI 10.1007/BF02108785; Hara T, 2008, ANN PROBAB, V36, P530, DOI 10.1214/009117907000000231; AIZENMAN M, 1982, COMMUN MATH PHYS, V86, P1, DOI 10.1007/BF01205659; Heydenreich M, 2008, J STAT PHYS, V132, P1001, DOI 10.1007/s10955-008-9580-5; Kozma G, 2011, J AM MATH SOC, V24, P375, DOI 10.1090/S0894-0347-2010-00684-4; BARSKY DJ, 1991, ANN PROBAB, V19, P1520, DOI 10.1214/aop/1176990221; Hara T, 2003, ANN PROBAB, V31, P349; VANDENBERG J, 1985, J APPL PROBAB, V22, P556; Bhattacharya RN, 2010, CLASS APPL MATH, V64, P1, DOI 10.1137/1.9780898719895; Blumenthal R.M., 1968, MARKOV PROCESSES POT; Chen LC, 2008, PROBAB THEORY REL, V142, P151, DOI 10.1007/s00440-007-0101-2; Chen LC, 2009, PROBAB THEORY REL, V145, P435, DOI 10.1007/s00440-008-0174-6; Chen LC, 2011, ANN PROBAB, V39, P507, DOI 10.1214/10-AOP557; GINIBRE J, 1970, COMMUN MATH PHYS, V16, P310, DOI 10.1007/BF01646537; Griffiths R. B., 1970, Journal of Mathematical Physics, V11, DOI 10.1063/1.1665211; Grimmett G., 1999, PERCOLATION, V321; HARA T., ONE ARM EXPONE UNPUB; HEYDENREICH M., 2011, ARXIV11084325; MADRAS N., 1993, SELF AVOIDING WALK P; Sakai A, 2007, COMMUN MATH PHYS, V272, P283, DOI 10.1007/s00220-007-0227-1; Sakai A, 2004, J STAT PHYS, V117, P111, DOI 10.1023/B:JOSS.0000044061.83860.62; SLADE G., 2006, LECT NOTES MATH, V1879; van der Hofstad R, 2002, PROBAB THEORY REL, V122, P389, DOI 10.1007/s004400100175	27	2	2	INST MATHEMATICAL STATISTICS	CLEVELAND	3163 SOMERSET DR, CLEVELAND, OH 44122 USA	0091-1798			ANN PROBAB	Ann. Probab.	MAR	2015	43	2					639	681		10.1214/13-AOP843		43	Statistics & Probability	Mathematics	CB3BN	WOS:000349503300006		
J	Gazal, S; Sacre, K; Allanore, Y; Teruel, M; Goodall, AH; Tohma, S; Alfredsson, L; Okada, Y; Xie, G; Constantin, A; Balsa, A; Kawasaki, A; Nicaise, P; Amos, C; Rodriguez-Rodriguez, L; Chiocchia, G; Boileau, C; Zhang, JY; Vittecoq, O; Barnetche, T; Gay, MAG; Furukawa, H; Cantagrel, A; Le Loet, X; Sumida, T; Hurtado-Nedelec, M; Richez, C; Chollet-Martin, S; Schaeverbeke, T; Combe, B; Khoryati, L; Coustet, B; El-Benna, J; Siminovitch, K; Plenge, R; Padyukov, L; Martin, J; Tsuchiya, N; Dieude, P				Gazal, Steven; Sacre, Karim; Allanore, Yannick; Teruel, Maria; Goodall, Alison H.; Tohma, Shigeto; Alfredsson, Lars; Okada, Yukinori; Xie, Gang; Constantin, Arnaud; Balsa, Alejandro; Kawasaki, Aya; Nicaise, Pascale; Amos, Christopher; Rodriguez-Rodriguez, Luis; Chiocchia, Gilles; Boileau, Catherine; Zhang, Jinyi; Vittecoq, Olivier; Barnetche, Thomas; Gonzalez Gay, Miguel A.; Furukawa, Hiroshi; Cantagrel, Alain; Le Loet, Xavier; Sumida, Takayuki; Hurtado-Nedelec, Margarita; Richez, Christophe; Chollet-Martin, Sylvie; Schaeverbeke, Thierry; Combe, Bernard; Khoryati, Liliane; Coustet, Baptiste; El-Benna, Jammel; Siminovitch, Katherine; Plenge, Robert; Padyukov, Leonid; Martin, Javier; Tsuchiya, Naoyuki; Dieude, Philippe		CARDIOGENICS Consortium	Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene	ANNALS OF THE RHEUMATIC DISEASES			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; AUTOIMMUNE-DISEASE; INTERFERON-ALPHA; DENDRITIC CELLS; OSTEOPONTIN; EXPRESSION; RISK; POLYMORPHISMS; POPULATION	Objective To evaluate the contribution of the SPP1 rs11439060 and rs9138 polymorphisms, previously reported as autoimmune risk variants, in the rheumatoid arthritis (RA) genetic background according to anti-citrullinated protein antibodies (ACPAs) status of RA individuals. Methods We analysed a total of 11 715 RA cases and 26 493 controls from nine independent cohorts; all individuals were genotyped or had imputed genotypes for SPP1 rs11439060 and rs9138. The effect of the SPP1 rs11439060 and rs9138 risk-allele combination on osteopontin (OPN) expression in macrophages and OPN serum levels was investigated. Results We provide evidence for a distinct contribution of SPP1 to RA susceptibility according to ACPA status: the combination of >= 3 SPP1 rs11439060 and rs9138 common alleles was associated mainly with ACPA negativity (p=1.29x10(-5), ORACPA-negative 1.257 (1.135 to 1.394)) and less with ACPA positivity (p=0.0148, ORACPA-positive 1.072 (1.014 to 1.134)). The ORs between these subgroups (ie, ACPA-positive and ACPA-negative) significantly differed (p=7.33x10(-3)). Expression quantitative trait locus analysis revealed an association of the SPP1 risk-allele combination with decreased SPP1 expression in peripheral macrophages from 599 individuals. To corroborate these findings, we found an association of the SPP1 risk-allele combination and low serum level of secreted OPN (p=0.0157), as well as serum level of secreted OPN correlated positively with ACPA production (p=0.005; r=0.483). Conclusions We demonstrate a significant contribution of the combination of SPP1 rs11439060 and rs9138 frequent alleles to risk of RA, the magnitude of the association being greater in patients negative for ACPAs.	[Gazal, Steven] Univ Paris Diderot, Bichat Hosp, Plateforme Genom Constitut Assistance Publ Hop Pa, PRES Sorbonne Paris Cite, Paris, France; [Sacre, Karim] Univ Paris Diderot, Bichat Hosp, AP HP, Dept Internal Med,DHU FIRE,INSERM U699,PRES Sorbo, Paris, France; [Allanore, Yannick] Univ Paris 05, Cochin Hosp, AP HP, Dept Rheumatol A, Paris, France; [Allanore, Yannick; Chiocchia, Gilles] Univ Paris 05, Cochin Hosp, INSERM U1016, Paris, France; [Teruel, Maria; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Goodall, Alison H.; CARDIOGENICS Consortium] Glenfield Hosp, Leicester Natl Inst Hlth Res Biomed Res Unit Card, Clin Sci Wing, Leicester, Leics, England; [Tohma, Shigeto; Furukawa, Hiroshi] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Okada, Yukinori] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Xie, Gang; Zhang, Jinyi; Siminovitch, Katherine] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Zhang, Jinyi; Siminovitch, Katherine] Toronto Gen Res Inst, Toronto, ON, Canada; [Xie, Gang; Zhang, Jinyi; Siminovitch, Katherine] Univ Toronto, Dept Med, Toronto, ON, Canada; [Constantin, Arnaud; Cantagrel, Alain] Univ Toulouse 3, Purpan Hosp, CHU Toulouse, Dept Rheumatol,INSERM,UMR 1027, F-31062 Toulouse, France; [Balsa, Alejandro] Hosp La Paz, Dept Rheumatol, Madrid, Spain; [Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Mol & Genet Epidemiol Lab, Fac Med, Tsukuba, Ibaraki, Japan; [Nicaise, Pascale; Chollet-Martin, Sylvie] Univ Paris Diderot, Bichat Hosp, AP HP, Dept Immunol,PRES Sorbonne Paris Cite, Paris, France; [Amos, Christopher] Dartmouth Coll, Family Med Geisel Sch Med, Genom Med Dept Commun, Hanover, NH 03755 USA; [Rodriguez-Rodriguez, Luis] Hosp Clin Madrid, Dept Rheumatol, Madrid, Spain; [Boileau, Catherine] Univ Paris Diderot, Bichat Hosp, AP HP, INSERM U698,PRES Sorbonne Paris Cite, Paris, France; [Vittecoq, Olivier; Le Loet, Xavier] Hop Rouen, CHU Rouen, Dept Rheumatol, Normandy, France; [Vittecoq, Olivier; Le Loet, Xavier] Univ Rouen, INSERM U905, IRIB, Normandy, France; [Barnetche, Thomas; Richez, Christophe; Schaeverbeke, Thierry; Khoryati, Liliane] Bordeaux Selagen Univ, Pellegrin Hosp, Dept Rheumatol, Bordeaux, France; [Gonzalez Gay, Miguel A.] Hosp Marques de Valdecilla, Dept Rheumatol, IFIMAV, Santander, Spain; [Sumida, Takayuki] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Hurtado-Nedelec, Margarita; El-Benna, Jammel] Univ Paris 07, INSERM, U773, CRB3, F-75018 Paris, France; [Hurtado-Nedelec, Margarita] Univ Paris Diderot, Bichat Hosp, UF Dysfonctionnements Immunitaires Assistance Pub, Dept Hematol & Immunol,PRES Sorbonne Paris Cite, Paris, France; [Combe, Bernard] Montpellier Univ Hosp, Dept Rheumatol, Montpellier, France; [Coustet, Baptiste; Dieude, Philippe] Univ Paris Diderot, Bichat Hosp, AP HP, Dept Rheumatol,DHU FIRE,PRES Sorbonne Paris Cite, Paris, France; [Plenge, Robert] Merck Res Labs, Dept Genet & Pharmacogen, Boston, MA USA; [Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Dieude, Philippe] Univ Paris Diderot, PRES Sorbonne Paris Cite, INSERM U699, Bichat Fac Med, Paris, France	Dieude, P (reprint author), Hop Bichat Claude Bernard, Serv Rhumatol, 46 Rue Henri Huchard, F-75018 Paris, France.	philippe.dieude@bch.aphp.fr	Rodriguez-Rodriguez, Luis/H-5880-2013; Martin, Javier/B-8141-2008; Gonzalez-Gay, Miguel/B-2306-2008; Padyukov, Leonid/A-4890-2009	Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Gonzalez-Gay, Miguel/0000-0002-7924-7406; Padyukov, Leonid/0000-0003-2950-5670			Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Chiocchetti A, 2010, INT J IMMUNOPATH PH, V23, P263; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Bos CL, 2009, GENES IMMUN, V10, P210, DOI 10.1038/gene.2008.98; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Seddighzadeh M, 2012, J RHEUMATOL, V39, P1509, DOI 10.3899/jrheum.111284; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; LAMPE MA, 1991, J IMMUNOL, V147, P2902; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Bilgic H, 2009, ARTHRITIS RHEUM-US, V60, P3436, DOI 10.1002/art.24936; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chiocchetti A, 2004, BLOOD, V103, P1376, DOI 10.1182/blood-2003-05-1748; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P694, DOI 10.1002/art.27294; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Giacopelli F, 2004, PHYSIOL GENOMICS, V20, P87, DOI 10.1152/physiolgenomics.00138.2004; van der Woude D, 2009, ARTHRITIS RHEUM, V60, P916, DOI 10.1002/art.24385; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Combe B, 2007, JOINT BONE SPINE, V74, P440, DOI 10.1016/j.jbspin.2007.06.001; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; Emamian ES, 2009, GENES IMMUN, V10, P285, DOI 10.1038/gene.2009.20; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barizzone N, 2011, HUM IMMUNOL, V72, P930, DOI 10.1016/j.humimm.2011.06.009; Chiocchetti A, 2005, J NEUROIMMUNOL, V163, P172, DOI 10.1016/j.jneuroim.2005.02.020; Comi C, 2012, CLIN DEV IMMUNOL, V2012; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Denhardt D T, 1998, J Cell Biochem Suppl, V30-31, P92; Forton AC, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9025; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029309; Han SZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001757; Huizinga TW, 2005, ARTHRITIS RHEUM; Kikuchi K, 2003, HEPATOL RES, V26, P87, DOI 10.1016/S1386-6346(03)00012-3; Ohshima S, 2002, ARTHRITIS RHEUM, V46, P1094, DOI 10.1002/art.10143; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Tahri-Daizadeh N, 2003, GENOME RES, V13, P1952, DOI 10.1101/gr.1254203; Trivedi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/802581; van der Pouw Kraan IC, 2008, GENES IMMUN, V9, P16; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	55	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	MAR	2015	74	3							e19	10.1136/annrheumdis-2013-204581		8	Rheumatology	Rheumatology	CB1YB	WOS:000349422800030		
J	Kim, K; Bang, SY; Lee, HS; Cho, SK; Choi, CB; Sung, YK; Kim, TH; Jun, JB; Yoo, DH; Kang, YM; Kim, SK; Suh, CH; Shim, SC; Lee, SS; Lee, J; Chung, WT; Choe, JY; Shin, HD; Lee, JY; Han, BG; Nath, SK; Eyre, S; Bowes, J; Pappas, DA; Kremer, JM; Gonzalez-Gay, MA; Rodriguez-Rodriguez, L; Arlestig, L; Okada, Y; Diogo, D; Liao, KP; Karlson, EW; Raychaudhuri, S; Rantapaa-Dahlqvist, S; Martin, J; Klareskog, L; Padyukov, L; Gregersen, PK; Worthington, J; Greenberg, JD; Plenge, RM; Bae, SC				Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Cho, Soo-Kyung; Choi, Chan-Bum; Sung, Yoon-Kyoung; Kim, Tae-Hwan; Jun, Jae-Bum; Yoo, Dae Hyun; Kang, Young Mo; Kim, Seong-Kyu; Suh, Chang-Hee; Shim, Seung-Cheol; Lee, Shin-Seok; Lee, Jisoo; Chung, Won Tae; Choe, Jung-Yoon; Shin, Hyoung Doo; Lee, Jong-Young; Han, Bok-Ghee; Nath, Swapan K.; Eyre, Steve; Bowes, John; Pappas, Dimitrios A.; Kremer, Joel M.; Gonzalez-Gay, Miguel A.; Rodriguez-Rodriguez, Luis; Arlestig, Lisbeth; Okada, Yukinori; Diogo, Dorothee; Liao, Katherine P.; Karlson, Elizabeth W.; Raychaudhuri, Soumya; Rantapaa-Dahlqvist, Solbritt; Martin, Javier; Klareskog, Lars; Padyukov, Leonid; Gregersen, Peter K.; Worthington, Jane; Greenberg, Jeffrey D.; Plenge, Robert M.; Bae, Sang-Cheol			High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci	ANNALS OF THE RHEUMATIC DISEASES			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY BILIARY-CIRRHOSIS; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; MULTIPLE COMMON; CELIAC-DISEASE; POPULATION; METAANALYSIS; VARIANT	Objective A highly polygenic aetiology and high degree of allele-sharing between ancestries have been well elucidated in genetic studies of rheumatoid arthritis. Recently, the high-density genotyping array Immunochip for immune disease loci identified 14 new rheumatoid arthritis risk loci among individuals of European ancestry. Here, we aimed to identify new rheumatoid arthritis risk loci using Korean-specific Immunochip data. Methods We analysed Korean rheumatoid arthritis case-control samples using the Immunochip and genome-wide association studies (GWAS) array to search for new risk alleles of rheumatoid arthritis with anticitrullinated peptide antibodies. To increase power, we performed a meta-analysis of Korean data with previously published European Immunochip and GWAS data for a total sample size of 9299 Korean and 45 790 European case-control samples. Results We identified eight new rheumatoid arthritis susceptibility loci (TNFSF4, LBH, EOMES, ETS1-FLI1, COG6, RAD51B, UBASH3A and SYNGR1) that passed a genome-wide significance threshold (p<5x10(-8)), with evidence for three independent risk alleles at 1q25/TNFSF4. The risk alleles from the seven new loci except for the TNFSF4 locus (monomorphic in Koreans), together with risk alleles from previously established RA risk loci, exhibited a high correlation of effect sizes between ancestries. Further, we refined the number of single nucleotide polymorphisms (SNPs) that represent potentially causal variants through a trans-ethnic comparison of densely genotyped SNPs. Conclusions This study demonstrates the advantage of dense-mapping and trans-ancestral analysis for identification of potentially causal SNPs. In addition, our findings support the importance of T cells in the pathogenesis and the fact of frequent overlap of risk loci among diverse autoimmune diseases.	[Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Cho, Soo-Kyung; Choi, Chan-Bum; Sung, Yoon-Kyoung; Kim, Tae-Hwan; Jun, Jae-Bum; Yoo, Dae Hyun; Bae, Sang-Cheol] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea; [Kim, Kwangwoo; Okada, Yukinori; Diogo, Dorothee; Liao, Katherine P.; Karlson, Elizabeth W.; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA; [Kim, Kwangwoo; Okada, Yukinori; Diogo, Dorothee; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Kim, Kwangwoo; Okada, Yukinori; Diogo, Dorothee; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Kang, Young Mo] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Taegu, South Korea; [Kim, Seong-Kyu; Choe, Jung-Yoon] Catholic Univ, Daegu Sch Med, Dept Internal Med, Div Rheumatol,Arthrit & Autoimmun Res Ctr, Taegu, South Korea; [Suh, Chang-Hee] Ajou Univ, Sch Med, Dept Rheumatol, Suwon 441749, South Korea; [Shim, Seung-Cheol] Chungnam Natl Univ Hosp, Daejeon Rheumatoid & Degenerat Arthrit Ctr, Div Rheumatol, Taejon, South Korea; [Lee, Shin-Seok] Chonnam Natl Univ, Med Sch & Hosp, Dept Internal Med, Div Rheumatol, Kwangju, South Korea; [Lee, Jisoo] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Chung, Won Tae] Dong A Univ, Dept Internal Med, Div Rheumatol, Pusan, South Korea; [Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Lee, Jong-Young; Han, Bok-Ghee] Osong Hlth Technol, Korea Natl Inst Hlth, Ctr Genome Sci, Chungcheongbuk Do, South Korea; [Nath, Swapan K.; Worthington, Jane] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Eyre, Steve; Bowes, John; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Pappas, Dimitrios A.] Columbia Univ, Dept Med, Div Rheumatol, New York, NY USA; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY USA; [Gonzalez-Gay, Miguel A.] Hosp Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain; [Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Arlestig, Lisbeth; Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Clin Med Rheumatoloy, Umea, Sweden; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars; Padyukov, Leonid] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Greenberg, Jeffrey D.] NYU, Sch Med, Div Rheumatol, New York, NY USA	Plenge, RM (reprint author), Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA.	rplenge@partners.org; scbae@hanyang.ac.kr	Rodriguez-Rodriguez, Luis/H-5880-2013; Martin, Javier/B-8141-2008; Gonzalez-Gay, Miguel/B-2306-2008; 	Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Gonzalez-Gay, Miguel/0000-0002-7924-7406; Eyre, Stephen/0000-0002-1251-6974	Korea Healthcare technology R&D project of Ministry for Health Welfare [A121983]; NIH [AI094377]; Arthritis Research UK [17552]; Manchester Biomedical Research Centre	This study is supported by grants from the Korea Healthcare technology R&D project of Ministry for Health & Welfare (A121983), NIH grant (AI094377), the Arthritis Research UK grant reference number 17552 and the Manchester Biomedical Research Centre.	Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Ishii N, 2010, ADV IMMUNOL, V105, P63, DOI 10.1016/S0065-2776(10)05003-0; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Lee HS, 2009, ARTHRITIS RHEUM, V60, P364, DOI 10.1002/art.24245; Leng RX, 2011, AUTOIMMUN REV, V10, P439, DOI 10.1016/j.autrev.2011.01.007; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marigorta UM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003566; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Okada Y, 2013, NATURE; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tsygankov AY, 2013, J CELL PHYSIOL, V228, P43, DOI 10.1002/jcp.24128; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	43	9	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	MAR	2015	74	3							e13	10.1136/annrheumdis-2013-204749		8	Rheumatology	Rheumatology	CB1YB	WOS:000349422800024		
J	Nakagawa, K; Gonzalez-Roca, E; Souto, A; Kawai, T; Umebayashi, H; Campistol, JM; Canellas, J; Takei, S; Kobayashi, N; Callejas-Rubio, JL; Ortego-Centeno, N; Ruiz-Ortiz, E; Rius, F; Anton, J; Iglesias, E; Jimenez-Trevino, S; Vargas, C; Fernandez-Martin, J; Calvo, I; Hernandez-Rodriguez, J; Mendez, M; Dordal, MT; Basagana, M; Bujan, S; Yashiro, M; Kubota, T; Koike, R; Akuta, N; Shimoyama, K; Iwata, N; Saito, MK; Ohara, O; Kambe, N; Yasumi, T; Izawa, K; Kawai, T; Heike, T; Yague, J; Nishikomori, R; Arostegui, JI				Nakagawa, Kenji; Gonzalez-Roca, Eva; Souto, Alejandro; Kawai, Toshinao; Umebayashi, Hiroaki; Maria Campistol, Josep; Canellas, Jeronima; Takei, Syuji; Kobayashi, Norimoto; Luis Callejas-Rubio, Jose; Ortego-Centeno, Norberto; Ruiz-Ortiz, Estibaliz; Rius, Fina; Anton, Jordi; Iglesias, Estibaliz; Jimenez-Trevino, Santiago; Vargas, Carmen; Fernandez-Martin, Julian; Calvo, Inmaculada; Hernandez-Rodriguez, Jose; Mendez, Maria; Teresa Dordal, Maria; Basagana, Maria; Bujan, Segundo; Yashiro, Masato; Kubota, Tetsuo; Koike, Ryuji; Akuta, Naoko; Shimoyama, Kumiko; Iwata, Naomi; Saito, Megumu K.; Ohara, Osamu; Kambe, Naotomo; Yasumi, Takahiro; Izawa, Kazushi; Kawai, Tomoki; Heike, Toshio; Yaguee, Jordi; Nishikomori, Ryuta; Arostegui, Juan I.			Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes	ANNALS OF THE RHEUMATIC DISEASES			English	Article							MULTISYSTEM INFLAMMATORY DISEASE; LOW-LEVEL MOSAICISM; ARTICULAR SYNDROME; CIAS1 MUTATIONS; ANAKINRA; PATIENT; HETEROGENEITY; IMPROVEMENT; ACTIVATION; ARTHRITIS	Familial cold autoinflammatory syndrome, Muckle-Wells syndrome (MWS), and chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome are dominantly inherited autoinflammatory diseases associated to gain-of-function NLRP3 mutations and included in the cryopyrin-associated periodic syndromes (CAPS). A variable degree of somatic NLRP3 mosaicism has been detected in approximate to 35% of patients with CINCA. However, no data are currently available regarding the relevance of this mechanism in other CAPS phenotypes. Objective To evaluate somatic NLRP3 mosaicism as the disease-causing mechanism in patients with clinical CAPS phenotypes other than CINCA and NLRP3 mutation-negative. Methods NLRP3 analyses were performed by Sanger sequencing and by massively parallel sequencing. Apoptosis-associated Speck-like protein containing a CARD (ASC)-dependent nuclear factor kappa-light chain-enhancer of activated B cells (NF-kappa B) activation and transfection-induced THP-1 cell death assays determined the functional consequences of the detected variants. Results A variable degree (5.5-34.9%) of somatic NLRP3 mosaicism was detected in 12.5% of enrolled patients, all of them with a MWS phenotype. Six different missense variants, three novel (p.D303A, p.K355T and p.L411F), were identified. Bioinformatics and functional analyses confirmed that they were disease-causing, gain-of-function NLRP3 mutations. All patients treated with anti-interleukin1 drugs showed long-lasting positive responses. Conclusions We herein show somatic NLRP3 mosaicism underlying MWS, probably representing a shared genetic mechanism in CAPS not restricted to CINCA syndrome. The data here described allowed definitive diagnoses of these patients, which had serious implications for gaining access to anti-interleukin 1 treatments under legal indication and for genetic counselling. The detection of somatic mosaicism is difficult when using conventional methods. Potential candidates should benefit from the use of modern genetic tools.	[Nakagawa, Kenji; Yasumi, Takahiro; Izawa, Kazushi; Kawai, Tomoki; Heike, Toshio; Nishikomori, Ryuta] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Gonzalez-Roca, Eva; Ruiz-Ortiz, Estibaliz; Rius, Fina; Yaguee, Jordi] Hosp Clin IDIBAPS, Dept Immunol CDB, Barcelona, Spain; [Souto, Alejandro] Hosp Univ Santiago de Compostela, Dept Rheumatol, Santiago De Compostela, Spain; [Kawai, Toshinao] Natl Ctr Child Hlth & Dev, Dept Human Genet, Tokyo, Japan; [Umebayashi, Hiroaki] Miyagi Childrens Hosp, Dept Gen Pediat, Sendai, Miyagi, Japan; [Maria Campistol, Josep] Hosp Clin IDIBAPS, Dept Nephrol, Barcelona, Spain; [Canellas, Jeronima] Hosp Badalona Germans Trias & Pujol, Dept Rheumatol, Badalona, Spain; [Takei, Syuji] Kagoshima Univ, Fac Med, Sch Hlth Sci, Kagoshima 890, Japan; [Kobayashi, Norimoto] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Luis Callejas-Rubio, Jose; Ortego-Centeno, Norberto] Hosp Univ San Cecilio, Dept Internal Med, Granada, Spain; [Anton, Jordi; Iglesias, Estibaliz] Hosp St Joan de Deu, Dept Pediat Rheumatol, Esplugues, Spain; [Jimenez-Trevino, Santiago] Univ Oviedo, Hosp Cent Asturias, Dept Pediat, E-33080 Oviedo, Spain; [Vargas, Carmen] Hosp Virgen de la Macarena, Dept Rheumatol, Seville, Spain; [Fernandez-Martin, Julian] Hosp Meixoeiro, Dept Internal Med, Vigo, Spain; [Calvo, Inmaculada] Hosp Univ La Fe, Dept Pediat Rheumatol, Valencia, Spain; [Hernandez-Rodriguez, Jose] Hosp Clin IDIBAPS, Dept Autoimmune Dis, Barcelona, Spain; [Mendez, Maria] Hosp Badalona Germans Trias & Pujol, Dept Pediat, Badalona, Spain; [Teresa Dordal, Maria] Hosp Municipal Badalona, Dept Allergy, Badalona, Spain; [Basagana, Maria] Hosp Badalona Germans Trias & Pujol, Allergy Unit, Badalona, Spain; [Bujan, Segundo] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain; [Yashiro, Masato] Okayama Univ, Grad Sch Med, Dept Pediat, Okayama 7008530, Japan; [Kubota, Tetsuo; Koike, Ryuji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med & Rheumatol, Tokyo, Japan; [Akuta, Naoko] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Shimoyama, Kumiko] Hamamatsu Univ Sch Med, Dept Internal Med 3, Hamamatsu, Shizuoka 4313192, Japan; [Iwata, Naomi] Aichi Childrens Hlth & Med Ctr, Dept Infect & Immunol, Obu, Japan; [Saito, Megumu K.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto 6068507, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Human Genome Res, Kisarazu, Japan; [Kambe, Naotomo] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba, Japan	Arostegui, JI (reprint author), Hosp Clin Barcelona, Immunol Dept Esc Pl 0 4, Villarroel 170, E-08036 Barcelona, Spain.	rnishiko@kuhp.kyoto-u.ac.jp; jiaroste@clinic.ub.es		RUIZ-ORTIZ, ESTIBALIZ/0000-0002-3003-934X; Anton, Jordi/0000-0002-8792-4219; Arostegui, Juan Ignacio/0000-0003-4757-504X	Spanish Ministry of Health [FIS PS09/01182]; Japan's Ministry of Health, Labor and Welfare; Japan's Ministry of Education, Culture, Sports, Science and Technology	Supported by the Spanish Ministry of Health (FIS PS09/01182), by the Japan's Ministry of Health, Labor and Welfare, and by the Japan's Ministry of Education, Culture, Sports, Science and Technology.	Rynne M, 2006, ANN RHEUM DIS, V65, P533, DOI 10.1136/ard.2005.038091; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2007, ARTHRITIS RHEUM, V56, P1273, DOI 10.1002/art.22491; Arostegui JI, 2004, ARTHRITIS RHEUM, V50, P4045, DOI 10.1002/art.20633; Arostegui JI, 2007, ARTHRITIS RHEUM, V56, P3805, DOI 10.1002/art.22966; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512; Aksentijevich I, 2002, ARTHRITIS RHEUM, V46, P3340, DOI 10.1002/art.10688; Mirault T, 2006, ARTHRITIS RHEUM, V54, P1697, DOI 10.1002/art.21807; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr/212802; Arostegui JI, 2010, ARTHRITIS RHEUM-US, V62, P1158, DOI 10.1002/art.27342; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Cuisset L, 2011, ANN RHEUM DIS, V70, P495, DOI 10.1136/ard.2010.138420; Neven B, 2010, ARTHRITIS RHEUM-US, V62, P258, DOI 10.1002/art.25057; Weegerink NJD, 2011, HEARING RES, V282, P243, DOI 10.1016/j.heares.2011.07.006; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Verma D, 2010, ARTHRITIS RHEUM-US, V62, P2138, DOI 10.1002/art.27489; Izawa K, 2012, DNA RES, V19, P143, DOI 10.1093/dnares/dsr047; Jimenez-Trevino S, 2013, ANN RHEUM DIS, V72, P1109, DOI 10.1136/annrheumdis-2012-202913; Kagami S, 2006, J DERMATOL, V33, P118, DOI 10.1111/j.1346-8138.2006.00025.x; KASTNER DL, 2007, PRIMARY IMMUNODEFICI, P367; Murphy G, 2011, RHEUMATOLOGY, V50, P419, DOI 10.1093/rheumatology/keq280; Ohnishi H, 2012, J CLIN IMMUNOL, V32, P221, DOI 10.1007/s10875-011-9629-0; Saito M, 2005, ARTHRITIS RHEUM, V52, P3579, DOI 10.1002/art.21404; Kuemmerle-Deschner JB, 2011, ARTHRITIS RHEUM-US, V63, P840, DOI 10.1002/art.30149; Wise CA, 2000, ARTHRITIS RHEUM, V43, P2041, DOI 10.1002/1529-0131(200009)43:9<2041::AID-ANR15>3.0.CO;2-G	31	9	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	MAR	2015	74	3					603	610		10.1136/annrheumdis-2013-204361		8	Rheumatology	Rheumatology	CB1YB	WOS:000349422800018		
J	Mori, S; Yoshitama, T; Hidaka, T; Hirakata, N; Ueki, Y				Mori, Shunsuke; Yoshitama, Tamami; Hidaka, Toshihiko; Hirakata, Naoyuki; Ueki, Yukitaka			Baseline characteristics and tocilizumab therapy for patients with RA who were registered in the ACTRA-RI study (n=405)	ANNALS OF THE RHEUMATIC DISEASES			English	Letter							RHEUMATOID-ARTHRITIS; MONOTHERAPY; DISEASE		[Mori, Shunsuke] NHO Kumamoto Saishunsou Natl Hosp, Clin Res Ctr Rheumat Dis, Dept Rheumatol, Kumamoto 8611196, Japan; [Yoshitama, Tamami] Yoshitama Clin Rheumat Dis, Kagoshima, Japan; [Hidaka, Toshihiko] Zenjinkai Shimin No Mori Hosp, Inst Rheumatol, Miyazaki, Japan; [Hirakata, Naoyuki; Ueki, Yukitaka] Sasebo Chuo Hosp, Rheumat & Collagen Dis Ctr, Sasebo, Nagasaki, Japan	Mori, S (reprint author), NHO Kumamoto Saishunsou Natl Hosp, Clin Res Ctr Rheumat Dis, Dept Rheumatol, 2659 Suya, Kumamoto 8611196, Japan.	moris@saisyunsou1.hosp.go.jp					Anders HJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3256; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Emery P, 2013, ANN RHEUM DIS, V72, P1897, DOI 10.1136/annrheumdis-2013-203485; Dougados M, 2013, ANN RHEUM DIS, V72, P43, DOI 10.1136/annrheumdis-2011-201282; Karie S, 2008, RHEUMATOLOGY, V47, P350, DOI 10.1093/rheumatology/kem370; Dougados M, 2014, ANN RHEUM DIS, V73, P803, DOI 10.1136/annrheumdis-2013-204761; Fassett RG, 2014, CLIN INTERV AGING, V9, P191, DOI 10.2147/CIA.S39763; Ng B, 2014, CLIN RHEUMATOL, V33, P21, DOI 10.1007/s10067-013-2353-9; Redal-Baigorri B, 2014, J CLIN LAB ANAL, V28, P83, DOI 10.1002/jcla.21648; Verstappen SMM, 2010, ANN RHEUM DIS, V69, P1044, DOI 10.1136/ard.2008.106617	10	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	MAR	2015	74	3					628	630		10.1136/annrheumdis-2014-206695		3	Rheumatology	Rheumatology	CB1YB	WOS:000349422800022		
J	Tamai, M; Kawakami, A				Tamai, Mami; Kawakami, Atsushi			Response to: 'Does adding the presence of MRI detected bone marrow oedema improve the accuracy of the 2010 EULAR/ACR criteria for rheumatoid arthritis?' by Nieuwenhuis et al	ANNALS OF THE RHEUMATIC DISEASES			English	Letter									[Tamai, Mami; Kawakami, Atsushi] Nagasaki Univ, Dept Immunol & Rheumatol, Grad Sch Biomed Sci, Nagasaki 8528501, Japan	Tamai, M (reprint author), Nagasaki Univ, Dept Immunol & Rheumatol, Grad Sch Biomed Sci, 1-7-1Sakamoto, Nagasaki 8528501, Japan.	mmtamami@yahoo.co.jp					Tamai M, 2012, MOD RHEUMATOL, V22, P654, DOI 10.1007/s10165-011-0575-8; Tamai M, 2009, ARTHRITIS RHEUM, V61, P752	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	MAR	2015	74	3					E30	E30		10.1136/annrheumdis-2014-206936		1	Rheumatology	Rheumatology	CB1YB	WOS:000349422800041		
J	Saito, K				Saito, Kazuya			Communicative focus on second language phonetic form: Teaching Japanese learners to perceive and produce English /(sic)/ without explicit instruction	APPLIED PSYCHOLINGUISTICS			English	Article							R-VERTICAL-BAR; L2 PRONUNCIATION DEVELOPMENT; FOREIGN ACCENT; ADULTS PERCEPTION; AMERICAN ENGLISH; LISTENERS; LANGUAGE; ACQUISITION; RECASTS; METAANALYSIS	The current study examines in depth how two types of form-focused instruction (FFI), which are FFI with and without corrective feedback (CF), can facilitate second language speech perception and production of // by 49 Japanese learners in English as a Foreign Langage settings. FFI effectiveness was assessed via three outcome measures (perception, controlled production, and spontaneous production) and also according to two lexical contexts (trained and untrained items). Two experimental groups received 4 hr of FFI treatment to notice and practice the target feature of // (but without any explicit instruction) in meaningful discourse. A control group (n = 14) received comparable instruction in the absence of FFI. During FFI, the instructors provided CF only to students in the FFI + CF group (n = 18) by recasting their mispronunciations of //, while no CF was provided to those in the FFI-only group (n = 17). Analyses of pre- and posttests showed that FFI itself can sufficiently promote the development of speech perception and production of // and the acquisitional value of CF in second language speech learning remains unclear. The results suggest that the beginner learners without much phonetic knowledge on how to repair their mispronunciation of // should be encouraged to learn the target sound only through FFI in a receptive mode without much pressure for modified output.	[Saito, Kazuya] Waseda Univ, Tokyo 1698050, Japan	Saito, K (reprint author), Waseda Univ, Sch Commerce, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	kazuya.saito@waseda.jp			Government of Canada Post-Doctoral Research Fellowship	This study was funded by the Government of Canada Post-Doctoral Research Fellowship. I gratefully acknowledge insightful comments from Murray Munro, Roy Lyster, Tracey Derwing, Helen Fraser, and three anonymous Applied Psycholinguistics reviewers on earlier versions of the manuscript. Finally, I extend my gratitude and appreciation to the administration staff, teachers, and students at ECC Foreign Language Institute, especially Noriaki Okamura, Yukio Nagato, and Anna-Marie Staniewski.	Spada N, 2011, LANG TEACHING, V44, P225, DOI 10.1017/S0261444810000224; Flege JE, 1996, J ACOUST SOC AM, V99, P1161, DOI 10.1121/1.414884; Trofimovich P, 2006, MOD LANG J, V90, P519, DOI 10.1111/j.1540-4781.2006.00464.x; Norris JM, 2000, LANG LEARN, V50, P417, DOI 10.1111/0023-8333.00136; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Derwing TM, 2004, LANG LEARN, V54, P655, DOI 10.1111/j.1467-9922.2004.00282.x; Saito K, 2012, LANG LEARN, V62, P595, DOI 10.1111/j.1467-9922.2011.00639.x; Espy-Wilson CY, 2000, J ACOUST SOC AM, V108, P343, DOI 10.1121/1.429469; FLEGE JE, 1995, J ACOUST SOC AM, V97, P3125, DOI 10.1121/1.413041; Bradlow AR, 1999, J ACOUST SOC AM, V106, P2074, DOI 10.1121/1.427952; Lin YH, 2003, APPL LINGUIST, V24, P439, DOI 10.1093/applin/24.4.439; Yang BG, 1996, J PHONETICS, V24, P245, DOI 10.1006/jpho.1996.0013; Lee B, 2006, STUD SECOND LANG ACQ, V28, P487, DOI 10.1017/S0272263106060207; Sheen Y, 2006, LANG TEACH RES, V10, P361, DOI 10.1191/1362168806ir2O3oa; Staehr LS, 2009, STUD SECOND LANG ACQ, V31, P577, DOI 10.1017/S0272263109990039; Hattori K, 2009, J ACOUST SOC AM, V125, P469, DOI 10.1121/1.3021295; Derwing TM, 2005, TESOL QUART, V39, P379; Spada N, 2010, LANG LEARN, V60, P263, DOI 10.1111/j.1467-9922.2010.00562.x; Kuhl PK, 2000, P NATL ACAD SCI USA, V97, P11850, DOI 10.1073/pnas.97.22.11850; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; Imai S, 2005, J ACOUST SOC AM, V117, P896, DOI 10.1121/1.1823291; Mackey A, 1998, MOD LANG J, V82, P338, DOI 10.2307/329960; Piske T, 2001, J PHONETICS, V29, P191, DOI 10.1006/jpho.2001.0134; Riney TJ, 2000, TESOL QUART, V34, P711, DOI 10.2307/3587782; Han ZH, 2008, APPL LINGUIST, V29, P597, DOI 10.1093/applin/amn010; Oswald FL, 2010, ANNU REV APPL LINGUI, V30, P85, DOI 10.1017/S0267190510000115; Schmitt N, 2008, LANG TEACH RES, V12, P329, DOI 10.1177/1362168808089921; FLEGE JE, 1995, LANG SPEECH, V38, P25; Isaacs T, 2012, STUD SECOND LANG ACQ, V34, P475, DOI 10.1017/S0272263112000150; Ammar A, 2006, STUD SECOND LANG ACQ, V28, P543, DOI 10.1017/S0272263106060268; SHELDON A, 1982, APPL PSYCHOLINGUIST, V3, P243, DOI 10.1017/S0142716400001417; Nicholas H, 2001, LANG LEARN, V51, P719, DOI 10.1111/0023-8333.00172; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; McClelland JL, 2002, PHYSIOL BEHAV, V77, P657, DOI 10.1016/S0031-9384(02)00916-2; Saito K, 2012, TESOL QUART, V46, P842, DOI 10.1002/tesq.67; Best Catherine T., 2007, LANGUAGE EXPERIENCE, P13, DOI DOI 10.1075/LLLT.17.07BES; Boersma P, 2011, PRAAT DOING PHONETIC; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; Bradlow A.R., 2008, PHONOLOGY 2 LANGUAGE, P287; Brajot F., BILINGUALIS IN PRESS; Bundgaard-Nielsen RL, 2011, STUD SECOND LANG ACQ, V33, P433, DOI 10.1017/S0272263111000040; Bundgaard-Nielsen RL, 2011, APPL PSYCHOLINGUIST, V32, P51, DOI 10.1017/S0142716410000287; Cadierno T., 1993, STUDIES 2ND LANGUAGE, V15, P225, DOI 10.1017/S0272263100011979; Celce-Murcia Marianne, 2010, TEACHING PRONUNCIATI; Cobb T. M., 2011, COMPLEAT LEXICAL TUT; Cutler A, 2005, FIGURE OF SPEECH: A FESTSCHRIFT FOR JOHN LAVER, P63; DeKeyser RM, 2007, CAM APPL L, P1, DOI 10.1017/CBO9780511667275; Doughty C., 2003, HDB 2 LANGUAGE ACQUI, P257; Ellis R., 2002, STUDIES 2 LANGUAGE A, V24, P223, DOI DOI 10.1017/S0272263102002073; Ellis R, 2006, AILA REV, V19, P18, DOI 10.1075/aila.19.04ell; Ellis R, 2005, STUD SECOND LANG ACQ, V27, P141, DOI 10.1017/S0272263105050096; Ellis R, 2001, LANG LEARN, V51, P1, DOI 10.1111/j.1467-1770.2001.tb00013.x; Flege J. E., 1998, STUDIES 2 LANGUAGE A, V20, P155; Flege James Emil, 1995, SPEECH PERCEPTION LI, P233; Flege JE, 2003, PHONETICS PHONOLOGY, P319, DOI DOI 10.1515/9783110895094.319; Gass S. M., 1997, INPUT INTERACTION 2; Guion SG, 2000, J ACOUST SOC AM, V107, P2711, DOI 10.1121/1.428657; Iverson P., 2003, COGNITION, V87, P847; Jenkins Jennifer, 2000, PHONOLOGY ENGLISH IN; Jiang N, 2007, LANG LEARN, V57, P1, DOI 10.1111/j.1467-9922.2007.00397.x; Kasper G., 2002, PRAGMATICS LANGUAGE; Levis J., 2005, TESOL Q, V39, P367, DOI DOI 10.2307/3588485; Logan J., 1992, J ACOUST SOC AM, V89, P874; Lyster R, 2007, LANG LEARN LANG TEAC, V18, P1; Major R., 2008, PHONOLOGY 2 LANGUAGE, P63, DOI DOI 10.1075/SIBIL.36.05MAJ; Munro M. J., 1998, STUDIES 2 LANGUAGE A, V20, P139; Ranta L, 2007, CAM APPL L, P141; Rau DV, 2009, LANG LEARN, V59, P581; Saito K, 2013, STUD SECOND LANG ACQ, V35, P1, DOI 10.1017/S0272263112000666; Saito K., LANGUAGE LE IN PRESS; Sheen Y., 2007, CONVERSATIONAL INTER, P301; Spada N., 1997, LANG TEACHING, V29, P73, DOI DOI 10.1017/S0261444800012799; Thomson RI, 2012, LANG LEARN, V62, P1231, DOI 10.1111/j.1467-9922.2012.00724.x; Trofimovich P, 2012, TESOL QUART, V46, P176, DOI 10.1002/tesq.9; Vandergrift L., 2007, LANG TEACHING, V56, P431; VanPatten B., 2004, INPUT PROCESSING GRA; Walley A., 2007, LANGUAGE EXPERIENCE, P315	77	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0142-7164	1469-1817		APPL PSYCHOLINGUIST	Appl. Psycholinguist.	MAR	2015	36	2					377	409		10.1017/S0142716413000271		33	Linguistics; Psychology, Experimental	Linguistics; Psychology	CB3TZ	WOS:000349553100010		
J	Romanenko, LA; Tanaka, N; Svetashev, VI; Mikhailov, VV				Romanenko, Lyudmila A.; Tanaka, Naoto; Svetashev, Vassilii I.; Mikhailov, Valery V.			Sphingorhabdus pacificus sp nov., isolated from sandy sediments of the Sea of Japan seashore	ARCHIVES OF MICROBIOLOGY			English	Article						Sphingorhabdus pacificus sp nov.; Marine; Sand sediments	EMENDED DESCRIPTION; GENUS SPHINGOPYXIS; WATER; ACID	An aerobic, Gram-negative, yellow-pigmented, non-motile rod-shaped bacterium designated KMM 9574(T) was isolated from a sand sediment sample collected from the Sea of Japan seashore. Comparative 16S rRNA gene sequence analysis showed that strain KMM 9574(T) belonged to the genus Sphingorhabdus sharing a highest sequence similarity to Sphingorhabdus marina JCM 14161(T) 96.8 %. Strain KMM 9574(T) was characterized by the major ubiquinone Q-10, and by the predominance of C-18:1 omega 7c, C-16:0 2-OH, C-16:1 omega 7c, C-17:1, followed by C-15:0 2-OH and C-14:0 2-OH in its fatty acid profile. Polar lipids consisted of phosphatidylcholine, sphingoglycolipid, phosphatidylethanolamine, phosphatidylglycerol, diphosphatidylglycerol, an unknown phospholipid, and an unknown lipid. The DNA G+C content was 56.5 mol %. Based on phylogenetic analysis and distinctive phenotypic characteristics, strain 9574(T) is concluded to represent a novel species of the genus Sphingorhabdus, for which the name Sphingorhabdus pacificus sp. nov., is proposed. The type strain of the species is strain KMM 9574(T) (= NRIC 0922(T) = JCM 30177(T)).	[Romanenko, Lyudmila A.; Mikhailov, Valery V.] Russian Acad Sci, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia; [Tanaka, Naoto] Tokyo Univ Agr, NODAI Culture Collect Ctr, Setagaya Ku, Tokyo 1568502, Japan; [Svetashev, Vassilii I.] Russian Acad Sci, Inst Marine Biol, Far Eastern Branch, Vladivostok 690041, Russia; [Mikhailov, Valery V.] Far Eastern Fed Univ, Vladivostok 690091, Russia	Romanenko, LA (reprint author), Russian Acad Sci, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Prospect 100 Let Vladivostoku,159, Vladivostok 690022, Russia.	lro@piboc.dvo.ru			RSF [14-14-00030]	We would like to thank Dr. Moriya Ohkuma, Japan Collection of Microorganisms, JCM, Japan, for providing Sphingorhabdus type strains for comparative analyses. This study was supported by a grant from the RSF "Biodiversity and biotechnological potential of marine bacteria and fungi" no. 14-14-00030.	Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Bruns A, 2001, INT J SYST EVOL MICR, V51, P1997; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Shida O, 1997, INT J SYST BACTERIOL, V47, P289; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Jogler M, 2013, INT J SYST EVOL MICR, V63, P1342, DOI 10.1099/ijs.0.043133-0; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P369, DOI 10.1099/ijs.0.63218-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; COLLINS MD, 1984, ARCH MICROBIOL, V137, P247, DOI 10.1007/BF00414552; Baik KS, 2013, INT J SYST EVOL MICR, V63, P1297, DOI 10.1099/ijs.0.044057-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Kim BS, 2008, INT J SYST EVOL MICR, V58, P2415, DOI 10.1099/ijs.0.65614-0; MITCHELL K, 1990, J GEN MICROBIOL, V136, P2035; Owen J, 1969, BIOPOLYMERS, V7, P503; Park JM, 2014, INT J SYST EVOL MICR, V64, P2551, DOI 10.1099/ijs.0.064378-0; Romanenko LA, 2009, INT J SYST EVOL MICR, V59, P1179, DOI 10.1099/ijs.0.003285-0; Romanenko LA, 2013, INT J SYST EVOL MICR, V63, P3079, DOI 10.1099/ijs.0.046607-0; Sasser M., 1990, 101 MIDI; Smibert Robert M., 1994, P607	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	MAR	2015	197	2					147	153		10.1007/s00203-014-1033-8		7	Microbiology	Microbiology	CB1MI	WOS:000349391400003		
J	Alves, N; Meirelles, PM; Santos, ED; Dutilh, B; Silva, GGZ; Paranhos, R; Cabral, AS; Rezende, C; Iida, T; de Moura, RL; Kruger, RH; Pereira, RC; Valle, R; Sawabe, T; Thompson, C; Thompson, F				Alves Junior, Nelson; Meirelles, Pedro Milet; Santos, Eidy de Oliveira; Dutilh, Bas; Silva, Genivaldo G. Z.; Paranhos, Rodolfo; Cabral, Anderson S.; Rezende, Carlos; Iida, Tetsuya; de Moura, Rodrigo L.; Kruger, Ricardo Henrique; Pereira, Renato C.; Valle, Rogerio; Sawabe, Tomoo; Thompson, Cristiane; Thompson, Fabiano			Microbial community diversity and physical-chemical features of the Southwestern Atlantic Ocean	ARCHIVES OF MICROBIOLOGY			English	Article						Metagenomics; South Atlantic Ocean; Microbial diversity; Water mass	ORGANIC-MATTER; WATER MASSES; ALTEROMONAS-MACLEODII; MARINE ENVIRONMENTS; VIRAL ABUNDANCE; NORTH-ATLANTIC; GLOBAL OCEAN; DARK OCEAN; DEEP; SEA	Microbial oceanography studies have demonstrated the central role of microbes in functioning and nutrient cycling of the global ocean. Most of these former studies including at Southwestern Atlantic Ocean (SAO) focused on surface seawater and benthic organisms (e.g., coral reefs and sponges). This is the first metagenomic study of the SAO. The SAO harbors a great microbial diversity and marine life (e.g., coral reefs and rhodolith beds). The aim of this study was to characterize the microbial community diversity of the SAO along the depth continuum and different water masses by means of metagenomic, physical-chemical and biological analyses. The microbial community abundance and diversity appear to be strongly influenced by the temperature, dissolved organic carbon, and depth, and three groups were defined [1. surface waters; 2. sub-superficial chlorophyll maximum (SCM) (48-82 m) and 3. deep waters (236-1,200 m)] according to the microbial composition. The microbial communities of deep water masses [South Atlantic Central water, Antarctic Intermediate water and Upper Circumpolar Deep water] are highly similar. Of the 421,418 predicted genes for SAO metagenomes, 36.7 % had no homologous hits against 17,451,486 sequences from the North Atlantic, South Atlantic, North Pacific, South Pacific and Indian Oceans. From these unique genes from the SAO, only 6.64 % had hits against the NCBI non-redundant protein database. SAO microbial communities share genes with the global ocean in at least 70 cellular functions; however, more than a third of predicted SAO genes represent a unique gene pool in global ocean. This study was the first attempt to characterize the taxonomic and functional community diversity of different water masses at SAO and compare it with the microbial community diversity of the global ocean, and SAO had a significant portion of endemic gene diversity. Microbial communities of deep water masses (236-1,200 m) are highly similar, suggesting that these water masses have very similar microbiological attributes, despite the common knowledge that water masses determine prokaryotic community and are barriers to microbial dispersal. The present study also shows that SCM is a clearly differentiated layer within Tropical waters with higher abundance of phototrophic microbes and microbial diversity.	[Alves Junior, Nelson; Meirelles, Pedro Milet; Santos, Eidy de Oliveira; Dutilh, Bas; Paranhos, Rodolfo; Cabral, Anderson S.; de Moura, Rodrigo L.; Thompson, Cristiane; Thompson, Fabiano] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Santos, Eidy de Oliveira] INMETRO, Rio De Janeiro, Brazil; [Silva, Genivaldo G. Z.] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Rezende, Carlos] Univ Estadual N Fluminen, Lab Environm Sci, Campos dos Goytacazes, Brazil; [Iida, Tetsuya] Osaka Univ, Osaka, Japan; [Kruger, Ricardo Henrique] Univ Brasilia, Enzymol Lab, Dept Cellular Biol, Inst Biol, Brasilia, DF, Brazil; [Pereira, Renato C.] Univ Fed Fluminense, Inst Biol, Niteroi, RJ, Brazil; [Valle, Rogerio; Thompson, Fabiano] SAGE COPPE, Rio De Janeiro, Brazil; [Sawabe, Tomoo] Hokkaido Univ, Microbiol Lab, Hakodate, Hokkaido, Japan	Thompson, F (reprint author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.	fabiano.thompson@biologia.ufrj.br		Dutilh, Bas E./0000-0003-2329-7890	CNPq; CAPES; FAPERJ	We thank the PIRATA project and the Seward Johnson crew for handling the CTD data, CENPES-PETROBRAS for providing sampling and analysis at Bacia de Campos study. We thank CNPq, CAPES, FAPERJ for funding. The present study is part of the PhD thesis of NAJ and PMM.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Amano-Sato C, 2013, AQUAT MICROB ECOL, V69, P101, DOI 10.3354/ame01624; Andrade L, 2004, HYDROBIOLOGIA, V511, P103, DOI 10.1023/B:HYDR.0000014033.81848.48; Andrade L, 2007, BRAZ J MICROBIOL, V38, P330, DOI 10.1590/S1517-83822007000200028; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/.j.mimet.2003.08.002; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2; Stramma L, 1999, J GEOPHYS RES-OCEANS, V104, P20863, DOI 10.1029/1999JC900139; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; JANNASCH HW, 1971, SCIENCE, V171, P672, DOI 10.1126/science.171.3972.672; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; [Anonymous], 2014, MATPLOTLIB BASEMAP T; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; ESTRADA M, 1993, MAR ECOL PROG SER, V92, P289, DOI 10.3354/meps092289; Wickham H, 2007, J STAT SOFTW, V21, P1; Frank JA, 2013, ISME J, V7, P1150, DOI 10.1038/ismej.2013.4; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Memery L, 2000, PROG OCEANOGR, V47, P69, DOI 10.1016/S0079-6611(00)00032-X; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; DeLong EF, 2009, NATURE, V459, P200, DOI 10.1038/nature08059; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Martin-Cuadrado AB, 2009, APPL ENVIRON MICROB, V75, P7436, DOI 10.1128/AEM.01283-09; FUHRMAN JA, 1992, NATURE, V356, P148; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Servain J, 1998, B AM METEOROL SOC, V79, P2019, DOI 10.1175/1520-0477(1998)079<2019:APRMAI>2.0.CO;2; BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457; Borcard D., 2011, NUMERICAL ECOLOGY R, P306; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Cavalcanti GS, 2013, CONT SHELF RES, V8, P52, DOI [10.1038/ismej.2013.133, DOI 10.1038/ISMEJ.2013.133]; Clasen JL, 2008, FRESHWATER BIOL, V53, P1090, DOI 10.1111/j.1365-2427.2008.01992.x; Foloni NH, 2010, WATER MASSES CAMPOS; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Fuhrman JA, 2005, APPL ENVIRON MICROB, V71, P4523, DOI 10.1128/AEM.71.8.4523-4530.2005; Grasshoff Klaus, 1999, METHODS SEAWATER ANA, P1; Hagberg AA, 2008, P 7 PYTH SCI C SCIPY, P11; Lopez-Perez M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00696; Oksanen J., 2005, VEGAN R FUNCTIONS VE; Parada V, 2007, APPL ENVIRON MICROB, V73, P4429, DOI 10.1128/AEM.00029-07; Pedrosa P, 2006, GEOCHIM BRAS, V20, P101; Rezende C, 2006, CARACTER HIDROBIOLOG, V60, P31; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; TOMCZAK M JR, 1981, Progress in Oceanography, V10, P147, DOI 10.1016/0079-6611(81)90010-0; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	61	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	MAR	2015	197	2					165	179		10.1007/s00203-014-1035-6		15	Microbiology	Microbiology	CB1MI	WOS:000349391400005		
J	Fukuma, NM; Koike, S; Kobayashi, Y				Fukuma, Naoki M.; Koike, Satoshi; Kobayashi, Yasuo			Monitoring of gene expression in Fibrobacter succinogenes S85 under the co-culture with non-fibrolytic ruminal bacteria	ARCHIVES OF MICROBIOLOGY			English	Article						Rumen bacteria; Fibrobacter succinogenes; Fiber digestion; Co-culture; mRNA expression	RUMEN FIBER DIGESTION; REAL-TIME PCR; RUMINOCOCCUS-FLAVEFACIENS; CELLULOLYTIC BACTERIA; METABOLIC-ACTIVITY; SHEEP; POPULATION; ENDOGLUCANASES; FERMENTATION; DEGRADATION	Fibrobacter succinogenes is one of the most pivotal fibrolytic bacterial species in the rumen. In a previous study, we confirmed enhancement of fiber digestion in a co-culture of F. succinogenes S85 with non-fibrolytic ruminal strains R-25 and/or Selenomonas ruminantium S137. In the present study, mRNA expression level of selected functional genes in the genome of F. succinogenes S85 was monitored by real-time RT-PCR. Growth profile of F. succinogenes S85 was similar in both the monoculture and co-cultures with non-fibrolytics. However, expression of 16S rRNA gene of F. succinogenes S85 in the co-culture was higher (P < 0.01) than that of the monoculture. This finding suggests that metabolic activity of F. succinogenes S85 was enhanced by coexistence with strains R-25 and/or S. ruminantium S137. The mRNA expression of fumarate reductase and glycoside hydrolase genes was up-regulated (P < 0.01) when F. succinogenes S85 was co-cultured with non-fibrolytics. These results indicate the enhancement of succinate production and fiber hydrolysis by F. succinogenes S85 in co-cultures of S. ruminantium and R-25 strains.	[Fukuma, Naoki M.; Koike, Satoshi; Kobayashi, Yasuo] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan	Koike, S (reprint author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan.	skoike7@anim.agr.hokudai.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [22780238, 17380157]	This study was supported in part by a Grant-in Aid for Scientific Research (No. 22780238 to S. K. and No. 17380157 to Y. K.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	LATHAM MJ, 1977, APPL ENVIRON MICROB, V34, P297; Saro C, 2012, J ANIM SCI, V90, P4487, DOI 10.2527/jas.2012-5265; Mosoni P, 2011, J ANIM SCI, V89, P783, DOI 10.2527/jas.2010-2947; Muttray AF, 2001, FEMS MICROBIOL ECOL, V38, P21, DOI 10.1111/j.1574-6941.2001.tb00878.x; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; COTTA MA, 1988, APPL ENVIRON MICROB, V54, P772; Koike S, 2007, ANIM SCI J, V78, P135, DOI 10.1111/j.1740-0929.2007.00417.x; BRYANT MP, 1953, J DAIRY SCI, V36, P205; Perez-Osorio AC, 2010, J BACTERIOL, V192, P2991, DOI 10.1128/JB.01598-09; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Koike S, 2009, ASIAN AUSTRAL J ANIM, V22, P131; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136; Kobayashi Y, 2008, FOLIA MICROBIOL, V53, P195, DOI 10.1007/s12223-008-0024-z; Yu ZT, 2004, BIOTECHNIQUES, V36, P808; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Malburg SRC, 1997, APPL ENVIRON MICROB, V63, P2449; Bera-Maillet C, 2000, BBA-PROTEIN STRUCT M, V1543, P77, DOI 10.1016/S0167-4838(00)00194-1; Bera-Maillet C, 2009, J MICROBIOL METH, V77, P8, DOI 10.1016/j.mimet.2008.11.009; Bera-Maillet C, 2000, BBA-PROTEIN STRUCT M, V1476, P191, DOI 10.1016/S0167-4838(99)00255-1; Berg Miller Margret E, 2009, PLoS One, V4, pe6650, DOI 10.1371/journal.pone.0006650; CAVICCHIOLI R, 1991, APPL ENVIRON MICROB, V57, P359; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; Fondevila M, 1996, J ANIM SCI, V74, P678; Fukuma N, 2012, FEMS MICROBIOL LETT, V336, P17, DOI 10.1111/j.1574-6968.2012.02649.x; HUANG L, 1987, APPL ENVIRON MICROB, V53, P1034; Jun HS, 2003, CAN J MICROBIOL, V49, P171, DOI 10.1139/W03-024; Koike S, 2010, APPL ENVIRON MICROB, V76, P1887, DOI 10.1128/AEM.02606-09; Koike S, 2014, ANIM SCI J, V85, P524, DOI 10.1111/asj.12176; KUDO H, 1987, CAN J MICROBIOL, V33, P244; Lettat A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-142; MCGAVIN M, 1990, APPL ENVIRON MICROB, V56, P1235; MCGAVIN MJ, 1989, J BACTERIOL, V171, P5587; Muttray AF, 1999, MICROBIAL ECOL, V38, P348, DOI 10.1007/s002489901005; PARADIS FW, 1993, J BACTERIOL, V175, P7666; Rychlik JL, 2000, CURR MICROBIOL, V40, P176, DOI 10.1007/s002849910035; Sawanon S, 2011, FEMS MICROBIOL LETT, V325, P170, DOI 10.1111/j.1574-6968.2011.02427.x; Shinkai T, 2014, ANIM SCI J, V85, P254, DOI 10.1111/asj.12145; Shinkai T, 2009, FEMS MICROBIOL LETT, V294, P183, DOI 10.1111/j.1574-6968.2009.01565.x; Suen G, 2011, J BACTERIOL, V193, P5574, DOI 10.1128/JB.05621-11; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; WILLIAMS AG, 1994, CURR MICROBIOL, V29, P133, DOI 10.1007/BF01570753	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	MAR	2015	197	2					269	276		10.1007/s00203-014-1049-0		8	Microbiology	Microbiology	CB1MI	WOS:000349391400012		
J	Mahler, M; Fritzler, MJ; Satoh, M				Mahler, Michael; Fritzler, Marvin J.; Satoh, Minoru			Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen	AUTOIMMUNITY REVIEWS			English	Review							EULAR SCLERODERMA TRIALS; RESEARCH GROUP DATABASE; SYSTEMIC-SCLEROSIS; ANTI-TH/TO; AUTOIMMUNE-DISEASES; CLINICAL-FEATURES; PREVALENCE; ANTIBODIES; COHORT; INSIGHTS	Antinuclear antibodies (ANA) represent valuable biomarkers in the diagnosis of systemic sclerosis (SSc) being present in the vast majority of the patients. Besides anti-topoisomerase I, anti-centromere and anti-RNA polymerase III antibodies as the main specificities, several other autoantibodies can be present in SSc patients including autoantibodies targeting the PM/Scl complex (also known as the exosome), U3-RNP/fibrillarin and the Th/To autoantigens.Anti-Th/To antibodies are one of the specificities that reportedly show homogenous nucleolar staining in conventional indirect immundluorescence (IIF) ANA tests. Almost all protein components of the mitochondrial RNA processing (MRP) and the evolutionarily related RNase P complex have been reported to be the target of anti-Th/To antibodies in systemic autoimmune rheumatic disease (SARD) patients. However, Rpp25, Rpp38 and hPop1 have been described as the main autoantigen. (C) 2014 Elsevier B.V. All rights reserved.	[Mahler, Michael] Inova Diagnost Inc, San Diego, CA 92131 USA; [Fritzler, Marvin J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Satoh, Minoru] Univ Occupat & Environm Hlth, Sch Hlth Sci, Dept Clin Nursing, Kitakyushu, Fukuoka 8078555, Japan	Mahler, M (reprint author), Inova Diagnost Inc, 9900 Old Grove Rd, San Diego, CA 92131 USA.	mmahler@inovadx.com					Mahler M, 2005, ARTHRITIS RES THER, V7, pR704, DOI 10.1186/ar1729; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Pope J, 2012, J RHEUMATOL, V39, P524, DOI 10.3899/jrheum.110121; Fischer A, 2006, J RHEUMATOL, V33, P1600; Wiik AS, 2010, J AUTOIMMUN, V35, P276, DOI 10.1016/j.jaut.2010.06.019; Rossi D, 2013, AUTOIMMUN REV, V12, P821, DOI 10.1016/j.autrev.2012.11.006; Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Mahler M, 2014, J RHEUMATOL, V41, P1334, DOI 10.3899/jrheum.131450; Krzyszczak ME, 2011, CLIN RHEUMATOL, V30, P1333, DOI 10.1007/s10067-011-1751-0; Villalta D, 2012, AUTOIMMUN REV, V12, P114, DOI 10.1016/j.autrev.2012.07.005; OKANO Y, 1990, ARTHRITIS RHEUM, V33, P1822, DOI 10.1002/art.1780331210; Mehra S, 2013, AUTOIMMUN REV, V12, P340, DOI 10.1016/j.autrev.2012.05.011; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Mitri GM, 2003, ARTHRITIS RHEUM, V48, P203, DOI 10.1002/art.10760; Meier FMP, 2012, ANN RHEUM DIS, V71, P1355, DOI 10.1136/annrheumdis-2011-200742; Walker JG, 2007, CURR OPIN RHEUMATOL, V19, P580, DOI 10.1097/BOR.0b013e3282e7d8f9; Graf SW, 2012, INT J RHEUM DIS, V15, P102, DOI 10.1111/j.1756-185X.2011.01688.x; van Eenennaam H, 2002, ARTHRITIS RHEUM, V46, P3266, DOI 10.1002/art.10673; Koenig M, 2008, ARTHRITIS RHEUM, V58, P3902, DOI 10.1002/art.24038; Mahler M, 2007, AUTOIMMUN REV, V6, P432, DOI 10.1016/j.autrev.2007.01.013; Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1151, DOI 10.1002/art.1780390712; Bluthner M, 2000, J MOL MED-JMM, V78, P47, DOI 10.1007/s001090050381; Bonroy C, 2012, J IMMUNOL METHODS, V379, P53, DOI 10.1016/j.jim.2012.03.001; Ceribelli A, 2010, J RHEUMATOL, V37, P2071, DOI 10.3899/jrheum.100316; Ceribelli A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3858; Hudson M, 2013, CLIN RHEUMATOL, V86, P127; Koenig M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2276; Kuwana M, 2002, ANN RHEUM DIS, V61, P842, DOI 10.1136/ard.61.9.842; Mahler M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4210; Mahler M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/494356; Mahler M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3029; Mierau R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3495; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; Satoh M, 2009, MOD RHEUMATOL, V19, P219, DOI 10.1007/s10165-009-0155-3; Van Eenennaam H, 2002, CLIN EXP IMMUNOL, V130, P532, DOI 10.1046/j.1365-2249.2002.01991.x	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9972	1873-0183		AUTOIMMUN REV	Autoimmun. Rev.	MAR	2015	14	3					254	257		10.1016/j.autrev.2014.11.007		4	Immunology	Immunology	CB3BS	WOS:000349503800010		
J	Bednarczyk, D; Takahashi, S; Satoh, H; Noy, D				Bednarczyk, Dominika; Takahashi, Shigekazu; Satoh, Hiroyuki; Noy, Dror			Assembly of water-soluble chlorophyll-binding proteins with native hydrophobic chlorophylls in water-in-oil emulsions	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						Water-soluble chlorophyll binding protein (WSCP); Water-in-oil emulsion	ENERGY-LEVEL STRUCTURE; LEPIDIUM-VIRGINICUM; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; BRUSSELS-SPROUTS; PIGMENT-PIGMENT; BRASSICA; PLANTS; CAULIFLOWER; DIFFERENCE	The challenges involved in studying cofactor binding and assembly, as well as energy- and electron transfer mechanisms in the large and elaborate transmembrane protein complexes of photosynthesis and respiration have prompted considerable interest in constructing simplified model systems based on their water-soluble protein analogs. Such analogs are also promising templates and building blocks for artificial bioinspired energy conversion systems. Yet, development is limited by the challenge of introducing the essential cofactors of natural proteins that are highly water-insoluble into the water-soluble protein analogs. Here we introduce a new efficient method based on water-in-oil emulsions for overcoming this challenge. We demonstrate the effectiveness of the method in the assembly of native chlorophylls with four recombinant variants of the water-soluble chlorophyll-binding protein of Brassicaceae plants. We use the method to gain new insights into the protein-chlorophyll assembly process, and demonstrate its potential as a fast screening system for developing novel chlorophyll-protein complexes. (C) 2014 Elsevier B.V. All rights reserved.	[Bednarczyk, Dominika] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Takahashi, Shigekazu; Satoh, Hiroyuki] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 2748510, Japan; [Noy, Dror] Migal Galilee Res Inst, IL-11016 Kiryat Shmona, Israel	Noy, D (reprint author), Migal Galilee Res Inst, IL-11016 Kiryat Shmona, Israel.	drorn@migal.org.il			EU FP7 project PEPDIODE [GA 256672]; EU FP7 project REGPOT-2012-2013-1 [GA 316157]; Israel Science Foundation [268/10]	DN acknowledges support from EU FP7 projects PEPDIODE (GA 256672) and REGPOT-2012-2013-1 (GA 316157), and a personal research grant (No. 268/10) from the Israel Science Foundation. We thank Prof. Shmuel Rubinstein, School of Engineering and Applied Sciences, Harvard University, Cambridge MA, USA for taking the confocal microscopy images.	Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/nchembio.1555, 10.1038/NCHEMBIO.1555]; Takahashi S, 2012, PLANT CELL PHYSIOL, V53, P879, DOI 10.1093/pcp/pcs031; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/nchem.1145, 10.1038/NCHEM.1145]; Damaraju S, 2011, J PLANT PHYSIOL, V168, P1444, DOI 10.1016/j.jplph.2011.02.007; Reinbothe C, 2004, PLANT PHYSIOL, V134, P1355, DOI 10.1104/pp.103.033613; Pieper J, 2011, J PHYS CHEM B, V115, P4042, DOI 10.1021/jp111455g; Alster J, 2014, J PHYS CHEM B, V118, P3524, DOI 10.1021/jp411174t; Miller OJ, 2006, NAT METHODS, V3, P561, DOI 10.1038/NMETH897; [Anonymous], J PHYS CHEM B; Renger G, 2011, J PLANT PHYSIOL, V168, P1462, DOI 10.1016/j.jplph.2010.12.005; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; Takahashi S, 2013, J PLANT PHYSIOL, V170, P406, DOI 10.1016/j.jplph.2012.10.007; Theiss C, 2007, J PHYS CHEM B, V111, P13325, DOI 10.1021/jp0723968; BEDDARD GS, 1976, NATURE, V260, P366, DOI 10.1038/260366a0; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Pieper J, 2011, J PHYS CHEM B, V115, P4053, DOI 10.1021/jp111457t; OMATA T, 1983, PLANT CELL PHYSIOL, V24, P1101; Schmidt K, 2003, BIOCHEMISTRY-US, V42, P7427, DOI 10.1021/bi034207r; Brouwer AM, 2011, PURE APPL CHEM, V83, P2213, DOI 10.1351/PAC-REP-10-09-31; Satoh H, 2001, PLANT CELL PHYSIOL, V42, P906, DOI 10.1093/pcp/pce117; Tronrud DE, 2009, PHOTOSYNTH RES, V100, P79, DOI 10.1007/s11120-009-9430-6; Bektas I, 2012, PLANTA, V236, P251, DOI 10.1007/s00425-012-1609-y; WINTERMA.JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; HINDMAN JC, 1978, P NATL ACAD SCI USA, V75, P2076, DOI 10.1073/pnas.75.5.2076; ITOH R, 1982, PLANT CELL PHYSIOL, V23, P557; Kamimura Y, 1997, PLANT CELL PHYSIOL, V38, P133; MURATA T, 1981, BIOCHIM BIOPHYS ACTA, V635, P341, DOI 10.1016/0005-2728(81)90032-3; MURATA T, 1980, BIOCHIM BIOPHYS ACTA, V593, P167, DOI 10.1016/0005-2728(80)90018-3; Satoh H, 1998, J BIOL CHEM, V273, P30568, DOI 10.1074/jbc.273.46.30568; Schulte T, 2010, EUR J CELL BIOL, V89, P990, DOI 10.1016/j.ejcb.2010.08.004; TABATA K, 1983, PLANT CELL PHYSIOL, V24, P987; Takahashi S, 2014, PROTEIN J, V33, P75, DOI 10.1007/s10930-013-9539-5	33	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	MAR	2015	1847	3					307	313		10.1016/j.bbabio.2014.12.003		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CB4HP	WOS:000349589100001		
J	Suzuki, M; Miura, T				Suzuki, Masako; Miura, Takashi			Effect of amyloid beta-peptide on the fluidity of phosphatidylcholine membranes: Uses and limitations of diphenylhexatriene fluorescence anisotropy	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Membrane fluidity; Amyloid beta-peptide; Raman spectroscopy; Induced circular dichroism; Diphenylhexatriene	SYNAPTIC PLASMA-MEMBRANES; ALZHEIMERS-DISEASE; PROTEIN INTERACTIONS; BILAYER FLUIDITY; FIBRIL FORMATION; CHOLESTEROL; SURFACE; BRAIN; NEUROTOXICITY; BINDING	There is accumulating evidence that peptide-induced perturbations in the order and dynamics of cellular membranes may play a role in the neurotoxicity of amyloid beta-peptide (A beta). Several studies have reported that A beta decreases fluidity of membranes based on an A beta-induced increase in the fluorescence anisotropy of diphenylhexatriene (DPH). However, the effect of A beta on the membrane fluidity is still a subject of controversy, because other studies that employed pyrene as a fluorescent probe have shown that A beta has the opposite effect. To reveal the reason for this discrepancy, we have examined the effect of A beta on the fluidity of phosphatidylcholine membranes using spectroscopic methods. The fluorescence anisotropy of DPH is dramatically increased on addition of A beta to DPH-containing phosphatidylcholine membranes. However, A beta does not affect the Raman spectrum of the membrane, which is sensitive to the packing order of the hydrocarbon chains of lipids. We have also found that circular dichroism (CD) bands of DPH appear during incubation of DPH-containing membranes with A beta, whereas DPH is an achiral molecule. The observed CD bands of DPH are induced by a chiral environment of A beta, but not by that of the lipids, because positive CD bands appear regardless of the D/L-chirality of phosphatidylcholine. The findings obtained from CD measurements provide evidence that DPH molecules translocate from the membrane to A beta. The peptide-mediated extraction of DPH from the membrane may cause changes in the fluorescence anisotropy of DPH, even though A beta does not affect the fluidity of membranes. (C) 2014 Elsevier B.V. All rights reserved.	[Suzuki, Masako; Miura, Takashi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Miura, T (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	tmiura@m.tohoku.ac.jp			JSPS [24590043]	This study was supported in part by Grants-in-Aid for Scientific Research (Grant 24590043) from JSPS.	McLaurin J, 1996, J BIOL CHEM, V271, P26482; GALLA HJ, 1974, BIOCHIM BIOPHYS ACTA, V339, P103, DOI 10.1016/0005-2736(74)90336-8; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Muller WE, 1998, AMYLOID, V5, P10, DOI 10.3109/13506129809007284; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Chochina SV, 2001, J LIPID RES, V42, P1292; Kastorna A, 2012, CHEM PHYS LIPIDS, V165, P331, DOI 10.1016/j.chemphyslip.2012.02.002; Eckert GP, 2000, DEMENT GERIATR COGN, V11, P181, DOI 10.1159/000017234; GABER BP, 1977, BIOCHIM BIOPHYS ACTA, V465, P260, DOI 10.1016/0005-2736(77)90078-5; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Wood WG, 2003, BBA-BIOMEMBRANES, V1610, P281, DOI 10.1016/S0005-2736(03)00025-7; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Yoda M, 2008, BIOCHEM BIOPH RES CO, V376, P56, DOI 10.1016/j.bbrc.2008.08.093; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; SPIKER RC, 1975, BIOCHIM BIOPHYS ACTA, V388, P361, DOI 10.1016/0005-2760(75)90095-8; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P1935, DOI 10.1016/j.bbamem.2007.02.009; Hou X, 2005, BIOCHEMISTRY-US, V44, P11618, DOI 10.1021/bi050700m; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Kremer JJ, 2001, BIOCHEMISTRY-US, V40, P8563, DOI 10.1021/bi010417x; Chauhan A, 2000, NEUROCHEM RES, V25, P423, DOI 10.1023/A:1007509608440; Avdulov NA, 1997, J NEUROCHEM, V68, P2086; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Bocchinfuso G, 2009, J PEPT SCI, V15, P550, DOI 10.1002/psc.1144; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; DEPAUW H, 1990, BIOCHIM BIOPHYS ACTA, V1024, P41, DOI 10.1016/0005-2736(90)90206-4; Eckert GP, 2001, J NEURAL TRANSM, V108, P1051, DOI 10.1007/s007020170024; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Li Y, 2007, J NEURAL TRANSM, V114, P1407, DOI 10.1007/s00702-007-0760-2; MACDONALD AG, 1988, BIOCHIM BIOPHYS ACTA, V938, P231, DOI 10.1016/0005-2736(88)90162-9; MIYAMOTO A, 1990, J NEUROCHEM, V55, P70, DOI 10.1111/j.1471-4159.1990.tb08822.x; MORGAN CG, 1982, BIOCHIM BIOPHYS ACTA, V692, P196, DOI 10.1016/0005-2736(82)90521-1; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; PARENTE RA, 1985, BIOCHEMISTRY-US, V24, P6178, DOI 10.1021/bi00343a022; PATEL JM, 1988, BIOCHEM PHARMACOL, V37, P1497, DOI 10.1016/0006-2952(88)90011-1; SZAMEL M, 1981, J BIOL CHEM, V256, P1618; TANG D, 1995, BIOPHYS J, V68, P1944; Van Blitterswijk M.J., 1981, BIOCHIM BIOPHYS ACTA, V644, P323; Walde P, 1997, LANGMUIR, V13, P1668, DOI 10.1021/la9610157; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881	45	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	MAR	2015	1848	3					753	759		10.1016/j.bbamem.2014.12.003		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CB4FB	WOS:000349582500001		
J	Yagi, H; Mizuno, A; So, M; Hirano, M; Adachi, M; Akazawa-Ogawa, Y; Hagihara, Y; Ikenoue, T; Lee, YH; Kawata, Y; Goto, Y				Yagi, Hisashi; Mizuno, Aiko; So, Masatomo; Hirano, Miki; Adachi, Masayuki; Akazawa-Ogawa, Yoko; Hagihara, Yoshihisa; Ikenoue, Tatsuya; Lee, Young-Ho; Kawata, Yasushi; Goto, Yuji			Ultrasonication-dependent formation and degradation of alpha-synuclein amyloid fibrils	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						Amorphous aggregation; Cytotoxicity; Parkinson's disease; Supersaturation; Solubility; Surface denaturation	PROTEIN CRYSTALLIZATION; CYCLIC AMPLIFICATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; COMMON MECHANISM; FIBRILLATION; OLIGOMERS; BETA(2)-MICROGLOBULIN; ACCELERATION; AGGREGATION	Ultrasonication can be used to break the supersaturation of a-synuclein, a protein associated with Parkinson's disease, at pH 7.4 above the critical concentration of fibrillation, thereby inducing the formation of amyloid fibrils. We speculated that ultrasonication could also be used to depolymerize preformed fibrils below the critical concentration. However, extensive ultrasonic irradiation transformed preformed fibrils into amorphous aggregates even above the critical concentration. Exposing preformed fibrils to the hydrophobic air-water interface of cavitation bubbles may have destabilized the fibrils and stabilized amorphous aggregates. Upon extensive ultrasonic irradiation, the accompanying decomposition of chemical structures was suggested when monitored by analytical ultracentrifugation. Amorphous aggregates produced by extensive ultrasonication showed higher cytotoxicity, suggesting that, although ultrasonication might be a useful approach for inactivating amyloid fibrils, potential cytotoxicity of amorphous aggregates should be considered. (C) 2014 Elsevier B.V. All rights reserved.	[Yagi, Hisashi; Mizuno, Aiko; So, Masatomo; Hirano, Miki; Adachi, Masayuki; Ikenoue, Tatsuya; Lee, Young-Ho; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Yagi, Hisashi] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808552, Japan; [Akazawa-Ogawa, Yoko; Hagihara, Yoshihisa] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Goto, Y (reprint author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp			JSPS KAKENHI Grant [24370067]; Takeda Science Foundation	This work was supported by JSPS KAKENHI Grant Number 24370067 and Takeda Science Foundation.	Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Durbin SD, 1996, ANNU REV PHYS CHEM, V47, P171, DOI 10.1146/annurev.physchem.47.1.171; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Yagi H, 2010, J BIOL CHEM, V285, P19660, DOI 10.1074/jbc.M109.076505; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Ogi H, 2006, JPN J APPL PHYS 1, V45, P4678, DOI 10.1143/JJAP.45.4678; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Kitayama H, 2013, BBA-PROTEINS PROTEOM, V1834, P2640, DOI 10.1016/j.bbapap.2013.09.016; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Kim HJ, 2007, J MICROBIOL BIOTECHN, V17, P2027; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lee Y.-H., 2008, J BIOL CHEM, P2169; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; THOMAS JR, 1959, J PHYS CHEM-US, V63, P1725, DOI 10.1021/j150580a038; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Yagi H, 2010, BBA-PROTEINS PROTEOM, V1804, P2077, DOI 10.1016/j.bbapap.2010.07.007; Yamaguchi K, 2012, PROTEIN SCI, V21, P38, DOI 10.1002/pro.755; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Yoshimura Y., 2013, JPN J APPL PHYS, V52, P01; Yoshimura Y, 2010, PROTEIN SCI, V19, P2347, DOI 10.1002/pro.515	50	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	MAR	2015	1854	3					209	217		10.1016/j.bbapap.2014.12.014		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CB4FA	WOS:000349582400003		
J	Ono, Y; Miyashita, M; Ono, Y; Okazaki, H; Watanabe, S; Tochio, N; Kigawa, T; Nishimura, C				Ono, Yu-ichi; Miyashita, Manami; Ono, Yumi; Okazaki, Honoka; Watanabe, Satoru; Tochio, Naoya; Kigawa, Takanori; Nishimura, Chiaki			Comparison of residual alpha- and beta-structures between two intrinsically disordered proteins by using NMR	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						NMR; Intrinsically disordered protein; N-tail protein; Peripherin-2; Protein dynamics; Amide-proton exchange	C-TERMINAL DOMAIN; MEASLES-VIRUS PHOSPHOPROTEIN; TRIPLE-RESONANCE NMR; CHEMICAL-SHIFTS; AMIDE-PROTON; SECONDARY STRUCTURE; HYDROGEN-EXCHANGE; MEMBRANE-FUSION; SYNUCLEIN; NUCLEOPROTEIN	Intrinsically disordered proteins contain some residual structures, which may fold further upon binding to the partner protein for function. The residual structures observed in two intrinsically disordered proteins, including the C-terminal segment of peripherin-2 (63 residues) and measles virus nucleocapsid protein N-tail (125 residues), were compared using NMR. Differences in the chemical shifts of alpha-, beta- and carbonyl carbons between the observed structure and calculated random coil revealed the existence of a helix and some possible beta-structures in both proteins. The intensity of signals in the C-terminal segment of peripherin-2 in NMR spectra was informative and locally low, particularly in the middle and N-terminal parts: this suggested the broadening of the signals caused by the formation of residual structures in those areas. Furthermore, the protection of exchange of amide protons was significantly observed at the N-terminus. Conversely, the intensities of signals for Ntail were random beyond the overall areas of protein, and indicated no characteristic pattern. Only a faint protection of amide-proton exchange in Mail was observed in the C-terminus. It was concluded that Nail was more intrinsically disordered than the C-terminal segment of peripherin-2. The combination of chemical shifts with the amide-proton exchanges and signal intensities was useful for the analyses of the remaining secondary structures. The beta-structure might be more detectable by the protection of amide-proton exchange than the helical structure, although the changes in chemical shifts were sensitive for the detection of elements of both secondary structures. (C) 2014 Elsevier B.V. All rights reserved.	[Ono, Yu-ichi; Miyashita, Manami; Ono, Yumi; Okazaki, Honoka; Nishimura, Chiaki] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo 1648530, Japan; [Watanabe, Satoru; Tochio, Naoya; Kigawa, Takanori] RIKEN, Syst & Struct Biol Ctr, NMR Pipeline Methodol Team, Yokohama, Kanagawa 2300045, Japan	Nishimura, C (reprint author), Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, 4-21-2 Nakano, Tokyo 1648530, Japan.	cnishimura@thu.ac.jp			Cooperative Research Program of RIKEN Yokohama Institute;  [23107726];  [23590049]	We thank Dr. Wataru Maruyama in REC Materials Inc. and Drs. Akimasa Matsugami and Fumiaki Hayashi at RIKEN Institute for technical support, and Ms. Yuka Ohori, Mrs. Yuki Sugiyama, and Masaya Komoto in Teikyo Heisei University for their technical assistance. This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (Molecular Science of Fluctuations toward Biological Functions) (23107726) and for Scientific Research C (23590049) in Japan. This work was performed with the support of the Cooperative Research Program of RIKEN Yokohama Institute.	GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Boesze-Battaglia K, 2003, EXP EYE RES, V77, P505, DOI 10.1016/S0014-4835(03)00151-9; Jensen MR, 2010, J AM CHEM SOC, V132, P1270, DOI 10.1021/ja909973n; Okazaki H, 2013, FEBS LETT, V587, P3709, DOI 10.1016/j.febslet.2013.09.039; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Cho MK, 2009, PROTEIN SCI, V18, P1840, DOI 10.1002/pro.194; Kingston RL, 2004, J VIROL, V78, P8630, DOI 10.1128/JVI.78-16.8630-8640.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Kobayashi N, 2000, BIOCHEMISTRY-US, V39, P6564, DOI 10.1021/bi000013p; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; Shu YL, 2012, J BIOL CHEM, V287, P11951, DOI 10.1074/jbc.M111.333088; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Gely S, 2010, J MOL RECOGNIT, V23, P435, DOI 10.1002/jmr.1010; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; BLANCO FJ, 1994, NAT STRUCT BIOL, V1, P584, DOI 10.1038/nsb0994-584; Boesze-Battaglia K, 2002, INT REV CYTOL, V217, P183; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; Croke RL, 2008, PROTEIN SCI, V17, P1434, DOI 10.1110/ps.033803.107; Damek-Poprawa M, 2005, J BIOL CHEM, V280, P9217, DOI 10.1074/jbc.M407166200; Dyer RB, 2007, CURR OPIN STRUC BIOL, V17, P38, DOI 10.1016/j.sbi.2007.01.001; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; Edrington TC, 2007, BIOCHEMISTRY-US, V46, P3605, DOI 10.1021/bi061820c; Kay L.E., 1990, J MAGN RESON, V213, P423; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Li X, 1999, GENOME INFORMATICS, V10, P30; McClendon S, 2009, PROTEIN SCI, V18, P1531, DOI 10.1002/pro.149; Obradovic Romero, 1997, GENOME INFORM SER WO, V8, P110; Ritter LM, 2005, PROTEIN PEPTIDE LETT, V12, P677, DOI 10.2174/0929866054696217; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	MAR	2015	1854	3					229	238		10.1016/j.bbapap.2014.12.007		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CB4FA	WOS:000349582400005		
J	Varquez, ACG; Nakayoshi, M; Kanda, M				Varquez, Alvin Christopher G.; Nakayoshi, Makoto; Kanda, Manabu			The Effects of Highly Detailed Urban Roughness Parameters on a Sea-Breeze Numerical Simulation	BOUNDARY-LAYER METEOROLOGY			English	Article						Sea breeze; Urban canopy model; Weather Research and Forecasting model	TOKYO METROPOLITAN-AREA; REGULAR BUILDING ARRAYS; ENERGY-BALANCE MODEL; NEW-YORK-CITY; HEAT-ISLAND; BOUNDARY-LAYER; SURFACE-TEMPERATURE; MESOSCALE MODEL; CANOPY MODEL; SENSITIVITY	We consider the effects of detailed urban roughness parameters on a sea-breeze simulation. An urban roughness database, constructed using a new aerodynamic parametrization derived from large-eddy simulations, was incorporated as a surface boundary condition in the advanced Weather Research and Forecasting model. The zero-plane displacement and aerodynamic roughness length at several densely built-up urban grids were three times larger than conventional values due to the consideration of building-height variability. A comparison between simulations from the modified model and its default version, which uses uniform roughness parameters within a conventional method, was conducted for a 2-month period during summer. Results showed a significant improvement in the simulation of surface wind speed but not with temperature. From the 2-month study period, a day with an evident sea-breeze penetration was selected and simulated at higher temporal resolution. Sea-breeze penetration weakened and was more delayed over urbanized areas. The slow sea-breeze penetration also lessened heat advection downwind allowing stronger turbulent mixing and a deeper boundary layer above urban areas. Horizontal wind-speed reduction due to the increased urban surface drag reached heights of several hundreds of metres due to the strong convection.	[Varquez, Alvin Christopher G.; Kanda, Manabu] Tokyo Inst Technol, Dept Int Dev Engn, Tokyo 152, Japan; [Nakayoshi, Makoto] Tokyo Univ Sci, Dept Civil Engn, Tokyo 162, Japan	Varquez, ACG (reprint author), Tokyo Inst Technol, Dept Int Dev Engn, Tokyo 152, Japan.	varquez.a.aa@m.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan;  [25249066]	This research was supported by the Research Program on Climate Change Adaptation (RECCA) Fund from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Grant-in-Aid for Scientific Research (A): 25249066	Kim YH, 2005, J APPL METEOROL, V44, P591, DOI 10.1175/JAM2226.1; Nakanishi M, 2006, BOUND-LAY METEOROL, V119, P397, DOI 10.1007/s10546-005-9030-8; Martilli A, 2002, BOUND-LAY METEOROL, V104, P261, DOI 10.1023/A:1016099921195; MacDonald RW, 1998, ATMOS ENVIRON, V32, P1857, DOI 10.1016/S1352-2310(97)00403-2; Kanda M, 2005, BOUND-LAY METEOROL, V116, P423, DOI 10.1007/s10546-004-7956-x; YOSHIKADO H, 1989, BOUND-LAY METEOROL, V48, P389, DOI 10.1007/BF00123061; Flagg DD, 2011, ATMOS CHEM PHYS, V11, P2951, DOI 10.5194/acp-11-2951-2011; Fujibe F, 2011, INT J CLIMATOL, V31, P162, DOI 10.1002/joc.2142; Kanda M, 2013, BOUND-LAY METEOROL, V148, P357, DOI 10.1007/s10546-013-9818-x; Salamanca F, 2011, J APPL METEOROL CLIM, V50, P1107, DOI 10.1175/2010JAMC2538.1; Kanda M, 2005, BOUND-LAY METEOROL, V114, P71, DOI 10.1007/s10546-004-8662-4; Kondo H, 2005, BOUND-LAY METEOROL, V116, P395, DOI 10.1007/s10546-005-0905-5; Kain JS, 2004, J APPL METEOROL, V43, P170, DOI 10.1175/1520-0450(2004)043<0170:TKCPAU>2.0.CO;2; Inoue T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018908; Holt T, 2007, MON WEATHER REV, V135, P1906, DOI 10.1175/MWR3372.1; Thompson G, 2008, MON WEATHER REV, V136, P5095, DOI 10.1175/2008MWR2387.1; Martilli A, 2003, BOUND-LAY METEOROL, V108, P91, DOI 10.1023/A:1023044100064; Miao SG, 2009, J APPL METEOROL CLIM, V48, P484, DOI 10.1175/2008JAMC1909.1; Chen F, 2011, INT J CLIMATOL, V31, P273, DOI 10.1002/joc.2158; ZHANG D, 1982, J APPL METEOROL, V21, P1594, DOI 10.1175/1520-0450(1982)021<1594:AHRMOT>2.0.CO;2; Burian SJ, 2009, EPA600R10007; Burian SJ, 2002, MORPHOLOGICAL ANAL U; Chen F, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015533; Childs PP, 2005, PURE APPL GEOPHYS, V162, P1955, DOI 10.1007/s00024-005-2700-0; Chou M- D, 1994, TECHNICAL REPORT SER, V3; Chuan-Yao L, 2008, ATMOS ENVIRON, V42, P5635, DOI [10.1016/j.atmosenv.2008.03.015, DOI 10.1016/J.ATMOSENV.2008.03.015]; Corpetti T, 2011, REMOTE SENS ENVIRON, V115, P306, DOI 10.1016/j.rse.2010.09.003; Damato F, 2003, WEATHER, V58, P219, DOI [10.1256/wea.50.02, DOI 10.1256/WEA.50.02]; Dandou A, 2009, BOUND-LAY METEOROL, V131, P35, DOI 10.1007/s10546-008-9306-x; Grimmond S, 1999, J APPL METEOROLOGY, V38, P1262, DOI [10.1175/1520-0450(1999)038<1262:APOUAD>2.0.CO;2, DOI 10.1175/1520-0450(1999)038<LESS THAN>1262:APOUAD<GREATER THAN>2.0.CO;2]; Kanda M, 2001, BOUND-LAY METEOROL, V98, P251, DOI 10.1023/A:1026504904902; Kawai T, 2009, J APPL METEOROL CLIM, V48, P693, DOI 10.1175/2008JAMC1891.1; Khiem M, 2010, ATMOS ENVIRON, V44, P4463, DOI 10.1016/j.atmosenv.2010.07.038; Kim Y, 2013, BOUND-LAY METEOROL, V149, P105, DOI 10.1007/s10546-013-9838-6; KIMURA F, 1991, ATMOS ENVIRON B-URB, V25, P155, DOI 10.1016/0957-1272(91)90050-O; Kondo H, 2008, J WIND ENG IND AEROD, V96, P1655, DOI 10.1016/j.jweia.2008.02.022; Lee SH, 2011, ATMOS CHEM PHYS, V11, P2127, DOI 10.5194/acp-11-2127-2011; Mlawer EJ, 1997, J GEOPHYS RES-ATMOS, V102, P16663, DOI 10.1029/97JD00237; Moriwaki R, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006624; Nakayoshi M, 2014, INT J BIOMETEOROL, DOI [10.1007/s00484-014-0864-y, DOI 10.1007/S00484-014-0864-Y]; Prtenjak MT, 2002, AIR POLLUTION MODELLING AND SIMULATION, PROCEEDINGS, P553; Skamarock WC, 2005, NCAR TECH NOTES, DOI [10.5065/D6DZ069T, DOI 10.5065/D6DZ069T]; Sugawara H, 2004, J APPL METEOROL, V43, P1168, DOI 10.1175/1520-0450(2004)043<1168:RATOTH>2.0.CO;2; Tso CP, 1996, ATMOS ENVIRON, V30, P507, DOI 10.1016/1352-2310(95)00083-6; Williams CN, 2000, B AM METEOROL SOC, V81, P2141, DOI 10.1175/1520-0477(2000)081<2141:CAVOLS>2.3.CO;2	45	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0006-8314	1573-1472		BOUND-LAY METEOROL	Bound.-Layer Meteor.	MAR	2015	154	3					449	469		10.1007/s10546-014-9985-4		21	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CB1DT	WOS:000349367700007		
J	Okami, N; Aihara, Y; Akagawa, H; Yamaguchi, K; Kawashima, A; Yamamoto, T; Okada, Y				Okami, Nobuya; Aihara, Yasuo; Akagawa, Hiroyuki; Yamaguchi, Koji; Kawashima, Akitsugu; Yamamoto, Toshiyuki; Okada, Yoshikazu			Network-based gene expression analysis of vascular wall of juvenile Moyamoya disease	CHILDS NERVOUS SYSTEM			English	Article						Cerebrovascular occlusive disease; Moyamoya disease; Gene expression	FIBROBLAST-GROWTH-FACTOR; CEREBROSPINAL-FLUID; CELLS; FEATURES	Little is known about the pathology and pathogenesis of the Moyamoya disease (MMD). To better understand the molecular processes involved in MMD gene expression analysis of Moyamoya artery tissue to a control artery, this study was conducted. Tissue samples of two MMD and two non-MMD were profiled using oligonucleotide microarrays. Gene ontology classification of the differentially expressed genes was analyzed, and regulatory functional networks and pathways were identified with a network-based computational pathway analysis tool. Analysis of MMD and control tissue revealed 104 differentially expressed genes. The two major significantly associated gene ontology terms was cellular development and cellular movement. Further network-based analysis showed significant interaction between RNF213 downstream gene networks and the top 3 score gene networks of MMD. Three major nodes of this network were evident in the merged network and were showing interactions with downstream network of RNF213. Our results demonstrate that cellular development and cellular movement in MMD are the key role of mechanisms.	[Okami, Nobuya; Aihara, Yasuo; Akagawa, Hiroyuki; Yamaguchi, Koji; Kawashima, Akitsugu; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan; [Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan	Aihara, Y (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yaihara@nij.twmu.ac.jp			Department of Neurosurgery, Tokyo Women's Medical University	This study was supported by research funds of the Department of Neurosurgery, Tokyo Women's Medical University.	SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; SUZUKI J, 1983, STROKE, V14, P104; Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Malek AM, 1997, PEDIATR NEUROSURG, V27, P182, DOI 10.1159/000121249; MASUDA J, 1993, STROKE, V24, P1960; Nanba R, 2005, CHILD NERV SYST, V21, P62, DOI 10.1007/s00381-004-1005-4; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Smith Jodi L, 2009, Neurosurg Focus, V26, pE4, DOI 10.3171/2000.01.FOCUS08306; Soriano SG, 2002, NEUROSURGERY, V50, P544, DOI 10.1097/00006123-200203000-00022; TAKAHASHI A, 1993, NEUROSCI LETT, V160, P214, DOI 10.1016/0304-3940(93)90416-I; Yamamoto M, 1997, STROKE, V28, P1733; Yamamoto M, 1998, STROKE, V29, P1188; Yoshimoto T, 1996, STROKE, V27, P2160	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2015	31	3					399	404		10.1007/s00381-014-2605-2		6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CB1CM	WOS:000349364200007		
J	Shimoji, T; Tominaga, D; Shimoji, K; Miyajima, M; Tasato, K				Shimoji, Takeyoshi; Tominaga, Daisuke; Shimoji, Kazuaki; Miyajima, Masaichi; Tasato, Kumiko			Analysis of pre- and post-operative symptoms of patients with mild trigonocephaly using several developmental and psychological tests	CHILDS NERVOUS SYSTEM			English	Article						Craniosynostosis; Mild trigonocephaly; Development delay; Developmental test	AUTISM SPECTRUM DISORDERS; CHILDREN	Over the past decade, we collected the cases where patients underwent decompressive cranioplasty for the treatment of mild metopic suture synostosis (mild trigonocephaly) with developmental delays. To evaluate the effectiveness of this surgery, we administered several developmental and psychological examinations to children with this condition who underwent decompressive cranioplasty. Thirty-four children (32 boys and 2 girls) who had developmental disorders with mild trigonocephaly underwent four different tests at three different time points (pre-operation, 3 and 6 months after surgery) including the: (a) Kyoto form developmental test (2001) to calculate the developmental quotient (DQ), (b) National Rehabilitation Center Sign-Significance Test (NRC S-S test) to evaluate the patients' language use and acquisition, (c) Pervasive Developmental Disorders Autism Society Japan Rating Scale (PARS) to identify autistic tendencies, and (d) Japanese Child Behavior Checklist (J-CBCL) to evaluate behavioral problems. The scores were initially analyzed using analyses of variance. When significant results were observed, Tukey-Kramer multiple comparison tests were applied for further statistical evaluation. Significant DQ improvements were observed, as assessed by the Kyoto form developmental test. Additionally, significant improvement in the expression of words (measured with the NRC S-S test), the scores on PARS, and some behavioral factors (measured with the J-CBCL) were observed. The results in this cohort suggest that decompressive cranioplasty may play an important role in supporting the improvement of developmental delays in these patients.	[Shimoji, Takeyoshi] Okinawa Pref Nanbu Med Ctr, Dept Neurosurg, Okinawa, Japan; [Shimoji, Takeyoshi] Childrens Med Ctr, Okinawa, Japan; [Tominaga, Daisuke] Univ Ryukyus, Fac Grad Sch Educ, Nishihara, Okinawa, Japan; [Shimoji, Kazuaki; Miyajima, Masaichi] Juntendo Univ, Sch Med, Dept Neurosurg, Bunkyou Ku, Tokyo 113, Japan; [Tasato, Kumiko] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan	Shimoji, T (reprint author), Okinawa Pref Nanbu Med Ctr, Dept Neurosurg, 901-1193 118-1 Arakawa Haebaru, Okinawa, Japan.	trigono.research@gmail.com					Achenbach T. M., 1992, MANUAL CHILD BEHAV C; Adachi J, 2006, JAPAN J CLIN PSYCH, V35, P1591; [Anonymous], 2001, KYOT FORM DEV TESTS; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Jonsdottir SL, 2007, J AUTISM DEV DISORD, V37, P1361, DOI 10.1007/s10803-006-0282-z; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Yamasaki S, 2010, BIOL PSYCHIAT, V68, P1141, DOI 10.1016/j.biopsych.2010.07.012; Collmann H, 1996, CHILD NERV SYST, V12, P664, DOI 10.1007/BF00366148; Iizuka N, 1998, JPN J LOGOP PHONIATR, V39, P245; Itani T, 2001, PSYCHIAT NEUROLOGIA, V41, P243; Jane JA, 2000, CRANIOSYNOSTOSIS DIA, P222; Kelleher MO, 2006, J NEUROSURG, V105, P382, DOI 10.3171/ped.2006.105.5.382; Kodera T, 2010, NATL REHABILITATION; Nakata Y, 1999, PSYCHIAT NEUROL PAED, V39, P317; Ogata K, 2012, JPN J APPL PSYCHOL, V37, P95; PARS Committee, 2008, PERV DEV DIS AUT SOC; Sato W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-99; Shimabukuro Satoshi, 2001, No To Hattatsu, V33, P487; Shimoji T, 2000, SHOUNI NO NOUSINKEI, V25, P43; Shimoji T, 2004, CHILD NERV SYST, V20, P749, DOI 10.1007/s00381-004-0970-y; Shimoji T, 2011, SHOUNI NOUSINKEI, V36, P1; Shimoji T, 2002, CHILD NERV SYST, V18, P215, DOI 10.1007/s00381-002-0568-1; Shiokawa H, 2010, PSYCHIAT NEUROL PAED, V50, P171; Tsujii M, 2006, JAPAN J CLIN PSYCHIA, V35, P1119	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2015	31	3					433	440		10.1007/s00381-014-2595-0		8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CB1CM	WOS:000349364200011		
J	Fukuoka, K; Yanagisawa, T; Watanabe, Y; Suzuki, T; Shirahata, M; Adachi, J; Mishima, K; Fujimaki, T; Matsutani, M; Wada, S; Sasaki, A; Nishikawa, R				Fukuoka, Kohei; Yanagisawa, Takaaki; Watanabe, Yuko; Suzuki, Tomonari; Shirahata, Mitsuaki; Adachi, Jun-ichi; Mishima, Kazuhiko; Fujimaki, Takamitsu; Matsutani, Masao; Wada, Satoru; Sasaki, Atsushi; Nishikawa, Ryo			Brainstem oligodendroglial tumors in children: two case reports and review of literatures	CHILDS NERVOUS SYSTEM			English	Article						Oligodendroglial tumor; Brainstem tumor; Pediatric brain tumor; Pathological diagnosis; Histone H 3.3 mutation	ANAPLASTIC OLIGODENDROGLIOMA; PEDIATRIC OLIGODENDROGLIOMAS; VINCRISTINE CHEMOTHERAPY; K27M MUTATION; GLIOMAS; 19Q; 1P	There is little information on pediatric oligodendroglial tumor located in the brainstem because of its rarity. Here, we present two pediatric cases of pontine oligodendroglial tumors with radiological findings atypical for diffuse intrinsic pontine glioma. The first patient was an 8-year-old boy. Brain magnetic resonance imaging (MRI) demonstrated diffuse high-intensity changes in the pons, left middle cerebellar peduncle, and part of the left cerebellar hemisphere on T2-weighted and fluid-attenuated inversion recovery images, with an enhanced spot lesion in the left cerebellar hemisphere. The pathological diagnosis was anaplastic oligodendroglioma, and we identified a mutation in histone H3.3 in the tumor specimen. He succumbed to massive disseminated relapse 7 months from diagnosis despite local radiation therapy. The second patient, a 2-year-old girl, was diagnosed with oligoastrocytoma. Brain MRI revealed a large mass in her rostral pons extended to the fourth ventricle with obstructive hydrocephalus. The tumor recurred with intracranial dissemination 56 months post-surgery. Pediatric brainstem oligodendroglial tumors can include histone H3.3-mutated tumors and have a tendency to disseminate throughout the neuroaxis at the time of relapse.	[Fukuoka, Kohei; Yanagisawa, Takaaki; Watanabe, Yuko; Suzuki, Tomonari] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Div Pediat Neurooncol, Hidaka, Saitama 3501298, Japan; [Shirahata, Mitsuaki; Adachi, Jun-ichi; Mishima, Kazuhiko; Matsutani, Masao; Nishikawa, Ryo] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Hidaka, Saitama 3501298, Japan; [Fujimaki, Takamitsu] Saitama Med Univ Hosp, Dept Neurosurg, Moroyama, Saitama, Japan; [Wada, Satoru] Saitama Med Univ, Int Med Ctr, Dept Breast Oncol, Hidaka, Saitama 3501298, Japan; [Sasaki, Atsushi] Saitama Med Univ, Dept Pathol, Moroyama, Saitama, Japan	Fukuoka, K (reprint author), Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Div Pediat Neurooncol, Yamane 1397-1, Hidaka, Saitama 3501298, Japan.	kohfukuoka@gmail.com					Adachi J, 2012, J NEURO-ONCOL, V107, P147, DOI 10.1007/s11060-011-0721-3; PACKER RJ, 1985, CANCER, V56, P195, DOI 10.1002/1097-0142(19850701)56:1<195::AID-CNCR2820560133>3.0.CO;2-3; Packer RJ, 1997, J NEUROSURG, V86, P747, DOI 10.3171/jns.1997.86.5.0747; Hyder DJ, 2007, J NEURO-ONCOL, V83, P1, DOI 10.1007/s11060-006-9299-6; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; MORK SJ, 1985, J NEUROSURG, V63, P881, DOI 10.3171/jns.1985.63.6.0881; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026; Raghavan R, 2003, J NEUROPATH EXP NEUR, V62, P530; Ogiwara H, 2013, CHILD NERV SYST, V29, P833, DOI 10.1007/s00381-013-2042-7; Gielen GH, 2013, AM J CLIN PATHOL, V139, P345, DOI 10.1309/AJCPABOHBC33FVMO; Kreiger PA, 2005, ACTA NEUROPATHOL, V109, P387, DOI 10.1007/s00401-004-0976-2; Broniscer A, 2008, CANCER, V113, P566, DOI 10.1002/cncr.23584; DOHRMANN GJ, 1978, SURG NEUROL, V10, P21; KRUEGER EG, 1952, NEUROLOGY, V2, P461; Lesniak MS, 2003, PEDIATR NEUROSURG, V39, P314, DOI 10.1159/000075260; Mittelbronn M, 2005, HUM PATHOL, V36, P854, DOI 10.1016/j.humpath.2005.05.017; Peters O, 2004, PEDIATR BLOOD CANCER, V43, P250, DOI 10.1002/pbc.20111; Pollack IF, 2003, PEDIATR NEUROSURG, V39, P114, DOI 10.1159/000071647; Reifenberger G, 2007, WHO CLASSIFICATION T, P54; Ronghe M, 2010, ONCOLOGY OF CNS TUMORS, SECOND EDITION, P453, DOI 10.1007/978-3-642-02874-8_29; Sanai N, 2010, PEDIAT CNS TUMORS, P49; Wang Kyu-Chang, 1993, Journal of Korean Medical Science, V8, P110	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2015	31	3					449	455		10.1007/s00381-014-2563-8		7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CB1CM	WOS:000349364200013		
J	Harada, A; Miya, F; Utsunomiya, H; Kato, M; Yamanaka, T; Tsunoda, T; Kosaki, K; Kanemura, Y; Yamasaki, M				Harada, Atsuko; Miya, Fuyuki; Utsunomiya, Hidetsuna; Kato, Mitsuhiro; Yamanaka, Takumi; Tsunoda, Tatsuhiko; Kosaki, Kenjiro; Kanemura, Yonehiro; Yamasaki, Mami			Sudden death in a case of megalencephaly capillary malformation associated with a de novo mutation in AKT3	CHILDS NERVOUS SYSTEM			English	Article						Megalencephaly capillary malformation; Sudden death; AKT3 mutation; Cerebellar tonsillar herniation; Posterior fossa decompression	MARMORATA-TELANGIECTATICA-CONGENITA; MACROCEPHALY-CUTIS-MARMORATA; DISTINCTIVE OVERGROWTH SYNDROME; HYDROCEPHALUS; POLYMICROGYRIA; MCAP; MPPH; PIK3R2; BRAIN	Megalencephaly capillary malformation (MCAP) is a syndrome involving brain overgrowth, characterized by megalencephaly, capillary malformations, asymmetric growth, polymicrogyria, polydactyly, and syndactyly. Cerebellar tonsillar herniation (CTH) and ventriculomegaly are also observed in over half the patients with this syndrome. Early sudden death has been reported in MCAP, but its causes and the surgical strategies for its prevention remain unclear. Here, we report on a patient with MCAP who died suddenly at 5 months of age. He presented with progressive macrocephaly and hypotonia. MRI performed at 4 months of age showed tight posterior fossa, bilateral perisylvian polymicrogyria, enlargement of the straight sinus, and a thickened corpus callosum. However, since the patient did not exhibit capillary malformation, polydactyly, or syndactyly, a definitive diagnosis of MCAP could not be made. He died suddenly while asleep at home 1 month later. The sudden death of MCAP patients was previously attributed to CTH, convulsion, or arrhythmia. In this case, progressive cerebellar enlargement appeared to be the underlying cause. After the patient's death, using his preserved DNA, a missense mutation in the AKT3 gene was identified. Vakt murine thymoma viral oncogene homologue (AKT) is a serine-threonine kinase that functions in the mammalian target of rapamycin (mTOR) pathway and plays an important role in cell proliferation. Accurate early diagnosis, including imaging and genetic analyses, and the recognition and treatment of critical conditions are required to prevent the sudden death of patients with MCAP.	[Harada, Atsuko; Yamanaka, Takumi; Yamasaki, Mami] Takatsuki Gen Hosp, Dept Pediat Neurosurg, Takatsuki, Osaka 5691192, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Utsunomiya, Hidetsuna] Int Univ Hlth & Welf, Dept Radiol Sci, Grad Sch, Fukuoka, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo, Japan; [Kanemura, Yonehiro; Yamasaki, Mami] Natl Hosp Org, Osaka Natl Hosp, Inst Clin Res, Div Regenerat Med, Osaka, Japan; [Kanemura, Yonehiro] Natl Hosp Org, Osaka Natl Hosp, Dept Neurosurg, Osaka, Japan	Yamasaki, M (reprint author), Takatsuki Gen Hosp, Dept Pediat Neurosurg, 1-3-13 Kosobecho, Takatsuki, Osaka 5691192, Japan.	myamasaki@ajk.takatsuki-hp.or.jp	Tsunoda, Tatsuhiko/K-2061-2014		Ministry of Health, Labor, and Welfare of Japan [2010-ID-131, H23-013]	We appreciate the support from the Health Sciences Research Grants for Research of Intractable Disease (2010-ID-131 to YM) and the Research on Applying Health Technology (H23-013 to FM, MK, KK, YK, and MY) from the Ministry of Health, Labor, and Welfare of Japan.	Akcar N, 2004, ANN GENET-PARIS, V47, P261, DOI 10.1016/j.anngen.2004.03.003; Moore CA, 1997, AM J MED GENET, V70, P67, DOI 10.1002/(SICI)1096-8628(19970502)70:1<67::AID-AJMG13>3.3.CO;2-4; Mirzaa GM, 2012, AM J MED GENET A, V158A, P269, DOI 10.1002/ajmg.a.34402; ClaytonSmith J, 1997, CLIN DYSMORPHOL, V6, P291, DOI 10.1097/00019605-199710000-00001; Mirzaa GM, 2013, AM J MED GENET C, V163C, P122, DOI 10.1002/ajmg.c.31361; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Conway RL, 2007, AM J MED GENET A, V143A, P2981, DOI 10.1002/ajmg.a.32040; Mirzaa G, 2004, NEUROPEDIATRICS, V35, P353, DOI 10.1055/s-2004-830497; Nakamura K, 2014, CLIN GENET, V85, P396, DOI 10.1111/cge.12188; Dhamija R, 2013, CLIN NEUROL NEUROSUR, V115, P1837, DOI 10.1016/j.clineuro.2013.05.025; Barnicoat A, 1996, CLIN DYSMORPHOL, V5, P339; Conway RL, 2007, J NEUROSURG, V106, P296, DOI 10.3171/ped.2007.106.4.296; Dueñas-Arias Jesus E, 2009, J Med Case Rep, V3, P9215, DOI 10.4076/1752-1947-3-9215; Ecran TE, 2013, J CHILD NEUROL, V28, P115; Franceschini P, 2000, AM J MED GENET, V90, P265, DOI 10.1002/(SICI)1096-8628(20000214)90:4<265::AID-AJMG1>3.3.CO;2-J; Franklin B, 2009, BRAIN DEV-JPN, V31, P706, DOI 10.1016/j.braindev.2008.10.006; Giuliano F, 2004, AM J MED GENET A, V126A, P99, DOI 10.1002/ajmg.a.20551; Gripp KW, 2009, AM J MED GENET A, V149A, P868, DOI 10.1002/ajmg.a.32732; Lapunzina P, 2004, AM J MED GENET A, V130A, P45, DOI 10.1002/ajmg.a.30235; Martinez-Lage JF, 2010, CHILD NERV SYST, V26, P13, DOI 10.1007/s00381-009-0972-x; Mitha AP, 2009, J NEUROS-PEDIATR, V4, P397, DOI 10.3171/2008.12.PEDS088; Reardon W, 1996, AM J MED GENET, V66, P144, DOI 10.1002/(SICI)1096-8628(19961211)66:2<144::AID-AJMG4>3.0.CO;2-R; Rekate HL, 2007, J NEUROSURG, V106, P292, DOI 10.3171/ped.2007.106.4.292; Robertson SP, 2000, CLIN DYSMORPHOL, V9, P1, DOI 10.1097/00019605-200009010-00001; Toriello HV, 2007, AM J MED GENET A, V143A, P2009; Wright DR, 2009, ARCH DERMATOL, V145, P287, DOI 10.1001/archdermatol.2008.545; Yano S, 2001, AM J MED GENET, V102, P149, DOI 10.1002/ajmg.1428	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2015	31	3					465	471		10.1007/s00381-014-2589-y		7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CB1CM	WOS:000349364200015		
J	Boyle, TA; Masago, K; Ellison, KE; Yatabe, Y; Hirsch, FR				Boyle, Theresa A.; Masago, Katsuhiro; Ellison, Kim E.; Yatabe, Yasushi; Hirsch, Fred R.			ROS1 Immunohistochemistry Among Major Genotypes of Non-Small-Cell Lung Cancer	CLINICAL LUNG CANCER			English	Article						Adenocarcinoma; Biomarker; Gene rearrangement; NSCLC; ROS1	RECEPTOR TYROSINE KINASE; ALK FUSIONS; ADENOCARCINOMA; REARRANGEMENT; IDENTIFICATION; EXPRESSION; GENE	Identification of ROS1 rearrangements in patients with lung cancer allows them to benefit from targeted therapy. We compared immunohistochemistry (IHC) with more cumbersome methods such as fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for identification of ROS1 rearrangements in patients with lung adenocarcinoma (n = 33). Our results showed that IHC is a sensitive (100%) and specific (100%) method to identify ROS1 rearrangements in patients with lung cancer. Background: ROS1 gene fusions cause several cancers by constitutively activating the ROS1 tyrosine kinase receptor. ROS1-targeted inhibitor therapy improves survival in the approximately 1% to 2% of patients with lung adenocarcinoma with ROS1 gene fusions. Although fluorescence in situ hybridization (FISH) is the standard diagnostic procedure for detecting ROS1 rearrangements, we studied immunohistochemistry (IHC). Materials and Methods: ROS1 IHC was performed on a selected cohort of 33 lung adenocarcinoma whole tissue specimens with alterations in the EGFR (n = 5), KRAS (n = 5), ERBB2 (HER2) (n = 3), ROS1 (n = 6), ALK (n = 5), and RET (n = 3) genes and pan-negative (n = 6) detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and FISH. Results: In the cohort of 33 specimens, both ROS1 gene fusion using RT-PCR and high ROS1 protein expression using IHC were detected in 6 specimens. Of these 6 specimens, 5 were also positive by FISH for ROS1 gene rearrangements. All 27 lung cancer specimens that were negative for ROS1 rearrangements by genetic testing had no to low ROS1 protein expression. Conclusion: We have optimized ROS1 IHC and scoring to provide high sensitivity and specificity for detecting ROS1 gene rearrangements in whole tissue. ROS1 IHC could be a practical and cost-effective method to screen for ROS1 gene rearrangements. (C) 2015 The Authors. Published by Elsevier Inc. All rights reserved.	[Boyle, Theresa A.; Ellison, Kim E.; Hirsch, Fred R.] Univ Colorado, Dept Med Oncol & Pathol, Aurora, CO 80045 USA; [Masago, Katsuhiro] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo, Japan; [Masago, Katsuhiro; Yatabe, Yasushi] Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan	Hirsch, FR (reprint author), Univ Colorado, Dept Med Oncol & Pathol, Denver Anschutz Med Campus,Mail Stop 8117, Aurora, CO 80045 USA.	Fred.Hirsch@ucdenver.edu			National Cancer Institute [2P50CA058187-19A1]; Specialized Programs of Research Excellence; Colorado Lung Cancer Association	The present study was supported by grants from the National Cancer Institute (2P50CA058187-19A1), the Specialized Programs of Research Excellence, and the Colorado Lung Cancer Association.	Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Ou SHI, 2012, ONCOLOGIST, V17, P1351, DOI 10.1634/theoncologist.2012-0311; Aisner DL, 2014, MOL CANCER RES, V12, P111, DOI 10.1158/1541-7786.MCR-13-0479-T; Warth A, 2014, HISTOPATHOLOGY, V65, P187, DOI 10.1111/his.12379; Yoshida A, 2014, MODERN PATHOL, V27, P711, DOI 10.1038/modpathol.2013.192; BIRCHMEIER C, 1987, P NATL ACAD SCI USA, V84, P9270, DOI 10.1073/pnas.84.24.9270; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Kim HR, 2013, ANN ONCOL, V24, P2364, DOI 10.1093/annonc/mdt220; Tomizawa K, 2011, LUNG CANCER, V74, P139, DOI 10.1016/j.lungcan.2011.01.014; Lee HJ, 2013, ANN SURG ONCOL, V20, P200, DOI 10.1245/s10434-012-2553-6; Davies KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Lee J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/cncr.27967; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Mescam-Mancini L, 2014, LUNG CANCER, V83, P168, DOI 10.1016/j.lungcan.2013.11.019; Chen YF, 2014, J THORAC ONCOL, V9, P1171, DOI 10.1097/JTO.0000000000000232; Birch AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028250; Bunn PA, 2014, CLIN CANCER RES, V20, P1727, DOI 10.1158/1078-0432.CCR-13-3387; Cha YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103333; Giacomini CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003464; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Shaw AT, N ENGL J MED; Sholl LM, 2013, AM J SURG PATHOL, V37, P1441, DOI 10.1097/PAS.0b013e3182960fa7	27	0	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1525-7304	1938-0690		CLIN LUNG CANCER	Clin. Lung Cancer	MAR	2015	16	2					106	111		10.1016/j.cllc.2014.10.003		6	Oncology	Oncology	CB5AN	WOS:000349640000009		
J	Kyomoto, M; Moro, T; Takatori, Y; Tanaka, S; Ishihara, K				Kyomoto, Masayuki; Moro, Toru; Takatori, Yoshio; Tanaka, Sakae; Ishihara, Kazuhiko			Multidirectional Wear and Impact-to-wear Tests of Phospholipid-polymer-grafted and Vitamin E-blended Crosslinked Polyethylene: A Pilot Study	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							ORTHOPEDIC BEARING SURFACE; POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE; ARTICULAR-CARTILAGE; ARTIFICIAL JOINTS; UNITED-STATES; RESISTANCE; LUBRICATION; IRRADIATION; OSTEOLYSIS	Modifying the surface and substrate of a crosslinked polyethylene (CLPE) liner may be beneficial for high wear resistance as well as high oxidative stability and excellent mechanical properties, which would be useful in contributing to the long-term performance of orthopaedic bearings. A grafted poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) layer on a vitamin E-blended crosslinked PE (HD-CLPE[VE]) surface may provide hydrophilicity and lubricity without compromising the oxidative stability or mechanical properties. (1) Will the modifications (PMPC grafting and vitamin E blending) affect the lubrication characteristics of the CLPE surface? (2) Will the modifications affect wear resistance? (3) Will the modifications affect fatigue resistance? We investigated the effects of surface and substrate modifications (PMPC grafting and vitamin E blending) on the wear and fatigue fracture of thin CLPE samples. For each of the untreated and PMPC-grafted CLPE surfaces with and without vitamin E blended (four groups), wettability and lubricity surface analyses were conducted as well as multidirectional wear and impact-to-wear tests using a pin-on-disk testing machine. The water wettability and lubricity (CLPE [mean +/- A 95% confidence interval]: 23.2A degrees A A +/- A 1.8A degrees, 0.005 +/- A 0.001; HD-CLPE[VE]: 26.0A degrees A A +/- A 2.3A degrees, 0.009 +/- A 0.003) of the PMPC-grafted surfaces were greater (p < 0.001) than that (CLPE: 90.3A degrees A A +/- A 1.2A degrees, 0.067 +/- A 0.015; HD-CLPE[VE]: 90.8A degrees A A +/- A 2.0A degrees, 0.063 +/- A 0.008) of the untreated surface regardless of vitamin E additives. It was observed that the PMPC grafting (CLPE: 0.23 +/- A 0.06 mg; HD-CLPE[VE]: 0.05 +/- A 0.10 mg) was associated with reduced gravimetric wear (CLPE: 0.53 +/- A 0.08 mg, p = 0.004 HD-CLPE[VE]: 0.23 +/- A 0.07 mg, p = 0.038) in the multidirectional wear test. The PMPC-grafted surface characteristics did not appear to affect the impact fatigue resistance regardless of vitamin E blending. PMPC grafting improved the surface hydrophilicity and lubricity, and it reduced the gravimetric wear in terms of multidirectional sliding. It did not result in differences in terms of the impact-to-unidirectional sliding regardless of vitamin E blending. Further research is needed to evaluate the wear resistance of PMPC-grafted HD-CLPE(VE) in long-term hip simulator tests under normal and severe conditions, which may offer useful clues to the possible performance of these materials in vivo. Our preliminary in vitro findings suggest that some improvement in the wear performance of crosslinked polyethylene acetabular liners in total hip arthroplasty could be obtained using PMPC grafting. Further research is needed to evaluate the wear resistance of PMPC-grafted HD-CLPE(VE) in long-term hip simulator tests under normal and severe conditions, which may offer useful clues to the possible performance of these materials in vivo.	[Kyomoto, Masayuki; Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Tokyo, Japan; [Kyomoto, Masayuki; Moro, Toru; Takatori, Yoshio] Univ Tokyo, Grad Sch Med, Div Sci Joint Reconstruct, Tokyo, Japan; [Kyomoto, Masayuki] KYOCERA Med Corp, Res Dept, Yodogawa Ku, Osaka 5320003, Japan; [Moro, Toru; Takatori, Yoshio; Tanaka, Sakae] Univ Tokyo, Fac Med, Tokyo 113, Japan	Kyomoto, M (reprint author), KYOCERA Med Corp, Res Dept, Yodogawa Ku, 3-3-31 Miyahara, Osaka 5320003, Japan.	masayuki.kyomoto@kyocera-md.jp			Japanese Ministry of Health, Labour and Welfare [H20-004, H24-001]	One or more of the authors (YT) received funding from a Health and Welfare Research Grant for Research on Medical Devices for Improving Impaired QOL (H20-004) and Research on Measures for Intractable Diseases (H24-001) from the Japanese Ministry of Health, Labour and Welfare.	Kyomoto M, 2013, BIOMATERIALS, V34, P7829, DOI 10.1016/j.biomaterials.2013.07.023; Kyomoto M, 2008, J BIOMED MATER RES B, V84B, P320, DOI 10.1002/jbm.b.30874; Kyomoto M, 2009, J BIOMED MATER RES A, V91A, P730, DOI 10.1002/jbm.a.32280; Currier BH, 2007, J BONE JOINT SURG AM, V89A, P2023, DOI 10.2106/JBJS.F.00336; CHANG DCM, 1995, BIOMATERIALS, V16, P219, DOI 10.1016/0142-9612(95)92120-U; Takatori Y, 2013, J ARTIF ORGANS, V16, P170, DOI 10.1007/s10047-012-0681-1; Oral E, 2008, BIOMATERIALS, V29, P3557, DOI 10.1016/j.biomaterials.2008.05.004; Moro T, 2014, J ORTHOP RES, V32, P369, DOI 10.1002/jor.22526; Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Kyomoto M, 2014, BIOMATERIALS, V35, P6677, DOI 10.1016/j.biomaterials.2014.04.051; Kyomoto M, 2008, J BIOMED MATER RES A, V86A, P439, DOI 10.1002/jbm.a.31511; Kyomoto M, 2009, J BIOMED MATER RES A, V90A, P362, DOI 10.1002/jbm.a.32092; Kyomoto M, 2011, CLIN ORTHOP RELAT R, V469, P2327, DOI 10.1007/s11999-010-1718-5; KIRK TB, 1993, J ORTHOP RHEUMATOL, V6, P21; Rodriguez JA, 2012, J BONE JOINT SURG BR, V94B, P52, DOI 10.1302/0301-620X.94B11.30508; Goldberg R, 2011, ADV MATER, V23, P3517, DOI 10.1002/adma.201101053; Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9; Ishikawa Y, 2006, WEAR, V261, P500, DOI 10.1016/j.wear.2005.12.001; Kyomoto M, 2010, BIOMATERIALS, V31, P1017, DOI 10.1016/j.biomaterials.2009.10.055; Kyomoto M, 2007, BIOMATERIALS, V28, P3121, DOI 10.1016/j.biomaterials.2007.03.010; Kyomoto M, 2007, J BIOMED MATER RES A, V82A, P10, DOI 10.1002/jbm.a.31134; Ast MP, 2014, J ARTHROPLASTY, V29, P1231, DOI 10.1016/j.arth.2013.12.022; Kyomoto M, 2012, BIOMATERIALS, V33, P4451, DOI 10.1016/j.biomaterials.2012.03.028; Baykal D, 2014, J MECH BEHAV BIOMED, V31, P117, DOI [10.1016/j.jmbbm.2013.05.020, 10.1016/j.jmbbm.2012.12.020]; Kyomoto M, 2007, J MATER SCI-MATER M, V18, P1809, DOI 10.1007/s10856-007-3063-0; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Shibata N, 2005, BIOMATERIALS, V26, P5755, DOI 10.1016/j.biomaterials.2005.02.035; MacDonald D, 2011, CLIN ORTHOP RELAT R, V469, P2278, DOI 10.1007/s11999-010-1728-3; ASTM, 2011, F73200 ASTM; Czichos H., 1978, TRIBOLOGY SYSTEMS AP, P1; HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46; International Organization for Standardization, 2004, 15989 ISO; Kurtz SM, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P1; Okubo Yasushi, 2010, Tribology Online, V5, DOI 10.2474/trol.5.96; Takatori Y, 2014, MOD RHEUMATOL, P1	36	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAR	2015	473	3					942	951		10.1007/s11999-014-3995-x		10	Orthopedics; Surgery	Orthopedics; Surgery	CA9KM	WOS:000349242200031		
J	Shimizu, T; Yamaguchi, T; Satake, Y; Shimazaki, J				Shimizu, Tsutomu; Yamaguchi, Takefumi; Satake, Yoshiyuki; Shimazaki, Jun			Topographic Hot Spot Before Descemet Stripping Automated Endothelial Keratoplasty Is Associated With Postoperative Hyperopic Shift	CORNEA			English	Article						hyperopic shift; endothelial keratoplasty; refractive outcome; cornea imaging	OPTICAL COHERENCE TOMOGRAPHY; CORNEAL SURFACE IRREGULARITY; PENETRATING KERATOPLASTY; SUBEPITHELIAL FIBROSIS; BULLOUS KERATOPATHY; TRIPLE PROCEDURE; FUCHS DYSTROPHY; ANTERIOR; DSAEK; PHACOEMULSIFICATION	Purpose: The aim of this study was to investigate topographic "hot spots" on the anterior corneal surface before Descemet stripping automated endothelial keratoplasty (DSAEK) and their effects on postoperative visual acuity and hyperopic shift. Methods: Twenty-seven eyes of 27 patients with bullous keratopathy, who underwent DSAEK were studied. We defined a hot spot as a focal area with relatively high refractive power on the anterior corneal surface in eyes with bullous keratopathy. Refractive spherical equivalent, keratometric value, and corneal topography were retrospectively evaluated using anterior segment optical coherence tomography (AS-OCT). Results: Hot spots were identified in 11 eyes (42.3%) before DSAEK and disappeared in 9 eyes of these eyes (81.8%) at 6 months after DSAEK. AS-OCT revealed focal epithelial thickening in the same areas as the hot spots. There was no significant difference in the postoperative visual acuity between eyes with and without hot spots (P > 0.05). The keratometric value of the anterior corneal surface significantly flattened from 45.7 +/- 2.7 diopters (D) before DSAEK to 44.2 +/- 2.7 D 1 month after DSAEK in eyes with hot spots (P = 0.01), whereas in eyes without hot spots, there were no significant differences in the keratometric values before and after DSAEK. At 6 months, the refractive change was +1.1 +/- 1.3 D in eyes with hot spots and -0.2 +/- 0.6 D in eyes without hot spots (P = 0.034). Conclusions: In eyes with focal epithelial thickening, topographic hot spots on the anterior corneal surface were observed using AS-OCT. The hot spots disappeared after DSAEK and had no influence on the postoperative visual acuity.	[Shimizu, Tsutomu; Yamaguchi, Takefumi; Shimazaki, Jun] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yamaguchi, Takefumi; Satake, Yoshiyuki; Shimazaki, Jun] Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Ophthalmol, Ichikawa, Chiba 2730041, Japan	Yamaguchi, T (reprint author), Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Ophthalmol, 5-11-13 Sugano, Ichikawa, Chiba 2730041, Japan.	tym.i.eye.i@gmail.com					Rao SK, 2008, AM J OPHTHALMOL, V145, P991, DOI 10.1016/j.ajo.2008.01.017; Dupps WJ, 2008, J CATARACT REFR SURG, V34, P578, DOI 10.1016/j.jcrs.2007.11.045; Yoo SH, 2008, ARCH OPHTHALMOL-CHIC, V126, P1052, DOI 10.1001/archopht.126.8.1052; Morishige N, 2009, INVEST OPHTH VIS SCI, V50, P3145, DOI 10.1167/iovs.08-3309; Lombardo M, 2010, GRAEF ARCH CLIN EXP, V248, P421, DOI 10.1007/s00417-009-1284-2; Guerra FP, 2011, OPHTHALMOLOGY, V118, P2368, DOI 10.1016/j.ophtha.2011.06.002; Price MO, 2008, J CATARACT REFR SURG, V34, P1423, DOI 10.1016/j.jcrs.2008.05.044; Bahar I, 2010, CURR EYE RES, V35, P961, DOI 10.3109/02713683.2010.506967; Yasuno Y, 2005, OPT EXPRESS, V13, P10652, DOI 10.1364/OPEX.13.010652; Parker J, 2012, J CATARACT REFR SURG, V38, P871, DOI 10.1016/j.jcrs.2011.11.038; Patel SV, 2009, ARCH OPHTHALMOL-CHIC, V127, P153, DOI 10.1001/archophthalmol.2008.581; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997; Ham L, 2011, J CATARACT REFR SURG, V37, P1455, DOI 10.1016/j.jcrs.2011.02.033; Koenig SB, 2007, CORNEA, V26, P670, DOI 10.1097/ICO.0b013e3180544902; Yamaguchi TD, 2009, J CATARACT REFR SURG, V35, P688, DOI 10.1016/j.jcrs.2008.11.062; Price MO, 2006, OPHTHALMOLOGY, V113, P1936, DOI 10.1016/j.ophtha.2006.05.034; Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Scorcia V, 2009, OPHTHALMOLOGY, V116, P1651, DOI 10.1016/j.ophtha.2009.04.035; Di Pascuale MA, 2009, AM J OPHTHALMOL, V148, P32, DOI 10.1016/j.ajo.2009.01.016; Price FW, 2005, J REFRACT SURG, V21, P339; Chaurasia S, 2014, CORNEA, V33, P335, DOI 10.1097/ICO.0000000000000078; Covert DJ, 2007, OPHTHALMOLOGY, V114, P1272, DOI 10.1016/j.ophtha.2006.12.030; Eagle R C Jr, 1989, Trans Am Ophthalmol Soc, V87, P107; Eagle Jr RC, 1989, T AM OPHTHAL SOC, V87, P19; Ghaznawi N, 2010, CURR OPIN OPHTHALMOL, V21, P283, DOI 10.1097/ICU.0b013e32833a8cc9; Hwang RY, 2011, INVEST OPHTH VIS SCI, V52, P1043, DOI 10.1167/iovs.10-5839; Knecht PB, 2010, AM J OPHTHALMOL, V150, P360, DOI 10.1016/j.ajo.2010.04.017; Kwon RO, 2010, J REFRACT SURG, V26, P972, DOI 10.3928/1081597X-20100212-08; Muftuoglu O, 2010, OPHTHALMOLOGY, V117, P878, DOI 10.1016/j.ophtha.2010.02.001; Paris FD, 2010, BRIT J OPHTHALMOL, V94, P773, DOI 10.1136/bjo.2009.158881; Uchino Y, 2006, OPHTHALMOLOGY, V113, P1098, DOI 10.1016/j.ophtha.2006.01.034; Uchino Y, 2011, CORNEA, V30, P287, DOI 10.1097/ICO.0b013e3181eeafd6; Yamaguchi T, 2010, CORNEA, V29, P1086, DOI 10.1097/ICO.0b013e3181d0092c	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	MAR	2015	34	3					257	263				7	Ophthalmology	Ophthalmology	CB2JS	WOS:000349453900007		
J	Yokokura, S; Hariya, T; Uematsu, M; Meguro, Y; Kobayashi, W; Nishida, K; Nakazawa, T				Yokokura, Shunji; Hariya, Takehiro; Uematsu, Megumi; Meguro, Yasuhiko; Kobayashi, Wataru; Nishida, Kohji; Nakazawa, Toru			Efficacy of Chandelier Illumination for Combined Cataract Operation and Penetrating Keratoplasty	CORNEA			English	Article						PKP triple procedure; chandelier illumination; continuous curvilinear capsulorhexis	ASSISTED PHACOEMULSIFICATION; CORNEAL OPACITY; CORE VITRECTOMY; SURGERY; CAPSULORHEXIS; EYES	Purpose: The aim of this study was to describe a method for non-open-sky continuous curvilinear capsulorhexis (CCC) with chandelier retroillumination for penetrating keratoplasty triple procedure and report its effectiveness in decreasing intraoperative complications and enabling successful primary intraocular lens (IOL) insertion in patients with moderate or dense central corneal opacities. Methods: Seventeen eyes of 17 patients were enrolled in this study, divided into a chandelier group, including 7 eyes of 7 patients, and a nonchandelier group, including 10 eyes of 10 patients. In each group, time to achieve CCC (in seconds), open-sky time (in seconds), and operation time (in minutes) were measured, and the rates of successful CCC completion, rupture of the posterior capsule or zonule of Zinn, and successful IOL insertion were recorded. Results: CCC time was not significantly different in both groups. In the chandelier group, however, open-sky time and operation time were significantly shorter than in the nonchandelier group (1429 +/- 67 vs. 2016 +/- 354 seconds, and 90.4 +/- 3.5 vs. 108.9 +/- 10.3 minutes, respectively). In the chandelier group, the rate of successful CCC completion was significantly higher than in the nonchandelier group (86% vs. 30%). The rates of posterior capsule or zonule of Zinn rupture and successful IOL insertion were not significantly different (14% vs. 40%, 14% vs. 10%, and 86% vs. 70%, respectively). Conclusions: Non-open-sky CCC with chandelier illumination has many advantages for penetrating keratoplasty triple procedure compared with open-sky CCC without chandelier illumination.	[Yokokura, Shunji; Hariya, Takehiro; Uematsu, Megumi; Meguro, Yasuhiko; Kobayashi, Wataru; Nakazawa, Toru] Tohoku Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 9808574, Japan; [Nishida, Kohji] Osaka Univ, Osaka Grad Sch Med, Dept Ophthalmol, Osaka, Japan	Yokokura, S (reprint author), Tohoku Grad Sch Med, Dept Ophthalmol, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	yokokura@oph.med.tohoku.ac.jp					Agarwal T, 2009, EYE, V23, P1345, DOI 10.1038/eye.2008.283; Akin T, 2007, OPHTHAL SURG LAS IM, V38, P520; Nishimura A, 2003, J CATARACT REFR SURG, V29, P2277, DOI 10.1016/S0886-3350(03)00493-0; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665; Nardi M, 2001, J CATARACT REFR SURG, V27, P1172, DOI 10.1016/S0886-3350(01)00748-9; Bhartiya P, 2002, BRIT J OPHTHALMOL, V86, P857, DOI 10.1136/bjo.86.8.857; Bhattacharjee K, 1999, J CATARACT REFR SURG, V25, P1045, DOI 10.1016/S0886-3350(99)00123-6; Farjo AA, 2003, J CATARACT REFR SURG, V29, P242, DOI 10.1016/S0886-3350(02)01535-3; Higaki S, 2012, CORNEA, V31, P730, DOI 10.1097/ICO.0b013e31820ce28a; MARTIN TP, 1994, OPHTHALMOLOGY, V101, P113; Melles GRJ, 1999, J CATARACT REFR SURG, V25, P7, DOI 10.1016/S0886-3350(99)80004-2; Oshima Y, 2007, J CATARACT REFR SURG, V33, P2018, DOI 10.1016/j.jcrs.2007.07.055; Praeger D L, 1975, Ophthalmic Surg, V6, P56; Shimomura Y, 1997, JPN J OPHTHALMOL, V41, P251, DOI 10.1016/S0021-5155(97)00046-4; Taylor D M, 1976, Ophthalmic Surg, V7, P31; Yamamoto N, 2005, OPHTHALMOLOGICA, V219, P338, DOI 10.1159/000088375	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	MAR	2015	34	3					275	278				4	Ophthalmology	Ophthalmology	CB2JS	WOS:000349453900010		
J	Nozue, T; Yamagishi, S; Hirano, T; Yamamoto, S; Tohyama, S; Fukui, K; Umezawa, S; Onishi, Y; Kunishima, T; Hibi, K; Terashima, M; Michishita, I				Nozue, Tsuyoshi; Yamagishi, Sho-ichi; Hirano, Tsutomu; Yamamoto, Shingo; Tohyama, Shinichi; Fukui, Kazuki; Umezawa, Shigeo; Onishi, Yuko; Kunishima, Tomoyuki; Hibi, Kiyoshi; Terashima, Mitsuyasu; Michishita, Ichiro			Pigment epithelium-derived factor is associated with necrotic core progression during statin therapy	CORONARY ARTERY DISEASE			English	Article						necrotic core; pigment epithelium-derived factor; statin; virtual histology intravascular ultrasound	OXYGEN SPECIES GENERATION; HISTOLOGY INTRAVASCULAR ULTRASOUND; ACUTE CORONARY SYNDROMES; FACTOR PEDF; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; ARTERY-DISEASE; ATHEROSCLEROSIS; EXPRESSION; ATORVASTATIN	Objective Pigment epithelium-derived factor (PEDF) is a potent inhibitor of angiogenesis and an important target molecule for preventing the progression of atherosclerosis. However, the relationship between PEDF and coronary atherosclerosis has not been fully examined. The aim of the present study is to evaluate the effects of statins on serum PEDF levels and the association between PEDF and coronary atherosclerosis. Patients and methods Coronary atherosclerosis in nonculprit lesions in the vessel of patients undergoing a percutaneous coronary intervention was evaluated using virtual histology intravascular ultrasound in 99 patients during percutaneous coronary intervention and after 8 months of statin therapy. Results Serum PEDF levels at baseline and at the 8-month follow-up did not differ. A significant decrease in the fibrofatty component (-0.24mm(3)/mm, P=0.0003) and increases in the necrotic core (0.13mm(3)/mm, P=0.02) and dense calcium components (0.11mm(3)/mm, P<0.0001) were observed during the 8-month statin therapy. On univariate regression analyses, serum PEDF levels (r=0.291, P=0.004) and unstable angina pectoris (r=0.203, P=0.04) showed significant positive correlations with the percentage change in necrotic core volume. Multivariate regression analysis showed that serum PEDF level was a significant independent predictor associated with necrotic core progression during statin therapy (beta=0.218, P=0.04). Conclusion Statin therapy had no effects on serum PEDF levels. Serum PEDF was a useful biomarker for predicting necrotic core progression during statin therapy, and its levels could be elevated as a counter-regulatory response mechanism to protect against necrotic core progression. Coron Artery Dis 26: 107-113 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Nozue, Tsuyoshi; Michishita, Ichiro] Yokohama Sakae Kyosai Hosp, Dept Internal Med, Div Cardiol, Yokohama, Kanagawa 2478581, Japan; [Yamamoto, Shingo] Tsurumi Nishiguchi Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Tohyama, Shinichi] Yokohama Seamens Insurance Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Fukui, Kazuki] Kanagawa Cardiovasc & Resp Ctr, Dept Cardiol, Yokohama, Kanagawa, Japan; [Hibi, Kiyoshi] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa 232, Japan; [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan; [Hirano, Tsutomu] Showa Univ, Sch Med, Dept Internal Med 1, Tokyo 142, Japan; [Umezawa, Shigeo; Onishi, Yuko] Hiratsuka Kyosai Hosp, Dept Cardiol, Hiratsuka, Kanagawa, Japan; [Kunishima, Tomoyuki] Teikyo Univ, Sch Med, Dept Internal Med 4, Mizonokuchi Hosp, Kawasaki, Kanagawa, Japan; [Terashima, Mitsuyasu] Cardiovasc Imaging Ctr, Toyohashi, Aichi, Japan	Nozue, T (reprint author), Yokohama Sakae Kyosai Hosp, Federat Natl Publ Serv Personnel Mutual Associat, Dept Internal Med, Div Cardiol,Sakae Ku, 132 Katsura Cho, Yokohama, Kanagawa 2478581, Japan.	nozue2493@yahoo.co.jp					Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Tahara N, 2011, ATHEROSCLEROSIS, V219, P311, DOI 10.1016/j.atherosclerosis.2011.06.022; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Baba H, 2005, ARTERIOSCL THROM VAS, V25, P1938, DOI 10.1161/01.ATV.0000175759.78338.1e; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Yamagishi SI, 2010, CURR MOL MED, V10, P284; Nasu K, 2009, JACC-CARDIOVASC INTE, V2, P689, DOI 10.1016/j.jcin.2009.04.016; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Hong MK, 2009, JACC-CARDIOVASC INTE, V2, P679, DOI 10.1016/j.jcin.2009.03.015; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Libby P, 2001, CIRCULATION, V104, P365; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Rychli K, 2009, EXPERT OPIN THER TAR, V13, P1295, DOI 10.1517/14728220903241641; Aikawa M, 2001, CIRCULATION, V103, P276; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Arimura T, 2011, CARDIOL J, V18, P515, DOI 10.5603/CJ.2011.0006; Chen C, 2010, J CLIN ENDOCR METAB, V95, P5074, DOI 10.1210/jc.2010-0727; Eshtehardi P, 2012, J INVASIVE CARDIOL, V24, P522; Inagaki Y, 2003, DIABETOLOGIA, V46, P284, DOI 10.1007/s00125-002-1013-4; Ito Y, 2011, CLIN CHEM, V57, P57, DOI 10.1373/clinchem.2010.149559; Iwata A, 2011, INTERNAL MED, V50, P1889, DOI 10.2169/internalmedicine.50.5460; Kohno H, 2000, CLIN BIOCHEM, V33, P243, DOI 10.1016/S0009-9120(00)00065-5; Nakamura K, 2007, AM J PATHOL, V170, P2159, DOI 10.2353/ajpath.2007.060838; Nozue T, 2012, AM HEART J, V163; Nozue T, 2013, AM J CARDIOL, V111, P923, DOI 10.1016/j.amjcard.2012.12.008; Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398; Takenaka K, 2008, ATHEROSCLEROSIS, V197, P25, DOI 10.1016/j.atherosclerosis.2007.07.041; Ueda S, 2011, AM J PATHOL, V178, P591, DOI 10.1016/j.ajpath.2010.10.018; Wang FF, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-56; Yamagishi SI, 2009, CURR PHARM DESIGN, V15, P1027; Yamagishi SI, 2004, J MOL CELL CARDIOL, V37, P497, DOI 10.1016/j.yjmcc.2004.04.007	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	MAR	2015	26	2					107	113		10.1097/MCA.0000000000000192		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB2JD	WOS:000349452300005		
J	Jia, HB; Hu, SN; Uemura, S; Park, SJ; Jang, Y; Prasad, A; Lee, S; Soeda, T; Abtahian, F; Vergallo, R; Tian, JW; Lee, H; Stone, PH; Yu, B; Jang, IK				Jia, Haibo; Hu, Sining; Uemura, Shiro; Park, Seung-Jung; Jang, Yangsoo; Prasad, Abhiram; Lee, Stephen; Soeda, Tsunenari; Abtahian, Farhad; Vergallo, Rocco; Tian, Jinwei; Lee, Hang; Stone, Peter H.; Yu, Bo; Jang, Ik-Kyung			Insights into the spatial distribution of lipid-rich plaques in relation to coronary artery bifurcations: an in-vivo optical coherence tomography study	CORONARY ARTERY DISEASE			English	Article						bifurcation; distribution; optical coherence tomography; vulnerable plaque	INTRAVASCULAR ULTRASOUND ANALYSIS; SHEAR-STRESS; ATHEROSCLEROTIC PLAQUES; VIRTUAL HISTOLOGY; RUPTURE; LESIONS; VULNERABILITY; CLASSIFICATION; LOCALIZATION; MORPHOLOGY	Objectives The aim of this study was to investigate the spatial location of vulnerable plaques at coronary artery bifurcations using frequency domain-optical coherence tomography. Background In-vivo data on geometric location of vulnerable plaques in relation to coronary bifurcation are limited. Materials and methods A total of 40 patients with left anterior descending artery bifurcation were studied. Plaque characteristics in five regions in relation to a side branch were compared: opposite flow divider (OFD); bifurcation site (BF); main branch side proximal (MBP); side branch side proximal (SBP); and flow divider (FD). Frequency domain-optical coherence tomography was used for plaque characterization. Results Seventy-two lipid-rich plaques and 15 thin-cap fibroatheroma (TCFA) were detected in 220 regions of 44 bifurcations. Overall, the main branch side had more vulnerable characteristics compared with the side branch side. The FD was rarely affected by lipid accumulation. The OFD showed the highest prevalence of lipid-rich plaques [47.7% (OFD) vs. 45.5% (MBP), 43.2% (BF), 18.2% (SBP), and 9.1% (FD), P < 0.0001] and TCFA [20.5% (OFD) vs. 6.8% (MBP), 6.8% (BF), 2.2% (SBP), and 0.0% (FD), P < 0.001] and the thinnest fibrous cap [88.7 +/- 43.7 mu m (OFD) vs. 123.5 +/- 62.7 mu m (MBP), 149.6 +/- 77.0 mu m (BF), 157.4 +/- 65.4 mu m (SBP), and 163.6 +/- 76.9 mu m (FD), P = 0.002] compared with other regions. Conclusion Lipid accumulation tends to develop in the zone opposite the side branch. TCFA was localized predominantly in the region OFD, whereas FD was rarely affected. Coron Artery Dis 26: 133-141 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Jia, Haibo; Hu, Sining; Tian, Jinwei; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin 150086, Peoples R China; [Jia, Haibo; Hu, Sining; Tian, Jinwei; Yu, Bo] Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Peoples R China; [Lee, Stephen] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Jia, Haibo; Hu, Sining; Soeda, Tsunenari; Abtahian, Farhad; Vergallo, Rocco; Tian, Jinwei; Jang, Ik-Kyung] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Stone, Peter H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA; [Uemura, Shiro] Nara Med Univ, Dept Med 1, Nara, Japan; [Park, Seung-Jung] Asan Med Ctr, Div Cardiol, Seoul, South Korea; [Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Prasad, Abhiram] Univ London, London, England	Yu, B (reprint author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Key Lab Myocardial Ischemia,Chinese Minist Educ, 246 Xuefu Rd, Harbin 150086, Peoples R China.	yubodr@163.com			LightLab Imaging/St Jude Medical; National Natural Science Foundation of China [81200076, 81300201, 81330033, 30871064]; Open Foundation of Key Laboratory of Myocardial Ischemia (Harbin Medical University); Chinese Ministry of Education [KF201205]; Enrico ed Enrica Sovena Foundation, Italy	This study was supported by grants from LightLab Imaging/St Jude Medical (I.-K.J.), National Natural Science Foundation of China (81200076/H.J., 81300201/J.T., 81330033/B.Y., 30871064/B.Y.), Open Foundation of Key Laboratory of Myocardial Ischemia (Harbin Medical University), Chinese Ministry of Education (KF201205/H.J.), Enrico ed Enrica Sovena Foundation, Italy (R.V.).	Kitabata H, 2010, AM J CARDIOL, V105, P1673, DOI 10.1016/j.amjcard.2010.01.346; MacNeill BD, 2004, J AM COLL CARDIOL, V44, P972, DOI 10.1016/j.jacc.2004.05.066; Medina A, 2006, REV ESP CARDIOL, V59, P183, DOI 10.1157/13084649; Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071; MYLER RK, 1992, J AM COLL CARDIOL, V19, P1641; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Wang JC, 2004, CIRCULATION, V110, P278, DOI 10.1161/01.CIR.0000135468.67850.F4; Di Vito L, 2014, CORONARY ARTERY DIS, V25, P172, DOI 10.1097/MCA.0000000000000072; Giannoglou GD, 2002, INT J CARDIOL, V86, P27, DOI 10.1016/S0167-5273(02)00188-2; Nakazawa G, 2010, J AM COLL CARDIOL, V55, P1679, DOI 10.1016/j.jacc.2010.01.021; Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P401, DOI 10.1038/ncpcardio0274; Lee SW, 2008, STROKE, V39, P2341, DOI 10.1161/STROKEAHA.107.510644; Prati F, 2012, EUR HEART J, V33, P2513, DOI 10.1093/eurheartj/ehs095; Papadopoulou SL, 2012, EUR HEART J-CARD IMG, V13, P635, DOI 10.1093/ehjci/jes083; Kimura BJ, 1996, J AM COLL CARDIOL, V27, P825, DOI 10.1016/0735-1097(95)00551-X; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONHA.105.590018; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Gonzalo N, 2009, JACC-CARDIOVASC IMAG, V2, P473, DOI 10.1016/j.jcmg.2008.11.016; Oviedo C, 2010, CIRC-CARDIOVASC INTE, V3, P105, DOI 10.1161/CIRCINTERVENTIONS.109.906016; Badak O, 2003, CORONARY ARTERY DIS, V14, P309, DOI 10.1097/01.mca.0000076511.29238.f1; GROTTUM P, 1983, ATHEROSCLEROSIS, V47, P55, DOI 10.1016/0021-9150(83)90071-0; Hong MK, 2005, J AM COLL CARDIOL, V46, P261, DOI 10.1016/j.jacc.2005.03.067; Hu SN, 2014, J AM COLL CARDIOL, V63, P1336, DOI 10.1016/j.jacc.2013.11.025; McDaniel MC, 2011, AM HEART J, V161, P508, DOI 10.1016/j.ahj.2010.11.005; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Soulis JV, 2006, CORONARY ARTERY DIS, V17, P351, DOI 10.1097/00019501-200606000-00005; Toggweiler S, 2010, ATHEROSCLEROSIS, V212, P524, DOI 10.1016/j.atherosclerosis.2010.06.045; von Birgelen C, 2001, J AM COLL CARDIOL, V37, P1864, DOI 10.1016/S0735-1097(01)01234-7	33	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	MAR	2015	26	2					133	141		10.1097/MCA.0000000000000188		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB2JD	WOS:000349452300009		
J	Won, KB; Chang, HJ; Niinuma, H; Sung, J; Shin, S; Cho, IJ; Shim, CY; Hong, GR; Kim, YJ; Choi, BW; Chung, N				Won, Ki-Bum; Chang, Hyuk-Jae; Niinuma, Hiroyuki; Sung, Jimin; Shin, Sanghoon; Cho, In-Jeong; Shim, Chi-Young; Hong, Geu-Ru; Kim, Young Jin; Choi, Byung-Wook; Chung, Namsik			Evaluation of the predictive value of coronary artery calcium score for obstructive coronary artery disease in asymptomatic Korean patients with type 2 diabetes mellitus	CORONARY ARTERY DISEASE			English	Article						coronary artery calcium score; coronary computed tomographic angiography; obstructive coronary plaque; type 2 diabetes mellitus	COMPUTED-TOMOGRAPHY; DIAGNOSTIC PERFORMANCE; MYOCARDIAL-ISCHEMIA; CARDIOVASCULAR RISK; PRACTICE GUIDELINES; HEART-ASSOCIATION; ANGIOGRAPHY; CALCIFICATION; INDIVIDUALS; PROGNOSIS	Background Compared with coronary computed tomographic angiography (CCTA), the coronary artery calcium score (CACS) may be limited in predicting adverse cardiovascular events in asymptomatic diabetic patients. Methods We evaluated the predictive value of CACS for obstructive coronary plaques (OCPs) assessed by CCTA in 328 consecutive asymptomatic patients with type 2 diabetes mellitus who had an estimated glomerular filtration rate greater than 60 ml/min/1.73 m(2). Results In total, 29 (9%) patients had OCPs: calcified or mixed OCPs and noncalcified OCPs were found in 26 (8%) and three (1%) patients, respectively. On the basis of a CACS of 0, 1-10, 11-100, and greater than 100, OCPs were found in 2, 5, 15, and 36% of patients, respectively. On receiver operating characteristic curve analysis, the optimal cutoff CACS for predicting OCPs was found to be 33, with 83% sensitivity and 81% specificity (area under the curve, 0.853; 95% confidence interval, 0.777-0.930; P < 0.001). Positive and negative predictive values of a CACS of 33 for OCPs were 30 and 98%, respectively. On multivariate logistic regression analysis, age [odds ratio (OR), 1.09], microalbuminuria (OR, 3.43), current smoking (OR, 3.93), and CACS greater than 33 (OR, 15.85) were found to be independently associated with an increased risk for OCPs (P < 0.05, respectively). The predictive significance of CACS greater than 33 for OCPs improved after considering the status of microalbuminuria and current smoking. Conclusion These findings suggest that CACS is an effective gatekeeper for evaluating obstructive coronary artery disease using CCTA in asymptomatic Korean patients with type 2 diabetes mellitus who have near-normal kidney function. Coron Artery Dis 26: 150-156 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Won, Ki-Bum; Chang, Hyuk-Jae; Shin, Sanghoon; Cho, In-Jeong; Shim, Chi-Young; Hong, Geu-Ru; Chung, Namsik] Yonsei Univ, Coll Med, Yonsei Cardiovasc Ctr, Div Cardiol, Seoul 120752, South Korea; [Kim, Young Jin; Choi, Byung-Wook] Yonsei Univ, Coll Med, Yonsei Cardiovasc Ctr, Div Radiol, Seoul 120752, South Korea; [Chang, Hyuk-Jae] Severance Biomed Sci Inst, Seoul, South Korea; [Sung, Jimin] CHA Univ, Grad Sch Hlth & Welf, Songnam, South Korea; [Won, Ki-Bum; Niinuma, Hiroyuki] St Lukes Int Hosp, Div Cardiol, Tokyo, Japan	Chang, HJ (reprint author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Ctr, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.	hjchang@yuhs.ac			Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012027176]	This research was supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (2012027176).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Nasir K, 2007, J AM COLL CARDIOL, V50, P953, DOI 10.1016/j.jacc.2007.03.066; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Grundy SM, 1999, CIRCULATION, V100, P1134; Rana JS, 2012, DIABETES CARE, V35, P1787, DOI 10.2337/dc11-2403; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIOBAHA.104.488916; Nakamura S, 2009, CLIN J AM SOC NEPHRO, V4, P1892, DOI 10.2215/CJN.04320709; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Park JY, 1997, DIABETES RES CLIN PR, V35, P49, DOI 10.1016/S0168-8227(96)01363-0; Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Levey AS, 2003, ANN INTERN MED, V139, P137; NESTO RW, 1988, ANN INTERN MED, V108, P170; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Bonow RO, 1996, AM J MED, V101, p4A17S; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Qu WC, 2003, DIABETES CARE, V26, P905, DOI 10.2337/diacare.26.3.905; Yamagami K, 2005, DIABETES OBES METAB, V7, P390, DOI 10.1111/j.1463-1326.2004.00408.x	24	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	MAR	2015	26	2					150	156		10.1097/MCA.0000000000000184		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB2JD	WOS:000349452300011		
J	Saito, S; Yanagisawa, R; Yoshikawa, K; Higuchi, Y; Koya, T; Yoshizawa, K; Tanaka, M; Sakashita, K; Kobayashi, T; Kurata, T; Hirabayashi, K; Nakazawa, Y; Shiohara, M; Yonemitsu, Y; Okamoto, M; Sugiyama, H; Koike, K; Shimodaira, S				Saito, Shoji; Yanagisawa, Ryu; Yoshikawa, Kentaro; Higuchi, Yumiko; Koya, Terutsugu; Yoshizawa, Kiyoshi; Tanaka, Miyuki; Sakashita, Kazuo; Kobayashi, Takashi; Kurata, Takashi; Hirabayashi, Koichi; Nakazawa, Yozo; Shiohara, Masaaki; Yonemitsu, Yoshikazu; Okamoto, Masato; Sugiyama, Haruo; Koike, Kenichi; Shimodaira, Shigetaka			Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1-specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature	CYTOTHERAPY			English	Article						dendritic cells; ELISPOT; HSCT; tetramer analysis; Wilms tumor 1	ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; WT1 PEPTIDE; IMMUNOTHERAPY; TRANSPLANTATION; LYMPHOCYTES; RESPONSES; TRIAL	A 15-year-old girl with acute lymphoblastic leukemia received allogeneic dendritic cell vaccination, pulsed with Wilms tumor 1 (WT1) peptide, after her third hematopoietic stem cell transplantation (HSCT). The vaccines were generated from the third HSCT donor, who was her younger sister, age 12 years. The patient received 14 vaccines and had no graft-versus-host disease or systemic adverse effect, aside from grade 2 skin reaction at the injection site. WT1-specific immune responses were detected after vaccination by both WT1-tetramer analysis and enzyme-linked immunosorbent spot assay. This strategy may be safe, tolerable and even feasible for patients with a relapse after HSCT.	[Saito, Shoji; Yanagisawa, Ryu; Yoshikawa, Kentaro; Higuchi, Yumiko; Koya, Terutsugu; Yoshizawa, Kiyoshi; Kobayashi, Takashi; Shimodaira, Shigetaka] Shinshu Univ Hosp, Ctr Adv Cell Therapy, Matsumoto, Nagano 3908621, Japan; [Saito, Shoji; Yanagisawa, Ryu; Yoshikawa, Kentaro; Tanaka, Miyuki; Sakashita, Kazuo; Kurata, Takashi; Hirabayashi, Koichi; Nakazawa, Yozo; Shiohara, Masaaki; Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Yonemitsu, Yoshikazu] Kyushu Univ, Grad Sch Pharmaceut Sci, R&D Lab Innovat Biotherapeut, Fukuoka 812, Japan; [Okamoto, Masato] Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan; [Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Osaka, Japan	Shimodaira, S (reprint author), Shinshu Univ Hosp, Ctr Adv Cell Therapy, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	shimodai@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24501330, 24791050]	We wish to thank nurse Kayo Horiuchi for taking care of the patients and harvesting the PBMCs from the HSCT donor. This clinical trial was supported by Management Expense Grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant number: 24501330 and 24791050).	Kimura Y, 2012, PANCREAS, V41, P195, DOI 10.1097/MPA.0b013e31822398c6; Kolb HJ, 2004, BLOOD, V103, P767, DOI 10.1182/blood-2003-02-0342; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Keilholz U, 2009, BLOOD, V113, P6541, DOI 10.1182/blood-2009-02-202598; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Spyridonidis A, 2012, LEUKEMIA, V26, P1211, DOI 10.1038/leu.2011.351; Tyler EM, 2013, BLOOD, V121, P308, DOI 10.1182/blood-2012-06-435040; Scheibenbogen C, 2002, BLOOD, V100, P2132, DOI 10.1182/blood-2002-01-0163; Kitawaki T, 2011, BRIT J HAEMATOL, V153, P796, DOI 10.1111/j.1365-2141.2010.08490.x; Rezvani K, 2007, BLOOD, V110, P1924, DOI 10.1182/blood-2007-03-076844; Fujii S, 2001, LEUKEMIA LYMPHOMA, V42, P357, DOI 10.3109/10428190109064592; Kitawaki T, 2008, AM J HEMATOL, V83, P315, DOI 10.1002/ajh.21127	13	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	MAR	2015	17	3					330	335		10.1016/j.jcyt.2014.10.003		6	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CB5FP	WOS:000349653200011		
J	Vastagh, C; Schwirtlich, M; Kwakowsky, A; Erdelyi, F; Margolis, FL; Yanagawa, Y; Katarova, Z; Szabo, G				Vastagh, Csaba; Schwirtlich, Marija; Kwakowsky, Andrea; Erdelyi, Ferenc; Margolis, Frank L.; Yanagawa, Yuchio; Katarova, Zoya; Szabo, Gabor			The Spatiotemporal Segregation of GAD Forms Defines Distinct GABA Signaling Functions in the Developing Mouse Olfactory System and Provides Novel Insights into the Origin and Migration of GnRH Neurons	DEVELOPMENTAL NEUROBIOLOGY			English	Article						GAD forms; gamma-aminobutyric acid; GnRH; olfactory development; cell migration	GONADOTROPIN-RELEASING-HORMONE; GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; IN-VITRO; AXOPHILIC MIGRATION; PROGENITOR CELLS; SECRETING NEURONS; MESSENGER-RNAS; MARKER PROTEIN; MICE DEFICIENT	Gamma-aminobutyric acid (GABA) has a dual role as an inhibitory neurotransmitter in the adult central nervous system (CNS) and as a signaling molecule exerting largely excitatory actions during development. The rate-limiting step of GABA synthesis is catalyzed by two glutamic acid decarboxylase isoforms GAD65 and GAD67 coexpressed in the GABAergic neurons of the CNS. Here we report that the two GADs show virtually nonoverlapping expression patterns consistent with distinct roles in the developing peripheral olfactory system. GAD65 is expressed exclusively in undifferentiated neuronal progenitors confined to the proliferative zones of the sensory vomeronasal and olfactory epithelia In contrast GAD67 is expressed in a subregion of the nonsensory epithelium/vomeronasal organ epithelium containing the putative Gonadotropin-releasing hormone (GnRH) progenitors and GnRH neurons migrating from this region through the frontonasal mesenchyme into the basal forebrain. Only GAD67+, but not GAD65+ cells accumulate detectable GABA. We further demonstrate that GAD67 and its embryonic splice variant embryonic GAD (EGAD) concomitant with GnRH are dynamically regulated during GnRH neuronal migration in vivo and in two immortalized cell lines representing migratory (GN11) and postmigratory (GT1-7) stage GnRH neurons, respectively. Analysis of GAD65/67 single and double knock-out embryos revealed that the two GADs play complementary (inhibitory) roles in GnRH migration ultimately modulating the speed and/or direction of GnRH migration. Our results also suggest that GAD65 and GAD67/EGAD characterized by distinct subcellular localization and kinetics have disparate functions during olfactory system development mediating proliferative and migratory responses putatively through specific subcellular GABA pools. (c) 2014 Wiley Periodicals, Inc. Develop Neurobiol 75: 249-270, 2015	[Vastagh, Csaba; Schwirtlich, Marija; Kwakowsky, Andrea; Erdelyi, Ferenc; Katarova, Zoya; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Div Med Gene Technol, Budapest, Hungary; [Vastagh, Csaba] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Schwirtlich, Marija] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Human Mol Genet, Belgrade, Serbia; [Kwakowsky, Andrea] Univ Otago, Otago Sch Med Sci, Ctr Neuroendocrinol, Dunedin, New Zealand; [Kwakowsky, Andrea] Univ Otago, Otago Sch Med Sci, Dept Physiol, Dunedin, New Zealand; [Margolis, Frank L.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 3718511, Japan; [Yanagawa, Yuchio] JST, CREST, Maebashi, Gumma 3718511, Japan	Szabo, G (reprint author), Hungarian Acad Sci, Inst Expt Med, Div Med Gene Technol, Budapest, Hungary.	katarova.zoja@koki.mta.hu; szabo.gabor@koki.mta.hu			Hungarian National Grant Agency (OTKA) [38098]; Ministry of Education and Science, Republic of Serbia [173051]; NIH [DC03112]	Contract grant sponsor: Hungarian National Grant Agency (OTKA); contract grant number: 38098 (to Z.K.).; Contract grant sponsor: Ministry of Education and Science, Republic of Serbia; contract grant number: 173051 (to M.S.).; Contract grant sponsor: NIH; contract grant number: DC03112 (to F.L.M.).	SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200; Wray S, 2010, J NEUROENDOCRINOL, V22, P743, DOI 10.1111/j.1365-2826.2010.02034.x; Condie BG, 1997, P NATL ACAD SCI USA, V94, P11451, DOI 10.1073/pnas.94.21.11451; Martin DL, 1998, PERSPECT DEV NEUROBI, V5, P119; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; GOTTLIEB DI, 1986, P NATL ACAD SCI USA, V83, P8808, DOI 10.1073/pnas.83.22.8808; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Lee K, 2010, ENDOCRINOLOGY, V151, P4428, DOI 10.1210/en.2010-0314; Kwakowsky A, 2007, DEV DYNAM, V236, P3532, DOI 10.1002/dvdy.21361; Ikeda K, 2007, DEV BIOL, V311, P53, DOI 10.1016/j.ydbio.2007.08.020; Sabado V, 2012, DEV BIOL, V362, P254, DOI 10.1016/j.ydbio.2011.12.016; Rawson NE, 2010, DEV DYNAM, V239, P1723, DOI 10.1002/dvdy.22315; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Lentini D, 2008, J NEUROCHEM, V104, P514, DOI 10.1111/j.1471-4159.2007.05005.x; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Errijgers V, 2007, GENES BRAIN BEHAV, V6, P552, DOI 10.1111/j.1601-183X.2006.00282.x; Han SK, 2002, ENDOCRINOLOGY, V143, P1459, DOI 10.1210/en.143.4.1459; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Carson C, 2006, DEV DYNAM, V235, P1678, DOI 10.1002/dvdy.20733; Varju P, 2001, CELL TISSUE RES, V305, P239, DOI 10.1007/s004410100356; Whitlock KE, 2005, TRENDS ENDOCRIN MET, V16, P145, DOI 10.1016/j.tem.2005.03.005; Tobet SA, 1996, ENDOCRINOLOGY, V137, P5415, DOI 10.1210/en.137.12.5415; Gamble JA, 2005, J NEUROSCI, V25, P3142, DOI 10.1523/JNEUROSCI.4759-04.2005; Fukushima T, 2009, J NEUROPHYSIOL, V102, P1459, DOI 10.1152/jn.91160.2008; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Cariboni A, 2007, TRENDS NEUROSCI, V30, P638, DOI 10.1016/j.tins.2007.09.002; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Fueshko SM, 1998, J NEUROSCI, V18, P2560; Cariboni A, 2011, HUM MOL GENET, V20, P336, DOI 10.1093/hmg/ddq468; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; Yamamoto T, 2004, DIABETOLOGIA, V47, P221, DOI 10.1007/s00125-003-1296-0; Katarova Z, 2000, J COMP NEUROL, V424, P607, DOI 10.1002/1096-9861(20000904)424:4<607::AID-CNE4>3.0.CO;2-C; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Schwarting GA, 2007, SEMIN REPROD MED, V25, P305, DOI 10.1055/s-2007-984736; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; Casoni F, 2012, J CELL SCI, V125, P5015, DOI 10.1242/jcs.101675; Ben-Ari Y, 2005, CURR OPIN NEUROL, V18, P141, DOI 10.1097/01.wco.0000162855.75391.6a; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Balmer CW, 2005, DEV DYNAM, V234, P464, DOI 10.1002/dvdy.20582; Barker JL, 1998, PERSPECT DEV NEUROBI, V5, P305; Beites CL, 2009, DEV NEUROBIOL, V7, P145; Bless EP, 2005, ENDOCRINOLOGY, V146, P463, DOI 10.1210/en.2004-0838; Bless EP, 2000, ENDOCRINOLOGY, V141, P1254, DOI 10.1210/en.141.3.1254; BOND RW, 1990, P NATL ACAD SCI USA, V87, P8771, DOI 10.1073/pnas.87.22.8771; BRINSTER RL, 1981, EXP CELL RES, V134, P291, DOI 10.1016/0014-4827(81)90428-6; Cariboni A, 2012, DEVELOPMENT, V139, P3326, DOI 10.1242/dev.079418; COSTANTINI F, 1981, NATURE, V294, P92, DOI 10.1038/294092a0; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Forni PE, 2012, MOL NEUROBIOL, V46, P349, DOI 10.1007/s12035-012-8286-5; FUESHKO S, 1994, DEV BIOL, V166, P331, DOI 10.1006/dbio.1994.1319; Fueshko SM, 1998, ENDOCRINOLOGY, V139, P2734, DOI 10.1210/en.139.6.2734; Fujioka H, 2007, J REPROD DEVELOP, V53, P323, DOI 10.1262/jrd.18103; Hablitz JJ, 2009, NEUROSCIENTIST, V15, P218, DOI 10.1177/1073858408326431; Hagiwara N, 2003, DEV BIOL, V254, P93, DOI 10.1016/S0012-1606(02)00030-1; Heger S, 2003, ENDOCRINOLOGY, V144, P2566, DOI 10.1210/en.2002-221107; Hutchins BI, 2013, J NEUROSCI, V33, P11361, DOI 10.1523/JNEUROSCI.3758-12.2013; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Katarova Z, 1998, EUR J NEUROSCI, V10, P989, DOI 10.1046/j.1460-9568.1998.00109.x; KATAROVA Z, 1990, EUR J NEUROSCI, V2, P190, DOI 10.1111/j.1460-9568.1990.tb00412.x; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; Kottler Marie-Laure, 2004, Journal de la Societe de Biologie, V198, P80; Kubo K, 2009, J PHARMACOL EXP THER, V329, P592, DOI 10.1124/jpet.109.151456; Lee JM, 2008, J NEUROENDOCRINOL, V20, P93, DOI 10.1111/j.1365-2826.2007.01623.x; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Maddox Dennis M., 2001, BMC Developmental Biology, V1, P1, DOI 10.1186/1471-213X-1-1; Maggi R, 2000, ENDOCRINOLOGY, V141, P2105, DOI 10.1210/en.141.6.2105; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; Martin DL, 2000, NEUROCHEM INT, V37, P111, DOI 10.1016/S0197-0186(00)00014-0; Merlo GR, 2007, J MOL HISTOL, V38, P347, DOI 10.1007/s10735-007-9109-2; Messina Andrea, 2013, Front Endocrinol (Lausanne), V4, P133, DOI 10.3389/fendo.2013.00133; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Mulrenin EM, 1999, ENDOCRINOLOGY, V140, P422, DOI 10.1210/en.140.1.422; Nguyen LD, 2003, AEROSPACE ENG, V23, P23; Nowak A, 2011, J CHEM NEUROANAT, V42, P30, DOI 10.1016/j.jchemneu.2011.02.003; OHLSSON B, 2010, BMC GASTROENTEROL, V10, P10; Romanelli RG, 2004, J BIOL CHEM, V279, P117, DOI 10.1074/jbc.M307955200; Rosenbaum JN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-6; Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; SZABO G, 1994, MOL CELL BIOL, V14, P7535; Tobet SA, 2006, ENDOCRINOLOGY, V147, P1159, DOI 10.1210/en.2005-1275; Treloar HB, 2010, NEUROBIOLOGY OLFACTI; Varja P, 2002, J NEUROCHEM, V80, P605, DOI 10.1046/j.0022-3042.2001.00733.x; Wray S, 1996, DEV BIOL, V180, P631, DOI 10.1006/dbio.1996.0334; Yoshida K, 1999, J NEUROSCI, V19, P794	92	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	MAR	2015	75	3					249	270		10.1002/dneu.22222		22	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CB4QL	WOS:000349612800003		
J	Stringer, F; DeJongh, J; Enya, K; Koumura, E; Danhof, M; Kaku, K				Stringer, Frances; DeJongh, Joost; Enya, Kazuaki; Koumura, Emiko; Danhof, Meindert; Kaku, Kohei			Evaluation of the Long-Term Durability and Glycemic Control of Fasting Plasma Glucose and Glycosylated Hemoglobin for Pioglitazone in Japanese Patients with Type 2 Diabetes	DIABETES TECHNOLOGY & THERAPEUTICS			English	Article							MODEL; DISEASE; PATHOPHYSIOLOGY; MELLITUS; AGONIST; DRUG; PHARMACOMETRICS; COMPLICATIONS; HYPERGLYCEMIA; METAANALYSIS	Background: This study applied a pharmacodynamic model-based approach to evaluate the long-term durability and glycemic control of pioglitazone in comparison with other oral glucose-lowering drugs in Japanese type 2 diabetes mellitus (T2DM) patients. Subjects and Methods: Japanese T2DM patients were enrolled in a prospective, randomized, open-label, blinded-end point study and received pioglitazone with or without other oral glucose-lowering drugs (excluding another thiazolidinedione [TZD]) (n=293) or oral glucose-lowering drugs excluding TZD (n=294). Treatment was adjusted to achieve glycosylated hemoglobin (HbA1c) <6.9%, and samples for fasting plasma glucose (FPG) and HbA1c were collected over 2.5-4 years. A simultaneous cascading indirect response model structure was applied to describe the time course of FPG and HbA1c. HbA1c levels were described using both an FPG-dependent and an FPG-independent function. To account for titration, drug effects for both treatment groups were implemented using a time-dependent E-max model. Results: Pioglitazone was superior in both time to maximum effect and the magnitude of reduction achieved in FPG and HbA1c. A greater reduction in median FPG (-21 mg/dL vs. -9 mg/dL) was observed with pioglitazone (P<0.05). Maximum drug effect for FPG was predicted to occur earlier (11 months) for pioglitazone than for the control group (14 months). The simulated additional reduction in FPG and HbA1c achieved with pioglitazone was predicted to be maintained beyond the currently observed study duration. Conclusions: Pioglitazone was found to result in improved glycemic control and durability compared with control treatment. This model-based approach enabled the quantification of differences in FPG and HbA1c for both treatment groups and simulation to evaluate longer-term durability on FPG and HbA1c.	[Stringer, Frances] Model Answers Pty Ltd, Brisbane, Qld, Australia; [DeJongh, Joost; Danhof, Meindert] LAP&P Consultants BV, Leiden, Netherlands; [DeJongh, Joost; Danhof, Meindert] Leiden Acad Ctr Drug Res, Div Pharmacol, Leiden, Netherlands; [Enya, Kazuaki; Koumura, Emiko] Takeda Pharmaceut Co, Osaka 5408645, Japan; [Kaku, Kohei] Kawasaki Med Univ, Okayama, Japan	Enya, K (reprint author), Takeda Pharmaceut Co, Chuo Ku, 1-1,Doshomachi 4 Chome, Osaka 5408645, Japan.	kazuaki.enya@takeda.com			AstraZeneca; Boehringer-Ingelheim; Chugai; Daiichi-Sankyo; Dainippon-Sumitomo; Kowa; MSD; Novartis; Novo Nordisk; Sanofi -Aventis; Sanwa; Taisho; Takeda; Tanabe-Mitsubishi	F.S. was an employee of Takeda Pharmaceutical Company during the conduct of the analysis. K.E. and E.K. are employees of Takeda Pharmaceutical Company. J.D. and M.D. are employees of LAP&P Consultants BV and of Leiden-Academic Centre for Drug Research. K.K. has received research funding, consultancy fees, or lecture fees from AstraZeneca, Boehringer-Ingelheim, Chugai, Daiichi-Sankyo, Dainippon-Sumitomo, Kowa, MSD, Novartis, Novo Nordisk, Sanofi -Aventis, Sanwa, Taisho, Takeda, and Tanabe-Mitsubishi.	Wallace TM, 2002, DIABETIC MED, V19, P465; Charbonnel B, 2005, DIABETOLOGIA, V48, P1093, DOI 10.1007/s00125-005-1751-1; Landersdorfer CB, 2008, CLIN PHARMACOKINET, V47, P417, DOI 10.2165/00003088-200847070-00001; Moller JB, 2014, DIABETES CARE, V37, P796, DOI 10.2337/dc13-0598; Petersson KJF, 2009, PHARM RES-DORD, V26, P2174, DOI 10.1007/s11095-009-9931-1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Post TM, 2008, J PHARMACOKINET PHAR, V35, P185, DOI 10.1007/s10928-007-9081-1; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; de Winter W, 2006, J PHARMACOKINET PHAR, V33, P313, DOI 10.1007/s10928-006-9008-2; Post TM, 2005, PHARM RES, V22, P1038, DOI 10.1007/s11095-005-5641-5; Davidson JA, 2009, DIABETES CARE, V32, pS331, DOI 10.2337/dc09-S333; Wahlby U, 2001, J PHARMACOKINET PHAR, V28, P231, DOI 10.1023/A:1011527125570; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Savic RM, 2009, AAPS J, V11, P558, DOI 10.1208/s12248-009-9133-0; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Peter R, 2009, DIABETIC MED, V26, P974, DOI 10.1111/j.1464-5491.2009.02809.x; Chen J, 2008, DIABETES OBES METAB, V10, P33, DOI 10.1111/j.1463-1326.2008.00885.x; DeFronzo RA, 2013, DIABETES CARE, V36, pS127, DOI 10.2337/dcS13-2011; Farmer AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e486; Hamren B, 2008, CLIN PHARMACOL THER, V84, P228, DOI 10.1038/clpt.2008.2; Hanefeld M, 2006, CURR MED RES OPIN, V22, P1211, DOI 10.1185/030079906X112598; Kaku K, 2009, CURR MED RES OPIN, V25, P2925, DOI 10.1185/03007990903328124; Kaku K, 2010, JMAJ, V53, P41; Lledo-Garcia R, 2013, J PHARMACOKINET PHAR, V40, P129, DOI 10.1007/s10928-012-9289-6; Manolis E, 2011, CLIN PHARMACOKINET, V50, P625, DOI 10.2165/11594340-000000000-00000; Noda M, 2010, ENDOCR J, V57, P629; Ozmen S, 2006, DIABETIC MED, V23, P1151, DOI 10.1111/j.1464-5491.2006.01927.x; Rohatagi S, 2008, J CLIN PHARMACOL, V48, P1420, DOI 10.1177/0091270008323260; Samtani MN, 2010, BIOPHARM DRUG DISPOS, V31, P162, DOI 10.1002/bdd.700; Stringer F, 2014, J CLIN PHARMACOL, V54, P453, DOI 10.1002/jcph.227; Wang Y, 2008, J CLIN PHARMACOL, V48, P146, DOI 10.1177/0091270007311111; Wilkins JJ, 2014, J CLIN PHARMACOL, V54, P267, DOI 10.1002/jcph.192; Yamasaki Y, 2010, J ATHEROSCLER THROMB, V17, P1132	36	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	MAR 1	2015	17	3					215	223		10.1089/dia.2014.0222		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CB9JT	WOS:000349948600011		
J	Ikehara, S; Tabak, AG; Akbaraly, TN; Hulman, A; Kivimaki, M; Forouhi, NG; Iso, H; Brunner, EJ				Ikehara, Satoyo; Tabak, Adam G.; Akbaraly, Tasnime N.; Hulman, Adam; Kivimaeki, Mika; Forouhi, Nita G.; Iso, Hiroyasu; Brunner, Eric J.			Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study	DIABETOLOGIA			English	Article						Cohort study; Ethnicity; Fasting glucose; Fasting insulin; Glycaemic trajectory; Insulin resistance; Insulin secretion; Insulin sensitivity; Post-load glucose; South Asian	BODY-FAT DISTRIBUTION; RISK-FACTORS; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; METABOLIC SYNDROME; ETHNIC-DIFFERENCES; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; SECRETION	South Asian individuals have an increased prevalence of type 2 diabetes, but little is known about the development of glycaemic traits in this ethnic group. We compared age-related changes in glycaemic traits between non-diabetic South Asian and white participants. In a prospective British occupational cohort with 5-yearly clinical examinations (n = 230/5,749 South Asian/white participants, age 39-79 years at baseline), age-related trajectories of fasting glucose (FG) and 2 h post-load glucose (PLG), log-transformed fasting insulin (FINS) and 2 h post-load insulin (PLINS), HOMA insulin sensitivity (HOMA2-%S) and HOMA insulin secretion (HOMA2-%B) were fitted for South Asian and white individuals who remained free of diabetes between 1991 and 2009. In sex-adjusted multilevel models, FG was stable in white participants but increased with age in South Asians (0.12 [SE = 0.04] mmol/l per decade). PLG, FINS and PLINS levels were lower among white participants (by 0.271 [SE = 0.092] mmol/l, 0.306 [SE = 0.046] log pmol/l, 0.707 [SE = 0.059] log pmol/l at age 50, respectively) compared with South Asians, although their age-related trajectories were parallel. HOMA2-%S was higher (0.226 [SE = 0.038] at age 50) and HOMA2-%B lower (by 0.189 [SE = 0.026] at age 50) among white than South Asian participants. The age-related decline in HOMA2-%S was similar in these groups, but the age-related increase in HOMA2-%B was greater in white participants (0.04 [SE = 0.02] per decade). This difference was explained by obesity, lifestyle and social status. Findings from a diabetes-free population suggest an inadequate pancreatic beta cell reserve in South Asians, as a significantly steeper age-related increase in FG was observed in this ethnic group compared with white individuals.	[Ikehara, Satoyo; Tabak, Adam G.; Akbaraly, Tasnime N.; Kivimaeki, Mika; Brunner, Eric J.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Ikehara, Satoyo; Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, H-1085 Budapest, Hungary; [Akbaraly, Tasnime N.] Univ Montpellier 2, INSERM, U1061, Montpellier, France; [Hulman, Adam] Univ Szeged, Dept Med Phys & Med Informat, Szeged, Hungary; [Forouhi, Nita G.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	Tabak, AG (reprint author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	a.tabak@ucl.ac.uk		Iso, Hiroyasu/0000-0002-9241-7289			Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; Barnett AH, 2006, DIABETOLOGIA, V49, P2234, DOI 10.1007/s00125-006-0325-1; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Whitty CJM, 1999, ATHEROSCLEROSIS, V142, P279, DOI 10.1016/S0021-9150(98)00239-1; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Garduno-Diaz SD, 2012, DIABETES-METAB RES, V28, P6, DOI 10.1002/dmrr.1219; Fischbacher CM, 2004, J PUBLIC HEALTH, V26, P250, DOI 10.1093/pubmed/fdh158; Mohan V, 2005, METABOLISM, V54, P476, DOI 10.1016/j.metabol.2004.10.016; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Forouhi NG, 2001, INT J OBESITY, V25, P1327, DOI 10.1038/sj.ijo.0801723; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Tillin T, 2013, DIABETES CARE, V36, P383, DOI 10.2337/dc12-0544; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Williams ED, 2011, J EPIDEMIOL COMMUN H, V65, P517, DOI 10.1136/jech.2009.102509; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Witte DR, 2010, DIABETIC MED, V27, P46, DOI 10.1111/j.1464-5491.2009.02891.x; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Goff LM, 2013, DIABETES VASC DIS RE, V10, P315, DOI 10.1177/1479164112467545; Health and Social Care Information Centre, 2005, HLTH SURV ENGL 2004, P1; Ning F, 2010, DIABETES-METAB RES, V26, P245, DOI 10.1002/dmrr.1078; Stringhini S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5452; Talmud PJ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4838; Whincup PH, 2005, DIABETIC MED, V22, P1275, DOI 10.1111/j.1464-5491.2005.01587.x; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Zaman MJS, 2011, J PUBLIC HEALTH-UK, V33, P430, DOI 10.1093/pubmed/fdq093	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	MAR	2015	58	3					534	542		10.1007/s00125-014-3448-9		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CA9LD	WOS:000349244100014		
J	Nishimura, W; Takahashi, S; Yasuda, K				Nishimura, Wataru; Takahashi, Satoru; Yasuda, Kazuki			MafA is critical for maintenance of the mature beta cell phenotype in mice	DIABETOLOGIA			English	Article						Beta cells; Cell plasticity; Dedifferentiation; Lineage tracing; MafA	TRANSCRIPTION FACTOR; ALPHA-CELL; PANCREATIC ALPHA; IN-VIVO; EXPRESSION; DEDIFFERENTIATION; DIFFERENTIATION; MECHANISM; IDENTITY; TRANSPLANTATION	The plasticity of adult somatic cells allows for their dedifferentiation or conversion to different cell types, although the relevance of this to disease remains elusive. Perturbation of beta cell identity leading to dedifferentiation may be implicated in the compromised functions of beta cells in diabetes, which is a current topic of islet research. This study aims to investigate whether or not v-Maf musculoaponeurotic fibrosarcoma oncogene family, protein A (MafA), a mature beta cell marker, is involved in maintaining mature beta cell phenotypes. The fate and gene expression of beta cells were analysed in Mafa knockout (KO) mice and mouse models of diabetes in which the expression of MafA was reduced in the majority of beta cells. Loss of MafA reduced the beta to alpha cell ratio in pancreatic islets without elevating blood glucose to diabetic levels. Lineage tracing analyses showed reduced/lost expression of insulin in most beta cells, with a minority of the former beta cells converted to glucagon-expressing cells in Mafa KO mice. The upregulation of genes that are normally repressed in mature beta cells or transcription factors that are transiently expressed in endocrine progenitors was identified in Mafa KO islets as a hallmark of dedifferentiation. The compromised beta cells in db/db and multiple low-dose streptozotocin mice underwent similar dedifferentiation with expression of Mafb, which is expressed in immature beta cells. The maturation factor MafA is critical for the homeostasis of mature beta cells and regulates cell plasticity. The loss of MafA in beta cells leads to a deeper loss of cell identity, which is implicated in diabetes pathology.	[Nishimura, Wataru; Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Metab Disorders,Shinjuku Ku, Tokyo 1628655, Japan; [Nishimura, Wataru] Jichi Med Univ, Div Anat Bioimaging & Neurocell Sci, Shimotsuke, Tochigi, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan	Nishimura, W (reprint author), Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Metab Disorders,Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	wnishimura@jichi.ac.jp; kyasuda@ri.ncgm.go.jp		Nishimura, Wataru/0000-0002-8068-1277			Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Nutt SL, 1999, NATURE, V401, P556; Pullen TJ, 2013, DIABETES OBES METAB, V15, P503, DOI 10.1111/dom.12029; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Laybutt DR, 2007, DIABETOLOGIA, V50, P2117, DOI 10.1007/s00125-007-0749-2; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Vicente-Duenas C, 2012, EMBO J, V31, P3704, DOI 10.1038/emboj.2012.227; Butler AE, 2012, DIABETOLOGIA, V55, P2985, DOI 10.1007/s00125-012-2666-2; Eto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104184; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Landsman L, 2011, P NATL ACAD SCI USA, V108, P17010, DOI 10.1073/pnas.1105404108; NERI F, 2013, CELL, V0026; Nishimura W, 2013, ENDOCRINOLOGY, V154, P4388; Shirato Y, 2006, DEVELOPMENT, V133, P343, DOI 10.1242/dev.02193	40	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	MAR	2015	58	3					566	574		10.1007/s00125-014-3464-9		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CA9LD	WOS:000349244100018		
J	Erami, MH; Miyajima, M; Kaneko, S; Toshima, T; Kishi, S				Erami, Mohammad Hossein; Miyajima, Masakatsu; Kaneko, Shogo; Toshima, Toshio; Kishi, Shozo			Pipe-soil interaction for segmented buried pipelines subjected to dip faults	EARTHQUAKE ENGINEERING & STRUCTURAL DYNAMICS			English	Article						pipe-soil interaction; dip fault; experimental test; FEM analysis; segmented buried pipeline; ductile iron pipe	MOVEMENT; DESIGN	This paper describes an investigation of pipe-soil interaction equations suggested by currently used pipeline seismic design codes and the applicability of these equations to segmented pipelines. The results of computer-aided analyses were compared to results obtained in full-scale experiments on a segmented ductile iron pipeline 93mm in diameter and 15m in length. The pipeline was installed 600mm below the ground surface in a sandy soil compacted to two different subgrade reaction values. The type of fault considered was a reverse fault with an intersection angle of 60 degrees with the pipeline, and the fault movement was a total of 350mm in three same steps in the fault trace direction. The findings of this study demonstrate the necessity of considering the nature of soil behavior in pipe-soil interaction equations and the effects of connection joints on the integrated response of pipelines to fault-induced ground deformations. A new combination of equations constituting a direction-wise selection from among the equations proposed by currently used guidelines is introduced as a new series to describe pipe-soil interaction for segmented pipelines and is verified using the results of full-scale experiments. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Erami, Mohammad Hossein; Miyajima, Masakatsu] Kanazawa Univ, Earthquake Engn Dept, Kanazawa, Ishikawa 9201192, Japan; [Kaneko, Shogo; Toshima, Toshio; Kishi, Shozo] Kubota Co, Ductile Iron Pipe R&D Dept, Amagasaki, Hyogo 6600095, Japan	Erami, MH (reprint author), Kanazawa Univ, Earthquake Engn Dept, Kanazawa, Ishikawa 9201192, Japan.	m_h_erami@yahoo.com					KENNEDY RP, 1977, TRANSPORT ENG-J ASCE, V103, P617; Abdoun TH, 2009, SOIL DYN EARTHQ ENG, V29, P415, DOI 10.1016/j.soildyn.2008.04.006; [Anonymous], 2007, DYNA2E US MAN VERS 7; [Anonymous], 2007, GUID SEISM DES BUR P; [Anonymous], 2004, SEISM DES GUID LOW P; [Anonymous], 2001, A1215 JIS; [Anonymous], 2005, SEISM GUID WAT PIP; Karamitros DK, 2007, SOIL DYN EARTHQ ENG, V27, P200, DOI 10.1016/j.solidyn.2006.08.001; Takada S, 2001, EARTHQUAKE ENG STRUC, V30, P1243, DOI 10.1002/eqe.62; [Anonymous], 2010, DES MAN JOINTS DUCT; WANG LRL, 1985, EARTHQUAKE ENG STRUC, V13, P75, DOI 10.1002/eqe.4290130109; ASCE, 1984, GUID SEISM DES OIL G; Bowless JE, 1975, FDN ANAL DESIGN; Dashs SR, 2008, J STRUCT ENG, V34, P349; Eramis MH, 2012, P ASCE PIP C US; Eramis MH, 2012, J SE EE JSCE, V68, P781, DOI [10.2208/jscejseee.68.I_781, DOI 10.2208/JSCEJSEEE.68.I_781]; Eramis MH, 2011, P 6 INT C SEISM EART; Ivanovs R, 2003, ANAL JOINTED PIPELIN, P203; Ivanovs R, 2003, J SE EE JSCE, V27, P1; JIS: Japanese Industrial Standard, 2000, A1204 JIS; Kuwatas Y, 2007, J SEISMOLOGY EARTHQU, V8, P195; Newmark N. M., 1975, P US NAT C EARTHQ EN, P416; O'Rourke M. J., 1999, RESPONSE BURIED PIPE; Trifonov OV, 2010, SOIL DYN EARTHQ ENG, V30, P1298, DOI 10.1016/j.soildyn.2010.06.002	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0098-8847	1096-9845		EARTHQ ENG STRUCT D	Earthq. Eng. Struct. Dyn.	MAR	2015	44	3					403	417		10.1002/eqe.2476		15	Engineering, Civil; Engineering, Geological	Engineering	CB0JZ	WOS:000349313300005		
J	Hirayama, H; So, T; Kasuya, E				Hirayama, Hiroyuki; So, Takayuki; Kasuya, Eiiti			Presence of conspecifics triggers host searching behavior in an egg parasitoid wasp	ENTOMOLOGIA EXPERIMENTALIS ET APPLICATA			English	Article						foraging strategy; solitary parasitoid; water strider; oviposition site selection; Tiphodytes gerriphagus; Hymenoptera; Scelionidae	TIPHODYTES-GERRIPHAGUS HYMENOPTERA; ADAPTIVE SUPERPARASITISM; SOLITARY PARASITOIDS; MARCHAL HYMENOPTERA; VENTURIA-CANESCENS; TIME ALLOCATION; MATING STATUS; PATCH TIME; HETEROPTERA; SCELIONIDAE	Parasitoids and predators compete for host or prey species. The efficiency of obtaining prey or host items is reduced by intraspecific competition. As the optimal search behavior depends on the intensity of competition, it is important for the parasitoid or predator to obtain information on this intensity. Previous studies have shown that parasitoids can obtain information regarding competition from encounters with already parasitized hosts. They then change their host searching behavior accordingly. However, whether parasitoids obtain the information directly from observing the presence of conspecifics remains unclear. We used Tiphodytes gerriphagus (Marchal) (Hymenoptera: Scelionidae), the solitary egg parasitoid of water striders, for testing the effect of density of conspecifics on host searching behavior. Females of T.gerriphagus dive into the water to search for hosts and sometimes they dive without hosts present. Thus, we investigated whether T.gerriphagus changed underwater activities in response to the density of conspecifics in the absence of hosts. Four densities (1, 2, 4, and 8 female T.gerriphagus) were investigated. Females in competitive situations (groups of 2, 4, and 8 females) displayed host searching behavior, but the solitary females did not. This indicates that the presence of conspecifics triggers host searching behavior and that T.gerriphagus femalesobtain information on competition directly from conspecifics and use it for modifying their behavior.	[Hirayama, Hiroyuki; So, Takayuki; Kasuya, Eiiti] Kyushu Univ, Fac Sci, Dept Biol, Lab Ecol Sci,Higashi Ku, Fukuoka 8128581, Japan	Hirayama, H (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Lab Ecol Sci,Higashi Ku, Hakozaki 6-1-10, Fukuoka 8128581, Japan.	hirohirayama@kyudai.jp			Japan Society for the Promotion of Science [22370010]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9];  [25650149]	We express our gratitude to all our colleagues at the Laboratory of Ecology, Kyushu University, for their help and encouragement. We also thank Chris Wood for editing the manuscript. This work was supported in part by Grant-in-Aid for Challenging Exploratory Research (No. 25650149), by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 22370010), and by the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan.	Amano H, 2008, ECOL ENTOMOL, V33, P560, DOI 10.1111/j.1365-2311.2008.00988.x; TAYLOR AD, 1988, AM NAT, V132, P417, DOI 10.1086/284861; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Brown MJF, 2000, BEHAV ECOL SOCIOBIOL, V47, P195, DOI 10.1007/s002650050011; Bernstein C, 1996, J ANIM ECOL, V65, P211, DOI 10.2307/5724; Castelo MK, 2003, J INSECT BEHAV, V16, P307, DOI 10.1023/A:1023928204793; Fauvergue X, 2008, OECOLOGIA, V156, P913, DOI 10.1007/s00442-008-1037-7; GIRALDEAU LA, 1994, BEHAV ECOL SOCIOBIOL, V34, P251, DOI 10.1007/BF00183475; Godfray H.C.J., 1994, PARASITOIDS BEHAV EV; Goubault M, 2005, BEHAV ECOL, V16, P693, DOI 10.1093/beheco/ari043; HEMERIK L, 1993, J ANIM ECOL, V62, P33, DOI 10.2307/5480; HENRIQUEZ NP, 1993, J INSECT BEHAV, V6, P455, DOI 10.1007/BF01049525; Hirayama H, 2009, ANIM BEHAV, V78, P935, DOI 10.1016/j.anbehav.2009.07.019; Hoffmeister TS, 2000, ETHOLOGY, V106, P145, DOI 10.1046/j.1439-0310.2000.00503.x; Holm G, 1979, SCANDINAVIAN J STAT, V6, P65; JAEGER RG, 1983, ANIM BEHAV, V31, P191, DOI 10.1016/S0003-3472(83)80188-2; Kohmura H, 2015, ETHOLOGY, V121, P168, DOI 10.1111/eth.12326; MICHAUD JP, 1994, CAN J ZOOL, V72, P1597, DOI 10.1139/z94-212; NUMMELIN M, 1988, ANN ZOOL FENN, V25, P299; R Core Team, 2013, R LANG ENV STAT COMP; Sousa JM, 2000, ANN ENTOMOL SOC AM, V93, P548, DOI 10.1603/0013-8746(2000)093[0548:EOMSAP]2.0.CO;2; Sousa JM, 2001, ANN ENTOMOL SOC AM, V94, P681, DOI 10.1603/0013-8746(2001)094[0681:HAAPBT]2.0.CO;2; SPENCE JR, 1986, CAN J ZOOL, V64, P2728, DOI 10.1139/z86-397; VANSALPHEN JJ, 1990, ANNU REV ENTOMOL, V35, P59; VISSER ME, 1990, BEHAVIOUR, V114, P21, DOI 10.1163/156853990X00031; VISSER ME, 1992, J ANIM ECOL, V61, P93, DOI 10.2307/5512; YDENBERG RC, 1986, ANIM BEHAV, V34, P1041, DOI 10.1016/S0003-3472(86)80163-4	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-8703	1570-7458		ENTOMOL EXP APPL	Entomol. Exp. Appl.	MAR	2015	154	3					222	227		10.1111/eea.12278		6	Entomology	Entomology	CB4VG	WOS:000349625800006		
J	Chung, Y; Lim, YH; Honda, Y; Guo, YLL; Hashizume, M; Bell, ML; Chen, BY; Kim, H				Chung, Yeonseung; Lim, Youn-Hee; Honda, Yasushi; Guo, Yue-Liang Leon; Hashizume, Masahiro; Bell, Michelle L.; Chen, Bing-Yu; Kim, Ho			Mortality Related to Extreme Temperature for 15 Cities in Northeast Asia	EPIDEMIOLOGY			English	Article							HEAT-RELATED MORTALITY; 9 FRENCH CITIES; UNITED-STATES; TIME-SERIES; AIR-POLLUTION; US CITIES; ASSOCIATIONS; IMPACT; MODELS; OZONE	Background: Multisite time-series studies for temperature-related mortality have been conducted mainly in the United States and Europe, but are lacking in Asia. This multisite time-series study examined mortality related to extreme temperatures (both cold and hot) in Northeast Asia, focusing on 15 cities of 3 high-income countries. Methods: This study includes 3 cities in Taiwan for 1994-2007, 6 cities in Korea for 1992-2010, and 6 cities in Japan for 1972-2009. We used 2-stage Bayesian hierarchical Poisson semiparametric regression to model the nonlinear relationship between temperature and mortality, providing city-specific and countrywide estimates for cold and heat effects. Various exposure time frames, age groups, and causes of death were considered. Results: Cold effects had longer time lags (5-11 days) than heat effects, which were immediate (1-3 days). Cold effects were larger for cities in Taiwan, whereas heat effects were larger for cities in Korea and Japan. Patterns of increasing effects with age were observed in both cold and heat effects. Both cold and heat effects were larger for cardiorespiratory mortality than for other causes of death. Several city characteristics related to weather or air pollution were associated with both cold and heat effects. Conclusions: Mortality increased with either cold or hot temperature in urban populations of high-income countries in Northeast Asia, with spatial variations of effects among cities and countries. Findings suggest that climate factors are major contributors to the spatial heterogeneity of effects in this region, although further research is merited to identify other factors as determinants of variability.	[Chung, Yeonseung] Korea Adv Inst Sci & Technol, Dept Math Sci, Taejon 305701, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul 151742, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Coll Med, Environm Hlth Ctr, Seoul 151742, South Korea; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Guo, Yue-Liang Leon; Chen, Bing-Yu] Natl Taiwan Univ, Taipei 10764, Taiwan; [Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan; [Bell, Michelle L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT USA; [Kim, Ho] Seoul Natl Univ, Dept Biostat & Epidemiol, Grad Sch Publ Hlth, Seoul 151742, South Korea; [Kim, Ho] Seoul Natl Univ, Inst Hlth & Environm, Seoul 151742, South Korea	Kim, H (reprint author), Seoul Natl Univ, Dept Biostat & Epidemiol, Grad Sch Publ Hlth, 1 Kwanak Ro, Seoul 151742, South Korea.	hokim@snu.ac.kr	Chung, Yeonseung/C-1844-2011; 	GUO, Yue Leon/0000-0002-8530-4809	International Research & Development Program [2012K1A3A1A12054839]; Global Research Laboratory Program [K21004000001-10A0500-00710]; Young Investigator Research Fund [20110013111]; Women Scientist Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology of Korea [2012R1A1A3005549]	Supported by the International Research & Development Program (2012K1A3A1A12054839), the Global Research Laboratory Program (K21004000001-10A0500-00710), the Young Investigator Research Fund (20110013111), and the Women Scientist Research Program (2012R1A1A3005549) of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea.	O'Neill MS, 2005, INT J BIOMETEOROL, V50, P121, DOI 10.1007/s00484-005-0269-z; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Chung JY, 2009, SCI TOTAL ENVIRON, V408, P390, DOI 10.1016/j.scitotenv.2009.09.009; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Lin YK, 2011, ENVIRON RES, V111, P1156, DOI 10.1016/j.envres.2011.06.008; Aylin P, 2001, INT J EPIDEMIOL, V30, P1100, DOI 10.1093/ije/30.5.1100; Reid CE, 2012, ENVIRON HEALTH PERSP, V120, P1627, DOI 10.1289/ehp.1205251; Barnett AG, 2007, EPIDEMIOLOGY, V18, P369, DOI 10.1097/01.ede.0000257515.34445.a0; Ha J, 2013, INT J BIOMETEOROL, V57, P535, DOI 10.1007/s00484-012-0580-4; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Buckley JP, 2014, EPIDEMIOLOGY, V25, P242, DOI 10.1097/EDE.0000000000000051; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Everson PJ, 2000, J ROY STAT SOC B, V62, P399, DOI 10.1111/1467-9868.00239; Filleul L, 2006, ENVIRON HEALTH PERSP, V114, P1344, DOI 10.1289/ehp.8328; Ren C, 2008, OCCUP ENVIRON MED, V65, P255, DOI 10.1136/oem.2007.033878; Goggins WB, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-59; Guo YM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-36; Guo YM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00830; Hashizume M, 2009, INT J EPIDEMIOL, V38, P1689, DOI 10.1093/ije/dyn376; KALKSTEIN LS, 1986, B AM METEOROL SOC, V67, P842, DOI 10.1175/1520-0477(1986)067<0842:AEOSDI>2.0.CO;2; Liu LQ, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-51	31	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1044-3983	1531-5487		EPIDEMIOLOGY	Epidemiology	MAR	2015	26	2					255	262		10.1097/EDE.0000000000000229		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CB1PO	WOS:000349400300034		
J	Homma, T; Hamaoka, T; Osada, T; Murase, N; Kime, R; Kurosawa, Y; Ichimura, S; Esaki, K; Nakamura, F; Katsumura, T				Homma, Toshiyuki; Hamaoka, Takafumi; Osada, Takuya; Murase, Norio; Kime, Ryotaro; Kurosawa, Yuko; Ichimura, Shiro; Esaki, Kazuki; Nakamura, Fumiko; Katsumura, Toshihito			Once-weekly muscle endurance and strength training prevents deterioration of muscle oxidative function and attenuates the degree of strength decline during 3-week forearm immobilization	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Countermeasure; Endurance and strength training; Muscle oxidative capacity; Muscle strength; Muscle unloading; (31)Phosphorus magnetic resonance spectroscopy	RESISTIVE VIBRATION EXERCISE; SHORT-DURATION SPACEFLIGHT; BED-REST; RESISTANCE EXERCISE; SKELETAL-MUSCLE; LEG MUSCLE; HUMAN CALF; ATROPHY; SIZE; YOUNG	Muscle unloading causes muscle function deterioration, but the extent to which training frequency or volume can be reduced while preserving muscle function during muscle unloading is unknown. We examined the effects of low-volume muscle endurance and strength training on forearm muscle oxidative capacity, endurance, and strength during a 3-week immobilization. Twenty-seven, healthy, male volunteers were divided into four groups: immobilization only (IMM); immobilization with endurance and strength training, once-weekly (IMM + EST1) or twice-weekly (IMM + EST2); and control, without immobilization or training (CNT). Endurance training involved dynamic handgrip exercise, at 30 % of maximal voluntary contraction (MVC), until exhaustion (similar to 60 s). Strength training involved intermittent isometric handgrip exercise at 70 % MVC (40 s). Muscle oxidative capacity was evaluated after exercise using the phosphocreatine recovery time constant using (31)phosphorus magnetic resonance spectroscopy. Endurance performance was evaluated according to the total work during dynamic handgrip exercise at 30 % MVC at 1 Hz until exhaustion. Muscle oxidative capacity and total work deterioration was restricted to the IMM (P < 0.05) group. MVC decreased in the IMM and IMM + EST1 (P < 0.05) groups. However, the MVC amplitude decrease in the IMM + EST1 group was smaller than that in the IMM (P < 0.05) group. MVC remained unchanged in the other groups. During the 3-week immobilization, twice-weekly low-volume muscle endurance and strength training prevented deterioration in muscle strength, oxidative capacity, and endurance performance. Moreover, once-weekly muscle endurance and strength training prevented the deterioration of muscle oxidative capacity and endurance performance, and attenuated the degree of muscle strength decline.	[Homma, Toshiyuki; Hamaoka, Takafumi; Kurosawa, Yuko] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan; [Osada, Takuya; Murase, Norio; Kime, Ryotaro; Katsumura, Toshihito] Tokyo Med Univ, Dept Sports Med Hlth Promot, Tokyo 1608402, Japan; [Ichimura, Shiro] Tokyo Univ Sci, Fac Sci & Technol, Chiba, Japan; [Esaki, Kazuki] Tokuyama Univ, Fac Econ, Yamaguchi, Japan; [Nakamura, Fumiko] Kokugakuin Univ, Fac Human Dev, Yokohama, Kanagawa, Japan	Hamaoka, T (reprint author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	kyp02504@nifty.com			National Space Development Agency of Japan; Japanese Ministry of Education, Science, Sports, and Culture	The authors wish to acknowledge the volunteers who participated in this study. We also thank the entire staff of Tokyo Medical University's Department of Sports Medicine for Health Promotion for their helpful advice and technical assistance. This work was supported, in part, by the National Space Development Agency of Japan and a grant-in-aid from the Japanese Ministry of Education, Science, Sports, and Culture.	Akima H, 2003, MED SCI SPORT EXER, V35, P655, DOI 10.1249/01.MSS.0000058367.66796.35; Akima H, 2000, MED SCI SPORT EXER, V32, P1743, DOI 10.1097/00005768-200010000-00013; Alkner BA, 2004, ACTA PHYSIOL SCAND, V181, P345, DOI 10.1111/j.1365-201X.2004.01293.x; Belavy DL, 2009, J MUSCULOSKEL NEURON, V9, P225; Holm L, 2008, J APPL PHYSIOL, V105, P1454, DOI 10.1152/japplphysiol.90538.2008; Trappe S, 2008, AM J PHYSIOL-REG I, V294, pR939, DOI 10.1152/ajpregu.00761.2007; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Nielsen J, 2010, AM J PHYSIOL-ENDOC M, V299, pE1053, DOI 10.1152/ajpendo.00324.2010; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Miokovic T, 2012, J APPL PHYSIOL, V113, P1545, DOI 10.1152/japplphysiol.00611.2012; HARRIS RC, 1974, SCAND J CLIN LAB INV, V33, P109; Miokovic T, 2014, MED SCI SPORT EXER, V46, P1506, DOI 10.1249/MSS.0000000000000279; Kawakami Y, 2001, EUR J APPL PHYSIOL, V84, P7, DOI 10.1007/s004210000330; Ferretti G, 1997, J PHYSIOL-LONDON, V501, P677, DOI 10.1111/j.1469-7793.1997.677bm.x; de Boer MD, 2007, J PHYSIOL-LONDON, V583, P1079, DOI 10.1113/jphysiol.2007.135392; Paganini AT, 1997, AM J PHYSIOL-CELL PH, V272, pC501; Schulze K, 2002, MED SCI SPORT EXER, V34, P303, DOI 10.1097/00005768-200202000-00019; LEBLANC AD, 1992, J APPL PHYSIOL, V73, P2172; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; HICKSON RC, 1985, J APPL PHYSIOL, V58, P492; MCCULLY KK, 1993, J APPL PHYSIOL, V75, P813; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Belavy DL, 2009, EUR J APPL PHYSIOL, V107, P489, DOI 10.1007/s00421-009-1136-0; Deschenes MR, 2002, AM J PHYSIOL-REG I, V282, pR578; EDGERTON VR, 1995, J APPL PHYSIOL, V78, P1733; Hamaoka T, 1998, JPN J APPL PHYSL, V28, P1; Homma T, 2009, ACTA PHYSIOL, V197, P313, DOI 10.1111/j.1748-1716.2009.02003.x; Kitahara A, 2003, MED SCI SPORT EXER, V35, P1697, DOI 10.1249/01.MSS.0000089339.07610.5F; KUSHMERICK MJ, 1985, AM J PHYSIOL, V248, pC542; Matsumura Mika, 2008, Dyn Med, V7, P1, DOI 10.1186/1476-5918-7-1; MCCOMAS AJ, 1994, MED SCI SPORT EXER, V26, P1498; MILES MP, 1994, MED SCI SPORT EXER, V26, P615; Motobe M, 2004, DYN MED, V3, P2, DOI DOI 10.1186/1476-5918-3-2; Ohmori F, 2010, EUR J APPL PHYSIOL, V110, P845, DOI 10.1007/s00421-010-1566-8; Sako T, 2001, J APPL PHYSIOL, V90, P338; Tesch PA, 2004, J APPL PHYSIOL, V96, P1451, DOI 10.1152/japplphysiol.01051.2003	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAR	2015	115	3					555	563		10.1007/s00421-014-3029-0		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CB1DF	WOS:000349366200010		
J	Yamaguchi, Y; Ikemura, T; Kashima, H; Hayashi, N				Yamaguchi, Yuji; Ikemura, Tsukasa; Kashima, Hideaki; Hayashi, Naoyuki			Effects of vasodilatation and pressor response on neurovascular coupling during dynamic exercise	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Posterior cerebral artery; Dynamic exercise; Exercise intensity; Visual stimulation	CEREBRAL-BLOOD-FLOW; TRANSCRANIAL DOPPLER ULTRASOUND; SEVERE PASSIVE HYPERTHERMIA; CEREBROVASCULAR FUNCTION; HUMANS; MECHANISMS; VELOCITY; OXYGEN; BRAIN	Visual stimulation increases the blood flow in the posterior cerebral artery (PCA), which supplies blood to the visual cortex by neurovascular coupling (NVC). Relative contributions of vasodilatation and pressor response on NVC during dynamic exercise are still unknown. We measured the blood flow velocity in the PCA (PCAv) by transcranial Doppler ultrasound flowmetry during rest and exercise in 14 healthy males while they performed 12-min submaximal leg-cycle exercises at mild-, moderate-, and high-intensity, which corresponded to heart rates of 120, 140, and 160 bpm, respectively. NVC was estimated as the relative change in PCAv from 20 s eye-closing to the peak response during 40 s looking at a reversed checkerboard. Conductance index was calculated for evaluating vasodilatation as pressure divided by blood flow. In response to visual stimulation, a magnitude of vasodilatation was significantly decreased under the moderate-intensity, while pressor response was significantly suppressed under the high-intensity exercises, compared with the control condition. Conversely, peak response to visual stimulation in PCAv was not affected by exercise intensity though relative and absolute responses were significantly lower in the moderate- and high-intensity exercises than the control. It is suggested that the contributions of pressor response and vasodilatation were modified by exercise intensity, partly playing a role for stabilizing the peak response of PCAv with visual stimulation during dynamic exercise.	[Yamaguchi, Yuji; Ikemura, Tsukasa; Kashima, Hideaki; Hayashi, Naoyuki] Kyushu Univ, Grad Sch Human Environm Studies, Kasuga, Fukuoka 8168580, Japan; [Yamaguchi, Yuji; Ikemura, Tsukasa; Hayashi, Naoyuki] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528852, Japan	Hayashi, N (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528852, Japan.	naohayashi@hum.titech.ac.jp			Kozuki Sports and Education Foundation	This study was supported in part by a Grant from the Kozuki Sports and Education Foundation (to N. Hayashi).	Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Nelson MD, 2011, J PHYSIOL-LONDON, V589, P4053, DOI 10.1113/jphysiol.2011.212118; LASSEN NA, 1959, PHYSIOL REV, V39, P183; Fan JL, 2008, J APPL PHYSIOL, V105, P433, DOI 10.1152/japplphysiol.00010.2008; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; JONES NL, 1979, J APPL PHYSIOL, V47, P954; Bain AR, 2013, J APPL PHYSIOL, V115, P653, DOI 10.1152/japplphysiol.00394.2013; Willie CK, 2011, J NEUROSCI METH, V198, P270, DOI 10.1016/j.jneumeth.2011.03.017; AASLID R, 1987, STROKE, V18, P771; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Szabo K, 2011, J NEUROL SCI, V309, P58, DOI 10.1016/j.jns.2011.07.026; Serrador JM, 2000, STROKE, V31, P1672; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Fabjan A, 2012, ULTRASOUND MED BIOL, V38, P13, DOI 10.1016/j.ultrasmedbio.2011.10.007; Smith KJ, 2012, RESP PHYSIOL NEUROBI, V184, P97, DOI 10.1016/j.resp.2012.07.014; Yamaguchi Y, 2014, J PHYSIOL SCI, V64, P195, DOI 10.1007/s12576-014-0311-1	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAR	2015	115	3					619	625		10.1007/s00421-014-3049-9		7	Physiology; Sport Sciences	Physiology; Sport Sciences	CB1DF	WOS:000349366200016		
J	Iwasaki, M; Franke, AA; Hamada, GS; Miyajima, NT; Sharma, S; Ishihara, J; Takachi, R; Tsugane, S; Le Marchand, L				Iwasaki, Motoki; Franke, Adrian A.; Hamada, Gerson S.; Miyajima, Nelson T.; Sharma, Sangita; Ishihara, Junko; Takachi, Ribeka; Tsugane, Shoichiro; Le Marchand, Loic			Comparison of plasma levels of nutrient-related biomarkers among Japanese populations in Tokyo, Japan, Sao Paulo, Brazil, and Hawaii, USA	EUROPEAN JOURNAL OF CANCER PREVENTION			English	Article						carotenoids; Japanese Americans; Japanese Brazilians; tocopherols	FOOD FREQUENCY QUESTIONNAIRE; COLORECTAL-CANCER RISK; LOS-ANGELES-COUNTY; COENZYME-Q10 LEVELS; MULTIETHNIC COHORT; WHITE IMMIGRANTS; ADENOMA; CAROTENOIDS; VITAMIN; SUPPLEMENTATION	Previous studies of Japanese migrants have suggested that the increase in colorectal cancer rates occurring after migration is slower among Japanese Brazilians than among Japanese Americans. We hypothesized that this difference may partly reflect differences in vegetable and fruit intake between the populations. Using data from validation studies of food frequency questionnaires being used in comparative case-control studies of colorectal adenoma in Tokyo, Sao Paulo, and Hawaii, plasma carotenoid, retinol, tocopherol, and coenzyme Q10 levels were measured by high-performance liquid chromatography, and 25-hydroxy vitamin D levels were estimated by enzyme-linked immunosorbent assay. Plasma levels were compared by analysis of covariance between 142 Japanese in Tokyo, 79 Japanese Brazilians in Sao Paulo, and 78 Japanese Americans in Hawaii. Overall, we found significantly lower plasma carotenoid levels, except for lycopene levels, and retinol levels in Japanese Americans compared with Japanese in Tokyo and Japanese Brazilians. The plasma total carotenoid level was highest in Japanese Brazilians. Compared with the mean level among Japanese Brazilians (1741.2 ng/ml), P for difference was 0.03 among Japanese in Tokyo (1514.4 ng/ml) and less than 0.01 for Japanese Americans (1257.7 ng/ml). Plasma lycopene and tocopherol levels did not substantially differ between the three populations. We also found significantly lower plasma levels of 25-hydroxy vitamin D and total coenzyme Q10 in Japanese in Tokyo than in Japanese Americans and Japanese Brazilians. Higher levels of plasma carotenoids among Japanese Brazilians than among Japanese in Tokyo and Hawaii may have contributed to the slower pace of the increase in colorectal cancer rates observed in that population after migration. European Journal of Cancer Prevention 24: 155-161 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Iwasaki, Motoki; Ishihara, Junko; Takachi, Ribeka; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo 1040045, Japan; [Ishihara, Junko] Sagami Womens Univ, Dept Nutr Management, Sagamihara, Kanagawa, Japan; [Takachi, Ribeka] Niigata Univ, Grad Sch Med & Dent Sci, Dept Community Prevent Med, Div Social & Environm Med, Niigata, Japan; [Franke, Adrian A.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96822 USA; [Hamada, Gerson S.] Cotia Hosp, Nikkei Dis Prevent Ctr, Sao Paulo, Brazil; [Miyajima, Nelson T.] Cotia Hosp, Soc Beneficente, Sao Paulo, Brazil; [Sharma, Sangita] Univ Alberta, Dept Med, Edmonton, AB, Canada	Iwasaki, M (reprint author), Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	moiwasak@ncc.go.jp		Sharma, Sangita/0000-0002-4995-0010	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [221S0001, 22700934]; Japan Society for the Promotion of Science; Foundation for Promotion of Cancer Research in Japan; American Institute for Cancer Research [06A102]; U.S. National Cancer Institute [CA119682, P30 CA71789]	This study was supported by a Grant-in-Aid for the Third-Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labor, and Welfare of Japan, and Grants-in-Aid for Scientific Research on Innovative Areas (221S0001) and for Young Scientists (B) (22700934) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for the Promotion of Science, and Foundation for Promotion of Cancer Research in Japan. It was also supported in part by American Institute for Cancer Research grant 06A102 and U.S. National Cancer Institute grants CA119682 and P30 CA71789.	Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; JACQUES PF, 1993, AM J CLIN NUTR, V57, P182; Iwasaki M, 2008, EUR J CANCER PREV, V17, P1; Yamaji T, 2009, AM J EPIDEMIOL, V170, P1502, DOI 10.1093/aje/kwp311; Al-Delaimy WK, 2005, EUR J CLIN NUTR, V59, P1387, DOI 10.1038/sj.ejcn.1602252; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Le Marchand L, 2010, CANCER EPIDEM BIOMAR, V19, P1471, DOI 10.1158/1055-9965.EPI-10-0128; Sharma S, 2009, INT J FOOD SCI NUTR, V60, P128, DOI 10.1080/09637480902740790; Takachi R, 2011, J EPIDEMIOL, V21, P447, DOI 10.2188/jea.JE20100173; Crane FL, 2001, J AM COLL NUTR, V20, P591; Ognjanovic S, 2010, CANCER CAUSE CONTROL, V21, P1131, DOI 10.1007/s10552-010-9540-7; SHIMIZU H, 1987, J NATL CANCER I, V78, P223; Kabat GC, 2012, EUR J CLIN NUTR, V66, P549, DOI 10.1038/ejcn.2011.207; TSUGANE S, 1990, CANCER CAUSE CONTROL, V1, P189, DOI 10.1007/BF00053172; Iwasaki M, 2004, JPN J CLIN ONCOL, V34, P673, DOI 10.1093/jjco/hyh123; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Weber C, 1997, INT J VITAM NUTR RES, V67, P123; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; COONEY RV, 1995, CANCER EPIDEM BIOMAR, V4, P207; SHIMIZU H, 1991, BRIT J CANCER, V63, P963, DOI 10.1038/bjc.1991.210; Chai WW, 2011, CANCER EPIDEM BIOMAR, V20, P708, DOI 10.1158/1055-9965.EPI-10-1309; Chai WW, 2010, CANCER EPIDEM BIOMAR, V19, P2351, DOI 10.1158/1055-9965.EPI-10-0396; FRANKE AA, 1993, J CHROMATOGR-BIOMED, V614, P43, DOI 10.1016/0378-4347(93)80222-P; Franke AA, 2010, FREE RADICAL BIO MED, V48, P1610, DOI 10.1016/j.freeradbiomed.2010.03.002; OLSON JA, 1984, J NATL CANCER I, V73, P1439; Pakseresht M, 2013, PUBLIC HEALTH NUTR, V16, P1445, DOI 10.1017/S1368980012003692; Parkin DM, 1992, CANC INCIDENCE 5 CON, VVI, P120; Record IR, 2001, BRIT J NUTR, V85, P459, DOI 10.1079/BJN2000292; Tsugane S, 1994, J EPIDEMIOL, V4, P37; Tsugane S, 1996, J EPIDEMIOL, V6, pS169; Tsugane S, 1996, GANN MONOGRAPH CANC, P43; Wakai K, 2005, NUTR CANCER, V51, P13, DOI 10.1207/s15327914nc5101_3; WILLETT WC, 1983, AM J CLIN NUTR, V38, P559; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-8278	1473-5709		EUR J CANCER PREV	Eur. J. Cancer Prev.	MAR	2015	24	2					155	161		10.1097/CEJ.0000000000000136		7	Oncology	Oncology	CA6FB	WOS:000349003700013		
J	Maruyama, H; Kondo, T; Sekimoto, T; Takahashi, M; Fujiwara, K; Imazeki, F; Yokosuka, O				Maruyama, Hitoshi; Kondo, Takayuki; Sekimoto, Tadashi; Takahashi, Masanori; Fujiwara, Keiichi; Imazeki, Fumio; Yokosuka, Osamu			Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology?	EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY			English	Article						hepatic venography; hepatic venous pressure gradient; portal hypertension; primary biliary cirrhosis	HEPATIC VENOUS-PRESSURE; DIGITAL-SUBTRACTION-ANGIOGRAPHY; CARBON-DIOXIDE; HYPERTENSION; VENOGRAPHY; GRADIENT; CO2; MANAGEMENT; DIAGNOSIS; THERAPY	Objective The aim of this study was to explore the underlying pathophysiological mechanism for portal hypertension in primary biliary cirrhosis (PBC) using radiological findings. Patients and methods The study included 10 patients with PBC (Scheuer stage I, one patient; stage II, two patients; and cirrhosis, seven patients) and 29 patients with viral cirrhosis. Both groups underwent Doppler ultrasound and hepatic venous catheterization. The Doppler data, pressure data, and vascular enhancement findings were compared between the groups. Results Hemodynamics in the portal trunk and hepatic vein upon Doppler sonography did not differ between patients with viral cirrhosis, cirrhotic PBC, and noncirrhotic PBC. The hepatic venous pressure gradient (mean +/- SD) was 225.5 +/- 77.1 mmH(2)O (range 125-445 mmH(2)O) in viral cirrhosis, 224.6 +/- 39.5 mmH(2)O (range 170-262 mmH(2)O) in cirrhotic PBC, and 41.3 +/- 7.4 mmH(2)O (range 33-47 mmH(2)O) in noncirrhotic PBC, being significantly higher in viral cirrhosis and cirrhotic PBC than noncirrhotic PBC (P=0.0005). The intrahepatic portal vein was detected in a retrograde manner on the hepatic venogram in 29/29 (100%) patients with viral cirrhosis (all with gastroesophageal varices), 7/7 (100%) patients with cirrhotic PBC (5/7 with gastroesophageal varices), and 3/3 (100%) patients with noncirrhotic PBC (none with gastroesophageal varices). The presence of veno-venous communication was found in 15/29 (51.7%) patients with viral cirrhosis, 6/7 (85.7%) patients with cirrhotic PBC, and 3/3 (100%) patients with noncirrhotic PBC. Conclusion The study suggested that sinusoidal blockage is the underlying pathophysiology even in the early-stage PBC, proved by the visible intrahepatic portal vein in three noncirrhotic PBC patients, and veno-venous communication in the liver is responsible for alleviated hepatic venous pressure gradient. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Maruyama, Hitoshi; Kondo, Takayuki; Sekimoto, Tadashi; Takahashi, Masanori; Fujiwara, Keiichi; Imazeki, Fumio; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan	Maruyama, H (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuou Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	maru-cib@umin.ac.jp					Debernardi-Venon W, 2000, GUT, V46, P856, DOI 10.1136/gut.46.6.856; Hillaire S, 2002, GUT, V51, P275, DOI 10.1136/gut.51.2.275; Karlsen TH, 2014, ALIMENT PHARM THER, V39, P282, DOI 10.1111/apt.12581; Abraldes JG, 2008, J HEPATOL, V48, P229, DOI 10.1016/j.jhep.2007.10.008; Siramolpiwat S, 2014, HEPATOLOGY, V59, P2276, DOI 10.1002/hep.26904; OKUDA K, 1984, GASTROENTEROLOGY, V86, P600; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Silveira MG, 2008, HEPATOLOGY, V48, P1149, DOI 10.1002/hep.22458; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Sarin SK, 2002, J GASTROEN HEPATOL, V17, P526, DOI 10.1046/j.1440-1746.2002.02764.x; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Sarin SK, 2007, HEPATOL INT, V1, P398, DOI 10.1007/s12072-007-9010-9; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Hawkins IF, 1998, EUR RADIOL, V8, P391, DOI 10.1007/s003300050400; Dooley JS, 2011, SHERLOCK'S DISEASES OF THE LIVER AND BILIARY SYSTEM, 12TH EDITION, P1, DOI 10.1002/9781444341294; FUTAGAWA S, 1981, RADIOLOGY, V141, P303; FUTAGAWA S, 1980, AM J ROENTGENOL, V134, P917; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kashyap R, 2010, J GASTROINTEST SURG, V14, P1362, DOI 10.1007/s11605-010-1256-1; Keiding S, 2002, SCAND J GASTROENTERO, V37, P960, DOI 10.1080/003655202760230946; KERNS SR, 1995, AM J ROENTGENOL, V164, P735; Krajina A, 2002, CARDIOVASC INTER RAD, V25, P171, DOI 10.1007/s00270-001-0096-5; Liang Y, 2012, HEPATOLOGY, V56, P1409, DOI 10.1002/hep.25788; Garcia RFL, 2001, HEPATOLOGY, V33, P22, DOI 10.1053/jhep.2001.20894; Maleux G, 2011, J VASC INTERV RADIOL, V22, P1553, DOI 10.1016/j.jvir.2011.08.003; Maruyama H, 2014, Clin Radiol, V69, pe140, DOI 10.1016/j.crad.2013.11.001; NAVASA M, 1987, J HEPATOL, V5, P292, DOI 10.1016/S0168-8278(87)80035-1; Okuda Kunio, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS204, DOI 10.1046/j.1440-1746.17.s3.2.x; Osada Y, 2008, DIGEST DIS SCI, V53, P7, DOI 10.1007/s10620-007-0039-3; Sakaguchi T, 2010, SURGERY, V147, P805, DOI 10.1016/j.surg.2009.11.009; Viral Hepatitis Surveillance United States, 2010, 2010 NAT CTR HIV SAT; Yang L, 1999, ACAD RADIOL, V6, P89, DOI 10.1016/S1076-6332(99)80487-5	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0954-691X	1473-5687		EUR J GASTROEN HEPAT	Eur. J. Gastroenterol. Hepatol.	MAR	2015	27	3					321	327		10.1097/MEG.0000000000000268		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA6FS	WOS:000349006000020		
J	Sato, Y; Breeuwer, JAJ; Egas, M; Sabelis, MW				Sato, Yukie; Breeuwer, Johannes A. J.; Egas, Martijn; Sabelis, Maurice W.			Incomplete premating and postmating reproductive barriers between two parapatric populations of a social spider mite	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Article						Contact zone; Male-male conflict; Courtship behaviour; Mating behaviour; Reproductive isolation; Speciation; Acari; Tetranychidae	SCHIZOTETRANYCHUS-MISCANTHI SAITO; STIGMAEOPSIS-MISCANTHI; MOLECULAR PHYLOGENY; MALE AGGRESSIVENESS; ACARI; TETRANYCHIDAE; INTERFERENCE; FORMS; SPECIATION; WEB	Closely related species with overlapping distributions often show premating reproductive barriers to avoid hybridization. Stigmaeopsis miscanthi (Saito) is a social spider mite infesting Chinese silver grass, and the species consists of two parapatric groups with frequent contacts within the contact zone. They differ in male-male aggressiveness, male morphology, female diapause traits, and life history parameters. There is incomplete but strong post-mating reproductive isolation between the two groups, and their DNA sequences are slightly different, suggesting that they diverged recently. In this study, we investigated premating reproductive barriers. We found that females from different groups frequently shared nest webs, indicating no barriers in the phase of nest establishment. However, inside nests, males from either group showed less courtship behaviour to females of the other group and they copulated less frequently with them when compared to females of the same group. However, the premating reproductive barrier was incomplete and asymmetric. Females of one group frequently resisted courtship by males from the other group, but females of the other group did not. We conclude that some gene flow may occur in the contact zone between the two groups.	[Sato, Yukie; Breeuwer, Johannes A. J.; Egas, Martijn; Sabelis, Maurice W.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands; [Sato, Yukie] Hokkaido Univ, Grad Sch Agr, Dept Systemat & Ecol, Anim Ecol Lab, Sapporo, Hokkaido 0608589, Japan; [Sato, Yukie] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano 3862204, Japan	Sato, Y (reprint author), Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano 3862204, Japan.	uchietan@gmail.com					Horita M, 2004, J ETHOL, V22, P105, DOI 10.1007/s10164-003-0101-3; Hochkirch A, 2007, J ANIM ECOL, V76, P633, DOI 10.1111/j.1365-2656.2007.01241.x; BOUDREAUX HB, 1963, ANNU REV ENTOMOL, V8, P137, DOI 10.1146/annurev.en.08.010163.001033; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Matsubayashi KW, 2009, EVOLUTION, V63, P2563, DOI 10.1111/j.1558-5646.2009.00738.x; HELLE W, 1967, ENTOMOL EXP APPL, V10, P103; Sato Y, 2013, EXP APPL ACAROL, V60, P451, DOI 10.1007/s10493-013-9668-8; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Noriyuki S, 2012, J ANIM ECOL, V81, P1077, DOI 10.1111/j.1365-2656.2012.01984.x; Oku K, 2008, EXP APPL ACAROL, V45, P53, DOI 10.1007/s10493-008-9157-7; Cone W.W., 1985, P243; Coyne J. A., 2004, SPECIATION; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Ito K, 2009, APPL ENTOMOL ZOOL, V44, P343, DOI 10.1303/aez.2009.343; Mori K, 1999, EXP APPL ACAROL, V23, P411, DOI 10.1023/A:1006165606428; R Development Core Team, 2012, R LANG ENV STAT COMP; Saito Yutaka, 1997, P443; Saito Y, 2013, EXP APPL ACAROL, V60, P313, DOI 10.1007/s10493-012-9646-6; SAITO Y, 1990, RES POPUL ECOL, V32, P263, DOI 10.1007/BF02512562; Saito Y, 1999, BEHAV ECOL SOCIOBIOL, V46, P25, DOI 10.1007/s002650050588; Saito Y, 2002, ECOL RES, V17, P645, DOI 10.1046/j.1440-1703.2002.00522.x; SAITO Y, 1995, EVOLUTION, V49, P413, DOI 10.2307/2410265; Sakagami T, 2009, ANN ENTOMOL SOC AM, V102, P360, DOI 10.1603/008.102.0303; Sato Y, 2008, EXP APPL ACAROL, V44, P265, DOI 10.1007/s10493-008-9147-9; Sato Y, 2000, APPL ENTOMOL ZOOL, V35, P605, DOI 10.1303/aez.2000.605; Sato Y, 2014, HEREDITY, V113, P495, DOI 10.1038/hdy.2014.53; Sato Y, 2000, APPL ENTOMOL ZOOL, V35, P611, DOI 10.1303/aez.2000.611; Sato Y, 2013, ECOL EVOL, V3, P2661, DOI 10.1002/ece3.661; Scopece G, 2013, EVOLUTION, V67, P2083, DOI 10.1111/evo.12091; Takafuji A, 1997, EXP APPL ACAROL, V21, P379, DOI 10.1023/A:1018423711166; Yano J, 2011, J ETHOL, V29, P337, DOI 10.1007/s10164-010-0265-6	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	MAR	2015	65	3					277	291		10.1007/s10493-015-9878-3		15	Entomology	Entomology	CB4LM	WOS:000349599200002		
J	Suzuki, T; Wang, CH; Gotoh, T; Amano, H; Ohyama, K				Suzuki, Takeshi; Wang, Chih-Hung; Gotoh, Tetsuo; Amano, Hiroshi; Ohyama, Katsumi			Deoxidant-induced anoxia as a physical measure for controlling spider mites (Acari: Tetranychidae)	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Article						Agricultural pests; Anoxia tolerance; Diapause; Physiological disorder; Seedlings	ATMOSPHERE TREATMENTS; CARBON-DIOXIDE; URTICAE; DIAPAUSE; DISINFESTATION; TOLERANCE; EGGS; IRRADIATION; GREENHOUSE; MANAGEMENT	Tiny agricultural pests such as spider mites (Acari: Tetranychidae) attached to seedlings grown outdoors often invade greenhouses, thereby triggering pest outbreaks. To solve the problem, we examined whether differences in anoxia tolerance between animals and plants would permit the application of an anoxic environment to control spider mites without the aid of acaricides. Under an anoxic environment created by using a commercial deoxidant at 25 A degrees C, the time for 50 % mortality of eggs, non-diapausing adults (summer form), and diapausing adults (winter form) were 6.1, 5.5, and 23.6 h, respectively, for Tetranychus urticae Koch and 5.4, 3.9, and 23.2 h, respectively, for Tetranychus kanzawai Kishida. With anoxia for 12 h, no eggs and non-diapausing adults survived in either species, whereas most diapausing adults (98 % for T. urticae and 88 % for T. kanzawai) survived. Under this treatment, host Phaseolus vulgaris L. seedlings showed serious physiological disorders in their primary leaves and apical buds, and unusual lateral buds developed in the cotyledon axils. The spider mites acquire anoxia tolerance during diapause, but anoxia can potentially control them during the summer if no negative effects are observed in the treated seedlings.	[Suzuki, Takeshi] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Suzuki, Takeshi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Wang, Chih-Hung; Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Ami, Ibaraki 3000393, Japan; [Amano, Hiroshi] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Ohyama, Katsumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan	Suzuki, T (reprint author), Univ Western Ontario, Dept Biol, 1151 Richmond St, London, ON N6A 5B7, Canada.	tsuzuki2@uwo.ca			Nippon Life Insurance Foundation; JSPS [25660276]	We thank Mitsubishi Gas Chemical Company for providing the deoxidants and polycarbonate containers used in this study. We also thank Dr. Fujio Kadono for providing an opportunity to use the scanning electron microscope in his laboratory. This study was supported by Nippon Life Insurance Foundation and JSPS Grant-in-Aid for Challenging Exploratory Research (25660276).	Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339; Ohtsuka K, 2009, ENVIRON ENTOMOL, V38, P920, DOI 10.1603/022.038.0346; Vermeiren L, 1999, TRENDS FOOD SCI TECH, V10, P77, DOI 10.1016/S0924-2244(99)00032-1; Suzuki T, 2013, J EXP BIOL, V216, P977, DOI 10.1242/jeb.079582; Suzuki T, 2009, J INSECT PHYSIOL, V55, P649, DOI 10.1016/j.jinsphys.2009.04.005; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Mitcham E, 2006, B ENTOMOL RES, V96, P213, DOI 10.1079/BER2006424; van Lenteren JC, 2000, CROP PROT, V19, P375, DOI 10.1016/S0261-2194(00)00038-7; Blokhina OB, 2001, J EXP BOT, V52, P1179, DOI 10.1093/jexbot/52.359.1179; Sakai Y, 2010, PHOTOCHEM PHOTOBIOL, V86, P925, DOI 10.1111/j.1751-1097.2010.00739.x; Den Houter J.G., 1976, Zeitschrift angew Ent, V81, P248; Fleurat-Lessard F., 1990, FOOD PRESERVATION MO, P21; Ghazy NA, 2014, EXP APPL ACAROL, V63, P49, DOI 10.1007/s10493-013-9760-0; Held DW, 2001, J ECON ENTOMOL, V94, P430, DOI 10.1603/0022-0493-94.2.430; Kamezaki Hiroki, 2007, Journal of the Acarological Society of Japan, V16, P145, DOI 10.2300/acari.16.145; Khodayari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054025; Khodayari S, 2012, J THERM BIOL, V37, P419, DOI 10.1016/j.jtherbio.2012.04.005; KOVEOS DS, 1994, J INSECT PHYSIOL, V40, P701, DOI 10.1016/0022-1910(94)90097-3; LayYee M, 1996, POSTHARVEST BIOL TEC, V7, P73, DOI 10.1016/0925-5214(95)00035-6; LEES AD, 1956, ANNU REV ENTOMOL, V1, P1, DOI 10.1146/annurev.en.01.010156.000245; LESTER PJ, 1995, J ECON ENTOMOL, V88, P1361; Lester PJ, 1997, ENTOMOL EXP APPL, V83, P189, DOI 10.1046/j.1570-7458.1997.00171.x; McENROE W. D., 1961, ANN ENT SOC AMER, V54, P883; Montzka S. A., 2011, SCI ASSESSMENT OZONE; Murata Y, 2014, J INSECT PHYSL, V59, P241; Neven LG, 2005, J ECON ENTOMOL, V98, P709; OHGUCHI Y, 1983, JPN J APPL ENTOMOL Z, V27, P270; Ohno S., 2010, Kyushu Plant Protection Research, V56, P58; Parr W. J., 1966, Hort Res, V6, P1; Popov SY, 1996, EXP APPL ACAROL, V20, P167, DOI 10.1007/BF00051482; R Development Core Team, 2013, R LANG ENV STAT COMP; Ristaino JB, 1997, PLANT DIS, V81, P964, DOI 10.1094/PDIS.1997.81.9.964; Seki M, 2012, APPL ENTOMOL ZOOL, V47, P433, DOI 10.1007/s13355-012-0138-2; Seki M, 2012, APPL ENTOMOL ZOOL, V47, P125, DOI 10.1007/s13355-012-0098-6; Suzuki Takeshi, 2012, Insects, V3, P1126, DOI 10.3390/insects3041126; Suzuki T, 2014, J INSECT PHYSIOL, V62, P1, DOI 10.1016/j.jinsphys.2014.01.005; Suzuki T, 2009, PHYSIOL ENTOMOL, V34, P278, DOI 10.1111/j.1365-3032.2009.00688.x; Takafuji A, 2001, APPL ENTOMOL ZOOL, V36, P169, DOI 10.1303/aez.2001.169; Tauber MJ, 1986, SEASONAL ADAPTATIONS; VEERMAN A, 1977, NATURE, V266, P526, DOI 10.1038/266526b0; Veerman A., 1985, P279; WADDELL BC, 1992, NEW ZEAL J CROP HORT, V20, P229; Yang NW, 2014, BIOL CONTROL, V68, P92, DOI 10.1016/j.biocontrol.2013.06.012; ZHANG B., 2013, RES J ENVIRON EARTH, V5, P256	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	MAR	2015	65	3					293	305		10.1007/s10493-015-9881-8		13	Entomology	Entomology	CB4LM	WOS:000349599200003		
J	Hata, A; Matsumori, K; Kitajima, M; Katayama, H				Hata, Akihiko; Matsumori, Katsuhito; Kitajima, Masaaki; Katayama, Hiroyuki			Concentration of Enteric Viruses in Large Volumes of Water Using a Cartridge-Type Mixed Cellulose Ester Membrane	FOOD AND ENVIRONMENTAL VIROLOGY			English	Article						Virus detection; Poliovirus; Murine norovirus; Environmental water samples; Virus concentration	COMBINED SEWER OVERFLOWS; HEPATITIS-A VIRUS; TAP WATER; ELECTROPOSITIVE FILTER; NORWALK VIRUS; ENTEROVIRUS; NOROVIRUSES; OUTBREAK; PCR; GASTROENTERITIS	A viral adsorption-elution method using a flat/disk-type electronegative membrane (diameter of 47-90 mm) has been widely utilized to concentrate viruses in relatively small volumes of water (up to 10 L) due to limited filtration area. In the present study, we aimed to develop a virus concentration method that is based on the same principle and yet allows concentration of large volumes of water using a cartridge-type electronegative membrane. We modified two electronegative membrane-based methods for this purpose (i.e., Mg2+ method and Al3+ method) and determined recovery efficiencies of poliovirus and murine norovirus inoculated in water samples. The virus recovery efficiency of the Al3+ method substantially decreased as the volume of water sample increased. In contrast, Mg2+ method showed stable virus recovery efficiencies (10-54 %) even when 40 to 1,000 L of river and tap water samples were processed. The volume of the concentrate (400 mL) can be further reduced to 1.5 mL by a Centricon plus-70 centrifugal ultrafiltration device with overall recovery efficiencies of 8.8-16 %. Our results demonstrated that the newly developed virus concentration method enables detection of as low as 10(1) copies/L of viruses in water samples.	[Hata, Akihiko] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan; [Matsumori, Katsuhito; Katayama, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kitajima, Masaaki] Singapore MIT Alliance Res & Technol, Ctr Environm Sensing & Modeling, Singapore 138602, Singapore	Hata, A (reprint author), Kyoto Univ, Res Ctr Environm Qual Management, 1-2 Yumihama, Otsu, Shiga 5200811, Japan.	hata.akihiko.33c@st.kyoto-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Corporation (JST)	This study was supported by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Corporation (JST).	Gofti-Laroche L, 2003, J CLIN VIROL, V27, P74, DOI 10.1016/S1386-6532(02)00130-0; Wong K, 2012, ENVIRON INT, V45, P151, DOI 10.1016/j.envint.2012.02.009; Karim MR, 2009, APPL ENVIRON MICROB, V75, P2393, DOI 10.1128/AEM.00922-08; Hata A, 2014, SCI TOTAL ENVIRON, V468, P757, DOI 10.1016/j.scitotenv.2013.08.093; Lodder WJ, 2012, APPL ENVIRON MICROB, V78, P3800, DOI 10.1128/AEM.07972-11; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741; Hamza IA, 2009, WATER RES, V43, P2657, DOI 10.1016/j.watres.2009.03.020; SOBSEY MD, 1980, APPL ENVIRON MICROB, V40, P201; Albinana-Gimenez N, 2009, WATER RES, V43, P2011, DOI 10.1016/j.watres.2009.01.025; Ikner LA, 2011, APPL ENVIRON MICROB, V77, P3500, DOI 10.1128/AEM.02705-10; Le Guyader FS, 2008, J CLIN MICROBIOL, V46, P4011, DOI 10.1128/JCM.01044-08; Fong TT, 2010, APPL ENVIRON MICROB, V76, P715, DOI 10.1128/AEM.01316-09; Cashdollar JL, 2013, APPL ENVIRON MICROB, V79, P215, DOI 10.1128/AEM.02270-12; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; SCHWAB KJ, 1995, APPL ENVIRON MICROB, V61, P531; Bennett HB, 2010, WATER SCI TECHNOL, V61, P317, DOI 10.2166/wst.2010.819; De Keuckelaere A, 2013, J VIROL METHODS, V187, P294, DOI 10.1016/j.jviromet.2012.11.028; Di Bartolo I, 2011, APPL ENVIRON MICROB, V77, P5545, DOI 10.1128/AEM.00278-11; Haramoto E, 2004, APPL ENVIRON MICROB, V70, P2154, DOI 10.1128/AEM.70.4.2154-2160.2004; Ikner LA, 2012, FOOD ENVIRON VIROL, V4, P41, DOI 10.1007/s12560-012-9080-2; Kitajima M., 2008, ENV ENG RES, V45, P361; Rutjes SA, 2005, APPL ENVIRON MICROB, V71, P3734, DOI 10.1128/AEM.71.7.3734-3740.2005; Tallon LA, 2008, APPL ENVIRON MICROB, V74, P6158, DOI 10.1128/AEM.02872-07; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; World Health Organization, 2011, GUID DRINK WAT QUAL, P117; Zhen H, 2014, WATER RES, V52, P51	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-0334	1867-0342		FOOD ENVIRON VIROL	Food Environ. Virol.	MAR	2015	7	1					7	13		10.1007/s12560-014-9169-x		7	Environmental Sciences; Microbiology; Virology	Environmental Sciences & Ecology; Microbiology; Virology	CB1PS	WOS:000349400700002		
J	Ito, T; Matsuoka, A				Ito, Tsuyoshi; Matsuoka, Atsushi			Imbricate structure of the Permian Yoshii Group in the Otakeyama area, Okayama Prefecture, southwest Japan	FRONTIERS OF EARTH SCIENCE			English	Article						accretionary complex; imbricate structure; Permian radiolaria; Yoshii Group; Okayama Prefecture; southwest Japan	EVOLUTION; CHERT	The Yoshii Group of the Akiyoshi terrane is distributed over the Otakeyama area, Okayama Prefecture, southwest Japan. The Yoshii Group is composed of siliceous rocks and clastics, comprising chert-clastic sequences. The Yoshii Group is divided into four structural units (Units Ot 1, Ot 2, Ot 3, and Ot 4) in structurally ascending order. Lithological similarities and radiolarian age suggest that these units exhibit almost identical ocean plate stratigraphy. These units are structurally-repeated to form an imbricate structure. This structure was possibly formed by off-scrape accretion at a toe of an accretionary complex. Additionally, a review of previous studies indicates that an imbricate structure is common in the Akiyoshi terrane. The presence of an imbricate structure in the Akiyoshi terrane, Permian accretionary complex, indicates the possibility that a specific horizon of Permian pelagic sequences acted as a d,collement zone.	[Ito, Tsuyoshi] China Univ Geosci, State Key Lab Geoproc & Mineral Resources, Wuhan 430074, Peoples R China; [Matsuoka, Atsushi] Niigata Univ, Dept Geol, Fac Sci, Niigata 9502181, Japan	Ito, T (reprint author), China Univ Geosci, State Key Lab Geoproc & Mineral Resources, Wuhan 430074, Peoples R China.	i.t.110244@gmail.com					KIMURA K, 1993, J STRUCT GEOL, V15, P145, DOI 10.1016/0191-8141(93)90092-O; MATSUDA T, 1991, TECTONICS, V10, P475, DOI 10.1029/90TC02134; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Isozaki Y, 2010, GONDWANA RES, V18, P82, DOI 10.1016/j.gr.2010.02.015; Choh R, 1939, J GEOLOGICAL SOC JAP, V46, P294; Ezaki Y, 1997, LATE PALAEOZOIC EARL, P134, DOI 10.1017/CBO9780511564413.015; Goto N, 1988, J GEOLOGICAL SOC JAP, V94, P501; Ichikawa K, 1990, PUBLICATION IGCP PRO, P1; Ishiga H, 1990, PUBLICATION IGCP PRO, V224, P285; Ishiga H., 1986, Earth Science (Tokyo), V40, P124; ISHIGA H, 1986, Journal of Geosciences Osaka City University, V29, P89; Kamata Y, 2000, MEMOIRS GEOLOGICAL S, V55, P203; Kametaka M, 2006, JAP GEOSC UN M 2006; Kanmera K, 1990, PUBL IGCP PROJ, V224, P49; Kawai M, 2001, NEWS OSAKA MICROPALE, V12, P23; Kimura K, 1997, B GEOLOGICAL SURVEY, V48, P313; Kobayashi T, 1937, J GEOLOGICAL SOC JAP, V44, P797; Kuwahara K., 1998, EARTH SCI, V52, P391; MATSUOKA A, 1992, PALAEOGEOGR PALAEOCL, V96, P71, DOI 10.1016/0031-0182(92)90060-I; Matsuoka A, 1994, TRIASSIC JURASSIC RA, P19; Matsuoka A, 1996, ISL ARC, V5, P203, DOI 10.1111/j.1440-1738.1996.tb00026.x; Matsuoka A, 1984, J GEOLOGICAL SOC JAP, V90, P455; Naka T, 1986, EARTH SCI, V40, P166; Nakano M, 1952, J GEOLOGICAL SOC JAP, V58, P288; Otoh S, 1985, J GEOLOGICAL SOC JAP, V91, P779; Otsuka T, 1988, J GEOSCI-OSAKA CITY, V31, P63; SADA K, 1985, P JPN ACAD B-PHYS, V61, P197, DOI 10.2183/pjab.61.197; Sada Kimiyoshi, 1992, P383; Sadagane S, 1981, B OKAYAMA PREFECTURA, V71, P1; Sano H., 1987, Journal of the Geological Society of Japan, V93, P865; SANO H, 1988, GEOLOGY, V16, P600, DOI 10.1130/0091-7613(1988)016<0600:PROAOR>2.3.CO;2; SANO H, 1988, Journal of the Geological Society of Japan, V94, P697; Sugiyama K., 1992, Transactions and Proceedings of the Palaeontological Society of Japan New Series, P1180; Tazawa J, 2002, 109 ANN M GEOL SOC J, P25; Uchiyama T, 1986, GEOLOGY, V16, P51; Wang Yu-Jing, 2011, Palaeoworld, V20, P134, DOI 10.1016/j.palwor.2011.05.001; Yanase A, 1993, J GEOLOGICAL SOC JAP, V99, P285; YAO A, 1980, Journal of Geosciences Osaka City University, V23, P135; Yoshimura N, 1961, GEOL REP HIROSHIMA U, V10, P1	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2095-0195	2095-0209		FRONT EARTH SCI-PRC	Front. Earth Sci.	MAR	2015	9	1					152	163		10.1007/s11707-014-0443-x		12	Geosciences, Multidisciplinary	Geology	CB2FC	WOS:000349441200013		
J	Chen, PC; Inui, A; Chen, CY				Chen, Po-Chun; Inui, Akio; Chen, Chih-Yen			Paradoxical responses of plasma glucagon and bile acid levels after duodenal nutrient exclusion	GUT			English	Letter							MICROBIOTA		[Chen, Po-Chun] Taipei Vet Gen Hosp, Dept Med, Taipei 112, Taiwan; [Inui, Akio] Kagoshima Univ Grad, Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima, Japan; [Chen, Chih-Yen] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei 112, Taiwan; [Chen, Chih-Yen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan	Chen, CY (reprint author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan.	chency@vghtpe.gov.tw					de Jonge C, 2013, OBES SURG, V23, P1354, DOI 10.1007/s11695-013-0921-3; Habegger KM, 2014, GUT, V63, P1238, DOI 10.1136/gutjnl-2013-304583; Osto M, 2013, PHYSIOL BEHAV, V119, P92, DOI 10.1016/j.physbeh.2013.06.008; Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	MAR	2015	64	3								10.1136/gutjnl-2014-307607		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB1GZ	WOS:000349376600020		
J	Asada, K; Nakajima, T; Shimazu, T; Yamamichi, N; Maekita, T; Yokoi, C; Oda, I; Ando, T; Yoshida, T; Nanjo, S; Fujishiro, M; Gotoda, T; Ichinose, M; Ushijima, T				Asada, Kiyoshi; Nakajima, Takeshi; Shimazu, Taichi; Yamamichi, Nobutake; Maekita, Takao; Yokoi, Chizu; Oda, Ichiro; Ando, Takayuki; Yoshida, Takeichi; Nanjo, Sohachi; Fujishiro, Mitsuhiro; Gotoda, Takuji; Ichinose, Masao; Ushijima, Toshikazu			Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study	GUT			English	Article							ABERRANT DNA METHYLATION; HELICOBACTER-PYLORI ERADICATION; EARLY GASTRIC-CANCER; FIELD DEFECT; ULCERATIVE-COLITIS; HEPATOCELLULAR-CARCINOMA; ENDOSCOPIC RESECTION; BARRETTS-ESOPHAGUS; COLORECTAL-CANCER; CHRONIC HEPATITIS	Background Epigenetic alterations accumulate in normal-appearing tissues of patients with cancer, producing an epigenetic field defect. Cross-sectional studies show that the degree of the defect may be associated with risk in some types of cancer, especially cancers associated with chronic inflammation. Objective To demonstrate, by a multicentre prospective cohort study, that the risk of metachronous gastric cancer after endoscopic resection (ER) can be predicted by assessment of the epigenetic field defect using methylation levels. Design Patients with early gastric cancer, aged 40-80 years, who planned to have, or had undergone, ER, were enrolled at least 6 months after Helicobacter pylori infection discontinued. Methylation levels of three preselected genes (miR-124a-3, EMX1 and NKX6-1) were measured by quantitative methylation-specific PCR. Patients were followed up annually by endoscopy, and the primary endpoint was defined as detection of a metachronous gastric cancer. Authentic metachronous gastric cancers were defined as cancers excluding those detected within 1 year after the enrolment. Results Among 826 patients enrolled, 782 patients had at least one follow-up, with a median follow-up of 2.97 years. Authentic metachronous gastric cancers developed in 66 patients: 29, 16 and 21 patients at 1-2, 2-3 and >= 3 years after the enrolment, respectively. The highest quartile of the miR-124a-3 methylation level had a significant univariate HR (95% CI) (2.17 (1.07 to 4.41); p=0.032) and a multivariate-adjusted HR (2.30 (1.03 to 5.10); p=0.042) of developing authentic metachronous gastric cancers. Similar trends were seen for EMX1 and NKX6-1. Conclusions Assessment of the degree of an epigenetic field defect is a promising cancer risk marker that takes account of life history.	[Asada, Kiyoshi; Ando, Takayuki; Nanjo, Sohachi; Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 1040045, Japan; [Nakajima, Takeshi; Yokoi, Chizu; Oda, Ichiro; Gotoda, Takuji] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Shimazu, Taichi] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Yamamichi, Nobutake; Fujishiro, Mitsuhiro] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; [Maekita, Takao; Yoshida, Takeichi; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan; [Yokoi, Chizu] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Gotoda, Takuji] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Ushijima, T (reprint author), Natl Canc Ctr, Res Inst, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tushijim@ncc.go.jp	Shimazu, Taichi/A-4470-2015	Shimazu, Taichi/0000-0001-6000-9830	Ministry of Health, Labour and Welfare [H20-genome-g-006]; National Cancer Center Research and Development Fund, Japan [H23-A-2]	This study was supported by a grant-in-aid for pioneering basic research from the Ministry of Health, Labour (H20-genome-g-006) and Welfare and by a National Cancer Center Research and Development Fund (H23-A-2), Japan.	Voutilainen ME, 2005, EUR J GASTROEN HEPAT, V17, P1345, DOI 10.1097/00042737-200512000-00013; Issa JPJ, 2001, CANCER RES, V61, P3573; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Maehata Y, 2012, GASTROINTEST ENDOSC, V75, P39, DOI 10.1016/j.gie.2011.08.030; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Kato M, 2013, GUT, V62, P1425, DOI 10.1136/gutjnl-2011-301647; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Jin Z, 2009, CANCER RES, V69, P4112, DOI 10.1158/0008-5472.CAN-09-0028; Takamaru H, 2012, CANCER PREV RES, V5, P1203, DOI 10.1158/1940-6207.CAPR-12-0056; Shen LL, 2005, J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Eads CA, 2000, CANCER RES, V60, P5021; Hsieh CJ, 1998, CANCER RES, V58, P3942; Hosokawa O, 1998, ENDOSCOPY, V30, P669, DOI 10.1055/s-2007-1001386; Lee YC, 2011, CANCER PREV RES, V4, P1982, DOI 10.1158/1940-6207.CAPR-11-0096; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; Nishiyama N, 2010, CANCER SCI, V101, P231, DOI 10.1111/j.1349-7006.2009.01330.x; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Grabsch HI, 2013, DIGEST SURG, V30, P150, DOI 10.1159/000350876; Chan AOO, 2006, GUT, V55, P463, DOI 10.1136/gut.2005.077776; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467; Nanjo S, 2012, GASTRIC CANCER, V15, P382, DOI 10.1007/s10120-011-0126-1; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hip.22110; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Azuara D, 2013, INFLAMM BOWEL DIS, V19, P165, DOI 10.1002/ibd.22994; MOERTEL CG, 1957, GASTROENTEROLOGY, V32, P1095; Nakajima Takeshi, 2006, Gastric Cancer, V9, P93, DOI 10.1007/s10120-006-0372-9; Nakajima T, 2010, J GASTROENTEROL, V45, P37, DOI 10.1007/s00535-009-0142-7; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Shin CM, 2012, J PATHOL, V226, P654, DOI 10.1002/path.2990; Shiotani A, 2012, DIGEST DIS SCI, V57, P643, DOI 10.1007/s10620-011-1916-3	37	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	MAR	2015	64	3					388	396		10.1136/gutjnl-2014-307094		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB1GZ	WOS:000349376600007		
J	Mochizuki, S; Uedo, N; Oda, I; Kaneko, K; Yamamoto, Y; Yamashina, T; Suzuki, H; Kodashima, S; Yano, T; Yamamichi, N; Goto, O; Shimamoto, T; Fujishiro, M; Koike, K				Mochizuki, Satoshi; Uedo, Noriya; Oda, Ichiro; Kaneko, Kazuhiro; Yamamoto, Yorimasa; Yamashina, Takeshi; Suzuki, Haruhisa; Kodashima, Shinya; Yano, Tomonori; Yamamichi, Nobutake; Goto, Osamu; Shimamoto, Takeshi; Fujishiro, Mitsuhiro; Koike, Kazuhiko		SAFE Trial Study Grp	Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicentre prospective randomised controlled non-inferiority trial	GUT			English	Article							RISK-FACTORS; ROUTINE 2ND-LOOK; CLINICAL-TRIAL; METAANALYSIS; MANAGEMENT; THERAPY; CANCER; ULCERS; 2ND	Objective To clarify the effectiveness of second-look endoscopy (SLE) at preventing bleeding after gastric endoscopic submucosal dissection (ESD). Design A multicentre prospective randomised controlled non-inferiority trial was conducted at five referral institutions across Japan. Patients with a solitary gastric neoplasm were enrolled. Exclusion criteria were previous oesophagogastric surgery or radiation therapy; perforation and the administration of antithrombotics, steroids or non-steroidal anti-inflammatory drugs. Patients were assigned to the SLE group or the non-SLE group by a computer-generated random sequence after ESD and were treated perioperatively with a proton pump inhibitor. SLE was performed one day after ESD. The primary endpoint was post-ESD bleeding, defined as an endoscopically proven haemorrhage. The trial had the power to detect a non-inferiority criterion of 7% between the groups. Results From February 2012 to February 2013, 130 and 132 patients were assigned to the SLE and the non-SLE groups, respectively. All patients were included in the intention-to-treat analysis of the primary endpoint. Post-ESD bleeding occurred in seven patients with (5.4%) SLE and five patients with (3.8%) non-SLE (risk difference -1.6% (95% CI -6.7 to 3.5); p(non-inferiority)<0.001), meeting the non-inferiority criterion. All 12 patients with post-ESD bleeding and one patient with a delayed perforation were successfully managed with conservative treatment. Conclusions SLE after gastric ESD is not routinely recommended because it does not contribute to the prevention of post-ESD bleeding for patients with an average bleeding risk.	[Mochizuki, Satoshi; Kodashima, Shinya; Yamamichi, Nobutake; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Uedo, Noriya; Yamashina, Takeshi] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan; [Oda, Ichiro; Suzuki, Haruhisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Kaneko, Kazuhiro; Yano, Tomonori] Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, Kashiwa, Chiba, Japan; [Yamamoto, Yorimasa] Canc Inst Hosp, Endoscopy Div, Gastrointestinal Ctr, Tokyo, Japan; [Goto, Osamu] Keio Univ, Sch Med, Ctr Canc, Div Res & Dev Minimally Invas Treatment, Tokyo, Japan; [Shimamoto, Takeshi] Kameda Med Ctr Makuhari, Dept Stat & Informat Management, Chiba, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo, Japan	Fujishiro, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mtfujish-kkr@umin.ac.jp	Suzuki, Hidekazu/J-4396-2013		Astellas Pharmaceutical; Takeda Pharmaceutical; Zeria Pharmaceutical; Otsuka Pharmaceutical; AstraZeneca Pharmaceutical; Dainihon-Sumitomo Pharmaceutical; Taiho Pharmaceutical; Ajinomoto Pharmaceutical; Daiichi-Sankyo Pharmaceutical; Aska Pharmaceutical; Eisai	MF has received unrestricted grants from Astellas Pharmaceutical, Takeda Pharmaceutical, Zeria Pharmaceutical, Otsuka Pharmaceutical, AstraZeneca Pharmaceutical, Dainihon-Sumitomo Pharmaceutical, Taiho Pharmaceutical, Ajinomoto Pharmaceutical, Daiichi-Sankyo Pharmaceutical, Aska Pharmaceutical, and Eisai for his department; non-financial support from HOYA Pentax, Olympus Medical Systems, and Fujifilm for his department; and honoraria from Olympus Medical Systems, HOYA Pentax, Eisai, Daiichi-Sankyo Pharmaceutical, AstraZeneca Pharmaceutical, Aska Pharmaceutical, Taisho-Toyama Pharmaceutical, Otsuka Pharmaceutical, Zeria Pharmaceutical, Takeda Pharmaceutical, Astellas Pharmaceutical, Johnson & Johnson, Ajinomoto Pharmaceutical, Amco, Novartis Pharmaceutical, Boston Scientific, and Boehringer-Ingelheim outside the submitted work. The other authors declare that they have no conflicts of interest.	Higashiyama M, 2011, DIGEST ENDOSC, V23, P290, DOI 10.1111/j.1443-1661.2011.01151.x; Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Goto O, 2010, GASTROINTEST ENDOSC, V71, P241, DOI 10.1016/j.gie.2009.08.030; El Ouali S, 2012, GASTROINTEST ENDOSC, V76, P283, DOI 10.1016/j.gie.2012.04.441; Dinis-Ribeiro M, 2009, GASTROINTEST ENDOSC, V69, P350, DOI 10.1016/j.gie.2008.08.035; Okada K, 2011, SURG ENDOSC, V25, P98, DOI 10.1007/s00464-010-1137-4; Ryu HY, 2013, GASTROINTEST ENDOSC, V78, P285, DOI 10.1016/j.gie.2013.02.008; Calvet X, 2004, GASTROENTEROLOGY, V126, P441, DOI 10.1053/j.gastro.2003.11.006; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Takizawa K, 2008, ENDOSCOPY, V40, P179, DOI 10.1055/s-2007-995530; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516; Goto O, 2012, DIGEST DIS SCI, V57, P435, DOI 10.1007/s10620-011-1886-5; HELDWEIN W, 1989, ENDOSCOPY, V21, P258, DOI 10.1055/s-2007-1010729; Hirasawa K, 2011, GASTROINTEST ENDOSC, V74, P1268, DOI 10.1016/j.gie.2011.07.067; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Marmo R, 2003, GASTROINTEST ENDOSC, V57, P62, DOI 10.1067/mge.2003.48; Takeuchi T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-136; Toyokawa T, 2011, J GASTROEN HEPATOL, V27, P907; Tsoi KKF, 2009, NAT REV GASTRO HEPAT, V6, P717, DOI 10.1038/nrgastro.2009.186	21	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	MAR	2015	64	3					397	405		10.1136/gutjnl-2014-307552		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB1GZ	WOS:000349376600008		
J	Suto, Y; Gotoh, T; Noda, T; Akiyama, M; Owaki, M; Darroudi, F; Hirai, M				Suto, Yumiko; Gotoh, Takaya; Noda, Takashi; Akiyama, Miho; Owaki, Makiko; Darroudi, Firouz; Hirai, Momoki			ASSESSING THE APPLICABILITY OF FISH-BASED PREMATURELY CONDENSED DICENTRIC CHROMOSOME ASSAY IN TRIAGE BIODOSIMETRY	HEALTH PHYSICS			English	Article						biological indicators; cytogenetics; dose assessment; emergencies, radiological	PERIPHERAL-BLOOD LYMPHOCYTES; IRRADIATED HUMAN-LYMPHOCYTES; IN-SITU HYBRIDIZATION; BIOLOGICAL DOSIMETRY; METAPHASE CHROMOSOMES; ACCURATE DETECTION; RADIATION; ABERRATIONS; KINETICS; COMBINATION	The dicentric chromosome assay (DCA) has been regarded as the gold standard of radiation biodosimetry. The assay, however, requires a 2-d peripheral blood lymphocyte culture before starting metaphase chromosome analyses to estimate biological doses. Other biological assays also have drawbacks with respect to the time needed to obtain dose estimates for rapid decision on the correct line of medical treatment. Therefore, alternative technologies that suit requirements for triage biodosimetry are needed. Radiation-induced DNA double strand breaks in G0 lymphocytes can be detected as interphase chromosome aberrations by the cell fusion-mediated premature chromosome condensation (PCC) method. The method, in combination with fluorescence in situ hybridization (FISH) techniques, has been proposed in early studies as a powerful tool for obtaining biological dose estimates without 2-d lymphocyte culture procedures. The present work assesses the applicability of FISH-based PCC techniques using pan-centromeric and telomeric peptide nucleic acid (PNA) probes in triage mode biodosimetry and demonstrates that an improved rapid procedure of the prematurely condensed dicentric chromosome (PCDC) assay has the potential for evaluating exposed radiation doses in as short as 6 h after the collection of peripheral blood specimens.	[Suto, Yumiko; Gotoh, Takaya; Akiyama, Miho; Owaki, Makiko; Hirai, Momoki] Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Chiba 2638555, Japan; [Noda, Takashi] Natl Inst Radiol Sci, Radiat Emergency Med Assistance Team, Chiba 2638555, Japan; [Darroudi, Firouz] Univ Coll North Atlantic, Dept Hlth Sci, Doha, Qatar	Suto, Y (reprint author), Natl Inst Radiol Sci, Biodosimetry Res Team, Radiat Dosimetry Res Grp, Res Ctr Radiat Emergency Med,Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	y-suto@nirs.go.jp			IAEA CRP [E3.50.08]; Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan; NIH (Dart Dose) grant; European Commission, RENEB project	This research project was partly supported by grants from IAEA CRP E3.50.08, the Ministry of Health, Labour and Welfare, and the Ministry of Education, Culture, Sports, Science and Technology, Japan. Studies conducted at Leiden University by Firouz Darroudi were partly supported by an NIH (Dart Dose) grant and a grant from the European Commission, RENEB project.	Ainsbury EA, 2010, HEALTH PHYS, V98, P290, DOI 10.1097/01.HP.0000346305.84577.b4; PANTELIAS GE, 1984, RADIAT RES, V99, P140, DOI 10.2307/3576452; PANTELIAS GE, 1985, MUTAT RES, V149, P67, DOI 10.1016/0027-5107(85)90010-7; Flegal FN, 2012, HEALTH PHYS, V102, P143, DOI 10.1097/HP.0b013e3182307758; Ainsbury EA, 2009, RADIAT RES, V172, P746, DOI 10.1667/RR1934.1; PANTELIAS GE, 1983, SOMAT CELL GENET, V9, P533, DOI 10.1007/BF01574257; Darroudi F, 1998, MUTAT RES-FUND MOL M, V404, P55, DOI 10.1016/S0027-5107(98)00095-5; Fomina J, 2001, INT J RADIAT BIOL, V77, P1175, DOI 10.1080/09553000110083951; VYAS RC, 1991, MUTAT RES, V249, P29, DOI 10.1016/0027-5107(91)90130-G; PANTELIAS GE, 1993, INT J RADIAT BIOL, V63, P349, DOI 10.1080/09553009314550461; Romm H, 2011, RADIAT RES, V175, P397, DOI 10.1667/RR2321.1; Fomina J, 2000, INT J RADIAT BIOL, V76, P807; Durante M, 1998, INT J RADIAT BIOL, V74, P457, DOI 10.1080/095530098141320; Chambrette V, 1999, RADIAT PROT DOSIM, V82, P125; Darroudi F, 1998, INT J RADIAT BIOL, V74, P207, DOI 10.1080/095530098141582; GREINERT R, 1995, RADIAT RES, V144, P190, DOI 10.2307/3579258; Greinert R, 2000, RADIAT RES, V154, P87, DOI 10.1667/0033-7587(2000)154[0087:TKOPCR]2.0.CO;2; Horn S, 2013, RADIAT RES, V180, P603, DOI 10.1667/RR13342.1; International Atomic Energy Agency, 2011, CYT DOS APPL PREP RE; International Atomic Energy Agency, 2001, CYT DOS APPL RAD EM; LOHMAN PHM, 1992, ENVIRON HEALTH PERSP, V98, P155, DOI 10.2307/3431263; Rothkamm K, 2013, RADIAT RES, V180, P111, DOI 10.1667/RR3231.1; Suto Y, 2013, CYTOLOGIA, V78, P97, DOI 10.1508/cytologia.78.97; Suto Y, 2013, HEALTH PHYS, V105, P366, DOI 10.1097/HP.0b013e3182995e42; Suto Y, 2012, CYTOLOGIA, V77, P261, DOI 10.1508/cytologia.77.261; WALDREN CA, 1974, P NATL ACAD SCI USA, V71, P1137, DOI 10.1073/pnas.71.4.1137	26	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	MAR	2015	108	3					371	376		10.1097/HP.0000000000000182		6	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CB2IY	WOS:000349451800010		
J	Milward, P				Milward, Peter			A Companion to the Early Printed Book in Britain 1476-1558	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						GILLESPIE V, 2014, COMPANION EARLY PRIN	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					313	315		10.1111/heyj.12239_7		3	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000017		
J	Milward, P				Milward, Peter			Imitatio Christi: The Poetics' of Piety in Early Modern England	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						PERRY N, 2014, IMITATIO CHRISTI POE	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					315	316		10.1111/heyj.12239_8		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000018		
J	Milward, P				Milward, Peter			Writing Faith and Telling Tales: Literature, Politics, and Religion in the Work of Thomas More	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						BETTERIDGE T, 2013, WRITING FAITH TELLIN	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					316	317		10.1111/heyj.12239_9		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000019		
J	Milward, P				Milward, Peter			John Skelton: The Career of an Early Tudor Poet	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						SCATTERGOOD J, 2014, J SKELTON CAREER EAR	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					317	318		10.1111/heyj.12239_10		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000020		
J	Milward, P				Milward, Peter			Treacherous Faith: The Specter of Heresy in Early Modern English Literature and Culture	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						LOEWENSTEIN D, 2013, TREACHEROUS FAITH SP	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					318	319		10.1111/heyj.12239_11		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000021		
J	Milward, P				Milward, Peter			Who Was William Shakespeare?	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						CALLAGHAN D, 2013, WHO WAS W SHAKESPEAR	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					319	321		10.1111/heyj.12239_12		3	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000022		
J	Milward, P				Milward, Peter			Mortal Thoughts: Religion: Secularity, & Identity in Shakespeare and Early Modern Culture	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						CUMMINGS B, 2013, MORTAL THOUGHTS RELI	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					322	323		10.1111/heyj.12239_14		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000024		
J	Milward, P				Milward, Peter			Passionate Playgoing in Early Modern England	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						HOBGOOD AP, 2014, PASSIONATE PLAYGOING	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					323	325		10.1111/heyj.12239_15		3	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000025		
J	Milward, P				Milward, Peter			Medieval Shakespeare: Pasts and Presents	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						Morse Ruth, 2013, MEDIEVAL SHAKESPEARE	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					325	327		10.1111/heyj.12239_16		3	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000026		
J	Milward, P				Milward, Peter			Making Make-Believe Real: Politics and Theater in Shakespeare's Time	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						WILLS G, 2014, MAKING MAKE BELIEVE	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					327	328		10.1111/heyj.12239_17		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000027		
J	Milward, P				Milward, Peter			A Will to Believe: Shakespeare and Religion	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						KASTAN DS, 2014, WILL BELIEVE SHAKESP	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					329	330		10.1111/heyj.12239_18		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000028		
J	Milward, P				Milward, Peter			Faith in Shakespeare	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						MCCOY RC, 2013, FAITH SHAKESPEARE	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					330	332		10.1111/heyj.12239_19		3	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000029		
J	Milward, P				Milward, Peter			The Hamlet Doctrine	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						CRITCHLEY S, 2013, HAMLET DOCTRINE	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					332	334		10.1111/heyj.12239_20		3	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000030		
J	Milward, P				Milward, Peter			Philosophical Pearls of the Shakespearean Deep	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						ZABEEH F, 2013, PHILOS PEARLS SHAKES	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					334	335		10.1111/heyj.12239_21		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000031		
J	Milward, P				Milward, Peter			Victorian Reformations: Historical Fiction and Religious Controversy, 1820-1900	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						BURSTEIN ME, 2014, VICTORIAN REFORMATIO	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					340	341		10.1111/heyj.12239_28		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000038		
J	Milward, P				Milward, Peter			John Henry Newman: Sermons 1824-1843, vol 4	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						MCGRATH FJ, 2011, JH NEWMAN SERMONS 18, V4	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					341	342		10.1111/heyj.12239_29		2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000039		
J	Milward, P				Milward, Peter			The Unexpected Professor: An Oxford Life in Books.	HEYTHROP JOURNAL			English	Book Review									[Milward, Peter] Sophia Univ, Tokyo 102, Japan	Milward, P (reprint author), Sophia Univ, Tokyo 102, Japan.						Carey John, 2014, UNEXPECTED PROFESSOR	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0018-1196	1468-2265		HEYTHROP J	Heythrop J.	MAR	2015	56	2					359	360				2	Philosophy; Religion	Philosophy; Religion	CB0GN	WOS:000349304000062		
J	Kamiunten, T; Ideno, H; Shimada, A; Nakamura, Y; Kimura, H; Nakashima, K; Nifuji, A				Kamiunten, Taichi; Ideno, Hisashi; Shimada, Akemi; Nakamura, Yoshiki; Kimura, Hiroshi; Nakashima, Kazuhisa; Nifuji, Akira			Coordinated expression of H3K9 histone methyltransferases during tooth development in mice	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Histone methylation; Tooth development; Cell differentiation; Gene expression	DNA METHYLATION; MAMMALIAN TOOTH; SET DOMAIN; G9A; GENE; GLP; MORPHOGENESIS; PROTEIN; TRANSCRIPTION; RECRUITMENT	Tissue-specific gene expression is subjected to epigenetic and genetic regulation. Posttranslational modifications of histone tails alter the accessibility of nuclear proteins to DNA, thus affecting the activity of the regulatory complex of nuclear proteins. Methylation at histone 3 lysine 9 (H3K9) is a crucial modification that affects gene expression and cell differentiation. H3K9 is known to have 0-3 methylation states, and these four methylated states are determined by the expression of sets of histone methyltransferases. During development, teeth are formed through mutual interactions between the mesenchyme and epithelium via a process that is subjected to the epigenetic regulation. In this study, we examined the expression of all H3K9 methyltransferases (H3K9MTases) during mouse tooth development. We found that four H3K9MTases-G9a, Glp, Prdm2, and Suv39h1-were highly expressed in the tooth germ, with expression peaks at around embryonic days 16.5 and 17.5 in mice. Immunohistochemical and in situ hybridization analyses revealed that all four H3K9MTases were enriched in the mesenchyme more than in the epithelium. Substrates of H3K9MTases, H3K9me1, H3K9me2, and H3K9me3 were also enriched in the mesenchyme. Taken together, these data suggested that coordinated expression of four H3K9MTases in the dental mesenchyme might play important roles in tooth development.	[Kamiunten, Taichi; Ideno, Hisashi; Shimada, Akemi; Nakashima, Kazuhisa; Nifuji, Akira] Tsurumi Univ, Dept Pharmacol, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan; [Kamiunten, Taichi; Nakamura, Yoshiki] Tsurumi Univ, Dept Orthodont, Sch Dent Med, Yokohama, Kanagawa 2308501, Japan; [Ideno, Hisashi; Nifuji, Akira] Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 260, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Nifuji, A (reprint author), Tsurumi Univ, Dept Pharmacol, Sch Dent Med, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	nifuji-a@tsurumi-u.ac.jp			JSPS KAKENHI [22390344, 23659862, 25670784]	This study was supported by grants-in-aid funding for scientific research (JSPS KAKENHI Grant Numbers 22390344, 23659862, 25670784 to A.N.).	Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad989402; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Tong X, 2013, J BIOL CHEM, V288, P5417, DOI 10.1074/jbc.M112.433482; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Chen YP, 1996, DEVELOPMENT, V122, P3035; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Chen XJ, 2012, GENE DEV, V26, P2499, DOI 10.1101/gad.200329.112; Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Jia SH, 2013, DEVELOPMENT, V140, P423, DOI 10.1242/dev.081927; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Saadi I, 2013, DEVELOPMENT, V140, P2697, DOI 10.1242/dev.088393; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Purcell DJ, 2012, J CELL BIOCHEM, V113, P2406, DOI 10.1002/jcb.24114; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Blackburn ML, 2003, BBA-GENE STRUCT EXPR, V1629, P8, DOI 10.1016/S0167-4781(03)00155-6; Dodge E, 2004, MOL CELL BIOL, V24, P2478; Ideno H, 2013, GENE EXPR PATTERNS, V13, P84, DOI 10.1016/j.gep.2013.01.002; Ideno H, 2014, J HISTOL, V2014, DOI [10.1155/2014/658293, DOI 10.1155/2014/658293]; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Nifuji A, 1999, J BONE MINER RES, V14, P2057, DOI 10.1359/jbmr.1999.14.12.2057; Nifuji A, 2010, EXP CELL RES, V316, P1127, DOI 10.1016/j.yexcr.2010.01.023; Oh ST, 2014, FEBS LETT, V588, P685, DOI 10.1016/j.febslet.2014.01.039	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	MAR	2015	143	3					259	266		10.1007/s00418-014-1284-0		8	Cell Biology; Microscopy	Cell Biology; Microscopy	CA9LX	WOS:000349246200003		
J	Konno, K; Takahashi-Iwanaga, H; Uchigashima, M; Miyasaka, K; Funakoshi, A; Watanabe, M; Iwanaga, T				Konno, Kohtarou; Takahashi-Iwanaga, Hiromi; Uchigashima, Motokazu; Miyasaka, Kyoko; Funakoshi, Akihiro; Watanabe, Masahiko; Iwanaga, Toshihiko			Cellular and subcellular localization of cholecystokinin (CCK)-1 receptors in the pancreas, gallbladder, and stomach of mice	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Cholecystokinin; CCK1 receptor; Pancreas; Stomach; Gallbladder	GASTRIC-ACID-SECRETION; CCK-B/GASTRIN RECEPTORS; ACINAR-CELLS; A RECEPTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; PEPSINOGEN SECRETION; EXOCRINE CELLS; SOLITARY TRACT; SMOOTH-MUSCLE; RAT PANCREAS	Information concerning the cellular localization of cholecystokinin (CCK)-1 receptors has been discrepant and remained scanty at ultrastructural levels. The present immunohistochemical study at light and electron microscopic levels revealed the distinct localization of CCK1 receptors in visceral organs. Immunohistochemistry by use of a purified antibody against mouse CCK1 receptor was applied to fixed tissue sections of the pancreas, gallbladder, stomach, and intestine of mice. A silver-intensified immunogold method revealed the subcellular localization under electron microscope. The immunoreactivity for CCK1 receptors was selectively found in the basolateral membrane of pancreatic acinar cells and gastric chief cells but was absent in pancreatic islets and gastric D cells. Another intense expression in the gut was seen in the myenteric nerve plexus of the antro-duodenal region and some populations of c-Kit-expressing pacemaker cells in the duodenal musculature. The gallbladder contained smooth muscle fibers with an intense immunoreactivity of CCK1 receptors on cell surfaces. The restricted localization of CCK1 receptors on the basolateral membrane of pancreatic acinar cells and gastric chief cells, along with their absence in the islets of Langerhans and gastric D cells, provides definitive information concerning the regulatory mechanism by circulating CCK. Especially, the subcellular localization in the acinar cells completes the investigation for the detection of circulating CCK by the basolateral membrane.	[Konno, Kohtarou; Takahashi-Iwanaga, Hiromi; Uchigashima, Motokazu; Watanabe, Masahiko; Iwanaga, Toshihiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Miyasaka, Kyoko] Tokyo Kasei Univ, Dept Physiol & Nutr, Tokyo 1738602, Japan; [Funakoshi, Akihiro] Fukuoka Sanno Hosp, Div Pancreatol, Dept Internal Med, Sawara Ku, Fukuoka 8140001, Japan	Iwanaga, T (reprint author), Hokkaido Univ, Dept Anat, Grad Sch Med, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	tiwanaga@med.hokudai.ac.jp	WATANABE, Masahiko/A-4055-2012		Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Cooperation;  [19100005]	This study is supported by Grants-in-Aid for Scientific Research 19100005 (to M.W.) and Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Cooperation (to M.W.).	Karlsson S, 1998, REGUL PEPTIDES, V78, P95, DOI 10.1016/S0167-0115(98)00136-0; Kageyama H, 2005, REGUL PEPTIDES, V126, P137, DOI 10.1016/j.regpep.2004.08.033; MORAN TH, 1990, BRAIN RES, V526, P95, DOI 10.1016/0006-8993(90)90253-8; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628; Blandizzi C, 1999, EUR J PHARMACOL, V373, P71, DOI 10.1016/S0014-2999(99)00212-5; Reubi JC, 1997, GASTROENTEROLOGY, V112, P1197, DOI 10.1016/S0016-5085(97)70131-8; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Bourassa J, 1999, BIOCHEM BIOPH RES CO, V260, P820, DOI 10.1006/bbrc.1999.0988; Morisset J, 2003, J HISTOCHEM CYTOCHEM, V51, P1501; Shin DM, 2001, J BIOL CHEM, V276, P44146, DOI 10.1074/jbc.M105203200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Patterson LM, 2001, CELL TISSUE RES, V305, P11, DOI 10.1007/s004410100402; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010; BOLENDER RP, 1974, J CELL BIOL, V61, P269, DOI 10.1083/jcb.61.2.269; BUCHAN AMJ, 1993, GASTROENTEROLOGY, V104, P1414; Criddle DN, 2009, AM J PHYSIOL-GASTR L, V297, pG1085, DOI 10.1152/ajpgi.00119.2009; DEWEERTH A, 1993, BIOCHEM BIOPH RES CO, V194, P811, DOI 10.1006/bbrc.1993.1894; Glatzle J, 2001, AM J PHYSIOL-REG I, V281, pR222; HABARA Y, 1991, CELL CALCIUM, V12, P533, DOI 10.1016/0143-4160(91)90073-N; Helander HF, 1997, ACTA PHYSIOL SCAND, V159, P313, DOI 10.1046/j.1365-201X.1997.114360000.x; Ji B, 2001, GASTROENTEROLOGY, V121, P1380; LADENHEIM EE, 1988, BRAIN RES, V474, P125, DOI 10.1016/0006-8993(88)90675-0; Li Q, 2004, J BIOL CHEM, V279, P27837, DOI 10.1074/jbc.C400184200; LIN CW, 1992, AM J PHYSIOL, V262, pG1113; LLOYD KCK, 1992, AM J PHYSIOL, V263, pG287; LLOYD KCK, 1992, GASTROENTEROLOGY, V102, P131; LLOYD KCK, 1994, PEPTIDES, V15, P223, DOI 10.1016/0196-9781(94)90006-X; MANTYH CR, 1994, GASTROENTEROLOGY, V107, P1019; MAWE GM, 1991, J PHYSIOL-LONDON, V439, P89; MORGAN KG, 1978, AM J PHYSIOL, V235, pE324; Murphy JA, 2008, GASTROENTEROLOGY, V135, P632, DOI 10.1053/j.gastro.2008.05.026; MURPHY RB, 1987, PEPTIDES, V8, P127, DOI 10.1016/0196-9781(87)90176-8; Ohlsson B, 2000, SCAND J GASTROENTERO, V35, P612; Owyang Chung, 2004, Gastroenterology, V127, P957, DOI 10.1053/j.gastro.2004.05.002; RAYBOULD HE, 1988, J NEUROSCI, V8, P3018; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; SCHEURER U, 1983, AM J PHYSIOL, V244, pG261; SCHJOLDAGER B, 1989, GASTROENTEROLOGY, V96, P1119; SCHMIDT WE, 1994, GASTROENTEROLOGY, V107, P1610; Schmitz F, 2001, REGUL PEPTIDES, V102, P101, DOI 10.1016/S0167-0115(01)00307-X; Schulz S, 2005, J CLIN ENDOCR METAB, V90, P6149, DOI 10.1210/jc.2005-0172; Singer MV, 2009, CELL BIOL INT, V33, P1, DOI 10.1016/j.cellbi.2008.09.008; SMITH GP, 1985, AM J PHYSIOL, V249, pR638; SMITH GT, 1984, AM J PHYSIOL, V246, pR127; Sternini C, 1999, GASTROENTEROLOGY, V117, P1136, DOI 10.1016/S0016-5085(99)70399-9; Suzuki S, 2001, JPN J PHYSIOL, V51, P585, DOI 10.2170/jjphysiol.51.585; Tang CW, 1996, GASTROENTEROLOGY, V111, P1621, DOI 10.1016/S0016-5085(96)70025-2; TANG LH, 1993, AM J PHYSIOL, V265, pG865; Walsh JH, 1987, PHYSL GASTROINTESTIN, P181; WILLIAMS JA, 1982, BIOMED RES-TOKYO, V3, P107	50	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	MAR	2015	143	3					301	312		10.1007/s00418-014-1281-3		12	Cell Biology; Microscopy	Cell Biology; Microscopy	CA9LX	WOS:000349246200007		
J	Nenoi, M; Wang, B; Vares, G				Nenoi, M.; Wang, B.; Vares, G.			In vivo radioadaptive response: A review of studies relevant to radiation-induced cancer risk	HUMAN & EXPERIMENTAL TOXICOLOGY			English	Review						Radioadaptive response; low-dose-rate radiation; intercellular signal transduction; protective bystander effect; endocrine regulation	LOW-DOSE RADIATION; CYTOGENETIC ADAPTIVE RESPONSE; FIELD GEL-ELECTROPHORESIS; P53 TUMOR-SUPPRESSOR; GLUCOCORTICOID-RECEPTOR; HUMAN-LYMPHOCYTES; IONIZING-RADIATION; DNA-DAMAGE; OCCUPATIONAL EXPOSURE; RESTRICTION ENZYMES	Radioadaptive response (RAR) describes phenomena where small conditioning doses of ionizing radiation (IR) reduce detrimental effects of subsequent higher IR doses. Current radiation protection regulations do not include RAR because of the large variability in expression among individuals and uncertainties of the mechanism. However, RAR should be regarded as an indispensable factor for estimation and control of individual IR sensitivity. In this article, RAR studies relevant to individual cancer risk are reviewed. Using various stains of mice, carcinogenic RAR has been demonstrated. Consistently much in vivo evidence for RAR with end points of DNA and chromosome damage is reported. Most in vivo RAR studies revealed efficient induction of RAR by chronic or repeated low-dose priming irradiation. Chronic IR-induced RAR was observed also in human individuals after environmental, occupational, and nuclear accident radiation exposure. These observations may be associated with an intrinsically distinct feature of in vivo experimental systems that mainly consist of nonproliferating mature cells. Alternatively, induction of RAR by gap junction-mediated bystander effects suggests that multicellular systems comprising densely communicating cells may be capable of responding to long-lasting low-dose-rate priming irradiation. Regulation by endocrine factors is also a plausible mechanism for RAR at an individual level. Emerging evidence suggests that glucocorticoids, known as stress hormones, participate in in vivo RAR induction following long-term low-dose-rate exposure to IR.	[Nenoi, M.; Wang, B.; Vares, G.] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 2638555, Japan	Nenoi, M (reprint author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	m_nenoi@nirs.go.jp	Vares,  Guillaume/A-9257-2011	Vares,  Guillaume/0000-0002-6191-9032	JSPS KAKENHI [25340041]	This work was partially supported by JSPS KAKENHI 25340041.	Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Maiyar AC, 1997, MOL ENDOCRINOL, V11, P312, DOI 10.1210/me.11.3.312; Feng ZH, 2012, P NATL ACAD SCI USA, V109, P7013, DOI 10.1073/pnas.1203930109; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P542, DOI 10.1073/pnas.79.2.542; Bhattacharjee D, 1996, MUTAT RES-FUND MOL M, V358, P231, DOI 10.1016/S0027-5107(96)00125-X; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Mitchel REJ, 2003, RADIAT RES, V159, P320, DOI 10.1667/0033-7587(2003)159[0320:LDORIT]2.0.CO;2; WIENCKE JK, 1986, MUTAGENESIS, V1, P375, DOI 10.1093/mutage/1.5.375; Kind JA, 2001, J TOXICOL ENV HEAL A, V63, P207, DOI 10.1080/15287390151101565; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Otsuka K, 2006, RADIAT RES, V166, P474, DOI 10.1667/RR0561.1; Klammer H, 2010, CANCER RES, V70, P8498, DOI 10.1158/0008-5472.CAN-10-1181; Day TK, 2006, RADIAT RES, V166, P757, DOI 10.1667/RR0689.1; LIU SZ, 1992, INT J RADIAT BIOL, V62, P187, DOI 10.1080/09553009214552001; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Sengupta S, 2001, GENE DEV, V15, P2367, DOI 10.1101/gad.202201; NAGASAWA H, 1992, CANCER RES, V52, P6394; Mitchel R. E. J., 2006, Dose-Response, V4, P75, DOI 10.2203/dose-response.04-002.Mitchel; Wang B, 2013, J RADIAT RES, V54, P45, DOI 10.1093/jrr/rrs077; CAI L, 1990, INT J RADIAT BIOL, V58, P187, DOI 10.1080/09553009014551541; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Matsumoto H, 2007, J RADIAT RES, V48, P97, DOI 10.1269/jrr.06090; Mitchel REJ, 1999, RADIAT RES, V152, P273, DOI 10.2307/3580327; Ina Y, 2005, RADIAT RES, V163, P153, DOI 10.1667/RR3289; Jiang BC, 2013, MUTAT RES-GEN TOX EN, V751, P127, DOI 10.1016/j.mrgentox.2012.12.003; Ghiassi-nejad M, 2002, HEALTH PHYS, V82, P87, DOI 10.1097/00004032-200201000-00011; Boonstra R, 2005, ENVIRON TOXICOL CHEM, V24, P334, DOI 10.1897/03-163R.1; Sasaki MS, 2002, MUTAT RES-FUND MOL M, V504, P101, DOI 10.1016/S0027-5107(02)00084-2; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; MUNCK A, 1984, ENDOCR REV, V5, P25; Masoro EJ, 1998, EXP GERONTOL, V33, P61, DOI 10.1016/S0531-5565(97)00071-5; POMERANTSEVA MD, 1984, MUTAT RES, V141, P195, DOI 10.1016/0165-7992(84)90096-4; SHADLEY JD, 1989, INT J RADIAT BIOL, V56, P107, DOI 10.1080/09553008914551231; BARQUINERO JF, 1995, INT J RADIAT BIOL, V67, P187, DOI 10.1080/09553009514550231; Cha HH, 1998, J BIOL CHEM, V273, P1998, DOI 10.1074/jbc.273.4.1998; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; Dubrova YE, 2002, MUTAT RES-FUND MOL M, V499, P143, DOI 10.1016/S0027-5107(01)00284-6; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Howell EK, 2013, RADIAT RES, V179, P29, DOI 10.1667/RR3029.1; ICRP, 2005, ANN ICRP, V35, P1; Ikeda M, 2007, MUTAT RES-GEN TOX EN, V626, P15, DOI 10.1016/j.mrgentox.2006.07.003; Jiang BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032040; Kakinuma S, 2009, J RADIAT RES, V50, P401, DOI 10.1269/jrr.09051; Kalina I, 1997, FOLIA BIOL-PRAGUE, V43, P91; Kellendonk C, 1999, J STEROID BIOCHEM, V69, P253, DOI 10.1016/S0960-0760(99)00041-2; Kleczkowska HE, 1996, MUTAT RES-FUND MOL M, V358, P215, DOI 10.1016/S0027-5107(96)00123-6; Liu Shu-Zheng, 2004, Nonlinearity Biol Toxicol Med, V2, P233, DOI 10.1080/15401420490507486; LOBRICH M, 1994, RADIAT RES, V138, P186, DOI 10.2307/3578588; LOBRICH M, 1994, INT J RADIAT BIOL, V65, P623, DOI 10.1080/09553009414550731; Matsumoto H, 2009, J RADIAT RES, V50, pA67, DOI 10.1269/jrr.09003S; Mitchel RE, 2006, DOSE-RESPONSE, V5, P1; Mosse L, 2000, RADIAT ENVIRON BIOPH, V39, P47; Nenoi M, 2009, RAD BIOL RES COMMUN, V44, P294; Nenoi M, 2012, RADIOL SCI, V55, P35; Nomura T, 2006, J RADIAT RES, V47, pB83, DOI 10.1269/jrr.47.B83; Ojima M, 2011, RADIAT PROT DOSIM, V146, P276, DOI 10.1093/rpd/ncr169; Phan N, 2012, RADIAT RES, V177, P164, DOI 10.1667/RR2532.1; Sengupta S, 2004, ANN NY ACAD SCI, V1024, P54, DOI 10.1196/annals.1321.005; Shimizu T, 1999, EXP CELL RES, V251, P424, DOI 10.1006/excr.1999.4582; Sorokina SS, 2011, RADIAT PROT DOSIM, V143, P305, DOI 10.1093/rpd/ncq531; Souchkevitch G, 1997, STEM CELLS, V15, P151; Takahashi A, 2008, INT J RADIAT ONCOL, V71, P550, DOI 10.1016/j.ijrobp.2008.02.001; Tapio S, 2006, RADIAT ENVIRON BIOPH, V46, P1; Thierens H, 2002, INT J RADIAT BIOL, V78, P1117, DOI 10.1080/0955300021000034710; Vares G, 2011, MUTAT RES-FUND MOL M, V706, P46, DOI 10.1016/j.mrfmmm.2010.10.009; Vares G, 2011, J RADIAT RES, V52, P249, DOI 10.1269/jrr.10110; Vares G, 2011, MUTAT RES-FUND MOL M, V712, P49, DOI [10.1016/j.mrfmmm.2011.03.004, 10.1016/j.mrfmmm.2011.04.004]; Vares G, 2006, INDIAN J RAD RES, V3, P16; Wu JY, 2006, MUTAT RES-FUND MOL M, V596, P1, DOI 10.1016/j.mrfmmm.2005.09.004; YOUNGBLOM JH, 1989, MUTAT RES, V227, P257, DOI 10.1016/0165-7992(89)90107-3	73	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0960-3271	1477-0903		HUM EXP TOXICOL	Hum. Exp. Toxicol.	MAR	2015	34	3					272	283		10.1177/0960327114537537		12	Toxicology	Toxicology	CB3BW	WOS:000349504200006		
J	Taniuchi, D; Liu, XP; Nakai, D; Maekawa, T				Taniuchi, Daisuke; Liu, Xiaopeng; Nakai, Daisuke; Maekawa, Takuya			Spring Model Based Collaborative Indoor Position Estimation With Neighbor Mobile Devices	IEEE JOURNAL OF SELECTED TOPICS IN SIGNAL PROCESSING			English	Article						Indoor positioning; received signal strength (RSS); fingerprinting; neighbor mobile devices; spring model; collaborative positioning	LOCATION; LOCALIZATION; SYSTEMS	Nowadays, as the widespread of smart-phones that equipped with Wi-Fi modules, many researchers have studied Wi-Fi based indoor positioning techniques. The existing method makes use of the Wi-Fi received signal strength (RSS) information that collected from several places indoors in advance to estimate the position of a mobile device by referring to a fingerprinting algorithm. Based on the existing method, this paper addresses a high-precision collaborative indoor positioning method. We first estimate the position coordinates of neighbor mobile devices and the distances between the devices by using the Wi-Fi and Bluetooth sensors on them. Then, by making use of the position and distance information, we utilize the spring model to correct the positioning errors. In addition, we performed the evaluation experiment in a real indoor environment, and confirmed the feasibility of our proposed method.	[Taniuchi, Daisuke; Liu, Xiaopeng; Nakai, Daisuke; Maekawa, Takuya] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Taniuchi, D (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	taniuchi.daisuke@ist.osaka-u.ac.jp; shuusei_shun@yahoo.co.jp; nakai.daisuke@ist.osaka-u.ac.jp; maekawa@ist.osaka-u.ac.jp	Ji, Kyung Yang/J-9304-2013				Kaemarungsi K, 2004, IEEE INFOCOM SER, P1012; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chawathe SS, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, P980; [Anonymous], 2010, P 16 ANN INT C MOB C, DOI 10.1145/1859995.1860013; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Liu H, 2007, IEEE T SYST MAN CY C, V37, P1067, DOI 10.1109/TSMCC.2007.905750; WANT R, 1992, ACM T INFORM SYST, V10, P91, DOI 10.1145/128756.128759; Wang YP, 2013, 2013 IEEE CONSUMER COMMUNICATIONS AND NETWORKING CONFERENCE (CCNC), P837; Bahl P., 2000, Proceedings IEEE INFOCOM 2000. Conference on Computer Communications. Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies (Cat. No.00CH37064), DOI 10.1109/INFCOM.2000.832252; Bing B., 2002, WIRELESS LOCAL AREA; Chan LW, 2006, LECT NOTES COMPUT SC, V3968, P50; Higuchi T., 2013, PERVASIVE MOB COMPUT, V13, P26; Kloch K, 2011, IEEE INT SYM WRBL CO, P37, DOI 10.1109/ISWC.2011.16; Krumm J, 2003, LECT NOTES COMPUT SC, V2864, P36; LaMarca A, 2005, LECT NOTES COMPUT SC, V3468, P116; Li W., 2005, P AS PAC S INF VIS A, P131; Popleteev A., 2012, P 2012 IEEE INT C PE, P171; Priyantha N. B., 2000, P 6 ANN INT C MOB CO, P32, DOI DOI 10.1145/345910.345917; SAHA S, 2003, P IEEE WIR COMM NETW, V3, P1987; Seshadri V., 2005, Proceedings. Third IEEE International Conference on Pervasive Computing and Communications. PerCom 2005; Wang Y., 2003, P INT S SAT NAV TECH; Witten I., 2004, DATA MINING PRACTICA	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4553	1941-0484		IEEE J-STSP	IEEE J. Sel. Top. Signal Process.	MAR	2015	9	2					268	277		10.1109/JSTSP.2014.2382478		10	Engineering, Electrical & Electronic	Engineering	CB3NK	WOS:000349534900008		
J	Nakahara, K; Wakayama, Y; Kitatani, T; Taniguchi, T; Fukamachi, T; Sakuma, Y; Tanaka, S				Nakahara, Kouji; Wakayama, Yuki; Kitatani, Takeshi; Taniguchi, Takafumi; Fukamachi, Toshihiko; Sakuma, Yasushi; Tanaka, Shigehisa			Direct Modulation at 56 and 50 Gb/s of 1.3-mu m InGaAlAs Ridge-Shaped-BH DFB Lasers	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Buried heterostructure; distributed feedback (DFB) lasers; quantum well lasers	1.3 MU-M; GBIT/S	Direct modulation at 56 and 50 Gb/s of 1.3-mu m InGaAlAs ridge-shaped-buried heterostructure (RS-BH) asymmetric corrugation-pitch-modulation (ACPM) distributed feedback lasers is experimentally demonstrated. The fabricated lasers have a low threshold current (5.6 mA at 85 degrees C), high temperature characteristics (71 K), high slope relaxation frequency (3.2 GHz/mA(1/2) at 85 degrees C), and wide bandwidth (22.1 GHz at 85 degrees C). These superior properties enable the lasers to run at 56 Gb/s and 55 degrees C and 50 Gb/s at up to 80 degrees C for back-to-back operation with clear eye openings. This is achieved by the combination of a low-leakage RS-BH and an ACPM grating. Moreover, successful transmission of 56- and 50-Gb/s modulated signals over a 10-km standard single-mode fiber is achieved. These results confirm the suitability of this type of laser for use as a cost-effective light source in 400 GbE and OTU5 applications.	[Nakahara, Kouji; Wakayama, Yuki; Kitatani, Takeshi; Taniguchi, Takafumi; Tanaka, Shigehisa] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 1858601, Japan; [Fukamachi, Toshihiko; Sakuma, Yasushi] Oclaro Japan Inc, Sagamihara, Kanagawa 2520205, Japan	Nakahara, K (reprint author), Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 1858601, Japan.	kouji.nakahara.gu@hitachi.com; yuki.wakayama.mg@hitachi.com; takeshi.kitatani@oclaro.com; takafumi.taniguchi.yu@hitachi.com; toshihiko.fukamachi@oclaro.com; yasushi.sakuma@oclaro.com; shigehisa.tanaka.pn@hitachi.com					Kobayashi W, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2238509; Adachi K, 2011, J LIGHTWAVE TECHNOL, V29, P2899, DOI 10.1109/JLT.2011.2163814; Fujisawa T, 2011, ELECTRON LETT, V47, P708, DOI 10.1049/el.2011.1126; Fukamachi T, 2011, IEEE J SEL TOP QUANT, V17, P1138, DOI 10.1109/JSTQE.2011.2114644; Nakadai K., 2013, P OFC, P1; Nakagawa K., 2014, P OFC, P1; Nakahara K., 2014, P ISLC, P66; Nakahara K, 2014, ELECTRON LETT, V50, P947, DOI 10.1049/el.2014.0797; OKAI M, 1994, J APPL PHYS, V75, P1, DOI 10.1063/1.355884; Simoyama T., 2012, P 38 ECOC SEP, P1; Tatsumi T., 2012, P OFC, P1; Trowbridge S. J., 2010, SCALING P802 3BA G 7	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	MAR 1	2015	27	5					534	536		10.1109/LPT.2014.2384520		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB4TM	WOS:000349621100021		
J	Ribeiro, VC; Luis, RS; Mendinueta, JMD; Puttnam, BJ; Shahpari, A; Muga, NJC; Lima, M; Shinada, S; Wada, N; Teixeira, A				Ribeiro, Vitor Costa; Luis, Ruben S.; Mendinueta, Jose Manuel D.; Puttnam, Benjamin J.; Shahpari, Ali; Muga, Nelson J. C.; Lima, Mario; Shinada, Satoshi; Wada, Naoya; Teixeira, Antonio			All-Optical Packet Alignment Using Polarization Attraction Effect	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Polarization attraction; optical packet switching	STABILIZATION; CONTROLLER; FIBER	We demonstrate submicrosecond polarization alignment of nonreturn to zero 10-Gbit/s optical packets using an all-optical polarization attraction effect in a low polarization-mode dispersion-shifted fiber. We experimentally demonstrate the alignment of optical packets having durations of 205 and 409 ns using a counter-propagating four-wave mixing process. To evaluate this technique, consecutive packets were aligned with distinctly different polarization states using a fiber interferometer. We experimentally demonstrate the recovery of optical packets that were lost due to their state of polarization (SOP) misalignment with the receiver. Polarization stability of the proposed system was assessed over a period of 30 min and it was observed that the scheme was able to correct the SOP and equalize the received optical power.	[Ribeiro, Vitor Costa; Shahpari, Ali; Muga, Nelson J. C.; Lima, Mario; Teixeira, Antonio] Inst Telecomunicacoes, Dept Elect Telecommun & Informat, P-3810193 Aveiro, Portugal; [Luis, Ruben S.; Mendinueta, Jose Manuel D.; Puttnam, Benjamin J.; Shinada, Satoshi; Wada, Naoya] Natl Inst Informat & Commun Technol, Photon Networks Res Grp, Tokyo, Japan	Ribeiro, VC (reprint author), Inst Telecomunicacoes, Dept Elect Telecommun & Informat, P-3810193 Aveiro, Portugal.	vitor.ribeiro@ua.pt; ruben.luis@nict.go.jp; mendi@nict.go.jp; ben@nict.go.jp; ali@ua.pt; muga@ua.pt; mlima@ua.pt; sshi-nada@nict.go.jp; wada@nict.go.jp; teixeira@ua.pt	Muga, Nelson/A-1935-2013; 	Muga, Nelson/0000-0003-4412-8025; Shahpari, Ali/0000-0001-7163-6493	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/69577/2010, SFRH/BD/71667/2010]	This work was supported by the Fundacao para a Ciencia e a Tecnologia under Grant SFRH/BD/69577/2010 and Grant SFRH/BD/71667/2010.	Morin P, 2011, OPT EXPRESS, V19, P17158, DOI 10.1364/OE.19.017158; Shmilovitch Z, 2011, OPT EXPRESS, V19, P25873, DOI 10.1364/OE.19.025873; Martinelli M, 2006, J LIGHTWAVE TECHNOL, V24, P4172, DOI 10.1109/JLT.2006.884228; Chiarello F, 2011, IEEE PHOTONIC TECH L, V23, P1457, DOI 10.1109/LPT.2011.2163061; Martinelli M, 2009, OPT EXPRESS, V17, P947, DOI 10.1364/OE.17.000947; Stiller B, 2012, OPT EXPRESS, V20, P27248, DOI 10.1364/OE.20.027248; Blumenthal D. J., 2003, IEEE Communications Magazine, V41, DOI 10.1109/MCOM.2003.1179494; Fatome J, 2012, IEEE J SEL TOP QUANT, V18, P621, DOI 10.1109/JSTQE.2011.2119467; Fatome J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00938; Fatome J, 2010, OPT EXPRESS, V18, P15311, DOI 10.1364/OE.18.015311; Hidayat A, 2008, OPT EXPRESS, V16, P18984, DOI 10.1364/OE.16.018984; Koch B, 2008, IEEE PHOTONIC TECH L, V20, P961, DOI 10.1109/LPT.2008.922910; Muga NJ, 2011, OPT EXPRESS, V19, P18707, DOI 10.1364/OE.19.018707; Ribeiro V., 2014, P OPT COMM C AUSTR C, P221; Yoo S. J. B., 2006, Journal of Lightwave Technology, V24, DOI 10.1109/JLT.2006.886060	15	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	MAR 1	2015	27	5					541	544		10.1109/LPT.2014.2384592		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB4TM	WOS:000349621100023		
J	Wang, P; Xian, LL; Li, HP				Wang, Peng; Xian, Lunlun; Li, Hongpu			Fabrication of Phase-Shifted Long-Period Fiber Grating and Its Application to Strain Measurement	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Long-period fiber grating; phase-shifted grating; strain sensor	TEMPERATURE-MEASUREMENT; DESIGN; SENSOR	Several kinds of phase-shifted long-period gratings (LPGs) have been fabricated using a high-repetition-rate CO2 laser, where both the grating and the inserted phase shift are simultaneously produced in a commonly used single-mode fiber. Furthermore, using one of the fabricated phase-shifted LPGs, a temperature-insensitive sensor that allows for large axial strain measurement with a value up to 7600 mu epsilon, is proposed and first demonstrated. Measurement accuracy for the strain ranging from 340 to 7600 mu epsilon is estimated to be +/- 30 mu epsilon, while the temperature is changed in a range of 20 degrees C-140 degrees C.	[Wang, Peng; Xian, Lunlun] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka 4368650, Japan; [Li, Hongpu] Shizuoka Univ, Fac Engn, Shizuoka 4368650, Japan	Li, HP (reprint author), Shizuoka Univ, Fac Engn, Shizuoka 4368650, Japan.	ne614601@ipc.shizuoka.ac.jp; allenxian55@yahoo.co.jp; dhli@ipc.shizuoka.ac.jp			Japan Society for the Promotion of Science [25289101]	This work was supported by the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research under Grant 25289101. (Corresponding author: Hongpu Li.)	Frazao O, 2006, IEEE PHOTONIC TECH L, V18, P2407, DOI 10.1109/LPT.2006.886139; CANNING J, 1994, ELECTRON LETT, V30, P1344, DOI 10.1049/el:19940920; Patrick HJ, 1996, IEEE PHOTONIC TECH L, V8, P1223, DOI 10.1109/68.531843; Guan BO, 2000, IEEE PHOTONIC TECH L, V12, P675; Falate R, 2006, APPL OPTICS, V45, P5066, DOI 10.1364/AO.45.005066; Kulishov M, 2007, OPT LETT, V32, P2978, DOI 10.1364/OL.32.002978; Han YG, 2003, OPT EXPRESS, V11, P476, DOI 10.1364/OE.11.000476; Zhou DP, 2009, IEEE PHOTONIC TECH L, V21, P468, DOI 10.1109/LPT.2009.2013640; Ke H, 1998, IEEE PHOTONIC TECH L, V10, P1596, DOI 10.1109/68.726761; Bhatia V, 1997, OPT LETT, V22, P648, DOI 10.1364/OL.22.000648; Chung KW, 2005, MICROW OPT TECHN LET, V45, P18, DOI 10.1002/mop.20710; Del Villar I, 2007, OPT EXPRESS, V15, P9326, DOI 10.1364/OE.15.009326; Gu YJ, 2009, IEEE PHOTONIC TECH L, V21, P657, DOI 10.1109/LPT.2009.2016217; Han KJ, 2004, IEEE PHOTONIC TECH L, V16, P2114, DOI 10.1109/LPT.2004.833081; Hishiki K, 2013, OPT EXPRESS, V21, P11901, DOI 10.1364/OE.21.011901; Liu Y, 1999, OPT COMMUN, V164, P27, DOI 10.1016/S0030-4018(99)00191-1; Rao YJ, 2004, OPT COMMUN, V229, P209, DOI 10.1016/j.optcom.2003.10.048	17	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	MAR 1	2015	27	5					557	560		10.1109/LPT.2014.2385067		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB4TM	WOS:000349621100027		
J	Fu, X; Zhang, H; Tan, E; Watabe, S; Asakawa, S				Fu, Xi; Zhang, Hong; Tan, Engkong; Watabe, Shugo; Asakawa, Shuichi			Characterization of the torafugu (Takifugu rubripes) immunoglobulin heavy chain gene locus	IMMUNOGENETICS			English	Article						Takifugurubripes; Immunoglobulin heavy chain; Gene locus; IMGT	V(D)J RECOMBINATION; MULTIGENE FAMILIES; FUGU-RUBRIPES; DEATH PROCESS; EVOLUTION; GENOME; EXPRESSION; SEQUENCE; PUFFERFISH; ISOTYPE	In this study, we investigated the immunoglobulin heavy (IGH) gene locus of torafugu (Takifugu rubripes) from publicly available assembly sequences and presented an annotated locus map, including the IGHV genes, pseudogenes, and IGHC genes. Three new IGHV gene families (IGHV3-IGHV5) were discovered. We observed the interspersion of IGHV1 and IGHV2 family members and that they often intermingled with each other, while other family members were further interspersed. Conservation of the promoter and recombination signal sequences (RSS) was observed in a family-specific manner. In addition to known variable region genes present on chromosome 5 (current torafugu genome assembly), we found 34 additional IGHV genes on scaffold 287 and three novel potentially functional IGHD genes on scaffold 483. In total, the variable region of the torafugu IGH locus consists of at least 48 IGHV genes, seven IGHD genes, and six IGHJ genes. IGHC genes have also been mapped in this study, with three genes encoding immunoglobulin classes: IgT, IgM, and IgD. We confirmed the expression of newly identified IGHV3 family sequences in the spleen and kidney of adult torafugu and found a favorable IGHV segment usage by IgM and IgT. Possible structural variation in the IGH delta locus was observed based on the current torafugu assembly. The complete characterization of the torafugu IGH locus will facilitate detailed studies of large-scale mechanisms associated with the recombination of the variable region genes and will offer insights into the genetic basis of the potential diversity in the antibody response observed in torafugu.	[Fu, Xi; Zhang, Hong; Tan, Engkong; Asakawa, Shuichi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo, Tokyo 1138657, Japan; [Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan	Asakawa, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo, Tokyo 1138657, Japan.	asakawa@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI [24248034, 25640099]	This work was supported by JSPS KAKENHI, Grant Numbers 24248034 and 25640099.	Das S, 2008, IMMUNOGENETICS, V60, P47, DOI 10.1007/s00251-007-0270-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Hendricks J, 2010, IMMUNOGENETICS, V62, P479, DOI 10.1007/s00251-010-0448-x; OTA T, 1994, MOL BIOL EVOL, V11, P469; Saha NR, 2005, MOL IMMUNOL, V42, P113, DOI 10.1016/j.molimm.2004.06.034; Savan R, 2005, EUR J IMMUNOL, V35, P3320, DOI 10.1002/eji.200535248; Fillatreau S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00028; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Zimmerman AM, 2011, MOL IMMUNOL, V48, P2220, DOI 10.1016/j.molimm.2011.06.441; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Saha NR, 2004, IMMUNOGENETICS, V56, P438, DOI 10.1007/s00251-004-0693-y; Flajnik MF, 2005, NAT IMMUNOL, V6, P229, DOI 10.1038/ni0305-229; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Gambon-Deza F, 2010, DEV COMP IMMUNOL, V34, P114, DOI 10.1016/j.dci.2009.08.011; Krangel MS, 2004, IMMUNOL REV, V200, P224; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P595, DOI 10.1101/pdb.top115; Peixoto BR, 2000, IMMUNOGENETICS, V51, P443, DOI 10.1007/s002510050643; Ramsden AD, 1996, EMBO J, V15, P3197; Zhang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06780; Zhang H, 2013, AQUACULTURE, V380, P114, DOI 10.1016/j.aquaculture.2012.12.003	39	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	MAR	2015	67	3					179	193		10.1007/s00251-014-0824-z		15	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CB1EQ	WOS:000349370100004		
J	Cai, M; Takagi, H; Nakagaito, AN; Katoh, M; Ueki, T; Waterhouse, GIN; Li, Y				Cai, Ming; Takagi, Hitoshi; Nakagaito, Antonio N.; Katoh, Masahiro; Ueki, Tomoyuki; Waterhouse, Geoffrey I. N.; Li, Yan			Influence of alkali treatment on internal microstructure and tensile properties of abaca fibers	INDUSTRIAL CROPS AND PRODUCTS			English	Article						Abaca fiber; Lumen; Twisting; Alkali treatment; Tensile properties	TRANSVERSE THERMAL-CONDUCTIVITY; X-RAY-DIFFRACTION; MECHANICAL-PROPERTIES; NATURAL-FIBER; POLYMER COMPOSITES; GREEN COMPOSITES; CHEMICAL-MODIFICATION; FLAX FIBERS; JUTE; WOOD	The objective of this study is to investigate the effect of alkali treatment on the internal microstructure and tensile properties of abaca fibers. The abaca fibers were immersed in aqueous solutions of NaOH (5, 10, or 15 wt%) for 30 min, rinsed and dried. The fibers were subsequently characterized by scanning electron microscopy, X-ray diffraction (XRD), Fourier transform-infrared spectroscopy (FT-IR), and tensile strength tests. The lumen is a hollow region in each elementary fiber of the abaca fiber bundles. It was found that the lumen of the abaca fibers completely collapsed after 10 and 15 wt% NaOH treatment, due to swelling of the fibers. The fibers also became twisted after these alkali treatments. It was found that cellulose I in abaca fibers was partially transformed to cellulose II after 15 wt% NaOH treatment, as evidenced by XRD measurements. FT-IR analysis indicated that the alkali treatment led to a gradual removal of binding materials; such as hemicelluloses and lignin, from the abaca fibers, resulting in the separation of abaca fiber bundles into individual elementary fibers. The tensile strength of alkali-treated abaca fibers did not vary with alkali concentration. The Young's modulus of the abaca fibers treated with 5 wt% NaOH solution increased by 41%, whereas those treated with 10 and 15 wt% NaOH solution decreased by 24 and 29%, respectively. A non-linear behavior was observed in the stress-strain curves of the abaca fibers after 10 and 15 wt% alkali treatment, which could be attributable to the twisting of the fibers. (C) 2014 Elsevier B.V. All rights reserved.	[Cai, Ming; Li, Yan] Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China; [Cai, Ming] Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima 7708506, Japan; [Takagi, Hitoshi; Nakagaito, Antonio N.; Katoh, Masahiro; Ueki, Tomoyuki] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Waterhouse, Geoffrey I. N.] Univ Auckland, Sch Chem Sci, Auckland 1142, New Zealand	Takagi, H (reprint author), Univ Tokushima, Inst Sci & Technol, 2-1 Minamijosanjima Cho, Tokushima 7708506, Japan.	takagi@tokushima-u.ac.jp	Takagi, erしtyofTokushima/E-8946-2012; 	Waterhouse, Geoffrey/0000-0002-3296-3093	Japan Society for the Promotion of Science (JSPS) KAKENHIGrant [25289243]; JSPS (Invitation Fellowship for Research in Japan) [S-13179]	This work was financially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHIGrant Number 25289243. The authors also thank the Double-Degree Exchange Program between The University of Tokushima (Japan) and Tongji University (China). GINW acknowledges funding support from the JSPS (Invitation Fellowship for Research in Japan, S-13179).	Alix S, 2009, BIORESOURCE TECHNOL, V100, P4742, DOI 10.1016/j.biortech.2009.04.067; Kobayashi K, 2011, CARBOHYD POLYM, V83, P483, DOI 10.1016/j.carbpol.2010.08.006; Liu K, 2012, COMPOS PART A-APPL S, V43, P1234, DOI 10.1016/j.compositesa.2012.02.020; Borysiak S, 2005, FIBRES TEXT EAST EUR, V13, P87; Sain M, 2006, IND CROP PROD, V23, P1, DOI 10.1016/j.indcrop.2005.01.006; Li Y, 2008, COMPOS PART A-APPL S, V39, P570, DOI 10.1016/j.compositesa.2007.07.005; Takagi H, 2008, COMPOS PART A-APPL S, V39, P685, DOI 10.1016/j.compositesa.2007.08.019; Liu LF, 2009, COMPOS PART A-APPL S, V40, P669, DOI 10.1016/j.compositesa.2009.03.002; Bledzki AK, 2007, EXPRESS POLYM LETT, V1, P755, DOI 10.3144/expresspolymlett.2007.104; Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5; Duval A, 2011, MATER LETT, V65, P797, DOI 10.1016/j.matlet.2010.11.053; Liu K, 2013, COMPOS PART A-APPL S, V45, P14, DOI 10.1016/j.compositesa.2012.09.006; Placet V, 2014, COMPOS PART A-APPL S, V56, P319, DOI 10.1016/j.compositesa.2012.11.019; John MJ, 2008, POLYM COMPOSITE, V29, P187, DOI 10.1002/pc.20461; Rahman MM, 2007, COMPOS SCI TECHNOL, V67, P2369, DOI 10.1016/j.compscitech.2007.01.009; Zhang YL, 2013, COMPOS SCI TECHNOL, V88, P172, DOI 10.1016/j.compscitech.2013.08.037; Baley C, 2002, COMPOS PART A-APPL S, V33, P939, DOI 10.1016/S1359-835X(02)00040-4; Yang WD, 2012, SCI CHINA TECHNOL SC, V55, P2278, DOI 10.1007/s11431-012-4943-1; Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002; Shibata M, 2003, MACROMOL MATER ENG, V288, P35, DOI 10.1002/mame.200290031; Amel BA, 2013, IND CROP PROD, V46, P117, DOI 10.1016/j.indcrop.2012.12.015; Kalia S, 2009, POLYM ENG SCI, V49, P1253, DOI 10.1002/pen.21328; Boopathi L, 2012, COMPOS PART B-ENG, V43, P3044, DOI 10.1016/j.compositesb.2012.05.002; Mwaikambo LY, 2002, J APPL POLYM SCI, V84, P2222, DOI 10.1002/app.10460; Gassan J, 1999, J APPL POLYM SCI, V71, P623, DOI 10.1002/(SICI)1097-4628(19990124)71:4<623::AID-APP14>3.0.CO;2-K; Yu T, 2014, COMPOS PART A-APPL S, V64, P139, DOI 10.1016/j.compositesa.2014.05.008; Bledzki AK, 2010, COMPOS SCI TECHNOL, V70, P854, DOI 10.1016/j.compscitech.2010.02.003; Holbery J, 2006, JOM-US, V58, P80, DOI 10.1007/s11837-006-0234-2; Ishikura Y., 2009, CELLULOSE, V17, P47; Knothe J., 2000, 3 INT WOOD NAT FIBR, P1; Liu K, 2012, COMPOS SCI TECHNOL, V72, P633, DOI 10.1016/j.compscitech.2012.01.009; Lu N., 2011, J COMPOS MATER; Mussig J., 2010, IND APPL NATURAL FIB, P269; Nakagaito A. N., 2007, CELLULOSE, V15, P323; Nakano T, 2000, HOLZFORSCHUNG, V54, P315, DOI 10.1515/HF.2000.053; Nakano T, 2010, CELLULOSE, V17, P711, DOI 10.1007/s10570-010-9414-x; Nishiyama Y, 2000, J WOOD SCI, V46, P452, DOI 10.1007/BF00765803; Oudiani A. E., 2011, CARBOHYD POLYM, V86, P1221; Punyamurthy R., 2012, BIORESOURCES, V7, P3515; Saenghirunwattana P, 2014, IND CROP PROD, V60, P144, DOI 10.1016/j.indcrop.2014.06.010; Sangappa B. L. Rao, 2014, COMPOS INTERFACE, V21, P153; Spence J. C., 1992, ELECT MICRODIFFRACTI; Sun RC, 1998, CARBOHYD POLYM, V37, P351, DOI 10.1016/S0144-8617(98)00046-0; Takagi H, 2004, JSME INT J A-SOLID M, V47, P551, DOI 10.1299/jsmea.47.551	44	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6690	1872-633X		IND CROP PROD	Ind. Crop. Prod.	MAR	2015	65						27	35		10.1016/j.indcrop.2014.11.048		9	Agricultural Engineering; Agronomy	Agriculture	CB2AV	WOS:000349430000005		
J	Murata, Y; Kubo, S; Togawa, E; Ramie, SFBM; Sulaiman, O; Hashim, R; Ibrahim, WA; Kosugi, A; Hirooka, A; Abe, H				Murata, Yoshinori; Kubo, Satoshi; Togawa, Eiji; Ramie, Sitti Fatimah Binti Mhd; Sulaiman, Othman; Hashim, Rokiah; Ibrahim, Wan Asma; Kosugi, Akihiko; Hirooka, Akiko; Abe, Hisashi			Detection of vascular bundles using cell wall birefringence on exposure to polarized light	INDUSTRIAL CROPS AND PRODUCTS			English	Article						Birefringence; Oil palm; Parenchyma; Polarization; Trunk; Vascular bundle	OIL PALM TRUNKS; BIODIVERSITY; PARENCHYMA	Vascular bundles (VBs) of oil palm trunks exhibited birefringence due to polarized orientation of their cell wall components, although another component of the trunks, parenchyma tissue (PT), did not. The intensity of the birefringence depended on the VB composition; therefore, it was possible to estimate the VB content readily using a polarizing microscope connected to an image analyzer. The method proposed in this manuscript should allow easier quantification of VBs in oil palm trunks than methods using X-ray diffraction. Both VBs and PT contained cellulose, hemicelluloses, lignin, and starch; however, the cellulose content of PT was less than half that of VBs. This difference in cellulose content between VB and PT may explain why VBs were detected under polarizing light. (C) 2014 Elsevier B.V. All rights reserved.	[Murata, Yoshinori; Kosugi, Akihiko; Hirooka, Akiko] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan; [Kubo, Satoshi; Togawa, Eiji; Abe, Hisashi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Ramie, Sitti Fatimah Binti Mhd; Sulaiman, Othman; Hashim, Rokiah] Univ Sains Malaysia, Usm 11800, Penang, Malaysia; [Ibrahim, Wan Asma] Forest Res Inst Malaysia, Kepong 52109, Selangor Darul, Malaysia	Murata, Y (reprint author), Japan Int Res Ctr Agr Sci, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan.	muratayo@affrc.go.jp	Sulaiman, Othman/G-1901-2010	Sulaiman, Othman/0000-0002-3711-3768	Japan Society for the Promotion of Science [2358043]	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) (C) number 2358043 from Japan Society for the Promotion of Science. We appreciate the assistance Dr. Kengo Magara of Forestry and Forest Products Research Institute for suggestions on chemical analysis of oil palm samples.	Yokoyama T, 2002, J AGR FOOD CHEM, V50, P1040, DOI 10.1021/jf011173q; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Sulaiman O, 2008, HOLZ ROH WERKST, V66, P5, DOI 10.1007/s00107-007-0194-4; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Prawitwong P, 2012, BIORESOURCE TECHNOL, V125, P37, DOI 10.1016/j.biortech.2012.08.136; WADA M, 1993, J APPL POLYM SCI, V49, P1491, DOI 10.1002/app.1993.070490817; Abe H, 2013, BIORESOURCES, V8, P1573; Ismail A., 2002, OIL PALM IND EC J, p[2, 11]; Lim S. C., 1999, Journal of Tropical Forest Products, V5, P209; Murata Y, 2013, BIOMASS BIOENERG, V51, P8, DOI 10.1016/j.biombioe.2012.12.007; Sahri M., 2008, FORMATION WOOD TROPI, P161; Segal L., 1957, AM DYEST REP, V46, P637; TAPPI standard, 2007, T204 CM 98 SOLV EXTR; TAPPI standard, 1932, T203CM 09 ALPH BET G; TOMIMURA Y, 1992, JARQ-JPN AGR RES Q, V25, P283; Wise L. E., 1946, Paper Trade Journal, V122, P35	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6690	1872-633X		IND CROP PROD	Ind. Crop. Prod.	MAR	2015	65						190	197		10.1016/j.indcrop.2014.11.055		8	Agricultural Engineering; Agronomy	Agriculture	CB2AV	WOS:000349430000025		
J	Hamaguchi, T; Ando, I				Hamaguchi, Tomohiko; Ando, Isao			Synthesis and characterisation of a new six-coordinated thermochromic Ni complex	INORGANICA CHIMICA ACTA			English	Article						Ni complex; Thermochromism; TD-DFT	CRYSTAL-STRUCTURE; SOLVOTHERMAL SYNTHESIS; CHLORIDE MONOHYDRATE; NI(II) COMPLEXES; DERIVATIVES; LIGANDS; DIEN; DIETHYLENETRIAMINE; STABILITY; COMPOUND	The Ni(II) complex [Ni(diethylenetriamine)(2,6-bis(hydroxymethyl) pyridine)]center dot PF6 center dot CF3COO center dot H2O is described here. A single crystal X-ray crystallographic study revealed that the Ni(II) in the complex has a six-coordinated octahedral structure. The complex shows thermochromic behaviour in the solid state. X-ray crystallographic studies at various temperatures suggested that the thermochromism is caused by anisotropic structural change. The relationship between the structural change and the colour change was confirmed by absorption spectrum and TD-DFT calculation. (C) 2014 Elsevier B.V. All rights reserved.	[Hamaguchi, Tomohiko; Ando, Isao] Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, Fukuoka 8140180, Japan	Hamaguchi, T (reprint author), Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	thama@fukuoka-u.ac.jp					Ohtsu H, 2004, INORG CHEM, V43, P3024, DOI 10.1021/ic035486+; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; IRIE M, 1988, J ORG CHEM, V53, P803, DOI 10.1021/jo00239a022; Burla MC, 2012, J APPL CRYSTALLOGR, V45, P357, DOI 10.1107/S0021889812001124; DAY JH, 1963, CHEM REV, V63, P65, DOI 10.1021/cr60221a005; DAY JH, 1968, CHEM REV, V68, P649, DOI 10.1021/cr60256a001; [Anonymous], DIG MET; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Kishimoto Y, 2009, J AM CHEM SOC, V131, P4227, DOI 10.1021/ja810032t; Zhang HX, 2003, INORG CHEM, V42, P6595, DOI 10.1021/ic034645m; Baho N, 2007, INORG CHEM, V46, P7621, DOI 10.1021/ic070093m; Bensch W, 2001, CHEM COMMUN, P477, DOI 10.1039/b009583o; BIAGINI S, 1970, J CHEM SOC A, P2398, DOI 10.1039/j19700002398; Cernak J, 2002, Z ANORG ALLG CHEM, V628, P344, DOI 10.1002/1521-3749(200202)628:2<344::AID-ZAAC344>3.0.CO;2-A; Cui AL, 2011, J CHEM EDUC, V88, P311, DOI 10.1021/ed100103a; Farrugia LJ, 1997, J APPL CRYSTALLOGR, V30, P565, DOI DOI 10.1107/S0021889897003117; Frisch M.J., 2013, GAUSSIAN 09 REVISION; Hayami S, 2009, CHEM LETT, V38, P490, DOI 10.1246/cl.2009.490; Hynes RC, 1996, ACTA CRYSTALLOGR C, V52, P1879, DOI 10.1107/S0108270196005835; Ishida M, 2010, DALTON T, V39, P2651, DOI 10.1039/b921609j; Johns CA, 2002, POLYHEDRON, V21, P395, DOI 10.1016/S0277-5387(01)00997-4; Junk PC, 2007, INORG CHIM ACTA, V360, P1661, DOI 10.1016/j.ica.2006.09.001; Marta L.F., 2003, INORG CHEM, V42, P664; Muga I, 2002, ACTA CRYSTALLOGR E, V58, pM524, DOI 10.1107/S160053680201591X; Muga I, 2003, ACTA CRYSTALLOGR E, V59, pM576, DOI 10.1107/S160053680301479X; Naumov P, 2006, J COORD CHEM, V59, P1307, DOI 10.1080/00958970500491010; Niu JY, 2004, J SOLID STATE CHEM, V177, P3411, DOI 10.1016/j.jssc.2004.06.001; Rodriguez V, 1999, INORG CHIM ACTA, V290, P57, DOI 10.1016/S0020-1693(99)00115-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stahler R, 2002, Z ANORG ALLG CHEM, V628, P1657, DOI 10.1002/1521-3749(200207)628:7<1657::AID-ZAAC1657>3.0.CO;2-C; Stahler R., 2003, J SOLID STATE CHEM, V174, P276; Stahler R, 2003, J SOLID STATE CHEM, V174, P264, DOI 10.1016/S0022-4596(03)00216-0; Suzuki T, 1997, ANGEW CHEM INT EDIT, V36, P1329, DOI 10.1002/anie.199713291; Taki M, 2008, B CHEM SOC JPN, V81, P590, DOI 10.1246/bcsj.81.590; HAY PJ, 1985, J CHEM PHYS, V82, P270, DOI 10.1063/1.448799; Winter S, 2004, J COORD CHEM, V57, P997, DOI 10.1080/00958970412331272395; Xiang J, 2006, INORG CHEM COMMUN, V9, P326, DOI 10.1016/j.inoche.2005.12.007; Yilmaz VT, 2003, J COORD CHEM, V56, P21, DOI 10.1080/0095897021000039052; Yutaka F., 2007, INORGANIC CHROMOTROP; Zhang DP, 2008, ACTA CRYSTALLOGR E, V64, pM1264, DOI 10.1107/S1600536808028663; Zhou J, 2007, INORG CHEM, V46, P6347, DOI 10.1021/ic070334q; Zhu HL, 2003, Z KRIST-NEW CRYST ST, V218, P43	42	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	MAR 1	2015	427						144	149		10.1016/j.ica.2014.12.013		6	Chemistry, Inorganic & Nuclear	Chemistry	CB2MT	WOS:000349462500019		
J	Zangrando, E; Islam, MT; Islam, MAAAA; Sheikh, MC; Tarafder, MTH; Miyatake, R; Zahan, R; Hossain, MA				Zangrando, E.; Islam, M. T.; Islam, M. Al-Amin A. A.; Sheikh, M. C.; Tarafder, M. T. H.; Miyatake, R.; Zahan, R.; Hossain, M. A.			Synthesis, characterization and bio-activity of nickel(II) and copper(II) complexes of a bidentate NS Schiff base of S-benzyl dithiocarbazate	INORGANICA CHIMICA ACTA			English	Article						Benzyldithiocarbazate; Crystal structure; Ni(II) complex; Cu(II) complex; Anti-inflammatory/analgesic activity	X-RAY CRYSTAL; METAL-COMPLEXES; SPECTROSCOPIC CHARACTERIZATION; PLATINUM(II) COMPLEXES; CADMIUM(II) COMPLEXES; BIOLOGICAL-ACTIVITIES; LIGAND; METHYLDITHIOCARBAZATE; NITROGEN; BENZYLDITHIOCARBAZATE	The reaction of S-benzyldithiocarbazate (SBDTC) with 3-hydroxyacetophenone afforded a bidentate NS Schiff base HL (HL = benzyl-3-(3-hydroxyphenyl methyl ethylene) hydrazine carbodithioate) which on further reaction with nickel(II) and copper(II) salt yielded bis-chelated inner complexes, NiL2 and CuL2, respectively with deprotonated L ligand. The ligand and its complexes were characterized by physicochemical techniques, viz., molar conductance, magnetic susceptibility measurement, IR, NMR, UV-Vis spectroscopy and mass spectroscopic techniques. The crystal structure of all the compounds was also characterized by single crystal X-ray crystallography. The ligand exists in its thione tautomeric form both in solution and in the solid state. In the complexes the two deprotonated ligands chelate the metal through the azomethine nitrogen and the thione sulfur atom with cis arrangement generating a tetrahedrally distorted square planar geometry around the metal center. Only complex CuL2 showed moderate analgesic activity at 60 min compared to Diclofenac sodium, while all the test compounds exhibited good anti-inflammatory activity as compared to standard drug Indomethacin. (C) 2014 Elsevier B.V. All rights reserved.	[Zangrando, E.] Dept Chem & Pharmaceut Sci, I-34127 Trieste, Italy; [Islam, M. T.; Islam, M. Al-Amin A. A.; Hossain, M. A.] Rajshahi Univ Engn & Technol, Dept Chem, Rajshahi 6204, Bangladesh; [Sheikh, M. C.] Toyama Univ, Fac Engn, Dept Appl Chem, Toyama 9308555, Japan; [Tarafder, M. T. H.] Rajshahi Univ, Dept Chem, Rajshahi 6205, Bangladesh; [Miyatake, R.] Toyama Univ, Water Qual Management Ctr, Toyama 9308555, Japan; [Zahan, R.] Rajshahi Univ, Dept Pharm, Rajshahi 6505, Bangladesh	Zangrando, E (reprint author), Dept Chem & Pharmaceut Sci, Via L Giorgieri 1, I-34127 Trieste, Italy.	ezangrando@units.it					Ali M. A., 1977, J INORG NUCL CHEM, V39, P265; Ali M. A., 1977, J INORG NUCL CHEM, V39, P1785, DOI [10.1016/0022-1902(77)80202-9, DOI 10.1016/0022-1902(77)80202-9]; Ali MA, 2001, INORG CHIM ACTA, V320, P1; Ali MA, 2002, TRANSIT METAL CHEM, V27, P27, DOI 10.1023/A:1013434113299; Ali MA, 2008, POLYHEDRON, V27, P71, DOI 10.1016/j.poly.2007.08.022; Ali MA, 2000, TRANSIT METAL CHEM, V25, P430, DOI 10.1023/A:1007009810572; [Anonymous], 2000, CRYST STRUCT 4 0 CRY, P196; Antonio MA, 1998, J ETHNOPHARMACOL, V61, P215, DOI 10.1016/S0378-8741(98)00049-X; Sutradhar M, 2010, INORG CHIM ACTA, V363, P3376, DOI 10.1016/j.ica.2010.06.025; ALLEN FH, 1983, ACCOUNTS CHEM RES, V16, P146, DOI 10.1021/ar00089a001; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; Bera P, 2008, POLYHEDRON, V27, P3433, DOI 10.1016/j.poly.2008.07.039; Bierbach U, 1999, INORG CHEM, V38, P3535, DOI 10.1021/ic981181x; Garoufis A, 2009, COORDIN CHEM REV, V253, P1384, DOI 10.1016/j.ccr.2008.09.011; Ravoof TBSA, 2010, TRANSIT METAL CHEM, V35, P871, DOI 10.1007/s11243-010-9406-6; Chan MHE, 2008, POLYHEDRON, V27, P1141, DOI 10.1016/j.poly.2007.11.035; Christopher R.M., 2005, LIFE SCI, V78, P476; ELISABETSKY E, 1995, J ETHNOPHARMACOL, V48, P77, DOI 10.1016/0378-8741(95)01287-N; Gupta M., 2006, ALTER MED, V36, P1472; How FNF, 2008, POLYHEDRON, V27, P3325, DOI 10.1016/j.poly.2008.07.022; Islam MAAAA, 2014, TRANSIT METAL CHEM, V39, P141, DOI 10.1007/s11243-013-9783-8; Islam MAAAA, 2011, TRANSIT METAL CHEM, V36, P531, DOI 10.1007/s11243-011-9499-6; KULKARNI SK, 1980, LIFE SCI, V27, P185, DOI 10.1016/0024-3205(80)90136-8; Li SL, 2006, OPT MATER, V28, P897, DOI 10.1016/j.optmat.2005.11.009; Nunez-Montenegro A, 2008, POLYHEDRON, V27, P2867, DOI 10.1016/j.poly.2008.06.018; Pal S, 1999, J PHARM PHARMACOL, V51, P313, DOI 10.1211/0022357991772312; Rakha TH, 2000, CHEM PHARM BULL, V48, P914; Ravoof TBSA, 2007, POLYHEDRON, V26, P1159, DOI 10.1016/j.poly.2006.03.007; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Singh HL, 2006, BIOINORG CHEM APPL, P1, DOI 10.1155/BCA/2006/23245; Takjoo R, 2012, J COORD CHEM, V65, P1569, DOI 10.1080/00958972.2012.675058; Takjoo R, 2013, J MOL STRUCT, V1031, P180, DOI 10.1016/j.molstruc.2012.07.018; Tarafder MTH, 2008, ACTA CRYSTALLOGR E, V64, pO1042, DOI 10.1107/S1600536808013354; Tarafder MTH, 2008, ACTA CRYSTALLOGR E, V64, pM416, DOI 10.1107/S1600536808002262; Tarafder MTH, 2001, SYN REACT INORG MET, V31, P115, DOI 10.1081/SIM-100001937; Tian YP, 1998, TRANSIT METAL CHEM, V23, P17; Yazdanbakhsh M, 2008, STRUCT CHEM, V19, P895, DOI 10.1007/s11224-008-9356-1; Zhang ML, 2004, TRANSIT METAL CHEM, V29, P596, DOI 10.1007/s11243-004-1208-2	40	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	MAR 1	2015	427						278	284		10.1016/j.ica.2014.12.014		7	Chemistry, Inorganic & Nuclear	Chemistry	CB2MT	WOS:000349462500038		
J	Nakanishi, T; Mukai, K; Hosokawa, Y; Takegawa, D; Matsuo, T				Nakanishi, T.; Mukai, K.; Hosokawa, Y.; Takegawa, D.; Matsuo, T.			Catechins inhibit vascular endothelial growth factor production and cyclooxygenase-2 expression in human dental pulp cells	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						catechin; cyclooxygenase-2; dental pulp; vascular endothelial growth factor	KAPPA-B ACTIVATION; GREEN TEA; (-)-EPIGALLOCATECHIN-3-GALLATE BLOCKS; VEGF EXPRESSION; FIBROBLASTS; INDUCTION; CYTOKINES; EPIGALLOCATECHIN-3-GALLATE; ANGIOGENESIS; INFLAMMATION	AimTo investigate the effect of catechins on vascular endothelial growth factor (VEGF) production and cyclooxygenase-2 (COX-2) expression in human dental pulp cells (HDPC) stimulated with bacteria-derived factors or pro-inflammatory cytokines. MethodologyMorphologically fibroblastic cells established from explant cultures of healthy human dental pulp tissues were used as HDPC. HDPC pre-treated with catechins, epigallocatechin-3-gallate (EGCG) or epicatechin gallate (ECG), were exposed to lipopolysaccharide (LPS), peptidoglycan (PG), interlukin-1 (IL-1) or tumour necrosis factor- (TNF-). VEGF production was examined by enzyme-linked immunosorbent assay, and COX-2 expression was assessed by immunoblot. ResultsEGCG and ECG significantly reduced LPS- or PG-mediated VEGF production in the HDPC in a dose-dependent manner. EGCG also prevented IL-1-mediated VEGF production. Although TNF- did not enhance VEGF production in the dental pulp cells, treatment of 20gmL(-1) of EGCG decreased the level of VEGF. In addition, the catechins attenuated COX-2 expression induced by LPS and IL-1. ConclusionsThe up-regulated VEGF and COX-2 expressions in the HDPC stimulated with these bacteria-derived factors or IL-1 were diminished by the treatment of EGCG and ECG. These findings suggest that the catechins may be beneficial as an anti-inflammatory tool of the treatment for pulpal inflammation.	[Nakanishi, T.; Mukai, K.; Hosokawa, Y.; Takegawa, D.; Matsuo, T.] Univ Tokushima, Inst Hlth Biosci, Dept Conservat Dent, Grad Sch, Tokushima 7708504, Japan	Nakanishi, T (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Conservat Dent, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	tnakanishi@tokushima-u.ac.jp			JSPS KAKENHI [20592228, 24592871]	This work was supported by JSPS KAKENHI Grant Number 20592228, 24592871 [Grant-in-Aid for Scientific Research (C)].	Jung YD, 2001, BRIT J CANCER, V84, P844, DOI 10.1054/bjoc.2000.1691; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Artese L, 2002, J ENDODONT, V28, P20, DOI 10.1097/00004770-200201000-00005; Zhang QZ, 2006, MOL CANCER THER, V5, P1227, DOI 10.1158/1535-7163.MCT-05-0490; Guven G, 2007, J ENDODONT, V33, P18, DOI 10.1016/j.joen.2006.07.014; Adachi T, 2007, J DENT RES, V86, P1217; Kim SJ, 2007, J NUTR BIOCHEM, V18, P587, DOI 10.1016/j.jnutbio.2006.11.001; Lin YL, 1997, MOL PHARMACOL, V52, P465; Hirao K, 2010, LIFE SCI, V86, P654, DOI 10.1016/j.lfs.2010.02.017; Hirao K, 2009, J DENT RES, V88, P762, DOI 10.1177/0022034509341779; Staquet MJ, 2008, J DENT RES, V87, P256; TANIISHII N, 1995, ORAL MICROBIOL IMMUN, V10, P213, DOI 10.1111/j.1399-302X.1995.tb00145.x; Miyauchi M, 1996, J ENDODONT, V22, P600, DOI 10.1016/S0099-2399(96)80029-X; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Nie D, 2002, CELL MOL LIFE SCI, V59, P799, DOI 10.1007/s00018-002-8468-9; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tran-Hung L, 2006, J DENT RES, V85, P819; Chu SC, 2004, J ENDODONT, V30, P704, DOI 10.1097/01.DON.0000129962.65752.C6; COHEN JS, 1985, J ENDODONT, V11, P330, DOI 10.1016/S0099-2399(85)80039-X; Lin SK, 2008, ARCH OTOLARYNGOL, V134, P522, DOI 10.1001/archotol.134.5.522; Matsushita K, 1999, INFECT IMMUN, V67, P1633; Nakanishi T, 2001, J ENDODONT, V27, P385, DOI 10.1097/00004770-200106000-00003; NAKANISHI T, 1995, J ENDODONT, V21, P131, DOI 10.1016/S0099-2399(06)80438-3; Nakanishi T, 2010, EUR J ORAL SCI, V118, P145, DOI 10.1111/j.1600-0722.2010.00714.x; Ohnishi T, 2000, J DENT RES, V79, P748; Tokuda H, 2007, J CELL BIOCHEM, V100, P1146, DOI 10.1002/jcb.21104	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	MAR	2015	48	3					277	282		10.1111/iej.12312		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB4TR	WOS:000349621600010		
J	Furukawa, H; Denison, R				Furukawa, Hiroko; Denison, Rayna			Disaster and relief: The 3.11 Tohoku and Fukushima disasters and Japan's media industries	INTERNATIONAL JOURNAL OF CULTURAL STUDIES			English	Article						anime; disaster relief; Great East Japan Earthquake; manga; media franchising; Tohoku Disaster		The earthquake and tsunami which occurred in the Tohoku region of Japan (northern Japan) on 11 March 2011 have taken the lives of more than 15,000 people. The disaster and the accident in the nuclear reactors in Fukushima have left about 330,000 people homeless. The catastrophe has affected not only Japanese politics, economics, society and people's mentalities, but also its cultural industries. This article attempts to investigate two contemporary issues tracing the effects of the Great East Japan Earthquake (the Tohoku Disaster) on Japan's media landscape: its impact on Japanese media production and distribution, particularly of its most transnationally famous forms, manga and anime; and how perceptions of soft power' have fluctuated in this difficult media moment. The research uses a cultural and industrial studies approach based on discourse analysis, focusing on the period immediately following the Tohoku Disaster in order to map significant shifts and unexpected results and responses from within Japan's cultural industries to the earthquake, tsunami and Fukushima power plant disasters.	[Furukawa, Hiroko] Tohoku Gakuin Univ, Sendai, Miyagi 980, Japan; [Denison, Rayna] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	Denison, R (reprint author), Univ E Anglia, Dept Film Televis & Media, Sch Art Media & Amer Studies, Norwich NR4 7TJ, Norfolk, England.	r.denison@uea.ac.uk			AHRC	The authors would like to thank the AHRC for their funding of the 'Manga Movies: Contemporary Japanese Cinema, Media Franchising and Adaptation' research project, which made this work possible.	Abel JE, 2011, INT J JAPANESE SOCIO, V20, P59; Anime News Network, 2011, ANIME NEWS NETWORK; [Anonymous], 2011, YOMIURI ONLINE  0329; [Anonymous], 2011, ASAHI NEWSPAPER 0512, P7; [Anonymous], 2011, HATENA BOOK MARK NEW; Versluys K, 2006, MFS-MOD FICT STUD, V52, P980, DOI 10.1353/mfs.2007.0011; Azuma F, 2011, COMMUNICATION; Broderick Mick, 1996, HIBAKUSHA CINEMA HIR; Hairston M, 2008, MECHADEMIA LIMITS HU, V3, P256; Hesmondhalgh D, 2007, CULTURAL IND; Holmberg R, 2011, COMIC J; Ide E, 2011, INDEPENDENT; Internet Watch, 2011, INTERNET WATCH; Ishihara S, 2011, ASAHI NEWSPAPER 0315, P23; Japanimate, 2011, AK PED PAR CLOS WHIL; Kasai J, 2011, ANIMEJU          JUN, P60; Malone PM, 2007, SUPER HEROES HERCULE, P111; Minami N, 2011, DAILY SPA       0908; Nakamura M, 2011, ASAHI NEWSPAPER 0318, P9; Nakayama H, 2011, CINEMA TODAY    0906; Napier SJ, 2005, ANIME AKIRA HOWLS MO; National Policy Agency, 2014, DAM GREAT E EARTHQ M; NHK, 2011, NHK             0809, V19, P30; Ohara A, 2014, ASAHI NEWSPAPER 0407; Okuno T, 2011, YOMIURI NEWSPAP 0416, P13; Rausch A, 2012, ELECT J CONT JAPANES, V12; Sada, 2011, SOMETIME BLOG   0811; Sasaki T, 2011, ASAHI           0403; Shimamura Y, 2011, CINEMA TODAY    0617; Shiriagari K, 2011, DAILY CYZO      0821; Shiriagari K, 2011, ASAHI NEWSPAPER 0702, P3; Staiger J, 1993, FILM THEORY GOES MOV, P161; Studio Ghibli, 2002, HAVE YOU SEEN NEWSPA; Takashige H, 2011, ASAHI NEWSPAPER 0405, P11; Takashige H, 2011, ASAHI NEWSPAPER 0518, P31; Takatsu Y, 2011, ASAHI NEWSPAPER 0518, P11; Tasukeai Japan, 2014, MAP CURR REC SIT; Tobin J, 1992, RE MADE JAPAN EVERYD; Tokyo International Anime Fair, 2012, EXH LIST; WASKO J, 2005, COMUNICAAOE SOCIEDAD, V7, P25; Yaguchi T, 2011, YAMAGATA NEWSPA 0915, P24	41	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1367-8779	1460-356X		INT J CULTURAL STUD	Int. J. Cult. Stud.	MAR	2015	18	2					225	241		10.1177/1367877914559301		17	Cultural Studies	Cultural Studies	CB4ZT	WOS:000349637900005		
J	Soltani, M; Maekawa, K				Soltani, Masoud; Maekawa, Koichi			Numerical simulation of progressive shear localization and scale effect in cohesionless soil media	INTERNATIONAL JOURNAL OF NON-LINEAR MECHANICS			English	Article						Shear band; Strain localization; Progressive failure; Size effect; Capacity	CONSTITUTIVE MODEL; BAND FORMATION; SAND; ANISOTROPY	Objective and methods: A multi-yield surface model of the total strain formulation, which takes into account the confinement dependency and has numerical consistency with the crack analysis of reinforced concrete, is presented to simulate the progressive failure and the shear band formation in a cohesionless soil media. Results: For experimental verification, a comparison of the numerical analysis results with the reality is carried out in view of the progressive failure. The scale effect on the nominal strength is discussed with regard to the shear localization. Conclusion: It is shown that by means of the proposed concept the scale effect of the static bearing capacity of foundation can be well simulated. (C) 2014 Elsevier Ltd. All rights reserved.	[Soltani, Masoud] Tarbiat Modares Univ, Fac Civil & Environm Engn, Tehran, Iran; [Maekawa, Koichi] Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Tokyo 1138656, Japan	Soltani, M (reprint author), Tarbiat Modares Univ, Fac Civil & Environm Engn, Jalaale Al Ahmad Ave, Tehran, Iran.				Japan Society for the Promotion of Science [23226011]	This study was financially supported by Grants-in-Aid for scientific Research (23226011) from the Japan Society for the Promotion of Science.	Al Hattamleh O, 2009, INT J NUMER ANAL MET, V33, P1255, DOI 10.1002/nag.768; Alsaleh M. I., 2004, THESIS LOUISIANA STA; An XH, 1997, CEMENT CONCRETE COMP, V19, P241, DOI 10.1016/S0958-9465(97)00014-0; Maekawa K, 2000, ENG FRACT MECH, V65, P335, DOI 10.1016/S0013-7944(99)00119-8; Zhou XP, 2009, COMPUT GEOTECH, V36, P861, DOI 10.1016/j.compgeo.2009.01.009; Okhovat MR, 2009, J ADV CONCR TECHNOL, V7, P439; Bolton M. D., 1989, P 12 INT C SOIL MECH, V2, P895; Cerato A. B., 2005, THESIS U MASSACHUSET; Dodds J., 2003, THESIS GEORGIA I TEC; Foster S., 2008, BULLETIN, V45; Hillerborg A, 1976, CEMENT CONCRETE RES, V6, P773, DOI DOI 10.1016/0008-8846(76)90007-7; Huang C. C., 1994, SOILS FOUND, V34, P27, DOI 10.3208/sandf1972.34.227; Li B., 1989, J FAC ENG U TOKYO, V40, P9; Maekawa K, 2003, NONLINEAR MECH REINF; Maki T., 2005, EARTHQ ENG STRUCT D, V99, P1; Murthy V. N., 2003, GEOTECHNICAL ENG PRI; Namikawa T, 2006, SOILS FOUND, V46, P491, DOI 10.3208/sandf.46.491; Okamura H., 1997, P JSCE, V564, P297; Okhovat M., 2010, THESIS U TOKYO; PARK CS, 1994, THIRTEENTH INTERNATIONAL CONFERENCE ON SOIL MECHANICS AND FOUNDATION ENGINEERING, PROCEEDINGS, VOL 1, P1; Peng FL, 2005, ACTA MECH SINICA, V21, P76, DOI 10.1007/s10409-004-0008-4; Sayao A, 1996, CAN GEOTECH J, V33, P822, DOI 10.1139/t96-108-328; Siddiquee M.S.A., 1999, SOILS FOUND, V39, P93; Siddiquee MSA, 2001, SOILS FOUND, V41, P53; Tatsuoka F., 1990, SOILS FOUND, V30, P35; Tatsuoka F., 1991, ASCE GEOTECHNICAL SP, V27, P788; Tatsuoka F., 1993, SOILS FOUND, V33, P60; Tejchman J, 2007, INT J NONLINEAR MECH, V42, P882, DOI [10.1016/j.ijnonlinmec.2007.03.015, 10.1016/j.ijnonlinmec]; Tejchman J., 1999, SOILS FOUND, V39, P47; Tejchman J, 1996, COMPUT GEOTECH, V18, P71, DOI 10.1016/0266-352X(95)00018-6; Towhata I., 1985, P 5 INT C NUM METH G, P523; Towhata I, 2008, SPRINGER SER GEOMECH, P3, DOI 10.1007/978-3-540-35783-4_1; Wu W, 2000, INT J NUMER ANAL MET, V24, P245, DOI 10.1002/(SICI)1096-9853(200003)24:3<245::AID-NAG52>3.0.CO;2-C; Xiaobing L., 2000, INT J NONLIN MECH, V35, P21, DOI 10.1016/S0020-7462(98)00083-3	34	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7462	1878-5638		INT J NONLIN MECH	Int. J. Non-Linear Mech.	MAR	2015	69						1	13		10.1016/j.ijnonlinmec.2014.10.014		13	Mechanics	Mechanics	CB3AE	WOS:000349499100001		
J	Hagihara, Y; Nara, T; Suzuki, T				Hagihara, Yasuo; Nara, Takashi; Suzuki, Takao			Severe erosive polyarthritis in a human skeleton dated to the early modern period of Japan	INTERNATIONAL JOURNAL OF PALEOPATHOLOGY			English	Article						Erosive arthritis; Rheumatoid arthritis; Psoriatic arthritis; Leprosy; Japan	RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; ANKYLOSIS; SPONDYLOARTHROPATHY; DIAGNOSIS; NORMANDY; DISEASE; GOUT	A human skeleton apparently afflicted with severe polyarthritis was unearthed from an early modern grave at the Tamukai site in the northernmost part of Honshu in Japan. The bones, likely from a late middle-aged male, showed severe resorptive lesions and ankylosis in many of the peripheral joints. Lesions were found in both bilateral and symmetrical distributions, sometimes accompanied by juxta-articular osteoporosis. Differential diagnoses included either rheumatoid arthritis, psoriatic arthritis, or leprosy, with psoriatic arthritis being the most likely. Whatever the final diagnosis, the identification of arthritis mutilans is clear. Because some bones were missing and a mixture of characteristics of both types of arthritis was evident, it was impossible to make a definitive diagnosis. However, this case is valuable for the severity of the lesions and the rarity of erosive polyarthritis found in archaeological skeletons from an Asian site. (C) 2014 Elsevier Inc. All rights reserved.	[Hagihara, Yasuo] Niigata Univ Hlth & Welf, Dept Rehabil Sci, Grad Sch Hlth & Welf, Kita Ku, Niigata 9503198, Japan; [Nara, Takashi] Niigata Univ Hlth & Welf, Dept Med Technol, Kita Ku, Niigata 9503198, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu City, Aichi, Japan	Hagihara, Y (reprint author), Niigata Univ Hlth & Welf, Dept Rehabil Sci, Grad Sch Hlth & Welf, Kita Ku, 1398 Shimami Cho, Niigata 9503198, Japan.	hpm13006@nuhw.acjp					Hukuda S, 2001, J RHEUMATOL, V28, P554; Buckley HR, 2007, CURR ANTHROPOL, V48, P741, DOI 10.1086/520967; Ichikawa N, 2012, INT J RHEUM DIS, V15, P462, DOI 10.1111/j.1756-185X.2012.01818.x; Antunes-Ferreira N., 2013, PORTUGAL ANTHR SCI, V121, P149; AVILA R, 1960, RADIOLOGY, V75, P691; Belt EA, 2001, JOINT BONE SPINE, V68, P154, DOI 10.1016/S1297-319X(00)00242-6; Bennett R., 2001, ARTHRITIS ALLIED CON, P1345; Blondiaux J, 1997, INT J OSTEOARCHAEOL, V7, P451, DOI 10.1002/(SICI)1099-1212(199709/10)7:5<451::AID-OA334>3.0.CO;2-4; Blondiaux Joel, 2007, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V19, P7; Fujita T., 2010, J JAPAN SPONDYLOARTH, V2, P47; Hacking P., 1994, INT J OSTEOARCHAEOL, V4, P251, DOI 10.1002/oa.1390040310; Hiramoto K., 1972, J ANTHR SOC NIPPON, V80, P221; HUGHES GR, 1968, ANN RHEUM DIS, V27, P67, DOI 10.1136/ard.27.1.67; Hukuda S., 2012, PALAEOPATHOLOGICAL E, P109; Inoue K, 1999, INT J OSTEOARCHAEOL, V9, P1; Inoue K, 2005, INT J OSTEOARCHAEOL, V15, P186, DOI 10.1002/oa.768; Kacki S, 2013, INT J PALEOPATHOL, V3, P274, DOI 10.1016/j.ijpp.2013.07.002; Kato H., 1991, J JOINT SURG, V10, P35; Kim D.K., 2009, INT J OSTEOARCHAEOL, V10, P1; Koba A., 2011, JPN J LEPR, V80, P11; Kojoh T., 1990, ORTHOP TRAUMATOL, V38, P1625; Leden I, 2012, INT J PALEOPATHOL, V2, P249, DOI 10.1016/j.ijpp.2012.09.001; Mann R, 1990, REGIONAL ATLAS BONE; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Moromizato K., 2007, ANTHR SCI JAPANESE S, V115, P25, DOI 10.1537/asj.115.25; Nagatani Y., 2001, J JOINT SURG, V20, P1111; Nara T., 2009, TAMUKAI SITE 2 REPOR, V122, P206; Ortner D.J., 2003, IDENTIFICATION PATHO; Pearson K., 1899, PHILOS T R SOC A, V192, P169, DOI 10.1098/rsta.1899.0004; Rogers J., 1989, RHEUMATOLOGY, V8, P141; Rogers J., 1989, C P, V5; Rothschild BM, 2005, ANN RHEUM DIS, V64, P286, DOI 10.1136/ard.2004.021303; Rothschild B.M., 1995, INT J OSTEOARCHAEOL, V9, P198; ROTHSCHILD BM, 1992, SEMIN ARTHRITIS RHEU, V22, P181, DOI 10.1016/0049-0172(92)90018-9; Shareef S.M., 2008, FOOT ANKLE J, V1, P2; Suchey JM, 1988, INSTRUCTIONS USE SUC; Suzuki K., 2010, PLOS ONE, V5; Suzuki T., 2001, LEPROSY BONE, V15, P507; Suzuki T, 1998, ANTHROPOL SCI, V106, P127; Tahara T., 1983, ORTHOP TRAUMATOL, V31, P512; Tokunaga D., 2008, ORTHOP SURG, V59, P855; Waldron T, 2009, CAMB MAN ARCHAEOL, P1	42	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1879-9817	1879-9825		INT J PALEOPATHOL	Int. J. Paleopathol.	MAR	2015	8						10	18		10.1016/j.ijpp.2014.10.002		9	Paleontology; Pathology	Paleontology; Pathology	CB1ZF	WOS:000349425800002		
J	Okada, A				Okada, Akira			COOPERATION AND INSTITUTION IN GAMES	JAPANESE ECONOMIC REVIEW			English	Article						C71; C72; C78; D02	COALITION-FORMATION; BARGAINING MODEL; PUBLIC-GOODS; NONCOOPERATIVE FOUNDATIONS; STATIONARY EQUILIBRIUM; INCOMPLETE INFORMATION; PERFECT EQUILIBRIUM; PRISONERS-DILEMMA; RANDOM PROPOSERS; SHAPLEY VALUE	Based on recent developments in non-cooperative coalitional bargaining theory, I review game theoretical analyses of cooperation and institution. First, I present basic results of the random-proposer model and apply them to the problem of involuntary unemployment in a labour market. I discuss extensions to cooperative games with externalities and incomplete information. Next, I consider the enforceability of an agreement as an institutional foundation of cooperation. I re-examine the contractarian approach to the problem of cooperation from the viewpoint that individuals may voluntarily create an enforcement institution.	Hitotsubashi Univ, Kunitachi, Tokyo, Japan	Okada, A (reprint author), Hitotsubashi Univ, Kunitachi, Tokyo, Japan.						Adachi T., 2007, J LAW ECON ORGAN, V24, P95, DOI DOI 10.1093/JLEO/EWM040; Albers W., 1975, OR VERFAHREN, VXXI, P1; Bloch F, 1996, GAME ECON BEHAV, V14, P90, DOI 10.1006/game.1996.0043; Gomes A, 2005, J POLIT ECON, V113, P626, DOI 10.1086/429136; Gomes A, 2005, ECONOMETRICA, V73, P1329, DOI 10.1111/j.1468-0262.2005.00617.x; Saijo T, 1999, J ECON THEORY, V84, P227, DOI 10.1006/jeth.1998.2476; Eraslan H, 2013, J ECON THEORY, V148, P2195, DOI 10.1016/j.jet.2013.09.007; Banks JS, 2000, AM POLIT SCI REV, V94, P73, DOI 10.2307/2586381; Stole LA, 1996, REV ECON STUD, V63, P375, DOI 10.2307/2297888; Okada A, 1996, GAME ECON BEHAV, V16, P97, DOI 10.1006/game.1996.0076; Laruelle A, 2008, GAME ECON BEHAV, V63, P341, DOI 10.1016/j.geb.2007.09.003; Traulsen A, 2012, P ROY SOC B-BIOL SCI, V279, P3716, DOI 10.1098/rspb.2012.0937; SUTTON J, 1986, REV ECON STUD, V53, P709, DOI 10.2307/2297715; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Perez-Castrillo D, 2001, J ECON THEORY, V100, P274, DOI 10.1006/jeth.2000.2704; GUL F, 1989, ECONOMETRICA, V57, P81, DOI 10.2307/1912573; Snyder JM, 2005, AM ECON REV, V95, P981, DOI 10.1257/0002828054825538; CHATTERJEE K, 1993, REV ECON STUD, V60, P463, DOI 10.2307/2298067; BARON DP, 1989, AM POLIT SCI REV, V83, P1181, DOI 10.2307/1961664; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Okada A, 2011, GAME ECON BEHAV, V73, P227, DOI 10.1016/j.geb.2011.01.008; Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Nash J, 1953, ECONOMETRICA, V21, P128, DOI 10.2307/1906951; Compte O, 2010, ECONOMETRICA, V78, P1593, DOI 10.3982/ECTA7883; Eraslan H, 2002, J ECON THEORY, V103, P11, DOI 10.1006/jeth.2001.2820; Ray D, 1999, GAME ECON BEHAV, V26, P286, DOI 10.1006/game.1998.0648; Montero M, 2006, GAME ECON BEHAV, V54, P380, DOI 10.1016/j.geb.2005.01.001; Hart S, 1996, ECONOMETRICA, V64, P357, DOI 10.2307/2171787; RUBINSTEIN A, 1982, ECONOMETRICA, V50, P97, DOI 10.2307/1912531; Dixit A, 2000, J PUBLIC ECON, V76, P309, DOI 10.1016/S0047-2727(99)00089-4; PERRY M, 1994, ECONOMETRICA, V62, P795, DOI 10.2307/2951733; OLIVER P, 1980, AM J SOCIOL, V85, P1356, DOI 10.1086/227168; MOLDOVANU B, 1994, J MATH ECON, V23, P533, DOI 10.1016/0304-4068(94)90011-6; Aumann R. J., 1961, T AM MATH SOC, V98, P539, DOI 10.2307/1993348; Bandyopadhyay S., 2006, ECON J, V116, P136; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Cooter R. D., 1989, NEW PALGRAVE ALLOCAT, P64; Dutta B, 2005, MATH SOC SCI, V50, P148, DOI 10.1016/j.mathsosci.2005.02.006; Evans R, 1997, GAME ECON BEHAV, V19, P211, DOI 10.1006/game.1997.0553; Farrell Joseph, 1989, GAME ECON BEHAV, V1, P327, DOI DOI 10.1016/0899-8256(89)90021-3; Forge F., 2013, INT GAME THEORY REV, V15, P1; Forges F, 2002, J MATH ECON, V38, P1, DOI 10.1016/S0304-4068(02)00073-3; Harsanyi J. C., 1972, MANAGE SCI, V18, P80, DOI DOI 10.1287/MNSC.18.5.80; HARSANYI JC, 1974, MANAGE SCI, V20, P1472, DOI 10.1287/mnsc.20.11.1472; Horniacek M, 2008, INT J GAME THEORY, V37, P235, DOI 10.1007/s00182-007-0111-4; Hurwicz L, 1960, MATH METHODS SOCIAL, P27; Hyndman K, 2007, REV ECON STUD, V74, P1125, DOI 10.1111/j.1467-937X.2007.00450.x; Kawamori T, 2008, MATH SOC SCI, V55, P292, DOI 10.1016/j.mathsocsci.2007.09.006; Keynes JM, 1936, GEN THEORY EMPLOYMEN; Maruta T, 2012, GAME ECON BEHAV, V74, P269, DOI 10.1016/j.geb.2011.05.006; Miyakawa T, 2009, ECON THEOR, V39, P291, DOI 10.1007/s00199-008-0334-z; MOLDOVANU B, 1995, GAME ECON BEHAV, V9, P21, DOI 10.1006/game.1995.1003; Montero M, 2007, JPN ECON REV, V58, P294, DOI 10.1111/j.1468-5876.2007.00351.x; Montero M, 2002, GAME ECON BEHAV, V41, P309, DOI 10.1016/S0899-8256(02)00501-8; Okada A, 2002, THEOR DECIS, V53, P1, DOI 10.1023/A:1020811218051; Okada A., 2013, 201315 HIT U; Okada A, 2008, PUBLIC CHOICE, V135, P165, DOI 10.1007/s11127-007-9252-z; Okada A., 1992, Control and Cybernetics, V21; Okada A, 2000, JPN ECON REV, V51, P34, DOI 10.1111/1468-5876.00137; Okada A, 2010, J ECON THEORY, V145, P2356, DOI 10.1016/j.jet.2010.07.001; Okada A, 2014, INT J GAME THEORY, V43, P953, DOI 10.1007/s00182-014-0413-2; Okada A, 2012, J ECON THEORY, V147, P1165, DOI 10.1016/j.jet.2012.01.009; OKADA A, 1993, PUBLIC CHOICE, V77, P629, DOI 10.1007/BF01047864; Osborne M.J., 1990, BARGAINING MARKETS; Ostrom E., 1990, GOVERNING COMMONS EV; PALFREY TR, 1984, J PUBLIC ECON, V24, P171, DOI 10.1016/0047-2727(84)90023-9; Parsons T., 1937, STRUCTURE SOCIAL ACT; Ray D., 2014, HDB GAME THEORY, V4, P239; Ray D., 2007, GAME THEORETIC PERSP; Seidmann DJ, 1998, REV ECON STUD, V65, P793, DOI 10.1111/1467-937X.00069; Selten R., 1973, INT J GAME THEORY, V2, P141, DOI 10.1007/BF01737566; Selten R., 1981, ESSAYS GAME THEORY M, P131; SERRANO R, 1995, J ECON THEORY, V67, P285, DOI 10.1006/jeth.1995.1075; Serrano R, 2007, J ECON THEORY, V134, P117, DOI 10.1016/j.jet.2006.02.002; Serrano R, 1997, SOC CHOICE WELFARE, V14, P513, DOI 10.1007/s003550050084; Smith A., 1776, INQUIRY NATURE CAUSE; Sutter M, 2010, REV ECON STUD, V77, P1540, DOI 10.1111/j.1467-937X.2010.00608.x; Vohra R, 1999, J ECON THEORY, V86, P123, DOI 10.1006/jeth.1999.2512; VonsNeumann J., 1944, THEORY GAMES EC BEHA; WILSON R, 1978, ECONOMETRICA, V46, P807, DOI 10.2307/1909750; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; Yan H, 2002, INT J GAME THEORY, V31, P527	82	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	MAR	2015	66	1					1	32		10.1111/jere.12058		32	Economics	Business & Economics	CB0IN	WOS:000349309300001		
J	Aoki, K				Aoki, Kosuke			RELATIVE PRICES AND INFLATION STABILIZATION	JAPANESE ECONOMIC REVIEW			English	Article						E3	OPTIMAL MONETARY-POLICY; FRAMEWORK	When price adjustment is sluggish, inflation is costly in terms of welfare because it distorts various kinds of relative prices. Stabilizing aggregate price inflation does not necessarily minimize these costs, but stabilizing a well-designed core inflation minimizes the cost of relative price fluctuations and, thus, the cost of inflation.	Univ Tokyo, Tokyo 1138654, Japan	Aoki, K (reprint author), Univ Tokyo, Tokyo 1138654, Japan.						Eusepi S, 2011, AM ECON J-MACROECON, V3, P53, DOI 10.1257/mac.3.3.53; Gertler M, 2008, J POLIT ECON, V116, P533, DOI 10.1086/589522; Aoki K, 2001, J MONETARY ECON, V48, P55, DOI 10.1016/S0304-3932(01)00069-1; Golosov M, 2007, J POLIT ECON, V115, P171, DOI 10.1086/512625; Rotemberg JJ, 1997, NBER MACROECON ANNU, V12, P297, DOI 10.2307/3585236; Benigno P, 2004, J INT ECON, V63, P293, DOI 10.1016/S0022-1996(03)00055-2; CALVO GA, 1983, J MONETARY ECON, V12, P383, DOI 10.1016/0304-3932(83)90060-0; Christiano LJ, 1999, HANDB ECON, V15, P65; Dotsey M, 1999, Q J ECON, V114, P655, DOI 10.1162/003355399556106; King RG, 1999, NBER CONF R, P349; Nakov A, 2014, INT J CENT BANK, V10, P49; Shiratsuka S., 2006, BANK JAPAN REV   NOV, P1; Woodford M, 2003, INTEREST AND PRICES: FOUNDATIONS OF A THEORY OF MONETARY POLICY, P1; Wynne MA, 2008, FED RESERVE BANK ST, V90, P205	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	MAR	2015	66	1					35	59		10.1111/jere.12060		25	Economics	Business & Economics	CB0IN	WOS:000349309300003		
J	Ishida, J				Ishida, Junichiro			HIERARCHIES VERSUS COMMITTEES: COMMUNICATION AND INFORMATION ACQUISITION IN ORGANIZATIONS	JAPANESE ECONOMIC REVIEW			English	Article						D03; D99	AUTHORITY; COLLUSION; INCENTIVES; DESIGN; FIRM; DECENTRALIZATION; COORDINATION; DELEGATION	In most firms workers are divided asymmetrically in terms of authority and responsibility. In this paper, we view the asymmetric allocations of authority and responsibility as essential features of hierarchy and examine why hierarchies often prevail in organizations from that perspective. A key departure is that we consider a case where the authority relationship is defined only by the allocation of responsibility through contingent contracts. Within this framework, we show that the contractual arrangement that allocates responsibility asymmetrically often emerges as the optimal organizational form, which gives rise to the chain of command pertaining to hierarchical organizations.	Osaka Univ, Suita, Osaka 565, Japan	Ishida, J (reprint author), Osaka Univ, Suita, Osaka 565, Japan.						Hart O, 2005, J POLIT ECON, V113, P675, DOI 10.1086/431794; GROSSMAN SJ, 1980, J FINANC, V35, P323, DOI 10.2307/2327390; Persico N, 2004, REV ECON STUD, V71, P165, DOI 10.1111/0034-6527.00280; Marino AM, 2010, J LAW ECON ORGAN, V26, P427, DOI 10.1093/jleo/ewp005; MILGROM PR, 1981, BELL J ECON, V12, P380, DOI 10.2307/3003562; SAH RK, 1988, ECON J, V98, P451, DOI 10.2307/2233377; Aghion P, 1997, J POLIT ECON, V105, P1, DOI 10.1086/262063; Faure-Grimaud A, 2003, REV ECON STUD, V70, P253, DOI 10.1111/1467-937X.000244; Van den Steen E, 2010, AM ECON REV, V100, P466, DOI 10.1257/aer.100.1.466; Che YK, 2001, AM ECON REV, V91, P525, DOI 10.1257/aer.91.3.525; Gershkov A, 2009, J ECON THEORY, V144, P36, DOI 10.1016/j.jet.2008.02.004; ITOH H, 1991, ECONOMETRICA, V59, P611, DOI 10.2307/2938221; Mookherjee D, 2006, J ECON LIT, V44, P367, DOI 10.1257/jel.44.2.367; Laffont JJ, 1998, RAND J ECON, V29, P280, DOI 10.2307/2555889; RADNER R, 1993, ECONOMETRICA, V61, P1109, DOI 10.2307/2951495; CRAWFORD VP, 1982, ECONOMETRICA, V50, P1431, DOI 10.2307/1913390; Van Zandt T, 1999, REV ECON STUD, V66, P633, DOI 10.1111/1467-937X.00101; Baliga S, 1998, J ECON THEORY, V83, P196, DOI 10.1006/jeth.1996.2462; Bolton P., 2013, HDB ORAGANIZATIONAL, P342; BOLTON P, 1994, Q J ECON, V109, P809, DOI 10.2307/2118349; Caillaud B, 2007, AM ECON REV, V97, P1877, DOI 10.1257/aer.97.5.1877; Choe C, 2012, J LAW ECON ORGAN, V28, P486, DOI 10.1093/jleo/ewr022; Dessein W, 2010, AM ECON J-MICROECON, V2, P77, DOI 10.1257/mic.2.4.77; Dessein W, 2002, REV ECON STUD, V69, P811, DOI 10.1111/1467-937X.00227; Friebel G, 2010, AM ECON J-MICROECON, V2, P1, DOI 10.1257/mic.2.2.1; Gerardi D, 2008, GAME ECON BEHAV, V62, P436, DOI 10.1016/j.geb.2007.06.007; Gromb D, 2007, J ECON THEORY, V137, P271, DOI 10.1016/j.jet.2007.01.003; Li H, 2001, J POLIT ECON, V109, P617, DOI 10.1086/321018; Li H, 2009, CAN J ECON, V42, P359, DOI 10.1111/j.1540-5982.2009.01512.x; Rajan RG, 2001, Q J ECON, V116, P805, DOI 10.1162/00335530152466241; Rantakari H., 2010, ORG DESIGN ENV VOLAT	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	MAR	2015	66	1					62	88		10.1111/jere.12055		27	Economics	Business & Economics	CB0IN	WOS:000349309300005		
J	Okubo, M				Okubo, Masakatsu			EARNINGS DYNAMICS AND PROFILE HETEROGENEITY: ESTIMATES FROM JAPANESE PANEL DATA	JAPANESE ECONOMIC REVIEW			English	Article						C33; D31	UNITED-STATES; LIFE-CYCLE; EMPLOYMENT TENURE; COVARIANCE STRUCTURE; INCOME PROCESSES; INEQUALITY; CONSUMPTION; INSURANCE; VARIANCE; MOBILITY	The recent empirical work on earnings processes using US panel data finds that ignoring heterogeneity in earnings profiles among individuals leads to an upward bias in the autoregressive parameter of earnings shocks. It then argues that the existing assumptions in incomplete markets and heterogeneous-agent models, almost all of which require highly persistent earnings shocks and no individual-specific and group-specific differences in earnings growth rates, may be inappropriate. This paper investigates the applicability of this US data-based debate to other developed countries by using a panel of Japanese male earnings. The results indicate that it is possible to corroborate the recent US arguments, despite some differences in the estimates.	Univ Tsukuba, Tsukuba, Ibaraki 305, Japan	Okubo, M (reprint author), Univ Tsukuba, Tsukuba, Ibaraki 305, Japan.						Abe N., 2007, ECON REV, V58, P15; Abe N, 2009, J JPN INT ECON, V23, P344, DOI 10.1016/j.jjie.2009.04.001; Abe Y, 2000, JPN ECON REV, V51, P252, DOI 10.1111/1468-5876.00150; Altonji Joseph G., 2009, 14743 NBER; DEATON A, 1994, J POLIT ECON, V102, P437, DOI 10.1086/261941; MACURDY TE, 1982, J ECONOMETRICS, V18, P83, DOI 10.1016/0304-4076(82)90096-3; Altonji JG, 1996, J BUS ECON STAT, V14, P353, DOI 10.2307/1392447; Storesletten K, 2004, J MONETARY ECON, V51, P609, DOI 10.1016/j.moneco.2003.06.005; HUBBARD RG, 1994, CARN ROCH CONF SERIE, V40, P59, DOI 10.1016/0167-2231(94)90004-3; Baker M, 1997, J LABOR ECON, V15, P338, DOI 10.1086/209836; Haider SJ, 2001, J LABOR ECON, V19, P799, DOI 10.1086/322821; Guvenen F, 2007, AM ECON REV, V97, P687, DOI 10.1257/aer.97.3.687; Blundell R, 2008, AM ECON REV, V98, P1887, DOI 10.1257/aer.98.5.1887; LILLARD LA, 1978, ECONOMETRICA, V46, P985, DOI 10.2307/1911432; ABOWD JM, 1989, ECONOMETRICA, V57, P411, DOI 10.2307/1912561; Huggett M, 1996, J MONETARY ECON, V38, P469, DOI 10.1016/S0304-3932(96)01291-3; Ono H, 2010, J JPN INT ECON, V24, P1, DOI 10.1016/j.jjie.2009.11.003; Lucas RE, 2003, AM ECON REV, V93, P1, DOI 10.1257/000282803321455133; HASHIMOTO M, 1985, AM ECON REV, V75, P721; Baker M, 2003, J LABOR ECON, V21, P289, DOI 10.1086/345559; Meghir C, 2004, ECONOMETRICA, V72, P1, DOI 10.1111/j.1468-0262.2004.00476.x; HAUSE JC, 1980, ECONOMETRICA, V48, P1013, DOI 10.2307/1912945; Browning M, 2010, REV ECON STUD, V77, P1353, DOI 10.1111/j.1467-937X.2010.00612.x; Storesletten K, 2004, J POLIT ECON, V112, P695, DOI 10.1086/383105; Tachibanaki T, 2006, JPN ECON REV, V57, P1, DOI 10.1111/j.1468-5876.2006.00355.x; Guvenen F, 2009, REV ECON DYNAM, V12, P58, DOI 10.1016/j.red.2008.06.004; Arellano M., 2003, PANEL DATA ECONOMETR; Attanasio O, 2008, AM ECON REV, V98, P1517, DOI 10.1257/aer.98.4.1517; Becker G., 1993, HUMAN CAPITAL THEORE; Carroll CD, 1997, J MONETARY ECON, V40, P41, DOI 10.1016/S0304-3932(97)00036-6; Chamberlain G., 1984, HDB ECONOMETRICS, V2, P1247, DOI 10.1016/S1573-4412(84)02014-6; CLARK RL, 1992, AM ECON REV, V82, P336; CLARK RL, 1992, IND LABOR RELAT REV, V45, P258, DOI 10.2307/2524833; Ehrenberg R. G., 2009, MODERN LABOR EC THEO; Guvenen F., 2010, UNDERSTANDING UNPUB; Guvenen F., 2009, INFERRING LABO UNPUB; HASHIMOTO M, 1992, AM ECON REV, V82, P346; Heathcote J., 2009, 420 FED RES BANK MIN; MINCER J, 1988, J JAPANESE INT EC, V0002; Hryshko D., 2009, RIP HIP DATA R UNPUB; HUBBARD RG, 1995, J POLIT ECON, V103, P360, DOI 10.1086/261987; Institute for Research on Household Economics, 1995, SHOUH SEIK NI KANS P; Kambayashi R., 2011, IZA DISCUSSION PAPER, V6183; Kawaguchi D., 2011, RIETI DISCUSSION PAP; Macurdy T, 2007, HBK ECON, V2, P4057, DOI 10.1016/S1573-4412(07)06062-X; Meghir C., 2010, 15914 NBER; Moffitt R. A., 1995, TRENDS COVARIA UNPUB; Moffitt R. A., 2009, TRENDS TRANSIT UNPUB; Moffitt RA, 2002, ECON J, V112, pC68, DOI 10.1111/1468-0297.00025; Moriguchi C, 2008, REV ECON STAT, V90, P713, DOI 10.1162/rest.90.4.713; Newey W. K., 1994, HDB ECONOMETRICS, V4, P2111, DOI DOI 10.1016/S1573-4412(05)80005-4; Ohtake F, 2008, ASIAN ECON POLICY R, V3, P87, DOI 10.1111/j.1748-3131.2008.00093.x; Ohtake F., 2005, NIHON NO FUBYOUDOU; Tachibanaki T, 2005, CONFRONTING INCOME I; TOPEL R, 1991, J POLIT ECON, V99, P145, DOI 10.1086/261744	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	MAR	2015	66	1					112	146		10.1111/jere.12045		35	Economics	Business & Economics	CB0IN	WOS:000349309300007		
J	Kado, Y; Soneda, Y; Yoshizawa, N				Kado, Yuya; Soneda, Yasushi; Yoshizawa, Noriko			Electrochemical behavior of MgO-templated mesoporous carbons in the propylene carbonate solution of sodium hexafluorophosphate	JOURNAL OF APPLIED ELECTROCHEMISTRY			English	Article						Mesoporous carbon; Rate performance; Organic electrolyte; Capacitive contribution	ION BATTERIES; ENERGY-STORAGE; CAPACITORS; ELECTRODE; SUPERCAPACITORS; PERFORMANCE; NA; PSEUDOCAPACITORS; NANOWIRES; NANOTUBES	MgO-templated mesoporous carbons annealed from 900 to 1,500 A degrees C were examined as active materials for negative electrodes in a propylene carbonate electrolyte containing 1 M sodium hexafluorophosphate. The carbons annealed at 1,000 A degrees C exhibited 180 mAh g(-1) at a rate of 0.1 A g(-1) in a potential range of 2.00-0.01 V versus Na+/Na. The carbons showed good rate capability as well as cyclability. It is considered that mesopores plays a role of easy diffusion pathway for ions, and also significantly relates to both electric double layer capacitance and faradaic reactions involving Na ions. X-ray diffraction patterns, nuclear magnetic resonance spectra and Raman spectra were discussed for characterization of the carbons. Raman spectra indicated a reversible interaction of reduced Na with carbons. However, Na intercalation in the carbon layers was not confirmed for the carbon annealed at 1,000 A degrees C. This is because the Na intercalation sites in the carbon layers are very few due to the disordered structure caused by the relatively low temperature annealing.	[Kado, Yuya; Soneda, Yasushi; Yoshizawa, Noriko] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058569, Japan	Kado, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	y.kado@aist.go.jp					ZHENG JP, 1995, J ELECTROCHEM SOC, V142, P2699, DOI 10.1149/1.2050077; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Conway BE, 1997, J POWER SOURCES, V66, P1, DOI 10.1016/S0378-7753(96)02474-3; Toupin M, 2004, CHEM MATER, V16, P3184, DOI 10.1021/cm049649j; Frackowiak E, 2006, ELECTROCHIM ACTA, V51, P2209, DOI 10.1016/j.electacta.2005.04.080; Frackowiak E, 1999, CARBON, V37, P61, DOI 10.1016/S0008-6223(98)00187-0; Kim SW, 2012, ADV ENERGY MATER, V2, P710, DOI 10.1002/aenm.201200026; Palacin MR, 2009, CHEM SOC REV, V38, P2565, DOI 10.1039/b820555h; Morishita T, 2010, CARBON, V48, P2690, DOI 10.1016/j.carbon.2010.03.064; Wang J, 2007, J PHYS CHEM C, V111, P14925, DOI 10.1021/jp074464w; Stevens DA, 2000, J ELECTROCHEM SOC, V147, P1271, DOI 10.1149/1.1393348; Gotoh K, 2013, J POWER SOURCES, V225, P137, DOI 10.1016/j.jpowsour.2012.10.025; Alcantara R, 2005, ELECTROCHEM SOLID ST, V8, pA222, DOI 10.1149/1.1870612; Karthikeyan K, 2014, CHEM-ASIAN J, V9, P852, DOI 10.1002/asia.201301289; Nishi Y, 2001, J POWER SOURCES, V100, P101, DOI 10.1016/S0378-7753(01)00887-4; Brezesinski K, 2011, SMALL, V7, P407, DOI 10.1002/smll.201001333; Cao YL, 2012, NANO LETT, V12, P3783, DOI 10.1021/nl3016957; Frackowiak E, 2001, CARBON, V39, P937, DOI 10.1016/S0008-6223(00)00183-4; Brezesinski T, 2010, NAT MATER, V9, P146, DOI [10.1038/nmat2612, 10.1038/NMAT2612]; Ryu KS, 2002, J POWER SOURCES, V103, P305, DOI 10.1016/S0378-7753(01)00862-X; Inagaki M, 2010, J POWER SOURCES, V195, P7880, DOI 10.1016/j.jpowsour.2010.06.036; Tang K, 2012, ADV ENERGY MATER, V2, P873, DOI 10.1002/aenm.201100691; Slater MD, 2013, ADV FUNCT MATER, V23, P947, DOI 10.1002/adfm.201200691; Laforgue A, 1999, J POWER SOURCES, V80, P142, DOI 10.1016/S0378-7753(98)00258-4; CONWAY BE, 1991, J ELECTROCHEM SOC, V138, P1539, DOI 10.1149/1.2085829; Raymundo-Pinero E, 2006, ADV MATER, V18, P1877, DOI 10.1002/adma.200501905; Kodama M, 2007, CARBON, V45, P1105, DOI 10.1016/j.carbon.2007.02.023; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Liang RL, 2011, CHEM COMMUN, V47, P10305, DOI 10.1039/c1cc14030b; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Kotz R, 2000, ELECTROCHIM ACTA, V45, P2483, DOI 10.1016/S0013-4686(00)00354-6; Liu KC, 1996, J ELECTROCHEM SOC, V143, P124, DOI 10.1149/1.1836396; Miller JR, 2008, SCIENCE, V321, P651, DOI 10.1126/science.1158736; Komaba S, 2011, ACS APPL MATER INTER, V3, P4165, DOI 10.1021/am200973k; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Chen Z, 2012, ACS NANO, V6, P4319, DOI 10.1021/nn300920e; Clarke FW, 1922, P NATL ACAD SCI USA, V8, P108, DOI 10.1073/pnas.8.5.108; Conway B. E., 1999, ELECTROCHEMICAL SUPE; RUDGE A, 1994, J POWER SOURCES, V47, P89, DOI 10.1016/0378-7753(94)80053-7; Frackowiak E, 2002, CARBON, V40, P1775, DOI 10.1016/S0008-6223(02)00045-3; Kado Y, 2015, ECS ELECTROCHEM LETT, V4, pA22, DOI 10.1149/2.0051502eel; Naoi K., 2008, J ELECTROCHEM SOC, V17, P34; Patel MN, 2010, J MATER CHEM, V20, P390, DOI 10.1039/b915370e; Rouzaud JN, 2014, CARB 2014 C JEJ KOR; Soneda Y, 2013, ELECTROCHEMISTRY, V81, P845, DOI 10.5796/electrochemistry.81.845; Wenzel A, 2011, ENERG ENVIRON SCI, V4, P3342	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0021-891X	1572-8838		J APPL ELECTROCHEM	J. Appl. Electrochem.	MAR	2015	45	3					273	280		10.1007/s10800-014-0786-8		8	Electrochemistry	Electrochemistry	CB3KM	WOS:000349526700007		
J	Hirabayashi, Y; Tsuboi, I; Nakachi, K; Kusunoki, Y; Inoue, T				Hirabayashi, Yoko; Tsuboi, Isao; Nakachi, Kei; Kusunoki, Yoichiro; Inoue, Tohru			Experimentally induced, synergistic late effects of a single dose of radiation and aging: significance in LKS fraction as compared with mature blood cells	JOURNAL OF APPLIED TOXICOLOGY			English	Article						radiation late effects; hematopoietic stem cells; gene expression profile; aging	HEMATOPOIETIC STEM-CELLS; IONIZING-RADIATION; OXIDATIVE STRESS; MYELOID-LEUKEMIA; GENE-EXPRESSION; X-IRRADIATION; C3H/HE MICE; AGE; EXPOSURE; CYCLE	The number of murine mature blood cells recovered within 6weeks after 2-Gy whole-body irradiation at 6weeks of age, whereas in the case of the undifferentiated hematopoietic stem/progenitor cell (HSC/HPC) compartment [cells in the lineage-negative, c-kit-positive and stem-cell-antigen-1-positive (LKS) fraction], the numerical differences between mice with and without irradiation remained more than a year, but conclusively the cells showed numerical recovery. When mice were exposed to radiation at 6months of age, acute damages of mature blood cells were rather milder probably because of their maturation with age; but again, cells in the LKS fraction were specifically damaged, and their numerical recovery was significantly delayed probably as a result of LKS-specific cellular damages. Interestingly, in contrast to the recovery of the number of cells in the LKS fraction, their quality was not recovered, which was quantitatively assessed on the basis of oxidative-stress-related fluorescence intensity. To investigate why the recovery in the number of cells in the LKS fraction was delayed, expression levels of genes related to cellular proliferation and apoptosis of cells in the bone marrow and LKS fraction were analyzed by real-time polymerase chain reaction (RT-PCR). In the case of 21-month-old mice after radiation exposure, Ccnd1, PiK3r1 and Fyn were overexpressed solely in cells in the LKS fraction. Because Ccnd1and PiK3r1 upregulated by aging were further upregulated by radiation, single-dose radiation seemed to induce the acceleration of aging, which is related to the essential biological responses during aging based on a lifetime-dependent relationship between a living creature and xenobiotic materials. Copyright (c) 2014 John Wiley & Sons, Ltd. The number of murine mature blood cells recovered within 6 weeks after 2-Gy whole-body irradiation, whereas in the case of the undifferentiated hematopoietic stem/progenitor cell compartment, their numerical recovery was significantly delayed. In the case of 21-month-old mice with radiation exposure, Ccnd1, PiK3r1, and Fyn were overexpressed solely in the undifferentiated hematopoietic stem/progenitor cell compartment. Because Ccnd1and PiK3r1 upregulated by aging were further upregulated by single-dose radiation, the prolonged effects of radiation seem to modify the xenobiotic processes during aging.	[Hirabayashi, Yoko] Natl Inst Hlth Sci, Cellular & Mol Toxicol Div, Natl Ctr Biol Safety & Res, Setagaya Ku, Tokyo 1588501, Japan; [Tsuboi, Isao; Inoue, Tohru] Nihon Univ, Sch Med, Dept Funct & Struct Med, Itabashi Ku, Tokyo 1738610, Japan; [Nakachi, Kei; Kusunoki, Yoichiro] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Minami Ku, Hiroshima 7320815, Japan	Hirabayashi, Y (reprint author), Natl Inst Hlth Sci, Cellular & Mol Toxicol Div, Natl Ctr Biol Safety & Res, Setagaya Ku, 1-18-1 Kamiyohga, Tokyo 1588501, Japan.	yokohira@nihs.go.jp			fund for the National Institute of Allergy and Infectious Diseases [HHSN272200900059C]; Nuclear Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; Tokyo, Japan); Japan Society for the Promotion of Science (Tokyo, Japan) [18510066, 20590388, 21510074, 24590467]; Human Sciences of Japan [KHC1204]; MHLW Research Funds of the National Institute of Health Sciences (Tokyo, Japan)	This study was supported in part by a fund for the National Institute of Allergy and Infectious Diseases (HHSN272200900059C), Nuclear Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; Tokyo, Japan), a Grant-in-Aid for Scientific Research C from the Japan Society for the Promotion of Science (Tokyo, Japan) (18510066, 20590388, 21510074, 24590467), The Human Sciences of Japan (KHC1204), and also by MHLW Research Funds of the National Institute of Health Sciences (Tokyo, Japan).	Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; BASS DA, 1983, J IMMUNOL, V130, P1910; Pearce DJ, 2007, STEM CELLS, V25, P828, DOI 10.1634/stemcells.2006-0405; Istvanffy R, 2011, BLOOD, V118, P2712, DOI 10.1182/blood-2010-05-287235; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Richardson RB, 2009, AGING-US, V1, P887; Finnberg N, 2008, CANCER BIOL THER, V7, P2023, DOI 10.4161/cbt.7.12.7417; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Caos L, 2007, CARCINOGENESIS, V28, P1401; Chen D, 2007, EXP HEMATOL, V35, P1344, DOI 10.1016/j.exphem.2007.06.004; Cronkites EP, 1979, RADIAT RES, P648; Dais JM, 2006, INT J RADIAT BIOL, V82, P511; Frank J, 2000, HISTOL HISTOPATHOL, V15, P173; Gruel G, 2006, RADIAT RES, V166, P746, DOI 10.1667/RR0260.1; Hirabayashi Y, 2005, CHEM-BIOL INTERACT, V153, P165, DOI 10.1016/j.cbi.2005.03.021; Hirabayashi Y, 2014, ANN NY ACAD SCI, V1310, P69, DOI 10.1111/nyas.12401; Hirabayashis Y, 2011, HDB SYSTEMS TOXICOLO, P432; Hirabayashis Y, 2012, TOXICOLOGY EPIGENETI, P475; Hirabayashi Y, 2007, EXP HEMATOL, V35, P125, DOI 10.1016/j.exphem.2007.01.020; Hirabayashi Yoko, 1997, Leukemia (Basingstoke), V11, P489; Hirabayashi Y, 2007, J MEMBRANE BIOL, V217, P105, DOI 10.1007/s00232-007-9042-z; ICHIMARU M, 1975, Journal of Radiation Research, V16, P89, DOI 10.1269/jrr.16.SUPPLEMENT_89; Krasilnikov M, 1999, MOL CARCINOGEN, V24, P64, DOI 10.1002/(SICI)1098-2744(199901)24:1<64::AID-MC9>3.0.CO;2-2; Lis GX, 2006, EXP HEMATOL, V34, P1687; LORIMORE SA, 1990, INT J RADIAT BIOL, V57, P385, DOI 10.1080/09553009014552481; Otsuka K, 2010, EXP HEMATOL, V38, P417, DOI 10.1016/j.exphem.2010.02.010; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI [10.3324/haematol.2009.013797, 10.3324/haemato1.2009.013797]; Pawlik A, 2011, RADIAT RES, V175, P66, DOI 10.1667/RR2282.1; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SASAKI S, 1991, J RADIAT RES, V32, P73, DOI 10.1269/jrr.32.SUPPLEMENT2_73; Shimura T, 2013, CELL CYCLE, V12, P2738, DOI 10.4161/cc.25746; Taos GZ, 2013, J BIOL CHEM, V288, P17214; Trends in Age-specific Mortality Rate, 1965, CANC STAT JAP 2013 F; Tsuboi I, 2008, J APPL TOXICOL, V28, P797, DOI 10.1002/jat.1341; Yoshida K, 2007, RADIAT RES, V167, P703, DOI 10.1667/RR0820.1; Yoshida K, 1997, P NATL ACAD SCI USA, V94, P2615, DOI 10.1073/pnas.94.6.2615	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	MAR	2015	35	3					230	240		10.1002/jat.3088		11	Toxicology	Toxicology	CB1EV	WOS:000349370600002		
J	Miyagawa, S; Lange, A; Tohyama, S; Ogino, Y; Mizutani, T; Kobayashi, T; Tatarazako, N; Tyler, CR; Iguchi, T				Miyagawa, Shinichi; Lange, Anke; Tohyama, Saki; Ogino, Yukiko; Mizutani, Takeshi; Kobayashi, Tohru; Tatarazako, Norihisa; Tyler, Charles R.; Iguchi, Taisen			Characterization of Oryzias latipes glucocorticoid receptors and their unique response to progestins	JOURNAL OF APPLIED TOXICOLOGY			English	Article						medaka; glucocorticoid receptor; reporter gene assay; progestins; species differences	MULTIPLE CORTICOSTEROID RECEPTORS; ANTIPROGESTIN MIFEPRISTONE RU486; TELEOST FISH; IN-VITRO; MINERALOCORTICOID RECEPTOR; ENDOCRINE DISRUPTION; SYNTHETIC PROGESTINS; ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; BETA-ISOFORM	Various receptor bioassays, including estrogens, androgens and thyroid hormones, have been developed and applied successfully for assessing hormone function in a wide range of animal species, including fish. In fish, corticosteroids play a pivotal role in physiology as they do in mammals, but far less is known about the corticosteroid receptor system in fish compared with in mammals. Here we established a transient transactivation assay using the Japanese medaka, Oryzias latipes, glucocorticoid receptors (olGRs) and mineralocorticoid receptor to analyse their functional properties in a fish. We found that olGR2 was highly responsive to glucocorticoids, similar to the human GR, whereas the olGR1 subtype was minimally responsive. Thus, olGR2 most likely mediates glucocorticoid signaling in medaka. We further tested crosstalk between GRs and other steroid hormones, and found that progestins could activate or inactivate olGR2-mediating transcription, depending on the presence or absence of cortisol. The transactivation assays developed for medaka GRs provide tools to gain useful insights into corticosteroid signaling in fish and for in vitro screening of environmental substances activating GRs. Copyright (c) 2014 John Wiley & Sons, Ltd. We here report the molecular characterization of medaka (Oryzias latipes) corticosteroid receptors (GRs), and show that GR2 is most likely the subtype mediating glucocorticoid signaling in the medaka. We also found that progestins could activate or inactivate GR2-mediated transcription, depending on the presence or absence of cortisol. These findings advance understanding of the basic mechanisms of GR-mediated transcription in medaka.	[Miyagawa, Shinichi; Tohyama, Saki; Ogino, Yukiko; Mizutani, Takeshi; Iguchi, Taisen] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Miyagawa, Shinichi; Tohyama, Saki; Ogino, Yukiko; Mizutani, Takeshi; Iguchi, Taisen] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Lange, Anke; Tyler, Charles R.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Tohyama, Saki; Kobayashi, Tohru] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Shizuoka 4228526, Japan; [Tatarazako, Norihisa] Natl Inst Environm Studies, Environm Qual Measurement Sect, Res Ctr Environm Risk, Tsukuba, Ibaraki 3058506, Japan	Iguchi, T (reprint author), Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan.	taisen@nibb.ac.jp			UK-Japan Research Collaboration on Endocrine Disruptors from Ministry of the Environment, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants of UK-Japan Research Collaboration on Endocrine Disruptors from Ministry of the Environment, Japan and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Greenwood AK, 2003, ENDOCRINOLOGY, V144, P4226, DOI 10.1210/en.2003-0566; Bluthgen N, 2013, AQUAT TOXICOL, V144, P83, DOI 10.1016/j.aquatox.2013.09.033; Bluthgen N, 2013, AQUAT TOXICOL, V144, P96, DOI 10.1016/j.aquatox.2013.09.030; NAGAHAMA Y, 1985, DEV BIOL, V109, P428, DOI 10.1016/0012-1606(85)90469-5; Kugathas S, 2011, ENVIRON SCI TECHNOL, V45, P2377, DOI 10.1021/es104105e; Prunet P, 2006, GEN COMP ENDOCR, V147, P17, DOI 10.1016/j.ygcen.2006.01.015; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; Oakley RH, 1996, J BIOL CHEM, V271, P9550; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; Atanasov AG, 2005, ENVIRON HEALTH PERSP, V113, P1600, DOI 10.1289/ehp.8209; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Stolte EH, 2008, J ENDOCRINOL, V198, P403, DOI 10.1677/JOE-08-0100; Bury NR, 2003, J MOL ENDOCRINOL, V31, P141, DOI 10.1677/jme.0.0310141; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; Bury NR, 2007, GEN COMP ENDOCR, V153, P47, DOI 10.1016/j.ygcen.2007.03.009; FOSKETT JK, 1983, J EXP BIOL, V106, P255; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; NAGAHAMA Y, 1994, INT J DEV BIOL, V38, P217; Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834; Takahashi H, 2013, GEN COMP ENDOCR, V181, P223, DOI 10.1016/j.ygcen.2012.11.016; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Colombe L, 2000, STEROIDS, V65, P319, DOI 10.1016/S0039-128X(00)00090-8; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1; Berns HA, 1992, AQUACULTURE, V100, P2337; GIANNOPOULOS G, 1981, ENDOCRINOLOGY, V108, P1414; Ingerslev F, 2003, PURE APPL CHEM, V75, P1881, DOI 10.1351/pac200375111881; Kims MA, 2011, GEN COMP ENDOCR, V171, P341; KONOPLYANNIKOV A G, 1977, Meditsinskaya Radiologiya, V22, P23; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; PATINO R, 1990, GEN COMP ENDOCR, V78, P474, DOI 10.1016/0016-6480(90)90036-L; SCHEIDEREIT C, 1984, P NATL ACAD SCI-BIOL, V81, P3029, DOI 10.1073/pnas.81.10.3029; Stavreva DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00937; Vizzini A, 2007, GEN COMP ENDOCR, V150, P114, DOI 10.1016/j.ygcen.2006.07.016; Bonga SEW, 1997, PHYSIOL REV, V77, P591; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012	42	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	MAR	2015	35	3					302	309		10.1002/jat.3020		8	Toxicology	Toxicology	CB1EV	WOS:000349370600010		
J	Kurabayashi, K; Hirakawa, Y; Tanimoto, K; Tomita, H; Hirakawa, H				Kurabayashi, Kumiko; Hirakawa, Yuko; Tanimoto, Koichi; Tomita, Haruyoshi; Hirakawa, Hidetada			Identification of a Second Two-Component Signal Transduction System That Controls Fosfomycin Tolerance and Glycerol-3-Phosphate Uptake	JOURNAL OF BACTERIOLOGY			English	Article							COMPLETE GENOME SEQUENCE; TRIMETHYLAMINE N-OXIDE; UROPATHOGENIC ESCHERICHIA-COLI; MICROBIOTA METABOLISM; MULTIDRUG-RESISTANT; RESPONSE REGULATOR; UNORTHODOX SENSOR; L-CARNITINE; EXPRESSION; O157-H7	Particular interest in fosfomycin has resurfaced because it is a highly beneficial antibiotic for the treatment of refractory infectious diseases caused by pathogens that are resistant to other commonly used antibiotics. The biological cost to cells of resistance to fosfomycin because of chromosomal mutation is high. We previously found that a bacterial two-component system, CpxAR, induces fosfomycin tolerance in enterohemorrhagic Escherichia coli (EHEC) O157: H7. This mechanism does not rely on irreversible genetic modification and allows EHEC to relieve the fitness burden that results from fosfomycin resistance in the absence of fosfomycin. Here we show that another two-component system, TorSRT, which was originally characterized as a regulatory system for anaerobic respiration utilizing trimethylamine-N-oxide (TMAO), also induces fosfomycin tolerance. Activation of the Tor regulatory pathway by overexpression of torR, which encodes the response regulator, or addition of TMAO increased fosfomycin tolerance in EHEC. We also show that phosphorylated TorR directly represses the expression of glpT, a gene that encodes a symporter of fosfomycin and glycerol-3-phosphate, and activation of the TorR protein results in the reduced uptake of fosfomycin by cells. However, cells in which the Tor pathway was activated had an impaired growth phenotype when cultured with glycerol-3-phosphate as a carbon substrate. These observations suggest that the TorSRT pathway is the second two-component system to reversibly control fosfomycin tolerance and glycerol-3-phosphate uptake in EHEC, and this may be beneficial for bacteria by alleviating the biological cost. We expect that this mechanism could be a potential target to enhance the utility of fosfomycin as chemotherapy against multidrug-resistant pathogens.	[Kurabayashi, Kumiko; Hirakawa, Hidetada] Gunma Univ, Adv Sci Res Leaders Dev Unit, Grad Sch Med, Gunma, Japan; [Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Dept Bacteriol, Gunma, Japan; [Hirakawa, Yuko; Tanimoto, Koichi; Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Lab Bacterial Drug Resistance, Gunma, Japan	Hirakawa, H (reprint author), Gunma Univ, Adv Sci Res Leaders Dev Unit, Grad Sch Med, Gunma, Japan.	hirakawa@gunma-u.ac.jp			JSPS KAKENHI [25870115]	This study was kindly supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) grant number 25870115, the JST program Improvement of Research Environment for Young Researchers, the Japanese Ministry of Education, Culture, Sport, Science and Technology (for Gunma University operation grants), the Inamori Foundation, the Institute for Fermentation, Osaka, Japan (IFO), the Sumitomo Foundation, and the Japanese Ministry of Health, Labor and Welfare (H24-ShinkouIppan- 010). This work was awarded the 6th Incentive Award in the Category of Basic Research Conferred by the Director of the East Japan Branch of the Japanese Society of Chemotherapy.	Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Denamur E, 2002, J BACTERIOL, V184, P605, DOI 10.1128/JB.184.2.605-609.2002; Dinh A, 2012, SCAND J INFECT DIS, V44, P182, DOI 10.3109/00365548.2011.616221; Nilsson AI, 2003, ANTIMICROB AGENTS CH, V47, P2850, DOI 10.1128/AAC.47.9.2850-2858.2003; Ussher JR, 2013, ATHEROSCLEROSIS, V231, P456, DOI 10.1016/j.atherosclerosis.2013.10.013; Baraquet C, 2006, J BIOL CHEM, V281, P38189, DOI 10.1074/jbc.M604321200; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Ikeda K, 1999, CLIN NEPHROL, V52, P357; Hirakawa H, 2009, MICROBIOL-SGM, V155, P541, DOI 10.1099/mic.0.020420-0; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; SIMON G, 1995, MOL MICROBIOL, V17, P971, DOI 10.1111/j.1365-2958.1995.mmi_17050971.x; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; Ansaldi M, 2001, J BACTERIOL, V183, P2691, DOI 10.1128/JB.183.8.2691-2695.2001; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Jourlin C, 1996, MOL MICROBIOL, V20, P1297, DOI 10.1111/j.1365-2958.1996.tb02648.x; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Link AJ, 1997, J BACTERIOL, V179, P6228; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bush K, 2012, REV SCI TECH OIE, V31, P43; ARGAST M, 1978, J BACTERIOL, V136, P1070; Bordi C, 2003, MOL MICROBIOL, V48, P211, DOI 10.1046/j.1365-2958.2003.03428.x; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; Ellington MJ, 2006, J ANTIMICROB CHEMOTH, V58, P848, DOI 10.1093/jac/dkl315; Horii T, 1999, ANTIMICROB AGENTS CH, V43, P789; KADNER RJ, 1973, J BACTERIOL, V113, P895; Kurabayashi K, 2014, J BACTERIOL, V196, P248, DOI 10.1128/JB.01151-13; Kurioka T, 1999, EUR J CLIN MICROBIOL, V18, P561, DOI 10.1007/s100960050348; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P712, DOI 10.1093/jac/dkp288; Schito GC, 2003, INT J ANTIMICROB AG, V22, pS79, DOI 10.1016/S0924-8579(03)00231-0; Shimizu M, 2000, ANTIMICROB AGENTS CH, V44, P2007, DOI 10.1128/AAC.44.7.2007-2008.2000; SIMON G, 1994, J BACTERIOL, V176, P5601; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Takeda T, 1998, ESCHERICHIA COLI O15, P385; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; VARGA MER, 1995, BIOCHEM CELL BIOL, V73, P147; VENKATES.PS, 1972, J BACTERIOL, V110, P935; Yang B, 1997, MOL MICROBIOL, V24, P511, DOI 10.1046/j.1365-2958.1997.3651733.x	42	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	MAR	2015	197	5					861	871		10.1128/JB.02491-14		11	Microbiology	Microbiology	CB1PC	WOS:000349399000006		
J	Takahashi, T; Yamahsita, S; Matsuda, Y; Kishino, T; Nakajima, T; Kushima, R; Kato, K; Igaki, H; Tachimori, Y; Osugi, H; Nagino, M; Ushijima, T				Takahashi, Takamasa; Yamahsita, Satoshi; Matsuda, Yasunori; Kishino, Takayoshi; Nakajima, Takeshi; Kushima, Ryoji; Kato, Ken; Igaki, Hiroyasu; Tachimori, Yuji; Osugi, Harushi; Nagino, Masato; Ushijima, Toshikazu			ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Epigenetics; DNA methylation; Biomarker; Esophageal squamous cell carcinoma; Chemoradiotherapy	DNA METHYLATION; GASTRIC CANCERS; PHASE-II; PROMOTER METHYLATION; COLORECTAL-CANCER; CISPLATIN; SURGERY; TRIAL; GENE; CHEMORADIORESISTANCE	Purpose Definitive chemoradiotherapy (dCRT) is one of the standard treatments for esophageal squamous cell carcinoma. Patients with a response to dCRT have a better prognosis than those resistant to dCRT while survival benefits for patients with residual tumors are limited. Nevertheless, few molecular markers to predict the response to dCRT are currently available. Here, we aimed to establish a DNA methylation marker to predict the response to dCRT. Methods A total of 104 patients were divided into screening (n = 43) and validation (n = 61) sets. A genome-wide DNA methylation analysis was performed using an Infinium HumanMethylation450 BeadChip array. Methylation levels were measured by quantitative methylation-specific PCR and normalized by the fraction of cancer cells in a sample. Results The genome-wide methylation analysis of seven responders and eight non-responders identified 18 genomic regions specifically (un) methylated in the responders. Among these, methylation of the promoter CpG island of ZNF695 was significantly associated with the response to dCRT in the screening set (P = 0.004), and a cutoff value was determined. In the validation set, the association was successfully validated (P = 0.021), and a high specificity (90 %) for the prediction of responders was obtained using the prefixed cutoff value. In addition, a multivariate analysis showed that ZNF695 methylation was an independent predictive factor for the response to dCRT (OR 7.55, 95 % CI 2.12-26.9, P = 0.002). Conclusion ZNF695 methylation was significantly associated with the response to dCRT and is a promising predictive marker for the response to dCRT.	[Takahashi, Takamasa; Yamahsita, Satoshi; Matsuda, Yasunori; Kishino, Takayoshi; Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Chuo Ku, Tokyo 1040045, Japan; [Takahashi, Takamasa; Kishino, Takayoshi; Igaki, Hiroyasu; Tachimori, Yuji] Natl Canc Ctr, Esophageal Surg Div, Tokyo, Japan; [Takahashi, Takamasa; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4648601, Japan; [Matsuda, Yasunori; Osugi, Harushi] Osaka City Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka 558, Japan; [Nakajima, Takeshi] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Kushima, Ryoji] Natl Canc Ctr, Pathol & Clin Lab Div, Tokyo, Japan; [Kato, Ken] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan	Ushijima, T (reprint author), Natl Canc Ctr, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tushijim@ncc.go.jp			Ministry of Education, Culture Sports, Science, and Technology, Japan; Ministry of Health, Labour, and Welfare, Japan [H22-general-002]; Foundation for Promotion of Cancer Research	We thank the National Cancer Center Research Core Facility for preparation of sections from paraffin-embedded biopsy specimens in this study. This study was supported by Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from the Ministry of Education, Culture Sports, Science, and Technology, Japan, and by the Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour, and Welfare, Japan (H22-general-002). T.T. and Y.M. are recipients of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Amatu A, 2013, CLIN CANCER RES, V19, P2265, DOI 10.1158/1078-0432.CCR-12-3518; Toyota M, 2009, CANCER SCI, V100, P787, DOI 10.1111/j.1349-7006.2009.01095.x; Shigematsu Y, 2012, ONCOL LETT, V4, P268, DOI 10.3892/ol.2012.708; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Turashvili G, 2012, EXP MOL PATHOL, V92, P33, DOI 10.1016/j.yexmp.2011.09.013; Issa JP, 2012, J CLIN ONCOL, V30, P2566, DOI 10.1200/JCO.2012.42.1016; Zhang JX, 2013, INT J CANCER, V132, P2567, DOI 10.1002/ijc.27930; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Tahara M, 2005, JPN J CLIN ONCOL, V35, P316, DOI 10.1093/jjco/hyi095; Brabender J, 2009, ANN SURG ONCOL, V16, P1378, DOI 10.1245/s10434-009-0356-1; Kleinberg L, 2007, J CLIN ONCOL, V25, P4110, DOI 10.1200/JCO.2007.12.0881; Park CK, 2009, NEUROPATHOLOGY, V29, P443, DOI 10.1111/j.1440-1789.2008.00998.x; Kato K, 2013, JPN J CLIN ONCOL, V43, P608, DOI 10.1093/jjco/hyt048; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Makuuchi Y, 2013, CANCER SCI, V104, P1045, DOI 10.1111/cas.12187; Mikeska T, 2012, EXPERT REV MOL DIAGN, V12, P473, DOI [10.1586/erm.12.45, 10.1586/ERM.12.45]; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.4760; Conroy T, 2014, LANCET ONCOL, V15, P305, DOI 10.1016/S1470-2045(14)70028-2; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Akutsu Y, 2011, ANN SURG ONCOL, V18, P2946, DOI 10.1245/s10434-011-1645-z; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Chung CS, 2010, J FORMOS MED ASSOC, V109, P408, DOI 10.1016/S0929-6646(10)60072-1; Funabashi KS, 2012, PATHOL RES PRACT, V208, P584, DOI 10.1016/j.prp.2012.07.001; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052589; Giovannetti E, 2012, NEW ENGL J MED, V366, P966, DOI 10.1056/NEJMc1201170#SA1; Goel A, 2010, FUTURE ONCOL, V6, P333, DOI [10.2217/fon.10.9, 10.2217/FON.10.9]; Juarez-Mendez S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-61; Kaneda A, 2004, CANCER LETT, V212, P203, DOI 10.1016/j.canlet.2004.03.020; Kim KJ, 2013, HUM PATHOL, V44, P1055, DOI 10.1016/j.humpath.2012.09.009; Kuwano H, 2008, ESOPHAGUS, V5, P61, DOI [10.1007/s10388-008-0151-2, DOI 10.1007/S10388-008-0151-2]; Loh M, 2010, DIAGN MOL PATHOL, V19, P243, DOI 10.1097/PDM.0b013e3181de4396; Oka D, 2009, CANCER, V115, P3412, DOI 10.1002/cncr.24394; Okamoto H, 2013, ANTICANCER RES, V33, P1463; Sato F, 2002, CANCER RES, V62, P6820; Sobin CW LH, 2002, TNM CLASSIFICATION M; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082302; Yang Mihi, 2012, Methods Mol Biol, V863, P67, DOI 10.1007/978-1-61779-612-8_5	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	MAR	2015	141	3					453	463		10.1007/s00432-014-1841-x		11	Oncology	Oncology	CB1FZ	WOS:000349373800007		
J	Goto, H; Kudo, E; Kariya, R; Taura, M; Katano, H; Okada, S				Goto, Hiroki; Kudo, Eriko; Kariya, Ryusho; Taura, Manabu; Katano, Harutaka; Okada, Seiji			Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Fluid retention; IL-6; Primary effusion lymphoma; VEGF	SARCOMA-ASSOCIATED HERPESVIRUS; VIRAL IL-6; PERMEABILITY FACTOR; EXPRESSION; RECEPTOR; ANGIOGENESIS; INHIBITION; CELLS; APOPTOSIS; CAVITY	Purpose Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma that shows malignant effusion most commonly seen in advanced AIDS patients. In this study, we clarified the potential role of VEGF and IL-6 in PEL fluid retention and evaluated the efficacy of humanized anti-VEGF monoclonal antibody (mAb), bevacizumab, and humanized anti-IL-6 receptor mAb, tocilizumab, against PEL. Methods The production of VEGF and IL-6, and the expression of IL-6R alpha in PEL cell lines were examined. The antiproliferative effect of bevacizumab and tocilizumab on PEL cells was evaluated in vitro. The effect of tocilizumab on VEGF was also examined. An intraperitoneal xenograft mouse model was used for in vivo efficacy. Results Although we found the production of VEGF and IL-6, and the expression of IL-6Ra in PEL cell lines, bevacizumab and tocilizumab did not inhibit the proliferation of PEL cells in vitro. Tocilizumab decreased VEGF mRNA and VEGF production by inhibiting Stat3 phosphorylation and Stat3 binding to VEGF promoter. In a PEL xenograft mouse model that showed profuse ascites, bevacizumab suppressed ascites formation completely, indicating the critical role of VEGF for PEL fluid retention. Tocilizumab also significantly inhibited ascites formation in vivo. Moreover, these mAbs improved the overall survival of treated mice. Conclusions IL-6-VEGF axis contributed to fluid retention, and bevacizumab and tocilizumab could be effective molecular targeting therapies for PEL.	[Goto, Hiroki; Kudo, Eriko; Kariya, Ryusho; Taura, Manabu; Okada, Seiji] Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Chuo Ku, Kumamoto 8600811, Japan; [Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan	Okada, S (reprint author), Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	okadas@kumamoto-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan [H25-AIDS-I-002]; Global COE program, "Global Education and Research Center Aiming at the Control of AIDS"; Ministry of Education, Science, Sports, and Culture of Japan [25114711]	We thank Ms. I. Suzu and Ms. S. Fujikawa for technical assistance and Ms. Y. Endo for secretarial assistance. This work was supported by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan (H25-AIDS-I-002), the Global COE program, "Global Education and Research Center Aiming at the Control of AIDS," and Grants-in-Aid for Science Research (No. 25114711) from the Ministry of Education, Science, Sports, and Culture of Japan.	Keller SA, 2000, BLOOD, V96, P2537; Mullberg J, 2000, J IMMUNOL, V164, P4672; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; BREEN EC, 1990, J IMMUNOL, V144, P480; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; AKIRA S, 1990, EMBO J, V9, P1897; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407; Mori Y, 2000, J MED VIROL, V61, P332, DOI 10.1002/1096-9071(200007)61:3<332::AID-JMV8>3.0.CO;2-3; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Castillo JJ, 2012, LEUKEMIA LYMPHOMA, V53, P2378, DOI 10.3109/10428194.2012.694075; Aoki Y, 2001, BLOOD, V98, P3042, DOI 10.1182/blood.V98.10.3042; Osborne J, 1999, HUM IMMUNOL, V60, P921, DOI 10.1016/S0198-8859(99)00083-X; Aoki Y, 1999, BLOOD, V93, P4034; Suthaus J, 2012, BLOOD, V119, P5173, DOI 10.1182/blood-2011-09-377705; Hong DS, 2007, CANCER, V110, P1911, DOI 10.1002/cncr.22999; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Boulanger E, 2005, J CLIN ONCOL, V23, P4372, DOI 10.1200/JCO.2005.07.084; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Goto H, 2012, CANCER SCI, V103, P775, DOI 10.1111/j.1349-7006.2012.02212.x; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Aoki Y, 1999, BLOOD, V94, P4247; BIRX DL, 1990, BLOOD, V76, P2303; Drexler HG, 1999, LEUKEMIA, V13, P634, DOI 10.1038/sj.leu.2401371; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Klass CM, 2005, BLOOD, V105, P4028, DOI 10.1182/blood-2004-09-3569; NAGY JA, 1995, CANCER RES, V55, P369; NAKAJIMA K, 1989, J IMMUNOL, V142, P531; Nicholas J, 1998, J NATL CANC I MONOGR, V23, P79; RIECKMANN P, 1991, J EXP MED, V173, P1, DOI 10.1084/jem.173.1.1; Wu W, 2005, LEUKEMIA RES, V29, P545, DOI 10.1016/j.leukres.2004.11.010	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	MAR	2015	141	3					465	474		10.1007/s00432-014-1842-9		10	Oncology	Oncology	CB1FZ	WOS:000349373800008		
J	Suzuki, S; Ishii, G; Matsuwaki, R; Neri, S; Hashimoto, H; Yamauchi, C; Aokage, K; Hishida, T; Yoshida, J; Kohno, M; Nagai, K; Ochiai, A				Suzuki, Shigeki; Ishii, Genichiro; Matsuwaki, Rie; Neri, Shinya; Hashimoto, Hiroko; Yamauchi, Chisako; Aokage, Keiju; Hishida, Tomoyuki; Yoshida, Junji; Kohno, Mitsutomo; Nagai, Kanji; Ochiai, Atsushi			Ezrin-expressing lung adenocarcinoma cells and podoplaninpositive fibroblasts form a malignant microenvironment	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Cancer microenvironment; Ezrin; Podoplanin; CAFs; Lung cancer	ERM PROTEINS; POSITIVE FIBROBLASTS; PHOSPHORYLATED EZRIN; TUMOR PROGRESSION; CANCER-CELLS; IN-VITRO; ACTIVATION; PROGNOSIS; CARCINOMA; MERLIN	Purpose Cancer cells and cancer-associated fibroblasts (CAFs) together create the tumor microenvironment, which affects malignant behavior. Lung adenocarcinomas with CAFs expressing podoplanin (PDPN) are clinically aggressive, but the molecular mechanism underlying this phenomenon has not been established. So we identified the characteristic immunophenotype of lung adenocarcinoma cells coexisting with PDPN-expressing CAFs (PDPNCAFs) and examined how it relates to an aggressive clinicopathological outcome. Methods We analyzed the clinicopathological characteristics of 119 adenocarcinomas with a uniform size (2-3 cm). The expression levels of ten invasiveness-related proteins which related to cell adhesion and invasiveness, such as Ezrin, were examined in cancer cells from PDPN-CAFs (+) cases and from PDPN-CAFs (-) cases (n = 20 each). To examine the functional importance of the identified protein on the invasion phenotype, we performed wound healing and a Matrigel invasion assay using shRNA-knockdown lung adenocarcinoma cells (PC-9). Results The PDPN-CAFs (+) cases had significantly higher rates of node metastasis (p < 0.01) and vascular invasion (p < 0.01). The cancer cells from the PDPN-CAFs (+) cases also had a significantly higher staining score for Ezrin (p < 0.01) than those from the PDPN-CAFs (-) cases. The migration and invasion activities of the shEzrin-induced PC-9 cells were significantly lower than those of the control cells. Conclusions Our results indicated that within a tumor microenvironment composed of PDPN-CAFs, increased Ezrin expression in cancer cells might play a key role in the invasiveness of lung adenocarcinoma.	[Suzuki, Shigeki; Ishii, Genichiro; Matsuwaki, Rie; Neri, Shinya; Hashimoto, Hiroko; Yamauchi, Chisako; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba 2778577, Japan; [Suzuki, Shigeki; Matsuwaki, Rie; Neri, Shinya; Aokage, Keiju; Hishida, Tomoyuki; Yoshida, Junji; Nagai, Kanji] Natl Canc Ctr Hosp East, Div Thorac Surg, Kashiwa, Chiba 2778577, Japan; [Suzuki, Shigeki; Kohno, Mitsutomo] Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 160, Japan	Ishii, G (reprint author), Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba 2778577, Japan.	gishii@east.ncc.go.jp			National Cancer Center Research and Development Fund [23-A-12, 23-K-18]; Foundation for the Promotion of Cancer Research, 3rd-Term Comprehensive 10-Year Strategy for Cancer Control; Advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); JSPS KAKENHI [24659185]	This work was supported by National Cancer Center Research and Development Fund (23-A-12 and 23-K-18), the Foundation for the Promotion of Cancer Research, 3rd-Term Comprehensive 10-Year Strategy for Cancer Control, the Advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), and JSPS KAKENHI (24659185).	TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tynninen O, 2004, NEUROPATH APPL NEURO, V30, P472, DOI 10.1111/j.1365-2990.2004.00562.x; Hasegawa Y, 2001, CANCER, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Hofheinz RD, 2003, ONKOLOGIE, V26, P44, DOI 10.1159/000069863; Zhang XQ, 2012, CLIN LUNG CANCER, V13, P196, DOI 10.1016/j.cllc.2011.04.002; Suzuki H, 2008, FEBS LETT, V582, P341, DOI 10.1016/j.febslet.2007.12.028; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Chen QY, 2013, MOL CELL BIOCHEM, V377, P207, DOI 10.1007/s11010-013-1586-x; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Ohta M, 2013, ORAL ONCOL, V49, P20, DOI 10.1016/j.oraloncology.2012.06.017; Scott AM, 2003, CLIN CANCER RES, V9, P1639; Ito S, 2012, BIOCHEM BIOPH RES CO, V422, P194, DOI 10.1016/j.bbrc.2012.04.158; Ishii G, 2005, INT J CANCER, V117, P212, DOI 10.1002/ijc.21199; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Ito TK, 2007, ONCOGENE, V26, P7194, DOI 10.1038/sj.onc.1210535; Xing F, 2010, FRONT BIOSCI, V15, P166, DOI 10.2741/3613; Karmakar S, 2004, J REPROD IMMUNOL, V64, P9, DOI 10.1016/j.jri.2004.04.005; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Ma L, 2013, CHINESE MED J-PEKING, V126, P242, DOI 10.3760/cma.j.issn.0366-6999.20110738; Cui YZ, 2010, CANCER INVEST, V28, P242, DOI 10.3109/07357900903124498; Di Cristofano C, 2010, MODERN PATHOL, V23, P1012, DOI 10.1038/modpathol.2010.77; Gottschling S, 2013, LUNG CANCER, V80, P19, DOI 10.1016/j.lungcan.2012.12.015; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Okusa Y, 1999, CANCER, V85, P1033, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1033::AID-CNCR4>3.3.CO;2-B; Xu Y, 2003, J BIOL CHEM, V278, P8661, DOI 10.1074/jbc.M208181200	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	MAR	2015	141	3					475	484		10.1007/s00432-014-1851-8		10	Oncology	Oncology	CB1FZ	WOS:000349373800009		
J	Shiota, M; Yokomizo, A; Takeuchi, A; Imada, K; Kiyoshima, K; Inokuchi, J; Tatsugami, K; Naito, S				Shiota, Masaki; Yokomizo, Akira; Takeuchi, Ario; Imada, Kenjiro; Kiyoshima, Keijiro; Inokuchi, Junichi; Tatsugami, Katsunori; Naito, Seiji			The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Androgen-deprivation therapy; Castration-resistant prostate cancer; Oncological outcome; Prostate cancer; Validation	RANDOMIZED-TRIALS; PROGNOSTIC IMPACT; YOUNG AGE; FOLLOW-UP; CASTRATION; BLOCKADE; TESTOSTERONE; BICALUTAMIDE; STATISTICS; CARCINOMA	Purpose Although androgen-deprivation therapy (ADT) for prostate cancer is initially effective, most tumors eventually recur even during ADT. To predict their prognosis, the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score was developed. However, there is no validation of this model using data from a single institution. Therefore, in this study, we clarified the oncological outcome of primary ADT and its prognostic factors, as well as validated the J-CAPRA score model in our institution. Methods This study included 248 Japanese patients with hormone-naive prostate cancer who were treated with primary ADT from 1996 through 2012. The oncological outcome and prognostic significance of several clinicopathological factors were analyzed. Also, J-CAPRA risk stratification model was validated in this cohort. Results During a median follow-up period of 42.2 months, the median progression-free survival (PFS) and overall survival (OS) were 89.3 and 103.3 months, respectively. Multivariate analysis identified clinical T-stage and M-stage for PFS and cancer-specific survival (CSS) and clinical M-stage for OS as significant predictors. The accuracy of J-CAPRA score model for predicting PFS, CSS, and OS was validated by high c-indices. Conclusions This study demonstrated the use of the J-CAPRA score system for predicting PFS, CSS, and OS among Japanese men treated with primary ADT in a single institution.	[Shiota, Masaki; Yokomizo, Akira; Takeuchi, Ario; Imada, Kenjiro; Kiyoshima, Keijiro; Inokuchi, Junichi; Tatsugami, Katsunori; Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, Fukuoka 812, Japan	Yokomizo, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 812, Japan.	yokoa@uro.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24890160, 25462484]	We would like to thank Edanz Group Japan for editorial assistance. This work was supported by Kakenhi Grants (24890160 and 25462484) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Akaza H, 2009, CANCER, V115, P3437, DOI 10.1002/cncr.24395; Akaza H, 2006, BJU INT, V98, P573, DOI 10.1111/j.1464-410X.2006.06349.x; Dalesio O, 2000, LANCET, V355, P1491; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Shiota M, 2013, PROSTATE, V73, P1336, DOI 10.1002/pros.22681; Potosky AL, 2014, J CLIN ONCOL, V32, P1324, DOI 10.1200/JCO.2013.52.5782; Morote J, 2009, BJU INT, V103, P332, DOI 10.1111/j.1464-410X.2008.08062.x; Huggins C, 1941, CANCER RES, V1, P293; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Ahmadi H, 2013, BJU INT, V111, P543, DOI 10.1111/j.1464-410X.2012.11774.x; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Fujimoto H, 2011, INT J UROL, V18, P876, DOI 10.1111/j.1442-2042.2011.02895.x; Niraula S, 2013, J CLIN ONCOL, V31, P2029, DOI 10.1200/JCO.2012.46.5492; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; Fujimoto H, 2005, INT J UROL, V12, P46; Grivas PD, 2013, CRIT REV ONCOL HEMAT, V85, P82, DOI 10.1016/j.critrevonc.2012.05.003; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Kimura T, 2014, INT J UROL, V21, P578, DOI 10.1111/iju.12389; Kitagawa Y, 2013, INT J UROL, V20, P708, DOI 10.1111/iju.12037; Park YH, 2009, J UROLOGY, V181, P2520, DOI 10.1016/j.juro.2009.01.104; Shiota M, 2013, CURR CANCER DRUG TAR, V13, P444; Shiota M, 2014, INT J UROL, V21, P583, DOI 10.1111/iju.12397; Sobin LH, 1997, TNM CLASSIFICATION M, P170; Sweeney C, 2014, J CLIN ONCOL S, V32, p5s	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	MAR	2015	141	3					495	503		10.1007/s00432-014-1828-7		9	Oncology	Oncology	CB1FZ	WOS:000349373800011		
J	Nakagami, T; Nishimura, R; Sone, H; Tajima, N				Nakagami, Tomoko; Nishimura, Rimei; Sone, Hirohito; Tajima, Naoko			The Combination of Elevated Triglycerides and Abnormal Fasting Glucose Increases Risk of Cerebral Infarction in Patients With Mild to Moderate Hypercholesterolemia: A Post Hoc Analysis of the MEGA Study	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article						hypercholesterolemia; triglycerides; glucose; cerebral infarction; clinical trial; statin	RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; JAPANESE PATIENTS; CHOLESTEROL; PRAVASTATIN; HYPERTRIGLYCERIDEMIA; COMPLICATIONS	Background: While triglycerides (TGs) and diabetes increase the risk of cardiovascular disease (CVD), their combined effects have not been quantified. We explored the combined effect of elevated TGs and glucose on CVD in a post hoc analysis of the large-scale Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study. Material and Methods: In the MEGA Study, 8214 patients with mild to moderate hypercholesterolemia were randomly allocated to the diet alone group or diet plus pravastatin group and followed for 5 years. Of those, 7832 patients included in the intention-to-treat analysis were stratified into 4 groups: abnormal fasting glucose (AFG) plus high TGs, high TGs alone, AFG alone, and normal fasting glucose plus normal TGs (reference). Cox proportional hazard models were used to compare the incidence of and mortality from CVD in the 4 groups. Results: Incidence of CVD and coronary heart disease was significantly higher in the groups with AFG alone (hazard ratio [HR], 2.02 and 3.38; P < .01, respectively) and AFG plus high TGs (HR, 2.87 and 3.87; P < .01, respectively) than the reference group. A similar relation was found in models adjusting for high-density lipoprotein cholesterol (HDL-C). Although the incidence of cerebral infarction was significantly higher only in the group with AFG plus high TGs (HR, 2.16; P = .01), it was marginally significantly higher than the reference group after adjustment for HDL-C (HR, 1.86; P = .06). Diet plus pravastatin treatment reduced the risk of cerebral infarction by 66% in the group with AFG plus high TGs (P = .03). Conclusions: Our findings contribute to the formulation of the hypothesis that patients with hypercholesterolemia having AFG plus high TGs have an increased risk of cerebral infarction. These are compatible with the result from the main study that patients with hypercholesterolemia randomized to diet plus pravastatin had a reduced risk of cerebral infarction.	[Nakagami, Tomoko] Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Shinjuku Ku, Tokyo 1628666, Japan; [Nishimura, Rimei] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, Tokyo, Japan; [Sone, Hirohito] Niigata Univ, Fac Med, Dept Internal Med, Chuo Ku, Niigata, Japan; [Tajima, Naoko] Jikei Univ, Sch Med, Minato Ku, Tokyo, Japan	Nakagami, T (reprint author), Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	nakagami@dmc.twmu.ac.jp			Daiichi Sankyo	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: Tomoko Nakagami, Rimei Nishimura, Hirohito Sone and Naoko Tajima received lecture fees, and Hirohito Sone received research grants from Daiichi Sankyo.	Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Tajima N, 2008, ATHEROSCLEROSIS, V199, P455, DOI 10.1016/j.atherosclerosis.2008.05.027; Nishiwaki M, 2013, J CARDIOL, V61, P196, DOI 10.1016/j.jjcc.2012.10.005; Sone H, 2011, J CLIN ENDOCR METAB, V96, P3448, DOI 10.1210/jc.2011-0622; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Schlesinger Z, 2000, CIRCULATION, V102, P21; Sarwar N, 2010, LANCET, V375, P2215; Ginsberg HN, 1998, ENDOCRIN METAB CLIN, V27, P503, DOI 10.1016/S0889-8529(05)70023-2; Uchiyama S, 2009, J NEUROL SCI, V284, P72, DOI 10.1016/j.jns.2009.04.002; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Florkowski Chris M, 2002, Am J Cardiovasc Drugs, V2, P15, DOI 10.2165/00129784-200202010-00003; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Ishikawa T, 2008, CIRC J, V72, P1576, DOI 10.1253/circj.CJ-08-0095; JANKA HU, 1985, HORM METAB RES, V15, P15; Kamouchi M, 2012, CEREBROVASC DIS, V34, P351, DOI 10.1159/000343503; Mason R Preston, 2004, Circulation, V109, pII34; SALOMAA VV, 1992, DIABETES CARE, V15, P657, DOI 10.2337/diacare.15.5.657	19	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-2484	1940-4034		J CARDIOVASC PHARM T	J. Cardiovasc. Pharmacol. Ther.	MAR	2015	20	2					169	173		10.1177/1074248414537706		5	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CA9ML	WOS:000349248100005		
J	Shimada, K; Uzui, H; Ueda, T; Lee, JD; Kishimoto, C				Shimada, Kana; Uzui, Hiroyasu; Ueda, Takanori; Lee, Jong-Dae; Kishimoto, Chiharu			N-Acetylcysteine Ameliorates Experimental Autoimmune Myocarditis in Rats via Nitric Oxide	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article						autoimmune myocarditis; N-acetylcysteine; free radicals; nitric oxide; oxidative stress	ENDOTHELIAL PROGENITOR CELLS; E-DEFICIENT MICE; E KNOCKOUT MICE; SUPEROXIDE-PRODUCTION; OXIDATIVE STRESS; HEART-FAILURE; ATHEROSCLEROSIS; SEVERITY; DISEASE; INJURY	Background: Oxidative stress may play an important role in the development of myocarditis. We investigated the effects of N-acetylcysteine (NAC), a potent antioxidant, on experimental autoimmune myocarditis (EAM) in rats. Methods and Results: A rat model of porcine myosin-induced EAM was used. After the immunization with myosin, NAC (20 mg/kg/d) or saline was injected intraperitoneally on days 1 to 21. Additional myosin-immunized rats treated with NAC were orally given 25 mg/kg/d of N-G-nitro-l-arginine methylester (l-NAME), an inhibitor of nitric oxide (NO) synthase, and N-G-nitro-d-arginine methylester (d-NAME), an inactive enantiomer. The NAC treatment improved cardiac pathology associated with reduced superoxide production. In the EAM rats treated with NAC associated with oral l-NAME, but not with oral d-NAME, the severity of myocarditis was not reduced. Expression of intercellular adhesion molecule 1 was reduced by NAC treatment. Myocardial c-kit(+) cells were demonstrated only in the NAC-treated group. Hemodynamic study showed that the increased left ventricular mass produced by myocardial inflammation tended to be reduced by NAC treatment. Conclusion: Treatment with NAC ameliorated myocardial injury via NO system in a rat model of myocarditis.	[Shimada, Kana; Kishimoto, Chiharu] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Uzui, Hiroyasu; Ueda, Takanori; Lee, Jong-Dae] Univ Fukui, Fac Med Sci, Dept Internal Med 1, Fukui 910, Japan	Kishimoto, C (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Kawaracho, Kyoto 6068507, Japan.	kkishi@kuhp.kyoto-u.ac.jp			All Japan Coffee Associations; Japanese Ministry of Education, Science, and Culture [18590772, 23591040]; Univers Foundation; Shimizu Foundation for the Promotion of Immunology Research	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Supported in part by research grants from All Japan Coffee Associations, the Japanese Ministry of Education, Science, and Culture (18590772 and 23591040), The Univers Foundation, and The Shimizu Foundation for the Promotion of Immunology Research.	Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664; Ivanovski O, 2005, KIDNEY INT, V67, P2288, DOI 10.1111/j.1523-1755.2005.00332.x; Krieger MH, 2006, NITRIC OXIDE-BIOL CH, V14, P12, DOI 10.1016/j.niox.2005.07.011; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Asahara T, 1999, CIRC RES, V85, P221; Yamazaki KG, 2012, AM J PHYSIOL-HEART C, V302, pH1387, DOI 10.1152/ajpheart.00496.2011; Pahan K, 1998, FREE RADICAL BIO MED, V24, P39, DOI 10.1016/S0891-5849(97)00137-8; KODAMA M, 1990, CLIN IMMUNOL IMMUNOP, V57, P250, DOI 10.1016/0090-1229(90)90039-S; Xia ZY, 2007, CARDIOVASC RES, V73, P770, DOI 10.1016/j.cardiores.2006.11.033; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Takaya T, 2006, ATHEROSCLEROSIS, V186, P402, DOI 10.1016/j.atherosclerosis.2005.08.009; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Miller FJ, 1998, CIRC RES, V82, P1298; Sata M, 2006, ARTERIOSCL THROM VAS, V26, P1008, DOI 10.1161/01.ATV.0000206123.94140.f3; Shimada K, 2009, CIRC J, V73, P1337; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; Ates B, 2008, FREE RADICAL RES, V42, P372, DOI 10.1080/10715760801998638; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; Crespo MJ, 2011, J CARDIOVASC PHARM T, V16, P197, DOI 10.1177/1074248410387281; Eriksson U, 2001, CIRCULATION, V103, P18; Hiraoka Y, 1996, J AM COLL CARDIOL, V28, P1610, DOI 10.1016/S0735-1097(96)00372-5; Miyamoto M, 2004, INT J CARDIOL, V95, P315, DOI 10.1016/j.ijcard.2003.10.009; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; Niwano S, 2011, CIRC J, V75, P662, DOI 10.1253/circj.CJ-10-0673; Roberts N, 2005, J CELL MOL MED, V9, P583, DOI 10.1111/j.1582-4934.2005.tb00490.x; Ronco MT, 2007, LIFE SCI, V81, P750, DOI 10.1016/j.lfs.2007.07.009; Rowbotham DS, 1997, INT J CARDIOL, V60, P315, DOI 10.1016/S0167-5273(97)00096-X; Shimada K, 2010, J MOL CELL CARDIOL, V49, P469, DOI 10.1016/j.yjmcc.2010.02.003; Shimada K, 2007, CIRC J, V71, P1147, DOI 10.1253/circj.71.1147; Shioji K, 2001, CIRC RES, V89, P540, DOI 10.1161/hh1801.096263; Tanaka T, 2008, CIRC J, V72, P563; Tsutsui Hiroyuki, 2008, Circ J, V72 Suppl A, pA31, DOI 10.1253/circj.CJ-08-0014; Valaperti A, 2008, J IMMUNOL, V180, P2686; Yuan ZY, 2005, AM J PHYSIOL-HEART C, V289, pH1147, DOI 10.1152/ajpheart.00078.2005	35	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-2484	1940-4034		J CARDIOVASC PHARM T	J. Cardiovasc. Pharmacol. Ther.	MAR	2015	20	2					203	210		10.1177/1074248414547574		8	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CA9ML	WOS:000349248100009		
J	Niikura, R; Nagata, N; Aoki, T; Shimbo, T; Tanaka, S; Sekine, K; Kishida, Y; Watanabe, K; Sakurai, T; Yokoi, C; Yanase, M; Akiyama, J; Mizokami, M; Uemura, N				Niikura, Ryota; Nagata, Naoyoshi; Aoki, Tomonori; Shimbo, Takuro; Tanaka, Shohei; Sekine, Katsunori; Kishida, Yoshihiro; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Mizokami, Masashi; Uemura, Naomi			Predictors for Identification of Stigmata of Recent Hemorrhage on Colonic Diverticula in Lower Gastrointestinal Bleeding	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						colonic diverticular hemorrhage; bleeding diverticula; lower gastrointestinal bleeding (LGIB); urgent colonoscopy	RANDOMIZED CONTROLLED-TRIAL; ENDOSCOPIC BAND LIGATION; RISK-FACTORS; URGENT COLONOSCOPY; HOSPITAL STAY; SINGLE-CENTER; EXPERIENCE; DIAGNOSIS	Goals: The aim of this study was to identify predictors for the identification of stigmata of recent hemorrhage (SRH) on colonic diverticula. Background: Several factors influence the identification of SRH in the diagnosis of colonic diverticular bleeding. Study: A total of 396 patients hospitalized for lower gastrointestinal bleeding were analyzed. Comorbidities, medications, timing of colonoscopy [< 24 h (h); urgent, 24 to 48 h, >48h], preparation, expert colonoscopist, use of a cap, use of a water-jet scope, total colonoscopy, and procedure time (over 60 min) were assessed. A multivariable logistic regression model was used to estimate odds ratio (OR) and 95% confidence interval (CI). Results: Two hundred fifteen patients were diagnosed with colonic diverticular bleeding and 37 (17%) were identified with SRH. Urgent colonoscopy (OR, 8.4; 95% CI, 2.3-30; P < 0.01), expert colonoscopist (OR, 3.0; 95% CI, 1.2-7.3; P = 0.02), use of a cap (OR, 3.4; 95% CI, 1.4-8.0; P = 0.01), and use of water-jet scope (OR, 5.8; 95% CI, 2.3-15; P < 0.01) were found to be independent predictive factors for SRH. The accuracy of these factors in combination was 0.90 (95% CI, 0.85-0.96) as measured by area under the receiver operating characteristic curve (ROC-AUC). SRH identification rate was higher in the urgent (22%) than in the 24 to 48 hours (2.9%, P < 0.01) and >48 hours groups (1.0%, P < 0.01), showing a tendency to decrease with time (P < 0.01 for trend). Conclusions: Factors of urgent colonoscopy, expert colonoscopist, use of a cap, and use of water-jet scope are useful for identifying SRH diverticula.	[Niikura, Ryota; Nagata, Naoyoshi; Aoki, Tomonori; Tanaka, Shohei; Sekine, Katsunori; Kishida, Yoshihiro; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med NCGM, Int Clin Res Ctr, Res Inst, Dept Gastroenterol & Hepatol, Tokyo 1628655, Japan; [Niikura, Ryota; Shimbo, Takuro] Natl Ctr Global Hlth & Med NCGM, Int Clin Res Ctr, Res Inst, Dept Clin Res & Informat, Tokyo 1628655, Japan; [Mizokami, Masashi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			Ministry of Health Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [271000]; National Center for Global Health and Medicine [22-302]	Supported in part by a Grant-in-Aid from the Ministry of Health Labor and Welfare of Japan, a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (271000), and the Grant of National Center for Global Health and Medicine (22-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angtuaco TL, 2001, AM J GASTROENTEROL, V96, P1782, DOI 10.1016/S0002-9270(01)02434-0; Niikura R, 2012, COLORECTAL DIS, V14, P302, DOI 10.1111/j.1463-1318.2011.02611.x; Strate LL, 2010, CLIN GASTROENTEROL H, V8, P333, DOI 10.1016/j.cgh.2009.12.017; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; Kaltenbach T, 2012, CLIN GASTROENTEROL H, V10, P131, DOI 10.1016/j.cgh.2011.10.029; Tanaka Y, 2012, GUT LIVER, V6, P334, DOI 10.5009/gnl.2012.6.3.334; Jansen A, 2009, WORLD J GASTROENTERO, V15, P457, DOI 10.3748/wjg.15.457; Ishii N, 2012, GASTROINTEST ENDOSC, V75, P382, DOI 10.1016/j.gie.2011.07.030; Suzuki K, 2012, DIGESTION, V85, P261, DOI 10.1159/000336351; Ishii N, 2010, DIGEST ENDOSC, V22, P232, DOI 10.1111/j.1443-1661.2010.00993.x; Laine L, 2010, AM J GASTROENTEROL, V105, P2636, DOI 10.1038/ajg.2010.277; Strate LL, 2005, GASTROINTEST ENDOSC, V61, P46, DOI 10.1016/S0016-5107(04)02227-8; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Bloomfeld RS, 2001, AM J GASTROENTEROL, V96, P2367, DOI 10.1111/j.1572-0241.2001.04048.x; Yamada A, 2008, DIS COLON RECTUM, V51, P116, DOI 10.1007/s10350-007-9137-8; Strate LL, 2003, AM J GASTROENTEROL, V98, P317, DOI 10.1016/S0002-9270(02)05900-2; de Wijkerslooth TR, 2012, GUT, V61, P1426, DOI 10.1136/gutjnl-2011-301327; FOUTCH PG, 1995, AM J GASTROENTEROL, V90, P564; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Bretagne JF, 2010, GASTROINTEST ENDOSC, V71, P335, DOI 10.1016/j.gie.2009.08.032; East JE, 2008, GUT, V57, P65, DOI 10.1136/gut.2007.128926; Schmulewitz N, 2003, GASTROINTEST ENDOSC, V58, P841, DOI 10.1016/S0016-5107(03)02304-6; Smoot RL, 2003, AM J GASTROENTEROL, V98, P1996, DOI 10.1016/S0002-9270(03)00546-X	23	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	MAR	2015	49	3					E24	E30				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB2QP	WOS:000349473100002		
J	Kawashima, R; Komurasaki, K; Schonherr, T				Kawashima, Rei; Komurasaki, Kimiya; Schoenherr, Tony			A hyperbolic-equation system approach for magnetized electron fluids in quasi-neutral plasmas	JOURNAL OF COMPUTATIONAL PHYSICS			English	Article						Plasma simulation; Electron fluid; Hyperbolic equation; Upwind method	HALL THRUSTER; HYBRID; SIMULATIONS; DIFFUSION; IMPLICIT; SCHEMES; MODEL; CODE; FLOW; SAIL	A new approach using a hyperbolic-equation system (HES) is proposed to solve for the electron fluids in quasi-neutral plasmas. The HES approach avoids treatments of cross-diffusion terms which cause numerical instabilities in conventional approaches using an elliptic equation (EE). A test calculation reveals that the HES approach can robustly solve problems of strong magnetic confinement by using an upwind method. The computation time of the HES approach is compared with that of the EE approach in terms of the size of the problem and the strength of magnetic confinement. The results indicate that the HES approach can be used to solve problems in a simple structured mesh without increasing computational time compared to the EE approach and that it features fast convergence in conditions of strong magnetic confinement. (C) 2014 Elsevier Inc. All rights reserved.	[Kawashima, Rei; Schoenherr, Tony] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Komurasaki, Kimiya] Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan	Kawashima, R (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	kawashima@al.t.u-tokyo.ac.jp; komurasaki@k.u-tokyo.ac.jp; schoenherr@al.u-tokyo.ac.jp	Schonherr, Tony/E-8777-2010	Schonherr, Tony/0000-0003-1545-3822	 [24-10079]	This work was supported by the Grant-in-Aid for JSPS Fellows, No. 24-10079.	STEGER JL, 1981, J COMPUT PHYS, V40, P263, DOI 10.1016/0021-9991(81)90210-2; HARLOW FH, 1965, PHYS FLUIDS, V8, P2182, DOI 10.1063/1.1761178; Koo JW, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2172191; Nishikawa H, 2010, J COMPUT PHYS, V229, P3989, DOI 10.1016/j.jcp.2009.10.040; Nishikawa H, 2007, J COMPUT PHYS, V227, P315, DOI 10.1016/j.jcp.2007.07.029; Parra FI, 2006, J APPL PHYS, V100, DOI 10.1063/1.2219165; KRAUSSVARBAN D, 1995, GEOPHYS RES LETT, V22, P3271, DOI 10.1029/95GL03414; ROGNLIEN TD, 1992, J NUCL MATER, V196, P347, DOI 10.1016/S0022-3115(06)80058-9; BEAM RM, 1978, AIAA J, V16, P393, DOI 10.2514/3.60901; Chen F. F., 1984, INTRO PLASMA PHYS CO; Chorin A.J., 1967, Journal of Computational Physics, V2, DOI 10.1016/0021-9991(67)90037-X; Fujii K., 860513 AIAA; GABUTTI B, 1983, COMPUT FLUIDS, V11, P207, DOI 10.1016/0045-7930(83)90031-2; GARDNER CL, 1991, IEEE T ELECTRON DEV, V38, P392, DOI 10.1109/16.69922; Kajimura Y, 2010, J PROPUL POWER, V26, P159, DOI 10.2514/1.45096; Kajimura Y, 2012, J PROPUL POWER, V28, P652, DOI 10.2514/1.B34334; KOMURASAKI K, 1995, J PROPUL POWER, V11, P1317, DOI 10.2514/3.23974; Mikellides IG, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3551583; Wang S, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2780136	19	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9991	1090-2716		J COMPUT PHYS	J. Comput. Phys.	MAR 1	2015	284						59	69		10.1016/j.jcp.2014.12.024		11	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	CA2SD	WOS:000348756700004		
J	Miyauchi, S; Takeuchi, S; Kajishima, T				Miyauchi, Suguru; Takeuchi, Shintaro; Kajishima, Takeo			A numerical method for mass transfer by a thin moving membrane with selective permeabilities	JOURNAL OF COMPUTATIONAL PHYSICS			English	Article						Mass transfer; Permeable membrane; Discontinuity; Transient state; Finite element method	IMMERSED INTERFACE METHOD; BOUNDARY METHOD; SIMULATION	We propose a numerical method for mass transfer by membrane movement in the framework of the non-conforming mesh with respect to the membrane. The method treats the discontinuity at the membrane by incorporating the concentration jump into the finite element discretization. Through coupling the weak forms of the unsteady convection-diffusion equation and membrane permeability equation, an implicit treatment of the jump value is derived, which is capable of handling both permeable and non-permeable membranes. Through some comparisons of the numerical tests with analytical solutions, the validity of the proposed method is established. The analytical solutions include the steady concentration distributions as well as transient state during the movement of the membrane. The method is applied to the mass transfer with a membrane of curved geometry, and the applicability for the membrane with arbitrary shape is demonstrated. (C) 2015 Elsevier Inc. All rights reserved.	[Miyauchi, Suguru; Takeuchi, Shintaro; Kajishima, Takeo] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan	Miyauchi, S (reprint author), Osaka Univ, Dept Mech Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	miyauchi@fluid.mech.eng.osaka-u.ac.jp			JSPS KAKENHI [25.6473]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23686030]	One of the authors, S.M., gratefully acknowledges the financial support of the JSPS KAKENHI Grant Number 25.6473. Also, this work was partly sponsored by the Grant-in-Aid for Young Scientist (A) (No. 23686030) of Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Peskin CS, 2002, ACT NUMERIC, V11, P479; Wiegmann A, 2000, SIAM J NUMER ANAL, V37, P827, DOI 10.1137/S0036142997328664; ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Xu S, 2006, J COMPUT PHYS, V216, P454, DOI 10.1016/j.jcp.2005.12.016; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; Kim Y, 2006, SIAM J SCI COMPUT, V28, P2294, DOI 10.1137/S1064827501389060; Lee L, 2003, SIAM J SCI COMPUT, V25, P832, DOI 10.1137/S1064827502414060; Huang HX, 2009, J COMPUT PHYS, V228, P5317, DOI 10.1016/j.jcp.2009.04.040; Layton AT, 2006, SIAM J SCI COMPUT, V28, P2189, DOI 10.1137/050642198; Li Z., 1994, THESIS U WASHINGTON; Li ZL, 1997, NUMER ALGORITHMS, V14, P269, DOI 10.1023/A:1019173215885; Schultz S.G., 1980, BASIC PRINCIPLES MEM, V2; Sherk T.R., 2011, THESIS U ONTARIO; Stockie JM, 2009, COMPUT STRUCT, V87, P701, DOI 10.1016/j.compstruc.2008.11.001	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9991	1090-2716		J COMPUT PHYS	J. Comput. Phys.	MAR 1	2015	284						490	504		10.1016/j.jcp.2014.12.048		15	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	CA2SD	WOS:000348756700024		
J	Sakamoto, Y; Minabe, T; Kato, T; Kishi, K				Sakamoto, Yoshiaki; Minabe, Toshiharu; Kato, Tatsuya; Kishi, Kazuo			Assessment of the RIVET fixation system for cranioplasty using the pull-out technique	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Cranioplasty; Hydroxyapatite; Bioabsorbable fixation; Physical strength; Cranial defect; Skull defect	HYDROXYAPATITE OSTEOSYNTHESIS; CORALLINE HYDROXYAPATITE; CERAMIC IMPLANTS; TITANIUM; BONE; SURGERY; MODEL	Cranioplasty using custom-made hydroxyapatite (HAP) ceramic implants is a common procedure to repair skull defects. However, commercially available titanium screws are only minimally stabilized due to characteristic brittleness. We developed the RIVET technique which involves fixing a bioabsorbable plate atop a HAP block using bioabsorbable screws extending beyond both layers, and evaluated fixation strength using the pull-out test and microtomography. Three experimental conditions were compared: a non-RIVET group, RIVET group, and dry skull control group. Pull-out strength significantly differed across groups (non-RIVET group, 1.33 +/- 1.21 kgf; RIVET group, 4.46 +/- 0.84 kgf; and control group, 6.99 +/- 1.14 kgf, P < 0.01). Microtomography of the dry skull control group revealed thread grooves fitted to the screws. The non-RIVET and RIVET groups presented fewer thread grooves than the control group, and the screws did not fit perfectly to the HAP block. However, fixation in the RIVET group was more stable, as the rivet was firmly lodged into the implant. In conclusion, by melting and creating the rivet, pull-out strength can be increased and rigid stabilization of HAP can be obtained. This technique uses commercially available absorbable plate and screws, and thus can be used widely in clinical applications involving HAP blocks with different porosities and thicknesses. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Sakamoto, Yoshiaki; Kato, Tatsuya; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 1608582, Japan; [Minabe, Toshiharu] Saitama Med Ctr, Dept Plast & Reconstruct Surg, Kawagoe, Saitama 3508550, Japan	Sakamoto, Y (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, 35 Shinanomachi,Shinjuku Ward, Tokyo 1608582, Japan.	ysakamoto@z8.keio.jp					Pompili A, 1998, J NEUROSURG, V89, P236, DOI 10.3171/jns.1998.89.2.0236; BYRD HS, 1993, PLAST RECONSTR SURG, V91, P642, DOI 10.1097/00006534-199304000-00011; FINN RA, 1980, J MAXILLOFAC SURG, V8, P217, DOI 10.1016/S0301-0503(80)80104-4; ONO I, 1993, PLAST RECONSTR SURG, V92, P819, DOI 10.1097/00006534-199392050-00007; BEALS SP, 1987, PLAST RECONSTR SURG, V79, P33, DOI 10.1097/00006534-198701000-00005; GRENGA TE, 1989, PLAST RECONSTR SURG, V84, P245, DOI 10.1097/00006534-198908000-00009; Ikenuma K, 1988, J ORAL MAXILLOFAC SU, V46, P10; Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d; Miyake H, 2000, NEUROSURGERY, V46, P414, DOI 10.1097/00006123-200002000-00028; Ono I, 2000, BIOMATERIALS, V21, P143, DOI 10.1016/S0142-9612(99)00141-6; Ono I, 1999, Biomaterials, V20, P1595; ONO I, 1994, PLAST RECONSTR SURG, V93, P1363, DOI 10.1097/00006534-199406000-00005; RAHN BA, 1989, CLIN PLAST SURG, V16, P21; SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008; Shido H, 2013, J CRANIOFAC SURG, V24, P946, DOI 10.1097/SCS.0b013e3182868876; SIMPSON D, 1965, J NEUROSURG, V22, P292, DOI 10.3171/jns.1965.22.3.0292; Tanaka Y, 2008, SURG NEUROL, V70, P545, DOI 10.1016/j.surneu.2007.10.021	17	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	MAR	2015	43	2					281	284		10.1016/j.jcms.2014.12.001		4	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CB3CT	WOS:000349506500018		
J	Yamada, K; Kawaguchi, D				Yamada, Ken; Kawaguchi, Daiji			The changing and unchanged nature of inequality and seniority in Japan	JOURNAL OF ECONOMIC INEQUALITY			English	Article						Wage inequality; Firm-specific human capital; Heterogeneous returns; Seniority wages; Composition effects	WAGE INEQUALITY; EARNINGS PROFILES; EMPLOYMENT TENURE; UNITED-STATES; MANDATORY RETIREMENT; JOB SENIORITY; RISE; SKILL; EDUCATION; DEMAND	Wage inequality declined in the 1990s, while it increased in the 2000s for full-time male workers in Japan. We find that a decreased return to firm-specific human capital, which has been neglected in previous empirical analyses of inequality, is a key factor preventing a rise in wage inequality during the prolonged period of economic stagnation, known as Japan's lost decades. We also find that, while changes in returns to general and specific human capital contributed to narrowing wage inequality in the 1990s and widening wage inequality in the 2000s, a significant fraction of the increase in wage inequality in the 2000s is attributable to composition effects arising from an increased share of educated and experienced workers, among whom wages are more dispersed.	[Yamada, Ken] Singapore Management Univ, Sch Econ, Bras Basah, Singapore; [Kawaguchi, Daiji] Hitotsubashi Univ, Fac Econ, Tokyo 1868601, Japan	Yamada, K (reprint author), Singapore Management Univ, Sch Econ, 90 Stamford Rd, Bras Basah, Singapore.	kenyamada@smu.edu.sg; kawaguch@econ.hit-u.ac.jp	YAMADA, Ken/D-1452-2009				Altonji JG, 2005, IND LABOR RELAT REV, V58, P370; Lemieux T, 2008, J POPUL ECON, V21, P21, DOI 10.1007/s00148-007-0169-0; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Autor DH, 2008, REV ECON STAT, V90, P300, DOI 10.1162/rest.90.2.300; Gindling TH, 2002, ECON EDUC REV, V21, P153, DOI 10.1016/S0272-7757(00)00049-2; Prescott EC, 2002, AM ECON REV, V92, P1, DOI 10.1257/000282802320188916; Hamaaki J, 2012, ILR REV, V65, P810; BOUND J, 1992, AM ECON REV, V82, P371; DiNardo J, 1996, ECONOMETRICA, V64, P1001, DOI 10.2307/2171954; Hayashi F, 2002, REV ECON DYNAM, V5, P206, DOI 10.1006/redy.2001.0149; Lemieux T, 2006, AM ECON REV, V96, P195, DOI 10.1257/000282806777211667; HASHIMOTO M, 1985, AM ECON REV, V75, P721; JUHN C, 1993, J POLIT ECON, V101, P410, DOI 10.1086/261881; Fortin N, 2011, HBK ECON, V4, P1, DOI 10.1016/S0169-7218(11)00407-2; Lemieux T, 2006, AM ECON REV, V96, P461, DOI 10.1257/aer.96.3.461; Becker G., 1994, HUMAN CAPITAL THEORE; Blanchflower David G., 1995, DIFFERENCES CHANGES, P25; Card D, 2001, Q J ECON, V116, P705, DOI 10.1162/00335530151144140; CLARK RL, 1992, AM ECON REV, V82, P336; CLARK RL, 1992, IND LABOR RELAT REV, V45, P258, DOI 10.2307/2524833; Farber H. S., 1999, HDB LABOR EC, V3B, P2439, DOI 10.1016/S1573-4463(99)30023-7; Genda Y., 1998, WAGE DIFFERENTIALS I, P35; Hart R.A., 1999, WORK PAY JAPAN; HASHIMOTO M, 1981, AM ECON REV, V71, P475; HASHIMOTO M, 1992, AM ECON REV, V82, P346; HASHIMOTO M, 1979, J POLIT ECON, V87, P1086, DOI 10.1086/260813; MINCER J, 1988, J JAPANESE INT EC, V0002; Kambayashi R, 2008, CAN J ECON, V41, P1329; Kambayashi R., 2011, JAPANS BUBBLE DEFLAT, P217; KATZ LF, 1992, Q J ECON, V107, P35, DOI 10.2307/2118323; Katz L.F., 1989, J JAPANESE INT EC, V3, P522, DOI 10.1016/0889-1583(89)90016-6; Kim D.-I., 1995, DIFFERENCES CHANGES, P25; Koike K., 1988, UNDERSTANDING IND RE; Lacuesta A, 2012, J POPUL ECON, V25, P511, DOI 10.1007/s00148-011-0371-y; LAZEAR EP, 1979, J POLIT ECON, V87, P1261, DOI 10.1086/260835; Lise J, 2014, REV ECON DYNAM, V17, P582, DOI 10.1016/j.red.2014.01.001; Mincer J., 1974, SCH EXPERIENCE EARNI; Moriguchi C, 2008, REV ECON STAT, V90, P713, DOI 10.1162/rest.90.4.713; OECD, 2012, EMPL OUTL; OECD, 2004, EMPL OUTL; Organization for Economic Cooperation and Development (OECD), 1997, EMPL OUTL; Toh M. H., 1999, ED EC, V7, P235, DOI 10.1080/09645299900000020; TOPEL R, 1991, J POLIT ECON, V99, P145, DOI 10.1086/261744; Violante GL, 2002, Q J ECON, V117, P297, DOI 10.1162/003355302753399517; WELCH F, 1979, J POLIT ECON, V87, pS65, DOI 10.1086/260823	45	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-1721	1573-8701		J ECON INEQUAL	J. Econ. Inequal.	MAR	2015	13	1					129	153		10.1007/s10888-014-9295-6		25	Economics	Business & Economics	CB0EO	WOS:000349298400008		
J	Kumagai, M; Kurosaki, K; Uchida, N; Ohishi, Y; Muta, H; Yamanaka, S				Kumagai, Masaya; Kurosaki, Ken; Uchida, Noriyuki; Ohishi, Yuji; Muta, Hiroaki; Yamanaka, Shinsuke			Synthesis and Characterization of Melt-Spun Metastable Al6Ge5	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric; metastable phase; Al6Ge5; melt spinning; semiconductor; thermal conductivity	TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; GE ALLOY SYSTEM; BAND-GAP; THERMOELECTRIC PROPERTIES; BASIS-SET; SEMICONDUCTORS; GERMANIUM; SILICON; PHASE	The electronic structure and thermoelectric (TE) properties of metastable Al6Ge5 were investigated. The crystal structure with nominal composition Al6Ge5 is identified as isostructural to the high-performance TE material Zn4Sb3. The calculated density of states (DOS) shows that Al6Ge5 is a semiconductor with small bandgap of E (g) = 0.44 eV. Moreover, as Al6Ge5 has sharp edges in the DOS near the Fermi energy, high Seebeck coefficient (S) values are expected. Ribbon samples of Al6Ge5 were prepared using a single-roll melt-spinning method. We developed a process to prepare Al6Ge5 as the main component using this method under various optimal conditions, mainly cooling rate. Room-temperature values for S and electrical conductivity are -17.5 mu V K-1 and 2.64 x 10(4) Omega(-1) m(-1), respectively. The kappa value of around 0.5 W m(-1) K-1 at room temperature is considerably low. Although Al6Ge5 has potential to be a good TE material, the S value of the prepared samples is low, like metals, mainly due to impurities existing in the samples. High zT is considered obtainable by preparing high-purity single-phase Al6Ge5 with optimized carrier concentration.	[Kumagai, Masaya; Kurosaki, Ken; Ohishi, Yuji; Muta, Hiroaki; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Uchida, Noriyuki] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Yamanaka, Shinsuke] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui 9140055, Japan	Kumagai, M (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kumagai-m@ms.see.eng.osaka-u.ac.jp; kurosaki@see.eng.osaka-u.ac.jp	Kurosaki, Ken/E-8081-2012		Ministry of Education, Culture, Sports, Science, and Technology of Japan [25289220]	This work was supported by a Grant-in-Aid for Scientific Research (Grant No. 25289220) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Mikhaylushkin AS, 2005, CHEM-EUR J, V11, P4912, DOI 10.1002/chem.200500020; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Caillat T, 1997, J PHYS CHEM SOLIDS, V58, P1119, DOI 10.1016/S0022-3697(96)00228-4; Joshi G, 2008, NANO LETT, V8, P4670, DOI 10.1021/nl8026795; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Vineis CJ, 2010, ADV MATER, V22, P3970, DOI 10.1002/adma.201000839; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; BLUDAU W, 1974, J APPL PHYS, V45, P1846, DOI 10.1063/1.1663501; OTTE HM, 1961, J APPL PHYS, V32, P1536, DOI 10.1063/1.1728392; Tani J, 2005, PHYSICA B, V364, P218, DOI 10.1016/j.physb.2005.04.017; DAVIS EA, 1970, PHILOS MAG, V22, P903, DOI 10.1080/14786437008221061; KAUFMAN MJ, 1985, ACTA METALL MATER, V33, P191, DOI 10.1016/0001-6160(85)90137-3; Kim E, 2000, JPN J APPL PHYS 1, V39, P4820, DOI 10.1143/JJAP.39.4820; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; LAOUI T, 1991, METALL TRANS A, V22, P2141, DOI 10.1007/BF02669882; Precker JW, 2002, AM J PHYS, V70, P1150, DOI 10.1119/1.1512658; SWAMY VT, 1990, MAT SCI ENG A-STRUCT, V123, P247, DOI 10.1016/0921-5093(90)90290-J; Swanson G., 1951, NATL BUR STAND CIRC, V1, P18; Uchida N, 2013, J APPL PHYS, V114, DOI 10.1063/1.4823814; VINCENT R, 1995, ACTA CRYSTALLOGR A, V51, P801, DOI 10.1107/S0108767395006404	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	MAR	2015	44	3					948	952		10.1007/s11664-014-3592-5		5	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CB2FK	WOS:000349442100020		
J	Alidoust, D; Kawahigashi, M; Yoshizawa, S; Sumida, H; Watanabe, M				Alidoust, Darioush; Kawahigashi, Masayuki; Yoshizawa, Shuji; Sumida, Hiroaki; Watanabe, Makiko			Mechanism of cadmium biosorption from aqueous solutions using calcined oyster shells	JOURNAL OF ENVIRONMENTAL MANAGEMENT			English	Article						Cadmium hydroxide; Ettringite; Otavite; Specific surface area; Surface precipitation; Waste shell calcination	MODIFIED BOMBYX-MORI; MOLLUSK SHELLS; METAL-CATIONS; ARAGONITE; SORPTION; DIFFUSION; REMOVAL; SILK; CD2+	The physicochemical properties of oyster shell-derived adsorbents prepared by calcination at different temperatures were characterized by elemental analysis, specific surface area, particle size distribution, Xray diffraction, and scanning electron microscopy. The pH value in natural oyster shell increased from 9 to 12.7 following calcination above 750 degrees C. All of the oyster shell-derived adsorbents exhibited a BET surface area that ranged from 1.8 to 64.6 m(2)/g. Clearly, the proportion of particles within the ranges 25 -50 mu m and 50-100 mu m increased after calcination, regardless of calcination temperature. The adsorption equilibrium and kinetics of cadmium (Cd) were investigated, and the mechanisms of sorption discussed. Experimental equilibrium data were fitted to a Langmuir adsorption isotherm model. Most Cd adsorption occurred during the initial hours of contact time, and a pseudo-second-order kinetic model best fitted the adsorption process. Cd sorption profiles indicated an initial, low Cd sorption region (25.25-3236 mg/g) that was associated with calcination temperatures of up to 650 degrees C for 2 h, and a second region that contributed to high Cd sorption from 750 degrees C, with the maximum sorption capacity reaching a value of 1666.67 mg/g at 900 degrees C. The high Cd-removal capacity of oyster shell-derived adsorbents above 750 degrees C is attributed to their enhanced specific surface area, their material porosity, the bulk precipitation of Cd hydroxide and otavite on shell fragments, the formation of ettringite as a secondary precipitate, and ion exchange via Ca ions. This study highlights the effectiveness of calcined oyster shells in Cd removal from highly contaminated water and wastewater. (C) 2014 Elsevier Ltd. All rights reserved.	[Alidoust, Darioush; Kawahigashi, Masayuki; Watanabe, Makiko] Tokyo Metropolitan Univ, Dept Geog, Lab Environm Geog, Hachioji, Tokyo 1920397, Japan; [Yoshizawa, Shuji] Meisei Univ, Dept Interdisciplinary Sci & Engn, Hino, Tokyo 1918506, Japan; [Sumida, Hiroaki] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Alidoust, D (reprint author), Tokyo Metropolitan Univ, Dept Geog, Lab Environm Geog, Hachioji, Tokyo 1920397, Japan.	Da.alidoust@gmail.com					Kohler SJ, 2007, ENVIRON SCI TECHNOL, V41, P112, DOI 10.1021/es060756j; Cubillas P, 2005, GEOCHIM COSMOCHIM AC, V69, P5459, DOI 10.1016/j.gca.2005.07.016; Prieto M, 2003, GEOCHIM COSMOCHIM AC, V67, P3859, DOI 10.1016/S0016-7037(00)00309-0; HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011; Ibaraki T, 2005, SOIL SCI PLANT NUTR, V51, P893, DOI 10.1111/j.1747-0765.2005.tb00124.x; Kwon HB, 2004, RESOUR CONSERV RECY, V41, P75, DOI 10.1016/j.resconrec.2003.08.005; Taddei P, 2003, J MOL STRUCT, V651, P433, DOI 10.1016/S0022-2860(02)00663-4; Arai T, 2001, J APPL POLYM SCI, V80, P297, DOI 10.1002/1097-4628(20010411)80:2<297::AID-APP1099>3.3.CO;2-Q; [Anonymous], 1996, CHEM METH MAD TOT 3; Cao Q, 2006, BIORESOURCE TECHNOL, V97, P110, DOI 10.1016/j.biortech.2005.02.026; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Hsu TC, 2009, J HAZARD MATER, V171, P995, DOI 10.1016/j.jhazmat.2009.06.105; Alvarez-Ayuso E, 2003, CLAY CLAY MINER, V51, P475, DOI 10.1346/CCMN.2003.0510501; Pehlivan E, 2007, J HAZARD MATER, V140, P299, DOI 10.1016/j.jhazmat.2006.09.011; Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040; Du Y, 2011, ENVIRON POLLUT, V159, P1763, DOI 10.1016/j.envpol.2011.04.017; Asaoka S, 2009, BIORESOURCE TECHNOL, V100, P4127, DOI 10.1016/j.biortech.2009.03.075; Astilleros JM, 2003, CHEM GEOL, V193, P93; Choi UK, 2011, MOLECULES, V16, P2313, DOI 10.3390/molecules16032313; FAO, 2007, FAO YB FISH STAT, V100/2; Horowitz AJ, 1987, APPL GEOCHEM, V2, P437, DOI DOI 10.1016/0883-2927(87)90027-8; Liu Y, 2009, J HAZARD MATER, V168, P156, DOI 10.1016/j.jhazmat.2009.02.009; Melegari S. P., 2012, CHEM CENT J, V86, P1; Moon DH, 2009, J HAZARD MATER, V168, P944, DOI 10.1016/j.jhazmat.2009.02.125; Okazaki M, 2008, J HAZARD MATER, V154, P287, DOI 10.1016/j.jhazmat.2007.10.119; STIPP SL, 1992, GEOCHIM COSMOCHIM AC, V56, P1941, DOI 10.1016/0016-7037(92)90321-9; US Environmental Protection Agency, 2002, INT RISK INF SYST DA; US Environmental Protection Agency Agency for Toxic Substances and Disease Registry, 2012, TOX PROF CD	28	2	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0301-4797	1095-8630		J ENVIRON MANAGE	J. Environ. Manage.	MAR 1	2015	150						103	110		10.1016/j.jenvman.2014.10.032		8	Environmental Sciences	Environmental Sciences & Ecology	CB3BX	WOS:000349504300011		
J	Lestari, S; Kotani, K; Kakinaka, M				Lestari, Sri; Kotani, Koji; Kakinaka, Makoto			Enhancing voluntary participation in community collaborative forest management: A case of Central Java, Indonesia	JOURNAL OF ENVIRONMENTAL MANAGEMENT			English	Article						Voluntary participation; Community collaborative forest management; Participation level; Indonesia	NEPAL; ATTITUDES; VIETNAM; SYSTEMS	This paper examines voluntary participation in community forest management, and characterizes how more participation may be induced. We implemented a survey of 571 respondents and conducted a case study in Central Java, Indonesia. The study's novelty lies in categorizing the degrees of participation into three levels and in identifying how socio-economic factors affect people's participation at each level. The analysis finds that voluntary participation responds to key determinants, such as education and income, in a different direction, depending on each of the three levels. However, the publicly organized programs, such as information provision of benefit sharing, are effective, irrespective of the levels of participation. Overall, the results suggest a possibility of further success and corrective measures to enhance the participation in community forest management. (C) 2014 Elsevier Ltd. All rights reserved.	[Lestari, Sri] Minist Forestry, Forestry Res Inst Palembang, Palembang, Indonesia; [Kotani, Koji] Kochi Univ Technol, Sch Econ & Management, Kami, Kochi 7828502, Japan; [Kakinaka, Makoto] Int Univ Japan, Grad Sch Int Relat, Niigata 9497277, Japan	Kotani, K (reprint author), Kochi Univ Technol, Sch Econ & Management, 185 Miyanokuchi,Tosayamada Cho, Kami, Kochi 7828502, Japan.	kotani.koji@kochi-tech.ac.jp; kakinaka@iuj.ac.jp	Kakinaka, Makoto/O-2150-2015; Kotani, Koji/C-6896-2011	Kotani, Koji/0000-0003-0667-1895	Japanese Society for the Promotion of Science	The authors thank anonymous referees, Hiroaki Miyamoto, Bondan Winarno, Toni Kuspuja and Ratih Madya for their comments, advice and supports. We are also grateful to the financial supports from the Japanese Society for the Promotion of Science as the Grant-in-Aid for Scientific Research C, Promotion Mutual Aid Cooperation for Private Schools of Japan and Kochi University of Technology.	Adhikari B., 2003, 103 S AS NETW DEV EN; Campbell B, 2001, WORLD DEV, V29, P589, DOI 10.1016/S0305-750X(00)00114-5; Sunderlin WD, 2006, FOREST POLICY ECON, V8, P386, DOI 10.1016/j.forpol.2005.08.008; Saito-Jensen M, 2010, ENVIRON CONSERV, V37, P327, DOI 10.1017/S0376892910000664; Schusser C, 2013, FOREST POLICY ECON, V36, P42, DOI 10.1016/j.forpol.2012.06.005; Schroeder RA, 1999, AFRICA, V69, P1, DOI 10.2307/1161075; Buffum B, 2012, SUSTAINABILITY-BASEL, V4, P1448, DOI 10.3390/su4071448; Chhetri BBK, 2012, ECOL ECON, V73, P113, DOI 10.1016/j.ecolecon.2011.09.023; Maskey V, 2006, J FOREST ECON, V11, P261, DOI 10.1016/j.jfe.2005.10.004; Mohan G, 2000, THIRD WORLD Q, V21, P247; Flint CG, 2008, SOC NATUR RESOUR, V21, P526, DOI 10.1080/08941920701746954; Adhikari B, 2004, ECOL ECON, V48, P245, DOI 10.1016/j.ecolecon.2003.08.008; Brekke KA, 2003, J PUBLIC ECON, V87, P1967, DOI 10.1016/S0047-2727(01)00222-5; Maryudi A, 2012, FOREST POLICY ECON, V14, P1, DOI 10.1016/j.forpol.2011.07.017; Gino F, 2008, ORGAN BEHAV HUM DEC, V107, P234, DOI 10.1016/j.obhdp.2008.03.001; Parfitt T, 2004, THIRD WORLD Q, V25, P537, DOI 10.1080/0143659042000191429; Dolnicar S, 2009, ENVIRON BEHAV, V41, P693, DOI 10.1177/0013916508319448; Kemmelmeier M, 2002, CROSS-CULT RES, V36, P256, DOI 10.1177/10697102036003004; Thoms CA, 2008, GEOFORUM, V39, P1452, DOI 10.1016/j.geoforum.2008.01.006; Pinyopusarerk K, 2014, LAND USE POLICY, V38, P257, DOI 10.1016/j.landusepol.2013.11.019; Salam MA, 2005, J ENVIRON MANAGE, V74, P43, DOI 10.1016/j.jenvman.2004.08.007; Arnold J.E.M., 1991, COMMUNITY FORESTRY 1; Barr S, 2007, ENVIRON BEHAV, V39, P435, DOI 10.1177/0013916505283421; Botetzagias Iosif, 2012, LOCAL ENV, V17, P93; Djajanti D., 2005, HANGING BALANCE EQUI, P63; Djamhuri TL, 2008, AGROFOREST SYST, V74, P83, DOI 10.1007/s10457-008-9150-5; Emtage N., 2004, SMALL SCALE FOR EC M, V3, P257; Franklin J. F., 1995, DEFINING MEASURING S, P355; Gardner P. H., 1995, APPL COGNITIVE PSYCH, V9, P555; Gibson C., 2000, PEOPLE FORESTS COMMU; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; GUNATILAKE HM, 1993, ECON BOT, V47, P275, DOI 10.1007/BF02862294; Ito K, 2005, J FOR RES-JPN, V10, P453, DOI 10.1007/s10310-005-0172-9; Kakinaka M, 2011, PUBLIC CHOICE, V147, P29, DOI 10.1007/s11127-010-9602-0; Khadka S. R., 2008, Local Environment, V13, P1, DOI 10.1080/13549830701581630; Khan N A, 1997, Dev Pract, V7, P260, DOI 10.1080/09614529754495; Layzer J, 2006, ENV CASE TRANSLATING; Malla Y. B., 1997, Journal of World Forest Resource Management, V8, P51; Martin A., 2005, J PEACE RES, V42, P326; Mather A. S., 1992, GLOBAL FOREST RESOUR; Perhutani Perum, 2010, PROFIL KESATUAN PEMA; Perhutani Perum, 2007, PEDOMAN PEMBINAAN LM; Prambudiarto, 2008, THESIS I PERTANIAN B; Sutopo A., 2005, THESIS DIPONEGORO U	44	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0301-4797	1095-8630		J ENVIRON MANAGE	J. Environ. Manage.	MAR 1	2015	150						299	309		10.1016/j.jenvman.2014.10.009		11	Environmental Sciences	Environmental Sciences & Ecology	CB3BX	WOS:000349504300032		
J	Yamana, S				Yamana, Shunsuke			Periods of residual automorphic forms	JOURNAL OF FUNCTIONAL ANALYSIS			English	Article						Rankin-Selberg methods; Periods of automorphic forms; Distinguished representations; Asai L-functions	UNITARY REPRESENTATIONS; EULER PRODUCTS; DISTINGUISHED REPRESENTATIONS; IRREDUCIBLE REPRESENTATIONS; CLASSIFICATION; GL(N); CONJECTURE; SPECTRUM; JACQUET; GL(2N)	We develop a technique for computing period integrals of noncuspidal automorphic forms. Applications include a formula for the integral of a square-integrable automorphic form on GL(n)(A(E)) over GL(n)(F)\GL(n)(A(F))(1) for a quadratic extension E of a number field F and a characterization of residual automorphic representations on which the period integral is nonvanishing. (C) 2014 Elsevier Inc. All rights reserved.	Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan	Yamana, S (reprint author), Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan.	yamana@math.kyushu-u.ac.jp			European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC Grant [290766]; JSPS [26800017]	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement No. 290766 (AAMOT). The author is partially supported by JSPS Grant-in-Aid for Young Scientists (B) 26800017.	Prasad D, 2001, DUKE MATH J, V109, P67, DOI 10.1215/S0012-7094-01-10912-5; ZELEVINSKY AV, 1980, ANN SCI ECOLE NORM S, V13, P165; JACQUET H, 1981, AM J MATH, V103, P777, DOI 10.2307/2374050; HARDER G, 1986, J REINE ANGEW MATH, V366, P53; Matringe N, 2011, INT MATH RES NOTICES, P74, DOI 10.1093/imrn/rnq058; Lapid EM, 2003, DUKE MATH J, V120, P153; Matringe N, 2010, MATH RES LETT, V17, P77; Jacquet H, 1999, J AM MATH SOC, V12, P173, DOI 10.1090/S0894-0347-99-00279-9; JACQUET H, 1981, AM J MATH, V103, P499, DOI 10.2307/2374103; Kable AC, 2004, AM J MATH, V126, P789, DOI 10.1353/ajm.2004.0030; Badulescu AI, 2010, COMPOS MATH, V146, P1115, DOI 10.1112/S0010437X10004707; Baruch EM, 2003, ANN MATH, V158, P207; Bernstein I.N., 1976, RUSS MATH SURV, V31, P1, DOI 10.1070/RM1976v031n03ABEH001532; BERNSTEIN JN, 1984, LECT NOTES MATH, V1041, P50; Cogdell J. W., 2004, CONTRIBUTIONS AUTOMO, P256; FLICKER YZ, 1991, J REINE ANGEW MATH, V418, P139; FLICKER YZ, 1995, P JPN ACAD A-MATH, V71, P114; FLICKER YZ, 1988, B SOC MATH FR, V116, P295; Gan W.T., 2013, TATA I FUND RES STUD, V22; Gelbart S, 2001, ISRAEL J MATH, V126, P173, DOI 10.1007/BF02784154; Hakim J, 2002, INT MATH RES NOTICES, P1857; Ichino A., COMPOS MATH IN PRESS; Jacquet H., 1990, AUTOMORPHIC FORMS SH, P143; Lapid E., 2011, CLAY MATH P, V13, P309; Liu Y., 2011, INT MATH RES NOT; Luo W., 1999, P S PURE MATH 2, V66, P301; Matringe N, 2010, MANUSCRIPTA MATH, V131, P415, DOI 10.1007/s00229-009-0327-7; Matringe N, 2014, PAC J MATH, V271, P445, DOI 10.2140/pjm.2014.271.445; Mceglin C., 1989, ANN SCI ECOLE NORM S, V22, P605; Offen O, 2006, DUKE MATH J, V134, P313, DOI 10.1215/S0012-7094-06-13423-3; Offen O., 2007, INT MATH RES NOT; Offen O, 2006, ISRAEL J MATH, V154, P253, DOI 10.1007/BF02773610; TADIC M, 1986, ANN SCI ECOLE NORM S, V19, P335; Waldspurger J.-L., 1995, CAMBRIDGE TRACTS MAT, V113; Wallach N., 1992, PURE APPL MATH, V132-11; Wallach N. R., 1988, PURE APPL MATH, V132; Zhang W, 2014, ANN MATH, V180, P971, DOI 10.4007/annals.2014.180.3.4; Zhang W., 2014, J AM MATH SOC, V7, P541	38	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-1236	1096-0783		J FUNCT ANAL	J. Funct. Anal.	MAR 1	2015	268	5					1078	1104		10.1016/j.jfa.2014.11.009		27	Mathematics	Mathematics	CB3EK	WOS:000349510800002		
J	Hu, HH; Li, G; Arao, T				Hu, H. H.; Li, G.; Arao, T.			The association of family social support, depression, anxiety and self-efficacy with specific hypertension self-care behaviours in Chinese local community	JOURNAL OF HUMAN HYPERTENSION			English	Article							BLOOD-PRESSURE; QUESTIONNAIRE SURVEY; AFRICAN-AMERICANS; CHRONIC DISEASE; MANAGEMENT; HEALTH; PREVALENCE; SCALE	This study aimed to test the role of family social support, depression, anxiety and self-efficacy on specific self-care behaviours. In a local community health center, 318 patients with hypertension completed a questionnaire assessing self-care, family social support, depression, anxiety and self-efficacy in 2012. Each self-care behaviour was separately analyzed with logistic regression models. The mean score of perceived family social support for hypertension treatment was 20.91 (maximum = 60). Adult children were identified as the primary support source. Approximately 22.3% and 15.4% of participants reported symptoms of anxiety and depression, respectively. Participants had moderately positive levels of confidence performing self-care (42.1 +/- 13.3 out of 60). After adjusting for demographic and health variables, a 10-unit increase in family social support increased the odds ratio (OR) of taking medication by 1.39 (95% confidence interval (CI) 1.03-1.87) and increased the OR for measuring blood pressure (BP) regularly by 1.33 (95% CI 1.02-1.74). Depression and anxiety were not associated with any self-care behaviours. A 10-unit increase in self-efficacy increased the adjusted OR for performing physical exercise to 1.25 (95% CI 1.04-1.49). In conclusion, family social support was positively associated with medication adherence and regular BP measurement. Strategies to improve family social support should be developed for hypertension control, yet further prospective studies are needed to understand the effects of family social support, depression, anxiety and self-efficacy on self-care behaviours.	[Hu, H. H.] Waseda Univ, Grad Sch Sport Sci, Lab Exercise Epidemiol, Saitama 3591141, Japan; [Li, G.] Inst Chron Dis Control & Prevent, Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Arao, T.] Waseda Univ, Fac Sport Sci, Lab Exercise Epidemiol, Saitama 3591141, Japan	Arao, T (reprint author), Waseda Univ, Fac Sport Sci, Lab Exercise Epidemiol, Saitama 3591141, Japan.	tarao@waseda.jp			GCOE in Waseda University	We thank all the participating patients for their commitment. Special thanks are addressed to field investigators for their invaluable help in the project. This research was supported by a grant from GCOE in Waseda University.	Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Wu SFV, 2011, INT J NURS STUD, V48, P1376, DOI 10.1016/j.ijnurstu.2011.04.008; Peters RM, 2008, RES NURS HEALTH, V31, P543, DOI 10.1002/nur.20287; Leventhal H, 2008, ANNU REV PSYCHOL, V59, P477, DOI 10.1146/annurev.psych.59.103006.093643; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Freund T, 2013, J EVAL CLIN PRACT, V19, P39, DOI 10.1111/j.1365-2753.2011.01764.x; Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7; Cornwell EY, 2012, J HEALTH SOC BEHAV, V53, P215, DOI 10.1177/0022146512446832; Anderson ES, 2006, HEALTH PSYCHOL, V25, P510, DOI 10.1037/0278-6133.25.4.510; Clark NM, 1999, HEALTH EDUC BEHAV, V26, P72, DOI 10.1177/109019819902600107; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Kennedy A, 2007, BRIT MED J, V335, P968, DOI 10.1136/bmj.39372.540903.94; Warren-Findlow J, 2012, J COMMUN HEALTH, V37, P15, DOI 10.1007/s10900-011-9410-6; Du S, 2010, INT NURS REV, V57, P159, DOI 10.1111/j.1466-7657.2009.00794.x; Baumann Linda C, 2012, Nurse Pract, V37, P32, DOI 10.1097/01.NPR.0000411104.12617.64; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Clarke DM, 2009, MED J AUSTRALIA, V190, P54; Cleroux J, 1999, CMAJ, V160, P21; Conn V S, 1991, Issues Ment Health Nurs, V12, P321; Farrell Kathleen, 2004, Clin Nurs Res, V13, P289, DOI 10.1177/1054773804267878; Hu H, 2013, INT J HYPERTENS, V2013, DOI [10.1155/2013/526949, DOI 10.1155/2013/526949]; Hu HH, 2013, ISRN PUBLIC HLTH, V19, P39; Jain A, 2009, CURR PSYCHIAT REP, V11, P219; Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7; Lawn S, 2011, PATIENT EDUC COUNS, V84, P5; Lee JE, 2010, INT J NURS STUD, V47, P411, DOI 10.1016/j.ijnurstu.2009.09.011; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085682; Marks Ray, 2005, Health Promot Pract, V6, P37, DOI 10.1177/1524839904266790; Lou PA, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-53; Martin MY, 2008, PATIENT EDUC COUNS, V72, P137, DOI 10.1016/j.pec.2008.02.012; Mishali M, 2011, FAM PRACT, V28, P82, DOI 10.1093/fampra/cmq086; Mollaoglu M, 2006, DIALYSIS TRANSPLANT, V35, P144, DOI 10.1002/dat.20002; Rosland Ann-Marie, 2010, Chronic Illn, V6, P7, DOI 10.1177/1742395309352254; Wang Huali, 2010, AGEING INT, V35, P72; Wang WR, 2009, J CLIN NURS, V18, P2436, DOI 10.1111/j.1365-2702.2009.02807.x; Warren-Findlow J, 2011, J NATL MED ASSOC, V103, P503; WHO, 1995, WHO TECHN REP SER; Wu SFV, 2013, NURS HEALTH SCI, V15, P213, DOI 10.1111/nhs.12022; Yan J, 2014, J EVAL CLIN PRACT, V20, P311, DOI 10.1111/jep.12125; Zhu SZ, 2012, J CLIN NURS, V21, P2118, DOI 10.1111/j.1365-2702.2012.04178.x	41	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9240	1476-5527		J HUM HYPERTENS	J. Hum. Hypertens.	MAR	2015	29	3					198	203		10.1038/jhh.2014.58		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB5MM	WOS:000349671500010		
J	Sun, GH; Matsui, T; Hakozaki, Y; Abe, S				Sun, Guanghao; Matsui, Takemi; Hakozaki, Yukiya; Abe, Shigeto			An infectious disease/fever screening radar system which stratifies higher-risk patients within ten seconds using a neural network and the fuzzy grouping method	JOURNAL OF INFECTION			English	Article						Mass screening; Influenza; Thermography; Oxygen saturation; Vital signs; Microwave radar	MEANS CLUSTERING-ALGORITHM; INFLUENZA-A; FEVER; INFORMATION; PNEUMONIA; VIRUS	Objectives: To classify higher-risk influenza patients within 10 s, we developed an infectious disease and fever screening radar system. Methods: The system screens infected patients based on vital signs, i.e., respiration rate measured by a radar, heart rate by a finger-tip photo-reflector, and facial temperature by a thermography. The system segregates subjects into higher-risk influenza (HR-I) group, lower-risk influenza (LR-I) group, and non-influenza (Non-I) group using a neural network and fuzzy clustering method (FCM). We conducted influenza screening for 35 seasonal influenza patients and 48 normal control subjects at the Japan Self-Defense Force Central Hospital. Pulse oximetry oxygen saturation (SpO(2)) was measured as a reference. Results: The system classified 17 subjects into HR-I group, 26 into LR-I group, and 40 into Non-I group. Ten out of the 17 HR-I subjects indicated SpO(2) < 96%, whereas only two out of the 26 LR-I subjects showed SpO(2) < 96%. The chi-squared test revealed a significant difference in the ratio of subjects showed SpO(2) < 96% between HR-I and LR-I group (p < 0.001). There were zero and nine normal control subjects in HR-I and LR-I groups, respectively, and there was one influenza patient in Non-I group. Conclusions: The combination of neural network and FCM achieved efficient detection of higher-risk influenza patients who indicated SpO(2) 96% within 10 s. (C) 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Sun, Guanghao; Matsui, Takemi] Tokyo Metropolitan Univ, Grad Sch Syst Design, Tokyo 1910065, Japan; [Hakozaki, Yukiya] Japan Self Def Forces Cent Hosp, Dept Internal Med, Setagaya Ku, Tokyo 1540001, Japan; [Abe, Shigeto] Takasaka Clin, Iwaki, Fukushima 9738407, Japan	Matsui, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, 6-6 Asahigaoka, Tokyo 1910065, Japan.	sun-guanghao@ed.tmu.ac.jp; tmatsui@tmu.ac.jp			Tokyo Metropolitan Government Asian Human Resources Fund; Japan Society for the Promotion of Science Research Fellowships for Young Scientists [13J05344]	This research was supported by the Tokyo Metropolitan Government Asian Human Resources Fund and the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (13J05344).	Ng EYK, 2004, MICROVASC RES, V68, P104, DOI 10.1016/j.mvr.2004.05.003; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Chuang KS, 2006, COMPUT MED IMAG GRAP, V30, P9, DOI 10.1016/j.compmedimag.2005.10.001; [Anonymous], 2006, J INFECT S1, V53, pi; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9; Hassan M, 2014, COMPUT METH PROG BIO, V113, P593, DOI 10.1016/j.cmpb.2013.10.012; Pal NR, 2005, IEEE T FUZZY SYST, V13, P517, DOI 10.1109/TFUZZ.2004.840099; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Chiang MF, 2008, J FORMOS MED ASSOC, V107, P937, DOI 10.1016/S0929-6646(09)60017-6; Krinidis S, 2010, IEEE T IMAGE PROCESS, V19, P1328, DOI 10.1109/TIP.2010.2040763; Beigel H, 2005, NEW ENGL J MED, V353, P1374; Bewick T, 2010, PRIM CARE RESP J, V19, P378, DOI 10.4104/pcrj.2010.00049; Bitar D, 2009, EURO SURVEILL, V14; Hay AD, 2004, BRIT J GEN PRACT, V54, P448; Lalezari J, 2001, ARCH INTERN MED, V161, P212, DOI 10.1001/archinte.161.2.212; LIN JC, 1975, P IEEE, V63, P1530, DOI 10.1109/PROC.1975.9992; MacQueen J., 1967, P 5 BERK S MATH STAT, P281, DOI DOI 10.1234/12345678; Matsui T., 2009, Journal of Medical Engineering & Technology, V33, P481, DOI 10.1080/03091900902952675; Matsui T, 2010, J INFECTION, V60, P271, DOI 10.1016/j.jinf.2010.01.005; Nishiura H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-111; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Sumriddetchkajorn S, 2009, INFRARED PHYS TECHN, V52, P119, DOI 10.1016/j.infrared.2009.04.002; Sun G., 2013, INT J E HLTH MED COM, V4, P20; Sun GH, 2012, J INFECTION, V65, P591, DOI 10.1016/j.jinf.2012.10.010	25	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	MAR	2015	70	3					230	236		10.1016/j.jinf.2014.12.007		7	Infectious Diseases	Infectious Diseases	CB4UJ	WOS:000349623400003		
J	Akamatsu, S; Hayes, CN; Tsuge, M; Miki, D; Akiyama, R; Abe, H; Ochi, H; Hiraga, N; Imamura, M; Takahashi, S; Aikata, H; Kawaoka, T; Kawakami, Y; Ohishi, W; Chayama, K				Akamatsu, Sakura; Hayes, C. Nelson; Tsuge, Masataka; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Ohishi, Waka; Chayama, Kazuaki			Differences in serum microRNA profiles in hepatitis B and C virus infection	JOURNAL OF INFECTION			English	Article						Serum biomarkers; microRNA; miR-122; miR-125b; HBeAg; Microarray	E-ANTIGEN; HEPATOCELLULAR-CARCINOMA; CIRCULATING MICRORNAS; GENE-EXPRESSION; LIVER-DISEASES; HUMAN PLASMA; RNA; REPLICATION; PROTEIN; COMPLEXES	Objectives: Patients infected with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) are at greater risk of cirrhosis and hepatocellular carcinoma. The objective of this study was to identify virus-specific serum microRNA profiles associated with liver function and disease progression. Microarray analysis of serum microRNAs was performed using the Toray 3D array system in 22 healthy subjects, 42 HBV patients, and 30 HCV patients. Selected microRNAs were then validated by qRT-PCR in 186 HBV patients, 107 HCV patients, and 22 healthy subjects. Results: Microarray analysis showed up-regulation of a number of microRNAs in serum of both HBV and HCV patients. In qRT-PCR analysis, miR-122, miR-99a, miR-125b, miR-720, miR-22, and miR-1275 were up-regulated both in HBV patients relative to healthy subjects, and all except miR-1275 were up-regulated in HBeAg-positive patients relative to HBeAg-negative patients. Specific microRNAs were independently associated with different aspects of HBV infection. MiR-122 was independently associated with HBV DNA level, whereas miR-125b was independently associated with levels of HBV DNA, HBsAg, and HBeAg. MiR-22 and miR-1275 were independently associated with serum g-glutamyl transpeptidase levels. Conclusions: Serum microRNA levels reflect differences in the etiology and stage of viral hepatitis. (C) 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Akamatsu, Sakura; Hayes, C. Nelson; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Akamatsu, Sakura; Hayes, C. Nelson; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Chayama, Kazuaki] RIKEN, Lab Digest Dis, Ctr Genom Med, Hiroshima, Japan; [Akamatsu, Sakura; Hayes, C. Nelson; Tsuge, Masataka; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima 7348551, Japan; [Tsuge, Masataka] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima 7348551, Japan; [Takahashi, Shoichi] Koyo New Town Hosp, Hiroshima, Japan; [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan	Chayama, K (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	chayama@hiroshima-u.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education Culture Sports Science and Technology, Government of Japan	This work was supported by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare and Ministry of Education Culture Sports Science and Technology, Government of Japan. No writing assistance was provided for this manuscript.	Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI 10.4161/rna.7.4.13141; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhao DJ, 2010, VIRUS RES, V151, P213, DOI 10.1016/j.virusres.2010.05.009; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; Takata A, 2011, BIOCHEM BIOPH RES CO, V411, P826, DOI 10.1016/j.bbrc.2011.07.048; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Nguyen DH, 2008, J VIROL, V82, P6852, DOI 10.1128/JVI.00465-08; Brechot C, 2010, PATHOL BIOL, V58, P278, DOI 10.1016/j.patbio.2010.05.001; D'Agostino DM, 2005, ADV CANCER RES, V94, P87, DOI 10.1016/S0065-230X(04)94003-1; LUM G, 1972, CLIN CHEM, V18, P358; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; Lang TL, 2011, J HEPATOL, V55, P762, DOI 10.1016/j.jhep.2010.12.042; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Arataki K, 2013, J MED VIROL, V85, P789, DOI 10.1002/jmv.23540; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Shi CL, 2013, BIOMED PHARMACOTHER, V67, P375, DOI 10.1016/j.biopha.2013.03.002; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; Fields B. N., 2007, FIELDS VIROLOGY; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; GARCIA PD, 1988, J CELL BIOL, V106, P1093, DOI 10.1083/jcb.106.4.1093; Hayes CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047490; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Liu AM, 2011, OMICS, V15, P187, DOI 10.1089/omi.2010.0098; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Shim HY, 2011, VIROLOGY, V410, P161, DOI 10.1016/j.virol.2010.11.005; Shwetha S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01555; Tong S, 2005, INT J MED SCI, V2, P2, DOI 10.7150/ijms.2.2; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Warner Brook G, 2014, Evol Med Public Health, V2014, P1, DOI 10.1093/emph/eot023; Winther TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058236; Wu S, 2012, J INFECT DIS, V206, P415, DOI 10.1093/infdis/jis363	56	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	MAR	2015	70	3					273	287		10.1016/j.jinf.2014.10.017		15	Infectious Diseases	Infectious Diseases	CB4UJ	WOS:000349623400008		
J	Guan, Y; Yamamoto, M; Kitazawa, T; Tripathi, SR; Takeya, K; Kawase, K				Guan, Yu; Yamamoto, Manabu; Kitazawa, Toshiyuki; Tripathi, Saroj R.; Takeya, Kei; Kawase, Kodo			A Concealed Barcode Identification System Using Terahertz Time-domain Spectroscopy	JOURNAL OF INFRARED MILLIMETER AND TERAHERTZ WAVES			English	Article						nondestructive identification; concealed barcode; thick envelope; terahertz wave	CHIPLESS RFID TAGS; PAPER; INSPECTION; DESIGN	We present a concealed terahertz barcode/chipless tag to achieve remote identification through an obstructing material using terahertz radiation. We show scanned terahertz reflection spectral images of barcodes concealed by a thick obstacle. A concealed and double- side printed terahertz barcode structure is proposed, and we demonstrate that our design has better performance in definition than a single-side printed barcode using terahertz time-domain spectroscopy. This technique combines the benefits of a chipless tag to read encoded information covered by an optically opaque material with low cost and a simple fabrication process. Simulations are also described, along with an explanation of the principle of the terahertz barcode identification system.	[Guan, Yu; Kitazawa, Toshiyuki; Tripathi, Saroj R.; Takeya, Kei; Kawase, Kodo] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yamamoto, Manabu] Dai Nippon Printing Co Ltd, Kashiwa, Chiba 2770871, Japan; [Kawase, Kodo] RIKEN, Aoba Ku, Sendai, Miyagi 9800845, Japan	Guan, Y (reprint author), Nagoya Univ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	gybing17@gmail.com			Japan Society for Promotion of Science (JSPS); JSPS KAKENHI [25220606]	The authors would like to thank to Dr. Irina Smirnova for fruitful discussions and helpful comments. The corresponding author Y. Guan gratefully acknowledges the Japan Society for Promotion of Science (JSPS) for the support of Research Fellowship for Young Scientists (DC2). This work was partially supported by the JSPS KAKENHI (25220606).	Preradovic S, 2009, IEEE T MICROW THEORY, V57, P1411, DOI 10.1109/TMTT.2009.2017323; Jin YS, 2006, J KOREAN PHYS SOC, V49, P513; Vena A, 2013, IEEE T ANTENN PROPAG, V61, P5868, DOI 10.1109/TAP.2013.2281742; Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549; Vena A, 2011, IEEE T MICROW THEORY, V59, P3356, DOI 10.1109/TMTT.2011.2171001; Yan GF, 2013, OPT LETT, V38, P2200, DOI 10.1364/OL.38.002200; STOCKMAN H, 1948, P IRE, V36, P1196, DOI 10.1109/JRPROC.1948.226245; Bernier M, 2011, APPL OPTICS, V50, P4648, DOI 10.1364/AO.50.004648; Exter M, 1989, Opt Lett, V14, P1128, DOI 10.1364/OL.14.001128; Finkenzeller K., 2010, RFID HDB FUNDAMENTAL; Hara M., 1998, US Patent, Patent No. [5,726,435, 5726435]; Hartmann C. S., 2002, P 2002 IEEE ULTR S M, V1, P65, DOI DOI 10.1109/ULTSYM.2002.1193354; Hattori T, 2010, P INFR MILL TER WAV; Hu SM, 2010, IEEE T ANTENN PROPAG, V58, P271, DOI 10.1109/TAP.2009.2037760; Jang HS, 2010, IEEE MICROW WIREL CO, V20, P640, DOI 10.1109/LMWC.2010.2073692; McVay J., 2006, P IEEE RAD WIR S, V1, P199; Mousavi P, 2009, APPL OPTICS, V48, P6541, DOI 10.1364/AO.48.006541; Perret E, 2011, RADIOENGINEERING, V20, P380; Shen YC, 2008, IEEE J SEL TOP QUANT, V14, P407, DOI [10.1109/JSTQE.2007.911309, 10.1109/.2007.JSTQE.911309]; Withayachumnankul W, 2014, J INFRARED MILLIM TE, V35, P610, DOI 10.1007/s10762-013-0042-z; Woodland N., 1952, U.S. Patent, Patent No. [2,612,994, 2612994]; Zimdars D, 2005, AIP CONF PROC, V760, P570	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6892	1866-6906		J INFRARED MILLIM TE	J. Infrared Millim. Terahertz Waves	MAR	2015	36	3					298	311		10.1007/s10762-014-0128-2		14	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB4XT	WOS:000349632400007		
J	Kloepper, JE; Baris, OR; Reuter, K; Kobayashi, K; Weiland, D; Vidali, S; Tobin, DJ; Niemann, C; Wiesner, RJ; Paus, R				Kloepper, Jennifer E.; Baris, Olivier R.; Reuter, Karen; Kobayashi, Ken; Weiland, Daniela; Vidali, Silvia; Tobin, Desmond J.; Niemann, Catherin; Wiesner, Rudolf J.; Paus, Ralf			Mitochondrial Function in Murine Skin Epithelium Is Crucial for Hair Follicle Morphogenesis and Epithelial-Mesenchymal Interactions	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							STEM-CELLS; HEMATOPOIETIC STEM; INDUCED ALOPECIA; DNA MUTATIONS; MICE; DIFFERENTIATION; EPIDERMIS; CYCLOPHOSPHAMIDE; PROLIFERATION; PIGMENTATION	Here, we studied how epithelial energy metabolism impacts overall skin development by selectively deleting intraepithelial mtDNA in mice by ablating a key maintenance factor (Tfam(EKO)), which induces loss of function of the electron transport chain (ETC). Quantitative (immuno)histomorphometry demonstrated that Tfam(EKO) mice showed significantly reduced hair follicle (HF) density and morphogenesis, fewer intrafollicular keratin15+ epithelial progenitor cells, increased apoptosis, and reduced proliferation. Tfam(EKO) mice also displayed premature entry into (aborted) HF cycling by apoptosis-driven HF regression (catagen). Ultrastructurally, Tfam(EKO) mice exhibited severe HF dystrophy, pigmentary abnormalities, and telogen-like condensed dermal papillae. Epithelial HF progenitor cell differentiation (Plet1, Lrig1 Lef1and beta-catenin), sebaceous gland development (adipophilin, Scd1, and oil red), and key mediators/markers of epithelial mesenchymal interactions during skin morphogenesis (NCAM, versican, and alkaline phosphatase) were all severely altered in Tfam(EKO) mice. Moreover, the number of mast cells, major histocompatibility complex class II+, or CD11b+ immunocytes in the skin mesenchyme was increased, and essentially no subcutis developed. Therefore, in contrast to their epidermal counterparts, pilosebaceous unit stem cells depend on a functional ETC. Most importantly, our findings point toward a frontier in skin biology: the coupling of HF keratinocyte mitochondrial function with the epithelial-mesenchymal interactions that drive overall development of the skin and its appendages.	[Kloepper, Jennifer E.; Vidali, Silvia; Paus, Ralf] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Baris, Olivier R.; Weiland, Daniela; Wiesner, Rudolf J.] Univ Cologne, Inst Vegetat Physiol, D-50931 Cologne, Germany; [Reuter, Karen; Niemann, Catherin] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Reuter, Karen; Niemann, Catherin; Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med Koln, D-50931 Cologne, Germany; [Kobayashi, Ken] Hokkaido Univ, Fac Agr, Lab Dairy Food Sci, Sapporo, Hokkaido 060, Japan; [Tobin, Desmond J.] Univ Bradford, Ctr Skin Sci, Bradford BD7 1DP, W Yorkshire, England; [Wiesner, Rudolf J.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Paus, Ralf] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England	Wiesner, RJ (reprint author), Univ Cologne, Inst Vegetat Physiol, Robert Koch St 39, D-50931 Cologne, Germany.	rudolf.wiesner@uni-koeln.de	Paus, Ralf/B-5279-2015	Paus, Ralf/0000-0002-3492-9358	DFG [DFG Pa 345/12-2, DFG Pa 345/13-1, SFB 829, DFG Wi 889/6-2, SFB 728, A3, C2]	We thank Nadine Dorwald, Ramona Hoppe, and Alexander Muller for the excellent technical help. This study was supported in part by a grant from DFG to RP (DFG Pa 345/12-2 and 13-1) to CN (SFB 829, A3) and RJW (DFG Wi 889/6-2 and SFB 728, C2).	Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Stenn KS, 2001, PHYSIOL REV, V81, P449; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Inoue SI, 2010, FEBS LETT, V584, P3402, DOI 10.1016/j.febslet.2010.06.036; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI [10.1016/j.stem.2011.03.009, 10.1016/j.stern.2011.03.009]; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Lindner G, 1997, AM J PATHOL, V151, P1601; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Ohyama M, 2010, EXP DERMATOL, V19, P89, DOI 10.1111/j.1600-0625.2009.00935.x; Botchkarev VA, 2004, PROG BRAIN RES, V146, P493; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; PAUS R, 1994, AM J PATHOL, V144, P719; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; Hornig-Do HT, 2007, J INVEST DERMATOL, V127, P1084, DOI 10.1038/sj.jid.5700666; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Bans OR, 2011, STEM CELLS, V29, P1459; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Chen CT, 2009, BIOCHIM BIOPHYS ACTA, V1800, P257; Frances D, 2012, DEV BIOL, V363, P138, DOI 10.1016/j.ydbio.2011.12.028; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117; KEALEY T, 1994, SKIN PHARMACOL, V7, P41; Knuever J, 2012, J CLIN ENDOCR METAB, V97, P978, DOI 10.1210/jc.2011-1096; Mantel C, 2010, CELL CYCLE, V9, P2008; Morokuma Y, 2008, INT J DERMATOL, V47, P1298, DOI 10.1111/j.1365-4632.2008.03783.x; Poeggeler B, 2010, FASEB J, V24, P1525, DOI 10.1096/fj.09-147728; Samuelov L, 2013, J INVEST DERMATOL, V133, P1591, DOI 10.1038/jid.2013.18; Scheffler IE, 2008, MITOCHONDRIA, V273, P325; Singh SK, 2012, J CELL SCI, V125, P4306, DOI 10.1242/jcs.102038; TOBIN DJ, 1991, AM J DERMATOPATH, V13, P248, DOI 10.1097/00000372-199106000-00006	49	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAR	2015	135	3					679	689		10.1038/jid.2014.475		11	Dermatology	Dermatology	CB2AH	WOS:000349428600010		
J	Hirose, M; Tiburzy, B; Ishii, N; Pipi, E; Wende, S; Rentz, E; Nimmerjahn, F; Zillikens, D; Manz, RA; Ludwig, RJ; Kasperkiewicz, M				Hirose, Misa; Tiburzy, Benjamin; Ishii, Norito; Pipi, Elena; Wende, Sabina; Rentz, Ellen; Nimmerjahn, Falk; Zillikens, Detlef; Manz, Rudolf A.; Ludwig, Ralf J.; Kasperkiewicz, Michael			Effects of Intravenous Immunoglobulins on Mice with Experimental Epidermolysis Bullosa Acquisita	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							DERMAL-EPIDERMAL SEPARATION; INDUCED TISSUE-DAMAGE; FC-GAMMA-RIV; VII COLLAGEN; PEMPHIGUS-VULGARIS; EXPERIMENTAL-MODEL; AUTOANTIBODIES; ANTIBODIES; INDUCTION; THERAPY	Although well-designed prospective trials are generally lacking, intravenous immunoglobulins (IVIG) seem an effective adjuvant treatment for autoimmune bullous skin diseases. Here, efficacy of IVIG monotherapy was compared with corticosteroid treatment in mice with immunization-induced experimental epidermolysis bullosa acquisita (EBA), an autoimmune bullous skin disease characterized by autoantibodies against type VII collagen. We found that IVIG significantly ameliorated clinical disease severity and skin neutrophil infiltration compared with vehicle-treated mice, whereas methylprednisolone showed comparatively less pronounced effects. Efficacy of IVIG was accompanied by reduced levels of autoantibodies, a shift toward noncomplement-fixing autoantibodies, and lower complement deposition at the dermal epidermal junction. In addition, peripheral Gr-1-positive cells of IVIG-treated animals showed reduced expression of the activating Fc gamma receptor IV, which we recently described as a major mediator of tissue injury in experimental EBA. These data show that treatment with IVIG is superior to systemic corticosteroids in experimental EBA and that the effects of IVIG are pleiotropic involving modulation of both the adaptive and innate immune response, although the detailed mode of action of IVIG in this model remains in need of further elucidation.	[Hirose, Misa; Pipi, Elena; Wende, Sabina; Zillikens, Detlef; Ludwig, Ralf J.; Kasperkiewicz, Michael] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Tiburzy, Benjamin; Manz, Rudolf A.] Med Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany; [Ishii, Norito] Kurume Med Univ, Dept Dermatol, Kurume, Fukuoka, Japan; [Rentz, Ellen] Biotest Inc, Dreieich, Germany; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Inst Genet, D-91054 Erlangen, Germany	Kasperkiewicz, M (reprint author), Med Univ Lubeck, Dept Dermatol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	Michael.Kasperkiewicz@uksh.de	Ludwig, Ralf/A-2629-2008; Hirose, Misa/A-2858-2014; Manz, Rudolf/C-8340-2011	Ludwig, Ralf/0000-0002-1394-1737; 	DFG [EXC 306/2, GRK1727/1, TP9, LU877/5-1]; University of Lubeck	We thank Claudia Kauderer (Department of Dermatology, University of Lubeck) for excellent technical support. This study was supported by DFG grants Excellence Cluster "Inflammation at Interfaces" (EXC 306/2), "Modulation of Autoimmunity" (GRK1727/1, TP9), and LU877/5-1, as well as the Focus Program "Autoimmunity" at the University of Lubeck.	Amagai M, 2009, J AM ACAD DERMATOL, V60, P595, DOI 10.1016/j.jaad.2008.09.052; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; WOODLEY DT, 1984, NEW ENGL J MED, V310, P1007, DOI 10.1056/NEJM198404193101602; Rezaei N, 2011, EXPERT REV CLIN IMMU, V7, P301, DOI [10.1586/eci.10.104, 10.1586/ECI.10.104]; Sitaru C, 2006, J IMMUNOL, V177, P3461; Mimouni D, 2010, CLIN EXP IMMUNOL, V162, P543, DOI 10.1111/j.1365-2249.2010.04265.x; Chen M, 2012, AUTOIMMUNITY, V45, P91, DOI 10.3109/08916934.2011.606450; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Kasperkiewicz M, 2012, J PATHOL, V228, P8, DOI 10.1002/path.4023; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Li N, 2005, J CLIN INVEST, V115, P3440, DOI 10.1172/JCI24394; Hammers CM, 2011, J IMMUNOL, V187, P5043, DOI [10.4049/jimmunol.1100796, 10.4049/jimmunol.110796]; Chiriac MT, 2007, J PATHOL, V212, P56, DOI 10.1002/path.2157; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; Kasperkiewicz M, 2011, BLOOD, V117, P6135, DOI 10.1182/blood-2010-10-314609; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Mihai S, 2007, J IMMUNOL, V178, P6514; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Hellberg L, 2013, J INVEST DERMATOL, V133, P2390, DOI 10.1038/jid.2013.91; Ishii N, 2010, CLIN REV ALLERG IMMU, V38, P186, DOI 10.1007/s12016-009-8153-y; Kasperkiewicz Michael, 2009, Curr Drug Discov Technol, V6, P270; Kasperkiewicz M, 2010, BRIT J DERMATOL, V162, P1064, DOI 10.1111/j.1365-2133.2010.09680.x; Ludwig RJ, 2013, ISRN DERMATOL, V2013; lwata H, 2013, J IMMUNOL, V191, P2978; Mimouni D, 2005, CLIN EXP IMMUNOL, V142, P426, DOI 10.1111/j.1365-2249.2005.02947.x; Sitaru AG, 2010, J IMMUNOL, V184, P1596, DOI 10.4049/jimmunol.0901412; WOODLEY DT, 1988, J CLIN INVEST, V81, P683, DOI 10.1172/JCI113373	29	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAR	2015	135	3					768	775		10.1038/jid.2014.453		8	Dermatology	Dermatology	CB2AH	WOS:000349428600020		
J	Sugiura, S; Tazuke, M; Ueno, S; Sugiura, Y; Kato, I; Miyahira, Y; Yamamoto, Y; Sato, H; Udagawa, J; Uehara, M; Sugiura, H				Sugiura, Shuji; Tazuke, Misao; Ueno, Shoichi; Sugiura, Yasuo; Kato, Ikuo; Miyahira, Yoshimitsu; Yamamoto, Yutaka; Sato, Hiroshi; Udagawa, Jun; Uehara, Masami; Sugiura, Hisashi			Effect of Prolactin-Induced Protein on Human Skin: New Insight into the Digestive Action of This Aspartic Peptidase on the Stratum Corneum and Its Induction of Keratinocyte Proliferation	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							ATOPIC-DERMATITIS; CD4-BINDING GLYCOPROTEIN; PROTEOMIC ANALYSIS; CANDIDA-ALBICANS; ECCRINE SWEAT; IDENTIFICATION; DEGRADATION; EXPRESSION; COMPONENTS; BINDING	Human prolactin-induced protein (PIP) is a major protein found in exocrine fluids such as saliva and sweat. Intriguingly, PIP possesses residues (human PIP (hPIP): PIP (29-63)) that display similarity to the aspartic peptidase candidapepsin. Here, we aimed to determine the effect of PIP as a protease on normal skin structure. Using an adhesive tape-stripping technique, we applied hPIP peptide on the corneocytes of normal-appearing facial skin from infants with eczema and healthy infants and then analyzed the morphological structure of corneocytes with Nile Red fluorescence. We also repeatedly applied the hPIP peptide onto the surface of a three-dimensional (3-D) human skin model and then analyzed any changes to the stratum corneum and epidermis using light microscopy and scanning electron microscopy. In both infant groups, a decrease in hydrophobic lipids from the cornified envelope was observed after treatment with hPIP. The peptide hPIP appeared to digest the fine structure of the stratum corneum and induce a proliferation of epidermal keratinocytes within the 3-D human skin model. Our results suggest that aspartic peptidase of PIP found in sweat or saliva deteriorates the skin barrier in a de novo manner, which potentially leads directly to the proliferation of epidermal keratinocytes without any external antigenic factors.	[Sugiura, Shuji] Shiga Univ Med Sci, Fac Med, Otsu, Shiga 52021, Japan; [Tazuke, Misao; Udagawa, Jun; Sugiura, Hisashi] Shiga Univ Med Sci, Div Anat & Cell Biol, Otsu, Shiga 52021, Japan; [Ueno, Shoichi; Yamamoto, Yutaka] Noevir, R&D Dept, Higashiomi, Japan; [Sugiura, Yasuo] Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Tokyo, Japan; [Kato, Ikuo] Kobe Pharmaceut Univ, Dept Med Biochem, Kobe, Hyogo 658, Japan; [Miyahira, Yoshimitsu] Shiga Univ Med Sci Hosp, Otsu, Shiga, Japan; [Sato, Hiroshi] Nagoya Bunri Univ, Fac Hlth & Human Life, Inazawa, Japan; [Uehara, Masami] Yasu Hosp, Dept Dermatol, Yasu, Japan; [Sugiura, Hisashi] Sugiura Skin Clin, Kusatsu, Japan	Sugiura, S (reprint author), Shiga Univ Med Sci, Fac Med, Otsu, Shiga 52021, Japan.	sugiurah@belle.shiga-med.ac.jp; sugiura.clinic@iris.eonet.ne.jp			Sugiura Skin Clinic; Sanofi KK; Otsuka Pharmaceutical; Noevir	We thank T Yamamoto for technical assistance with manipulation of the scanning electron microscope and M Arashima for laboratory analysis using 3-D skin model and T Chano for immunofluorescence studies of human skin. We also thank K Suita for useful clinical advice concerning the effect of sweat on patients with atopic dermatitis. Finally, we thank A Hirono for critical advice regarding our manuscript. This work was supported by grants from Sugiura Skin Clinic, Sanofi KK, Otsuka Pharmaceutical, and Noevir.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535; Vasilopoulos Y, 2004, J INVEST DERMATOL, V123, P62, DOI 10.1111/j.0022-202X.2004.22708.x; Rajka G, 1989, Acta Derm Venereol Suppl (Stockh), V144, P13; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Fortugno P, 2012, HUM MOL GENET, V21, P4187, DOI 10.1093/hmg/dds243; Gaubin M, 1999, J IMMUNOL, V162, P2631; Raiszadeh MM, 2012, J PROTEOME RES, V11, P2127, DOI 10.1021/pr2007957; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Hiragun T, 2013, J ALLERGY CLIN IMMUN, V132, P608, DOI 10.1016/j.jaci.2013.03.047; Schenkels LCPM, 1997, BIOL CHEM, V378, P83, DOI 10.1515/bchm.1997.378.2.83; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Colina AR, 1996, INFECT IMMUN, V64, P4514; Baechle D, 2006, J BIOL CHEM, V281, P5406, DOI 10.1074/jbc.M504670200; Park JH, 2011, EXP DERMATOL, V20, P369, DOI 10.1111/j.1600-0625.2010.01218.x; GOTOH T, 1995, BIOSCI BIOTECH BIOCH, V59, P367; JENKINS HL, 1969, J SOC COSMET CHEM, V20, P451; AUTIERO M, 1991, EXP CELL RES, V197, P268, DOI 10.1016/0014-4827(91)90432-T; Basmaciogullari S, 2000, BIOCHEMISTRY-US, V39, P5332, DOI 10.1021/bi992398l; Bein M, 2002, CURR DRUG TARGETS, V3, P351, DOI 10.2174/1389450023347542; Caputo E, 2003, BIOCHEMISTRY-US, V42, P6169, DOI 10.1021/bi034038a; Caputo E, 2000, J BIOL CHEM, V275, P7935, DOI 10.1074/jbc.275.11.7935; Deleuran M, 1998, ACTA DERM-VENEREOL, V78, P241; Hatta N, 1997, J DERMATOL SCI, V14, P154, DOI 10.1016/S0923-1811(96)00567-1; Hirao T, 2001, EXP DERMATOL, V10, P35, DOI 10.1034/j.1600-0625.2001.100105.x; Kageyama T, 2006, BIOCHEMISTRY-US, V45, P14415, DOI 10.1021/bi061467a; Miedzobrodzki J, 2002, EUR J CLIN MICROBIOL, V21, P269, DOI 10.1007/s10096-002-0706-4; Morschhauser J, 1997, FEMS MICROBIOL LETT, V153, P349, DOI 10.1016/S0378-1097(97)00273-5; Rajka G, 1989, ESSENTIAL ASPECTS AT, P216; SANCHEZ LM, 1992, CANCER RES, V52, P95; Sugibayashi Kenji, 2004, Drug Metab Pharmacokinet, V19, P352, DOI 10.2133/dmpk.19.352; Sugiura S, 2010, BRIT J DERMATOL, V162, P1286, DOI 10.1111/j.1365-2133.2010.09756.x; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x	35	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAR	2015	135	3					776	785		10.1038/jid.2014.448		10	Dermatology	Dermatology	CB2AH	WOS:000349428600021		
J	Matsui, MS; Petris, MJ; Niki, Y; Karaman-Jurukovska, N; Muizzuddin, N; Ichihashi, M; Yarosh, DB				Matsui, Mary S.; Petris, Michael J.; Niki, Yoko; Karaman-Jurukovska, Nevena; Muizzuddin, Neelam; Ichihashi, Masamitsu; Yarosh, Daniel B.			Omeprazole, a Gastric Proton Pump Inhibitor, Inhibits Melanogenesis by Blocking ATP7A Trafficking	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							REGULATED TRAFFICKING; TYROSINASE; MENKES; TRANSPORT; IDENTIFICATION; DEGRADATION; EXPRESSION; DISEASE; ATPASE; MODEL	Omeprazole is a proton pump inhibitor used in the treatment of peptic ulcer disease and gastrosophageal reflux disease and acts by irreversibly blocking ATP4A, a P-type H+/K+ ATPase in gastric parietal cells. We found that omeprazole and its closely related congeners inhibited melanogenesis at micromolar concentrations in B16 mouse melanoma cells, normal human epidermal melanocytes, and in a reconstructed human skin model. Omeprazole topically applied to the skin of UV-irradiated human subjects significantly reduced pigment levels after 3 weeks compared with untreated controls. Omeprazole had no significant inhibitory effect on the activities of purified human tyrosinase or on the mRNA levels of tyrosinase, dopachrome tautomerase, Prnel17, or MITF mRNA levels. Although melanocytes do not express ATP4A, they do express ATP7A, a copper transporting P-type ATPase in the trans-Golgi network that is required for copper acquisition by tyrosinase. ATP7A relocalization from the trans-Golgi network to the plasma membrane in response to elevated copper concentrations in melanocytes was inhibited by omeprazole. Omeprazole treatment increased the proportion of EndoH sensitive tyrosinase, indicating that tyrosinase maturation was impaired. In addition, omeprazole reduced tyrosinase protein abundance in the presence of cycloheximide, suggestive of increased degradation. Our findings are consistent with the hypothesis that omeprazole reduces melanogenesis by inhibiting ATP7A and by enhancing degradation of tyrosinase.	[Matsui, Mary S.; Karaman-Jurukovska, Nevena; Muizzuddin, Neelam; Yarosh, Daniel B.] Estee Lauder Co, R&D, Basic Sci Res, Melville, NY 11747 USA; [Petris, Michael J.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Niki, Yoko] Kobe Skin Res Dept, Kobe, Hyogo, Japan; [Ichihashi, Masamitsu] Doshisha Univ, Antiaging Med Res Ctr, Kyoto 602, Japan	Matsui, MS (reprint author), Estee Lauder Co, Biol Res Div, 125 Pinelawn Rd, Melville, NY 11747 USA.	mmatsui@estee.com			Estee Lauder Companies	MSM, NK-J, NM, and DBY are full-time employees of The Estee Lauder Companies. MJP and MI received consulting fees from The Estee Lauder Companies. YN received financial support in the form of a research grant from The Estee Lauder Companies.	Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x; Ando H, 2010, INT J MOL SCI, V11, P2566, DOI 10.3390/ijms11062566; Petris MJ, 1996, EMBO J, V15, P6084; Roche VF, 2006, AM J PHARM EDUC, V70; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Hall AM, 2005, PIGM CELL RES, V18, P122, DOI 10.1111/j.1600-0749.2005.00213.x; Hamdan II, 2001, PHARMAZIE, V56, P877; Ito S, 1998, PIGM CELL RES, V11, P120, DOI 10.1111/j.1600-0749.1998.tb00721.x; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Lambrecht N, 1998, J BIOL CHEM, V273, P13719, DOI 10.1074/jbc.273.22.13719; Leonhardt K, 2009, ARCH BIOCHEM BIOPHYS, V463, P134; Olivares C, 2003, J BIOL CHEM, V278, P15735, DOI 10.1074/jbc.M300658200; Petris MJ, 2002, J BIOL CHEM, V277, P46736, DOI 10.1074/jbc.M208864200; Shin JM, 2013, J EUR ACAD DERMATOL, V28, P1475; ZHAO HQ, 1994, AM J MED SCI, V308, P322, DOI 10.1097/00000441-199412000-00003	17	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAR	2015	135	3					834	841		10.1038/jid.2014.461		8	Dermatology	Dermatology	CB2AH	WOS:000349428600027		
J	Yokotani, K				Yokotani, Kenji			Links Between Impolite Spousal Forms of Address and Intimate Partner Violence Against Women	JOURNAL OF LANGUAGE AND SOCIAL PSYCHOLOGY			English	Article						spousal forms of address; (im)politeness theory; face-threatening act; intimate partner violence	COMMUNICATION PATTERNS; DOMESTIC VIOLENCE; COUPLES; HEALTH	Impolite forms of address to others are linked with impolite behaviors. The present study sought to examine a possible link between spousal forms of address and intimate partner violence (IPV). Study 1 validated impolite scale ratings of spousal forms of address. Study 2 examined the links between spousal forms of address and IPV. Thirty-six heterosexual couples were sampled (N = 72). Husbands' negative impoliteness ratings were positively linked with physical IPV against their wives.	[Yokotani, Kenji] Niigata Seiryo Univ, Niigata 9518121, Japan	Yokotani, K (reprint author), Niigata Seiryo Univ, Grad Sch Clin Psychol, Chuo Ku, 1-5939 Suidocho, Niigata 9518121, Japan.	yokotani@n-seiryo.ac.jp					Kropp PR, 2000, LAW HUMAN BEHAV, V24, P101, DOI 10.1023/A:1005430904495; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; Simmons RA, 2005, PSYCHOL SCI, V16, P932, DOI 10.1111/j.1467-9280.2005.01639.x; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Crozier WR, 1999, BRIT J EDUC PSYCHOL, V69, P505, DOI 10.1348/000709999157860; Johnson MP, 2000, J MARRIAGE FAM, V62, P948, DOI 10.1111/j.1741-3737.2000.00948.x; CORDOVA JV, 1993, J ABNORM PSYCHOL, V102, P559, DOI 10.1037/0021-843X.102.4.559; Culpeper J, 2003, J PRAGMATICS, V35, P1545, DOI 10.1016/S0378-2166(02)00118-2; Keltner D, 1998, J PERS SOC PSYCHOL, V75, P1231, DOI 10.1037//0022-3514.75.5.1231; Brown P., 1987, POLITENESS SOME UNIV; Brown R., 1960, STYLE LANG, P253; Culpeper J, 1996, J PRAGMATICS, V25, P349, DOI 10.1016/0378-2166(95)00014-3; Goffman E., 1967, INTERACTION RITUAL E; Heaven PCL, 2006, J RES PERS, V40, P829, DOI 10.1016/j.jrp.2005.09.012; Ishii A., 2003, CLIN PSYCHIATR, V45, P817; KENNY DA, 1985, J PERS SOC PSYCHOL, V48, P339, DOI 10.1037//0022-3514.48.2.339; Peng Fred, 1974, LANG SCI, V31, P32; Robertson K, 2006, J LANG SOC PSYCHOL, V25, P406, DOI 10.1177/0261927X06292991; Seiter JS, 2013, J APPL SOC PSYCHOL, V43, P1592, DOI 10.1111/jasp.12110; Suzuki K., 1993, B WAKO I SOCIAL CULT, V1993, P112; Tafoya MA, 2012, J LANG SOC PSYCHOL, V31, P49, DOI 10.1177/0261927X11425035; Wood L. A., 1991, J LANG SOC PSYCHOL, V10, P145, DOI 10.1177/0261927X91103001; Yokotani K., 2013, INT J BRIEF THERAPY, V3, P1; Yokotani K, 2013, PSYCHOLOGIA, V56, P20; Yokotani K, 2012, ASIAN J SOC PSYCHOL, V15, P284, DOI 10.1111/j.1467-839X.2012.01382.x; Yokotani K., 2013, PSYCHOL LANGUAGE COM, V17, P65	27	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0261-927X	1552-6526		J LANG SOC PSYCHOL	J. Lang. Soc. Psychol.	MAR	2015	34	2					213	221		10.1177/0261927X14551610		9	Communication; Linguistics; Psychology, Social	Communication; Linguistics; Psychology	CB0MH	WOS:000349319800006		
J	He, BB; Ding, D; Ling, YH; Xu, JM; Zhao, L				He, Beibei; Ding, Dong; Ling, Yihan; Xu, Jianmei; Zhao, Ling			Efficient modification for enhancing surface activity of Ba0.5Sr0.5Co0.8Fe0.2O3-delta oxygen permeation membrane	JOURNAL OF MEMBRANE SCIENCE			English	Article						Oxygen permeation; Surface modification; Infiltration	HOLLOW-FIBER MEMBRANES; OXIDE FUEL-CELLS; ELECTRICAL-CONDUCTIVITY RELAXATION; PEROVSKITE-TYPE OXIDE; HIGH-PERFORMANCE; CATHODE PERFORMANCE; CERAMIC MEMBRANES; PARTIAL OXIDATION; EXCHANGE; SEPARATION	The surface modification of Gd0.1Ce0.9O1.95 (GDC) particles on Ba0.5Sr0.5Co0.8Fe0.2O3-delta (BSCF) sandwich membrane is prepared for oxygen permeation by the infiltration method. The oxygen fluxes of BSCF membrane after infiltration provide relatively high performance due to the improved surface exchange kinetics, which is confirmed by the study of electrical conductivity relaxation. So far, the modified BSCF sandwich membrane has presented the highest performance of oxygen permeation among MIEC membranes at low temperature, such as 650 degrees C and 600 degrees C. The encouraging results demonstrate that the infiltration way is an alternative to develop highly efficient oxygen permeation membrane. (C) 2015 Elsevier B.V. All rights reserved.	[He, Beibei; Xu, Jianmei; Zhao, Ling] China Univ Geosci, CUG AU Inst Funct Mat, Dept Mat Sci & Chem, Wuhan 430074, Peoples R China; [Ding, Dong] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Ling, Yihan] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Zhao, L (reprint author), China Univ Geosci, CUG AU Inst Funct Mat, Dept Mat Sci & Chem, Wuhan 430074, Peoples R China.	ling.zhao.ustc@gmail.com	Zhao, Ling/L-6001-2015	Zhao, Ling/0000-0002-9500-3110	Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) [CUG140608]	The project was supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) (Grant no. CUG140608).	Chen XB, 2013, J MATER CHEM A, V1, P4871, DOI 10.1039/c3ta10230k; Zhao L, 2010, INT J HYDROGEN ENERG, V35, P753, DOI 10.1016/j.ijhydene.2009.10.102; Kao WX, 2010, J POWER SOURCES, V195, P2220, DOI 10.1016/j.jpowsour.2009.10.057; Zhang L, 2011, ELECTROCHEM COMMUN, V13, P711, DOI 10.1016/j.elecom.2011.04.017; Chen CH, 1997, SOLID STATE IONICS, V98, P7, DOI 10.1016/S0167-2738(97)00097-0; Mauvy F, 2004, J EUR CERAM SOC, V24, P1265, DOI 10.1016/S0955-2219(03)00500-4; Bouwmeester HJM, 2003, CATAL TODAY, V82, P141, DOI 10.1016/S0920-5861(03)00222-0; Leo A, 2009, J MEMBRANE SCI, V340, P148, DOI 10.1016/j.memsci.2009.05.022; Cox-Galhotra RA, 2010, SOLID STATE IONICS, V181, P1429, DOI 10.1016/j.ssi.2010.08.006; Ding D, 2014, ENERG ENVIRON SCI, V7, P552, DOI 10.1039/c3ee42926a; Jiang HQ, 2008, ANGEW CHEM INT EDIT, V47, P9341, DOI 10.1002/anie.200803899; Tan L, 2004, J MEMBRANE SCI, V230, P21, DOI 10.1016/j.memsci.2003.10.019; Yi JX, 2013, CHEM MATER, V25, P815, DOI 10.1021/cm303666v; Zhang K, 2008, ACTA MATER, V56, P4876, DOI 10.1016/j.actamat.2008.06.004; Lane JA, 2000, SOLID STATE IONICS, V136, P997, DOI 10.1016/S0167-2738(00)00554-3; Leo A, 2011, J MEMBRANE SCI, V368, P64, DOI 10.1016/j.memsci.2010.11.002; Han DZ, 2013, CERAM INT, V39, P431, DOI 10.1016/j.ceramint.2012.06.044; Lee YL, 2011, ENERG ENVIRON SCI, V4, P3966, DOI 10.1039/c1ee02032c; Jiang HQ, 2009, ANGEW CHEM INT EDIT, V48, P2983, DOI 10.1002/anie.200804582; Wang Y, 2012, INT J HYDROGEN ENERG, V37, P2182, DOI 10.1016/j.ijhydene.2011.11.008; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Liu XJ, 2013, J POWER SOURCES, V222, P92, DOI 10.1016/j.jpowsour.2012.08.019; Zhang K, 2011, RSC ADV, V1, P1661, DOI 10.1039/c1ra00419k; Caro J, 2007, IND ENG CHEM RES, V46, P2286, DOI 10.1021/ie0609620; Kim CH, 2010, SCIENCE, V327, P1624, DOI 10.1126/science.1184087; Wang HH, 2005, ADV MATER, V17, P1785, DOI 10.1002/adma.200401608; Xu SJ, 1999, CHEM ENG SCI, V54, P3839, DOI 10.1016/S0009-2509(99)00015-9; Yi JX, 2013, J MEMBRANE SCI, V437, P49, DOI 10.1016/j.memsci.2013.02.049; Jiang HQ, 2010, ANGEW CHEM INT EDIT, V49, P5656, DOI 10.1002/anie.201000664; Schulze-Kuppers F, 2013, J MEMBRANE SCI, V433, P121, DOI 10.1016/j.memsci.2013.01.028; Hong T, 2012, J POWER SOURCES, V218, P254, DOI 10.1016/j.jpowsour.2012.07.004; Watenabe K, 2010, ADV MATER, V22, P2367, DOI 10.1002/adma.200903953; Sunarso J, 2008, J MEMBRANE SCI, V320, P13, DOI 10.1016/j.memsci.2008.03.074; Zhou W, 2007, J POWER SOURCES, V174, P237, DOI 10.1016/j.jpowsour.2007.08.087; Xia CR, 2002, SOLID STATE IONICS, V149, P11, DOI 10.1016/S0167-2738(02)00131-5; He BB, 2014, J MEMBRANE SCI, V464, P55, DOI 10.1016/j.memsci.2014.03.075; Liu MF, 2012, INT J HYDROGEN ENERG, V37, P8613, DOI 10.1016/j.ijhydene.2012.02.139; Zhao L, 2009, J POWER SOURCES, V194, P835, DOI 10.1016/j.jpowsour.2009.06.010; Shao ZP, 2000, J MEMBRANE SCI, V172, P177, DOI 10.1016/S0376-7388(00)00337-9; Ding D, 2013, ADV ENERGY MATER, V3, P1149, DOI 10.1002/aenm.201200984; Wei YY, 2011, AICHE J, V57, P975, DOI 10.1002/aic.12321; Nagai T, 2007, SOLID STATE IONICS, V177, P3433, DOI 10.1016/j.ssi.2006.10.022; Baumann S, 2011, J MEMBRANE SCI, V377, P198, DOI 10.1016/j.memsci.2011.04.050; Ren ZA, 2009, ADV MATER, V21, P4584, DOI 10.1002/adma.200901049; Chen DJ, 2011, INT J HYDROGEN ENERG, V36, P6948, DOI 10.1016/j.ijhydene.2011.02.087; Tan XY, 2005, IND ENG CHEM RES, V44, P61, DOI 10.1021/ie040179c; Bose A.C., 2009, INORGANIC MEMBRANES; Chen X, 2002, SOLID STATE IONICS, V146, P405, DOI 10.1016/S0167-2738(01)01031-1; Ding D, 2008, J POWER SOURCES, V179, P177, DOI 10.1016/j.jpowsour.2007.12.059; Garcia-Barriocanal J, 2008, SCIENCE, V321, P676, DOI 10.1126/science.1156393; Pan H., 2012, J MEMBRANE SCI, V428, P198; Shao X, 2013, J MATER CHEM A, V1, P9641, DOI 10.1039/c3ta11952a; Wang L., 2009, APPL PHYS LETT, V94; Wang YL, 2014, J MATER CHEM A, V2, P136, DOI 10.1039/c3ta12787g; Yoon JS, 2010, SOLID STATE IONICS, V181, P1387, DOI 10.1016/j.ssi.2010.06.056	55	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-7388	1873-3123		J MEMBRANE SCI	J. Membr. Sci.	MAR 1	2015	477						7	13		10.1016/j.memsci.2014.12.020		7	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CB1JJ	WOS:000349383100002		
J	Kimura, M; Matsui, Y; Saito, S; Takahashi, T; Nakagawa, M; Shirasaki, N; Matsushita, T				Kimura, Masaoki; Matsui, Yoshihiko; Saito, Shun; Takahashi, Tomoya; Nakagawa, Midori; Shirasaki, Nobutaka; Matsushita, Taku			Hydraulically irreversible membrane fouling during coagulation-microfiltration and its control by using high-basicity polyaluminum chloride	JOURNAL OF MEMBRANE SCIENCE			English	Article						Ceramic; Foulant; Silicate; Coagulant; Basicity	COAGULATION/ULTRAFILTRATION HYBRID PROCESS; WATER-TREATMENT; FLOC PROPERTIES; ALUMINUM; PRETREATMENT; POLYMER; PERMEABILITY; SPECIATION; REMOVAL; SIZE	The extent of hydraulically irreversible membrane fouling in a coagulation-filtration system depends on several factors, including properties of the coagulant. Effects of polyaluminum chloride (PACI) coagulant properties, specifically basicity and sulfation, were investigated by conducting long-term direct filtration experiments. Elemental analysis determined Al and Si to be the major foulants, though the Si/Al ratios of the foulants differed from those of coagulated floc particles. While floc particle size depended on the concentrations of sulfate ions and polymeric species in the PACIs, floc-size changes did not affect transmembrane pressure (TMP) buildup and thus did not affect irreversible fouling. Differences in PACI basicity, which affected the distribution of aluminum species, resulted in changes to the degree of irreversible fouling. Pretreatment with high-basicity (71%) PACI was superior to pretreatment with normal-basicity (51%) PACI in reducing irreversible fouling and attenuating TMP buildup during filtration. Higher basicities resulted in less Al breakthrough and a decrease in the Si/Al ratio of the foulants. However, IMP buildup was the same for PACIs with basicities of 71% and 90%; therefore, TMP buildup is not simply related to Al breakthrough and deposition. Increasing the basicity of PACIs would be an effective way to reduce the amount of foulant deposited on the membrane by decreasing the amount of aluminum that passes through the membrane. (C) 2014 Elsevier B.V. All rights reserved,	[Kimura, Masaoki; Saito, Shun; Takahashi, Tomoya; Nakagawa, Midori] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Matsui, Yoshihiko; Shirasaki, Nobutaka; Matsushita, Taku] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan	Matsui, Y (reprint author), Hokkaido Univ, Fac Engn, N13W8, Sapporo, Hokkaido 0608628, Japan.	matsui@eng.hokudai.ac.jp			Japan Society for the Promotion of Science [24226012]	This study was supported by a Grant-in-Aid for Scientific Research S (24226012) from the Japan Society for the Promotion of Science.	Amirtharaja A., 1990, WATER QUALITY TREATM; Wang DS, 2004, COLLOID SURFACE A, V243, P1, DOI 10.1016/j.colsurfa.2004.04.073; PARTHASARATHY N, 1985, WATER RES, V19, P25, DOI 10.1016/0043-1354(85)90319-7; Matsui Y, 2009, WATER RES, V43, P5160, DOI 10.1016/j.watres.2009.08.021; Huang H, 2009, ENVIRON SCI TECHNOL, V43, P3011, DOI 10.1021/es802473r; Chen Y, 2007, DESALINATION, V204, P181, DOI 10.1016/j.desal.2006.04.029; Choi YH, 2008, SEP PURIF TECHNOL, V62, P529, DOI 10.1016/j.seppur.2008.03.001; Barbot E, 2008, J MEMBRANE SCI, V325, P520, DOI 10.1016/j.memsci.2008.07.054; Waite TD, 1999, J COLLOID INTERF SCI, V212, P264, DOI 10.1006/jcis.1998.6040; Yu WZ, 2011, J MEMBRANE SCI, V385, P194, DOI 10.1016/j.memsci.2011.09.039; Wang J, 2008, J MEMBRANE SCI, V321, P132, DOI 10.1016/j.memsci.2008.04.008; Liu T, 2011, WATER RES, V45, P4260, DOI 10.1016/j.watres.2011.05.037; Kimura M, 2013, WATER RES, V47, P2075, DOI 10.1016/j.watres.2013.01.037; Xu WY, 2012, J MEMBRANE SCI, V415, P153, DOI 10.1016/j.memsci.2012.04.046; Gao BY, 2005, J ENVIRON MANAGE, V76, P143, DOI 10.1016/j.jenvman.2004.12.006; Cho MH, 2005, WATER SCI TECHNOL, V51, P143; International Humic Substance Society, 2013, EL COMP STABL IS RAT; Matsui Y, 2013, SEP PURIF TECHNOL, V119, P58, DOI 10.1016/j.seppur.2013.09.006; Matsui Y., 2003, Water Science and Technology: Water Supply, V3, P93; Ohno K, 2010, DESALINATION, V254, P17, DOI 10.1016/j.desal.2009.12.020; Tran T, 2006, J MEMBRANE SCI, V280, P560, DOI 10.1016/j.memsci.2006.02.013; Xu WY, 2012, CHEM ENG J, V181, P407, DOI 10.1016/j.cej.2011.11.107; Zhao BQ, 2011, WATER SCI TECH-W SUP, V11, P97, DOI 10.2166/ws.2011.014; Zhao BQ, 2010, SEP PURIF TECHNOL, V72, P22, DOI 10.1016/j.seppur.2009.12.023; Zhao H, 2009, ENVIRON SCI TECHNOL, V43, P5067, DOI 10.1021/es8034347	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-7388	1873-3123		J MEMBRANE SCI	J. Membr. Sci.	MAR 1	2015	477						115	122		10.1016/j.memsci.2014.12.033		8	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CB1JJ	WOS:000349383100013		
J	Messaoud, SB; Takagaki, A; Sugawara, T; Kikuchi, R; Oyama, ST				Messaoud, Souha Belhaj; Takagaki, Atsushi; Sugawara, Takashi; Kikuchi, Ryuji; Oyama, S. Ted			Alkylamine-silica hybrid membranes for carbon dioxide/methane separation	JOURNAL OF MEMBRANE SCIENCE			English	Article						Hybrid membrane; CO2/CH4 separation; Primary amine; Secondary amine; Chemical vapor deposition	GAS PERMEATION PROPERTIES; GAMMA-ALUMINA MEMBRANES; HYDROGEN SEPARATION; MESOPOROUS SILICA; CO2 SEPARATION; COMPOSITE MEMBRANES; CO2/CH4 SEPARATION; SAPO-34 MEMBRANES; CERAMIC MEMBRANE; WATER-VAPOR	Hybrid membranes are promising materials for the purification of natural gas from carbon dioxide. The present paper investigates the effect of the incorporation of primary and secondary amine functional groups on the performance of an organic inorganic hybrid silica membrane for CO2/CH4 separation. Hybrid membranes were synthesized by chemical vapor deposition using 3-aminopropyltrimethoxysilane and (3-methylaminopropyl)trimethoxysilane as primary and secondary alkylamine-silica precursors, respectively. The amino functionalized membranes were compared to an amine-free membrane prepared using propyltrimethoxysilane as precusor. The amine-free membrane had a pore size of 0.37 nrn, and at 393 K a CO2 permeance of 2.1 x 10(-8) mol m(-2) s(-1) Pa-1 and a CO2/CH4 selectivity of 4. The primary amine membrane had a pore size of 0.36 nm, and at 393 K displayed a CO2 permeance of 2.1 x 10(-8) mol m(-2) s(-1) Pa-1 and a CO2/CH4 selectivity of 70. The secondary amine hmembrane had a pore size of 0.43 nm and achieved a CO2 permeance of 1.3 x 10(-7) mol m(-2) s(-1) Pa-1 and a CO2/CH4 selectivity of 140. The pore sizes were estimated by Tsuru`s method. The transport mechanism of CO2 throughout the amino silica hybrid membranes was surface diffusion. The secondary amino silica hybrid membrane was stable for 60 h under a relative humidity of 20%. (C) 2014 Elsevier B.V. All rights reserved.	[Messaoud, Souha Belhaj; Takagaki, Atsushi; Sugawara, Takashi; Kikuchi, Ryuji; Oyama, S. Ted] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Oyama, S. Ted] Virginia Polytech Inst & State Univ, Dept Chem Engn, Environm Catalysis & Nanomat Lab, Blacksburg, VA 24061 USA	Oyama, ST (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	oyama@vt.edu	Takagaki, Atsushi/E-6788-2010; Kikuchi, Ryuji/H-4255-2015	Takagaki, Atsushi/0000-0002-7829-3451; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [CBET-084316]	The support for this work was funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Director, National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) under Grant CBET-084316.	Adewole JK, 2013, INT J GREENH GAS CON, V17, P46, DOI 10.1016/j.ijggc.2013.04.012; Lee HR, 2011, AICHE J, V57, P2755, DOI 10.1002/aic.12501; Oyama ST, 2011, J JPN PETROL INST, V54, P298; Tomita T, 2004, MICROPOR MESOPOR MAT, V68, P71, DOI 10.1016/j.micromeso.2003.11.016; Kanezashi M, 2009, J AM CHEM SOC, V131, P414, DOI 10.1021/ja806762q; Mebane DS, 2013, J PHYS CHEM C, V117, P26617, DOI 10.1021/jp4076417; Mathur S, 2006, SURF COAT TECH, V201, P807, DOI 10.1016/j.surfcoat.2005.12.039; Sea BK, 1996, GAS SEP PURIF, V10, P187, DOI 10.1016/0950-4214(96)00020-5; Nijmeijer A, 1998, MICROPOR MESOPOR MAT, V25, P179, DOI 10.1016/S1387-1811(98)00205-4; Gu YF, 2007, J MEMBRANE SCI, V306, P216, DOI 10.1016/j.memsci.2007.08.045; Cui Y, 2004, J MATER CHEM, V14, P924, DOI 10.1039/b311881a; Gu YF, 2008, J MEMBRANE SCI, V310, P28, DOI 10.1016/j.memsci.2007.10.025; de Vos RM, 1999, J MEMBRANE SCI, V158, P277, DOI 10.1016/S0376-7388(99)00035-6; Xomeritakis G, 2005, SEP PURIF TECHNOL, V42, P249, DOI 10.1016/j.seppur.2004.08.003; Calvo A, 2008, CHEM MATER, V20, P4661, DOI 10.1021/cm800597k; Hiyoshi N, 2004, CHEM LETT, V33, P510, DOI 10.1246/cl.2004.510; Zhang Y, 2013, INT J GREENH GAS CON, V12, P84, DOI 10.1016/j.ijggc.2012.10.009; Xomeritakis G, 2009, J MEMBRANE SCI, V341, P30, DOI 10.1016/j.memsci.2009.05.024; Li SG, 2010, J MEMBRANE SCI, V352, P7, DOI 10.1016/j.memsci.2010.01.037; Li BY, 2013, APPL ENERG, V102, P1439, DOI 10.1016/j.apenergy.2012.09.009; Jin N, 2013, PROG MATER SCI, V58, P1490, DOI 10.1016/j.pmatsci.2013.07.001; Sea BK, 1997, J MEMBRANE SCI, V130, P41, DOI 10.1016/S0376-7388(97)00002-1; Lindmark J, 2010, J MEMBRANE SCI, V360, P284, DOI 10.1016/j.memsci.2010.05.025; Sayari A, 2010, J AM CHEM SOC, V132, P6312, DOI 10.1021/ja1013773; Bernardo P, 2010, PETROL CHEM+, V50, P271, DOI 10.1134/S0965544110040043; Oyama ST, 2004, J MEMBRANE SCI, V244, P45, DOI 10.1016/j.memsci.2004.06.046; Spijksma GI, 2006, ADV MATER, V18, P2165, DOI 10.1002/adma.200502568; Xing R, 2011, J MEMBRANE SCI, V367, P91, DOI 10.1016/j.memsci.2010.10.039; Ockwig NW, 2007, CHEM REV, V107, P4078, DOI 10.1021/cr0501792; Castricum HL, 2008, CHEM COMMUN, P1103, DOI 10.1039/b718082a; TSAPATSIS M, 1994, J MEMBRANE SCI, V87, P281, DOI 10.1016/0376-7388(94)87034-9; Hooper AE, 2001, SURF INTERFACE ANAL, V31, P809, DOI 10.1002/sia.1125; Baker RW, 2008, IND ENG CHEM RES, V47, P2109, DOI 10.1021/ie071083w; Kanezashi M, 2012, IND ENG CHEM RES, V51, P944, DOI 10.1021/ie201606k; Hiyoshi N, 2005, MICROPOR MESOPOR MAT, V84, P357, DOI 10.1016/j.micromeso.2005.06.010; Ohta Y, 2008, J MEMBRANE SCI, V315, P93, DOI 10.1016/j.memsci.2008.02.008; Yamaguchi T, 2007, J MEMBRANE SCI, V294, P16, DOI 10.1016/j.memsci.2007.01.028; Kreiter R, 2011, J SOL-GEL SCI TECHN, V57, P245, DOI 10.1007/s10971-010-2208-7; Li SG, 2008, MICROPOR MESOPOR MAT, V110, P310, DOI 10.1016/j.micromeso.2007.06.016; VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y; Gu YF, 2007, ADV MATER, V19, P1636, DOI 10.1002/adma.200602637; Breck D. W., 1973, ZEOLITE MOL SIEVES S; Dimitrova Z, 2005, MATER RES BULL, V40, P333, DOI 10.1016/j.materresbull.2004.10.017; Fernandes D, 2012, J CHEM THERMODYN, V54, P183, DOI 10.1016/j.jct.2012.03.030; Gopalakrishnan S, 2007, J MEMBRANE SCI, V297, P5, DOI 10.1016/j.memsci.2007.03.034; Han HH, 2013, J MEMBRANE SCI, V431, P72, DOI 10.1016/j.memsci.2012.11.017; Hiyoshi N, 2005, J JPN PETROL INST, V48, P29, DOI 10.1627/jpi.48.29; Hyun SH, 1996, J MEMBRANE SCI, V120, P197, DOI 10.1016/0376-7388(96)00160-3; Iler R., 1979, CHEM SILICA SOLUBILI; Ivanova T, 2002, MATER LETT, V53, P250, DOI 10.1016/S0167-577X(01)00486-4; Koutsonikolas D, 2009, J MEMBRANE SCI, V342, P131, DOI 10.1016/j.memsci.2009.06.032; Li K., 2007, CERAMIC MEMBRANES SE; Li Y.S., 2001, SEP PURIF TECHNOL, V25, P39; Miyamoto M, 2011, DESALIN WATER TREAT, V34, P266, DOI 10.5004/dwt.2011.2896; Moek E.M.V., 2013, MEMBRANE SCI TECHNOL; MOROOKA S, 1995, J MEMBRANE SCI, V101, P89, DOI 10.1016/0376-7388(94)00293-8; Osborne NS, 1934, BUR STAND J RES, V13, P1; Ostwal M, 2011, J MEMBRANE SCI, V369, P139, DOI 10.1016/j.memsci.2010.11.053; Oyama ST, 2011, MEMBR SCI TECH SER, V14, P1; Oyama ST, 2001, J MATER SCI, V36, P5213, DOI 10.1023/A:1012450029714; Pan M, 1999, J MEMBRANE SCI, V158, P235, DOI 10.1016/S0376-7388(99)00016-2; Paradis GG, 2012, J MATER CHEM, V22, P7258, DOI 10.1039/c2jm15417j; Poshusta J.C., 1999, J MEMBRANE SCI, V160, P1797; RAMAN NK, 1995, J MEMBRANE SCI, V105, P273, DOI 10.1016/0376-7388(95)00067-M; Scholes Colin A, 2008, Recent Patents on Chemical Engineering, V1; SHELEKHIN AB, 1992, J MEMBRANE SCI, V75, P233, DOI 10.1016/0376-7388(92)85066-R; Suzuki S, 2014, J MEMBRANE SCI, V471, P402, DOI 10.1016/j.memsci.2014.08.029; Titus M.P., 2014, CHEM REV, V114, P1413; Tobin J., 2013, CRUCIAL LINK NATURAL; van den Broeke LJP, 1999, CHEM ENG SCI, V54, P259, DOI 10.1016/S0009-2509(98)00242-5; Wei Q, 2008, J PHYS CHEM B, V112, P9354, DOI 10.1021/jp711573f; Yampolskii Y., 2006, MAT SCI MEMBRANES GA	72	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-7388	1873-3123		J MEMBRANE SCI	J. Membr. Sci.	MAR 1	2015	477						161	171		10.1016/j.memsci.2014.12.022		11	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CB1JJ	WOS:000349383100019		
J	Kiriyama, K; Ohtaki, H; Kobayashi, N; Murai, N; Matsumoto, M; Sasaki, S; Sawa, C; Satoh, K; Matsunaga, M; Shioda, S				Kiriyama, Keisuke; Ohtaki, Hirokazu; Kobayashi, Natsuki; Murai, Norimitsu; Matsumoto, Minako; Sasaki, Shun; Sawa, Chika; Satoh, Kazue; Matsunaga, Masaji; Shioda, Seiji			A Nucleoprotein-Enriched Diet Suppresses Dopaminergic Neuronal Cell Loss and Motor Deficit in Mice with MPTP-Induced Parkinson's Disease	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Nucleoprotein; Parkinson's disease; Oxidative stress; Dopaminergic neuron	CEREBRAL-ARTERY OCCLUSION; OXIDATIVE STRESS; HIPPOCAMPAL-NEURONS; MOUSE MODEL; NEUROINFLAMMATION; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; NEURODEGENERATION; NEUROTOXICITY; MECHANISMS; PROTECTION	Parkinson's disease (PD) is an obstinate progressive neurodegenerative disease and characterized by locomotor impairment and dopaminergic neuronal degeneration in the substantia nigra pars compacta (SNc). We examined in here the dietary effect of nucleoprotein (NP) extracted from salmon soft roe on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-injected PD-like mice model to prevent the symptom as an alternative medicine. Male C57/BL6 mice were given either an artificially modified NP-free diet (NF) or NF supplied with 1.2 % NP for 1 week. Then, mice were injected intraperitoneally four times with 20 mg/kg MPTP. Seven days later, locomotor activity was examined, and the brains were immunostained with tyrosine hydroxylase (TH) and Iba1 antibodies. Moreover, in situ detection of superoxide anion (O-2(-)) and gene expression of mitochondrial electron transfer chain gene, Cox8b was evaluated in mid-brains. NP-fed animals showed significantly reduced locomotor impairment and an increased number of TH-positive cells in the SNc compared with NF animals. The NP-fed animals also showed reduced lower levels of O-2(-) and up-regulation of Cox8b levels and Iba1 immunoreactivity, suggesting that inflammation and oxidative stress were suppressed and mitochondrial impairment was relieved in these animals. Supplementation of the diet with NP may serve as a useful preventive measure to slow the onset of PD.	[Kiriyama, Keisuke; Ohtaki, Hirokazu; Kobayashi, Natsuki; Murai, Norimitsu; Matsumoto, Minako; Sasaki, Shun; Sawa, Chika; Satoh, Kazue; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Matsunaga, Masaji] Gene Trophol Res Inst, Tokyo 1300012, Japan	Shioda, S (reprint author), Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shioda@med.showa-u.ac.jp			MEXT	This work was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012.	Goldberg NRS, 2011, J NEUROSCI RES, V89, P1698, DOI 10.1002/jnr.22699; Taylor JM, 2013, NEUROCHEM INT, V62, P803, DOI 10.1016/j.neuint.2012.12.016; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Chung YC, 2011, NEUROPHARMACOLOGY, V60, P963, DOI 10.1016/j.neuropharm.2011.01.043; Murakami K, 1998, J NEUROSCI, V18, P205; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Khan MM, 2013, NEUROCHEM INT, V62, P379, DOI 10.1016/j.neuint.2013.01.029; Chen TH, 2000, J NUTR, V130, P3085; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Langston JW, 1996, NEUROLOGY, V47, pS153; Matsunaga M, 2003, NEUROSCI RES, V47, P269, DOI 10.1016/S0168-0102(03)00215-3; Ohtaki H, 2007, NEUROSCI RES, V58, P349, DOI 10.1016/j.neures.2007.04.005; Ohtaki H, 2010, J CLIN BIOCHEM NUTR, V46, P93, DOI 10.3164/jcbn.09-61; SINGER TP, 1987, J NEUROCHEM, V49, P1, DOI 10.1111/j.1471-4159.1987.tb03384.x; Speciale SG, 2002, NEUROTOXICOL TERATOL, V24, P607, DOI 10.1016/S0892-0362(02)00222-2; Sudo N, 2000, CLIN EXP ALLERGY, V30, P979, DOI 10.1046/j.1365-2222.2000.00811.x; Tanaka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-143; TURSKI L, 1991, NATURE, V349, P414, DOI 10.1038/349414a0; Yofu S, 2010, JPN J APPL PHYSL, V40, P137	26	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2015	55	3					803	811		10.1007/s12031-014-0432-2		9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CB0BL	WOS:000349289600024		
J	Yashiro, K; Iwata, A; Takada, K; Murakami, S; Uchiyama, Y; Furukawa, S				Yashiro, K.; Iwata, A.; Takada, K.; Murakami, S.; Uchiyama, Y.; Furukawa, S.			Temporomandibular joint articulations on working side during chewing in adult females with cross-bite and mandibular asymmetry	JOURNAL OF ORAL REHABILITATION			English	Article						kinematics; mastication; normalised jerk-cost; TMJ articulation	DISPLACEMENT; SENSITIVITY; MOVEMENT; ANATOMY; JERK	Influence of mandibular asymmetry and cross-bite on temporomandibular joint (TMJ) articulation remained unknown. This study aimed to investigate whether/how the working-side condylar movement irregularity and articular spaces during chewing differ between patients with mandibular asymmetry/cross-bite and control subjects. The cross-bite group and the control group consisted of 10 adult female patients and 10 adult female subjects, respectively. They performed unilateral gum-chewing. The mandibular movements were recorded using a video-based opto-electronic system. The 3D articular surface of the TMJ for each individual was reconstructed using CT/MRI data. For local condylar points, the normalised jerk cost (NJC) towards normal direction to the condylar surface, the angle between tangential velocity vector and condylar long axis and intra-articular space were measured. Three rotatory angles at centre of the condyle were also measured. During closing and intercuspation, (i) movements of posterior portion of the deviated side condyle showed significantly less smoothness as compared with those for the non-deviated side and control subjects, (ii) the rotations of the condyle on the deviated side induced greater intra-articular space at posterior and lateral portions. These findings suggest that chewing on the side of mandibular deviation/cross-bite may cause irregular movement and enlarged intra-articular space at posterior portion of the deviated side condyle.	[Yashiro, K.; Iwata, A.] Osaka Univ, Dept Orthodont & Dentofacial Orthoped, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Yashiro, K.; Iwata, A.] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Takada, K.] Natl Univ Singapore, Discipline Orthodont & Paediat Dent, Fac Dent, Singapore 117548, Singapore; [Murakami, S.; Uchiyama, Y.; Furukawa, S.] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Radiol, Suita, Osaka 5650871, Japan	Yashiro, K (reprint author), Osaka Univ, Ctr Adv Med Engn & Informat, Grad Sch Dent & Adjunct Associate Prof, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kohkohya846@gmail.com			Japanese Ministry of Education, Science and Culture [C-05671706]	The Ethics Committee of the Dental School approved the experiment (permission #H16-4-1). This work was partially supported by a Grant-in-Aid for Scientific Research (C-05671706) from the Japanese Ministry of Education, Science and Culture. There are no conflict of interests.	Alomar X, 2007, SEMIN ULTRASOUND CT, V28, P170, DOI 10.1053/j.sult.2007.02.002; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Ahn SJ, 2005, AM J ORTHOD DENTOFAC, V128, P583, DOI 10.1016/j.ajodo.2004.06.038; Takada K, 2006, PHYSIOL MEAS, V27, P609, DOI 10.1088/0967-3334/27/7/005; Gallo LM, 2008, J DENT RES, V87, P726; Gallo LM, 2000, J DENT RES, V79, P1740; Benigno MIM, 2001, J ORAL REHABIL, V28, P113, DOI 10.1046/j.1365-2842.2001.00683.x; Daniels C, 2000, J Orthod, V27, P149, DOI 10.1093/ortho/27.2.149; ERIKSSON L, 1992, J ORAL MAXIL SURG, V50, P869, DOI 10.1016/0278-2391(92)90282-5; Griffin C J, 1975, Monogr Oral Sci, V4, P1; Huddleston SJJR, 1999, J DENT RES, V78, P1815, DOI 10.1177/00220345990780120801; Kobayashi T, 1999, BRIT J ORAL MAX SURG, V37, P455, DOI 10.1054/bjom.1999.0016; Lebiedowska MK, 2011, J NEUROSCI METH, V198, P255, DOI 10.1016/j.jneumeth.2011.04.018; Link J J, 1992, Int J Adult Orthodon Orthognath Surg, V7, P161; Miyawaki S, 2004, AM J ORTHOD DENTOFAC, V126, P549, DOI 10.1016/j.ajodo.2003.10.033; Nickerson JW, 1989, ORAL MAXILLOFAC SURG, V1, P27; Palla S, 2003, Orthod Craniofac Res, V6 Suppl 1, P37, DOI 10.1034/j.1600-0544.2003.233.x; PROFFIT W R, 1990, International Journal of Adult Orthodontics and Orthognathic Surgery, V5, P81; Ress LA, 1954, BRIT DENT J, V96, P125; Roberts D, 2013, P I MECH ENG H, V227, P1104, DOI 10.1177/0954411913493724; Sakata K, 2010, GAIT POSTURE, V31, P27, DOI 10.1016/j.gaitpost.2009.08.239; Takada K, 2010, ELEMENTS ORTHODONTIC, P90; TALLENTS R H, 1991, Journal of Craniomandibular Disorders, V5, P135; Yashiro K, 2014, ADV BIOMED ENG, V3, P44; Yashiro K, 2002, IA 02 P INT S YOUNG, P83	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	MAR	2015	42	3					163	172		10.1111/joor.12266		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB1MD	WOS:000349390900001		
J	Komiyama, O; Obara, R; Iida, T; Asano, T; Masuda, M; Uchida, T; De Laat, A; Kawara, M				Komiyama, O.; Obara, R.; Iida, T.; Asano, T.; Masuda, M.; Uchida, T.; De Laat, A.; Kawara, M.			Comparison of direct and indirect occlusal contact examinations with different clenching intensities	JOURNAL OF ORAL REHABILITATION			English	Article						interocclusal recording; occlusal examination; occlusal contact area; tooth clenching; electromyography	DUAL-ARCH TRAYS; BITE FORCE; CUSTOM TRAY; ACCURACY; PRESSURE; AREA; IMPRESSIONS; CAST	The aims of this study were to examine the change of occlusal contact area following the increment of clenching intensity using silicone materials and electromyography (EMG) in normal subjects and to compare direct intra-oral examination with indirect examination using dental casts mounted by means of two impression methods. Participants were 7 men and 5 women with no more than one missing tooth per quadrant and no pain in the head and neck region. During the task, intercuspal position was maintained with minimal force, 20% maximum voluntary contraction (MVC) and 40% MVC using electromyography visual feedback. Three types of occlusal contact examinations were performed with the aid of blue silicone material in randomised order: (i) intra-oral direct occlusal contact examination (DE), (ii) indirect occlusal contact examination with dental casts using conventional impression method (IEC) and (iii) using occlusal impression method (IEO). Total occlusal contact area during DE and IEO significantly increased from baseline to 20% MVC and from baseline to 40% MVC, but not during IEC. Total occlusal contact area during DE in all tooth clenching conditions was significantly larger compared to IEO and IEC (P<005). At 40% MVC, total occlusal contact area during IEO was significantly larger than during IEC (P<005). These findings suggest that indirect occlusal contact examinations may not accurately reflect the intra-oral occlusal condition. If the intra-oral condition is reproduced using dental casts, these findings also suggest the occlusal impression method was more accurate compared to the conventional method (240 words).	[Komiyama, O.; Obara, R.; Iida, T.; Asano, T.; Masuda, M.; Kawara, M.] Nihon Univ, Sch Dent Matsudo, Dept Oral Funct & Rehabil, Matsudo, Chiba 2718587, Japan; [Uchida, T.] Nihon Univ, Sch Dent Matsudo, Dept Oral Diag, Matsudo, Chiba 2718587, Japan; [De Laat, A.] Katholieke Univ Leuven, Dept Oral Hlth Sci, Leuven, Belgium; [De Laat, A.] Univ Hosp Leuven, Dept Dent, Leuven, Belgium	Komiyama, O (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Oral Funct & Rehabil, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	komiyama.osamu@nihon-u.ac.jp			Japanese Society for the Promotion of Science [C 26462959]; Ministry of Education, Culture, Sports, Science and Technology [B 26861655]	This study was supported by Grants-in-Aid for Scientific Research (C 26462959) from the Japanese Society for the Promotion of Science and a grant-in-aid for young scientists (B 26861655) from the Ministry of Education, Culture, Sports, Science and Technology.	Koyano K, 2012, J ORAL REHABIL, V39, P513, DOI 10.1111/j.1365-2842.2012.02303.x; Wostmann B, 2009, INT J PROSTHODONT, V22, P158; Baba K, 2014, J PROSTHODONT RES, V58, P1, DOI 10.1016/j.jpor.2013.12.003; Hattori Y, 2003, J DENT RES, V82, P532; KORIOTH TWP, 1994, J DENT RES, V73, P56, DOI 10.1177/00220345940730010801; BREEDING LC, 1994, J PROSTHET DENT, V71, P265, DOI 10.1016/0022-3913(94)90465-0; Ceyhan JA, 2003, J PROSTHET DENT, V90, P228, DOI 10.1016/S0022-3913(03)00237-3; desAvila ED, 2013, J PROSTHODONT RES, V57, P268; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Eriksson A, 2002, BRIT DENT J, V192, P395, DOI 10.1038/sj.bdj.4801384; Hidaka O, 1999, J DENT RES, V78, P1336; Kikuchi M, 1997, J DENT RES, V76, P1316; Larson TD, 2002, J PROSTHET DENT, V87, P625, DOI 10.1067/mpr.2002.125180; Meng JC, 2010, J PROSTHET DENT, V104, P122, DOI 10.1016/S0022-3913(10)60105-9; Millstein P, 1998, J ORAL REHABIL, V25, P645; Obara R, 2013, J ORAL REHABIL, V40, P834, DOI 10.1111/joor.12088; Obara R, 2014, J ORAL REHABIL, V41, P218, DOI 10.1111/joor.12134; Ockert-Eriksson G, 2000, INT J PROSTHODONT, V13, P152; Parker MH, 1997, J PROSTHET DENT, V78, P255, DOI 10.1016/S0022-3913(97)70023-4; Sato S, 1999, J ORAL REHABIL, V26, P906, DOI 10.1046/j.1365-2842.1999.00481.x; Shigeta Y, 2013, J PROSTHODONT RES, V57, P122, DOI 10.1016/j.jpor.2012.11.004; Sultana MH, 2002, J ORAL REHABIL, V29, P484, DOI 10.1046/j.1365-2842.2002.00849.x; Suzuki Y, 2012, J PROSTHODONT RES, V56, P293, DOI 10.1016/j.jpor.2012.02.005; WARREN K, 1990, International Journal of Prosthodontics, V3, P341	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	MAR	2015	42	3					185	191		10.1111/joor.12242		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB1MD	WOS:000349390900003		
J	Shiomi, A; Izumi, K; Uenoyama, A; Saito, T; Saito, N; Ohnuki, H; Kato, H; Kanatani, M; Nomura, S; Egusa, H; Maeda, T				Shiomi, A.; Izumi, K.; Uenoyama, A.; Saito, T.; Saito, N.; Ohnuki, H.; Kato, H.; Kanatani, M.; Nomura, S.; Egusa, H.; Maeda, T.			Cyclic mechanical pressure-loading alters epithelial homeostasis in a three-dimensional in vitro oral mucosa model: clinical implications for denture-wearers	JOURNAL OF ORAL REHABILITATION			English	Article						mouth mucosa; epithelial cell; fibroblast; dentures; in vitro; pressure	HUMAN EPIDERMAL-KERATINOCYTES; PALATAL MUCOSA; HUMAN SKIN; DIFFERENTIATION; MATRIX; PROLIFERATION; STIMULATION; SURVIVAL; ADHESION; PROGRAM	Denture-wearing affects the quality and quantity of epithelial cells in the underlying healthy oral mucosa. The physiologic mechanisms, however, are poorly understood. This study aimed to compare histologic changes and cellular responses of an epithelial cell layer to cyclic mechanical pressure-loading mimicking denture-wearing using an organotypic culture system to develop a three-dimensional in vitro oral mucosa model (3DOMM). Primary human oral keratinocytes and fibroblasts were serially grown in a monolayer culture, and cell viability was measured under continuous cyclic mechanical pressure (50kPa) for 7days (cycles of 60min on, 20s off to degas and inject air). Upon initiation of an air-liquid interface culture for epithelial stratification, the cyclic pressure, set to the mode above mentioned, was applied to the 3DOMMs for 7days. Paraffin-embedded 3DOMMs were examined histologically and immunohistochemically. In the monolayer culture, the pressure did not affect the viability of oral keratinocytes or fibroblasts. Few histologic changes were observed in the epithelial layer of the control and pressure-loaded 3DOMMs. Immunohistochemical examination, however, revealed a significant decrease in Ki-67 labelling and an increase in filaggrin and involucrin expression in the suprabasal layer of the pressure-loaded 3DOMMs. Pressure-loading attenuated integrin 1 expression and increased matrix metalloproteinase-9 activity. Incomplete deposition of laminin and type IV collagen beneath the basal cells was observed only in the pressure-loaded 3DOMM. Cyclic pressure-loading appeared to disrupt multiple functions of the basal cells in the 3DOMM, resulting in a predisposition towards terminal differentiation. Thus, denture-wearing could compromise oral epithelial homeostasis.	[Shiomi, A.] Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Educ Res Dev, Niigata 9518514, Japan; [Shiomi, A.; Uenoyama, A.; Saito, T.; Saito, N.; Ohnuki, H.; Kato, H.; Maeda, T.] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Anat, Niigata 9518514, Japan; [Izumi, K.; Kanatani, M.] Niigata Univ, Grad Sch Med & Dent Sci, Div Biomimet, Niigata 9518514, Japan; [Nomura, S.] Niigata Univ, Grad Sch Med & Dent Sci, Div Comprehens Prosthodont, Niigata 9518514, Japan; [Egusa, H.] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Sendai, Miyagi, Japan	Izumi, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Biomimet, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	izumik@dent.niigata-u.ac.jp			Grant for Promotion of Niigata University Research Projects [25H053]	We would like to thank Drs. Kayoko Nozawa-Inoue, Yoshiro Kawano and Michiko Terada-Nakaishi for their critical reading and valuable comments on this manuscript. We also thank Mr. Masaaki Hoshino for his technical assistance. This work was supported in part by a Grant for Promotion of Niigata University Research Projects (25H053 to K.M.).	Akal U K, 1997, J Marmara Univ Dent Fac, V2, P665; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Segal N, 2008, MATRIX BIOL, V27, P163, DOI 10.1016/j.matbio.2007.09.002; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Nishimura K, 2009, J SURG RES, V155, P125, DOI 10.1016/j.jss.2008.07.029; Takei T, 1997, J CELL PHYSIOL, V173, P64, DOI 10.1002/(SICI)1097-4652(199710)173:1<64::AID-JCP8>3.0.CO;2-H; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Mills AA, 1999, NATURE, V398, P708; Yano S, 2006, EXP DERMATOL, V15, P356, DOI 10.1111/j.0906-6705.2006.00425.x; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Nasca MR, 2007, SKIN PHARMACOL PHYS, V20, P305, DOI 10.1159/000108146; Reichelt J, 2007, EUR J CELL BIOL, V86, P807, DOI 10.1016/j.ejcb.2007.06.004; Piwko-Czuchra A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005488; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x; Levy L, 2000, MOL BIOL CELL, V11, P453; Arold SP, 2009, RESP RES, V10, DOI [10.1186/1465-9921-10-5, 10.1186/1465-9921-10-9]; Carlson MW, 2008, CURR PROTOC CELL BIO, V41; Chinnathambi S, 2005, J PERIODONTOL, V76, P1072, DOI 10.1902/jop.2005.76.7.1072; COOK RJ, 1991, J DENT, V19, P135, DOI 10.1016/0300-5712(91)90001-F; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; GORMAR FE, 1990, ARCH DERMATOL RES, V282, P22, DOI 10.1007/BF00505641; Hara T, 1996, J ORAL REHABIL, V23, P363, DOI 10.1111/j.1365-2842.1996.tb00865.x; JANI RM, 1976, J PROSTHET DENT, V36, P254, DOI 10.1016/0022-3913(76)90179-7; JENNINGS KJ, 1992, J DENT, V20, P250, DOI 10.1016/0300-5712(92)90098-W; KAPUR K, 1963, J PROSTHET DENT, V13, P1030, DOI 10.1016/0022-3913(63)90256-7; Nagarajan P, 2008, CRIT REV EUKAR GENE, V18, P57; NEDELMAN C, 1970, J PROSTHET DENT, V23, P265, DOI 10.1016/0022-3913(70)90181-2; OSTLUND STIG GLSON, 1958, ACTA ODONTOL SCAND, V16, P1, DOI 10.3109/00016355809028181; PENDLETON EC, 1951, J AM DENT ASSOC, V42, P1; Saito T, 2014, INT J ORAL MAX SURG, V43, P373, DOI 10.1016/j.ijom.2013.06.016; SHARMA AK, 1986, J PROSTHET DENT, V56, P574, DOI 10.1016/0022-3913(86)90424-5; Stromberg WR., 1955, J PROSTHET DENT, V5, P268, DOI 10.1016/0022-3913(55)90123-2; TURCK D, 1965, J PROSTHET DENT, V15, P419, DOI 10.1016/S0022-3913(65)80010-5; WATSON IB, 1982, J PROSTHET DENT, V47, P133, DOI 10.1016/0022-3913(82)90176-7; Xue ML, 2008, J INVEST DERMATOL, V128, P2676, DOI 10.1038/jid.2008.136; Zentner A, 2000, EUR J ORTHODONT, V22, P639, DOI 10.1093/ejo/22.6.639	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	MAR	2015	42	3					192	201		10.1111/joor.12254		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB1MD	WOS:000349390900004		
J	Wada, A; Nakamura, T; Urano, N; Kubota, H; Oketani, Y; Taketa, M; Fujii, T				Wada, Akifusa; Nakamura, Tomoyuki; Urano, Noriko; Kubota, Hideaki; Oketani, Yutaka; Taketa, Mayuki; Fujii, Toshio			Foot centralization for tibial hemimelia	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						Brown procedure; foot centralization; limb salvage treatment; tibial hemimelia; Weber patella arthroplasty	CONGENITAL LONGITUDINAL DEFICIENCY; LIMB SALVAGE TREATMENT; FIBULAR TRANSFER; TOTAL ABSENCE; CLASSIFICATION; MANAGEMENT	Nineteen foot centralizations were performed in 14 patients with Jones type I and II tibial hemimelia. All feet showed equinovarus deformity and were treated by foot centralization by means of calcaneofibular arthrodesis. The average age of patients at the time of surgery was 1.3 years (range 0.4-3.8 years). The average follow-up postoperative period was 10.2 years (range 2.2-22.9). At the time of the final follow-up, four of the operated feet were plantigrade without secondary surgery. The remaining 15 limbs, however, required secondary surgery to treat postoperative early loss of correction and/or recurrent foot deformities such as equinus, varus and adduction, in addition to talipes calcaneal deformities, and fibular angular deformity at the fibular shortening osteotomy site. The deformities were treated either by repeat foot centralization, or fibular or calcaneal osteotomy. Careful observation for recurrence of the deformity is necessary until the distal fibular epiphysis closes, and the cartilagenous distal fibular end and calcaneus finally achieve ankyloses. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Wada, Akifusa; Kubota, Hideaki; Oketani, Yutaka; Taketa, Mayuki; Fujii, Toshio] Saga Handicapped Childrens Hosp, Kinryu, Saga 8490906, Japan; [Nakamura, Tomoyuki] Fukuoka Childrens Hosp, Fukuoka, Japan; [Urano, Noriko] Urano Orthopaed Clin, Fukuoka, Japan	Wada, A (reprint author), Saga Handicapped Childrens Hosp, Dept Orthopaed Surg, 2215-27 Kinryu, Kinryu, Saga 8490906, Japan.	ssgwada@vip.saganet.ne.jp					SCHOENECKER PL, 1989, J BONE JOINT SURG AM, V71A, P278; KALAMCHI A, 1985, J BONE JOINT SURG BR, V67, P581; JAYAKUMAR SS, 1979, CLIN ORTHOP RELAT R, P97; EPPS CH, 1991, J BONE JOINT SURG AM, V73A, P858; Wada A, 2006, J PEDIATR ORTHOPED, V26, P226; JONES D, 1978, J BONE JOINT SURG BR, V60, P31; Hosny GA, 2005, J PEDIATR ORTHOP B, V14, P250; Birch JG, 2011, J BONE JOINT SURG AM, V93A, P1144, DOI [10.2106/JBJS.J.00683, 10.2106/JBJSJ.00683]; BLAUTH W, 1991, PROSTHET ORTHOT INT, V15, P127; BROWN FW, 1965, J BONE JOINT SURG AM, VA 47, P695; Changulani M, 2010, J Child Orthop, V4, P519, DOI 10.1007/s11832-010-0291-5; CHRISTINI D, 1993, J PEDIATR ORTHOPED, V13, P378; Courvoisier A, 2009, ORTHOP TRAUMATOL-SUR, V95, P431, DOI 10.1016/j.otsr.2009.04.017; DESANCTIS N, 1990, J PEDIATR ORTHOPED, V10, P198; Fernandez-Palazzi F, 1998, J PEDIATR ORTHOP B, V7, P298; Javid M, 2000, J PEDIATR ORTHOPED, V20, P160, DOI 10.1097/00004694-200003000-00005; Kara CS, 2001, J PEDIATR ORTHOP B, V10, P161, DOI 10.1097/00009957-200104000-00015; Loder RT, 1998, CHILD WITH A LIMB DEFICIENCY, P223; Meyers TH, 1910, AM J ORTHOP SURG, V3, P72; Wada A, 2013, J PEDIATR ORTHOP B, V22, P457, DOI 10.1097/BPB.0b013e3283620640; Weber M, 2002, J PEDIATR ORTHOP B, V11, P53, DOI 10.1097/00009957-200201000-00009	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	MAR	2015	24	2					147	153		10.1097/BPB.0000000000000149		7	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CA6ED	WOS:000349000900013		
J	Tonogai, I; Takahashi, M; Yukata, K; Sato, R; Nikawa, T; Yasui, N; Sairyo, K				Tonogai, Ichiro; Takahashi, Mitsuhiko; Yukata, Kiminori; Sato, Ryosuke; Nikawa, Takeshi; Yasui, Natsuo; Sairyo, Koichi			Osteoactivin attenuates skeletal muscle fibrosis after distraction osteogenesis by promoting extracellular matrix degradation/remodeling	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						distraction osteogenesis; fibrosis; matrix metalloprotease; osteoactivin; skeletal muscle	TIBIALIS ANTERIOR MUSCLES; CONNECTIVE-TISSUE; EXPRESSION; COMPLICATIONS; FIBROBLASTS; STIFFNESS; RABBIT; CELLS; MMP-3; MICE	The aim of this study was to determine whether osteoactivin attenuated skeletal muscle fibrosis caused by distraction osteogenesis. Tibial osteotomies were performed on wildtype and osteoactivin-transgenic (OA-Tg) mice, and tibiae were distracted for 2 weeks. Ankle plantar flexion torque and the gastrocnemius muscles were analyzed. The amount and area of collagenous tissue and the passive torque were reduced in the OA-Tg group at 8 weeks after osteotomy. Transcript levels of matrix metalloprotease (mmp)-3 and MMP-9 were upregulated, and MMP-3 and MMP-9 proteins were increased in the OA-Tg group. Osteoactivin-mediated increase in MMPs may attenuate skeletal muscle fibrosis. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Tonogai, Ichiro; Takahashi, Mitsuhiko; Yukata, Kiminori; Sato, Ryosuke; Yasui, Natsuo; Sairyo, Koichi] Univ Tokushima, Grad Sch, Dept Orthoped, Inst Hlth Biosci, Tokushima 7708503, Japan; [Nikawa, Takeshi] Univ Tokushima, Grad Sch, Dept Nutr Physiol, Inst Hlth Biosci, Tokushima 7708503, Japan	Sairyo, K (reprint author), Univ Tokushima, Grad Sch, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	sairyokun@hotmail.com			Medicine and Dental Encouragement Grant of General Incorporated Foundation Kojinkai of the University of Tokushima Graduate School; Ministry of Education, Culture, Sports, Science and technology of Japan [22591658]	This study was partially funded by the Medicine and Dental Encouragement Grant of General Incorporated Foundation Kojinkai of the University of Tokushima Graduate School, and supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and technology of Japan (22591658).	Williams P, 1999, ANAT REC, V255, P78; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Dahiya S, 2011, HUM MOL GENET, V20, P4345, DOI 10.1093/hmg/ddr362; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1153/ajpcell.00565.2004; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; GUERIN CW, 1995, DEV DYNAM, V202, P91; Nakamura A, 2007, EXP TOXICOL PATHOL, V59, P53, DOI 10.1016/j.etp.2007.03.005; ILIZAROV GA, 1990, CLIN ORTHOP RELAT R, P8; Antoci V, 2006, J PEDIATR ORTHOPED, V26, P634; Calandriello B., 1975, ITAL J ORTHOP TRAUMA, V1, P231; De Deyne PG, 2000, CLIN ORTHOP RELAT R, P259; Fitch RD, 1996, IOWA ORTHOP J, V16, P10; Furochi Harumi, 2007, J Med Invest, V54, P248, DOI 10.2152/jmi.54.248; LEE DY, 1993, ACTA ORTHOP SCAND, V64, P688, DOI 10.3109/17453679308994599; Mu X, 2010, OPER TECH ORTHOP, V20, P110; Nishisho T, 2012, J ORTHOP RES, V30, P1767, DOI 10.1002/jor.22136; PALEY D, 1990, CLIN ORTHOP RELAT R, P81; SIMPSON AHRW, 1995, J BONE JOINT SURG BR, V77B, P630; Williams P, 2001, CELLS TISSUES ORGANS, V169, P395, DOI 10.1159/000047907; Williams P, 1998, J ANAT, V193, P131, DOI 10.1046/j.1469-7580.1998.19310131.x	26	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	MAR	2015	24	2					162	169		10.1097/BPB.0000000000000117		8	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CA6ED	WOS:000349000900016		
J	Momose, W; Katz, JM; Drennen, JK; Anderson, CA				Momose, Wataru; Katz, Jeffrey M.; Drennen, James K., III; Anderson, Carl A.			Development of NIR Methods for Blend Analysis Using Small Quantities of Materials	JOURNAL OF PHARMACEUTICAL INNOVATION			English	Article						Process analytical technology; Near-infrared spectroscopy; Principle component analysis; 2D correlation spectroscopy; Blending	INFRARED CORRELATION SPECTROSCOPY; FOURIER-TRANSFORM-RAMAN; POWDER BLENDS; EXCIPIENTS	An approach for the efficient development of near-infrared (NIR) methods for blend analysis using simulated real blending conditions is described. Spectra used to calculate a model were collected from small volume pharmaceutical blends in a die subject to well-controlled forces. Blend end-point detection by NIR spectroscopy is widely used. Strategic deployment of analytical technology is critical to companies seeking to utilize quality by design (QbD) and process analytical technology (PAT) concepts. However, pilot and commercial scale experiments using near-infrared spectroscopy (NIRS) are often limited due to resources. Specifically, limitations to the quantity of active pharmaceutical ingredients (APIs) available during development stage can dissuade early PAT method development. Such experiments are often necessary due to substantial differences between NIR data collected from small-scale (laboratory) blend systems and larger scale equipment. In the present work, data collected from small samples of pharmaceutical powders placed in an Instron testing station under carefully controlled forces matched conditions of the same powders in a blender. Use of this strategy for development of NIR-based blend end-point methods requires minimal quantities of pharmaceutical powders. Principal component analysis (PCA), two-dimensional (2D) correlation spectroscopy analysis, and Hotelling's T-2 ellipse results demonstrated that NIR spectra obtained in the small die matched NIR spectra in a blender when forces to the die were carefully applied. This strategy has the potential to significantly reduce the cost of development of NIR methods for blending.	[Momose, Wataru; Katz, Jeffrey M.; Drennen, James K., III; Anderson, Carl A.] Duquesne Univ, Duquesne Ctr Pharmaceut Technol, Pittsburgh, PA 15282 USA; [Momose, Wataru] Astellas Pharma Inc, Pharmaceut Res & Technol Labs, Yaizu, Shizuoka 4250072, Japan; [Katz, Jeffrey M.; Drennen, James K., III; Anderson, Carl A.] Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15282 USA	Anderson, CA (reprint author), Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15282 USA.	andersonca@duq.edu			Astellas Pharma Inc.	Authors would like to thank Astellas Pharma Inc. for their financial supports for this project and JDSU for the use of the compact NIR spectrometer. Authors also would like to thank Dr. I. S. Buckner for his input on the use of the Instron testing station.	Shi ZQ, 2008, J PHARMACEUT BIOMED, V47, P738, DOI 10.1016/j.jpba.2008.03.013; Sekulic SS, 1996, ANAL CHEM, V68, P509, DOI 10.1021/ac950964m; Kramer K, 2000, ANAL CHIM ACTA, V420, P155, DOI 10.1016/S0003-2670(00)00877-1; Noda I, 2006, J MOL STRUCT, V799, P2, DOI 10.1016/j.molstruc.2006.03.053; NODA I, 1995, J PHYS CHEM-US, V99, P3068, DOI 10.1021/j100010a016; Sasic S, 2000, J PHYS CHEM A, V104, P6388, DOI 10.1021/jp0005118; Segtnan VH, 2001, ANAL CHEM, V73, P3153, DOI 10.1021/ac010102n; Momose W, 2011, POWDER TECHNOL, V210, P122, DOI 10.1016/j.powtec.2011.03.005; Li WY, 2005, INT J PHARMACEUT, V295, P213, DOI 10.1016/j.ijpharm.2005.02.019; Wu HQ, 2009, INT J PHARMACEUT, V372, P39, DOI 10.1016/j.ijpharm.2009.01.002; Kano M, 2003, AICHE J, V49, P969, DOI 10.1002/aic.690490414; Berntsson O, 2002, POWDER TECHNOL, V123, P185, DOI 10.1016/S0032-5910(01)00456-9; Blanco M, 2010, TRAC-TREND ANAL CHEM, V29, P1127, DOI 10.1016/j.trac.2010.07.007; Burns DA, 2001, HDB NEAR INFRARED AN, P814; FDA, 2004, PAT A FRAM WORK INN; FDA, 1995, FDA GUID IND IMM REL; FDA/ICH. Guidance for Industry, 2007, Q10 PHARM QUAL SYST; FDA/ICH. Guidance for Industry, 2006, Q8 PHARM DEV; FDA/ICH. Guidance for Industry, 2006, Q9 QUAL RISK MAN; Katz JM, 2013, J PHARM SCI-US, V102, P3687, DOI 10.1002/jps.23676; Matsushita A, 2000, VIB SPECTROSC, V24, P171, DOI 10.1016/S0924-2031(00)00062-X; Noda I., 2004, 2 DIMENSIONAL CORREL; NODA I, 1993, APPL SPECTROSC, V47, P1329, DOI 10.1366/0003702934067694; Ren Y, 2000, VIB SPECTROSC, V23, P207, DOI 10.1016/S0924-2031(00)00063-1; Shinzawa H, 2013, VIB SPECTROSC, V65, P28, DOI 10.1016/j.vibspec.2012.11.009; Sulub Y, 2009, J PHARMACEUT BIOMED, V49, P48, DOI 10.1016/j.jpba.2008.10.001; Wang CY, 2009, J CHEMOMETR, V23, P463, DOI 10.1002/cem.1237; Wargo DJ, 1996, J PHARMACEUT BIOMED, V14, P1415, DOI 10.1016/0731-7085(96)01739-6	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1872-5120	1939-8042		J PHARM INNOV	J. Pharm. Innov.	MAR	2015	10	1					36	46		10.1007/s12247-014-9204-3		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CB3UV	WOS:000349555400004		
J	Chiang, WP; Yin, DJ; Shimizu, H				Chiang, Wen-Po; Yin, Dejun; Shimizu, Hiroshi			Slip-based regenerative ABS control for in-wheel-motor drive EV	JOURNAL OF THE CHINESE INSTITUTE OF ENGINEERS			English	Article						antilock braking system (ABS); in-wheel-motor drive electric vehicle (EV); logic threshold control; regenerative brake system	ELECTRIC VEHICLES; BRAKING STRATEGY	Research on regenerative brake systems on electric vehicles (EVs) has progressed considerably, but anti-slip functions have not been practical due to the difficulty in coordinating with conventional hydraulic brake systems. This paper takes advantage of the features of driving electric motors to derive an allowable torque according to the expected relation between the vehicle and wheel acceleration. Then, an innovative saturation control in a regenerative antilock braking system (ABS), which adopts logic threshold control, is presented. The control system realizes lock prevention on a wheel by constraining the motor reference torque directly with the derived allowable value. By theoretical analyses and simulation studies, including a comparison with conventional ABS control, the resulting control design is shown to be effective in anti-slip performance.	[Chiang, Wen-Po; Shimizu, Hiroshi] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa 2520882, Japan; [Yin, Dejun] Nanjing Univ Sci & Technol, Sch Mech Engn, Nanjing 210094, Jiangsu, Peoples R China	Chiang, WP (reprint author), Keio Univ, Grad Sch Media & Governance, 5322 Endo, Fujisawa, Kanagawa 2520882, Japan.	bradbogy@sfc.keio.ac.jp					Guo JG, 2009, IEEE INT VEH SYM, P864, DOI 10.1109/IVS.2009.5164393; Xu GQ, 2011, ENERGIES, V4, P1461, DOI 10.3390/en4091461; Mi CT, 2005, IEEE T VEH TECHNOL, V54, P486, DOI 10.1109/TVT.2004.841552; Fujimoto H., 2004, P 8 IEEE INT WORKSH, P35; Ioannou P., 1996, ROBUST ADAPTIVE CONT; Japan ABS Co. Ltd, 1993, ABS RES AUT ANT BRAK; Mutoh N, 2007, IEEE T IND ELECTRON, V54, P1168, DOI 10.1109/TIE.2007.892731; Pacejka H. B., 1992, VEHICLE SYSTEM DYNAM, V21, P1, DOI DOI 10.1080/00423119208969994; Sakai S., 2000, P 5 INT S ADV VEH CO, P712; Song C., 2011, J COMPUTERS, V6, P618, DOI [10.4304/jcp.6.3.618-626, DOI 10.4304/JCP.6.3.618-626]; Suzuki T., 2010, IEEJ T IND APPL, V130, P512, DOI [10.1541/ieejias.130.512.10.1541/ieejias.130.512, DOI 10.1541/IEEJIAS.130.512]; Wang F., 2000, JAPANESE J ERGONOMIC, V36, P191, DOI [10.5100/jje.36.191.10.5100/jje.36.191, DOI 10.5100/JJE.36.191]; Zhou L., 2007, P 8 INT WORKSH MULT, P1, DOI 10.1145/1341920.1341929; Zhuo G., 2011, P INT C EL CONTR ENG, P782	14	0	0	CHINESE INST ENGINEERS	TAIPEI	#1, 4TH FL, SEC 2, JEN-AI RD, TAIPEI 10019, TAIWAN	0253-3839	2158-7299		J CHIN INST ENG	J. Chin. Inst. Eng.	MAR	2015	38	2					220	231		10.1080/02533839.2014.955974		12	Engineering, Multidisciplinary	Engineering	CB3TC	WOS:000349550600009		
J	Tanno, T; Silberberg, A				Tanno, Takayuki; Silberberg, Alan			Inter-response-time reinforcement and relative reinforcer frequency control choice	LEARNING & BEHAVIOR			English	Article						Matching law; Inter-response-time reinforcement; Time allocation; Local response rate; Rat; Lever press	CONCURRENT VARIABLE-INTERVAL; INTERRESPONSE TIMES; SCHEDULES; BOUTS; ALLOCATION; BEHAVIOR; PRIMACY; RATIO; PERFORMANCE; ENVIRONMENT	In Conditions 1 and 3 of our Experiment 1, rats pressed levers for food in a two-component multiple schedule. The first component was concurrent variable-ratio (VR) 20 variable-interval (VI) 90 s, and the second was concurrent yoked VI (its reinforcement rate equaled that of the prior component's VR) VI 90 s. In Condition 2, the VR was changed to tandem VR 20, differential reinforcement of low rates (DRL) 0.8 s. Local response rates were higher in the VR than in the yoked VI schedule, and this difference disappeared between tandem VR DRL and yoked VI. The relative time allocations to VR and yoked VI, as well as to tandem VR DRL and yoked VI, were approximately the same across conditions. In Experiment 2, rats chose in a single session between five different VI pairs, each lasting for 12 reinforcer presentations (variable-environment procedure). The across-schedule hourly reinforcement rates were 120 and 40, respectively, in Conditions 1-3 and 4-6. During Conditions 2 and 5, one lever's VI was changed to tandem VI, DRL 2 s. High covariation between relative time allocations and relative reinforcer frequencies, as well as invariance in local response rates to the schedules, was evident in all conditions. In addition, the relative local response rates were biased toward the unchanged VI in Conditions 2 and 5. These results demonstrate two-process control of choice: Inter-response-time reinforcement controls the local response rate, and relative reinforcer frequency controls relative time allocations.	[Tanno, Takayuki] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan; [Silberberg, Alan] Amer Univ, Dept Psychol, Washington, DC 20016 USA	Tanno, T (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, 1-1-155 Uegahara, Nishinomiya, Hyogo 6628501, Japan.	tantantan01@gmail.com			JSPS KAKENHI [00237309]	This work was supported by JSPS KAKENHI #JSPS KAKENHI .	HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Tanno T, 2012, PSYCHON B REV, V19, P759, DOI 10.3758/s13423-012-0267-1; BAUM WM, 1969, J EXP ANAL BEHAV, V12, P861, DOI 10.1901/jeab.1969.12-861; Baum WM, 2004, J EXP ANAL BEHAV, V81, P85, DOI 10.1901/jeab.2004.81-85; Shull RL, 2003, J EXP ANAL BEHAV, V80, P159, DOI 10.1901/jeab.2003.80-159; FLESHLER M, 1962, J EXP ANAL BEHAV, V5, P529, DOI 10.1901/jeab.1962.5-529; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; ANGER D, 1956, J EXP PSYCHOL, V52, P145, DOI 10.1037/h0041255; PEELE DB, 1984, J EXP PSYCHOL ANIM B, V10, P149; Smith TT, 2014, J EXP ANAL BEHAV, V102, P102, DOI 10.1002/jeab.90; Tanno T, 2008, J EXP ANAL BEHAV, V89, P5, DOI 10.1901/jeab.2008.89-5; Shull RL, 2004, J EXP ANAL BEHAV, V81, P65, DOI 10.1901/jeab.2004.81-65; Shull RL, 2001, J EXP ANAL BEHAV, V75, P247, DOI 10.1901/jeab.2001.75-247; BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; STUBBS DA, 1969, J EXP ANAL BEHAV, V12, P887, DOI 10.1901/jeab.1969.12-887; Baum WM, 2010, J EXP ANAL BEHAV, V94, P161, DOI 10.1901/jeab.2010.94-161; BAUMAN RA, 1975, J EXP ANAL BEHAV, V24, P53, DOI 10.1901/jeab.1975.24-53; BROWNSTE.AJ, 1968, J EXP ANAL BEHAV, V11, P683, DOI 10.1901/jeab.1968.11-683; Davison M, 2000, J EXP ANAL BEHAV, V74, P1, DOI 10.1901/jeab.2000.74-1; de Villiers P. A., 1977, HDB OPERANT BEHAVIOR, P233; HERRSTEIN RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HERRNSTEIN RJ, 1979, J EXP ANAL BEHAV, V31, P209, DOI 10.1901/jeab.1979.31-209; Morse W. H., 1966, OPERANT BEHAV AREAS, P52; MYERS DL, 1977, J EXP ANAL BEHAV, V27, P203, DOI 10.1901/jeab.1977.27-203; Nevin J. A., 1982, QUANTITATIVE ANAL BE, V2, P53; SHIMP CP, 1984, J EXP ANAL BEHAV, V42, P407, DOI 10.1901/jeab.1984.42-407; SHIMP CP, 1974, J EXP ANAL BEHAV, V21, P491, DOI 10.1901/jeab.1974.21-491; SHIMP CP, 1969, J EXP ANAL BEHAV, V12, P403, DOI 10.1901/jeab.1969.12-403; SHIMP CP, 1990, J EXP PSYCHOL ANIM B, V16, P288; SHIMP CP, 1976, J EXP ANAL BEHAV, V26, P113, DOI 10.1901/jeab.1976.26-113; Shull R. L., 2011, EUROPEAN J BEHAV ANA, V12, P49; Tanno T, 2010, LEARN BEHAV, V38, P382, DOI 10.3758/LB.38.4.382	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1543-4494	1543-4508		LEARN BEHAV	Learn Behav.	MAR	2015	43	1					54	71		10.3758/s13420-014-0161-y		18	Psychology, Biological; Behavioral Sciences; Psychology, Experimental; Zoology	Psychology; Behavioral Sciences; Zoology	CB0KT	WOS:000349315500006		
J	Kuniba, A; Okado, M; Sergeev, S				Kuniba, Atsuo; Okado, Masato; Sergeev, Sergey			Tetrahedron Equation and Quantum R Matrices for Modular Double of U-q (D-n+1((2))), U-q (A(2n)((2))) and U-q (C-n((1)))	LETTERS IN MATHEMATICAL PHYSICS			English	Article						Tetrahedron equation; q-oscillator algebra; Yang-Baxter equation; modular double	REPRESENTATIONS; MODELS	We introduce a homomorphism from the quantum affine algebras , to the n-fold tensor product of the q-oscillator algebra . Their action commutes with the solutions of the Yang-Baxter equation obtained by reducing the solutions of the tetrahedron equation associated with the modular and the Fock representations of . In the former case, the commutativity is enhanced to the modular double of these quantum affine algebras.	[Kuniba, Atsuo] Univ Tokyo, Inst Phys, Tokyo 1538902, Japan; [Okado, Masato] Osaka City Univ, Dept Math, Sumiyoshi Ku, Osaka 5588585, Japan; [Sergeev, Sergey] Univ Canberra, Fac Educ Sci Technol Engn & Math, Canberra, ACT 2106, Australia	Kuniba, A (reprint author), Univ Tokyo, Inst Phys, Tokyo 1538902, Japan.	atsuo@gokutan.c.u-tokyo.ac.jp; okado@sci.osaka-cu.ac.jp; Sergey.Sergeev@canberra.edu.au			Australian Research Council; JSPS [23340007, 24540203]	This work is supported by Australian Research Council and Grants-in-Aid for Scientific Research No. 23340007 and No. 24540203 from JSPS.	Kuniba A, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/46/465206; JIMBO M, 1985, LETT MATH PHYS, V10, P63, DOI 10.1007/BF00704588; Sergeev SM, 2008, LETT MATH PHYS, V83, P231, DOI 10.1007/s11005-008-0219-x; HAYASHI T, 1990, COMMUN MATH PHYS, V127, P129, DOI 10.1007/BF02096497; Baxter R.J., 2007, EXACTLY SOLVED MODEL; BAZHANOV VV, 1992, J STAT PHYS, V69, P453, DOI 10.1007/BF01050423; Bazhanov VV, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/07/P07004; BAZHANOV VV, 1991, COMMUN MATH PHYS, V138, P393, DOI 10.1007/BF02099497; Bazhanov VV, 2006, J PHYS A-MATH GEN, V39, P3295, DOI 10.1088/0305-4470/39/13/009; DATE E, 1991, COMMUN MATH PHYS, V137, P133, DOI 10.1007/BF02099119; Drinfeld V. G., 1987, P INT C MATH BERKELE, V1, P798; DRINFELD VG, 1987, P INT C MATH, V2, P798; Faddeev L, 2000, MATH PHYS S, V21, P149; Frenkel I.B., ARXIV11111033; Ip I., ARXIV12052940; KAC V. G., 1990, INFINITE DIMENSIONAL; Kapranov M. M., 1994, P S PURE MATH 2, V56, P177; Kashaev R.V., 2000, AM MATH SOC TRANSL S, V2, P79; Kuniba A., COMMUN MATH IN PRESS; Kuniba A, 2013, COMMUN MATH PHYS, V324, P695, DOI 10.1007/s00220-013-1808-9; Schmudgen K., 1994, MATH PHYS, V159, P217; Sergeev SM, 1997, MOD PHYS LETT A, V12, P1393, DOI 10.1142/S0217732397001424; Sergeev SM, 1996, J STAT PHYS, V82, P31, DOI 10.1007/BF02189224; TARASOV V, 1993, COMMUN MATH PHYS, V158, P459, DOI 10.1007/BF02096799; Zamolodchikov A B, 1980, SOV PHYS JETP, V79, P641	25	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0377-9017	1573-0530		LETT MATH PHYS	Lett. Math. Phys.	MAR	2015	105	3					447	461		10.1007/s11005-015-0747-0		15	Physics, Mathematical	Physics	CB0ZL	WOS:000349356100005		
J	Payne, NL; van der Meulen, DE; Suthers, IM; Gray, CA; Taylor, MD				Payne, Nicholas L.; van der Meulen, Dylan E.; Suthers, Iain M.; Gray, Charles A.; Taylor, Matthew D.			Foraging intensity of wild mulloway Argyrosomus japonicus decreases with increasing anthropogenic disturbance	MARINE BIOLOGY			English	Article							ANTIPREDATOR BEHAVIOR; MARINE RESERVES; NOISE IMPACTS; FISH; RISK; TELEMETRY; MOVEMENT; SIZE; ACCELEROMETERS; PERFORMANCE	The influence of anthropogenic disturbance on the behaviour of wild animals is increasingly recognised for terrestrial systems. Data on free-ranging aquatic animals are comparatively scarce, and this represents a problem for estimating the consequences of human disturbance for organism fitness and therefore the functioning of aquatic systems. We used acoustic accelerometer and depth transmitters implanted in wild fish and archival stomach content data to test for relationships between the intensity of boating and the activity levels and foraging efficiency of an estuarine predatory fish, the mulloway Argyrosomus japonicus. Increasing boating activity (inferred from week-long trends in underwater noise and local maritime records) was associated with a reduction in activity levels and increased depth distributions of mulloway. Stomach content data from a nearby estuary revealed a far-lower feeding rate and altered diet composition on weekends (when boating activity is greatest) compared to weekdays for this species, and an inferred foraging success rate almost one-third that of weekdays. These data suggest the behaviour and foraging intensity of mulloway is significantly influenced by anthropogenic disturbance. The overall fitness costs of the reduction in foraging success will depend on how readily mulloway can reallocate foraging to less disturbed conditions, and the extent of stress-related responses to disturbance in this species. This study supports earlier predictions that anthropogenic disturbances like noise could have significant impacts on the behaviour and fitness of aquatic animals.	[Payne, Nicholas L.; van der Meulen, Dylan E.; Suthers, Iain M.; Gray, Charles A.] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2043, Australia; [Payne, Nicholas L.] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [van der Meulen, Dylan E.] Batemans Bay Fisheries Ctr, New South Wales Dept Primary Ind, Batemans Bay 2536, Australia; [Gray, Charles A.] WildFish Res, Grays Point 2232, Australia; [Taylor, Matthew D.] Port Stephens Fisheries Inst, New South Wales Dept Primary Ind, Nelson Bay 2315, Australia	Payne, NL (reprint author), Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2043, Australia.	n.payne@unsw.edu.au	Payne, Nicholas/E-7811-2013; Suthers, Iain/C-4559-2008	Suthers, Iain/0000-0002-9340-7461	Australian Research Council [LP100100367]; NSW Recreational Fishing Trust	Thanks Jerom Stocks, Grant Clark, Gwenael Cadiou and James McLeod for assistance with fieldwork, and James A. Smith, Stephanie Brodie, Hansjoerg Kunc and two anonymous reviewers for helpful suggestions on the manuscript. We thank B. Pease for supplying stomach content data from the 1977-1979 Botany Bay State Pollution Control Commission Study (database accessed in 2004). Financial support was provided by an Australian Research Council Linkage Grant (LP100100367) with the NSW Recreational Fishing Trust.	Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Francis CD, 2013, FRONT ECOL ENVIRON, V11, P305, DOI 10.1890/120183; Wale MA, 2013, ANIM BEHAV, V86, P111, DOI 10.1016/j.anbehav.2013.05.001; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; LAGARDERE JP, 1982, MAR BIOL, V71, P177, DOI 10.1007/BF00394627; Graham AL, 2008, AQUAT CONSERV, V18, P1315, DOI 10.1002/aqc.941; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Popper AN, 2003, FISHERIES, V28, P24, DOI 10.1577/1548-8446(2003)28[24:EOASOF]2.0.CO;2; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Kight CR, 2011, ECOL LETT, V14, P1052, DOI 10.1111/j.1461-0248.2011.01664.x; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Walsh CT, 2012, ECOL FRESHW FISH, V21, P145, DOI 10.1111/j.1600-0633.2011.00534.x; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Gannon R, 2014, J EXP BIOL, V217, P3033, DOI 10.1242/jeb.104455; Kokubun N, 2011, J EXP BIOL, V214, P3760, DOI 10.1242/jeb.058263; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Higginson AD, 2012, AM NAT, V180, P589, DOI 10.1086/667885; Bruintjes R, 2013, ANIM BEHAV, V85, P1343, DOI 10.1016/j.anbehav.2013.03.025; Bernier NJ, 2006, GEN COMP ENDOCR, V146, P45, DOI 10.1016/j.ygcen.2005.11.016; Cagua EF, 2013, CORAL REEFS, V32, P1123, DOI 10.1007/s00338-013-1069-2; Cooke SJ, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:TEAOOR]2.0.CO;2; Frid A., 2002, CONSERV ECOL, P6; Gillum ZD, 2012, J EXP MAR BIOL ECOL, V413, P21, DOI 10.1016/j.jembe.2011.11.020; Gjelland KO, 2013, METHODS ECOL EVOL, V4, P665, DOI 10.1111/2041-210X.12057; Kaiser H, 2011, AFR J AQUAT SCI, V36, P83, DOI 10.2989/16085914.2011.559712; Kunc HP, 2014, AM NAT, V184, pE93, DOI 10.1086/677545; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 1998, ADV STUDY BEHAV; Parsons MJ, 2009, ICES J MAR SCI, V66, P1007, DOI 10.1093/icesjms/fsp016; Parsons MJG, 2012, J ACOUST SOC AM, V132, P3559, DOI 10.1121/1.4756927; Payne NL, 2011, J ANIM ECOL, V80, P422, DOI 10.1111/j.1365-2656.2010.01758.x; Payne NL, 2011, OECOLOGIA, V165, P341, DOI 10.1007/s00442-010-1729-7; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pease B, 1981, BOOK BBS 23B; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; Robson AA, 2012, J R SOC INTERFACE, V9, P1486, DOI 10.1098/rsif.2011.0713; Stocks JR, 2014, MAR TECHNOL SOC J, V48, P28; Taylor MD, 2006, ESTUARIES COASTS, V29, P785; Voegeli FA, 1996, UNDERWATER BIOTELEME; Watanabe YY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2376; Wildermuth RP, 2013, CONSERV LETT, V6, P86, DOI 10.1111/j.1755-263X.2012.00298.x	55	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	MAR	2015	162	3					539	546		10.1007/s00227-014-2603-7		8	Marine & Freshwater Biology	Marine & Freshwater Biology	CB1GI	WOS:000349374800004		
J	Fujishiro, F				Fujishiro, Fumito			Electrical conductivity of cubic perovskite Ba-2(Fe1-xInx)(2)O-5 with disordered oxygen vacancies	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Oxides; Electrical conductivity; Powder diffraction; Crystal structure	STRUCTURAL PHASE-TRANSITION; BA2IN2O5; BA2FE2O5+DELTA	The crystal structure and electrical conductivity of Ba-2(Fe1-xInx)(2)O-5 were studied. It was found that Ba-2(Fe1-xInx)(2)O-5 has the cubic perovskite structure with disordered oxygen vacancies at room temperature. The variation of the molar volume with the In3+ content obeyed Vegard's law, indicating that In3+ was successfully substituted into Fe3+ sites at random. Thermogravimetry-differential thermal analysis revealed that Ba-2(Fe1-xInx)(2)O-5 (x not equal 0, 1) does not undergo structural phase transitions between room temperature and 1200 degrees C under a N-2 flow. The electrical conductivity was measured by the four-probe method under a N-2 flow. Although the types of conductivity were not clearly determined, the conductivity for x = 0.1 exhibited the maximum value of more than 10(-1) S/cm above 600 degrees C (C) 2015 Elsevier B.V. All rights reserved.	Kochi Univ, Fac Sci, Dept Nat Sci, Kochi 7808520, Japan	Fujishiro, F (reprint author), Kochi Univ, Fac Sci, Dept Nat Sci, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	f.fujishiro@kochi-u.ac.jp					Berastegui P, 2002, J SOLID STATE CHEM, V164, P119, DOI 10.1006/jssc.2001.9455; Fujishiro F, 2012, THERMOCHIM ACTA, V549, P110, DOI 10.1016/j.tca.2012.09.019; Yao T, 2000, SOLID STATE IONICS, V132, P189, DOI 10.1016/S0167-2738(00)00658-5; GOODENOUGH JB, 1990, SOLID STATE IONICS, V44, P21, DOI 10.1016/0167-2738(90)90039-T; Fujishiro F, 2013, THERMOCHIM ACTA, V574, P151, DOI 10.1016/j.tca.2013.08.010; MORI S, 1966, J AM CERAM SOC, V49, P600, DOI 10.1111/j.1151-2916.1966.tb13176.x; PARRAS M, 1989, EUR J SOL STATE INOR, V26, P299; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Ta TQ, 2006, J ALLOY COMPD, V408, P253, DOI 10.1016/j.jallcom.2004.04.163; Yoshinaga M, 2004, SOLID STATE IONICS, V169, P9, DOI 10.1016/j.ssi.2003.10.019; ZOU XD, 1993, ACTA CRYSTALLOGR A, V49, P27, DOI 10.1107/S0108767392007979	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	MAR 1	2015	153						5	8		10.1016/j.matchemphys.2015.01.022		4	Materials Science, Multidisciplinary	Materials Science	CB3CL	WOS:000349505700002		
J	Yamaura, S; Nakajima, T; Satoh, T; Ebata, T; Furuya, Y				Yamaura, Shin-ichi; Nakajima, Takashi; Satoh, Takenobu; Ebata, Takashi; Furuya, Yasubumi			Magnetostriction of heavily deformed Fe-Co binary alloys prepared by forging and cold rolling	MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS			English	Article						Iron-cobalt alloy; Magnetostriction; Magnetization; Cold rolling; Forging	THIN-FILMS; GIANT MAGNETOSTRICTION; MAGNETIC-PROPERTIES; FECO-2V ALLOY; GA ALLOYS; MEMS; ANISOTROPY; TEXTURE; SYSTEM	Magnetostriction of Fe1-xCox (x=50-90 at%) alloys prepared by forging and subsequent cold-rolling was studied as functions of alloy compositions and thermomechanical treatments. Magnetostriction of the as-forged Fe25Co75 alloy was 108 ppm and that of the as-cold rolled Fe25Co75 alloy measured parallel to the rolling direction (RD) was 128 ppm. The cold-rolled Fe25Co75 alloy possessed a nearly {1 0 0}<0 1 1> texture, leading to the maximum magnetostriction of 140 ppm when measured at an angle of 45 degrees to RD. Moreover, the fully annealed Fe25Co75 and Fe20Co80 alloys were gradually cold rolled and magnetostriction were measured. Results showed that the magnetostriction of those cold-rolled alloys drastically increased with increasing reduction rate. According to the XRD and TEM observations, intensity of the fcc peak gradually decreased with increasing reduction rate and that the alloys became to be in a bcc single state at a reduction rate higher than 90%, leading to a drastic increase in magnetostriction. (C) 2014 Elsevier B.V. All rights reserved.	[Yamaura, Shin-ichi; Nakajima, Takashi] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Satoh, Takenobu; Ebata, Takashi] Tohoku Steel Co Ltd, Shibata 9891393, Japan; [Furuya, Yasubumi] Hirosaki Univ, North Japan Res Inst Sustainable Energy, Aomori 0300813, Japan	Yamaura, S (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	yamaura@imr.tohoku.ac.jp			Revitalization Promotion Project of the Japan Science and Technology Agency (JST) [H24SEN II-35]; six-university collaboration project on Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials - Ministry of Education, Culture, Sports, Science and Technology of japan (MEXT)	This study was partially supported by the Revitalization Promotion Project (2012-2014, H24SEN II-35) of the Japan Science and Technology Agency (JST) and by the six-university collaboration project on Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials supported by the Ministry of Education, Culture, Sports, Science and Technology of japan (MEXT). The authors would like to express their deepest appreciation to Dr. R.Y. Umetsu and Mr. K. Abe for their technical help in preparing alloy samples and in measurement of magnetostriction.	HATHAWAY KB, 1993, MRS BULL, V18, P34; KOON NC, 1991, J MAGN MAGN MATER, V100, P173, DOI 10.1016/0304-8853(91)90819-V; Pauling L, 1938, PHYS REV, V54, P899, DOI 10.1103/PhysRev.54.899; Summers EM, 2007, J MATER SCI, V42, P9582, DOI 10.1007/s10853-007-2096-6; Wang L, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/4/045009; Bell DJ, 2005, J MICROMECH MICROENG, V15, pS153, DOI 10.1088/0960-1317/15/7/022; HALL RC, 1960, J APPL PHYS, V31, pS157, DOI 10.1063/1.1984643; Slater JC, 1936, PHYS REV, V49, P0537, DOI 10.1103/PhysRev.49.537; Ludwig A, 2000, J APPL PHYS, V87, P4691, DOI 10.1063/1.373132; Sundar RS, 2005, INT MATER REV, V50, P157, DOI 10.1179/175328005X14339; Clark AE, 2003, J APPL PHYS, V93, P8621, DOI 10.1063/1.1540130; Sourmail T, 2005, PROG MATER SCI, V50, P816, DOI 10.1016/j.pmatsci.2005.04.001; Piramanayagam SN, 2006, J MAGN MAGN MATER, V303, pE152, DOI 10.1016/j.jmmm.2006.01.215; Boisse J, 2011, ACTA MATER, V59, P2656, DOI 10.1016/j.actamat.2011.01.002; Olabi AG, 2008, MATER DESIGN, V29, P469, DOI 10.1016/j.matdes.2006.12.016; Yang S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.197201; Babu VH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2751124; Cao H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.127201; Clark A. E., 1995, GIANT MAGNETOSTRICTI; Clark AE, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831360; Cooke MD, 2000, J PHYS D APPL PHYS, V33, P1450, DOI 10.1088/0022-3727/33/12/304; Dai L., 2007, UNPUB; Deng JN, 2009, J MATER SCI TECHNOL, V25, P219; Deng JN, 2005, MATER SCI FORUM, V495-497, P731; Gibbs MRJ, 2004, J PHYS D APPL PHYS, V37, pR237, DOI 10.1088/0022-3727/37/22/R01; Hansen M, 1958, CONSTITUTION BINARY; Hunter D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1529; KAWAHARA K, 1983, J MATER SCI, V18, P3437, DOI 10.1007/BF00544172; KAWAHARA K, 1983, J MATER SCI, V18, P1709, DOI 10.1007/BF00542066; Kubota T, 2002, J MAGN MAGN MATER, V239, P551, DOI 10.1016/S0304-8853(01)00662-X; Liu JH, 2012, SCI CHINA TECHNOL SC, V55, P1319, DOI 10.1007/s11431-012-4810-0; Masiyama Y., 1932, Science Reports of the Tohoku Imperial University, V21; Nakajima T, 2014, MATER TRANS, V55, P556, DOI 10.2320/matertrans.MBW201315; Niarchos D, 2003, SENSOR ACTUAT A-PHYS, V106, P255, DOI 10.1016/S0924-4247(03)00179-1; Nishiyama Z., 1936, Science Reports of the Tohoku Imperial University, V25; Ohnuma I, 2002, ACTA MATER, V50, P379, DOI 10.1016/S1359-6454(01)00337-8; Srisukhumbowornchai N, 2001, J APPL PHYS, V90, P5680, DOI 10.1063/1.1412840; SRIVASTAVA RS, 1977, J APPL PHYS, V48, P1355, DOI 10.1063/1.323730; Sugano M., 1972, SOC MAT SCI JPN, V21, P260; Szymczak H, 1999, J MAGN MAGN MATER, V200, P425, DOI 10.1016/S0304-8853(99)00374-1; Takahashi T, 2009, SCRIPTA MATER, V60, P847, DOI 10.1016/j.scriptamat.2009.01.020; Uchida H, 2002, J MAGN MAGN MATER, V239, P540, DOI 10.1016/S0304-8853(01)00659-X; Ustinovshikov Y, 2006, J ALLOY COMPD, V424, P145, DOI 10.1016/j.jallcom.2005.12.091; Yabe H, 2003, JPN J APPL PHYS 1, V42, P96, DOI 10.1143/JJAP.42.96	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-5107	1873-4944		MATER SCI ENG B-ADV	Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.	MAR	2015	193						121	129		10.1016/j.mseb.2014.12.009		9	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	CB4GQ	WOS:000349586600018		
J	Kato, Y; Ninomiya, M; Yamaguchi, Y; Koketsu, M				Kato, Yuki; Ninomiya, Masayuki; Yamaguchi, Yuji; Koketsu, Mamoru			Synthesis of triazole- and tetrazole-xyloside analogues as potent hyaluronidase inhibitors	MEDICINAL CHEMISTRY RESEARCH			English	Article						Hyaluronidase inhibitor; Triazole-xyloside; Tetrazole-xyloside; Desulfurizative cyclization	EXPRESSION	Hyaluronidase is one of the most important enzymes in the development of many diseases. In this study, a series of xyloside analogues bearing a triazole and tetrazole at the anomeric position were prepared from xylosylthioureas and evaluated their inhibitory effects on the hyaluronidase. Triazole and tetrazole skeletons were formed via the Hg(OAc)(2)-mediated desulfurizative cyclization through carbodiimide intermediates. According to in vitro anti-hyaluronidase assay, tetrazole-xylosides having p-chloro- or p-nitro-substitution exhibited the high inhibition rates, whereas the compound having p-trifluoromethyl group on the structure did not show the potency. Our results demonstrated the importance of tetrazole-xylosides as hyaluronidase inhibitors.	[Kato, Yuki; Ninomiya, Masayuki; Yamaguchi, Yuji; Koketsu, Mamoru] Gifu Univ, Dept Mat Sci & Technol, Fac Engn, Gifu 5011193, Japan; [Ninomiya, Masayuki; Koketsu, Mamoru] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan; [Yamaguchi, Yuji] MicroAlgae Corp, MAC Gifu Res Inst, Gifu 5008148, Japan	Koketsu, M (reprint author), Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan.	koketsu@gifu-u.ac.jp					Allen FH, 1987, J CHEM SOC P2, V2, pS; McKee CM, 1997, J BIOL CHEM, V272, P8013; Lokeshwar VB, 2008, SEMIN CANCER BIOL, V18, P281, DOI 10.1016/j.semcancer.2008.03.008; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Ghosh S, 2009, BIOORG MED CHEM LETT, V19, P386, DOI 10.1016/j.bmcl.2008.11.070; Herr RJ, 2002, BIOORGAN MED CHEM, V10, P3379, DOI 10.1016/S0968-0896(02)00239-0; Ferreira SB, 2010, J MED CHEM, V53, P2364, DOI 10.1021/jm901265h; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Zhou CH, 2012, CURR MED CHEM, V19, P239; Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832; Gao MZ, 2008, HETEROATOM CHEM, V19, P199, DOI 10.1002/hc.20388; EDELSTAM GAB, 1992, INFLAMMATION, V16, P459, DOI 10.1007/BF00918972; Gakunga P, 1997, DEVELOPMENT, V124, P3987; Jadhav NC, 2013, TETRAHEDRON LETT, V54, P101, DOI 10.1016/j.tetlet.2012.10.114; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; Natarajan A, 2005, J ORG CHEM, V70, P6362, DOI 10.1021/jo0508189; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125; PRASAD RS, 1986, CONTRACEPTION, V33, P89, DOI 10.1016/0010-7824(86)90036-3	19	1	1	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1054-2523	1554-8120		MED CHEM RES	Med. Chem. Res.	MAR	2015	24	3					1180	1188		10.1007/s00044-014-1203-x		9	Chemistry, Medicinal	Pharmacology & Pharmacy	CB1SA	WOS:000349407100025		
J	Rao, CVD; Santosh, M; Tang, YJ				Rao, C. V. Dharma; Santosh, M.; Tang, Yan-Jie			Re-Os isotope systematics of Archean chromitites from the Chimalpahad Anorthosite Complex, south-east India: Implications for mantle extraction processes	ORE GEOLOGY REVIEWS			English	Article						Re-Os geochemistry; Chromitites; Anorthosites; Heterogeneous mantle source; Tectonics	ZIRCON U-PB; SUBCONTINENTAL LITHOSPHERIC MANTLE; MESOPROTEROZOIC ARC MAGMATISM; RB-SR ISOTOPE; BUSHVELD COMPLEX; GHATS BELT; PERIDOTITE XENOLITHS; ABYSSAL PERIDOTITES; OPHIOLITIC MELANGE; LAYERED INTRUSION	The Chimalpahad Anorthosite Complex, which contains layers of chromitites, is located within the Archean Peninsular Gneissic Complex in the SE Indian shield. Here we present Re-Os isotope systematics of the chromitites and associated websterites and anorthosites in tracing the petrogenetic history and heterogeneity of the source mantle. The average initial Os-187/Os-188 compositions of chromitites are 0.1045 with negative gamma Os values of -17.67, whereas the websterites and anorthosites have average initial Os-187/Os-188 compositions of 14.86 and 11.79 with positive gamma Os values of +467 and + 215, respectively. Mantle extraction ages (T-MA) of the chromites indicate depletion of primitive mantle beginning as early as similar to 3.5 Ga. The subchondritic signature of Os in the chromitite is comparable with those of the chromites from ultramafic intrusions in the Zimbabwe Craton interpreted to reflect sequential extraction from evolving Archean subcontinental lithospheric mantle. The younger (T-MA) ages of 2.77-1.41 Ga of the websterites and anorthosites indicate Proterozoic melt depletion or complex isotopic systematics resulting from overprinting of tectonic events. The geochemical data and Re-Os isotope systematics presented in this study suggest that the Chimalpahad Complex formed from protracted evolution of ultramafic-mafic magmas in a deep-seated chamber of a magmatic arc along the SE margin of the Indian plate. (C) 2014 Elsevier B.V. All rights reserved.	[Rao, C. V. Dharma] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Dept Interdisciplinaiy Sci, Fac Sci, Akebono, Kochi 7808520, Japan; [Tang, Yan-Jie] Chinese Acad Sci, Inst Geol & Geophys, Beijing 100029, Peoples R China	Rao, CVD (reprint author), 208-D Nirman Bhavan, New Delhi 110001, India.		Tang, Yan-Jie/A-9391-2011; Santosh, M/B-2563-2012				Ahmed H.A., 2006, EARTH PLANET SC LETT, V245, P777; Rao CVD, 2009, J ASIAN EARTH SCI, V36, P261, DOI 10.1016/j.jseaes.2009.05.009; Chu ZY, 2009, J PETROL, V50, P1857; Meisel T, 2001, GEOCHIM COSMOCHIM AC, V65, P1311, DOI 10.1016/S0016-7037(00)00566-4; Mondal SK, 2007, J PETROL, V48, P495, DOI 10.1093/petrology/egl069; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Carlson RW, 2004, S AFR J GEOL, V107, P81, DOI 10.2113/107.1-2.81; Rollinson H, 2002, J PETROL, V43, P2143, DOI 10.1093/petrology/43.11.2143; Rao CVD, 2011, TECTONOPHYSICS, V510, P151, DOI 10.1016/j.tecto.2011.06.025; PEARSON DG, 1995, EARTH PLANET SC LETT, V134, P341, DOI 10.1016/0012-821X(95)00125-V; Walker RJ, 2008, GEOCHIM COSMOCHIM AC, V72, P2198, DOI 10.1016/j.gca.2008.01.021; PEARSON DG, 1995, GEOCHIM COSMOCHIM AC, V59, P959, DOI 10.1016/0016-7037(95)00014-3; Saha D, 2011, J ASIAN EARTH SCI, V42, P158, DOI 10.1016/j.jseaes.2011.04.024; LAMBERT DD, 1994, J PETROL, V35, P1717; McCandless TE, 1999, GEOCHIM COSMOCHIM AC, V63, P911, DOI 10.1016/S0016-7037(99)00092-7; Day JMD, 2008, J PETROL, V49, P1255, DOI 10.1093/petrology/egn024; SHIREY SB, 1995, ANAL CHEM, V67, P2136, DOI 10.1021/ac00109a036; Rao CVD, 2011, GONDWANA RES, V19, P384, DOI 10.1016/j.gr.2010.06.007; Schiano P, 1997, EARTH PLANET SC LETT, V150, P363, DOI 10.1016/S0012-821X(97)00098-8; Walker RJ, 2002, GEOCHIM COSMOCHIM AC, V66, P329, DOI 10.1016/S0016-7037(01)00767-0; Mohan MR, 2013, GONDWANA RES, V23, P539, DOI 10.1016/j.gr.2012.04.004; Malitch KN, 2004, CHEM GEOL, V208, P157, DOI 10.1016/j.chemgeo.2004.04.010; Bose S, 2011, GEOL SOC AM BULL, V123, P2031, DOI 10.1130/B30336.1; Mondal SK, 2006, PRECAMBRIAN RES, V148, P45, DOI 10.1016/j.precamres.2006.04.001; Harvey J, 2006, EARTH PLANET SC LETT, V244, P606, DOI 10.1016/j.epsl.2006.02.031; Meibom A, 2002, NATURE, V419, P705, DOI 10.1038/nature01067; Chesley JT, 1999, GEOCHIM COSMOCHIM AC, V63, P1203, DOI 10.1016/S0016-7037(99)00004-6; Walker RJ, 2005, EARTH PLANET SC LETT, V230, P211, DOI 10.1016/j.epsl.2004.11.009; Pearson DG, 2007, NATURE, V449, P202, DOI 10.1038/nature06122; CARLSON RW, 1994, EARTH PLANET SC LETT, V126, P457, DOI 10.1016/0012-821X(94)90124-4; SNOW JE, 1995, EARTH PLANET SC LETT, V133, P411, DOI 10.1016/0012-821X(95)00099-X; Dasgupta S, 2013, PRECAMBRIAN RES, V227, P247, DOI 10.1016/j.precamres.2012.04.005; [Anonymous], 2012, GEOSCI FRONT, DOI DOI 10.1016/j.gsf.2012.04.003; Rao CVD, 2012, J ASIAN EARTH SCI, V49, P362, DOI 10.1016/j.jseaes.2011.07.005; Appavadhanulu K., 1976, GEOL SURV INDIA MISC, V23, P267; Nicholas Arndt, 2013, [Geoscience Frontiers, 地学前缘], V4, P195; Ashwal L.D., 1993, ANORTHOSITES; Barnes S.-J., 1998, 17 GEN M INT MIN ASS; CAMERON EN, 1975, GEOCHIM COSMOCHIM AC, V39, P1021, DOI 10.1016/0016-7037(75)90044-7; Carlson R.W., 2005, REV GEOPHYS, V43; [储著银 CHU Zhuyin], 2007, [岩矿测试, Rock and Mineral Analysis], V26, P431; Dasgupta S, 2003, GEOL SOC SPEC PUBL, P131; Rao CVD, 2011, J ASIAN EARTH SCI, V40, P1027, DOI 10.1016/j.jseaes.2010.11.004; Rao CVD, 2013, J ASIAN EARTH SCI, V75, P183, DOI 10.1016/j.jseaes.2013.07.021; Dharma Rao C.V., 2010, J ASIAN EARTH SCI, V40, P1027; Dobmeier C. J., 2003, GEOL SOC LOND SPEC P, V206, P145, DOI 10.1144/GSL.SP.2003.206.01.09; Frei R, 2006, EARTH PLANET SC LETT, V241, P466, DOI 10.1016/j.epsl.2005.11.043; Gupta S., 2014, GEOSCI FRONT, V5, P17, DOI DOI 10.1016/j.gsf.2013.04.001; Hanghoj K, 2001, GEOCHEM GEOPHY GEOSY, V2; Hassler DR, 1998, SCIENCE, V280, P418, DOI 10.1126/science.280.5362.418; Henderson B., 2013, GONDWANA RES; KANUNGO DN, 1986, J GEOL SOC INDIA, V27, P428; KANUNGO DN, 1978, J GEOL SOC INDIA, V19, P87; Kovach V.P., 2001, GONDWANA RES, V4, P666, DOI DOI 10.1016/S1342-937X; Lee CT, 2001, NATURE, V411, P69, DOI 10.1038/35075048; Marques FO, 2013, TECTONOPHYSICS, V608, P517, DOI 10.1016/j.tecto.2013.08.035; Mishra D C, 2014, [Geoscience Frontiers, 地学前缘], V5, P25; Nagler TF, 1997, SCHWEIZ MINER PETROG, V77, P123; Parkinson IJ, 1998, SCIENCE, V281, P2011, DOI 10.1126/science.281.5385.2011; Pearson D. G., 2000, CHEM GEOL, V165, P57; Ramam P.K., 1997, GEOLOGY ANDHRA PRADE; Rao, 2013, CHEM GEOL, V353, P36; Rollinson H., 2007, EARLY EARTH SYSTEMS; Saal AE, 2001, J PETROL, V42, P25, DOI 10.1093/petrology/42.1.25; Sarvothaman H., 1994, REC GEOL SURV INDIA, V127, P62; Schoenberg R, 1999, EARTH PLANET SC LETT, V172, P49, DOI 10.1016/S0012-821X(99)00198-3; Schoenberg R, 2003, J GEOL, V111, P565, DOI 10.1086/376766; Shi RD, 2012, GONDWANA RES, V21, P194, DOI 10.1016/j.gr.2011.05.011; Tsuru T., 2000, J GEOPHY RES, V105; Walker RJ, 2001, CHEM GEOL, V175, P567, DOI 10.1016/S0009-2541(00)00358-2; WALKER RJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1583, DOI 10.1016/0016-7037(89)90240-8	71	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1368	1872-7360		ORE GEOL REV	Ore Geol. Rev.	MAR	2015	65		1				274	282		10.1016/j.oregeorev.2014.09.033		9	Geology; Mineralogy; Mining & Mineral Processing	Geology; Mineralogy; Mining & Mineral Processing	AZ2TE	WOS:000348084400016		
J	Li, H; Xi, XS				Li, Huan; Xi, Xiao-Shuang			Sedimentary fans: A new genetic model for sedimentary exhalative ore deposits	ORE GEOLOGY REVIEWS			English	Article						Sedimentary-exhalative ore deposit; Sedimentary fan; Metallogenic facies; Fluid geochemistry; Xitieshan; Zhaokalong	SOUTH CHINA CONSTRAINTS; CAMBRIAN BLACK SHALES; ZN-PB DEPOSITS; SB-AU DEPOSIT; FLUID INCLUSIONS; SW CHINA; HYDROTHERMAL SYSTEM; REE GEOCHEMISTRY; GEJIU DISTRICT; UNITED-STATES	Sedimentary-exhalative (SEDEX) deposits are one of the most important types of metal ore deposits. The genesis of such economic deposits has been problematic; thus a holistic model is urgently needed to explain their formation. Based on field surveys and geochemical analyses of the Xitieshan Pb-Zn, the Zhaokalong Fe-Cu polymetallic, and several other typical sedimentary-exhalative deposits in China, this study proposes a "sedimentary fan model" to explain such deposits. The results of this research suggest that the ore forming fluid of sedimentary-exhalative deposits can be considered as a kind of turbidity current. These fluids originated from the exhalative process itself, passing through syngenetic faults, flowing into the marine basin, and forming fan-shaped sedimentary ore deposits. The ore bodies of sedimentary fans consist of three parts: pipe, central, and marginal fades. The fans typically show zonations of mineralization, trace elements, fluid inclusions, isotopes, redox environments, etc. Pipe facies is deeply sourced and proximal to synsedimentary faults, generally constituted by unstratified, altered stockworks, exhalite (e.g., siliceous rocks) and ore bodies, and characterized by high temperatures and salinities. Central and marginal facies mainly occur as stratiform ore bodies, exhibiting typical characteristics of sedimentary origin. From the central facies to the marginal fades, increasing seawater components enter into the ore-forming process, resulting in a gradual change of metallogenic environment. This sedimentary fan model is used with satisfactory results to predict metallogenesis in the Xitieshan, the Zhaokalong and other sedimentary-exhalative deposits in China. (C) 2014 Elsevier B.V. All rights reserved.	[Li, Huan] Kyushu Univ, Dept Earth Resources Engn, Fac Engn, Fukuoka 8190395, Japan; [Xi, Xiao-Shuang] Cent S Univ, Sch Geosci & Infophys, Changsha 410083, Hunan, Peoples R China	Li, H (reprint author), Kyushu Univ, Dept Earth Resources Engn, Fac Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	li-huan@mine.kyushu-u.ac.jp			China Scholarship Council (CSC); Global COE Program in Novel Carbon Resource Sciences, Kyushu University	This work was supported by the China Scholarship Council (CSC) and the Global COE Program in Novel Carbon Resource Sciences, Kyushu University. Field work was supported by the Xitieshan Mine and the Zhaokalong Mine, Qinghai, China. We thank Dr. Jillian Aira S. Gabo and Dr. Thomas D. Tindell for their comments on the early draft. Two anonymous reviewers are appreciated for the detailed and valuable suggestions that helped us to improve the article. Special thanks are due to Dr. Franco Pirajno (Editor-in-Chief) for his help in polishing the final article.	Jiang SY, 1999, CHEM GEOL, V157, P49, DOI 10.1016/S0009-2541(98)00200-9; Cheng Y, 2013, ORE GEOL REV, V53, P50, DOI 10.1016/j.oregeorev.2012.12.008; Tornos F, 2008, CHEM GEOL, V247, P195, DOI 10.1016/j.chemgeo.2007.10.011; Muchez P, 2005, ORE GEOL REV, V27, P241, DOI 10.1016/j.oregeorev.2005.07.013; Zhang HT, 1999, ORE GEOL REV, V14, P129, DOI 10.1016/S0169-1368(98)00019-5; Hou ZQ, 2007, ORE GEOL REV, V31, P48, DOI 10.1016/j.oregeorev.2004.12.007; Xue CJ, 2007, ORE GEOL REV, V31, P337, DOI 10.1016/j.oregeorev.2005.04.007; Steiner M, 2001, PALAEOGEOGR PALAEOCL, V169, P165, DOI 10.1016/S0031-0182(01)00208-5; Wang CM, 2014, ORE GEOL REV, V56, P327, DOI 10.1016/j.oregeorev.2013.06.004; PLUMLEE GS, 1994, ECON GEOL BULL SOC, V89, P1361; Douville E, 1999, GEOCHIM COSMOCHIM AC, V63, P627, DOI 10.1016/S0016-7037(99)00024-1; Tornos F, 2006, ORE GEOL REV, V28, P259, DOI 10.1016/j.oregeorev.2004.12.005; Wilkinson JJ, 2010, ECON GEOL, V105, P417, DOI 10.2113/gsecongeo.105.2.417; Clark SHB, 2004, ORE GEOL REV, V24, P85, DOI 10.1016/j.oregeorev.2003.08.009; Kampunzu AB, 2009, ORE GEOL REV, V35, P263, DOI 10.1016/j.oregeorev.2009.02.003; Xu LG, 2013, ORE GEOL REV, V52, P66, DOI 10.1016/j.oregeorev.2012.06.003; Stow DAV, 2000, MAR PETROL GEOL, V17, P125, DOI 10.1016/S0264-8172(99)00064-1; Decree S, 2008, ORE GEOL REV, V34, P285, DOI 10.1016/j.oregeorev.2008.01.002; Cheng YB, 2012, ORE GEOL REV, V48, P180, DOI 10.1016/j.oregeorev.2012.03.004; He LQ, 2009, ORE GEOL REV, V36, P106, DOI 10.1016/j.oregeorev.2008.11.001; Canet C, 2014, ORE GEOL REV, V56, P292, DOI 10.1016/j.oregeorev.2013.06.009; Chen J.P., 2008, STUDY METALLOGENIC R; Cooke DR, 2000, ECON GEOL BULL SOC, V95, P1; Cooke DR, 2003, J GEOCHEM EXPLOR, V78-9, P519, DOI 10.1106/S0375-6742(03)00074-8; Ding ZJ, 2003, ACTA PETROL SIN, V19, P792; Emsbo P., 1999, GEOLOGY, V27, P59, DOI DOI 10.1130/0091-7613(1999)027<0059:SAOTCT>2.3.CO;2; Goodfellow W.D., 2007, SPECIAL PUBLICATION, V5, P163; Gu X, 2003, ORE GEOL REV, V22, P91, DOI 10.1016/S0169-1368(02)00110-5; Gu XX, 2007, ORE GEOL REV, V31, P319, DOI 10.1016/j.oregeorev.2005.01.003; Gu XX, 2012, J ASIAN EARTH SCI, V57, P54, DOI 10.1016/j.jseaes.2012.06.006; Heinrich D.H., 2005, ECON GEOL, V100, P1489; Hinman M., 1996, EC GEOLOGY RES UNIT, V55, P56; Kawasaki K, 2010, J GEOCHEM EXPLOR, V106, P137, DOI 10.1016/j.gexplo.2009.12.001; Kelley K.D., 1992, US GEOL SURV B, V2041, P60; KIMBERLEY M. M., 1989, ORE GEOL REV, V5, P13, DOI 10.1016/0169-1368(89)90003-6; Kyle J.R., 1996, SOC EC GEOLOGISTS SP, V4, P218; Large D.E., 1981, HDB STRATABOUND STRA, V9, P459; Large R.R., 2005, ECON GEOL, V100, P931; Large RR, 1998, ECON GEOL BULL SOC, V93, P1345; Li H, 2013, ACTA GEOL SIN-ENGL, V87, P486, DOI 10.1111/1755-6724.12063; [李欢 LI Huan], 2011, [地质与勘探, Geology and Prospecting], V47, P380; Li Huan, 2012, Chinese Journal of Nonferrous Metals, V22; Li WB, 2007, ACTA GEOL SIN-ENGL, V81, P442; Liu B., 2000, SOFTWARES EXAMPLES C, P1; Liu J.J., 1992, ACTA GEOL SICHUAN, V12, P112; Liu J.J., 1996, MINERAL RESOUR GEOL, V10, P145; Liu XJ, 2012, GONDWANA RES, V22, P597, DOI 10.1016/j.gr.2012.01.001; [刘耀辉 LIU Yaohui], 2006, [地质与勘探, Geology and Prospecting], V42, P47; Lott DA, 1999, ECON GEOL BULL SOC, V94, P1051; Lottermoser B.G., 1991, AUSTR EC GEOL, V86, P870; MacIntyre D., 1995, SELECTED BRIT COLUMB, V1, P37; MacIntyre D.G., 1991, ORE DEPOSITS TECTONI, P25; Meng Y.F., 1998, GEOLOGY PROSPECTING, V34, P16; Miao YX, 1992, GEOCHIMICA, V4, P375; Paradis S, 1998, ECON GEOL BULL SOC, V93, P184; PARR JM, 1992, CHEM GEOL, V100, P73, DOI 10.1016/0009-2541(92)90103-C; Philip A., 2005, BASIN ANAL PRINCIPLE; Prokin VA, 1998, ORE GEOL REV, V14, P1, DOI 10.1016/S0169-1368(98)00014-6; Radulescu M, 2010, CARPATH J EARTH ENV, V5, P67; Ruffell AH, 1998, ORE GEOL REV, V12, P207, DOI 10.1016/S0169-1368(97)00029-2; Russell MJ, 1996, ORE GEOL REV, V10, P199, DOI 10.1016/0169-1368(95)00023-2; RUSSELL MJ, 1981, MINER DEPOSITA, V16, P113; Sangster DF, 1998, EXPLORATION MINING G, V7, P341; Seal II R.R., 2004, SEDIMENT HOSTED LEAD, P191; Shi CH, 2014, ORE GEOL REV, V59, P73, DOI 10.1016/j.oregeorev.2013.12.007; Solomon M., 1992, EXPLOR MIN GEOL, V1, P85; Song X.X., 1997, ACTA GEOL SINICA, V71, P263; SPIRAKIS CS, 1995, ORE GEOL REV, V10, P1, DOI 10.1016/0169-1368(95)00008-P; Tang J.R., 2006, THESIS CENTRAL S U C, P24; Taylor S., 1985, CONTINENTAL CRUST IT; Vishwakarma RK, 1996, PRECAMBRIAN RES, V77, P117, DOI 10.1016/0301-9268(95)00049-6; Wang LJ, 2008, ACTA PETROL SIN, V24, P2433; Wang LJ, 2009, ACTA PETROL SIN, V25, P3007; [王真光 Wang Zhenguang], 2011, [矿床地质, Mineral Deposits], V30, P754; Xi XS, 2005, J CENT SOUTH UNIV T, V12, P340, DOI 10.1007/s11771-005-0157-z; 薛春纪, 1997, 矿床地质, V16, P21; [闫升好 Yan Shenghao], 2005, [矿床地质, Mineral Deposits], V24, P25; Yang KH, 2005, ECON GEOL, V100, P1085, DOI 10.2113/100.6.1085; Yang KH, 1996, NATURE, V383, P420, DOI 10.1038/383420a0; Ye Q.T., 1993, REGIONAL GEOCHEMICAL; Yu JJ, 2014, ORE GEOL REV, V57, P351, DOI 10.1016/j.oregeorev.2013.08.018; [张志斌 Zhang Zhibin], 2010, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V40, P791; Zheng M.H., 1993, J CHENGDU COLL GEOL, V20, P9; [祝新友 ZHU Xinyou], 2007, [地球化学, Geochimica], V36, P37	84	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1368	1872-7360		ORE GEOL REV	Ore Geol. Rev.	MAR	2015	65		1				375	389		10.1016/j.oregeorev.2014.10.001		15	Geology; Mineralogy; Mining & Mineral Processing	Geology; Mineralogy; Mining & Mineral Processing	AZ2TE	WOS:000348084400022		
J	Llado, X; Imiya, A; Mason, D; Reyes-Aldasorod, CC; Aoki, K; Kudo, M; Zhang, YJ; Argyriou, V				Llado, Xavier; Imiya, Atsushi; Mason, David; Reyes-Aldasorod, Constantino Carlos; Aoki, Kazuaki; Kudo, Mineichi; Zhang, Yu-Jin; Argyriou, Vasileios			Homage to Professor Maria Petrou (vol 48, pg 2, 2014)	PATTERN RECOGNITION LETTERS			English	Correction									[Llado, Xavier] Univ Girona, Girona, Spain; [Imiya, Atsushi] Chiba Univ, Chiba, Japan; [Mason, David] Univ Reading, Reading RG6 2AH, Berks, England; [Reyes-Aldasorod, Constantino Carlos] City Univ London, London, England; [Aoki, Kazuaki] Tokyo Univ Agr & Technol, Fuchu, Tokyo 183, Japan; [Kudo, Mineichi] Hokkaido Univ, Sapporo, Hokkaido 060, Japan; [Zhang, Yu-Jin] Tsinghua Univ, Beijing, Peoples R China; [Argyriou, Vasileios] Kingston Univ London, Kingston Upon Thames, Surrey, England	Reyes-Aldasorod, CC (reprint author), City Univ London, London, England.						Llado X, 2014, PATTERN RECOGN LETT, V48, P2, DOI 10.1016/j.patrec.2014.06.008	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8655	1872-7344		PATTERN RECOGN LETT	Pattern Recognit. Lett.	MAR 1	2015	54						I	I		10.1016/j.patrec.2015.01.006		1	Computer Science, Artificial Intelligence	Computer Science	CB3VI	WOS:000349556800016		
J	Hara, K; Inoue, K; Urahama, K				Hara, Kenji; Inoue, Kohei; Urahama, Kiichi			Gradient operators for feature extraction from omnidirectional panoramic images	PATTERN RECOGNITION LETTERS			English	Article						Omnidirectional panoramic image; Feature extraction; Laplacian operator; Corner detector		We propose an extension of the Laplacian operator and the class of differential corner detectors for omnidirectional panoramic images covering 360 degrees views. It solves two problems of nonuniformity of spatial resolution and spherical polar coordinates singularity. For the first problem, we derive a Laplacian operator and a class of differential corner detectors that can handle spatial inhomogeneities in omnidirectional panoramic images using differential schemes. To solve the second problem, we use an overset grid system on the sphere called the Yin-Yang grid. This is realized based on the property that each of the modified Laplacian operator and corner detector is invariant with respect to coordinate transformation between the two spherical polar coordinate systems associated with the Yin-Yang grid system. (C) 2015 Elsevier B.V. All rights reserved.	[Hara, Kenji; Inoue, Kohei; Urahama, Kiichi] Kyushu Univ, Dept Visual Commun Design, Minami Ku, Fukuoka 8158540, Japan	Hara, K (reprint author), Kyushu Univ, Dept Visual Commun Design, Minami Ku, 4-9-1 Shiobaru, Fukuoka 8158540, Japan.	hara@design.kyushu-u.ac.jp			JPSP [23500214]; Telecommunication Advancement Foundation	This research was supported by a Grant-in-Aid for Scientific Research (C) from JPSP (No. 23500214) and the Telecommunication Advancement Foundation.	[Anonymous], 1988, P 4 ALV VIS C, P147; Cruz-Mota J, 2012, INT J COMPUT VISION, V98, P217, DOI 10.1007/s11263-011-0505-4; Kageyama A, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000734; Sato I, 1999, IEEE T VIS COMPUT GR, V5, P1, DOI 10.1109/2945.764865; Arican Z., 2010, P IEEE INT C IM PROC, P3505; Funaki H., 2012, P 15 M IM REC UND, pIS2; Hansen P., 2008, P DICTA, P525; Hansen P., 2007, P INT C COMP VIS, P1; Hara Kenji, 2007, Proceedings 2007 IEEE International Conference on Image Processing, ICIP 2007; Kazhdan M, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1866158.1866175; Kitchen L, 1982, PATTERN RECOGN LETT, V1, P95, DOI 10.1016/0167-8655(82)90020-4; Li S., 2010, P INT C PATT REC, P2337; Li SG, 2013, IEEJ T ELECTR ELECTR, V8, pS61, DOI 10.1002/tee.21919; Lindeberg T., 1994, SCALE SPACE THEORY C; Moravec H. P., 1977, P 5 INT JOINT C ART, P584; Nakano M., 2007, Systems and Computers in Japan, V38, DOI 10.1002/scj.20631; Pauling L., 1935, INTRO QUANTUM MECH A; Research Pointgrey, 2008, OV LAD IM STITCH PRO; Schroder P., 1995, P SIGGRAPH 95, P161, DOI 10.1145/218380.218439; Smith S. M., 1997, INT J COMPUT VISION, V23, P295; Zuniga O. A., 1983, Proceedings of the IEEE Computer Society Conference on Computer Vision and Pattern Recognition	21	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8655	1872-7344		PATTERN RECOGN LETT	Pattern Recognit. Lett.	MAR 1	2015	54						89	96		10.1016/j.patrec.2014.12.010		8	Computer Science, Artificial Intelligence	Computer Science	CB3VI	WOS:000349556800013		
J	Hama, T; Nakanishi, K; Shima, Y; Sato, M; Mukaiyama, H; Togawa, H; Hamahira, K; Tanaka, R; Kaito, H; Nozu, K; Iijima, K; Yoshikawa, N				Hama, Taketsugu; Nakanishi, Koichi; Shima, Yuko; Sato, Masashi; Mukaiyama, Hironobu; Togawa, Hiroko; Hamahira, Kiyoshi; Tanaka, Ryojiro; Kaito, Hiroshi; Nozu, Kandai; Iijima, Kazumoto; Yoshikawa, Norishige			Renal biopsy criterion in idiopathic nephrotic syndrome with microscopic hematuria at onset	PEDIATRIC NEPHROLOGY			English	Article						Minimal change disease; Focal segmental glomerulosclerosis; IgA nephropathy; Membranoproliferative glomerulonephritis; Receiver operating characteristic analysis		The criterion for performing a renal biopsy in children with idiopathic nephrotic syndrome (NS) showing microscopic hematuria at onset remains controversial. To determine an adequate renal biopsy criterion in children with NS showing hematuria, the optimal cutoff for the maximum red blood cell (RBC) range in urine sediment to separate minimal change disease (MCD) from other glomerular changes was obtained by receiver operating characteristic analysis. We studied 29 children with NS showing hematuria who were screened from 1,320 patients who underwent renal biopsies between January 2001 and September 2011. Patients were divided into two groups according to the cutoff value to verify its validity. The optimal maximum RBC range was 30-49/high-power field (HPF). In group 1 (RBC a parts per thousand currency sign29/HPF, n = 14), 3 patients showed nephritis and the other 11 patients showed MCD. In group 2 (RBC a parts per thousand yen30/HPF, n = 15), 1 patient showed focal segmental glomerulosclerosis, 12 showed nephritis, and the other 2 showed MCD. These findings indicated that the ratio of non-MCD/MCD was significantly higher in group 2 than in group 1 (P < 0.01). The use of maximum RBC range (30-49/HPF) for a criterion of renal biopsy in patients with NS showing hematuria may be reasonable for clinical practice.	[Hama, Taketsugu; Nakanishi, Koichi; Shima, Yuko; Sato, Masashi; Mukaiyama, Hironobu; Togawa, Hiroko; Yoshikawa, Norishige] Wakayama Med Univ, Dept Pediat, Wakayama 6418509, Japan; [Hamahira, Kiyoshi] Himeji Red Cross Hosp, Dept Pediat, Himeji, Hyogo, Japan; [Tanaka, Ryojiro] Hyogo Prefectural Kobe Childrens Hosp, Dept Nephrol, Kobe, Hyogo, Japan; [Kaito, Hiroshi; Nozu, Kandai; Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 657, Japan	Nakanishi, K (reprint author), Wakayama Med Univ, Dept Pediat, 811-1 Kimiidera, Wakayama 6418509, Japan.	knakanis@wakayama-med.ac.jp			Novartis Pharma K.K.; Asahi Kasei Pharma Corporation; Pfizer Japan; Takeda Pharmaceutical Co., Ltd.	TH has received lecture fees from Novartis Pharma K.K.; KN has received lecture fees from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation; YS has received lecture fees from Novartis Pharma K.K.; KH has received lecture fees from Novartis Pharma K.K.; RT has received lecture fees from Pfizer Japan, Novartis Pharma K.K., and Asahi Kasei Pharma Corporation; HK has received lecture fees from Novartis Pharma K.K.; KN has received lecture fees from Novartis Pharma K.K.; KI has received grants from Takeda Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corporation, and Novartis Pharma K.K., and has also received lecture fees from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation; NY has received grants from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation, and has also received lecture fees from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation. No other disclosures were reported.	Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Diven SC, 2000, PEDIATR NEPHROL, V14, P65; International Study of Kidney Disease in Children, 1981, J PEDIAT, V98, P561; International Study of Kidney Disease in Children, 1982, J PEDIAT, V101, P514; International Study of Kidney Disease in Children, 1978, KIDNEY INT, V13, P159; WINKEL P, 1974, CLIN CHEM, V20, P436	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-041X	1432-198X		PEDIATR NEPHROL	Pediatr. Nephrol.	MAR	2015	30	3					445	450		10.1007/s00467-014-2946-9		6	Pediatrics; Urology & Nephrology	Pediatrics; Urology & Nephrology	CB2EX	WOS:000349440700010		
J	Ishikura, K; Yoshikawa, N; Nakazato, H; Sasaki, S; Nakanishi, K; Matsuyama, T; Ito, S; Hamasaki, Y; Yata, N; Ando, T; Iijima, K; Honda, M				Ishikura, Kenji; Yoshikawa, Norishige; Nakazato, Hitoshi; Sasaki, Satoshi; Nakanishi, Koichi; Matsuyama, Takeshi; Ito, Shuichi; Hamasaki, Yuko; Yata, Nahoko; Ando, Takashi; Iijima, Kazumoto; Honda, Masataka		Japanese Study Grp Renal Dis	Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial	PEDIATRIC NEPHROLOGY			English	Article						Children; Follow-up; Long-term; Nephrotic syndrome; Randomized; Controlled trial; Non-remission	STEROID-RESISTANT; CYCLOSPORINE; CHILDHOOD; THERAPY; ONSET; AGE	To investigate the long-term outcome in children with frequently relapsing nephrotic syndrome (FRNS) we conducted a follow-up of a previous randomized controlled trial (RCT) 10 years after the initiation of the treatment protocol. We previously conducted an RCT on the efficacy of cyclosporine for treating children with FRNS. After 2 years of treatment, a recommended a management protocol of steroids, and immunosuppressants was provided. Valid information was available for 46 of the 56 patients (82.1 %) enrolled in the original RCT. The median follow-up period was 10.3 years from the start of protocol treatment with cyclosporine. At last follow-up (mean age 18.7 years), only ten patients (21.7 %) showed disease-free remission (no relapse for at least 2 years). In contrast, 23 (50.0 %) continued to relapse frequently or were on immunosuppressants, eight patients (17.4 %) had infrequent relapses without immunosuppressants. Adverse effects attributable to treatment included short stature (6 patients), osteoporosis (six patients), obesity (4 patients), cataracts (3 patients) and hypertension (3 patients). No lethal event or renal dysfunction occurred during follow-up. This 10-year follow-up study shows that most children with FRNS experience relapses after 2 years of cyclosporine treatment, in adolescence and into adulthood. Outcomes in terms of life expectancy and renal function are favorable.	[Ishikura, Kenji; Hamasaki, Yuko; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Fuchu, Tokyo 1838561, Japan; [Yoshikawa, Norishige; Nakanishi, Koichi] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Nakazato, Hitoshi] Kumamoto Univ, Fac Life Sci, Dept Pediat, Kumamoto, Japan; [Sasaki, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Matsuyama, Takeshi] Fussa Hosp, Dept Pediat, Tokyo, Japan; [Ito, Shuichi] Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Tokyo, Japan; [Hamasaki, Yuko] Toho Univ, Dept Pediat Nephrol, Fac Med, Tokyo, Japan; [Yata, Nahoko] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat, Tokyo, Japan; [Ando, Takashi] Nonprofit Org, Japan Clin Res Support Unit, Tokyo, Japan; [Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 657, Japan	Ishikura, K (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	kenzo@ii.e-mansion.com			Kidney Foundation, Japan; Novartis Pharma K.K.; Asahi Kasei Pharma Corporation; Astellas Pharma; Terumo Medical Corporation; Chugai Pharmaceutical Co. Ltd.; Pfizer Japan; Takeda Pharmaceutical Co., Ltd.; Novartis Pharma	This study was supported by the Kidney Foundation, Japan.; Kenji Ishikura has received lecture fees from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation. Norishige Yoshikawa has received grants from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation and has also received lecture fees from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation. Koichi Nakanishi has received lecture fees from Novartis Pharma K.K., Asahi Kasei Pharma Corporation, and Astellas Pharma. Takeshi Matsuyama has received lecture fees from Asahi Kasei Pharma Corporation and Terumo Medical Corporation. Shuichi Ito received lecture fees from Asahi Kasei Pharma Corporation, Novartis Pharma K.K., and Chugai Pharmaceutical Co. Ltd. Yuko Hamasaki has received research grants from Novartis Pharma K.K., and lecture fees from Novartis Pharma K.K., Astellas Pharma, and Pfizer Japan. Kazumoto Iijima has received grants from Takeda Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corporation, and Novartis Pharma K.K., and lecture fees from Novartis Pharma K.K. and Asahi Kasei Pharma Corporation. Masataka Honda has received lecture fees from Novartis Pharma and Asahi Kasei Pharma Corporation. The other authors have no conflicts of interest to declare.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ishikura K, 2012, CLIN J AM SOC NEPHRO, V7, P1576, DOI 10.2215/CJN.00110112; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Fakhouri F, 2003, AM J KIDNEY DIS, V41, P550, DOI 10.1053/ajkd.2003.50116; TROMPETER RS, 1985, LANCET, V1, P368; Kamei K, 2009, PEDIATR NEPHROL, V24, P1321, DOI 10.1007/s00467-009-1191-0; Ruth EM, 2005, J PEDIATR-US, V147, P202, DOI 10.1016/j.jpeds.2005.03.050; Latta K, 2001, PEDIATR NEPHROL, V16, P271; Gipson DS, 2009, PEDIATRICS, V124, P747, DOI 10.1542/peds.2008-1559; [Anonymous], 1982, J PEDIAT, V101, P514; Kemper MJ, 2012, NEPHROL DIAL TRANSPL, V27, P1910, DOI 10.1093/ndt/gfr548; Cammas B, 2011, NEPHROL DIAL TRANSPL, V26, P178, DOI 10.1093/ndt/gfq405; Goto Miwa, 2006, Nihon Jinzo Gakkai Shi, V48, P365; Iijima K, 2014, CLIN J AM SOC NEPHRO, V9, P271, DOI 10.2215/CJN.13071212; Ishikura K, 2008, KIDNEY INT, V73, P1167, DOI 10.1038/ki.2008.24; Ishikura K, 2010, NEPHROL DIAL TRANSPL, V25, P3956, DOI 10.1093/ndt/gfq318; Kabuki N, 1998, PEDIATR NEPHROL, V12, P467; Kawasaki Y, 2005, NEPHROL DIAL TRANSPL, V20, P2243, DOI 10.1093/ndt/gfh996; Kyrieleis HAC, 2007, AM J KIDNEY DIS, V49, P592, DOI 10.1053/j.ajkd.2007.02.270; LEWIS MA, 1989, LANCET, V1, P255; Lombel RM, 2013, PEDIATR NEPHROL, V28, P415, DOI 10.1007/s00467-012-2310-x; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Nishiyama S, 1993, J JPN PEDIAT SOC, V103, P1131; Pravitsitthikul N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002290.pub4; van Husen M, 2011, PEDIATR NEPHROL, V26, P881, DOI 10.1007/s00467-010-1717-5; Zagury A, 2011, PEDIATR NEPHROL, V26, P915, DOI 10.1007/s00467-011-1825-x	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-041X	1432-198X		PEDIATR NEPHROL	Pediatr. Nephrol.	MAR	2015	30	3					459	468		10.1007/s00467-014-2955-8		10	Pediatrics; Urology & Nephrology	Pediatrics; Urology & Nephrology	CB2EX	WOS:000349440700012		
J	Noda, M; Hiyama, T				Noda, Masaharu; Hiyama, Takeshi Y.			Sodium sensing in the brain	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Salt homeostasis; Na+ sensing; Na-x channel; Sensory circumventricular organs; Subfornical organ	CENTRAL-NERVOUS-SYSTEM; SALT-INTAKE BEHAVIOR; IDIOPATHIC HYPOTHALAMIC DYSFUNCTION; SENSORY CIRCUMVENTRICULAR ORGANS; SUBFORNICAL ORGAN; NA-X; BLOOD-PRESSURE; ESSENTIAL HYPERNATREMIA; ADIPSIC HYPERNATREMIA; LEVEL SENSOR	Sodium (Na) homeostasis is crucial for life, and the Na+ level ([Na+]) of body fluids is strictly maintained at a range of 135-145 mM. However, the existence of a [Na+] sensor in the brain has long been controversial until Na-x was identified as the molecular entity of the sensor. This review provides an overview of the [Na+]-sensing mechanism in the brain for the regulation of salt intake by summarizing a series of our studies on Na-x. Na-x is a Na channel expressed in the circumventricular organs (CVOs) in the brain. Among the CVOs, the subfornical organ (SFO) is the principal site for the control of salt intake behavior, where Na-x populates the cellular processes of astrocytes and ependymal cells enveloping neurons. A local expression of endothelin-3 in the SFO modulates the [Na+] sensitivity for Na-x activation, and thereby Na-x is likely to be activated in the physiological [Na+] range. Na-x stably interacts with Na+/K+-ATPase whereby Na+ influx via Na-x is coupled with activation of Na+/K+-ATPase associated with the consumption of ATP. The consequent activation of anaerobic glucose metabolism of Na-x-positive glial cells upregulates the cellular release of lactate, and this lactate functions as a gliotransmitter to activate GABAergic neurons in the SFO. The GABAergic neurons presumably regulate hypothetic neurons involved in the control of salt intake behavior. Recently, a patient with essential hypernatremia caused by autoimmunity to Na-x was found. In this case, the hypernatremia was considered to be induced by the complement-mediated cell death in the CVOs, where Na-x specifically populates.	[Noda, Masaharu; Hiyama, Takeshi Y.] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Noda, Masaharu; Hiyama, Takeshi Y.] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan	Noda, M (reprint author), Natl Inst Basic Biol, Div Mol Neurobiol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp					Adams JM, 2009, HYPERTENSION, V54, P308, DOI 10.1161/HYPERTENSIONAHA.108.127803; ANDERSSON B, 1978, PHYSIOL REV, V58, P582; ANDERSSO.B, 1971, AM SCI, V59, P408; Tasker JG, 2012, J NEUROENDOCRINOL, V24, P566, DOI 10.1111/j.1365-2826.2011.02259.x; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; De Wardener HE, 2001, PHYSIOL REV, V81, P1599; GOTO A, 1982, AM J PHYSIOL, V243, pH614; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Noda M, 2013, TRENDS NEUROSCI, V36, P661, DOI 10.1016/j.tins.2013.08.004; [Anonymous], AM J PHYSL RENAL PHY, V303, pF105; Leenen FHH, 2010, BBA-MOL BASIS DIS, V1802, P1132, DOI 10.1016/j.bbadis.2010.03.004; FELIPE A, 1994, J BIOL CHEM, V269, P30125; Akopian AN, 1997, FEBS LETT, V400, P183, DOI 10.1016/S0014-5793(96)01389-0; JOHNSON AK, 1993, FASEB J, V7, P678; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Watanabe E, 2000, J NEUROSCI, V20, P7743; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; Smith PM, 2010, AM J PHYSIOL-REG I, V299, pR405, DOI [10.1152/ajpregu.00103.2010, 10.1152/ajpregu.00103.2010.]; Watanabe E, 2002, NEUROSCI LETT, V330, P109, DOI 10.1016/S0304-3940(02)00708-5; Blaustein MP, 2012, AM J PHYSIOL-HEART C, V302, pH1031, DOI 10.1152/ajpheart.00899.2011; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; Hiyama TY, 2013, CELL METAB, V17, P507, DOI 10.1016/j.cmet.2013.02.018; BERECEK KH, 1982, HYPERTENSION, V4, P131; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; THRASHER TN, 1982, ENDOCRINOLOGY, V110, P1837; Hiyama TY, 2010, NEURON, V66, P508, DOI 10.1016/j.neuron.2010.04.017; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Watanabe E, 2006, AM J PHYSIOL-REG I, V290, pR568, DOI 10.1152/ajpregu.00618.2005; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; ARIEFF AI, 1993, BRIT MED J, V307, P305; AVIOLI LV, 1962, ANN INTERN MED, V56, P131; Ayus JC, 1996, J PHYSIOL-LONDON, V492, P243; Bappal B, 2006, SAUDI MED J, V27, P727; Buggy J, 1977, Circ Res, V40, pI110; BUGGY J, 1978, CLIN EXP HYPERTENS, V1, P337, DOI 10.3109/10641967809068612; Cauble MS, 2001, J PEDIATR ENDOCR MET, V14, P1163; CONLEY SB, 1976, J PEDIATR-US, V89, P898, DOI 10.1016/S0022-3476(76)80593-8; COX PS, 1987, AM J PHYSIOL, V252, pR1; Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; DERUBERTIS FR, 1974, ARCH INTERN MED, V134, P889, DOI 10.1001/archinte.134.5.889; DURIVAGE SK, 1985, PEDIATRICS, V75, P896; FITZSIMONS JT, 1989, ACTA PHYSIOL SCAND, V136, P15; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; GEORGE AL, 1992, P NATL ACAD SCI USA, V89, P4893, DOI 10.1073/pnas.89.11.4893; Grob M, 2004, J NEUROSCI, V24, P3974, DOI 10.1523/JNEUROSCI.3720-03.2004; HAYEK A, 1982, PEDIATRICS, V70, P275; HAYWOOD JR, 1983, AM J PHYSIOL, V245, pH683; Hindmarch C, 2008, AM J PHYSIOL-REG I, V295, pR1914, DOI 10.1152/ajpregu.90560.2008; Johnson RF, 2003, AM J PHYSIOL-REG I, V285, pR394, DOI 10.1152/ajpregu.00130.2003; Kaplan NM, 2006, KAPLANS CLIN HYPERTE; Kinsman B, 2014, AM J PHYSIOL-REG I, V307, pR1092, DOI 10.1152/ajpregu.00102.2014; MANGIAPANE ML, 1984, BRAIN RES BULL, V13, P43, DOI 10.1016/0361-9230(84)90006-6; MCKINLEY MJ, 1978, BRAIN RES, V141, P89, DOI 10.1016/0006-8993(78)90619-4; Nehme B, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00026; Noda M, 2007, EXP PHYSIOL, V92, P513, DOI 10.1113/expphysiol.2006.035659; Noda M, 2014, NEUROSCIENTIST, DOI [10.1177/1073858414541009, DOI 10.1177/1073858414541009]; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; Orlov SN, 2007, AM J PHYSIOL-HEART C, V293, pH2039, DOI 10.1152/ajpheart.00325.2007; PARK R, 1989, BRAIN RES, V493, P123, DOI 10.1016/0006-8993(89)91006-8; Peruzzo M, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-78; SCHAAD U, 1979, HELV PAEDIATR ACTA, V34, P63; Stiefel D, 2007, NEUROCRIT CARE, V6, P67, DOI 10.1385/Neurocrit.Care2007;06:67-71; WELT LG, 1962, ANN INTERN MED, V56, P161	67	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	MAR	2015	467	3					465	474		10.1007/s00424-014-1662-4		10	Physiology	Physiology	CB1GX	WOS:000349376300004		
J	Ueda, S; Makino, K; Itoh, Y; Tsuchiya, T				Ueda, Sumie; Makino, Kumi; Itoh, Yoshiaki; Tsuchiya, Takashi			Logistic growth for the Nuzi cuneiform tablets: Analyzing family networks in ancient Mesopotamia	PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS			English	Article						Family tree; Social network; Published year; Least square method	MODEL	We reconstruct the published year of each cuneiform tablet of the Nuzi society in ancient Mesopotamia. The tablets are on land transaction, marriage, loan, slavery contracts, etc. The number of tablets seems to increase by logistic growth. It may show the dynamics of concentration of lands or other properties into few powerful families in a period of about sixty years and most of them are in about thirty years. We reconstruct family trees and social networks of Nuzi and estimate the published years of cuneiform tablets consistently with the trees and networks, formulating least squares problems with linear inequality constraints. (C) 2014 Elsevier B.V. All rights reserved.	[Ueda, Sumie; Itoh, Yoshiaki] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Makino, Kumi] Kamakura Womens Univ, Kamakura, Kanagawa 2478512, Japan; [Tsuchiya, Takashi] Natl Grad Inst Policy Studies, Minato Ku, Tokyo 1068677, Japan	Itoh, Y (reprint author), Inst Stat Math, 10-3 Midori Cho, Tachikawa, Tokyo 1908562, Japan.	ueda@ism.ac.jp; kumi@kamakura-u.ac.jp; itoh@ism.ac.jp; tsuchiya@grips.ac.jp			Ministry of Education Science and Culture of Japan [07207245, 09204245, 24310112]; ISM Cooperative Research [2011-ISMCRP-1022]; US National Science Foundation [DMS 0443803]	The authors are grateful for the helpful comments by the reviewers. Some comments are included in the text. The computer program is improved by the comment by # 3 reviewer. He pointed out an error in Fig. 1 of the previous version. Also he introduced Ref. [21] to us. The connection with the name ambiguity problem is pointed out by # 2 reviewer. This work is in part supported by Ministry of Education Science and Culture of Japan (Research Project 07207245, Research Project 09204245 and Research Project 24310112), and ISM Cooperative Research (2011-ISMCRP-1022). Y.I. is supported in part by US National Science Foundation Grant DMS 0443803 to Rockefeller University.	Itoh Y, 2004, PHYSICA D, V198, P333, DOI 10.1016/j.physd.2004.09.006; Fort J, 1999, PHYS REV LETT, V82, P867, DOI 10.1103/PhysRevLett.82.867; Cassin E., 1977, ANTHROPONYMIE ANTHR, V1; Chiera E., 1930, PUBLICATIONS BAGHDAD, VII; Evans T, 2009, METHODS SER, V7, P451, DOI 10.1007/978-1-4020-9663-1_18; Feuerverger A, 2008, ANN APPL STAT, V2, P3, DOI 10.1214/08-AOAS99; Gelb I. J., 1943, NUZI PERSONAL NAMES; Han H, 2005, PROCEEDINGS OF THE 5TH ACM/IEEE JOINT CONFERENCE ON DIGITAL LIBRARIES, PROCEEDINGS, P334, DOI 10.1145/1065385.1065462; Itoh Y, 2000, PHYSICA D, V142, P29, DOI 10.1016/S0167-2789(00)00057-9; Itoh Y., 1998, ESTIMATING POPULATIO; Itoh Y, 1998, J APPL PROBAB, V35, P633; Krapivsky P.L., 2000, PHYS REV LETT, V85, P4532; Lotka A. J., 1925, ELEMENTS PHYS BIOL; Maidman M. P., 2010, NUZI TEXTS THEIR USE; Maidman M.A., 1976, JCS, V28, P127, DOI 10.2307/1359758; Makino K., 1991, SHIGAKU, V60, P91; Morrison M.A., 1981, STUDIES CIVILIZATION; Starr R.F.S., 1937, NUZI REPORT EXCAVATI, V2; Ueda S., 2010, THESIS GRADUATE U AD; Ueda S., COMPUTATION NUZI PER; Ueda S., 2005, P I STAT MATH, V53, P285; Volterra Vito, 1931, LECONS THEORIE MATH, V1; Yamashita T, 2007, PHYSICA A, V374, P764, DOI 10.1016/j.physa.2006.08.021	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4371	1873-2119		PHYSICA A	Physica A	MAR 1	2015	421						223	232		10.1016/j.physa.2014.11.025		10	Physics, Multidisciplinary	Physics	CA1RB	WOS:000348688200021		
J	Abe, S; Suzuki, N				Abe, Sumiyoshi; Suzuki, Norikazu			Universal clustering structure and C approximate to 0.85 scaling in complex earthquake networks	PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS			English	Article						Earthquake networks; Universal clustering structure	SUCCESSIVE EARTHQUAKES; DYNAMICAL EVOLUTION	Earthquake network captures the complexity of seismicity in a peculiar manner. Given a seismic data, the procedure of constructing an earthquake network proposed by Abe and Suzuki (2004) contains as a single parameter the size of the cells, into which a geographical region under consideration is divided. Then, the characteristics of the network depend on the cell size, in general. Here, the dependency of the clustering coefficient, C, of network on the cell size is studied. Remarkably, C of the earthquake networks constructed from the seismic data taken from California, Japan and Iran well coincide for each value of the rescaled dimensionless cell size. It is found that the networks in California and Japan are three-dimensional, whereas the one in Iran is rather two-dimensional. In addition, the values of C of all these three networks monotonically converge to C approximate to 0.85 as the dimensionless cell size becomes larger than a common value, highlighting a universal aspect of the concept of earthquake network. An implication of the result to understanding the physics of seismicity is discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Abe, Sumiyoshi] Mie Univ, Dept Engn Phys, Tsu, Mie 5148507, Japan; [Suzuki, Norikazu] Nihon Univ, Coll Sci & Technol, Chiba 2748501, Japan	Abe, S (reprint author), Mie Univ, Dept Engn Phys, Tsu, Mie 5148507, Japan.	suabe@sf6.so-net.ne.jp			Japan Society for the Promotion of Science [26400391]; College of Science and Technology, Nihon University	The work of SA was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 26400391). NS acknowledges the support by a Grant-in-Aid for Fundamental Scientific Research from College of Science and Technology, Nihon University.	Abe S, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48008; Abe S, 2007, EUR PHYS J B, V59, P93, DOI 10.1140/epjb/e2007-00259-3; Abe S, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/39001; Corral A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108501; Baek WH, 2012, PHYSICA A, V391, P2279, DOI 10.1016/j.physa.2011.11.047; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Abe S, 2005, PHYSICA A, V350, P588, DOI 10.1016/j.physa.2004.10.040; Abe S, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026113; Abe S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002220; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Ferreira DSR, 2014, PHYSICA A, V408, P170, DOI 10.1016/j.physa.2014.04.024; Corral A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.178501; Abe S, 2011, PHYSICA A, V390, P1343, DOI 10.1016/j.physa.2010.11.033; Abe S, 2004, EUROPHYS LETT, V65, P581, DOI 10.1209/epl/i2003-10108-1; Lotfi N, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20623-x; Peng ZG, 2013, B SEISMOL SOC AM, V103, P595, DOI 10.1785/0120120253; Steeples DW, 1996, B SEISMOL SOC AM, V86, P921	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4371	1873-2119		PHYSICA A	Physica A	MAR 1	2015	421						343	346		10.1016/j.physa.2014.11.011		4	Physics, Multidisciplinary	Physics	CA1RB	WOS:000348688200031		
J	Uechi, L; Akutsu, T; Stanley, HE; Marcus, AJ; Kenett, DY				Uechi, Lisa; Akutsu, Tatsuya; Stanley, H. Eugene; Marcus, Alan J.; Kenett, Dror Y.			Sector dominance ratio analysis of financial markets	PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS			English	Article						Financial markets; Sector dominance ratio; Market structure	SYSTEMIC RISK	In this paper we present a new measure to investigate the functional structure of financial markets, the Sector Dominance Ratio (SDR). We study the information embedded in raw and partial correlations using random matrix theory (RMT) and examine-the evolution of economic sectoral makeup on a yearly and monthly basis for four stock markets, those of the US, UK, Germany and Japan, during the period from January 2000 to December 2010. We investigate the information contained in raw and partial correlations using the sector dominance ratio and its variation over time. The evolution of economic sectoral activities can be discerned through the largest eigenvectors of both raw correlation and partial correlation matrices. We find a characteristic change of the largest eigenvalue from raw and partial correlations and the SDR that coincides with sharp breaks in asset valuations. Finally, we propose the SDR as an indicator for changes in VIX indexes. (C) 2014 Elsevier B.V. All rights reserved.	[Uechi, Lisa; Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto 6110011, Japan; [Stanley, H. Eugene; Kenett, Dror Y.] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Stanley, H. Eugene; Kenett, Dror Y.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Marcus, Alan J.] Boston Coll, Carroll Sch Management, Dept Finance, Chestnut Hill, MA 02467 USA	Uechi, L (reprint author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto 6110011, Japan.	uechir@kuicr.kyoto-u.ac.jp			JSPS International Training Program (ITP); DTRA [HDTRA-1-10-1-0014, HDTRA-1-09-1-0035]; ONR [N00014-09-1-0380, N00014-12-1-0548]	We thank Shlomo Havlin for his insightful comments on this work. LU and TA acknowledge financial support by JSPS International Training Program (ITP). DYK and HES acknowledge financial support by DTRA (Grant HDTRA-1-10-1-0014, Grant HDTRA-1-09-1-0035) and ONR (Grant N00014-09-1-0380, Grant N00014-12-1-0548).	Nakayama Y, 2009, PROG THEOR PHYS SUPP, P60, DOI 10.1143/PTPS.179.60; Schinckus C, 2009, PHYSICA A, V388, P4415, DOI 10.1016/j.physa.2009.07.008; Tumminello M, 2010, J ECON BEHAV ORGAN, V75, P40, DOI 10.1016/j.jebo.2010.01.004; Kritzman M, 2011, J PORTFOLIO MANAGE, V37, P112, DOI 10.3905/jpm.2011.37.4.112; Gopikrishnan P, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.035106; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; MERTON RC, 1973, ECONOMETRICA, V41, P867, DOI 10.2307/1913811; Garas A, 2007, PHYSICA A, V380, P399, DOI 10.1016/j.physa.2007.02.097; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Rao KR, 2007, CHEMOMETR INTELL LAB, V86, P68, DOI 10.1016/j.chemolab.2006.08.007; Billio M, 2012, J FINANC ECON, V104, P535, DOI 10.1016/j.jfineco.2011.12.010; Kenett DY, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501817; ROSS SA, 1976, J ECON THEORY, V13, P341, DOI 10.1016/0022-0531(76)90046-6; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; Bouchaud J.P., POWER LAWS EC FINANC; Bouchaud J.-P., 2003, THEORY FINANCIAL RIS; Bouchaud J.P., ARXIV09101205; Chou Y., 1975, STAT ANAL BUSINESS E; Coronnello C., CONDMAT0508122 ARXIV; Eom C, 2009, PHYSICA A, V388, P4780, DOI 10.1016/j.physa.2009.07.023; FAMA EF, 1993, J FINANC ECON, V33, P3, DOI 10.1016/0304-405X(93)90023-5; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Granger C.W.J., 1969, ECONOMETRICA, V37, P424, DOI DOI 10.2307/1912791; Kenett DY, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/38001; Kenett D.Y., 2009, J PROBAB STAT; Kenett D.Y., ARXIV14021405; Kenett Dror Y., 2012, International Journal of Modern Physics: Conference Series, V16, DOI 10.1142/S201019451200774X; Kenett D.Y., 2013, SCI REP, V3; Kenett DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031144; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kenett YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023912; Kinlaw W.B., DETERMINING SYSTEMIC; Laloux L, 2000, INT J THEOR APPL FIN, V03, P391, DOI DOI 10.1142/S0219024900000255; Madi A, 2011, CHAOS, V21, DOI 10.1063/1.3543800; Mantegna R N, 1999, INTRO ECONOPHYSICS C; Mauboussin M.J., 2002, J APPL CORPORATE FIN, V14, P47, DOI 10.1111/j.1745-6622.2002.tb00448.x; Munnix MC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00644; Pearson K., 1895, PHILOS T R SOC A, V186, P343, DOI DOI 10.1098/RSTA.1895.0010; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Potters M., FINANCIAL APPL RANDO; Ren F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097711; Schuster HG, 2005, DETERMINISTIC CHAOS: AN INTRODUCTION, 4TH EDITION, P1, DOI 10.1002/3527604804; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; Uechi L., ARXIV12091118; Uechi L, 2012, PROG THEOR PHYS SUPP, P210; Voit J, 2005, STAT MECH FINANCIAL	48	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4371	1873-2119		PHYSICA A	Physica A	MAR 1	2015	421						488	509		10.1016/j.physa.2014.11.055		22	Physics, Multidisciplinary	Physics	CA1RB	WOS:000348688200044		
J	Kusuda, H; Koga, W; Kusano, M; Oikawa, A; Saito, K; Hirai, MY; Yoshida, KT				Kusuda, Hiroki; Koga, Wataru; Kusano, Miyako; Oikawa, Akira; Saito, Kazuki; Hirai, Masami Yokota; Yoshida, Kaoru T.			Ectopic expression of myo-inositol 3-phosphate synthase induces a wide range of metabolic changes and confers salt tolerance in rice	PLANT SCIENCE			English	Article						Abiotic stress; Abscisic acid; Metabolomics; Oryza sativa L; ROS scavenger	COARCTATA ROXB. TATEOKA; TRANSGENIC RICE; OXIDATIVE STRESS; 1-PHOSPHATE SYNTHASE; SALINITY TOLERANCE; HYDROGEN-PEROXIDE; CHLOROGENIC ACID; WILD-RICE; ARABIDOPSIS; PLANTS	Salt stress is an important factor that limits crop production worldwide. The salt tolerance of plants is a complex biological process mediated by changes in gene expression and metabolite composition. The enzyme myo-inositol 3-phosphate synthase (MIPS; EC 5.5.1.4) catalyzes the first step of myo-inositol biosynthesis, and overexpression of the MIPS gene enhances salt stress tolerance in several plant species. In this study, we performed metabolite profiling of both MIPS-overexpressing and wild-type rice. The enhanced salt stress tolerance of MIPS-overexpressing plants was clear based on growth and the metabolites under salt stress. We found that constitutive overexpression of the rice MIPS gene resulted in a wide range of metabolic changes. This study demonstrates for the first time that overexpression of the MIPS gene increases various metabolites responsible for protecting plants from abiotic stress. Activation of both basal metabolism, such as glycolysis, the pentose phosphate pathway, and the tricarboxylic acid cycle, and inositol metabolism is induced in MIPS-overexpressing plants. We discuss the relationship between the metabolic changes and the improved salt tolerance observed in transgenic rice. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kusuda, Hiroki; Koga, Wataru; Yoshida, Kaoru T.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Kusano, Miyako; Oikawa, Akira; Saito, Kazuki; Hirai, Masami Yokota] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Kusano, Miyako] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Oikawa, Akira] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba, Japan	Yoshida, KT (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Conservat Ecol, Bunkyo Ku, Tokyo 1138657, Japan.	ayosida@mail.ecc.u-tokyo.ac.jp	Saito, Kazuki/D-2670-2009		Salt Science Foundation [1316]; Japan Advanced Plant Science Network	This work was supported by research grants from the Salt Science Foundation (1316 for K.T.Y.). This research was supported by Japan Advanced Plant Science Network. We thank Mr. Makoto Kobayashi and Mr. Ryosuke Sasaki for their assistances in GC-MS and CE-MS analyses. We are grateful to Mr. Masanobu Miyamoto for his help in selection of RINO1ox lines. The authors would like to acknowledge Dr. Junko Kyozuka for kindly providing the pBIAct/nos vector.	Ishitani M, 1996, PLANT J, V9, P537, DOI 10.1046/j.1365-313X.1996.09040537.x; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s; Kusano M, 2011, PLANT J, V66, P456, DOI 10.1111/j.1365-313X.2011.04506.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; VERNIQUET F, 1991, BIOCHEM J, V276, P643; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Kuwano M, 2009, PLANT BIOTECHNOL J, V7, P96, DOI 10.1111/j.1467-7652.2008.00375.x; Tan JL, 2013, PLANT CELL ENVIRON, V36, P288, DOI 10.1111/j.1365-3040.2012.02573.x; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Todaka D, 2012, RICE, V5, DOI 10.1186/1939-8433-5-6; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Nanjo T, 1999, PLANT J, V18, P185, DOI 10.1046/j.1365-313X.1999.00438.x; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Yoshida KT, 1999, PLANT PHYSIOL, V119, P65, DOI 10.1104/pp.119.1.65; Suzuki M, 2007, GENE, V405, P55, DOI 10.1016/j.gene.2007.09.006; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Das-Chatterjee A, 2006, FEBS LETT, V580, P3980, DOI 10.1016/j.febslet.2006.06.033; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; Feng XG, 2004, PLANT BIOTECHNOL, V21, P183, DOI 10.5511/plantbiotechnology.21.183; Joshi R, 2013, PLANT PHYSIOL BIOCH, V65, P61, DOI 10.1016/j.plaphy.2013.01.009; Kempa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003935; Kuwano M, 2006, MOL BREEDING, V18, P263, DOI 10.1007/s11032-006-9038-x; Lehmann M, 2012, METABOLOMICS, V8, P143, DOI 10.1007/s11306-011-0296-1; Majee M, 2004, J BIOL CHEM, V279, P28539, DOI 10.1074/jbc.M310138200; MizobuchiFukuoka R, 1996, BREEDING SCI, V46, P35; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oikawa A, 2011, PLANT PHYSIOL, V157, P544, DOI 10.1104/pp.111.183772; RAO MV, 1995, PHOTOCHEM PHOTOBIOL, V61, P71, DOI 10.1111/j.1751-1097.1995.tb09245.x; Sengupta S, 2010, PLANT CELL ENVIRON, V33, P526, DOI 10.1111/j.1365-3040.2009.02054.x; Sentoku N, 2000, DEV BIOL, V220, P358, DOI 10.1006/dbio.2000.9624; Witzel K, 2010, PLANT CELL ENVIRON, V33, P211, DOI 10.1111/j.1365-3040.2009.02071.x; ZHANG WG, 1991, PLANT CELL, V3, P1155, DOI 10.1105/tpc.3.11.1155	41	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	MAR	2015	232						49	56		10.1016/j.plantsci.2014.12.009		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CB4CK	WOS:000349575600006		
J	Li, Y; Itoi, T; Takahashi, H; Maki, M				Li, Yue; Itoi, Tomomi; Takahashi, Hiroshi; Maki, Masayuki			Morphological and genetic variation in populations in a hybrid zone between Leucosceptrum japonicum and L-stellipilum (Lamiaceae) in the central Japanese mainland	PLANT SYSTEMATICS AND EVOLUTION			English	Article						Hybrid zone; Internal transcribed spacer; Leucosceptrum; Multivariate morphometrics; trnL-F; Pollen fertility	NUCLEAR RIBOSOMAL DNA; CHLOROPLAST DNA; PLANT HYBRIDIZATION; CONCERTED EVOLUTION; MOLECULAR EVIDENCE; SPECIATION; PATTERNS; BRASSICACEAE; INTROGRESSION; REGIONS	Hybrid zones between two species can reflect the combined effects of gene flow, genetic novelty, selection, and isolation barriers. Leucosceptrum japonicum and L. stellipilum are two morphologically distinct species belonging to Lamiaceae, which are endemic to Japan with partially overlapping distributions. In the present study, morphological and genetic variation in 11 populations in a putative hybrid zone between L. japonicum and L. stellipilum were investigated. No introgression was observed in the sympatric parental populations based on the cpDNA haplotype. Morphological intermediacy, ITS additivity and reduced pollen fertility confirmed the occurrence of hybridization between L. japonicum and L. stellipilum. Hybrid individuals appear to be not only early hybrid generation, but also advanced hybrid generation and/or backcross hybrids. The morphology of the putative early hybrid generation was too variable to distinguish all these hybrids from the parental species. The factors that facilitated and maintained hybridization between L. japonicum and L. stellipilum are discussed.	[Li, Yue; Itoi, Tomomi] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Li, Yue; Maki, Masayuki] Tohoku Univ, Bot Gardens, Sendai, Miyagi 9800862, Japan; [Takahashi, Hiroshi] Gifu Univ, Dept Biol, Fac Educ, Gifu 5011193, Japan	Li, Y (reprint author), Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan.	yueli@life.biology.tohoku.ac.jp			Japan Society for the Promotion of Science; China Scholarship Council	This study was partly supported by a Grant-in-Aid from the Japan Society for the Promotion of Science to MM. We are grateful to the following for their efforts in sampling, comments, and technical advice: S. Horie, T. Yamada, K. Yonekura, Y. Tsujita, Y. Sakamoto and K. Shimizu. We also thank the anonymous reviewers for helpful comments on the manuscript. The stay of YL in Japan is supported by the China Scholarship Council.	Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Widmer A, 1999, AM J BOT, V86, P1282, DOI 10.2307/2656776; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1999, GENETICS, V152, P713; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Galbany-Casals M, 2012, PLANT BIOLOGY, V14, P789, DOI 10.1111/j.1438-8677.2012.00568.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Chase MW, 2005, PHILOS T ROY SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; MEYER A, 1987, EVOLUTION, V41, P1357, DOI 10.2307/2409100; Hardig TM, 2000, MOL ECOL, V9, P9, DOI 10.1046/j.1365-294X.2000.00757.x; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Emms SK, 2000, OIKOS, V91, P568, DOI 10.1034/j.1600-0706.2000.910319.x; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Marhold K, 2006, PLANT SYST EVOL, V259, P143, DOI 10.1007/s00606-006-0417-x; Aguilar JF, 1999, MOL ECOL, V8, P1341, DOI 10.1046/j.1365-294X.1999.00690.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Wolfe AD, 1998, P NATL ACAD SCI USA, V95, P5112, DOI 10.1073/pnas.95.9.5112; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; ARNOLD ML, 1993, AM J BOT, V80, P577, DOI 10.2307/2445375; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; WINTER P, 1995, WORLD J MICROB BIOT, V11, P438, DOI 10.1007/BF00364619; Arnold ML, 2012, HEREDITY, V108, P159, DOI 10.1038/hdy.2011.65; Hamilton MB, 1999, MOL ECOL, V8, P521; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; ANDERSON E, 1948, EVOLUTION, V2, P1, DOI 10.2307/2405610; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; Arnold M.L., 1997, NATURAL HYBRIDIZATIO; BAKER HG, 1947, NATURE, V159, P546, DOI 10.1038/159546a0; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bures P, 2010, PRESLIA, V82, P391; Campbell DR, 2002, AM NAT, V159, P438, DOI 10.1086/339457; Carine MA, 2007, BOT J LINN SOC, V154, P187, DOI 10.1111/j.1095-8339.2007.00657.x; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dobzhansky TG, 1937, GENETICS ORIGIN SPEC; Durrett R, 2000, HEREDITY, V84, P9, DOI 10.1046/j.1365-2540.2000.00566.x; Egan SP, 2009, P NATL ACAD SCI USA, V106, P19426, DOI 10.1073/pnas.0909424106; Endler J. A., 1977, GEOGRAPHIC VARIATION; Funamoto Tsuneo, 2004, Chromosome Science, V8, P109; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hamilton JA, 2013, AM J BOT, V100, P1651, DOI 10.3732/ajb.1200654; Kearns C.A., 1993, TECHNIQUES POLLINATI; Kikuchi R, 2010, NEW PHYTOL, V188, P879, DOI 10.1111/j.1469-8137.2010.03398.x; Lihova J, 2007, ANN BOT-LONDON, V99, P1083, DOI 10.1093/aob/mcm056; Maki M, 1999, MOL ECOL, V8, P145, DOI 10.1046/j.1365-294X.1999.00517.x; MURATA G., 1993, FLORA JAPAN A, VIIIa, P84; R Development Core Team, 2012, R LANG ENV STAT COMP; Randell RA, 2004, CONSERV GENET, V5, P217, DOI 10.1023/B:COGE.0000030006.30410.5d; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Shi SH, 2003, CHINESE SCI BULL, V48, P1576, DOI 10.1360/03wc0081; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takahashi H, 2001, B FLORAL SOC GIFU PR, V17, P95; WILSON P, 1992, TAXON, V41, P11, DOI 10.2307/1222481; Wu CA, 2005, MOL ECOL, V14, P781, DOI 10.1111/j.1365-294X.2005.02441.x	59	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0378-2697	1615-6110		PLANT SYST EVOL	Plant Syst. Evol.	MAR	2015	301	3					1029	1041		10.1007/s00606-014-1134-5		13	Plant Sciences; Evolutionary Biology	Plant Sciences; Evolutionary Biology	CB1NJ	WOS:000349394300013		
J	Nishiyama, H; Niinuma, K; Shinoki, S; Takana, H				Nishiyama, Hideya; Niinuma, Kei; Shinoki, Shohei; Takana, Hidemasa			Decomposition of Acetic Acid Using Multiple Bubble Jets with Pulsed Electrical Discharge	PLASMA CHEMISTRY AND PLASMA PROCESSING			English	Article						Water treatment; Persistent organic pollutants; Acetic acid decomposition; Hydroxyl radicals; Bubble jets; Pulsed electrical discharge	WATER; FLOW; RADICALS; REACTOR	The oxidation potential of ozone (2.07 V) is not sufficient to achieve the efficient decomposition of persistent organic pollutants in the conventional water treatment process. Strong oxidizing agents such as OH and O radicals (oxidation potential 2.80 and 2.42 V, respectively) were successfully generated using multiple bubble jets with pulsed electrical discharge and used for the decomposition of acetic acid (CH3COOH), as a model pollutant. The flow dynamics of this novel water treatment process was clarified experimentally. The dynamic behavior of bubble jets with pulsed electrical discharge, streamer propagation along the bubble interface, and radical generation were investigated by high-speed visualization and spectroscopic measurements. The decomposition characteristics of CH3COOH were determined such as applied frequency, the duty ratio of applied voltage, gas flow rate, the initial CH3COOH concentration to achieve the maximum decomposition of CH3COOH, and higher energy efficiency compared to the previous electrical discharge gas-liquid processes.	[Nishiyama, Hideya; Takana, Hidemasa] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Niinuma, Kei; Shinoki, Shohei] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Nishiyama, H (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahiara, Sendai, Miyagi 9808577, Japan.	nishiyama@ifs.tohoku.ac.jp			MEXT, Japan; Japan Society for the Promotion of Science [23246032, 26249015]; JST [AS232Z01376B]	This work was supported in part by the Global COE Program, "World Center of Education and Research for Trans-disciplinary Flow Dynamics (2012)," MEXT, Japan, the Japan Society for the Promotion of Science under a Grant-in-Aid for Scientific Research (A) (Nos. 23246032 and 26249015), and A-STEP, Exploratory Research (AS232Z01376B), JST. We would like to give our sincere thanks to Prof. Koichi Yasuoka with Tokyo Institute of Technology, Mr. Satoru Taguchi of Kawase Pro. Ltd., and Ph.D. student Mr. Tomohiro Shibata of IFS, Tohoku University, for their valuable comments and also to technicians Mr. Kazunari Katagiri and Mr. Tomoki Nakajima of IFS, Tohoku University, for their skillful technical supports. Furthermore, we would like to appreciate Nobby Tech Ltd. for using the ultrahigh-speed framing camera.	Babaeva NY, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/13/132003; Ognier S, 2009, PLASMA CHEM PLASMA P, V29, P261, DOI 10.1007/s11090-009-9179-x; Sommers BS, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/8/082001; Tochikubo F, 2004, JPN J APPL PHYS 1, V43, P315, DOI 10.1143/JJAP.43.315; Matsui Y, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034015; Shih KY, 2010, PLASMA CHEM PLASMA P, V30, P1, DOI 10.1007/s11090-009-9207-x; Katayama H, 2009, IEEE T PLASMA SCI, V37, P897, DOI 10.1109/TPS.2009.2017124; Tachibana K, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034005; De Smedt F, 2005, J PHYS CHEM A, V109, P2401, DOI 10.1021/jp044679v; Igor S, 1997, HDB PHYS QUANTITIES; Leitner NKV, 1997, WATER RES, V31, P1383; Locke BR, 2012, PLASMA CHEM CATALYSI, P183; Nishiyama H, 2013, J FLUID SCI TECHNOL, V8, P65; Nishiyama H, 2011, IEEE T PLASMA SCI, V39, P2660, DOI 10.1109/TPS.2011.2160367; Sano N, 2004, SEP PURIF TECHNOL, V37, P169, DOI 10.1016/S1383-5866(03)00166-7; Shibata T, 2014, PLASMA CHEM PLASMA P, V34, P1331, DOI 10.1007/s11090-014-9575-8; Yamatake A, 2006, IEEE T PLASMA SCI, V34, P1375, DOI 10.1109/TPS.2006.877249	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4324	1572-8986		PLASMA CHEM PLASMA P	Plasma Chem. Plasma Process.	MAR	2015	35	2					339	354		10.1007/s11090-014-9607-4		16	Engineering, Chemical; Physics, Applied; Physics, Fluids & Plasmas	Engineering; Physics	CB3LQ	WOS:000349529800004		
J	Oh, SS; Kim, J				Oh, Seong Soo; Kim, Jungbu			Science and Engineering Majors in the Federal Service: Lessons for Eliminating Sexual and Racial Inequality	REVIEW OF PUBLIC PERSONNEL ADMINISTRATION			English	Article						STEM majors; women and minorities; federal service; pay disparity	GENDER-DIFFERENCES; COLLEGE MAJOR; PUBLICATION PRODUCTIVITY; WAGE GAP; EARNINGS; WOMEN; SCIENTISTS; EDUCATION; RETURNS; CAREERS	This study explores how the gender and racial composition of the science, technology, engineering, and mathematics (STEM) portion of the federal workforce has changed, and how female and minority employees with STEM degrees compare with White majorities and those with degrees in non-STEM fields. Using a series of ordinary least square analyses of a 1% random sample of federal employees for 1983, 1996, and 2009, this study finds that gender and racial pay disparities have decreased over the study period, and that the extant gender pay gap can be explained largely by educational attainment, work experience, and particularly by the changing composition in STEM majors. Despite the decrease in pay disparity, a racial pay gap still remains even after controlling for education level, federal experience, and other major factors.	[Oh, Seong Soo] Hanyang Univ, Seoul 133791, South Korea; [Kim, Jungbu] Int Univ Japan, Publ Management & Policy Anal Program, Minami Uonuma, Niigata 9497277, Japan	Kim, J (reprint author), Int Univ Japan, Publ Management & Policy Anal Program, 777 Kokusai Cho, Minami Uonuma, Niigata 9497277, Japan.	j.kim@iuj.ac.jp					And S., 2011, CONDITION ED 2011; MAJOR B, 1984, ACAD MANAGE J, V27, P777, DOI 10.2307/255878; Lewis GB, 1996, IND LABOR RELAT REV, V49, P472, DOI 10.2307/2524198; Fox MF, 2001, SOC STUD SCI, V31, P109, DOI 10.1177/030631201031001006; FOX MF, 1983, SOC STUD SCI, V13, P285, DOI 10.1177/030631283013002005; Weinberg SL, 2008, J HIGH EDUC, V79, P365; BELMAN D, 1991, REV ECON STAT, V73, P720, DOI 10.2307/2109413; Blackwell LV, 2009, J DIVERS HIGH EDUC, V2, P195, DOI 10.1037/a0016974; HUNGERFORD T, 1987, REV ECON STAT, V69, P175, DOI 10.2307/1937919; Arcidiacono P, 2004, J ECONOMETRICS, V121, P343, DOI 10.1016/j.jeconom.2003.10.010; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505; LONG JS, 1992, SOC FORCES, V71, P159, DOI 10.2307/2579971; ETZKOWITZ H, 1994, SCIENCE, V266, P51, DOI 10.1126/science.7939644; Bedard K, 2001, J POLIT ECON, V109, P749, DOI 10.1086/322089; LONG JS, 1993, AM SOCIOL REV, V58, P703, DOI 10.2307/2096282; DAYMONT TN, 1984, J HUM RESOUR, V19, P408, DOI 10.2307/145880; STEVENS CK, 1993, J APPL PSYCHOL, V78, P723, DOI 10.1037/0021-9010.78.5.723; Krueger AB, 2001, J ECON LIT, V39, P1101, DOI 10.1257/jel.39.4.1101; Brown C, 1997, J LABOR ECON, V15, P431, DOI 10.1086/209867; Fox MF, 2005, SOC STUD SCI, V35, P131, DOI 10.1177/0306312705046630; Barron LA, 2003, HUM RELAT, V56, P635, DOI 10.1177/00187267030566001; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Leahey E, 2006, GENDER SOC, V20, P754, DOI 10.1177/0891243206293030; Finnie R, 2003, ECON EDUC REV, V22, P179, DOI 10.1016/S0272-7757(02)00003-1; LONG JS, 1995, ANNU REV SOCIOL, V21, P45; Babcock K, 2008, WOMEN DONT ASK NEGOT; Bebbington D, 2002, HIGHER ED Q, V56, P360, DOI DOI 10.1111/1468-2273.00225; Becker G., 1993, HUMAN CAPITAL THEORE; Becker G., 1975, HUMAN CAPITAL THEORE; BERGER MC, 1988, IND LABOR RELAT REV, V41, P418, DOI 10.2307/2523907; Black DA, 2003, ECON INQ, V41, P365, DOI 10.1093/ei/cbg014; Blau FD, 1997, J LABOR ECON, V15, P1, DOI 10.1086/209845; Bowels S, 2001, J ECON LIT, V39, P1137; Burke K, 2005, SOC SCI J, V42, P165, DOI 10.1016/j.soscij.2005.03.006; Burke R. J., 2007, WOMEN MINORITIES SCI; Cole J., 1984, ADV MOTIVATION ACHIE, V2, P217; Committee on Equal Opportunities in Science and Engineering (CEOSE), 1996, 1996 BIENN REP C; Committee on Equal Opportunities in Science and Engineering (CEOSE), 2011, 2009 2010 BIENN REP; Dix L. S, 1987, P WORKSH WASH DC NAT; DOLTON PJ, 1990, ECON J, V100, P237, DOI 10.2307/2233610; DOLTON PJ, 1990, STUD HIGH EDUC, V15, P31, DOI 10.1080/03075079012331377581; GERHART B, 1990, IND LABOR RELAT REV, V43, P418, DOI 10.2307/2524131; Gilbreath K, 2006, J LEGAL EC, V13, P79; Glover J., 2000, WOMEN SCI EMPLOYMENT; GROOT W, 1994, REV ECON STAT, V76, P317, DOI 10.2307/2109885; Hecker DE, 1998, MON LABOR REV, V121, P62; Hill P. L, 2011, INNOVATIVE HIGHER ED, V36, P19, DOI 10.1007/s10755-010-9154-8; Lechuga V. M, 2012, J LATINOS ED, V11, P107; Lee G, 2011, THESIS U LLINOIS CHI; Leslie LL, 1998, J HIGH EDUC, V69, P239, DOI 10.2307/2649188; Lewis GB, 2009, AM REV PUBLIC ADM, V39, P107, DOI 10.1177/0275074008317158; LONG JS, 1990, SOC FORCES, V68, P1297, DOI 10.2307/2579146; Loury LD, 1997, IND LABOR RELAT REV, V50, P580, DOI 10.2307/2525263; LOURY LD, 1995, J LABOR ECON, V13, P289, DOI 10.1086/298375; McIlwee J. S., 1992, WOMEN ENG GENDER POW; Mincer J., 1993, STUDIES HUMAN CAPITA; Montgomery M, 2003, IND RELAT, V42, P396, DOI 10.1111/1468-232X.00297; MURPHY KM, 1992, Q J ECON, V107, P285, DOI 10.2307/2118330; Naff K. C, 2004, REV PUBLIC PERS ADM, V24, P191, DOI 10.1177/0734371X04266710; National Academy of Sciences National Academy of Engineering Institute of Medicine, 2007, BIAS BARR FULF POT W; National Science Board, 2004, BROAD PART SCI ENG F; National Science Board, 2010, SCI ENG IND 2010 NSB; National Science Board, 2010, PREP NEXT GEN STEM I; National Science Foundation Division of Science Resources Statistics (NSF/SRS), 2011, WOM MIN PERS DIS SCI; Nelson D. J, 2007, NATL ANAL MINORIETS; Nigro L. G, 1990, PUBLIC ADM STATE DIS, P185; Psacharopoulos G, 1984, INT COMPARISONS PROD, P335; Small DA, 2007, J PERS SOC PSYCHOL, V93, P600, DOI 10.1037/0022-3514.93.4.600; Snyder T. D., 2011, DIGEST ED STAT 2010; Sonnert G, 1999, ANN NY ACAD SCI, V869, P34, DOI 10.1111/j.1749-6632.1999.tb08353.x; Spence A. M., 1974, MARKET SIGNALING INF; THOMAS D, 1990, J HUM RESOUR, V25, P635, DOI 10.2307/145670; U. S. Office of Personnel Management, 2002, 2002 DEM PROF FED WO; U.S. Congress Joint Economic Committee, 2010, WOM EC 2010 25 YEARS; Woodhall M, 1995, INT ENCY EC ED, P24; Xie Y., 2003, WOMEN SCI CAREER PRO; Zukerman H, 1991, OUTER CIRCLE WOMEN S	77	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0734-371X	1552-759X		REV PUBLIC PERS ADM	Rev. Public Pers. Adm.	MAR	2015	35	1					24	46		10.1177/0734371X13504117		23	Public Administration	Public Administration	CA9FZ	WOS:000349228600002		
J	Maruoka, D; Arai, M; Ishigami, H; Okimoto, K; Saito, K; Minemura, S; Matsumura, T; Nakagawa, T; Katsuno, T; Yokosuka, O				Maruoka, Daisuke; Arai, Makoto; Ishigami, Hideaki; Okimoto, Kenichiro; Saito, Keiko; Minemura, Shoko; Matsumura, Tomoaki; Nakagawa, Tomoo; Katsuno, Tatsuro; Yokosuka, Osamu			Sporadic nonampullary duodenal adenoma/carcinoma is associated with not only colon adenoma/carcinoma but also gastric cancer: association of location of duodenal lesions with comorbid diseases	SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY			English	Article						colorectal adenoma; duodenal adenoma; gastric cancer; Helicobacter pylori	FAMILIAL ADENOMATOUS POLYPOSIS; ENDOSCOPIC RESECTION; PRIMARY ADENOCARCINOMA; HELICOBACTER-PYLORI; SMALL-INTESTINE; VILLOUS TUMORS; LARGE-BOWEL; NEOPLASMS; CARCINOMA; PREVALENCE	Background. It is well known that in patients with sporadic nonampullary duodenal adenoma/carcinoma (SNADA) with no polyposis syndrome, including familial adenomataous polyposis, the rates of colorectal adenoma/carcinoma are high. However, the prevalence rates of other tumor types, for example, gastric cancer, in SNADA patients remain unknown. In this study, we aimed to analyze the prevalence rate of comorbid diseases in SNADA patients. Methods. We retrospectively analyzed 78 patients with SNADA treated by endoscopic resection between May 2005 and September 2014 at our institution. Results. Overall, 51 of the 78 (65.4%) SNADA patients had comorbid colorectal adenoma/carcinoma. Further, 10 of the 78 (12.8%) SNADA patients had comorbid gastric cancer, and all of them were positive for Helicobacter pylori infection. SNADA lesions were located significantly more frequently at the oral side of the major papilla in patients with H. pylori infection than in those without H. pylori infection (27 of 36 [75.0%] vs. 19 of 42 [45.2%], p = 0.008, chi-square test). In contrast, SNADA lesions were located significantly more frequently at the anal side of the major papilla in patients with colorectal adenoma/carcinoma than in those without colorectal adenoma/carcinoma (27 of 51 [52.9%] vs. 5 of 27 [18.5%], p = 0.003, chi-square test). Conclusion. SNADA patients showed comorbidity with not only colorectal adenoma/carcinoma but also gastric cancer. H. pylori infection is known to cause gastric cancer and may influence tumorigenesis of SNADA lesions at the oral side of the major papilla.	[Maruoka, Daisuke; Arai, Makoto; Ishigami, Hideaki; Okimoto, Kenichiro; Saito, Keiko; Minemura, Shoko; Matsumura, Tomoaki; Nakagawa, Tomoo; Katsuno, Tatsuro; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan; [Maruoka, Daisuke] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan	Arai, M (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	araim-cib@umin.ac.jp					Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; NEUGUT AI, 1993, CANCER EPIDEM BIOMAR, V2, P551; Shibata C, 2013, TOHOKU J EXP MED, V229, P143, DOI 10.1620/tjem.229.143; Groves CJ, 2002, GUT, V50, P636, DOI 10.1136/gut.50.5.636; Alexander S, 2009, GASTROINTEST ENDOSC, V69, P66, DOI 10.1016/j.gie.2008.04.061; IWAMA T, 1993, ANN SURG, V217, P101, DOI 10.1097/00000658-199302000-00002; ALWMARK A, 1980, ANN SURG, V191, P13, DOI 10.1097/00000658-198001000-00003; Maruoka D, 2013, ENDOSCOPY, V45, P138, DOI 10.1055/s-0032-1325799; IIDA M, 1989, GASTROENTEROLOGY, V96, P1301; Oka S, 2003, J CLIN GASTROENTEROL, V37, P381, DOI 10.1097/00004836-200311000-00006; Murray MA, 2004, GUT, V53, P261, DOI 10.1136/gut.2003.025320; Apel D, 2005, ENDOSCOPY, V37, P444, DOI 10.1055/s-2005-861287; Farnell MB, 2000, J GASTROINTEST SURG, V4, P13, DOI 10.1016/S1091-255X(00)80028-1; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; JEPSEN JM, 1994, SCAND J GASTROENTERO, V29, P483, DOI 10.3109/00365529409092458; ROSS RK, 1991, BRIT J CANCER, V63, P143, DOI 10.1038/bjc.1991.29; Fanning SB, 2012, GASTROINTEST ENDOSC, V75, P805, DOI 10.1016/j.gie.2011.11.038; Lepilliez V, 2008, ENDOSCOPY, V40, P806, DOI 10.1055/s-2008-1077619; BJORK KJ, 1990, ARCH SURG-CHICAGO, V125, P961; Cunningham JD, 1997, ANN SURG, V225, P300, DOI 10.1097/00000658-199703000-00010; DOLL R, 1969, BRIT J CANCER, V23, P1, DOI 10.1038/bjc.1969.1; HAENSZEL W, 1973, J NATL CANCER I, V51, P1765; Honda T, 2009, DIGEST ENDOSC, V21, P270, DOI 10.1111/j.1443-1661.2009.00908.x; INOUE H, 1992, SURG ENDOSC-ULTRAS, V6, P264, DOI 10.1007/BF02498820; Kasahara Y, 1985, MED J KINKI U, V10, P1; KRUKOWSKI ZH, 1988, BRIT J SURG, V75, P150, DOI 10.1002/bjs.1800750221; LOWENFEL.AB, 1973, LANCET, V1, P24; MOERTEL CG, 1961, CANCER, V14, P221, DOI 10.1002/1097-0142(196103/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6; MOSS WM, 1974, ARCH SURG-CHICAGO, V108, P805; Negri E, 1999, INT J CANCER, V82, P171, DOI 10.1002/(SICI)1097-0215(19990719)82:2<171::AID-IJC3>3.0.CO;2-T; Onoe S, 2006, JPN J GASTROENTEROL, V39, P1458; SARRE RG, 1987, GUT, V28, P306, DOI 10.1136/gut.28.3.306; SCHNUR PL, 1973, JAMA-J AM MED ASSOC, V223, P1229, DOI 10.1001/jama.223.11.1229; Shepherd N, 2010, WHO CLASSIFICATION T, P98; SPIRA IA, 1977, CANCER, V39, P1721, DOI 10.1002/1097-0142(197704)39:4<1721::AID-CNCR2820390450>3.0.CO;2-M; TADA M, 1993, ENDOSCOPY, V25, P445, DOI 10.1055/s-2007-1010365; Tanaka Y, 2004, J KANAZAWA MED U, V29, P115; Ueda S, 1996, J JPN SOC CLIN SURG, V57, P3019; van Heumen BWH, 2012, J CLIN GASTROENTEROL, V46, P390, DOI 10.1097/MCG.0b013e318238e72d; Warren S, 1932, AM J CANCER, V16, P1358; WYNDER EL, 1967, CANCER, V20, P1520, DOI 10.1002/1097-0142(196709)20:9<1520::AID-CNCR2820200920>3.0.CO;2-3	41	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0036-5521	1502-7708		SCAND J GASTROENTERO	Scand. J. Gastroenterol.	MAR	2015	50	3					333	340		10.3109/00365521.2014.1003399		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB1PG	WOS:000349399400010		
J	Aslan, F; Alper, E; Cekic, C; Yurtlu, DA; Ekinci, N; Arabul, M; Unsal, B; Miura, Y; Yamamoto, H				Aslan, Fatih; Alper, Emrah; Cekic, Cem; Yurtlu, Derya Arslan; Ekinci, Nese; Arabul, Mahmut; Unsal, Belkis; Miura, Yoshimasa; Yamamoto, Hironori			Endoscopic submucosal dissection in gastric lesions: the 100 cases experience from a tertiary reference center in West	SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY			English	Article						endoscopic submucosal dissection; gastric cancer; learning curve	LEARNING-CURVE; NEOPLASM; RESECTION; MUCOSAL; KNIFE	Objective. Endoscopic submucosal dissection (ESD) is an endoscopic treatment method widely used in premalignant and malignant lesions in countries of the Far East. This method, which is difficult technically and has a high complication risk rate, has rarely been performed in the West, because of the fewer number of upper gastrointestinal lesions. In the present study, we aimed to present our results of gastric ESD procedures in respect to the learning curve. Methods. A total of 100 ESD procedures, which were performed in the stomach between April 2012 and September 2014, were recorded prospectively before and after the procedure. Patient data were analyzed retrospectively. ESD procedures were numbered chronologically; the first 30 patients constituted group 1, whereas the rest were classified as the group 2. ESD results were compared between the groups. Results. In a total of 95 patients, 100 gastric ESDs were performed. The overall en-bloc and complete resection rates were 93% and 92%, respectively. In respect of the learning curve, there were significant differences in the sizes of lesions and tissues obtained, procedure duration and dissection rate, snare use and knife preferences between groups (p=0.002, p<0.001, p = 0.003, p < 0.001, p = 0.009, and p < 0.001, respectively). No significant difference was detected in the en-bloc and complete resection rates and complications between the groups. Conclusion. According to guideline recommendations and masters for ESD, if ESD training is initiated and continued, successful ESD may be performed in localized lesions in the stomach.	[Aslan, Fatih; Alper, Emrah; Cekic, Cem; Arabul, Mahmut; Unsal, Belkis] Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Gastroenterol, TR-35360 Izmir, Turkey; [Yurtlu, Derya Arslan] Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Anesthesiol & Reanimat, TR-35360 Izmir, Turkey; [Ekinci, Nese] Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Pathol, TR-35360 Izmir, Turkey; [Miura, Yoshimasa; Yamamoto, Hironori] Jichi Med Univ, Dept Endoscop Res & Int Educ, Shimotsuke, Tochigi, Japan	Aslan, F (reprint author), Katip Celebi Univ, Ataturk Egitim & Arastirma Hastanesi, Gastroenterol Klin, Basin Sitesi, TR-35360 Izmir, Turkey.	drfatihaslan@hotmail.com					Farhat S, 2011, ENDOSCOPY, V43, P664, DOI 10.1055/s-0030-1256413; Sakamoto T, 2011, DIS COLON RECTUM, V54, P1307, DOI 10.1097/DCR.0b013e3182282ab0; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Choi IJ, 2005, GASTROINTEST ENDOSC, V62, P860, DOI 10.1016/j.gie.2005.04.033; Yamamoto H, 2012, NAT REV GASTRO HEPAT, V9, P519, DOI 10.1038/nrgastro.2012.97; Draganov PV, 2013, GASTROINTEST ENDOSC, V78, P677, DOI 10.1016/j.gie.2013.07.033; Goda K, 2012, DIGEST ENDOSC, V24, P136, DOI 10.1111/j.1443-1661.2012.01274.x; Gotoda T, 2005, GASTROINTEST ENDOSC, V62, P866, DOI 10.1016/j.gie.2005.07.055; Teoh AYB, 2010, SURG ENDOSC, V24, P1049, DOI 10.1007/s00464-009-0724-8; Yamamoto Y, 2012, DIGEST ENDOSC, V24, P148, DOI 10.1111/j.1443-1661.2012.01278.x; Probst A, 2010, ENDOSCOPY, V42, P1037, DOI 10.1055/s-0030-1255668; Schumacher B, 2012, GASTROINTEST ENDOSC, V75, P1166, DOI 10.1016/j.gie.2012.02.027; Coman Roxana M, 2013, World J Gastrointest Endosc, V5, P369, DOI 10.4253/wjge.v5.i8.369; Gotoda Takuji, 2014, Gastrointest Endosc Clin N Am, V24, P213, DOI 10.1016/j.giec.2013.11.009; Kim Mi-Young, 2014, Gastrointest Endosc Clin N Am, V24, P283, DOI 10.1016/j.giec.2013.11.001; Neuhaus H, 2010, ENDOSCOPY, V42, P860, DOI 10.1055/s-0030-1255724; Neuhaus Horst, 2014, Gastrointest Endosc Clin N Am, V24, P295, DOI 10.1016/j.giec.2013.11.002; Ribeiro-Mourao F, 2010, ENDOSCOPY, V42, P814, DOI 10.1055/s-0030-1255778; Rosch T, 2004, ENDOSCOPY, V36, P788, DOI 10.1055/s-2004-825838; Suk KT, 2013, HEPATO-GASTROENTEROL, V60, P2107, DOI 10.5754/hge.12802; Toyonaga T, 2010, Acta Chir Iugosl, V57, P41; Yamashita T, 2010, SURG LAPARO ENDO PER, V20, P180, DOI 10.1097/SLE.0b013e3181e0d5db	23	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0036-5521	1502-7708		SCAND J GASTROENTERO	Scand. J. Gastroenterol.	MAR	2015	50	3					368	375		10.3109/00365521.2014.999253		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB1PG	WOS:000349399400015		
J	Maeda, S; Sumiya, S; Kasahara, J; Matsuo, A				Maeda, S.; Sumiya, S.; Kasahara, J.; Matsuo, A.			Scale effect of spherical projectiles for stabilization of oblique detonation waves	SHOCK WAVES			English	Article						Hypersonic projectiles; Detonation initiation; Oblique detonation waves; High-speed camera	GASEOUS DETONATIONS; DIRECT INITIATION; ENERGY; BODIES; COMBUSTION; MIXTURES	Oblique detonation waves (ODWs) were stabilized by launching a spherical projectile with 1.2-1.4 times the Chapman-Jouguet (C-J) velocity into detonable mixtures at rest. We used smaller projectiles (3.18 mm diameter) than those (4.76 mm diameter) in our previous studies and investigated the effect of the projectile scale on the stabilization of ODWs. We carried out high time resolution schlieren visualization using a high-speed camera. The detonable mixtures used were stoichiometric oxygen mixtures with acetylene, ethylene or hydrogen. They were diluted with argon with a 50 % volumetric fraction, and a dilute mixture containing 75 % argon was also tested for the acetylene/oxygen mixture. Here, we discuss the detonation stability in terms of the curvature effect arising from the three-dimensional nature of a stabilized ODW around a projectile. The curvature effect attenuated the detonation wave to below its C-J velocity in the vicinity of the projectile before the wave velocity asymptotically reached the C-J velocity in the far field. Our previous study showed that the propagation limit of the curvature effect is responsible for the stabilizing criticality of detonation waves. By obtaining detailed distributions of the wave propagation velocity and radius of curvature at the stabilizing criticality, we showed that the radius of curvature at the local minimum point of the wave propagation velocity represents the critical radius of curvature required for curved self-sustained detonation. In this study, we focused on this critical mode of the stabilized ODW for a small projectile (3.18 mm diameter). Distributions of the wave velocity and radius of curvature were obtained in the critical mode of the stabilized ODW. We compare these distributions with those for a larger projectile (4.76 mm diameter) and discuss the stabilizing criticality. For the small projectile, the observed combustion regimes had qualitatively the same trend for the initial pressure of the mixture as that observed for the large projectile. However, the initial pressure for each combustion regime was quantitatively different for the different projectile scales. The small projectile required a higher initial pressure to stabilize the ODW than the large projectile. For the critical mode of the stabilized ODW, the wave velocity distribution had a local minimum value (0.8-0.9 times the C-J velocity) due to the curvature effect. The radius of curvature at this characteristic point was about five times the projectile radius, regardless of the mixture composition. The radius of curvature normalized by the cell size was about 8-10 and 15 for mixtures diluted with 50 and 75 % argon, respectively, regardless of the projectile diameter. These results mean that the projectile radius (diameter) proportionally affects the geometrical scale of the wave around the projectile, and the fraction of the gas used for dilution affects the cell size required to sustain a curved detonation wave. The stabilizing criticality, expressed as the dimensionless projectile diameter (projectile diameter normalized by cell size), was about 3.5 and 5.5 for mixtures diluted with 50 and 75 % argon, respectively. These criticalities agreed with those of the large projectile of the previous study. This indicates that the dimensionless projectile diameter is a unique parameter for the stabilizing criticality regardless of the projectile diameter.	[Maeda, S.; Sumiya, S.; Kasahara, J.] Univ Tsukuba, Dept Engn Mech & Energy, Tsukuba, Ibaraki 3058573, Japan; [Matsuo, A.] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Kasahara, J (reprint author), Univ Tsukuba, Dept Engn Mech & Energy, 3F Bldg Room 109,1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	kasahara@nuae.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20241040, 21360411]; Institute of Space and Astronautical Science, the Japan Aerospace Exploration Agency	This work was subsidized by the Ministry of Education, Culture, Sports, Science and Technology via a Grant-in-Aid for Scientific Research (A), No. 20241040; a Grant-in-Aid for Scientific Research (B), No. 21360411; and the Research Grant Program from the Institute of Space and Astronautical Science, the Japan Aerospace Exploration Agency.	Shepherd JE, 2009, P COMBUST INST, V32, P83, DOI 10.1016/j.proci.2008.08.006; Maeda S, 2012, COMBUST FLAME, V159, P887, DOI 10.1016/j.combustflame.2011.09.001; HE LT, 1994, J FLUID MECH, V277, P227, DOI 10.1017/S0022112094002740; Choi JY, 2009, P COMBUST INST, V32, P2387, DOI 10.1016/j.proci.2008.06.212; Maeda S, 2013, P COMBUST INST, V34, P1973, DOI 10.1016/j.proci.2012.05.035; Zhang B, 2012, SHOCK WAVES, V22, P275, DOI 10.1007/s00193-011-0351-x; BILLIG FS, 1967, J SPACECRAFT ROCKETS, V4, P822, DOI 10.2514/3.28969; Verreault J, 2013, P COMBUST INST, V34, P1913, DOI 10.1016/j.proci.2012.07.040; Choi JY, 2007, P COMBUST INST, V31, P2473, DOI 10.1016/j.proci.2006.07.173; LEE JHS, 1977, ANNU REV PHYS CHEM, V28, P75, DOI 10.1146/annurev.pc.28.100177.000451; YAO J, 1995, COMBUST FLAME, V100, P519, DOI 10.1016/0010-2180(94)00144-H; Zhang B, 2011, P COMBUST INST, V33, P2265, DOI 10.1016/j.proci.2010.06.165; CHERNYAVSKII SY, 1973, COMBUST EXPLO SHOCK+, V9, P687, DOI 10.1007/BF00743020; Desbordes D., 1993, PROG ASTRONAUT AERON, V153, P347; HERTZBERG A, 1988, AIAA J, V26, P195, DOI 10.2514/3.9872; Higgins A.J., 1996, 960342 AIAA; Kaneshige M, 1997, FM978 GALCIT; Kaneshige MJ, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P3015; Kasahara J, 2002, P COMBUST INST, V29, P2817, DOI 10.1016/S1540-7489(02)80344-3; Kasahara J, 2001, AIAA J, V39, P1553, DOI 10.2514/2.1480; Lee J.H.S., 1982, FUEL AIR EXPLOSIONS, P157; Lee J.H.S., 1997, PROG ASTRONAUT AERON, V173, P293; LEHR HF, 1972, ASTRONAUT ACTA, V17, P589; LI CP, 1994, PHYS FLUIDS, V6, P1600, DOI 10.1063/1.868273; Maeda S, 2011, P COMBUST INST, V33, P2343, DOI 10.1016/j.proci.2010.06.066; Maeda S., 2012, T JSASS AEROSP TECH, V10, pPe1; MOEN IO, 1986, PROG ASTRONAUT AERON, V106, P220; Nakayama H, 2013, P COMBUST INST, V34, P1939, DOI 10.1016/j.proci.2012.06.012; Powers J.M., 1994, COMBUSTION HIGH SPEE; Redulescu M.I., 2003, J FLUID MECH, V480, P1; Reynolds W.C., 1986, A3991 STANF U; Shepherd J.E., 1986, P 21 S INT COMB PITT, P1649; Vasiljev A. A., 1994, Shock Waves, V3, DOI 10.1007/BF01415830; Verreault J, 2011, P COMBUST INST, V33, P2311, DOI 10.1016/j.proci.2010.07.086; Viguier C., 1998, P 27 INT S COMB, P2207	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	MAR	2015	25	2					141	150		10.1007/s00193-015-0549-4		10	Mechanics	Mechanics	CB1FT	WOS:000349373100003		
J	Oishi, AS; Chan, RKH; Wang, LLR; Kim, JH				Oishi, Akiko Sato; Chan, Raymond K. H.; Wang, Lillian Lih-Rong; Kim, Ju-Hyun			Do Part-Time Jobs Mitigate Workers' Work-Family Conflict and Enhance Wellbeing? New Evidence from Four East-Asian Societies	SOCIAL INDICATORS RESEARCH			English	Article						Work-family conflict; Job satisfaction; Happiness; Part-time work; East Asia	SATISFACTION; HEALTH; EMPLOYMENT; GENDER; WOMEN; LABOR	Studies in Western countries have shown that part-time work is associated with lower work-family conflict and higher job satisfaction, especially in the case of women. The present study addressed three questions: (1) are part-time workers more likely to report a lower level of work-family conflict and higher levels of job satisfaction and life satisfaction than those who work full-time? (2) Does having children or living with an older person who needs to be cared for affect individuals' work-family conflict, job satisfaction and life satisfaction? (3) Are gender-role beliefs associated with work-family conflict, job satisfaction and life satisfaction? To answer these questions, joint ordered probit models were estimated using a merged dataset on workers in four East-Asian societies: Hong Kong, Japan, Korea, and Taiwan. The outcome measures used in the analyses were: work-family conflict, family-work conflict, job satisfaction, and life satisfaction. Controlling for personal and family attributes, part-time work was negatively associated with work-family conflict and job satisfaction, but not with life satisfaction. Although having children was not related to outcome measures, living with a frail elderly person significantly increased work-family and family-work conflicts. Married women who accepted gender-role beliefs were less likely to have work-family conflict.	[Oishi, Akiko Sato] Chiba Univ, Fac Law & Econ, Inage Ku, Chiba 2638522, Japan; [Chan, Raymond K. H.] City Univ Hong Kong, Dept Appl Social Studies, Kowloon, Hong Kong, Peoples R China; [Wang, Lillian Lih-Rong] Natl Taiwan Univ, Dept Social Work, Taipei 10626, Taiwan; [Kim, Ju-Hyun] Seoul Natl Univ, Inst Social Dev & Policy Res, Seoul 151742, South Korea	Oishi, AS (reprint author), Chiba Univ, Fac Law & Econ, Inage Ku, Yayoi Cho 1-33, Chiba 2638522, Japan.	oishi@le.chiba-u.ac.jp		Chan, Raymond K H/0000-0003-1892-8053			Allen T D, 2000, J Occup Health Psychol, V5, P278, DOI 10.1037/1076-8998.5.2.278; Grzywacz JG, 2000, AM J HEALTH PROMOT, V14, P236; Greenstein TN, 2009, J MARRIAGE FAM, V71, P1039; Lyness KS, 2012, AM SOCIOL REV, V77, P1023, DOI 10.1177/0003122412465331; Kossek EE, 2001, ACAD MANAGE J, V44, P29, DOI 10.2307/3069335; ZELLNER A, 1962, J AM STAT ASSOC, V57, P348, DOI 10.2307/2281644; Frone MR, 1997, J OCCUP ORGAN PSYCH, V70, P325, DOI 10.1111/j.2044-8325.1997.tb00652.x; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; Booth AL, 2008, ECON J, V118, pF77; Bardasi E, 2004, SOC SCI MED, V58, P1671, DOI 10.1016/S0277-9536(03)00400-3; Aycan Z., 2011, HDB WORK FAMILIY INT, P353; BLANK RM, 1989, AM ECON REV, V79, P295; Booth A. L., 2002, ECON J, V112, P189; Booth AL, 2009, ECONOMICA, V76, P176, DOI 10.1111/j.1468-0335.2007.00670.x; Booth AL, 2013, J POPUL ECON, V26, P263, DOI 10.1007/s00148-012-0417-9; Dorio JM, 2008, HANDBOOK OF WORK-FAMILY INTEGRATION: RESEARCH, THEORY, AND BEST PRACTICES, P157, DOI 10.1016/B978-012372574-5.50012-0; FRONE MR, 1993, J ORGAN BEHAV, V14, P545, DOI 10.1002/job.4030140604; Geurts Sabine, 2004, COMMUNITY WORK FAMIL, V7, P285, DOI DOI 10.1080/1366880042000295727; Higgins C, 2000, HUM RESOURCE MANAGE, V39, P17, DOI 10.1002/(SICI)1099-050X(200021)39:1<17::AID-HRM3>3.3.CO;2-P; Hofstede G. H., 1980, CULTURES CONSEQUENCE; Kelloway E K, 1999, J Occup Health Psychol, V4, P337, DOI 10.1037//1076-8998.4.4.337; Ko JJR, 2013, SOC INDIC RES, V110, P453, DOI 10.1007/s11205-011-9937-z; Lee B.-H. V., 2011, J ASIAN PUBLIC POLIC, V4, P103; Lin K, 2013, SOC INDIC RES, V112, P641, DOI 10.1007/s11205-012-0074-0; Ngo H., 2002, INT J HUM RESOUR MAN, V13, P361; OECD, 2012, EMPL OUTL 2012; Organisation for Economic Co-operation and Development (OECD), 2010, EMPL OUTL 2010; Tilly Chris, 1996, HALF JOB BAD GOOD PA	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300	1573-0921		SOC INDIC RES	Soc. Indic. Res.	MAR	2015	121	1			SI		5	25		10.1007/s11205-014-0624-8		21	Social Sciences, Interdisciplinary; Sociology	Social Sciences - Other Topics; Sociology	CB0OK	WOS:000349325700002		
J	Chen, J; Choi, YJ; Mori, K; Sawada, Y; Sugano, S				Chen, Joe; Choi, Yun Jeong; Mori, Kota; Sawada, Yasuyuki; Sugano, Saki			An Analysis of Suicides in Japan, 1997-2007: Changes in Incidence, Persistence, and Age Profiles	SOCIAL INDICATORS RESEARCH			English	Article						Suicide; Decomposition; Degree of contribution; Panel data regression		This study investigates the abrupt increase in the number of suicides in Japan in 1998 and the subsequent persistence of suicide thereafter; it does so by undertaking data decompositions in terms of demographic factors, reasons for suicide, employment status, and access to the means of committing suicide. The decomposition results regarding the growth in the Japanese suicide rate from 1997 to 1998 show that a large proportion of the abrupt increase in the number of suicides can be attributed to middle-aged men with financial problems, and that the self-employed subset of the population contributed significantly to growth in the suicide rate. Meanwhile, persistently high suicide rates since 1998 can be largely attributed to the younger generation (i.e., those aged 20-39). In accordance with the decomposition results, prefecture-level panel data regression established a correlation between suicide and economic hardship. In particular, the unemployment rate and the individual bankruptcy rate were found to be positively associated with the suicide rates of all males, males aged 20-39, and males aged 40-59, while individual bankruptcy was found to affect middle-aged males more than younger males.	[Chen, Joe] Natl Chengchi Univ, Dept Publ Finance, Taipei 11605, Taiwan; [Choi, Yun Jeong] Yonsei Univ, Sch Econ, Seoul 120749, South Korea; [Mori, Kota] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Sawada, Yasuyuki] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan; [Sugano, Saki] Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Tokyo 1130033, Japan; [Sugano, Saki] Japan Soc Promot Sci, Tokyo, Japan	Choi, YJ (reprint author), Yonsei Univ, Sch Econ, 50 Yonsei Ro, Seoul 120749, South Korea.	joe@nccu.edu.tw; yun.choi@yonsei.ac.kr; kota.mori@yale.edu; sawada@e.u-tokyo.ac.jp; esugano@mail.ecc.u-tokyo.ac.jp					Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Chen J, 2012, J ECON SURV, V26, P271, DOI 10.1111/j.1467-6419.2010.00645.x; Asano H., 2011, RIETI DISCUSSION PAP, V11-E-021; Chen J., 2008, CIRJE DISCUSSION PAP, V558; Chen J, 2009, JPN WORLD ECON, V21, P140, DOI 10.1016/j.japwor.2008.06.001; Chen J, 2010, ECON LETT, V109, P69, DOI 10.1016/j.econlet.2010.08.007; Conwell Y, 1995, Int Psychogeriatr, V7, P149, DOI 10.1017/S1041610295001943; HAMERMES.DS, 1974, J POLIT ECON, V82, P83, DOI 10.1086/260171; Japan National Police Agency, 2009, ANN REP SUIC; Mori K., 2012, EC B, V32, P2710; Organization for Small and Medium Enterprises and Regional Innovation, ENT BANKR SURV ANN R; Suicide Investigation Team, 2008, JIS JITT HAK 2008; Watanabe R., 2006, 626 KYOT I EC RES	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300	1573-0921		SOC INDIC RES	Soc. Indic. Res.	MAR	2015	121	1			SI		253	272		10.1007/s11205-014-0635-5		20	Social Sciences, Interdisciplinary; Sociology	Social Sciences - Other Topics; Sociology	CB0OK	WOS:000349325700015		
J	Alberton, P; Dex, S; Popov, C; Shukunami, C; Schieker, M; Docheva, D				Alberton, Paolo; Dex, Sarah; Popov, Cvetan; Shukunami, Chisa; Schieker, Matthias; Docheva, Denitsa			Loss of Tenomodulin Results in Reduced Self-Renewal and Augmented Senescence of Tendon Stem/Progenitor Cells	STEM CELLS AND DEVELOPMENT			English	Article							MESENCHYMAL STEM-CELLS; CHONDROMODULIN-I; BONE-MARROW; GENE; DIFFERENTIATION; EXPRESSION; ANGIOGENESIS; SCLERAXIS; DOMAIN; IDENTIFICATION	Tenomodulin (Tnmd) is a well-known gene marker for the tendon and ligament lineage, but its exact functions in these tissues still remain elusive. In this study, we investigated Tnmd loss of function in mouse tendon stem/progenitor cells (mTSPC) by implicating a previously established Tnmd knockout (KO) mouse model. mTSPC were isolated from control and Tnmd KO tail tendons and their stemness features, such as gene marker profile, multipotential, and self-renewal, were compared. Immunofluorescence and reverse transcriptase-polymerase chain reaction analyses for stem cell-, tenogenic-, osteogenic-, and chondrogenic-related genes confirmed their stemness and lineage specificity and demonstrated no profound differences between the two genotypes. Multipotential was not significantly affected since both cell types differentiated successfully into adipogenic, osteogenic, and chondrogenic lineages. In contrast, self-renewal assays validated that Tnmd KO TSPC exhibit significantly reduced proliferative potential, which was also reflected in lower Cyclin D1 levels. When analyzing possible cellular mechanisms behind the observed decreased self-renewability of Tnmd KO TSPC, we found that cellular senescence plays a major role, starting earlier and cumulating more in Tnmd KO compared with control TSPC. This was accompanied with augmented expression of the cell cycle inhibitor p53. Finally, the proliferative effect of Tnmd in TSPC was confirmed with transient transfection of Tnmd cDNA into Tnmd KO TSPC, which rescued their proliferative deficit. Taken together, we can report that loss of Tnmd affects significantly the self-renewal and senescence properties, but not the multipotential of TSPC.	[Alberton, Paolo; Dex, Sarah; Popov, Cvetan; Schieker, Matthias; Docheva, Denitsa] Univ Munich, Dept Surg, D-80336 Munich, Germany; [Shukunami, Chisa] Kyoto Univ, Inst Frontier Med Sci, Dept Cellular Differentiat, Kyoto, Japan; [Shukunami, Chisa] Inst Biomed & Hlth Sci, Dept Mol Biol & Biochem, Hiroshima, Japan	Docheva, D (reprint author), Univ Munich, Dept Surg, Nussbaumstr 20, D-80336 Munich, Germany.	denitsa.docheva@med.uni-muenchen.de	Schieker, Matthias/J-6511-2015	Schieker, Matthias/0000-0002-1230-3653	German Research Foundation (DFG) [DD 1414/3-1, PO 1718/1-1]; Bavarian Research Foundation [DOK-100-08]	D.D. acknowledges the German Research Foundation (DFG grant. DD 1414/3-1). P.A. and D.D. acknowledge the support of the Bavarian Research Foundation (Project: DOK-100-08). C.P. was supported by the German Research Foundation (DFG grant: PO 1718/1-1). M.S. current address is at Amgen GmbH, Munich.	Kimura N, 2008, CIRCULATION, V118, P1737, DOI 10.1161/CIRCULATIONAHA.108.780031; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Tempfer H, 2009, HISTOCHEM CELL BIOL, V131, P733, DOI 10.1007/s00418-009-0581-5; Takimoto A, 2012, EXP CELL RES, V318, P1492, DOI 10.1016/j.yexcr.2012.04.002; Mienaltowski MJ, 2013, TISSUE ENG PT A, V19, P199, DOI [10.1089/ten.TEA.2012.0182, 10.1089/ten.tea.2012.0182]; Bocker WG, 2008, J MOL MED, V86, P1183, DOI 10.1007/s00109-008-0378-3; Kohler J, 2013, AGING CELL, V12, P988, DOI 10.1111/acel.12124; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Brent AE, 2005, DEVELOPMENT, V132, P515, DOI 10.1242/dev.01605; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Gouttenoire J, 2010, EUR J CELL BIOL, V89, P307, DOI 10.1016/j.ejcb.2009.10.018; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Brandau O, 2001, DEV DYNAM, V221, P72, DOI 10.1002/dvdy.1126; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Zhou ZP, 2010, AGING CELL, V9, P911, DOI 10.1111/j.1474-9726.2010.00598.x; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; SPRING FA, 1988, IMMUNOLOGY, V64, P37; Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150; Inoue H, 1997, BIOCHEM BIOPH RES CO, V241, P395, DOI 10.1006/bbrc.1997.7820; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Komiyama Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060203; LENDAHL U, 1990, TRENDS NEUROSCI, V13, P132, DOI 10.1016/0166-2236(90)90004-T; Oshima Y, 2004, J CELL SCI, V117, P2731, DOI 10.1242/jcs.01112; Saiki A, 2009, J CLIN ENDOCR METAB, V94, P3987, DOI 10.1210/jc.2009-0292; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Shukunami C, 2001, BIOCHEM BIOPH RES CO, V280, P1323, DOI 10.1006/bbrc.2001.4271; Shukunami C, 2007, CURR PHARM DESIGN, V13, P2101; Tolppanen AM, 2007, OBESITY, V15, P1082, DOI 10.1038/oby.2007.613; Tolppanen AM, 2010, ANN MED, V42, P265, DOI 10.3109/07853891003801123	38	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	MAR 1	2015	24	5					597	609		10.1089/scd.2014.0314		13	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	CB7RG	WOS:000349824400006		
J	Yin, FT; Futagawa, T; Li, D; Ma, YX; Lu, MH; Lu, L; Li, S; Chen, Y; Cao, YJ; Yang, ZZ; Oiso, S; Nishida, K; Kuchiiwa, S; Watanabe, K; Yamada, K; Takeda, Y; Xiao, ZC; Ma, QH				Yin, Feng-Ting; Futagawa, Toshitaka; Li, Di; Ma, Yan-Xia; Lu, Mei-Hong; Lu, Li; Li, Shen; Chen, Yao; Cao, Yong-Jun; Yang, Zara Zhuyun; Oiso, Shigeru; Nishida, Kentaro; Kuchiiwa, Satoshi; Watanabe, Kazutada; Yamada, Katsushi; Takeda, Yasuo; Xiao, Zhi-Cheng; Ma, Quan-Hong			Caspr4 Interaction with LNX2 Modulates the Proliferation and Neuronal Differentiation of Mouse Neural Progenitor Cells	STEM CELLS AND DEVELOPMENT			English	Article							AUTISM SPECTRUM DISORDERS; WNT/BETA-CATENIN PATHWAY; HIPPOCAMPAL NEUROGENESIS; NEUREXIN SUPERFAMILY; SIGNALING PATHWAY; MYELINATED AXONS; NERVOUS-SYSTEM; PDZ DOMAINS; K+ CHANNELS; STEM-CELLS	Contactin-associated protein 4 (Caspr4), also known as contactin-associated protein-like protein (CNTNAP4), is expressed in various regions of the brain. Recent reports suggest that CNTNAP4 is a susceptibility gene of autism spectrum disorders (ASDs). However, the molecular function of Caspr4 in the brain has yet to be identified. In this study, we show an essential role of Caspr4 in neural progenitor cells (NPCs). Caspr4 is expressed in NPCs in the subventricular zone (SVZ), a neurogenic region in the developing cortex. Knocking down of Caspr4 enhances the proliferation of NPCs derived from the SVZ of embryonic day 14 mouse. Neuronal differentiation is increased by overexpression of Caspr4, but decreased by knocking down of Caspr4 in cultured mouse NPCs. Transfection of the intracellular domain of Caspr4 (C4ICD) rescues the abnormal decreased neuronal differentiation of Caspr4-knocking down NPCs. Ligand of Numb protein X2 (LNX2), a binding partner of Numb, interacts with Caspr4 in a PDZ domain-dependent manner and plays a similar role to Caspr4 in NPCs. Moreover, transfection of LNX2 rescues the decreased neuronal differentiation in Caspr4-knocking down NPCs. In contrast, transfection of C4ICD fails to do so in LNX2-knocking down NPCs. These results indicate that Caspr4 inhibits neuronal differentiation in a LNX-dependent manner. Therefore, this study reveals a novel role of Caspr4 through LNX2 in NPCs, which may link to the pathogenesis of ASDs.	[Yin, Feng-Ting; Li, Di; Ma, Yan-Xia; Lu, Mei-Hong; Cao, Yong-Jun; Ma, Quan-Hong] Soochow Univ, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Suzhou 215021, Jiangsu, Peoples R China; [Yin, Feng-Ting; Li, Di; Ma, Yan-Xia; Lu, Mei-Hong; Cao, Yong-Jun; Ma, Quan-Hong] Soochow Univ, Inst Neurosci, Suzhou 215021, Jiangsu, Peoples R China; [Futagawa, Toshitaka; Lu, Li; Yang, Zara Zhuyun; Xiao, Zhi-Cheng] Monash Univ, Dept Anat & Dev Biol, Shunxi Monash Immune Regenerat & Neurosci Labs, Clayton, Vic 3800, Australia; [Futagawa, Toshitaka; Oiso, Shigeru; Nishida, Kentaro; Yamada, Katsushi; Takeda, Yasuo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 8908520, Japan; [Futagawa, Toshitaka; Lu, Li; Yang, Zara Zhuyun; Xiao, Zhi-Cheng] Kunming Med Univ, Inst Mol & Clin Med, Key Lab Stem Cells & Regenerat Med, Kunming, Peoples R China; [Lu, Li] Shanxi Med Univ, Dept Anat, Taiyuan, Peoples R China; [Li, Shen] Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Neurol, Dalian, Peoples R China; [Chen, Yao] Chinese PLA 309 Hosp, Organ Transplant Inst, Beijing, Peoples R China; [Kuchiiwa, Satoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neuroanat, Kagoshima 890, Japan; [Watanabe, Kazutada] Nagaoka Coll, Natl Inst Technol, Nagaoka, Niigata, Japan	Xiao, ZC (reprint author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	takeda@m.kufm.kagoshima-u.ac.jp; zhicheng.xiao@monash.edu; maquanhong@suda.edu.cn			National Program on Key Basic Research Project [2013CB945602]; National Natural Science Foundation of China [31171313]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Suzhou Science and Technology Development Program [SZS201205]; Soochow University Satrtup Foundation [Q421500110]; Monash Professorial Fellowship, Monash University, Australia; Ministry of Education, Culture, Sports, Science, and Technology of Japan [15500275, 20590149]	This work was supported by grants to Q.-H.M. from the National Program on Key Basic Research Project (2013CB945602), National Natural Science Foundation of China (31171313), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Suzhou Science and Technology Development Program (SZS201205), Soochow University Satrtup Foundation (Q421500110), to Z.-C.X. from the Talent Program, Yunnan Province, China and Monash Professorial Fellowship, Monash University, Australia; Y.T. as Grant-in-Aid for General Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (15500275, 20590149). We thank Dr. Kerstin for providing LNX2 and LNX1 cDNA and LNX2 antibody, Dr. Kazutada Watanabe for his support and advice, and Ms. Sha sha Lu for organizing the figures.	Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Traut W, 2006, MAMM GENOME, V17, P723, DOI 10.1007/s00335-005-0157-1; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Devanathan V, 2010, J NEUROSCI, V30, P9292, DOI 10.1523/JNEUROSCI.5657-09.2010; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; D'Agostino M, 2011, J CELL SCI, V124, P3545, DOI 10.1242/jcs.081224; Scott K, 1998, NATURE, V395, P805; Camps J, 2013, CANCER RES, V73, P2003, DOI 10.1158/0008-5472.CAN-12-3159; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Taupin P, 2009, CURR ALZHEIMER RES, V6, P461; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Kansaku A, 2006, ONCOGENE, V25, P5071, DOI 10.1038/sj.onc.1209468; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Wang LS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-134	37	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	MAR 1	2015	24	5					640	652		10.1089/scd.2014.0261		13	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	CB7RG	WOS:000349824400009		
J	Mizota, T; Watanabe, Y; Madani, A; Takemoto, N; Yamada, H; Poudel, S; Miyasaka, Y; Kurashima, Y				Mizota, Tomoko; Watanabe, Yusuke; Madani, Amin; Takemoto, Norihiro; Yamada, Hidehisa; Poudel, Saseem; Miyasaka, Yuji; Kurashima, Yo			Liquid-injection for preperitoneal dissection of transabdominal preperitoneal (TAPP) inguial hernia repair	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article; Proceedings Paper	Annual Meeting of the Society-of-American-Gastrointestinal-and-Endoscopic-Surgeons (SAGES)	APR 02-05, 2014	Salt Lake City, UT	Soc Amer Gastrointestinal & Endoscop Surg		Laparoscopic inguinal hernia repair; Endoscopic hernia repair; Preperitoneal dissection; Dissection technique	COMPLICATIONS	The creation of an adequate peritoneal flap during laparoscopic transabdominal preperitoneal (TAPP) inguinal hernia repair, while avoiding injuring surrounding structures can be technically challenging. Liquid infiltration of the preperitoneal space can help facilitate dissection and avoid inadvertent injuries. We describe a novel technique for TAPP inguinal hernia repair using liquid-injection for preperitonal dissection and report our initial experience. TAPP inguinal hernia repair using a liquid-injection technique during preperitoneal dissection was performed by a single surgical resident without prior TAPP repair experience from July 2013 to January 2014. After trocar placement, 60 mL of 0.3 % lidocaine with 1:300,000 dilution of epinephrine was injected percutaneously using a blunt needle under laparoscopic visualization into the preperitoneal space to assist with the dissection and parietalization of the vas deferens, spermatic vessels, and epigastric vessels. The initial peritoneal incision is performed at the lateral side of the inguinal canal, followed by blunt dissection of the preperitoneal space. Eleven patients (median age: 69; 8 male) with a total of 12 inguinal hernias underwent a TAPP repair using a liquid-injection preperitoneal dissection technique. Ten patients had unilateral hernias (4 indirect, 6 direct), and one patient had bilateral direct hernias. The median operative time, median injection time, and median dissection time were 116, 3.5, and 42 min, respectively. Estimated blood loss was less than 10 mL for all cases. No intraoperative injuries, conversions to open repair, or 30-day postoperative complications occurred. There were no hernia recurrences after a median follow-up of 143 days. Our preliminary experience suggests that liquid-injection to assist preperitoneal dissection during TAPP inguinal hernia repair appears to be safe and feasible. This novel method facilitates the dissection of spermatic cord structures, and can be used to minimize trauma to surrounding structures, especially when performed by trainees with limited operative experience.	[Mizota, Tomoko; Takemoto, Norihiro; Yamada, Hidehisa; Miyasaka, Yuji] NTT East Sapporo Hosp, Sapporo, Hokkaido, Japan; [Mizota, Tomoko; Watanabe, Yusuke; Poudel, Saseem; Kurashima, Yo] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Madani, Amin] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada	Mizota, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	tmizota@huhp.hokudai.ac.jp; ywatanabe328@gmail.com; amin.madani@mail.mcgill.ca; nori-take@pop16.odn.ne.jp; h-yamada@east.ntt.co.jp; saseem@gmail.com; cs-miya@east.ntt.co.jp; yo.kurashima@huhp.hokudai.ac.jp					Bittner R, 2011, SURG ENDOSC, V25, P2773, DOI 10.1007/s00464-011-1799-6; Bittner R, 2002, BRIT J SURG, V89, P1062, DOI 10.1046/j.1365-2168.2002.02178.x; Edwards CC, 2000, SURG LAPARO ENDO PER, V10, P149, DOI 10.1097/00019509-200006000-00010; Tong YS, 2014, HERNIA, V18, P177, DOI 10.1007/s10029-013-1100-0; Felix EL, 1999, SURG ENDOSC-ULTRAS, V13, P328, DOI 10.1007/s004649900982; Lovisetto F, 2007, SURG ENDOSC, V21, P646, DOI 10.1007/s00464-006-9031-9; Quinn T H, 1995, Clin Anat, V8, P245, DOI 10.1002/ca.980080402; Tokumura H, 2011, J JPN SURG ASS, V72, P2204; Wake BL, 2005, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004703.PUB2	9	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	MAR	2015	29	3					516	520		10.1007/s00464-014-3703-7		5	Surgery	Surgery	CB0DU	WOS:000349296400004		
J	Mizota, T; Watanabe, Y; Madani, A; Takemoto, N; Yamada, H; Poudel, S; Miyasaka, Y; Kurashima, Y				Mizota, Tomoko; Watanabe, Yusuke; Madani, Amin; Takemoto, Norihiro; Yamada, Hidehisa; Poudel, Saseem; Miyasaka, Yuji; Kurashima, Yo			Liquid-injection for preperitoneal dissection of transabdominal preperitoneal (TAPP) inguinal hernia repair (vol 29, pg 516, 2015)	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Correction									[Mizota, Tomoko; Takemoto, Norihiro; Yamada, Hidehisa; Miyasaka, Yuji] NTT East Sapporo Hosp, Sapporo, Hokkaido, Japan; [Mizota, Tomoko; Watanabe, Yusuke; Poudel, Saseem; Kurashima, Yo] Hokkaido Univ, Grad Sch Med, Dept Surg Gastroenterol 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Madani, Amin] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada	Mizota, T (reprint author), NTT East Sapporo Hosp, Sapporo, Hokkaido, Japan.	tmizota@huhp.hokudai.ac.jp; ywatanabe328@gmail.com; amin.madani@mail.mcgill.ca; nori-take@pop16.odn.ne.jp; h-yamada@east.ntt.co.jp; saseem@gmail.com; cs-miya@east.ntt.co.jp; yo.kurashima@huhp.hokudai.ac.jp					Mizota T, 2015, SURG ENDOSC, V29, P516, DOI 10.1007/s00464-014-3703-7	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	MAR	2015	29	3					521	521		10.1007/s00464-014-4058-9		1	Surgery	Surgery	CB0DU	WOS:000349296400005		
J	Nakamura, F; Saito, Y; Sakamoto, T; Otake, Y; Nakajima, T; Yamamoto, S; Murakami, Y; Ishikawa, H; Matsuda, T				Nakamura, Fumihiko; Saito, Yutaka; Sakamoto, Taku; Otake, Yosuke; Nakajima, Takeshi; Yamamoto, Seiichiro; Murakami, Yoshitaka; Ishikawa, Hideki; Matsuda, Takahisa			Potential perioperative advantage of colorectal endoscopic submucosal dissection versus laparoscopy-assisted colectomy	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Colon; Early colorectal cancer; Endoscopic submucosal dissection; Laparoscopy-assisted colectomy; Quality of life	TIPPED ELECTROSURGICAL KNIFE; LATERALLY SPREADING TUMORS; OF-LIFE OUTCOMES; MUCOSAL RESECTION; GASTRIC-CANCER; EFFICACY; NEOPLASMS; INVASION; SURGERY; LARGER	Endoscopic submucosal dissection (ESD) has recently provided a new treatment strategy for large colorectal neoplasms, as an alternative to laparoscopy-assisted colectomy (LAC). Prospective comparative data on the perioperative course of ESD vis-A -vis LAC are scarce. We prospectively evaluated the perioperative course of colorectal ESD in 300 patients. We evaluated en bloc and curative resection, procedure duration, postoperative parameters [white blood cell count (WBC), C-reactive protein (CRP), and hemoglobin], pain, recovery duration (time to achieve full mobilization, normal diet, and length of hospitalization), and complications. We also prospectively evaluated 190 patients undergoing LAC as a control group. The median size of the lesions was 30 mm for ESDs (LACs: 20 mm). The median procedure time was 90 min for ESDs (LACs: 185 min). Postoperative pyrexia was reported in 4 % of ESDs (LACs: 54 %). Only 4 % of ESDs required analgesia (LACs: 61 %). Between the preoperative period and postoperative day 1, the mean difference in WBC and CRP was +1,300/mu l for ESDs (LACs: +3,100/mu l), and +0.91 mg/dl for ESDs (LACs: +3.96 mg/dl), respectively. A a parts per thousand yen2 g/dl decrease in hemoglobin was observed in 5 % of ESDs (LACs: 30.0 %). Complications were seen in 7 % of ESDs (LACs: 15 %). The rate of delayed bleeding and perforation was 5 and 1.7 % of ESDs, respectively. Although only one of them required laparotomy for peritonitis caused by delayed perforation, others could be managed endoscopically. Additional LAC was required in 16 ESDs due to redefined risk for lymph node metastases. The median hospital stay was 5 days for ESDs (LACs: 10 days). These were consecutive patients with prospective data collection. Colorectal ESD is effective, minimally invasive and safe in terms of periperative clinical course. Colorectal ESD provides advantages for treatment of large adenomas and early cancers with no risk of lymph node metastasis.	[Nakamura, Fumihiko; Saito, Yutaka; Sakamoto, Taku; Otake, Yosuke; Nakajima, Takeshi; Matsuda, Takahisa] Natl Canc Ctr, Endoscopy Div, Chuo Ku, Tokyo 1040045, Japan; [Nakamura, Fumihiko] Kohseichuo Gen Hosp, Ctr Digest Dis, Tokyo, Japan; [Yamamoto, Seiichiro] Natl Canc Ctr, Colorectal Surg Div, Tokyo 1040045, Japan; [Yamamoto, Seiichiro] Hiratsuka City Hosp, Dept Surg, Hiratsuka, Kanagawa, Japan; [Murakami, Yoshitaka] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga, Japan; [Ishikawa, Hideki] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan	Nakamura, F (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	jymxg256@ybb.ne.jp; ytsaito@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-19, 25-A-12]	This prospective study was partially supported by National Cancer Center Research and Development Fund (23-A-19 and 25-A-12) to Dr. Saito. The other authors disclosed no financial relationships relevant to this publication.	Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Saito Y, 2010, SURG ENDOSC, V24, P343, DOI 10.1007/s00464-009-0562-8; Kobayashi T, 2004, JPN J CLIN ONCOL, V34, P118, DOI 10.1093/jjco/hyh025; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Repici A, 2013, GASTROINTEST ENDOSC, V77, P96, DOI 10.1016/j.gie.2012.08.036; Saito Y, 2007, GASTROINTEST ENDOSC, V65, P537, DOI 10.1016/j.gie.2006.11.002; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Yamamoto H, 2003, ENDOSCOPY, V35, P690; Kiriyama S, 2012, ENDOSCOPY, V44, P1024, DOI 10.1055/s-0032-1310259; Park SU, 2012, ENDOSCOPY, V44, P1031, DOI 10.1055/s-0032-1310015; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Gotoda T, 1999, GASTROINTEST ENDOSC, V50, P560, DOI 10.1016/S0016-5107(99)70084-2; Matsuda T, 2008, AM J GASTROENTEROL, V103, P2700, DOI 10.1111/j.1572-0241.2008.02190.x; Weeks JC, 2002, JAMA-J AM MED ASSOC, V287, P321, DOI 10.1001/jama.287.3.321; Ohkuwa M, 2001, ENDOSCOPY, V33, P221, DOI 10.1055/s-2001-12805; Aoki T, 2012, WORLD J GASTROENTERO, V18, P3721, DOI 10.3748/wjg.v18.i28.3721; Fu KI, 2008, DIGEST DIS SCI, V53, P1886, DOI 10.1007/s10620-007-0104-y; Hosokawa K, 1998, JPN J CANC CHEMOTHER, V25, P476; Kiriyama S, 2011, J GASTROEN HEPATOL, V26, P1028, DOI 10.1111/j.1440-1746.2011.06684.x; Kondo H, 2004, GASTROINTEST ENDOSC, V59, P284, DOI 10.1016/S0016-5107(03)02533-1; Saito Y, 2005, GASTROINTEST ENDOSC, V62, P297, DOI 10.1016/S0016-5107(05)00546-8; Sakamoto T, 2012, J GASTROENTEROL, V47, P635, DOI 10.1007/s00535-011-0524-5; Sano Y, 2006, ENDOSCOPY, V38, pE95, DOI 10.1055/s-2006-944622; Tanaka S, 2001, GASTROINTEST ENDOSC, V54, P62, DOI 10.1067/mge.2001.115729; Velanovich V, 2000, SURG ENDOSC-ULTRAS, V14, P16, DOI 10.1007/s004649900003; Yamamoto Hironori, 2005, Clin Gastroenterol Hepatol, V3, pS74, DOI 10.1016/S1542-3565(05)00254-5	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	MAR	2015	29	3					596	606		10.1007/s00464-014-3705-5		11	Surgery	Surgery	CB0DU	WOS:000349296400016		
J	Suda, K; Man-i, M; Ishida, Y; Kawamura, Y; Satoh, S; Uyama, I				Suda, Koichi; Man-i, Mariko; Ishida, Yoshinori; Kawamura, Yuichiro; Satoh, Seiji; Uyama, Ichiro			Potential advantages of robotic radical gastrectomy for gastric adenocarcinoma in comparison with conventional laparoscopic approach: a single institutional retrospective comparative cohort study	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Gastric cancer; Robotic gastrectomy; Laparoscopic gastrectomy; Complication; Pancreatic fistula	CLAVIEN-DINDO CLASSIFICATION; MINIMALLY INVASIVE SURGERY; SURGICAL COMPLICATIONS; CANCER SURGERY; ONCOLOGY-GROUP; METAANALYSIS; MORBIDITY; D2; MORTALITY; OUTCOMES	We have previously reported that laparoscopic approach improved short-term postoperative courses even for advanced gastric adenocarcinoma, but not morbidity, in comparison with open approach. The objective of this study was to determine the impact of the use of the surgical robot, da Vinci Surgical System, in minimally invasive radical gastrectomy on short-term outcomes. A single institutional retrospective cohort study was performed (UMIN000011749). Five hundred twenty-six patients who underwent radical gastrectomy were enrolled. Eighty-eight patients who agreed to uninsured use of the surgical robot underwent robotic gastrectomy, whereas the remaining 438 patients who wished for laparoscopic (lap) approach with health insurance coverage underwent conventional laparoscopic gastrectomy. In the robotic group, morbidity (robotic vs lap 2.3 vs 11.4 %, p = 0.009) and hospital stay following surgery (robotic vs lap 14 [2-31] vs 15 [8-136] days, p = 0.021) were significantly improved, even though operative time (p = 0.003) and estimated blood loss (p = 0.026) were slightly greater. In particular, local (robotic vs lap 1.1 vs 9.8 %, p = 0.007) rather than systemic (robotic vs lap 1.1 vs 2.5 %, p = 0.376) complication rates were attenuated using the surgical robot. Multivariate analyses revealed that non-use of the surgical robot (OR 6.174 [1.454-26.224], p = 0.014), total gastrectomy (OR 4.670 [2.503-8.713], p < 0.001), and D2 lymphadenectomy (OR 2.095 [1.124-3.903], p = 0.020) were the significant independent risk factors determining postoperative complications. The use of the surgical robot might reduce surgery-related complications, leading to further improvement in short-term postoperative courses following minimally invasive radical gastrectomy.	[Suda, Koichi; Man-i, Mariko; Ishida, Yoshinori; Kawamura, Yuichiro; Satoh, Seiji; Uyama, Ichiro] Fujita Hlth Univ, Dept Surg, Div Upper GI, Toyoake, Aichi 4701192, Japan	Suda, K (reprint author), Fujita Hlth Univ, Dept Surg, Div Upper GI, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	ko-suda@nifty.com					Shinohara T, 2013, SURG ENDOSC, V27, P286, DOI 10.1007/s00464-012-2442-x; Uyama I, 2012, WORLD J SURG, V36, P331, DOI 10.1007/s00268-011-1352-8; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Lee JH, 2012, SURG ENDOSC, V26, P1287, DOI 10.1007/s00464-011-2027-0; Persiani R, 2008, J AM COLL SURGEONS, V207, P13, DOI 10.1016/j.jamcollsurg.2007.12.050; Bamboat ZM, 2013, J SURG ONCOL, V107, P271, DOI 10.1002/jso.23237; Angst E, 2010, J AM COLL SURGEONS, V211, P412, DOI 10.1016/j.jamcollsurg.2010.05.019; Park SS, 2012, SURG ENDOSC, V26, P60, DOI 10.1007/s00464-011-1828-5; Kanaya S, 2002, J AM COLL SURGEONS, V195, P284, DOI 10.1016/S1072-7515(02)01239-5; Park DJ, 2005, BRIT J SURG, V92, P1099, DOI 10.1002/bjs.4952; Komatsu S, 2013, WORLD J GASTROENTERO, V19, P8696, DOI 10.3748/wjg.v19.i46.8696; Liao GX, 2013, ASIAN PAC J CANCER P, V14, P4871, DOI 10.7314/APJCP.2013.14.8.4871; Hyun MH, 2013, BRIT J SURG, V100, P1566, DOI 10.1002/bjs.9242; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Suda K, 2012, WORLD J SURG, V36, P1608, DOI 10.1007/s00268-012-1538-8; Xiong BH, 2012, SURG ONCOL, V21, P274, DOI 10.1016/j.suronc.2012.05.004; Wei HB, 2011, SURG LAPARO ENDO PER, V21, P383, DOI 10.1097/SLE.0b013e31822d02dc; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Boone J, 2009, BRIT J SURG, V96, P878, DOI 10.1002/bjs.6647; Kanaya S, 2011, SURG ENDOSC, V25, P3928, DOI 10.1007/s00464-011-1792-0; Coratti A, 2013, WORLD J SURG, V37, P2771, DOI 10.1007/s00268-013-2100-z; Camarillo DB, 2004, AM J SURG, V188, p2S, DOI 10.1016/j.amjsung.2004.08.025; Inaba K, 2010, J AM COLL SURGEONS, V211, pE25, DOI 10.1016/j.jamcollsurg.2010.09.005; Japan Clinical Oncology Group, POST COMPL CRIT ACC; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Junfeng Zhou, 2014, Surg Endosc, V28, P1779, DOI 10.1007/s00464-013-3385-6; Kenngott HG, 2012, LANGENBECK ARCH SURG, V397, P333, DOI 10.1007/s00423-011-0859-7; Noshiro H, 2013, SURG ENDOSC, V28, P1180; Ruurda JP, 2002, ANN ROY COLL SURG, V84, P223, DOI 10.1308/003588402320439621; [The Ministry of Health Labour and Welfare Ministry of Health Labour and Welfare], ANN HLTH LAB WELF RE; Uyama I, 1999, GASTRIC CANCER, V2, P230, DOI DOI 10.1007/S101209900041; Uyama Ichiro, 2013, J Gastric Cancer, V13, P19, DOI 10.5230/jgc.2013.13.1.19; Yu Hyeong Won, 2013, J Gastric Cancer, V13, P179, DOI 10.5230/jgc.2013.13.3.179	36	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	MAR	2015	29	3					673	685		10.1007/s00464-014-3718-0		13	Surgery	Surgery	CB0DU	WOS:000349296400025		
J	Sato, N; Shibao, K; Mori, Y; Higure, A; Yamaguchi, K				Sato, Norihiro; Shibao, Kazunori; Mori, Yasuhisa; Higure, Aiichiro; Yamaguchi, Koji			Postoperative complications following single-incision laparoscopic cholecystectomy: a retrospective analysis in 360 consecutive patients	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Single-incision laparoscopic cholecystectomy; Postoperative complication; Wound	RANDOMIZED CONTROLLED-TRIAL; BILE-DUCT INJURY; SURGERY; SCORES; PAIN; CHOLANGIOGRAPHY; METAANALYSIS	Single-incision laparoscopic cholecystectomy (SILC) is being increasingly performed based on recent evidence showing its cosmetic advantages. However, there is limited information on outcome data for SILC with respect to postoperative complications. We retrospectively reviewed a consecutive series of 360 patients undergoing SILC to evaluate the rate, features, and risk factors of postoperative complications. During a median follow-up period of 671 days, 17 patients (4.7 %) developed postoperative complications, including bile duct injuries, intraabdominal abscess, wound infection, incisional hernia, paralytic ileus, and pneumonia. Reoperation was required in five patients (1.4 %). Overall inpatient mortality occurred in one patient (0.3 %) who developed aspiration pneumonia. In multivariate stepwise regression analyses, poor physical status (American Society of Anesthesiologists score of a parts per thousand yen3) and preoperative diagnosis of acute cholecystitis were identified as significant risk factors for the development of postoperative complications (P = 0.0009 and P = 0.04, respectively). These findings suggest that SILC is a relatively safe procedure with an acceptable postoperative complication rate but requires careful attention especially in patients with poor physical status and/or acute cholecystitis.	[Sato, Norihiro; Shibao, Kazunori; Mori, Yasuhisa; Higure, Aiichiro; Yamaguchi, Koji] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 8078555, Japan	Sato, N (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 8078555, Japan.	norisato@med.uoeh-u.ac.jp					Nuzzo G, 2005, ARCH SURG-CHICAGO, V140, P986, DOI 10.1001/archsurg.140.10.986; Verbeek FPR, 2014, SURG ENDOSC, V28, P1076, DOI 10.1007/s00464-013-3305-9; Leung D, 2012, J AM COLL SURGEONS, V215, P702, DOI 10.1016/j.jamcollsurg.2012.05.038; Phillips MS, 2012, SURG ENDOSC, V26, P1296, DOI 10.1007/s00464-011-2028-z; Sato N, 2013, J GASTROINTEST SURG, V17, P668, DOI 10.1007/s11605-012-2123-z; Joseph M, 2012, ANN SURG, V256, P1, DOI 10.1097/SLA.0b013e3182583fde; STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101; Garg P, 2012, J GASTROINTEST SURG, V16, P1618, DOI 10.1007/s11605-012-1906-6; Weiss HG, 2014, ANN SURG, V259, P89, DOI 10.1097/SLA.0b013e31827b7818; Markar SR, 2012, SURG ENDOSC, V26, P1205, DOI 10.1007/s00464-011-2051-0; Hall TC, 2012, ARCH SURG-CHICAGO, V147, P657, DOI 10.1001/archsurg.2012.814; Curcillo PG, 2010, SURG ENDOSC, V24, P1854, DOI 10.1007/s00464-009-0856-x; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; Arezzo A, 2013, SURG ENDOSC, V27, P2293, DOI 10.1007/s00464-012-2763-9; Piskun G, 1999, J LAPAROENDOSC ADV A, V9, P361, DOI 10.1089/lap.1999.9.361; Waage A, 2006, ARCH SURG-CHICAGO, V141, P1207, DOI 10.1001/archsurg.141.12.1207; Tsimoyiannis EC, 2010, SURG ENDOSC, V24, P1842, DOI 10.1007/s00464-010-0887-3; Cao ZG, 2011, SURG LAPARO ENDO PER, V21, P311, DOI 10.1097/SLE.0b013e31822cfacd; Geng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076530; Hernandez JM, 2009, AM SURGEON, V75, P681; Kumar S S, 1992, J Laparoendosc Surg, V2, P247, DOI 10.1089/lps.1992.2.247; Marks J, 2011, AM J SURG, V201, P369, DOI 10.1016/j.amjsurg.2010.09.012; Navarra G, 2008, SURG ENDOSC, V22, P2103, DOI 10.1007/s00464-008-9960-6; Navarra G, 1997, BRIT J SURG, V84, P695, DOI 10.1002/bjs.1800840536; Raakow R, 2011, MINIM INVASIVE SURG, V2011, DOI [10.1155/2011/915735, DOI 10.1155/2011/915735]]; Trastulli S, 2012, BRIT J SURG, V100, P191; Zapf M, 2013, SURGERY, V154, P662, DOI 10.1016/j.surg.2013.04.043	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	MAR	2015	29	3					708	713		10.1007/s00464-014-3726-0		6	Surgery	Surgery	CB0DU	WOS:000349296400029		
J	Zhu, CH; Takatera, M				Zhu, Chunhong; Takatera, Masayuki			Effects of hydrophobic yarns on liquid migration in woven fabrics	TEXTILE RESEARCH JOURNAL			English	Article						liquid migration; hydrophobic yarn; hydrophilic yarn; wicking coefficient	CAPILLARY-FLOW; RETENTION PROPERTIES; FIBROUS ASSEMBLIES; WICKING PROPERTIES; KNITTED FABRICS; FILAMENT YARNS; TRANSPORT; DYNAMICS; FIBERS; RISE	Liquid migration in woven fabrics was investigated by measuring the wicking coefficients of hydrophilic cotton and hydrophobic PVDF (polyvinylidene fluoride) monofilament fabrics and some other fabrics. The coefficients of fabrics with cotton warp yarns were essentially equal along the weft direction but differed along the warp because of variations in the warp yarn crimps. Then factors affecting the liquid migration along the weft direction were investigated, especially the effect of hydrophobic weft yarns, by using three different warp weave densities for fabrics with both cotton and PVDF weft yarns. The results showed that in the warp direction, liquid moved along longitudinal yarns and migrated to hydrophilic but not hydrophobic transverse yarns. In the weft direction, similar results were obtained for fabrics with cotton weft yarns. Fabrics with PVDF weft yarns, however, showed no migration through the longitudinal yarns, although liquid did move along the transverse direction of connected cotton warp yarns. The largest wicking coefficient was associated with the highest warp weave density. Liquid did not move through transverse yarns separated from one another. It is apparent that liquids can migrate along transverse, adjacent, in-contact hydrophilic yarns of fabrics incorporating longitudinal hydrophobic yarns.	[Zhu, Chunhong] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan; [Takatera, Masayuki] Shinshu Univ, Inst Fiber Engn IFES, ICCER, Ueda, Nagano 3868567, Japan	Takatera, M (reprint author), Shinshu Univ, Inst Fiber Engn IFES, ICCER, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.	takatera@shinshu-u.ac.jp			Grants for International Fiber Engineering Course and Excellent Graduate Schools, MEXT, Japan; Global COE Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JSPS KAKENHI [24220012]	This work was supported by Grants for International Fiber Engineering Course and Excellent Graduate Schools, MEXT, Japan and by a Grant-in-Aid from the Global COE Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by JSPS KAKENHI (grant number 24220012).	HSIEH YL, 1995, TEXT RES J, V65, P299, DOI 10.1177/004051759506500508; [Anonymous], 1986, 3424 BS 18; Yanilmaz M, 2012, TEXT RES J, V82, P820, DOI 10.1177/0040517511435851; Li N, 2010, DESALINATION, V250, P530, DOI 10.1016/j.desal.2008.10.027; Kissa E, 1996, TEXT RES J, V66, P660, DOI 10.1177/004051759606601008; Wong KK, 2001, TEXT RES J, V71, P49; Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273; [Anonymous], 2006, L01052006 JAP IND ST; Perwuelz A, 2000, TEXT RES J, V70, P333, DOI 10.1177/004051750007000409; [Anonymous], 1997, 539241997 DIN; [Anonymous], 1994, L19071994 JAP IND ST; Babu VR, 2011, INDIAN J FIBRE TEXT, V36, P99; BAYRAMLI E, 1991, COLLOID SURFACE, V56, P83, DOI 10.1016/0166-6622(91)80115-5; Erik K, 1984, HDB FIBER SCI TECHNO, P144; Francois LB, 2014, INT J MATER FORM, V7, P93; Hamdaoui M, 2007, J APPL POLYM SCI, V104, P3050, DOI 10.1002/app.25642; HSIEH YL, 1992, TEXT RES J, V62, P677; HSIEH YL, 1992, TEXT RES J, V62, P697; ITO H, 1993, TEXT RES J, V63, P414, DOI 10.1177/004051759306300706; Jiang XY, 2010, J FIBER BIOENG INFOR, V3, P88; KAMATH YK, 1994, TEXT RES J, V64, P33, DOI 10.1177/004051759406400104; Kang TJ, 2001, TEXT RES J, V71, P261; KAWASE T, 1986, TEXT RES J, V56, P409, DOI 10.1177/004051758605600702; Mhetre S, 2010, J TEXT I, V101, P621, DOI 10.1080/00405000802696469; Nyoni AB, 2006, J TEXT I, V97, P119, DOI 10.1533/joti.2005.0128; Ozturk MK, 2011, TEXT RES J, V81, P324, DOI 10.1177/0040517510383611; Rajagopalan D, 2001, TEXT RES J, V71, P813; Wang N, 2008, FIBER POLYM, V9, P97, DOI 10.1007/s12221-008-0016-2; Yoneda M, 1992, SEN-I GAKKAISHI, V48, P288; Zhu C., 2013, J FIBER BIOENGINEERI, V6, P205, DOI [10.3993/jfbi06201309, DOI 10.3993/JFBI06201309]; Zhu CH, 2014, TEXT RES J, V84, P513, DOI 10.1177/0040517513503729; Zhu CH, 2012, J FIBER BIOENG INFOR, V5, P433	32	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0040-5175	1746-7748		TEXT RES J	Text. Res. J.	MAR	2015	85	5					479	486		10.1177/0040517514549986		8	Materials Science, Textiles	Materials Science	CB2IU	WOS:000349451400004		
J	Ahmad, S				Ahmad, Sohail			Housing demand and housing policy in urban Bangladesh	URBAN STUDIES			English	Article						housing demand; housing policy; income elasticity; price elasticity; urban Bangladesh	DEVELOPING-COUNTRIES; HOUSEHOLD DATA; MARKET; DELHI; INDIA	This paper estimates demand for housing and its attributes in urban Bangladesh using a survey of 4400 owner, renter and squatter households. The results revealed that housing demand is inelastic with respect to income and price; and price elasticity is less than income elasticity in absolute terms. Estimates of demand for housing attributes showed that owner and renter households value structural quality, sanitation and electricity, as well as a living room and dining room/kitchen. Squatter households value living space, pit latrine, water supply and electricity, but place less emphasis on structural quality. Irrespective of these submarkets, income improvement strategies are likely to be the most effective means of enhancing housing consumption. The rental submarket might be improved by rent liberalisation, while slum improvement strategies should focus on tenure security and incremental improvement. However, contrary to current practice, the emphasis should be on the size of squatter dwellings rather than on their structural quality.	[Ahmad, Sohail] SPAV, Nidamanuru 521104, Vijayawada, India; [Ahmad, Sohail] UNU IAS, Tokyo, Japan; [Ahmad, Sohail] Tokyo Inst Technol, Tokyo, Japan	Ahmad, S (reprint author), SPAV, Sy 71-1,NH-5, Nidamanuru 521104, Vijayawada, India.	architectsohail@gmail.com					Ahmad S, 2013, HABITAT INT, V38, P90, DOI 10.1016/j.habitatint.2012.02.003; Ahmed KI, 2007, URBAN POOR HOUSING B; Angeles G., 2009, INT J HEALTH GEOGR, V8, P19; MALPEZZI S, 1987, ECON DEV CULT CHANGE, V35, P687, DOI 10.1086/451618; Kemp PA, 2011, HOUSING STUD, V26, P1019, DOI 10.1080/02673037.2011.615155; Field E, 2005, J EUR ECON ASSOC, V3, P279, DOI 10.1162/1542476054472937; Ahmad S, 2013, CITIES, V31, P641, DOI 10.1016/j.cities.2012.12.006; ARIMAH BC, 1994, ENVIRON PLANN A, V26, P107, DOI 10.1068/a260107; Bangladesh Bureau of Statistics, 2010, HOUS INC EXP SURV 20; Bangladesh Bureau of Statistics, 2011, REP HOUS INC EXP SUR, P198; Committee on Urban Local Governments, 2011, NAT URB SECT POL; Green RK, 2003, PRIMER HOUSING MARKE; Islam N, 1996, HABITAT INT, V20, P377, DOI 10.1016/0197-3975(96)00016-1; Islam N, 2004, POORS ACCESS LAND HO; Islam N, 2006, URBANIZATION SUSTAIN, P43; LODHI A, 1991, URBAN STUD, V28, P623, DOI 10.1080/00420989120080691; MAYO SK, 1981, J URBAN ECON, V10, P95, DOI 10.1016/0094-1190(81)90025-5; Mehta S, 1989, METROPOLITAN HOUSING; Narayan A, 2007, TRENDS PATTERN POVER; Nawaz R, 2004, INT C AD AFF HOUS AL; Nazem IN, 2011, URBAN FUTURES BANGLA, P1; Nenova T, 2010, EXPANDING HOUSING FINANCE TO THE UNDERSERVED IN SOUTH ASIA: MARKET REVIEW AND FORWARD AGENDA, P1, DOI 10.1596/978-0-8213-8322-3; Sivam A, 2002, HABITAT INT, V26, P523, DOI 10.1016/S0197-3975(02)00025-5; Sivam A, 2003, CITIES, V20, P135, DOI 10.1016/S0264-2751(02)00121-X; Tiwari P, 1997, J POLICY MODEL, V19, P295, DOI 10.1016/S0161-8938(96)00053-1; Tiwari P, 1998, URBAN STUD, V35, P2111; UN-Habitat, 2011, CIT CLIM CHANG GLOB; United Nations Children's Fund-Bangladesh, 2010, UND URB IN BANGL PRE, P1; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD URB PROSP 2011	29	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0042-0980	1360-063X		URBAN STUD	Urban Stud.	MAR	2015	52	4					738	755		10.1177/0042098014528547		18	Environmental Studies; Urban Studies	Environmental Sciences & Ecology; Urban Studies	CA6EN	WOS:000349002000007		
J	Maria, KH; Mieno, T				Maria, Kazi Hanium; Mieno, Tetsu			Synthesis of single-walled carbon nanotubes by low-frequency bipolar pulsed arc discharge method	VACUUM			English	Article						Single-walled carbon nanotubes; Bipolar pulsed arc discharge; Synthesis; Input power; Raman spectroscopy	CHEMICAL-VAPOR-DEPOSITION; DIAMETER	The effective synthesis of single-walled carbon nanotubes (SWNTs) by low-frequency bipolar pulsed arc discharge method using a newly developed bipolar pulsed current circuit with constant current and constant pulse duration is reported. In this method, there is no cathode deposit, which means that all the sublimated carbon becomes soot containing single-walled nanotubes. The soot production rate of the bipolar pulsed arc discharge method is compared with those of the DC, the AC, and the unipolar pulsed arc discharge methods. It is found that the soot production rate increases with increasing frequency whereas the quality of the produced SWNTs remains almost the same. The nanostructures of the synthesized SWNTs are characterized by a TEM and Raman spectroscopy. (C) 2014 Elsevier Ltd. All rights reserved.	[Maria, Kazi Hanium; Mieno, Tetsu] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka 4228529, Japan; [Mieno, Tetsu] Shizuoka Univ, Dept Phys, Shizuoka 4228529, Japan	Maria, KH (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka 4228529, Japan.	kazimaria@univdhaka.edu					Anglaret E, 2002, PHYSICA B, V323, P38, DOI 10.1016/S0921-4526(02)00962-6; Waldorff EI, 2004, J APPL PHYS, V95, P2749, DOI 10.1063/1.1642737; Metters JP, 2012, VACUUM, V86, P507, DOI 10.1016/j.vacuum.2011.06.007; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Ando Y, 2006, NEW DIAM FRONT C TEC, V16, P123; Cheng HM, 1998, CHEM PHYS LETT, V289, P602, DOI 10.1016/S0009-2614(98)00479-5; Matsuura T, 2007, THIN SOLID FILMS, V515, P4240, DOI 10.1016/j.tsf.2006.02.086; Maruyama S, 2002, CHEM PHYS LETT, V360, P229, DOI 10.1016/S0009-2614(02)00838-2; Jang HS, 2006, VACUUM, V81, P422, DOI 10.1016/j.vacuum.2006.06.009; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; Gavillet J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.275504; Journet C, 1997, NATURE, V388, P756; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Maultzsch J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205438; Liao HW, 2004, J PHYS CHEM B, V108, P6941, DOI 10.1021/jp048566n; Ohkohchi M, 1999, JPN J APPL PHYS 1, V38, P4158, DOI 10.1143/JJAP.38.4158; Yao Z, 1999, NATURE, V402, P273; Zeng H, 1998, CARBON, V36, P259, DOI 10.1016/S0008-6223(97)00167-X; Izak T., 2008, VACUUM, V82, P134; Jorio A, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/139; Jorio A, 2008, CARBON NANOTUBES ADV, P101; Keidar M, 2007, J PHYS D APPL PHYS, V40, P2388, DOI 10.1088/0022-3727/40/8/S18; Li ZJ, 2008, CARBON, V46, P1819, DOI 10.1016/j.carbon.2008.07.005; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Mieno Tetsu, 2011, Carbon Nanotubes - Synthesis, Characterization, Applications; Mieno T, 2004, JPN J APPL PHYS 2, V43, pL1527, DOI [10.1143/JJAP.43.L1527, 10.1143/JJPA.43.L1527]; Mieno T, 2006, NEW DIAM FRONT C TEC, V16, P139; Rahman MJ, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.056201; Satake N, 2002, PHYSICA B, V323, P290, DOI 10.1016/S0921-4526(02)01025-6; Scott CD, 2001, APPL PHYS A-MATER, V72, P573, DOI 10.1007/s003390100761; Sugai T, 2000, J CHEM PHYS, V112, P6000, DOI 10.1063/1.481172	31	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	MAR	2015	113						11	18		10.1016/j.vacuum.2014.11.025		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CB4JC	WOS:000349593000003		
J	Maeda, K; Ohta, M; Momohara, I				Maeda, Kei; Ohta, Masamitsu; Momohara, Ikuo			Relationship between the mass profile and the strength property profile of decayed wood	WOOD SCIENCE AND TECHNOLOGY			English	Article							WHITE; FUNGI	To resolve degradation problems of timber structures, analysis of the development of a fungal attack on structural timber is important. The progression of wood decay especially that of structural timber is not always uniform and reduces strength locally. Therefore, the strength profile is important in estimating the strength of decayed wood. In this study, Sitka spruce (20 mm x 20 mm x 100 mm (longitudinal direction)) was exposed to brown- and white-rot fungi for 3 to 15 weeks from the end surface. After decay, mass profiles of an oven-dried specimen were obtained by X-ray densitometry, and specimens for compressive and tensile tests were cut from the decayed wood to determine both compressive and tensile strength distribution profiles in the longitudinal direction. Except for some results of the tensile strength, after 3 weeks treatment with brown-rot fungus, both strength and mass were reduced. For the same decrease in mass, the tensile strength was reduced more by the brown-rot fungus than by the white-rot fungus, whereas the results for compression strength were almost the same for the two fungi. The results suggested that it is possible to estimate the strength loss of the decayed wood from the mass profile.	[Maeda, Kei; Momohara, Ikuo] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Ohta, Masamitsu] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Maeda, K (reprint author), Forestry & Forest Prod Res Inst, 1 Matsunosato, Tsukuba, Ibaraki 305, Japan.	maedakei1985@ffpri.affrc.go.jp					Messner K, 2003, ACS SYM SER, V845, P73; Goodell B, 2003, ACS SYM SER, V845, P97; Bouslimi B, 2014, INT BIODETER BIODEGR, V87, P87, DOI 10.1016/j.ibiod.2013.11.006; Brischke C, 2008, HOLZ ROH WERKST, V66, P433, DOI 10.1007/s00107-008-0257-1; Curling SF, 2002, INT BIODETER BIODEGR, V49, P13, DOI 10.1016/S0964-8305(01)00101-9; Forest Products Society, 2011, WOOD HDB WOOD ENG MA; Gonzalez JM, 2012, WOOD FIBER SCI, V44, P343; Green B, 2011, WOOD SCI TECHNOL, V45, P583, DOI 10.1007/s00226-010-0368-9; Japanese Industrial Standard Committee JIS Z 2101, 2009, Z2101 JIS; Kennedy R. W., 1962, TAPPI, V45, P725; Maeda K., 2011, Pro Ligno, V7, P18; Przewloka SR, 2008, HOLZFORSCHUNG, V62, P270, DOI 10.1515/HF.2008.024; Schmidt O., 2006, WOOD TREE FUNGI BIOL; Smith I, 2003, FRACTURE FATIGUE WOO; Venalainen M, 2014, INT BIODETER BIODEGR, V86, P150; WILCOX WW, 1978, WOOD FIBER SCI, V9, P252	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0043-7719	1432-5225		WOOD SCI TECHNOL	Wood Sci. Technol.	MAR	2015	49	2					331	344		10.1007/s00226-014-0696-2		14	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CB1HO	WOS:000349378200008		
J	Dallai, R; Gottardo, M; Mercati, D; Rafael, J; Machida, R; Mashimo, Y; Matsumura, Y; Beutel, R				Dallai, Romano; Gottardo, Marco; Mercati, David; Rafael, Jose Albertino; Machida, Ryuichiro; Mashimo, Yuta; Matsumura, Yoko; Beutel, Rolf Georg			The intermediate sperm type and genitalia of Zorotypus shannoni Gurney: evidence supporting infraordinal lineages in Zoraptera (Insecta)	ZOOMORPHOLOGY			English	Article						Polyneoptera; Spermatozoa; Ultrastructure; Transmission electron microscopy (TEM); Phylogeny	CAUDELLI KARNY ZORAPTERA; REPRODUCTIVE-SYSTEMS; FINE-STRUCTURE; MANTOPHASMATODEA; COEVOLUTION; MORPHOLOGY; PHYLOGENY; SPERMATOGENESIS; SPERMATOZOA; CHARACTERS	The sperm ultrastructure and the male and female genital apparatus of Zorotypus shannoni were examined and documented in detail, mainly using transmission electron microscopy micrographs. The findings suggest an evolutionary trend shared with Z. hubbardi and Z. impolitus. The three species are characterized by enlarged mitochondrial derivatives and related modifications. Giant sperm are probably a synapomorphy of Z. hubbardi and Z. impolitus, whereas an intermediate condition of this feature is found in Z. shannoni. The monophyletic origin of Z. caudelli, Z. magnicaudelli, Z. huxleyi and Z. weidneri is suggested by characteristically modified axonemes. The presence of extra-acrosomal material is also an unusual feature for Zoraptera, but this condition also occurs in the majority of polyneopteran groups. The long and convoluted female spermathecal duct with secretory and duct-forming cells is a constant feature in Zoraptera. The enlarged seminal receptacle suggests an evolutionary link between the male genital structures and the sperm size on one hand, and the size of the female spermatheca on the other. The small and otherwise uniform group Zoraptera exhibits a remarkable variation of sperm types and genital structures, suggesting the impact of different types of selection. It is likely that cryptic female choice plays a major role in shaping the genital apparatus.	[Dallai, Romano; Gottardo, Marco; Mercati, David] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Rafael, Jose Albertino] Inst Nacl de Pesquisas da Amazonia, BR-69067375 Manaus, Amazonas, Brazil; [Machida, Ryuichiro; Mashimo, Yuta] Univ Tsukuba, Sugadaira Montane Res Ctr, Nagano 3862204, Japan; [Matsumura, Yoko; Beutel, Rolf Georg] Univ Jena, Entomol Grp, Inst Spezielle Zool & Evolut Biol, Phyletischem Museum, D-07743 Jena, Germany	Dallai, R (reprint author), Univ Siena, Dept Life Sci, Via A Moro 2, I-53100 Siena, Italy.	romano.dallai@unisi.it; gottardo@unisi.it; david.mercati@unisi.it; jarafael@inpa.gov.br; machida@sugadaira.tsukuba.ac.jp; mashimo@sugadaira.tsukuba.ac.jp; yoko.matumura.hamupeni@gmail.com; rolf.beutel@uni-jena.de		Dallai, Romano/0000-0002-2258-8891; Mashimo, Yuta/0000-0001-6866-1778	JSP	We thank J. T. Camera and F. F. Xavier Filho for their help in collecting material. YM was supported by JSP Postdoctoral Fellowships for research abroad.	Dallai R, 2012, ARTHROPOD STRUCT DEV, V41, P337, DOI 10.1016/j.asd.2012.01.003; Dallai R, 2014, ARTHROPOD STRUCT DEV, V43, P371, DOI 10.1016/j.asd.2014.03.001; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Wipfler B, 2014, SYST ENTOMOL, V39, P800, DOI 10.1111/syen.12088; Mashimo Y, 2014, J MORPHOL, V275, P295, DOI 10.1002/jmor.20215; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Yoshizawa K, 2005, MOL PHYLOGENET EVOL, V37, P572, DOI 10.1016/j.ympev.2005.05.008; Dallai R, 2014, ARTHROPOD STRUCT DEV, V43, P257, DOI 10.1016/j.asd.2014.04.002; Dallai R, 2003, ZOOMORPHOLOGY, V122, P67, DOI 10.1007/s00435-002-0070-z; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Blanke A, 2012, CLADISTICS, V28, P560, DOI 10.1111/j.1096-0031.2012.00405.x; Dallai R, 2011, ARTHROPOD STRUCT DEV, V40, P531, DOI 10.1016/j.asd.2011.07.001; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; Letsch H, 2013, SYST ENTOMOL, V38, P783, DOI 10.1111/syen.12028; Matsumura Y, 2014, BIOL J LINN SOC, V112, P40, DOI 10.1111/bij.12260; Mashimo Y, 2011, TISSUE CELL, V43, P230, DOI 10.1016/j.tice.2011.04.001; Dallai R, 2012, ARTHROPOD STRUCT DEV, V41, P51, DOI 10.1016/j.asd.2011.08.003; Mashimo Y, 2013, ZOOTAXA, V3717, P498; Dallai R, 2013, NATURWISSENSCHAFTEN, V100, P581, DOI 10.1007/s00114-013-1055-0; Dallai R, 2014, ARTHROPOD STRUCT DEV, V43, P135, DOI 10.1016/j.asd.2013.10.002; Baccetti B., 1987, P12; Choe Jae C., 1997, P130, DOI 10.1017/CBO9780511721946.008; DYBAS LK, 1981, EVOLUTION, V35, P168, DOI 10.2307/2407950; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Fausto AM, 2001, ARTHROPOD STRUCT DEV, V30, P55, DOI 10.1016/S1467-8039(01)00019-6; Gottardo M, 2012, ZOOMORPHOLOGY, V131, P209, DOI 10.1007/s00435-012-0158-z; Grimaldi David, 2005, pi; GURNEY ASHLEY BUELL, 1938, PROC ENT SOC WASHINGTON, V40, P57; Hennig W., 1969, STAMMESGESCHICHTE IN; Higginson DM, 2012, P NATL ACAD SCI USA, V109, P4338; Mashimo Y, 2014, INSECT SYST EVOL, V45, P371, DOI 10.1163/1876312X-45012110; Miller GT, 2003, J EVOLUTION BIOL, V16, P114, DOI 10.1046/j.1420-9101.2003.00476.x; Minder AM, 2005, J EVOLUTION BIOL, V18, P60, DOI 10.1111/j.1420-9101.2004.00799.x; Misof B, 2007, ZOOLOGY, V110, P409, DOI 10.1016/j.zool.2007.08.003; NEW TR, 1978, SYST ENTOMOL, V3, P361, DOI 10.1111/j.1365-3113.1978.tb00005.x; Pohl Hans, 2000, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V10, P1; Quennedey A., 1998, MICROSCOPIC ANATOM A, V11A, P177; Silvestri F., 1913, B LAB ZOOL PORTICI, V7, P193; Simon S, 2012, GENOME BIOL EVOL, V4, P1259; Wang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053679; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI 10.1006/clad.2000.0147; Willmann R, 2005, WIRBELLOSE TIERE, VI, P1	44	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0720-213X	1432-234X		ZOOMORPHOLOGY	Zoomorphology	MAR	2015	134	1					79	91		10.1007/s00435-014-0244-5		13	Anatomy & Morphology; Zoology	Anatomy & Morphology; Zoology	CB1OW	WOS:000349398400007		
J	Kitazawa, C; Akahoshi, S; Sohara, S; Noh, JT; Tajika, A; Yamanaka, A; Komatsu, M				Kitazawa, Chisato; Akahoshi, Sae; Sohara, Sinya; Noh, Jong Tae; Tajika, Atsushi; Yamanaka, Akira; Komatsu, Miko			Development of the brittle star Ophiothrix exigua Lyman, 1874 a species that bypasses early unique and typical planktotrophic ophiopluteus stages	ZOOMORPHOLOGY			English	Article						Ophiothrix exigua; Wrinkled egg; Wrinkled blastula; Indirect development; Metamorphosis	AMPHIPHOLIS-SQUAMATA ECHINODERMATA; FRAGILIS ECHINODERMATA; BLASTULA FORMATION; WRINKLED BLASTULA; OPHIUROIDEA; REPRODUCTION; EVOLUTION; LARVAE; BIOLUMINESCENCE; MORPHOGENESIS	The development of Ophiothrix exigua from spawning through metamorphosis was studied by light and scanning electron microscopy. When some ripe males and females were kept in the same container and subjected to cycles of temperature and light shock, males released sperm, and then, females spawned eggs. After release, spermatozoa survived for approximately 28 h at 24 A degrees C. After fertilization, the egg surface changed from smooth to wrinkled, and then, the fertilized eggs produced polar bodies. After the wrinkles disappeared, the eggs started to cleave holoblastically and equally. The arrangement of blastomeres was irregular after the third cleavage. The embryonic surface developed a thick hyaline layer, and blastomeres were connected to each other by projections and filopodia. After the wrinkled blastula stage, embryos hatched and primary mesenchyme cell ingression occurred. At the initiation of gastrulation, embryos formed tetraradiate spicules and then became typical planktotrophic ophioplutei with four pairs of larval arms. The larvae developed coelomic pouches on their left and right sides, and the pouches divided into anterior and posterior parts. After the left anterior pouch formed a hydropolic lobe, the larvae resorbed all inner larval arms except for the posterolateral arms and then formed an adult rudiment. Finally, juveniles released the pair of posterolateral arms and completed metamorphosis. Our findings indicate that larval development (typical planktotrophic ophioplutei until metamorphosis) of O. exigua is similar to that of other Ophiothrix species, but early development is modified involving the formation of the wrinkled eggs and blastulae.	[Kitazawa, Chisato; Akahoshi, Sae] Yamaguchi Univ, Inst Biol, Fac Educ, Yamaguchi 7538513, Japan; [Sohara, Sinya; Tajika, Atsushi] Toyama Univ, Dept Biol, Fac Sci, Toyama 9308555, Japan; [Noh, Jong Tae] Toyama Univ, Grad Sch Sci & Engn Educ, Dept Biol, Toyama 9308555, Japan; [Yamanaka, Akira] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Yamaguchi 7538512, Japan; [Komatsu, Miko] Toyama Univ, Grad Sch Sci & Engn Res, Dept Biol, Toyama 9308555, Japan	Kitazawa, C (reprint author), Yamaguchi Univ, Inst Biol, Fac Educ, Yoshida 1677-1, Yamaguchi 7538513, Japan.	chisak@yamaguchi-u.ac.jp			Yamaguchi University Foundation; JSPS KAKENHI [24770227]; Narishige Zoological Science Award	We thank Dr. M. Noguchi for providing of algae and students in our laboratories for collecting of animals and suggestion. We appreciate T. Baba, T. Fujii and C. Miyahara for animal collecting and discussion. We also thank the department of fishery in Yamaguchi Prefecture and Yamaguchi Fisheries Cooperative Association for permission to collect sea urchins. This work was financially supported in part by Yamaguchi University Foundation, JSPS KAKENHI Grant Number 24770227 and from Narishige Zoological Science Award to C. K.	HENDLER G, 1978, BIOL BULL, V154, P79, DOI 10.2307/1540776; Cisternas PA, 2005, CAN J ZOOL, V83, P1067, DOI 10.1139/Z05-092; Balser EJ, 1998, BIOL BULL-US, V194, P187, DOI 10.2307/1543049; Byrne M, 2006, ATLAS MARINE INVERTE, P481; CERRA A, 1995, ACTA ZOOL-STOCKHOLM, V76, P155; Cisternas P., 2004, P521; Deheyn D, 1996, ZOOMORPHOLOGY, V116, P195; Deheyn D, 2000, CELL TISSUE RES, V299, P115, DOI 10.1007/s004419900144; Deheyn D, 2000, J EXP MAR BIOL ECOL, V245, P245, DOI 10.1016/S0022-0981(99)00166-5; FENAUX LUCIENNE, 1963, VIE MILIEU, V14, P91; FENAUX L, 1969, CAH BIOL MAR, V10, P59; Fujita T, 2000, DIVERSITY EVOLUTION, P238; FUKUSHI TSUKASA, 1960, BULL MARINE BIOL STA ASAMUSHI TOHOKU UNIV, V10, P57; Gilbert S.F., 1997, EMBRYOLOGY CONSTRUCT; Grave C, 1903, BIOL BULL-US, V5, P169, DOI 10.2307/1535519; GUILLE ALAIN, 1964, VIE MILIEU, V15, P243; HENDLER G, 1982, BIOL BULL, V163, P431, DOI 10.2307/1541454; HENRY JJ, 1991, DEV GROWTH DIFFER, V33, P317; Irimura S, 1995, GUIDE SEASHORE ANIMA, VII, P529; KANATANI H, 1969, EXP CELL RES, V57, P333, DOI 10.1016/0014-4827(69)90158-X; Kitazawa C, 2009, BIOL BULL-US, V217, P215; Kitazawa C, 2012, ZOOL STUD, V51, P1481; Kitazawa C, 2010, INFORMATION-TOKYO, V13, P1075; KLUGE B, 1995, ZYGOTE, V3, P141; KOMATSU M, 1993, ZOOL SCI, V10, P295; MacBride EW, 1907, Q J MICROSC SCI, V51, P557; McEward LR, 2001, CAN J ZOOL, V79, P1125; Millott N., 1966, P487; MLADENOV PV, 1985, BIOL BULL, V168, P285, DOI 10.2307/1541241; MLADENOV PV, 1979, MAR BIOL, V55, P55, DOI 10.1007/BF00391717; MLADENOV PV, 1985, B MAR SCI, V36, P384; Morgan R, 2004, MAR BIOL, V145, P265, DOI 10.1007/s00227-004-1327-5; Morgan R, 2005, BIOL BULL-US, V208, P92, DOI 10.2307/3593117; Mortensen T, 1921, STUDIES DEV LARVAL F; Mortensen T., 1938, Kongelige Danske Videnskabernes Selskabs Skrifter (9), V7, P1; Mortensen TH, 1937, D KGL DANSKE VIDENSK, V7, P1; Mortensen TH, 1931, D KGL DANSKE VIDENSS, V7, P1; Nakamura S, 2001, ZOOL SCI, V18, P807, DOI 10.2108/zsj.18.807; Olsen H, 1942, BERGENS MUS ARB NATU, V6, P1; Selvakumaraswamy P, 2006, EVOL DEV, V8, P183, DOI 10.1111/j.1525-142X.2006.00088.x; Selvakumaraswamy P, 2000, INVERTEBR BIOL, V119, P394; Selvakumaraswamy P, 2000, BIOL BULL, V198, P379, DOI 10.2307/1542693; Sewell MA, 1997, BIOL BULL, V193, P297, DOI 10.2307/1542932; STANCYK SE, 1973, MAR BIOL, V21, P7, DOI 10.1007/BF00351186; Strathmann RR, 1987, REPROD DEV MARINE IN, P556; Thorson G, 1946, ECHINODERMATA MEDD K, V4, P343; Tominaga H, 2004, BIOL BULL-US, V206, P25, DOI 10.2307/1543195; YAMASHITA M, 1983, J EXP ZOOL, V228, P109, DOI 10.1002/jez.1402280112; YAMASHITA M, 1985, BIOL BULL, V169, P131, DOI 10.2307/1541393; Yamashita M, 1988, DEV INVERTEBRATES, VII, P357	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0720-213X	1432-234X		ZOOMORPHOLOGY	Zoomorphology	MAR	2015	134	1					93	105		10.1007/s00435-014-0233-8		13	Anatomy & Morphology; Zoology	Anatomy & Morphology; Zoology	CB1OW	WOS:000349398400008		
J	Daut, RA; Busch, EF; Ihne, J; Fisher, D; Mishina, M; Grant, SGN; Camp, M; Holmes, A				Daut, Rachel A.; Busch, Erica F.; Ihne, Jessica; Fisher, Daniel; Mishina, Masayoshi; Grant, Seth G. N.; Camp, Marguerite; Holmes, Andrew			Tolerance to ethanol intoxication after chronic ethanol: role of GluN2A and PSD-95	ADDICTION BIOLOGY			English	Article						chronic ethanol; GluN2A and PSD-95; tolerance	CHRONIC INTERMITTENT ETHANOL; NMDA RECEPTOR NR2A; MICE; DEPENDENCE; ASSOCIATION; ALCOHOLISM; MODULATION; SUBUNIT	The neural and genetic factors underlying chronic tolerance to alcohol are currently unclear. The GluN2AN-methyl-D-aspartate receptors (NMDAR) subunit and the NMDAR-anchoring protein PSD-95 mediate acute alcohol intoxication and represent putative mechanisms mediating tolerance. We found that chronic intermittent ethanol exposure (CIE) did not produce tolerance [loss of righting reflex (LORR)] or withdrawal-anxiety in C57BL/6J, GluN2A or PSD-95 knockout mice assayed 2-3 days later. However, significant tolerance to LORR was evident 1 day after CIE in C57BL/6J and PSD-95 knockouts, but absent in GluN2A knockouts. These data suggest a role for GluN2A in tolerance, extending evidence that human GluN2A gene variation is involved in alcohol dependence.	[Daut, Rachel A.; Busch, Erica F.; Ihne, Jessica; Fisher, Daniel; Camp, Marguerite; Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, NIH, Bethesda, MD USA; [Mishina, Masayoshi] Ritsumeikan Univ, Res Org Sci & Technol, Brain Sci Lab, Kusatsu, Japan; [Grant, Seth G. N.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Grant, Seth G. N.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland	Holmes, A (reprint author), 5625 Fishers Lane Room 2N09, Rockville, MD 20852 USA.	Andrew.Holmes@nih.gov			NIAAA Intramural Research Program	We are very grateful to Dr. Howard Becker, Dr. Marcelo Lopez, Dr. Nicolas Jury, Miss Benita Hurd and Miss Erica Sagalyn for valuable assistance with the CIE procedure. Research was supported by the NIAAA Intramural Research Program.	Lopez MF, 2012, ALCOHOL CLIN EXP RES, V36, P1180, DOI 10.1111/j.1530-0277.2011.01717.x; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Boyce-Rustay JM, 2006, PSYCHOPHARMACOLOGY, V187, P455, DOI 10.1007/s00213-006-0448-6; Feyder M, 2010, AM J PSYCHIAT, V167, P1508, DOI 10.1176/appi.ajp.2010.10040484; Boyce-Rustay JM, 2005, SYNAPSE, V56, P222, DOI 10.1002/syn.20143; Camp MC, 2011, ADDICT BIOL, V16, P428, DOI 10.1111/j.1369-1600.2010.00282.x; Chen YC, 2009, NEUROPSYCHOPHARMACOL, V34, P1454, DOI 10.1038/npp.2008.182; DeBrouse L, 2013, ALCOHOL CLIN EXP RES, V37, P223, DOI 10.1111/j.1530-0277.2012.01922.x; Domart MC, 2012, ADDICT BIOL, V17, P783, DOI 10.1111/j.1369-1600.2011.00321.x; DSM-5 A, 2013, DIAGN STAT MAN MENT, V5th; Metten P, 2010, ALCOHOL CLIN EXP RES, V34, P1552, DOI 10.1111/j.1530-0277.2010.01240.x; Rimondini R, 2008, ADDICT BIOL, V13, P26, DOI 10.1111/j.1369-1600.2007.00079.x; Schumann G, 2008, ARCH GEN PSYCHIAT, V65, P826, DOI 10.1001/archpsyc.65.7.826	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-6215	1369-1600		ADDICT BIOL	Addict. Biol.	MAR	2015	20	2					259	262		10.1111/adb.12110		4	Biochemistry & Molecular Biology; Substance Abuse	Biochemistry & Molecular Biology; Substance Abuse	CB0HG	WOS:000349305900005		
J	Kato, Y; Saeki, T; Mizuno, S				Kato, Yuichi; Saeki, Tetsuro; Mizuno, Shoutaro			Proposal of a statistical test rule induction method by use of the decision table	APPLIED SOFT COMPUTING			English	Article						Rough sets; Rule induction; Statistical test; Rule box; p-Value	ROUGH SET	Rough sets theory is widely used as a method for estimating and/or inducing the knowledge structure of if-then rules from various decision tables. This paper presents the results of a retest of rough set rule induction ability by the use of simulation data sets. The conventional method has two main problems: firstly the diversification of the estimated rules, and secondly the strong dependence of the estimated rules on the data set sampling from the population. We here propose a new rule induction method based on the view that the rules existing in their population cause partiality of the distribution of the decision attribute values. This partiality can be utilized to detect the rules by use of a statistical test. The proposed new method is applied to the simulation data sets. The results show the method is valid and has clear advantages, as it overcomes the above problems inherent in the conventional method. (C) 2014 Elsevier B.V. All rights reserved.	[Kato, Yuichi; Mizuno, Shoutaro] Shimane Univ, Interdisciplinary Fac Sci & Engn, Matsue, Shimane 6908504, Japan; [Saeki, Tetsuro] Yamaguchi Univ, Fac Engn, Yamaguchi 7558611, Japan	Kato, Y (reprint author), Shimane Univ, Interdisciplinary Fac Sci & Engn, 1060 Nishikawatsu Cho, Matsue, Shimane 6908504, Japan.	ykato@cis.shimane-u.ac.jp					SHAN N, 1995, COMPUT INTELL, V11, P357, DOI 10.1111/j.1467-8640.1995.tb00038.x; Asuncion Arthur, 2007, UCI MACHINE LEARNING; Bao Y. G., 2004, T JAPANESE SOC ARTIF, V19, P166, DOI 10.1527/tjsai.19.166; GEDIGA G, 2000, NEW DEV KNOWLEDGE DI, V56, P545; Gillet F., 2007, STUDIES COMPUTATIONA, V43; Grzymala-Busse J. W., 1992, HDB APPL ADV ROUGH S, P3; Jaworski W, 2008, LECT NOTES ARTIF INT, V5306, P170, DOI 10.1007/978-3-540-88425-5_18; Nishimura T., 2011, LECT NOTES ARTIF INT, V8743, P240; PAWLAK Z, 1982, INT J COMPUT INF SCI, V11, P341, DOI 10.1007/BF01001956; Skowron A, 1992, HDB APPL ADV ROUGH S, V11, P331; Tsumoto S, 2002, LECT NOTES ARTIF INT, V2475, P373; Walpole R. E., 2007, PROBABILITY STAT ENG, P187; ZIARKO W, 1993, J COMPUT SYST SCI, V46, P39, DOI 10.1016/0022-0000(93)90048-2	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-4946	1872-9681		APPL SOFT COMPUT	Appl. Soft. Comput.	MAR	2015	28						160	166		10.1016/j.asoc.2014.11.041		7	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	AZ8GF	WOS:000348452500017		
J	Bulbul, M; Koshio, S; Ishikawa, M; Yokoyama, S; Kader, MA				Bulbul, Mahbuba; Koshio, Shunsuke; Ishikawa, Manabu; Yokoyama, Saichiro; Kader, Md Abdul			Growth performance of juvenile kuruma shrimp, Marsupenaeus japonicus (Bate) fed diets replacing fishmeal with soybean meal	AQUACULTURE RESEARCH			English	Article						Marsupenaeus japonicas; fishmeal replacement; soybean meal; growth; nutrient utilization; body composition	PACIFIC WHITE SHRIMP; FLOUNDER PARALICHTHYS-OLIVACEUS; TROUT ONCORHYNCHUS-MYKISS; SOY PROTEIN-CONCENTRATE; ESSENTIAL AMINO-ACIDS; BLACK TIGER SHRIMP; BY-PRODUCT MEAL; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; PRACTICAL DIETS	A feeding trail was conducted to evaluate the effect of lowering dietary fishmeal (FM) levels while increasing levels of dehulled soybean meal (SBM) on growth, nutrient utilization and body composition of juvenile kuruma shrimp, Marsupenaeus japonicas. Five experimental diets were formulated to be isoenergetic, isolipidic and isonitrogenous with decreasing FM levels from 40 to 16% while increasing SBM from 0 to 33% respectively. Quadruplicate groups of shrimp (initial wt = 1.5 g) were fed the test diets for 56 days under the flow-through system. There were no significant differences in final weight (g) and specific growth rate (SGR, % day) among shrimp fed FM40, FM34, FM28 and FM22 diets respectively. Growth parameters significantly decreased in shrimp when fed FM16 diet, which was the lowest level of FM. Feed intake was positively correlated with the SGR of shrimp, and the lowest one was found in shrimp fed FM16 diet. Protein gain and retention, whole body lipid, arginine and methionine significantly decreased in FM16 fed group. Thus, it is concluded that dietary FM could be reduced down to 22% with SBM without compromising growth, nutrient utilization and retention, and whole body composition of kuruma shrimp.	[Bulbul, Mahbuba] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900056, Japan; [Koshio, Shunsuke; Ishikawa, Manabu; Yokoyama, Saichiro; Kader, Md Abdul] Kagoshima Univ, Fac Fisheries, Lab Aquat Anim Nutr, Kagoshima 8900056, Japan	Koshio, S (reprint author), Kagoshima Univ, Fac Fisheries, Lab Aquat Anim Nutr, Shimoarata 4-50-20, Kagoshima 8900056, Japan.	koshio@fish.kagoshima-u.ac.jp			Management Expenses Grants of the United Graduate School of Agricultural Sciences, Kagoshima University	The research was partially funded by the Management Expenses Grants of the United Graduate School of Agricultural Sciences, Kagoshima University provided to SK and MI. The authors thank Mr. Jeffrie Fredrik Mokolensang for his generous support during the conduct of this research.	Forster IP, 2003, AQUACULTURE, V219, P655, DOI 10.1016/S0044-8486(02)00457-X; Du L, 2003, AQUACULT NUTR, V9, P139, DOI 10.1046/j.1365-2095.2003.00239.x; Sudaryono A, 1999, AQUACULT NUTR, V5, P277; Kader MA, 2012, AQUACULTURE, V368, P95, DOI 10.1016/j.aquaculture.2012.09.014; Smith DM, 2007, AQUACULTURE, V269, P436, DOI 10.1016/j.aquaculture.2007.05.022; Tibaldi E, 2006, AQUACULTURE, V261, P182, DOI 10.1016/j.aquaculture.2006.06.026; LIM C, 1990, AQUACULTURE, V87, P53, DOI 10.1016/0044-8486(90)90210-E; Samocha TM, 2004, AQUACULTURE, V231, P197, DOI 10.1016/j.aquaculture.2003.08.023; Richard L, 2011, AQUACULTURE, V322, P109, DOI 10.1016/j.aquaculture.2011.09.032; Rahman SHA, 2010, AQUAC RES, V41, pe299, DOI 10.1111/j.1365-2109.2010.02530.x; TESHIMA S, 1986, AQUACULTURE, V51, P225, DOI 10.1016/0044-8486(86)90314-5; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Hernandez C, 2008, AQUACULTURE, V277, P244, DOI 10.1016/j.aquaculture.2008.02.016; Suresh AV, 2011, AQUACULTURE, V319, P132, DOI 10.1016/j.aquaculture.2011.06.039; Deng JM, 2006, AQUACULTURE, V258, P503, DOI 10.1016/j.aquaculture.2006.04.004; Teshima S, 2002, AQUAC RES, V33, P395, DOI 10.1046/j.1365-2109.2002.00684.x; Teshima S, 2001, HYDROBIOLOGIA, V449, P293, DOI 10.1023/A:1017568615695; Harter T, 2011, AQUACULT NUTR, V17, P542, DOI 10.1111/j.1365-2095.2010.00845.x; Coman GJ, 1996, COMP BIOCHEM PHYS A, V113, P247, DOI 10.1016/0300-9629(96)00031-X; Alvarez JS, 2007, AQUAC RES, V38, P689, DOI 10.1111/j.1365-2109.2007.01654.x; Amaya EA, 2007, AQUACULTURE, V262, P393, DOI 10.1016/j.aquaculture.2006.11.015; Paripatananont T, 2001, AQUAC RES, V32, P369, DOI 10.1046/j.1355-557x.2001.00045.x; RODEHUTSCORD M, 1995, J NUTR, V125, P956; Kader MA, 2010, AQUACULTURE, V308, P136, DOI 10.1016/j.aquaculture.2010.07.037; AOAC, 1990, OFFICIAL METHODS ANA; Choi SM, 2004, AQUAC RES, V35, P410, DOI 10.1111/j.1365-2109.2004.01046.x; Forster I.P., 2002, AVANCES NUTRICIONACU, P526; Garcia-Ulloa GM, 2003, AQUACULT NUTR, V9, P25, DOI 10.1046/j.1365-2095.2003.00224.x; Glencross B, 2007, AQUACULT NUTR, V13, P462, DOI 10.1111/j.1365-2095.2007.00499.x; Kader MA, 2012, AQUAC RES, V43, P1427, DOI 10.1111/j.1365-2109.2011.02945.x; KOSHIO S, 1993, AQUACULTURE, V113, P101, DOI 10.1016/0044-8486(93)90344-X; Liu X., 2011, AQUAC RES, V43, P745; Mackie A.M., 1985, P177; Refsite S., 2000, AQUACULTURE, V190, P9; Saitoh S., 2000, SUISANZOSHOKU, V48, P649; Venou B, 2006, AQUACULTURE, V261, P343, DOI 10.1016/j.aquaculture.2006.07.030	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	MAR	2015	46	3					572	580		10.1111/are.12201		9	Fisheries	Fisheries	AZ9KO	WOS:000348532900004		
J	Ragaza, JA; Koshio, S; Mamauag, RE; Ishikawa, M; Yokoyama, S; Villamor, SS				Ragaza, Janice Alano; Koshio, Shunsuke; Mamauag, Roger Edward; Ishikawa, Manabu; Yokoyama, Saichiro; Villamor, Shiela S.			Dietary supplemental effects of red seaweed Eucheuma denticulatum on growth performance, carcass composition and blood chemistry of juvenile Japanese flounder, Paralichthys olivaceus	AQUACULTURE RESEARCH			English	Article						Eucheuma denticulatum; Paralichthys olivaceus; growth performance; carcass composition; blood chemistry	ULVA MEAL SUPPLEMENTATION; SEA BREAM; FATTY-ACIDS; CAULERPA-LENTILLIFERA; KAPPAPHYCUS-ALVAREZII; SARGASSUM-POLYCYSTUM; NUTRITIONAL ASPECTS; TILAPIA NILOTICUS; MARINE MACROALGAE; LIPID-METABOLISM	A 56-day feeding trial was conducted to determine the effects of supplementing diets of juvenile Japanese flounder, Paralichthys olivaceus, with Eucheuma denticulatum (EDP). Isonitrogenous and isolipidic test diets were prepared using a fishmeal-based positive control diet (PC) and a fishmeal-soy protein concentrate negative control diet (NC) supplemented with 3 (D3%), 6 (D6%) and 9% (D9%) EDP. The test diets were assigned to tanks (12 fish tank(-1), initial mean body weight of 0.42 +/- 0.01 g) in triplicates. Results of the feeding trial indicated that growth rates and feed efficiency significantly improved (P < 0.05) when 3% EDP was supplemented in the diets. However, there was a significant reduction (P < 0.05) of growth and feed efficiency in fish fed diets with higher supplementation levels. Protein, lipid, dry matter and ash contents of carcass and their corresponding nutrient retention values were not markedly altered in all dietary treatments. Fish fed diets supplemented with EDP exhibited higher (P < 0.05) omega-3 polyunsaturated fatty acid accumulation in dorsal muscle when compared with those of fish fed NC. Blood chemical parameters showed significant differences (P < 0.05) in total cholesterol and triglyceride levels. These results suggest that EDP can be efficiently utilized by Japanese flounder and can promote best growth and feed utilization at a level of 3%.	[Ragaza, Janice Alano] Ateneo Manila Univ, Sch Sci & Engn, Dept Biol, Quezon City 1108, Philippines; [Koshio, Shunsuke; Ishikawa, Manabu; Yokoyama, Saichiro] Kagoshima Univ, Fac Fisheries, Lab Aquat Anim Nutr, Kagoshima 890, Japan; [Mamauag, Roger Edward] SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo, Philippines; [Villamor, Shiela S.] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan	Ragaza, JA (reprint author), Ateneo Manila Univ, Sch Sci & Engn, Dept Biol, Katipunan Ave, Quezon City 1108, Philippines.	janice_a_ragaza@yahoo.com			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government; Management Expenses Grants of the United Graduate School of Agricultural Sciences of Kagoshima University	The first author is grateful to the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government for the scholarship. Dr Gad S. Lim is also acknowledged for his assistance and contribution to the editing and correction of the manuscript. The research was partially funded by Management Expenses Grants of the United Graduate School of Agricultural Sciences of Kagoshima University provided to Shunsuke Koshio.	Matanjun P, 2009, J APPL PHYCOL, V21, P75, DOI 10.1007/s10811-008-9326-4; Yone Y., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P1465; Soler-Vila A, 2009, J APPL PHYCOL, V21, P617, DOI 10.1007/s10811-009-9423-z; Galland-Irmouli AV, 1999, J NUTR BIOCHEM, V10, P353, DOI 10.1016/S0955-2863(99)00014-5; Dawczynski C, 2007, FOOD CHEM, V103, P891, DOI 10.1016/j.foodchem.2006.09.041; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1301/nr.2007.dee.535-543; HASHIM R, 1992, AQUACULTURE, V108, P299, DOI 10.1016/0044-8486(92)90114-Z; Kumari P, 2010, FOOD CHEM, V120, P749, DOI 10.1016/j.foodchem.2009.11.006; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Dvir I, 2009, NUTRIENTS, V1, P156, DOI 10.3390/nu1020156; NAKAGAWA H, 1987, AQUACULTURE, V62, P109, DOI 10.1016/0044-8486(87)90315-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Wahbeh MI, 1997, AQUACULTURE, V159, P101, DOI 10.1016/S0044-8486(97)00183-X; Khotimchenko SV, 2002, BOT MAR, V45, P17, DOI 10.1515/BOT.2002.003; APPLER HN, 1983, AQUACULTURE, V30, P21, DOI 10.1016/0044-8486(83)90148-5; FLEURENCE J, 1994, J APPL PHYCOL, V6, P527, DOI 10.1007/BF02182406; Fleurence J, 1999, TRENDS FOOD SCI TECH, V10, P25, DOI 10.1016/S0924-2244(99)00015-1; Panlasigui LN, 2003, ASIA PAC J CLIN NUTR, V12, P209; Colombo ML, 2006, PLANT FOOD HUM NUTR, V61, P67, DOI 10.1007/s11130-006-0015-7; MABEAU S, 1993, TRENDS FOOD SCI TECH, V4, P103, DOI 10.1016/0924-2244(93)90091-N; Yamashita Y, 2001, J SEA RES, V45, P205, DOI 10.1016/S1385-1101(01)00049-1; APPLER HN, 1985, J FISH BIOL, V27, P327, DOI 10.1111/j.1095-8649.1985.tb04034.x; Plaza M, 2008, TRENDS FOOD SCI TECH, V19, P31, DOI 10.1016/j.tifs.2007.07.012; Xu SD, 2011, AQUACULT INT, V19, P1007, DOI 10.1007/s10499-011-9418-z; Valente LMP, 2006, AQUACULTURE, V252, P85, DOI 10.1016/j.aquaculture.2005.11.052; Hernandez LHH, 2007, AQUACULTURE, V262, P444, DOI 10.1016/j.aquaculture.2006.10.012; SATOH K, 1987, NIPPON SUISAN GAKK, V53, P1115; Kader MA, 2010, AQUACULTURE, V308, P136, DOI 10.1016/j.aquaculture.2010.07.037; Azaza MS, 2008, J APPL ICHTHYOL, V24, P202, DOI 10.1111/j.1439-0426.2007.01017.x; Burtin P., 2003, AGR FOOD CHEM, V2, P498; Dantagnan P, 2009, AQUAC RES, V41, P87, DOI 10.1111/j.1365-2109.2009.02308.x; Darcy-Vrillon B, 1993, INT J FOOD SCI NUTR, V44, P23; Davies SJ, 1997, AQUACULTURE, V152, P249, DOI 10.1016/S0044-8486(96)01513-X; Hamauzu Keizo, 1997, Suisan Zoshoku, V45, P357; Helrich K, 1990, OFF METH AN, P1298; Kalla A, 2008, FISHERIES SCI, V74, P104, DOI 10.1111/j.1444-2906.2007.01501.x; Kikuchi K., 2008, AVANCES NUTR AQUICOL, VIX, P108; Kim KW, 2002, J WORLD AQUACULT SOC, V33, P425, DOI 10.1111/j.1749-7345.2002.tb00021.x; LEARY DF, 1975, T AM FISH SOC, V104, P328, DOI 10.1577/1548-8659(1975)104<328:VOFIPD>2.0.CO;2; Lunn J., 2006, Nutrition Bulletin, V31, P178, DOI 10.1111/j.1467-3010.2006.00571.x; Matanjun P, 2010, J MED FOOD, V13, P792, DOI 10.1089/jmf.2008.1212; Morioka K., 2008, WORLD AQ 2008 19 23, P508; Mustafa G., 1995, FISHERIES SCI, V61, P25; Mustafa G.M., 1994, J FAC APPL BIOL SCI, V33, P125; Mustafa G.M., 1995, ISR J AQUACULT BARNI, V47, P155; Nakagawa H, 2007, DIETARY SUPPLEMENTS FOR THE HEALTH AND QUALITY OF CULTURED FISH, P133, DOI 10.1079/9781845931995.0133; Nakagawa H., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P1887; Nakagawa H., 1981, Suisan Zoshoku, V29, P109; Nakagawa Heisuke, 1993, Asian Fisheries Science, V6, P139; NAKAJIMA K, 1991, NIPPON SUISAN GAKK, V57, P673; Penaflorida VD, 1996, AQUACULTURE, V143, P393; Potty H.V, 1996, J FOOD SCI TECHNOL, V33, P1; Ragaza J.A., 2012, AQUACULTURE SCI, V60, P485; Skulas-Ray AC, 2008, EXPERT OPIN PHARMACO, V9, P1237, DOI [10.1517/14656566.9.7.1237, 10.1517/14656560802025496]; Teshima S.-i., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P159; Wassef E.A., 2005, EGYPT J AQUAT RES, V31, P321; Xu B.T., 1993, AQUAC SCI, V41, P461; Yi Young-Ho, 1994, Bulletin of the Korean Fisheries Society, V27, P69	58	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	MAR	2015	46	3					647	657		10.1111/are.12211		11	Fisheries	Fisheries	AZ9KO	WOS:000348532900012		
J	Henning, MA; Malpas, P; Manalo, E; Ram, S; Vijayakumar, V; Hawken, SJ				Henning, Marcus A.; Malpas, Phillipa; Manalo, Emmanuel; Ram, Sanya; Vijayakumar, Vidushan; Hawken, Susan J.			Ethical Learning Experiences and Engagement in Academic Dishonesty: A Study of Asian and European Pharmacy and Medical Students in New Zealand	ASIA-PACIFIC EDUCATION RESEARCHER			English	Article						Asian students; European students; Academic dishonesty; Ethical learning experiences; Pharmacy; Medicine; New Zealand higher education	PLAGIARISM; PSYCHOLOGY; CURRICULUM	In higher education in New Zealand, there is a burgeoning interest in, and concern with, the way students conduct themselves in their learning practices. Engagement in academically honest and dishonest behaviours is a crucial area of study within higher education. To operationalize effective teaching and assessment, it is critically important to consider how different ethnic groups operate within the learning environment when preparing for, and completing, assessments. The present study investigated differences between two ethnic groups studying in New Zealand (Asian and European) with respect to their disclosures of academic dishonesty and engagement with ethical learning experiences (ELE). Responses from 312 pharmacy and medical students were analysed in this study. A questionnaire was designed to elicit responses about engagement in academic dishonesty and ELEs. The findings emphasise that there were low rates of engagement in academically dishonest behaviours by both groups and there were no differences in disclosure of cheating and ELE. The findings showed small but significant differences between Asian and European students with respect to disclosure in the areas of copying and collusion. Subtle interactions were also noted for ethnicity and year of study, and ethnicity and gender, indicating that later year students diverged more than earlier year students and differences were more apparent amongst male students. Lastly, the findings showed that those students who read the student code of conduct were more likely to engage in academically 'honest' behaviours. These findings have implications for educationalists throughout the world, and it is possible that the hidden curriculum is playing a strong role in reframing the notion and practice of ethical conduct.	[Henning, Marcus A.] Univ Auckland, Ctr Med & Hlth Sci Educ, Auckland 1142, New Zealand; [Malpas, Phillipa; Hawken, Susan J.] Univ Auckland, Fac Med & Hlth Sci, Dept Psychol Med, Auckland 1142, New Zealand; [Manalo, Emmanuel] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Ram, Sanya] Univ Auckland, Sch Pharm, Auckland 1142, New Zealand; [Vijayakumar, Vidushan] Univ Auckland, Auckland 1142, New Zealand	Henning, MA (reprint author), Univ Auckland, Ctr Med & Hlth Sci Educ, Private Bag 92019, Auckland 1142, New Zealand.	m.henning@auckland.ac.nz					Aggarwal R, 2002, PHARM J, V269, P529; Amsberry D., 2009, REFERENCE LIB, V51, P31; Ercegovac Z, 2004, COLL RES LIBR, V65, P301; Pecorari D, 2003, J SECOND LANG WRIT, V12, P317, DOI 10.1016/j.jslw.2003.08.004; Kember D, 2000, HIGH EDUC, V40, P99, DOI 10.1023/A:1004036826490; Park-Saltzman J, 2012, COUNS PSYCHOL, V40, P895, DOI 10.1177/0011000011429831; Bilic-Zulle L, 2005, CROAT MED J, V46, P126; van der Vleuten CPM, 2012, MED TEACH, V34, P205, DOI 10.3109/0142159X.2012.652239; Harden RM, 2001, MED TEACH, V23, P123; Kanagawa C, 2001, PERS SOC PSYCHOL B, V27, P90, DOI 10.1177/0146167201271008; Donaldson L, 2013, J MANAGE STUD, V50, P153, DOI 10.1111/j.1467-6486.2012.01069.x; Austin Z, 2006, AM J PHARM EDUC, V70; Bennet R., 2005, ASSESS EVAL HIGH EDU, V30, P137, DOI 10.1080/0260293042000264244; Cheng K., 1996, J EDUC ADMIN, V34, P32, DOI 10.1108/09578239610148269; Coverdale J., 1998, ROY AUSTR NZ C PSYCH; Coverdale JH, 2000, MED TEACH, V22, P582; Cunha MPE, 2010, J BUS ETHICS, V97, P189, DOI 10.1007/s10551-010-0504-3; DELAMBERT K., 2003, J AM ACAD BUSINESS, V3, P98; Draper C., 2007, MED TEACH, V29, P100; Fitzjohn J., 2003, NZ MED J, V116; Fletcher JF, 2012, EDUC REV, V64, P425, DOI 10.1080/00131911.2011.625112; Forinash A. B., 2010, CURRENTS PHARM TEACH, V2, P100, DOI 10.1016/j.cptl.2010.01.004; Gitanjali B, 2004, J Postgrad Med, V50, P281; Granitz N, 2007, J BUS ETHICS, V72, P293, DOI 10.1007/s10551-006-9171-9; Harries R., 2005, PHARM ED, V5, P53, DOI 10.1080/15602210400026030; Hay D., 2001, TEACHING BUSINESS ET, V5, P331, DOI 10.1023/A:1011445614132; Henning MA, 2013, MED TEACH, V35, pE1211, DOI 10.3109/0142159X.2012.737962; Henning Marcus A, 2009, N Z Med J, V122, P102; Henning MA, 2011, PHARM ED, V11, P158; Hollinger R. C., 2010, J STUDENT AFFAIRS RE, V46, P1137; Holmes P., 2005, COMMUN EDUC, V54, P289, DOI DOI 10.1080/03634520500442160; Jones L. R., 2001, ACAD INTEGRITY ACAD; Maxwell A., 2006, GUIDANCE COUNSELLING, V21, P210; Maxwell A., 2008, INT J ED INTEGRITY, V4.2, P25; MCCABE DL, 1993, J HIGH EDUC, V64, P522, DOI 10.2307/2959991; Ministry of Social Development, 2010, ETHN COMP POP; Mu C., 2007, REFERENCE SERVICES R, V35, P571, DOI 10.1108/00907320710838390; Muijs D., 2011, DOING QUANTITATIVE R; Rasanathan K., 2004, P IN INT AS HLTH C A; Schafheutle E. I., 2009, MPHARM STUDENT CODE; The University of Auckland, 2011, AC HON CHEAT PLAG; Tsai J L, 2001, Cultur Divers Ethnic Minor Psychol, V7, P284, DOI 10.1037/1099-9809.7.3.284; Whitley HP, 2010, CURR PHARM TEACH LEA, V2, P94, DOI DOI 10.1016/J.CPTL.2010.01.009	43	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0119-5646	2243-7908		ASIA-PAC EDUC RES	Asia-Pac. Educ. Res.	MAR	2015	24	1					201	209		10.1007/s40299-014-0172-7		9	Education & Educational Research	Education & Educational Research	CB0LK	WOS:000349317300019		
J	Arai, Y; Aoyama, T; Inaba, Y; Okabe, H; Ihaya, T; Kichikawa, K; Ohashi, Y; Sakamoto, J; Oba, K; Saji, S				Arai, Yasuaki; Aoyama, Toru; Inaba, Yoshitaka; Okabe, Haruumi; Ihaya, Takashi; Kichikawa, Kimihiko; Ohashi, Yasuo; Sakamoto, Junichi; Oba, Koji; Saji, Shigetoyo			Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer (JFMC28 study)	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Article						colorectal cancer; hepatic arterial infusion; liver metastases	TECHNICAL COMPLICATIONS; IMPLANTABLE PORT; FLUOROURACIL; LEUCOVORIN; IRINOTECAN; CARCINOMA; TRIAL; LEVAMISOLE; EXPERIENCE; RESECTION	AimThis prospective multicenter study aimed to evaluate the efficacy and adverse events of hepatic arterial infusion chemotherapy (HAIC) using percutaneous catheter placement techniques for liver metastases from colorectal cancer (CRC). MethodsWe administered 5-fluorouracil at 1000mg/m(2) over 5h via hepatic arterial infusion on a weekly schedule. The primary endpoint was the overall response rate (RR). The secondary endpoints were the overall survival (OS), progression-free survival (PFS) and toxicities. ResultsBetween February 2000 and March 2002, seventy-seven eligible patients were enrolled in this study. After a median of 26 treatment cycles, 4 patients achieved a complete response, 29 achieved a partial response, 28 had stable disease, 15 had progressive disease and the status of one patient was unknown. The overall RR was 42.9% and the disease control rate (DCR) was 79.2%. The median PFS and OS times were 203 and 560 days, respectively. The most common grade 3 or 4 hematological and non-hematological toxicities were total bilirubin level elevation (10.4%) and gamma-glutamyl transferase level elevation (10.4%). With regard to the relationship between the background factors and treatment outcomes, the DCR, RR, PFS and OS were different between patients with and without extrahepatic lesions (DCR: 86.5% vs 64%, RR: 46.2% vs 36.0%, PFS: 233 days vs 99 days, OS: 587 days vs 558 days). ConclusionThe primary endpoint of this study was not met. HAIC using percutaneous catheter placement techniques did not improve the RR for liver metastasis from CRC.	[Arai, Yasuaki] Univ Tokyo, Cent Hosp, Natl Canc Ctr, Tokyo, Japan; [Ohashi, Yasuo] Univ Tokyo, Dept Biostat, Tokyo, Japan; [Oba, Koji] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Oba, Koji] Univ Tokyo, Grad Sch Interdisciplinary Informat Studies Lib, Interfac Initiat Informat Studies, Tokyo, Japan; [Saji, Shigetoyo] Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan; [Aoyama, Toru] Miura City Hosp, Miura, Kanagawa 2380222, Japan; [Inaba, Yoshitaka] Cent Hosp, Aichi Canc Ctr, Nagoya, Aichi, Japan; [Okabe, Haruumi] Uji Takeda Hosp, Radiotherapy Ctr, Uji, Japan; [Ihaya, Takashi] Sann In Rosai Hosp, Yonaga, Japan; [Kichikawa, Kimihiko] Nara Med Univ, Kashihara, Nara 634, Japan; [Sakamoto, Junichi] Tokai Cent Hosp, Kakamigahara, Japan	Aoyama, T (reprint author), Miura City Hosp, 4-33 Koyo Cho, Miura, Kanagawa 2380222, Japan.	t-aoyama@lilac.plala.or.jp			non-profit organization Epidemiological & Clinical Research Information Network (ECRIN)	The authors thank Kenichi Katoh of Iwate Medical University, Kenji Takizawa of St. Marianna University School of Medicine, Kazuyoshi Matsumura of Shizuoka Prefectural General Hospital, Hiroshi Seki of the School of Medicine at Niigata University, Yoshitaka Inaba of the Aichi Cancer Center Hospital, Takashi Kumada of the Ogaki Municipal Hospital, Naoshi Tanaka of Iga City General Hospital, Haruumi Okabe of the Japanese Red Cross Society Kyoto Daiichi Hospital, Norio Nakano of Hyogo College of Medicine, Kimihiko Kichikawa of Nara Medical University, Takashi Ihaya of Tottori Red Cross Hospital, and Hideyuki Higashihara of Fukuoka University. This study was supported in part by the non-profit organization Epidemiological & Clinical Research Information Network (ECRIN).	Allen PJ, 2005, J AM COLL SURGEONS, V201, P57, DOI 10.1016/j.jamcollsurg.2005.03.019; PIEDBOIS P, 1992, J CLIN ONCOL, V10, P896; Arai Y, 2012, J VASC INTERV RADIOL, V23, P1261, DOI 10.1016/j.jvir.2012.06.031; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Wolmark N, 1999, J CLIN ONCOL, V17, P3553; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Buyse M, 1996, J NATL CANCER I, V88, P252; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Tanaka T, 2003, J VASC INTERV RADIOL, V14, P63, DOI 10.1097/01.RVI.0000052292.26939.59; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; PETRELLI N, 1989, J CLIN ONCOL, V7, P1419; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Goldberg RM, 2006, J CLIN ONCOL, V24, P3347, DOI 10.1200/JCO.2006.06.1317; Mocellin S, 2007, J CLIN ONCOL, V25, P5649, DOI 10.1200/JCO.2007.12.1764; Arai Y, 1999, INTERVENTIONAL RADIO, P175; Arai Y, 1997, INTERVENTIONAL RADIO, P99192; Arai Y, 1997, CANCER CHEMOTH PHARM, V40, P526, DOI 10.1007/s002800050697; CAMPBELL KA, 1993, J CLIN ONCOL, V11, P822; CURLEY SA, 1993, SURGERY, V114, P928; desGramont A, 2000, J CLIN ONCOL, V18, P2938; ENSMINGER WD, 1978, CANCER RES, V38, P3784; Heinrich S, 2003, SURGERY, V133, P40, DOI 10.1067/msy.2003.37; Melichar B, 2012, BIOMED PAP, V156, P81, DOI 10.5507/bp.2012.047; Scaife CL, 2003, ANN SURG ONCOL, V10, P348, DOI 10.1245/ASO.2003.08.019; Seki H, 1999, CLIN RADIOL, V54, P221, DOI 10.1016/S0009-9260(99)91155-8; Seki H, 1996, J COMPUT ASSIST TOMO, V20, P343, DOI 10.1097/00004728-199605000-00002; Shah SA, 2007, J AM COLL SURGEONS, V205, P676, DOI 10.1016/j.jamcollsurg.2007.06.283; Sone M, 2002, J COMPUT ASSIST TOMO, V26, P515, DOI 10.1097/01.RCT.0000029049.35986.A0; Torzilli G, 2011, SURG TODAY, V41, P1184, DOI 10.1007/s00595-010-4527-2	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	MAR	2015	11	1					41	48		10.1111/ajco.12324		8	Oncology	Oncology	CA6KD	WOS:000349021000008		
J	Ushio, T; Wu, T; Yoshida, S				Ushio, Tomoo; Wu, Ting; Yoshida, Satoru			Review of recent progress in lightning and thunderstorm detection techniques in Asia	ATMOSPHERIC RESEARCH			English	Review						Lightning; Radar; Thunderstorm	NARROW BIPOLAR EVENTS; BAND DIGITAL INTERFEROMETRY; ARRAY WEATHER RADAR; ALAMOS SFERIC ARRAY; BROAD-BAND; INTRACLOUD DISCHARGES; WINTER THUNDERSTORMS; MAPPING SYSTEM; INITIAL-STAGE; PULSE TRAINS	In recent years, lightning and thunderstorm detection techniques have been rapidly developed in many regions of Asia. As the most populous continent, hazards caused by lightning and related phenomena are being paid more and more attentions and lightning observations and detections are booming in many countries. In this paper, we will give a brief review on recent progress of lightning and thunderstorm detection techniques in Asia. First, we will introduce several widely used lightning location systems including VHF interferometers, VHF time-of-arrival systems and LF time-of-arrival systems. As an example, a newly-developed system called BOLT is described and recent observation results are introduced. Second, we will review studies of a special type of intracloud discharge called "narrow bipolar event" (NBE). NBE studies in Asia are flourishing in recent years and are making great contributions to the understanding of various properties of NBE. Finally, we will introduce a fast-scanning phased array radar (PAR) system installed in Osaka University. This radar system has a temporal resolution of 10-30 s, which is much faster than the traditional weather radar and is ideal for observations of fast-evolving storm structures and the analysis of their relationship with lightning activities. Preliminary observation results with PAR are described. (C) 2014 Elsevier B.V. All rights reserved.	[Ushio, Tomoo; Wu, Ting] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Osaka, Japan; [Yoshida, Satoru] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki, Japan	Ushio, T (reprint author), Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Osaka, Japan.		Wu, Ting/B-7385-2014	Wu, Ting/0000-0002-3932-2803			Ahmad NA, 2010, J ATMOS SOL-TERR PHY, V72, P534, DOI 10.1016/j.jastp.2010.02.006; Akita M, 2014, J GEOPHYS RES-ATMOS, V119, P6085, DOI 10.1002/2013JD020378; Wu T, 2014, J GEOPHYS RES-ATMOS, V119, P7425, DOI 10.1002/2014JD021842; Shao XM, 2006, J ATMOS OCEAN TECH, V23, P1273, DOI 10.1175/JTECH1908.1; Ushio T, 1997, GEOPHYS RES LETT, V24, P2769, DOI 10.1029/97GL02953; Baharudin ZA, 2012, ATMOS RES, V117, P111, DOI 10.1016/j.atmosres.2012.01.012; Chen ML, 2013, ATMOS RES, V129, P97, DOI 10.1016/j.atmosres.2012.09.003; Li YJ, 2013, ATMOS RES, V134, P137, DOI 10.1016/j.atmosres.2013.07.020; Lu FC, 2013, J GEOPHYS RES-ATMOS, V118, P4458, DOI 10.1002/jgrd.50295; Bluestein HB, 2010, B AM METEOROL SOC, V91, P579, DOI 10.1175/2009BAMS2914.1; Akita M, 2011, J ATMOS SCI, V68, P719, DOI 10.1175/2010JAS3597.1; Nishihashi M, 2013, J ATMOS OCEAN TECH, V30, P325, DOI 10.1175/JTECH-D-12-00084.1; Lang TJ, 2002, MON WEATHER REV, V130, P2492, DOI 10.1175/1520-0493(2002)130<2492:RBCSKP>2.0.CO;2; Yoshikawa E, 2013, IEEE T GEOSCI REMOTE, V51, P3077, DOI 10.1109/TGRS.2012.2211607; Smith DA, 1999, J GEOPHYS RES-ATMOS, V104, P4189, DOI 10.1029/1998JD200045; Zhang GS, 2008, SCI CHINA SER D, V51, P694, DOI 10.1007/s11430-008-0049-9; Morimoto T, 2005, ATMOS RES, V76, P445, DOI 10.1016/j.atmosres.2004.11.024; Kawasaki Z, 2000, GEOPHYS RES LETT, V27, P3189, DOI 10.1029/1999GL011058; Rison W, 1999, GEOPHYS RES LETT, V26, P3573, DOI 10.1029/1999GL010856; Wu T, 2013, GEOPHYS RES LETT, V40, P618, DOI 10.1002/grl.50112; Shao XM, 2013, NAT GEOSCI, V6, P29, DOI 10.1038/NGEO1668; WILLETT JC, 1989, J GEOPHYS RES-ATMOS, V94, P16255, DOI 10.1029/JD094iD13p16255; Qie XS, 2009, ATMOS RES, V91, P244, DOI 10.1016/j.atmosres.2008.04.014; Akita M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012016; Sharma SR, 2008, J ATMOS SOL-TERR PHY, V70, P1251, DOI 10.1016/j.jastp.2008.03.002; Wurman J, 2012, B AM METEOROL SOC, V93, P1147, DOI 10.1175/BAMS-D-11-00010.1; Cooray V, 2014, ATMOS RES, V149, P346, DOI 10.1016/j.atmosres.2013.12.011; Stock MG, 2014, J GEOPHYS RES-ATMOS, V119, P3134, DOI 10.1002/2013JD020217; Yoshida S, 2012, ATMOS RES, V106, P86, DOI 10.1016/j.atmosres.2011.11.010; Jacobson AR, 2005, MON WEATHER REV, V133, P1144, DOI 10.1175/MWR2915.1; Xie YR, 2013, ATMOS RES, V129, P49, DOI 10.1016/j.atmosres.2012.12.012; Zhang GS, 2010, SCI CHINA EARTH SCI, V53, P591, DOI 10.1007/s11430-009-0116-x; Bitzer PM, 2013, J GEOPHYS RES-ATMOS, V118, P3120, DOI 10.1002/jgrd.50271; Cao DJ, 2012, ACTA PHYS SIN-CH ED, V61; Chen ML, 2013, ATMOS RES, V128, P13, DOI 10.1016/j.atmosres.2013.02.012; Cui H, 2009, ATMOS RES, V91, P425, DOI 10.1016/j.atmosres.2008.06.007; Dong WS, 2001, CHINESE SCI BULL, V46, P1561, DOI 10.1007/BF02900582; Dong WS, 2002, SCI CHINA SER D, V45, P259, DOI 10.1360/02yd9028; Isom B, 2013, J ATMOS OCEAN TECH, V30, P655, DOI 10.1175/JTECH-D-12-00063.1; Jiang RB, 2013, ATMOS RES, V129, P90, DOI 10.1016/j.atmosres.2012.09.005; Kawasaki Z., 2002, J ATMOS ELECT, V22, P55; Krehbiel P.R, 1979, IEEE T GEOSCI ELECT, V17, P196; La F., 2010, EL COMP APEMC 2010 A, P1235; Liu DX, 2013, ATMOS RES, V132, P423, DOI 10.1016/j.atmosres.2013.06.010; Liu HY, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016185; Lu FC, 2013, SCI CHINA EARTH SCI, V56, P1459, DOI 10.1007/s11430-012-4484-2; Makela A, 2014, ATMOS RES, V137, P91, DOI 10.1016/j.atmosres.2013.09.012; Mardiana R, 2000, GEOPHYS RES LETT, V27, P2917, DOI 10.1029/1999GL010997; MAZUR V, 1989, J GEOPHYS RES-ATMOS, V94, P3311, DOI 10.1029/JD094iD03p03311; Morimoto T., 2004, IEEJ T FUNDAM MAT, V124, P1232, DOI [10.1541/ieejfms.124.1232, DOI 10.1541/IEEJFMS.124.1232]; Nag A, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012957; Qie XS, 2009, ATMOS RES, V91, P310, DOI 10.1016/j.atmosres.2008.08.007; Qie XS, 2014, ATMOS RES, V135, P322, DOI 10.1016/j.atmosres.2012.11.012; Qiu S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018542; Qiu S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011655; Saito M, 2009, IEEJ T PE, V129, P929; Sharma SR, 2011, J ATMOS SOL-TERR PHY, V73, P483, DOI 10.1016/j.jastp.2010.11.006; Smith DA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000502; Smith DA, 2004, RADIO SCI, V39, DOI 10.1029/2002RS002790; Sun Z., 2012, ATMOS RES, V129, P58; Suszcynsky DM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017834; Takayanagi Y., 2011, IEEJ T FM, V131, P716, DOI DOI 10.1541/IEEJFMS.131.716; Takayanagi Y., 2012, IEEJ T FUNDAM MAT, V131, P716; Wang YH, 2012, J ATMOS SOL-TERR PHY, V84-85, P7, DOI 10.1016/j.jastp.2012.05.003; Wiens KC, 2008, J GEOPHYS RES-ATMOS, V113, DOI [10.1029/2007JD009400, 10.1029/007JD009400]; Wu T, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017054; Wu T, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015233; Wu T, 2014, J GEOPHYS RES-ATMOS, V119, P555, DOI 10.1002/2013JD020369; Wurman J., 2001, 30 C RAD MET; Wurman J., 2011, 35 C RAD MET; Wurman J., 2008, 24 C SEV LOC STORMS; Yang J, 2009, ATMOS RES, V91, P393, DOI 10.1016/j.atmosres.2008.04.010; Yoshida S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042065; Yoshida S., 2014, IEEJ T FUNDAM MAT, V134, P188; Yoshida S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017657; Yoshikawa E, 2010, IEEE T GEOSCI REMOTE, V48, P3225, DOI 10.1109/TGRS.2010.2045762; Yoshikawa E, 2012, J ATMOS OCEAN TECH, V29, P1757, DOI 10.1175/JTECH-D-12-00012.1; Zhang TL, 2009, ATMOS RES, V92, P475, DOI 10.1016/j.atmosres.2009.01.020; Zhang YJ, 2014, ATMOS RES, V135, P330, DOI 10.1016/j.atmosres.2013.02.010; Zhu BY, 2010, J ATMOS SOL-TERR PHY, V72, P271, DOI 10.1016/j.jastp.2009.12.002; Zhu BY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012021	81	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0169-8095	1873-2895		ATMOS RES	Atmos. Res.	MAR 1	2015	154						89	102		10.1016/j.atmosres.2014.10.001		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA0RZ	WOS:000348625500007		
J	Kojima, W				Kojima, Wataru			Mechanism of synchronous metamorphosis: larvae of a rhinoceros beetle alter the timing of pupation depending on maturity of their neighbours	BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY			English	Article						Social information; Metamorphosis; Coleoptera; Scarab beetle; Developmental plasticity; Dynastinae	CUTICULAR HYDROCARBONS; REPRODUCTIVE SYNCHRONY; TRYPOXYLUS-DICHOTOMUS; PREDATOR SATIATION; SIZE; COLEOPTERA; POPULATION; DURATION; SURVIVAL; DENSITY	Synchronous development is widespread throughout the animal kingdom, but how synchrony is achieved remains largely unknown. I examined whether (1) a group-living rhinoceros beetle Trypoxylus dichotomus prepares for pupation (i.e. prepupates) synchronously in the field, (2) whether the synchrony occurs through social interactions, and (3) whether the synchrony incurs physiological costs. I found that larvae prepupate synchronously within natural humus sites. Laboratory experiments show that, when pairs of larvae are placed in the same cage, they prepupate on almost the same day, while two larvae chosen from different cages are expected to prepupate at 6-day intervals. I examined the mechanism of synchronous prepupation by inducing maturity asynchrony between two individuals. Less advanced larvae shortened the larval period in the presence of more advanced neighbours, whilst advanced individuals prolonged the larval periods in the presence of less advanced neighbours. However, variations in the prolongation or shortening of the larval period were dependant on the sites from which the larvae were collected, and in no site did both prolongation and shortening occur together. When the larval periods were prolonged or shortened, the body weight of the resulting pupae decreased. These data show that larvae of this species alter the timing of prepupation depending on the maturity of their neighbours. This developmental plasticity is likely to incur physiological costs due to pupation in suboptimal timing. The pupae and prepupae of this species may gain some benefits such as predator avoidance through the synchrony, which outweigh the cost in terms of reduced body weight.	Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Kojima, W (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan.	koj.wataru@gmail.com			Japan Society for the Promotion of Science	I thank T. Saga for collection of field data; Y. Okada and two anonymous reviewers for constructive suggestions and invaluable comments on the manuscript; S. Hoshizaki and M. Abe for advice on the analyses; and M. Shimada for his help and suggestions throughout study. The Research Fellowship for Young Scientists provided by the Japan Society for the Promotion of Science was greatly appreciated.	Spencer RJ, 2001, OIKOS, V93, P401, DOI 10.1034/j.1600-0706.2001.930305.x; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Miramontes O, 1996, J THEOR BIOL, V181, P373, DOI 10.1006/jtbi.1996.0138; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; Hongo Y, 2007, BEHAV ECOL SOCIOBIOL, V62, P245, DOI 10.1007/s00265-007-0459-2; IMS RA, 1990, AM NAT, V136, P485, DOI 10.1086/285109; Archer MS, 1998, AUST J ENTOMOL, V37, P158, DOI 10.1111/j.1440-6055.1998.tb01564.x; Kojima W, 2012, BEHAV ECOL SOCIOBIOL, V66, P171, DOI 10.1007/s00265-011-1264-5; Mukai H, 2012, ANIM BEHAV, V84, P1443, DOI 10.1016/j.anbehav.2012.09.012; Lane SJ, 2002, J ANIM ECOL, V71, P780, DOI 10.1046/j.1365-2656.2002.00644.x; PECHENIK JA, 1993, MAR BIOL, V115, P287, DOI 10.1007/BF00346346; Loman J, 1999, AMPHIBIA-REPTILIA, V20, P421, DOI 10.1163/156853899X00466; HOWARD RD, 1980, ANIM BEHAV, V28, P705, DOI 10.1016/S0003-3472(80)80130-8; Kojima W, 2014, NATURWISSENSCHAFTEN, V101, P687, DOI 10.1007/s00114-014-1199-6; TEJEDO M, 1994, OIKOS, V71, P295, DOI 10.2307/3546278; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Hugo LE, 2006, AM J TROP MED HYG, V74, P462; Telang A, 2007, J EXP BIOL, V210, P854, DOI 10.1242/jeb.02715; BREDEN F, 1982, ECOLOGY, V63, P1682, DOI 10.2307/1940110; CRUMP ML, 1989, COPEIA, P794, DOI 10.2307/1445521; Etile E, 2008, OIKOS, V117, P135, DOI 10.1111/j.2007.0030-1299.16114.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Fantinou AA, 2008, EUR J ENTOMOL, V105, P625; Hanus R, 2010, P R SOC B, V277, P995, DOI 10.1098/rspb.2009.1857; Hirashima A, 1998, ARCH INSECT BIOCHEM, V37, P33, DOI 10.1002/(SICI)1520-6327(1998)37:1<33::AID-ARCH5>3.0.CO;2-W; HOPPENSTEADT FC, 1976, SCIENCE, V194, P335, DOI 10.1126/science.987617; Ikeda H, 2006, J EXP ZOOL PART A, V305A, P459, DOI 10.1002/jez.a.280; Karban R, 2000, ECOL LETT, V3, P253, DOI 10.1046/j.1461-0248.2000.00164.x; KARBAN R, 1982, ECOLOGY, V63, P321, DOI 10.2307/1938949; Kingsolver JG, 2007, P ROY SOC B-BIOL SCI, V274, P977, DOI 10.1098/rspb.2006.0036; Koenig WD, 2013, AM NAT, V181, P145, DOI 10.1086/668596; Kojima W, 2012, BIOL LETT, V8, P517; Kojima Wataru, 2012, Communicative &  Integrative Biology, V5, P262, DOI 10.4161/cib.19886; Lack D., 1968, ECOLOGICAL ADAPTATIO; Marlatt C.L., 1907, B USDA BUREAU ENTOMO, V71, P1; McGlashan JK, 2012, P ROY SOC B-BIOL SCI, V279, P1709, DOI 10.1098/rspb.2011.2074; Mukai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087932; ODONOGHUE M, 1995, OIKOS, V74, P115, DOI 10.2307/3545680; Persson I, 1999, ETHOLOGY, V105, P1087, DOI 10.1046/j.1439-0310.1999.10512489.x; PETERS TM, 1977, ANNU REV ENTOMOL, V22, P431, DOI 10.1146/annurev.en.22.010177.002243; Ruxton G.D., 2002, LIVING GROUPS; Ryan TJ, 2001, AM MIDL NAT, V145, P46, DOI 10.1674/0003-0031(2001)145[0046:EOHOMI]2.0.CO;2; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Spencer RJ, 2011, INTEGR COMP BIOL, V51, P100, DOI 10.1093/icb/icr045; SWEENEY BW, 1982, EVOLUTION, V36, P810, DOI 10.2307/2407894; THOMFORD.LL, 1968, ANN ENTOMOL SOC AM, V61, P1235; Tsurumaki H, 1987, SAISHU TO SHIIKU, V49, P254; Tucker JK, 2008, BEHAV ECOL, V19, P35, DOI 10.1093/beheco/arm097; Wassersug R.J., 1973, P273; Vince M. A., 1969, P233; Walsh PT, 2008, FUNCT ECOL, V22, P699, DOI 10.1111/j.1365-2435.2008.01429.x; TSCHINKE.WR, 1971, J EXP ZOOL, V176, P137, DOI 10.1002/jez.1401760203; Xu H, 2014, FORENSIC SCI INT, V242, P236, DOI 10.1016/j.forsciint.2014.07.003; Yamanaka Mikio, 1994, New Entomologist, V43, P60	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-5443	1432-0762		BEHAV ECOL SOCIOBIOL	Behav. Ecol. Sociobiol.	MAR	2015	69	3					415	424		10.1007/s00265-014-1854-0		10	Behavioral Sciences; Ecology; Zoology	Behavioral Sciences; Environmental Sciences & Ecology; Zoology	CA9GQ	WOS:000349230400007		
J	Kishi, C; Minematsu, T; Huang, LJ; Mugita, Y; Kitamura, A; Nakagami, G; Yamane, T; Yoshida, M; Noguchi, H; Funakubo, M; Mori, T; Sanada, H				Kishi, Chihiro; Minematsu, Takeo; Huang, Lijuan; Mugita, Yuko; Kitamura, Aya; Nakagami, Gojiro; Yamane, Takumi; Yoshida, Mikako; Noguchi, Hiroshi; Funakubo, Megumi; Mori, Taketoshi; Sanada, Hiromi			Hypo-osmotic Shock-Induced Subclinical Inflammation of Skin in a Rat Model of Disrupted Skin Barrier Function	BIOLOGICAL RESEARCH FOR NURSING			English	Article						elderly; hygiene care; hypo-osmotic shock; inflammation; skin barrier function	DRY SKIN; AGING SKIN; PRURITUS; EXPRESSION; MICE	Aging disrupts skin barrier function and induces xerosis accompanied by pruritus. In many cases, elderly patients complain of pruritus during skin hygiene care, a condition called aquagenic pruritus of the elderly (APE). To date, the pathophysiology and mechanism of action of APE have not been elucidated. We conducted the present study to test the hypothesis that hypo-osmotic shock of epidermal cells induces skin inflammation and elongation of C-fibers by nerve growth factor (NGF) as a basic mechanism of APE. The dorsal skin of HWY rats, which are a model for disrupted skin barrier function, was treated with distilled water (hypotonic treatment [Hypo] group) or normal saline (isotonic treatment [Iso] group) by applying soaked gauze for 7 days. Untreated rats were used as a control (no-treatment [NT] group). Histochemical and immunohistochemical analyses revealed inflammatory responses in the epidermis and the dermal papillary layer in the Hypo group, while no alterations were observed in the Iso or NT groups. Induction of expression and secretion of NGF and elongation of C-fibers into the epidermis were found in the Hypo group. In contrast, secretion of NGF was significantly lower and elongation of C-fibers was not observed in the Iso group. These results suggest that hypo-osmotic shock-induced inflammatory reactions promote hypersensitivity to pruritus in skin with disrupted barrier function.	[Kishi, Chihiro; Minematsu, Takeo; Huang, Lijuan; Mugita, Yuko; Kitamura, Aya; Nakagami, Gojiro; Yamane, Takumi; Funakubo, Megumi; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Div Hlth Sci & Nursing, Tokyo 1130033, Japan; [Yoshida, Mikako; Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol Molten, Tokyo 1130033, Japan	Sanada, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Div Hlth Sci & Nursing,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hsanada-tky@umin.ac.jp			Tokyo Association of Medical Sciences	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: A part of this study was supported by the Tokyo Association of Medical Sciences.	Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; Farage MA, 2007, CUTAN OCUL TOXICOL, V26, P343, DOI 10.1080/15569520701622951; Tominaga M, 2007, J DERMATOL SCI, V48, P103, DOI 10.1016/j.jdermsci.2007.06.003; Okawa T, 2012, J DERMATOL SCI, V66, P136, DOI 10.1016/j.jdermsci.2012.02.004; White-Chu EF, 2011, CLIN DERMATOL, V29, P37, DOI 10.1016/j.clindermatol.2010.07.005; Minematsu T, 2011, J DERMATOL SCI, V62, P160, DOI 10.1016/j.jdermsci.2011.03.005; Jankowski MP, 2010, J NEUROSCI, V30, P16272, DOI 10.1523/JNEUROSCI.2195-10.2010; Farage MA, 2009, AM J CLIN DERMATOL, V10, P73, DOI 10.2165/00128071-200910020-00001; Murota Hiroyuki, 2010, Allergology International, V59, P345, DOI 10.2332/allergolint.10-OA-0182; Bangham A D, 1968, Prog Biophys Mol Biol, V18, P29, DOI 10.1016/0079-6107(68)90019-9; Berger TG, 2011, SEMIN CUTAN MED SURG, V30, P113, DOI 10.1016/j.sder.2011.04.002; BIRCHER AJ, 1988, ARCH DERMATOL, V124, P84, DOI 10.1001/archderm.124.1.84; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Dyble Tina, 2011, Br J Community Nurs, V16, ppassim; Fagerstrom C, 2011, AGING MENT HEALTH, V15, P204, DOI 10.1080/13607863.2010.513039; Finch Mary, 2003, Nurs Older People, V15, P29; Hodgkinson Brent, 2005, Int J Evid Based Healthc, V3, P65, DOI 10.1111/j.1479-6988.2005.00022.x; LANDMANN L, 1988, ANAT EMBRYOL, V178, P1, DOI 10.1007/BF00305008; Luebberding S., 2013, SKIN PHARMACOL PHYS, V27, P9; Minematsu T, 2014, ADV SKIN WOUND CARE, V27, P272, DOI 10.1097/01.ASW.0000448461.25542.36; Nix D H, 2000, J Wound Ostomy Continence Nurs, V27, P260, DOI 10.1067/mjw.2000.107876; Norman Robert A, 2003, Dermatol Ther, V16, P254, DOI 10.1046/j.1529-8019.2003.01635.x; Penzer R, 2001, Nurs Stand, V15, P46; Ramos-e-Silva M, 2012, CLIN DERMATOL, V30, P274, DOI 10.1016/j.clindermatol.2011.08.024; SanchezCarpintero I, 1997, REV NEUROLOGIA, V25, pS222; Seyfarth F, 2011, CLIN DERMATOL, V29, P31, DOI 10.1016/j.clindermatol.2010.07.004; Smith D. R., 2002, YAMANASHI MED J, V17, P99; STEINMAN HK, 1987, BRIT J DERMATOL, V116, P329, DOI 10.1111/j.1365-2133.1987.tb05846.x; Thaipisuttikul Yupin, 1998, Journal of Dermatology (Tokyo), V25, P153; Wei TP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-181; Xia W, 2013, AGING CELL, V12, P661, DOI 10.1111/acel.12089; Yosipovitch Gil, 2004, Dermatol Nurs, V16, P325	32	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	MAR	2015	17	2					135	141		10.1177/1099800414532827		7	Nursing	Nursing	CB0QT	WOS:000349332300002		
J	Cheng, J; Ding, LK; Xia, A; Lin, RC; Li, YY; Zhou, JH; Cen, KF				Cheng, Jun; Ding, Lingkan; Xia, Ao; Lin, Richen; Li, Yuyou; Zhou, Junhu; Cen, Kefa			Hydrogen production using amino acids obtained by protein degradation in waste biomass by combined dark- and photo-fermentation	BIORESOURCE TECHNOLOGY			English	Article						Hydrogen production; Amino acid; Dark-fermentation; Photo-fermentation	PLATENSIS WET BIOMASS; SEQUENTIAL GENERATION; METHANE; WATER; METHANOGENESIS; COMBINATION; CONVERSION; EFFICIENT; BACTERIA; SLUDGE	The biological hydrogen production from amino acids obtained by protein degradation was comprehensively investigated to increase heating value conversion efficiency. The five amino acids (i.e., alanine, serine, aspartic acid, arginine, and leucine) produced limited hydrogen (0.2-16.2 mL/g) but abundant soluble metabolic products (40.1-84.0 mM) during dark-fermentation. The carbon conversion efficiencies of alanine (85.3%) and serine (94.1%) during dark-fermentation were significantly higher than those of other amino acids. Residual dark-fermentation solutions treated with zeolite for NH4+ removal were inoculated with photosynthetic bacteria to further produce hydrogen during photo-fermentation. The hydrogen yields of alanine and serine through combined dark- and photo-fermentation were 418.6 and 270.2 mL/g, respectively. The heating value conversion efficiency of alanine to hydrogen was 25.1%, which was higher than that of serine (21.2%). (C) 2014 Elsevier Ltd. All rights reserved.	[Cheng, Jun; Ding, Lingkan; Xia, Ao; Lin, Richen; Zhou, Junhu; Cen, Kefa] Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou 310027, Peoples R China; [Li, Yuyou] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi 9808579, Japan	Cheng, J (reprint author), Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou 310027, Peoples R China.	juncheng@zju.edu.cn	Xia, Ao/N-5390-2014	Xia, Ao/0000-0003-0428-287X	National Natural Science Foundation - China [51176163, 51476141]; National High Technology R&D Program - China [2012AA050101]; International Sci. & Tech. Cooperation Program - China [2012DFG61770]; Zhejiang Provincial Natural Science Foundation - China [LR14E060002]; Program for New Century Excellent Talents in University - China [NCET-11-0446]; Specialized Research Fund for the Doctoral Program of Higher Education - China [20110101110021]; Science and Technology Project of Guangxi Province - China [1346011-1]; Program of Introducing Talents of Discipline to University - China [B08026]	This study was supported by the National Natural Science Foundation - China (51176163, 51476141), National High Technology R&D Program - China (2012AA050101), International Sci. & Tech. Cooperation Program - China (2012DFG61770), Zhejiang Provincial Natural Science Foundation - China (LR14E060002), Program for New Century Excellent Talents in University - China (NCET-11-0446), Specialized Research Fund for the Doctoral Program of Higher Education - China (20110101110021), Science and Technology Project of Guangxi Province - China (1346011-1), and Program of Introducing Talents of Discipline to University - China (B08026).	Wang JL, 2009, INT J HYDROGEN ENERG, V34, P799, DOI 10.1016/j.ijhydene.2008.11.015; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; Cheng J, 2012, INT J HYDROGEN ENERG, V37, P13330, DOI 10.1016/j.ijhydene.2012.06.071; Konst PM, 2010, ADV SYNTH CATAL, V352, P1493, DOI 10.1002/adsc.201000034; Lee DY, 2010, BIORESOURCE TECHNOL, V101, pS42, DOI 10.1016/j.biortech.2009.03.037; Yang XW, 1999, THERMOCHIM ACTA, V329, P109; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Fang HHP, 2006, INT J HYDROGEN ENERG, V31, P2223, DOI 10.1016/j.ijhydene.2006.03.005; Sostaric M, 2012, NEW BIOTECHNOL, V29, P325, DOI 10.1016/j.nbt.2011.12.002; Chen CY, 2008, INT J HYDROGEN ENERG, V33, P4755, DOI 10.1016/j.ijhydene.2008.06.055; Fan YT, 2008, INT J HYDROGEN ENERG, V33, P6058, DOI 10.1016/j.ijhydene.2008.08.005; Lay JJ, 1999, WATER RES, V33, P2579, DOI 10.1016/S0043-1354(98)00483-7; Yoshida H, 2009, BIORESOURCE TECHNOL, V100, P2933, DOI 10.1016/j.biortech.2009.01.047; Yang ZM, 2011, INT J HYDROGEN ENERG, V36, P3465, DOI 10.1016/j.ijhydene.2010.12.018; Saady NMC, 2013, INT J HYDROGEN ENERG, V38, P13172, DOI 10.1016/j.ijhydene.2013.07.122; Su HB, 2009, INT J HYDROGEN ENERG, V34, P8846, DOI 10.1016/j.ijhydene.2009.09.001; NAGASE M, 1982, BIOTECHNOL BIOENG, V24, P2227, DOI 10.1002/bit.260241009; Lay JJ, 2003, INT J HYDROGEN ENERG, V28, P1361, DOI 10.1016/S0360-3199(03)00027-2; Ramsay IR, 2001, BIODEGRADATION, V12, P247, DOI 10.1023/A:1013116728817; Xiao ND, 2013, WATER RES, V47, P5700, DOI 10.1016/j.watres.2013.06.047; Lin CY, 2006, INT J HYDROGEN ENERG, V31, P832, DOI 10.1016/j.ijhydene.2005.08.010; Tao YZ, 2007, INT J HYDROGEN ENERG, V32, P200, DOI 10.1016/j.ijhydene.2006.06.034; Barnett J. W., 1994, Australasian Biotechnology, V4, P26; Cheng J, 2012, INT J HYDROGEN ENERG, V37, P6536, DOI 10.1016/j.ijhydene.2012.01.025; Cheng J, 2012, INT J HYDROGEN ENERG, V37, P13323, DOI 10.1016/j.ijhydene.2012.06.049; Cheng J, 2011, INT J HYDROGEN ENERG, V36, P1474, DOI 10.1016/j.ijhydene.2010.11.009; Li Dong, 2009, International Journal of Hydrogen Energy, V34, DOI 10.1016/j.ijhydene.2008.11.031; MEISTER A, 1951, J BIOL CHEM, V189, P577; Obradovic A, 2013, INT J HYDROGEN ENERG, V38, P1419, DOI 10.1016/j.ijhydene.2012.11.015; Obradovic A, 2013, IND ENG CHEM RES, V52, P13597, DOI 10.1021/ie401551m; Rodriguez JRB, 1997, BIOMED CHROMATOGR, V11, P335, DOI 10.1002/(SICI)1099-0801(199711)11:6<335::AID-BMC684>3.0.CO;2-T; Song WL, 2010, INT J HYDROGEN ENERG, V35, P3141, DOI 10.1016/j.ijhydene.2009.09.102; Xia A, 2013, BIORESOURCE TECHNOL, V131, P146, DOI 10.1016/j.biortech.2012.12.009; Xia A, 2013, ENERGY, V55, P631, DOI 10.1016/j.energy.2013.03.061; Ying YL, 2008, J ENVIRON SCI-CHINA, V20, P1118, DOI 10.1016/S1001-0742(08)62158-0	35	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	179						13	19		10.1016/j.biortech.2014.11.109		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AZ2CG	WOS:000348041600003		
J	Kimura, K; Nishimura, SI; Miyoshi, R; Hoque, A; Miyoshi, T; Watanabe, Y				Kimura, Katsuki; Nishimura, Shin-Ichiro; Miyoshi, Risho; Hoque, Asiful; Miyoshi, Taro; Watanabe, Yoshimasa			Application of glyco-blotting for identification of structures of polysaccharides causing membrane fouling in a pilot-scale membrane bioreactor treating municipal wastewater	BIORESOURCE TECHNOLOGY			English	Article						Wastewater treatment; Capsular polysaccharides; Lipo-polysaccharides; Glyco-blotting; MALDI-TOF/MS	ACTIVATED-SLUDGE; MBRS; TEMPERATURE; GLYCOPROTEINS; DIFFERENCE; FOULANTS; RELEASE; SURFACE; IMPACT; FLUX	A new approach for the analysis of polysaccharides in membrane bioreactor (MBR) is proposed in this study. Enrichment of polysaccharides by glyco-blotting, in which polysaccharides are specifically collected via interactions between the aldehydes in the polysaccharides and aminooxy groups on glycoblotting beads, enabled MALDI-TOF/MS analysis at a high resolution. Structures of polysaccharides extracted from fouled membranes used in a pilot-scale MBR treating municipal wastewater and those in the supernatant of the mixed liquor suspension in the MBR were investigated. It was found that the overlap between polysaccharides found in the supernatants and those extracted from the fouled membrane was rather limited, suggesting that polysaccharides that dominate in supernatants may not be important in membrane fouling in MBRs. Analysis using a bacterial carbohydrate database suggested that capsular polysaccharides (CPS) and/or lipo-polysaccharides (LPS) produced by gram-negative bacteria are key players in the evolution of membrane fouling in MBRs. (C) 2014 Elsevier Ltd. All rights reserved.	[Kimura, Katsuki; Hoque, Asiful] Hokkaido Univ, Grad Sch Engn, Div Environm Engn, Sapporo, Hokkaido 0608628, Japan; [Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010012, Japan; [Miyoshi, Risho] Med Chem Pharmaceut LLC, Kita Ku, Sapporo, Hokkaido 0600807, Japan; [Miyoshi, Taro; Watanabe, Yoshimasa] Hokkaido Univ, Ctr Environm Nano & Bio Engn, Sapporo, Hokkaido 0608628, Japan	Kimura, K (reprint author), Hokkaido Univ, Grad Sch Engn, Div Environm Engn, Sapporo, Hokkaido 0608628, Japan.	kkatsu@eng.hokudai.ac.jp	Miyoshi, Taro/F-6919-2013; Kimura, Katsuki/C-1785-2012	Miyoshi, Taro/0000-0002-3958-9647; 	The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24360212]; Japan Science and Technology Agency (JST)	This study was supported by Scientific Research (B) (General) (24360212) provided by The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and Core Research of Evolutional Science & Technology (CREST) for "Innovative Technology and System for Sustainable Water Use" from the Japan Science and Technology Agency (JST).	Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.3.CO;2-2; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Kimura K, 2009, WATER RES, V43, P1033, DOI 10.1016/j.watres.2008.11.024; Malaeb L, 2013, WATER RES, V47, P5447, DOI 10.1016/j.watres.2013.06.033; Teychene B, 2008, DESALINATION, V231, P27, DOI 10.1016/j.desal.2007.12.006; Rosenberger S, 2006, WATER RES, V40, P710, DOI 10.1016/j.watres.2005.11.028; Miura Y, 2008, MOL CELL PROTEOMICS, V7, P370, DOI 10.1074/mcp.M700377-MCP200; Bouhabila E, 2001, SEP PURIF TECHNOL, V22-3, P123, DOI 10.1016/S1383-5866(00)00156-8; Kimura K, 2005, ENVIRON SCI TECHNOL, V39, P6293, DOI 10.1021/es0502425; Miura Y, 2010, ANAL CHEM, V82, P10021, DOI 10.1021/ac101599p; Miyoshi T, 2009, WATER RES, V43, P5109, DOI 10.1016/j.watres.2009.08.035; Hirose K, 2011, BIOCHEMISTRY-US, V50, P4757, DOI 10.1021/bi101940x; Krzeminski P, 2012, J MEMBRANE SCI, V423, P348, DOI 10.1016/j.memsci.2012.08.032; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Yamato N, 2006, J MEMBRANE SCI, V280, P911, DOI 10.1016/j.memsci.2006.03.009; van den Brink P, 2011, WATER RES, V45, P4491, DOI 10.1016/j.watres.2011.05.046; Kimura K, 2004, WATER RES, V38, P3431, DOI 10.1016/j.watres.2004.05.007; RIETSCHEL ET, 1992, SCI AM, V267, P54; Al-Halbouni D, 2009, WATER RES, V43, P97, DOI 10.1016/j.watres.2008.10.008; Kita Y, 2007, MOL CELL PROTEOMICS, V6, P1437, DOI 10.1074/mcp.T600063-MCP200; Amano M, 2010, MOL CELL PROTEOMICS, V9, P523, DOI 10.1074/mcp.M900559-MCP200; Asano T., 2006, WATER REUSE ISSUES T; Defrance L, 2000, BIORESOURCE TECHNOL, V73, P105, DOI 10.1016/S0960-8524(99)00163-7; Fan FS, 2006, WATER RES, V40, P205, DOI 10.1016/j.watres.2005.10.037; Goncalves VM, 2006, J APPL MICROBIOL, V101, P1009, DOI 10.1111/j.1365-2672.2006.03012.x; Hoque A, 2012, SEP PURIF TECHNOL, V93, P83, DOI 10.1016/j.seppur.2012.03.027; Kimura K, 2012, WATER RES, V46, P5725, DOI 10.1016/j.watres.2012.08.004; Kimura K, 2008, DESALINATION, V231, P268, DOI 10.1016/j.desal.2007.10.030; Ma Z, 2013, BIORESOURCE TECHNOL, V133, P462, DOI 10.1016/j.biortech.2013.01.023; Madigan MT, 2006, BROCK BIOL MICROORGA; Prescott L., 2005, MICROBIOLOGY; Siembida B, 2010, WATER RES, V44, P4037, DOI 10.1016/j.watres.2010.05.016; Sutherland I.W., 2007, COMPREHENSIVE GLYCOS, V2	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	179						180	186		10.1016/j.biortech.2014.12.017		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AZ2CG	WOS:000348041600026		
J	Huang, WL; Li, B; Zhang, C; Zhang, ZY; Lei, ZF; Lu, BW; Zhou, BB				Huang, Wenli; Li, Bing; Zhang, Chao; Zhang, Zhenya; Lei, Zhongfang; Lu, Baowang; Zhou, Beibei			Effect of algae growth on aerobic granulation and nutrients removal from synthetic wastewater by using sequencing batch reactors	BIORESOURCE TECHNOLOGY			English	Article						Aerobic granules; Sunlight; Algae; Nitrification; Phosphorus removal	EXTRACELLULAR POLYMERIC SUBSTANCES; BIOLOGICAL PHOSPHORUS REMOVAL; ACTIVATED-SLUDGE; STRUCTURAL STABILITY; NITRIFICATION; INHIBITION; GRANULES; AMMONIA; DENITRIFICATION; COMPETITION	The effect of algae growth on aerobic granulation and nutrients removal was studied in two identical sequencing batch reactors (SBRs). Sunlight exposure promoted the growth of algae in the SBR (Rs), forming an algal-bacterial symbiosis in aerobic granules. Compared to the control SBR (Rc), Rs had a slower granulation process with granules of loose structure and smaller particle size. Moreover, the specific oxygen uptake rate was significantly decreased for the granules from Rs with secretion of 25.7% and 22.5% less proteins and polysaccharides respectively in the extracellular polymeric substances. Although little impact was observed on chemical oxygen demand (COD) removal, algal-bacterial symbiosis deteriorated N and P removals, about 40.7-45.4% of total N and 44% of total P in Rs in contrast to 52.9-58.3% of TN and 90% of TP in Rc, respectively. In addition, the growth of algae altered the microbial community in Rs, especially unfavorable for Nitrospiraceae and Nitrosomonadaceae. (C) 2014 Elsevier Ltd. All rights reserved.	[Huang, Wenli; Li, Bing; Zhang, Chao; Zhang, Zhenya; Lei, Zhongfang] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Lu, Baowang] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan; [Zhou, Beibei] Shanghai Biotechnol Corp, Shanghai 201203, Peoples R China	Lei, ZF (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	lei.zhongfang.gu@u.tsukuba.ac.jp	Lei, Zhongfang/B-3611-2014				Abdel-Raouf N, 2012, SAUDI J BIOL SCI, V19, DOI 10.1016/j.sjbs.2012.04.005; Adav SS, 2008, J HAZARD MATER, V154, P1120, DOI 10.1016/j.jhazmat.2007.11.058; Pijuan M, 2010, WATER RES, V44, P6063, DOI 10.1016/j.watres.2010.07.075; Su YY, 2012, BIORESOURCE TECHNOL, V105, P67, DOI 10.1016/j.biortech.2011.11.113; Zhang LL, 2007, ENZYME MICROB TECH, V41, P551, DOI 10.1016/j.enzmictec.2007.05.001; Adav SS, 2008, WATER RES, V42, P1644, DOI 10.1016/j.watres.2007.10.013; Baumann B, 1996, J BACTERIOL, V178, P4367; Boelee NC, 2014, ECOL ENG, V64, P213, DOI 10.1016/j.ecoleng.2013.12.035; ANTHONISEN AC, 1976, J WATER POLLUT CON F, V48, P835; Adav SS, 2008, BIOTECHNOL ADV, V26, P411, DOI 10.1016/j.biotechadv.2008.05.002; Maszenan AM, 2011, BIOTECHNOL ADV, V29, P111, DOI 10.1016/j.biotechadv.2010.09.004; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; MISHIMA K, 1991, WATER SCI TECHNOL, V23, P981; Marcilhac C, 2014, WATER RES, V64, P278, DOI [10.1016/j.watres.2014.07.012, 10.1016/j.waters.2014.07.012]; Shao YQ, 2009, INT J SYST EVOL MICR, V59, P526, DOI 10.1099/ijs.0.65670-0; Ni BJ, 2009, WATER RES, V43, P751, DOI 10.1016/j.watres.2008.11.009; Lee DJ, 2010, BIOTECHNOL ADV, V28, P919, DOI 10.1016/j.biotechadv.2010.08.007; Choi O, 2010, BIOTECHNOL BIOENG, V107, P1004, DOI 10.1002/bit.22860; Allen MS, 2004, ENVIRON MICROBIOL, V6, P780, DOI 10.1111/j.1462-2920.2004.00615.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Wong MT, 2005, WATER RES, V39, P2901, DOI 10.1016/j.watres.2005.05.015; APHA, 1998, STANDARD METHODS EXA; Barak Y, 1998, APPL ENVIRON MICROB, V64, P813; Bernardet J.-F., 2006, PROKARYOTES HDB BIOL, V7, P455; Crossman LC, 1997, MICROBIOL-SGM, V143, P3775; de Godos I, 2009, APPL MICROBIOL BIOT, V82, P187, DOI 10.1007/s00253-008-1825-3; Gumaelius L, 2001, INT J SYST EVOL MICR, V51, P999; Huang WL, 2014, BIORESOURCE TECHNOL, V171, P139, DOI 10.1016/j.biortech.2014.08.043; Kaplan D, 2000, WATER SCI TECHNOL, V42, P167; Long B, 2014, BIORESOURCE TECHNOL, V166, P57, DOI 10.1016/j.biortech.2014.05.039; Philips Sarah, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P115, DOI 10.1023/A:1020892826575; Risgaard-Petersen N, 2004, APPL ENVIRON MICROB, V70, P5528, DOI 10.1128/AEM.70.9.5528-5537.2004; Stante L, 1997, WATER RES, V31, P1317, DOI 10.1016/S0043-1354(96)00351-X; Strauch E., 2006, MICROBIOL MONOGR, V4, P131; Yang SF, 2004, BIOCHEM ENG J, V17, P41, DOI 10.1016/S1369-703X(03)00122-0	35	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	179						187	192		10.1016/j.biortech.2014.12.024		6	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AZ2CG	WOS:000348041600027		
J	Cheng, J; Lin, RC; Ding, LK; Song, WL; Li, YY; Zhou, JH; Cen, KF				Cheng, Jun; Lin, Richen; Ding, Lingkan; Song, Wenlu; Li, Yuyou; Zhou, Junhu; Cen, Kefa			Fermentative hydrogen and methane cogeneration from cassava residues: Effect of pretreatment on structural characterization and fermentation performance	BIORESOURCE TECHNOLOGY			English	Article						Cassava residue; Microwave-heated acid; Steam-heated acid; Hydrogen; Methane	SUGARCANE BAGASSE; LIGNOCELLULOSIC BIOMASS; DIGESTIBILITY; IRRADIATION; HYDROLYSIS; STILLAGE	The physicochemical properties of cassava residues subjected to microwave (or steam)-heated acid pretreatment (MHAP or SHAP) were comparatively investigated to improve fermentative hydrogen and methane cogeneration. The hydrogen yield from cassava residues with MHAP and enzymolysis was higher (106.2 mL/g TVS) than that with SHAP and enzymolysis (102.1 mL/g TVS), whereas the subsequent methane yields showed opposite results (75.4 and 93.2 mL/g TVS). Total energy conversion efficiency increased to 24.7%. Scanning electron microscopy images revealed MHAP generated numerous regular micropores (similar to 6 mu m) and SHAP generated irregular fragments (similar to 23 mu m) in the destroyed lignocellulose matrix. Transmission electron microscopy images showed SHAP generated wider cracks (similar to 0.2 mu m) in delaminated cell walls than MHAP (similar to 0.1 mu m). X-ray diffraction patterns indicated MHAP caused a higher crystallinity index (33.00) than SHAP (25.88), due to the deconstruction of amorphous cellulose. Fourier transform infrared spectroscopy indicated MHAP caused a higher crystallinity coefficient (1.20) than SHAP (1.12). (C) 2014 Elsevier Ltd. All rights reserved.	[Cheng, Jun; Lin, Richen; Ding, Lingkan; Song, Wenlu; Zhou, Junhu; Cen, Kefa] Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou 310027, Zhejiang, Peoples R China; [Song, Wenlu] Jining Univ, Dept Life Sci & Engn, Jining 273155, Peoples R China; [Li, Yuyou] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi 9808579, Japan	Cheng, J (reprint author), Zhejiang Univ, State Key Lab Clean Energy Utilizat, Hangzhou 310027, Zhejiang, Peoples R China.	juncheng@zju.edu.cn			National Natural Science Foundation - China [51176163, 51476141]; National High Technology R&D Program - China [2012AA050101]; International Sci. & Tech. Cooperation Program - China [2012DFG61770]; Zhejiang Provincial Natural Science Foundation - China [LR14E060002]; Program for New Century Excellent Talents in University - China [NCET-11-0446]; Specialized Research Fund for the Doctoral Program of Higher Education - China [20110101110021]; Science and Technology Project of Guangxi Province - China [1346011-1]; Program of Introducing Talents of Discipline to University - China [B08026]	This study was supported by the National Natural Science Foundation - China (51176163, 51476141), National High Technology R&D Program - China (2012AA050101), International Sci. & Tech. Cooperation Program - China (2012DFG61770), Zhejiang Provincial Natural Science Foundation - China (LR14E060002), Program for New Century Excellent Talents in University - China (NCET-11-0446), Specialized Research Fund for the Doctoral Program of Higher Education - China (20110101110021), Science and Technology Project of Guangxi Province - China (1346011-1) and Program of Introducing Talents of Discipline to University - China (B08026).	Abraham RE, 2013, BIOMASS BIOENERG, V58, P180, DOI 10.1016/j.biombioe.2013.06.006; Kwietniewska E, 2014, RENEW SUST ENERG REV, V34, P491, DOI 10.1016/j.rser.2014.03.041; Zhang QH, 2011, BIORESOURCE TECHNOL, V102, P8899, DOI 10.1016/j.biortech.2011.06.061; Zheng Y, 2013, APPL ENERG, V105, P1, DOI 10.1016/j.apenergy.2012.11.070; Moretti MMD, 2014, APPL ENERG, V122, P189, DOI 10.1016/j.apenergy.2014.02.020; Wang W, 2011, BIORESOURCE TECHNOL, V102, P3833, DOI 10.1016/j.biortech.2010.12.012; Monlau F, 2013, CRIT REV ENV SCI TEC, V43, P260, DOI 10.1080/10643389.2011.604258; Cheng J, 2010, INT J HYDROGEN ENERG, V35, P3029, DOI 10.1016/j.ijhydene.2009.07.012; Chundawat SPS, 2011, ENERG ENVIRON SCI, V4, P973, DOI 10.1039/c0ee00574f; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; Kallioinen A, 2013, BIORESOURCE TECHNOL, V140, P414, DOI 10.1016/j.biortech.2013.04.098; Liao ZD, 2011, BIORESOURCE TECHNOL, V102, P7953, DOI 10.1016/j.biortech.2011.05.067; Oh SY, 2005, CARBOHYD RES, V340, P2376, DOI 10.1016/j.carres.2005.08.007; Hu ZH, 2008, BIOCHEM ENG J, V38, P369, DOI 10.1016/j.bej.2007.08.001; Xia A, 2013, BIORESOURCE TECHNOL, V146, P436, DOI 10.1016/j.biortech.2013.07.077; Kumar R, 2009, BIORESOURCE TECHNOL, V100, P3948, DOI 10.1016/j.biortech.2009.01.075; Chen WH, 2011, APPL ENERG, V88, P2726, DOI 10.1016/j.apenergy.2011.02.027; Binod P, 2012, RENEW ENERG, V37, P109, DOI 10.1016/j.renene.2011.06.007; Luo G, 2010, INT J HYDROGEN ENERG, V35, P11733, DOI 10.1016/j.ijhydene.2010.08.033; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Cheng J, 2014, ENERG FUEL, V28, P563, DOI 10.1021/ef402388j; Chen WH, 2012, APPL ENERG, V93, P237, DOI 10.1016/j.apenergy.2011.12.014; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Cheng CL, 2011, BIORESOURCE TECHNOL, V102, P8514, DOI 10.1016/j.biortech.2011.04.059; Guragain YN, 2011, BIORESOURCE TECHNOL, V102, P4416, DOI 10.1016/j.biortech.2010.11.125; Zheng Y, 2014, PROG ENERG COMBUST, V42, P35, DOI 10.1016/j.pecs.2014.01.001	27	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	179						407	413		10.1016/j.biortech.2014.12.050		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AZ2CG	WOS:000348041600054		
J	Widayatno, WB; Guan, GQ; Rizkiana, J; Du, X; Hao, XG; Zhang, ZL; Abudula, A				Widayatno, Wahyu Bambang; Guan, Guoqing; Rizkiana, Jenny; Du, Xiao; Hao, Xiaogang; Zhang, Zhonglin; Abudula, Abuliti			Selective catalytic conversion of bio-oil over high-silica zeolites	BIORESOURCE TECHNOLOGY			English	Article						Biomass; Bio-oil; High silica zeolite; Selective catalytic conversion; Deoxygenation	CALCINED SCALLOP SHELL; TEMPERATURE-PROGRAMMED DESORPTION; FAST PYROLYSIS; LIGNOCELLULOSIC BIOMASS; HZSM-5 ZEOLITE; BETA-ZEOLITE; H-MORDENITE; TAR; AMMONIA; ACIDITY	Four high silica zeolites, i.e., HSZ-385, 890, 960, and 990 were utilized for the selective catalytic conversion of bio-oil from Fallopia japonica to certain chemicals in a fixed-bed reactor. The Beta-type HSZ-960 zeolite showed the highest selectivity to hydrocarbons, especially to aromatics as well as PAH compounds with the lowest unwanted chemicals while HSZ-890 showed high selectivity to aromatics. NH3-Temperature Programmed Desorption (TPD) analysis indicated that different amounts of acid sites in different zeolites determined the catalytic activity for the oxygen removal from bio-oil, in which the acid sites at low temperature (LT) region gave more contribution within the utilized temperature region. The reusability test of HSZ-960 showed the stability of hydrocarbons yield at higher temperature due to the significant contribution of coke gasification which assisted further deoxygenation of bio-oil. These results provide a guidance to select suitable zeolite catalysts for the upgrading of bio-oil in a practical process. (C) 2014 Elsevier Ltd. All rights reserved.	[Widayatno, Wahyu Bambang; Guan, Guoqing; Rizkiana, Jenny; Abudula, Abuliti] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368560, Japan; [Guan, Guoqing; Du, Xiao; Abudula, Abuliti] Hirosaki Univ, NJRISE, Aomori 0300813, Japan; [Du, Xiao; Hao, Xiaogang; Zhang, Zhonglin] Taiyuan Univ Technol, Sch Chem & Chem Engn, Taiyuan 030024, Peoples R China	Abudula, A (reprint author), Hirosaki Univ, NJRISE, 2-1-3 Matsubara, Aomori 0300813, Japan.	abuliti@cc.hirosaki-u.ac.jp	Guan, Guoqing/K-6555-2013		Strategic International Collaborative Research Program (SICORP), Japan Science and Technology (JST); Aomori City Government, Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	This study is supported by Strategic International Collaborative Research Program (SICORP), Japan Science and Technology (JST) and Aomori City Government, Japan. Wahyu BW and Jenny Rizkiana greatly acknowledge the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan for PhD scholarship.	Demirbas A, 2011, APPL ENERG, V88, P17, DOI 10.1016/j.apenergy.2010.07.016; Gong FY, 2011, BIORESOURCE TECHNOL, V102, P9247, DOI 10.1016/j.biortech.2011.07.009; Jacobson K, 2013, RENEW SUST ENERG REV, V23, P91, DOI 10.1016/j.rser.2013.02.036; Cordella M, 2012, J HAZARD MATER, V231, P26, DOI 10.1016/j.jhazmat.2012.06.030; Kanaujia PK, 2014, J ANAL APPL PYROL, V105, P55, DOI 10.1016/j.jaap.2013.10.004; Goyal HB, 2008, RENEW SUST ENERG REV, V12, P504, DOI 10.1016/j.rser.2006.07.014; Guan GQ, 2013, FUEL, V109, P241, DOI 10.1016/j.fuel.2012.11.074; Lonyi F, 2001, MICROPOR MESOPOR MAT, V47, P293, DOI 10.1016/S1387-1811(01)00389-4; Shirazi L, 2008, CRYST RES TECHNOL, V43, P1300, DOI 10.1002/crat.200800149; Bartholomew CH, 2001, APPL CATAL A-GEN, V212, P17, DOI 10.1016/S0926-860X(00)00843-7; Guan GQ, 2012, APPL CATAL B-ENVIRON, V115, P159, DOI 10.1016/j.apcatb.2011.12.009; Guan GQ, 2013, BIORESOURCE TECHNOL, V139, P280, DOI 10.1016/j.biortech.2013.04.007; NIWA M, 1995, J PHYS CHEM-US, V99, P8812, DOI 10.1021/j100021a056; Li CS, 2010, RESOUR CONSERV RECY, V54, P905, DOI 10.1016/j.resconrec.2010.01.009; Foster AJ, 2012, APPL CATAL A-GEN, V423, P154, DOI 10.1016/j.apcata.2012.02.030; Lehto J, 2014, APPL ENERG, V116, P178, DOI 10.1016/j.apenergy.2013.11.040; Miyamoto Y, 2000, MICROPOR MESOPOR MAT, V40, P271, DOI 10.1016/S1387-1811(00)00264-X; Carlson TR, 2009, TOP CATAL, V52, P241, DOI 10.1007/s11244-008-9160-6; Mihalcik DJ, 2011, J ANAL APPL PYROL, V92, P224, DOI 10.1016/j.jaap.2011.06.001; Fan YS, 2014, J ANAL APPL PYROL, V108, P185, DOI 10.1016/j.jaap.2014.05.001; Widayatno WB, 2014, FUEL, V132, P204, DOI 10.1016/j.fuel.2014.04.089; Vitolo S, 2001, FUEL, V80, P17, DOI 10.1016/S0016-2361(00)00063-6; Oasmaa A, 2003, ENERG FUEL, V17, P1075, DOI 10.1021/ef030011o; Qi WY, 2006, GREEN CHEM, V8, P183, DOI 10.1039/b510602h; Cerny R, 2013, CATAL TODAY, V204, P46, DOI 10.1016/j.cattod.2012.07.041; Kaewpanha M, 2014, FUEL PROCESS TECHNOL, V120, P106, DOI 10.1016/j.fuproc.2013.12.013; Mante OD, 2013, FUEL, V108, P451, DOI 10.1016/j.fuel.2012.12.027; Bi PY, 2013, BIORESOURCE TECHNOL, V136, P222, DOI 10.1016/j.biortech.2013.02.100; Camiloti AM, 1999, APPL CATAL A-GEN, V182, P107, DOI 10.1016/S0926-860X(98)00418-9; Cheng D, 2014, ENERG CONVERS MANAGE, V87, P378, DOI 10.1016/j.enconman.2014.06.084; Lee HW, 2014, ENERGY, V66, P2, DOI 10.1016/j.energy.2013.05.023; Lonyi F, 2001, THERMOCHIM ACTA, V373, P53, DOI 10.1016/S0040-6031(01)00458-0; Rodriguez-Gonzalez L, 2007, APPL CATAL A-GEN, V328, P174, DOI 10.1016/j.apcata.2007.06.003; Wang HL, 2001, CATAL LETT, V76, P225, DOI 10.1023/A:1012244526995; Wonglimpiyarat J, 2010, APPL ENERG, V87, P749, DOI 10.1016/j.apenergy.2009.08.043	35	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2015	179						518	523		10.1016/j.biortech.2014.12.046		6	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AZ2CG	WOS:000348041600069		
J	Noguchi, K; Morishima, Y; Takahashi, S; Ishihara, H; Shibano, T; Murata, M				Noguchi, Kengo; Morishima, Yoshiyuki; Takahashi, Shinichi; Ishihara, Hiroaki; Shibano, Toshiro; Murata, Mitsuru			Impact of nonsynonymous mutations of factor X on the functions of factor X and anticoagulant activity of edoxaban	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						anticoagulant; edoxaban; factor Xa; factor Xa inhibitor; interpatient variability; single-nucleotide polymorphisms	ADVERSE DRUG-REACTIONS; COAGULATION FACTOR-X; BLOOD-COAGULATION; HEALTHY-VOLUNTEERS; IN-VITRO; WARFARIN; INHIBITOR; CLOPIDOGREL; PHARMACOKINETICS; DEFICIENCY	Edoxaban is an oral direct factor Xa (FXa) inhibitor and its efficacy as an oral anticoagulant is less subject to drug - food and drug-drug interaction than existing vitamin K antagonists. Although this profile of edoxaban suggests it is well suited for clinical use, it is not clear whether genetic variations of factor X influence the activity of edoxaban. Our aim was to investigate a possible impact of singlenucleotide polymorphisms (SNPs) in the factor X gene on the functions of factor X and the activity of edoxaban. Two nonsynonymous SNPs within mature factor X, Ala152Thr and Gly192Arg, were selected as possible candidates that might affect the functions of FXa and the activity of edoxaban. We measured catalytic activities of wild type and mutant FXas in a chromogenic assay using S-2222 and coagulation times including prothrombin time (PT) and activated partial thrombin time (aPTT) of plasma-containing recombinant FXs in the presence and absence of edoxaban. Michaelis-Menten kinetic parameters of FXas, K-m and V-max values, PT and aPTT were not influenced by either mutation indicating these mutations do not affect the FXa catalytic and coagulation activities. The Ki values of edoxaban for the FXas and the concentrations of edoxaban required to double PT and aPTT were not different between wild type and mutated FXas indicating that both mutations have little impact on the activity of edoxaban. In conclusion, these data suggest that edoxaban has little interpatient variability stemming from SNPs in the factor X gene. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Noguchi, Kengo; Morishima, Yoshiyuki; Takahashi, Shinichi; Ishihara, Hiroaki; Shibano, Toshiro; Murata, Mitsuru] Keio Univ, Keio Daiichi Project Genet Thrombosis, Tokyo, Japan; [Noguchi, Kengo; Morishima, Yoshiyuki; Takahashi, Shinichi] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo 1408710, Japan; [Ishihara, Hiroaki] Daiichi Sankyo Co Ltd, New Drug Regulatory Affairs Dept, Tokyo 1408710, Japan; [Shibano, Toshiro] Daiichi Sankyo Co Ltd, Res Oversight Funct, R&D Div, Tokyo 1408710, Japan; [Murata, Mitsuru] Keio Univ, Sch Med, Tokyo, Japan	Noguchi, K (reprint author), Daiichi Sankyo Co Ltd, R&D Div, Biol Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	noguchi.kengo.gn@daiichisankyo.co.jp			Daiichi Sankyo Co., Ltd.	This study presented here is sponsored by Daiichi Sankyo Co., Ltd., K.N., Y.M., S.T., H.I. and T.S. are employees of Daiichi Sankyo Co., Ltd. M.M. is funded by Daiichi Sankyo Co., Ltd.	Baglin TP, 2006, BRIT J HAEMATOL, V132, P277, DOI 10.1111/j.1365-2141.2005.05856.x; Raskob G, 2010, THROMB HAEMOSTASIS, V104, P642, DOI 10.1160/TH10-02-0142; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Mendell J, 2011, J CLIN PHARMACOL, V51, P687, DOI 10.1177/0091270010370974; Samama MM, 2012, THROMB RES, V129, pE77, DOI 10.1016/j.thromres.2011.07.026; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; MANN KG, 1990, BLOOD, V76, P1; Angiolillo DJ, 2004, BLOOD COAGUL FIBRIN, V15, P89, DOI 10.1097/01.mbc.0000061380.39736.eb; Herrmann FH, 2006, HAEMOPHILIA, V12, P479, DOI 10.1111/j.1365-2516.2006.01303.x; Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Becquemont L, 2009, PHARMACOGENOMICS, V10, P961, DOI [10.2217/pgs.09.37, 10.2217/PGS.09.37]; Hirsh J, 2003, CIRCULATION, V107, P1692, DOI 10.1161/01.CIR.0000063575.17904.4E; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066; Dewerchin M, 2000, THROMB HAEMOSTASIS, V83, P185; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; Klein TE, 2009, NEW ENGL J MED, V360, P753; Levigne S, 2007, J BIOL CHEM, V282, P31569, DOI 10.1074/jbc.M704837200; LEYTUS SP, 1984, P NATL ACAD SCI-BIOL, V81, P3699, DOI 10.1073/pnas.81.12.3699; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Sheffield Leslie J, 2009, Clin Biochem Rev, V30, P55; Soulieres D, 2010, CURR ONCOL, V17, pS31; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200	28	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	MAR	2015	26	2					117	122		10.1097/MBC.0000000000000147		6	Hematology	Hematology	CA6GC	WOS:000349007300001		
J	Yang, M; Zhang, MF; Kunioka, M; Yuge, R; Ichihashi, T; Iijima, S; Yudasaka, M				Yang, Mei; Zhang, Minfang; Kunioka, Masao; Yuge, Ryota; Ichihashi, Toshinari; Iijima, Sumio; Yudasaka, Masako			Photothermal conversion of carbon nanohorns enhancing caprolactone polymerization	CARBON			English	Article							NANOTUBES	Photothermal conversion of nanocarbons has potential applications in medical and energy engineering. It is expected that the photothermal conversion of tubular nanocarbons can thermally enhance polymer formation on their surfaces and insides. We show in this report that light irradiation enhanced the catalytic polymerization of caprolactone (CL) on tubular carbon nanohorns, and polycaprolactone (PCL) was formed on the outside and, more abundantly, inside the carbon nanohorns. The PCL particles were of nanometer size, which indicated another unique effect of this method of preparation. The abundant PCL preparation inside the nanohorns was probably caused by the confinement of CL molecules and thermal energies inside the nanohorns, which could enhance the polymerization of CLs. Other nanocarbons that had photothermal conversion properties would similarly enhance polymerization and other chemical reactions to provide unique methods of synthesizing materials. (C) 2014 Elsevier Ltd. All rights reserved.	[Yang, Mei; Zhang, Minfang; Kunioka, Masao; Iijima, Sumio; Yudasaka, Masako] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan; [Yuge, Ryota; Ichihashi, Toshinari; Iijima, Sumio] NEC Corp Ltd, Smart Energy Res Inst, Tsukuba, Ibaraki 3058561, Japan; [Iijima, Sumio] Meijo Univ, Fac Sci & Technol, Tenpaku, Nagoya, Aichi 4688502, Japan	Yudasaka, M (reprint author), Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, 5-2,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.		Iijima, Sumio /E-6234-2015				Liu XW, 2011, BIOMATERIALS, V32, P144, DOI 10.1016/j.biomaterials.2010.08.096; Robinson JT, 2010, NANO RES, V3, P779, DOI 10.1007/s12274-010-0045-1; Miyako E, 2012, P NATL ACAD SCI USA, V109, P7523, DOI 10.1073/pnas.1204391109; Zhang M, 2008, P NATL ACAD SCI USA, V105, P14773, DOI 10.1073/pnas.0801349105; Iijima S, 1999, CHEM PHYS LETT, V309, P165, DOI 10.1016/S0009-2614(99)00642-9; Azami T, 2008, J PHYS CHEM C, V112, P1330, DOI 10.1021/jp076365o; Fan J, 2006, J PHYS CHEM B, V110, P1587, DOI 10.1021/jp0538870; Irie M, 2010, CHEM PHYS LETT, V500, P96, DOI 10.1016/j.cplett.2010.10.018; Miyako E, 2011, ANGEW CHEM INT EDIT, V50, P1; Nisha JA, 2000, CHEM PHYS LETT, V328, P381, DOI 10.1016/S0009-2614(00)00956-8	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	MAR	2015	83						15	20		10.1016/j.carbon.2014.11.022		6	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CA5MF	WOS:000348951800002		
J	Tsuruoka, S; Matsumoto, H; Koyama, K; Akiba, E; Yanagisawa, T; Cassee, FR; Saito, N; Usui, Y; Kobayashi, S; Porter, DW; Castranova, V; Endo, M				Tsuruoka, Shuji; Matsumoto, Hidetoshi; Koyama, Kenichi; Akiba, Eiji; Yanagisawa, Takashi; Cassee, Flemming R.; Saito, Naoto; Usui, Yuki; Kobayashi, Shinsuke; Porter, Dale W.; Castranova, Vincent; Endo, Morinobu			Radical scavenging reaction kinetics with multiwalled carbon nanotubes	CARBON			English	Article							METAL; BIOAVAILABILITY; IMPURITIES; TOXICITY	Progress in the development of carbon nanotubes (CNTs) has stimulated great interest among industries providing new applications. Meanwhile, toxicological evaluations on nanomaterials are advancing leading to a predictive exposure limit for CNTs, which implies the possibility of designing safer CNTs. To pursue safety by design, the redox potential in reactions with CNTs has been contemplated recently. However, the chemical reactivity of CNTs has not been explored kinetically, so that there is no scheme to express a redox reaction with CNTs, though it has been investigated and reported. In addition, the reactivity of CNTs is discussed with regard to impurities that consist of transition metals in CNTs, which obfuscates the contribution of CNTs to the reaction. The present work aimed at modeling CNT scavenging in aqueous solution using a kinetic approach and a simple first-order reaction scheme. The results show that CNTs follow the redox reaction assumption in a simple chemical system. As a result, the reaction with multiwalled CNTs is semiquantitatively denoted as redox potential, which suggests that their biological reactions may also be evaluated using a redox potential scheme. (C) 2014 Elsevier Ltd. All rights reserved.	[Tsuruoka, Shuji; Koyama, Kenichi; Usui, Yuki] Shinshu Univ, Aquat Innovat Ctr, Nagano 3808553, Japan; [Matsumoto, Hidetoshi] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro ku, Tokyo 1528552, Japan; [Akiba, Eiji] Kuraray Living Co Ltd, Osaka 5308611, Japan; [Yanagisawa, Takashi] GSI Creos Corp, Kawasaki, Kanagawa 2100855, Japan; [Cassee, Flemming R.] Natl Inst Publ Hlth & Environm, NL-3721 MA Bilthoven, Netherlands; [Cassee, Flemming R.] Univ Utrecht, Inst Risk Assessment Sci, NL-3584 CM Utrecht, Netherlands; [Saito, Naoto; Kobayashi, Shinsuke] Shinshu Univ, Dept Appl Phys Therapy, Matsumoto, Nagano 390, Japan; [Porter, Dale W.] Natl Inst Occupat Safety & Hlth, Pathol & Physiol Res Branch, Morgantown, WV 26505 USA; [Castranova, Vincent] W Virginia Univ, Dept Basic Pharmaceut Sci, Sch Pharm, Morgantown, WV 26506 USA; [Endo, Morinobu] Shinshu Univ, Inst Carbon Sci & Technol, Nagano 3808553, Japan	Tsuruoka, S (reprint author), Shinshu Univ, Aquat Innovat Ctr, 4-17-1 Wakasato, Nagano 3808553, Japan.	s_tsuruoka@shinshu-u.ac.jp	Matsumoto, Hidetoshi/C-6863-2011	Matsumoto, Hidetoshi/0000-0002-4949-1184	Ministry of Economy, Trade and Industry (METI) of Japan; Exotic Nanocarbon Projects, Japan Regional Innovation Strategy Program by Excellence, Japan Science and Technology Agency (JST)	This work is a part of the research program "Development of innovative methodology for safety assessment of industrial nanomaterials" supported by the Ministry of Economy, Trade and Industry (METI) of Japan. ST, KK, and UY were supported by the Exotic Nanocarbon Projects, Japan Regional Innovation Strategy Program by Excellence, Japan Science and Technology Agency (JST). We would like to thank Dr. K. Fujisawa for preparation of the graphic figure for Fig. 1.	Weeks KR, 2000, SOIL SEDIMENT CONTAM, V9, P331, DOI 10.1080/10588330091134284; Pumera M, 2007, LANGMUIR, V23, P6453, DOI 10.1021/la070088v; Toh RJ, 2012, CHEM-EUR J, V18, P11593, DOI 10.1002/chem.201201955; Endo M, 2005, NATURE, V433, P476, DOI 10.1038/433476a; Pumera M, 2009, NANOSCALE, V1, P260, DOI 10.1039/b9nr00071b; Endo M, 2002, APPL PHYS LETT, V80, P1267, DOI 10.1063/1.1450264; Liu X, 2008, CARBON, V46, P489, DOI 10.1016/j.carbon.2007.12.018; Sotowa C, 2008, CHEMSUSCHEM, V1, P911, DOI 10.1002/cssc.200800170; Ge CC, 2008, ANAL CHEM, V80, P9426, DOI 10.1021/ac801469b; Guo L, 2007, CHEM MATER, V19, P3472, DOI 10.1021/cm062691p; Peng TY, 2011, ENERG FUEL, V25, P2203, DOI 10.1021/ef200369z; Shi XM, 2012, CARBON, V50, P1005, DOI 10.1016/j.carbon.2011.10.003; Fenoglio I, 2008, CHEM RES TOXICOL, V21, P1690, DOI 10.1021/tx800100s; KRUSIC PJ, 1991, SCIENCE, V254, P1183, DOI 10.1126/science.254.5035.1183; Tsuruoka S, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-44; Porter DW, 2013, NANOTOXICOLOGY, V7, P1179, DOI 10.3109/17435390.2012.719649; Donaldson K, 2013, CURR OPIN BIOTECH, V24, P724, DOI 10.1016/j.copbio.2013.05.003; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Liu Y, 2013, ACCOUNTS CHEM RES, V46, P702, DOI 10.1021/ar300028m; Eklund P., 2007, WTEC PANEL REPORT IN; Endo M, 2010, IND ENG CHEM RES, V49, P9798, DOI 10.1021/ie1008663; Endo M, 2008, ADV FUNCT MATER, V18, P3403, DOI 10.1002/adfm.200801136; Fenoglio I, 2006, FREE RADICAL BIO MED, V40, P227; Fujimori T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3162; Ge C, 2012, NPG ASIA MATER, V4, P1; Harris PJF, 2009, CARBON NANOTUBE SCI, P146, DOI 10.1017/CBO9780511609701.007; Hayashi T, 2013, NANOSCALE, V5, P10043; Howard J., 2013, CURRENT INTELLIGENCE; Martinez-Morlanes MJ, 2012, CARBON, V50, P2442, DOI 10.1016/j.carbon.2012.01.066; Muramatsu H, 2009, SMALL, V5, P2678, DOI 10.1002/smll.200901305; Muramatsu H, 2011, ADV MATER, V23, P1761, DOI 10.1002/adma.201004709; Pertersen EJ, 2013, SMALL, V9, P205; Saito R, 1998, PHYS PROPERTIES CARB; Takuma Y., 2008, THESIS TOKYO I TECHN; Tsuruoka S., 2012, PRIVATE MEMORANDUM P; Tsuruoka S., 2013, SOC TOX 52 ANN M SAN, P427; Tsuruoka S, 2013, MATER EXPRESS, V4, P21; Tsuruoka S, 2014, SOC TOX 53 ANN M PHO; Tsuruoka S, 2013, J PHYS C SER, V429; Ullah M., 2013, SPRINGER SERIES MAT, V173	40	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	MAR	2015	83						232	239		10.1016/j.carbon.2014.10.009		8	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CA5MF	WOS:000348951800027		
J	Leto, A; De Portu, G; Mereadelli, E; Sanson, A; Pezzotti, G				Leto, A.; De Portu, G.; Mereadelli, E.; Sanson, A.; Pezzotti, G.			Visualization of oxygen off-stoichiometry in oxide ceramics by cathodoluminescence spectroscopy	CERAMICS INTERNATIONAL			English	Article						Oxygen vacancy; Stoichiometry; Cathodoluminescence; Alumina; Zirconia	LUMINESCENCE; ELECTROLYTES; CONDUCTIVITY; INTERFACES; VACANCIES; DEFECTS; FILMS; ZRO2	In this study, we used cathodoluminescence (CL) to investigate the influence of annealing treatments with different temperatures and atmospheres on oxygen vacancy concentrations in two paradigmatic ceramic oxides, yttria-stabilized cubic zirconia and alumina. Significant stoichiometric differences were seen for surfaces exposed to either oxidizing or reducing atmospheres by comparison with the respective assintered samples. In the case of zirconia, monitoring the CL band located at 500 nm enabled us to visualize the trends of oxygen vacancy formation or annihilation, depending on the annealing conditions selected. In the case of alumina, CL mapping could reveal different processes of oxygen vacancy formation, annihilation and migration (towards grain boundaries) as a consequence of annealing procedures conducted in different gas mixtures. Monitoring the CL intensity of the F+-center in alumina made it possible to assess the complex stoichiometric state developing at the joint interface between a metal and polycrystalline alumina with nanometric resolution. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Leto, A.] Piezotech Japan Ltd, Sakyo Ku, Kyoto 6068126, Japan; [De Portu, G.; Mereadelli, E.; Sanson, A.] CNR, Inst Sci & Technol Ceram ISTEC, I-48018 Faenza, RA, Italy; [Pezzotti, G.] Kyoto Inst Technol, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6038585, Japan	Leto, A (reprint author), Piezotech Japan Ltd, Sakyo Ku, Mukaihata Cho 4, Kyoto 6068126, Japan.	andrea.leto@gmail.com			Japan Society for the Promotion of Science (JSPS) [S-11723 (2011)]	G. de Portu is extremely grateful to the Japan Society for the Promotion of Science (JSPS) (Grant no. S-11723 (2011)) for the fellowship granted for him to conduct this research at the Department of Materials Science and Engineering, Kyoto Institute of Technology.	ALONSO PJ, 1989, J PHYS CHEM SOLIDS, V50, P1185, DOI 10.1016/0022-3697(89)90029-2; LI P, 1993, PHYS REV B, V48, P10063, DOI 10.1103/PhysRevB.48.10063; HEIMKE G, 1980, MED BIOL ENG COMPUT, V18, P503, DOI 10.1007/BF02443328; LEE KH, 1979, PHYS REV B, V19, P3217, DOI 10.1103/PhysRevB.19.3217; Liu D, 2009, MICROELECTRON ENG, V86, P1668, DOI 10.1016/j.mee.2009.03.011; Li HT, 2011, J AM CERAM SOC, V94, pS154, DOI 10.1111/j.1551-2916.2011.04405.x; DRAEGER BG, 1979, PHYS REV B, V19, P1172, DOI 10.1103/PhysRevB.19.1172; Smits K, 2007, PHYS STATUS SOLIDI C, V4, P770, DOI 10.1002/pssc.200673850; Kurumada M, 2005, ACTA MATER, V53, P4839, DOI 10.1016/j.actamat.2005.06.027; Chang SM, 2004, J PHYS CHEM B, V108, P18098, DOI 10.1021/jp047440n; Hui SQ, 2007, J POWER SOURCES, V172, P493, DOI 10.1016/j.jpowsour.2007.07.071; Yueh HK, 2003, J NUCL MATER, V323, P57, DOI 10.1016/j.jnucmat.2003.08.025; WACHSMAN ED, 1992, SOLID STATE IONICS, V52, P213, DOI 10.1016/0167-2738(92)90107-Z; Nguyen Q.M., 1995, SCI TECHNOLOGY CERAM, P69; Petrik NG, 1999, J APPL PHYS, V85, P6770, DOI 10.1063/1.370192; Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035; Shuk P., 2008, SENSORS TRANSDUCERS, V90, P174; Singhal S.C., 2003, HIGH TEMPERATURE SOL; Smits K., 2010, THESIS U LATVIA RIGA; Xie X, 2010, J POWER SOURCES, V195, P5660, DOI 10.1016/j.jpowsour.2010.03.054	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	MAR	2015	41	2	A				2247	2252		10.1016/j.ceramint.2014.10.027		6	Materials Science, Ceramics	Materials Science	CA5PX	WOS:000348961400040		
J	Wang, B; Zhang, H; Phuong, HT; Jin, F; Yang, JF; Ishizaki, K				Wang, Bo; Zhang, Hui; Phuong, Hoang-Tuan; Jin, Feng; Yang, Jian-Feng; Ishizaki, Kozo			Gas permeability and adsorbability of the glass-bonded porous silicon carbide ceramics with controlled pore size	CERAMICS INTERNATIONAL			English	Article						Silicon carbide; Pore size; Porosity; Gas permeability; Adsorption force	MECHANICAL-PROPERTIES; PARTICLE-SIZE; SIC CERAMICS; POROSITY; ALUMINA; FABRICATION; BEHAVIOR; FOAMS; FLOW	Glass-bonded porous silicon carbide ceramics were fabricated by conventional method. The porosity and pore size could be tailored by changing the glass content and particle size of silicon carbide starting powder. The influence of microstructure on the gas permeability and the adsorption force between chucking work-pieces and porous SiC ceramic vacuum chuck was investigated. The permeability increased with the increase of porosity and average pore diameter. High permeability (1.45-6.53 x 10(-12) m(2)) of the porous SiC ceramics with a porosity of 32.1-64.7% could be achieved. Compared with porosity, pore size had a dominant effect on the permeability and adsorption force. The samples with the same porosity but smaller average pore size exhibited lower permeability and much higher adsorption force. The adsorption force of porous SiC ceramics was dependent on both microstructure and permeability. The P1000V70 sample with a pressure drop (Delta P) of 0.055 MPa and permeability of 1.94 x 10(-12) m(2) exhibited the highest adsorption force of 196 N/cm(2). (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Wang, Bo; Zhang, Hui; Yang, Jian-Feng] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Shaanxi, Peoples R China; [Wang, Bo; Jin, Feng] Xi An Jiao Tong Univ, Sch Aerosp Engn, State Key Lab Strength & Vibrat Mech Struct, Xian 710049, Shaanxi, Peoples R China; [Phuong, Hoang-Tuan; Ishizaki, Kozo] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan	Wang, B (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xianning West Rd 28, Xian 710049, Shaanxi, Peoples R China.	xiaoboking@gmail.com; yang155@mail.xjtu.edu.cn	Wang, Bo/I-4960-2013	Wang, Bo/0000-0002-9496-7161	National Natural Science Foundation of China [51302208, 51272205]; Doctoral Fund of Ministry of Education of China [20130201120003]; China Postdoctoral Science Foundation [2012M521763]; Fundamental Research Funds for the Central Universities [xjj2013110]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 51302208, 51272205), by Doctoral Fund of Ministry of Education of China (Grant No. 20130201120003), by China Postdoctoral Science Foundation (Grant No. 2012M521763), and by the Fundamental Research Funds for the Central Universities (Grant No. xjj2013110).	Song IH, 2010, J EUR CERAM SOC, V30, P2671, DOI 10.1016/j.jeurceramsoc.2010.04.027; Ding SQ, 2007, J MATER SCI, V42, P7171, DOI 10.1007/s10853-007-1577-y; Fukushima M, 2006, J AM CERAM SOC, V89, P1523, DOI 10.1111/j.1551-2916.2006.00931.x; Montanaro L, 1998, J EUR CERAM SOC, V18, P1339, DOI 10.1016/S0955-2219(98)00063-6; Isobe T, 2007, J EUR CERAM SOC, V27, P53, DOI 10.1016/j.jeurceramsoc.2006.02.030; Durazo-Cardenas IS, 2014, CERAM INT, V40, P3041, DOI 10.1016/j.ceramint.2013.10.003; Wu YS, 1998, TRANSPORT POROUS MED, V32, P117, DOI 10.1023/A:1006535211684; Fukushima M, 2010, J EUR CERAM SOC, V30, P2889, DOI 10.1016/j.jeurceramsoc.2010.03.018; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Carman P.C., 1937, T I CHEM ENG-LOND, V15, P150, DOI DOI 10.1016/S0263-8762(97)80003-2; Cliffel E.M., 1966, MODERN DEV POWDER ME, P14; Eom JH, 2013, CERAM SOC, V1, P220; Eom JH, 2012, J EUR CERAM SOC, V32, P1283, DOI 10.1016/j.jeurceramsoc.2011.11.040; GERMAN RM, 1981, POWDER TECHNOL, V30, P81, DOI 10.1016/0032-5910(81)85029-2; Jang BK, 2007, SCI TECHNOL ADV MAT, V8, P655, DOI 10.1016/j.stam.2007.08.003; Kennedy GP, 2011, MET MATER INT, V17, P599, DOI 10.1007/s12540-011-0811-y; Kitaoka S, 2004, J AM CERAM SOC, V87, P906; Klinkenberg L.J., 1941, DRILLING PRODUCTION, P200; Kwan YBP, 2001, J POROUS MAT, V8, P119, DOI 10.1023/A:1009638608102; Mouazer R, 2004, ADV ENG MATER, V6, P340, DOI 10.1002/adem.200400009; Roach C.J., 2001, THESIS CRANFIELD U C; Une A, 2002, MICROELECTRON ENG, V61-2, P113, DOI 10.1016/S0167-9317(02)00457-4; Yaws C.L., 2001, MATHESON GAS DATA BO, Vvi; Zhu XW, 2002, MAT SCI ENG A-STRUCT, V323, P232, DOI 10.1016/S0921-5093(01)01352-1	24	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	MAR	2015	41	2	A				2279	2285		10.1016/j.ceramint.2014.10.032		7	Materials Science, Ceramics	Materials Science	CA5PX	WOS:000348961400045		
J	Hanaoka, T; Miyazawa, T; Shimura, K; Hirata, S				Hanaoka, Toshiaki; Miyazawa, Tomohisa; Shimura, Katsuya; Hirata, Satoshi			Jet fuel synthesis from Fischer-Tropsch product under mild hydrocracking conditions using Pt-loaded catalysts	CHEMICAL ENGINEERING JOURNAL			English	Article						Pt catalyst; Biomass-to-liquid; FT synthesis; Hydrocracking; Jet fuel	N-DECANE; ZIRCONIA CATALYSTS; MIDDLE DISTILLATE; SILICA-ALUMINA; HYDROISOMERIZATION; WAX; CONVERSION; BIOMASS; ALKANES; DESIGN	The development of effective Pt-loaded catalysts for high jet fuel yield was investigated in hydrocracking step in the proposed conversion process from biomass to jet fuel. Screening studies of Pt-loaded catalyst supports were performed using an autoclave in hydrocracldng of n-C28H58 and n-C36H74 as model compounds over ten different supports loaded with Pt (Pt content: 0.5 wt%). The Pt-loaded beta-type zeolite catalyst exhibited a high corresponding jet fuel yield using both feedstocks. The effect of the reaction temperature, reaction pressure, and Pt content on the hydrocracking behavior was studied in hydrocracking of n-C36H74 over Pt-loaded beta-type zeolite catalyst. The corresponding jet fuel yield was maximized at 250-350 degrees C, and 0.9-1.4 MPa, and 0.1-1.0 wt% Pt content. The liquid product with carbon numbers 5-68 was obtained as Fischer-Tropsch (FT) product through the operation of a bench-scale biomass-to-liquid (BTL) plant. The effect of the reaction temperature and reaction pressure on the hydrocracking behavior was investigated in hydrocracking of the FT product over Pt-loaded beta-type zeolite catalyst (Pt content: 0.1 wt%). The corresponding jet fuel yield was the maximum value (21.5%) at 250 degrees C and 1.5 MPa. (C) 2014 Elsevier B.V. All rights reserved.	[Hanaoka, Toshiaki; Miyazawa, Tomohisa; Shimura, Katsuya; Hirata, Satoshi] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Higashihiroshima, Hiroshima 7390046, Japan	Hanaoka, T (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan.	t.hanaoka@aist.go.jp					Al M.A., 2002, APPL CATAL A-GEN, V233, P77; Damartzis T, 2011, RENEW SUST ENERG REV, V15, P366, DOI 10.1016/j.rser.2010.08.003; LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6; Liu YY, 2009, TOP CATAL, V52, P597, DOI 10.1007/s11244-009-9239-8; [Anonymous], 2008, INT ENERGY J, V9, P73; Francis J, 2011, APPL CATAL A-GEN, V409, P140, DOI 10.1016/j.apcata.2011.09.040; de Haan R, 2007, APPL CATAL A-GEN, V327, P247, DOI 10.1016/j.apcata.2007.05.022; Roussel M, 2005, APPL CATAL A-GEN, V279, P53, DOI 10.1016/j.apcata.2004.10.011; Miyazawa T, 2013, APPL CATAL A-GEN, V467, P47, DOI 10.1016/j.apcata.2013.07.010; Zhang WN, 2010, FUEL PROCESS TECHNOL, V91, P866, DOI 10.1016/j.fuproc.2009.07.010; Corma A, 1997, APPL CATAL A-GEN, V152, P107, DOI 10.1016/S0926-860X(96)00338-9; van Vliet OPR, 2009, ENERG CONVERS MANAGE, V50, P855, DOI 10.1016/j.enconman.2009.01.008; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; ARCHIBALD RC, 1960, IND ENG CHEM, V52, P745, DOI 10.1021/ie50609a021; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Bohringer W., 2007, STUD SURF SCI CATAL, V163, P345; Busto M, 2009, APPL CATAL A-GEN, V355, P123, DOI 10.1016/j.apcata.2008.12.009; Camblor MA, 1998, J CATAL, V179, P537, DOI 10.1006/jcat.1998.2249; Cho KM, 2009, CHEM ENG J, V146, P307, DOI 10.1016/j.cej.2008.10.008; Collins J. P., 2006, J NAT GAS CHEM, V15, P1, DOI 10.1016/S1003-9953(06)60001-7; Gambaro C, 2011, AICHE J, V57, P711, DOI 10.1002/aic.12291; Hanaoka Toshiaki, 2011, Journal of the Japan Institute of Energy, V90, DOI 10.3775/jie.90.1072; Krylova A. Yu., 2007, SOLID FUEL CHEM, V41, P335; Lee J, 2010, KOREAN J CHEM ENG, V27, P1755, DOI 10.1007/s11814-010-0279-3; Liu YY, 2009, FUEL PROCESS TECHNOL, V90, P901, DOI 10.1016/j.fuproc.2009.04.004; Liu YY, 1999, J MOL CATAL A-CHEM, V141, P145, DOI 10.1016/S1381-1169(98)00258-1; Rezgui Y, 2005, APPL CATAL A-GEN, V282, P45, DOI 10.1016/j.apcata.2004.11.044; Robinson P. R., 2006, PRACTICAL ADV PETROL, V1, P177; Sunde K, 2011, FOREST POLICY ECON, V13, P591, DOI 10.1016/j.forpol.2011.05.008; WEITKAMP J, 1975, ACS SYM SER, P1; Zhou Z, 2003, FUEL PROCESS TECHNOL, V83, P67, DOI 10.1016/S0738-3820(03)00076-6	31	3	3	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	MAR 1	2015	263						178	185		10.1016/j.cej.2014.11.042		8	Engineering, Environmental; Engineering, Chemical	Engineering	CA6YE	WOS:000349062900021		
J	Einaga, H; Tokura, J; Teraoka, Y; Ito, K				Einaga, Hisahiro; Tokura, Junya; Teraoka, Yasutake; Ito, Kazuhide			Kinetic analysis of TiO2-catalyzed heterogeneous photocatalytic oxidation of ethylene using computational fluid dynamics	CHEMICAL ENGINEERING JOURNAL			English	Article						Photocatalytic oxidation; TiO2; Ethylene; Kinetic analysis; Computational fluid dynamics	INDOOR AIR PURIFICATION; TIO2 THIN-FILMS; OF-THE-ART; GAS-PHASE; CATALYST DEACTIVATION; FIELD CALCULATIONS; REATTACHING FLOWS; TURBULENCE MODEL; QUALITY-CONTROL; HEAT-TRANSFER	Photocatalytic oxidation of ethylene was carried out over a TiO2 catalyst at 295 K using two types of non-ideal fixed-bed flow reactors: a rectangular reactor and a cylindrical reactor. Computational fluid dynamics (CFD) analysis using a low Reynolds number-type k-epsilon turbulence model was conducted to investigate the ethylene oxidation behavior in the reactors at various gas flow rates and ethylene concentrations in the inlet gas (ethylene concentration of 50-250 ppm and gas flow rate of 50-250 mL/min). In the rectangular reactor, steady-state activities were obtained for ethylene oxidation under all conditions. The rate of ethylene oxidation on the TiO2 surface was analyzed in terms of Langmuir-Hinshelwood (L-H) type kinetics. The kinetic parameters for the surface reactions obtained via CFD analysis fit well with the experimental data. The CFD analysis also revealed that the ethylene concentration distribution in the reactor depended on the gas residence time distribution. We also carried out CFD analysis for the cylindrical reactor and compared the ethylene oxidation behavior with that in the rectangular reactor. (C) 2014 Elsevier B.V. All rights reserved.	[Einaga, Hisahiro; Tokura, Junya; Teraoka, Yasutake] Kyushu Univ, Fac Engn Sci, Dept Energy & Mat Sci, Kasuga, Fukuoka 8168580, Japan; [Ito, Kazuhide] Kyushu Univ, Fac Engn Sci, Dept Energy & Environm Engn, Kasuga, Fukuoka 8168580, Japan	Einaga, H (reprint author), Kyushu Univ, Fac Engn Sci, Dept Energy & Mat Sci, Kasuga, Fukuoka 8168580, Japan.	einaga.hisahiro.399@m.kyushu-u.ac.jp	Hisahiro, Einaga/I-5440-2015	Hisahiro, Einaga/0000-0002-4819-9755			ABE K, 1995, INT J HEAT MASS TRAN, V38, P1467, DOI 10.1016/0017-9310(94)00252-Q; Adjimi S, 2014, CHEM ENG J, V251, P381, DOI 10.1016/j.cej.2014.04.013; Almeida AR, 2008, J PHYS CHEM C, V112, P1552, DOI 10.1021/jp077143t; Ameen MM, 1999, J CATAL, V184, P112, DOI 10.1006/jcat.1999.2442; Einaga H, 2002, APPL CATAL B-ENVIRON, V38, P215, DOI 10.1016/S0926-3373(02)00056-5; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Salvado-Estivill I, 2007, ENVIRON SCI TECHNOL, V41, P2028, DOI 10.1021/es061569o; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Daghrir R, 2013, IND ENG CHEM RES, V52, P3581, DOI 10.1021/ie303468t; Agrios AG, 2005, J APPL ELECTROCHEM, V35, P655, DOI 10.1007/s10800-005-1627-6; Ochiai T, 2012, J PHOTOCH PHOTOBIO C, V13, P247, DOI 10.1016/j.jphotochemrev.2012.07.001; Cao SL, 2009, APPL CATAL B-ENVIRON, V86, P127, DOI 10.1016/j.apcatb.2008.08.019; Panayotov DA, 2003, J PHYS CHEM B, V107, P10571, DOI 10.1021/jp030489t; Einaga H, 2013, CATALYSTS, V3, P219, DOI 10.3390/catal3010219; ABE K, 1994, INT J HEAT MASS TRAN, V37, P139, DOI 10.1016/0017-9310(94)90168-6; Cao SL, 2006, APPL CATAL B-ENVIRON, V68, P99, DOI 10.1016/j.apcatb.2006.07.022; Bagheri M, 2014, CHEM ENG J, V256, P51, DOI 10.1016/j.cej.2014.06.068; Einaga H, 2004, J CATAL, V227, P304, DOI 10.1016/j.jcat.2004.07.029; Vincent G, 2011, PROCESS SAF ENVIRON, V89, P35, DOI 10.1016/j.psep.2010.08.004; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Wang SB, 2007, ENVIRON INT, V33, P694, DOI 10.1016/j.envint.2007.02.011; Cao S, 2007, APPL CATAL B-ENVIRON, V76, P64, DOI 10.1016/j.apcatb.2007.05.009; Queffeulou A, 2010, IND ENG CHEM RES, V49, P6890, DOI 10.1021/ie9017308; Xu C, 2013, CHEM ENG J, V221, P398, DOI 10.1016/j.cej.2013.01.108; Zhang Z, 2007, HVAC&R RES, V13, P871, DOI 10.1080/10789669.2007.10391460; Cao LX, 2000, J CATAL, V196, P253, DOI 10.1006/jcat.2000.3050; Mo JH, 2009, ATMOS ENVIRON, V43, P2229, DOI 10.1016/j.atmosenv.2009.01.034; Boulinguiez B, 2008, J PHOTOCH PHOTOBIO A, V200, P254, DOI 10.1016/j.jphotochem.2008.08.005; Ollis DF, 2000, CR ACAD SCI II C, V3, P405, DOI 10.1016/S1387-1609(00)01169-5; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Sorensen DN, 2003, INDOOR AIR, V13, P2; Passalia C, 2011, IND ENG CHEM RES, V50, P9077, DOI 10.1021/ie200756t; Wang ZM, 2012, J HAZARD MATER, V215, P25, DOI 10.1016/j.jhazmat.2012.02.021; Yamazaki S, 1999, J PHOTOCH PHOTOBIO A, V121, P55, DOI 10.1016/S1010-6030(98)00448-1; Denny F, 2010, ENVIRON SCI TECHNOL, V44, P5558, DOI 10.1021/es100421u; Kozlov DV, 2003, APPL CATAL B-ENVIRON, V42, P77, DOI 10.1016/S0926-3373(02)00217-5; Kitano M, 2007, APPL CATAL A-GEN, V325, P1, DOI 10.1016/j.apcata.2007.03.013; Chong SH, 2011, AICHE J, V57, P724, DOI 10.1002/aic.12295; Coronado JM, 2003, APPL CATAL B-ENVIRON, V43, P329, DOI 10.1016/S0926-3373(03)00022-5; Davis M. E., 2003, FUNDAMENTALS CHEM RE; Davit P, 2003, J MOL CATAL A-CHEM, V204, P693, DOI 10.1016/S1381-1169(03)00354-6; Denny F, 2009, CHEM ENG SCI, V64, P1695, DOI 10.1016/j.ces.2008.12.021; Duran JE, 2011, IND ENG CHEM RES, V50, P824, DOI 10.1021/ie101736d; Duran JE, 2010, CHEM ENG SCI, V65, P1201, DOI 10.1016/j.ces.2009.09.075; Fogler HS, 1999, ELEMENTS CHEM REACTI; Josset S, 2010, ENVIRON SCI TECHNOL, V44, P2605, DOI 10.1021/es902997v; Lewandowski M, 2003, APPL CATAL B-ENVIRON, V43, P309, DOI 10.1016/S0926-3373(02)00310-7; Passalia C, 2012, J HAZARD MATER, V211, P357, DOI 10.1016/j.jhazmat.2011.10.007; Paz Y, 2010, APPL CATAL B-ENVIRON, V99, P448, DOI 10.1016/j.apcatb.2010.05.011; Puma GL, 2009, SEP PURIF TECHNOL, V67, P226, DOI 10.1016/j.seppur.2009.03.011; Raillard C, 2004, J PHOTOCH PHOTOBIO A, V163, P425, DOI 10.1016/j.jphotochem.2004.01.014; Rusu CN, 2000, J PHYS CHEM B, V104, P12292, DOI 10.1021/jp002560q; Verbruggen SW, 2015, CHEM ENG J, V262, P1, DOI 10.1016/j.cej.2014.09.041; Yu QL, 2010, APPL CATAL B-ENVIRON, V99, P58, DOI 10.1016/j.apcatb.2010.05.032; Zhai ZJ, 2007, HVAC&R RES, V13, P853, DOI 10.1080/10789669.2007.10391459; Zhao J, 2003, BUILD ENVIRON, V38, P645, DOI 10.1016/S0360-1323(02)00212-3; Zhu Q, 2007, INDOOR AIR, V17, P178, DOI 10.1111/j.1600-0668.2006.00453.x	57	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	MAR 1	2015	263						325	335		10.1016/j.cej.2014.11.017		11	Engineering, Environmental; Engineering, Chemical	Engineering	CA6YE	WOS:000349062900037		
J	Zhen, GY; Lu, XQ; Li, YY; Liu, Y; Zhao, YC				Zhen, Guangyin; Lu, Xueqin; Li, Yu-You; Liu, Yuan; Zhao, Youcai			Influence of zero valent scrap iron (ZVSI) supply on methane production from waste activated sludge	CHEMICAL ENGINEERING JOURNAL			English	Article						Waste activated sludge; Zero valent scrap iron (ZVSI); Anaerobic digestion; Methane production	EXTRACELLULAR POLYMERIC SUBSTANCES; ANAEROBIC-DIGESTION PROCESS; WATER TREATMENT; PERSULFATE OXIDATION; HYDROGEN UTILIZATION; AZO-DYE; PRETREATMENT; METHANOGENESIS; DEWATERABILITY; TEMPERATURE	The use potential of zero valent scrap iron (ZVSI) for promoting anaerobic production of waste activated sludge (WAS) was assessed. The results indicated that the presence of ZVSI effectively enhanced WAS methane production. Methane yield reached the maximum of 174.9 +/- 1.5 mL/g VSSfed with addition of 1.0 g-ZVSI/g VSS, increasing by 38.3%. The corresponding values for sludge hydrolysis (%H), acidogenesis (%A), and methanogenesis rate (%M) increased into 52.6 +/- 0.4%, 44.5 +/- 2.9% and 40.8 +/- 0.3%, respectively, versus 45.2 +/- 0.5%, 40.9 +/- 2.0% and 29.5 +/- 0.2% in the test without ZVSI. Further investigations confirmed that ZVSI could offer electrons (H-2/[H]), promote H-2 consumption and afford beneficial pH environment for WAS digestion, which stimulated the metabolisms of critical microbes involved in the process and, subsequently accelerated the hydrolysis-acidification-methanation steps of WAS. As a result of this, methane production was upgraded. The superior ability of ZVSI to serve as a source of electron donors will open a new door for WAS treatment. Moreover, ZVSI is less expensive, and convenient to use, providing a cost-efficient alternative for simultaneous energy recovery along with waste iron scrap conservation. (C) 2014 Elsevier B.V. All rights reserved.	[Zhen, Guangyin; Lu, Xueqin; Li, Yu-You] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Sendal, Miyagi 9808579, Japan; [Zhen, Guangyin] Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; [Liu, Yuan] Tohoku Univ, Grad Sch Environm Studies, Sendal, Miyagi 9808579, Japan; [Zhao, Youcai] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China	Zhen, GY (reprint author), Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, 6-6-06 Aza Aoba, Sendal, Miyagi 9808579, Japan.	zhenguangyin@163.com; yyli@epl1.civil.toboku.ac.jp			Japan Society for Promotion of Science (JSPS) [PU 14016]; China Scholarship Council (CSC) [201306890003]	The authors wish to thank the Japan Society for Promotion of Science (JSPS, ID No. PU 14016) and China Scholarship Council (CSC, File No. 201306890003) for partial support of this study.	Etchebehere C, 1998, INT J SYST BACTERIOL, V48, P1297; Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Gallipoli A, 2014, BIORESOURCE TECHNOL, V159, P207, DOI 10.1016/j.biortech.2014.02.084; Ariunbaatar J, 2014, APPL ENERG, V123, P143, DOI 10.1016/j.apenergy.2014.02.035; THAUER RK, 1977, BACTERIOL REV, V41, P100; Zhang YB, 2014, BIORESOURCE TECHNOL, V159, P297, DOI 10.1016/j.biortech.2014.02.114; Zhen GY, 2014, APPL ENERG, V128, P93, DOI 10.1016/j.apenergy.2014.04.062; Xiao X, 2013, WATER RES, V47, P6007, DOI 10.1016/j.watres.2013.07.025; Ahn SC, 2008, J HAZARD MATER, V156, P17, DOI 10.1016/j.jhazmat.2007.11.104; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P1783, DOI 10.1128/AEM.00668-09; DANIELS L, 1987, SCIENCE, V237, P509, DOI 10.1126/science.237.4814.509; Adav SS, 2008, WATER RES, V42, P1644, DOI 10.1016/j.watres.2007.10.013; ZINDER SH, 1992, APPL ENVIRON MICROB, V58, P3323; Chastain BK, 2010, ICARUS, V208, P198, DOI 10.1016/j.icarus.2010.02.024; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Liu XM, 2010, ENVIRON SCI TECHNOL, V44, P4355, DOI 10.1021/es9016766; Son A, 2006, WATER RES, V40, P2027, DOI 10.1016/j.watres.2006.03.027; Karri S, 2005, BIOTECHNOL BIOENG, V92, P810, DOI 10.1002/bit.20623; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; Meng XS, 2013, BIOCHEM ENG J, V73, P80, DOI 10.1016/j.bej.2013.02.004; Abelleira J, 2012, RESOUR CONSERV RECY, V59, P52, DOI 10.1016/j.resconrec.2011.03.008; Liu YW, 2011, WATER RES, V45, P1258, DOI 10.1016/j.watres.2010.10.002; Subramanian SB, 2010, WATER RES, V44, P2253, DOI 10.1016/j.watres.2009.12.046; Coelho NMG, 2011, WATER RES, V45, P2822, DOI 10.1016/j.watres.2011.02.032; Astals S, 2013, WATER RES, V47, P6033, DOI 10.1016/j.watres.2013.07.019; Kumar N, 2014, WATER RES, V51, P64, DOI 10.1016/j.watres.2013.09.042; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Park ND, 2012, BIOMASS BIOENERG, V46, P750, DOI 10.1016/j.biombioe.2012.05.014; Feng YH, 2014, WATER RES, V52, P242, DOI 10.1016/j.watres.2013.10.072; O'Carroll D, 2013, ADV WATER RESOUR, V51, P104, DOI 10.1016/j.advwatres.2012.02.005; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Yang Y, 2013, WATER RES, V47, P6790, DOI 10.1016/j.watres.2013.09.012; Jang HM, 2014, WATER RES, V48, P1, DOI 10.1016/j.watres.2013.06.041; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Neyens E, 2003, J HAZARD MATER, V98, P51, DOI 10.1016/S0304-3894(02)00320-5; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Rani RU, 2012, BIORESOURCE TECHNOL, V103, P415, DOI 10.1016/j.biortech.2011.09.124; Zhen GY, 2013, BIORESOURCE TECHNOL, V136, P654, DOI 10.1016/j.biortech.2013.03.007; Zhang JX, 2011, CHEM ENG J, V174, P159, DOI 10.1016/j.cej.2011.08.069; Yadav AK, 2012, ECOL ENG, V49, P53, DOI 10.1016/j.ecoleng.2012.08.032; Pervin HM, 2013, WATER RES, V47, P7098, DOI 10.1016/j.watres.2013.07.053; Tiehm A, 2001, WATER RES, V35, P2003, DOI 10.1016/S0043-1354(00)00468-1; Wilen BM, 2003, WATER RES, V37, P2127, DOI 10.1016/S0043-1354(02)00629-2; Fey A, 2000, APPL ENVIRON MICROB, V66, P4790, DOI 10.1128/AEM.66.11.4790-4797.2000; Poxon TL, 1997, WATER RES, V31, P749, DOI 10.1016/S0043-1354(96)00319-3; Neyens E, 2004, J HAZARD MATER, V106, P83, DOI 10.1016/j.jhazmat.2003.11.014; Luostarinen S, 2009, BIORESOURCE TECHNOL, V100, P79, DOI 10.1016/j.biortech.2008.06.029; MCCARTY PL, 1986, ENVIRON SCI TECHNOL, V20, P1200, DOI 10.1021/es00154a002; APHA, 1998, STANDARD METHODS EXA; BELAY N, 1990, ANTON LEEUW INT J G, V57, P1, DOI 10.1007/BF00400329; Chen JJ, 2010, BIOMASS RENEWABLE EN; Devlin DC, 2011, BIORESOURCE TECHNOL, V102, P4076, DOI 10.1016/j.biortech.2010.12.043; Dogan I., 2009, WATER RES, P2139; Field J., 1988, P 4 S WAST AN TREAT; Grady C.P.L., 1999, BIOL WASTEWATER TREA; Hou YP, 2014, J BIOSCI BIOENG, V117, P519, DOI 10.1016/j.jbiosc.2013.10.006; Hwang KY, 1997, WATER SCI TECHNOL, V36, P111, DOI 10.1016/S0273-1223(97)00731-2; Kim D.H., 2010, WATER RES, V4, P3093; KUS F, 1995, WATER RES, V29, P1437, DOI 10.1016/0043-1354(94)00285-F; Liu YW, 2012, BIORESOURCE TECHNOL, V121, P148, DOI 10.1016/j.biortech.2012.06.115; Parsa JB, 2013, ULTRASON SONOCHEM, V20, P1442, DOI 10.1016/j.ultsonch.2013.04.013; Ponsa' S., 2008, WATER RES, V42, P3972; RAJAGOPAL BS, 1989, APPL MICROBIOL BIOT, V31, P406; Rani RU, 2014, ULTRASON SONOCHEM, V21, P1065, DOI 10.1016/j.ultsonch.2013.11.007; Ren H. Q., 2007, BIORESOURCE TECHNOL, V98, P1774; SHEN CF, 1993, WATER RES, V27, P25, DOI 10.1016/0043-1354(93)90191-J; Smatlak CR, 1996, ENVIRON SCI TECHNOL, V30, P2850, DOI 10.1021/es9602455; Zhen GY, 2013, CHEM ENG J, V233, P274, DOI 10.1016/j.cej.2013.08.038; Zhu L, 2012, WATER RES, V46, P6291, DOI 10.1016/j.watres.2012.08.029	69	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	MAR 1	2015	263						461	470		10.1016/j.cej.2014.11.003		10	Engineering, Environmental; Engineering, Chemical	Engineering	CA6YE	WOS:000349062900052		
J	Mizouchi, S; Ichiba, M; Takigami, H; Kajiwara, N; Takamuku, T; Miyajima, T; Kodama, H; Someya, T; Ueno, D				Mizouchi, Shigekazu; Ichiba, Masayoshi; Takigami, Hidetaka; Kajiwara, Natsuko; Takamuku, Toshiyuki; Miyajima, Toru; Kodama, Hiroki; Someya, Takashi; Ueno, Daisuke			Exposure assessment of organophosphorus and organobromine flame retardants via indoor dust from elementary schools and domestic houses	CHEMOSPHERE			English	Article						Phosphorus (organophosphate phosphate ester) flame retardants (PFRs); Brominated (organobromine) flame retardants (BFRs); Indoor house dust; School child; Domestic house; Risk assessment	POLYBROMINATED DIPHENYL ETHERS; FOOD-CONSUMPTION; UNITED-KINGDOM; NEW-ZEALAND; CANADA; PLASTICIZERS; PBDES; HEXABROMOCYCLODODECANES; CONTAMINANTS; INGESTION	To assess the exposure of flame retardants (FRs) for school-children, organophosphorus flame retardants and plasticizers (PFRs) and organobromine flame retardants (BFRs) were determined in the indoor dust samples collected from elementary schools and domestic houses in Japan in 2009 and 2010. PFRs were detected in all the dust samples analyzed and the highest concentration of total PFRs was thousand-fold higher than that of BFRs. Among the PFRs, tris(butoxyethyl)phosphate (TBOEP) showed the highest concentration with a median (med.) of 270000 ng g(-1) dry weight (3700-5500000 ng g(-1) dry weight), followed by tris(methylphenyl)phosphate (TMPPs) > triphenyl phosphate (TPHP) = tris(1,3-dichloro-2propyl)phosphate (TDCIPP) = tris(2-chloroisopropyl)phosphate (TCIPP) = tris(2chloroethyl)phosphate (TCEP) > ethylhexyl diphenyl phosphate (EHDPP). Significantly higher concentrations of TBOEP, tri-n-butyl phosphate (TNBP), TPHP, TMPPs, and total-PERs were found in dust samples from elementary schools than from domestic houses. It might be due to that higher concentrations of TBOEP (as leveling agent) were detected from the floor polisher/wax products collected in those elementary schools. On the other hand, significantly higher concentrations of TCEP, TCIPPs, and total chloroalkyl-PERs were found in domestic houses than in elementary schools. Exposure assessments of PFRs via indoor dust from elementary schools and domestic houses were conducted by calculating the hazard quotient (HQ). Among PFRs, HQs for TBOEP exceeded 1 (higher than reference dose: RfD) and its highest value was 1.9. To reduce the intake of TBOEP by school-children, it is recommended that the use of floor polisher/wax containing TBOEP be reduced in schools. (C) 2014 Elsevier Ltd. All rights reserved.	[Mizouchi, Shigekazu; Takamuku, Toshiyuki; Miyajima, Toru] Saga Univ, Grad Sch Sci & Engn, Saga 8408502, Japan; [Ichiba, Masayoshi] Saga Univ, Fac Med, Saga 8498501, Japan; [Takigami, Hidetaka; Kajiwara, Natsuko] Natl Inst Environm Studies, Res Ctr Mat Cycles & Waste Management, Tsukuba, Ibaraki 3058506, Japan; [Kodama, Hiroki] Saga Univ, Analyt Res Ctr Expt Sci, Saga 8408502, Japan; [Someya, Takashi; Ueno, Daisuke] Saga Univ, Fac Agr, Saga 8408502, Japan	Ueno, D (reprint author), Saga Univ, Fac Agr, 1 Honjyo, Saga 8408502, Japan.	uenod@cc.saga-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21710068]	This research was supported by "Grant-in-Aid for Young Scientists (B), KAKENHI" (21710068) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The author thanks T. Kose (Niigata University) and A. Matsumoto, H. Miyazaki, Y. Nakamura, H. Sejima, R. Kubota, T. Asakawa, R. Ogawa, N. Tawara, and the members of Saga-Kankyo-Forum (Saga University) for their technical support.	Gevao B, 2006, CHEMOSPHERE, V64, P603, DOI 10.1016/j.chemosphere.2005.11.055; Meeker JD, 2010, ENVIRON HEALTH PERSP, V118, P318, DOI 10.1289/ehp.0901332; Van den Eede N, 2012, TALANTA, V89, P292, DOI 10.1016/j.talanta.2011.12.031; Marklund A, 2003, CHEMOSPHERE, V53, P1137, DOI 10.1016/S0045-6535(03)00666-0; Stapleton HM, 2008, ENVIRON SCI TECHNOL, V42, P6910, DOI 10.1021/es801070p; Wilford BH, 2005, ENVIRON SCI TECHNOL, V39, P7027, DOI 10.1021/es050759g; Harrad S, 2008, ENVIRON INT, V34, P232, DOI 10.1016/j.envint.2007.08.008; Jones-Otazo HA, 2005, ENVIRON SCI TECHNOL, V39, P5121, DOI 10.1021/es048267b; Abdallah MAE, 2008, ENVIRON SCI TECHNOL, V42, P6855, DOI 10.1021/es801110a; Abdallah MAE, 2008, ENVIRON SCI TECHNOL, V42, P459, DOI 10.1021/es702378t; Carlsson H, 1997, ENVIRON SCI TECHNOL, V31, P2931, DOI 10.1021/es970123s; Sjodin A, 2008, CHEMOSPHERE, V73, pS131, DOI 10.1016/j.chemosphere.2007.08.075; Ali N, 2013, ENVIRON INT, V55, P62, DOI 10.1016/j.envint.2013.02.001; Kim JW, 2011, ENVIRON POLLUT, V159, P3653, DOI 10.1016/j.envpol.2011.07.020; Dirtu AC, 2010, ENVIRON SCI TECHNOL, V44, P6297, DOI 10.1021/es101233z; Kanazawa A, 2010, INDOOR AIR, V20, P72, DOI 10.1111/j.1600-0668.2009.00629.x; Sundkvist AM, 2010, J ENVIRON MONITOR, V12, P943, DOI 10.1039/b921910b; Araki A, 2014, INDOOR AIR, V24, P3, DOI 10.1111/ina.12054; D'Hollander W, 2010, CHEMOSPHERE, V81, P478, DOI 10.1016/j.chemosphere.2010.07.043; Shoeib M, 2012, ENVIRON POLLUT, V169, P175, DOI 10.1016/j.envpol.2012.01.043; van den Eede N, 2011, ENVIRON INT, V37, P454, DOI 10.1016/j.envint.2010.11.010; Fischer D, 2006, ENVIRON HEALTH PERSP, V114, P1581, DOI 10.1289/ehp.8554; Stapleton HM, 2011, ENVIRON SCI TECHNOL, V45, P5323, DOI 10.1021/es2007462; Stapleton HM, 2005, ENVIRON SCI TECHNOL, V39, P925, DOI 10.1021/es0486824; Wang J, 2010, ENVIRON INT, V36, P535, DOI 10.1016/j.envint.2010.04.005; Ali N, 2011, CHEMOSPHERE, V83, P1360, DOI 10.1016/j.chemosphere.2011.02.078; Takigami H, 2009, ENVIRON INT, V35, P688, DOI 10.1016/j.envint.2008.12.007; Toms LML, 2009, ENVIRON INT, V35, P864, DOI 10.1016/j.envint.2009.03.001; Brommer S, 2012, J ENVIRON MONITOR, V14, P2482, DOI 10.1039/c2em30303e; Bergman A, 2012, ENVIRON INT, V49, P57, DOI 10.1016/j.envint.2012.08.003; Ali N, 2012, CHEMOSPHERE, V88, P1276, DOI 10.1016/j.chemosphere.2012.03.100; Saito I, 2007, INDOOR AIR, V17, P28, DOI 10.1111/j.1600-0668.2006.00442.x; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Garcia M, 2007, J CHROMATOGR A, V1152, P280, DOI 10.1016/j.chroma.2006.11.046; Rauert C, 2014, SCI TOTAL ENVIRON, V493, P639, DOI 10.1016/j.scitotenv.2014.06.029; Dirtu AC, 2012, ENVIRON INT, V49, P1, DOI 10.1016/j.envint.2012.08.002; Roosens L, 2009, ENVIRON HEALTH PERSP, V117, P1707, DOI 10.1289/ehp.0900869; Stapleton HM, 2009, ENVIRON SCI TECHNOL, V43, P7490, DOI 10.1021/es9014019; Watanabe I, 2003, ENVIRON INT, V29, P665, DOI 10.1016/S0160-4120(03)00123-5; Takigami H, 2008, CHEMOSPHERE, V73, P161, DOI 10.1016/j.chemosphere.2008.06.032; Dirtu A. C., 2012, INDOOR AIR, V22, P200; García M, 2007, Anal Chim Acta, V590, P17, DOI 10.1016/j.aca.2007.03.026; Matsugami H., 2014, J ENV CHEM, V24, P41; USEPA, 1997, EXP FACT HDB, V1; WHO, 2000, ENV HLTH CRIT, V218; WHO, 1990, ENV HLTH CRIT; WHO, 1991, ENV HLTH CRIT; WHO World Health Organization, 1998, ENV HLTH CRIT, P209; World Health Organization, 1991, ENV HLTH CRIT	49	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	MAR	2015	123						17	25		10.1016/j.chemosphere.2014.11.028		9	Environmental Sciences	Environmental Sciences & Ecology	CA9VB	WOS:000349271800003		
J	Inui, H; Hirota, M; Goto, J; Yoshihara, R; Kodama, N; Matsui, T; Yamazaki, K; Eun, H				Inui, Hideyuki; Hirota, Matashi; Goto, Junya; Yoshihara, Ryouhei; Kodama, Noriko; Matsui, Tomomi; Yamazaki, Kiyoshi; Eun, Heesoo			Zinc finger protein genes from Cucurbita pepo are promising tools for conferring non-Cucurbitaceae plants with ability to accumulate persistent organic pollutants	CHEMOSPHERE			English	Article						Cucurbita pepo; Dioxins; Polychlorinated biphenyls; Transgenic plants; Zinc finger proteins	TRANSGENIC TOBACCO PLANTS; DIOXIN-LIKE COMPOUNDS; WEATHERED P,P'-DDE; DIFFERENTIAL UPTAKE; SOIL; PHYTOEXTRACTION; CUCUMBER; DIELDRIN; ACIDS; FIELD	Some cultivars of cucumbers, melons, pumpkins, and zucchini, which are members of the Cucurbitaceae family, are uniquely subject to contamination by hydrophobic pollutants such as the organohalogen insecticides DDT. However, the molecular mechanisms for the accumulation of these pollutants in cucurbits have not been determined. Here, cDNA subtraction analysis of Cucurbita pepo cultivars that are low and high accumulators of hydrophobic contaminants revealed that a gene for zinc finger proteins (ZFPs) are preferentially expressed in high accumulators. The cloned CpZFP genes were classified into 2 types: (1) the PEG type, which were expressed in C. pepo cultivars Patty Green, Black Beauty, and Gold Rush, and (2) the BG type, which were expressed in Black Beauty and Gold Rush. Expression of these CpZFP genes in transgenic tobacco plants carrying an aryl hydrocarbon receptor-based inducible gene expression system significantly induced E-glucuronidase activity when the plants were treated with a polychlorinated biphenyl (PCB) compound, indicating that highly hydrophobic PCBs accumulated in the plants. In transgenic tobacco plants carrying CpZFPs, accumulation of dioxins and dioxin-like compounds increased in their aerial parts when they were cultivated in the dioxin-contaminated soil. In summary, we propose that addition of CpZFP genes is a promising tool for conferring noncucurbits with the ability to accumulate hydrophobic contaminants. (C) 2014 Elsevier Ltd. All rights reserved.	[Inui, Hideyuki; Yoshihara, Ryouhei] Kobe Univ, Res Ctr Environm Genom, Nada Ku, Kobe, Hyogo 6578501, Japan; [Inui, Hideyuki; Hirota, Matashi; Goto, Junya; Kodama, Noriko; Matsui, Tomomi; Yamazaki, Kiyoshi] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Eun, Heesoo] Natl Inst Agroenvironm Sci, Chem Anal Res Ctr, Tsukuba, Ibaraki 3058604, Japan	Inui, H (reprint author), Kobe Univ, Res Ctr Environm Genom, Nada Ku, 1-1 Rokkodaicho, Kobe, Hyogo 6578501, Japan.	hinui@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17208029, 23241028]	We thank Dr. Tsuyoshi Nakagawa of Shimane University for providing the plant expression plasmid pGWB502 Omega. This work was funded in part through Grants-in-Aid for Scientific Research A from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 17208029 and 23241028).	Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; White JC, 2003, ENVIRON POLLUT, V124, P71, DOI 10.1016/S0269-7491(02)00409-8; White JC, 2002, CHEMOSPHERE, V49, P143, DOI 10.1016/S0045-6535(02)00277-1; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Hashimoto Y, 2005, J PESTIC SCI, V30, P397, DOI 10.1584/jpestics.30.397; HULSTER A, 1994, ENVIRON SCI TECHNOL, V28, P1110; Inui H, 2008, CHEMOSPHERE, V73, P1602, DOI 10.1016/j.chemosphere.2008.08.013; Inui H, 2013, PLANT PHYSIOL, V161, P2128, DOI 10.1104/pp.112.213645; Inui H, 2012, J ENVIRON SCI HEAL B, V47, P59, DOI 10.1080/03601234.2012.611018; Kodama S, 2007, PLANTA, V227, P37, DOI 10.1007/s00425-007-0592-1; Kodama S, 2009, PLANT BIOTECHNOL J, V7, P119, DOI 10.1111/j.1467-7652.2008.00378.x; Otani T, 2007, SOIL SCI PLANT NUTR, V53, P86, DOI 10.1111/j.1747-0765.2007.00102.x; Wang XP, 2004, INT J PHYTOREMEDIAT, V6, P363, DOI 10.1080/16226510490888910; White JC, 2003, ENVIRON SCI TECHNOL, V37, P4368, DOI 10.1021/es034357p; White JC, 2010, ENVIRON SCI TECHNOL, V44, P5165, DOI 10.1021/es100706t; Yoshihara R, 2014, J PESTIC SCI, V39, P162, DOI 10.1584/jpestics.D14-054	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	MAR	2015	123						48	54		10.1016/j.chemosphere.2014.11.068		7	Environmental Sciences	Environmental Sciences & Ecology	CA9VB	WOS:000349271800007		
J	Duong, HT; Kadokami, K; Shirasaka, H; Hidaka, R; Chau, HTC; Kong, LX; Nguyen, TQ; Nguyen, TT				Hanh Thi Duong; Kadokami, Kiwao; Shirasaka, Hanako; Hidaka, Rento; Hong Thi Cam Chau; Kong, Lingxiao; Trung Quang Nguyen; Thao Thanh Nguyen			Occurrence of perfluoroalkyl acids in environmental waters in Vietnam	CHEMOSPHERE			English	Article						Perfluoroalkyl acids; PFOS; PFOA; Environmental water; Vietnam	ORGANIC PERSISTENT POLLUTANTS; PERFLUORINATED COMPOUNDS; CARBOXYLIC-ACIDS; DRINKING-WATER; RIVER; BIODEGRADATION; CONTAMINATION; SURFACTANTS; SEDIMENT; CHINA	This is the first nationwide study of perfluoroalkyl acids (PFAAs) in environmental waters in Vietnam. Twenty-eight river water and 22 groundwater samples collected in four major cities and 14 river water samples from the Red River were screened to investigate the occurrence and sources of 16 PFAAs. Perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), and perfluorononanoic acid (PFNA) were the most prevalent of 11 detected PFAAs with maximum concentrations in urban river water of 5.3, 18 and 0.93 ng L-1, respectively, and in groundwater of 8.2, 4.5 and 0.45 ng L-1, respectively. PFAAs in the Red River water were detected at low levels. PFAA concentrations in river water were higher in the rainy season than in the dry season, possibly due to storm water runoff, a common phenomenon in Southeast Asian countries. The highest concentrations of PFAAs in river water were observed in samples from highly populated and industrialized areas, perhaps sourced from sewage. The PFAA concentrations observed were similar to those in other Southeast Asian countries, but lower than in developed nations. From the composition profiles of PFAAs, industrial products containing PFAAs imported from China and Japan might be one of the major sources of PFAAs in the Vietnamese aquatic environment. According to the health-based values and advisory issued by the United States Environmental Protection Agency (USEPA), the concentrations of detected PFAAs in this study do not pose an immediate health risk to humans and aquatic organisms. (C) 2014 Elsevier Ltd. All rights reserved.	[Hanh Thi Duong; Kadokami, Kiwao; Shirasaka, Hanako; Hidaka, Rento; Hong Thi Cam Chau; Kong, Lingxiao] Univ Kitakyushu, Grad Sch Environm Engn, Kitakyushu, Fukuoka 8080135, Japan; [Trung Quang Nguyen; Thao Thanh Nguyen] Vietnam Acad Sci & Technol, Inst Environm Technol, Dept Environm Toxicol Anal, Hanoi, Vietnam	Kadokami, K (reprint author), Univ Kitakyushu, Grad Sch Environm Engn, 1-1 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	kadokami@kitakyu-u.ac.jp			Japan Society for the Promotion of Science - Japan (JSPS) [12308030]; Vietnam Academy of Science and Technology - Vietnam (VAST) [VAST.HTQT.NHAT.01/2012-2014]; Kitakyushu City - Japan	This study was supported by a bilateral joint research project between Japan Society for the Promotion of Science - Japan (JSPS, project No. 12308030) and Vietnam Academy of Science and Technology - Vietnam (VAST, project code: VAST.HTQT.NHAT.01/2012-2014) and a research grant of Kitakyushu City - Japan. The authors also wish to thank the researchers in the Department of Environmental Toxicology Analysis, IET, VAST for their assistance in sample collection and analysis. We thank our laboratory members for their enthusiastic support of this work. We are grateful to Dr. Graeme Allinson (University of Melbourne, Melbourne, Australia) and Dr. Mayumi Allinson (University of Melbourne, Melbourne, Australia) for their kind proofreading, useful comments, and constructive suggestions on this manuscript.	Agency for Toxic Substances and Disease Registry, 2009, TOX PROF PERFL DRAFT; American Public Health A Eaton AD American Water Works A Water Environment F, 2005, STANDARD METHODS EXA; Murakami M, 2009, ENVIRON SCI TECHNOL, V43, P3480, DOI 10.1021/es803556w; Benskin JP, 2011, ENVIRON SCI TECHNOL, V45, P7188, DOI 10.1021/es2011176; Skutlarek D, 2006, ENVIRON SCI POLLUT R, V13, P299, DOI 10.1065/espr2006.07.326; Clarke BO, 2011, ENVIRON INT, V37, P226, DOI 10.1016/j.envint.2010.06.004; HAGEN DF, 1981, ANAL BIOCHEM, V118, P336, DOI 10.1016/0003-2697(81)90591-1; Murakami M, 2008, ENVIRON SCI TECHNOL, V42, P6566, DOI 10.1021/es800353f; Loos R, 2008, CHEMOSPHERE, V71, P306, DOI 10.1016/j.chemosphere.2007.09.022; Filipovic M, 2013, ENVIRON SCI TECHNOL, V47, P4088, DOI 10.1021/es400174y; Dinglasan MJA, 2004, ENVIRON SCI TECHNOL, V38, P2857, DOI 10.1021/es0350177; Post GB, 2013, ENVIRON SCI TECHNOL, V47, P13266, DOI 10.1021/es402884x; Suja F, 2009, WATER SCI TECHNOL, V60, P1533, DOI 10.2166/wst.2009.504; Hansen KJ, 2002, ENVIRON SCI TECHNOL, V36, P1681, DOI 10.1021/es010780r; Vieira VM, 2013, ENVIRON HEALTH PERSP, V121, P318, DOI 10.1289/ehp.1205829; Fromel T, 2010, REV ENVIRON CONTAM T, V208, P161, DOI 10.1007/978-1-4419-6880-7_3; So MK, 2004, ENVIRON SCI TECHNOL, V38, P4056, DOI 10.1021/es049441z; Plumlee MH, 2008, CHEMOSPHERE, V72, P1541, DOI 10.1016/j.chemosphere.2008.04.057; Rostkowski P, 2006, ENVIRON TOXICOL CHEM, V25, P2374, DOI 10.1897/05-627R.1; Yang LP, 2011, CHEMOSPHERE, V83, P806, DOI 10.1016/j.chemosphere.2011.02.075; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Conder JM, 2008, ENVIRON SCI TECHNOL, V42, P995, DOI 10.1021/es070895g; Naile JE, 2010, ENVIRON POLLUT, V158, P1237, DOI 10.1016/j.envpol.2010.01.023; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; So MK, 2007, CHEMOSPHERE, V68, P2085, DOI 10.1016/j.chemosphere.2007.02.008; Simcik MF, 2005, ENVIRON SCI TECHNOL, V39, P8678, DOI 10.1021/es0511218; Mclachlan MS, 2007, ENVIRON SCI TECHNOL, V41, P7260, DOI 10.1021/es071471p; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; Loos R, 2010, WATER RES, V44, P4115, DOI 10.1016/j.watres.2010.05.032; Vestergren R, 2009, ENVIRON SCI TECHNOL, V43, P5565, DOI 10.1021/es900228k; Zushi Y, 2011, ENVIRON SCI TECHNOL, V45, P2887, DOI [10.1021/es103917r, 10.1021/e5103917r]; Kim SK, 2007, ENVIRON SCI TECHNOL, V41, P8328, DOI 10.1021/es072107t; Environment Canada, 2010, ENV PERF AGR AGR RES; European Chemicais Agency, 2014, CAND LIST SUBST VER; Rayne S, 2009, J ENVIRON SCI HEAL A, V44, P1145, DOI 10.1080/10934520903139811; Giesy J. P., 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI DOI 10.1021/ES022253T; GILLILAND FD, 1993, J OCCUP ENVIRON MED, V35, P950, DOI 10.1097/00043764-199309000-00020; Guruge KS, 2007, MAR POLLUT BULL, V54, P1667, DOI 10.1016/j.marpolbul.2007.05.021; Isobe T., 2012, INTERDISC STUD ENV C, P239; Kim JW, 2013, ENVIRON MONIT ASSESS, V185, P2909, DOI 10.1007/s10661-012-2759-x; Lau C., 2012, MOL CLIN ENV TOX E S, V101, P47; Lien N P H, 2006, ENV ENG RES, V43, P611; Lien N.P.H., 2006, 15 KKNN S; Ministry of Industry and Trade of the Socialist Republic of Vietnam, 2013, REP PLAN IMPL 2013 2; Minnesota Department of Health, 2013, 2013 MDH DER HLTH RI; New Jersey Department of Environmental Protection, 2007, GUID PFOA DRINK WAT; Parsons JR, 2008, REV ENVIRON CONTAM T, V196, P53, DOI 10.1007/978-0-387-78444-1_2; UN Environment Programme, 2009, GOV UN STEP UPR GLOB; US Environmental Protection Agency, 2013, REG ACT PFAS LCPFAC; US Environmental Protection Agency, 2012, PROV HLTH ADV PERFL; US Environmental Protection Agency, 1995, FED REGISTER, V60, P15366; US Environmental Protection Agency, 2006, SCI ADV BOARD REV EP; U.S. EPA, 2011, 2010 2015 PFOA STEW; US Geological Survey, 2010, REP FY2010 2010AZ380	54	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	MAR	2015	122						115	124		10.1016/j.chemosphere.2014.11.023		10	Environmental Sciences	Environmental Sciences & Ecology	CA5MK	WOS:000348952300016		
J	Kong, LX; Kadokami, K; Wang, SP; Duong, HT; Chau, HTC				Kong, Lingxiao; Kadokami, Kiwao; Wang, Shaopo; Hanh Thi Duong; Hong Thi Cam Chau			Monitoring of 1300 organic micro-pollutants in surface waters from Tianjin, North China	CHEMOSPHERE			English	Article						Principle component analysis; Organic micro-pollutants; PPCPs; PAHs	POLYCYCLIC AROMATIC-HYDROCARBONS; CHROMATOGRAPHY-MASS SPECTROMETRY; DRINKING-WATER; RIVER; PHARMACEUTICALS; ENVIRONMENT; SEDIMENTS; ESTERS; PAHS; QUANTIFICATION	In spite of the quantities and species of chemicals dramatically increased with rapid economic growth in China in the last decade, the focus of environmental research was mainly on limited number of priority pollutants. Therefore, to elucidate environmental pollution by organic micro-pollutants, this work was conducted as the first systematic survey on the occurrence of 1300 substances in 20 surface water samples of Tianjin, North China, selected as a representative area of China. The results showed the presence of 227 chemicals. The most relevant compounds in terms of frequency of detection and median concentration were bis(2-ethylhexyl) phthalate (100%; 0.26 mu g L-1), siduron (100%; 0.20 mu g L-1), lidocaine (100%; 96 ng L-1), antipyrine (100%; 76 ng L-1), caffeine (95%; 0.28 mu g L-1), cotinine (95%; 0.201 mu g L-1), phenanthrene (95%; 0.17 mu g L-1), metformin (90%; 0.61 mu g L-1), diethyl phthalate (90%; 0.19 mu g L-1), quinoxaline-2-carboxylic acid (90%; 0.14 mu g L-1), 2-(methylthio)-benzothiazole (85%; 0.11 mu g L-1) and anthraquinone (85%; 54 ng L-1). Cluster analysis discriminated three highly polluted sites from others based on data similarity. Principle component analysis identified four factors, corresponding to industrial wastewater, domestic discharge, tire production and atmospheric deposition, accounting for 78% of the total variance in the water monitoring data set. This work provides a wide reconnaissance on broad spectrum of organic micro-contaminants in surface waters in China, which indicates that the aquatic environment in China has been polluted by a large number of chemicals. (C) 2014 Elsevier Ltd. All rights reserved.	[Kong, Lingxiao; Kadokami, Kiwao; Hanh Thi Duong; Hong Thi Cam Chau] Univ Kitakyushu, Fac Environm Engn, Kitakyushu, Fukuoka 8080135, Japan; [Wang, Shaopo] Tianjin Chengjian Univ, Fac Environm & Municipal Engn, Tianjin 300384, Peoples R China	Kadokami, K (reprint author), Univ Kitakyushu, Fac Environm Engn, 1-1 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	kadokami@kitakyu-u.ac.jp					Pan SY, 2014, CHEMOSPHERE, V99, P109, DOI 10.1016/j.chemosphere.2013.10.038; Bolz U, 2001, ENVIRON POLLUT, V115, P291, DOI 10.1016/S0269-7491(01)00100-2; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Zheng XX, 2014, SCI TOTAL ENVIRON, V476, P107, DOI 10.1016/j.scitotenv.2013.12.111; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Zhang SY, 2007, CHEMOSPHERE, V66, P1057, DOI 10.1016/j.chemosphere.2006.06.067; Du X, 2013, PROCEDIA ENVIRON SCI, V18, P882, DOI 10.1016/j.proenv.2013.04.119; de Jongh CM, 2012, SCI TOTAL ENVIRON, V427, P70, DOI 10.1016/j.scitotenv.2012.04.010; Vryzas Z, 2009, WATER RES, V43, P1, DOI 10.1016/j.watres.2008.09.021; Martins CC, 2007, J BRAZIL CHEM SOC, V18, P106, DOI 10.1590/S0103-50532007000100012; Jin XL, 2004, CHEMOSPHERE, V56, P1113, DOI 10.1016/j.chemosphere.2004.04.052; Zhang ZL, 2004, ENVIRON POLLUT, V130, P249, DOI 10.1016/j.envpol.2003.12.002; GRIMALT JO, 1990, ENVIRON SCI TECHNOL, V24, P357, DOI 10.1021/es00073a011; Jinya D, 2013, ANAL SCI, V29, P483; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; Pies C, 2008, CHEMOSPHERE, V72, P1594, DOI 10.1016/j.chemosphere.2008.04.021; Kadokami K, 2005, J CHROMATOGR A, V1089, P219, DOI 10.1016/j.chroma.2005.06.052; De La Torre-Roche RJ, 2009, J HAZARD MATER, V163, P946, DOI 10.1016/j.jhazmat.2008.07.089; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; He W, 2013, SCI TOTAL ENVIRON, V461, P672, DOI [10.1016/j.scitotenv.2013.05.049, 10.1016/j.scitotenv2013.05.049]; Scheurer M, 2012, WATER RES, V46, P4790, DOI 10.1016/j.watres.2012.06.019; Areddy JT., 2013, WALL STREET J, pA9; Hanh D.T., 2013, SE ASIAN WATER ENV, V5, P195; Kadokami K., 2009, J ENV CHEM, V19, P351; Leeming R., 1998, 204 WAT SERV ASS AUS; LI J, 2014, WATER RES, V54, P53; Martinez-Carballo E, 2007, SCI TOTAL ENVIRON, V388, P290, DOI 10.1016/j.scitotenv.2007.08.005; Peng XZ, 2008, SCI TOTAL ENVIRON, V397, P158, DOI 10.1016/j.scitotenv.2008.02.059	28	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	MAR	2015	122						125	130		10.1016/j.chemosphere.2014.11.025		6	Environmental Sciences	Environmental Sciences & Ecology	CA5MK	WOS:000348952300017		
J	Guo, SJ; Saki, S; Okuno, K; Saito, T; Nakagawa, T; Sato, K; Sawada, H				Guo, Sujuan; Saki, Soma; Okuno, Keita; Saito, Tomoya; Nakagawa, Takeshi; Sato, Katsuyuki; Sawada, Hideo			Preparation and properties of fluorinated aliphatic alcohols/silica nanocomposites - Application to the encapsulation of anatase titanium oxide nanoparticles into these composite cores	COMPOSITES PART B-ENGINEERING			English	Article						Hybrid; Surface properties; Thermal properties; Wettability	END-CAPPED OLIGOMERS; OIL-REPELLENT SURFACES; SILICA-GEL MATRICES; 800 DEGREES-C; FLUOROALKANOYL PEROXIDES; PHOTOCATALYTIC ACTIVITY; ATMOSPHERIC CONDITIONS; POLYMERS; EVEN; 800-DEGREES-C	A variety of fluorinated aliphatic alcohols ERF-CH2CH2OH; RF = CF3(CF2)3CF12(CF2)5, CF3(CF2); n = 3, 5, 7] were applied to the preparation of the corresponding fluorinated alcohols/silica nanocomposites [RF-CH2_ CH2OH/Si021 through the sol-gel reactions with tetraethoxysilane (TEOS) and silica nanoparticles under alkaline conditions. RF-CH2CH2OH/Si02 nanocomposites thus obtained have a good dispersibility and stability in not only water but also traditional organic solvents such as methanol, ethanol, 1,2-dichloroethane and tetrahydrofuran. FE-SEM (field emission scanning electron microscopy) and dynamic light scattering (DLS) measurements show that these composites are nanometer size-controlled fine particles in methanol. These fluorinated nanocomposites were also applied to the surface modification of glass to exhibit a superhydrophilic characteristic with a superoleophobicity on the modified surface. Interestingly, RF-CH2CH2OH/Si02 nanocomposites were found to exhibit no weight loss behavior corresponding to the contents of the alcohols in the composites even after calcination at 800 C. In addition, anatase TiO2 nanoparticles (an-Ti02) were effectively encapsulated into RF-CH2CH2OH/Si02 nanocomposite cores under the similar sol-gel reactions to give the corresponding fluorinated alcohol/Si02/an-Ti02 nanocomposites. These obtained nanocomposites can give a higher photocatalytic activity even after calcination at 1000 C for the decolorization of methylene blue under UV light irradiation than that of the an-TiO2 nanoparticles under the similar conditions, although the parent TiO2 nanoparticles after calcination were unable to give a photocatalytic activity. (C) 2014 Elsevier Ltd. All rights reserved.	[Guo, Sujuan; Saki, Soma; Okuno, Keita; Saito, Tomoya; Sawada, Hideo] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Nakagawa, Takeshi; Sato, Katsuyuki] Unimatec Co Ltd, Kitaibaraki, Ibaraki 3191593, Japan	Sawada, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan.	hideosaw@cc.hirosaki-u.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan [24550220]	This work was partially supported by a Grant-in-Aid for Scientific Research 24550220 from the Ministry of Education, Science, Sports, and Culture, Japan.	Ameduri B, 2011, MACROMOLECULES, V44, P2394, DOI 10.1021/ma2003536; Ameduri B, 2000, J FLUORINE CHEM, V104, P53, DOI 10.1016/S0022-1139(00)00227-X; Ameduri B, 2004, WELL ARCHITECTURED F, P231, DOI 10.1016/B978-008044388-1/50013-3; Taurino R, 2008, J COLLOID INTERF SCI, V325, P149, DOI 10.1016/j.jcis.2008.05.007; Imae T, 2003, CURR OPIN COLLOID IN, V8, P307, DOI 10.1016/S1359-0294(03)00050-5; Goto Y, 2011, J COLLOID INTERF SCI, V362, P375, DOI 10.1016/j.jcis.2011.06.045; Srinivasan S, 2011, POLYMER, V52, P3209, DOI 10.1016/j.polymer.2011.05.008; Dolbier WR, 2005, J FLUORINE CHEM, V126, P157, DOI 10.1016/j.jfluchem.2004.09.033; Yao X, 2011, ADV MATER, V23, P719, DOI 10.1002/adma.201002689; Berret JF, 2003, CURR OPIN COLLOID IN, V8, P296, DOI 10.1016/S1359-0294(03)00048-7; Han XG, 2009, J AM CHEM SOC, V131, P3152, DOI 10.1021/ja8092373; Tsujii K, 1997, ANGEW CHEM INT EDIT, V36, P1011, DOI 10.1002/anie.199710111; Liu M, 2010, CHEM COMMUN, V46, P1664, DOI 10.1039/b924172h; Monteiro MJ, 2005, MACROMOLECULES, V38, P1538, DOI 10.1021/ma0478557; Ameduri B, 2009, CHEM REV, V109, P6632, DOI 10.1021/cr800187m; Shibuichi S, 1998, J COLLOID INTERF SCI, V208, P287, DOI 10.1006/jcis.1998.5813; Liu MJ, 2009, ADV MATER, V21, P665, DOI 10.1002/adma.200801782; Liu SW, 2012, ADV COLLOID INTERFAC, V173, P35, DOI 10.1016/j.cis.2012.02.004; Liu G, 2010, CHEM COMMUN, V46, P755, DOI 10.1039/b919895d; Wu GS, 2008, LANGMUIR, V24, P3503, DOI 10.1021/la703098g; Feng J, 2009, J COLLOID INTERF SCI, V336, P268, DOI 10.1016/j.jcis.2009.03.025; Patil Y, 2013, POLYM CHEM-UK, V4, P2783, DOI 10.1039/c3py21139h; Liu KS, 2013, PROG MATER SCI, V58, P503, DOI 10.1016/j.pmatsci.2012.11.001; Peng XS, 2006, ADV FUNCT MATER, V16, P1355, DOI 10.1002/adfm.200500464; Guo SJ, 2012, J COLLOID INTERF SCI, V387, P141, DOI 10.1016/j.jcis.2012.08.005; Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0; Xie QD, 2004, ADV MATER, V16, P302, DOI 10.1002/adma.200306281; Boschet F, 2012, POLYM CHEM-UK, V3, P217, DOI 10.1039/c1py00394a; Chen YC, 2004, J POLYM SCI POL CHEM, V42, P1789, DOI 10.1002/pola.20033; Cho J. W., 2001, FIBER POLYM, V2, P135, DOI 10.1007/BF02875326; Destarac M, 2000, MACROMOLECULES, V33, P4613, DOI 10.1021/ma9918351; Fabbri P, 2006, POLYMER, V47, P1055, DOI 10.1016/j.polymer.2005.12.028; Feiring AE, 2000, J POLYM SCI POL CHEM, V38, P3313, DOI 10.1002/1099-0518(20000915)38:18<3313::AID-POLA100>3.0.CO;2-D; Gomez-Romero P., 2004, FUNCTIONAL HYBRID MA; Hilonga A, 2010, J MATER SCI, V45, P1264, DOI 10.1007/s10853-009-4077-4; Hilonga A, 2010, J MATER SCI, V45, P1255, DOI 10.1007/s10853-009-4076-5; Ho W, 2006, CHEM COMMUN, P1115, DOI 10.1039/b515513d; Imae T, 2000, COLLOID SURFACE A, V167, P73, DOI 10.1016/S0927-7757(99)00484-7; Lebreton P, 2002, MACROMOL CHEM PHYSIC, V203, P522, DOI 10.1002/1521-3935(20020201)203:3<522::AID-MACP522>3.0.CO;2-L; Madras G, 2007, J AM CERAM SOC, V90, P250, DOI 10.1111/j.1551-2916.2006.01369.x; Sawada H, 2003, J FLUORINE CHEM, V121, P111, DOI 10.1016/S0022-1139(03)00040-X; Sawada H, 2008, POLYM ADVAN TECHNOL, V19, P739, DOI 10.1002/pat.1050; Sawada H, 2011, J COLLOID INTERF SCI, V356, P8, DOI 10.1016/j.jcis.2010.12.037; Sawada H, 2011, MACROMOLECULES, V44, P1114, DOI 10.1021/ma102532k; Sawada H, 2007, PROG POLYM SCI, V32, P509, DOI 10.1016/j.progpolymsci.2007.02.002; Sawada H, 2007, COLLOID POLYM SCI, V285, P977, DOI 10.1007/s00396-007-1641-9; Sawada H, 2000, J FLUORINE CHEM, V105, P219, DOI 10.1016/S0022-1139(00)00279-7; Sawada H, 2001, KOBUNSHI RONBUNSHU, V58, P255; Sawada H, 2001, KOBUNSHI RONBUNSHU, V58, P147; Sawada H, 2012, POLYM CHEM-UK, V3, P46, DOI 10.1039/c1py00325a; Sawada H, 2010, POLYM J, V42, P167, DOI 10.1038/pj.2009.316; Sawada H, 2011, POLYM SCI SER A, V1070, P49; Sawada H, 2009, J APPL POLYM SCI, V112, P3482, DOI 10.1002/app.29942; Sawada H, 1996, CHEM REV, V96, P1779, DOI 10.1021/cr9411482; Shi ZQ, 2005, MACROMOLECULES, V38, P4193, DOI 10.1021/ma0477549; Soma S, 2014, J POLYM SCI POL CHEM, V52, P1869, DOI 10.1002/pola.27195; Yang GH, 2009, J AM CHEM SOC, V131, P4078; Yano S, 1996, MACROMOL SYMP, V108, P279, DOI 10.1002/masy.19961080123; Zhang Dieqing, 2009, Chem Commun (Camb), P4381, DOI 10.1039/b907963g	59	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-8368	1879-1069		COMPOS PART B-ENG	Compos. Pt. B-Eng.	MAR 1	2015	70						80	91		10.1016/j.compositesb.2014.09.020		12	Engineering, Multidisciplinary; Materials Science, Composites	Engineering; Materials Science	CA5ME	WOS:000348951700008		
J	Mvungi, B; Iwaihara, M				Mvungi, Basilisa; Iwaihara, Mizuho			Associations between privacy, risk awareness, and interactive motivations of social networking service users, and motivation prediction from observable features	COMPUTERS IN HUMAN BEHAVIOR			English	Article						Online privacy; SNS privacy settings; Motivation analysis; User behavior analysis	ONLINE	In this paper, we use survey data firstly to study how significantly motivations of using social networking service (SNS), risk awareness, and profile attributes affect user's disclosure activities. Openness score is calculated from the number of disclosed items. We study influential factors and their rankings at various disclosure scopes and openness scores. Our findings reveal that gender, profile photo, certain motivations, and risk awareness highly affect private information disclosure activities. However the ranking of influential factors is not uniform. Gender and profile photo have greater influence, however, their influence becomes lower and loses significance as openness is getting higher, falling behind motivations and number of friends. Secondly, we discuss constructing prediction models based on binary logistic regression to predict motivations from number of friends and profile attributes that are visible from the public. We classify motives into inward motive to interact with existing social networking service friends, outward motive to acquire via the SNS, and neutral motive which cannot distinguish whether user have inward or outward motive. Results show that the models can predict motives well and have good discrimination power. Using dimensional reduction, important predictors for optimum models are identified. (C) 2014 Elsevier Ltd. All rights reserved.	[Mvungi, Basilisa; Iwaihara, Mizuho] Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, Kitakyushu, Fukuoka 8080135, Japan	Mvungi, B (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, 2-7 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	basilisam@akane.waseda.jp; iwaihara@waseda.jp					Acquisti A, 2006, LECT NOTES COMPUT SC, V4258, P36; Debatin B, 2009, J COMPUT-MEDIAT COMM, V15, P83, DOI 10.1111/j.1083-6101.2009.01494.x; Subrahmanyam K, 2008, J APPL DEV PSYCHOL, V29, P420, DOI 10.1016/j.appdev.2008.07.003; Lampe C, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P721; Joinson AN, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1027; Smock AD, 2011, COMPUT HUM BEHAV, V27, P2322, DOI 10.1016/j.chb.2011.07.011; Lewis K, 2008, J COMPUT-MEDIAT COMM, V14, P79, DOI 10.1111/j.1083-6101.2008.01432.x; Papacharissi Z, 2011, COMMUN SOC-SER, P212; Dwyer C., 2007, P AMCIS 2007 KEYST; Giancristofaro R., 2003, MODEL PERFORMANCE AN, VLXIII; Gross R., 2005, P ACM WORKSH PRIV EL; Hasib A., 2008, THREATS ONL SOC NETW; Kisilevich S., 2011, KNOWL INF SYST, V32, P609; Lampe C., 2006, P 2006 20 ANN C COMP, P167, DOI DOI 10.1145/1180875.1180901; Maximilien E., 2009, WORKSH WEB 2 0 SEC P; Mvungi B., 2013, LNCS, V8238, P119; Spiliotopoulos T., 2013, P SIGCHI C HUM FACT, P3287; Steinfield Charles, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI DOI 10.1111/J.1083-6101.2007.00367.X; TARASZOW T., 2010, INT J MEDIA CULTURAL, V6, P81, DOI [10.1386/macp.6.1.81/1, DOI 10.1386/MACP.6.1.81/1, DOI 10.1386/MACP.6.1.81/]; Tufekci Z, 2008, B SCI TECHNOL SOC, V28, P20, DOI DOI 10.1177/0270467607311484; Tuunainen VK, 2009, 22ND BLED ECONFERENCE-EENABLEMENT: FACILITATING AN OPEN, EFFECTIVE AND REPRESENTATIVE ESOCIETY, P1	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0747-5632	1873-7692		COMPUT HUM BEHAV	Comput. Hum. Behav.	MAR	2015	44						20	34		10.1016/j.chb.2014.11.023		15	Psychology, Multidisciplinary; Psychology, Experimental	Psychology	CA5RH	WOS:000348965000003		
J	Kato, Y; Kato, S				Kato, Yuuki; Kato, Shogo			Reply speed to mobile text messages among Japanese college students: When a quick reply is preferred and a late reply is acceptable	COMPUTERS IN HUMAN BEHAVIOR			English	Article						Mobile text messaging; Reply timing; Reply speed; Emotion; M-learning; Digital native	COMPUTER-MEDIATED COMMUNICATION; SOCIAL PRESENCE; GENDER; DEPENDENCY; RICHNESS; DESIGN; CUES	Speed of exchange is important in communication using mobile phones. This study analyzes responses to a questionnaire survey of Japanese university students about replies to mobile text messages. Respondents were asked to indicate situations where a quick reply was desired and situations where a slow reply was acceptable. Free responses were classified broadly into seven groups such as "attributes of the other party," "one's own emotional state," "one's own situation," and "situation of the other party." Additionally, gender differences were seen in these free responses, with men more often referring to the attributes of the other party and their own situation and women more often referring to the content of the text messages. The results of the questions asking respondents to rank emotions by desired speed of response showed that there are individual differences in the relation between the type of emotion conveyed and the desired speed of reply (e.g., a quick reply was desired when joy or apology was conveyed). These individual differences were then aggregated into three types by cluster analysis. (C) 2014 Elsevier Ltd. All rights reserved.	[Kato, Yuuki] Sagami Womens Univ, Minami Ku, Sagamihara, Kanagawa 2520383, Japan; [Kato, Shogo] Tokyo Womans Christian Univ, Suginami Ku, Tokyo 1678585, Japan	Kato, Y (reprint author), Sagami Womens Univ, Minami Ku, 2-1-1 Bunkyo, Sagamihara, Kanagawa 2520383, Japan.	y-katou@star.sagami-wu.ac.jp; shogu@lab.twcu.ac.jp					WALTHER JB, 1994, COMMUN RES, V21, P460, DOI 10.1177/009365094021004002; Ogara SO, 2014, COMPUT HUM BEHAV, V36, P453, DOI 10.1016/j.chb.2014.03.064; Skierkowski D, 2012, COMPUT HUM BEHAV, V28, P744, DOI 10.1016/j.chb.2011.11.023; WALTHER JB, 1992, HUM COMMUN RES, V19, P50, DOI 10.1111/j.1468-2958.1992.tb00295.x; SIEGEL J, 1986, ORGAN BEHAV HUM DEC, V37, P157, DOI 10.1016/0749-5978(86)90050-6; Lu X, 2011, COMPUT HUM BEHAV, V27, P1702, DOI 10.1016/j.chb.2011.02.009; Dietz S, 2014, COMPUT HUM BEHAV, V36, P163, DOI 10.1016/j.chb.2014.03.045; KIESLER S, 1984, AM PSYCHOL, V39, P1123, DOI 10.1037//0003-066X.39.10.1123; DAFT RL, 1986, MANAGE SCI, V32, P554, DOI 10.1287/mnsc.32.5.554; DAFT RL, 1984, RES ORGAN BEHAV, V6, P191; Savicki V, 2000, CYBERPSYCHOL BEHAV, V3, P817, DOI 10.1089/10949310050191791; Coyne SM, 2011, FAM RELAT, V60, P150, DOI 10.1111/j.1741-3729.2010.00639.x; Tossell CC, 2012, COMPUT HUM BEHAV, V28, P659, DOI 10.1016/j.chb.2011.11.012; Tu CH, 2000, J NETW COMPUT APPL, V23, P27, DOI 10.1006/jnca.1999.0099; Bennett S, 2008, BRIT J EDUC TECHNOL, V39, P775, DOI 10.1111/j.1467-8535.2007.00793.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Joinson AN, 2001, EUR J SOC PSYCHOL, V31, P177, DOI 10.1002/ejsp.36; Faulkner X, 2005, INTERACT COMPUT, V17, P167, DOI 10.1016/j.intcom.2004.11.002; Boneva B. S., 2006, COMPUTERS PHONES INT, P201; Garrison Anthony, 2011, Computers and Composition, V28, DOI 10.1016/j.compcom.2011.04.001; Garrison D. R., 2003, E LEARNING 21 CENTUR; Gunawardena C. N., 1995, INT J ED TELECOMMUNI, V1, P147; Gunawardena C.N., 1997, AM J DISTANCE ED, V11, P8, DOI DOI 10.1080/08923649709526970; HOY M.G., 2010, J INTERACTIVE ADVERT, V10, P28, DOI DOI 10.1080/15252019.2010.10722168; Ishii K, 2006, TELEMATICS INFORM, V23, P95, DOI 10.1016/j.tele.2005.05.002; Joinson A., 2007, OXFORD HDB INTERNET; Kato S., 2009, INT J E LEARNING, V8, P385; Kato Y., 2013, USER BEHAV UBIQUITOU, P1; Kato Y., 2002, Proceedings International Conference on Computers in Education, DOI 10.1109/CIE.2002.1185966; Kato Y., 2012, VIRTUAL WORK HUMAN I, P99; Kato Y., 2013, J JAPAN SOC ED INFOR, V29, P21; Kato Y., 2010, INT J E LEARNING IJE, V9, P203; Kato Y., 2011, P WORLD C ED MULT HY, P170; Kirby M. R., 1995, PEOPLE COMPUTERS, P289; Leung L, 2007, TELEMAT INFORM, V24, P115, DOI 10.1016/j.tele.2006.01.002; Lin A. M. Y., 2007, J MEDIA CULTURAL STU, V21, P303; Lu X, 2014, PSYCHIAT RES, V216, P255, DOI 10.1016/j.psychres.2013.12.024; Matheson K., 1988, Computers in Human Behaviour, V4, DOI 10.1016/0747-5632(88)90015-5; MATHESON K, 1991, COMPUT HUM BEHAV, V7, P137, DOI 10.1016/0747-5632(91)90003-J; MCGUIRE TW, 1987, J PERS SOC PSYCHOL, V52, P917, DOI 10.1037//0022-3514.52.5.917; Ministry of Internal Affairs and Communications, 2012, WHIT PAP INF COMM JA; Picciano A. G., 2002, J ASYNCHRONOUS LEARN, V6, P21; Richardson J.C, 2003, J ASYNCHRONOUS LEARN, V7, P68, DOI DOI 10.1080/14792779443000049; Rutter D. R., 1984, LOOKING SEEING ROLE; RUTTER DR, 1981, BRIT J SOC PSYCHOL, V20, P41; Savicki V, 1999, COMPUT HUM BEHAV, V15, P185, DOI 10.1016/S0747-5632(99)00017-5; Scott D. J., 2012, P WORLD C E LEARN CO, P1912; Scott D. J., 2009, ADV ELECT BUSINESS S, V4, P201; Short J., 1976, SOCIAL PSYCHOL TELEC; SPROULL L, 1986, MANAGE SCI, V32, P1492, DOI 10.1287/mnsc.32.11.1492; Sugimura K., 2005, JAPANESE ED TECHNOLO, V29, P93; Swan K, 2002, ED COMMUNICATION INF, V2, P23, DOI DOI 10.1080/1463631022000005016; Swan K., 2003, LEARNING TEACHING TE, P147; WALTHER JB, 1992, COMMUN RES, V19, P52, DOI 10.1177/009365092019001003; Walther JB, 1996, COMMUN RES, V23, P3, DOI 10.1177/009365096023001001; Walther J. B., 1995, Journal of Organizational Computing, V5	56	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0747-5632	1873-7692		COMPUT HUM BEHAV	Comput. Hum. Behav.	MAR	2015	44						209	219		10.1016/j.chb.2014.11.047		11	Psychology, Multidisciplinary; Psychology, Experimental	Psychology	CA5RH	WOS:000348965000023		
J	Grassi, W; Okano, T; Filippucci, E				Grassi, Walter; Okano, Tadashi; Filippucci, Emilio			Use of ultrasound for diagnosis and monitoring of outcomes in crystal arthropathies	CURRENT OPINION IN RHEUMATOLOGY			English	Review						calcium pyrophosphate dihydrate crystal deposition disease; crystal arthropathies; gout; ultrasound	PYROPHOSPHATE DEPOSITION DISEASE; ASYMPTOMATIC HYPERURICEMIA; SONOGRAPHIC ASSESSMENT; HYALINE CARTILAGE; GOUTY-ARTHRITIS; ULTRASONOGRAPHY; CHONDROCALCINOSIS; KNEE; INVOLVEMENT; IMPACT	Purpose of review In the latest recommendations for the diagnosis and management of gout and calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, the diagnostic potential of ultrasound has been recognized. This review highlights the recent advances of research on ultrasound in gout and CPPD crystal deposition disease. Recent findings Ultrasound allows highly sensitive, noninvasive and quick detection of microcrystal aggregates in multiple anatomic areas. Ultrasound can be used as a safe and reliable guide to aspirate even minimal fluid collections suitable for microscopic analysis, and as a tool for monitoring monosodium urate crystal dissolution induced by urate-lowering therapy. The first metatarsophalangeal joint and the knee should be regarded as the anatomic regions with the highest probability of being respectively positive for monosodium urate and CPPD crystal aggregates. Summary The detection of highly evocative signs in patients with equivocal clinical findings may have a deep impact on the clinical decision-making process, narrowing the differential diagnostic spectrum and avoiding time-consuming and expensive diagnostic procedures. Ultrasound differential diagnosis between gout and CPPD crystal deposition disease is based on the characteristics of crystal aggregates and their preferential localization in different anatomical areas.	[Grassi, Walter; Okano, Tadashi; Filippucci, Emilio] Univ Politecn Marche, Osped C Urbani, Clin Reumatol, I-60035 Ancona, Italy; [Okano, Tadashi] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan	Grassi, W (reprint author), Univ Politecn Marche, Osped C Urbani, Clin Reumatol, Via Colli 52, I-60035 Ancona, Italy.	walter.grassi@univpm.it			Department of Rheumatology, 'Carlo Urbani' Hospital, Jesi, Ancona, Italy	This work was supported by the Department of Rheumatology, 'Carlo Urbani' Hospital, Jesi, Ancona, Italy.	Dalbeth N, 2014, ANN RHEUM DIS, V73, P1598, DOI 10.1136/annrheumdis-2014-205304; Delle Sedie A, 2007, CLIN EXP RHEUMATOL, V25, P513; Peiteado D, 2012, CLIN EXP RHEUMATOL, V30, P830; Thiele RG, 2010, RHEUMATOL INT, V30, P495, DOI 10.1007/s00296-009-1002-8; Filippucci E, 2011, CLIN EXP RHEUMATOL, V29, P901; Carter JD, 2009, RHEUMATOLOGY, V48, P1442, DOI 10.1093/rheumatology/kep278; Perez-Ruiz F, 2007, J RHEUMATOL, V34, P1888; Zhang W, 2011, ANN RHEUM DIS, V70, P563, DOI 10.1136/ard.2010.139105; Filippucci E, 2009, OSTEOARTHR CARTILAGE, V17, P178, DOI 10.1016/j.joca.2008.06.003; Rettenbacher T, 2008, EUR RADIOL, V18, P621, DOI 10.1007/s00330-007-0802-z; Wright SA, 2007, ANN RHEUM DIS, V66, P859, DOI 10.1136/ard.2006.062802; Sconfienza LM, 2010, CLIN EXP RHEUMATOL, V28, P144; Thiele RG, 2007, RHEUMATOLOGY, V46, P1116, DOI 10.1093/rheumatology/kem058; Ottaviani S, 2012, CLIN EXP RHEUMATOL, V30, P499; Gutierrez M, 2013, ARTHRIT CARE RES, V65, P1265, DOI 10.1002/acr.22009; De Miguel E, 2012, ANN RHEUM DIS, V71, P157, DOI 10.1136/ard.2011.154997; Grassi W, 2006, SEMIN ARTHRITIS RHEU, V36, P197, DOI 10.1016/j.semarthrit.2006.08.001; Filippucci E, 2010, CLIN EXP RHEUMATOL, V28, P2; Puig JG, 2008, NUCLEOS NUCLEOT NUCL, V27, P592, DOI 10.1080/15257770802136040; Huppertz A, 2014, RHEUMATOL INT, V34, P763, DOI 10.1007/s00296-014-2979-1; Howard RG, 2011, ARTHRIT CARE RES, V63, P1456, DOI 10.1002/acr.20527; Girish G, 2013, AM J ROENTGENOL, V201, P515, DOI 10.2214/AJR.13.10776; Barskova VG, 2013, RHEUMATOLOGY, V52, P1090, DOI 10.1093/rheumatology/kes433; Chowalloor PV, 2013, ANN RHEUM DIS, V72, P638, DOI 10.1136/annrheumdis-2012-202301; de vila Fernandes E, 2011, SKELETAL RADIOL, V40, P309; Di Geso L, 2011, JCR-J CLIN RHEUMATOL, V17, P344, DOI 10.1097/RHU.0b013e31822e0d36; Ellabban AS, 2012, RHEUMATOL INT, V32, P3863, DOI 10.1007/s00296-011-2320-1; Ellabban AS, 2012, CLIN RHEUMATOL, V31, P697, DOI 10.1007/s10067-011-1911-2; Filippou G, 2013, ANN RHEUM DIS, V72, P1836, DOI 10.1136/annrheumdis-2012-202748; Filippou G, 2012, ANN RHEUM DIS, V71, P1426, DOI 10.1136/annrheumdis-2011-201001; Filippou G, 2007, ANN RHEUM DIS, V66, P1126, DOI 10.1136/ard.2007.069344; Filippucci E, 2014, CLIN EXP RHEUMATOL, V32, pS42; Filippucci E, 2013, CLIN EXP RHEUMATOL, V31, P659; Filippucci E, 2012, RHEUMATOLOGY, V51, P18, DOI 10.1093/rheumatology/kes332; Frediani B, 2005, ANN RHEUM DIS, V64, P638, DOI 10.1136/ard.2004.024109; Gruber M, 2014, RHEUMATOLOGY, V53, P173, DOI 10.1093/rheumatology/ket341; Gutierrez M, 2010, J RHEUMATOL, V37, P2602, DOI 10.3899/jrheum.100653; Gutierrez M, 2014, ARTHRIT CARE RES, V66, P69, DOI 10.1002/acr.22190; Kang MH, 2014, J CLIN ULTRASOUND, DOI [10.1002/jcu.22206, DOI 10.1002/JCU.22206]; Lamers-Karnebeek FBG, 2014, CLIN RHEUMATOL, V33, P555, DOI 10.1007/s10067-014-2505-6; Naredo E, 2014, ANN RHEUM DIS, V73, P1522, DOI 10.1136/annrheumdis-2013-203487; Peiteado D, 2010, ANN RHEUM DIS     S3, V69, P713; Pineda C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3223; Roddy E, 2013, JOINT BONE SPINE, V80, P295, DOI 10.1016/j.jbspin.2012.09.017; Schueller-Weidekamm C, 2007, EUR J RADIOL, V62, P437, DOI 10.1016/j.ejrad.2006.12.005; Sivera F, 2014, ANN RHEUM DIS, V73, P328, DOI 10.1136/annrheumdis-2013-203325; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095743	47	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-8711	1531-6963		CURR OPIN RHEUMATOL	Curr. Opin. Rheumatol.	MAR	2015	27	2					147	155		10.1097/BOR.0000000000000142		9	Rheumatology	Rheumatology	CA6FW	WOS:000349006600009		
J	Shiramoto, M; Eto, T; Irie, S; Fukuzaki, A; Teichert, L; Tillner, J; Takahashi, Y; Koyama, M; Dahmen, R; Heise, T; Becker, RHA				Shiramoto, M.; Eto, T.; Irie, S.; Fukuzaki, A.; Teichert, L.; Tillner, J.; Takahashi, Y.; Koyama, M.; Dahmen, R.; Heise, T.; Becker, R. H. A.			Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes	DIABETES OBESITY & METABOLISM			English	Article						insulin analogues; pharmacodynamics; pharmacokinetics; type 1 diabetes	GLUCOSE CONTROL; 100 UNITS/ML; HYPOGLYCEMIA; FORMULATION; PROFILE; BASAL; FLAT	Aims: Two single-dose studies were conducted in Japan and Europe to compare the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of new insulin glargine 300 U/ml (Gla-300) and insulin glargine 100 U/ml (Gla-100) in people with type 1 diabetes mellitus. Methods: In two double-blind, randomized, crossover studies, 18 Japanese participants (aged 20-65 years) and 24 European participants (aged 18-65 years) with glycated haemoglobin levels <= 9.0% (<= 75 mmol/mol) received single subcutaneous doses of Gla-300, 0.4, 0.6 and 0.9 U/kg (0.9 U/kg in the European study only), and Gla-100, 0.4 U/kg. A 36-h euglycaemic clamp procedure was performed after each dosing. Results: The serum insulin glargine concentration (INS) and glucose infusion rate (GIR) developed more gradually into more constant and prolonged profiles with Gla-300 than with Gla-100. In support of this, the times to 50% of glargine exposure and insulin activity were longer for all Gla-300 doses than for Gla-100 during the 36-h clamp period, indicating a more evenly distributed exposure and metabolic effect beyond 24 h. Exposure to insulin glargine and glucose utilization were lower with the 0.4 and 0.6 U/ml Gla-300 doses in both studies compared with the 0.4 U/ml Gla-100 dose. Glucose-lowering activity was detected for up to 36 h with all doses of Gla-300. Conclusions: Single-dose injections of Gla-300 present more constant and prolonged PK and PD profiles compared with Gla-100, maintaining blood glucose control for up to 36 h in euglycaemic clamp settings in Japanese and European participants with type 1 diabetes.	[Shiramoto, M.; Eto, T.; Irie, S.] LTA Clin Pharmacol Ctr, Hakata Clin, Fukuoka, Japan; [Fukuzaki, A.; Takahashi, Y.; Koyama, M.] Sanofi, Tokyo, Japan; [Teichert, L.; Tillner, J.; Dahmen, R.; Becker, R. H. A.] Sanofi Aventis Deutschland GmbH, D-65926 Frankfurt, Germany; [Heise, T.] Profil, Neuss, Germany	Becker, RHA (reprint author), Sanofi Aventis Deutschland GmbH, Bldg H831,Room C 0550, D-65926 Frankfurt, Germany.	reinhard.becker@sanofi.com			Sanofi	This study was funded by Sanofi. Medical writing and editorial assistance was provided by Victoria Panagakis at Fishawack Communications Ltd, and this service was supported by Sanofi. The data were previously published in abstract form at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), 23-27 September 2013, Barcelona, Spain.	Steinstraesser A, 2014, DIABETES OBES METAB, V16, P873, DOI 10.1111/dom.12283; Cochran E, 2005, DIABETES CARE, V28, P1240, DOI 10.2337/diacare.28.5.1240; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Bolli GB, 2014, DIABETES, V63, pA19; Home PD, 2014, DIABETES S1A, V63, pLB19; Jax T, 2013, DIABETOLOGIA, V56, pS414; Matsuhisa M, 2014, DIABETES S1A, V63, pLB22; Pieber TR, 2000, DIABETES CARE, V23, P157, DOI 10.2337/diacare.23.2.157; Riddle MC, 2014, DIABETES CARE, V37, P2755, DOI 10.2337/dc14-0991; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Terauchi Y, 2014, DIABETES S1A, V63, pLB24; The Expert Committee On The Diagnosis And Classification Of Diabetes Mellitus, 1998, DIABETES CARE, V21, ps9; Tillner JA, 2013, DIABETOLOGIA, V56, pS415; Yamamoto-Honda R, 2007, INTERNAL MED, V46, P937, DOI 10.2169/internalmedicine.46.6467; Yki-Jarvinen H, 2014, DIABETES CARE, V37, P3235, DOI 10.2337/dc14-0990	15	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	MAR	2015	17	3					254	260		10.1111/dom.12415		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CB1PE	WOS:000349399200005		
J	Kashiwagi, A; Kazuta, K; Goto, K; Yoshida, S; Ueyama, E; Utsuno, A				Kashiwagi, A.; Kazuta, K.; Goto, K.; Yoshida, S.; Ueyama, E.; Utsuno, A.			Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study	DIABETES OBESITY & METABOLISM			English	Article						ipragliflozin; Japanese; metformin; randomized controlled trial; SGLT2; type 2 diabetes	GLUCOSE COTRANSPORTER 2; HEALTHY-SUBJECTS; GLYCEMIC CONTROL; INHIBITOR; MELLITUS; ASP1941; TRIAL	This multicenter, double-blind, placebo-controlled study examined the efficacy and safety of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, in combination with metformin in Japanese patients with type 2 diabetes mellitus (T2DM). Patients were randomized in a 2 : 1 ratio to 50 mg ipragliflozin (n= 112) or placebo (n= 56) once daily for 24 weeks, followed by a 28-week open-label extension in which all patients received 50 or 100 mg ipragliflozin, while continuing metformin. The primary outcome was the change in glycated haemoglobin (HbA1c) from baseline to week 24. HbA1c decreased significantly in the ipragliflozin group (-0.87%; adjusted mean difference from placebo: -1.30%; p< 0.001). The overall incidence of treatment-emergent adverse events was similar in both groups, although pollakiuria and constipation were more common in the ipragliflozin group; thus, ipragliflozin significantly improved glycaemic control and reduced body weight without major safety issues in Japanese patients with T2DM.	[Kashiwagi, A.] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Kazuta, K.; Goto, K.; Yoshida, S.; Ueyama, E.; Utsuno, A.] Astellas Pharma Inc Japan, Tokyo 1038411, Japan	Ueyama, E (reprint author), Astellas Pharma Inc Japan, Chuo Ku, 2-5-1 Nihonbashi Honcho, Tokyo 1038411, Japan.	eiji.ueyama@astellas.com			Astellas Pharma Inc., Japan; Astellas	This study was sponsored by Astellas Pharma Inc., Japan. Medical writing and editorial support was funded by Astellas and provided by Dr Nicholas D. Smith and ELMCOM (TM).	Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Schwartz SL, 2011, DIABETES TECHNOL THE, V13, P1219, DOI 10.1089/dia.2011.0012; Tahara A, 2012, N-S ARCH PHARMACOL, V385, P423, DOI 10.1007/s00210-011-0713-z; Smulders RA, 2012, DIABETES OBES METAB, V14, P937, DOI 10.1111/j.1463-1326.2012.01624.x; Veltkamp SA, 2011, CLIN DRUG INVEST, V31, P839, DOI 10.2165/11594330-000000000-00000; Kashiwagi A, 2014, J DIABETES INVEST, V5, P382, DOI 10.1111/jdi.12156; Kashiwagi A, 2015, DIABETOL INT, V6, P8, DOI 10.1007/s13340-014-0164-0; Veltkamp SA, 2012, CLIN THER, V34, P1761, DOI 10.1016/j.clinthera.2012.06.027; Wilding JP, 2012, DIABETES OBES METAB, V15, P403	10	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	MAR	2015	17	3					304	308		10.1111/dom.12331		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CB1PE	WOS:000349399200011		
J	Yokoyama, Y; Hiromoto, Y; Takagi, K; Ishii, K; Delbaere, S; Watanobe, Y; Ubukata, T				Yokoyama, Yasushi; Hiromoto, Yuma; Takagi, Kazuya; Ishii, Katsuhiro; Delbaere, Stephanie; Watanobe, Yuta; Ubukata, Takashi			Solubility control of organic acid-base salts by photochromism	DYES AND PIGMENTS			English	Article						Photochromism; Bisthienylethene; Oxalic acid; Phenanthroline; Organic salts; Solubility control	DYNAMIC LIGHT-SCATTERING; DIARYLETHENE DERIVATIVES; PKA VALUES; HUMAN SKIN; SPECTROSCOPY; COMPLEXES; DIFFUSION; SWITCHES; CHEMISTRY; MEMORIES	The open form of a bisthienylethene with two phenanthroline groups at both ends of the molecule formed, upon the addition of oxalic acid, a sudden precipitation in solution. UV irradiation to the suspension induced dissolution of the precipitate together with the coloration of the solution. The chemical structure of the precipitate was investigated by low-coherence DLS, DOSY, SEM, powder XRD, and DFT calculations. Light of any wavelength is scattered when the bisthienylethene takes the open form structure while light with wavelengths longer than 800 nm is transparent for the closed form. We have, therefore, succeeded in constructing a photon-working aggregation-dissolution system which works as an optical shutter of the near-IR light as well as the prototype for the photon-working regulator of material concentration in solution. (C) 2014 Elsevier Ltd. All rights reserved.	[Yokoyama, Yasushi; Hiromoto, Yuma; Takagi, Kazuya; Watanobe, Yuta; Ubukata, Takashi] Yokohama Natl Univ, Grad Sch Engn, Dept Adv Mat Chem, Yokohama, Kanagawa 2408501, Japan; [Ishii, Katsuhiro] Grad Sch Creat New Photon Ind, Opt Informat Proc & Syst Engn Course, Nishi Ku, Hamamatsu, Shizuoka 4311202, Japan; [Delbaere, Stephanie] Univ Lille Nord France, Fac Sci Pharmaceut & Biol, F-59006 Lille, France	Yokoyama, Y (reprint author), Yokohama Natl Univ, Grad Sch Engn, Dept Adv Mat Chem, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	yyokoyam@ynu.ac.jp			JSPS, Japan [23655123]; MEXT, Japan [26107009]	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (No. 23655123) from JSPS, Japan, and a Grant-in-Aid for Scientific Research on Innovative Areas "Photosynergetics" (No. 26107009) from MEXT, Japan. The use of analytical devices (NMR, MS, SEM, and Powder XRD) of Instrument Analysis Center, Yokohama National University is gratefully acknowledged.	Oliveira S, 2012, MOL IMAGING, V11, P33, DOI 10.2310/7290.2011.00025; MACCARTHY P, 1978, ANAL CHEM, V50, P2165, DOI 10.1021/ac50036a059; Morinaka K, 2009, ORG LETT, V11, P3890, DOI 10.1021/ol901497t; Pregosin PS, 2005, CHEM REV, V105, P2977, DOI 10.1021/cr0406716; YOKOYAMA Y, 1994, B CHEM SOC JPN, V67, P3297, DOI 10.1246/bcsj.67.3297; Attas EM, 2002, BIOPOLYMERS, V67, P96, DOI 10.1002/bip.10056; Tian H, 2004, CHEM SOC REV, V33, P85, DOI 10.1039/b302356g; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; GUTHRIE JP, 1978, CAN J CHEM, V56, P2342, DOI 10.1139/v78-385; Myles AJ, 2002, ADV FUNCT MATER, V12, P167, DOI 10.1002/1616-3028(200203)12:3<167::AID-ADFM167>3.0.CO;2-M; Timmerman P, 2000, J CHEM SOC PERK T 2, P2077, DOI 10.1039/b003968n; Ogawa H, 2012, CHEM COMMUN, V48, P11838, DOI 10.1039/c2cc35793c; Hirose T, 2006, J ORG CHEM, V71, P7499, DOI 10.1021/jo060505t; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Pons M, 2001, PROG NUCL MAG RES SP, V38, P267, DOI 10.1016/S0079-6565(00)00029-7; Yokoyama Y, 2000, CHEM REV, V100, P1717, DOI 10.1021/cr980070c; Gniadecka M, 1998, J INVEST DERMATOL, V110, P393, DOI 10.1046/j.1523-1747.1998.00146.x; Hirose T, 2008, ADV MATER, V20, P2137, DOI 10.1002/adma.200702314; Zhang JJ, 2013, ADV MATER, V25, P378, DOI 10.1002/adma.201201521; Jia ZJ, 2001, ELECTROPHORESIS, V22, P1112, DOI 10.1002/1522-2683()22:6<1112::AID-ELPS1112>3.3.CO;2-T; Brown HC, 1955, DETERMINATION ORG, V1, P567; Cowan JA, 2007, ACTA CRYSTALLOGR E, V63, po1240, DOI 10.1107/S1600536807005156; Durr H., 2003, PHOTOCHROMISM MOL SY; GELB RI, 1971, ANAL CHEM, V43, P1110, DOI 10.1021/ac60303a028; Ishi K, 2008, JPN J APPL PHYS, V47, P8397, DOI 10.1143/JJAP.47.8397; Ishii K, 2005, OPT LETT, V30, P555, DOI 10.1364/OL.30.000555; Lee CH, 2013, PLOS ONE, V8, DOI e75360-1-e75360-10; Liu HH, 2012, J PHYS CHEM A, V116, P9900, DOI 10.1021/jp3070163; Loening NM, 2001, J MAGN RESON, V153, P103, DOI 10.1006/jmre.2001.2423; Olenik B, 2003, CRYST GROWTH DES, V3, P183, DOI 10.1021/cg034003; Pastor A, 2008, COORDIN CHEM REV, V252, P2314, DOI 10.1016/j.ccr.2008.01.025; Patra A, 2012, CHEM COMMUN, V48, P2489, DOI 10.1039/c1cc14561d; Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x; Kobatake S, 2007, CHEM COMMUN, P1698, DOI 10.1039/b700177k; Uehara S, 2012, DYES PIGMENTS, V92, P861, DOI 10.1016/j.dyepig.2011.04.003; Wunsch A, 2014, PHOTOMED LASER SURG, V32, P93, DOI 10.1089/pho.2013.3616; Xia H, 2005, JPN J APPL PHYS 1, V44, P6261, DOI 10.1143/JJAP.44.6261; YOKOYAMA Y, 1991, J CHEM SOC CHEM COMM, P1722, DOI 10.1039/c39910001722; Yumoto K, 2008, ORG LETT, V10, P2051, DOI 10.1021/ol8005216; Zhang J, 2003, J MOL STRUCT, V660, P119, DOI 10.1016/j.molstruc.2003.08.025; Zheng Wen-Ni, 2012, Acta Crystallogr Sect E Struct Rep Online, V68, po1625, DOI 10.1107/S1600536812019137	41	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-7208	1873-3743		DYES PIGMENTS	Dyes Pigment.	MAR	2015	114						1	7		10.1016/j.dyepig.2014.10.015		7	Chemistry, Applied; Engineering, Chemical; Materials Science, Textiles	Chemistry; Engineering; Materials Science	CA5MV	WOS:000348953400001		
J	Seno, R; Kobatake, S				Seno, Ryuta; Kobatake, Seiya			Synthesis and characterization of amphiphilic silica nanoparticles covered by block copolymers branching photochromic diarylethene moieties on side chain	DYES AND PIGMENTS			English	Article						Silica nanoparticle; RAFT polymerization; Photochromism; Diarylethene; Sedimentation; Organic/inorganic hybrid	TRANSFER RADICAL POLYMERIZATION; GRAFT-POLYMERIZATION; SOLAR-CELLS; BRUSHES; SURFACE	Silica nanoparticles covered with polystyrene branching diarylethene moieties to the side chains are synthesized by reversible addition-fragmentation chain transfer polymerization on silica nanoparticles. The resulting nanoparticles are soluble in toluene and tetrahydrofuran and show reversible photo-isomerization upon alternating irradiation with ultraviolet and visible light. The photoreversible isomerization follows color change, which is called photochromism. During the photochromic reactions, the nanoparticles are dispersed in solutions such as tetrahydrofuran. The modification by further block copolymerization of N-isopropylacrylamide results in fabrication of photochromic silica nanoparticles soluble in both tetrahydrofuran and water. (C) 2014 Elsevier Ltd. All rights reserved.	[Seno, Ryuta; Kobatake, Seiya] Osaka City Univ, Grad Sch Engn, Dept Appl Chem, Sumiyoshi Ku, Osaka 5588585, Japan	Kobatake, S (reprint author), Osaka City Univ, Grad Sch Engn, Dept Appl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	kobatake@a-chem.eng.osaka-cu.ac.jp	Kobatake, Seiya/P-4989-2015	Kobatake, Seiya/0000-0002-1526-4629	Japan Society for the Promotion of Science (JSPS) [24550161]; MEXT, Japan [26107013]	This work was partly supported by a Grant-in-Aid for Scientific Research (C) (No. 24550161) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Scientific Research on Innovative Areas "Photosynergetics" (No. 26107013) from MEXT, Japan. The authors also thank Nippon Zeon Co., Ltd. for providing octafluorocyclopentene.	STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Jung HY, 2013, CHEM COMMUN, V49, P7528, DOI 10.1039/c3cc42852d; Ejaz M, 1998, MACROMOLECULES, V31, P5934, DOI 10.1021/ma980240n; Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5; Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k; Plass R, 2002, J PHYS CHEM B, V106, P7578, DOI 10.1021/jp0204531; Myles AJ, 2002, ADV FUNCT MATER, V12, P167, DOI 10.1002/1616-3028(200203)12:3<167::AID-ADFM167>3.0.CO;2-M; Ohno K, 2005, MACROMOLECULES, V38, P2137, DOI 10.1021/ma048011q; Pardo R, 2011, CHEM SOC REV, V40, P672, DOI 10.1039/c0cs00065e; Nagase K, 2012, ACS APPL MATER INTER, V4, P1998, DOI 10.1021/am201832b; Folling J, 2008, SMALL, V4, P134, DOI 10.1002/smll.200700440; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Tsujii Y, 2001, MACROMOLECULES, V34, P8872, DOI 10.1021/ma010733j; Pedone A, 2011, CHEM MATER, V23, P5016, DOI 10.1021/cm202436b; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Li CZ, 2005, MACROMOLECULES, V38, P5929, DOI 10.1021/ma050216r; Bae SW, 2012, CHEM COMMUN, V48, P2270, DOI 10.1039/c2cc16306c; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Zhao XJ, 2004, ADV MATER, V16, P173, DOI 10.1002/adma.200305622; Brown G. H., 1971, PHOTOCHROMISM; Durr H., 2003, PHOTOCHROMISM MOL SY; Farmer SC, 2002, J POLYM SCI POL CHEM, V40, P555, DOI 10.1002/pola.10143; Kobatake S, 2004, B CHEM SOC JPN, V77, P195, DOI 10.1246/bcsj.77.195; Kobatake S, 2006, CHEM LETT, V35, P628, DOI 10.1246/cl.2006.628; MINKO S., 2008, POLYM SURFACES INTER, P215, DOI 10.1007/978-3-540-73865-7_11; Tian H, 2007, CHEM COMMUN, P781, DOI 10.1039/b610004j; Tran HN, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/4/043001	27	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-7208	1873-3743		DYES PIGMENTS	Dyes Pigment.	MAR	2015	114						166	174		10.1016/j.dyepig.2014.11.010		9	Chemistry, Applied; Engineering, Chemical; Materials Science, Textiles	Chemistry; Engineering; Materials Science	CA5MV	WOS:000348953400023		
J	Nakajima, H; Hara, K; Yamamoto, Y; Itoh, K				Nakajima, Hiromitsu; Hara, Kojiro; Yamamoto, Yoshikazu; Itoh, Kiminori			Effects of Cu on the content of chlorophylls and secondary metabolites in the Cu-hyperaccumulator lichen Stereocaulon japonicum	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						Heavy metal pollution; Copper stress; Photobiont algae; Carbohydrates; UV-vis absorption spectroscopy	MOSS SCOPELOPHILA-CATARACTAE; CLADONIA-HUMILIS; POLLUTED SITES; HEAVY-METALS; COPPER; DEGRADATION; PIGMENTS; STRESS; MITIS; JAPAN	Understanding the relationship between Cu and Cu-hyperaccumulator lichens is important for their application in monitoring and assessing heavy metal pollution. We investigated the Cu-hyperaccumulator lichen Stereocaulon japonicum at several Cu-polluted and control sites in Japan, and found the lichen to be widely distributed. Its concentrations of Cu, chlorophylls, and secondary metabolites, chlorophyll-related indices, and absorption spectra were measured, and we observed negative effects of Cu on these concentrations and indices. For highly Cu-polluted samples ( > 100 ppm dry weight), however, we found significant linear correlations between Cu and chlorophyll concentrations. This can be considered as the response of the photobiont in S. japonicum to Cu stress. In highly Cu-polluted samples the chlorophyll-related indices and concentration of total secondary metabolites were almost constant regardless of Cu concentration. This suggests that the increase in chlorophyll concentration with the increase in Cu concentration enhances photosynthetic productivity per unit biomass, which will allow the production of extra structure and energy for maintaining the chlorophyll-related indices under Cu stress. The relationship between the increase in chlorophyll concentration of S. japonicum and the decrease in secondary metabolite concentration of the lichen can be explained by considering the balance of carbohydrates in the lichen. We found that a spectral index A(372) - A(394) can be a useful index of the concentrations of Cu and total secondary metabolites in S. japonicum. These findings show the adjustment of the content of chlorophylls and secondary metabolites in S. japonicum to Cu stress, and provide a better understanding of the relationship between Cu and the Cu-hyperaccumulator lichen. (C) 2014 Elsevier Inc. All rights reserved.	[Nakajima, Hiromitsu; Itoh, Kiminori] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Hara, Kojiro; Yamamoto, Yoshikazu] Akita Prefectural Univ, Grad Sch Bioresource Sci, Shimoshinjyo Nakano, Akita 0100195, Japan	Nakajima, H (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Tokiwadai 79-7, Yokohama, Kanagawa 2408501, Japan.	h-nakaji@ynu.ac.jp		Itoh, Kiminori/0000-0003-3619-8824	JSPS KAKENHI Grant [26340045]	We thank Hieizan Enryakuji Temple for permission to collect samples. This study was partly supported by JSPS KAKENHI Grant Number 26340045.	Adlassnig W., 2012, BIOGEOINTERACTIONS M, V31, P201; NIEBOER E, 1980, ENVIRON POLLUT B, V1, P3, DOI 10.1016/0143-148X(80)90017-8; RONEN R, 1984, ENVIRON EXP BOT, V24, P239, DOI 10.1016/0098-8472(84)90004-2; Molnar K, 2010, Z NATURFORSCH C, V65, P157; Nakajima H, 2012, ECOTOX ENVIRON SAFE, V84, P341, DOI 10.1016/j.ecoenv.2012.08.009; Piovar J, 2011, PLANT GROWTH REGUL, V63, P81, DOI 10.1007/s10725-010-9515-4; PURVIS OW, 1987, LICHENOLOGIST, V19, P193, DOI 10.1017/S0024282987000161; Nakajima H, 2013, ECOTOX ENVIRON SAFE, V97, P154, DOI 10.1016/j.ecoenv.2013.07.026; Yoshimura Isao, 2002, P3; Backor M, 2011, CHEMOSPHERE, V85, P106, DOI 10.1016/j.chemosphere.2011.05.035; Aptroot A., 1999, TROPICAL BRYOLOGY, V17, P57; Backor M, 2009, CHEMOSPHERE, V76, P1340, DOI 10.1016/j.chemosphere.2009.06.029; Backor M, 2004, ENVIRON EXP BOT, V52, P149, DOI 10.1016/j.envexpbot.2004.01.014; Boonpragob K, 2002, NATO SCI S SS IV EAR, V7, P323; Chettri MK, 1998, ENVIRON EXP BOT, V39, P1, DOI 10.1016/S0098-8472(97)00024-5; Dobson F.S., 2005, LICHENS; Garty J, 2001, CRIT REV PLANT SCI, V20, P309, DOI 10.1016/S0735-2689(01)80040-X; Huang MR, 2010, ACTA OECOL, V36, P173, DOI 10.1016/j.actao.2009.11.007; Huneck S., 1996, IDENTIFICATION LICHE; Nakajima H, 2011, J PHOTOCH PHOTOBIO B, V104, P467, DOI 10.1016/j.jphotobiol.2011.06.001; Nakajima H, 2010, CHEM LETT, V39, P284, DOI 10.1246/cl.2010.284; Nash III T.H., 1989, HEAVY METAL TOLERANC, P119; Pawlik-Skowronska B, 2011, ENVIRON EXP BOT, V72, P64, DOI 10.1016/j.envexpbot.2010.07.002; PURVIS O. W., 1996, LICHENOLOGIST, V28, P571; Purvis O. W., 2010, Ecology of industrial pollution, P41; PURVIS OW, 1985, LICHENOLOGIST, V17, P221, DOI 10.1017/S0024282985000299; Purvis O.W., 2000, LICHENS; Rajakaruna N, 2011, RHODORA, V113, P1, DOI 10.3119/10-03.1; Smith P.L., 2013, INDICATOR PLANTS USI, P58; Wellborn A.R., 1994, J PLANT PHYSL, V8, P307; Yamamoto Y., 2002, BIBL LICHENOL, V82, P251; Yoshimura I., 1974, LICHEN FLORA JAPAN C	32	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	MAR	2015	113						477	482		10.1016/j.ecoenv.2014.12.038		6	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CA5RV	WOS:000348966400057		
J	Ametani, A; Carpinelli, G; Shahidehpour, M				Ametani, Aki; Carpinelli, Guido; Shahidehpour, Mohammad			Guest Editorial Introduction to the Special Issue on "Smart Grids: World's Actual Implementations"	ELECTRIC POWER SYSTEMS RESEARCH			English	Editorial Material									[Ametani, Aki] Doshisha Univ, Kyoto 602, Japan; [Carpinelli, Guido] Univ Naples Federico II, Naples, Italy; [Shahidehpour, Mohammad] IIT, Chicago, IL 60616 USA	Ametani, A (reprint author), Doshisha Univ, Kyoto 602, Japan.			Carpinelli, Guido/0000-0002-6235-3616				0	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0378-7796	1873-2046		ELECTR POW SYST RES	Electr. Power Syst. Res.	MAR	2015	120				SI		1	1		10.1016/j.epsr.2014.12.011		1	Engineering, Electrical & Electronic	Engineering	CA4PA	WOS:000348885700001		
J	Ota, Y; Taniguchi, H; Baba, J; Yokoyama, A				Ota, Yutaka; Taniguchi, Haruhito; Baba, Jumpei; Yokoyama, Akihiko			Implementation of autonomous distributed V2G to electric vehicle and DC charging system	ELECTRIC POWER SYSTEMS RESEARCH			English	Article						Electric vehicle; Vehicle-to-Grid; Scheduled charging; DC charging system; Fast demand response; Battery management		Vehicle-to-Grid (V2G) has potential for providing the distributed spinning reserve to the power system. We proposed an autonomous V2G control scheme managing the vehicle user's convenience, the battery condition during the idle time, and the contribution to the power system, simultaneously. V2G power is controlled corresponding to the frequency deviation detected at the plug-in terminal and the desirable battery State-of-Charge for the plug-out. In this paper, the proposed control scheme is implemented to an electric vehicle and charging system. Performances of the interface, communication and control structure, and system efficiency and time response are verified by using the test system coordinating an electric vehicle battery test bed with a DC charging port, a controllable bi-directional power conditioner, and an integrated interface controller. (C) 2014 The Authors. Published by Elsevier B.V.	[Ota, Yutaka; Taniguchi, Haruhito; Baba, Jumpei; Yokoyama, Akihiko] Univ Tokyo, Tokyo 1138654, Japan	Ota, Y (reprint author), Eng Bldg 13-204,7-3-1,Bunkyo Ku, Tokyo 1138656, Japan.	yota@upn.t.u-tokyo.ac.jp			CREST from Japan Science and Technology Agency; Ubiquitous Power Network Endowed Chair of the University of Tokyo	This work was supported by CREST from Japan Science and Technology Agency, and Ubiquitous Power Network Endowed Chair of the University of Tokyo. Mitsubishi Motors Corporation supplied an EV battery test-bed. Nichikon Corporation manufactured an order made power conditioner for the V2G. CHAdeMO association instructed about the CHAdeMO protocol. Authors gratefully acknowledge their support.	Anderson P. B., 2012, P 2012 3 IEEE PES IN, P1; Brooks A, 2010, IEEE POWER ENERGY M, V8, P20, DOI 10.1109/MPE.2010.936349; [Anonymous], 2013, NEXT GENERATION EV C; [Anonymous], 2012, V2G INTERFACT SPECIF; Lopes JAP, 2011, P IEEE, V99, P168, DOI 10.1109/JPROC.2010.2066250; Shimada K, 2011, PANCREAS, V40, P464, DOI 10.1097/MPA.0b013e31820b5d37; Ota Y, 2012, IEEE T SMART GRID, V3, P559, DOI 10.1109/TSG.2011.2167993; Sortomme E, 2012, IEEE T SMART GRID, V3, P70, DOI 10.1109/TSG.2011.2170099; Galus MD, 2011, IEEE T IND ELECTRON, V58, P4568, DOI 10.1109/TIE.2011.2107715; Ferreira R. J., 2011, P IEEE PES INN SMART, P1; Ikegami T., 2012, P IEEE INT EL VEH C, P1; Kempton W., 2009, TEST VEHICLE TO GRID; Markel T., 2012, P IEEE INT EL VEH C, P1; Nakano K., 2002, P POW SYST COMP C, P1; Sekyung Han, 2011, IEEE Transactions on Smart Grid, V2, DOI 10.1109/TSG.2011.2160299; Tang L., 2012, P IEEE EL VEH C MAR, P1	16	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0378-7796	1873-2046		ELECTR POW SYST RES	Electr. Power Syst. Res.	MAR	2015	120				SI		177	183		10.1016/j.epsr.2014.05.016		7	Engineering, Electrical & Electronic	Engineering	CA4PA	WOS:000348885700018		
J	Liu, P; Yin, LN; Wang, SW; Zhang, MJ; Deng, XP; Zhang, SQ; Tanaka, K				Liu, Peng; Yin, Lina; Wang, Shiwen; Zhang, Meijuan; Deng, Xiping; Zhang, Suiqi; Tanaka, Kiyoshi			Enhanced root hydraulic conductance by aquaporin regulation accounts for silicon alleviated salt-induced osmotic stress in Sorghum bicolor L	ENVIRONMENTAL AND EXPERIMENTAL BOTANY			English	Article						Aquaporin; H2O2; Root hydraulic conductance; Salt stress; Silicon	HORDEUM-VULGARE L.; WATER CHANNELS AQUAPORINS; PLASMA-MEMBRANE; STOMATAL CONDUCTANCE; SALINITY TOLERANCE; HYDROGEN-PEROXIDE; PIP AQUAPORINS; PLANT-GROWTH; ANTIOXIDANT; TRANSPORT	It has been widely reported that silicon (Si) improves the resistance of plants to salt stress. Most of the previous studies have examined how silicon prevents Na+ uptake, but the performance and underlying mechanism through which silicon alleviates salt-induced osmotic stress has been largely ignored. In the present study, the mechanism through which Si alleviates salt-induced osmotic stress was investigated using sorghum in a hydroponic system. Si had no effect on seedling growth under normal conditions. Under salt stress, the photosynthesis and transpiration rate were decreased, but these decreases were alleviated by Si application. In addition, the leaf water content and leaf elongation rate were maintained at higher levels with Si than without Si. The root hydraulic conductance ( L-p) of the seedlings were inhibited by salt, but Si application alleviated this inhibition. Under salt stress, the transpiration rates of the seedlings both with and without Si were decreased to the same level by HgCl2 treatment and partially rescued by beta-mercaptoethanol treatment, suggesting that aquaporin was responsible for the alleviation of the decrease in L-p. Moreover, transcript levels of several aquaporin genes were upregulated by Si. Under salt stress, Si inhibited the increase in the root H2O2 levels and enhanced the activities of antioxidant enzymes. Moreover, similar to Si, pre-treatment with catalase alleviated the decrease in the transpiration rate, indicating that Si enhanced aquaporin activity by reducing H2O2 accumulation. These results indicate that under short-term salt stress, Si application can alleviate the decrease in L-p by mediating aquaporin activity, leading to increased water uptake and resistance to salt-induced osmotic stress. (C) 2014 Elsevier B.V. All rights reserved.	[Liu, Peng; Yin, Lina; Wang, Shiwen; Deng, Xiping; Zhang, Suiqi] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Liu, Peng; Yin, Lina; Wang, Shiwen; Deng, Xiping; Zhang, Suiqi] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Liu, Peng; Yin, Lina; Wang, Shiwen; Deng, Xiping; Zhang, Suiqi] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China; [Liu, Peng; Zhang, Meijuan] Shandong Agr Univ, Dept Plant Protect, Tai An 271018, Shandong, Peoples R China; [Zhang, Meijuan; Tanaka, Kiyoshi] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Tanaka, Kiyoshi] Tottori Univ, Fac Agr, Tottori 6808533, Japan	Wang, SW (reprint author), Northwest A&F Univ, Inst Soil & Water Conservat, 26 Xinong Rd, Yangling 712100, Shaanxi, Peoples R China.	lewis08201@gmail.com; linayin@nwsuaf.edu.cn; shiwenwang@nwsuaf.edu.cn; zmj521good@163.com; dengxp@ms.iswc.ac.cn; sqzhang@ms.iswc.ac.cn; jotanaka@muses.tottori-u.ac.jp		邓, 西平/0000-0003-4577-9217	National Natural Science Foundation of China [31101597]; Chinese Universities Scientific Fund [QN2012048]; National Basic Research Program of China [2015CB150402]; West Light Foundation of the Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (No. 31101597), the West Light Foundation of the Chinese Academy of Sciences, Chinese Universities Scientific Fund (QN2012048), and the National Basic Research Program of China (2015CB150402).	Agre P., 1998, J BIOL CHEM, V273, P9; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; Liang YC, 2006, ENVIRON EXP BOT, V57, P212, DOI 10.1016/j.envexpbot.2005.05.012; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Gong HJ, 2006, PLANT CELL ENVIRON, V29, P1970, DOI 10.1111/j.1365-3040.2006.01572.x; Ruiz-Lozano JM, 2012, J EXP BOT, V63, P4033, DOI 10.1093/jxb/ers126; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x; Liang YC, 2003, J PLANT PHYSIOL, V160, P1157, DOI 10.1078/0176-1617-01065; Hubbard RM, 2001, PLANT CELL ENVIRON, V24, P113, DOI 10.1046/j.1365-3040.2001.00660.x; Soylemezoglu G, 2009, SCI HORTIC-AMSTERDAM, V123, P240, DOI 10.1016/j.scienta.2009.09.005; Azad AK, 2004, PLANT CELL PHYSIOL, V45, P608, DOI 10.1093/pcp/pch069; Suga S, 2002, PLANT CELL PHYSIOL, V43, P1229, DOI 10.1093/pcp/pcf148; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; KOCHBA J, 1977, PLANT CELL PHYSIOL, V18, P463; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; Romero-Aranda MR, 2006, J PLANT PHYSIOL, V163, P847, DOI 10.1016/j.jplph.2005.05.010; Steudle E, 2000, PLANT SOIL, V226, P45, DOI 10.1023/A:1026439226716; Comstock JP, 2002, J EXP BOT, V53, P195, DOI 10.1093/jexbot/53.367.195; Knipfer T, 2011, J EXP BOT, V62, P4115, DOI 10.1093/jxb/err075; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Hachez C, 2012, PLANT CELL ENVIRON, V35, P185, DOI 10.1111/j.1365-3040.2011.02429.x; Machado S, 2001, PLANT SOIL, V233, P179, DOI 10.1023/A:1010346601643; Sutka M, 2011, PLANT PHYSIOL, V155, P1264, DOI 10.1104/pp.110.163113; Yin LN, 2013, ACTA PHYSIOL PLANT, V35, P3099, DOI 10.1007/s11738-013-1343-5; Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x; Martre P, 2002, PLANT PHYSIOL, V130, P2101, DOI 10.1104/pp.009019; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; MATOH T, 1986, SOIL SCI PLANT NUTR, V32, P295; Rodriguez-Gamir J, 2011, PLANT SOIL, V347, P91, DOI 10.1007/s11104-011-0826-7; Ruiz-Lozano JM, 2009, PLANT MOL BIOL, V70, P565, DOI 10.1007/s11103-009-9492-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Yin LN, 2010, PLANT PHYSIOL, V152, P1406, DOI 10.1104/pp.109.151449; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020; BEAUCHAM.CO, 1973, BIOCHIM BIOPHYS ACTA, V317, P50, DOI 10.1016/0005-2795(73)90198-0; Boursiac Yann, 2008, Plant Signal Behav, V3, P1096; Comic G., 2000, TRENDS PLANT SCI, V5, P187; Hamurcu M, 2013, PLANT GROWTH REGUL, V70, P217, DOI 10.1007/s10725-013-9793-8; Henzler T, 2004, PLANT CELL ENVIRON, V27, P1184, DOI 10.1111/j.1365-3040.2004.01226.x; Hoagland D. R., 1950, CIRCULAR, V347; MEYER RF, 1972, PLANTA, V108, P77, DOI 10.1007/BF00386508; Miyamoto N, 2001, J EXP BOT, V52, P1835, DOI 10.1093/jexbot/52.362.1835; Qian Z.J., 2014, PLANT CELL ENV; Ye Q, 2006, PLANT CELL ENVIRON, V29, P459, DOI 10.1111/j.1365-3040.2005.01423.x	53	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0098-8472	1873-7307		ENVIRON EXP BOT	Environ. Exp. Bot.	MAR	2015	111						42	51		10.1016/j.envexpbot.2014.10.006		10	Plant Sciences; Environmental Sciences	Plant Sciences; Environmental Sciences & Ecology	CA4SQ	WOS:000348895100005		
J	Morita, SH; Morita, K; Hamatsu, T; Chimura, M; Yamashita, Y; Sasaki, K; Sato, T				Morita, Shoko H.; Morita, Kentaro; Hamatsu, Tomonori; Chimura, Masayuki; Yamashita, Yuuho; Sasaki, Kei; Sato, Tomoki			Differential effects of the environment on the growth of arabesque greenling (Pleurogrammus azonus): does rising temperature benefit young but not old fish?	ENVIRONMENTAL BIOLOGY OF FISHES			English	Article						Age-specific; Arabesque greenling; Demersal fish; Growth; Pleurogrammus azonus; Thermal condition	POLLOCK THERAGRA-CHALCOGRAMMA; PACIFIC SALMON ONCORHYNCHUS; SEXUAL SIZE DIMORPHISM; NORTH-SEA; BODY-SIZE; RECRUITMENT; CLIMATE; OCEAN; COD; STOCK	Annual and spatial variations in the growth condition of the arabesque greenling (Pleurogrammus azonus) were examined in relation to temperature and food availability. We found age-dependent effects of temperature and sex-dependent effects of zooplankton biomass on the growth condition. Growth condition increased with bottom temperature in the 1+ group, but this effect was reversed in the older groups. This age-dependent effect of temperature on growth condition was consistent with regional differences in growth patterns. Arabesque greenling living in cool sea areas reached a larger final adult size (i.e. larger L (a)), but the juveniles grew slower (i.e. smaller k) than those living in warm sea areas. Based on our results, we suggest that the negative effect of climate warming on growth condition might be more severe for older individuals and that a climate change-driven decrease in the somatic growth of adult fish could bring a population growth rate decline through maternal effects.	[Morita, Shoko H.; Morita, Kentaro; Sasaki, Kei; Sato, Tomoki] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Sapporo, Hokkaido 0620922, Japan; [Hamatsu, Tomonori; Chimura, Masayuki; Yamashita, Yuuho] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Kushiro, Hokkaido 0850802, Japan	Morita, SH (reprint author), Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Sapporo, Hokkaido 0620922, Japan.	shokoh@affrc.go.jp	Morita, Kentaro/G-2578-2015	Morita, Kentaro/0000-0002-7803-2438	Fisheries Agency of Japan	We thank the captains and crews of the Hokkou maru, Dainana-Kaiyo maru, and Daigo-Kaiyo maru for their co-operation during the field observations; Satoshi Honda for providing the data used in this study; and Yoshiaki Hiyama and Keizou Yabuki for their helpful discussions. Zooplankton data used in this study originated from the juvenile salmon monitoring program initiated by the former National Salmon Resources Center (Seki 2007). This research complied with the current laws of Japan. This study was partially sponsored by the Fisheries Agency of Japan.	Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bjornsson B, 2002, CAN J FISH AQUAT SCI, V59, P494, DOI 10.1139/F02-028; Brunel T, 2010, MAR ECOL PROG SER, V405, P15, DOI 10.3354/meps08491; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Henderson BA, 2003, CAN J FISH AQUAT SCI, V60, P1345, DOI 10.1139/F03-115; Ohlberger J, 2013, FUNCT ECOL, V27, P991, DOI 10.1111/1365-2435.12098; Funamoto T, 2011, FISH OCEANOGR, V20, P95, DOI 10.1111/j.1365-2419.2010.00570.x; Funamoto T, 2007, FISH OCEANOGR, V16, P515, DOI 10.1111/j.1365-2419.2007.00454.x; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Takasuka A, 2007, CAN J FISH AQUAT SCI, V64, P768, DOI 10.1139/F07-052; Morita K, 2010, OIKOS, V119, P1265, DOI 10.1111/j.1600-0706.2009.18125.x; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Arabesque Greenling Research Group, 1983, LAT RES AR GREENL RE, P44; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/S0065-2504(08)60212-3; Baudron AR, 2011, J FISH BIOL, V78, P1874, DOI 10.1111/j.1095-8649.2011.02940.x; Brett J., 1979, FISH PHYSIOL, V8, P599; Elliott J. M., 1994, QUANTITATIVE ECOLOGY; Hiyama Yoshiaki, 1998, Bulletin of the Japan Sea National Fisheries Research Institute, V48, P17; Hosino N, 2009, SCI REP HOKKAIDO FIS, V76, P1; Houde HD, 2002, FISHERY SCI UNIQUE C; Imsland AK, 2006, J FISH BIOL, V68, P1107, DOI 10.1111/j.1095-8649.2005.00989.x; Jenkins GP, 2006, OECOLOGIA, V147, P641, DOI 10.1007/s00442-005-0336-5; Jobling M, 2008, HDB FISH BIOL FISHER, V1, P97; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; McDermott SF, 2011, MAR COAST FISH, V3, P324, DOI 10.1080/19425120.2011.608592; Morita K, 2011, FISH OCEANOGR, V20, P258, DOI 10.1111/j.1365-2419.2011.00578.x; Morita K, 2010, J FISH BIOL, V77, P1024, DOI 10.1111/j.1095-8649.2010.02721.x; Morita SH, 2012, ENVIRON BIOL FISH, V94, P505, DOI 10.1007/s10641-010-9613-1; Morita SH, 2012, MARINE FISHERIES STO, P995; Munehara H, 2003, RUSSIA B FISH SCI HO, V54, P67; Nishimura A, 2001, FISH OCEANOGR, V10, P367; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Quinn II. T., 1999, QUANTITATIVE FISH DY; Roff D. A., 1992, EVOLUTION LIFE HIST; Seki J, 2007, N PAC ANADR FISH COM, V7, P14; Stearns S. C., 1992, EVOLUTION LIFE HIST; Takashima T, 2013, NIPPON SUISAN GAKK, V79, P383; Tamate T, 2006, EVOLUTION, V60, P196; Tanaka Y, 2006, MAR ECOL PROG SER, V319, P225, DOI 10.3354/meps319225; Tsuboi J, 2013, J ICHTHYOLOGY, V53, P884; Venturelli PA, 2009, P R SOC B, V276, P919, DOI 10.1098/rspb.2008.1507; Wertheimer AC, 2004, REV FISH BIOL FISHER, V14, P321, DOI 10.1007/s11160-004-2942-4; Yabuki K, 1994, GSK KITA NIHON SOKOU, V27, P39; Yamamura O, 2013, MAR ECOL PROG SER, V491, P221, DOI 10.3354/meps10445	48	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0378-1909	1573-5133		ENVIRON BIOL FISH	Environ. Biol. Fishes	MAR	2015	98	3					801	809		10.1007/s10641-014-0316-x		9	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CA6NA	WOS:000349029800005		
J	Kokushi, E; Uno, S; Pal, S; Koyama, J				Kokushi, Emiko; Uno, Seiichi; Pal, Sandipan; Koyama, Jiro			Effects of Chlorpyrifos on the Metabolome of the Freshwater Carp, Cyprinus Carpio	ENVIRONMENTAL TOXICOLOGY			English	Article						metabolomics; fish; chlorpyrifos; plasma; acetylcholinesterase inhibition	CHROMATOGRAPHY-MASS SPECTROMETRY; H-1-NMR METABOLOMICS; NMR; FISH; RATS; URINE; LIVER; SERUM; ORGANOPHOSPHORUS; STARVATION	This study investigated the effects of waterborne chlorpyrifos with concentrations of 1 and 100 mu g/L for L and H-groups, respectively, on metabolome profiles of carp plasma using H-1-NMR. Principal component analysis suggests that chlorpyrifos exposure firstly affected in L and H-groups on day 2 or 4, and followed a second effect in both exposure groups on day 14. Levels of metabolites related to the energy production in the body, such as glucose, glycerol, valine, leucine, isoleucine, lactate, alanine, 3-D-hydroxybutyrates and acetoacetate, significantly changed by exposures of chlorpyrifos. Those results suggest that energy production was severely affected in carp. The exposure could also be highly elevated ammonia levels especially in H-group due to severe convulsion in muscle caused by the inhibition of acetylcholinesterase activity. (c) 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 253-260, 2015.	[Kokushi, Emiko; Uno, Seiichi; Koyama, Jiro] Kagoshima Univ, Educ & Res Ctr Marine Resources & Environm, Fac Fisheries, Kagoshima 8900056, Japan; [Pal, Sandipan] Univ Burdwan, Dept Environm Sci, Golapbag Burdwan 713104, W Bengal, India	Uno, S (reprint author), Kagoshima Univ, Educ & Res Ctr Marine Resources & Environm, Fac Fisheries, 4-50-20 Shimoarata, Kagoshima 8900056, Japan.	uno@fish.kagoshima-u.ac.jp			Environment Research and Technology Development fund of the Ministry of the Environment, Japan [RF-0909]	Contract grant sponsor: Environment Research and Technology Development fund of the Ministry of the Environment, Japan, Contract grant number: RF-0909	Vallejo M, 2009, ANAL BIOANAL CHEM, V394, P1517, DOI 10.1007/s00216-009-2610-6; Wei L, 2008, TOXICOL APPL PHARM, V227, P417, DOI 10.1016/j.taap.2007.11.015; Banaee M, 2011, PESTIC BIOCHEM PHYS, V99, P1, DOI 10.1016/j.pestbp.2010.09.001; Viant MR, 2006, AQUAT TOXICOL, V77, P359, DOI 10.1016/j.aquatox.2006.01.009; Luskova V, 2002, ACTA VET BRNO, V71, P117, DOI 10.2754/avb200271010117; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Jacobson SM, 2010, AQUAT TOXICOL, V100, P101, DOI 10.1016/j.aquatox.2010.07.015; Sharbidre AA, 2011, PESTIC BIOCHEM PHYS, V101, P132, DOI 10.1016/j.pestbp.2011.09.002; Li ZH, 2011, CHEMOSPHERE, V83, P572, DOI 10.1016/j.chemosphere.2010.12.024; Sandahl JF, 2005, ENVIRON TOXICOL CHEM, V24, P136, DOI 10.1897/04-195R.1; Kokushi E, 2012, ENVIRON TOXICOL, V27, P404, DOI 10.1002/tox.20653; Bhattacharjee S, 2012, B ENVIRON CONTAM TOX, V89, P348, DOI 10.1007/s00128-012-0686-8; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Xing HJ, 2012, CHEMOSPHERE, V88, P377, DOI 10.1016/j.chemosphere.2012.02.049; Chowdhury AZ, 2012, B ENVIRON CONTAM TOX, V89, P202, DOI 10.1007/s00128-012-0641-8; Kienle C, 2009, ECOTOX ENVIRON SAFE, V72, P1740, DOI 10.1016/j.ecoenv.2009.04.014; Ali D, 2009, FOOD CHEM TOXICOL, V47, P650, DOI 10.1016/j.fct.2008.12.021; Michell AW, 2008, METABOLOMICS, V4, P191, DOI 10.1007/s11306-008-0111-9; Waters NJ, 2001, CHEM RES TOXICOL, V14, P1401, DOI 10.1021/tx010067f; Lei RH, 2008, TOXICOL APPL PHARM, V232, P292, DOI 10.1016/j.taap.2008.06.026; Begum G, 2004, AQUAT TOXICOL, V66, P83, DOI 10.1016/j.aquatox.2003.08.002; Brosnan JT, 2000, J NUTR, V130, p988S; Ekman DR, 2007, AQUAT TOXICOL, V85, P104, DOI 10.1016/j.aquatox.2007.08.005; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245; Halappa R, 2009, TURK J FISH AQUAT SC, V9, P233, DOI 10.4194/trjfas.2009.0218; Kimberly RH, 2008, AQUAT TOXICOL, V88, P48, DOI DOI 10.1016/J.AQUATOX.2008.03.002; Kokushi E, 2011, NIPPON SUISAN GAKK, V77, P75, DOI 10.2331/suisan.77.75; Kokushi E, 2013, JPN J ENV TOXICOL, V16, P1; Moraes EP, 2011, ELECTROPHORESIS, V32, P2055, DOI 10.1002/elps.201000546; Nicholas PC, 2008, CHEM RES TOXICOL, V21, P408, DOI 10.1021/tx700324t; Ramesh M., 2008, International Journal of Integrative Biology, V3, P80; Shimomura Y, 2004, J NUTR, V134, p1583S; Uno S, 2008, J ENV TOXICOL, V11, P63; Uno S, 2012, ENVIRON SCI POLLUT R, V19, P2595, DOI 10.1007/s11356-012-0834-z; Wu HF, 2005, J INORG BIOCHEM, V99, P2151, DOI 10.1016/j.jinorgbio.2005.07.014; ZAMMIT VA, 1979, BIOCHEM J, V184, P313	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-4081	1522-7278		ENVIRON TOXICOL	Environ. Toxicol.	MAR	2015	30	3					253	260		10.1002/tox.21903		8	Environmental Sciences; Toxicology; Water Resources	Environmental Sciences & Ecology; Toxicology; Water Resources	CA8NS	WOS:000349178300001		
J	Okami, M; Kato, Y; Kobayashi, N; Yamagishi, J				Okami, Midori; Kato, Yoichiro; Kobayashi, Nobuya; Yamagishi, Junko			Morphological traits associated with vegetative growth of rice (Oryza sativa L.) during the recovery phase after early-season drought	EUROPEAN JOURNAL OF AGRONOMY			English	Article						Drought; Phenotypic plasticity; Plant architecture; Recovery growth; Tillering	PLANT PHENOTYPIC PLASTICITY; SAVING AEROBIC CULTURE; WATER-DEFICIT; EARLY VIGOR; RESPONSES; YIELD; STAGE; ADAPTATION; CULTIVARS; STRESS	Rapid leaf growth during the recovery period after a dry spell is essential for the adaptation of rice (Oryza sativa L.) to drought-prone environments. However, how rice plants resume growth when the drought stress ends is not well understood. The objective of this study was to determine the traits and mechanisms associated with the above-ground morphological response to rewatering after early-season drought, by comparing three rice lines with contrastive plant architectures. In the field, we measured the above-ground architecture, carbohydrate partitioning, and consumption of non-structural carbohydrates by IR64 (indica rice), a New Plant Type line (tropical japonica rice) and an IR64 introgression line (IL) with large leaves and reduced tillering under fully irrigated and drought + rewatered conditions. In an ancillary pot experiment, we monitored changes in tiller number and leaf growth under fully irrigated, droughted and drought + rewatered conditions. There were genotypic differences in recovery growth patterns upon rewatering after drought: the New Plant Type lines prioritized individual tiller growth, while IR64 and the IR64 IL prioritized the production of new tillers and concomitantly consumed much carbohydrate. The increase in tiller number during the recovery period was lower in the IR64 IL than in IR64 owing to the longer phyllochron and larger amount of assimilate required to produce new tillers in the IL Rice development during the recovery period depends on the plant type (constitutive tiller number to size ratio) and tillering response to soil moisture regime, which would be mediated mainly by phyllochron and tiller production per assimilate. Rapid increase in tiller number upon rewatering in IR64 was associated with the low amount of assimilate required to produce new tillers rather than with the short phyllochron. (C) 2015 Elsevier B.V. All rights reserved.	[Okami, Midori; Yamagishi, Junko] Univ Tokyo, Inst Sustainable Agroecosyst Serv, Tokyo 1880002, Japan; [Kato, Yoichiro; Kobayashi, Nobuya] Int Rice Res Inst, Manila, Philippines; [Kobayashi, Nobuya] Japan Int Res Ctr Agr Sci, Ibaraki 3058686, Japan	Kato, Y (reprint author), Int Rice Res Inst, DAPO Box 7777, Manila, Philippines.	y.kato@irri.org			JAPAN-CGIAR Fellowship Program of the Agriculture, Forestry and Fisheries Research Council, Ministry of Agriculture, Forestry and Fisheries of Japan	We thank Dr D. Fujita (Kyushu University, Japan), who provided valuable suggestions for our experiments. We thank Messrs K. Ichikawa, R. Soga, and K. Yatsuda (The University of Tokyo) and Xernan S. Acenas (International Rice Research Institute) for technical assistance in carrying out these experiments. The IR64 ILs were developed in an IRRI-Japan collaborative research project. This work was supported in part by the JAPAN-CGIAR Fellowship Program of the Agriculture, Forestry and Fisheries Research Council, Ministry of Agriculture, Forestry and Fisheries of Japan (to MO).	Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Lafarge T, 2010, FUNCT PLANT BIOL, V37, P413, DOI 10.1071/FP09137; Mitchell JH, 1998, FIELD CROP RES, V55, P129, DOI 10.1016/S0378-4290(97)00074-9; Rebolledo MC, 2013, FUNCT PLANT BIOL, V40, P582, DOI 10.1071/FP12312; Wopereis MCS, 1996, FIELD CROP RES, V46, P21, DOI 10.1016/0378-4290(95)00084-4; Mitchell JH, 2013, J EXP BOT, V64, P3439, DOI 10.1093/jxb/ert181; NEMOTO K, 1995, CROP SCI, V35, P24; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Kato Y, 2014, PLANT PROD SCI, V17, P1, DOI 10.1626/pps.17.1; Kato Y, 2010, FIELD CROP RES, V117, P9, DOI 10.1016/j.fcr.2009.12.003; McDonald PG, 2003, FUNCT ECOL, V17, P50, DOI 10.1046/j.1365-2435.2003.00698.x; Wassmann R, 2009, ADV AGRON, V102, P91, DOI 10.1016/S0065-2113(09)01003-7; Okami M, 2014, EUR J AGRON, V58, P11, DOI 10.1016/j.eja.2014.03.001; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; BLUM A, 1990, FIELD CROP RES, V24, P67, DOI 10.1016/0378-4290(90)90022-4; de Datta S.K., 1973, WATER MANAGEMENT PHI, P1; DEDATTA SK, 1988, FIELD CROP RES, V19, P123, DOI 10.1016/0378-4290(88)90050-0; Dingkuhn M, 2006, FUNCT PLANT BIOL, V33, P325, DOI 10.1071/FP05267; Fischer KS, 2003, BREEDING RICE DROUGH, P5; Fujita D., 2010, 66 JIRCAS; GRiSP (Global Rice Partnership), 2013, RIC ALM; Guo W, 2007, J ARID ENVIRON, V69, P385, DOI 10.1016/j.jaridenv.2006.10.003; Institute SAS, 2003, SAS US GUID STAT VER; Lafitte HR, 2002, FIELD CROP RES, V75, P171, DOI 10.1016/S0378-4290(02)00025-4; LILLEY JM, 1994, FIELD CROP RES, V37, P215, DOI 10.1016/0378-4290(94)90100-7; Luquet D, 2006, FUNCT PLANT BIOL, V33, P309, DOI 10.1071/FP05266; Luquet D, 2008, FUNCT PLANT BIOL, V35, P689, DOI 10.1071/FP08027; MALABUYOC JA, 1985, FIELD CROP RES, V10, P105, DOI 10.1016/0378-4290(85)90018-8; Okami M, 2011, FIELD CROP RES, V124, P124, DOI 10.1016/j.fcr.2011.06.013; Okami M, 2013, PLANT PROD SCI, V16, P276, DOI 10.1626/pps.16.276; Okami M, 2012, FIELD CROP RES, V131, P17, DOI 10.1016/j.fcr.2012.02.014; Pantuwan G, 2004, FIELD CROP RES, V89, P281, DOI 10.1016/j.fcr.2004.02.007; Sasaki H, 2005, PLANT PROD SCI, V8, P8, DOI 10.1626/pps.8.8	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1161-0301	1873-7331		EUR J AGRON	Eur. J. Agron.	MAR	2015	64						58	66		10.1016/j.eja.2014.12.006		9	Agronomy	Agriculture	CB1YY	WOS:000349425100007		
J	Takahashi, G; Shibata, S; Ishikura, H; Miura, M; Fukui, Y; Inoue, Y; Endo, S				Takahashi, Gaku; Shibata, Shigehiro; Ishikura, Hiroyasu; Miura, Masanao; Fukui, Yasuo; Inoue, Yoshihiro; Endo, Shigeatsu			Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation A prospective, multicentre, observational study	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE UNITS; SOLUBLE CD14; EMERGENCY-DEPARTMENT; SEPTIC SHOCK; SEPSIS; PROCALCITONIN; SEVERITY; ADULTS	BACKGROUND Few prospective studies have described the prognostic accuracy of presepsin for 28-day mortality during days 0 to 7, or its role in the diagnosis of disseminated intravascular coagulation (DIC) in patients with infection. OBJECTIVE We aimed to evaluate the clinical usefulness of presepsin levels by comparing infection markers such as procalcitonin, interleukin-6 and C-reactive protein, as well as markers of DIC such as fibrin degradation products (FDPs) and D-dimer, from days 0 to 7. DESIGN A prospective, multicentre, observational study. SETTING Four medical institutions between June 2010 and June 2011. PATIENTS A total of 191 patients who fulfilled at least one of the systemic inflammatory response syndrome (SIRS) criteria were enrolled in the study. MAIN OUTCOME MEASURES The presepsin levels were evaluated for their diagnostic accuracy in discriminating between SIRS and sepsis, the prognostic accuracy for 28-day mortality from days 0 to 7 and the diagnostic accuracy for DIC in patients with infection by comparison with other infection markers. RESULTS The diagnostic accuracy for discriminating between SIRS and sepsis from combining the presepsin and procalcitonin measurements [area under the curve (AUC), 0.91; likelihood ratio, 4.96] was higher than that of presepsin (AUC, 0.89; likelihood ratio, 4.75) or procalcitonin (AUC, 0.85; likelihood ratio, 3.18) alone. Not only the correlation coefficient between the presepsin level and the sequential organ failure assessment (SOFA) score but also the prognostic accuracy of presepsin for 28-day mortality increased with the elapsed time, and both were highest at day 7. The diagnostic accuracy for DIC generated by combining presepsin and FDP (AUC, 0.84; likelihood ratio, 3.57) was higher than that of FDP (AUC, 0.82; likelihood ratio, 2.64) or presepsin (AUC, 0.80; likelihood ratio, 2.94) alone. CONCLUSION The prognosis and severity of infection may be assessed more accurately by measuring the presepsin levels until day 7. Presepsin is a useful diagnostic tool for DIC with infection.	[Takahashi, Gaku; Shibata, Shigehiro; Inoue, Yoshihiro; Endo, Shigeatsu] Iwate Med Univ, Dept Crit Care Med, Morioka, Iwate 0208505, Japan; [Ishikura, Hiroyasu] Fukuoka Univ, Dept Emergency & Crit Care Med, Fac Med, Fukuoka 81401, Japan; [Miura, Masanao] Toyota Gen Hosp, Anesthesiol Emergency & Crit Care Ctr, Kariya, Aichi, Japan; [Fukui, Yasuo] Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, Kochi, Japan	Takahashi, G (reprint author), Iwate Med Univ, Dept Crit Care Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	gakut@iwate-med.ac.jp					ACCP/SCCM Consensus Conference Committee, 1992, CRIT CARE MED, V20, P867; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; Endo S, 2012, J INFECT CHEMOTHER, V18, P891, DOI 10.1007/s10156-012-0435-2; Iba T, 2007, J TRAUMA, V63, P1093, DOI 10.1097/01.ta.0000251420.41427.d3; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1016/j.ccc.2009.08.004; ENDO S, 1994, RES COMMUN CHEM PATH, V84, P17; Seki Y, 2013, INTERNAL MED, V52, P1893, DOI 10.2169/internalmedicine.52.0571; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; BAZIL V, 1991, J IMMUNOL, V147, P1567; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Iba T, 1994, J JPN ASS ACUTE MED, V5, P365; Ishikura H, 2014, CRIT CARE, V18, DOI 10.1186/cc13700; Kafkas Nikolaos, 2008, Acute Card Care, V10, P30, DOI 10.1080/17482940701534800; Laughlin GA, 2000, J CLIN ENDOCR METAB, V85, P3561, DOI 10.1210/jc.85.10.3561; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; Masson S, 2014, CRIT CARE, V18, DOI 10.1186/cc13183; Nakamura M, 2008, CRIT CARE S2, V12, P194; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	24	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	MAR	2015	32	3					199	206		10.1097/EJA.0000000000000178		8	Anesthesiology	Anesthesiology	CA2WC	WOS:000348765100008		
J	Onoda, M; Hyodo, T; Murakami, T; Okada, M; Uto, T; Hori, M; Miyati, T				Onoda, Minori; Hyodo, Tomoko; Murakami, Takamichi; Okada, Masahiro; Uto, Tatsuro; Hori, Masatoshi; Miyati, Tosiaki			Optimizing signal intensity correction during evaluation of hepatic parenchymal enhancement on gadoxetate disodium-enhanced MRI: Comparison of three methods	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Magnetic resonance imaging; Gadoxetate disodium; Liver function tests	GD-EOB-DTPA; LIVER-FUNCTION; HEPATOCELLULAR-CARCINOMA; SCINTIGRAPHY; PERFUSION; SYSTEM	Objective: To compare signal intensity (SI) correction using scale and rescale slopes with SI correction using SIs of spleen and muscle for quantifying multiphase hepatic contrast enhancement with Gd-EOB-DTPA by assessing their correlation with T-1 values generated from Look-Locker turbo-field-echo (LL-TFE) sequence data (ER-T-1). Materials and methods: Thirty patients underwent Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in this prospective clinical study. For each patient, breath-hold T-1-weighted fat-suppressed three-dimensional (3D) gradient echo sequences (e-THRIVE) were acquired before and 2 (first phase), 10 (second phase), and 20 min (third phase) after intravenous Gd-EOB-DTPA. Look-Locker turbo-fieldecho (LL-TFE) sequences were acquired before and 1.5 (first phase), 8 (second phase), and 18 min (third phase) postcontrast. The liver parenchyma enhancement ratios (ER) of each phase were calculated using the SI from e-THRIVE sequences (ER-SI) and the T-1 values generated from LL-TFE sequence data (ER-T-1) respectively. ER-SIs were calculated in three ways: (1) comparing with splenic SI (ER-SI-s), (2) comparing with muscle SI (ER-SI-m), (3) using scale and rescale slopes obtained from DICOM headers (ER-SI-c), to eliminate the effects of receiver gain and scaling. For each of the first, second and third phases, correlation and agreement were assessed between each ER-SI and ER-T-1. Results: In the first phase, all ER-SIs correlated weakly with ER-Ti. In the second and third phases, ER-SI-c showed a stronger linear correlation with ER-Ti (r(2) =0.71-0.72, p <0.01) than did ER-SI-s (r(2) =0.37-0.39, p <0.01) or ER-SI-m (r(2) =0.30-0.41, p <0.01). Conclusion: SI correction using scale and rescale slopes from DICOM data is the most acceptable algorithm for evaluating delayed-phase Gd-EOB-DTPA hepatic enhancement. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Onoda, Minori; Uto, Tatsuro] Kinki Univ Hosp, Dept Radiol Technol, Osaka 5898511, Japan; [Onoda, Minori; Miyati, Tosiaki] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Hyodo, Tomoko; Murakami, Takamichi; Okada, Masahiro] Kinki Univ, Fac Med, Dept Radiol, Osaka 5898511, Japan; [Hori, Masatoshi] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan	Murakami, T (reprint author), Kinki Univ Hosp, Dept Radiol Technol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	onoda@radt.med.kindai.ac.jp; neneth@m.ehime-u.ac.jp; murakami@med.kindai.ac.jp; okada777@med.u-ryukyu.ac.jp; chuho@med.kindai.ac.jp; mhori@radiol.med.osaka-u.ac.jp; ramiyati@mhs.mp.kanazawa-u.ac.jp					Jackson A, 2004, BRIT J RADIOL, V77, pS154, DOI 10.1259/bjr/16652509; Motosugi U, 2009, EUR RADIOL, V19, P2623, DOI 10.1007/s00330-009-1467-6; Kwon A, 1997, HEPATOLOGY, V25, P426; Nishie A, 2012, EUR J RADIOL, V81, P1100, DOI 10.1016/j.ejrad.2011.02.053; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Katsube T, 2012, EUR J RADIOL, V81, P1460, DOI 10.1016/j.ejrad.2011.03.073; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Katsube T, 2011, INVEST RADIOL, V46, P277, DOI 10.1097/RLI.0b013e318200f67d; de Bazelaire C, 2006, EUR RADIOL, V16, P2083, DOI 10.1007/s00330-006-0198-1; Kaibori M, 2003, HEPATO-GASTROENTEROL, V50, P491; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Takayama Y, 2012, EUR J RADIOL, V81, P3035, DOI 10.1016/j.ejrad.2012.03.026; Fujita M, 1997, JMRI-J MAGN RESON IM, V7, P768, DOI 10.1002/jmri.1880070426; Botta F, 2003, GUT, V52, P134, DOI 10.1136/gut.52.1.134; Crelier G, 2011, USER MANUAL RECON PR; Dietrich O, 2008, MAGN RESON MED, V60, P1477, DOI 10.1002/mrm.21784; Kamimura K, 2013, J MAGN RESON IMAGING, V40, P884; Kautman S, 2003, AM J PHYSIOL-REG I, V284, pR1580; Kim T, 1997, JMRI-J MAGN RESON IM, V7, P683, DOI 10.1002/jmri.1880070413; Kirsch J E, 1991, Top Magn Reson Imaging, V3, P1; Nakamura S, 2012, JPN J RADIOL, V30, P25, DOI 10.1007/s11604-011-0003-1; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Saito Kazuhiro, 2005, Magn Reson Med Sci, V4, P1, DOI 10.2463/mrms.4.1; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59; Shimizu J, 1999, DIGEST DIS SCI, V44, P1330, DOI 10.1023/A:1026679113772; Tsuda N, 2010, EUR J RADIOL, V73, P137, DOI 10.1016/j.ejrad.2008.09.036	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAR	2015	84	3					339	345		10.1016/j.ejrad.2014.11.014		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA8NN	WOS:000349177800001		
J	Hiraoka, A; Kawamura, T; Aibiki, T; Okudaira, T; Toshimori, A; Yamago, H; Nakahara, H; Suga, Y; Azemoto, N; Miyata, H; Miyamoto, Y; Ninomiya, T; Murakami, T; Ishimaru, Y; Kawasaki, H; Hirooka, M; Abe, M; Matsuura, B; Hiasa, Y; Michitaka, K				Hiraoka, Atsushi; Kawamura, Tomoe; Aibiki, Toshihiko; Okudaira, Tomonari; Toshimori, Akiko; Yamago, Hiroka; Nakahara, Hiromasa; Suga, Yoshifumi; Azemoto, Nobuaki; Miyata, Hideki; Miyamoto, Yasunao; Ninomiya, Tomoyuki; Murakami, Tadashi; Ishimaru, Yoshihiro; Kawasaki, Hideki; Hirooka, Masashi; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi; Michitaka, Kojiro			Prognosis and therapy for ruptured hepatocellular carcinoma: Problems with staging and treatment strategy	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Hepatocellular carcinoma; Rupture; Prognosis; Transcatheter arterial embolization; Surgical resection	MANAGEMENT; EXPERIENCE	Background: There are no clear criteria established for treating a ruptured hepatocellular carcinoma (HCC). To elucidate the clinical features of affected patients, we examined prognosis and therapy choices. Materials/methods: We enrolled 67 patients treated for a ruptured HCC (HCV 44, HBV 5, HBV + HCV 1, alcohol 2, others 15; na ve HCC 34, recurrent 33) from 2000 to 2013, and investigated their clinical background and prognosis. Results: Median survival time (MST) for all cases was 4 months. For patients who survived for more than 1 year after rupture, the percentages of Child-Pugh C and positive for portal vein tumor thrombosis (PVTT)/extrahepatic metastasis were less than for those who died within 1 year. Child-Pugh classification (A:B:C = 14:15:5 vs. 4:9:20, P <0.001) was better, while the percentage of patients with multiple tumors was lower [19/34(55.9%) vs. 29/33(87.9%), respectively; P<0.001] in the na ve group. The 1- and 3-year survival rates were better in the na ve as compared to the recurrent group (60.6% and 33.3% vs. 12.6% and 0%, respectively; P<0.01). MST according to modified TNM stage (UICC 7th) calculated after exclusion of T4 factor of rupture, stage I was better than others (22.7 vs. (II) 2.2, (III) 1.2, and (IV) 0.7 months) (P = 0.010). Conclusion: In patients with a ruptured HCC, especially those with a single tumor, and without decompensated liver cirrhosis and PVTT/extrahepatic metastasis, better prognosis can be expected with curative treatment. The present na ve group included more of such cases than the recurrent group, indicating the effectiveness of curative therapy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Hiraoka, Atsushi; Kawamura, Tomoe; Aibiki, Toshihiko; Okudaira, Tomonari; Toshimori, Akiko; Yamago, Hiroka; Nakahara, Hiromasa; Suga, Yoshifumi; Azemoto, Nobuaki; Miyata, Hideki; Miyamoto, Yasunao; Ninomiya, Tomoyuki; Michitaka, Kojiro] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Matsuyama, Ehime 7900024, Japan; [Murakami, Tadashi; Ishimaru, Yoshihiro] Ehime Prefectural Cent Hosp, Dept Radiol, Matsuyama, Ehime 7900024, Japan; [Kawasaki, Hideki] Ehime Prefectural Cent Hosp, Dept Surg, Matsuyama, Ehime 7900024, Japan; [Hirooka, Masashi; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan	Hiraoka, A (reprint author), Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Kasuga Cho 83, Matsuyama, Ehime 7900024, Japan.	hirage@m.ehime-u.ac.jp					American Joint Committee on Cancer (AJCC), 2009, CANC STAGING MANUAL; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Liu CL, 2001, J CLIN ONCOL, V19, P3725; MIYAMOTO M, 1991, AM J GASTROENTEROL, V86, P67; Battula N, 2009, AM J SURG, V197, P164, DOI 10.1016/j.amjsurg.2007.10.016; Kim JY, 2012, EUR J GASTROEN HEPAT, V24, P640, DOI 10.1097/MEG.0b013e3283524d32; [Anonymous], 2005, KANZO, V46, P234; Shin BS, 2011, ACTA RADIOL, V52, P331, DOI 10.1258/ar.2010.100369; Hiraoka A, 2011, HEPATO-GASTROENTEROL, V58, P955; Miyoshi A, 2011, HEPATO-GASTROENTEROL, V58, P99; Tanaka Akira, 2001, International Journal of Clinical Oncology, V6, P291, DOI 10.1007/s10147-001-8030-z; Yoshida H, 2008, J HEPATO-BILIARY-PAN, V15, P178, DOI 10.1007/s00534-007-1239-0	14	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAR	2015	84	3					366	371		10.1016/j.ejrad.2014.11.038		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA8NN	WOS:000349177800005		
J	Nishioka, H; Hirose, J; Okamoto, N; Okada, T; Oka, K; Taniwaki, T; Nakamura, E; Yamashita, Y; Mizuta, H				Nishioka, Hiroaki; Hirose, Jun; Okamoto, Nobukazu; Okada, Tatsuya; Oka, Kiyoshi; Taniwaki, Takuya; Nakamura, Eiichi; Yamashita, Yasuyuki; Mizuta, Hiroshi			Evaluation of the relationship between T1 rho and T2 values and patella cartilage degeneration in patients of the same age group	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						T1p mapping; T2 mapping; MRI; Osteoarthritis; Patella cartilage; Aging	ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; RELAXATION-TIMES; HEALTHY-SUBJECTS; EARLY OA; T-1-RHO; JOINT; MRI; T-2; ARTHROPLASTY	Objective: The aim of this study was to investigate the association between the Tip and 12 values and the progression of cartilage degeneration in patients of the same age group. Materials and methods: Sagittal Tip and 12 mapping and three-dimensional (3D) gradient-echo images were obtained from 78 subjects with medial knee osteoarthritis (OA). The degree of patella cartilage degeneration was classified into four groups using MRI-based grading: apparently normal cartilage, mild OA, moderate OA, and severe OA group. We measured the T1p and T2 values (ms) in the regions of interest set on the full-thickness patella cartilage. Then, we analyzed the relationship between the T1p and 12 values and the degree of patella cartilage degeneration. Results: There were no significant differences in age among the four groups. Both the Tip and 12 values showed a positive correlation with the degree of OA progression (p = 0.737 and p = 0.632, respectively). By comparison between the apparently normal cartilage and the mild OA groups, there were significant differences in the Tip mapping, but not in the 12 mapping. Conclusions: Our study confirmed that Tip and 12 mapping can quantitatively evaluate the degree of patella cartilage degeneration in patients within the same age group. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishioka, Hiroaki; Hirose, Jun; Okamoto, Nobukazu; Okada, Tatsuya; Oka, Kiyoshi; Taniwaki, Takuya; Nakamura, Eiichi; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, Kumamoto 8608556, Japan; [Yamashita, Yasuyuki] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Chuo Ku, Kumamoto 8608556, Japan	Nishioka, H (reprint author), Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	kinuhnishiok@fc.kuh.kumamoto-u.ac.jp					Stahl R, 2009, EUR RADIOL, V19, P132, DOI 10.1007/s00330-008-1107-6; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Hirose J, 2012, EUR J RADIOL, V81, P2776, DOI 10.1016/j.ejrad.2011.11.019; Williams A, 2011, OSTEOARTHR CARTILAGE, V19, P84, DOI 10.1016/j.joca.2010.10.018; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Mosher TJ, 2004, ARTHRITIS RHEUM-US, V50, P2820, DOI 10.1002/art.20473; Wang LG, 2012, EUR J RADIOL, V81, P2329, DOI 10.1016/j.ejrad.2011.07.017; Duvvuri U, 1997, MAGNET RESON MED, V38, P863, DOI 10.1002/mrm.1910380602; Rauscher I, 2008, RADIOLOGY, V249, P591, DOI 10.1148/radiol.2492071870; Jordan JM, 2007, J RHEUMATOL, V34, P172, DOI 10.3899/jrheum.080677; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Froimson MI, 1997, OSTEOARTHR CARTILAGE, V5, P377, DOI 10.1016/S1063-4584(97)80042-8; Thuillier DU, 2013, AM J SPORT MED, V41, P1813, DOI 10.1177/0363546513495167; Borthakur A, 2006, NMR BIOMED, V19, P781, DOI 10.1002/nbm.1102; Prasad AP, 2013, OSTEOARTHR CARTILAGE, V21, P69, DOI 10.1016/j.joca.2012.09.011; Oka H, 2008, OSTEOARTHR CARTILAGE, V16, P1300, DOI 10.1016/j.joca.2008.03.011; Keenan KE, 2011, OSTEOARTHR CARTILAGE, V19, P171, DOI 10.1016/j.joca.2010.11.009; Bolbos RI, 2008, OSTEOARTHR CARTILAGE, V16, P1150, DOI 10.1016/j.joca.2008.02.018; Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208; REDFIELD AG, 1969, SCIENCE, V164, P1015, DOI 10.1126/science.164.3883.1015; Xia Y, 2000, INVEST RADIOL, V35, P602, DOI 10.1097/00004424-200010000-00007; Nishioka H, 2012, J MAGN RESON IMAGING, V35, P147, DOI 10.1002/jmri.22811; Hunter DJ, 2006, ARTHRITIS RHEUM, V54, P2488, DOI 10.1002/art.22016; Takayama Y, 2013, EUR J RADIOL, V82, pE192, DOI 10.1016/j.ejrad.2012.11.031; Borkhoff CM, 2011, CLIN ORTHOP RELAT R, V469, P1829, DOI 10.1007/s11999-011-1879-x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conaghan PG, 2006, OSTEOARTHR CARTIL SA, V14, pSA116; HARRISON MM, 1994, CLIN ORTHOP RELAT R, P56; Liebl H, 2014, ANN RHEUM DIS; Link TM, 2011, CARTILAGE IMAGING: SIGNIFICANCE, TECHNIQUES, AND NEW DEVELOPMENTS, P67, DOI 10.1007/978-1-4419-8438-8_7; Martin J A, 2001, Iowa Orthop J, V21, P1; Reichenbach S, 2010, ANN RHEUM DIS, V69, P143, DOI 10.1136/ard.2008.099200; Wong CS, 2013, EUR J RADIOL, V82, P647, DOI 10.1016/j.ejrad.2012.11.036	33	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAR	2015	84	3					463	468		10.1016/j.ejrad.2014.11.015		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA8NN	WOS:000349177800020		
J	Koyama, H; Ohno, Y; Seki, S; Nishio, M; Yoshikawa, T; Matsumoto, S; Maniwa, Y; Itoh, T; Nishimura, Y; Sugimura, K				Koyama, Hisanobu; Ohno, Yoshiharu; Seki, Shinichiro; Nishio, Mizuho; Yoshikawa, Takeshi; Matsumoto, Sumiaki; Maniwa, Yoshimasa; Itoh, Tomoo; Nishimura, Yoshihiro; Sugimura, Kazuro			Value of diffusion-weighted MR imaging using various parameters for assessment and characterization of solitary pulmonary nodules	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Lung neoplasms; Solitary pulmonary nodule; Magnetic resonance imaging; Diffusion magnetic resonance imaging	INTRAVOXEL INCOHERENT MOTION; LUNG LESIONS; IN-VIVO; COEFFICIENT; PERFUSION; CANCER; BENIGN	Objectives: To determine the appropriate parameters and evaluation method for characterizing solitary pulmonary nodules (SPNs) using quantitative parameters of diffusion-weighted imaging (DWI). Methods: Thirty-two subjects with 36 SPNs underwent DWI with seven different b values (0, 50, 100, 150,300, 500, and 1000 s/mm(2)). Five quantitative parameters were obtained from the region of interest drawn over each SPN: apparent diffusion coefficients (ADCs), true diffusion coefficients (DCs), and perfusion fractions (PFs), and signal-intensity ratios between lesion and spinal cord from DWI (b values: 1000 [LSR1000] and 500 [LSR500)]). All quantitative parameters and the diagnostic capabilities were statistically compared. Results: SPNs were diagnosed as follow: malignant (n = 27) and benign (n = 9). Parameter comparisonsfor malignant and benign showed both LSRs differed significantly (p < 0.05). Applying feasible threshold values showed LSR500 specificity (88.9% [8/9]) and accuracy (77.8% [28/36]) were significantly higher than ADC, DC, and PF specificity and accuracy (p < 0.05). LSR1000 accuracy (72.2% [26/36]) was significantly higher than DC accuracy, and its specificity (88.9% [8/9]) was significantly higher than ADC, DC, and PF specificities (p < 0.05). Conclusions: For quantitative differentiation of SPNs, LSR evaluation was more useful and practical than ADC, DC, and PF, and choice of b values showed little impact for the differentiation. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Koyama, Hisanobu; Seki, Shinichiro; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Div Radiol, Kobe, Hyogo 6500017, Japan; [Ohno, Yoshiharu; Nishio, Mizuho; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Kobe, Hyogo 6500017, Japan; [Ohno, Yoshiharu; Nishio, Mizuho; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res, Kobe, Hyogo 6500017, Japan; [Maniwa, Yoshimasa] Kobe Univ, Grad Sch Med, Dept Gen Thorac Surg, Kobe, Hyogo 6500017, Japan; [Itoh, Tomoo] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Kobe, Hyogo 6500017, Japan; [Nishimura, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med, Kobe, Hyogo 6500017, Japan	Koyama, H (reprint author), Kobe Univ, Grad Sch Med, Dept Radiol, Chou Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hkoyama@med.kobe-u.ac.jp			Philips Healthcare	This study was technically supported by Philips Healthcare, and Dr. Ohno and Prof. Sugimura, who were co-authors, were financially supported by Philips Healthcare.	LEBIHAN D, 1988, RADIOLOGY, V168, P497; Chen LH, 2013, J MAGN RESON IMAGING, V37, P1351, DOI 10.1002/jmri.23939; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; LEBIHAN D, 1986, RADIOLOGY, V161, P401; TURNER R, 1990, RADIOLOGY, V177, P407; BENVENISTE H, 1992, STROKE, V23, P746; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Holder CA, 2000, AM J NEURORADIOL, V21, P1799; Satoh S, 2008, AM J ROENTGENOL, V191, P464, DOI 10.2214/AJR.07.3133; Koyama H, 2010, EUR RADIOL, V20, P790, DOI 10.1007/s00330-009-1615-z; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Liu HD, 2010, EUR RADIOL, V20, P807, DOI 10.1007/s00330-009-1629-6; Uto T, 2009, RADIOLOGY, V252, P247, DOI 10.1148/radiol.2521081195; Attariwala R, J MAGN RESON IMAG; Bernardin L, 2014, EUR RADIOL, V24, P502, DOI 10.1007/s00330-013-3048-y; Doblas S, 2013, INVEST RADIOL, V8, P722; Herneth AM, 2003, EUR J RADIOL, V45, P208; Higashi K, 2001, J NUCL MED, V42, P1489; Jeong YJ, SOLITARY PULMONARY N; Koyama H, 2013, J THORAC IMAG, V28, P138, DOI 10.1097/RTI.0b013e31828d4234; Pauls S, 2010, EUR J RADIOL, V81, P178; PROVENCHER SW, 1976, BIOPHYS J, V16, P27; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Tanaka R, 2009, J THORAC IMAG, V24, P4, DOI 10.1097/RTI.0b013e31818703b7; Wahidi MM, 2007, CHEST, V132, p94S, DOI 10.1378/chest.07-1352	30	4	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAR	2015	84	3					509	515		10.1016/j.ejrad.2014.11.024		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA8NN	WOS:000349177800026		
J	Tobino, K; Johkoh, T; Fujimoto, K; Sakai, F; Arakawa, H; Kurihara, M; Kumasaka, T; Koike, K; Takahashi, K; Seyama, K				Tobino, Kazunori; Johkoh, Takeshi; Fujimoto, Kiminori; Sakai, Fumikazu; Arakawa, Hiroaki; Kurihara, Masatoshi; Kumasaka, Toshio; Koike, Kengo; Takahashi, Kazuhisa; Seyama, Kuniaki			Computed tomographic features of lymphangioleiomyomatosis: Evaluation in 138 patients	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Lymphangioleiomyomatosis; Tuberous sclerosis; Computed tomography	TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; CT FINDINGS; UTERINE; CYST	Purpose: The aim was to characterize the computed tomographic (CT) findings from Japanese patients with lymphangioleiomyomatosis (LAM). Materials and methods: CT scans of the chest, abdomen, and pelvis from 124 patients with sporadic LAM (S-LAM, mean age, 37.4 years) and 14 patients with tuberous sclerosis complex (TSC)-LAM (mean age, 35.6 years) were analyzed. Results: Pulmonary nodules (18.8%) and hepatic angiomyolipoma (AML, 24.3%) were more common in our patients than those in previous reports. Compared with TSC-LAM, S-LAM group had a higher frequency of pulmonary nodules (28.6% vs 32.3%, P < 0.01) and lower frequencies of air-space consolidation (21.4% vs 2.4%, P < 0.01), pneumothorax (28.6% vs 8.1%, P = 0.02), pulmonary hilar lymphadenopathy (14.3% vs 0.8%, P < 0.01), renal AML (85.7% vs 17.4%, P < 0.01), hepatic AML (71.4% vs 17.4%, P < 0.01), and retrocrural lymphadenopathy (14.3% vs 1.4%, P = 0.04). Axial lymphatic abnormalities (i.e., thoracic duct dilatation, lymphadenopathy, and lymphangioleiomyoma) were most common in the pelvis and tended to decrease in incidence with increased distance from the pelvis. Conclusion: The incidence of some CT findings in Japanese patients differed from those in previous reports. Axial lymphatic abnormalities noted here suggest that the origin of LAM cells may be the pelvis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Tobino, Kazunori] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka 8200018, Japan; [Tobino, Kazunori; Koike, Kengo; Takahashi, Kazuhisa; Seyama, Kuniaki] Juntendo Univ, Fac Med, Div Resp Med, Tokyo 113, Japan; [Tobino, Kazunori; Koike, Kengo; Takahashi, Kazuhisa; Seyama, Kuniaki] Juntendo Univ, Fac Med, Grad Sch Med, Bunkyo Ku, Tokyo 113, Japan; [Tobino, Kazunori; Kurihara, Masatoshi; Kumasaka, Toshio; Seyama, Kuniaki] Study Grp Pneumothorax & Cyst Lung Dis, Setagaya Ku, Tokyo 1580095, Japan; [Johkoh, Takeshi] Kinki Cent Hosp, Publ Sch Teachers, Dept Radiol, Mutual Aid Assoc, Itami, Hyogo 6640872, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 8300011, Japan; [Fujimoto, Kiminori] Kurume Univ Hosp, Ctr Diagnost Imaging, Kurume, Fukuoka 8300011, Japan; [Sakai, Fumikazu] Saitama Med Univ, Saitama Int Med Ctr, Dept Diagnost Radiol, Hidaka, Saitama 3501298, Japan; [Arakawa, Hiroaki] Dokkyo Med Univ, Dept Radiol, Mibu, Tochigi 3210293, Japan; [Kurihara, Masatoshi] Nissan Tamagawa Hosp, Pneumothorax Ctr, Setagaya Ku, Tokyo 1580095, Japan; [Kumasaka, Toshio] Japanese Red Cross Med Ctr, Dept Pathol, Shibuya Ku, Tokyo 1500012, Japan	Tobino, K (reprint author), Juntendo Univ, Fac Med, Div Resp Med, 2-1-1 Hongo, Tokyo 113, Japan.	tobino@juntendo.ac.jp			Ministry of Health, Labour and Welfare, Japan; High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Institute for Environmental and Gender-Specific Medicine, Juntendo University, Graduate School of Medicine	We thank Dr. Yoshihito Hoshika of the Department of Respiratory Medicine, Juntendo University Hospital, and the medical technologists including Mr. Toyoaki Takahashi, Mr. Hideaki Sudo, and Mr. Kazuhiko Doryo of the Department of Radiology, Juntendo University Hospital for their assistance in obtaining the CT data. This study was supported in part by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan, a High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Institute for Environmental and Gender-Specific Medicine, Juntendo University, Graduate School of Medicine. We thank Ms. Phyllis Minick for her excellent proofreading of our English writing.	Casper KA, 2002, RADIOLOGY, V225, P451, DOI 10.1148/radiol.2252011584; Kumasaka T, 2005, AM J SURG PATHOL, V29, P1356, DOI 10.1097/01.pas.0000172192.25295.45; KITAICHI M, 1995, AM J RESP CRIT CARE, V151, P527; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Avila NA, 2000, RADIOLOGY, V216, P147; Pallisa E, 2002, RADIOGRAPHICS, V22, pS185; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; PEDERSEN JF, 1993, BRIT J RADIOL, V66, P581; JOZWIAK S, 1992, ARCH DIS CHILD, V67, P1363; Roach ES, 1998, J CHILD NEUROL, V13, P624; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Avila NA, 2007, RADIOLOGY, V242, P277, DOI 10.1148/radiol.2421051767; BAERT L, 1977, J UROLOGY, V118, P707; BLAND JM, 1986, LANCET, V1, P307; CARRINGTON CB, 1977, AM REV RESPIR DIS, V116, P977; Chao Cheng-Han, 2004, Chang Gung Med J, V27, P696; Hayashi T, 2011, AM J SURG PATHOL, V35, P1776, DOI 10.1097/PAS.0b013e318235edbd; Iwasa Y, 2011, INT J GYNECOL PATHOL, V30, P470, DOI 10.1097/PGP.0b013e318212e1e6; Kirchner J, 1999, EUR RADIOL, V9, P49, DOI 10.1007/s003300050626; LENOIR S, 1990, RADIOLOGY, V175, P329; Mitsumine T, 2009, HLTH EVAL PROMOT, V36, P361; Neumann H P, 1998, Semin Pediatr Neurol, V5, P269, DOI 10.1016/S1071-9091(98)80005-3; Sullivan EJ, 1998, CHEST, V114, P1689, DOI 10.1378/chest.114.6.1689	23	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAR	2015	84	3					534	541		10.1016/j.ejrad.2014.12.008		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA8NN	WOS:000349177800029		
J	Johkoh, T; Fukuoka, J; Tanaka, T				Johkoh, Takeshi; Fukuoka, Junya; Tanaka, Tomonori			Rare idiopathic intestinal pneumonias (IIPs) and histologic patterns in new ATS/ERS multidisciplinary classification of the IIPs	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Idiopathic interstitial pneumonias; CT; Consensus classification	PLEUROPARENCHYMAL FIBROELASTOSIS; INTERSTITIAL PNEUMONIA; ORGANIZING PNEUMONIA; FEATURES; ENTITY	The new American Thoracic Society/European Respiratory Society (ATS/ERS) update to the multidisciplinary classification of idiopathic interstitial pneumonias (IIPs) defines both rare IIPs and rare histologic patterns of IIPs. Although these diseases are rare, each has some distinguishing imaging and pathologic characteristics. Common findings for IIPs in computed tomography (CT) include cysts in lymphoid interstitial pneumonia (LIP), upper lobe subpleural consolidation in pleuropulmonary fibroelastosis (PPFE), symmetrical consolidation in acute fibrinous organizing pneumonia (AFOP), and peribronchovascular consolidation or centrilobular nodules in bronchiolocentric pattern of interstitial pneumonia. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Johkoh, Takeshi] Kinki Cent Hosp, Publ Sch Teachers, Dept Radiol, Mutual Aid Assoc, Itami, Hyogo, Japan; [Fukuoka, Junya; Tanaka, Tomonori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki, Japan	Johkoh, T (reprint author), Kinki Cent Hosp, Publ Sch Teachers, Dept Radiol, Mutual Aid Assoc, Itami, Hyogo, Japan.	johkot@aol.com; fukuokaj@nagasaki-u.ac.jp; yotsudukayama@yahoo.com					American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Amitani R, 1992, KOKYU, V11, P693; Becker CD, 2008, MODERN PATHOL, V21, P784, DOI 10.1038/modpathol.2008.56; Frankel SK, 2004, CHEST, V126, P2007, DOI 10.1378/chest.126.6.2007; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; Cha SI, 2006, EUR RESPIR J, V28, P364, DOI 10.1183/09031936.06.00076705; Johkoh T, 1999, RADIOLOGY, V212, P567; Yousem SA, 2002, MODERN PATHOL, V15, P1148, DOI 10.1097/01.MP.0000037309.04985.B4; Yokogawa N, 2007, AIDS, V21, P2116; Beasley MB, 2002, ARCH PATHOL LAB MED, V126, P1064; Fukuoka J, 2005, AM J SURG PATHOL, V29, P948, DOI 10.1097/01.pas.0000168177.71405.ac; Hariri LP, 2012, HUM PATHOL, V43, P660, DOI 10.1016/j.humpath.2011.06.001; Balduin R, 2007, OFF J WASOG, V24, P78	13	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAR	2015	84	3					542	546		10.1016/j.ejrad.2014.11.032		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA8NN	WOS:000349177800030		
J	Yamawo, A				Yamawo, Akira			Relatedness of Neighboring Plants Alters the Expression of Indirect Defense Traits in an Extrafloral Nectary-Bearing Plant	EVOLUTIONARY BIOLOGY			English	Review						Competition; Intraspecific interaction; Kin recognition; Mallotus japonicus; Resource allocation	KIN RECOGNITION; TRADE-OFFS; ANTIHERBIVORE DEFENSES; NUTRIENT AVAILABILITY; PHENOTYPIC PLASTICITY; MACARANGA-TANARIUS; INDUCED RESISTANCE; COMPETITION; HERBIVORY; RESPONSES	Different degrees of genetic relatedness among plants living in close proximity create differences in resource allocation and change the expression of defense traits. I investigated the plasticity of defense traits in young Mallotus japonicus growing with half-siblings or non-siblings, and examined direct defense traits (trichome density, pellucid dot density, and total phenolic content) and indirect defense traits (number of extrafloral nectaries, volume of extrafloral nectar, and number of food bodies) on the leaves. The plants growing with non-siblings invested proportionally more in shoots at high root biomass. Most defense traits did not differ between the two conditions, but the volume of extrafloral nectar was significantly larger with non-siblings. Although trichome density was not correlated with total plant biomass, some relationships between defense and growth differed significantly between the conditions, indicating a trade-off between plant growth and the expression of each defense trait (representing defense allocation costs). The chemical defense traits (pellucid dot density, total phenolic compounds) were negatively correlated with total biomass in plants growing with half-siblings, but were significantly positively correlated with total biomass in plants growing with non-siblings. The indirect defense traits were significantly positively correlated with total biomass in plants growing with non-siblings. These results suggest that the relatedness of neighboring plants alters their defense strategy and defense allocation costs, and that the local genetic relatedness of plants may play an important role in plant-animal interactions.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan	Yamawo, A (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	yamawo.aki@gmail.com			 [234305];  [251712]	This work was supported in part by Grants-in-aid for JSPS fellows to A.Y. (234305 and 251712).	Agrawal AA, 2004, AM J BOT, V91, P1990, DOI 10.3732/ajb.91.12.1990; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Yamawo A, 2012, J ECOL, V100, P802, DOI 10.1111/j.1365-2745.2011.01934.x; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331; Dyer LA, 2001, J CHEM ECOL, V27, P581, DOI 10.1023/A:1010345123670; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Redman AM, 2001, OECOLOGIA, V126, P380, DOI 10.1007/s004420000522; ODOWD DJ, 1979, OECOLOGIA, V43, P233, DOI 10.1007/BF00344773; WEINER J, 1992, ECOLOGY, V73, P648, DOI 10.2307/1940771; Yamawo A, 2014, J ECOL, V102, P238, DOI 10.1111/1365-2745.12169; Kelly JK, 1996, AM NAT, V147, P899, DOI 10.1086/285885; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868; Kobayashi S, 2008, ANN BOT-LONDON, V101, P1035, DOI 10.1093/aob/mcn033; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Karban R, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3062; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; File AL, 2012, P ROY SOC B-BIOL SCI, V279, P209, DOI 10.1098/rspb.2011.1995; Inderjit, 1997, BOT REV, V63, P221, DOI 10.1007/BF02857949; Rudgers JA, 2004, AM J BOT, V91, P871, DOI 10.3732/ajb.91.6.871; Barton KE, 2006, OECOLOGIA, V150, P442, DOI 10.1007/s00442-006-0531-z; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Siemens DH, 2003, EVOL ECOL, V17, P247, DOI 10.1023/A:1025517229934; Holzapfel C, 2003, OECOLOGIA, V134, P72, DOI 10.1007/s00442-002-1062-x; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Heil M, 2002, OIKOS, V99, P457, DOI 10.1034/j.1600-0706.2002.11954.x; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Olson DM, 2009, BIOL CONTROL, V49, P239, DOI 10.1016/j.biocontrol.2009.02.011; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Katayama N, 2011, PLANT ECOL, V212, P743, DOI 10.1007/s11258-010-9862-2; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; Boege K, 2010, ECOLOGY, V91, P2628, DOI 10.1890/09-0543.1; Chen JX, 2012, SYNLETT, V23, P157, DOI 10.1055/s-0031-1290104; CHEPLICK GP, 1992, J ECOL, V80, P567, DOI 10.2307/2260699; Cipollini D, 2010, EVOL ECOL, V24, P59, DOI 10.1007/s10682-008-9290-0; Cipollini D, 2007, NEW PHYTOL, V173, P146, DOI 10.1111/j.1469-8137.2006.01882.x; Cipollini DF, 2001, J CHEM ECOL, V27, P593, DOI 10.1023/A:1010384805014; File AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045648; Guhling O, 2005, J CHEM ECOL, V31, P2323, DOI 10.1007/s10886-005-7104-1; Holland JN, 2009, J ECOL, V97, P89, DOI 10.1111/j.1365-2745.2008.01446.x; Horikawa Y, 1972, ATLAS JAPANESE FLORA; Howe H., 1988, ECOLOGICAL RELATIONS; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; KARBAN R, 1989, AM NAT, V134, P749, DOI 10.1086/285009; KOPTUR S., 1992, INSECT PLANT INTERAC, VIV, P81; Kurashige NS, 2005, AM J BOT, V92, P21, DOI 10.3732/ajb.92.1.21; Lepik A, 2012, FUNCT ECOL, V26, P1214, DOI 10.1111/j.1365-2435.2012.02037.x; Lin Y, 2014, OIKOS, V123, P248, DOI 10.1111/j.1600-0706.2013.00921.x; Morris WF, 2006, OIKOS, V112, P102, DOI 10.1111/j.0030-1299.2006.14253.x; Ness JH, 2003, OECOLOGIA, V134, P210, DOI 10.1007/s00442-002-1110-6; Oliveira PS, 2007, ECOLOGY EVOLUTION AN; R Development Core Team, 2012, R LANG ENV STAT COMP; Sato Shigeho, 2005, Japanese Journal of Ornithology, V54, P23, DOI 10.3838/jjo.54.23; SHIMODA K, 1994, ECOL RES, V9, P85, DOI 10.1007/BF02347245; STEWARD JL, 1988, OIKOS, V53, P79, DOI 10.2307/3565666; Tseng MH, 2003, J CHEM ECOL, V29, P1269, DOI 10.1023/A:1023846010108; Vickery ML, 1981, SECONDARY PLANT META; Walters D, 2011, PLANT DEFENSE WARDIN; WASHITANI I, 1987, Ecological Research, V2, P191, DOI 10.1007/BF02349773; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Yamasaki E, 2013, AUST J BOT, V61, P60, DOI 10.1071/BT12202; Yamawo A., 2012, THESIS KAGOSHIMA U S; Yamawo A, 2012, PLANT ECOL, V213, P127, DOI 10.1007/s11258-011-9957-4; Young B, 2010, AM J BOT, V97, P601, DOI 10.3732/ajb.0900281; Zhao-Hui L, 2010, MOLECULES, V15, P8933	66	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0071-3260	1934-2845		EVOL BIOL	Evol. Biol.	MAR	2015	42	1					12	19		10.1007/s11692-014-9295-2		8	Evolutionary Biology	Evolutionary Biology	CB0SD	WOS:000349336200002		
J	Fujimoto, S; Miyake, T; Yamahira, K				Fujimoto, Shingo; Miyake, Takashi; Yamahira, Kazunori			Latitudinal Variation in Male Competitiveness and Female Choosiness in a Fish: Are Sexual Selection Pressures Stronger at Lower Latitudes?	EVOLUTIONARY BIOLOGY			English	Review						Fisherian runaway; Mating experiment; Oryzias latipes complex; Reproductive seasonality; Sexual dimorphism	MEDAKA ORYZIAS-LATIPES; LIFE-HISTORY; JAPANESE MEDAKA; ARTIFICIAL SELECTION; GEOGRAPHIC-VARIATION; WILD POPULATIONS; MATE CHOICE; BODY-SIZE; ADRIANICHTHYIDAE; PREFERENCE	Tropical animals are characterized by their showy ornaments and conspicuous colors, and numerous studies on sexual selection have been conducted using tropical species as a model system. In this study, hypothesizing that sexual selection pressures are stronger at lower latitudes, we examined the latitudinal variation in the degree of (1) male aggressiveness in male-male competitions, (2) male eagerness in courtship, and (3) female choosiness to mates in the medaka fish (Oryzias latipes complex). Laboratory mating experiments revealed that males from lower-latitude populations fight each other and court females more frequently than males from higher-latitude populations, supporting the hypothesis that both intra- and intersexual selection pressures are stronger at lower latitudes. In addition, females from lower-latitude populations, where males are more conspicuous, did not accept males easily, especially when mated with higher-latitude males, suggesting that female choosiness has also coevolved across latitudes through Fisherian runaway process. We suggest that latitudinal cline in reproductive seasonality, which is the case not only in the medaka but also among a variety of taxa, leads to latitudinal cline in operational sex ratios of local populations, which ultimately results in latitudinal cline in sexual selection pressures.	[Fujimoto, Shingo] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Miyake, Takashi] Gifu Univ, Fac Educ, Gifu 5011193, Japan; [Yamahira, Kazunori] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan	Fujimoto, S (reprint author), Univ Ryukyus, Grad Sch Engn & Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	bibliotaker@gmail.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [JSPS 254092, KAKENHI 20570019, 20322589]	We would like to thank M. Kawajiri, M. Abe, T. Nakata, S. Kiso, and K. Sasaki for assistance in keeping experimental fish. We also thank T. Irie for assistance in statistical analyses. This study was partially supported by a Research Fellowship for Young Scientists (JSPS 254092) to S. F. and by a Grant-in-Aid for Scientific Research (KAKENHI 20570019 and 20322589) to K. Y., both from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Andersson M., 1994, SEXUAL SELECTION; Vollestad LA, 2003, ANIM BEHAV, V66, P561, DOI 10.1006/anbe.2003.2237; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494; Grant JWA, 1996, BEHAV ECOL, V7, P165, DOI 10.1093/beheco/7.2.165; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Corbet Philip S., 2006, International Journal of Odonatology, V9, P1; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Vila-Gispert A, 2002, REV FISH BIOL FISHER, V12, P417, DOI 10.1023/A:1025352026974; Parenti LR, 2010, COPEIA, P268, DOI 10.1643/CI-09-108; ARAK A, 1983, NATURE, V306, P261, DOI 10.1038/306261a0; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Asai T, 2011, ICHTHYOL EXPLOR FRES, V22, P289; Stuart-Fox D, 2003, J EVOLUTION BIOL, V16, P659, DOI 10.1046/j.1420-9101.2003.00573.x; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; KODRICBROWN A, 1985, BEHAV ECOL SOCIOBIOL, V17, P199, DOI 10.1007/BF00300137; Zerbe P, 2012, BIOL REV, V87, P965, DOI 10.1111/j.1469-185X.2012.00238.x; AWAJI M, 1987, NIPPON SUISAN GAKK, V53, P959; Cardillo M, 2002, J ANIM ECOL, V71, P79, DOI 10.1046/j.0021-8790.2001.00577.x; Chui CKS, 2009, J BIOGEOGR, V36, P1945, DOI 10.1111/j.1365-2699.2009.02132.x; CONOVER DO, 1992, J FISH BIOL, V41, P161, DOI 10.1111/j.1095-8649.1992.tb03876.x; Darwin C., 1871, DESCENT MAN SELECTIO; EGAMI N, 1988, ZOOL SCI, V5, P1149; GRANT JWA, 1995, ANIM BEHAV, V49, P367, DOI 10.1006/anbe.1995.9998; HILL GE, 1994, BEHAV ECOL, V5, P64, DOI 10.1093/beheco/5.1.64; Howard RD, 1998, ANIM BEHAV, V55, P1151, DOI 10.1006/anbe.1997.0682; IMS RA, 1988, EVOL ECOL, V2, P338, DOI 10.1007/BF02207565; Iwamatsu T, 2006, INTEGRATED BOOK BIOL; Kawajiri M, 2009, BIOL J LINN SOC, V97, P571; Kawajiri M, 2011, J THERM BIOL, V36, P306, DOI 10.1016/j.jtherbio.2011.06.003; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Monteiro NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044251; Ono Y., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P197; Reichard M, 2008, MOL ECOL, V17, P642, DOI 10.1111/j.1365-294X.2007.03602.x; MORRIS MR, 1992, COPEIA, P980, DOI 10.2307/1446627; SAKAIZUMI M, 1992, J EXP ZOOL, V264, P85, DOI 10.1002/jez.1402640113; Sugano YC, 2011, BEHAV ECOL, V22, P701, DOI 10.1093/beheco/arr036; VANOORTMERSSEN GA, 1981, BEHAV GENET, V11, P115; Wallace AR, 1889, DARWINISM EXPOSITION; WALTER RO, 1970, ANIM BEHAV, V18, P125, DOI 10.1016/0003-3472(70)90079-5; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, DOI 10.1002/2013EO450001	51	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0071-3260	1934-2845		EVOL BIOL	Evol. Biol.	MAR	2015	42	1					75	87		10.1007/s11692-014-9300-9		13	Evolutionary Biology	Evolutionary Biology	CB0SD	WOS:000349336200007		
J	Kubo, MO; Takatsuki, S				Kubo, Mugino O.; Takatsuki, Seiki			Geographical Body Size Clines in Sika Deer: Path Analysis to Discern Amongst Environmental Influences	EVOLUTIONARY BIOLOGY			English	Review						Bergmann's rule; Body mass; Intraspecific comparison; Island rule; Path analysis; Skull	D-LOOP SEQUENCES; BERGMANNS RULE; CERVUS-NIPPON; SEXUAL DIMORPHISM; RED DEER; MAMMALS; FOLLOW; BIRDS; NDVI; EVOLUTION	Using Japanese sika deer from boreal and subtropical forests, we investigated the effects of environmental factors on body size variation and tested the following ecological hypotheses pertaining to Bergmann's rule in mammals: (1) heat conservation, (2) heat dissipation, (3) starvation resistance, (4) food availability and (5) insularity. Data on body sizes and habitats of sika deer from 31 populations on the Japanese archipelago were collected. Body mass and cranial greatest length (CGL; reflecting skeletal body size) were measured and analysed separately among gender groups. Path analyses were used to clarify inter-variable relationships and estimate direct and indirect effects of environmental variables on body size. Consistent with Bergmann's rule, a clear latitudinal cline of body size was found for sika deer. Subsequent path analyses showed that the abiotic factors, specifically mean annual temperature and annual precipitation, had significant negative effects on body size, and annual temperature had the greatest effect among tested environmental variables. Winter severity and food availability during spring were significantly associated with body mass but not with CGL. Both heat conservation and dissipation hypotheses were accepted and food availability and starvation resistance hypotheses were applicable to variation of body mass but not to CGL, indicating that phenotypic changes in fat reserves strongly influence variation in body mass. Path diagram modelling of inter-variable relationships fit well for females but not for males, and unexplained variation of male body size suggested the presence of unidentified factors. Variation in mating systems among populations may effect body size variation of the male sika deer.	[Kubo, Mugino O.] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Takatsuki, Seiki] Azabu Univ, Lab Wildlife Ecol, Sagamihara, Kanagawa 2298509, Japan	Kubo, MO (reprint author), Univ Tokyo, Univ Museum, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mugino@um.u-tokyo.ac.jp			 [25-10506]	This work was made possible by the persistent efforts of wildlife managers, field researchers and hunters all over Japan, who have substantially contributed specimens of culled sika deer and data collection. Special appreciation is extended to Ohtaishi, N., Masaki, E., Yoshida, T., Kaji, K., Endo, H. and Taru, H. for allowing the use of sika deer specimens in their collections. Comments from two anonymous reviewers improved the paper greatly. This research was supported by a Grant-in-Aid for JSPS Fellows (25-10506).	Terada C, 2012, OECOLOGIA, V169, P981, DOI 10.1007/s00442-012-2270-7; Nagata J, 1999, MOL PHYLOGENET EVOL, V13, P511, DOI 10.1006/mpev.1999.0668; Meiri S, 2003, J BIOGEOGR, V30, P331; MITCHELL B, 1976, J ZOOL, V180, P107; Lomolino MV, 2012, J BIOGEOGR, V39, P842, DOI 10.1111/j.1365-2699.2011.02656.x; Kaji Koichi, 2009, P421, DOI 10.1007/978-4-431-09429-6_30; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; Meiri S, 2011, GLOBAL ECOL BIOGEOGR, V20, P203, DOI 10.1111/j.1466-8238.2010.00577.x; Ashton KG, 2002, CAN J ZOOL, V80, P708, DOI 10.1139/Z02-049; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Clauss M, 2013, OIKOS, V122, P1465, DOI 10.1111/j.1600-0706.2013.00463.x; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Ozaki M, 2007, J ZOOL, V272, P244, DOI 10.1111/j.1469-7998.2006.00264.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI 10.2307/2411138; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; Bergmann C., 1847, GOTTINGER STUDIEN, V1, P595; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; Boyer AG, 2010, J BIOGEOGR, V37, P47, DOI 10.1111/j.1365-2699.2009.02175.x; Christianson D, 2009, ECOL APPL, V19, P1323, DOI 10.1890/08-0987.1; Geist V., 1999, DEER OF THE WORLD; Hatsukaichi City, 2012, HATS CIT REP CONS MA; JAMES FC, 1991, AM ZOOL, V31, P694; Janis C.M., 1990, P255; Japan Wildlife Research Center, 1998, JAP WILDL RES CTR AN; Kaji K., 2001, STUDY CONSERVATION M; Kira T., 1948, KANTI NOGAKU, V2, P143; Koganezawa M., 1986, MEMOIRS TOCHIGI PREF, V4, P29; Kojima T., 2013, COVARIANCE STRUCTURE; Martinez-Jauregui M, 2009, GLOBAL CHANGE BIOL, V15, P1727, DOI 10.1111/j.1365-2486.2008.01778.x; MIURA S, 1984, Z TIERPSYCHOL, V64, P33; Nagasaki Prefectural Board of Education, 1983, NAG PREF BOARD ED RE; Nagata Junco, 2009, P27, DOI 10.1007/978-4-431-09429-6_3; Ochiai Keiji, 1997, Journal of the Natural History Museum and Institute Chiba, V4, P159; Ochiai Keiji, 1995, Journal of the Natural History Museum and Institute Chiba, V3, P223; Ogura Go, 2003, Japanese Journal of Zoo and Wildlife Medicine, V8, P55; Ohtaishi N., 1986, HONYURUI KAGAKU, V53, P1317; Pedhazur EJ, 1982, MULTIPLE REGRESSION; RINEY T., 1955, NEW ZEALAND JOUR SCI AND TECHNOL SER E, V36, P429; ROSENZWE.ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Shiroma T., 1996, REPORT CONSERVATION, P13; Shizuma T., 2006, THESIS YAMAGUCHI U Y; Sondaar PY, 1977, MAJOR PATTERNS VERTE, P671; Suzuki M, 2001, CAN J ZOOL, V79, P154, DOI 10.1139/cjz-79-1-154; Takatsuki S., 1998, LIFE SIKA DEER READ; Takatsuki S., 2006, ECOLOGICAL HIST SIKA; Takiguchi H, 2012, ZOOL SCI, V29, P433, DOI 10.2108/zsj.29.433; Tamate HB, 1998, J MAMMAL, V79, P1396, DOI 10.2307/1383030; Tochigi Prefectural Museum, 1989, CAT MAT TOCH PREF MU; Von den Driesch A., 1976, GUIDE MEASUREMENT AN; Whitehead GK, 1972, DEER WORLD; Wigginton JD, 1999, CAN J ZOOL, V77, P802, DOI 10.1139/cjz-77-5-802; Wolverton S, 2009, AM MIDL NAT, V162, P403, DOI 10.1674/0003-0031-162.2.403; Yuasa T, 2007, ECOL RES, V22, P97, DOI 10.1007/s11284-006-0190-x	60	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0071-3260	1934-2845		EVOL BIOL	Evol. Biol.	MAR	2015	42	1					115	127		10.1007/s11692-015-9303-1		13	Evolutionary Biology	Evolutionary Biology	CB0SD	WOS:000349336200010		
J	Wang, E; Omiya, M				Wang, E.; Omiya, M.			Finite element analysis of crack mouth opening displacement compliance in crack length evaluation for clamped single edge tension specimens	FATIGUE & FRACTURE OF ENGINEERING MATERIALS & STRUCTURES			English	Article						BS 8571; compliance equation; crack length measurement; effective elastic modulus (E-e); finite element analysis (FEA); J-integral (J)	UNLOADING COMPLIANCE; RESISTANCE CURVES; GROWTH	In the unloading compliance method developed for clamped single edge tension (SE(T)) specimens, six crack mouth opening displacement (CMOD)-based compliance equations (i.e. a/W=f(BCE)) were proposed for the crack length evaluation without clearly clarifying the corresponding predictive accuracies. In addition, the effective elastic modulus (E-e) that reflects the actual state of stress should also be introduced in the crack length evaluation for SE(T) specimens, because the actual state of stress in the remaining ligament of the test specimen is neither plane stress (E) nor plane strain (E). In this study, two-dimensional (2D) plane strain and three-dimensional (3D) finite element analyses (FEAs) are carried out to investigate predictive accuracies of the six compliance equations. In both 2D and 3D FEA, specimens with a wide range of crack lengths and geometric configurations are included. For a given specimen, the value of E-e that presents the equivalent stress state in the remaining ligament is calculated on the basis of 3D FEA data. A set of formulae for the clamped SE(T) specimen is proposed that allows to evaluate E-e from the corresponding CMOD compliance. This approach is verified using numerical data. The observations of the numerical verification suggest that the use of E-e instead of E or E in CMOD-based compliance equations markedly improves the accuracy of the predicted crack length for clamped SE(T) specimens.	[Wang, E.; Omiya, M.] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Wang, E (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	enyang.wang@gmail.com					ADINA, 2001, THEOR MOD GUID; Shen G, 2009, J TEST EVAL, V37, P347; Graba M, 2007, J THEOR APPL MECH, V45, P225; Cravero S, 2007, INT J FRACTURE, V148, P387, DOI 10.1007/s10704-008-9211-9; Mathias LLS, 2013, INT J PRES VES PIP, V111, P106, DOI 10.1016/j.ijpvp.2013.06.003; [Anonymous], 2006, DNVRPF108; Cravero S, 2007, ENG FRACT MECH, V74, P2735, DOI 10.1016/j.engfracmech.2007.01.012; Nourpanah N, 2011, ENG FRACT MECH, V78, P1201, DOI 10.1016/j.engfracmech.2010.11.021; Nourpanah N, 2011, ENG FRACT MECH, V78, P2010, DOI 10.1016/j.engfracmech.2011.03.018; CLARKE GA, 1979, J TEST EVAL, V7, P264; ASTM, 2011, E182011 ASTM INT; BSI, 1997, 7448 BSI; Clarkes G. A., 1976, ASTM STP, P27; Donatos G. H. B., 2013, ASME 2013 PRESS VESS, P1; Fairchild D, 2012, 9 INT PIP C IPC ASME, P297; FONZO A, 2009, ASME 28 INT C OC OFF, P249; Joyces J. A., 1992, FRACT MECH 22 S, P904; Mohr W., 2003, STRAIN BASED DESIGN; Pisarski HG, 2013, 2013 PIP TECHN C PTC; Shen G, 2009, 19 INT OFFSH POL ENG, P92; SHEN GW, 2012, ASME 2012 PRESS VESS, P903; Shens G., 2004, 2004 PIP TECHN C PTC, P703; Shens G., 2008, 200818TR CANMET MTL; Steekamp P. A. J. M., 1988, ASTM STP, P583; Tada H., 1973, STRESS ANAL CRACKS H; TANG H, 2010, 8 INT PIP C IPC ASME, P303; Wang EY, 2013, J TEST EVAL, V41, P770, DOI 10.1520/JTE20120269; WANG EY, 2012, ASME 2012 PRESS VESS, P419; Wang YY, 2011, 2 GENERATION MODELS; Wangs E., 2014, J TEST EVAL, V43, P1; Zhus X. K., 2008, ASME 2008 PRESS VESS, P61	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8756-758X	1460-2695		FATIGUE FRACT ENG M	Fatigue Fract. Eng. Mater. Struct.	MAR	2015	38	3					315	329		10.1111/ffe.12233		15	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	CA7NX	WOS:000349105300007		
J	Mukoyama, T; Shimoda, N; Satokawa, S				Mukoyama, Takashi; Shimoda, Naohiro; Satokawa, Shigeo			Catalytic decomposition of methanethiol to hydrogen sulfide over TiO2	FUEL PROCESSING TECHNOLOGY			English	Article						Desulfurization; Methanethiol; Direct decomposition; Hydrogen sulfide; Titanium oxide; Metal oxides	SOLID ACID CATALYSTS; SULFUR-COMPOUNDS; ACTIVATED CARBONS; DEEP DESULFURIZATION; DIBENZOTHIOPHENE ADSORPTION; SELECTIVE ADSORPTION; METHYL MERCAPTAN; PI-COMPLEXATION; LIQUID FUELS; NATURAL-GAS	As a new desulfurization process for fuel cell systems, catalytic direct decomposition of methanethiol into hydrogen sulfide on various metal oxides without hydrogen addition has been examined. Methanethiol was decomposed into hydrogen sulfide over several metal oxide catalysts at 300 degrees C. Major metal oxide catalysts used in this study decomposed methanethiol completely at 500 degrees C. However they would be sulfurized immediately by the decomposed products. Among them, titania (TiO2) catalyst exhibited a remarkable methanethiol decomposition activity and it was hardly sulfurized. The methanethiol conversion of TiO2 catalyst depended on the specific surface area. Hydrogen sulfide and dimethyl sulfide were produced with the same amount at below 250 degrees C. The methanethiol seems to be decomposed by the following equation at low temperature range: 2CH(3)SH -> H2S + (CH3)(2)S. In contrast, hydrogen sulfide and methane were produced as gas phase products and carbon species were also formed on TiO2 surface above 400 degrees C. The methanethiol seems to be decomposed by the following equation at high temperature range: 2CH(3)SH -> 2H(2)S + CH4 + C. We conclude that the direct decomposition of methanethiol on TiO2 surface proceeds via different reaction pathways depending on the reaction temperatures. (C) 2014 Elsevier B.V. All rights reserved.	[Mukoyama, Takashi; Shimoda, Naohiro; Satokawa, Shigeo] Seikei Univ, Fac Sci & Technol, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan	Satokawa, S (reprint author), Seikei Univ, Fac Sci & Technol, Dept Mat & Life Sci, 3-3-1 Kichijoji kitamachi, Musashino, Tokyo 1808633, Japan.	satokawa@st.seiket.ac.jp					Akisawa A., 2012, J JAPAN I ENERGY, V91, P1066; Song C, 2003, APPL CATAL B-ENVIRON, V41, P207, DOI 10.1016/S0926-3373(02)00212-6; Sano Y, 2004, APPL CATAL B-ENVIRON, V49, P219, DOI 10.1016/j.apcatb.2003.12.007; Song CS, 2002, CATAL TODAY, V77, P17, DOI 10.1016/S0920-5861(02)00231-6; Gao YF, 2003, J MATER CHEM, V13, P608, DOI 10.1039/b208681f; Mohtadi R, 2004, J POWER SOURCES, V138, P216, DOI 10.1016/j.jpowsour.2004.06.036; Srivastava VC, 2012, RSC ADV, V2, P759, DOI 10.1039/c1ra00309g; Haji S, 2003, IND ENG CHEM RES, V42, P6933, DOI 10.1021/ie030518m; Ania CO, 2006, CARBON, V44, P2404, DOI 10.1016/j.carbon.2006.05.016; Klingenberg B, 1996, CHEM MATER, V8, P2755, DOI 10.1021/cm9602555; [Anonymous], 1996, CATAL SCI T; McNamara ND, 2013, J CATAL, V305, P217, DOI 10.1016/j.jcat.2013.05.021; Huguet E, 2013, APPL CATAL B-ENVIRON, V134, P344, DOI 10.1016/j.apcatb.2013.01.037; Whitehurst DD, 1998, ADV CATAL, V42, P345, DOI 10.1016/S0360-0564(08)60631-8; Chen YS, 2010, PHYS CHEM CHEM PHYS, V12, P5707, DOI 10.1039/b925910b; Kumagai S, 2010, FUEL, V89, P365, DOI 10.1016/j.fuel.2009.08.013; Tao H, 2009, FUEL, V88, P1961, DOI 10.1016/j.fuel.2009.03.020; Song CS, 2003, CATAL TODAY, V86, P211, DOI 10.1016/S0920-5861(03)00412-7; Liu G, 2002, J PHYS CHEM B, V106, P9883, DOI 10.1021/jp021155r; Seredych M, 2009, ENERG FUEL, V23, P3737, DOI 10.1021/ef900254k; Yang YX, 2007, CARBON, V45, P3042, DOI 10.1016/j.carbon.2007.10.016; Blomen Leo J.M.J., 1993, FUEL CELL SYSTEMS; Foeger K., 2005, J PHYS CHEM B, V109, P2149; Hernandez-Maldonado AJ, 2003, IND ENG CHEM RES, V42, P3103, DOI 10.1021/ie0301132; Hernandez-Maldonado AJ, 2005, APPL CATAL B-ENVIRON, V61, P212, DOI 10.1016/j.apcatb.2005.05.003; Hulea V, 2014, APPL CATAL B-ENVIRON, V144, P547, DOI 10.1016/j.apcatb.2013.07.056; Koottungal L, 2007, OIL GAS J, V105, P18; KOSHELEV CN, 1989, REACT KINET CATAL L, V39, P367, DOI 10.1007/BF02071354; Lide D.R., 2000, HDB CHEM PHYS, P9; Loborde-Boutet C., 2006, IND ENG CHEM RES, V45, P8111; MASHKIN VY, 1991, REACT KINET CATAL L, V44, P475, DOI 10.1007/BF02073018; Pack DJ, 2007, HYDROCARB PROCESS, V86, P47; Radman G., 1997, ADSORPT SCI TECHNOL, V15, P311; Salem ABSH, 1997, CHEM ENG TECHNOL, V20, P342, DOI 10.1002/ceat.270200511; Satokawa S, 2003, STUD SURF SCI CATAL, V145, P399, DOI 10.1016/S0167-2991(03)80244-6; Satokawa S, 2010, J JPN PETROL INST, V53, P83, DOI 10.1627/jpi.53.83; Sotelo JL, 2002, STUD SURF SCI CATAL, V142, P1579; Travert A, 2002, J PHYS CHEM B, V106, P1350, DOI 10.1021/jp0126762; Uchida H., 1976, OIL GAS J, V74, P131; Ziolek M., 1989, STUD SURF SCI CATAL, V46, P305; Ziolek M, 1997, STUD SURF SCI CATAL, V105, P1625; Zou A., 2006, J PHYS CHEM B, V110, P4699	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	MAR	2015	131						117	124		10.1016/j.fuproc.2014.11.013		8	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CA4NP	WOS:000348881700015		
J	Shigehisa, T; Inoue, T; Kumagai, H				Shigehisa, Takuo; Inoue, Toshinori; Kumagai, Haruo			Mathematical model of water sorption isotherms of UBC	FUEL PROCESSING TECHNOLOGY			English	Article						Low rank coal; UBC; Water sorption isotherms; Mathematical model; Henderson model; Weibull function	PART 1; ADSORPTION; DESORPTION	Mathematical models for sorption isotherms were investigated as for UBC (Upgraded Brown Coal) and its feed-stock coals, dried and not dried. Studies on classic models proved that: (1) Characteristic curves of Polanyi plot showed that UBC is more hydrophobic than its dried feedstock coal. (2) BET model is applicable in the range of 5 to 40% relative humidity and can provide a rough estimation of the heat of adsorption. Among modern models, Henderson model showed the best fitting but several other models gave satisfactory results when regression constants were properly adjusted. The fact that different models based on different theories describe a phenomenon, depending on regression constant values, implies that a reasonable interpretation of the constants is essential in understanding the phenomena through models. This is normally difficult but the constant of Henderson model was successfully interpreted through analogy to application of Weibull function to reliability engineering. Furthermore, it was proved that the constants of this model do not depend on temperature when moisture is non-dimensionalized. (C) 2014 Elsevier B.V. All rights reserved.	[Shigehisa, Takuo] Kobe Steel Ltd, Tech Dev Grp, Coal & Energy Technol Dept, Takasago, Hyogo 6768670, Japan; [Inoue, Toshinori] Kobeko Res Inst Inc, Div Appl Chem, Dept Technol, Nishi Ku, Kobe, Hyogo 6512271, Japan; [Kumagai, Haruo] Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Shigehisa, T (reprint author), Kobe Steel Ltd, Tech Dev Grp, Coal & Energy Technol Dept, 2-3-1 Shinhama, Takasago, Hyogo 6768670, Japan.	shigehisa.takuo@kobelco.com					HALSEY G, 1948, J CHEM PHYS, V16, P931, DOI 10.1063/1.1746689; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Bon J., 2012, REV BIOTECNOLOGIA SE, V10, P325; Bongers GD, 1998, FUEL PROCESS TECHNOL, V57, P41, DOI 10.1016/S0378-3820(98)00066-6; Chen CC, 1990, CHINESE AGR RES, V39, P367; Durie R.A., 1991, SCI VICTORIAN BROWN, P106; Emmett P.H., 1954, CATALYSIS 1, V1, P1; HENDERSON S. M., 1952, Agric. Engng., V33, P29; Huston ND, 1997, ADSORPTION, V3, P189; Kameoka, 1988, NOUGYO KIKAI GAKKAIS, V50, P37; Kinoshita S., 2010, KOBELCO TECHNOL REV, V29, P93; Nascimento FR, 2011, B CTR PESQUI PROC AL, V29, P43; Norinaga K, 1999, ENERG FUEL, V13, P1058, DOI 10.1021/ef990024v; Pakowski Z, 2011, FUEL, V90, P3330, DOI 10.1016/j.fuel.2011.06.044; Seid R. M., 2012, Agricultural Engineering International: CIGR Journal, V14, P163; Shigehisa T, 2014, ENERG FUEL, V28, P4986, DOI 10.1021/ef501029r; Shigehisa T., 2007, J JPN I ENERGY, V86, P822; Sun D.W., 1999, CIGR E J, V1; Vega-Galvez A, 2008, QUIM NOVA, V31, P1417, DOI 10.1590/S0100-40422008000600026; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Young D.M., 1962, PHYS ADSORPTION GASE	21	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	MAR	2015	131						133	141		10.1016/j.fuproc.2014.11.023		9	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CA4NP	WOS:000348881700017		
J	Komatsu, Y; Sciazko, A; Zakrzewski, M; Kimijima, S; Hashimoto, A; Kaneko, S; Szmyd, JS				Komatsu, Yosuke; Sciazko, Anna; Zakrzewski, Marcin; Kimijima, Shinji; Hashimoto, Akira; Kaneko, Shozo; Szmyd, Janusz S.			An experimental investigation on the drying kinetics of a single coarse particle of Belchatow lignite in an atmospheric superheated steam condition	FUEL PROCESSING TECHNOLOGY			English	Article						Low-rank coal; Lignite; Brown coal; Upgrading lignite quality; Drying characteristics; Drying process in atmospheric superheated; steam condition	LOW-RANK COALS; TEMPERATURE; WATER; POWER; AIR	The efficiency of lignite-fired power plants is sacrificed by the high moisture content of this energy carrier. The most adequate effort for upgrading the potential of lignite is the drying process, influenced by both the drying conditions and the physicochemical features of lignite. This paper presents studies on the drying kinetic of the Belchatow lignite originating from the biggest Polish lignite mine. Experimental attempts were conducted for spherical lignite samples dried in a superheated steam atmosphere at the temperature range of 110-170 degrees C. Each experiment includes the simultaneous measurements of changes in weight and temperature profiles for a single sample. Additionally, the drying process was recorded to observe the cracking on the surface of the sample and its shrinkage. The kinetics were described in the form of moisture content, drying rate and temperature profiles over the drying process. The time and rate of the superheated steam drying process depending on the sample size and steam temperature were estimated. Those parameters are essential for the design of an effective industrial coal drying system, which allows for the latent heat recovery of water evaporation from the lignite, which in turn will improve the thermal efficiency of the lignite-fired power generation. (C) 2014 Elsevier B.V. All rights reserved.	[Komatsu, Yosuke; Sciazko, Anna] Shibaura Inst Technol, Grad Sch Engn & Sci, Div Reg Environm Syst, Minuma Ku, Saitama 3378570, Japan; [Komatsu, Yosuke; Kimijima, Shinji; Hashimoto, Akira; Kaneko, Shozo] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Sciazko, Anna; Zakrzewski, Marcin; Szmyd, Janusz S.] AGH Univ Sci & Technol, Fac Energy & Fuels, Dept Fundamental Res Energy Engn, PL-30059 Krakow, Poland; [Kimijima, Shinji] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Machinery & Control Syst, Minuma Ku, Saitama 3378570, Japan	Komatsu, Y (reprint author), Shibaura Inst Technol, Grad Sch Engn & Sci, Div Reg Environm Syst, Minuma Ku, 307 Fukasaku, Saitama 3378570, Japan.	m610101@sic.shibaura-it.ac.jp	Komatsu, Yosuke/F-6004-2014	Komatsu, Yosuke/0000-0002-8609-4348	Japan Coal Energy Center (JCOAL); Polish National Centre	This work was financially supported by the Japan Coal Energy Center (JCOAL) and the Polish National Centre for Research and Development (NCBR Project: I_POL-JAP). The authors greatly acknowledge Dr. Tsuyoshi Kiriyama (a cooperative research fellow at Institute of Industrial Science, the University of Tokyo) for invaluable contribution to this work.	Allardice D.J., 1984, ADVANTAGES SCI VICTO, P85; Allardice D.J., 2001, 18 INT PITTB COAL C; Allardice D.J., 1993, SCI VICTORIAN BROWN, P103; YOSHIDA T, 1970, IND ENG CHEM PROC DD, V9, P207, DOI 10.1021/i260034a008; Fushimi C, 2011, DRY TECHNOL, V29, P105, DOI 10.1080/07373937.2010.482719; Zhang K, 2010, ENERG FUEL, V24, P6428, DOI 10.1021/ef101198k; Tahmasebi A, 2012, ENERG FUEL, V26, P3651, DOI 10.1021/ef300559b; Zheng HJ, 2014, FUEL PROCESS TECHNOL, V126, P259, DOI 10.1016/j.fuproc.2014.05.009; Bongers GD, 2000, FUEL PROCESS TECHNOL, V64, P13, DOI 10.1016/S0378-3820(99)00070-3; Chen Z, 2000, FUEL, V79, P961, DOI 10.1016/S0016-2361(99)00217-3; Osman H, 2011, DRY TECHNOL, V29, P1763, DOI 10.1080/07373937.2011.616443; Bongers GD, 1998, FUEL PROCESS TECHNOL, V57, P41, DOI 10.1016/S0378-3820(98)00066-6; Chen Z, 2001, FUEL, V80, P209, DOI 10.1016/S0016-2361(00)00081-8; Hausbrand E., 1924, J SOC CHEM IND LOND, V43, P919; Hoehne O, 2010, DRY TECHNOL, V28, P5, DOI 10.1080/07373930903423491; Kiriyama T., 2014, METALLURGICAL MAT E, V1, P349; Kiriyama T, 2013, MATER TRANS, V54, P1725, DOI 10.2320/matertrans.M-M2013817; Klutz H., 2011, GORNICTWO GEOINTYNIE, V35, P147; KOPP OC, 1984, INT J COAL GEOL, V3, P333, DOI 10.1016/0166-5162(84)90003-X; Kozlowski Z, 2003, APPL ENERG, V74, P323, DOI 10.1016/S0306-2619(02)00192-7; Law C. L., 2006, HDB IND DRYING, P174; Looi AY, 2002, CHEM ENG J, V87, P329, DOI 10.1016/S1385-8947(01)00244-3; Mujumdar A, 2006, HDB IND DRYING, P439; Olufemi BA, 2010, CHEM BIOCHEM ENG Q, V24, P29; Osman P.H., 2001, DRYING LOW RANK COAL; Pakowski Z, 2012, CHEM PROCESS ENG-INZ, V33, P43, DOI 10.2478/v10176-012-0004-3; Pikon J., 2006, HDB IND DRYING, P993; POTTER OE, 1984, DRY TECHNOL, V2, P219; POTTER OE, 1981, FUEL PROCESS TECHNOL, V4, P217, DOI 10.1016/0378-3820(81)90015-1; POTTER OE, 1979, J I ENERGY, V52, P143; Tahmasebi A., 2012, ENERG FUEL, V27, P154; Umar DF, 2005, COAL PREP, V25, P313, DOI 10.1080/0734934050044554; WENZEL L, 1951, IND ENG CHEM, V43, P1829, DOI 10.1021/ie50500a043	33	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	MAR	2015	131						356	369		10.1016/j.fuproc.2014.12.005		14	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CA4NP	WOS:000348881700043		
J	Li, ZH; Wang, Y; Yao, H; Lin, SY				Li, Zehua; Wang, Yin; Yao, Hong; Lin, Shiying			Novel CO2 sorbent: Ca(OH)(2) with high strength	FUEL PROCESSING TECHNOLOGY			English	Article						CO2 capture; Ca(OH)(2) particle; Strength; Breaking model; Hydration	CAO-BASED SORBENT; CARBON-DIOXIDE; LIMESTONE CALCINATION; HYDROGEN-PRODUCTION; CALCIUM-OXIDE; CAPTURE; STEAM; DECOMPOSITION; REACTIVITY; CYCLES	Using CaO-based sorbents to circularly absorb CO2 is one of the most interesting technologies for CO2 capture during coal combustion and gasification. The hydration step not only improves the reactivity of the Ca0-based sorbent but also produces high-strength Ca(OH)(2) particles for long-term CO2 absorption. A novel method of producing Ca(OH)(2) with high strength (>7.0 MPa) under different temperatures and/or steam partial pressures is proposed in this study. The mechanism and the particle breaking model are also discussed. Results indicate that high steam partial pressure and relatively low temperature are suitable conditions for the production of high-strength Ca(OH)(2) particles. High steam partial pressure changes the particle structure, such as porosity, and thus enhances the strength of Ca (OH)(2) particles. However, high temperature results in low Ca(OH)(2) particle strength. This result may be due to the increase in the S-BET of Ca(OH)(2) particles. A particle breaking model has been developed to explain this. Furthermore, when Ca(OH)(2) is decomposed to CaO, the strength of CaO particles becomes lower than that of the original Ca(OH)(2). Lastly, a CO2 capture approach that involves the use of Ca(OH)(2) particles with high strength is proposed. (C) 2014 Elsevier B.V. All rights reserved.	[Li, Zehua; Wang, Yin] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Pollutant Convers, Xiamen 361021, Peoples R China; [Li, Zehua; Yao, Hong] Huazhong Univ Sci & Technol, State Key Lab Coal Combust, Wuhan 430074, Peoples R China; [Lin, Shiying] Japan Coal Energy Ctr, Tokyo 1080073, Japan	Wang, Y (reprint author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Pollutant Convers, Xiamen 361021, Peoples R China.	yinwang@iue.ac.cn			National Natured Science Foundation [51176197]; Chinese Academy Sciences [KZZD-EW-16]; Xiamen Science & Technology Major Program [3502Z20131018]	Financial supports for this work by National Natured Science Foundation (No.51176197), Main Project of Chinese Academy Sciences (KZZD-EW-16) and Xiamen Science & Technology Major Program (No. 3502Z20131018) are gratefully acknowledged.	Lin SY, 2002, FUEL, V81, P2079, DOI 10.1016/S0016-2361(02)00187-4; Manovic V, 2007, ENVIRON SCI TECHNOL, V41, P1420, DOI 10.1021/es0621344; Grasa GS, 2006, IND ENG CHEM RES, V45, P8846, DOI 10.1021/ie0606946; Lu H, 2006, IND ENG CHEM RES, V45, P3944, DOI 10.1021/ie051325x; Wang Y, 2008, ENERG FUEL, V22, P2326, DOI 10.1021/ef800039k; RYSHKEWITCH E, 1953, J AM CERAM SOC, V36, P65, DOI 10.1111/j.1151-2916.1953.tb12837.x; Kierzkowska AM, 2013, INT J GREENH GAS CON, V15, P48, DOI 10.1016/j.ijggc.2013.01.046; Broda M, 2012, ACS CATAL, V2, P1635, DOI 10.1021/cs300247g; Gupta H, 2002, IND ENG CHEM RES, V41, P4035, DOI 10.1021/ie010867l; Donat F, 2012, ENVIRON SCI TECHNOL, V46, P1262, DOI 10.1021/es202679w; Broda M, 2013, ENVIRON SCI TECHNOL, V47, P6007, DOI 10.1021/es305113p; Abanades JC, 2002, CHEM ENG J, V90, P303, DOI 10.1016/S1385-8947(02)00126-2; Yin JJ, 2013, IND ENG CHEM RES, V52, P18215, DOI 10.1021/ie403080c; MONTEIRO PJM, 1995, CEMENT CONCRETE RES, V25, P1605, DOI 10.1016/0008-8846(95)00154-9; Anthony EJ, 2011, GREENH GASES, V1, P36, DOI [10.1002/ghg.32, 10.1002/ghg3.002]; Kierzkowska AM, 2013, CHEMSUSCHEM, V6, P1130, DOI 10.1002/cssc.201300178; Broda M, 2014, ENVIRON SCI TECHNOL, V48, P5322, DOI 10.1021/es405668f; Butler JW, 2011, CHEM ENG RES DES, V89, P1794, DOI 10.1016/j.cherd.2010.10.004; Herzog H, 2001, ENVIRON SCI TECHNOL, V35, p148A, DOI 10.1021/es012307j; Hiramatsu Y., 1965, J MIN METALL I JPN, V81, P1024; Iyer MV, 2004, IND ENG CHEM RES, V43, P3939, DOI 10.1021/ie0341911; Kasai J., 1958, GYPSUM LIME, V35, P20; Lin S, 2001, J S AFR I MIN METALL, V101, P53; Lin SY, 2009, ENERG FUEL, V23, P2855, DOI 10.1021/ef801088x; Perry R.H., 1997, PERRYS CHEM ENG HDB; Sakahashi H., 1986, Limestone Mineral Association, V68, Patent No. 2007226919; Wang Y, 2009, ENERG FUEL, V23, P2804, DOI 10.1021/ef801105j	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	MAR	2015	131						437	442		10.1016/j.fuproc.2014.12.023		6	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CA4NP	WOS:000348881700054		
J	Ohta, A				Ohta, Atsuyuki			Speciation Study of Cr in a Geochemical Reference Material Sediment Series Using Sequential Extraction and XANES Spectroscopy	GEOSTANDARDS AND GEOANALYTICAL RESEARCH			English	Article						speciation; Cr; valence state; sequential extraction; X-ray absorption near edge structure; geochemical reference material; speciation; Cr; etat de valence; extraction sequentielle; structure fine d'absorption des rayons X; materiau de reference geochimique	ROCK REFERENCE SAMPLES; CONTAMINATED SOILS; MANGANESE-DIOXIDE; METAL SPECIATION; HUMIC SUBSTANCES; CHROMIUM; REDUCTION; JSO-2; ELEMENTS; CR(VI)	Speciation of Cr in geochemical reference materials was characterised by sequential extraction and X-ray absorption near-edge structure (XANES) spectroscopy to identify Cr(III) resulting from the reduction of pollutant Cr(VI). Sequential extraction suggested that the amount of Cr associated with an acetic acid soluble fraction was low; Cr associated with a reducible phase and an oxidisable phase was extracted at 5-10% of the total Cr concentration, and the residual phase was found to be the dominant Cr-containing fraction. Cr speciation in soil artificially doped with Cr(VI) and sediment samples collected from highly populated and industrialised areas was different from that in naturally occurring materials. Substantial Cr was extracted as a reducible phase (15-30%) and an oxidisable phase (30-60%) for these samples. Through subsequent XANES spectroscopy analysis, the reducible phase was explained by Cr bound to Fe hydroxide, while the oxidisable phase was a mixture of Cr bound to humic substances and Cr hydroxides. That is, Cr(VI) present as a contaminant in sediments and soils was reduced to Cr(III), which then bound to Fe hydroxide and humic substances, precipitating as a hydroxide. Thus, a combination of sequential extraction and XANES spectroscopy allows for effective identification and quantification of the chemical forms of Cr in sediments and soils. La speciation du Cr dans des materiaux de reference geochimiques a ete caracterise par extraction sequentielle et spectroscopie de structure pres du front d'absorption de rayons X (XANES) afin d'identifier le Cr(III) resultant de la reduction du polluant Cr(VI). L'extraction sequentielle suggere que la quantite de Cr associe a une fraction soluble d'acide acetique etait faible; le Cr associe a une phase reductible et une phase oxydable a ete extrait a 5-10% de la concentration totale en Cr et il est apparu que la phase residuelle est la fraction dominante contenant du Cr. La speciation du Cr dans un sol dope artificiellement avec Cr(VI) et des echantillons de sediments preleves dans des zones fortement peuplees et industrialisees est differente de celle dans des materiaux naturels. En effet une part substantielle de Cr a ete extraite sous forme d'une phase reductible (15-30%) et d'une phase oxydable (30-60%) pour ces echantillons naturels. Grace a des analyses ulterieures par spectroscopie XANES, la phase reductible a ete explique par du Cr lie des hydroxydes de Fe, tandis que la phase oxydable etait un melange de Cr lie a des substances humiques et d'hydroxydes de Cr. Autrement dit, le Cr (VI) present en tant que contaminant dans les sediments et les sols a ete reduit en Cr (III), qui ensuite s'est lie a des hydroxydes de Fe et des substances humiques, precipitant sous forme d'hydroxyde. Ainsi, une combinaison entre l'extraction sequentielle et la spectroscopie XANES permet une identification et une quantification efficace des formes chimiques du Cr dans les sediments et les sols.	AIST, Geol Survey Japan, Ibaraki 3058567, Japan	Ohta, A (reprint author), AIST, Geol Survey Japan, Ibaraki 3058567, Japan.	a.ohta@aist.go.jp	Ohta, Atsuyuki/B-9808-2009	Ohta, Atsuyuki/0000-0002-0770-3273	Photon Factory Program Advisory Committee [2006G107, 2011G255]	The XANES experiments were performed with the approval of the Photon Factory Program Advisory Committee (2006G107 and 2011G255). I particularly thank Hiroyuki Kagi (University of Tokyo) for his useful suggestions that helped to improve the manuscript. I am also grateful to Hiroaki Nitani, Hitoshi Abe and Yasuhiro Niwa for their technical support in obtaining the experimental data at the beam line 12C in KEK-PF and to Hidemi Ishibashi and Koji Maruyama for their help in measuring the XANES spectra at KEK-PF.	ANDO A, 1989, GEOCHEM J, V23, P143; Ando A., 1990, B GEOL SURV JAPAN, V41, P27; Wittbrodt PR, 1996, ENVIRON SCI TECHNOL, V30, P2470, DOI 10.1021/es950731c; MURRAY JW, 1974, J COLLOID INTERF SCI, V46, P357, DOI 10.1016/0021-9797(74)90045-9; Rauret G, 2000, J ENVIRON MONITOR, V2, P228, DOI 10.1039/b001496f; Ostergren JD, 1999, ENVIRON SCI TECHNOL, V33, P1627, DOI 10.1021/es980660s; SCHROEDER DC, 1975, WATER AIR SOIL POLL, V4, P355, DOI 10.1007/BF00280721; Kim CS, 2003, ENVIRON SCI TECHNOL, V37, P5102, DOI 10.1021/es0341485; Peterson ML, 1997, GEOCHIM COSMOCHIM AC, V61, P3399, DOI 10.1016/S0016-7037(97)00165-8; Rauret G, 1999, J ENVIRON MONITOR, V1, P57, DOI 10.1039/a807854h; Sahuquillo A, 1999, ANAL CHIM ACTA, V382, P317, DOI 10.1016/S0003-2670(98)00754-5; Imai N, 1996, GEOSTANDARD NEWSLETT, V20, P165, DOI 10.1111/j.1751-908X.1996.tb00184.x; EARY LE, 1987, ENVIRON SCI TECHNOL, V21, P1187, DOI 10.1021/es00165a005; BAJT S, 1993, ANAL CHEM, V65, P1800, DOI 10.1021/ac00061a026; WITTBRODT PR, 1995, ENVIRON SCI TECHNOL, V29, P255, DOI 10.1021/es00001a033; Elzinga EJ, 2010, J HAZARD MATER, V183, P145, DOI 10.1016/j.jhazmat.2010.06.130; Pantsar-Kallio M, 2001, ANAL CHIM ACTA, V439, P9, DOI 10.1016/S0003-2670(01)00840-6; COETZEE PP, 1995, WATER SA, V21, P51; KHEBOIAN C, 1987, ANAL CHEM, V59, P1417, DOI 10.1021/ac00137a010; Sutherland RA, 2010, ANAL CHIM ACTA, V680, P10, DOI 10.1016/j.aca.2010.09.016; Calmano W, 2001, FRESEN J ANAL CHEM, V371, P823, DOI 10.1007/s00216-001-1106-9; desGroot F., 2009, J PHYS CONDENS MATT, V21; Gomez-Ariza JL, 1999, ANAL CHIM ACTA, V399, P295, DOI 10.1016/S0003-2670(99)00460-2; Kappen P, 2008, TALANTA, V75, P1284, DOI 10.1016/j.talanta.2008.01.041; Kouh N., 2000, ES T, V34, P112; Kubota R, 2014, GEOCHEM J, V48, P165, DOI 10.2343/geochemj.2.0297; Nomura M., 1996, DESIGN PERFORMANCE N, V95, P1; Nomura M., 1998, DESIGN PERFORMANCE M, V98, P1; Ohta A., 2007, B GEOL SURV JAPAN, V58, P201; Ohta A, 2012, GEOCHEM J, V46, P409; Ohta A, 2011, B GEOL SURV JAPAN, V62, P347; Ohta A, 2011, GEOCHEM-EXPLOR ENV A, V11, P211, DOI 10.1144/1467-7873/10-042; Okai T., 2004, GEOCHEMISTRY, V38, P281; Terashima S, 2000, BUNSEKI KAGAKU, V49, P319, DOI 10.2116/bunsekikagaku.49.319; TERASHIMA S, 1990, GEOSTANDARD NEWSLETT, V14, P1, DOI 10.1111/j.1751-908X.1990.tb00062.x; Terashima S, 2002, GEOSTANDARD NEWSLETT, V26, P85, DOI 10.1111/j.1751-908X.2002.tb00626.x; Tokunaga TK, 2003, J ENVIRON QUAL, V32, P1641; Tsuno H, 2006, GEOSTAND GEOANAL RES, V30, P55, DOI 10.1111/j.1751-908X.2006.tb00911.x; Ure AM, 2002, CHEM SPECIATION ENV, P265, DOI DOI 10.1002/9780470988312.CH10; Wittbrodt PR, 1997, EUR J SOIL SCI, V48, P151, DOI 10.1111/j.1365-2389.1997.tb00194.x	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1639-4488	1751-908X		GEOSTAND GEOANAL RES	Geostand. Geoanal. Res.	MAR	2015	39	1					87	103		10.1111/j.1751-908X.2014.00292.x		17	Geochemistry & Geophysics	Geochemistry & Geophysics	CA8FC	WOS:000349151600008		
J	Satoh, T; Ohtsuld, S; Iwagami, N; Ueno, M; Uemizu, K; Suzuki, M; Hashimoto, GL; Sakanoi, T; Kasaba, Y; Nakamura, R; Imamura, T; Nakamura, M; Fukuhara, T; Yamazaki, A; Yamada, M				Satoh, Takehiko; Ohtsuld, Shoko; Iwagami, Naomoto; Ueno, Munetaka; Uemizu, Kazunori; Suzuki, Makoto; Hashimoto, George L.; Sakanoi, Takeshi; Kasaba, Yasumasa; Nakamura, Ryosuke; Imamura, Takeshi; Nakamura, Masato; Fukuhara, Tetsuya; Yamazaki, Atsushi; Yamada, Manabu			Venus' clouds as inferred from the phase curves acquired by IR1 and IR2 on board Akatsuki	ICARUS			English	Article						Venus, atmosphere; Atmospheres, structure; Photometry; Infrared observations; Radiative transfer	ORBITER AKATSUKI; CAMERA ONBOARD; SCATTERING; PLANET; SULFUR	We present phase curves for Venus in the 1-2 mu m wavelength region, acquired with IR1 and IR2 on board Akatsuki (February-March 2011). A substantial discrepancy with the previously-published curves was found in the small phase angle range (0-30 degrees). Through analysis by radiative-transfer computation, it was found that the visibility of larger (similar to 1 mu m or larger) cloud particles was significantly higher than in the standard cloud model. Although the cause is unknown, this may be related to the recently reported increase in the abundance of SO2 in the upper atmosphere. It was also found that the cloud top is located at similar to 75 km and that 1-mu m particles exist above the cloud, both of these results being consistent with recent studies based on the Venus Express observations in 2006-2008. Further monitoring, including photometry for phase curves, polarimetry for aerosol properties, spectroscopy for SO2 abundance, and cloud opacity measurements in the near-infrared windows, is required in order to understand the mechanism of this large-scale change. (C) 2014 Elsevier Inc. All rights reserved.	[Satoh, Takehiko; Ueno, Munetaka; Suzuki, Makoto; Imamura, Takeshi; Nakamura, Masato; Yamazaki, Atsushi] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Satoh, Takehiko] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Ohtsuld, Shoko] Senshu Univ, Sch Commerce, Tama Ku, Kawasaki, Kanagawa 2148580, Japan; [Iwagami, Naomoto] Univ Tokyo, Bunkyo Ku, Tokyo 1330033, Japan; [Uemizu, Kazunori] Natl Astron Observ, Mitaka, Tokyo 1818588, Japan; [Hashimoto, George L.] Okayama Univ, Kita Ku, Okayama 7008530, Japan; [Sakanoi, Takeshi; Kasaba, Yasumasa] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Nakamura, Ryosuke] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Fukuhara, Tetsuya] Hokkaido Univ, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamada, Manabu] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan	Satoh, T (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	satoh@stp.isas.jaxa.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20227937]	The authors are grateful to W. Markiewicz for useful discussions. The observations would not have been possible without the selfless assistance of the engineering staff and operations-support staff. Comments from A. Mallama and another knowledgeable reviewer were of great help to improve the manuscript. This study was carried out with the Grants-in-Aid for Scientific Research (A) (20227937) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). This study is also supported in part by the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (for S.O.).	Imamura T, 2001, J ATMOS SCI, V58, P3597, DOI 10.1175/1520-0469(2001)058<3597:MOVCIR>2.0.CO;2; Svedhem H, 2007, NATURE, V450, P629, DOI 10.1038/nature06432; TOON OB, 1982, ICARUS, V51, P358, DOI 10.1016/0019-1035(82)90089-6; IRVINE WM, 1968, J ATMOS SCI, V25, P610, DOI 10.1175/1520-0469(1968)025<0610:MPCAAF>2.0.CO;2; Satoh T, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003184; Velikodsky YI, 2011, ICARUS, V214, P30, DOI 10.1016/j.icarus.2011.04.021; Wilquet V, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003186; Belyaev D, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003143; Nakamura M, 2007, PLANET SPACE SCI, V55, P1831, DOI 10.1016/j.pss.2007.01.009; HANSEN JE, 1974, SPACE SCI REV, V16, P527, DOI 10.1007/BF00168069; Fukuhara T, 2011, EARTH PLANETS SPACE, V63, P1009, DOI 10.5047/eps.2011.06.019; GRINSPOON DH, 1993, PLANET SPACE SCI, V41, P515, DOI 10.1016/0032-0633(93)90034-Y; Mallama A, 2006, ICARUS, V182, P10, DOI 10.1016/j.icarus.2005.12.014; Braak C.J., 2002, J GEOPHYS RES, V107, p[5032, 1]; Esposito L. W., 1985, Advances in Space Research, V5, DOI 10.1016/0273-1177(85)90274-1; Esposito L. W., 1983, Venus; GarciaMunoz A., 2014, ASTRON ASTROPHYS, V566, P1; Gottwald M., 2006, SCIAMACHY MONITORING; Houghton J. T., 1986, PHYS ATMOSPHERES; Ignatiev N.I., 2009, J GEOPHYS RES, V114, P1; Iwagami N., 2011, SESTD10003 ISASJAXA, P155; Iwagami N, 2011, EARTH PLANETS SPACE, V63, P487, DOI 10.5047/eps.2011.03.007; Iwagami N., 2012, SESTD11006 ISASJAXA, P137; Kawabata K., 1980, J GEOPHYS RES, V85, P8129, DOI DOI 10.1029/JA085IA13P08129; Kawabata K., 1986, P 15 INT S SPAC TECH, P1829; Markiewicz W.J., 2011, EPSCDPS20114642, V6; NA CY, 1994, ICARUS, V112, P389, DOI 10.1006/icar.1994.1193; Nakamura M, 2014, ACTA ASTRONAUT, V93, P384, DOI 10.1016/j.actaastro.2013.07.027; Nakamura M, 2011, EARTH PLANETS SPACE, V63, P443, DOI 10.5047/eps.2011.02.009; Sato T., 2012, SESTD11006 ISASJAXA, P143; Satoh T., 2011, SESTD10003 ISASJAXA, P162	31	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	MAR 1	2015	248						213	220		10.1016/j.icarus.2014.10.030		8	Astronomy & Astrophysics	Astronomy & Astrophysics	AZ7PR	WOS:000348411000012		
J	Kiuchi, M; Nakamura, AM				Kiuchi, Masato; Nakamura, Akiko M.			Relationship between regolith particle size and porosity on small bodies (vol 239, pg 291, 2014)	ICARUS			English	Correction									[Kiuchi, Masato; Nakamura, Akiko M.] Kobe Univ, Dept Earth & Planetary Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Kiuchi, M (reprint author), Kobe Univ, Dept Earth & Planetary Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	mkiuchi@stu.kobe-u.ac.jp					Kiuchi M, 2014, ICARUS, V239, P291, DOI 10.1016/j.icarus.2014.05.029	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	MAR 1	2015	248						221	221		10.1016/j.icarus.2014.10.039		1	Astronomy & Astrophysics	Astronomy & Astrophysics	AZ7PR	WOS:000348411000013		
J	Rodriguez, JAP; Leonard, GJ; Platz, T; Tanaka, KL; Kargel, JS; Fairen, AG; Gulick, V; Baker, VR; Glines, N; Miyamoto, H; Jianguo, Y; Oguma, M				Rodriguez, J. Alexis P.; Leonard, Gregory J.; Platz, Thomas; Tanaka, Kenneth L.; Kargel, Jeffrey S.; Fairen, Alberto G.; Gulick, Virginia; Baker, Victor R.; Glines, Natalie; Miyamoto, Hideaki; Jianguo, Yan; Oguma, Midori			New insights into the Late Amazonian zonal shrinkage of the martian south polar plateau	ICARUS			English	Article						Mars; Polar caps; Polar geology; Ices	GLOBAL SURVEYOR DATA; LAYERED DEPOSITS; GEOLOGIC HISTORY; MARS; REGIONS; FLOW; ACCUMULATION; TOPOGRAPHY; MECHANISMS; ORIGIN	The martian south polar plateau, Planum Australe, comprises the largest known water-ice surface deposit on the planet. Here, we present evidence for an episode of extensive polar plateau retreat during the Late Amazonian, which affected regions flanking circum-polar terrains located between Cavi Angusti and Sisyphi Montes. (C) 2014 Published by Elsevier Inc.	[Rodriguez, J. Alexis P.; Gulick, Virginia; Glines, Natalie] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Rodriguez, J. Alexis P.; Platz, Thomas] Planetary Sci Inst, Tucson, AZ 85719 USA; [Leonard, Gregory J.; Kargel, Jeffrey S.; Baker, Victor R.] Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA; [Platz, Thomas] Free Univ Berlin, Inst Geol Sci, D-12249 Berlin, Germany; [Tanaka, Kenneth L.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Fairen, Alberto G.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Gulick, Virginia] SETI Inst, Mountain View, CA 94043 USA; [Miyamoto, Hideaki; Oguma, Midori] Univ Tokyo, Univ Museum, Tokyo 1130033, Japan; [Jianguo, Yan] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430070, Peoples R China	Rodriguez, JAP (reprint author), NASA, Ames Res Ctr, Mail Stop 239-20, Moffett Field, CA 94035 USA.		Platz, Thomas/F-7539-2013	Platz, Thomas/0000-0002-1253-2034	DFG grant [PL613/2-1]; Helmholtz association; KAKENHI [23340126]	Funding provided by NASA's NPP program to J. Alexis P. Rodriguez and by MRO HiRISE Co-Investigator funds to V.C. Gulick. T. Platz was supported by a DFG grant (PL613/2-1) and the Helmholtz association through the research alliance "Planetary Evolution and Life". HiRISE images were analyzed using HiView developed by the Lunar and Planetary Laboratory at the University of Arizona. The participation of Hideaki Miyamoto was supported by grant KAKENHI 23340126.	CLIFFORD SM, 1987, J GEOPHYS RES-SOLID, V92, P9135, DOI 10.1029/JB092iB09p09135; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; WILHELMS DE, 1973, J GEOPHYS RES, V78, P4084, DOI 10.1029/JB078i020p04084; Herkenhoff KE, 2000, ICARUS, V144, P243, DOI 10.1006/icar.1999.6287; Ghatan GJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001972; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Phillips RJ, 2011, SCIENCE, V332, P838, DOI 10.1126/science.1203091; BLASIUS KR, 1982, ICARUS, V50, P140, DOI 10.1016/0019-1035(82)90122-1; Byrne S., 2004, J GEOPHYS RES, V109; Cuffey K.M., 2010, PHYS GLACIERS; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; CUTTS JA, 1973, J GEOPHYS RES, V78, P4211, DOI 10.1029/JB078i020p04211; Fastook JL, 2014, PLANET SPACE SCI, V91, P60, DOI 10.1016/j.pss.2013.12.002; FISHER DA, 1993, ICARUS, V105, P501, DOI 10.1006/icar.1993.1144; Ghatan G.J., 2004, J GEOPHYS RES, P109; Grima C, 2011, ICARUS, V212, P96, DOI 10.1016/j.icarus.2010.12.017; Head JW, 2001, J GEOPHYS RES-PLANET, V106, P12275, DOI 10.1029/2000JE001359; Head J.W., 2000, INT C MARS POL SCI E, P66; Head J.W., 2007, 7 INT C MARS; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; HOWARD AD, 1978, ICARUS, V34, P581, DOI 10.1016/0019-1035(78)90047-7; Howard AD, 2000, ICARUS, V144, P267, DOI 10.1006/icar.1999.6305; Kargel J.S., 2004, MARS WARMER; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; Kolb E.J., 2006, PLANUM AUSTRALE MARS, V2, P1; Koutnik M, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001805; Koutnik MR, 2005, ICARUS, V174, P490, DOI 10.1016/j.icarus.2004.09.015; Mellon MT, 1996, ICARUS, V124, P268, DOI 10.1006/icar.1996.0203; Milkovich S.M., 2008, J GEOPHYS RES, V113; MURRAY BC, 1972, ICARUS, V17, P328, DOI 10.1016/0019-1035(72)90004-8; Phillips R.J., 2009, MARS LUNAR PLANET SC, VXL; Plaut J.J., 2007, LUNAR PLANET SCI, VXXXVIII, P2144; PLAUT JJ, 1988, ICARUS, V76, P357, DOI 10.1016/0019-1035(88)90076-0; Pratt S., 2002, LUNAR PLANET SCI, VXXXIII; Ross RG, 1998, ASTROPHYS SPACE SC L, V227, P33; Sharp R.P., 1973, MARS J GEOPHYS RES, P4222; Smith IB, 2013, J GEOPHYS RES-PLANET, V118, P1835, DOI 10.1002/jgre.20142; Smith IB, 2010, NATURE, V465, P450, DOI 10.1038/nature09049; Tanaka KL, 2001, ICARUS, V154, P3, DOI 10.1006/icar.2001.6675; Thomas P., 1992, POLAR DEPOSITS MARS, P767; WEIJERMARS R, 1986, EARTH PLANET SC LETT, V76, P227, DOI 10.1016/0012-821X(86)90075-0	42	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	MAR 1	2015	248						407	411		10.1016/j.icarus.2014.08.047		5	Astronomy & Astrophysics	Astronomy & Astrophysics	AZ7PR	WOS:000348411000028		
J	Kebukawa, Y; Cody, GD				Kebukawa, Yoko; Cody, George D.			A kinetic study of the formation of organic solids from formaldehyde: Implications for the origin of extraterrestrial organic solids in primitive Solar System objects	ICARUS			English	Article						Asteroids; Comets; Kuiper belt; Meteorites; Organic chemistry	INTERPLANETARY DUST; COMET 81P/WILD-2; CARBONACEOUS METEORITES; INTERSTELLAR-MOLECULES; INFRARED-SPECTROSCOPY; MURCHISON METEORITE; AQUEOUS ALTERATION; FORMOSE REACTION; PARENT BODIES; MATTER	Aqueous organic solid formation from formaldehyde via the formose reaction and subsequent reactions is a possible candidate for the origin of complex primitive chondritic insoluble organic matter (IOM) and refractory carbon in comets. The rate of formation of organic solids from formaldehyde was studied as a function of temperature and time, with and without ammonia, in order to derive kinetic expressions for polymer yield. The evolution in molecular structure as a function of time and temperature was studied using infrared spectroscopy. Using these kinetic expressions, the yield of organic solids is estimated for extended time and temperature ranges. For example, the half-life for organic solid formation is similar to 5 days at 373 K, similar to 200 days at 323 K, and similar to 70 years at 273 K with ammonia, and similar to 25 days at 373 K, similar to 13 years at 323 K, and similar to 2 x 10(4) years at 273 K without ammonia. These results indicate that organic solids could form during the aqueous alteration in meteorite parent bodies. If liquid water existed early in the interiors of Kuiper belt objects (KBOs), formaldehyde could convert into organic solids at temperatures close to 273 K, and possibly even below 273 K in the ammonia-water system. (C) 2014 Elsevier Inc. All rights reserved.	[Kebukawa, Yoko; Cody, George D.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Kebukawa, Y (reprint author), Yokohama Natl Univ, Fac Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	kebukawa@ynu.ac.jp			NASA Astrobiology Institute; JSPS Postdoctoral Fellowships; W.M. Keck Foundation	We thank Dr. Joseph Nuth and an anonymous reviewer for their careful reviews and constructive comments. This research was supported by the NASA Astrobiology Institute. Y.K. acknowledges support through the JSPS Postdoctoral Fellowships. The FTIR facility at the Geophysical Laboratory was supported by the W.M. Keck Foundation. We thank Dr. Bjorn O. Mysen for providing access to the FTIR.	Alexander CMO, 2007, GEOCHIM COSMOCHIM AC, V71, P4380, DOI 10.1016/j.gca.2007.06.052; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Flynn GJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4791, DOI 10.1016/j.gca.2003.09.001; Ciesla FJ, 2012, SCIENCE, V336, P452, DOI 10.1126/science.1217291; LOURVANIJ K, 1994, APPL CATAL A-GEN, V109, P147, DOI 10.1016/0926-860X(94)85008-9; Cooper G, 2011, P NATL ACAD SCI USA, V108, P14015, DOI 10.1073/pnas.1105715108; [Anonymous], 2008, THE SOLAR SYSTEM BEY; Garvie LAJ, 2008, METEORIT PLANET SCI, V43, P899; Kebukawa Y, 2011, GEOCHIM COSMOCHIM AC, V75, P3530, DOI 10.1016/j.gca.2011.03.037; Cody GD, 2011, P NATL ACAD SCI USA, V108, P19171, DOI 10.1073/pnas.1015913108; Halfen DT, 2006, ASTROPHYS J, V639, P237, DOI 10.1086/499225; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Hanner MS, 2010, LECT NOTES PHYS, V815, P203, DOI 10.1007/978-3-642-13259-9_4; Cooper G, 2001, NATURE, V414, P879, DOI 10.1038/414879a; Kebukawa Y, 2010, METEORIT PLANET SCI, V45, P99, DOI 10.1111/j.1945-5100.2009.01008.x; ZOLENSKY ME, 1989, ICARUS, V78, P411, DOI 10.1016/0019-1035(89)90188-7; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; Gonzalez JM, 2006, CLAY CLAY MINER, V54, P38, DOI 10.1346/CCMN.2006.0540105; Saito M, 2009, ASTROPHYS J LETT, V703, pL147, DOI 10.1088/0004-637X/703/2/L147; MCSWEEN HY, 1989, GEOCHIM COSMOCHIM AC, V53, P3263, DOI 10.1016/0016-7037(89)90106-3; SHAPIRO R, 1988, ORIGINS LIFE EVOL B, V18, P71, DOI 10.1007/BF01808782; LOURVANIJ K, 1993, IND ENG CHEM RES, V32, P11, DOI 10.1021/ie00013a002; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; [Anonymous], 1965, CHEMICAL KINETICS; Charnley SB, 2008, SPACE SCI REV, V138, P59, DOI 10.1007/s11214-008-9331-6; [Anonymous], 2012, J LETT; Weber AL, 2001, ORIGINS LIFE EVOL B, V31, P71, DOI 10.1023/A:1006750423942; Kopetzki D, 2011, NEW J CHEM, V35, P1787, DOI 10.1039/c1nj20191c; Gounelle M, 2006, METEORIT PLANET SCI, V41, P135; [Anonymous], 2013, LUNAR PLANET SCI; NELSON R, 1987, J GEOPHYS RES-SOLID, V92, pE657, DOI 10.1029/JB092iB04p0E657; [Anonymous], 2007, MARCHS ADV ORGANIC C; MORGAN WA, 1991, SCIENCE, V252, P109, DOI 10.1126/science.252.5002.109; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; [Anonymous], 2000, NEW ERA BIOASTRONOMY; Kwok S, 2011, NATURE, V479, P80, DOI 10.1038/nature10542; Dello Russo N, 2014, ICARUS, V238, P125, DOI 10.1016/j.icarus.2014.05.021; Aikawa Y, 2003, ASTROPHYS J, V593, P906, DOI 10.1086/376616; Lowe AB, 2003, POLYMER, V44, P6761, DOI 10.1016/j.polymer.2003.08.039; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; Keller LP, 2011, GEOCHIM COSMOCHIM AC, V75, P5336, DOI 10.1016/j.gca.2011.06.040; Berger EL, 2011, GEOCHIM COSMOCHIM AC, V75, P3501, DOI 10.1016/j.gca.2011.03.026; Nuth JA, 2008, IAU SYMP P SERIES, V4, P403, DOI 10.1017/S1743921308022047; [Anonymous], 2005, LUNAR PLANET SCI; Zhao L, 2010, CARBON, V48, P3778, DOI 10.1016/j.carbon.2010.06.040; [Anonymous], 2004, PHYSICS AND CHEMISTR; PRIALNIK D, 1995, ICARUS, V117, P420, DOI 10.1006/icar.1995.1166; Cody GD, 2005, GEOCHIM COSMOCHIM AC, V69, P1085, DOI 10.1016/j.gca.2004.08.031; Bockelee-Morvan D, 2004, SPACE SCI S, P391; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; [Anonymous], 2010, LUNAR PLANET SCI; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; Ishii HA, 2008, SCIENCE, V319, P447, DOI 10.1126/science.1150683; Yao C, 2007, J PHYS CHEM C, V111, P15141, DOI 10.1021/jp0741881; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Miles R, 2012, ICARUS, V219, P567, DOI 10.1016/j.icarus.2012.03.036; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; ANDERS E, 1973, SCIENCE, V182, P781, DOI 10.1126/science.182.4114.781; Baccile N, 2009, J PHYS CHEM C, V113, P9644, DOI 10.1021/jp901582x; Ehrenfreund P, 2001, P NATL ACAD SCI USA, V98, P2138, DOI 10.1073/pnas.051502898; Schmitt-Kopplin P, 2010, P NATL ACAD SCI USA, V107, P2763, DOI 10.1073/pnas.0912157107; GREENBERG JM, 1995, ASTROPHYS J, V455, pL177, DOI 10.1086/309834; Hollis JM, 2000, ASTROPHYS J, V540, pL107, DOI 10.1086/312881; Cody GD, 2008, METEORIT PLANET SCI, V43, P353; Brownlee D, 2012, METEORIT PLANET SCI, V47, P453, DOI 10.1111/j.1945-5100.2012.01339.x; [Anonymous], 1861, CR HEBD ACAD SCI; Beltran MT, 2009, ASTROPHYS J LETT, V690, pL93, DOI 10.1088/0004-637X/690/2/L93; Bernstein MP, 2003, ASTROPHYS J, V582, pL25, DOI 10.1086/345941; Boogert A. C. A., 2004, ASP C SER, V309, P547; Brearley A.J., 2006, METEORITES EARLY SOL, P587; BRESLOW R, 1959, TETRAHEDRON LETT, P22; Brown ME, 2012, ANNU REV EARTH PL SC, V40, P467, DOI 10.1146/annurev-earth-042711-105352; de Bergh C, 2004, ASTRON ASTROPHYS, V416, P791, DOI 10.1051/0004-6361:20031727; Deer W.A., 1966, AN INTRODUCTION TO T; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hulbert S.F., 1969, J BRIT CERAM SOC, V6, P11; Kebukawa Y, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/19; Llorca J, 2000, METEORIT PLANET SCI, V35, P841; Lourvanij K, 1997, J CHEM TECHNOL BIOT, V69, P35, DOI 10.1002/(SICI)1097-4660(199705)69:1<35::AID-JCTB685>3.0.CO;2-9; Nakamura K., 2002, INT J ASTROBIOL, V1, P179, DOI 10.1017/S1473550402001167; Nakamura-Messenger K, 2011, METEORIT PLANET SCI, V46, P843, DOI 10.1111/j.1945-5100.2011.01197.x; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Weber AL, 2008, ORIGINS LIFE EVOL B, V38, P279, DOI 10.1007/s11084-008-9141-6; Weber AL, 2005, ORIGINS LIFE EVOL B, V35, P523, DOI 10.1007/s11084-005-0234-1; Young ED, 2003, EARTH PLANET SC LETT, V213, P249, DOI 10.1016/S0012-821X(03)00345-5	85	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	MAR 1	2015	248						412	423		10.1016/j.icarus.2014.11.005		12	Astronomy & Astrophysics	Astronomy & Astrophysics	AZ7PR	WOS:000348411000029		
J	Kouyama, T; Imamura, T; Nakamura, M; Satoh, T; Futaana, Y				Kouyama, Toru; Imamura, Takeshi; Nakamura, Masato; Satoh, Takehiko; Futaana, Yoshifumi			Vertical propagation of planetary-scale waves in variable background winds in the upper cloud region of Venus	ICARUS			English	Article						Venus, atmosphere; Atmospheres, dynamics; Meteorology	GALILEO SSI IMAGES; JUPITERS STRATOSPHERE; MONITORING CAMERA; MIDDLE ATMOSPHERE; THERMAL TIDES; MEAN FLOW; OSCILLATION; MAINTENANCE; TRACKING; EXPRESS	Recently it was found that the low-latitude zonal wind and the amplitudes of Kelvin and Rossby waves at the cloud top of Venus show long-term variations in a synchronized manner. For the purpose of explaining this synchronization, we investigated the influence of the background zonal wind profile on the upward propagation of Kelvin and Rossby waves at altitudes 60-80 km. Results from a linearized primitive equation model suggests that Kelvin waves can reach the cloud top height when the background wind speed is slow, whereas Rossby waves can reach the cloud top when the background wind speed is fast. These features obtained from the model are consistent with the observations. Since the momentum deposition by these waves can accelerate or decelerate the mean flow, these waves may contribute to the variation of the background wind. The calculated spatial distributions of the momentum dissipation indicate that the Kelvin waves accelerate the low-latitude atmosphere, and thus they can act to induce transition from the slow wind period to the fast wind period. On the other hand, the Rossby waves decelerate mainly the mid-latitude atmosphere, so that additional mechanisms are required to decelerate the low-latitude atmosphere. A possible mechanism is momentum advection caused by the Rossby wave-induced meridional circulation. (C) 2014 Elsevier Inc. All rights reserved.	[Kouyama, Toru] Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Imamura, Takeshi; Nakamura, Masato; Satoh, Takehiko] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Basic Space Sci, Sagamihara, Kanagawa 2525210, Japan; [Imamura, Takeshi; Nakamura, Masato; Satoh, Takehiko] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Solar Syst Sci, Sagamihara, Kanagawa 2525210, Japan; [Futaana, Yoshifumi] Swedish Inst Space Phys, SE-98128 Kiruna, Sweden	Kouyama, T (reprint author), Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Umezono 1-1-1, Tsukuba, Ibaraki 3058568, Japan.	t.kouyama@aist.go.jp	Futaana, Yoshifumi/P-5899-2014	Futaana, Yoshifumi/0000-0002-7056-3517			Andrews D. G., 1987, MIDDLE ATMOSPHERE DY; ROSSOW WB, 1990, J ATMOS SCI, V47, P2053, DOI 10.1175/1520-0469(1990)047<2053:CTWFVO>2.0.CO;2; TOIGO A, 1994, ICARUS, V109, P318, DOI 10.1006/icar.1994.1097; PLUMB RA, 1977, J ATMOS SCI, V34, P1847, DOI 10.1175/1520-0469(1977)034<1847:TIOTIW>2.0.CO;2; BELTON MJS, 1991, SCIENCE, V253, P1531, DOI 10.1126/science.253.5027.1531; Peralta J, 2007, ICARUS, V190, P469, DOI 10.1016/j.icarus.2007.03.028; ROSSOW WB, 1979, J ATMOS SCI, V36, P377, DOI 10.1175/1520-0469(1979)036<0377:LSMITV>2.0.CO;2; DELGENIO AD, 1990, J ATMOS SCI, V47, P293, DOI 10.1175/1520-0469(1990)047<0293:PSWATC>2.0.CO;2; GIERASCH PJ, 1975, J ATMOS SCI, V32, P1038, DOI 10.1175/1520-0469(1975)032<1038:MCATMO>2.0.CO;2; Hueso R, 2012, ICARUS, V217, P585, DOI 10.1016/j.icarus.2011.04.020; CRISP D, 1989, ICARUS, V77, P391, DOI 10.1016/0019-1035(89)90096-1; Baker RD, 2000, J ATMOS SCI, V57, P200, DOI 10.1175/1520-0469(2000)057<0200:CGIGWI>2.0.CO;2; NEWMAN M, 1992, SCIENCE, V257, P647, DOI 10.1126/science.257.5070.647; Zasova LV, 2007, PLANET SPACE SCI, V55, P1712, DOI 10.1016/j.pss.2007.01.011; ANDREWS DG, 1976, J ATMOS SCI, V33, P2031, DOI 10.1175/1520-0469(1976)033<2031:PWIHAV>2.0.CO;2; Markiewicz WJ, 2007, PLANET SPACE SCI, V55, P1701, DOI 10.1016/j.pss.2007.01.004; Khatuntsev IV, 2013, ICARUS, V226, P140, DOI 10.1016/j.icarus.2013.05.018; Limaye SS, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002814; Moissl R, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003117; Counselman C.C., 1980, J GEOPHYS RES, V85, P8026, DOI 10.1029/JA085iA13p08026; COVEY C, 1982, J ATMOS SCI, V39, P2397, DOI 10.1175/1520-0469(1982)039<2397:PSWITV>2.0.CO;2; Fels S. B., 1974, Geophysical Fluid Dynamics, V6, DOI 10.1080/03091927409365793; Friedson AJ, 1999, ICARUS, V137, P34, DOI 10.1006/icar.1998.6038; Imamura T, 1997, J GEOPHYS RES-PLANET, V102, P6615, DOI 10.1029/96JE03882; Imamura T, 2006, J ATMOS SCI, V63, P1623, DOI 10.1175/JAS3684.1; Imamura T, 2014, ICARUS, V228, P181, DOI 10.1016/j.icarus.2013.10.012; Kouyama T, 2013, J GEOPHYS RES-PLANET, V118, DOI 10.1029/2011JE004013; Kouyama T, 2012, PLANET SPACE SCI, V60, P207, DOI 10.1016/j.pss.2011.08.008; Lebonnois S, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003458; LEOVY CB, 1991, NATURE, V354, P380, DOI 10.1038/354380a0; Li X, 2000, PLANET SPACE SCI, V48, P637, DOI 10.1016/S0032-0633(00)00033-7; Lomb L. R., 1976, ASTROPHYS SPACE SCI, V39, P447; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Nakamura M, 2014, ACTA ASTRONAUT, V93, P384, DOI 10.1016/j.actaastro.2013.07.027; Ogohara K, 2012, ICARUS, V217, P661, DOI 10.1016/j.icarus.2011.05.017; Peralta J, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003185; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schubert G., 1983, Venus; Takagi M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026168; Woo R., 1981, NATURE, V289, P384; Yamamoto M, 1997, J ATMOS SCI, V54, P1472, DOI 10.1175/1520-0469(1997)054<1472:FAMOTD>2.0.CO;2	41	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	MAR 1	2015	248						560	568		10.1016/j.icarus.2014.07.011		9	Astronomy & Astrophysics	Astronomy & Astrophysics	AZ7PR	WOS:000348411000039		
J	Amemiya, T; Taki, M; Kanazawa, T; Hiratani, T; Arai, S				Amemiya, Tomohiro; Taki, Masato; Kanazawa, Toru; Hiratani, Takuo; Arai, Shigehisa			Optical Lattice Model Toward Nonreciprocal Invisibility Cloaking	IEEE JOURNAL OF QUANTUM ELECTRONICS			English	Article						Quantum theory; electromagnetic propagation; optical resonance	ELECTROMAGNETIC-FIELDS; METAMATERIALS; FREQUENCIES; OPTOMECHANICS; DEVICES; MEDIA; LIGHT	We propose the design theory of nonreciprocal invisibility cloaking for an optical camouflage device with unidirectional transparency in which a person in the cloak can see the outside but cannot be seen from the outside. Existing theories of designing invisibility cloaks cannot be used for this purpose, because they are based on the transformation optics that uses the Riemannian metric tensor independent of direction. To realize nonreciprocal cloaking, we propose the theory of effective electromagnetic field for photons, which is an extended version of the theory of effective magnetic field for photons. The effective electromagnetic field can be generated using a photonic resonator lattice. The Hamiltonian for a photon in this field has a similar form to that of the Hamiltonian for a charged particle in an electromagnetic field. Incident photons, therefore, experience a Lorentz-like force and a Coulomb-like force and show nonreciprocal movement depending on their traveling direction. We design an actual invisibility cloaking system on the basis of this theory and, with the aid of computer simulation, confirm the nonreciprocal propagation of light needed for nonreciprocal cloaking.	[Amemiya, Tomohiro; Arai, Shigehisa] Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Tokyo 1528550, Japan; [Taki, Masato] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Kanazawa, Toru] Tokyo Inst Technol, Dept Phys Elect, Tokyo 1528552, Japan; [Hiratani, Takuo] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528552, Japan	Amemiya, T (reprint author), Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Tokyo 1528550, Japan.	amemiya.t.ab@m.titech.ac.jp; taki@riken.jp; kanazawa.t.aa@m.titech.ac.jp; hiratani.t.aa@m.titech.ac.jp; arai@pe.titech.ac.jp	Amemiya, Tomohiro/J-7999-2014		Japan Society for the Promotion of Science - Ministry of Education, Culture, Sports, Science, and Technology [24246061, 25420321, 25420322]	This work was supported by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research within the Ministry of Education, Culture, Sports, Science, and Technology under Grant 24246061, Grant 25420321, and Grant 25420322.	Amemiya T, 2011, IEEE J QUANTUM ELECT, V47, P736, DOI 10.1109/JQE.2011.2108268; Amemiya T, 2011, OPT LETT, V36, P2327, DOI 10.1364/OL.36.002327; Winn JN, 1999, PHYS REV B, V59, P1551, DOI 10.1103/PhysRevB.59.1551; LUTTINGER JM, 1951, PHYS REV, V84, P814, DOI 10.1103/PhysRev.84.814; GRAF M, 1995, PHYS REV B, V51, P4940, DOI 10.1103/PhysRevB.51.4940; Philbin TG, 2008, SCIENCE, V319, P1367, DOI 10.1126/science.1153625; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Peierls R, 1933, Z PHYS, V80, P763, DOI 10.1007/BF01342591; Kippenberg TJ, 2007, OPT EXPRESS, V15, P17172, DOI 10.1364/OE.15.017172; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Fang KJ, 2012, NAT PHOTONICS, V6, P782, DOI 10.1038/NPHOTON.2012.236; Leonhardt U, 1999, PHYS REV A, V60, P4301, DOI 10.1103/PhysRevA.60.4301; Linden S, 2006, IEEE J SEL TOP QUANT, V12, P1097, DOI 10.1109/JSTQE.2006.880600; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Zheludev NI, 2011, OPT PHOTONICS NEWS, V22, P30, DOI 10.1364/OPN.22.3.000030; Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/118; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Gharghi M, 2011, NANO LETT, V11, P2825, DOI 10.1021/nl201189z; Umucalilar RO, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043804; Danner AJ, 2010, OPT EXPRESS, V18, P3332, DOI 10.1364/OE.18.003332; Fang KJ, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043847; Leonhardt U., 2012, GEOMETRY LIGHT SCI I; Ramakrishna S. A., 2008, PHYS APPL NEGATIVE R; Shimizu W, 2013, OPT EXPRESS, V21, P21961, DOI 10.1364/OE.21.021961; Smolyaninov II, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213901; Walser RM, 2001, P SOC PHOTO-OPT INS, V4467, P1, DOI 10.1117/12.432921; Zang XF, 2013, APPL OPTICS, V52, P1832, DOI 10.1364/AO.52.001832	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9197	1558-1713		IEEE J QUANTUM ELECT	IEEE J. Quantum Electron.	MAR	2015	51	3							6100110	10.1109/JQE.2015.2389853		10	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CB0SJ	WOS:000349337000001		
J	Ozaki, M; Yagitani, S; Takahashi, K; Imachi, T; Koji, H; Higashi, R				Ozaki, Mitsunori; Yagitani, Satoshi; Takahashi, Ken; Imachi, Tomohiko; Koji, Hiroki; Higashi, Ryoichi			Equivalent Circuit Model for the Electric Field Sensitivity of a Magnetic Search Coil of Space Plasma	IEEE SENSORS JOURNAL			English	Article						Magnetic search coils; electric field sensitivity; sheath impedance; space plasmas	DIPOLE ANTENNA; IMPEDANCE; MAGNETOPLASMA; MAGNETOMETER; IONOSPHERE; DESIGN; WAVES	Magnetic search coils (MSCs) are sensitive to both magnetic and electric fields, but detecting electric fields is unnecessary for magnetic observations of plasma waves. However, it is important to evaluate both sensitivities for different geometries and electrostatic shields to avoid electric field pickup. An equivalent circuit model for the electric field sensitivity of an MSC in a collisionless isotropic cold plasma is developed here using electrical coupling through a sheath capacitance. That sensitivity is defined by a relationship between the MSC impedance and the sheath capacitance. To confirm the validity of the circuit model, the sensitivity to an electric field is measured by imposing an external electric field using charged parallel metallic plates in laboratory experiments. The coupling capacitance between the MSC and charged plates is equivalent to the sheath capacitance in a space plasma. The measured results show good agreement with an approximate expression deduced from the equivalent circuit model.	[Ozaki, Mitsunori; Yagitani, Satoshi; Imachi, Tomohiko; Koji, Hiroki] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Takahashi, Ken] Panason Syst Networks R&D Lab Co Ltd, Kanazawa, Ishikawa 9200024, Japan; [Higashi, Ryoichi] Ishikawa Natl Coll Technol, Kahoku, Ishikawa 9290392, Japan	Ozaki, M (reprint author), Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan.	ozaki@is.t.kanazawa-u.ac.jp; yagitani@is.t.kanazawa-u.ac.jp; takahashi.ken005@jp.panasonic.com; imachi@imc.kanazawa-u.ac.jp; kouji@reg.is.t.kanazawa-u.ac.jp; higashi@ishikawa-nct.ac.jp	YAGITANI, Satoshi/E-7072-2015; OZAKI, Mitsunori/E-7076-2015		Japan Society for the Promotion of Science [25420403]	This work was supported in part by the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research (C) under Grant 25420403. The associate editor coordinating the review of this paper and approving it for publication was Dr. Hsiao-Wen Zan.	Bansevicius R, 2006, J ELECTROSTAT, V64, P226, DOI 10.1016/j.elstat.2005.06.002; Seran HC, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1884026; Coillot C, 2007, SENS LETT, V5, P167, DOI 10.1166/sl.2007.050; Kasaba Y, 2010, PLANET SPACE SCI, V58, P238, DOI 10.1016/j.pss.2008.07.017; Kletzing CA, 2013, SPACE SCI REV, V179, P127, DOI 10.1007/s11214-013-9993-6; BALMAIN KG, 1964, IEEE T ANTENN PROPAG, VAP12, P605, DOI 10.1109/TAP.1964.1138278; Baumjohann W., 1997, BASIC SPACE PLASMA P; Cattell C., 2008, GEOPHYS RES LETT, V35; Cavoit C, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2214693; Chevalier T. W., 2010, RADIO SCI, V45; Chevalier TW, 2008, IEEE T ANTENN PROPAG, V56, P2454, DOI 10.1109/TAP.2008.927497; Gurnett DA, 1998, GEOPH MONOG SERIES, V103, P121; MATSUMOTO H, 1994, J GEOMAGN GEOELECTR, V46, P59; OYA H, 1971, RADIO SCI, V6, P1131, DOI 10.1029/RS006i012p01131; Ozaki M, 2014, IEEE SENS J, V14, P421, DOI 10.1109/JSEN.2013.2284011; SHKAROFS.IP, 1972, RADIO SCI, V7, P503, DOI 10.1029/RS007i004p00503; Miyoshi Y, 2012, GEOPHYS MONOGR SER, V199, P103, DOI 10.1029/2012GM001304; WANG TNC, 1972, IEEE T ANTENN PROPAG, VAP20, P394, DOI 10.1109/TAP.1972.1140212; YAGITANI S, 1994, RADIO SCI, V29, P39, DOI 10.1029/93RS01728	19	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	MAR	2015	15	3					1680	1689		10.1109/JSEN.2014.2365495		10	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CA4EZ	WOS:000348858300012		
J	Lee, YN; Shin, JK; Lee, YT; Ishida, M; Lee, W				Lee, You-Na; Shin, Jang-Kyoo; Lee, Young-Tae; Ishida, Makoto; Lee, Wanghoon			SOI-Based Schottky Barrier Diode Array for Ultraviolet Line-Scanner	IEEE SENSORS JOURNAL			English	Article						Photodetectors; Schottky contacts; silicon on insulator technology; UV line scanner	QUANTUM EFFICIENCY; HIGH-SPEED; PHOTODETECTORS; PHOTODIODE	This paper reports on fabrication and characterization of Schottky barrier diodes, which were obtained by Schottky contacts between aluminum electrodes and phosphorous-doped single crystalline silicon layer of silicon-on-insulator (SOI) structure. Our photodetectors (PDs) with this structure have advantages, which are simple fabrication process and compatible with complementary metal-oxide-semiconductor devices. The detector performed with the highest external quantum efficiency of 0.397 at 360 nm in ultraviolet spectral range and compared with other devices in previously reported papers. The light sensitivity of 116.2 mV/mW.cm(2) and stable response time of similar to 1.3 ms were achieved at 3 V applied voltage. In addition, operation of an SoI-based 1 x 6 PD array was demonstrated to verify the availability of ultraviolet line-scanner.	[Lee, You-Na; Shin, Jang-Kyoo] Kyungpook Natl Univ, Sch Elect Engn, Taegu 110810, South Korea; [Lee, Young-Tae] Andong Natl Univ, Dept Elect Engn Educ, Andong 760749, South Korea; [Ishida, Makoto] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Lee, Wanghoon] Gumi Elect & Informat Technol Res Inst, Res Dev Dept, Gumi 730853, South Korea	Lee, YN (reprint author), Kyungpook Natl Univ, Sch Elect Engn, Taegu 110810, South Korea.	2.una.biblio@gmail.com; jkshin@ee.knu.ac.kr; ytlee@andong.ac.kr; ishida@ee.tut.ac.jp; whlee@geri.re.kr					Lee HY, 2013, SOLID STATE ELECTRON, V79, P223, DOI 10.1016/j.sse.2012.07.008; Mazzillo M, 2011, IEEE NUCL SCI CONF R, P1642, DOI 10.1109/NSSMIC.2011.6154652; Hammig MD, 2013, IEEE T NUCL SCI, V60, P1175, DOI 10.1109/TNS.2012.2228503; Lien WC, 2012, IEEE ELECTR DEVICE L, V33, P1586, DOI 10.1109/LED.2012.2214759; Muller A., 2008, P INT SEM C SIN ROM, P91; ROGERS DL, 1991, J LIGHTWAVE TECHNOL, V9, P1635, DOI 10.1109/50.108707; Satoh H, 2013, IEEE PHOTONIC TECH L, V25, P1133, DOI 10.1109/LPT.2013.2260138; Shi JW, 2013, J LIGHTWAVE TECHNOL, V31, P3956, DOI 10.1109/JLT.2013.2278273; Shi L, 2012, IEEE SENS J, V12, P2453, DOI 10.1109/JSEN.2012.2192103; Szyszka A., 2013, P INT SEM C DRESD GR, P1; Wang GS, 2013, IEEE PHOTONIC TECH L, V25, P652, DOI 10.1109/LPT.2013.2248056; Wang K, 2010, IEEE T ELECTRON DEV, V57, P1953, DOI 10.1109/TED.2010.2051370; Xing J, 2012, IEEE SENS J, V12, P2561, DOI 10.1109/JSEN.2012.2196429; Zhu SY, 2008, IEEE PHOTONIC TECH L, V20, P1396, DOI 10.1109/LPT.2008.927876; Zimmermann H, 2010, SPRINGER SER OPT SCI, V148, P29	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	MAR	2015	15	3					1727	1731		10.1109/JSEN.2014.2363872		5	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CA4EZ	WOS:000348858300017		
J	Oida, T; Tsuchida, M; Takata, H; Kobayashi, T				Oida, Takenori; Tsuchida, Masahiro; Takata, Hiroto; Kobayashi, Tetsuo			Actively Shielded Bias Field Tuning Coil for Optically Pumped Atomic Magnetometer Toward Ultralow Field MRI	IEEE SENSORS JOURNAL			English	Article						Optically pumped atomic magnetometer; actively shielded coil; ultra-low-field magnetic resonance imaging	DESIGN	In this paper, we describe a method for directly detecting magnetic resonance (MR) signals using optically pumped atomic magnetometers (OPAMs) in ultra-low-field MR imaging (ULF-MRI). For direct detection with OPAMs in ULF-MRI, we propose the use of an actively shielded bias field tuning coil to match the resonant frequencies between MR signals and OPAM. Design of the tuning coil was based on both a target field approach and a stream function method. The results of field distribution analyses demonstrated that the resonant frequency of an OPAM could be tuned by the actively shielded bias field tuning coil. In addition, the actively shielded bias field tuning coil minimized the distortion of an external magnetic field in the sample region. These results indicate that actively shielded bias field tuning coil can be designed to match the resonant frequencies of MR signal and an OPAM with the inhomogeneity of sample region <0.25%. However, the actively shielded bias field tuning coil must be fabricated with an error of 0.5 mm or less between the centers of the primary and shield coils.	[Oida, Takenori; Tsuchida, Masahiro; Takata, Hiroto; Kobayashi, Tetsuo] Kyoto Univ, Grad Sch Engn, Dept Elect Engn, Kyoto 6158510, Japan	Oida, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Elect Engn, Kyoto 6158510, Japan.	oida@kuee.kyoto-u.ac.jp; tsuchida@bfe.kuee.kyoto-u.ac.jp; takata@bfe.kuee.kyoto-u.ac.jp; tetsuo@kuee.kyoto-u.ac.jp			JSPS KAKENHI [26820156, 26560466, 24240081]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported JSPS KAKENHI Grant 26820156, Grant 26560466, and Grant 24240081 and the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The associate editor coordinating the review of this paper and approving it for publication was Dr. Hsiao-Wen Zan.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; [Anonymous], 2013, MAGN RESON MED, V69, P1795; TURNER R, 1993, MAGN RESON IMAGING, V11, P903, DOI 10.1016/0730-725X(93)90209-V; TURNER R, 1986, J PHYS E SCI INSTRUM, V19, P876, DOI 10.1088/0022-3735/19/10/023; Budker D, 2007, NAT PHYS, V3, P227, DOI 10.1038/nphys566; Magnelind PE, 2011, IEEE T APPL SUPERCON, V21, P456, DOI 10.1109/TASC.2010.2088353; Kamada K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.056602; Lee S. W., 2006, APPL PHYS LETT, V89; Oida T, 2011, IEEE T MAGN, V47, P3074, DOI 10.1109/TMAG.2011.2156765; Oida T, 2012, J MAGN RESON, V217, P6, DOI 10.1016/j.jmr.2012.01.015; Savukov I, 2013, J MAGN RESON, V231, P39, DOI 10.1016/j.jmr.2013.02.020; Savukov IM, 2009, J MAGN RESON, V199, P188, DOI 10.1016/j.jmr.2009.04.012; TURNER R, 1986, J PHYS D APPL PHYS, V19, pL147, DOI 10.1088/0022-3727/19/8/001	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	MAR	2015	15	3					1732	1737		10.1109/JSEN.2014.2365011		6	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CA4EZ	WOS:000348858300018		
J	Kono, T				Kono, Tetsuya			A Comment on Andrew C. Papanicolaou's "BEYOND EDDINGTON'S ARGUMENT": Pragmatism in Scientific Knowledge and Perception	INTEGRATIVE PSYCHOLOGICAL AND BEHAVIORAL SCIENCE			English	Article						Entity realism; Scientific realism; Pragmatism; Direct perception; Consciousness		I agree with Andrew C. Papanicolaou's claim that human beings' cognitive ability can reach to the real world, but don't agree with his claim that the order of this world is akin to our thought. In this commentary paper, I will first defend a recent pragmatic scientific realism called as "entity realism" or "referential realism" which affirms that we are able to reach the real world not by inference but by technological, engineering settings. In the second half of this paper, I will also affirm that our perceptual ability directly reaches the reality too, in referring to the ecological psychology of James J. Gibson.	Rikkyo Univ, Dept Educ, Tokyo 171, Japan	Kono, T (reprint author), Rikkyo Univ, Dept Educ, Tokyo 171, Japan.	VYQ05706@nifty.com					Bachelard Gaston, 1970, ETUDES; Baird D, 2004, THING KNOWLEDGE: A PHILOSOPHY OF SCIENTIFIC INSTRUMENTS, P1; Cartwright N, 1983, LAWS PHYS LIE; Cartwright N, 1999, DAPPLED WORLD STUDY; Davidson Donald, 2001, SUBJECTIVE INTERSUBJ; Gibson J.J., 1986, ECOLOGICAL APPROACH; Ian Hacking, 1983, REPRESENTING INTERVE; James William, 1976, ESSAYS RADICAL EMPIR; Putnam Hilary, 1999, THREEFOLD CORD MIND; Rorty R., 1981, PHILOS MIRROR NATURE; Van Fraassen Bas C., 1980, SCI IMAGE	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1932-4502	1936-3567		INTEGR PSYCHOL BEHAV	Integr. Psychol. Behav. Sci.	MAR	2015	49	1					9	18		10.1007/s12124-014-9264-4		10	Psychology, Biological; Neurosciences	Psychology; Neurosciences & Neurology	CA5CZ	WOS:000348926900002		
J	Imamura, Y; Mizoguchi, Y; Nabeta, H; Matsushima, J; Watanabe, I; Kojima, N; Kawashima, T; Yamada, S; Monji, A				Imamura, Yoshiomi; Mizoguchi, Yoshito; Nabeta, Hiromi; Matsushima, Jun; Watanabe, Itaru; Kojima, Naoki; Kawashima, Toshiro; Yamada, Shigeto; Monji, Akira			Belief in life after death, salivary 3-methoxy-4-hydroxyphenylglycol, and well-being among older people without cognitive impairment dwelling in rural Japan	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						belief in life after death; well-being; religiosity; sMHPG; elderly	RELIGIOUS INVOLVEMENT; SOCIAL SUPPORT; HEALTH; SPIRITUALITY; ADULTS; MHPG; DEPRESSION; GENDER; PLASMA; EXPLANATIONS	ObjectivesResearch has found that spirituality/religiosity has a salutary association with mental/physical health. However, the association of belief in life after death with well-being has rarely been studied, and the same is true of its association with biological indices, such as monoamine transmitters. Therefore, we examined the associations between well-being and religiosity, salivary 3-methoxy-4-hydroxyphenylglycol (sMHPG), and demographic characteristics. MethodsThe participants were 346 community-dwelling people, aged 65years or older, without cognitive or mental deficits, in rural Japan. Measures of religiosity consisted of belief in life after death, attachment to life, and experiences related to death and religion. The measures were assessed by scales specifically suited for Japanese religious orientations. Participants' well-being was assessed by a life satisfaction scale containing two subscales. We also measured sMHPG, a major metabolite of noradrenaline that is thought to reflect certain psychological states, such as psychomotor retardation and effortful attention. ResultsOne subscale of life satisfaction was positively associated with belief in life after death and sMHPG, and the other life satisfaction subscale was positively associated with education and death/religion-related experiences (e.g.,visiting family graves or loss of a friend). Gender differences were found in afterlife beliefs and each life satisfaction subscale. ConclusionsThese results suggest that religiosity, including belief in life after death and death/religion-related experiences, is salubriously associated with mental health among older people, especially women, living in rural Japan. The basal level of sMHPG was positively associated with life satisfaction, but not with belief in life after death. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Imamura, Yoshiomi; Mizoguchi, Yoshito; Nabeta, Hiromi; Matsushima, Jun; Watanabe, Itaru; Kawashima, Toshiro; Yamada, Shigeto; Monji, Akira] Saga Univ, Fac Med, Dept Psychiat, Saga 840, Japan; [Imamura, Yoshiomi] Kurume Univ, Inst Comparat Studies Int Cultures & Soc, Kurume, Fukuoka 830, Japan; [Kojima, Naoki] Kojima Hosp, Imari, Saga, Japan; [Yamada, Shigeto] St Lucias Hosp, Kurume, Fukuoka, Japan	Imamura, Y (reprint author), Saga Univ, Fac Med, Dept Psychiat, Saga 840, Japan.	e7730@edu.cc.saga-u.ac.jp			Japan's Ministry of Health, Labour and Welfare [22000002]	This study was financially supported, in part, by a research grant from Japan's Ministry of Health, Labour and Welfare (no. 22000002).	Bolger N, 2000, J PERS SOC PSYCHOL, V79, P953, DOI 10.1037//0022-3514.79.6.953; Iwamoto R, 2011, PSYCHIAT CLIN NEUROS, V65, P638, DOI 10.1111/j.1440-1819.2011.02256.x; Green M, 2010, J RELIG HEALTH, V49, P149, DOI 10.1007/s10943-009-9242-1; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Flannelly KJ, 2006, J NERV MENT DIS, V194, P524, DOI 10.1097/01.nmd.0000224876.63035.23; Miller AS, 2002, AM J SOCIOL, V107, P1399, DOI 10.1086/342557; Ellison CG, 2009, SOC SCI RES, V38, P656, DOI 10.1016/j.ssresearch.2009.02.002; McClain CS, 2003, LANCET, V361, P1603, DOI 10.1016/S0140-6736(03)13310-7; Berntson GG, 2008, ANN BEHAV MED, V35, P198, DOI 10.1007/s12160-008-9027-x; Bradshaw M, 2010, SOC SCI MED, V71, P196, DOI 10.1016/j.socscimed.2010.03.015; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037//0021-9010.78.1.98; Koenig HG, 2006, AGING MENT HEALTH, V10, P1, DOI 10.1080/13607860500308132; Musick MA, 2000, J ADULT DEV, V7, P73, DOI 10.1023/A:1009523722920; Buyukdura JS, 2011, PROG NEURO-PSYCHOPH, V35, P395, DOI 10.1016/j.pnpbp.2010.10.019; Egami M, 2013, HUM PSYCHOPHARM CLIN, V28, P7, DOI 10.1002/hup.2273; Barton YA, 2013, J AFFECT DISORDERS, V146, P53, DOI 10.1016/j.jad.2012.08.037; ELLISON CG, 1991, J HEALTH SOC BEHAV, V32, P80, DOI 10.2307/2136801; Flannelly KJ, 2008, J PSYCHOL THEOL, V36, P94; Fujiyoshis J., 1989, ZEN TO JODOKYO; Genku, 1198, SENCHAKU HONGAN NEMB; Haraokas K., 2004, KURUME U PSYCHOL RES, V3, P33; Hoshis M, 2008, THESIS U ARIZONA; Ikejima C, 2012, PSYCHOGERIATRICS, V12, P120, DOI 10.1111/j.1479-8301.2012.00415.x; Koenigs HG, 2008, MED RELIG HLTH SCI S; Krause N, 1999, J HEALTH SOC BEHAV, V40, P405, DOI 10.2307/2676333; KRAUSE N, 1993, RES AGING, V15, P170, DOI 10.1177/0164027593152003; Krause N, 2002, J GERONTOL B-PSYCHOL, V57, pS96; LAWLOR BA, 1995, BIOL PSYCHIAT, V38, P185, DOI 10.1016/0006-3223(94)00259-6; LECKMAN JF, 1980, LIFE SCI, V26, P2179, DOI 10.1016/0024-3205(80)90606-2; Levin JS, 1998, J AGING HEALTH, V10, P504, DOI 10.1177/089826439801000406; Lis GY, 2004, NEUROPSYCHOBIOLOGY, V50, P336; Lis GY, 2006, BIOL PSYCHOL, V73, P209; Lis GY, 2008, PSYCHIAT CLIN NEUROS, V62, P562; MAAS JW, 1976, BRAIN RES, V118, P167, DOI 10.1016/0006-8993(76)90854-4; Miller AS, 1998, REV RELIG RES, V39, P360, DOI 10.2307/3512444; Moxey A, 2011, AUSTRALAS J AGEING, V30, P82, DOI 10.1111/j.1741-6612.2010.00453.x; Nakamuras M, 2001, B FACULTY ED EHIME U, V47, P59; Reuster T, 2002, PSYCHOPHARMACOLOGY, V162, P415, DOI 10.1007/s00213-002-1125-z; Roth LM, 2007, AM SOCIOL REV, V72, P205; Sugishita M, 2009, JPN J COGN NEUROSCI, V11, P87; Sullins DP, 2006, AM J SOCIOL, V112, P838, DOI 10.1086/507852; Taylors SE, 2002, TENDING INSTINCT; THORSON JA, 1990, J CLIN PSYCHOL, V46, P379, DOI 10.1002/1097-4679(199007)46:4<379::AID-JCLP2270460402>3.0.CO;2-A; Watanabe I, 2012, INT J GERIATR PSYCH, V27, P321, DOI 10.1002/gps.2729; Yajima J, 2001, BIOGENIC AMINES, V16, P173; Yang RK, 1997, BIOL PSYCHIAT, V42, P821, DOI 10.1016/S0006-3223(97)00055-3	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	MAR	2015	30	3					256	264		10.1002/gps.4135		9	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CA7ER	WOS:000349081000004		
J	Chiba, Y; Fujishiro, H; Ota, K; Kasanuki, K; Arai, H; Hirayasu, Y; Sato, K; Iseki, E				Chiba, Yuhei; Fujishiro, Hiroshige; Ota, Kazumi; Kasanuki, Koji; Arai, Heii; Hirayasu, Yoshio; Sato, Kiyoshi; Iseki, Eizo			Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Parkinson's disease; FDG PET; cerebral metabolism; DLB; visual hallucination; extracampine hallucination	POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; SLEEP BEHAVIOR DISORDER; DIAGNOSIS; PET; DIFFERENTIATION; ASSOCIATION; CONSORTIUM; FEATURES; COMMON	ObjectivesIt is well known that Alzheimer's disease (AD)-type pathology is commonly present in dementia with Lewy bodies (DLB) brains and that the degree of AD-type pathology has an influence on the clinical characteristics of DLB. Although significant hypometabolism in the temporoparietal/precuneus on [F-18]fluoro-d-glucose (F-18-FDG) positron emission tomography (PET) scans is considered to support a diagnosis of AD, some DLB patients also exhibit this metabolic pattern. The clinical significance of the metabolic pattern on DLB remains unknown. MethodsTwenty-three DLB patients, 10 AD patients, and 11 controls underwent F-18-FDG PET scans. According to the degree of hypometabolism in the parietal/precuneus regions, representing the AD-like metabolic pattern, 12 patients were placed in the DLB-AD(+) group and 11 patients were placed in the DLB-AD(-) group. The demographics and clinical variables were compared among the four groups. ResultsIn addition to the parietal/precuneus regions, the DLB-AD(+) group exhibited significantly greater posterior cingulate hypometabolism than the DLB-AD(-) group, although occipital metabolism did not differ. The prevalence of visual hallucinations and extracampine hallucinations, and the Bender-Gestalt test score were significantly higher in the DLB-AD(+) group than the DLB-AD(-) group, although there were no differences in the demographics and other examined clinical variables between the two DLB groups. These clinical differences were absent in the DLB-AD(-) group, AD group, and controls. ConclusionsParietal/precuneus hypometabolism may be associated with clinical characteristics in DLB patients. Further multiple imaging modalities that are sensitive to AD-type pathology are needed to reveal the neurobiological basis of the AD-like metabolic pattern. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Chiba, Yuhei; Fujishiro, Hiroshige; Ota, Kazumi; Kasanuki, Koji; Sato, Kiyoshi; Iseki, Eizo] Juntendo Univ, Sch Med, Juntendo Tokyo Koto Geriatr Med Ctr, PET CT Dementia Res Ctr, Tokyo 113, Japan; [Chiba, Yuhei; Kasanuki, Koji; Arai, Heii; Iseki, Eizo] Juntendo Univ, Sch Med, Dept Psychiat, Tokyo 113, Japan; [Chiba, Yuhei; Hirayasu, Yoshio] Yokohama City Univ, Sch Med, Dept Psychiat, Yokohama, Kanagawa, Japan; [Fujishiro, Hiroshige] Nagoya Univ, Sch Med, Dept Sleep Med, Nagoya, Aichi 4648601, Japan	Fujishiro, H (reprint author), Juntendo Univ, Sch Med, Juntendo Tokyo Koto Geriatr Med Ctr, PET CT Dementia Res Ctr, Tokyo 113, Japan.	fujishiro17@hotmail.co.jp			Anti-Aging Research Center of the Juntendo University School of Medicine; Ogasawara Foundation for the Promotion of Science and Engineering; Ministry of Education, Culture, Sports, Science and Technology in Japan [20536924]; Nihon Medi-Physics	This study was supported in part by the Anti-Aging Research Center of the Juntendo University School of Medicine, the Ogasawara Foundation for the Promotion of Science and Engineering and Nihon Medi-Physics, and a Grant-in-Aid for Young Scientists (B) 20536924 from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Kantarci K, 2012, NEUROBIOL AGING, V33, P2091, DOI 10.1016/j.neurobiolaging.2011.09.024; Kasanuki K, 2012, J NEUROL SCI, V314, P111, DOI 10.1016/j.jns.2011.10.010; Gomperts SN, 2012, MOVEMENT DISORD, V27, P965, DOI 10.1002/mds.25048; Yoshita M, 2006, NEUROLOGY, V66, P1850, DOI 10.1212/01.wnl.0000219640.59984.a7; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Merdes AR, 2003, NEUROLOGY, V60, P1586; Chiba Y, 2012, DEMENT GERIATR COGN, V33, P273, DOI 10.1159/000339363; Fujishiro H, 2008, J NEUROPATH EXP NEUR, V67, P649, DOI 10.1097/NEN.0b013e31817d7a1d; Ferman TJ, 2011, NEUROLOGY, V77, P875, DOI 10.1212/WNL.0b013e31822c9148; Boeve BF, 2010, ANN NY ACAD SCI, V1184, P15, DOI 10.1111/j.1749-6632.2009.05115.x; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Fujishiro H, 2010, NEUROSCI LETT, V486, P19, DOI 10.1016/j.neulet.2010.09.036; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Gilman S, 2005, EXP NEUROL, V191, pS95, DOI 10.1016/j.expneurol.2004.06.017; FAZEKAS F, 1991, AM J NEURORADIOL, V12, P915; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Ishii K, 2007, J NUCL MED, V48, P704, DOI 10.2967/junmed.106.035691; Antonini A, 1998, NEUROLOGY, V51, P803; Chan D, 2002, LANCET, V360, P2064, DOI 10.1016/S0140-6736(02)11998-2; Dickson Dennis W, 2009, Parkinsonism Relat Disord, V15 Suppl 3, pS1, DOI 10.1016/S1353-8020(09)70769-2; Dugger BN, 2012, MOVEMENT DISORD, V27, P72, DOI 10.1002/mds.24003; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fujishiro H, 2012, INT J GERIATR PSYCH, V27, P1138, DOI 10.1002/gps.2836; Fujishiro H, 2008, ACTA NEUROPATHOL, V116, P17, DOI 10.1007/s00401-008-0383-1; Halliday GM, 2010, ANN NY ACAD SCI, V16, P653; Iseki E, 2010, INT J GERIATR PSYCH, V25, P352, DOI 10.1002/gps.2346; Kenny RA, 2004, J NEUROL NEUROSUR PS, V75, P966, DOI 10.1136/jnnp.2003.023812; Murayama N, 2007, DEMENT GERIATR COGN, V23, P258, DOI 10.1159/000100772; Olichney JM, 2005, J NEUROL NEUROSUR PS, V76, P1342, DOI 10.1136/jnnp.2003.032003	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	MAR	2015	30	3					316	323		10.1002/gps.4144		8	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CA7ER	WOS:000349081000011		
J	Tokumitsu, Y; Tamesa, T; Matsukuma, S; Hashimoto, N; Maeda, Y; Tokuhisa, Y; Sakamoto, K; Ueno, T; Hazama, S; Ogihara, H; Fujita, Y; Hamamoto, Y; Oka, M; Iizuka, N				Tokumitsu, Yukio; Tamesa, Takao; Matsukuma, Satoshi; Hashimoto, Noriaki; Maeda, Yoshinari; Tokuhisa, Yoshihiro; Sakamoto, Kazuhiko; Ueno, Tomio; Hazama, Shoichi; Ogihara, Hiroyuki; Fujita, Yusuke; Hamamoto, Yoshihiko; Oka, Masaaki; Iizuka, Norio			An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						hepatocellular carcinoma; recurrence; staging system; prognostic factor; Akaike information criterion	RISK-FACTORS; CLIP SCORE; JIS SCORE; INTRAHEPATIC RECURRENCE; VENOUS-PRESSURE; RESECTION; LIVER; JAPAN; CIRRHOSIS; PROPOSAL	The aim of this study was to develop an accurate predictive system for prognosis of hepatocellular carcinoma (HCC) patients after hepatectomy. We pooled data of clinicopathological features of 234 HCC patients who underwent curative hepatectomy. On the basis of the pooled data, we established a simple predictive staging system (PS score) scored by the mathematical product of tumor number and size, and degree of liver function. We compared the prognostic abilities of the PS score (score 0-3) with those of six well-known clinical staging systems. Then, we found that there were significant differences (P<0.05) in both disease-free survival (DFS) and overall survival (OS) between patients with different PS scores (PS score 0 vs. 1; PS score 1 vs. 2), and there was a significant difference in DFS, but not OS, between patients with PS score 2 and those with PS score 3. Moreover, the PS score had smaller values of the Akaike information criterion for both DFS and OS than any of the six well-known clinical staging systems. These results suggest that the PS score serves as a simple, accurate predictor for the prognosis of HCC patients after hepatectomy.	[Tokumitsu, Yukio; Tamesa, Takao; Matsukuma, Satoshi; Hashimoto, Noriaki; Maeda, Yoshinari; Tokuhisa, Yoshihiro; Sakamoto, Kazuhiko; Ueno, Tomio; Hazama, Shoichi; Iizuka, Norio] Yamaguchi Univ, Dept Digest Surg & Surg Oncol, Grad Sch Med, Yamaguchi, Japan; [Ogihara, Hiroyuki; Fujita, Yusuke; Hamamoto, Yoshihiko] Yamaguchi Univ, Dept Biomol Engn Appl Mol Biosci, Grad Sch Med, Yamaguchi, Japan; [Oka, Masaaki] Yamaguchi Univ, Yamaguchi, Japan	Tokumitsu, Y (reprint author), Yamaguchi Univ, Dept Digest Surg & Surg Oncol, Grad Sch Med, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	yukio790604@gmail.com					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Boleslawski E, 2012, BRIT J SURG, V99, P855, DOI 10.1002/bjs.8753; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Ikai I, 2006, J GASTROENTEROL, V41, P884, DOI 10.1007/s00535-006-1878-y; Shao YY, 2012, BRIT J CANCER, V107, P1672, DOI 10.1038/bjc.2012.466; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Tateishi R, 2005, GUT, V54, P419, DOI 10.1136/gut.2003.035055; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; ADACHI E, 1995, GASTROENTEROLOGY, V108, P768, DOI 10.1016/0016-5085(95)90450-6; Kim SH, 2011, J GASTROINTEST SURG, V15, P598, DOI 10.1007/s11605-011-1452-7; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Nanashima A, 2004, EJSO, V30, P765, DOI 10.1016/j.ejso.2004.05.003; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; IKEDA K, 1993, CANCER, V71, P19, DOI 10.1002/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO;2-I; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Perrone F, 2000, HEPATOLOGY, V31, P840; Nanashima A, 2006, J GASTROENTEROL, V41, P250, DOI 10.1007/s00535-005-1751-4; [Anonymous], 2010, GEN RULES CLIN PATHO; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Toyama T, 2008, J CLIN GASTROENTEROL, V42, P317, DOI 10.1097/MCG.0b013e3180ebe790; Manghisi G, 1998, HEPATOLOGY, V28, P751; Chung H, 2007, HEPATOL RES, V37, pS210, DOI 10.1111/j.1872-034X.2007.00187.x; Fukuda S, 2007, WORLD J SURG, V31, P345, DOI 10.1007/s00268-006-0513-7; Han KH, 2011, ONCOLOGY-BASEL, V81, P158, DOI 10.1159/000333280; Henderson J M, 2003, HPB (Oxford), V5, P243, DOI 10.1080/13651820310015833; Hidaka M, 2012, BRIT J SURG, V99, P1284, DOI 10.1002/bjs.8861; Iizuka N, 2004, LANCET, V364, P1837, DOI 10.1016/S0140-6736(04)17455-2; Kim BK, 2008, J SURG ONCOL, V97, P246, DOI 10.1002/jso.20953; Kinoshita A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-52; Lau H, 1997, BRIT J SURG, V84, P1255; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Luo KZ, 2008, J GASTROENTEROL, V43, P369, DOI 10.1007/s00535-008-2164-y; Matsuda M, 2013, INTERNAL MED, V52, P847, DOI 10.2169/internalmedicine.52.9356; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Omagari K, 2004, J GASTROEN HEPATOL, V19, P805, DOI 10.1111/j.1400-1746.2004.03350.x; op den Winkel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045066; OuYang PY, 2013, BRIT J CANCER, V109, P2987, DOI 10.1038/bjc.2013.659; Pons Fernando, 2005, HPB (Oxford), V7, P35, DOI 10.1080/13651820410024058; Toyoda H, 2005, AM J GASTROENTEROL, V100, P1764, DOI 10.1111/j.1572-0241.2005.41943.x; Wakabayashi H, 2004, J SURG RES, V116, P248, DOI 10.1016/S0022-4804(03)00699-1	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					944	952		10.3892/ijo.2014.2798		9	Oncology	Oncology	CA6XW	WOS:000349061800005		
J	Wada, N; Kawano, Y; Fujiwara, S; Kikukawa, Y; Okuno, Y; Tasaki, M; Ueda, M; Ando, Y; Yoshinaga, K; Ri, M; Iida, S; Nakashima, T; Shiotsu, Y; Mitsuya, H; Hata, H				Wada, Naoko; Kawano, Yawara; Fujiwara, Shiho; Kikukawa, Yoshitaka; Okuno, Yutaka; Tasaki, Masayoshi; Ueda, Mitsuharu; Ando, Yukio; Yoshinaga, Kazuya; Ri, Masaki; Iida, Shinsuke; Nakashima, Takayuki; Shiotsu, Yukimasa; Mitsuya, Hiroaki; Hata, Hiroyuki			Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						multiple myeloma; apoptosis; necroptosis; heat shock protein; proteasome	INDUCED APOPTOSIS; DOWN-REGULATION; CANCER CELLS; DEATH; INDUCTION; PATHWAY; LINES; IDENTIFICATION; ACTIVATION; STRESS	Shikonin (SHK), a natural small agent (MW 288.3), reportedly induces cell death in various tumor cells. We have found that SHK also exerts potent cytocidal effects on human multiple myeloma (MM) cells, but its anticancer mechanism in MM cells remains to be elucidated. SHK at 2.5-5 mu M induced apoptosis in seven MM cell lines, including the bortezomib-resistant cell line KMS11/BTZ. The IC50 value of SHK against KMS11/BTZ was comparable to that of a parental cell line KMS11 (1.1 and 1.56 mu M, respectively). SHK induces accumulation of ubiquitinated proteins and activates XBP-1 in MM cells, suggesting that SHK functions as a proteasome inhibitor, eventually inducing ER stress-associated apoptosis. SHK increases levels of HSP70/72, which protects cells from apoptosis, and exerts greater cytocidal effects in combination with the HSP70/72 inhibitor VER-155008. At higher concentrations (10-20 mu M), SHK induced cell death, which was completely inhibited by a necroptosis inhibitor, necrostatin-1 (Nec-1), while the cytocidal activity was unaffected by Z-VAD-FMK, strongly suggesting that cell death is induced by SHK at high concentrations through necroptosis. The present data show for the first time that SHK induces cell death in MM cells. SHK efficiently induces apoptosis and combination of heat shock protein inhibitor with low dose SHK enhances apoptosis, while high dose SHK induces necroptosis in MM cells. These findings together support the use of SHK as a potential therapeutic agent for MM.	[Wada, Naoko; Fujiwara, Shiho; Kikukawa, Yoshitaka; Okuno, Yutaka; Mitsuya, Hiroaki; Hata, Hiroyuki] Kumamoto Univ Hosp, Dept Hematol, Kumamoto, Japan; [Kawano, Yawara] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ri, Masaki; Iida, Shinsuke] Nagoya City Univ, Dept Hematol & Oncol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Tasaki, Masayoshi; Ueda, Mitsuharu; Ando, Yukio] Kumamoto Univ, Dept Neurol, Grad Sch Med Sci, Kumamoto, Japan; [Tasaki, Masayoshi; Hata, Hiroyuki] Kumamoto Univ, Div Informat Clin Sci, Grad Sch Hlth Sci, Kumamoto, Japan; [Yoshinaga, Kazuya] Kumamoto Univ, Dept Anat, Grad Sch Hlth Sci, Kumamoto, Japan; [Nakashima, Takayuki] Kyowa Hakko Kirin Co Ltd, Res Funct Unit, Tokyo, Japan; [Shiotsu, Yukimasa] Kyowa Hakko Kirin Calif Inc, Translat Oncol, La Jolla, CA USA	Hata, H (reprint author), Kumamoto Univ, Div Informat Clin Sci, Fac Med Sci, Kumamoto, Japan.	hata@kumamoto-u.ac.jp			Amyloidosis Research Committee from the Ministry of Health, Labour, and Welfare, Japan	We are grateful to the Institute of Natural Medicine, Toyama University, Japan for providing natural herbal compounds. This study was supported in part by a grant from the Amyloidosis Research Committee from the Ministry of Health, Labour, and Welfare, Japan. We are also grateful to Ms. Y. Otake for technical assistance. We thank Gene Technology Center, Institute of Resource Development and Analysis, Kumamoto University for technical assistances regarding proteasome activity analysis.	Ahmed K, 2012, INT J HYPERTHER, V28, P1, DOI 10.3109/02656736.2011.627408; Zhang L, 2013, CANCER LETT, V339, P49, DOI 10.1016/j.canlet.2013.07.023; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Duan DZ, 2014, FREE RADICAL BIO MED, V70, P182, DOI 10.1016/j.freeradbiomed.2014.02.016; Munshi NC, 2004, BLOOD, V103, P1799, DOI 10.1182/blood-2003-02-0402; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Chromik J, 2014, CANCER LETT, V344, P101, DOI 10.1016/j.canlet.2013.10.018; Nakamura M, 2006, LEUKEMIA LYMPHOMA, V47, P531, DOI 10.1080/10428190500312196; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066326; Nimmanapalli R, 2008, BRIT J HAEMATOL, V142, P551, DOI 10.1111/j.1365-2141.2008.07217.x; Chatterjee M, 2013, HAEMATOLOGICA, V98, P1132, DOI 10.3324/haematol.2012.066175; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Min R, 2008, PHYTOTHER RES, V22, P407, DOI 10.1002/ptr.2340; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195; Ahn J, 2013, APOPTOSIS, V18, P870, DOI 10.1007/s10495-013-0835-5; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen CH, 2012, ANN SURG ONCOL, V19, P3097, DOI 10.1245/s10434-012-2324-4; Eremenko E M, 2010, Tsitologiia, V52, P235; Fu ZZ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-580; He SP, 2011, KAOHSIUNG J MED SCI, V27, P477, DOI 10.1016/j.kjms.2011.06.010; Hsu PC, 2004, J AGR FOOD CHEM, V52, P6330, DOI 10.1021/jf0495993; IKEYAMA S, 1986, MOL IMMUNOL, V23, P159; Jang SY, 2014, INT J ONCOL, V44, P1455, DOI 10.3892/ijo.2014.2306; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; OHTSUKI T, 1989, BRIT J HAEMATOL, V73, P199, DOI 10.1111/j.1365-2141.1989.tb00252.x; Tatetsu H, 2007, CANCER RES, V67, P5328, DOI 10.1158/0008-5472.CAN-06-4265; TOGAWA A, 1982, INT J CANCER, V29, P495, DOI 10.1002/ijc.2910290502; Uneda S, 2003, BRIT J HAEMATOL, V120, P53, DOI 10.1046/j.1365-2141.2003.04040.x; Yoon Y, 1999, PLANTA MED, V65, P532, DOI 10.1055/s-1999-14010; Zhang FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081815	39	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					963	972		10.3892/ijo.2014.2804		10	Oncology	Oncology	CA6XW	WOS:000349061800007		
J	Suzuki, O; Abe, M; Hashimoto, Y				Suzuki, Osamu; Abe, Masafumi; Hashimoto, Yuko			Sialylation by beta-galactoside alpha-2,6-sialyltransferase and N-glycans regulate cell adhesion and invasion in human anaplastic large cell lymphoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						sialic acid; glycans; beta-galactoside alpha-2,6-sialyltransferase; cell adhesion; invasion; galectin-8; Rho; PI3K; MAPK	HUMAN COLON-CANCER; SURFACE SIALYLATION; CLASSICAL HODGKIN; T-CELLS; GALECTIN-1; DEATH; APOPTOSIS; ROLES; GLYCOSYLATION; EXPRESSION	The interaction between cell surface glycans and extracellular matrix (ECM) including galectins is known to be closely associated with tumor cell adhesion, invasion and metastasis. We analyzed the roles of cell surface sialylation or glycosylation in galectin or ECM-mediated cell adhesion and invasion of human malignant lymphoma cells. Neuraminidase from Arthrobacter ureafaciens (AU) treatment resulted in reduction of cell adhesion to galectin-8 in human anaplastic large cell lymphoma (H-ALCL) which was established in our laboratory. The knockdown of beta-galactoside alpha-2,6-sialyltransferase (ST6Ga11) by siRNA showed inhibition of ST6Ga11 expression in the cytoplasm of H-ALCL cells on immunohistochemical findings, and showed dramatic enhancement of cell adhesion to galectin-8. On the other hand, alpha-2,3-specific neuraminidase treatment resulted in moderate enhancement of cell adhesion to galectin-8. We performed chemically artificial modification of cell surface O-glycans by treatment of benzyl 2-acetamido-2-deoxy-alpha-D-galactopyranoside (Bz-alpha-GalNAc) in H-ALCL. Cell adhesion to galectin-8 was enhanced by treatment of Bz-a-GalNAc suggesting that inhibition of elongation of O-glycans may enhance cell adhesion to galectin-8 in H-ALCL cells. On the other hand inhibition of elongation of N-glycosylation by tunicamycin (TM) resulted in inhibition of Phaseolus vulgaris-L (L-PHA) lectin-binding activity and inhibited cell adhesion to galectin-8,1aminin and fibronectin. Neuraminidase treatment enhanced cell adhesion to laminin, and knockdown of ST6Ga11 resulted in enhancement of cell adhesion to laminin, but not to fibronectin, collagen type 1 and 4. Galectin-8 pre-treatment dramatically enhanced cell adhesion to laminin and neuraminidase treatment also enhanced cell adhesion to laminin in combination with galectin-8. Rho inhibitor, C3-transferase pre-treatment resulted in inhibition of cell invasion to galectin-8. Phosphatidylinositol 3-phosphate kinase (PI3K) inhibitor, wortmannin inhibits the cell invasive capacity to galectin-8. Neuraminidase treatment induces growth inhibition of lymphoma cells by galectin-8.	[Suzuki, Osamu; Abe, Masafumi; Hashimoto, Yuko] Fukushima Med Univ, Dept Diagnost Pathol, Sch Med, Fukushima 9601295, Japan	Suzuki, O (reprint author), Fukushima Med Univ, Dept Diagnost Pathol, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	osuzuki@fmu.ac.jp					Suzuki O, 1999, PATHOL INT, V49, P874, DOI 10.1046/j.1440-1827.1999.00960.x; Rodig SJ, 2008, CLIN CANCER RES, V14, P3338, DOI 10.1158/1078-0432.CCR-07-4709; Suzuki O, 2005, INT J ONCOL, V26, P1063; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Dall'Olio F, 2000, INT J CANCER, V88, P58, DOI 10.1002/1097-0215(20001001)88:1<58::AID-IJC9>3.0.CO;2-Q; Suzuki O, 2014, INT J ONCOL, V44, P1433, DOI 10.3892/ijo.2014.2319; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429; Hadari YR, 2000, J CELL SCI, V113, P2385; Suzuki O, 2006, INT J ONCOL, V28, P155; Dall'Olio F, 1999, INT J CANCER, V81, P243; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Diskin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044400; Fouillit M, 2000, GLYCOBIOLOGY, V10, P413, DOI 10.1093/glycob/10.4.413; Landemarre L, 2013, GLYCOCONJUGATE J, P195; Suzuki O, 2008, INT J MOL MED, V22, P339, DOI 10.3892/ijmm_00000028; Suzuki O, 2002, INT J ONCOL, V20, P1005; Suzuki O, 2008, ONCOL REP, V19, P743; Yamamoto H, 2008, J BIOCHEM, V143, P311, DOI 10.1093/jb/mvm223; Zick Yehiel, 2004, Glycoconjugate Journal, V19, P517	22	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					973	980		10.3892/ijo.2015.2818		8	Oncology	Oncology	CA6XW	WOS:000349061800008		
J	Izumi, H; Touge, H; Igishi, T; Makino, H; Nishii-Ito, S; Takata, M; Nakazaki, H; Ueda, Y; Matsumoto, S; Kodani, M; Kurai, J; Takeda, K; Sakamoto, T; Yanai, M; Tanaka, N; Nirodi, CS; Shimizu, E				Izumi, Hiroki; Touge, Hirokazu; Igishi, Tadashi; Makino, Haruhiko; Nishii-Ito, Shizuka; Takata, Miyako; Nakazaki, Hirofumi; Ueda, Yasuto; Matsumoto, Shingo; Kodani, Masahiro; Kurai, Jun; Takeda, Kenichi; Sakamoto, Tomohiro; Yanai, Masaaki; Tanaka, Natsumi; Nirodi, Chaitanya S.; Shimizu, Eiji			Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase-inhibitory fluoropyrimidine in EGFR-mutated lung adenocarcinoma: Retrospective and in vitro studies	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						vinorelbine; dihydropyrimidine dehydrogenase-inhibitory fluoropyrimidine; 5-fluorouracil; epidermal growth factor receptor; lung adenocarcinoma	RANDOMIZED PHASE-III; CANCER CELL-LINES; ADJUVANT CHEMOTHERAPY; PLUS VINORELBINE; RECEPTOR; MUTATIONS; GEFITINIB; TRIAL; S-1; JAPAN	Although cytotoxic chemotherapy is essential in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), it is unclear which regimen is most effective. We retrospectively compared the efficacy of standard platinum-based chemotherapy with that of combination chemotherapy using vinorelbine (VNR) plus dihydropyrimidine dehydrogenase-inhibitory fluoropyrimidine (DIF) in EGFR-mutated lung adenocarcinomas, and we investigated a potential mechanism by which the combination chemotherapy of VNR + DIF was favorable in the treatment of EGFR-mutated lung adenocarcinoma in vitro. In our retrospective analysis, the response rate and disease control rate afforded by the VNR + DIP treatment tended to be better than those by platinum-based chemotherapy, and the progression-free survival of the 24 VNR + DIF-treated patients was significantly longer than that of the 15 platinum-based chemotherapy patients. In EGFR-mutated PC9 cells, VNR induced EGFR dephosphorylation at a clinically achievable concentration. 1BR3-LR cells, a line of fibroblast cells transfected with a mutant EGFR construct, were completely resistant to gefitinib in the medium containing 10% fetal bovine serum (FBS), whereas the sensitivity of these cells to gefitinib was increased in 0.5% FBS-containing medium. Similarly, the sensitivity of 1BR3-LR cells to VNR was increased when they were cultured in low-serum condition. In addition, sodium orthovanadate (Na3VO4) inhibited the EGFR dephosphorylation induced by VNR or gefitinib and suppressed the cell growth inhibition by these agents in PC9 cells. VNR and gefitinib showed synergistic cell growth inhibition in combination with 5-fluorouracil (5-FU) in PC9 cells. We propose that the EGFR dephosphorylation induced by VNR is related to cell growth inhibitory activity of VNR, and that this is one of the mechanisms of the synergistic effect of VNR + 5-FU in EGFR-mutated lung cancer cells. In conclusion, the combination chemotherapy of VNR + DIP may be a promising treatment for NSCLC patients with EGFR mutations.	[Izumi, Hiroki; Touge, Hirokazu; Igishi, Tadashi; Makino, Haruhiko; Nishii-Ito, Shizuka; Takata, Miyako; Nakazaki, Hirofumi; Ueda, Yasuto; Matsumoto, Shingo; Kodani, Masahiro; Kurai, Jun; Takeda, Kenichi; Sakamoto, Tomohiro; Yanai, Masaaki; Tanaka, Natsumi; Shimizu, Eiji] Tottori Univ, Div Med Oncol & Mol Respirol, Fac Med, Yonago, Tottori 6838504, Japan; [Nirodi, Chaitanya S.] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36604 USA	Igishi, T (reprint author), Tottori Univ, Div Med Oncol & Mol Respirol, Fac Med, 36-1 Nishi Machi, Yonago, Tottori 6838504, Japan.	igishi@med.tottori-u.ac.jp					Takano T, 2008, J CLIN ONCOL, V26, P5589, DOI 10.1200/JCO.2008.16.7254; Okamoto I, 2010, J CLIN ONCOL, V28, P5240, DOI 10.1200/JCO.2010.31.0326; Nana-Sinkam SP, 2013, CHEST, V143, pE30, DOI 10.1378/chest.12-2346; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Muggia FM, 1996, CLIN CANCER RES, V2, P1461; Pujol JL, 2006, LUNG CANCER-J IASLC, V51, P335, DOI 10.1016/j.lungcan.2005.11.001; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Okabe T, 2008, MOL CANCER THER, V7, P599, DOI 10.1158/1535-7163.MCT-07-0567; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Butts CA, 2010, J CLIN ONCOL, V28, P29, DOI 10.1200/JCO.2009.24.0333; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dickgreber NJ, 2009, CLIN CANCER RES, V15, P382, DOI 10.1158/1078-0432.CCR-08-0128; Dunant A, 2005, CLIN CANCER RES, V11, p5017S, DOI 10.1158/1078-0432.CCR-05-9006; Ginsberg Doron, 2007, Sci STKE, V2007, ppe4, DOI 10.1126/stke.3712007pe4; Gridelli C, 2001, ONCOLOGIST S, V6, pS4; Hirata K, 1999, CLIN CANCER RES, V5, P2000; Igishi T, 2009, J THORAC ONCOL, V4, P376, DOI 10.1097/JTO.0b013e3181989dfc; Khayat D, 2004, CANCER CHEMOTH PHARM, V54, P193, DOI 10.1007/s00280-004-0794-1; Kodani M, 2011, EUR J CANCER, V47, pS620; Lee KH, 2006, JPN J CLIN ONCOL, V36, P344, DOI 10.1093/jjco/hyl039; Matsumoto S, 2004, INT J ONCOL, V25, P1311; Nakagawa M, 2005, ANN ONCOL, V16, P75, DOI 10.1093/annonc/mdi021; Takata M, 2012, CANCER BIOL THER, V13, P369, DOI [10.4161/cbt.19238, 10.4161/cbt.13.6.19238]; Wada Y, 2006, INT J CANCER, V119, P783, DOI 10.1002/ijc.21879; Wu XP, 2013, INT J ONCOL, V42, P297, DOI 10.3892/ijo.2012.1710	36	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					989	998		10.3892/ijo.2015.2815		10	Oncology	Oncology	CA6XW	WOS:000349061800010		
J	Okabe, N; Ezaki, J; Yamaura, T; Muto, S; Osugi, J; Tamura, H; Imai, JI; Ito, E; Yanagisawa, Y; Honma, R; Gotoh, M; Watanabe, S; Waguri, S; Suzuki, H				Okabe, Naoyuki; Ezaki, Junji; Yamaura, Takumi; Muto, Satoshi; Osugi, Jun; Tamura, Hirosumi; Imai, Jun-Ichi; Ito, Emi; Yanagisawa, Yuka; Honma, Reiko; Gotoh, Mitsukazu; Watanabe, Shinya; Waguri, Satoshi; Suzuki, Hiroyuki			FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						FAM83B; squamons cell carcinoma; diagnostic marker; prognostic marker; non-small cell lung cancer	PHASE-III; CANCER; CHEMOTHERAPY; MUTATIONS; ONCOGENE; THERAPY; GENE; EGFR; SOX2; IDENTIFICATION	Personalized therapy for non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma, has recently been significantly improved by the discovery of various molecular targets. However, this has not been the case for lung squamous cell carcinoma (SCC). In the present study, we identified the family with sequence similarity 83, member B (FAM83B) as a candidate marker for SCC through a comprehensive gene expression analysis and examined its correlations with various clinicopathological factors. The subjects of this study consisted of 215 patients with NSCLC who underwent complete resection from 2005 to 2011 at the Fukushima Medical University Hospital (Fukushima, Japan). They included 102 patients with adenocarcinoma and 113 with SCC. FAM83B expression was first examined in some of the samples by gene expression analysis and western blotting, and then all clinical specimens were evaluated by immunohistochemistry (IHC). The relationship between the quantitative values for IHC and clinicopathological factors was statistically analyzed. The results showed that FAM83B mRNA expression was significantly higher in SCC than in normal lung or adenocarcinoma (P<0.0001). Immunoblot analysis also confirmed this trend. Specimens containing >10% positive area for FAM83B were judged as 'positive'; 94.3% (107/113) of SCC and 14.7% (15/102) of adenocarcinoma were positive. Patients were divided into two subgroups according to expression (54 high-expression and 53 low-expression patients); the high-expression group was associated with a better disease-free survival (DFS) rate (P=0.042, log-rank test). In conclusion, FAM83B may be a reliable diagnostic and prognostic biomarker for SCC. Detailed analyses of FAM83B function in lung cancer are required to understand how its expression is associated with better prognosis in SCC.	[Okabe, Naoyuki; Yamaura, Takumi; Muto, Satoshi; Osugi, Jun; Gotoh, Mitsukazu; Suzuki, Hiroyuki] Fukushima Med Univ, Dept Regenerat Surg, Sch Med, Fukushima 9601295, Japan; [Ezaki, Junji; Tamura, Hirosumi; Imai, Jun-Ichi; Ito, Emi; Watanabe, Shinya; Waguri, Satoshi] Fukushima Med Univ, Med Ind Translat Res Ctr, Sch Med, Fukushima 9601295, Japan; [Yanagisawa, Yuka; Honma, Reiko] Nippon Gene Co Ltd, Tokyo 1010054, Japan	Suzuki, H (reprint author), Fukushima Med Univ, Dept Regenerat Surg, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	hiro@fmu.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) (Tokyo, Japan); Fukushima Prefecture	This research was partially supported by grants for translational research programs from New Energy and Industrial Technology Development Organization (NEDO) (Tokyo, Japan) and Fukushima Prefecture. Dr Y. Yanagisawa and Dr R. Honma are employees of Nippon Gene Co., Ltd. We are extremely grateful to Ms. Y. Kikuta for her technical assistance.	Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Pelosi G, 2012, J THORAC ONCOL, V7, P281, DOI 10.1097/JTO.0b013e31823815d3; Ou SHI, 2009, J THORAC ONCOL, V4, P1202, DOI 10.1097/JTO.0b013e3181b28fb9; Miura A, 2006, FEBS LETT, V580, P6871, DOI 10.1016/j.febslet.2006.11.041; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Cipriano R, 2014, ONCOGENE, V33, P3298, DOI 10.1038/onc.2013.293; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Ocque R, 2011, AM J CLIN PATHOL, V136, P81, DOI 10.1309/AJCPFKOLGL6PMOF3; Cipriano R, 2013, ONCOTARGET, V4, P729; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Kim HS, 2013, LUNG CANCER, V80, P249, DOI 10.1016/j.lungcan.2013.02.015; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Hainsworth JD, 2011, J THORAC ONCOL, V6, P109, DOI 10.1097/JTO.0b013e3181f94ad4; Khuder SA, 2001, LUNG CANCER-J IASLC, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Cipriano R, 2012, J CLIN INVEST, V122, P3197, DOI 10.1172/JCI60517; Conde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012209; Gold KA, 2012, CLIN CANCER RES, V18, P3002, DOI 10.1158/1078-0432.CCR-11-2055; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kogure Y, 2013, J THORAC ONCOL, V8, P753, DOI 10.1097/JTO.0b013e31828b51f5; Noh S, 2012, LUNG CANCER, V76, P51, DOI 10.1016/j.lungcan.2011.09.008; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Turner NC, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001942	34	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					999	1006		10.3892/ijo.2015.2817		8	Oncology	Oncology	CA6XW	WOS:000349061800011		
J	Tomizawa, M; Shinozaki, F; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Ishige, Naoki			Gastric cancer cell proliferation is suppressed by frizzled-2 short hairpin RNA	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						frizzled genes; real-time quantitative PCR; MTS assay; scratch assay; cyclin D1; matrix metallopeptidase	MOLECULAR-CLONING; SIGNALING PATHWAY; POOR SURVIVAL; WNT PATHWAY; GENE; METHYLATION; EXPRESSION; TARGET; MMP-9	In order to identify novel targets for the molecular therapy of gastric cancer (GC), we investigated the mRNA and protein expression of frizzled-2 (Fz2), a Wnt signaling pathway receptor. Reverse-transcriptase polymerase chain reaction (PCR) amplification was utilized to determine the expression patterns of Fz genes in normal stomach and in the GC cell lines MKN45 and MKN74. Immunostaining was performed on surgical specimens of GC using an antibody against Fz2. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfopheny1)-2H-tetrazolium inner salt (MTS) assay was performed on MKN45 cells and MKN74 cells transfected with Fz2 short-hairpin (sh) RNA. Cell motility was analyzed by scratch assay following Fz2 shRNA. Real-time quantitative PCR was performed to analyze the expression levels of cyclin D1 and matrix metallopeptidase 9 (MMP-9). Fz1, 3, 6 and 8 were expressed in normal stomach, and in MKN45 and MKN74 cells. Fz2 was expressed in normal stomach and in MKN45, but not in MKN74 cells. Well-differentiated GC tissue was weakly positive for Fz2 in cell membranes. Fz2 was positive in both the cell membrane and cytoplasm of GC tissues of moderately differentiated and poorly differentiated adenocarcinoma. Signet ring cells were positive for cytoplasmic Fz2. Proliferation of MKN45 and MKN74 cells was suppressed by Fz2 shRNA, and a scratch assay demonstrated that Fz2 shRNA suppressed also MKN45 and MKN74 cell motility. Furthermore, Fz2 shRNA application led to downregulated mRNA expression of both cyclin D1 and MMP-9. Fz2, 3, 6 and 8 were expressed in normal stomach, and in MKN45 and MKN74 GC cells. Fz2 shRNA suppressed cell proliferation and motility of MKN45 and MKN74 cells, and downregulated cyclin D1 and MMP-9 expression in these GC cell lines.	[Tomizawa, Minoru] Shimoshizu Hosp, Dept Gastroenterol, Natl Hosp Org, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Dept Radiol, Natl Hosp Org, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Shimoshizu Hosp, Dept Neurol, Natl Hosp Org, Chiba 2840003, Japan; [Sugiyama, Takao] Shimoshizu Hosp, Dept Rheumatol, Natl Hosp Org, Chiba 2840003, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Dept Pediat, Natl Hosp Org, Chiba 2840003, Japan; [Ishige, Naoki] Shimoshizu Hosp, Dept Neurosurg, Natl Hosp Org, Chiba 2840003, Japan	Tomizawa, M (reprint author), Shimoshizu Hosp, Dept Gastroenterol, Natl Hosp Org, 934-5 Shikawatashi, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp					Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Yu J, 2009, CANCER, V115, P49, DOI 10.1002/cncr.23989; Gomez-Orte E, 2013, TRENDS GENET, V29, P545, DOI 10.1016/j.tig.2013.06.003; Tanaka SS, 2011, DEV GROWTH DIFFER, V53, P843, DOI 10.1111/j.1440-169X.2011.01292.x; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Tomizawa M, 2013, ONCOTARGETS THER, V6, P1685, DOI 10.2147/OTT.S50065; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Jamieson C, 2014, SEMIN CANCER BIOL, V27, P20, DOI 10.1016/j.semcancer.2014.04.012; Saitoh T, 2001, INT J ONCOL, V18, P991; Takahashi-Yanaga F, 2013, BIOCHEM PHARMACOL, V86, P191, DOI 10.1016/j.bcp.2013.04.022; Katoh M, 2005, ONCOL REP, V14, P1583; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Casimiro MC, 2014, EXPERT OPIN INV DRUG, V23, P295, DOI 10.1517/13543784.2014.867017; Fujimoto T, 2009, INT J ONCOL, V35, P861, DOI 10.3892/ijo_00000400; Sagara N, 1998, BIOCHEM BIOPH RES CO, V252, P117, DOI 10.1006/bbrc.1998.9607; Cui JX, 2014, INT J MOL MED, V34, P197, DOI 10.3892/ijmm.2014.1759; De Vita F, 2014, WORLD J GASTROENTERO, V20, P14537, DOI 10.3748/wjg.v20.i40.14537; Hibi K, 2012, HEPATO-GASTROENTEROL, V59, P2661, DOI 10.5754/hge09664; Kim MY, 2014, WORLD J GASTROENTERO, V20, P13273, DOI 10.3748/wjg.v20.i37.13273; Kirikoshi H, 1999, BIOCHEM BIOPH RES CO, V264, P955, DOI 10.1006/bbrc.1999.1612; Kirikoshi H, 2000, BIOCHEM BIOPH RES CO, V271, P8, DOI 10.1006/bbrc.2000.2578; Koike J, 1999, BIOCHEM BIOPH RES CO, V262, P39, DOI 10.1006/bbrc.1999.1161; Lee MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-125; Saitoh T, 2001, INT J ONCOL, V19, P105; Tokuhara M, 1998, BIOCHEM BIOPH RES CO, V243, P622, DOI 10.1006/bbrc.1998.8143; Tomizawa M, 2014, ONCOL LETT, V8, P1519; Tomizawa M, 2014, ONCOL LETT, V7, P74; Wang YK, 1997, HUM MOL GENET, V6, P465, DOI 10.1093/hmg/6.3.465	30	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1018	1024		10.3892/ijo.2015.2830		7	Oncology	Oncology	CA6XW	WOS:000349061800013		
J	Kogita, A; Togashi, Y; Hayashi, H; Banno, E; Terashima, M; De Velasco, MA; Sakai, K; Fujita, Y; Tomida, S; Takeyama, Y; Okuno, K; Nakagawa, K; Nishio, K				Kogita, Akihiro; Togashi, Yosuke; Hayashi, Hidetoshi; Banno, Eri; Terashima, Masato; De Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Takeyama, Yoshifumi; Okuno, Kiyotaka; Nakagawa, Kazuhiko; Nishio, Kazuto			Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						non-small cell lung cancer; EML4-ALK rearrangement; alectinib; crizotinib; MET	GROWTH-FACTOR RECEPTOR; CRIZOTINIB RESISTANCE; ACQUIRED-RESISTANCE; GEFITINIB RESISTANCE; GENE AMPLIFICATION; MUTATIONS; EML4-ALK; ADENOCARCINOMA; CH5424802; TARGET	Non-small cell lung cancer (NSCLC) carrying echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangements is hypersensitive to ALK inhibitors, including crizotinib and alectinib. Crizotinib was initially designed as a MET inhibitor, whereas alectinib is a selective ALK inhibitor. The MET signal, which is inhibited by crizotinib but not by alectinib, is dysregulated in many human cancers. However, the role of the MET signal in ALK-positive NSCLC remains unclear. In this study, we found that hepatocyte growth factor (HGF), ligand of MET, mediated the resistance to alectinib, but not to crizotinib, via the MET signal in ALK-positive NSCLC cell lines (H3122 and H2228 cell lines). In addition, alectinib activated the MET signal even in the absence of HGF and the inhibition of the MET signal enhanced the efficacy of alectinib. These findings suggest that activated MET acts as a salvage signal in ALK-positive NSCLC. This novel role of the MET signal in ALK-positive NSCLC may pave the way for further clinical trials examining MET inhibitors.	[Kogita, Akihiro; Togashi, Yosuke; Hayashi, Hidetoshi; Banno, Eri; Terashima, Masato; De Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nishio, Kazuto] Kinki Univ, Dept Genome Biol, Fac Med, Osaka 5898511, Japan; [Kogita, Akihiro; Takeyama, Yoshifumi; Okuno, Kiyotaka] Kinki Univ, Dept Surg, Fac Med, Osaka 5898511, Japan; [Hayashi, Hidetoshi; Nakagawa, Kazuhiko] Kinki Univ, Dept Med Oncol, Fac Med, Osaka 5898511, Japan	Nishio, K (reprint author), Kinki Univ, Dept Genome Biol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	knishio@med.kindai.ac.jp			Japan Society for Promotion of Science Fellows	We thank Mr. Shinji Kurashimo, Mr. Yoshihiro Mine, Ms. Eiko Honda, Ms. Tomoko Kitayama, and Ms. Ayaka Kurumatani for their technical assistance. We thank Dr P.A. Janne (Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA) for providing the H3122 cell line. This study was supported by the Third-Term Comprehensive 10-Year Strategy for Cancer Control and Grant-in Aid for Japan Society for Promotion of Science Fellows.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Tanizaki J, 2012, CLIN CANCER RES, V18, P6219, DOI 10.1158/1078-0432.CCR-12-0392; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Feng Y, 2014, J THORAC ONCOL, V9, P646, DOI 10.1097/JTO.0000000000000145; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Kim HR, 2013, MOL ONCOL, V7, P1093, DOI 10.1016/j.molonc.2013.08.001; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Corso S, 2013, CANCER DISCOV, V3, P978, DOI 10.1158/2159-8290.CD-13-0040; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Voena C, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.7; Gouji T, 2014, J THORAC ONCOL, V9, pE27, DOI 10.1097/JTO.0000000000000113; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; Yamaguchi N, 2014, LUNG CANCER, V83, P37, DOI 10.1016/j.lungcan.2013.09.019	37	4	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1025	1030		10.3892/ijo.2014.2797		6	Oncology	Oncology	CA6XW	WOS:000349061800014		
J	Mataki, H; Seki, N; Chiyomaru, T; Enokida, H; Goto, Y; Kumamoto, T; Machida, K; Mizuno, K; Nakagawa, M; Inoue, H				Mataki, Hiroko; Seki, Naohiko; Chiyomaru, Takeshi; Enokida, Hideki; Goto, Yusuke; Kumamoto, Tomohiro; Machida, Kentaro; Mizuno, Keiko; Nakagawa, Masayuki; Inoue, Hiromasa			Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						lung squamous cell carcinoma; microRNA; miR-206; tumor suppressor; receptor tyrosine kinase; EGFR; MET	GROWTH-FACTOR RECEPTOR; ACQUIRED-RESISTANCE; KINASE INHIBITORS; EXPRESSION LEVELS; TYROSINE KINASES; CANCER CELLS; CHEMOTHERAPY; GEFITINIB; ERLOTINIB; INVASION	Expression of the oncogene hepatocyte growth factor receptor (MET) and phosphorylation of the MET protein have been associated with both primary and acquired resistance to tyrosine kinase inhibitors (TKIs) used in therapy targeting the epidermal growth factor receptor (EGFR) in patients with non-small cell lung cancers (NSCLCs). Therefore, simultaneous inhibition of both of these receptor tyrosine kinases (RTKs) should improve disease treatment. Our previous study of microRNA (miRNA) expression signatures of lung squamous cell carcinoma (lung-SCC) revealed that microRNA-206 (miR-206) was significantly reduced in lung-SCC tissues, suggesting that miR-206 functions as a tumor suppressor in the disease. Furthermore, putative miR-206 binding sites were annotated in the 3'-UTRs of MET and EGFR RTKs in miRNA databases. The aim of the study was to investigate the functional significance of miR-206 in lung-SCC and to confirm the inhibition of both MET and EGFR oncogenic signaling by expression of miR-206 in cancer cells. We found that restoration of mature miR-206 inhibited cancer cell proliferation, migration, and invasion in EBC-1 cells through downregulation of both mRNA and protein levels of MET and EGFR. Interestingly, phosphorylation of ERK1/2 and AKT signaling were inhibited by restoration of miR-206 in cancer cells. Overexpression of MET and EGFR were observed in clinical specimens of lung-SCC. Tumor-suppressive miR-206 inhibited dual signaling networks activated by MET and EGFR, and these findings will provide new insights into the novel molecular mechanisms of lung-SCC oncogenesis and new therapeutic approaches for the treatment of this disease.	[Mataki, Hiroko; Kumamoto, Tomohiro; Machida, Kentaro; Mizuno, Keiko; Inoue, Hiromasa] Kagoshima Univ, Dept Pulm Med, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; [Chiyomaru, Takeshi; Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Dept Urol, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; [Seki, Naohiko; Goto, Yusuke] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan	Inoue, H (reprint author), Kagoshima Univ, Dept Pulm Med, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	inoue-pulm@umin.net					Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Hidaka H, 2012, ONCOTARGET, V3, P44; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Georgantas RW, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12200; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Rolfo C, 2014, CURR PHARM BIOTECHNO, V15, P475; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Cipriani NA, 2009, LUNG CANCER, V63, P169, DOI 10.1016/j.lungcan.2008.06.011; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Moriya Y, 2012, J HUM GENET, V57, P38, DOI 10.1038/jhg.2011.126; Nohata N, 2012, ONCOTARGET, V3, P9; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; CADENA DL, 1992, FASEB J, V6, P2332; Koeppen H, 2014, CLIN CANCER RES, V20, P4488, DOI 10.1158/1078-0432.CCR-13-1836; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Chen XY, 2012, CANCER LETT, V314, P41, DOI 10.1016/j.canlet.2011.09.014; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Gately K, 2014, CLIN LUNG CANCER, V15, P58, DOI 10.1016/j.cllc.2013.08.005; Itesako T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084311; Missiaglia E, 2010, BRIT J CANCER, V102, P1769, DOI 10.1038/sj.bjc.6605684; Maroun CR, 2014, PHARMACOL THERAPEUT, V142, P316, DOI 10.1016/j.pharmthera.2013.12.014; Sacher AG, 2014, CANCER-AM CANCER SOC, V120, P2289, DOI 10.1002/cncr.28723	44	2	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1039	1050		10.3892/ijo.2014.2802		12	Oncology	Oncology	CA6XW	WOS:000349061800016		
J	Isozaki, Y; Hoshino, I; Akutsu, Y; Hanari, N; Mori, M; Nishimori, T; Murakami, K; Akanuma, N; Takeshita, N; Maruyama, T; Toyozumi, T; Takahashi, M; Suito, H; Matsubara, H				Isozaki, Yuka; Hoshino, Isamu; Akutsu, Yasunori; Hanari, Naoyuki; Mori, Mikito; Nishimori, Takanori; Murakami, Kentaro; Akanuma, Naoki; Takeshita, Nobuyoshi; Maruyama, Tetsuro; Toyozumi, Takeshi; Takahashi, Masahiko; Suito, Hiroshi; Matsubara, Hisahiro			Usefulness of microRNA-375 as a prognostic and therapeutic tool in esophageal squamous cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						microRNA-375; tumor-suppressive microRNA; esophageal squamous cell carcinoma; delivery system; microRNA-based therapy	HISTONE DEACETYLASE INHIBITOR; LACTATE DEHYDROGENASE-B; CANCER-SURGERY; EXPRESSION; MIDKINE; GROWTH; FK228; SIRNA	The aim of this study was to clarify the importance of microRNA-375 (miR-375) expression in patients with esophageal squamous cell carcinoma (ESCC) and to examine the in vivo antitumor effects of miR-375 in a model of ESCC using a non-viral delivery system. We estimated the miR-375 and LDHB and AEG-1/MTDH mRNA expression of the ESCC tumors from 85 patients. The correlation between the miR-375 expression and clinicopathological features, including the prognosis, were evaluated. The presence of high miR-375 expression was associated with lymphatic vessel invasion, while a low expression of miR-375 significantly correlated with a poor prognosis for the 85 ESCC patients. We also found that there was a significant inverse correlation between the expression of miR-375 and that of LDHB. Before the examination of miR-375 in the in vivo assay, we confirmed that atelocollagen prolonged the accumulation of miRNA by using fluorescently-labeled miRNA and an in vivo imaging system. We injected the miR-375/atelocollagen complex or a control-miRNA/atelocollagen complex into mice bearing TE2 and T.Tn xenografts via subcutaneous (s.c.) injections. The growth of both the TE2 and T.Tn tumors in the miR-375 groups was significantly suppressed compared with that in the control-miRNA groups. In addition, The LDHB mRNA expression of TE2 xenografts was significantly downregulated after miR-375 treatment. In conclusion, it might be possible for the level of miR-375 expression to be a utilized as a prognostic indicator for ESCC patients. The administration of miR-375 using a non-viral delivery might represent a powerful new treatment for ESCC.	[Isozaki, Yuka; Hoshino, Isamu; Akutsu, Yasunori; Hanari, Naoyuki; Mori, Mikito; Nishimori, Takanori; Murakami, Kentaro; Akanuma, Naoki; Takeshita, Nobuyoshi; Maruyama, Tetsuro; Toyozumi, Takeshi; Takahashi, Masahiko; Suito, Hiroshi; Matsubara, Hisahiro] Chiba Univ, Dept Frontier Surg, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	Hoshino, I (reprint author), Chiba Univ, Dept Frontier Surg, Grad Sch Med, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	i_hosino@chiba-u.jp					Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Inaba S, 2012, MOL THER, V20, P356, DOI 10.1038/mt.2011.221; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Kinoshita T, 2012, INT J ONCOL, V40, P185, DOI 10.3892/ijo.2011.1196; Hoshino I, 2013, SURG TODAY, V43, P467, DOI 10.1007/s00595-012-0392-5; Nissan T, 2008, RNA, V14, P1480, DOI 10.1261/rna.1072808; Dettmer M, 2013, THYROID, V23, P1383, DOI 10.1089/thy.2012.0632; Takei Y, 2006, CANCER, V107, P864, DOI 10.1002/cncr.22068; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Banno H, 2006, J VASC SURG, V44, P633, DOI 10.1016/j.jvs.2006.04.044; Chen Y, 2006, LUNG CANCER, V54, P95, DOI 10.1016/j.lungcan.2006.06.014; Hoshino I, 2007, ONCOL REP, V18, P585; Hoshino I, 2005, CLIN CANCER RES, V11, P7945, DOI 10.1158/1078-0432.CCR-05-0840; Hoshino I, 2010, SURG TODAY, V40, P809, DOI 10.1007/s00595-010-4300-6; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Isozaki Y, 2012, INT J ONCOL, V41, P985, DOI 10.3892/ijo.2012.1537; Kinoshita T, 2012, J HUM GENET, V57, P556, DOI 10.1038/jhg.2012.75; Li JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053582; Nguyen Han Christine Ngoc, 2013, Prostate, V73, P346, DOI 10.1002/pros.22572; Ruol A, 2009, ARCH SURG-CHICAGO, V144, P247, DOI 10.1001/archsurg.2008.574	27	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1059	1066		10.3892/ijo.2014.2789		8	Oncology	Oncology	CA6XW	WOS:000349061800018		
J	Hartomo, TB; Pham, TVH; Yamamoto, N; Hirase, S; Hasegawa, D; Kosaka, Y; Matsuo, M; Hayakawa, A; Takeshima, Y; Iijima, K; Nishio, H; Nishimura, N				Hartomo, Tri Budi; Thi Van Huyen Pham; Yamamoto, Nobuyuki; Hirase, Satoshi; Hasegawa, Daiichiro; Kosaka, Yoshiyuki; Matsuo, Masafumi; Hayakawa, Akira; Takeshima, Yasuhiro; Iijima, Kazumoto; Nishio, Hisahide; Nishimura, Noriyuki			Involvement of aldehyde dehydrogenase 1A2 in the regulation of cancer stem cell properties in neuroblastoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						neuroblastoma; cancer stem cell; sphere; aldehyde dehydrogenase 1A2; 13-cis-retinoic acid	RETINOIC ACID SYNTHESIS; TUMOR-INITIATING CELL; INDUCED DIFFERENTIATION; PROSTATE-CANCER; ALDH1A2; EXPRESSION; GENE; OPPORTUNITIES; CHEMOTHERAPY; SUPPRESSOR	Despite the introduction of 13-cis-retinoic acid (13-cis-RA) into the current chemotherapy, more than half of high-risk neuroblastoma patients have experienced tumor relapses driven by chemoresistant cancer stem cells (CSCs) that can be isolated by their ability to grow as spheres. Although aldehyde dehydrogenase (ALDH) has been used to characterize CSCs in certain cancers, ALDH remains elusive in neuroblastoma. In the present study, we determined ALDH activity and expression of its 19 isoforms in spheres and parental cells of neuroblastoma. ALDH activity and several ALDH isoforms were consistently induced in spheres of different neuroblastoma cells. While ALDH1A2, ALDH1L1 and ALDH3B2 expression was consistently induced in spheres and associated with the sphere and colony formation, only ALDH1A2 expression was significantly correlated with the poor prognosis of neuroblastoma patients. ALDH1A2 expression was further associated with the growth and undifferentiation of neuroblastoma xenografts and the resistance of neuroblastoma cells to 13-cis-RA. These results suggest that ALDH1A2 is involved in the regulation of CSC properties in neuroblastoma.	[Hartomo, Tri Budi; Nishio, Hisahide; Nishimura, Noriyuki] Kobe Univ, Grad Sch Med, Dept Epidemiol, Kobe, Hyogo 6500017, Japan; [Thi Van Huyen Pham; Yamamoto, Nobuyuki; Hirase, Satoshi; Hayakawa, Akira; Takeshima, Yasuhiro; Iijima, Kazumoto; Nishio, Hisahide; Nishimura, Noriyuki] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Hasegawa, Daiichiro; Kosaka, Yoshiyuki] Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo 6540081, Japan; [Matsuo, Masafumi] Kobe Gakuin Univ, Dept Rehabil Med, Kobe, Hyogo 6512180, Japan	Nishimura, N (reprint author), Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nnishi@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Children's Cancer Association of Japan; Hyogo Science and Technology Association	We thank the staff of animal facilities at Kobe University Graduate School of Medicine and of Advanced Tissue Staining Center at Kobe University Hospital for excellent technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from the Children's Cancer Association of Japan and Hyogo Science and Technology Association.	TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Hsu DM, 2013, CANCER RES, V73, P4134, DOI 10.1158/0008-5472.CAN-12-4056; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Chen Y, 2011, BIOCHEM BIOPH RES CO, V405, P173, DOI 10.1016/j.bbrc.2011.01.002; Jackson Brian, 2011, Human Genomics, V5, P283; Touma SE, 2009, BIOCHEM PHARMACOL, V78, P1127, DOI 10.1016/j.bcp.2009.06.022; Patel M, 2008, LUNG CANCER, V59, P340, DOI 10.1016/j.lungcan.2007.08.033; Sartelet H, 2012, HISTOPATHOLOGY, V60, P1144, DOI 10.1111/j.1365-2559.2012.04191.x; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; KASTAN MB, 1990, BLOOD, V75, P1947; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Cole KA, 2012, CLIN CANCER RES, V18, P2423, DOI 10.1158/1078-0432.CCR-11-1409; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CANT-07-0718; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Kim H, 2005, CANCER RES, V65, P8118, DOI 10.1158/0008-5472.CAN-04-4562; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pans.0400067101; Coulon A, 2011, NEOPLASIA, V13, P991, DOI 10.1593/neo.11800; Deak KL, 2005, BIRTH DEFECTS RES A, V73, P868, DOI 10.1002/bdra.20183; Kanda I, 2008, ONCOGENE, V27, P1687, DOI 10.1038/sj.onc.1210812; Laverdiere C, 2009, J NATL CANCER I, V101, P1131, DOI 10.1093/jnci/djp230; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Nishimura Noriyuki, 2012, Environmental Health and Preventive Medicine, V17, P246, DOI 10.1007/s12199-011-0239-5; Nishimura N, 2011, ONCOL REP, V26, P145, DOI 10.3892/or.2011.1255; Pavan M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-113; Pham Thi Van Huyen, 2012, Oncol Rep, V27, P2045, DOI 10.3892/or.2012.1731	39	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1089	1098		10.3892/ijo.2014.2801		10	Oncology	Oncology	CA6XW	WOS:000349061800021		
J	Koseki, J; Colvin, H; Fukusumi, T; Nishida, N; Konno, M; Kawamoto, K; Tsunekuni, K; Matsui, H; Doki, Y; Mori, M; Ishii, H				Koseki, Jun; Colvin, Hugh; Fukusumi, Takahito; Nishida, Naohiro; Konno, Masamitsu; Kawamoto, Koichi; Tsunekuni, Kenta; Matsui, Hidetoshi; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi			Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating beta-oxygenation pathway in colorectal cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						isocitrate dehydrogenase; colorectal cancer; mathematical computing; alpha-hydroxyglutarate; (D)-isomer; alpha-ketoglutarate	MUTATIONS; GENE; LEUKEMIA; PROGRESSION; DEFICIENCY; PROGNOSIS; CARCINOMA; GENOME; IDH2	Bioinformatics and computational modeling offer innovative approaches to investigate cancer metabolism and predict the secondary and tertiary cellular responses. Dysregulation of metabolism has also been implicated in the pathophysiology of cancer. A significant proportion of patients with glioblastoma and hematological malignancies harbor the mutated forms of the oxidative phosphorylation (OxPhos) enzymes, isocitrate dehydrogenase (IDH) 1 or 2. The mutated forms of IDH1 and IDH2 produce an oncogenic metabolite, D-2-hydroxyglutarate (D2HG). A recent study of breast cancer patients showed that D2HG can also be produced in the absence of mutated IDH, through an alternative route involving over-activated MYC signaling. We developed a novel methodology to computationally analyze gene expression in colorectal cancer (CRC), and identified novel sets of genes that are associated with patient survival. The study of OxPhos-related genes revealed that an imbalance between the expression of IDH1 and IDH2, defined as overexpression of one isoform in relation to the other, was associated with worse prognosis in CRC patients. This effect was further accentuated by reduced expression of the beta-oxygenation enzyme, 3-D-hydroxyacyl-CoA dehydratase (HCDH) 4, which has been reported to contribute to metabolism of intracellular D2HG. The present computational analysis revealed a novel and potential mechanism of CRC development, through overproduction of D2HG when there is an imbalance between IDH1 and IDH2 expression, resulting in decreased clearance of D2HG when the beta-oxidization pathway is diminished. Additional validation analysis with another gene expression dataset resulted in IDH1/2 imbalanced expression with a shorter DFS compared with balanced expression. Altogether, these findings provide a strong rationale for studying this mechanism further in order to discover novel therapeutic targets for the treatment of CRC.	[Koseki, Jun; Colvin, Hugh; Tsunekuni, Kenta; Ishii, Hideshi] Osaka Univ, Dept Canc Profiling Discovery, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fukusumi, Takahito; Nishida, Naohiro; Konno, Masamitsu; Kawamoto, Koichi; Ishii, Hideshi] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka 5650871, Japan; [Colvin, Hugh; Kawamoto, Koichi; Tsunekuni, Kenta; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fukusumi, Takahito] Osaka Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Tsunekuni, Kenta] Taiho Pharmaceut Co Ltd, Chiyoda Ku, Tokyo 1010054, Japan; [Matsui, Hidetoshi] Kyushu Univ, Fac Math, Fukuoka 8128581, Japan	Ishii, H (reprint author), Osaka Univ, Dept Canc Profiling Discovery, Grad Sch Med, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	hishii@gesurg.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; Cancer Control, Ministry of Health, Labor, and Welfare; Kobayashi Cancer Research Foundation; Princess Takamatsu Cancer Research Fund, Japan; National Institute of Biomedical Innovation; Osaka University Drug Discovery Funds; Taiho Pharmaceutical Co., Ltd; EBMRCE, Chugai Co., Ltd; Yakult Honsha Co., Ltd; Merck Co., Ltd; Takeda Science Foundation; Takeda Medical Research Foundation through institutional endowments	We thank Dr R. Daniel Beauchamp and Dr Pengcheng Lu, Vanderbilt Medical Center, TN, USA, for the critical review of our manuscript. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology; a Grant-in-Aid from the Third Comprehensive 10-year Strategy for Cancer Control, Ministry of Health, Labor, and Welfare; a grant from the Kobayashi Cancer Research Foundation; a grant from the Princess Takamatsu Cancer Research Fund, Japan; a grant from the National Institute of Biomedical Innovation; and a grant from the Osaka University Drug Discovery Funds. Partial support was received from Taiho Pharmaceutical Co., Ltd., EBMRCE, Chugai Co., Ltd., Yakult Honsha Co., Ltd. (J.K., N.N., M.K., K.K. and H.I.), Merck Co., Ltd., Takeda Science Foundation and Takeda Medical Research Foundation through institutional endowments.	Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Haffner MC, 2011, ONCOTARGET, V2, P627; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Smith DR, 1996, CLIN CANCER RES, V2, P1049; Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ponnaluri VKC, 2013, BIOCHEM BIOPH RES CO, V436, P115, DOI 10.1016/j.bbrc.2013.05.077; Takatsuno Y, 2013, ANN SURG ONCOL, V20, P1395, DOI 10.1245/s10434-012-2657-z; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Bian YS, 2002, GASTROENTEROLOGY, V122, P1113, DOI 10.1053/gast.2002.32370; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Chen M, 2006, J BIOMED INFORM, V39, P147, DOI 10.1016/j.jbi.2005.05.005; Frisch M.J., 2009, GAUSSIAN 09; Micci F, 2010, GENE CHROMOSOME CANC, V49, P1046, DOI 10.1002/gcc.20813; Montrose DC, 2012, CANCER PREV RES, V5, P1358, DOI 10.1158/1940-6207.CAPR-12-0160; NOWELL P C, 1986, American Journal of Pathology, V125, P8; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; Team RC, 2013, LANG ENV STAT COMP; Therneau TM, 2000, MODELING SURVIVAL DA; Unoki M, 2003, INT J ONCOL, V22, P1217; Yaniv M, 2014, CANCER GENET-NY, V207, P352, DOI 10.1016/j.cancergen.2014.03.006	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1181	1191		10.3892/ijo.2015.2833		11	Oncology	Oncology	CA6XW	WOS:000349061800030		
J	Osawa, Y; Yokoyama, Y; Shigeto, T; Futagami, M; Mizunuma, H				Osawa, Yuki; Yokoyama, Yoshihito; Shigeto, Tatsuhiko; Futagami, Masayuki; Mizunuma, Hideki			Decreased expression of carbonyl reductase 1 promotes ovarian cancer growth and proliferation	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						carbonyl reductase 1; ovarian cancer; siRNA; MMP-9; E-cadherin; VEGF-C	EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; MATRIX-METALLOPROTEINASE-9; CARCINOMA; CELLS; LYMPHANGIOGENESIS; 9-KETOREDUCTASE; RECEPTOR	Carbonyl reductase 1 (CBR1) expression level is related to tumor progression. Decreased CBR1 expression is associated with poor prognosis in ovarian cancer. We investigated the relationship between CBR1 expression level and malignant potential of ovarian cancer. OVCAR-3 cells overexpressing CBR1 or knocked down for CBR1 were obtained by transfecting CBR1 plasmid DNA (pDNA) or small interfering RNA (siRNA) by electroporation. In vitro cell proliferation and invasion were compared between the two cell types. Subcutaneous CBR1-overexpressed OVCAR-3 cells (n=10) and wild-type ones (n=5) were injected into nude mice. The CBR1 siRNA was then injected twice a week into five of the 10 CBR1-overexpressed OVCAR-3 tumors. Tumor growth and metastatic behavior were observed 3 weeks after cell transplantation. Cell proliferation significantly decreased in CBR1-overexpressed cells as compared to the control, whereas cell proliferation and invasion significantly increased in CBR1-suppressed cells as compared to the control. The size of the CBR1 siRNA-injected tumors (n=5) increased significantly as compared to the other two groups (n=5 for each group). The number of metastatic foci in the lungs was significantly higher in mice injected with CBR1 siRNA (7.0 +/- 2.0) compared to CBR1-overexpressed and wild-type tumors (0 and 2.0 +/- 2.0, respectively). Western blot analysis showed that, while vascular endothelial growth factor (VEGF)-C expression was stable in the CBR1-siRNA-injected tumors, E-cadherin expression was decreased, whereas matrix metalloproteinase (MMP)-9 was increased in CBR1-siRNA-injected tumors compared to the other two groups. These results showed that CBR1 decreases promoted tumor proliferation and growth as well as invasion and metastasis, suggesting that CBR1 has potential to become a new candidate for molecular targeting therapy.	[Osawa, Yuki; Yokoyama, Yoshihito; Shigeto, Tatsuhiko; Futagami, Masayuki; Mizunuma, Hideki] Hirosaki Univ, Dept Obstet & Gynecol, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Yokoyama, Y (reprint author), Hirosaki Univ, Dept Obstet & Gynecol, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yokoyama@cc.hirosaki-u.ac.jp			Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan) [20591935]	This study was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan) (no. 20591935 to Dr Y. Yokoyama).	Alshenawy HA, 2010, ANN DIAGN PATHOL, V14, P387, DOI 10.1016/j.anndiagpath.2010.05.005; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Yokoyama Y, 2007, MOL CANCER THER, V6, P1379, DOI 10.1158/1535-7163.MCT-06-0722; Ozalp S, 2003, EUR J GYNAECOL ONCOL, V24, P417; Umemoto M, 2001, BRIT J CANCER, V85, P1032, DOI 10.1054/bjoc.2001.2034; Waclawik A, 2007, J ENDOCRINOL, V194, P499, DOI 10.1677/JOE-07-0155; Sheng HM, 1998, CANCER RES, V58, P362; Murakami A, 2012, CANCER LETT, V323, P69, DOI 10.1016/j.canlet.2012.03.035; Plebuch M, 2007, CANCER LETT, V255, P49, DOI 10.1016/j.canlet.2007.03.018; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sillanpaa S, 2007, GYNECOL ONCOL, V104, P296, DOI 10.1016/j.ygyno.2006.09.004; Olson LE, 2003, CANCER RES, V63, P6602; Wakui M, 2010, J CANCER RES CLIN, V136, P1143, DOI 10.1007/s00432-010-0761-7; WERMUTH B, 1988, J BIOL CHEM, V263, P16185; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Murakami A, 2011, CANCER LETT, V311, P77, DOI 10.1016/j.canlet.2011.06.036; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Gonzalez-Covarrubias V, 2007, DRUG METAB DISPOS, V35, P973, DOI 10.1124/dmd.107.014779; Gyftopoulos K, 2014, UROL ANN, V6, P224; Ikeda K, 2014, ANTICANCER RES, V34, P3911; Ismail E, 2000, CANCER RES, V60, P1173; Li LN, 2013, ASIAN PAC J CANCER P, V14, P4107, DOI 10.7314/APJCP.2013.14.7.4107; Abbasi MM, 2014, ASIAN PAC J CANCER P, V15, P6227, DOI 10.7314/APJCP.2014.15.15.6227; Peppicelli S, 2014, ONCOL LETT, V8, P1133, DOI 10.3892/ol.2014.2297; SCHIEBER A, 1992, EUR J BIOCHEM, V206, P491, DOI 10.1111/j.1432-1033.1992.tb16952.x; Wang Hui, 2012, Clin Med Insights Oncol, V6, P107, DOI 10.4137/CMO.S9005; Yokoyama Y, 2003, BRIT J CANCER, V88, P237, DOI 10.1038/sj.bjc.6600701; Yokoyama Y, 2014, MOL CLIN ONCOL, V2, P212	31	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1252	1258		10.3892/ijo.2014.2810		7	Oncology	Oncology	CA6XW	WOS:000349061800037		
J	Jung, J; Jeong, SY; Park, SS; Shin, SH; Ju, EJ; Choi, J; Park, J; Lee, JH; Kim, I; Suh, YA; Hwang, JJ; Kuroda, S; Lee, JS; Song, SY; Choi, EK				Jung, Joohee; Jeong, Seong-Yun; Park, Seok Soon; Shin, Seol Hwa; Ju, Eun Jin; Choi, Jinhyang; Park, Jaesook; Lee, Jae Hee; Kim, Inki; Suh, Young-Ah; Hwang, Jung Jin; Kuroda, Shun'ichi; Lee, Jung Shin; Song, Si Yeol; Choi, Eun Kyung			A cisplatin-incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						cisplatin; liposome; epidermal growth factor receptor antibody; drug delivery system; radiotherapy; non-small cell lung cancer	ACUTE KIDNEY INJURY; CELL LUNG-CANCER; IN-VIVO; SOLID TUMORS; INHIBITOR	Radiotherapy (RT) is one of the major modalities for non-small cell lung cancer (NSCLC), but its efficacy is often compromised by cellular resistance caused by various mechanisms including the overexpression of epidermal growth factor receptor (EGFR). Although cis-diamminedichloroplatinum(II) (cisplatin, CDDP) has been well characterized as an effective radiosensitizer, its clinical application is limited by its severe nephrotoxic effects. In our current study, we developed a CDDP-incorporated liposome (LP) conjugated with EGFR antibodies (EGFR:LP-CDDP) and evaluated its potential to radiosensitize EGFR-overexpressing cells without exerting nephrotoxic effects. EGFR:LP-CDDP showed higher cytotoxicity than non-targeting liposomal CDDP (LP-CDDP) in the cells expressing EGFR in vitro. In an A549 cell-derived xenograft tumor mouse model, increased delays in tumor growth were observed in the mice treated with a combination of EGFR:LP-CDDP and radiation. Notably, the EGFR:LP-CDDP-treated animals showed no differences in body weight loss, survival rates of nephrotoxicity compared with untreated control mice. In contrast, the use of CDDP caused lower body weights and poorer survival outcomes accompanied by a significant level of nephrotoxicity [e.g., decreased kidney weight, increased blood urea nitrogen (BUN) and creatinine, and pathological change]. These findings suggest the feasibility of using EGFR:LP-CDDP to radiosensitize cells in a targeted manner without inducing nephrotoxic effects. This compound may therefore have clinical potential as part of a tailored chemoradiotherapy strategy.	[Jung, Joohee; Jeong, Seong-Yun; Park, Seok Soon; Shin, Seol Hwa; Ju, Eun Jin; Choi, Jinhyang; Park, Jaesook; Lee, Jae Hee; Suh, Young-Ah; Hwang, Jung Jin; Lee, Jung Shin; Song, Si Yeol; Choi, Eun Kyung] Univ Ulsan, Inst Innovat Canc Res, Asan Med Ctr, Coll Med, Seoul 138736, South Korea; [Jung, Joohee] Duksung Womens Univ, Coll Pharm, Seoul 132714, South Korea; [Jung, Joohee] Duksung Womens Univ, Innovat Drug Ctr, Seoul 132714, South Korea; [Park, Seok Soon; Shin, Seol Hwa; Ju, Eun Jin; Choi, Jinhyang; Park, Jaesook; Lee, Jae Hee; Kim, Inki; Suh, Young-Ah; Hwang, Jung Jin] Univ Ulsan, Asan Inst Life Sci, Asan Med Ctr, Coll Med, Seoul 138736, South Korea; [Kuroda, Shun'ichi] Nagoya Univ, Dept Bioengn Sci, Grad Sch Bioagr Sci, Aichi 4648601, Japan; [Lee, Jung Shin] Univ Ulsan, Dept Internal Med, Coll Med, Seoul 138736, South Korea; [Song, Si Yeol; Choi, Eun Kyung] Univ Ulsan, Dept Radiat Oncol, Asan Med Ctr, Coll Med, Seoul 138736, South Korea; [Choi, Eun Kyung] Asan Med Ctr, Ctr Dev & Commercializat Anticanc Therapeut, Seoul 138736, South Korea	Choi, EK (reprint author), Univ Ulsan, Dept Radiat Oncol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.	coocoori@amc.seoul.kr; ekchoi@amc.seoul.kr			Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (Seoul, Korea) - Ministry for Health and Welfare, Seoul, Republic of Korea [HI06C0868, HI10C2014, HI14C1090]; National Research Foundation of Korea (NRF) (Seoul, Korea) - Korea government (MEST) [NRF-2012R1A2A2A01014671, NRF-2013R1A1A2011346]	This research was supported by grants from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (Seoul, Korea), funded by the Ministry for Health and Welfare, Seoul, Republic of Korea (HI06C0868, HI10C2014 and HI14C1090), and the National Research Foundation of Korea (NRF) (Seoul, Korea) grant funded by the Korea government (MEST) (NRF-2012R1A2A2A01014671 and NRF-2013R1A1A2011346).	Ansell SM, 2000, METH MOLEC MED, V25, P51, DOI 10.1385/1-59259-075-6:51; Song SX, 2008, INT J PHARMACEUT, V363, P155, DOI 10.1016/j.ijpharm.2008.07.012; Drummond DC, 1999, PHARMACOL REV, V51, P691; Ghafoori P, 2008, ONCOLOGY-NY, V22, P37; Baumann M, 2007, RADIOTHER ONCOL, V83, P238, DOI 10.1016/j.radonc.2007.04.006; Ajima K, 2008, ACS NANO, V2, P2057, DOI 10.1021/nn800395t; Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Tseng CL, 2009, BIOMATERIALS, V30, P3476, DOI 10.1016/j.biomaterials.2009.03.010; Liang K, 2003, INT J RADIAT ONCOL, V57, P246, DOI 10.1016/S0360-3016(03)00511-X; Graves EE, 2010, SEMIN RADIAT ONCOL, V20, P156, DOI 10.1016/j.semradonc.2010.01.003; Dirkes S, 2011, CRIT CARE NURSE, V31, P37, DOI 10.4037/ccn2011946; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Nishiyama N, 2003, CANCER RES, V63, P8977; Baas P, 2011, CURR OPIN ONCOL, V23, P140, DOI 10.1097/CCO.0b013e328341eed6; Castelo-Branco PA, 2007, CHEM BIODIVERS, V4, P2745, DOI 10.1002/cbdv.200790223; Giaccone G, 2004, ANN ONCOL S15, V4, piv81; Hirai M, 2010, INT J PHARMACEUT, V391, P274, DOI 10.1016/j.ijpharm.2010.02.030; HWANG KJ, 1987, BIOCHIM BIOPHYS ACTA, V901, P88, DOI 10.1016/0005-2736(87)90259-8; Jeong SY, 2009, J CONTROL RELEASE, V139, P239, DOI 10.1016/j.jconrel.2009.07.007; Jung J, 2012, INT J ONCOL, V40, P385, DOI 10.3892/ijo.2011.1205; Kolhatkar Rohit, 2011, Curr Drug Discov Technol, V8, P197; van der Meel R, 2012, J CONTROL RELEASE, V159, P281, DOI 10.1016/j.jconrel.2011.12.027; Wainford RD, 2008, TOXICOLOGY, V249, P184, DOI 10.1016/j.tox.2008.05.006; Yaklin KM, 2011, NEPHROL NURS J, V38, P13	25	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1268	1274		10.3892/ijo.2014.2806		7	Oncology	Oncology	CA6XW	WOS:000349061800039		
J	Suwa, S; Kasubata, A; Kato, M; Iida, M; Watanabe, K; Miura, O; Fukuda, T				Suwa, Shihoko; Kasubata, Aya; Kato, Miyu; Iida, Megumi; Watanabe, Ken; Miura, Osamu; Fukuda, Tetsuya			The tryptophan derivative, tranilast, and conditioned medium with indoleamine 2,3-dioxygenase-expressing cells inhibit the proliferation of lymphoid malignancies	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						indoleamine 2,3-dioxygenase; tryptophan; tranilast; lymphoid malignancy	ARYL-HYDROCARBON RECEPTOR; T-CELL; DENDRITIC CELLS; IDO EXPRESSION; CATABOLISM; DISEASE; LYMPHOCYTES; PREVENTION; APOPTOSIS	Indoleamine 2,3-dioxygenase (IDO) is an enzyme that catalyzes tryptophan degradation and induces immunosuppression. Although IDO is an important factor that allows tumors to escape from immunological attack, its effect on lymphoid malignancies has not been fully revealed. We evaluated the expression of IDO in samples from patients with B-cell malignancies. The IDO expression in the tumor samples was comparable to those in peripheral blood mononuclear cells from healthy donors and had mainly originated from non-B cell populations. We introduced IDO gene into Chinese hamster ovary (CHO) cells. We then cultured various cell lines using CHO- or CHO-IDO-conditioned medium. Compared with the CHO medium (CHO-CM), the CHO-IDO medium (IDO-CM) decreased the viability of lymphoid cell lines but not those of the non-lymphoid lines. Next, we examined the effects of tryptophan metabolites on lymphoid tumors, and revealed that the drug N[3,4'-dimethoxycinnamoyl] anthranilic acid (tranilast), a synthetic derivative of the tryptophan metabolite, was able to repress proliferation and dose-dependently induce cell death of lymphoid cell lines. Tranilast induced the activation of the c-Jun N-terminal kinase, which is activated by cellular stress, in lymphoid cells. The effect of tranilast on lymphoid cells was independent of the aryl hydrocarbon receptor (AhR) although tranilast has been reported to be an AhR agonist. Finally, the administration of tranilast decreased murine lymphoid tumor progression in vivo. These results indicated that IDO and tryptophan derivatives, particularly tranilast, can be tools for the therapy for lymphoid malignancies.	[Suwa, Shihoko; Kasubata, Aya; Kato, Miyu; Iida, Megumi; Watanabe, Ken; Miura, Osamu; Fukuda, Tetsuya] Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan	Fukuda, T (reprint author), Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	fuku.hema@tmd.ac.jp					Rogosnitzky M, 2012, ANTICANCER RES, V32, P2471; Maby-El Hajjami H, 2009, CANCER RES, V69, P3228, DOI 10.1158/0008-5472.CAN-08-3000; Fallarino F, 2006, J IMMUNOL, V176, P6752; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Ninomiya S, 2011, ANN HEMATOL, V90, P409, DOI 10.1007/s00277-010-1093-z; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Jasperson LK, 2008, BLOOD, V111, P3257, DOI 10.1182/blood-2007-06-096081; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Behrens A, 1999, NAT GENET, V21, P326; Inaba T, 2009, GYNECOL ONCOL, V115, P185, DOI 10.1016/j.ygyno.2009.07.015; Godin-Ethier J, 2011, MOL IMMUNOL, V49, P253, DOI 10.1016/j.molimm.2011.08.017; Ino K, 2008, CLIN CANCER RES, V14, P2310, DOI 10.1158/1078-0432.CCR-07-4144; Gupta S, 1996, EMBO J, V15, P2760; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Chikaraishi A, 2001, EUR J PHARMACOL, V427, P151, DOI 10.1016/S0014-2999(01)01215-8; Fallarino F., 2002, Cell Death and Differentiation, V9, P1069, DOI 10.1038/sj.cdd.4401073; Hu D, 1999, CELL IMMUNOL, V195, P43, DOI 10.1006/cimm.1999.1513; Jasperson Lisa K, 2009, Blood, V114, P5062, DOI 10.1182/blood-2009-06-227587; Platten M, 2003, BIOCHEM PHARMACOL, V66, P1263, DOI 10.1016/S0006-2952(03)00449-0; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; TOHDA S, 1991, BLOOD, V78, P1789	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1369	1376		10.3892/ijo.2015.2825		8	Oncology	Oncology	CA6XW	WOS:000349061800049		
J	Tamura, D; Saito, T; Murata, K; Kawashima, M; Asano, R				Tamura, Dai; Saito, Teruyoshi; Murata, Kanae; Kawashima, Masafumi; Asano, Ryuji			Celecoxib exerts antitumor effects in canine mammary tumor cells via COX-2-independent mechanisms	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						cyclooxygenase-2; celecoxib; apoptosis; intrinsic pathway; extrinsic pathway; canine mammary tumor	COLON-CANCER CELLS; I-KAPPA-B; ELEVATED CYCLOOXYGENASE-2 EXPRESSION; BREAST-CANCER; INDUCED APOPTOSIS; PROGNOSTIC-SIGNIFICANCE; PROSTAGLANDIN E-2; DOWN-REGULATION; CYTOCHROME-C; COX-2	Celecoxib plays antitumor roles via multiple mechanisms in a variety of human cancers. The aim of this study was to clarify the mechanism of action of celecoxib in canine mammary tumors. We examined the antitumor effects of celecoxib in AZACB canine mammary tumor cells expressing low levels of cyclooxygenase-2 (COX-2) to minimize the effect of COX-2 on its activity. Our data revealed that celecoxib inhibited cell proliferation mainly via COX-2-independent mechanisms. Specifically, celecoxib decreased the proportion of cells in S phase and increased G2/M arrest, which was associated with increased expression of the cyclin-dependent kinase inhibitors (CDKIs) p21 and p27. In addition, treatment with celecoxib downregulated COX-2 expression, and induced apoptosis via both the intrinsic and extrinsic pathways. These findings suggest that celecoxib might be a useful agent for the treatment of canine mammary tumors, regardless of COX-2 expression. In the future, it might be possible to use a combination of celecoxib and other antitumor agents to treat canine mammary tumors.	[Tamura, Dai; Saito, Teruyoshi; Murata, Kanae; Kawashima, Masafumi; Asano, Ryuji] Nihon Univ, Coll Bioresource Sci, Lab Vet Pharmacol, Fujisawa, Kanagawa 2528510, Japan	Saito, T (reprint author), Nihon Univ, Coll Bioresource Sci, Lab Vet Pharmacol, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.	saitou.teruyoshi@nihon-u.ac.jp			Nihon University	We thank Ms. Mitsune Suzuki and Ms. Aiko Sato (Nihon University, Kanagawa, Japan) for help in performing the experiments. This study was supported in part by a Grant-in-Aid from Nihon University (to T. Saito).	Jendrossek V, 2003, FASEB J, V17, P1547, DOI 10.1096/fj.02-0947fje; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Ristimaki A, 2002, CANCER RES, V62, P632; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Queiroga FL, 2011, VET J, V189, P77, DOI 10.1016/j.tvjl.2010.06.022; Kardosh A, 2005, CANCER BIOL THER, V4, P571; Saikawa Y, 2004, ANTICANCER RES, V24, P2723; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Kato M, 2001, J PHARM PHARMACOL, V53, P1679, DOI 10.1211/0022357011778070; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Saito T, 2014, ONCOL REP, V31, P1637, DOI 10.3892/or.2014.3010; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.16248699; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Spugnini EP, 2005, HISTOL HISTOPATHOL, V20, P1309; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Sheng HM, 1998, CANCER RES, V58, P362; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Queiroga FL, 2005, ANTICANCER RES, V25, P4269; Saito T, 2011, INT J ONCOL, V39, P1311, DOI 10.3892/ijo.2011.1114; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Saito T, 2013, ONCOL LETT, V5, P1068, DOI 10.3892/ol.2013.1124; Seo KW, 2014, RES VET SCI, V96, P482, DOI 10.1016/j.rvsc.2014.03.003; Shao JY, 2004, J BIOL CHEM, V279, P14287, DOI 10.1074/jbc.M313276200; Ranger GS, 2004, ANTICANCER RES, V24, P2349; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Liu XG, 2004, J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Dore M, 2011, VET PATHOL, V48, P254, DOI 10.1177/0300985810379434; Sanderson RO, 2009, VET REC, V164, P418; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Dore M, 2003, VET PATHOL, V40, P207, DOI 10.1354/vp.40-2-207; Gurpinar Evrim, 2013, Front Oncol, V3, P181, DOI 10.3389/fonc.2013.00181; He Q, 2002, ONCOGENE, V21, P6032, DOI 10.1038/sj.onc.1205897; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Klopfleisch R, 2011, VET PATHOL, V48, P98, DOI 10.1177/0300985810390826; Liu B, 2009, CELL BIOL INT, V34, P21; Luque I, 1997, SEMIN CANCER BIOL, V8, P103, DOI 10.1006/scbi.1997.0061; Muller AC, 2008, BIOCHEM PHARMACOL, V76, P1082, DOI 10.1016/j.bcp.2008.08.012; Nagatsuka I, 2002, INT J CANCER, V100, P515, DOI 10.1002/ijc.10508; Queiroga FL, 2010, RES VET SCI, V88, P441, DOI 10.1016/j.rvsc.2009.10.009; Saito T, 2013, ONCOL REP, V29, P335, DOI 10.3892/or.2012.2100; Sun YJ, 2002, CANCER RES, V62, P6323; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2	55	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	MAR	2015	46	3					1393	1404		10.3892/ijo.2015.2820		12	Oncology	Oncology	CA6XW	WOS:000349061800052		
J	Akamatsu, M; Yasuhara, K; Kaneda, M; Ozoe, H				Akamatsu, Masato; Yasuhara, Kaoru; Kaneda, Masayuki; Ozoe, Hiroyuki			Heat transfer rate characteristics of the magnetothermal Rayleigh-Benard convection of paramagnetic air	INTERNATIONAL JOURNAL OF THERMAL SCIENCES			English	Article						Magnetothermal Rayleigh-Benard convection; Rayleigh-Benard convection; Magnetic force; Gravitational buoyant force; Air	EXTERNAL MAGNETIC-FIELD; NATURAL-CONVECTION; NUMERICAL COMPUTATION; THERMAL-CONVECTION; AERIAL FLOW; ENCLOSURE; DIRECTION; GRADIENT; FLUID; FORCE	We carried out complete transient three-dimensional numerical computations to clarify the heat transfer rate characteristics of magnetothermal Rayleigh-Benard convection of paramagnetic air induced by both magnetic and gravitational buoyant forces. The shallow vertical cylindrical enclosure filled with air was heated from below and cooled from above. The enclosure was assumed to be located inside the bore space of a superconducting magnet. In addition, the enclosure was fixed at the location where the magnetic force in the axial direction was more uniform in the radial direction, as was the gravitational force. The average heat transfer rates were computed for various Rayleigh numbers and magnetic strengths. The results are plotted versus both the Rayleigh number and the magnetic Rayleigh number, Ra-m, defined by Braithwaite et al. in comparison with experiments by Silveston. For the range 2310 < Ra-m < 10,000, the average Nusselt numbers are found to distribute around the data by Silveston. However, in the range Ra-m < 2310, the average Nusselt numbers are overestimated compared to those by Silveston. Probably, this is because the magnetic force approximated with a one-turn coil includes radial directional acceleration force and the convection mode differs from the unidirectional gravitational one. On the other hand, in the rage, Ra-m > 10,000, the overestimated Nusselt numbers may be due to a linear model. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Akamatsu, Masato; Yasuhara, Kaoru] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 9928510, Japan; [Kaneda, Masayuki] Osaka Prefecture Univ, Dept Mech Engn, Sakai, Osaka 5998531, Japan; [Ozoe, Hiroyuki] Kyushu Univ, Emeritus, Inst Mat Chem & Engn, Fukuoka 8168580, Japan	Akamatsu, M (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Yamagata 9928510, Japan.	akamatsu@yz.yamagata-u.ac.jp					Akamatsu M, 2005, PROG COMPUT FLUID DY, V5, P236, DOI 10.1504/PCFD.2005.006758; Akamatsu M, 2001, INT J HEAT MASS TRAN, V44, P3253, DOI 10.1016/S0017-9310(00)00367-7; Uetake H, 2000, J APPL PHYS, V87, P6310, DOI 10.1063/1.372689; HIRT CW, 1972, J COMPUT PHYS, V10, P324, DOI 10.1016/0021-9991(72)90070-8; Qi JW, 2001, INT J HEAT MASS TRAN, V44, P3043, DOI 10.1016/S0017-9310(00)00354-9; BRAITHWAITE D, 1991, NATURE, V354, P134, DOI 10.1038/354134a0; Tagawa T, 2002, INT J HEAT MASS TRAN, V45, P267, DOI 10.1016/S0017-9310(01)00149-1; Watanabe M, 1999, PROG CRYST GROWTH CH, V38, P215, DOI 10.1016/S0960-8974(99)00013-3; OKADA K, 1992, J HEAT TRANS-T ASME, V114, P107, DOI 10.1115/1.2911234; Sheikholeslami M, 2014, POWDER TECHNOL, V256, P490, DOI 10.1016/j.powtec.2014.01.079; Akamatsu M, 2003, NUMER HEAT TR A-APPL, V43, P9, DOI 10.1080/10407780390122547; Bai B, 1999, AIAA J, V37, P1538, DOI 10.2514/2.652; Chandrasekhar S., 1961, HYDRODYNAMIC HYDROMA, P64; Filar P., INT J HEAT MASS TRAN, V48; Japan Society of Thermophysical Properties, 2008, THERM PROP HDB, P67; Kenjeres S, 2014, FLOW TURBUL COMBUST, V92, P371, DOI 10.1007/s10494-013-9490-8; Kenjeres S, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046312; Kenjeres S, 2011, J PHYS CONF SER, V318, DOI 10.1088/1742-6596/318/7/072028; Leonard B.P., 1981, COMPUTATIONAL TECHNI, V2, P1; Maki S, 2002, J HEAT TRANS-T ASME, V124, P667, DOI 10.1115/1.1482082; Ozoe H, 2005, MAGNETIC CONVECTION, P1, DOI 10.1142/9781860947124; Rosensweig RE, 1985, FERROHYDRODYNAMICS; Silveston P.L, 1958, FORSCH INGENIEURWES, V24, P59, DOI 10.1007/BF02557095; Tagawa T, 2001, CHEM ENG SCI, V56, P4217, DOI 10.1016/S0009-2509(01)00105-1; Tagawa T, 1997, J HEAT TRANS-T ASME, V119, P265, DOI 10.1115/1.2824219; Tagawa T, 2003, INT J HEAT MASS TRAN, V46, P4097, DOI 10.1016/S0017-9310(03)00223-0; Uetake H, 1999, J APPL PHYS, V85, P5735, DOI 10.1063/1.370268	27	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1290-0729	1778-4166		INT J THERM SCI	Int. J. Therm. Sci.	MAR	2015	89						13	22		10.1016/j.ijthermalsci.2014.10.007		10	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CA4MU	WOS:000348879400002		
J	Shen, B; Zhang, P				Shen, B.; Zhang, P.			Three-dimensional thermoconvection from a non-uniformly heated plate near the liquid-vapor critical point	INTERNATIONAL JOURNAL OF THERMAL SCIENCES			English	Article						Supercritical fluids; Piston effect; Numerical simulation; Natural convection; Vortical structures; Non-uniform heating	RAYLEIGH-BENARD CONVECTION; NEAR-CRITICAL FLUID; DIRECT NUMERICAL-SIMULATION; CRITICAL SPEEDING-UP; SUPERCRITICAL-FLUID; THERMOACOUSTIC CONVECTION; THERMAL DISTURBANCE; CONFINED GAS; CAVITY; PREDICTION	Three-dimensional buoyancy-driven convection close to the liquid vapor critical point is numerically investigated. We consider a supercritical nitrogen-filled rectangular cavity with horizontal/vertical aspect ratios of 3:1 and 2:1, which is heated differentially at the bottom by a constant heat flux of 10 W/m2. Dependent on the size of the heating area (covering, namely, the full, a half, and a quarter of the bottom wall, respectively), spatiotemporal descriptions of the development of hydrodynamic instabilities are obtained for both near-critical and weakly-critical fluid conditions based on real-fluid properties, which include the vortex cores educed by the second invariant of the velocity gradient tensor. Direct numerical simulations are performed on a hydrodynamic model modified by the low-Mach-number approximation using a finite volume-based SIMPLE method. In addition, a co-located multigrid strategy is adopted to accelerate the simulation. The results capture the influences of the distance to the critical point on the evolution of the flow pattern and convective heat transfer under increasingly more complex heating arrangements. The strong equivalency among different near-critical fluids is demonstrated by a comparison between Rayleigh Benard flows in supercritical nitrogen and CO2 with comparable degrees of criticality. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Shen, B.; Zhang, P.] Shanghai Jiao Tong Univ, Inst Refrigerat & Cryogen, Shanghai 200240, Peoples R China; [Shen, B.] Kyushu Univ, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan; [Shen, B.] Kyushu Univ, Int Inst Carbon Neutral Energy Res I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Zhang, P (reprint author), Shanghai Jiao Tong Univ, Inst Refrigerat & Cryogen, Shanghai 200240, Peoples R China.	zhangp@sjtu.edu.cn	Zhang, Peng/F-9792-2010	Zhang, Peng/0000-0002-5980-8229	National Natural Science Foundation of China [51376128]; World Premier International Research Center Initiative (WPI), MEXT; International Institute for Carbon-Neutral Energy Research (WPI-I2CNER), Kyushu University, Japan	This research is supported by the National Natural Science Foundation of China under Contract No. 51376128. B. Shen gratefully acknowledges financial support by World Premier International Research Center Initiative (WPI), MEXT, and International Institute for Carbon-Neutral Energy Research (WPI-I<SUP>2</SUP>CNER), Kyushu University, Japan.	Accary G, 2009, J FLUID MECH, V619, P127, DOI 10.1017/S0022112008004175; Accary G., C R MECANIQUE, V332, P209; Accary G, 2006, COMPUT FLUIDS, V35, P1316, DOI 10.1016/j.compfluid.2005.05.004; Accary G, 2005, PHYS FLUIDS, V17, DOI [10.1063/1.2011469, 10.1063/1.2044469]; Accary G, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2432159; Accary G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.035301; Accary G, 2005, CR MECANIQUE, V333, P397, DOI 10.1016/j.crme.2005.03.004; Amiroudine S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.105303; Kogan AB, 1999, PHYS REV LETT, V82, P4635, DOI 10.1103/PhysRevLett.82.4635; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Amiroudine S, 2001, J FLUID MECH, V442, P119; Miura Y, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.010101; Shen B, 2012, INT J HEAT MASS TRAN, V55, P7151, DOI 10.1016/j.ijheatmasstransfer.2012.07.031; Niemela JJ, 2000, NATURE, V404, P837, DOI 10.1038/35009036; Carles P, 2010, J SUPERCRIT FLUID, V53, P2, DOI 10.1016/j.supflu.2010.02.017; Shen B, 2013, INT J THERM SCI, V71, P1, DOI 10.1016/j.ijthermalsci.2013.04.010; Chavanne X, 1997, PHYS REV LETT, V79, P3648, DOI 10.1103/PhysRevLett.79.3648; RHIE CM, 1983, AIAA J, V21, P1525, DOI 10.2514/3.8284; HORTMANN M, 1990, INT J NUMER METH FL, V11, P189, DOI 10.1002/fld.1650110206; Bailly D, 2000, PHYS REV E, V62, P2353, DOI 10.1103/PhysRevE.62.2353; BOUKARI H, 1990, PHYS REV A, V41, P2260, DOI 10.1103/PhysRevA.41.2260; Carles P, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2397577; Carles P, 1999, PHYSICA D, V126, P69, DOI 10.1016/S0167-2789(98)00261-9; GITERMAN MS, 1970, J APPL MATH MECH-USS, V34, P305, DOI 10.1016/0021-8928(70)90145-0; KASSOY DR, 1979, SIAM J APPL MATH, V36, P624, DOI 10.1137/0136044; Kogan AB, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.056310; Landau L.D., 1987, FLUID MECH, P7; Nitsche K., 1987, P 6 EUR S MAT SCI MI, P109; ONUKI A, 1990, PHYS REV A, V41, P2256, DOI 10.1103/PhysRevA.41.2256; OZOE H, 1980, CHEM ENG COMMUN, V5, P203, DOI 10.1080/00986448008935964; Patankar S. V., 1980, NUMERICAL HEAT TRANS; RADHWAN AM, 1984, J ENG MATH, V18, P133; Raspo I, 2004, CR MECANIQUE, V332, P353, DOI 10.1016/j.crme.2004.02.003; Shashank, 2010, J COMPUT PHYS, V229, P4425; Shen B, 2010, INT J HEAT MASS TRAN, V53, P4832, DOI 10.1016/j.ijheatmasstransfer.2010.06.009; Shen B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011115; TRILLING L, 1955, J ACOUST SOC AM, V27, P425, DOI 10.1121/1.1907920; Valencia L, 2005, NUMER HEAT TR A-APPL, V47, P333, DOI 10.1080/10407780590889130; ZAPPOLI B, 1995, EUR J MECH B-FLUID, V14, P41; ZAPPOLI B, 1990, PHYS REV A, V41, P2264, DOI 10.1103/PhysRevA.41.2264; Zhang P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.060103	41	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1290-0729	1778-4166		INT J THERM SCI	Int. J. Therm. Sci.	MAR	2015	89						136	153		10.1016/j.ijthermalsci.2014.10.015		18	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CA4MU	WOS:000348879400012		
J	Hirata, A; Nomura, T; Laakso, I				Hirata, Akimasa; Nomura, Tomoki; Laakso, Ilkka			Computational estimation of body temperature and sweating in the aged during passive heat exposure	INTERNATIONAL JOURNAL OF THERMAL SCIENCES			English	Article						Bioheat equation; The aged; Thermoregulatory response; Heat stroke; Decline in sweating rate	HUMAN THERMOREGULATION; ADULT MALES; WIDE-RANGE; DRY HEAT; RESPONSES; DECREMENTS; ELEVATION; EQUATION; FEMALES; WEIGHT	This study discusses the difference in temperature elevation and sweating between younger and older adults during ambient heat exposure. The bioheat equation is solved computationally in an anatomically based human body model to track the variation in the temperature and sweating in the time domain. Our computational code is improved by introducing different blood temperatures in different body regions and taking into account the maximum possible evaporative heat loss. The reduced thermal sensitivity of the hypothalamus in the aged adults (mean age of 73.9 years) is also estimated from literature data and taken into account in a revised formula for the thermoregulatory response. For ambient heat exposure (a temperature of 40 degrees C and relative humidity of 42%), our computational results are in good agreement with measurement data in the literature for both younger adults (mean age of 23.5 years) and the elderly (67.8 years old), suggesting the effectiveness of our improved bioheat modeling. The reduction in the thermal sensitivity of the hypothalamus is estimated as 0.6 +/- 0.2 degrees C for the aged (mean age of 73.9 years), although it was not significant for the elderly (67.8 years). For an ambient temperature of 35 degrees C and relative humidity of 60%, the computed core temperature elevation in the model corresponding to the thermophysiological response of the aged is 0.92 degrees C, which is higher than those for the younger adults, 0.25 degrees C, and for the elderly, 0.45 degrees C. This difference in the core temperature elevation is attributable mainly to the decline in the thermal sensitivity of the hypothalamus. The total perspiration at ages of 67.8 years and 73.9 years was 904 g and 645 g, respectively, which is smaller than that of the younger adults, 1090 g. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Hirata, Akimasa; Nomura, Tomoki; Laakso, Ilkka] Nagoya Inst Technol, Dept Comp Sci & Engn, Nagoya, Aichi 4668555, Japan	Hirata, A (reprint author), Nagoya Inst Technol, Dept Comp Sci & Engn, Nagoya, Aichi 4668555, Japan.	ahirata@nitech.ac.jp	Laakso, Ilkka/J-8699-2014; Hirata, Akimasa/I-8245-2012	Hirata, Akimasa/0000-0001-8336-1140			Adair Eleanor R, 2003, Bioelectromagnetics, VSuppl 6, pS17; Anderson GS, 1996, EUR J APPL PHYSIOL O, V73, P278, DOI 10.1007/BF02425488; Bernardi P, 2003, IEEE T BIO-MED ENG, V50, P295, DOI 10.1109/TBME.2003.808809; SHOENFELD Y, 1978, J APPL PHYSIOL, V44, P1; WATSON PE, 1980, AM J CLIN NUTR, V33, P27; Lichtenbelt WDV, 2007, INT J BIOMETEOROL, V51, P169, DOI 10.1007/s00484-006-0060-9; Du Bois D, 1916, ARCH INTERN MED, V17, P863; Fiala D, 2001, INT J BIOMETEOROL, V45, P143, DOI 10.1007/s004840100099; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; PENNES HH, 1948, J APPL PHYSIOL, V1, P93; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; Fiala D, 1999, J APPL PHYSIOL, V87, P1957; Wang JQ, 1999, IEEE T MICROW THEORY, V47, P1528; NISHI Y, 1970, J APPL PHYSIOL, V29, P830; Chua KJ, 2013, INT J THERM SCI, V70, P17, DOI 10.1016/j.ijthermalsci.2013.03.019; Dufour A, 2007, EUR J APPL PHYSIOL, V100, P19, DOI 10.1007/s00421-007-0396-9; CROWE JP, 1974, J PHYSIOL-LONDON, V236, pP43; Fennell W.H., 1973, J PHYSL, V231; FOSTER K G, 1976, Age and Ageing, V5, P91, DOI 10.1093/ageing/5.2.91; Hanatani R., 2011, Progress In Electromagnetics Research B, V34; HELLON RF, 1956, J PHYSIOL-LONDON, V133, P132; Hirata A, 2009, PHYS MED BIOL, V54, pN189, DOI 10.1088/0031-9155/54/10/N02; Hirata A, 2012, PHYSIOL MEAS, V33, pN51, DOI 10.1088/0967-3334/33/8/N51; Hirata A, 2008, PHYS MED BIOL, V53, P5223, DOI 10.1088/0031-9155/53/18/025; ICRP, 1975, REPORT TASK GROUP RE; Inbar O, 2004, EXP PHYSIOL, V89, P691, DOI 10.1113/expphysiol.2004.027979; Inoue Y, 1999, EUR J APPL PHYSIOL O, V79, P121, DOI 10.1007/s004210050485; Inoue Y, 1996, EUR J APPL PHYSIOL O, V74, P72, DOI 10.1007/BF00376497; Inoue Y, 1996, EUR J APPL PHYSIOL O, V74, P78, DOI 10.1007/BF00376498; Karaki W, 2013, INT J THERM SCI, V67, P41, DOI 10.1016/j.ijthermalsci.2012.12.010; Kotte A, 1996, PHYS MED BIOL, V41, P865, DOI 10.1088/0031-9155/41/5/004; Miyake Y, 2010, J JPN ASS ACUTE MED, V21, P230; Nakai S, 2007, JPN J PHYS FIT SPORT, V56, P437; Rida M., 2014, INT J BIOMETEOROL, P1; Samaras T, 2006, PHYS MED BIOL, V51, pN221, DOI 10.1088/0031-9155/51/11/N02; Smith CJ, 2013, AM J PHYSIOL-REG I, V305, pR877, DOI 10.1152/ajpregu.00290.2013; Stolwijk J.A.J., 1971, NASA CONTRACTOR REPO; Taylor N. A., 2013, EXTREM PHYSL MED, V2, P1; Tochihara Y, 2011, J THERM BIOL, V36, P105, DOI 10.1016/j.jtherbio.2010.11.007	40	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1290-0729	1778-4166		INT J THERM SCI	Int. J. Therm. Sci.	MAR	2015	89						154	163		10.1016/j.ijthermalsci.2014.11.001		10	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CA4MU	WOS:000348879400013		
J	Watanabe, M				Watanabe, Masaki			On a relation between certain character values of symmetric groups and its connection with creation operators of symmetric functions	JOURNAL OF ALGEBRAIC COMBINATORICS			English	Article						Symmteric groups; Murnaghan-Nakayama rule; Symmetric functions; Brauer algebras	BRAUER CENTRALIZER ALGEBRAS; REPRESENTATIONS	In this paper, we derive a relation of new kind between certain character values of symmetric groups in terms of the so-called maya diagrams. We also investigate a relation between our result and Bernstein's creation operators for Schur functions, and consider analogous relations for projective characters of symmetric groups through creation operators for Schur -functions. We also consider analogous relations for characters of Brauer algebras and walled Brauer algebras.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Watanabe, M (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	mwata@ms.u-tokyo.ac.jp					RAM A, 1995, PAC J MATH, V169, P173; KOIKE K, 1989, ADV MATH, V74, P57, DOI 10.1016/0001-8708(89)90004-2; Brauer R, 1937, ANN MATH, V38, P857, DOI 10.2307/1968843; BENKART G, 1994, J ALGEBRA, V166, P529, DOI 10.1006/jabr.1994.1166; Benkart G. M., 1990, MEM AM MATH SOC, V85; Halverson T, 1996, PAC J MATH, V174, P359; Hoffman P. N., 1992, PROJECTIVE REPRESENT; Kac V. G., 1987, BOMBAY LECT HIGHEST; Macdonald I.G., 1999, SYMMETRIC FUNCTIONS; KAC VG, 1981, P NATL ACAD SCI USA, V78, P3308, DOI 10.1073/pnas.78.6.3308; WENZL H, 1988, ANN MATH, V128, P173, DOI 10.2307/1971466	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0925-9899	1572-9192		J ALGEBR COMB	J. Algebr. Comb.	MAR	2015	41	2					257	273		10.1007/s10801-014-0535-4		17	Mathematics	Mathematics	CA9MB	WOS:000349246800002		
J	Imada, S; Iviatsuo, N; Acharya, K; Yamanaka, N				Imada, Shogo; Iviatsuo, Naoko; Acharya, Kumud; Yamanaka, Norikazu			Effects of salinity on fine root distribution and whole plant biomass of Tamarix ramosissima cuttings	JOURNAL OF ARID ENVIRONMENTS			English	Article						Biomass partitioning; Fine roots; Halophyte; Saline irrigation; Salt tolerance	WATER; ECOLOGY; SOIL; ECOPHYSIOLOGY; SALINIZATION; SALTCEDAR; RESPONSES; PATTERNS; GROWTH; SPP.	To increase understanding of the influence of soil salinity on fine-root development and whole-plant growth of halophytic species, Tamarix ramosissima cuttings were exposed to various salinity conditions at a constant water table depth. Rooted cuttings of Tamarix ramosissima were individually grown in pots in a greenhouse for 416 days in the following five treatments: 0 (field water only), 50, 100, 200, and 400 mM NaCl. Irrigation water was applied from the bottom of the pots and the water table was kept constant during the experiment. Fine roots were scarce at the surface layer probably because of low moisture and/or high salinity concentrations. Fine-root biomass and length increased in layers with higher soil moisture availability in the control, 50, and 100 mM NaCl treatments. In contrast, the distribution of fine roots appeared to be influenced by salinity in the 200 and 400 mM NaCl treatments. Total biomass and total fine-root length were highest in the 100 mM NaCl treatment, and total biomass was positively correlated with total fine-root length under all conditions, suggesting that variation in fine-root length may have an important effect on the whole-plant biomass of the cuttings across a salinity gradient. (C) 2014 Elsevier Ltd. All rights reserved.	[Imada, Shogo; Yamanaka, Norikazu] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan; [Iviatsuo, Naoko] Mie Univ, Fac Bioresources, Tsu, Mie 5148507, Japan; [Acharya, Kumud] Desert Res Inst, Div Hydrol Sci, Las Vegas, NV 89119 USA	Imada, S (reprint author), Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan.	sho.imada@gmail.com			Global Center of Excellence for Dryland Science at Ministry of Education, Culture, Sports, Science and Technology, Japan [E-058]	We thank Taishi Masani and Kazuki Imai, Mie University and Naoki Murata and Fumiko Iwanaga, Tottori University, Japan for their help during this experiment. We also thank two anonymous reviewers for their valuable comments on our manuscript. Financial support for the study was provided by the Global Center of Excellence for Dryland Science (E-058) at the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; Rewald B, 2011, ENVIRON EXP BOT, V72, P107, DOI 10.1016/j.envexpbot.2010.12.018; Bui EN, 2013, J ARID ENVIRON, V92, P14, DOI 10.1016/j.jaridenv.2012.12.014; Imada S, 2013, J ARID ENVIRON, V92, P46, DOI 10.1016/j.jaridenv.2013.01.006; Glenn EP, 2005, J ARID ENVIRON, V61, P419, DOI 10.1016/j.jaridenv.2004.09.025; Di Tomaso JM, 1998, WEED TECHNOL, V12, P326; PREGITZER KS, 1993, NEW PHYTOL, V125, P575, DOI 10.1111/j.1469-8137.1993.tb03905.x; Stromberg JC, 2009, RESTOR ECOL, V17, P177, DOI 10.1111/j.1526-100X.2008.00514.x; Stromberg JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P381, DOI 10.1111/j.1466-8238.2007.00297.x; EISSENSTAT DM, 1991, NEW PHYTOL, V118, P63, DOI 10.1111/j.1469-8137.1991.tb00565.x; Muscolo A, 2013, ENVIRON EXP BOT, V92, P55, DOI 10.1016/j.envexpbot.2012.07.009; Imada S, 2008, FUNCT ECOL, V22, P1018, DOI 10.1111/j.1365-2435.2008.01454.x; Glenn EP, 2012, J ARID ENVIRON, V79, P56, DOI 10.1016/j.jaridenv.2011.11.025; Eissenstat DM, 2000, NEW PHYTOL, V147, P33, DOI 10.1046/j.1469-8137.2000.00686.x; Nippert JB, 2010, OECOLOGIA, V162, P283, DOI 10.1007/s00442-009-1455-1; Zhang X, 2005, J ARID ENVIRON, V60, P567, DOI 10.1016/j.jaridenv.2004.07.008; Kranjcec J, 1998, FOREST ECOL MANAG, V110, P77, DOI 10.1016/S0378-1127(98)00276-X; Barbour B.G., 1970, AM MIDL NAT, V84, P105; Batanouny KH, 2001, PLANTS DESERTS MIDDL; Breckle SW, 2004, SALINITY ENV PLANTS, P53, DOI 10.1007/0-306-48155-3_3; Jaoudé R. A., 2012, Ecological Research, V27, P857, DOI 10.1007/s11284-012-0963-3; EVERITT BL, 1980, ENVIRON GEOL, V3, P77; Imada S, 2010, TREES-STRUCT FUNCT, V24, P499, DOI 10.1007/s00468-010-0419-8; Inoue M., 1983, SAND DUNE RES, V30, P15; Ohrtman M. K., 2013, TAMARIX CASE STUDY E, P123; Reich PB, 2002, PLANT ROOTS HIDDEN H, P205; Sakaguchi Y., 2004, DRAIN RECLAM ENG, V232, P379; Salama RB, 1999, HYDROGEOL J, V7, P46, DOI 10.1007/s100400050179; Shafroth PB, 2008, RESTOR ECOL, V16, P94, DOI 10.1111/j.1526-100X.2007.00362.x; Waisel Y., 2002, PLANT ROOTS HIDDEN H, P1194	32	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0140-1963	1095-922X		J ARID ENVIRON	J. Arid. Environ.	MAR	2015	114						84	90		10.1016/j.jaridenv.2014.11.011		7	Ecology; Environmental Sciences	Environmental Sciences & Ecology	CA9VM	WOS:000349272900011		
J	Tamura, A; Fukumoto, I; Yui, N; Matsumura, M; Miura, H				Tamura, Atsushi; Fukumoto, Izumi; Yui, Nobuhiko; Matsumura, Mitsuaki; Miura, Hiroyuki			Increasing the repeating units of ethylene glycol-based dimethacrylates directed toward reduced oxidative stress and co-stimulatory factors expression in human monocytic cells	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						triethylene glycol dimethacrylate; poly(ethylene glycol); dental resins; oxidative stress; co-stimulatory factor	TEST H-CLAT; 2-HYDROXYETHYL METHACRYLATE; GENE-EXPRESSION; TEGDMA; LINE; CYTOTOXICITY; FIBROBLASTS; GLUTATHIONE; ACTIVATION; CHEMICALS	The ethylene glycol-based dimethacrylates are commonly used in biomaterials and dental restorative materials as a cross-linking agent. In this study, toxic effect of triethylene glycol dimethacrylate (TEGDMA) and poly(ethylene glycol) dimethacrylates (PEG-DMAs) with various ethylene glycol repeating units was investigated in terms of cytotoxicity, oxidative stress, and the expression of co-stimulatory factors in human leukemia cell line (THP-1 cells) to verify the effect of ethylene glycol repeating units. Note that the 1-octanol/water partition coefficient of PEG-based dimethacrylates decreased with increasing the ethylene glycol repeating units, indicating that the hydrophilicity of PEG-DMAs increased with ethylene glycol repeating units. The toxic effect of PEG-DMAs such as cytotoxicity, oxidative stress, and the expression of CD86 in treated THP-1 cells are reduced with increasing the ethylene glycol repeating units in PEG-DMAs. However, the expression of CD54 in treated THP-1 cells was not influenced with the ethylene glycol repeating units and the maximal expression level of CD54 was observed at the concentration range of 2-4 mM for all samples. Accordingly, hydrophilic character of PEG-DMAs with long ethylene glycol chains definitely alleviates the some toxic aspect of PEG-based DMAs. This finding would provide important insight into the design of new biomaterials and dental materials with superior biocompatibility. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1060-1066, 2015.	[Tamura, Atsushi; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Chiyoda Ku, Tokyo 1010062, Japan; [Fukumoto, Izumi; Matsumura, Mitsuaki; Miura, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Oral Hlth Sci, Dept Restorat Sci,Bunkyo Ku, Tokyo 1138549, Japan	Tamura, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	tamura.org@tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [2306, 23107004]	Contract grant sponsor: Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; contract grant number: 23107004	Aalto-Korte K, 2007, CONTACT DERMATITIS, V57, P324, DOI 10.1111/j.1600-0536.2007.01237.x; Stanislawski L, 2003, J BIOMED MATER RES A, V66A, P476, DOI 10.1002/jbm.a.10600; DEBRUIJN J, 1989, ENVIRON TOXICOL CHEM, V8, P499, DOI 10.1897/1552-8618(1989)8[499:DOWPCF]2.0.CO;2; NAKABAYASHI N, 1992, DENT MATER, V8, P259, DOI 10.1016/0109-5641(92)90096-U; FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x; Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363; Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876; Eckhardt A, 2009, BIOMATERIALS, V30, P2006, DOI 10.1016/j.biomaterials.2008.12.045; Peutzfeldt A, 1997, EUR J ORAL SCI, V105, P97, DOI 10.1111/j.1600-0722.1997.tb00188.x; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; Malacarne J, 2006, DENT MATER, V22, P973, DOI 10.1016/j.dental.2005.11.020; Geurtsen W, 2001, J DENT RES, V80, P2046; Engelmann J, 2005, J BIOMED MATER RES B, V75B, P272, DOI 10.1002/jbm.b.30360; Krifka S, 2012, BIOMATERIALS, V33, P5177, DOI 10.1016/j.biomaterials.2012.04.013; Sakaguchi H, 2007, ARCH DERMATOL RES, V298, P427, DOI 10.1007/s00403-006-0714-9; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Yoshida Y, 2003, TOXICOL IN VITRO, V17, P221, DOI 10.1016/S0887-2333(03)00006-7; Durner J, 2010, DENT MATER, V26, P91, DOI 10.1016/j.dental.2009.08.014; Schweikl H, 2008, BIOMATERIALS, V29, P1377, DOI 10.1016/j.biomaterials.2007.11.049; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Lefeuvre M, 2005, BIOMATERIALS, V26, P5130, DOI 10.1016/j.biomaterials.2005.01.014; Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263; Nocca G, 2010, BIOMATERIALS, V31, P2508, DOI 10.1016/j.biomaterials.2009.12.015; Vamnes JS, 2004, COMMUNITY DENT ORAL, V32, P150, DOI 10.1111/j.0301-5661.2004.00148.x; Chang HH, 2010, BIOMATERIALS, V31, P6917, DOI 10.1016/j.biomaterials.2010.05.059; Eckhardt A, 2009, BIOMATERIALS, V30, P1665, DOI 10.1016/j.biomaterials.2008.09.024; Fukumoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082540; Moszner N, 2001, PROG POLYM SCI, V26, P536; Schmalz G, 2000, EUR J ORAL SCI, V108, P4426; VansLanduyt KL, 2007, BIOMATERIALS, V28, P3757; Washizaki K, 2002, ENV DERMATOL, V9, P128	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	MAR	2015	103	3					1060	1066		10.1002/jbm.a.35251		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA7NG	WOS:000349103500022		
J	Ichihara-Takeda, S; Yazawa, S; Murahara, T; Toyoshima, T; Shinozaki, J; Ishiguro, M; Shiraishi, H; Ikeda, N; Matsuyama, K; Funahashi, S; Nagamine, T				Ichihara-Takeda, Satoe; Yazawa, Shogo; Murahara, Takashi; Toyoshima, Takanobu; Shinozaki, Jun; Ishiguro, Masanori; Shiraishi, Hideaki; Ikeda, Nozomu; Matsuyama, Kiyoji; Funahashi, Shintaro; Nagamine, Takashi			Modulation of Alpha Activity in the Parieto-occipital Area by Distractors during a Visuospatial Working Memory Task: A Magnetoencephalographic Study	JOURNAL OF COGNITIVE NEUROSCIENCE			English	Article							VISUAL-SPATIAL ATTENTION; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; OCCIPITAL CORTEX; BAND; OSCILLATIONS; INHIBITION; MOVEMENT; MEG; SYNCHRONIZATION	Oscillatory brain activity is known to play an essential role in information processing in working memory. Recent studies have indicated that alpha activity (8-13 Hz) in the parieto-occipital area is strongly modulated in working memory tasks. However, the function of alpha activity in working memory is open to several interpretations, such that alpha activity may be a direct neural correlate of information processing in working memory or may reflect disengagement from information processing in other brain areas. To examine the functional contribution of alpha activity to visuospatial working memory, we introduced visuospatial distractors during a delay period and examined neural activity from the whole brain using magnetoencephalography. The strength of event-related alpha activity was estimated using the temporal spectral evolution (TSE) method. The results were as follows: (1) an increase of alpha activity during the delay period as indicated by elevated TSE curves was observed in parieto-occipital sensors in both the working memory task and a control task that did not require working memory; and (2) an increase of alpha activity during the delay period was not observed when distractors were presented, although TSE curves were constructed only from correct trials. These results indicate that the increase of alpha activity is not directly related to information processing in working memory but rather reflects the disengagement of attention from the visuospatial input.	[Ichihara-Takeda, Satoe; Yazawa, Shogo; Murahara, Takashi; Toyoshima, Takanobu; Shinozaki, Jun; Ishiguro, Masanori; Ikeda, Nozomu; Matsuyama, Kiyoji; Nagamine, Takashi] Sapporo Med Univ, Sapporo, Hokkaido 0608556, Japan; [Shiraishi, Hideaki] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan; [Funahashi, Shintaro] Kyoto Univ, Kyoto 6068501, Japan	Ichihara-Takeda, S (reprint author), Sapporo Med Univ, Sch Hlth Sci, Dept Occupat Therapy, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	satoe@sapmed.ac.jp			Japan Society for the Promotion of Science [21700541, 24700542, 22500373]	The authors thank Dr. K. Takeda for offering valuable comments regarding the working memory task, Mr. A. Yoshida for providing technical support for the working memory task, and Ms. E. Takeda for providing support for MEG recording. This study was supported by a Grant-in-Aid for Young Scientists (B; 21700541, 24700542) to S. T. and a Grant-in-Aid for Scientific Research (C; 22500373) to T. N. from the Japan Society for the Promotion of Science.	Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1738, DOI 10.1152/jn.00994.2003; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919; Worden MS, 2000, J NEUROSCI, V20, part. no.; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; PARK S, 1995, ARCH GEN PSYCHIAT, V52, P821; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Carlson S, 1998, CEREB CORTEX, V8, P743, DOI 10.1093/cercor/8.8.743; Tamura Y, 2005, EUR J NEUROSCI, V21, P2555, DOI 10.1111/j.1460-9568.2005.04096.x; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Ichihara-Takeda S, 2007, EXP BRAIN RES, V181, P409, DOI 10.1007/s00221-007-0941-0; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Vanni S, 1997, J NEUROSCI, V17, P7141; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Nagamine T, 1996, ELECTROEN CLIN NEURO, V99, P274; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Baddeley A. D, 1986, WORKING MEMORY; Ciesielski KT, 2007, HUM BRAIN MAPP, V28, P1401, DOI 10.1002/hbm.20365; Goldman-Rakic P., 1987, HDB PHYSL 1, V5, P373; Ichikawa A, 2007, NEUROSCI RES, V58, P285, DOI 10.1016/j.neures.2007.03.012; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Salenius S, 1995, ELECTROEN CLIN NEURO, V95, P453, DOI 10.1016/0013-4694(95)00155-7	37	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0898-929X	1530-8898		J COGNITIVE NEUROSCI	J. Cogn. Neurosci.	MAR	2015	27	3					453	463		10.1162/jocn_a_00718		11	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	CA7DP	WOS:000349078000003		
J	Maeda, K; Ishida, H; Nakajima, K; Inase, M; Murata, A				Maeda, Kazutaka; Ishida, Hiroaki; Nakajima, Katsumi; Inase, Masahiko; Murata, Akira			Functional Properties of Parietal Hand Manipulation-related Neurons and Mirror Neurons Responding to Vision of Own Hand Action	JOURNAL OF COGNITIVE NEUROSCIENCE			English	Article							VENTRAL PREMOTOR CORTEX; GRASPING-RELATED NEURONS; MACAQUE MONKEY; SELECTIVE PERTURBATION; PREHENSION MOVEMENTS; ACTION ORGANIZATION; REACHING MOVEMENTS; VISUAL GUIDANCE; AREA F5; MOTOR	Parietofrontal pathways play an important role in visually guided motor control. In this pathway, hand manipulation-related neurons in the inferior parietal lobule represent 3-D properties of an object and motor patterns to grasp it. Furthermore, mirror neurons show visual responses that are concerned with the actions of others and motor-related activity during execution of the same grasping action. Because both of these categories of neurons integrate visual and motor signals, these neurons may play a role in motor control based on visual feedback signals. The aim of this study was to investigate whether these neurons in inferior parietal lobule including the anterior intraparietal area and PFG of macaques represent visual images of the monkey's own hand during a self-generated grasping action. We recorded 235 neurons related to hand manipulation tasks. Of these, 54 responded to video clips of the monkey's own hand action, the same as visual feedback during that action or clips of the experimenter's hand action in a lateral view. Of these 54 neurons, 25 responded to video clips of the monkey's own hand, even without an image of the target object. We designated these 25 neurons as "hand-type." Thirty-three of 54 neurons that were defined as mirror neurons showed visual responses to the experimenter's action and motor responses. Thirteen of these mirror neurons were classified as hand-type. These results suggest that activity of hand manipulation-related and mirror neurons in anterior intraparietal/PFG plays a fundamental role in monitoring one's own body state based on visual feedback.	[Maeda, Kazutaka; Nakajima, Katsumi; Inase, Masahiko; Murata, Akira] Kinki Univ, Fac Med, Ohno Higashi, Osakasayama 5898511, Japan; [Maeda, Kazutaka] Japan Soc Promot Sci, Tokyo, Japan; [Ishida, Hiroaki] Ist Italiano Tecnol, Parma, Italy	Murata, A (reprint author), Kinki Univ, Fac Med, Dept Physiol, Ohno Higashi, Osakasayama 5898511, Japan.	akiviola@med.kindai.ac.jp			Japanese MEXT [13210133, 14017090, 15016102, 16015307, 18047026, 20033022]; JSPS KAKENHI [23500486, 26350989, 26120002]; Narishige Neuroscience Research Foundation; Nakayama Foundation for Human Science;  [13J00039]	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas (13210133, 14017090, 15016102, 16015307), "Emergence of Adaptive Motor Function through Interaction between Body, Brain, and Environment" (18047026, 20033022) from the Japanese MEXT, JSPS KAKENHI (23500486, 26350989, 26120002), Grant-in-Aid for JSPS Fellows (13J00039), the Narishige Neuroscience Research Foundation, and Nakayama Foundation for Human Science. We thank all the staff of the Life Science Laboratory for caring for the animals.	DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176; Catmur C, 2013, NEUROSCI LETT, V540, P21, DOI 10.1016/j.neulet.2012.10.001; Murata A, 2000, J NEUROPHYSIOL, V83, P2580; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Bonaiuto J, 2010, BIOL CYBERN, V102, P341, DOI 10.1007/s00422-010-0371-0; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Oztop E, 2005, COGNITIVE BRAIN RES, V22, P129, DOI 10.1016/j.cogbrainres.2004.08.004; Lehmann SJ, 2013, J NEUROSCI, V33, P7038, DOI 10.1523/JNEUROSCI.5568-12.2013; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Desmurget M, 1999, NAT NEUROSCI, V2, P563; Murata A, 1997, J NEUROPHYSIOL, V78, P2226; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; Oztop E, 2013, NEUROSCI LETT, V540, P43, DOI 10.1016/j.neulet.2012.10.005; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Caggiano V, 2011, CURR BIOL, V21, P144, DOI 10.1016/j.cub.2010.12.022; Tchernichovski O, 2008, NATURE, V451, P249, DOI 10.1038/451249a; Pani P, 2014, J COGNITIVE NEUROSCI, V26, P2342, DOI 10.1162/jocn_a_00647; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Townsend BR, 2011, J NEUROSCI, V31, P14386, DOI 10.1523/JNEUROSCI.2451-11.2011; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Gregoriou GG, 2006, J COMP NEUROL, V496, P422, DOI 10.1002/cne.20933; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; Reichenbach A, 2011, CEREB CORTEX, V21, P1602, DOI 10.1093/cercor/bhq225; HOFF B, 1993, J MOTOR BEHAV, V25, P175; Cooper RP, 2013, NEUROSCI LETT, V540, P28, DOI 10.1016/j.neulet.2012.10.002; Fadiga L, 2013, PEERJ, V1, DOI 10.7717/peerj.88; Gardner EP, 2002, BEHAV BRAIN RES, V135, P213, DOI 10.1016/S0166-4328(02)00167-5; Ishida H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069931; Murata A, 1996, J NEUROPHYSIOL, V75, P2180; Murata A., 2007, REPRESENTATION BRAIN, P151, DOI 10.1007/978-4-431-73021-7_6; Sakaguchi Y, 2010, J NEUROPHYSIOL, V104, P3625, DOI 10.1152/jn.00125.2010	51	1	1	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0898-929X	1530-8898		J COGNITIVE NEUROSCI	J. Cogn. Neurosci.	MAR	2015	27	3					560	572		10.1162/jocn_a_00742		13	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	CA7DP	WOS:000349078000011		
J	Rahman, MM; Gilmour, S; Akter, S; Abe, SK; Saito, E; Shibuya, K				Rahman, Md. Mizanur; Gilmour, Stuart; Akter, Shamima; Abe, Sarah K.; Saito, Eiko; Shibuya, Kenji			Prevalence and control of hypertension in Bangladesh: a multilevel analysis of a nationwide population-based survey	JOURNAL OF HYPERTENSION			English	Article						awareness; Bangladesh; control; hypertension; prevalence; treatment	MIDDLE-INCOME COUNTRIES; RISK-FACTORS; SOCIOECONOMIC-STATUS; GLOBAL BURDEN; AWARENESS; ADULTS; WOMEN; INDIA; PREHYPERTENSION; DISEASES	Objectives: We investigated the prevalence, awareness, treatment, and control of hypertension and associated risk factors in the Bangladeshi adult population. Methods: The data for this study were extracted from the nationally-representative 2011 Bangladesh Demographic and Health Survey. Socio-demographic profiles, height, weight, blood pressure measurements, and management were recorded from 7876 adults aged 35 years or older. Multilevel logistic regression models were used to identify the risk factors for hypertension awareness, treatment, and control. Results: Overall, age-standardized prevalence of prehypertension and hypertension were 27.1 and 24.4%, respectively. Among patients with hypertension, 50.1% were aware of their condition, 41.2% were in treatment, but only 31.4% had controlled hypertension. There was a wide disparity in hypertension management between the poor and the wealthy households. Rich households were more likely to be aware of their hypertension [odds ratio (OR) 1.92, 95% confidence interval (CI) 0.97-3.79, P = 0.06], receiving treatment (OR 3.34, 95% CI 1.55-7.18, P<0.001) and controlling their condition (OR 2.88, 95% CI 1.28-6.46, P = 0.01), as compared to the poor residents. Participants who had lower education were less likely to be aware of, in treatment for, and in control of their condition. Conclusion: One in four adults had hypertension in Bangladesh, and awareness and treatment of hypertension are quite low. Improvements in detection and treatment strategies are needed to prevent the growing disease burden associated with hypertension.	[Rahman, Md. Mizanur; Gilmour, Stuart; Abe, Sarah K.; Saito, Eiko; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo 1130033, Japan; [Rahman, Md. Mizanur] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Akter, Shamima] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Clin Res Ctr, Tokyo, Japan	Rahman, MM (reprint author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mizanur_rub@yahoo.com			Japan Ministry of Health, Labor and Welfare [H24-25 chikyu kibo ippan 007]	Sources of funding: This work was supported by a grant from the Japan Ministry of Health, Labor and Welfare (Grant H24-25 chikyu kibo ippan 007).	Ahmed A.U., 2013, STATUS FOOD SE UNPUB; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Razzaque A, 2011, ASIA-PAC J PUBLIC HE, V23, P183, DOI 10.1177/1010539510392743; Corsi DJ, 2011, J NUTR, V141, P631, DOI 10.3945/jn.110.131599; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; Shihab HM, 2012, CIRCULATION, V126, P2983, DOI 10.1161/CIRCULATIONAHA.112.117333; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Andaleeb SS, 2007, HEALTH POLICY PLANN, V22, P263, DOI 10.1093/heapol/czm017; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1; Rabe-Hesketh S, 2006, J ROY STAT SOC A STA, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Gupta R, 2013, AM J HYPERTENS, V26, P83, DOI 10.1093/ajh/hps013; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Islam MZ, 2004, ASIA PAC J CLIN NUTR, V13, P61; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; BBS, 2011, HOUS INC EXP SURV 20; Bernabe-Ortiz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035127; Griffiths P, 2005, EUR J CLIN NUTR, V59, P1217, DOI 10.1038/sj.ejcn.1602228; Gupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044098; Haseen F, 2007, ASIA PAC J CLIN NUTR, V16, P58; Huque R., 2014, USE TRADITIONAL MED; Institute for Health Metrics and Evaluation HDN, 2013, GLOB BURD DIS GEN EV; IRIN, 2013, BANGL BATTL FAK LOW; Islam A K M Monwarul, 2012, Indian Heart J, V64, P319, DOI 10.1016/S0019-4832(12)60096-0; Janghorbani M, 2008, J HYPERTENS, V26, P419, DOI 10.1097/HJH.0b013e3282f2d34d; Khan RJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-55; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Law M, 2009, BMJ-BRIT MED J, V338, pb1669; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Malekzadeh MM, 2013, J HYPERTENS, V31, P1364, DOI 10.1097/HJH.0b013e3283613053; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Rahman M, 2006, BEHAV FACTORS UNPUB; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Twisk J, 2006, APPL MULTILEVEL ANAL	42	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	MAR	2015	33	3					465	472		10.1097/HJH.0000000000000421		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CA6EX	WOS:000349003300007		
J	de Portu, G; Glaeser, AM; Reynolds, TB; Takahashi, Y; Boffelli, M; Pezzotti, G				de Portu, Goffredo; Glaeser, Andreas M.; Reynolds, Thomas B.; Takahashi, Yasuhito; Boffelli, Marco; Pezzotti, Giuseppe			A comparative assessment of metal-Al2O3 joints formed using two distinct transient-liquid-phase-forming interlayers	JOURNAL OF MATERIALS SCIENCE			English	Article							METAL-CERAMIC INTERFACES; RESIDUAL-STRESS; CHEMICAL-REACTIONS; GRAIN-BOUNDARIES; ALUMINA; DIFFUSION; NICKEL; CATHODOLUMINESCENCE; NANOINDENTATION; FLUORESCENCE	Multilayer metallic interlayers with two different architectures, one Nb-based and the other V-based, both designed to produce a thin transient-liquid-phase layer, have been used to bond high-purity Al2O3 ceramics. The mechanical properties of the resulting Al2O3-metal joints were examined at both macro- and nano-scale levels. The roles of the interlayer designs (Ni/Mo/Nb/Mo/Ni vs. Ni/Nb/V/Nb/Ni), resulting joint microstructures, lattice defects, and residual stresses on mechanical properties and failure modes were evaluated. Reduced residual stresses and improved ceramic/metal interfacial microstructures contribute to the superior performance obtained with the Ni/Mo/Nb/Mo/Ni multilayer interlayer.	[de Portu, Goffredo] Natl Res Council Italy ISTEC CNR, Inst Sci & Technol Ceram, I-48018 Faenza, Italy; [Glaeser, Andreas M.; Reynolds, Thomas B.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Takahashi, Yasuhito; Boffelli, Marco; Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan; [Takahashi, Yasuhito] Tokyo Med Univ, Dept Bone & Joint Biomat Res, Shinjuku Ku, Tokyo 1600023, Japan	de Portu, G (reprint author), Natl Res Council Italy ISTEC CNR, Inst Sci & Technol Ceram, Via Granarolo 64, I-48018 Faenza, Italy.	goffredo.deportu@istec.cnr.it			JSPS [S-11723]; CNR; STM Program grant	G. de Portu is grateful to JSPS for providing the financial support (Grant N. S-11723) for his stay at Kyoto Institute of Technology and to CNR that funded, in the framework of the Short Term Mobility Program, the visit to the University of California Berkeley. A. M. Glaeser acknowledges long-term support from the GRF, and a prior STM Program grant that initiated this collaboration. Thanks are also due to S. Guicciardi and C. Melandri for the nanoindentation measurements, to Y. Yamamoto for the assistance in fluorescence and CL spectroscopic measurements and to A. Leto for SEM micrographs.	ABLITZER D, 1977, PHILOS MAG, V35, P1239, DOI 10.1080/14786437708232950; AGARWALA RP, 1972, T JPN I MET, V13, P425; ALLEN RV, 1983, J MATER SCI, V18, P2835, DOI 10.1007/BF00547601; Locatelli MR, 1997, CERAM INT, V23, P313, DOI 10.1016/S0272-8842(96)00024-7; Fernie JA, 2009, INT MATER REV, V54, P283, DOI 10.1179/174328009X461078; SHALZ ML, 1994, J MATER SCI, V29, P3200, DOI 10.1007/BF00356663; Bolshakov A, 1996, J MATER RES, V11, P760, DOI 10.1557/JMR.1996.0092; Hong SM, 2008, ADV MATER, V20, P4799, DOI 10.1002/adma.200801550; Valenza F, 2013, J EUR CERAM SOC, V33, P539, DOI 10.1016/j.jeurceramsoc.2012.10.009; Wang L, 2011, ACTA MATER, V59, P2858, DOI 10.1016/j.actamat.2011.01.025; Munro RG, 1997, J AM CERAM SOC, V80, P1919; BERAUD C, 1989, J MATER SCI, V24, P4545, DOI 10.1007/BF00544543; DUVALL DS, 1974, WELD J, V53, P203; Wang K, 1998, MAT SCI ENG R, V23, P101, DOI 10.1016/S0927-796X(98)00011-4; Sugar JD, 2006, J EUR CERAM SOC, V26, P363, DOI 10.1016/j.jeurceramsoc.2005.06.034; Dean J, 2011, ACTA MATER, V59, P2749, DOI 10.1016/j.actamat.2011.01.014; Xu ZH, 2005, ACTA MATER, V53, P1913, DOI 10.1016/j.actamat.2005.01.002; Saiz E, 2008, ANNU REV MATER RES, V38, P197, DOI 10.1146/annurev.matsci.38.060407.132443; BARTLETT A, 1991, ACTA METALL MATER, V39, P1579, DOI 10.1016/0956-7151(91)90245-V; Brandon D, 1997, JOINING PROCESSES IN; BRANDT G, 1987, WEAR, V115, P243, DOI 10.1016/0043-1648(87)90215-8; CINDAS LLC, 2013, GLOB BENCHM CRIT EV; de Portu G, 2005, ACTA MATER, V53, P1511, DOI 10.1016/j.actamat.2004.12.003; ELSSNER G, 1990, ISIJ INT, V30, P1011, DOI 10.2355/isijinternational.30.1011; EVANS AG, 1993, MAT SCI ENG A-STRUCT, V162, P1, DOI 10.1016/0921-5093(90)90025-X; Hong S, 2009, THESIS U CALIFORNIA; Hong SM, 2010, INT J MATER RES, V101, P133, DOI 10.3139/146.110249; Hwang KS, 2003, ACTA MATER, V51, P3915, DOI 10.1016/S1359-6454(03)00216-7; Locatelli M. R., 1995, Key Engineering Materials, V111-112; MacDonald DW, 1992, ANNU REV MATER SCI, V22, P23; MCNANEY JM, 1994, INT J FRACTURE, V66, P227, DOI 10.1007/BF00042586; Munisso MC, 2007, J PHYS CHEM A, V111, P3526, DOI 10.1021/jp068557+; OHUCHI FS, 1991, J AM CERAM SOC, V74, P1163, DOI 10.1111/j.1151-2916.1991.tb04086.x; Oliver C, 1992, J MATER RES, V7, P1564; Penisson JM, 2000, ACTA MATER, V48, P3303, DOI 10.1016/S1359-6454(00)00157-9; Pezzotti G, 1998, J AM CERAM SOC, V81, P187; Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035; Pezzotti G, 2012, WEAR, V284, P91, DOI 10.1016/j.wear.2012.02.007; Rabkin E, 1996, PHIL MAG LETT, V73, P187, DOI 10.1080/095008396180821; Razumovskii IM, 1996, MAT SCI ENG A-STRUCT, V212, P45, DOI 10.1016/0921-5093(96)10184-2; REIMANIS IE, 1992, ACTA METALL MATER, V40, pS67, DOI 10.1016/0956-7151(92)90265-G; Reynolds TB, 2012, THESIS U CALIFORNIA; HEIJWEGE.CP, 1974, ACTA METALL MATER, V22, P1269; RUHLE M, 1989, MAT SCI ENG A-STRUCT, V107, P187, DOI 10.1016/0921-5093(89)90387-0; SHALZ ML, 1993, J MATER SCI, V28, P1673, DOI 10.1007/BF00363367; Shi XM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3155443; Takahashi Y, 2011, J MECH BEHAV BIOMED, V4, P993, DOI 10.1016/j.jmbbm.2011.02.014	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2461	1573-4803		J MATER SCI	J. Mater. Sci.	MAR	2015	50	6					2467	2479		10.1007/s10853-014-8803-1		13	Materials Science, Multidisciplinary	Materials Science	CA5WH	WOS:000348978000012		
J	Kobayashi, M; Oya, Y; Munakata, K; Okuno, K				Kobayashi, Makoto; Oya, Yasuhisa; Munakata, Kenzo; Okuno, Kenji			Developing a tritium release model for Li2TiO3 with irradiation-induced defects	JOURNAL OF NUCLEAR MATERIALS			English	Article							LITHIUM METATITANATE; BREEDER MATERIALS; BEHAVIOR; HYDROGEN; PELLETS; GRAIN	The annihilation kinetics of irradiation-induced defects in Li2TiO3 was evaluated by electron spin resonance. The radiation defects were stabilized with increasing defect density by interaction with neighboring defects. Subsequently, the tritium migration model in Li2TiO3 was established by integrating the kinetics of tritium diffusivity in Li2TiO3 crystalline grains, tritium trapping/detrapping at oxygen vacancies and hydroxyl groups, and annihilation of irradiation-induced defects. The contribution of hydrogen isotopes contained in tritium recovery gas was also considered in this model. The model can demonstrate an overall profile of out-of-pile tritium release for Li2TiO3 with various neutron fluences. Tritium release behavior under neutron irradiation was also estimated by the present established model. The tritium inventory increased under high neutron flux because of the continuous generation of tritium trapping sites, and the addition of hydrogen isotopes to the purge gas could reduce the tritium inventory for Li2TiO3. (C) 2014 Elsevier B. V. All rights reserved.	[Kobayashi, Makoto; Oya, Yasuhisa; Okuno, Kenji] Shizuoka Univ, Fac Sci, Radiosci Res Lab, Shizuoka 4228017, Japan; [Munakata, Kenzo] Akita Univ, Fac Engn & Resource Sci, Akita 010, Japan	Kobayashi, M (reprint author), Shizuoka Univ, Fac Sci, Radiosci Res Lab, Shizuoka 4228017, Japan.	makoto.kobayashi.0714@gmail.com			Center for Instrumental Analysis at Shizuoka University	This work was supported by a Grant-in-Aid for JSPS Fellows. This work was also supported by the facilities of the Research Reactor Institute at Kyoto University, and the Center for Instrumental Analysis at Shizuoka University.	Munakata K, 2005, FUSION ENG DES, V75-79, P673, DOI 10.1016/j.fusengdes.2005.06.138; Gierszewski P, 1998, FUSION ENG DES, V39-40, P739, DOI 10.1016/S0920-3796(97)00168-3; Kumar S, 2013, J NUCL MATER, V443, P207, DOI 10.1016/j.jnucmat.2013.07.045; Katayama K, 2012, FUSION ENG DES, V87, P927, DOI 10.1016/j.fusengdes.2012.02.050; Kinjyo T, 2008, FUSION ENG DES, V83, P580, DOI 10.1016/j.fusengdes.2007.11.011; PRESSOUYRE GM, 1981, METALL TRANS A, V12, P835, DOI 10.1007/BF02648348; Crank J., 1975, MATH DIFFUSION; HAYASHI T, 1990, J NUCL MATER, V170, P60, DOI 10.1016/0022-3115(90)90327-J; Inagaki Y, 2009, FUSION SCI TECHNOL, V56, P821; Kinjyo T, 2006, FUSION ENG DES, V81, P573, DOI 10.1016/j.fusengdes.2005.09.012; Kobayashi M, 2013, J NUCL MATER, V439, P159, DOI 10.1016/j.jnucmat.2013.04.020; Kobayashi M, 2014, COLLOID SURFACE A, V440, P1, DOI 10.1016/j.colsurfa.2013.10.043; Krom Bakker, 2000, METALL MAT T B B, V31B, P1475; OHIRA S, 1986, J NUCL MATER, V138, P235, DOI 10.1016/0022-3115(86)90011-5; Osuo J., 2011, FUSION ENG DES, V9, P2362; Suzuki S, 2010, FUSION ENG DES, V85, P2331, DOI 10.1016/j.fusengdes.2010.09.022	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						22	28		10.1016/j.jnucmat.2014.11.047		7	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600003		
J	Ohsawa, K; Nakamori, F; Hatano, Y; Yamaguchi, M				Ohsawa, Kazuhito; Nakamori, Fumihiro; Hatano, Yuji; Yamaguchi, Masatake			Thermodynamics of hydrogen- induced superabundant vacancy in tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							H ALLOYS; BCC-FE; METALS; ENERGY		[Ohsawa, Kazuhito] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Nakamori, Fumihiro] Univ Fukui, Grad Sch Engn, Tsuruga, Fukui 9140055, Japan; [Hatano, Yuji] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Yamaguchi, Masatake] Japan Atom Energy Agcy, Ctr Computat Sci & e Syst, Tokai, Ibaraki 3191195, Japan	Ohsawa, K (reprint author), Kyushu Univ, Appl Mech Res Inst, Kasuga Koen 6-1, Kasuga, Fukuoka 8168580, Japan.	ohsawa@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015				Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Alimov VK, 2008, J NUCL MATER, V375, P192, DOI 10.1016/j.jnucmat.2008.01.008; Henriksson KOE, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103390; Ikeda T, 2011, J NUCL MATER, V415, pS684, DOI 10.1016/j.jnucmat.2010.12.007; Matsumoto R, 2009, SCRIPTA MATER, V60, P555, DOI 10.1016/j.scriptamat.2008.12.009; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; FUKAI Y, 1994, PHYS REV LETT, V73, P1640, DOI 10.1103/PhysRevLett.73.1640; Nazarov R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.224104; Yoshida N, 1999, J NUCL MATER, V266, P197, DOI 10.1016/S0022-3115(98)00817-4; Ohsawa K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184117; Fukai Y, 2003, J ALLOY COMPD, V356, P263, DOI 10.1016/S0925-8388(02)01269-0; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Ohsawa K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094102; Liu YL, 2009, J NUCL MATER, V390-91, P1032, DOI 10.1016/j.jnucmat.2009.01.277; Liu YL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.172103; Fukai Y, 2001, J ALLOY COMPD, V329, P195, DOI 10.1016/S0925-8388(01)01603-6; Sugimoto H, 2014, ACTA MATER, V67, P418, DOI 10.1016/j.actamat.2013.12.041; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; MILLS G, 1995, SURF SCI, V324, P305, DOI 10.1016/0039-6028(94)00731-4; Barrow G. M., 1962, INTRO MOL SPECTROSCO; BUNKER PR, 1972, J MOL SPECTROSC, V42, P478, DOI 10.1016/0022-2852(72)90224-X; Flynn C. P., 1972, POINT DEFECTS DIFFUS; Gao AY, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40552-x; Ikeda T, 2011, J NUCL MATER, V417, P568, DOI 10.1016/j.jnucmat.2010.12.116; Ji M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.024105; Jonsson H., 1998, CLASSICAL QUANTUM DY, P385, DOI DOI 10.1142/9789812839664_0016; Kato D., 2009, J PLASMA FUSION RES, V8, P404; Kittel C., 1986, INTRO SOLID STATE PH; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Tateyama Y, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174105; Van Kranendonk J., 1983, SOLID HYDROGEN	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						187	197				11	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600022		
J	Kumar, SP; Gopal, B				Kumar, Sathasivam Pratheep; Gopal, Buvaneswari			Simulated monazite crystalline wasteform La0.4Nd0.1Y0.1Gd0.1Sm0.1Ce0.1Ca0.1(P0.9Mo0.1O4): Synthesis, phase stability and chemical durability study	JOURNAL OF NUCLEAR MATERIALS			English	Article							HIGH-LEVEL WASTE; MONAZITE/BRABANTITE SOLID-SOLUTIONS; LONG-TERM BEHAVIOR; RADIOACTIVE-WASTES; PHOSPHATE CERAMICS; LEACHING BEHAVIOR; STATE SYNTHESIS; IMMOBILIZATION; GLASS; ACTINIDES	In this work, incorporation of hexavalent molybdenum and selected trivalent lanthanides using divalent calcium as charge compensator into the monazite structure were studied. Rare earth substituted phosphomolybdates of the formula REE0.9Ca0.1P0.9Mo0.1O4 (REE = Ce, Nd, Sm, Gd) and the wasteform La0.4Nd0.1Y0.1Gd0.1Sm0.1Ce0.1Ca0.1P0.9Mo0.1O4 were synthesized by simple solution route. The prepared compounds were characterized by powder X-ray diffraction, Fourier transformed infrared spectra, thermogravimetric analysis, energy dispersive X-ray analysis and scanning electron microscopic techniques. Chemical durability of the wasteform was studied by dynamic MCC-5 test for a period of one month. Normalized elemental mass loss and leach rate of molybdenum was found to be in the order of 103 g/m(2) and 10(3)-10(1) g/m(2)/d respectively. Polymer-monazite composite wasteform was prepared to control the leaching of molybdenum. The composite approach reduced molybdenum leach rate order from 10(1) to 10 (4) g/m(2)/d. (C) 2014 Elsevier B.V. All rights reserved.	[Kumar, Sathasivam Pratheep; Gopal, Buvaneswari] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India	Kumar, SP (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	pratheepvit@gmail.com					Oelkers EH, 2008, ELEMENTS, V4, P113, DOI 10.2113/GSELEMENTS.4.2.113; Pinet O, 2006, J NON-CRYST SOLIDS, V352, P3095, DOI [10.1016/j.jnoncrysol.2006.02.103, 10.1016/jjnonerysol.2006.02.103]; Rose PB, 2011, J NON-CRYST SOLIDS, V357, P2989, DOI 10.1016/j.jnoncrysol.2011.04.003; NI YX, 1995, AM MINERAL, V80, P21; ISHIDA M, 1987, J NUCL SCI TECHNOL, V24, P404, DOI 10.3327/jnst.24.404; Li ZP, 2003, MATER LETT, V57, P4605, DOI 10.1016/S0167-577X(03)00369-0; Schlenz H, 2013, Z KRISTALLOGR, V228, P113, DOI 10.1524/zkri.2013.1597; EWING RC, 1991, CERAM INT, V17, P287, DOI 10.1016/0272-8842(91)90024-T; Veilly E, 2008, INORG CHEM, V47, P10971, DOI 10.1021/ic801169d; Xu K, 2013, J NUCL MATER, V441, P262, DOI 10.1016/j.jnucmat.2013.06.008; Zhang Y, 2009, J NUCL MATER, V395, P69, DOI 10.1016/j.jnucmat.2009.09.019; Arinicheva Y, 2014, PROG NUCL ENERG, V72, P144, DOI 10.1016/j.pnucene.2013.09.004; Clavier N, 2006, INORG CHEM, V45, P220, DOI 10.1021/ic051607p; Lumpkin GR, 2006, ELEMENTS, V2, P365, DOI 10.2113/gselements.2.6.365; Clavier N, 2011, J EUR CERAM SOC, V31, P941, DOI 10.1016/j.jeurceramsoc.2010.12.019; Terra O, 2003, NEW J CHEM, V27, P957, DOI 10.1039/b212805p; Kumar SP, 2013, MATER RES BULL, V48, P324, DOI 10.1016/j.materresbull.2012.10.027; Loiseau P, 2010, J NUCL MATER, V402, P38, DOI 10.1016/j.jnucmat.2010.04.021; Sengupta P, 2011, J HAZARD MATER, V190, P229, DOI 10.1016/j.jhazmat.2011.03.031; Bingham PA, 2009, J NON-CRYST SOLIDS, V355, P1526, DOI 10.1016/j.jnoncrysol.2009.03.008; Bregiroux D, 2007, J NUCL MATER, V366, P52, DOI 10.1016/j.jnucmat.2006.12.042; Gin S, 2013, MATER TODAY, V16, P243, DOI 10.1016/j.mattod.2013.06.008; Ojovan MI, 2011, J HAZARD MATER, V187, P296, DOI 10.1016/j.jhazmat.2011.01.004; Nikolic VM, 2007, ELECTROCHEM COMMUN, V9, P2661, DOI 10.1016/j.elecom.2007.08.022; Strachan DM, 2001, J NUCL MATER, V298, P69, DOI 10.1016/S0022-3115(01)00572-4; Linthout K, 2007, CAN MINERAL, V45, P503, DOI 10.2113/gscanmin.45.3.503; Beche E, 2008, SURF INTERFACE ANAL, V40, P264, DOI 10.1002/sia.2686; Terra O, 2008, J AM CERAM SOC, V91, P3673, DOI 10.1111/j.1551-2916.2008.02678.x; Donald IW, 1997, J MATER SCI, V32, P5851, DOI 10.1023/A:1018646507438; Dacheux N, 2004, CR CHIM, V7, P1141, DOI 10.1016/j.crci.2004.02.019; Takita Y, 2005, APPL CATAL A-GEN, V296, P63, DOI 10.1016/j.apcata.2005.07.049; de Kerdaniel ED, 2007, J NUCL MATER, V362, P451, DOI 10.1016/j.jnucmat.2007.01.132; Bregiroux D, 2007, INORG CHEM, V46, P10372, DOI 10.1021/ic7012123; Dacheux N, 2013, AM MINERAL, V98, P833; AUDERO MA, 1995, J NUCL MATER, V223, P151, DOI 10.1016/0022-3115(94)00686-5; Boatner L. A., 1988, Radioactive waste forms for the future; Buvaneswari G, 2000, MATER RES BULL, V35, P1313, DOI 10.1016/S0025-5408(00)00316-0; Campbell J.H., 1986, TECHNICAL REPORT; Caporuscio FA, 2014, NUCL ENG DES, V266, P180, DOI 10.1016/j.nucengdes.2013.10.029; Gallini S, 2005, J EUR CERAM SOC, V25, P2003, DOI 10.1016/j.jeurceramsoc.2005.03.004; GHATTAS NK, 1992, CEMENT CONCRETE RES, V22, P311, DOI 10.1016/0008-8846(92)90070-C; Hanna A.A., 2007, INT J APPL CHEM, V3, P145; Hawks HT, 1997, MAT RES S C, V465, P387; He Y, 2002, J NUCL MATER, V305, P202, DOI 10.1016/S0022-3115(02)00920-0; Heuser J, 2014, PROG NUCL ENERG, V72, P149, DOI 10.1016/j.pnucene.2013.09.003; Kubo U, 1997, J VAC SCI TECHNOL A, V15, P683, DOI 10.1116/1.580801; Kumar SP, 2011, J AM CERAM SOC, V94, P1008, DOI 10.1111/j.1551-2916.2010.04183.x; Luca V, 2006, J NUCL MATER, V358, P139, DOI 10.1016/j.jnucmat.2006.06.017; Luo SG, 1998, WASTE MANAGE, V18, P55, DOI 10.1016/S0956-053X(97)00019-6; Milankovic A. M., 2003, J NONCRYST SOLIDS, V325, P76; Mondino AV, 1999, RADIAT PHYS CHEM, V55, P723, DOI 10.1016/S0969-806X(99)00219-4; Ojovan M. I., 2014, INTRO NUCL WASTE IMM, V2nd; Pet'kov VI, 2003, CZECH J PHYS, V53, pA671, DOI 10.1007/s10582-003-0086-8; Pierre J.S., 1984, J NUCL MATER, V125, P320; Rengifo F, 2004, IND ENG CHEM RES, V43, P7492, DOI 10.1021/ie049561f; ROY R, 1982, MATER RES BULL, V17, P585, DOI 10.1016/0025-5408(82)90040-X; Saleh HM, 2011, J NUCL MATER, V411, P185, DOI 10.1016/j.jnucmat.2011.01.126; Seida Y., 2005, P GLOB TSUK JAP, P390; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SIEGBAHN PEM, 1993, CHEM PHYS LETT, V201, P15, DOI 10.1016/0009-2614(93)85026-K; Stewart M.W.A., 2006, WM 06 C TUCS; Sugantha M, 1998, WASTE MANAGE, V18, P275, DOI 10.1016/S0956-053X(98)00026-9; Sukhanov M.V., 2003, RADIOKHIMIYA, V45, P560; Tamain C, 2007, J NUCL MATER, V362, P459, DOI 10.1016/j.jnucmat.2007.01.098; Wagner C.D., 1979, HDB XRAY PHOTOELECTR, P38; Weber W.J., 1998, J MATER RES, V13, P1435; Zakharova KP, 2000, ATOM ENERGY+, V89, P646, DOI 10.1023/A:1011399408845	67	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						224	232		10.1016/j.jnucmat.2014.12.081		9	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600026		
J	Lu, ZP; Chen, JJ; Shoji, T; Meng, FJ				Lu, Zhanpeng; Chen, Junjie; Shoji, Tetsuo; Meng, Fanjiang			Dependence of crack growth kinetics on dendrite orientation and water chemistry for Alloy 182 weld metal in high-temperature water	JOURNAL OF NUCLEAR MATERIALS			English	Article							STRESS-CORROSION CRACKING; ENVIRONMENTALLY ASSISTED CRACKING; OXYGENATED PURE WATER; 316L STAINLESS-STEEL; BRANCHED CRACKS; NICKEL-ALLOYS; LOADING MODE; PREDICTION; HYDROGEN	Stress corrosion cracking growth rates of Alloy 182 weld metals in T-S and T-L orientations in 288 degrees C pure water with various dissolved oxygen and hydrogen concentrations were measured. Extensive inter-dendritic stress corrosion cracking paths on the side surfaces and fracture surfaces were observed. The crack growth path in the T-S orientation specimen was perpendicular to the applied loading direction, and parallel to the loading direction in the T-L specimen. Crack growth rates of the T-S specimen were significantly higher than those of the T-L specimen under the same test conditions. The crack growth rate decreased significantly with decreasing dissolved oxygen concentration. Adding dissolved hydrogen in water caused an apparent decrease of the alternating current potential drop signal during crack growth monitoring. (C) 2014 Elsevier B.V. All rights reserved.	[Lu, Zhanpeng; Chen, Junjie] Shanghai Univ, Inst Mat Sci, Sch Mat Sci & Engn, Shanghai 200072, Peoples R China; [Lu, Zhanpeng; Shoji, Tetsuo] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan; [Meng, Fanjiang] Shanghai Nucl Engn Res & Design Inst, Shanghai 200233, Peoples R China	Lu, ZP (reprint author), Shanghai Univ, Inst Mat Sci, Sch Mat Sci & Engn, Shanghai 200072, Peoples R China.	zplu@shu.edu.cn			Japan Society for the Promotion of Science [23560078]; POLIM program; Shanghai Pujiang Program [12PJ1403600]; Ph.D. Programs Foundation of Ministry of Education of China [20123108110021]	This work has been performed under the support of Grant-in-Aid for Scientific Research (C) 23560078, Japan Society for the Promotion of Science, and the POLIM program. Z.P. Lu acknowledges the support of Shanghai Pujiang Program No. 12PJ1403600 and The Ph.D. Programs Foundation of Ministry of Education of China No. 20123108110021. The help from Y. Takeda for the experiments is gratefully appreciated.	Andresen P.L., 2009, P 14 INT C ENV DEGR, P382; ANDRESEN PL, 1988, CORROSION, V44, P376; ANDRESEN PL, 1988, MAT SCI ENG A-STRUCT, V103, P167, DOI 10.1016/0025-5416(88)90564-2; Lu ZP, 2011, CORROS SCI, V53, P247, DOI 10.1016/j.corsci.2010.09.018; Shoji T, 2010, CORROS SCI, V52, P769, DOI 10.1016/j.corsci.2009.10.041; Andresen PL, 2008, J NUCL MATER, V383, P97, DOI 10.1016/j.jnucmat.2008.08.005; Terachi T, 2003, J NUCL SCI TECHNOL, V40, P509, DOI 10.3327/jnst.40.509; Ford FP, 1996, CORROSION, V52, P375; Lu ZP, 2011, CORROS SCI, V53, P1916, DOI 10.1016/j.corsci.2011.02.009; Lu ZP, 2012, J NUCL MATER, V423, P28, DOI 10.1016/j.jnucmat.2011.12.030; Andresen PL, 2008, CORROSION, V64, P707; [Anonymous], 2002, MRP115 EPRI; Lu ZP, 2008, CORROS SCI, V50, P625, DOI 10.1016/j.corsci.2007.08.021; Qiu YB, 2011, CORROS SCI, V53, P1983, DOI 10.1016/j.corsci.2011.02.020; Lu ZP, 2010, CORROS SCI, V52, P2547, DOI 10.1016/j.corsci.2010.03.027; NEWMAN RC, 1994, CORROSION, V50, P682; Attanasio S.A., 2003, P 11 INT C ENV DEGR, P143; Bamford W.H., 2001, P 11 INT C ENV DEGR; BRIANT CL, 1987, CORROSION, V43, P539; Bruemmer S.M., 2007, P 13 INT C ENV DEGR; Itow M., 2005, P 11 INT C ENV DEGR, P1192; Jacko R.J., 2005, P C VESS PEN INSP CR, P413; Ljungberg LG, 1997, PROCEEDINGS OF THE EIGHTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS - WATER REACTORS, VOLS 1 AND 2, P704; Lu Z, 2007, CORROSION, V63, P1021, DOI 10.5006/1.3278317; Lu Z.P., 2010, P 2010 ASME PRESS VE; Lu Z.P., 2014, CORROS ENG IN PRESS; Lu ZP, 2008, CORROS SCI, V50, P561, DOI 10.1016/j.corsci.2007.08.005; Lu Z.P., 2012, CORROS SCI, V53, P211; Lu Z.P., 2013, J PRES VES TECHNOL, V135; MATELEC, ACPD TECHN US MAN; Matsunaga T., 2003, P 11 INT C NUCL ENG; Ozawa M., 2005, P 13 INT C ENV DEGR; Scott P., 2005, P 12 INT C ENV DEGR; Scott PM, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P3; Shoji T., 2008, P 2008 ASME PRESS VE; SURESH S, 1986, INT J FRACTURE, V30, P237, DOI 10.1007/BF00019705; Sureshi S., ELASTIC PLASTIC FRAC; Venkatasubramanian T.V., 1984, J PHYS E, V17, P756; VITEK V, 1977, INT J FRACTURE, V13, P481; White G. A., 2005, P 12 INT C ENV DEGR, P511	40	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						253	263		10.1016/j.jnucmat.2014.12.083		11	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600030		
J	Fujii, K; Fukuya, K; Kasada, R; Kimura, A; Ohkubo, T				Fujii, K.; Fukuya, K.; Kasada, R.; Kimura, A.; Ohkubo, T.			Effects of tensile stress on Cu clustering in irradiated Fe-Cu alloy	JOURNAL OF NUCLEAR MATERIALS			English	Article							DEFECT PRODUCTION; ION IRRADIATIONS; ELECTRON; STEEL; CREEP; IRON	Effects of tensile stress on Cu clustering were explained using atom probe tomography (APT) results of Fe-0.6 wt.%Cu alloy specimens irradiated with 6.4 MeV Fe ions while applying a tensile stress of 60 MPa at room temperature (less than 50 degrees C) and 290 degrees C. The hardening under the tensile-stressed irradiation was smaller than that under the stress-free irradiation at both room temperature and 290 degrees C. APT results showed that well-defined Cu clusters were formed in all specimens even under the room temperature irradiation. The Cu clusters under the tensile-stressed condition were smaller and had higher densities than those under the stress-free condition. The lower Cu content in clusters and more diffuse Cu clustering were obtained for the specimens irradiated under the tensile-stressed condition. The hardening efficiency of Cu clusters was correlated with the Cu content in clusters and the coherency of interface between a cluster and the matrix. Application of tensile stress would control hardening by changing the nature of Cu clusters. (C) 2014 Elsevier B.V. All rights reserved.	[Fujii, K.; Fukuya, K.] Inst Nucl Safety Syst Inc, Mihama 9191205, Japan; [Kasada, R.; Kimura, A.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Ohkubo, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Fujii, K (reprint author), Inst Nucl Safety Syst Inc, Mihama 9191205, Japan.	fujiik@inss.co.jp			MEXT	Heavy ion irradiations were supported by the MEXT supported program "Open Advanced Facilities to Industry'', in the Project ADMIRE (Application of DuET and MUSTER for Industrial Research and Engineering). The authors thank Dr. Sosuke Kondo, Mr. Okinobu Hashitomi and Dr. Kiyohiro Yabuuchi for their support of the heavy ion irradiations.	WOLFER WG, 1972, NUCL TECHNOL, V16, P55; Pharr GM, 2010, ANNU REV MATER RES, V40, P271, DOI 10.1146/annurev-matsci-070909-104456; HEALD PT, 1974, PHILOS MAG, V29, P1075, DOI 10.1080/14786437408226592; Nagai Y, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.134110; Chen YM, 2009, SCRIPTA MATER, V61, P693, DOI 10.1016/j.scriptamat.2009.05.043; FISHER SB, 1985, PHILOS T R SOC A, V315, P301, DOI 10.1098/rsta.1985.0042; Fujii K, 2010, J NUCL MATER, V407, P151, DOI 10.1016/j.jnucmat.2010.09.055; Hernandez-Mayoral M, 2010, J NUCL MATER, V399, P146, DOI 10.1016/j.jnucmat.2009.11.013; Ishino S, 2003, J NUCL MATER, V323, P354, DOI 10.1016/j.jnucmat.2003.08.012; Miyashiro S, 2011, J NUCL MATER, V415, P1, DOI 10.1016/j.jnucmat.2011.03.056; Nomoto A., 2005, Q04019 CRIEPI; Odette GR, 1998, RADIAT EFF DEFECT S, V144, P189, DOI 10.1080/10420159808229676; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Pareige P, 2001, NUCL INSTRUM METH B, V178, P233, DOI 10.1016/S0168-583X(00)00467-5; Radiguet B, 2007, J NUCL MATER, V360, P104, DOI 10.1016/j.jnucmat.2006.09.007; RUSSELL KC, 1972, ACTA METALL MATER, V20, P969, DOI 10.1016/0001-6160(72)90091-0; Sato K, 2003, MAT SCI ENG A-STRUCT, V350, P220, DOI 10.1016/S0921-5093(02)00692-5; Sato K, 2002, RADIAT EFF DEFECT S, V157, P171, DOI 10.1080/10420150290026828; Tobita T, 2001, J NUCL MATER, V299, P267, DOI 10.1016/S0022-3115(01)00694-8; Tsuru T., 2010, J SOC MAT SCI JPN, V59, P583; Ziegler J. F., SRIM 2006	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						281	287		10.1016/j.jnucmat.2014.12.108		7	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600034		
J	Jiang, J; Wu, YC; Liu, XB; Wang, RS; Nagai, Y; Inoue, K; Shimizu, Y; Toyama, T				Jiang, J.; Wu, Y. C.; Liu, X. B.; Wang, R. S.; Nagai, Y.; Inoue, K.; Shimizu, Y.; Toyama, T.			Microstructural evolution of RPV steels under proton and ion irradiation studied by positron annihilation spectroscopy	JOURNAL OF NUCLEAR MATERIALS			English	Article							PRESSURE-VESSEL STEEL; ATOM-PROBE TOMOGRAPHY; MODEL ALLOYS; NEUTRON-IRRADIATION; NANOSTRUCTURAL EVOLUTION; DEFECT ACCUMULATION; A533B STEEL; HIGH-NICKEL; EMBRITTLEMENT; FE	The microstructural evolution of reactor pressure vessel (RPV) steels induced by proton and heavy ion irradiation at low temperature (similar to 373 K) has been investigated using positron annihilation spectroscopy (PAS), atom probe tomography (APT), transmission electron microscopy (TEM) and nanoindentation. The PAS results indicated that both proton and heavy ion irradiation produce a large number of matrix defects, which contain small-size defects such as vacancies, vacancy-solute complexes, dislocation loops, and large-size vacancy clusters. In proton irradiated RPV steels, the size and number density of vacancy cluster defects increased rapidly with increasing dose due to the migration and agglomeration of vacancies. In contrast, for Fe ion irradiated steels, high density, larger size vacancy clusters can be easily induced at low dose, showing saturation in PAS response with increasing dose. No clear precipitates, solute-enriched clusters or other forms of solute segregation were observed by APT. Furthermore, dislocation loops were observed by TEM after 1.0 dpa, 240 keV proton irradiation, and an increase of the average nanoindentation hardness was found. It is suggested that ion irradiation produces many point defects and vacancy cluster defects, which induce the formation of dislocation loops and the increase of nanoindentation hardness. (C) 2014 Elsevier B.V. All rights reserved.	[Jiang, J.; Wu, Y. C.] Wuhan Univ, Sch Phys & Technol, Hubei Nucl Solid Phys Key Lab, Wuhan 430072, Peoples R China; [Liu, X. B.; Wang, R. S.] Suzhou Nucl Power Res Inst, Ctr Plant Life Management, Suzhou 215004, Peoples R China; [Jiang, J.; Nagai, Y.; Inoue, K.; Shimizu, Y.; Toyama, T.] Tohoku Univ, Inst Mat Res, Oarai Ctr, Oarai, Ibaraki 3111313, Japan	Wu, YC (reprint author), Wuhan Univ, Sch Phys & Technol, Hubei Nucl Solid Phys Key Lab, Wuhan 430072, Peoples R China.	ycwu@whu.edu.cn	Nagai, Yasuyoshi/A-8995-2011; Toyama, Takeshi/A-8480-2011; Shimizu, Yasuo/A-8116-2011	Toyama, Takeshi/0000-0001-5166-653X; Shimizu, Yasuo/0000-0002-6844-8165	National Natural Science Foundation of China [51071111, 11175136, J1210061]; Fundamental Research Funds for the Central Universities [20082020101000014]; National High Technology Research and Development Program of China (863 Program) [2012AA050901]	The authors would like to thank Prof. P.G. Coleman at University of Bath, UK and Dr. A. Kinomura at AIST in Japan for fruitful discussions, and the latter for PALS measurements. This research is supported by the National Natural Science Foundation of China under Grants 51071111, 11175136 and J1210061, the Fundamental Research Funds for the Central Universities (20082020101000014), the National High Technology Research and Development Program of China (863 Program) under Grant 2012AA050901, and is also performed under the contract between Suzhou Nuclear Power Research Institute Co., Ltd., IMR of Tohoku University and Wuhan University.	Odette GR, 2009, JOM-US, V61, P17, DOI 10.1007/s11837-009-0097-4; Miller MK, 2007, J NUCL MATER, V371, P145, DOI 10.1016/j.jnucmat.2007.05.003; Fujii K, 2005, J NUCL MATER, V336, P323, DOI 10.1016/j.jnucmat.2004.10.090; Bachhav M, 2014, SCRIPTA MATER, V74, P48, DOI 10.1016/j.scriptamat.2013.10.001; Marian J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.255507; Iwai T, 2004, J NUCL MATER, V329, P963, DOI 10.1016/j.jnucmat.2004.04.064; Odette GR, 1997, J NUCL MATER, V251, P157, DOI 10.1016/S0022-3115(97)00267-5; Williams CA, 2011, J NUCL MATER, V412, P100, DOI 10.1016/j.jnucmat.2011.02.029; PUSKA MJ, 1983, J PHYS F MET PHYS, V13, P333, DOI 10.1088/0305-4608/13/2/009; Bachhav M, 2014, J NUCL MATER, V453, P334, DOI 10.1016/j.jnucmat.2014.06.050; Kuramoto A, 2012, J NUCL MATER, V425, P65, DOI 10.1016/j.jnucmat.2011.10.019; Pareige P, 1997, J NUCL MATER, V249, P165, DOI 10.1016/S0022-3115(97)00215-8; Meslin E, 2013, ACTA MATER, V61, P6246, DOI 10.1016/j.actamat.2013.07.008; Miller MK, 2005, ULTRAMICROSCOPY, V102, P287, DOI [10.1016/j.ultramic.2004.10.011, 10.1016/J.ULTRAMIC.2004.10.011]; Toyama T, 2007, ACTA MATER, V55, P6852, DOI 10.1016/j.actamat.2007.08.047; Certain A, 2013, J NUCL MATER, V434, P311, DOI 10.1016/j.jnucmat.2012.11.021; Nishiyama Y, 2008, ACTA MATER, V56, P4510, DOI 10.1016/j.actamat.2008.05.026; Chen YM, 2014, J NUCL MATER, V451, P130, DOI 10.1016/j.jnucmat.2014.03.034; PHYTHIAN WJ, 1993, J NUCL MATER, V205, P162, DOI 10.1016/0022-3115(93)90079-E; Meslin E, 2010, J NUCL MATER, V406, P73, DOI 10.1016/j.jnucmat.2009.12.021; Lambrecht M, 2009, J NUCL MATER, V385, P334, DOI 10.1016/j.jnucmat.2008.12.020; VANVEEN A, 1995, APPL SURF SCI, V85, P216, DOI 10.1016/0169-4332(94)00334-3; VALKEALAHTI S, 1984, APPL PHYS A-MATER, V35, P51, DOI 10.1007/BF00620300; Kuriplach J, 2006, APPL SURF SCI, V252, P3303, DOI 10.1016/j.apsusc.2005.08.075; Miller MK, 2006, J MATER SCI, V41, P7808, DOI 10.1007/s10853-006-0518-5; Idrees Y, 2013, J NUCL MATER, V433, P95, DOI 10.1016/j.jnucmat.2012.09.014; Marquis EA, 2010, MAT SCI ENG R, V69, P37, DOI 10.1016/j.mser.2010.05.001; Eldrup M, 1997, J NUCL MATER, V251, P132, DOI 10.1016/S0022-3115(97)00221-3; Bergner F, 2009, PHIL MAG LETT, V89, P795, DOI 10.1080/09500830903304117; Bergner F, 2010, J NUCL MATER, V399, P129, DOI 10.1016/j.jnucmat.2009.11.011; Cumblidge S. E., 2002, THESIS PENNSYLVANIA, P103; Dubinko VI, 2011, NUCL INSTRUM METH B, V269, P1634, DOI 10.1016/j.nimb.2010.12.012; Eldrup M, 2003, J NUCL MATER, V323, P346, DOI 10.1016/j.jnucmat.2003.08.011; Eldrup M, 2002, J NUCL MATER, V307, P912, DOI 10.1016/S0022-3115(02)01160-1; Fluss M. J., 2002, CHARACTERIZATION MAT; Fujii K, 2011, J NUCL MATER, V417, P949, DOI 10.1016/j.jnucmat.2010.12.192; Fujii K, 2010, J NUCL MATER, V407, P151, DOI 10.1016/j.jnucmat.2010.09.055; Gurovich B, 2013, J NUCL MATER, V435, P25, DOI 10.1016/j.jnucmat.2012.12.020; Hernandez-Mayoral M, 2010, J NUCL MATER, V399, P146, DOI 10.1016/j.jnucmat.2009.11.013; Hunter A. H., 2012, METALL MATER TRANS A, V44, P1741; Hyde J. M., 2000, P MRS 2000 FALL M S, P650; Ishizaki T, 2004, MATER TRANS, V45, P9, DOI 10.2320/matertrans.45.9; Kempf R, 2013, J NUCL MATER, V434, P411, DOI 10.1016/j.jnucmat.2012.12.004; Kuramoto A, 2013, ACTA MATER, V61, P5236, DOI 10.1016/j.actamat.2013.05.016; Liu XB, 2012, RADIAT PHYS CHEM, V81, P1586, DOI 10.1016/j.radphyschem.2012.05.014; Liu XB, 2014, J NUCL MATER, V451, P249, DOI 10.1016/j.jnucmat.2014.04.008; Luo S, 2014, MAT SCI ENG A-STRUCT, V596, P25, DOI 10.1016/j.msea.2013.09.091; Miller MK, 2007, J NUCL MATER, V361, P248, DOI 10.1016/j.jnucmat.2006.12.015; Miller MK, 2013, J NUCL MATER, V437, P107, DOI 10.1016/j.jnucmat.2013.01.312; Miller MK, 2003, J NUCL MATER, V320, P177, DOI 10.1016/S0022-3115(03)00108-9; Nagai Y, 2000, PHYS REV B, V61, P6574, DOI 10.1103/PhysRevB.61.6574; Nagai Y, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.224202; Odette GR, 1998, RADIAT EFF DEFECT S, V144, P189, DOI 10.1080/10420159808229676; Ohkubo H, 2003, MAT SCI ENG A-STRUCT, V350, P95, DOI 10.1016/S0921-5093(02)00705-0; Pareige P, 2005, PHILOS MAG, V85, P429, DOI 10.1080/02678370412331320233; RUSSELL KC, 1973, ACTA METALL MATER, V21, P187, DOI 10.1016/0001-6160(73)90002-3; Slugen V, 2011, J PHYS CONF SER, V265, DOI 10.1088/1742-6596/265/1/012008; TRIFTSHAUSER W, 1982, PHYS REV LETT, V48, P1741, DOI 10.1103/PhysRevLett.48.1741; Ulbricht A, 2007, PHILOS MAG, V87, P1855, DOI 10.1080/14786430601102999; Watanabe H, 2011, J NUCL MATER, V417, P932, DOI 10.1016/j.jnucmat.2010.12.179; Wu YC, 2006, APPL SURF SCI, V252, P3278, DOI 10.1016/j.apsusc.2005.08.051; Xin Y, 2013, J NUCL MATER, V432, P120, DOI 10.1016/j.jnucmat.2012.08.043; Zeman A, 2006, APPL SURF SCI, V252, P3290, DOI 10.1016/j.apsusc.2005.08.107; Zhang ZW, 2012, ACTA MATER, V60, P3034, DOI 10.1016/j.actamat.2012.02.008	64	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						326	334		10.1016/j.jnucmat.2014.12.113		9	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600040		
J	Sekio, Y; Yamashita, S; Sakaguchi, N; Takahashi, H				Sekio, Yoshihiro; Yamashita, Shinichiro; Sakaguchi, Norihito; Takahashi, Heishichiro			Void denuded zone formation for Fe-15Cr-15Ni steel and PNC316 stainless steel under neutron and electron irradiations	JOURNAL OF NUCLEAR MATERIALS			English	Article							ALLOYING ELEMENTS; GRAIN-BOUNDARIES; SEGREGATION; METALS; RADIATION; EXPOSURE; GROWTH; BIAS; CR	Irradiation-induced void denuded zone (VDZ) formation near grain boundaries was studied to clarify the effects of minor alloying elements on vacancy diffusivity during irradiation in practical PNC316 stainless steel developed for nuclear reactor core materials. The test materials were Fe-15Cr-15Ni steel without additives and PNC316 stainless steel; the latter contains minor alloying elements to improve the void swelling resistance. These steels were neutron-irradiated in the experimental fast reactor JOYO at temperatures from 749 K to 775 K and fast neutron doses of 18-103 dpa, and electron irradiation was also carried out using 1 MeV high voltage electron microscopy at temperatures of 723 K and 773 K and doses up to 14.4 dpa. VDZ formation was analyzed by TEM microstructural observation after irradiation by considering radiation-induced segregation near the grain boundaries. VDZs were formed near random grain boundaries with higher misfit angles in both Fe-15Cr-15Ni and PNC316 steels. The VDZ widths in the PNC316 stainless steel were narrower than those for the Fe-15Cr-15Ni steel for all neutron and electron irradiations. The VDZ width analysis implied that the vacancy diffusivity was reduced in PNC316 stainless steel as a result of interaction of vacancies with minor alloying elements. (C) 2014 Elsevier B.V. All rights reserved.	[Sekio, Yoshihiro; Yamashita, Shinichiro; Takahashi, Heishichiro] Japan Atom Energy Agcy, Oarai Res & Dev Ctr, Ibaraki 3111393, Japan; [Sakaguchi, Norihito; Takahashi, Heishichiro] Hokkaido Univ, Ctr Adv Res Energy Technol, Sapporo, Hokkaido 0600808, Japan	Sekio, Y (reprint author), Japan Atom Energy Agcy, Oarai Res & Dev Ctr, Fukushima Fuels & Mat Dept, Mat Monitoring Sect, Ibaraki 3111393, Japan.	sekio.yoshihiro@jaea.go.jp			Japan Society for the Promotion of Science [23561024]	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI, No. 23561024) from the Japan Society for the Promotion of Science. The authors also thank Mr. K. Ohkubo for the technical support in the HVEM operations.	Dubinko VI, 2005, J NUCL MATER, V336, P11, DOI 10.1016/j.jnucmat.2004.07.034; Sekio Y, 2014, MATER TRANS, V55, P438, DOI 10.2320/matertrans.MD201309; SINGH BN, 1974, PHILOS MAG, V29, P25, DOI 10.1080/14786437408213551; OKAMOTO PR, 1974, J NUCL MATER, V53, P336, DOI 10.1016/0022-3115(74)90267-0; LARCHE FC, 1982, ACTA METALL MATER, V30, P1835, DOI 10.1016/0001-6160(82)90023-2; BATES JF, 1981, J NUCL MATER, V102, P200, DOI 10.1016/0022-3115(81)90560-2; OKAMOTO PR, 1979, J NUCL MATER, V83, P2, DOI 10.1016/0022-3115(79)90587-7; Bokshtein S. Z., 1965, DIFFUSION PROCESSES, P2; BRAILSFO.AD, 1972, J NUCL MATER, V44, P121, DOI 10.1016/0022-3115(72)90091-8; ELEN JD, 1992, J NUCL MATER, V191, P766, DOI 10.1016/0022-3115(92)90575-6; GARNER FA, 1993, J NUCL MATER, V205, P98, DOI 10.1016/0022-3115(93)90076-B; GARNER FA, 1988, J NUCL MATER, V155, P833, DOI 10.1016/0022-3115(88)90425-4; Garner F.A., 1981, J NUCL MATER, V103-104, P803; KATO T, 1991, MATER T JIM, V32, P921; KONOBEEV YV, 1975, PHYS STATUS SOLIDI A, V29, pK121, DOI 10.1002/pssa.2210290246; Konobeev YV, 2000, AM SOC TEST MATER, V1366, P699, DOI 10.1520/STP12425S; Masumura R. A., 2000, Materials Physics and Mechanics, V1; MAYER RM, 1980, J NUCL MATER, V95, P92, DOI 10.1016/0022-3115(80)90084-7; Millett PC, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/6/064003; Ovid'ko IA, 1999, J PHYS D APPL PHYS, V32, P2833, DOI 10.1088/0022-3727/32/22/301; Sakaguchi N, 2001, ACTA MATER, V49, P1129, DOI 10.1016/S1359-6454(01)00031-3; SHAIKH MA, 1992, J NUCL MATER, V187, P303, DOI 10.1016/0022-3115(92)90511-I; SHIBAHARA I, 1994, J NUCL MATER, V212, P487, DOI 10.1016/0022-3115(94)90109-0; Singh B. N., 1973, 287 RISQ; SINGH BN, 1994, J NUCL MATER, V212, P168, DOI 10.1016/0022-3115(94)90050-7; Stiegler J. O., 1971, Radiation Effects, V8, DOI 10.1080/00337577108231006; TAKAHASHI H, 1984, J NUCL MATER, V122, P327, DOI 10.1016/0022-3115(84)90619-6; TAKEYAMA T, 1982, J NUCL MATER, V108, P465, DOI 10.1016/0022-3115(82)90518-9; WATANABE H, 1988, J NUCL MATER, V155, P815, DOI 10.1016/0022-3115(88)90422-9	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						355	360		10.1016/j.jnucmat.2014.12.054		6	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600044		
J	Iwamoto, Y; Yoshiie, T; Yoshida, M; Nakamoto, T; Sakamoto, M; Kuriyama, Y; Uesugi, T; Ishi, Y; Xu, Q; Yashima, H; Takahashi, F; Mori, Y; Ogitsu, T				Iwamoto, Yosuke; Yoshiie, Toshimasa; Yoshida, Makoto; Nakamoto, Tatsushi; Sakamoto, Masaaki; Kuriyama, Yasutoshi; Uesugi, Tomonori; Ishi, Yoshihiro; Xu, Qiu; Yashima, Hiroshi; Takahashi, Fumiaki; Mori, Yoshiharu; Ogitsu, Toru			Measurement of the displacement cross-section of copper irradiated with 125 MeV protons at 12 K	JOURNAL OF NUCLEAR MATERIALS			English	Article							RADIATION-DAMAGE; DEFECT PRODUCTION; FCC METALS; PHITS; RECOVERY; RATES	To validate Monte Carlo codes for the prediction of radiation damage in metals irradiated by >100 MeV protons, the defect-induced electrical resistivity changes related to the displacement cross-section of copper were measured with 125 MeV proton irradiation at 12 K. The cryogenic irradiation system was developed with a Gifford-McMahon cryocooler to cool the sample via an oxygen-free high-conductivity copper plate by conduction cooling. The sample was a copper wire with a 250-lm diameter and 99.999% purity sandwiched between two aluminum nitride ceramic sheets. The electrical resistivity changes of the copper wire were measured using the four-probe technique. After 125 MeV proton irradiation with 1.45 x 10(18) protons/m(2) at 12 K, the total resistivity increase was 4.94 x 10(-13) Omega m (resistance increase: 1.53 mu Omega), while the resistivity of copper before irradiation was 9.44 x 10(-12) Omega m (resistance: 29.41 mu Omega). The resistivity increase did not change during annealing after irradiation below 15 K. The experimental displacement cross-section for 125 MeV irradiation shows similar results to the experimental data for 1.1 and 1.94 GeV. Comparison with the calculated results indicated that the defect production efficiency in Monte Carlo codes gives a good quantitative description of the displacement cross-section in the energy region >100 MeV. (C) 2015 Elsevier B.V. All rights reserved.	[Iwamoto, Yosuke; Takahashi, Fumiaki] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Yoshiie, Toshimasa; Sakamoto, Masaaki; Kuriyama, Yasutoshi; Uesugi, Tomonori; Ishi, Yoshihiro; Xu, Qiu; Yashima, Hiroshi; Mori, Yoshiharu] Kyoto Univ, Inst Res Reactor, Sennan, Osaka 5900494, Japan; [Yoshida, Makoto; Nakamoto, Tatsushi; Ogitsu, Toru] High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki 3050801, Japan	Iwamoto, Y (reprint author), 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	iwamoto.yosuke@jaea.go.jp		Iwamoto, Yosuke/0000-0003-4688-6508	Ministry of Education, Culture, Sports, Science and Technology of Japan [25820450]	The authors wish to express their gratitude to the technical staff at KURRI, and Mr. Hirokatsu Ohata and Dr. Kenichi Sasaki at KEK and Dr. Norito Ishikawa at JAEA for their generous support. This study was supported by a Japan Grant-in-Aid for Young Scientists (B) (25820450) and "Clarification of material behaviors in accelerator driven systems by an FFAG accelerator" carried out under the Strategic Promotion Program for Basic Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Mokhov NV, 2007, AIP CONF PROC, V896, P50, DOI 10.1063/1.2720456; Pyeon CH, 2009, J NUCL SCI TECHNOL, V46, P1091; Broeders CHM, 2004, J NUCL MATER, V328, P197, DOI 10.1016/j.jnucmat.2004.05.002; Boudard A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014606; GUINAN MW, 1982, J NUCL MATER, V108, P95, DOI 10.1016/0022-3115(82)90476-7; Iwamoto Y, 2014, J NUCL SCI TECHNOL, V51, P98, DOI 10.1080/00223131.2013.851042; NORGETT MJ, 1975, NUCL ENG DES, V33, P50, DOI 10.1016/0029-5493(75)90035-7; [Anonymous], 2009, E52196 ASTM; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; BETHE HA, 1953, PHYS REV, V89, P1256, DOI 10.1103/PhysRev.89.1256; Bordini B, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2180693; Caturla MJ, 2001, J NUCL MATER, V296, P90, DOI 10.1016/S0022-3115(01)00569-4; CORBETT JW, 1957, PHYS REV, V108, P954, DOI 10.1103/PhysRev.108.954; EHRHART P, 1974, J PHYS F MET PHYS, V4, P1575, DOI 10.1088/0305-4608/4/10/006; Ferrari A., 2005, CERN200510; Filges D., 2009, HDB SPALLATION RES T, P215; GUINAN MW, 1985, J NUCL MATER, V133, P357, DOI 10.1016/0022-3115(85)90167-9; HORAK JA, 1973, J NUCL MATER, V49, P161, DOI 10.1016/0022-3115(73)90005-6; Ishi Y., 2010, P IPAC 10 KYOT JAP, P1327; Iwamoto Y, 2012, NUCL INSTRUM METH B, V274, P57, DOI 10.1016/j.nimb.2011.11.038; IWATA T, 1990, RADIAT EFF DEFECT S, V113, P135, DOI 10.1080/10420159008213060; Konobeyev A. Yu., 2007, P 8 INT TOP M NUCL A, P241; MacFarlane R. E., 2000, NJOY99 0 CODE SYSTEM; Pitcher E. J., 2004, P 6 INT M NUCL APPL, P881; Pyeon C. H., 2013, KURRIKRCD40; Rossi L., 2012, CERNATS2012236; Stoller RE, 2000, NUCL ENG DES, V195, P129, DOI 10.1016/S0029-5493(99)00241-1; Suslov AV, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3463691; Wang J, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2165567; Water L.S., 2002, LACP02408 LOS AL NAT	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	MAR	2015	458						369	375		10.1016/j.jnucmat.2014.12.125		7	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KS	WOS:000349169600046		
J	Yasuhara, H; Koga, K; Nakashima, S				Yasuhara, Hiroki; Koga, Kazuki; Nakashima, Satoru			Synthesis and oxidation study of the simplest binuclear metallocene compound of osmium, biosmocene	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Biosmocene; Mixed-valence state; Variable-temperature NMR; Valence-detrapping	VALENCE STATES; MOLECULAR-STRUCTURES; ELECTRON-TRANSFER; SALTS; FERROCENES; RUTHENIUM; CRYSTAL; ANION	Selective mono-lithiation method of bis(cyclopentadienyl) osmium(II) (osmocene) was established. Iodoosmocene(C5H4I)Os(C5H5) (OcI), which is the first monohalogenated product of osmocene, was prepared by the reaction of lithioosmocene with I-2. Ullmann coupling reaction of iodoosmoene allowed to prepare biosmocene(C5H5)Os(mu(2)-eta(5):eta(5)-C10H8)Os(C5H5) (OcOc). OcOc reacted with I-2, giving mixed-valence biosmocenium salt [(C5H5)Os-II(mu(2)-eta(5):eta(5)-C10H8) (C5H5)(OsI)-I-IV]I-3(A). The structure of A was determined by single crystal X-ray structural analysis. The intramolecular electron transfer reaction between Os-II and Os (IV) was observed by using H-1 NMR spectroscopy, accompanied by the exchange of I- anion between the two units. The activation energy of the electron transfer reaction was estimated and the value was larger than that of binuclear ruthenocenium salt [(C5H5)Ru-II(mu(2)-eta(5):eta(5)-C10H8) (C5H5)(RuI)-I-IV]I-3(B). (C) 2015 Elsevier B.V. All rights reserved.	[Yasuhara, Hiroki; Koga, Kazuki; Nakashima, Satoru] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan	Nakashima, S (reprint author), Hiroshima Univ, Nat Sci Ctr Basic Res & Dev N BARD, Higashihiroshima 7398526, Japan.	snaka@hiroshima-u.ac.jp					Sanders R, 1996, J ORGANOMET CHEM, V512, P219, DOI 10.1016/0022-328X(95)05914-B; DONG TY, 1985, J AM CHEM SOC, V107, P7996, DOI 10.1021/ja00312a034; Oda T, 2003, INORG CHEM, V42, P5376, DOI 10.1021/ic0343455; Inkpen MS, 2013, DALTON T, V42, P2813, DOI 10.1039/c2dt32779a; BOEYENS JCA, 1986, J CRYST SPECTROSC, V16, P519; GOLDBERG SI, 1963, J ORG CHEM, V28, P1708, DOI 10.1021/jo01041a509; KAMBARA T, 1987, J CHEM PHYS, V86, P2362, DOI 10.1063/1.452084; KUR SA, 1995, INORG CHEM, V34, P414, DOI 10.1021/ic00105a067; Mochida T, 2005, INORG CHEM, V44, P8628, DOI 10.1021/ic048285u; NAKASHIMA S, 1989, B CHEM SOC JPN, V62, P3012, DOI 10.1246/bcsj.62.3012; Nakashima S., 1995, DALTON T, P513; NEUSE EW, 1981, TRANSIT METAL CHEM, V6, P260, DOI 10.1007/BF00620742; Sheldrick G M, 1997, SHELXS 97 PROGRAM SO; SMITH TP, 1987, INORG CHEM, V26, P2882, DOI 10.1021/ic00264a033; Watanabe M, 1996, J ORGANOMET CHEM, V523, P153, DOI 10.1016/0022-328X(96)06408-X; WATANABE M, 1992, INORG CHEM, V31, P177, DOI 10.1021/ic00028a010; WATANABE M, 1993, J ORGANOMET CHEM, V455, P197, DOI 10.1016/0022-328X(93)80399-V; Watanabe M, 1999, B CHEM SOC JPN, V72, P715, DOI 10.1246/bcsj.72.715; WATANABE M, 1990, CHEM LETT, P1667, DOI 10.1246/cl.1990.1667	19	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	MAR 1	2015	779						86	90		10.1016/j.jorganchem.2014.12.030		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CA8LO	WOS:000349172100012		
J	Nishikawa, S; Kami, S; Ashikin, N; Haswan, B; Uno, T; Itoh, T; Kubo, M				Nishikawa, Shinji; Kami, Sayaka; Ashikin, Nurul; Haswan, Badrul; Uno, Takahiro; Itoh, Takahito; Kubo, Masataka			Hybridization of Emitting Polyfluorene with Silicone	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						composites; conjugated polymers; networks; silicones	POLYMERS; FLUORENE	Polyfluorenes with pendant allyl groups were prepared by terpolymerization of 9,9-dihexylfluorene-2,7-bis(trimethyleneborate), 2,7-dibromo-9,9-bis(2-allyloxyethyl)fluorene, and 4,7-dibromo-2,1,3-benzothiazole, or 4,7-dibromo-2,1,3-naphthoselenadiazole using Suzuki coupling reaction. The subsequent hydrosilylation reaction of these precursor polymers with ethoxydimethylsilane quantitatively converted the allyl groups to ethoxysilyl groups. Hybridization of the emitting polyfluorenes with silicone was successfully achieved by the solvent-free sol-gel reaction of tetraethoxysilane and silanol-terminated polydimethylsiloxane in the presence of the ethoxysilyl-functionalized polyfluorenes. Fluorescence spectra of these luminescent silicones revealed that emitting polyfluorenes were dispersed homogeneously in the matrix of silicone without aggregation. (c) 2014 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2015, 53, 622-628	[Nishikawa, Shinji; Kami, Sayaka; Uno, Takahiro; Itoh, Takahito] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie 5148507, Japan; [Ashikin, Nurul; Haswan, Badrul] TATI Univ Coll, Fac Chem Engn Technol, Kemaman 24000, Terengganu, Malaysia; [Kubo, Masataka] Mie Univ, Grad Sch Reg Innovat Studies, Div Adv Integrat Engn, Tsu, Mie 5148507, Japan	Kubo, M (reprint author), Mie Univ, Grad Sch Reg Innovat Studies, Div Adv Integrat Engn, Tsu, Mie 5148507, Japan.	kubo@chem.mie-u.ac.jp					Lim E, 2003, MACROMOLECULES, V36, P4288, DOI 10.1021/ma034168r; Alexandru M, 2010, J SOL-GEL SCI TECHN, V56, P310, DOI 10.1007/s10971-010-2307-5; Quites FJ, 2013, EUR POLYM J, V49, P693, DOI 10.1016/j.eurpolymj.2012.12.014; Yang J, 2004, MACROMOLECULES, V37, P1211, DOI 10.1021/ma035743u; Fichou D., 1999, HDB OLIGO POLYTHIOPH; Kubo M., 2005, MACROMOLECULES, V38; Mark J. E., 1982, ELASTOMERS RUBBER EL; MARK JE, 1982, ADV POLYM SCI, V44, P1; Miyao A, 2010, J POLYM SCI POL CHEM, V48, P5322, DOI 10.1002/pola.24332; Pilatt A., 1980, ORGANOMETALLICS, V1, P1089; Silbey R., 1991, CONJUGATED POLYM; Skotheim T. A., 2007, CONJUGATED POLYM PRO; Skotheim T. A., 2006, CONJUGATED POLYM THE; Sugiura Y, 2006, POLYM BULL, V57, P865, DOI 10.1007/s00289-006-0659-3	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	MAR 1	2015	53	5					622	628		10.1002/pola.27493		7	Polymer Science	Polymer Science	CA7AL	WOS:000349069300002		
J	Tanaka, R; Kamei, I; Cai, ZG; Nakayama, Y; Shiono, T				Tanaka, Ryo; Kamei, Issei; Cai, Zhengguo; Nakayama, Yuushou; Shiono, Takeshi			Ethylene-Propylene Copolymerization Behavior of ansa-Dimethylsilylene(fluorenyl)(amido)dimethyltitanium Complex: Application to Ethylene-Propylene-Diene or Ethylene-Propylene-Norbornene Terpolymers	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						polyolefins; cycloolefin copolymer; ethylene-propylene rubber; random copolymerization; NMR characterization	OLEFIN POLYMERIZATION; REACTIVITY RATIOS; CATALYST SYSTEM; PROPENE; METHYLALUMOXANE; MICROSTRUCTURE; METALLOCENES; ELASTOMERS; MECHANISM; COMONOMER	Copolymerization behavior of ethylene (E) and propylene (P) using ansa-dimethylsilylene(fluorenyl)(amido)dimethyltitanium complex was investigated. P was more reactive than E regardless of the chain-end monomer unit, which was very unusual in the coordination polymerization system. The terpolymerizations of E, P and norbornene (NB) or 5-ethylidene-2-norbornene (5E2N) were also performed. The each content in the E/P/NB terpolymer was independently controlled by the initial concentration of NB and E/P feed ratio. Glass transition temperature (T-g) of the terpolymer was raised in proportion to the NB content and close to that of the corresponding NB/E random copolymer with the same NB content. (c) 2014 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2015, 53, 685-691	[Tanaka, Ryo; Kamei, Issei; Cai, Zhengguo; Nakayama, Yuushou; Shiono, Takeshi] Hiroshima Univ, Dept Appl Chem, Grad Sch Engn, Hiroshima 7398527, Japan	Shiono, T (reprint author), Hiroshima Univ, Dept Appl Chem, Grad Sch Engn, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.	tshiono@hiroshima-u.ac.jp	Tanaka, Ryo/K-8254-2014; SHIONO, Takeshi/D-7024-2011	Tanaka, Ryo/0000-0002-6085-074X; SHIONO, Takeshi/0000-0002-1118-9991			Tian J, 2001, J AM CHEM SOC, V123, P5134, DOI 10.1021/ja0157189; ZAMBELLI A, 1991, MAKROMOL CHEM-RAPID, V12, P523; Busico V, 2003, J AM CHEM SOC, V125, P12402, DOI 10.1021/ja0372412; Shiono T, 2008, MACROMOLECULES, V41, P8292, DOI 10.1021/ma802119d; McKnight AL, 1997, ORGANOMETALLICS, V16, P2879, DOI 10.1021/om9609628; Lee JW, 2013, J POLYM SCI POL CHEM, V51, P5085, DOI 10.1002/pola.26940; Edson JB, 2008, J AM CHEM SOC, V130, P4968, DOI 10.1021/ja077772g; KAKUGO M, 1982, MACROMOLECULES, V15, P1150, DOI 10.1021/ma00232a037; Shiono T, 2013, MACROMOL CHEM PHYS, V214, P2239, DOI 10.1002/macp.201300347; Boggioni L, 2010, MACROMOLECULES, V43, P4543, DOI 10.1021/ma100268h; COZEWITH C, 1971, MACROMOLECULES, V4, P482, DOI 10.1021/ma60022a025; Fan W, 2001, J AM CHEM SOC, V123, P9555, DOI 10.1021/ja0100773; Galimberti M, 1999, MACROMOL RAPID COMM, V20, P214; Hagihara H, 1997, MACROMOLECULES, V30, P4783, DOI 10.1021/ma970352z; Hasan T, 2004, MACROMOLECULES, V37, P8503, DOI 10.1021/ma048492d; Hasan T, 2005, MACROMOLECULES, V38, P1071, DOI 10.1021/ma048117l; Heuer B, 2005, MACROMOLECULES, V38, P3054, DOI 10.1021/ma048009z; Irwin LJ, 2004, J AM CHEM SOC, V126, P16716, DOI 10.1021/ja044678g; Jin JH, 1998, MACROMOL RAPID COMM, V19, P337, DOI 10.1002/marc.1998.030190702; KAMINSKY W, 1985, J POLYM SCI POL CHEM, V23, P2151, DOI 10.1002/pol.1985.170230807; Matsugi T, 2002, MACROMOLECULES, V35, P4880, DOI 10.1021/ma0122268; Muller G, 2002, PROG POLYM SCI, V27, P815, DOI 10.1016/S0079-6700(01)00030-2; NATTA G, 1961, J POLYM SCI, V51, P411, DOI 10.1002/pol.1961.1205115603; Nishii K, 2006, J ORGANOMET CHEM, V691, P193, DOI 10.1016/j.jorganchem.2005.08.027; Seraidaris T, 2005, MACROMOL CHEM PHYSIC, V206, P1319, DOI 10.1002/macp.200400542; Threadingham D., 2009, ULLMANNS ENCY IND CH; VANDERVELDEN G, 1983, MACROMOLECULES, V16, P85, DOI 10.1021/ma00235a017; Voegele J, 2002, MACROMOL CHEM PHYSIC, V203, P1918, DOI 10.1002/1521-3935(200209)203:13<1918::AID-MACP1918>3.0.CO;2-4	28	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	MAR 1	2015	53	5					685	691		10.1002/pola.27494		7	Polymer Science	Polymer Science	CA7AL	WOS:000349069300009		
J	Tsuchiya, K; Goto, E; Ishida, Y; Higashihara, T; Kameyama, A; Ueda, M				Tsuchiya, Kousuke; Goto, Eisuke; Ishida, Yoshihito; Higashihara, Tomoya; Kameyama, Atsushi; Ueda, Mitsuru			Synthesis of Polyisocyanurates by Thermal Rearrangement of Polycyanurates	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						polycondensation; polycyanurates; polyisocyanurates; thermal properties; thermal rearrangement; transparency	POLY(ARYL ETHER KETONE)S; COATINGS	Polyisocyanurates have been successfully prepared by the thermal rearrangement of polycyanurates, which were obtained from 2,4-dichloro-6-methoxy-1,3,5-triazine and bisphenol monomers. The thermal rearrangement was carried out in the presence of a small amount of tetrabutylammonium bromide (TBAB) as a catalyst at 200 degrees C for 30 or 60 min in an argon atmosphere, and the degree of arrangement was greater than 95%. Transparent and amorphous polyisocyanurate films were obtained and showed a good thermal stability with a 5% weight loss temperature above 340 degrees C in nitrogen and the glass transition temperature above 210 degrees C. Films with a 10-mu m thickness exhibited an excellent transparency above 90% at 400 nm. Furthermore, the thermal rearrangement of 2,6-bis(4-methoxyphenyl)-6-methoxy-1,3,5-triazine to 1,3-bis(4-methoxyphenyl)-5-methyl-1,3,5-triazinane-2,4,6-trione was investigated in detail. It was found that the complete thermal rearrangement was successfully accomplished in the presence of 2 wt % TBAB at 150 degrees C for 20 min in an argon atmosphere. (c) 2014 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2015, 53, 692-698	[Tsuchiya, Kousuke; Ishida, Yoshihito; Kameyama, Atsushi; Ueda, Mitsuru] Kanagawa Univ, Dept Chem, Kanagawa Ku, Yokohama, Kanagawa 2218686, Japan; [Goto, Eisuke; Higashihara, Tomoya] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Ueda, M (reprint author), Kanagawa Univ, Dept Chem, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa 2218686, Japan.	ueda.m.ad@m.titech.ac.jp		Tsuchiya, Kousuke/0000-0003-2364-8275			FANG T, 1995, PROG POLYM SCI, V20, P61, DOI 10.1016/0079-6700(94)E0006-M; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Dabai S., 1981, EUR POLYM J, V17, P35; Dabai S., 1980, EUR POLYM J, V16, P831; Ghosh M. K., 1996, POLYIMIDES FUNDAMENT; Hamerton I, 2013, REACT FUNCT POLYM, V73, P1046, DOI 10.1016/j.reactfunctpolym.2013.04.012; Liu BJ, 2008, J MATER CHEM, V18, P4675, DOI 10.1039/b806690f; Ma XY, 2007, J PHOTOCH PHOTOBIO A, V188, P43, DOI 10.1016/j.jphotochem.2006.11.016; March J., 1992, ADV ORG CHEM, P1051; NAKAMURA Y, 1969, J POLYM SCI A1, V7, P3089, DOI 10.1002/pol.1969.150071105; OLTCHIK N, 1988, EUR POLYM J, V24, P479, DOI 10.1016/0014-3057(88)90089-4; Piron F, 2010, SYNTHESIS-STUTTGART, P1639, DOI 10.1055/s-0029-1218724; Rao X, 2007, J POLYM SCI POL CHEM, V45, P4844, DOI 10.1002/pola.22223; Saito Y, 2013, J POLYM SCI POL CHEM, V51, P3950, DOI 10.1002/pola.26803; SATTERTH.AC, 1974, J AM CHEM SOC, V96, P7031, DOI 10.1021/ja00829a035; Schulenberg J. W., 1965, ORG REACTIONS, V14, P1; Yu H, 2010, POLYMER, V51, P3269, DOI 10.1016/j.polymer.2010.04.054	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	MAR 1	2015	53	5					692	698		10.1002/pola.27492		7	Polymer Science	Polymer Science	CA7AL	WOS:000349069300010		
J	Mori, H; Suetsugu, M; Nishinaga, S; Chang, N; Nonobe, H; Okuda, Y; Nishihara, Y				Mori, Hiroki; Suetsugu, Masato; Nishinaga, Shuhei; Chang, Ning-hui; Nonobe, Hikaru; Okuda, Yasuhiro; Nishihara, Yasushi			Synthesis, Characterization, and Solar Cell and Transistor Applications of Phenanthro[1,2-b:8,7-b ']dithiophene-Diketopyrrolopyrrole Semiconducting Polymers	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						diketopyrrolopyrrole; molecular ordering; organic field-effect transistors; organic photovoltaics; phenanthrodithiophene; semiconducting polymers	FIELD-EFFECT TRANSISTORS; LOW-BANDGAP POLYMERS; POWER CONVERSION EFFICIENCY; 25TH ANNIVERSARY ARTICLE; THIN-FILM TRANSISTORS; HIGH HOLE MOBILITY; CONJUGATED POLYMERS; SIDE-CHAINS; DIKETOPYRROLOPYRROLE POLYMER; PROCESSING ADDITIVES	Synthesis, characterization, and polymer solar cell and transistor application of a series of phenanthro[1,2-b:8,7-b]dithiophene-based donor-acceptor (D-A)-type semiconducting polymers combined with a diketopyrrolopyrrole unit are reported. The present polymers showed some unique features such as strong aggregation behavior, high thermal stability, and short - stacking distance (3.5-3.6 angstrom), which are suitable for high performance organic materials. In addition, they have a significantly extended absorption up to 1000 nm with a band gap of ca. 1.2 eV. However, such strong intermolecular interaction reduced their solubility and molecular weights, which resulted in low crystalline nature and moderate field-effect mobility of 0.01 cm(2) V-1 s(-1). Furthermore, such strong aggregation behavior led to the large-scale phase separation in the blend films, which may prevent the effective photocurrent generation, limiting J(sc) and power conversion efficiency of 2.0%. (c) 2015 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2015, 53, 709-718	[Mori, Hiroki; Suetsugu, Masato; Nishinaga, Shuhei; Chang, Ning-hui; Nonobe, Hikaru; Okuda, Yasuhiro; Nishihara, Yasushi] Okayama Univ, Div Earth Life & Mol Sci, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Nishihara, Yasushi] Japan Sci & Technol Agcy, ACT C, Kawaguchi, Saitama 3320012, Japan	Nishihara, Y (reprint author), Okayama Univ, Div Earth Life & Mol Sci, Grad Sch Nat Sci & Technol, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	ynishiha@okayama-u.ac.jp	Nishihara, Yasushi/B-4611-2008; Mori, Hiroki/F-4872-2015	Nishihara, Yasushi/0000-0001-5409-4207; 	MEXT; Okayama Foundation for Science and Technology	This study was partly supported by MEXT Program for promoting the enhancement of research universities and Okayama Foundation for Science and Technology. The 2D-GIXD experiments were performed at BL46XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal 2014A1530). We gratefully thank Dr. Itaru Osaka (RIKEN, CEMS) and Dr. Tomoyuki Koganezawa (JASRI) for the measurements of 2D-GIXD images, Prof. Takeshi Shiono and Dr. Ryo Tanaka (Hiroshima University) for the GPC measurements, Dr. Koichi Sakamaki (ADEKA Corporation) for the TG and DSC analysis, Prof. Koichi Mitsudo and Prof. Seiji Suga (Okayama University) for the CV measurements, Prof. Yoshihiro Kubozono and Ms. Shino Hamao (Okayama University) for the EQE and OFET measurements, Prof. Naoshi Ikeda (Okayama University) for the AFM images, Ms. Megumi Kosaka and Mr. Motonari Kobayashi at the Department of Instrumental Analysis, Advanced Science Research Center, Okayama University, for the measurements of elemental analyses, and the SC-NMR Laboratory of Okayama University for the NMR spectral measurements.	Osaka I, 2011, J AM CHEM SOC, V133, P6852, DOI 10.1021/ja201591a; Wu JS, 2012, CHEM MATER, V24, P2391, DOI 10.1021/cm301176s; Dou LT, 2012, J AM CHEM SOC, V134, P10071, DOI 10.1021/ja301460s; Wu Y, 2013, ADV MATER, V25, P3449, DOI 10.1002/adma.201301174; Chen CC, 2014, ADV MATER, V26, P5670, DOI 10.1002/adma.201402072; Guo XG, 2013, NAT PHOTONICS, V7, P825, DOI 10.1038/NPHOTON.2013.207; Deng YF, 2014, ADV MATER, V26, P471, DOI 10.1002/adma.201303586; Tseng HR, 2014, ADV MATER, V26, P2993, DOI 10.1002/adma.201305084; Chang NH, 2013, ORG LETT, V15, P3558, DOI 10.1021/ol401375n; Osaka I, 2012, J AM CHEM SOC, V134, P3498, DOI 10.1021/ja210687r; Osaka I, 2014, J MATER CHEM C, V2, P2307, DOI 10.1039/c3tc32386b; Lee JK, 2008, J AM CHEM SOC, V130, P3619, DOI 10.1021/ja710079w; Mei JG, 2013, J AM CHEM SOC, V135, P6724, DOI 10.1021/ja400881n; Dou LT, 2013, ADV MATER, V25, P6642, DOI 10.1002/adma.201302563; Yang LQ, 2013, ENERG ENVIRON SCI, V6, P316, DOI 10.1039/c2ee23235a; Lei T, 2012, ADV MATER, V24, P6457, DOI 10.1002/adma.201202689; Huang J, 2014, J POLYM SCI POL CHEM, V52, P1652, DOI 10.1002/pola.27163; Holliday S, 2014, CHEM MATER, V26, P647, DOI 10.1021/cm402421p; Zhong HL, 2013, J AM CHEM SOC, V135, P2040, DOI 10.1021/ja311700u; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Matthews JR, 2013, CHEM MATER, V25, P782, DOI 10.1021/cm303953e; Li WW, 2013, J AM CHEM SOC, V135, P18942, DOI 10.1021/ja4101003; Tsao HN, 2011, J AM CHEM SOC, V133, P2605, DOI 10.1021/ja108861q; Small CE, 2012, NAT PHOTONICS, V6, P115, DOI [10.1038/nphoton.2011.317, 10.1038/NPHOTON.2011.317]; Meager I, 2013, J AM CHEM SOC, V135, P11537, DOI [10.1021/ja406934j, 10.1021/ja405934j]; Kouijzer S, 2013, J AM CHEM SOC, V135, P12057, DOI 10.1021/ja405493j; Cabanetos C, 2013, J AM CHEM SOC, V135, P4656, DOI 10.1021/ja400365b; Chen ZH, 2014, ADV MATER, V26, P2586, DOI 10.1002/adma.201305092; Li WW, 2012, J AM CHEM SOC, V134, P13787, DOI 10.1021/ja305358z; Li WT, 2014, ADV MATER, V26, P4456, DOI 10.1002/adma.201305251; Facchetti A, 2011, CHEM MATER, V23, P733, DOI 10.1021/cm102419z; Biniek L, 2013, MACROMOLECULES, V46, P727, DOI 10.1021/ma302390z; Mori H, 2014, J ORG CHEM, V79, P4973, DOI 10.1021/jo500543h; Boudreault PLT, 2011, CHEM MATER, V23, P456, DOI 10.1021/cm1021855; Beaujuge PM, 2011, J AM CHEM SOC, V133, P20009, DOI 10.1021/ja2073643; Dong HL, 2013, ADV MATER, V25, P6158, DOI 10.1002/adma.201302514; Kim G, 2014, J AM CHEM SOC, V136, P9477, DOI 10.1021/ja504537v; Chang NH, 2013, CHEM LETT, V42, P1257, DOI 10.1246/cl.130584; Hyodo K, 2014, TETRAHEDRON LETT, V55, P4002, DOI 10.1016/j.tetlet.2014.05.035; Huo LJ, 2009, MACROMOLECULES, V42, P6564, DOI 10.1021/ma9012972; Cho S, 2011, ADV FUNCT MATER, V21, P1910, DOI 10.1002/adfm.201002651; Zhou HX, 2012, MACROMOLECULES, V45, P607, DOI 10.1021/ma201648t; Kang I, 2013, J AM CHEM SOC, V135, P14896, DOI 10.1021/ja405112s; Osaka I, 2013, J AM CHEM SOC, V135, P8834, DOI 10.1021/ja404064m; Okamoto H, 2008, J AM CHEM SOC, V130, P10470, DOI 10.1021/ja803291a; Ye L, 2014, ACCOUNTS CHEM RES, V47, P1595, DOI 10.1021/ar5000743; Osaka I, 2010, J AM CHEM SOC, V132, P5000, DOI 10.1021/ja101125p; Cheng YJ, 2009, CHEM REV, V109, P5868, DOI 10.1021/cr900182s; Osaka I, 2012, ADV MATER, V24, P425, DOI 10.1002/adma.201103065; Bijleveld JC, 2010, ADV MATER, V22, pE242, DOI 10.1002/adma.201001449; Chen HJ, 2013, J POLYM SCI POL CHEM, V51, P2208, DOI 10.1002/pola.26602; Komura N., 2012, APPL PHYS LETT, V101; Li J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00754; Nishihara Y, 2013, RSC ADV, V3, P19341, DOI 10.1039/c3ra44050h; Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411; Zhang XR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3238	57	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	MAR 1	2015	53	5					709	718		10.1002/pola.27500		10	Polymer Science	Polymer Science	CA7AL	WOS:000349069300012		
J	Oishi, J; Otomo, J; Oshima, Y; Koyama, M				Oishi, Junya; Otomo, Junichiro; Oshima, Yoshito; Koyama, Michihisa			The effects of minor elements in La0.6Sr0.4Co0.2Fe0.8O3-delta cathodes on oxygen reduction reaction	JOURNAL OF POWER SOURCES			English	Article						Solid oxide fuel cell; Minor elements; Cathode; Conductivity relaxation method; Surface exchange coefficient; X-ray photoelectron spectroscopy	OXIDE FUEL-CELLS; CONDUCTIVITY RELAXATION; SR SEGREGATION; PEROVSKITES; IMPURITIES; SOFCS; MICROSTRUCTURE; DEGRADATION; INTERFACE; STABILITY	It is known that the minor elements affect the performance of solid oxide fuel cell (SOFC). In this study, we focus on the influence of minor elements on the SOFC cathode properties. The Ca, Ba, Al, and Si, which originate from raw materials and production processes for SOFC cathodes, are investigated as minor elements that may have effect on the properties of La(0.6)Sr(0.4)Co(0.2)Fe(0.8)o(3-delta)(LSCF) cathode. To examine the effects of minor elements on the cathode properties, Ca, Ba, Al, and Si with a controlled concentration are added to the LSCF reference sample. Conductivity relaxation measurements are conducted to determine the chemical diffusion coefficient (D-chem) and surface exchange coefficient (k(tr)), which governs the overpotential characteristics of the LSCF cathode. The results show that Al and Si have negative effects on both D-chem and k(tr) while Ca and Ba do not alter D-chem and show weakly positive effects on k(tr). The effects of Ca and Ba for the cathode properties are discussed on the basis of XPS measurements. (C) 2014 Elsevier B.V. All rights reserved.	[Oishi, Junya; Otomo, Junichiro; Oshima, Yoshito] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, Kashiwa, Chiba 2778563, Japan; [Koyama, Michihisa] Kyushu Univ, Inamori Frontier Res Ctr, Nishi Ku, Fukuoka 8190395, Japan; [Koyama, Michihisa] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Koyama, Michihisa] Int Inst Carbon Neutral Energy Res, Nishi Ku, Fukuoka 8190395, Japan	Otomo, J (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778563, Japan.	otomo@k.u-tokyo.ac.jp			"Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), japan [12024046]; KYOCERA Corporation	Material characterization such as ICP-AES, XRD and SEM was performed at the Institute for Solid State Physics, the University of Tokyo. XPS analysis was supported by the "Nanotechnology Platform" (project No. 12024046) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), japan. Activities of Inamori Frontier Research Center, Kyushu University are supported by KYOCERA Corporation.	Dupin JC, 2000, PHYS CHEM CHEM PHYS, V2, P1319, DOI 10.1039/a908800h; Chen Y, 2012, ENERG ENVIRON SCI, V5, P7979, DOI 10.1039/c2ee21463f; Cai ZH, 2012, CHEM MATER, V24, P1116, DOI 10.1021/cm203501u; CIACCHI FT, 1994, SOLID STATE IONICS, V73, P49, DOI 10.1016/0167-2738(94)90263-1; Jung W, 2012, ENERG ENVIRON SCI, V5, P5370, DOI 10.1039/c1ee02762j; Payne R, 2009, ECS TRANSACTIONS, V25, P231, DOI 10.1149/1.3205530; Lane JA, 2000, SOLID STATE IONICS, V136, P997, DOI 10.1016/S0167-2738(00)00554-3; van der Heide PAW, 2002, SURF INTERFACE ANAL, V33, P414, DOI 10.1002/sia.1227; Rasmussen JFB, 2009, J POWER SOURCES, V191, P534, DOI 10.1016/j.jpowsour.2009.02.001; Sasaki K, 2011, J POWER SOURCES, V196, P9130, DOI 10.1016/j.jpowsour.2010.09.122; Galenda A, 2007, CHEM MATER, V19, P2796, DOI 10.1021/cm062742i; den Otter MW, 2000, SOLID STATE IONICS, V134, P259, DOI 10.1016/S0167-2738(00)00684-6; Hertz JL, 2009, J ELECTROCERAM, V22, P428, DOI 10.1007/s10832-008-9475-5; Horita T, 2009, J POWER SOURCES, V193, P194, DOI 10.1016/j.jpowsour.2008.10.127; TABATA K, 1987, J MATER SCI, V22, P1882, DOI 10.1007/BF01132422; Hagen A, 2008, J ELECTROCHEM SOC, V155, pB1047, DOI 10.1149/1.2960938; Wang FF, 2011, J ELECTROCHEM SOC, V158, pB1391, DOI 10.1149/2.059111jes; Bouwmeester HJM, 2004, J SOLID STATE ELECTR, V8, P599, DOI 10.1007/s10008-003-0488-3; Jensen KV, 2003, SOLID STATE IONICS, V160, P27, DOI 10.1016/S0167-2738(03)00147-4; Badwal SPS, 1998, SOLID STATE IONICS, V109, P167, DOI 10.1016/S0167-2738(98)00079-4; Barfod R, 2006, FUEL CELLS, V6, P141, DOI 10.1002/fuce.200500113; Cayan FN, 2008, J POWER SOURCES, V185, P595, DOI 10.1016/j.jpowsour.2008.06.058; den Otter M.W., 2001, J ELECTROCHEM SOC, V148, P11; Gedziorowski B, 2012, SOLID STATE IONICS, V225, P437, DOI 10.1016/j.ssi.2012.05.025; Horiuchi K., 2013, ECS T, V57, P3; Kozhukharov V, 1996, J MATER SCI LETT, V15, P1727, DOI 10.1007/BF00636208; Kuwabara A, 2004, J PHYS CHEM B, V108, P9168, DOI 10.1021/jp049808m; Liu YL, 2005, SOLID STATE IONICS, V176, P435, DOI 10.1016/j.ssi.2004.08.018; Merkle R, 2012, J ELECTROCHEM SOC, V159, pB219, DOI 10.1149/2.077202jes; Otomo J, 2013, INT J HYDROGEN ENERG, V38, P14337, DOI 10.1016/j.ijhydene.2013.08.110; Park E, 2014, INT J HYDROGEN ENERG, V39, P1463, DOI 10.1016/j.ijhydene.2013.11.030; Preis W, 2004, SOLID STATE IONICS, V175, P393, DOI 10.1016/j.ssi.2003.12.045; Wang B, 2009, J MEMBRANE SCI, V344, P101, DOI 10.1016/j.memsci.2009.07.040; Wang L, 2010, J ELECTROCHEM SOC, V157, pB1802, DOI 10.1149/1.3494224	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	MAR 1	2015	277						44	51		10.1016/j.jpowsour.2014.12.001		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CA5OF	WOS:000348957000006		
J	Young, K; Wong, DF; Wang, L; Nei, J; Ouchi, T; Yasuoka, S				Young, K.; Wong, D. F.; Wang, L.; Nei, J.; Ouchi, T.; Yasuoka, S.			Mn in misch-metal based superlattice metal hydride alloy - Part 1 structural, hydrogen storage and electrochemical properties	JOURNAL OF POWER SOURCES			English	Article						Hydrogen absorbing materials; Transition metal alloys; Metal hydride electrode; Electrochemical reactions	NIMH BATTERY APPLICATION; MULTICOMPONENT ALLOYS; A(2)B(7) ALLOYS; DEGREES-C; ELECTRODES; AB(2); AB(5)	The structural, gaseous phase hydrogen storage, and electrochemical properties of a series of Mn-modified misch-metal based superlattice metal hydride alloys were investigated in part one of this two-part series of papers. X-ray diffraction analysis showed that these alloys are all multi-phased compositions with different abundances of AB(2), AB(3), A(2)B(7), AB(4), and AB(5) phases. Substitution of Ni in the B-site by Mn promotes AB5 phase formation and decreases both gaseous phase and electrochemical capacities due to the reduction in the abundance of main hexagonal A(2)B(7) phase. AC impedance and magnetic susceptibility measurement were employed to characterize the surface of Mn-free and Mn-modified alloys and show deterioration in surface catalytic ability as the Mn-content increases. Mn-modification adversely affected misch-metal based superlattice metal hydride alloy properties such as phase homogeneity, capacity, cycle stability, high-rate performance, and surface reaction. (C) 2014 Elsevier B.V. All rights reserved.	[Young, K.; Wong, D. F.; Wang, L.; Nei, J.; Ouchi, T.] BASF Battery Mat Ovon, Rochester Hills, MI 48309 USA; [Wong, D. F.; Wang, L.] Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA; [Yasuoka, S.] FDK Twicell Co Ltd, Takasaki, Gunma 3700071, Japan	Young, K (reprint author), BASF Battery Mat Ovon, 2983 Waterview Dr, Rochester Hills, MI 48309 USA.	Icwo.young@basf.com		Wong, Diana/0000-0001-7231-9107			Young KH, 2013, MATERIALS, V6, P4574, DOI 10.3390/ma6104574; Young K, 2013, J ALLOY COMPD, V575, P65, DOI 10.1016/j.jallcom.2013.04.005; Denys RV, 2011, J ALLOY COMPD, V509, pS540, DOI 10.1016/j.jallcom.2010.11.205; Young K, 2008, J ALLOY COMPD, V464, P238, DOI 10.1016/j.jallcom.2007.09.096; Young K, 2010, J ALLOY COMPD, V506, P831, DOI 10.1016/j.jallcom.2010.07.086; SAKAI T, 1990, J LESS-COMMON MET, V161, P193, DOI 10.1016/0022-5088(90)90027-H; Kleperis J, 2001, J SOLID STATE ELECTR, V5, P229, DOI 10.1007/s100080000149; Young K, 2011, J ALLOY COMPD, V509, P7611, DOI 10.1016/j.jallcom.2011.04.102; Li F, 2009, J ALLOY COMPD, V471, P371, DOI 10.1016/j.jallcom.2008.03.084; Hu WK, 2013, ELECTROCHIM ACTA, V96, P27, DOI 10.1016/j.electacta.2013.02.064; Young K, 2010, J ALLOY COMPD, V490, P282, DOI 10.1016/j.jallcom.2009.09.180; Young K, 2013, J ALLOY COMPD, V580, pS349, DOI 10.1016/j.jallcom.2013.01.125; Pan HG, 1999, J ALLOY COMPD, V293, P648, DOI 10.1016/S0925-8388(99)00359-X; Young K, 2011, INT J HYDROGEN ENERG, V36, P12296, DOI 10.1016/j.ijhydene.2011.06.117; Kadir K, 1997, J ALLOY COMPD, V257, P115, DOI 10.1016/S0925-8388(96)03132-5; Yasuoka S, 2006, J POWER SOURCES, V156, P662, DOI 10.1016/j.jpowsour.2005.05.054; Cuevas F, 2001, APPL PHYS A-MATER, V72, P225, DOI 10.1007/s003390100775; Young K, 2011, J POWER SOURCES, V196, P8815, DOI 10.1016/j.jpowsour.2011.06.010; Bobet JL, 1998, J ALLOY COMPD, V267, P136, DOI 10.1016/S0925-8388(97)00565-3; Chang JK, 2002, J POWER SOURCES, V103, P280, DOI 10.1016/S0378-7753(01)00866-7; Gakkai Nihon Kinzoku, 1975, NIHON KINZOKU GAKKAI, P296; Gao ZJ, 2010, J RARE EARTH, V28, P425, DOI 10.1016/S1002-0721(10)60280-3; Kai T., 2013, P 54 BATT S JAP, P210; Li R, 2007, J ALLOY COMPD, V432, P183, DOI 10.1016/j.jallcom.2006.05.102; Parthe E., 1975, ACTA CRYSTALLOGR B, V31, P879; STUCKI F, 1980, J LESS-COMMON MET, V74, P143, DOI 10.1016/0022-5088(80)90084-3; Teraoka H., DEV LOW SELF DISCHAR; Yasuoka S, 2006, RARE EARTHS, V48, P112; Young K, 2015, J POWER SOURCES, V277, P433, DOI 10.1016/j.jpowsour.2014.10.092; Young K, 2009, J ALLOY COMPD, V477, P749, DOI 10.1016/j.jallcom.2008.10.102; Yvon K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.066403; Zhang FL, 2006, J ALLOY COMPD, V424, P218, DOI 10.1016/j.jallcom.2005.10.095; Zheng Q, 2004, T NONFERR METAL SOC, V14, P1129; Zhou X, 2013, J ALLOY COMPD, V580, pS373, DOI 10.1016/j.jallcom.2013.03.014	34	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	MAR 1	2015	277						426	432		10.1016/j.jpowsour.2014.10.093		7	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CA5OF	WOS:000348957000050		
J	Young, K; Koch, J; Yasuoka, S; Shen, H; Bendersky, LA				Young, K.; Koch, J.; Yasuoka, S.; Shen, H.; Bendersky, L. A.			Mn in misch-metal based superlattice metal hydride alloy - Part 2 Ni/MH battery performance and failure mechanism	JOURNAL OF POWER SOURCES			English	Article						Hydrogen absorbing materials; Transition metal alloys; Metal hydride electrode; Nickel metal hydride battery	A(2)B(7) ALLOYS; ELECTROCHEMICAL PROPERTIES; STORAGE PROPERTIES; NICKEL-HYDROXIDE; SELF-DISCHARGE; SURFACE; AB(5); AB(2); AL	The performance and failure mode of Ni/MH batteries made from a series of Mn-modified A(2)B(7) super-lattice and a commercially available AB(5) metal hydride alloys were studied and reported. Cells with the Mn-free A(2)B(7) alloy generally show improved low-temperature, higher peak power, and similar charge-retention behavior over those with a conventional AB(5) alloy. As Mn-additive amount increased, cell voltage and high-rate capacity improved, low temperature, charge retention, and cycle life first improved, but then deteriorated, and peak power and high temperature voltage stand deteriorated. Analysis of battery performance test results show the use of a superlattice alloy containing 2.3% Mn as the best overall alloy composition. Failure analysis of the highly cycled AB(5) alloy containing cells indicate a balanced degradation in negative, positive, separator, and a moderate loss of electrolyte. Same analysis on cells containing the various superlattice alloys suffered from a high degree of pulverization and oxidation of its negative electrode (with the 9.3% Mn content experiencing the worst amount of pulverization/oxidation) and a high degree of electrolyte loss. (C) 2014 Elsevier B.V. All rights reserved.	[Young, K.; Koch, J.; Shen, H.] BASF Ovon, Rochester, MI 48309 USA; [Yasuoka, S.] FDK Twicell Co Ltd, Takasaki, Gunma 3700071, Japan; [Shen, H.; Bendersky, L. A.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA	Young, K (reprint author), BASF Ovon, 2983 Waterview Dr,Hills, Rochester, MI 48309 USA.	kwo.young@basf.com			ARPA-E under the robust affordable next generation EV-storage (RANGE) program [DE-AR0000386]	Part of this work (NIST portion) is financially supported by ARPA-E under the robust affordable next generation EV-storage (RANGE) program (DE-AR0000386).	Young KH, 2013, MATERIALS, V6, P4574, DOI 10.3390/ma6104574; Young K, 2014, J ALLOY COMPD, V606, P97, DOI 10.1016/j.jallcom.2014.04.033; Young K, 2010, J ALLOY COMPD, V506, P831, DOI 10.1016/j.jallcom.2010.07.086; Liu B, 2004, INT J HYDROGEN ENERG, V29, P453, DOI 10.1016/S0360-3199(03)00058-7; Young K, 2011, J ALLOY COMPD, V509, P7611, DOI 10.1016/j.jallcom.2011.04.102; Young K, 2012, J ALLOY COMPD, V543, P90, DOI 10.1016/j.jallcom.2012.07.125; Young K, 2012, INT J HYDROGEN ENERG, V37, P9882, DOI 10.1016/j.ijhydene.2012.03.117; Young K, 2011, INT J HYDROGEN ENERG, V36, P12296, DOI 10.1016/j.ijhydene.2011.06.117; Yasuoka S, 2006, J POWER SOURCES, V156, P662, DOI 10.1016/j.jpowsour.2005.05.054; Young K, 2011, INT J HYDROGEN ENERG, V36, P3547, DOI 10.1016/j.ijhydene.2010.12.051; Young K, 2011, J ALLOY COMPD, V509, P3995, DOI 10.1016/j.jallcom.2010.12.205; Young K, 2011, J POWER SOURCES, V196, P8815, DOI 10.1016/j.jpowsour.2011.06.010; Fetcenko M.A., 2004, U.S. Patent, Patent No. [6,830,725 B2, 6830725]; Fetcenko M.A., 2008, US Patent, Patent No. [7,393,500, 7393500]; Kong L, 2012, J POWER SOURCES, V213, P128, DOI 10.1016/j.jpowsour.2012.03.099; Liu B, 1999, J APPL ELECTROCHEM, V29, P855; SCHLAPBACH L, 1981, SURF SCI, V106, P157, DOI 10.1016/0039-6028(81)90194-1; SCHLAPBACH L, 1980, J LESS-COMMON MET, V73, P145, DOI 10.1016/0022-5088(80)90354-9; Shinyama K, 2005, J POWER SOURCES, V143, P265, DOI 10.1016/j.jpowsour.2004.11.051; Teraoka H., DEV LOW SELF DISCHAR; Yasuoka S, 2006, RARE EARTHS, V48, P112; Young K, 2012, J ALLOY COMPD, V510, P97, DOI 10.1016/j.jallcom.2011.08.091; Young K, 2013, J ALLOY COMPD, V560, P33, DOI 10.1016/j.jallcom.2013.01.146; Young K, 2015, J POWER SOURCES, V277, P426, DOI 10.1016/j.jpowsour.2014.10.093; Young M, 2013, J ALLOY COMPD, V580, pS171, DOI 10.1016/j.jallcom.2013.02.087; Zhou X, 2013, J ALLOY COMPD, V580, pS373, DOI 10.1016/j.jallcom.2013.03.014	26	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	MAR 1	2015	277						433	442		10.1016/j.jpowsour.2014.10.092		10	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CA5OF	WOS:000348957000051		
J	Ohtsuka, T; Tsai, YHR; Giga, Y				Ohtsuka, T.; Tsai, Y-H R.; Giga, Y.			A Level Set Approach Reflecting Sheet Structure with Single Auxiliary Function for Evolving Spirals on Crystal Surfaces	JOURNAL OF SCIENTIFIC COMPUTING			English	Article						Evolution of spirals; Level set method; Sheet structure function; Eikonal and curvature flow; Finite difference scheme	ROTATING SPIRALS; VISCOSITY SOLUTIONS; CURVATURE FLOWS; THIN-FILMS; GROWTH; MOTION; UNIQUENESS; EXISTENCE; EQUATIONS; MODEL	We introduce a new level set method to simulate motion of spirals in a crystal surface governed by an eikonal-curvature flow equation. Our formulation allows collision of several spirals and different strength (different modulus of Burgers vectors) of screw dislocation centers. We represent a set of spirals by a level set of a single auxiliary function u minus a pre-determined multi-valued sheet structure function theta, which reflects the strength of spirals (screw dislocation centers). The level set equation used in our method for u - theta is the same as that of the eikonal-curvature flow equation. The multi-valued nature of the sheet structure function is only invoked when preparing the initial auxiliary function, which is nontrivial, and in the final step when extracting information such as the height of the spiral steps. Our simulation enables us not only to reproduce all speculations on spirals in a classical paper by Burton et al. (Philos Trans R Soc Lond Ser A Math Phys Sci 243, 299-358, 1951) but also to find several new phenomena.	[Ohtsuka, T.] Gunma Univ, Div Pure & Appl Sci, Fac Sci & Technol, Maebashi, Gunma 3718510, Japan; [Tsai, Y-H R.] Univ Texas Austin, Dept Math, ICES, Austin, TX 78712 USA; [Tsai, Y-H R.] KTH Royal Inst Technol, Stockholm, Sweden; [Giga, Y.] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Ohtsuka, T (reprint author), Gunma Univ, Div Pure & Appl Sci, Fac Sci & Technol, 4-2 Aramaki Machi, Maebashi, Gunma 3718510, Japan.	tohtsuka@gunma-u.ac.jp; ytsai@ices.utexas.edu; labgiga@ms.u-tokyo.ac.jp		Tsai, Yen-Hsi Richard/0000-0001-8441-3678	Japan Society for the Promotion of Science (JSPS) [22740109, 26400158]; NSF [DMS-1217203, DMS-0914465, DMS-0914840]; Simons Foundation; JSPS [Kiban(S)26220702, Kiban(A)23244015, Houga 25610025]	The work of the first author is partly supported by the Japan Society for the Promotion of Science (JSPS) through Grant-in-Aid for Young Scientists (B)22740109 and for Scientific Research (C)26400158. The work of the second author is partly supported by NSF Grants DMS-1217203, DMS-0914465, DMS-0914840, and Simons Foundation. The work of the third author is partly supported by JSPS Grants Kiban(S)26220702, Kiban(A)23244015 and Houga 25610025.	Shtukenberg AG, 2013, P NATL ACAD SCI USA, V110, P17195, DOI 10.1073/pnas.1311637110; Zhao HK, 1996, J COMPUT PHYS, V127, P179, DOI 10.1006/jcph.1996.0167; Xiang Y, 2003, ACTA MATER, V51, P5499, DOI 10.1016/S1359-6454(03)00415-4; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Xiang Y, 2004, ACTA MATER, V52, P1745, DOI 10.1016/j.actamat.2003.12.016; Karma A, 1998, PHYS REV LETT, V81, P4444, DOI 10.1103/PhysRevLett.81.4444; Osher S, 2001, J COMPUT PHYS, V169, P463, DOI 10.1006/jcph.2000.6636; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Caflisch RE, 2008, J SCI COMPUT, V37, P3, DOI 10.1007/s10915-008-9206-8; CHEN YG, 1991, J DIFFER GEOM, V33, P749; Cheng LT, 2008, J COMPUT PHYS, V227, P4002, DOI 10.1016/j.jcp.2007.12.018; CRANDALL MG, 1992, B AM MATH SOC, V27, P1, DOI 10.1090/S0273-0979-1992-00266-5; Evans L. C., 1991, I J DIFF GEOM, V33, P635; Fiedler B, 2004, J DIFFER EQUATIONS, V205, P211, DOI [10.1016/j.jde.2004.02.012, 10.1016/j.ide.2004.02.012]; Fiedler B, 2006, ANN MAT PUR APPL, V185, pS259, DOI 10.1007/s10231-004-0145-1; Forcadel N, 2012, INTERFACE FREE BOUND, V14, P365, DOI 10.4171/IFB/285; Giga Y., 2006, MONOGRAPHS MATH, V99; Giga Y., 2002, ADV MATH SCI APPL, V12, P393; Giga Y, 2013, COMMUN PART DIFF EQ, V38, P199, DOI 10.1080/03605302.2012.739671; Goto S, 2008, INDIANA U MATH J, V57, P2571, DOI 10.1512/iumj.2008.57.3350; Guo JS, 2006, JPN J IND APPL MATH, V23, P1; Hirth J., 1968, THEORY DISLOCATIONS; Imai H, 1999, RAIRO-MATH MODEL NUM, V33, P797; Ishimura N, 1998, TOHOKU MATH J, V50, P197, DOI 10.2748/tmj/1178224973; Ishiwata T, 2014, DISCRETE CONT DYN-S, V7, P53, DOI 10.3934/dcdss.2014.7.53; Kobayashi R, 2010, AIP CONF PROC, V1270, P282, DOI 10.1063/1.3476232; Kublik C, 2013, J COMPUT PHYS, V247, P279, DOI 10.1016/j.jcp.2013.03.049; Oberman A, 2011, COMMUN MATH SCI, V9, P637; Ogiwara T, 2003, PUBL RES I MATH SCI, V39, P767, DOI 10.2977/prims/1145476046; Ohara M., 1973, MODELING CRYSTAL GRO; Ohtsuka T., GROWTH RATE CR UNPUB; Ohtsuka T, INACTIVE PAIR UNPUB; Ohtsuka T., 2003, ADV MATH SCI APPL, V13, P225; Protter M. H., 1967, MAXIMUM PRINCIPLES D; Schulze TP, 1999, PHYSICA D, V132, P520, DOI 10.1016/S0167-2789(99)00108-6; Sethian J. A., 1999, LEVEL SET METHODS FA; Smereka P, 2000, PHYSICA D, V138, P282, DOI 10.1016/S0167-2789(99)00216-X; Sunagawa I., 1982, GROWTH MECH SILICON, V7, P1; Tsai YHR, 2005, ACT NUMERIC, V14, P509, DOI 10.1017/S0962492904000273	39	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7474	1573-7691		J SCI COMPUT	J. Sci. Comput.	MAR	2015	62	3					831	874		10.1007/s10915-014-9877-2		44	Mathematics, Applied	Mathematics	CA5YH	WOS:000348984100009		
J	Murakami, Y; Uemura, K; Hashimoto, Y; Kondo, N; Nakagawa, N; Sasaki, H; Hatano, N; Kohmo, T; Sueda, T				Murakami, Yoshiaki; Uemura, Kenichiro; Hashimoto, Yasushi; Kondo, Naru; Nakagawa, Naoya; Sasaki, Hayato; Hatano, Naoto; Kohmo, Toshiaki; Sueda, Taijiro			Does Preoperative Biliary Drainage Compromise the Long-Term Survival of Patients With Pancreatic Head Carcinoma?	JOURNAL OF SURGICAL ONCOLOGY			English	Article						pancreatic head carcinoma; preoperative biliary drainage; endoscopic retrograde biliary drainage; percutaneous transhepatic biliary drainage; long-term survival	PLUS S-1 CHEMOTHERAPY; CATHETER TRACT RECURRENCE; OBSTRUCTIVE-JAUNDICE; SURGICAL RESECTION; DUCTAL ADENOCARCINOMA; PANCREATICODUODENECTOMY; CHOLANGIOCARCINOMA; COMPLICATIONS; DECOMPRESSION; MORBIDITY	Background and ObjectivesThe aim of this study was to determine the impact of preoperative biliary drainage (PBD) on long-term survival in patients with pancreatic head carcinoma after surgical resection. MethodsMedical records of 160 patients with pancreatic head carcinoma who underwent surgical resection were reviewed retrospectively. Clinicopathological parameters including long-term survival were compared between patients who did and did not undergo PBD. ResultsOverall survival of patients who underwent PBD (n=93) was significantly worse than that of patients who did not (n=67) by univariate analysis (P=0.030). However, multivariate analysis revealed that PBD was not an independent prognostic factor for overall survival (P=0.227). Patients who underwent percutaneous transhepatic biliary drainage (PTBD) had significantly worse survival than patients who underwent endoscopic retrograde biliary drainage (ERBD, P=0.038) and patients who did not undergo PBD (P=0.001). The rate of peritoneal recurrence in patients who underwent PTBD was significantly higher than that of patients who underwent ERBD (P=0.033) or patients who did not undergo PBD (P=0.034). ConclusionsPBD may not affect the long-term survival of patients with pancreatic head carcinoma if ERBD is used. J. Surg. Oncol. 2015 111:270-276. (c) 2014 Wiley Periodicals, Inc.	[Murakami, Yoshiaki; Uemura, Kenichiro; Hashimoto, Yasushi; Kondo, Naru; Nakagawa, Naoya; Sasaki, Hayato; Hatano, Naoto; Kohmo, Toshiaki; Sueda, Taijiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Hiroshima 7348551, Japan	Murakami, Y (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	mura777@hiroshima-u.ac.jp					Murakami Y, 2008, AM J SURG, V195, P757, DOI 10.1016/j.amjsurg.2007.04.018; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; GREVE JW, 1990, GASTROENTEROLOGY, V98, P478; Pisters PWT, 2001, ANN SURG, V234, P47, DOI 10.1097/00000658-200107000-00008; Murakami Y, 2013, J SURG ONCOL, V107, P414, DOI 10.1002/jso.23229; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Coates JM, 2009, ARCH SURG-CHICAGO, V144, P841, DOI 10.1001/archsurg.2009.152; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/01.SLA.0000018565.87010.B8; Hwang S, 2012, WORLD J SURG, V36, P379, DOI 10.1007/s00268-011-1364-4; Jagannath P, 2005, BRIT J SURG, V92, P356, DOI 10.1002/bjs.4864; Hodul P, 2003, AM J SURG, V186, P420, DOI 10.1016/j.amjsurg.2003.07.005; Eshuis WJ, 2010, ANN SURG, V252, P840, DOI 10.1097/SLA.0b013e3181fd36a2; Murakami Y, 2010, WORLD J SURG, V34, P1900, DOI 10.1007/s00268-010-0577-2; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Murakami Y, 2012, J SURG ONCOL, V106, P174, DOI 10.1002/jso.23068; Takahashi Y, 2010, BRIT J SURG, V97, P1860, DOI 10.1002/bjs.7228; Povoski SP, 1999, ANN SURG, V230, P131, DOI 10.1097/00000658-199908000-00001; DENNING DA, 1981, AM J SURG, V141, P61, DOI 10.1016/0002-9610(81)90013-1; GLENN F, 1962, ANN SURG, V156, P451, DOI 10.1097/00000658-196209000-00012; GUNDRY SR, 1984, ARCH SURG-CHICAGO, V119, P703; Heslin MJ, 1998, ARCH SURG-CHICAGO, V133, P149, DOI 10.1001/archsurg.133.2.149; Hirano S, 2014, J HEPATOBILIARY PANC, V21, P499; Kang MJ, 2013, WORLD J SURG, V37, P437, DOI 10.1007/s00268-012-1844-1; Marcus SG, 1998, J CLIN GASTROENTEROL, V26, P125, DOI 10.1097/00004836-199803000-00008; Martignoni ME, 2001, AM J SURG, V181, P52, DOI 10.1016/S0002-9610(00)00528-6; MILLER GA, 1983, AM J ROENTGENOL, V141, P561; Murakami Y, 2006, SURGERY, V140, P443; Murakami Y, 2008, J SURG ONCOL, V97, P205, DOI 10.1002/jso.20903; Murakami Y, 2009, J GASTROINTEST SURG, V13, P85, DOI 10.1007/s11605-008-0650-4; OSNES M, 1979, ARCH SURG-CHICAGO, V114, P862; Smith RA, 2008, ANN SURG ONCOL, V15, P3138, DOI 10.1245/s10434-008-0148-z; Sobin LH, 2010, INT UNION CANC UICC; Yoshida T, 1999, HEPATO-GASTROENTEROL, V46, P3274	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	MAR 1	2015	111	3					270	276		10.1002/jso.23797		7	Oncology; Surgery	Oncology; Surgery	CA2CR	WOS:000348717100005		
J	Hiroshima, Y; Maawy, AA; Katz, MHG; Fleming, JB; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Maawy, Ali A.; Katz, Matthew H. G.; Fleming, Jason B.; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Selective Efficacy of Zoledronic Acid on Metastasis in a Patient-Derived Orthotopic Xenograph (PDOX) Nude-Mouse Model of Human Pancreatic Cancer	JOURNAL OF SURGICAL ONCOLOGY			English	Article						pancreatic cancer; PDOX; orthotopic; nude mouse; zoledronic acid; gemcitabine; combination	FLUORESCENCE-GUIDED SURGERY; HUMAN COLON-CANCER; ANTI-CEA ANTIBODY; POTENTIAL TARGETS; IMAGING-SYSTEM; BREAST-CANCER; INTACT TISSUE; IN-VITRO; MICE; MACROPHAGES	Background and ObjectivesPatient-derived orthotopic xenograft (PDOX) nude-mouse models replicate the behavior of clinical cancer, including metastasis. The objective of the study was to determine the efficacy of zoledronic acid (ZA) on metastasis of a patient-derived orthotopic xenograft (PDOX) nude-mouse model of pancreatic cancer. MethodsIn the present study, we examined the efficacy of ZA on pancreatic cancer growth and metastasis in a PDOX nude-mouse model. ResultsZA monotherapy did not significantly suppress primary tumor growth. However, the primary tumor weight of gemcitabine (GEM) and combination GEM+ZA-treated mice was significantly decreased compared to the control group (GEM: P=0.003; GEM+ZA: P=0.002). The primary tumor weight of GEM+ZA-treated mice was significantly decreased compared to GEM-treated mice (P=0.016). The metastasis weight decreased in ZA- or GEM-treated mice compared to the control group (ZA: P=0.009; GEM: P=0.007. No metastasis was detected in combination GEM+ZA-treated mice compared to the control group (GEM+ZA; P=0.005). ConclusionsThe results of the present study indicate that ZA can selectively target metastasis in a pancreatic cancer PDOX model and that the combination of ZA and GEM should be evaluated clinically in the near future for this highly treatment-resistant disease. J. Surg. Oncol. 2015 111:311-315. (c) 2014 Wiley Periodicals, Inc.	[Hiroshima, Yukihiko; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hiroshima, Yukihiko; Maawy, Ali A.; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Endo, Itaru] Yokohama City Univ Grad Sch Med, Yokohama, Kanagawa, Japan; [Katz, Matthew H. G.; Fleming, Jason B.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Surg, Houston, TX 77030 USA	Bouvet, M (reprint author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu			National Cancer Institute [CA132971, CA142669]; JSPS KAKENHI [26830081, 26462070, 24592009]	Grant sponsor: National Cancer Institute; Grant numbers: CA132971, CA142669; Grant sponsor: JSPS KAKENHI; Grant numbers: 26830081, 26462070, 24592009.	Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Rietkotter E, 2013, ONCOTARGET, V4, P1449; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Menen RS, 2012, IN VIVO, V26, P565; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Garralda E, 2014, CLIN CANCER RES, V20, P2476, DOI 10.1158/1078-0432.CCR-13-3047; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; FURUKAWA T, 1993, CANCER RES, V53, P3070; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Bouvet M, 2000, AM J SURG, V180, P13, DOI 10.1016/S0002-9610(00)00405-0; Burris HA, 1997, J CLIN ONCOL, V15, P2403; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; FIDLER IJ, 1990, CANCER METAST REV, V9, P149, DOI 10.1007/BF00046341; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1993, ANTICANCER RES, V13, P283; FU XY, 1993, ANTICANCER RES, V13, P901; FURUKAWA T, 1993, CANCER RES, V53, P1204; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103382; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Märten Angela, 2007, J Immunother, V30, P370; Rogers TL, 2013, CELL ONCOL, V36, P505, DOI 10.1007/s13402-013-0156-2; Rogers TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-177; Sanford D. E., 2013, J CANC THER, V4, P797; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; WANG XO, 1992, INT J CANCER, V51, P992; Zhao M, 2012, CANCER SCI, V103, P58, DOI 10.1111/j.1349-7006.2011.02113.x	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	MAR 1	2015	111	3					311	315		10.1002/jso.23816		5	Oncology; Surgery	Oncology; Surgery	CA2CR	WOS:000348717100011		
